<SEC-DOCUMENT>0000064803-23-000016.txt : 20230503
<SEC-HEADER>0000064803-23-000016.hdr.sgml : 20230503
<ACCEPTANCE-DATETIME>20230503063846
ACCESSION NUMBER:		0000064803-23-000016
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		107
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230503
DATE AS OF CHANGE:		20230503

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		23881576

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cvs-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:a5201116-fa32-47d9-bf67-a4b1f9934cb7,g:676c592e-810f-43b8-9a45-1cf85e252b17,d:fc438c7598ac4033b496900bad31bcfa--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:cvs="http://www.cvshealth.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF8zLTEtMS0xLTIzMjU0Nw_9b281632-4622-4096-80db-32f411543a32">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF80LTEtMS0xLTIzMjU0Nw_6cd9f7d3-ab36-465b-bcc2-ce8980d22a23">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF81LTEtMS0xLTIzMjU0Nw_5e923756-312d-4633-870b-f58575adddde">2023</ix:nonNumeric><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF82LTEtMS0xLTIzMjU0Nw_283ade20-6b1b-466e-88cb-8d76a728f1a5">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF83LTEtMS0xLTIzMjU0Nw_8e687914-24e1-41ef-b352-bfef29d8166a">false</ix:nonNumeric><ix:nonNumeric contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0wLTEtMS0yMzI1NDc_112c1de1-6ac2-4f44-a85c-ce76b5723e12">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0wLTEtMS0yMzI1NDc_251d0c44-9e0d-4edc-a097-0115cf0f41fb">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_4a540ca2-c5a0-4370-9572-5e1f1b60ec25">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_effb7122-9853-4ffd-bc90-e0ef6a32ea42">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMjE5OTAyMzI1NzE0NQ_e6900be7-0b3a-4d0a-abd8-725b8e9077ce">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91b26ed1eaac4b94ac243c6f30365065_I20230426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1c4d4c6f963c4f73bc0cc280e69d641b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifcc0efcf324e4c67accd1041ac8b9ce1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28dec895582849b98979be68d4b8999a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4ff0943b4f746ffb566b7dab6c56ede_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i80e4bbee9f2f48ff8554d030ba033144_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i745cd9060f244c0591aa68a99e2834de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97beaa9151e94932b8318858d3577500_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0126d2a2d5b4cdd9ca3e3d805ece7c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d661cb6c0504a1fa9228d0757d805ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca8df10bb3e4ef68a134deb6f91845f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3a6802840048fbb777cb7cb063f606_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0919e504ed6344d68c00a6acaebcde05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a977074046f41a89c7f4a1f6b9bcc1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie33015c34edd4999b191485b67da92a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6966b4e2696f4a24ac2798c5d341762a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebd6ef7eeaab42469a4c1b85aecdbcbe_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ca517c88528406bb73b9e7287a1467b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icda684d607d94e4984c89b2b79d866e6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i607b6600b7634e74b9a25dba310ddfe6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14bff4dd44434085ac94c47f67cf0b94_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8a97180d2514a9b93e7596cf96be425_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18f0bf58dc2749449f2f66468faccce3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6bfce6ac5f8468eb136aac914a9ef04_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i500c40e14a1143a3aa4e9627c448de62_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic92b2e37d0234aa2aee969f6ead4b607_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91059cc4e3514c71825e73b0a7423eba_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44ee7f171b49433c9fee60c78374b031_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc256cbbfdbe4919bd580b89b5853b65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5d7bc6153ed403bbf10a74c29ce4dc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8a735ca1fa940769d12496008f05980_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i769f64156cf4441d9b8d63169d946693_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1ee5670de504ce3adee519f2e40ffd2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af24bdfc747494e8034faa02222d96f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8177aa632cf4772aa7e3d0690fab4e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1236f0a166354cc7b555200e4c10809a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ec450630a5482c819c7ba9bb97985e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaaa42d004654ea98904e4011dbecabb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ae773548b24dbf955bf39d91ac8fa8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c46457ec075463b998b7704930f1527_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia04b5afab2af4259b71dabfaa547a322_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87e905aad04499185592c649df0501d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76890c43bde24648bc18aa2102227d8d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ffe2b44a55945b284180e30309e8aad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68525f7e800f4c59b752a9f19135d07d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4688929cda745bb98a6c1e716bcf78d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75183c2d4ace4f5787e50b8f1271e1f7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea2fdd12e3c9442ebce0208dc0b9d3a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c83419b19394b2b9e56453a8077baa2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19ac4c954a3448a8ad572bcd89c79da_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e44e45d682450d8e8f9d28b40f3de4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34ba550f20da42bf8e118610bd9d1e54_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:context id="i6efe121123d64cc4871d92d64ebb6df8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="people"><xbrli:measure>cvs:people</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:context id="i9b1e8e047ca74e2da7465cdbe0294566_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i4ef8067610324631a99b73d483b1c819_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:context id="i686abe201e9f4a07bc66c9a037f0de35_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i477ed67917444c06928e6bdfe4442b96_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibadef73562a5415eb23fb67f37c780fa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifad147213d8945ffa73f99ae94585db9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07754849794b4b5a972e925beaa2e2d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83fccfbc3a1e442bbaec480edae8a85b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9c868143b7940b3b6159cc722b2c499_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70419a8aec904963b0fc2149a92a6feb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3b7119cdf445b286ff5a2b3bba733c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i913d7229910442739c4ca1921c7d8667_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c623b94ee8462ebc5e118b823a3e98_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b014ab5cfd341f7ae8d078ed0c475f0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7faa0d9a8c2d46d9a7fd1311b46dda78_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a3448fe5bcb4de789f0540bb778b942_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fde3795c73045aca5218db1a3bf0627_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f01a502bc824fe1bcb34881c372163e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ed4956174e64851ad6fceaaf2191dc6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d66e496f5549518e1bb751fee97f54_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af16b8edb9d4671b5a7ce811f1e9a3e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i074bb083281146a4814aa0c3ac130d88_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic730a4294079499a823806ec14836c28_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e959c8f50844bdc9d92aa231cd7d852_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a5b5bb1e9dd42a2aa9b210432135329_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i150b57bf1a274deead0798dbcbbc2bab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e9712c1179476e90472386d3884dae_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21838ca5480d43e99c84c865f63fae2a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b6e52d861e413ca3dcbe8cf24ddbe8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2726cf35a1549a39f68c6d870831a3a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6726b8f30277400383f48e1c4916b2ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d9bf2d1bfaf4038bee28037421646dc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1599d39404424e269c1dd6dd7a2f8beb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5217fa8bc5cb48358a723612bde7d479_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i003831bfd1e24cfc94e47ab4156fd856_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib416aea626f043fd9431aa5342e2b4c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19d1a8e74194a419ec6e6349cf88ae9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea8ab3ccda94b4fb2323193afbc272e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib60d284b94f343769d7fb6d50fda05c9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb268de0eb0840c6ad11a4d9d30093e4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i834cc79324ef46228461e0711bc261e1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5614313bb744e009682b28fbc6584fc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d1785a62b574847bd8bd9762c88ad05_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8416ff007f2346618a642e998ffbde5f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea625c13b80a41a38461b27d7dc98167_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d2ab9d4f54a4545aa1a48d8fcffe4a3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33693ee297b14cd1b0fd9a47d4d4f880_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd51d95f7ef41039d8cfa9e1d363b8f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe185f8b39742e6bf6fc4a03b2c1cec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ided2d67f45094a79a717c8cee0eb96d0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie000fac120824472bf6fbd96bd370915_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i108159c26e0d4ad68b98ccf1c5e9a35f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d1376e4b4e47bc99fff3a44a2e7122_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if04e21b8463b4e6eb6cb2ca6a5197ca2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i177844ba7569439393b0dd8b1f8727ff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29b95f23f2f4497e8f422c459c2ad25c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20a226c3f2ff49e2848ef2bd802993fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcbcab26d09246a984f88af308a36bde_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f7b0dd6afc04d5fb6dec0b03362681a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dbfb3606fe14686af2486fd20b1659d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b9544478beb4979bd59c64b69d4a6a1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5bb2b68e6b044e298527de5f04d708d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d3ac659a2774583871cc2f66cd8f09e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a6ae917fc994efda306a7228aff6320_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd36720f2ede47418003c3eca8540ff9_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201812Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id410b8ee1a2f45edad8defa2042f4b1b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb57f57ab4aa4756834cf154419fa446_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d3bb136a1f4e01a755060f96bc46f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9884f3d8910649048241aa4449af5b47_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04e56abae24c4188a3a7c997d9c465c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a54fdeeb3e044288d6c4a1818ab4dee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42eb8ce2ba0b4cf0bf9748577c25dae5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81d253afd2a9475db0569365a548c9c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i649b9f03c30f4132b55105d20f98cd1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i977993d8848741e6a20cfa0d2b47e0ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59381ee9dfea4532add1e4bb94d27155_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b1cc55a9704aeea04b6939f5195e76_I20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1bc1e1b3223b4f1cb3c91d8f034eb45b_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">cvs:PreCombinationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d0721ccf873491b96d1a9065be7d6f9_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">cvs:PostCombinationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd3ba4757bbe45faaadd9ba0c14cda5a_I20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5520b236fefd42c6ac7b83e8db7d39d0_I20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib28b96b93836450fbebf6c84e59a6a20_I20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4af840426f5742b98ce7a573b0ca84b1_I20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfddb8845ccc4274844fac816ac10c32_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic82fb46fef07440d83a4d87da8d741a2_I20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida41df4f3f8347ed801d55304618efc9_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fb2931d2f6141989e86bc6f9e479fa5_I20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a52af93ed8c4145bf21e078f72a0933_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46c86ba47653492db774e9e6bbe191b4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i839190f328204596bd4e7f2b5c29b42b_I20230502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc946f669dc44ab69a194363c6a5ce91_D20230502-20230502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f8c4df47be4b3bb9037e0c92c557ba_D20230501-20230501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i327cce141c0e4abb8b30e48daa9e4ec1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0debc62e945846f3839159ee0a6f9a4d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb07919adac2412abcdc705eb562b3c7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327aba17f5014740927f4d6f30982b5d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id164ef0f52604d3090071179b7c674e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i867b324806204e6a8e1477d0e3cb2fc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb893d91703146878373e8b9e7346cb8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e08e1c1bd8548999900b632892e8ecb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b1e23607d9b4a6091501bbce5031d11_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic36a1c6051fe46d29e86c02619938c15_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d0df874b4644f05949c4d3711ac6210_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic991c189663c4129a0fde857c5cebba3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfd177924cc3495f977df5f06e848f4a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee54db0edd84b02b83911d676d2521a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03a42f31cb6c4a84bff5f04071d84127_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4256325af2f4601ba2bc2b417b0cc41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3433e18f57964e288d423f861ddf29db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb3983d4da1c4a63b445b21520061727_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if70be69bf99746f0b1a2639e28853784_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2657b2a0824346879b134134d44a0a15_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2114bac1bd054f9bbf533d596e9ab742_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="i8ff23176b1c647b08e43d79fec054b16_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab2edb2f7584b39b2e4c10c2b4cf2bd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514f278578014b3ea9214b4c5b8aa393_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i220d86c07d6f4153933adc26fb1b8c40_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11f7f0a3fb574018bd69ea4301436dc8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c66f45a22194ea1bd25a835ded92b94_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c46b634040b42af82927fa3b3a9c69e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7071e99aae74c26818ee4fc1078006f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f338d30818a45c8b71f0f0dbd66b6d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61edd147d4fd41509a556db54902c84c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36bbbfa3da2b4326bc60719fa6fd45ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib52a1527e7b349ec89e29f3f0ba90ad4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71d3db81712f4239be8f0051d1d897a8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie97b341035254171803036112d834dc3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf9687fc8f6c4d6db21b6785089b7e8f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfdc0c8d72f342cb92f5fc2b1a42d622_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64f1950f0b744460b168ac0882235a7a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68d8282968274787bf68cd11594aa0c5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if11186980b9e4cf698fbb8587274f2dd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3bda5d9087a4425bd1f312345cf6dcb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26be39686ba45b1acebc43952d4c3e3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied1ab1eca1634f0698b6d31cd0ccd36a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ae3ae19a3841afaf0cd279b4c39bbe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56aa2cf3462544d8979682eaef70c07f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i539fd33dac17452e8380f33c7328399a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2310718e6df44f9ba6d23f2c10ce4f28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a0c27fd53e74ac09581adda8572f037_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd736e093284b1f90094c25759f3a5d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4a7c42e398848ce8ae91911c305983e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d25dd9c66fa49e183749b9de751d7ac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcaa27ca17db4c80894a80bd3c652fd5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d38be3dbd9f47b1a656a54014fe335e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a81db5279004ab98255bc257a8b932a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddee2adad35a4a8192069f6cafdf1201_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ccefd85418d453d9737f46e41f5fb23_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfed1454e7274af982d6b45ba703168a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57fe3eeb911349678a7bf8df45f05778_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e26089b884345fc8d7fc1a31ebe1941_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdbe7e2001e5451395afcf0f04039747_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbcc5f5ebbc94676a14ee20dd1d88ee3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d3af566c97447eb29044226498a483_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a07081ff1e147c7b62955fae3341f9c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc787c3d87de4e529b1a1214d25dd219_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42cb4a9358d245a9b06a8c263fbba453_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i639de7dfa3ed4105824a383022ae604b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e3d483e0784d668c5fcccc53c0c0c4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27fd2cc36f7841a7931db67ed478f1d4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i925fade534304e14aa08d9d00d456adc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f043b01d8c84596bf6c16f669ae0033_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f1f3e2b054b410ebbfba28ae8d5bf9c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb7b70ddd11a47b5b376a5b3fbcfc34a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbb066670e8741e7b46db0c89fb8f532_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c073aee648d483b8b99e031c637e88d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i785a7204a25949809c4a78f9d83a56fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4727e084447d41309188d3fa8292bd52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9145c1132d8f4904bd34c706c2b8da19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib210e2369b7443789e3ea95a893fa4a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i388162eb095246c8ae3b452b6fb6d79d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30017e91965849e3b86010cef96f9638_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6302cce667044a7c840558fd40b16281_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7156bae6dfd14a4c86bad30abbbff44b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd294f5249d4543b203a1badf1bd045_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d2723b92ac44880b50abda5a89b505e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47b68ae2c1f64fd19f95c3e5bd640eb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9e6f409f64046f1a01d80570a92c6dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a992fa5adc941b1a529b3cf351ef331_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc1567be7a7f4866ad74e7c9bc298305_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i001598a6451343debc1eff9c7e4e32c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2962e842fe1042c48b78d2a92f8ba363_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63617743472146bca1ddf9b17d4cd4c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd1a57a9ec4148a9907fb88d8b662710_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i913e95c8d14844cab43aae1b5ee9d5d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b1894678fde443f82f89be4a6696366_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8265c25c9ead4bd99cf15809d148a000_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb917855ecff45e8a8e787e07790f532_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec14ebc629645989483a19e0343e21c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88836880a6c74131ab0d5e56774644d3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b7647c520143b2b49538ae9a39be8e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ebc837ea9594ee285981ba3f282c096_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dbe5953d7534e6b8caf8d57ca5ede7b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13296d918c654fd9985778c3de5b1aeb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e6a6329197e4602bc28dcb00294a999_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbcb7186ed06424e99a7e02812bf766d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2cc79aa32c24877bb38fed7bb662b80_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i940d96b554da411a9cba8e0f8ac4b3f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibccf07ea07e5473386720165a8d80e66_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f12a0b1caec43ed8a5cff4d6a9e3476_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfa4161feae48dab889801774d4b2e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f3cbe1cfcb4a5f9a47d208546e9394_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1af15065f24c48d597eeba3d21822866_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i018e0921466c4187bd61ec7f759a162b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c8746221ad488b9529c5494d1ea6ec_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa81968af7b42edb313c43eed5dac3b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13000e7829fd4c77a7fd14783d62bd3f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff376ec3f339421eb5832e29861ce655_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a515693d5ce41788531f520d6f67ec0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie41a3c6e1c99451a98b32769c140d8ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1fb2239301f45369894d81b5bef30af_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ddde48bac0413a905db67674a8e7bd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i638494ab1b4746019b02aed9c1bf8d9c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4104a3224bf9493180199848515bb756_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bfdfa7a6f4b458dbd8ae201cba1db28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e4d1e5638a949eeaec6c1e059aa2887_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b1abdb4a43b4e52a6d8356ebe217244_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e5e884e58f40ecb2c2247c7abe2f3e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic203ee5d324b425a8a68bfeed0a05433_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id123001a7f8d495091ca8cf8640c1149_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae365fa794744d8889721900ea6b2235_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c5c14abc11642c596325a01b162322f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d88303b2f434c308ad61792e9ee3b36_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie608b61ad1604ca986c8862e56a56332_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86995cf6b1d84d179178e116a1a20f11_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6cd9790208a42bea5215d04c5eb3401_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bc5a5cd534c4f698abae8407f367bcb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54953c6cd4614dc1ab7325d790cf34e5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d69ccacd09d405b9d774c898769ad31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f28276f9544efdb371f2ddf105d27b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e915bd1e3b34f25ae6de550809d67f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e187738c64a4f819165a5dd65b86de2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb701bf9661948ebac5ec92842c42cd1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20104417b40c467083117d2e267a0d8d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38b061f9764a45d58ce926b44ad26d44_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c1a5f7cda7b418fb2105151c6cebdd9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac657fdf5ab45fdbf03530b75c2f55a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i442caee6095c4be4950552f634b6d7a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e51a45df88d476ab23a4e8b55ec1e22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie42c87aeb9a142048b4d45e04a53dabf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58584562df924c35a92246868059ade9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i180e642f281a4428bccbf1a1d28a4863_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96a5d0edeea40438700b57fea0592cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66a3623a5b404531b6aaf3bc4355290f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9130e432ea74b33b7edc370ab5d3ac3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d5e7a806a404590beb00542a88de708_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a0a094fa23b4862beaf7cd2379edd3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9302529dcf26467bbd2db62d902d4ad9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c7d300ceec143fb95566216335aac05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic966dffda67f45128f343cfed0076de3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dadf84326ee476a8256a97b1954777b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e69bfca3ac4909baeee8e3bb375ac6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e7e9cfafd4471d888f09553e3a8397_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i711edb971fdc4948ae77077c034cd4f3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05330bee1a9f44669bc7deddcd19520f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d6560e9fbc4acf849607bd7a325af1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367940a0c0de44c9bc97abafd36441db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b59adf13cdf461f9fe4939c39d5a82f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db4636fab2045e79a50da511dac639e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib837b245fbf5401cab8f7e03d387b150_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c3faf213d24ed792c56ec2ff526497_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152425578ab245479d4240084913937c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d385b28a05d4c32befb019eea226fb0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i174f156a210a439ca784589516304147_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a8530e6bd584994b387406e0a034c9f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id949c9b2b95046068211c24d3d40a4e2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b279c3a46845edac9bcef54ebf51b5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9580fad210c4bd8811feeca4fa82016_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3ce116f77d4736ad8797c395b90826_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1530c22fff264f3083979c2e12ffcde9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35bd935f9c8045c1baaeabbec9492fe0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cf824a61ec042a2b9b0f1108219276e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd3f75c2d0b04f1e92ad90c558bfb862_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9216a5f76034bf488b5c23d00f7740f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0477daecdf25494cb2366e0b03619181_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73f84be43c284e9ea81738a715edabe2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6db07e1d8d6441eace2fba24d4330f2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1683e51a0304fd1b7b78196b6cd714f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd649305f8964805951ac2c94e102d7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie82772095666435b8c2ba849a5d87d24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i243d234bfce84d389bc036ddb4b85c74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2391cba71e9345508d7ce650a306647c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63539f261c8e469cb1db341cc5be5d7e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e7cab3f0f04b0f9ce8ce12e0f930f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ecb5c351dba4689987a3a609b0cfb43_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i767908569cc8444db0b335059e1f47f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42367ec111444b5db6d88802bba1dba7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01151808097d494ea4b5cc15684dc01a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64dbb0605566455397f86d75767eabfe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e5aacbdfc34e248dd6ad1cabff65bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f67171bf8fe46e184c0ac18933c3013_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie30887d94add43ff8de3f123add67684_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963eadfc020e4b0bb4c52e215959124d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3739f888e9fa4ab18bf2d985de27fe27_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d351d5ac104a9383183f6130aa4991_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2651627654ef4f4c91f509c8eb1bb477_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a146d6f9c44eb0987d661df9a8f498_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0dca12fc0564290869461416690d5fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8903f0df33854a12b5260ff32cb9efff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf917e365bae42a0b79ce78cefbe94e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791de71b848e4eaab8372e1b5f61e096_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ddedc311f014abe8cb88591cd05edb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8eb0165ec524ac69eafcbce65d1384d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a92f64233d34b92b691ec5e6b31bc87_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6451d539af494cc08958d87d42063dd5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d919deafdff42c08b18845673c9987c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id68cb38e243a4c0589c5dc10a30a7ad0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0643f3ad93414fdb8de5a7dd49b4a6f3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4056481f5b44ae287fa3901ab72f3a3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b28e0a23a584695a4622d30105683e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i180077daf73946ae866928c89b89e292_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68a2a42d2c314267a6ba9a48f7231396_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie123d33508a44c209de9379671362b7f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i452ce3dfebd34199a05e64ce393bc4c8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifacd64ecac6a4aac953d15d34d578d88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86c5d299901045239a89b149c86fc62b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if83a48cee9f5421f959a40efc914a409_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i662502d2b9824d468b5ea7e46559f0d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if223ef4f1cb04f89aaed72f66b1ea655_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6045cebcc054f359aeda689be7966b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdba47c662a241d796fcf13177996678_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a9e113db05c4437a869964daf990132_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7df477b572d04891896d991e4831089e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6116e07db6564d4bbfa404e6b3bb00a2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee90579e8a1b4b1da229e849035d343d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic932276a2f124dba92225829473c58a6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0b686b402cc4958a97490b22451eac1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia094aa9bc0e247adbf9401a23f3358a1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b3614b59a37444c9c0ce65c076cc76b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55ff9d813bee44a0965aa5d87884e5ff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d86193e1b54a5cb7daa5b1dc397607_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903d499b0d9b49e49eaa2a9bb04df017_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8213443c893d488d8dac56b4a243aa90_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e609944ebb4c7abcd29efc5ac7a42a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fdf4d6af289497db86f4e1ef5b01c5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47a06c42b0d441a9bffe6e38635b3abb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec5f2382c744b1386a167b07243b1ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1389fe77fa0245a3b7288b5f5b6fd60a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8195e760c0664b8ebc5acf22c0705628_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4e614b3ac4b4f9b8791bb6db2978b36_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6084b97edd8d4f4fbf531a21307abe4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e7e4e1aac0e46b59b1c064b844b1068_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ee3f756fd384578983ede98c5a0fc5c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18c1afd8891d4f5c94b81a067731189a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bca211743f44200bcddc914732f3f5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63f3531d3fe74d638d45ecfa6b71c325_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11ee92e3968142fc8a1f00b97f55b501_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c5c27de38b4adb9c680fe62498e820_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53af89ad853e4e88a7223062ff9de426_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5be82f9aa84b8f82e19cbbd50d5017_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes50DueFebruary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93656a700a24e76938502046d84db62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes50DueFebruary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7f76b8c0b544a3a59704c58a83c665_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic060d61cd4084e17b433a1b12fa6cd89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide95dae98a2245b1acb066495f097ca2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i858a0f59e1c349d6b9a6c24cbe1894b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb777320df5b48f797263822df4f0e9d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic312216e7bc34f27ae9ab07c90920b49_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7bf61a5560341df80eaf86640920cf8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i619ee922ba3248eabc18dc25aa73b06f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cdf17416ddc41a6b3022410dc3d2705_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31b29cbacf5446fdac7dcf2a511e8029_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d28f166a4b43a397fdfaabad32194b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i061715fa0d744784ba4cc2d892ac4b03_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38635e749f46407a80cdf7fc2ea4d372_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84a442e85b6e4b94a98823c08df1f043_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b311c6d410f4978bd5331eecaecaa64_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5125DueFebruary2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f0e5fbb301a40e6827651a423c2292d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5125DueFebruary2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6eb4e9251184548a1634972c55a28d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i529f1b8b3f1f4b42b2e5446768b8e87e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie07bdea3da6f451c9bcba9f549201961_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i175bb047294f462da1aa8e1333b6d0ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a02874bdf04d5b9a706cad560999ac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8c414c1efc476fa3e1e6d77efcaa3e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41089ddd19eb470282adb9570456e08e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63f6643ec5754faebede440568434de3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8700d2108e4ab496a24690db04dcf2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes525DueFebruary2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib41b9178e08b45cb91563f0883c36a2a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes525DueFebruary2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45cd1f1f6e8b4f41986ce9a7b9e9e696_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b01afccbbf34ad4a1781cb89df8712b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fac5abf1e74d54a53dc666fcc47f4d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792622491465439c87c4cca105f8d743_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5ddad65b5b4fecb1c2c210aba362c8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97a596cb57ed46fab4eba2c7de95bc00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9459ad3944423592e566ee3f8a9f55_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e871c110bd4599ada469473b42a2e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd1bc3205234dbc80620f09b4404f44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78517656fb3e4be49efce58b458d7215_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i780cead0663d47e985eb7cde37891351_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39881b60def4677ad68de30d76d707e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5934de2b48064b68824f5a5e12dbbb82_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i245129fe18fc45cdadddd2c037c1005c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib080a75dab51499e8152c514ed6ab74c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i444c1838f8c64b14a5caef64a8ccd662_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd7de97cfdf412381d46297d5991484_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if350f271cef34debb54ac8e3ae82abe9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c4d09214db040b5b5740899c41892e6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8122b6f5dd094913857934bb5ac9998a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e903c49671d4c7bb899e91247869f60_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791829c941b64e9cb8aac4352fd31278_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48586d4589464091a486da7ecff7be86_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a52fb5322d941878151c5480cdcb452_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib95efcc5698746f887d004c6b539186f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife5a3762af674b319552867bf484df1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id09a1af1b14f4dedb5552601fe0a898b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fc72c0ca3044aefa6c543e50d9f5073_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a9a69c0387a4dbb9cba44bbcb236d31_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad107da7cf74913a7fb43e2fa78c217_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i855756e5c4f640c09e72c199fabc5c3e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38b6295bbdec46108d23d6648619dc7d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i089e716c693541d38cbcfc0f339c6165_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5625DueFebruary2053Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i061610d07ab54236a1e052f4440a4b61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5625DueFebruary2053Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i765e8c9bf1514d37b538d56d98f8673d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843857ee2e25408ba0949fae0a27ddc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93ceac7923443509811589be6f2fda6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825b614ae6f949128593ec129680423e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57dc9b642fb340ec9fbef3cdb67f4dc4_I20230501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:TermLoanAgreement364DayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84cea09dba14f6bb1e7a65458f7d779_D20230502-20230502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:TermLoanAgreement364DayMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f22263a3b694849ac61d1b0059ba4c0_I20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes50DueFebruary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3088c2dbfe5d4a469e09d45deecf17d4_I20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5125DueFebruary2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i466f42736e3c44f8a5bb7b033dc6dcc0_I20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes525DueFebruary2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96c354a2d55441de977ed5f9a4c0d071_I20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5625DueFebruary2053Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i409ce543d75747f6a86747b1e3200724_D20230221-20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-21</xbrli:startDate><xbrli:endDate>2023-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d3f405559b34436a7dd9bda0df240e1_I20221117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33e778ae14014217b9adbc2e50448ccd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b66500cbc3494cbb2171885f5e9eaf_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8259b9e69e843db9bea20eeb8e3c4e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9b17aee558d466d97018672fae58058_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i220c5401ed2f49ac8453e559cfa0869a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic891f32373a24150b07a0e2e79451ecf_I20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i356ddbd8c27d4b8c951a6be4585f1092_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82104008040f4e91b57c7a3d066cd708_I20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i165725ae3ea04060af45b3a4c66096f0_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb54f39d1c8482b9e757ee875b765cb_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice6b8f5b6cc749a6a4fce5808629a093_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f99461356ba4ce58d8b75de3a097310_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1e6b8b47724b91aaf561c27d054b14_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e4ce7d668647199a9963ba9223fb1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cee30098f554ffc83dd60ace24f2da1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b0bf32f4024d9a901bb71692e6457b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia973432534304c319e71bd7ba226880a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50bde2997fe64d2fa6e63680de08d727_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e3b16b861e34693a440d9cbeb7ff083_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ce902132c444a37ae7bef2d65504f51_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf12a3d04a2473399581bc3408cd6bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2a52a92c5c54930b5139ac668af203b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e51eab27f6049da87e49ecefc750401_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b73ef515fa74bda9625d4853a2c40af_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc48e18e68b24845a7b17fbee590d05e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4233cdd857c84c5495036af966d69c1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69ec3798d5e44b4d9eec0a23d4f9102b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbaec47994724954be26c44f88b1be41_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5349061ce37a4635b17c190c002a1781_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c1adaa533e24a38b010ac1f6be0ca13_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib634cfe740504bac99546a361cf5b67c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8471dc1ae7b4c3ea316bf53d8400d96_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37a9e3c8866a4ad8be85672e565cf864_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e7ed44250004f0abd93cfd873764497_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80edf5a59a3b4b4cbde630d40e6cf394_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a2ced1961f54c58a58691eb07a37938_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d62eb54342479d9c8f667ab299427d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd2694bab621470b83d6016dd198125c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e064e345951488e83346591a86aa59e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i428c873482a54c03a2844bcfd0128950_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ecd33b2f0d4bf79158216e8e771219_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506d0959bcbe41b386b645d218ba7cad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b89e03562af42418df598d66e518fc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2abc6620160466c96132f7287192b1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d618aaf5d4485a9bcc280348fd703a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a84c750be7040c4995da886f9ea1771_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9431e6a492f4c89b178b2b1528cc6f0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fb588d338ae42bcbcfae34f3bc52d4b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic10b551416e249919ddba15b607f1f4c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i578b2414d82040be9c8f73746252c42e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb438f2d815843dcbab2c539cffbd7ad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>cvs:lease</xbrli:measure></xbrli:unit><xbrli:context id="i834bdaa838194915943ae1dd41b66214_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30f76719657045dc97c61d48649aabd8_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73c2c711a9e144129bf8bcee89201591_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if91f496db0cd4ebeb4308b49828714b9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef4e0c2d2c244c393a5cfcced1e4a15_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie999f8648a0f440188249767603b220a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0692ab80d568422b875c73998e65a989_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27b20e43185e4a60b4de68bbfd17424a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cvs:claim</xbrli:measure></xbrli:unit><xbrli:context id="i43eb35c724574445b70e64a0712e5fd0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6c819332a1f49149907bd79dbb6e5ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea3c803bd92470ca456a8cbd46b65d7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id46d76788ff04d0c89d679c03b4d8113_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b33e78be95e46aa8781e4f5cd708b7b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icceee7f19d8144d1838edd528b32a625_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id25124c88573450f860bbc033280cab3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72d3de15fdb141208e8be43677f48e7a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf51c4d778d74146836a38c29f6f5806_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8949cbfc8744ae59620e133dc98603d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f5c687add1743e5809d22a9d77525eb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5a711f48e1345a19a731927269c49cc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73dedc2c29fd4e33a88a7a1d2a1957db_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b32d6ef57d9481e855325b36afb4145_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eef6ef05c314ac8991556b8d8d5dd5e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i832630f4a1134a15bb6da5125d24a7d0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i153b35e7e97042bb9c9cb483ab1d7c90_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS01LTEtMS0yMzI1NDc_60714424-be32-4073-9ab4-938d817d7181 id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNS0xLTEtMjMyNTQ3_346a8441-b914-40c1-b85c-35d5bc62cd0c id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0yLTEtMS0yMzI1NDc_c4b41d6b-e368-44ff-af4a-a3036171ac0b id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMi0xLTEtMjMzOTQz_fdcec20a-0da2-4cba-a702-049f79ca14bf id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0yLTEtMS0yMzI1NDc_6c050194-16c0-477f-9fb5-b8d19017455a id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNS0xLTEtMjMzOTQz_45f485e3-9b46-4c82-8d3e-9d058ed4b98a id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMi0xLTEtMjMzOTQz_55cc909c-b93b-412d-b0f0-4aa7a02e4690 id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMi0xLTEtMjMzOTQz_4ddd1924-457b-4a04-9c51-c099d307ce1f id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtNS0xLTEtMjMzOTQz_076ae2ba-235c-4cf0-8ff1-3b73daa62000 id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNS0xLTEtMjMzOTQz_6499dc29-8bea-4f59-bb31-f6b0fc576c54 id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS01LTEtMS0yMzI1NDc_c54fad51-69a2-43bb-97b9-e8c59b2e1614 id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMi0xLTEtMjMyNTQ3_bac58b12-1fef-43ba-9745-c0d784911361" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjc5ODE0_835d5494-8d96-4df1-89c5-db14d9bd351c id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjc5ODE0_2aeead0b-ce92-4b84-b456-8a22a76d1c5d id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNi0xLTEtMjc5ODE0_e9b07a15-ac08-413e-805f-2b66fd5510a8 id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTI3OTgxNA_2ae192ea-b3ef-4e45-8040-5fa42904c6d3" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctNC0xLTEtMjMzOTQz_e4aa5458-f5dc-47fc-8f5c-4dba67141cac id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNC0xLTEtMjMyNTQ3_68f228d6-24ee-4fb5-982a-a6c3d0e74abb id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC00LTEtMS0yMzI1NDc_9308e9cc-7702-426d-abe9-b51cbf5ec8ee id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNC0xLTEtMjMzOTQz_40ae901a-05df-4b91-86cd-5b3d8a1815e0 id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS00LTEtMS0yMzI1NDc_ca4b0262-df78-433e-bef7-8786581d587d id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNC0xLTEtMjMzOTQz_b9c39463-580f-4dd6-9019-a7a4fd5ac7f9" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ifc438c7598ac4033b496900bad31bcfa_1"></div><div style="min-height:22.5pt;width:100%"><div style="padding-left:101.25pt;padding-right:101.25pt;text-align:center;text-indent:-184.5pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV84Ng_2e45f684-5f70-4141-b933-6c3ec8fee55d">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI2_f7ae20f9-4c5b-4560-9588-21686e98d15c">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMjQ_1d70c69d-ee0a-47ce-b09b-85790d289e4e">March&#160;31, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI3_1e8d33be-4a36-4f8d-857b-0f2d1fae1f5e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________ to_________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI4_8e54eb90-d670-4020-918c-3a7b8b386801">001-01011</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="cvs-20230331_g1.jpg" alt="cvshealtha39.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:104px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI5_b9417f6e-d037-4369-973a-f96bdc8854c3">CVS HEALTH CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6NzBkZTA0NGU1NDE2NGFjNTg5YzFkOGIzOWJmN2E4ZGMvdGFibGVyYW5nZTo3MGRlMDQ0ZTU0MTY0YWM1ODljMWQ4YjM5YmY3YThkY18wLTAtMS0xLTIzMjU0Nw_5f04f0c7-7a58-4b7a-af67-dd78cc93888a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6NzBkZTA0NGU1NDE2NGFjNTg5YzFkOGIzOWJmN2E4ZGMvdGFibGVyYW5nZTo3MGRlMDQ0ZTU0MTY0YWM1ODljMWQ4YjM5YmY3YThkY18wLTItMS0xLTIzMjU0Nw_a00c147c-0dde-4c83-9f8a-8ba417c6c171">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:4.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTEtMS0xLTIzMjU0Nw_afeac430-cfed-4a03-86bd-464b8f9afb80">One CVS Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTItMS0xLTIzMjU0Nw_0700b350-734a-4538-b955-185b9c5698d7">Woonsocket,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTMtMS0xLTIzMjU0Nw_89e82fd8-7f29-42a5-b75f-5b6c7a2c1e4c">Rhode Island</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTUtMS0xLTIzMjU0Nw_4d39f74e-4581-4dd4-95ea-2eb96b14a433">02895</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Zip Code)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code: &#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8zLTUtMS0xLTIzMjU0Nw_38516939-c3b9-4ae3-9a74-838879a1d5ee">(401)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8zLTYtMS0xLTIzMjU0Nw_3f3d4e75-f1a3-4930-ba51-86dc8817dc0c">765-1500</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former name, former address and former fiscal year, if changed since last report:</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></div></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZWY4NTAxNGUzMTEwNDA5ZDk2NDdjMTcwM2VmYTIyMmYvdGFibGVyYW5nZTplZjg1MDE0ZTMxMTA0MDlkOTY0N2MxNzAzZWZhMjIyZl8xLTAtMS0xLTIzMjU0Nw_1754c9c8-9b89-4515-97b2-ff8f3fb1ff3d">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZWY4NTAxNGUzMTEwNDA5ZDk2NDdjMTcwM2VmYTIyMmYvdGFibGVyYW5nZTplZjg1MDE0ZTMxMTA0MDlkOTY0N2MxNzAzZWZhMjIyZl8xLTEtMS0xLTIzMjU0Nw_cc9212b5-ef87-493a-8e94-63560c250718">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZWY4NTAxNGUzMTEwNDA5ZDk2NDdjMTcwM2VmYTIyMmYvdGFibGVyYW5nZTplZjg1MDE0ZTMxMTA0MDlkOTY0N2MxNzAzZWZhMjIyZl8xLTItMS0xLTIzMjU0Nw_055de72b-d94e-4848-bf34-bc749d9bfd81">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                            </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDMw_e2fb1289-d7e5-4f55-b45d-ecfc565dcd38">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                                                               &#160;&#160;&#160;&#160;                  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDMx_8e9b9a61-e248-4209-ae64-fab022ff0448">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZTMwYjMyZGFiYTkzNGNjZGI3ODIwMzk1NWFhMWI4NDAvdGFibGVyYW5nZTplMzBiMzJkYWJhOTM0Y2NkYjc4MjAzOTU1YWExYjg0MF8wLTAtMS0xLTIzMjU0Nw_1e8a2a3a-344c-46f0-9e35-421506efd24f">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer                     </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZTMwYjMyZGFiYTkzNGNjZGI3ODIwMzk1NWFhMWI4NDAvdGFibGVyYW5nZTplMzBiMzJkYWJhOTM0Y2NkYjc4MjAzOTU1YWExYjg0MF8xLTMtMS0xLTIzMjU0Nw_ee241baf-7eaf-4d4f-95a4-793e87ce4107">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZTMwYjMyZGFiYTkzNGNjZGI3ODIwMzk1NWFhMWI4NDAvdGFibGVyYW5nZTplMzBiMzJkYWJhOTM0Y2NkYjc4MjAzOTU1YWExYjg0MF8yLTMtMS0xLTIzMjU0Nw_bc908718-487b-4a47-9786-fc029f122835">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDMy_6ac19bb8-785c-4de9-939d-ef8773308612">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;26, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="i91b26ed1eaac4b94ac243c6f30365065_I20230426" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8xOTc4_e5b214da-01c5-48ab-b0ee-03f0bc821cf1">1,282,025,283</ix:nonFraction> shares of common stock issued and outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Information</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_76">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_109">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_112">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_112">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_118">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_118">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_121">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_121">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_124">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_124">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_127">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_127">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_130">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_130">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_133">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_133">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_136">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_136">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_139">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_139">72</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.25pt">Financial Information</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_13"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Financial Statements</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Condensed Consolidated Financial Statements</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Operations (Unaudited) for the three months ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_19">2</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three months ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets (Unaudited) as of March 31, 2023 and December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_25">4</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_28">5</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Shareholders&#8217; Equity (Unaudited) for the three months ended March 31, 2023 and 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_31">7</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_34">8</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_73">48</a></span></div></td></tr></table></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_16"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c4d4c6f963c4f73bc0cc280e69d641b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMy0xLTEtMS0yMzI1NDc_b9a52f88-92cb-4567-9b13-d6f69b05c17f">58,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc0efcf324e4c67accd1041ac8b9ce1_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMy0zLTEtMS0yMzI1NDc_d5c4b317-18b8-4e93-8939-ae590a55171b">52,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNC0xLTEtMS0yMzI1NDc_c9a5afa4-a1e7-4959-bfbe-2e3d08588630">24,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNC0zLTEtMS0yMzI1NDc_21f23924-1caf-4a9d-8116-b6e153f97418">21,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dec895582849b98979be68d4b8999a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNS0xLTEtMS0yMzI1NDc_1f3285d7-21bb-45a6-bc57-9bd0edc2fda2">2,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ff0943b4f746ffb566b7dab6c56ede_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNS0zLTEtMS0yMzI1NDc_9d4c1a3f-ef5f-4d14-9f88-91711f9387e1">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNi0xLTEtMS0yMzI1NDc_8ad1fc94-8369-4f36-a823-f9081963da25">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNi0zLTEtMS0yMzI1NDc_68182511-c892-46a9-b884-399efe12b076">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNy0xLTEtMS0yMzI1NDc_d36a3845-e09f-417e-a8e3-15643f8c2bc3">85,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNy0zLTEtMS0yMzI1NDc_5ad70118-e0dc-4397-908a-14022f940851">76,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0wLTEtMS0yMzI1NDc_112c1de1-6ac2-4f44-a85c-ce76b5723e12"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0wLTEtMS0yMzI1NDc_251d0c44-9e0d-4edc-a097-0115cf0f41fb">Cost of products sold</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0xLTEtMS0yMzI1NDc_65d0aef6-de3b-4d53-b182-62023c7109f1">51,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0zLTEtMS0yMzI1NDc_2352de72-775a-47c5-a78c-79487382cee0">45,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTAtMS0xLTEtMjMyNTQ3_42c7f528-9907-495f-b4ee-6b1e00750a7a">20,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTAtMy0xLTEtMjMyNTQ3_af123d43-513b-44ba-a71b-946aacfecb82">17,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTEtMS0xLTEtMjMyNTQ3_a0f43641-dbe1-42a5-8373-4ccecd64040b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTEtMy0xLTEtMjMyNTQ3_0826074a-ba48-497a-bcc8-9acb906daa5e">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTItMS0xLTEtMjMyNTQ3_c679066b-96d9-452b-ba8e-a7ecea508eb3">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTItMy0xLTEtMjMyNTQ3_6e6b1b42-86d9-49b3-be1f-dbacb1771b5d">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTQtMS0xLTEtMjMyNTQ3_72a04fe3-f13c-409d-b9a4-480fbf0ef4bc">9,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTQtMy0xLTEtMjMyNTQ3_5cfa9f8f-0d16-4b6c-9eca-882984f5a753">9,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTUtMS0xLTEtMjMyNTQ3_2763243d-bd5c-4bb3-8f56-a8577583737c">81,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTUtMy0xLTEtMjMyNTQ3_b435b4b6-e9cb-4c0f-b8bc-9c3d033224b3">73,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTYtMS0xLTEtMjMyNTQ3_db9e4611-6bf8-4762-b824-3af94278c473">3,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTYtMy0xLTEtMjMyNTQ3_f9eaf016-0d3b-4c90-a29b-6d0b8760d5fe">3,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTctMS0xLTEtMjMyNTQ3_c1dca56a-ac30-46de-819a-9dd0990794f1">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTctMy0xLTEtMjMyNTQ3_cf1f2ed7-2384-42fa-bedd-881b17eca10b">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTktMS0xLTEtMjMyNTQ3_ecf8635d-ede4-46d9-af56-3fb24a7b7151">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTktMy0xLTEtMjMyNTQ3_91cb0730-e117-46ba-b43f-ae9dd25afcae">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjAtMS0xLTEtMjMyNTQ3_26befb4a-294f-464d-b370-02815f9b1c3e">2,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjAtMy0xLTEtMjMyNTQ3_4220c23a-266f-49d4-9216-69e6e087f323">3,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjEtMS0xLTEtMjMyNTQ3_201a2647-a274-4361-b119-c1eeab61c999">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjEtMy0xLTEtMjMyNTQ3_4de42585-7a61-4e23-b064-95764b36f079">646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjQtMS0xLTEtMjMyNTQ3_c62d34ee-711f-4b87-aabb-5584188c25a4">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjQtMy0xLTEtMjMyNTQ3_f78b4905-8d7d-425d-a80c-62ed90fac177">2,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjUtMS0xLTEtMjMyNTQ3_9c6fe787-bec4-4189-bb05-c8cf0892f1d6">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjUtMy0xLTEtMjMyNTQ3_f3f3d65f-5257-4df7-8e74-6ee2b70ccb9f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjYtMS0xLTEtMjMyNTQ3_5c03c564-3352-4370-99f5-a77c9f73c5f3">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjYtMy0xLTEtMjMyNTQ3_818b7541-6262-4bff-9e70-465a719dc1da">2,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjktMS0xLTEtMjMyNTQ3_36cd68c8-4a0e-46af-9991-851c4acc6ce9">1.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjktMy0xLTEtMjMyNTQ3_8b329685-2f7e-4062-89ac-faf3a78fecc5">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzAtMS0xLTEtMjMyNTQ3_ca9fe2d0-bf81-4d2a-968f-7b84cb077096">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzAtMy0xLTEtMjMyNTQ3_1223cc4d-14ee-4f4a-903a-0743d66bb84e">1.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzItMS0xLTEtMjMyNTQ3_9da5002e-8081-46bc-958b-82e0338c97f6">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzItMy0xLTEtMjMyNTQ3_0e88b8a3-e7fb-4f0d-97aa-f0baaf5c70e2">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzMtMS0xLTEtMjMyNTQ3_38559511-737e-457b-ab84-7177537349e3">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzMtMy0xLTEtMjMyNTQ3_dd70be0b-fa4d-49ae-a7c5-d297e1420d8b">1,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNDQtMS0xLTEtMjMyNTQ3_380a0392-0805-482e-8f69-ebc38b20e1e5">0.605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNDQtMy0xLTEtMjMyNTQ3_e1860c3e-2fec-4383-a31c-66f80569d6b3">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMi0xLTEtMS0yMzI1NDc_c62d34ee-711f-4b87-aabb-5584188c25a4">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMi0zLTEtMS0yMzI1NDc_f78b4905-8d7d-425d-a80c-62ed90fac177">2,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNC0xLTEtMS0yMzI1NDc_6cd06882-b028-483c-a5f5-1246a9b513ae">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNC0zLTEtMS0yMzI1NDc_a778011f-f4fb-480a-8d5f-e13b22595cd3">1,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate on long-duration insurance reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0xLTEtMS0yNTUzNjY_18ac345f-7951-4f76-ba84-0fe852fdcb6a">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0zLTEtMS0yNTUzNjY_f99282de-feee-412a-baaf-8df7ed0d3b4a">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0xLTEtMS0yMzI1NDc_2273207f-5b9c-4d26-8cdd-269d1b4e7489">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0zLTEtMS0yMzI1NDc_2e064b4e-5b81-498b-b181-c1394fbfccb2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNi0xLTEtMS0yMzI1NDc_1c9fe3d8-19cf-474d-8093-6d410ffb69a0">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNi0zLTEtMS0yMzI1NDc_723ffca7-3a93-48d0-99b0-93e48b0c2f4e">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOC0xLTEtMS0yMzI1NDc_4c27407e-f669-43bf-86bc-26d05b744422">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOC0zLTEtMS0yMzI1NDc_e6eaf794-78af-4d43-ac12-1e788911a08d">763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOS0xLTEtMS0yMzI1NDc_2737ef5c-1355-42ba-b00d-9651c88e22a0">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOS0zLTEtMS0yMzI1NDc_45a9cffe-0d64-41e3-80c2-87437ffc8a56">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTAtMS0xLTEtMjMyNTQ3_9c6fe787-bec4-4189-bb05-c8cf0892f1d6">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTAtMy0xLTEtMjMyNTQ3_b9946ba6-d394-4477-aabd-a2630aa0012a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTEtMS0xLTEtMjMyNTQ3_bc4b29bd-cd21-480b-8605-6534dcfa8f64">2,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTEtMy0xLTEtMjMyNTQ3_e64f8473-060c-4654-9c42-9b75fa62faea">1,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMi0xLTEtMS0yMzI1NDc_41ee416c-eaaf-4cda-bfda-3e1ab92d4b4e">14,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMi0zLTEtMS0yMzI1NDc_300c1f9e-7d1b-4890-8716-09c0ce261859">12,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMy0xLTEtMS0yMzI1NDc_34afa4ed-0715-4975-a5a6-98aeab2290b1">3,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMy0zLTEtMS0yMzI1NDc_7641b8d1-e225-4e59-8a88-de94d02a9d23">2,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNC0xLTEtMS0yMzI1NDc_5832cacc-1ac1-452b-ae5f-f7236168d763">28,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNC0zLTEtMS0yMzI1NDc_6f43ca95-bca4-494f-8f26-54fb7a208e10">27,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNS0xLTEtMS0yMzI1NDc_0ff249f3-2087-4ca6-a39c-66733e71223c">18,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNS0zLTEtMS0yMzI1NDc_1990705d-fbb4-4f1b-8861-602c983ee5f5">19,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNi0xLTEtMS0yMzI1NDc_ea562812-d681-4c16-8925-0bc8d8b69901">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNi0zLTEtMS0yMzI1NDc_a26a97c5-4610-4af7-99f6-7e3433627b7e">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNy0xLTEtMS0yMzI1NDc_a9a6b2db-bd1e-41cd-bd63-c21d12639def">3,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNy0zLTEtMS0yMzI1NDc_7c51a329-af02-4134-977d-06cf71ea8e5c">2,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOC0xLTEtMS0yMzI1NDc_09c44bdf-00d8-4042-a35f-b9686762b3c7">68,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOC0zLTEtMS0yMzI1NDc_48343724-c8aa-4a77-b3f9-c0bc092b6e12">65,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOS0xLTEtMS0yMzI1NDc_726d64e3-af2d-4b41-83de-e3891e8c6642">21,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOS0zLTEtMS0yMzI1NDc_877cc319-dacc-4885-9b2f-281270662870">21,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTAtMS0xLTEtMjMyNTQ3_ea857df9-8590-46fd-80d5-9c0f2d0413df">12,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTAtMy0xLTEtMjMyNTQ3_69bb66dd-ae92-4cc0-889b-fa5791d1d3b4">12,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTEtMS0xLTEtMjMyNTQ3_e2f3d64e-e037-453a-b655-e61e02cc2c29">17,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTEtMy0xLTEtMjMyNTQ3_8851dc37-c330-4da1-ae21-9836ca107a12">17,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTItMS0xLTEtMjMyNTQ3_8b5fd314-67cf-4e3e-bca1-6e188690586a">84,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTItMy0xLTEtMjMyNTQ3_0648735d-dfd6-4225-8542-34a4417ff98f">78,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTMtMS0xLTEtMjMyNTQ3_199c2b1f-0c9a-44fc-a10f-2aaf4f475086">26,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTMtMy0xLTEtMjMyNTQ3_adbd7d5a-a921-4cbe-b7f9-de71376210a3">24,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTQtMS0xLTEtMjMyNTQ3_e2dd235d-978a-459c-b4a3-346260a67d70">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTQtMy0xLTEtMjMyNTQ3_c6f04f8c-3013-4cf0-bc21-33a471a3fdfb">3,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTUtMS0xLTEtMjMyNTQ3_290993c9-a51d-4100-81ea-b1ea510e10d4">4,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTUtMy0xLTEtMjMyNTQ3_f27219a9-2e62-4133-994c-04b434ca6d5f">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTYtMS0xLTEtMjMyNTQ3_127d95cc-05ba-4045-97ce-a64c6aad1e0b">239,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTYtMy0xLTEtMjMyNTQ3_047de142-3ba4-41e9-8239-c5b123707b99">228,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTktMS0xLTEtMjMyNTQ3_5196cfe7-a7d4-41d7-8ba6-60f58b00e4bc">12,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTktMy0xLTEtMjMyNTQ3_e7db1a7c-8a20-425a-9579-ba755b62a36d">14,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:PharmacyClaimsAndDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjAtMS0xLTEtMjMyNTQ3_dde0a226-804f-4550-ac9a-5aba901ed77f">20,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:PharmacyClaimsAndDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjAtMy0xLTEtMjMyNTQ3_a806592d-9ceb-431f-a08f-f111bd1a1cc8">19,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjEtMS0xLTEtMjMyNTQ3_fd034af5-3d06-4735-92d8-1a720abe13c0">10,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjEtMy0xLTEtMjMyNTQ3_1b87b921-220c-4c90-80c6-e4b9194fe255">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjItMS0xLTEtMjMyNTQ3_40d3e99b-9d9d-4f0c-a650-ec2f15f84ca7">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjItMy0xLTEtMjMyNTQ3_a6a029f1-d78c-4bcf-9b27-444faa20a925">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjMtMS0xLTEtMjMyNTQ3_3c6a1c67-89df-4b40-8ad6-6828d99a697e">21,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjMtMy0xLTEtMjMyNTQ3_d5b7cdb9-fabe-4fac-903b-03e168bc8dbd">18,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjQtMS0xLTEtMjMyNTQ3_f0c8bdeb-1525-47c7-81a3-0c3ea5a48a2f">4,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjQtMy0xLTEtMjMyNTQ3_67d4d027-bfa8-4a12-a445-1c27169937dc">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjUtMS0xLTEtMjMyNTQ3_9976844a-dbb0-4b3f-97a6-cdfca5fdb58d">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjUtMy0xLTEtMjMyNTQ3_7042cfb9-5bf4-490b-9119-514ef5ab698b">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjctMS0xLTEtMjMyNTQ3_d0d04b99-c5d7-4f12-8017-cbd78b0547ae">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjctMy0xLTEtMjMyNTQ3_0500d774-d5c9-4488-bb72-b2eb583ec23a">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjgtMS0xLTEtMjMyNTQ3_30d41041-4c69-4d2a-8a47-3f255b80479d">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjgtMy0xLTEtMjMyNTQ3_f48e5b63-7300-4fe4-a122-904f567ba0a1">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjktMS0xLTEtMjMyNTQ3_832ccb2c-1131-424a-80b2-9cd053165835">75,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjktMy0xLTEtMjMyNTQ3_a675def8-5727-43cd-bd6e-9f2e47829cb2">69,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzAtMS0xLTEtMjMyNTQ3_a1c63492-365a-453d-b491-6f0cd7228924">16,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzAtMy0xLTEtMjMyNTQ3_78300935-e8a0-47d6-9683-92f74fa987e3">16,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzEtMS0xLTEtMjMyNTQ3_47625641-975b-4d78-8837-264bc7c6f2d5">56,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzEtMy0xLTEtMjMyNTQ3_94c07124-1c68-427b-a97a-2baac1008072">50,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzItMS0xLTEtMjMyNTQ3_fc584574-fc6a-4d38-bcd6-770794bcecb7">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzItMy0xLTEtMjMyNTQ3_9cf67eca-2087-441f-91cf-aca4213e2a14">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzMtMS0xLTEtMjMyNTQ3_eb01d0db-7a32-4a83-85de-8ec96ec27226">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzMtMy0xLTEtMjMyNTQ3_0cbc51ad-f239-40bd-b379-7706dac3fbc0">3,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzQtMS0xLTEtMjMyNTQ3_e9d07c73-4c65-4807-ab1d-0aa9ba962ec1">5,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzQtMy0xLTEtMjMyNTQ3_2c1413a1-1792-47f1-b8e8-1f9be215e518">5,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzUtMS0xLTEtMjMyNTQ3_8a702d02-6834-41e7-9842-9293b1f30e16">6,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzUtMy0xLTEtMjMyNTQ3_c4a6f5ff-b533-4973-a6b7-5c94ef420264">6,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzYtMS0xLTEtMjMyNTQ3_e7b11ad9-017c-4a13-822b-b41b4bcab741">167,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzYtMy0xLTEtMjMyNTQ3_845eeef1-2c0e-43a7-9e4b-37f4a2eb4804">156,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzE_0bab64e1-9ecb-461c-8d07-e4091e1c193b"><ix:nonFraction unitRef="usdPerShare" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzE_3218c8c2-2c65-4a5c-88a1-2516da28dfc7">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzU_3e58aba6-b73f-46e9-9bc6-4999c0fd00da"><ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzU_74ba2298-ce33-4681-a165-49eed5295a9d">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_16193b71-8df7-486a-b5fb-212480c0a448"><ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_3f74eeac-1ca4-436c-81a5-57e63ceaaf84"><ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_48e1eea2-7db3-4043-bc3a-e881af3c35fd"><ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_b5debfa6-faba-4ae8-9a9c-089ddddb00d0">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>ne issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMS0xLTEtMjMyNTQ3_ae8f08f6-8f4c-4508-bae8-a56f0f358873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMy0xLTEtMjMyNTQ3_5850144c-d7d3-4ee3-b38d-60a33a66e571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMjg_3656a802-1cf7-4dfe-8590-cb089d14b586"><ix:nonFraction unitRef="usdPerShare" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMjg_f5506cdf-6712-4a2e-9cd2-305c52948c3c">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMzI_1335ac0b-5705-4a68-bc66-e08bbb9dd60a"><ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMzI_c69c6caa-e8f2-4118-ae71-e115cbcf2087">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfNTQ_7987d1d4-8801-4170-b4fe-132725b92412">1,759</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfNzU_1631d98e-5e4f-48e4-b325-f98128993e16">1,279</ix:nonFraction> shares outstanding at March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMTA3_d8526503-b02d-4dd6-9e1c-516f0d234a4a">1,758</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMTI4_3692e92c-8732-4f6b-a187-d2363b49ab22">1,300</ix:nonFraction> shares outstanding at December&#160;31, 2022 and capital surplus</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMS0xLTEtMjMyNTQ3_74028079-cbd8-46e3-b22d-559f35fb0590">48,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMy0xLTEtMjMyNTQ3_33640132-a2ea-44b4-8aa4-8640f385affc">48,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTliYzBiNGEzMDQ1NDFhOTlhMWE5ODM3ZDUxMjc2YjNfMjk_57bc6cc9-3ccd-4b34-8f1b-f8108ace13bb">480</ix:nonFraction> shares at March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTliYzBiNGEzMDQ1NDFhOTlhMWE5ODM3ZDUxMjc2YjNfNDk_89951800-aad8-4a45-8213-bb4b31d960e7">458</ix:nonFraction> shares at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMS0xLTEtMjMyNTQ3_c9c414c3-1b63-4e6f-8d35-93c98afedb57">33,802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMy0xLTEtMjMyNTQ3_1c757777-b172-4dd5-84ba-365a384cf40c">31,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDItMS0xLTEtMjMyNTQ3_330a2be3-0457-4d57-941b-4c52856305fb">57,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDItMy0xLTEtMjMyNTQ3_6f33730e-c4a3-45c6-a7c6-e0199e6dd408">56,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDMtMS0xLTEtMjMyNTQ3_81a6cdcb-9ab9-4978-b5e9-c8d700969f88">875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDMtMy0xLTEtMjMyNTQ3_5a79ef76-9a0c-4275-9caf-219ad05560c7">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDQtMS0xLTEtMjMyNTQ3_ac758b1a-4fd9-40d9-a9e1-014bd9e936b4">71,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDQtMy0xLTEtMjMyNTQ3_854173a0-78c0-4c97-a194-ac94f423e20f">71,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDUtMS0xLTEtMjMyNTQ3_bff3a22b-4c03-4135-8348-ee7fb3ec3299">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDUtMy0xLTEtMjMyNTQ3_c53d577d-9f74-4b6b-b478-74627640c1d9">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDYtMS0xLTEtMjMyNTQ3_c4a28e2d-d7b5-4e51-9ade-6a8b136cac4a">71,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDYtMy0xLTEtMjMyNTQ3_76a2af78-6f99-4e14-8f69-4c40a5c9269d">71,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDctMS0xLTEtMjMyNTQ3_811f4b3a-e8e8-40da-bd06-f62e6164af4e">239,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDctMy0xLTEtMjMyNTQ3_d72743fa-8ba7-42a4-b9d0-e30cd61d850e">228,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMy0xLTEtMS0yMzI1NDc_49d5f9ea-23df-470c-a810-04e9e595389b">87,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMy0zLTEtMS0yMzI1NDc_9828c5f0-963a-4c2c-b92d-b31847543d66">74,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for prescriptions dispensed and health services rendered</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNC0xLTEtMS0yMzI1NDc_4c1bca05-241a-4341-8bc7-4bc71b2e36e7">50,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNC0zLTEtMS0yMzI1NDc_cfd6a6ff-f83b-4713-8e61-336fb6170d45">44,365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:PaymentsForInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNS0xLTEtMS0yMzI1NDc_24351f2d-1f39-4230-87d2-87613a8908f0">19,757</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:PaymentsForInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNS0zLTEtMS0yMzI1NDc_02d78f0a-844d-4a82-bffd-5b2a219ce6a0">16,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNi0xLTEtMS0yMzI1NDc_9ebe4954-5e3c-41e7-ba95-12bed8a694a3">9,958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNi0zLTEtMS0yMzI1NDc_f74c2152-f70b-43ff-8598-cd8b122b105c">8,969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNy0xLTEtMS0yMzI1NDc_6f42f96c-cb07-46bc-9922-defb17f70677">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNy0zLTEtMS0yMzI1NDc_03d950dd-4cb0-44a3-81e6-4c8dd42bc3e0">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOC0xLTEtMS0yMzI1NDc_7da870db-e268-4240-9f2b-18952a7028e2">773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOC0zLTEtMS0yMzI1NDc_b26a7753-7ba7-4f8d-8b53-cf845c08c316">782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOS0xLTEtMS0yMzI1NDc_8a7e5c83-ea75-433f-aa64-3fb9f0433e05">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOS0zLTEtMS0yMzI1NDc_471a7793-7788-48fb-84c2-c2c97baf3642">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTAtMS0xLTEtMjMyNTQ3_125c1f39-5d0a-48e5-b0a3-d38bbf605f16">7,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTAtMy0xLTEtMjMyNTQ3_4dc6650e-2052-4b6e-8c9a-00e8c1f25ce1">3,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTMtMS0xLTEtMjMyNTQ3_802f1131-063e-4fd8-99ff-2becef4e2bed">1,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTMtMy0xLTEtMjMyNTQ3_df95f42c-1020-45e7-9542-4f60dbf9655b">2,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTQtMS0xLTEtMjMyNTQ3_dcbbe042-7381-4db8-b9a3-b228c28411b3">2,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTQtMy0xLTEtMjMyNTQ3_cc828ca1-1d60-4802-9aae-44de1c52125a">3,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTUtMS0xLTEtMjMyNTQ3_16b08f09-38b8-455e-8ef9-019cf18fb127">984</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTUtMy0xLTEtMjMyNTQ3_d8272b4d-27fd-4d3a-ab5d-2f21775c2f58">1,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTYtMS0xLTEtMjMyNTQ3_44b5973c-a06d-40a4-a657-3e1c524eb6d6">7,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTYtMy0xLTEtMjMyNTQ3_b88dd388-01ac-4ede-96b1-683351b1a640">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTgtMS0xLTEtMjMyNTQ3_eb7198af-7c97-4fa6-8bc7-765cce2885aa">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTgtMy0xLTEtMjMyNTQ3_b420bcf5-fd92-4bc0-a920-0c4e7858f5a3">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTktMS0xLTEtMjMyNTQ3_c5229e73-6fc2-4ad5-9e97-70c316b14817">8,514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTktMy0xLTEtMjMyNTQ3_515704f9-527a-4b9b-a6ec-181e405c560e">1,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjMtMS0xLTEtMjMyNTQ3_2e333c31-ea2a-4409-b5c0-444b6b534c78">5,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjMtMy0xLTEtMjMyNTQ3_d91ca827-097e-4c8d-adab-25785e461ffe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjQtMS0xLTEtMjMyNTQ3_cbd07ca3-0f05-4530-9355-cd2537318cde">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjQtMy0xLTEtMjMyNTQ3_b3b4f7c3-13ee-4a44-b925-8078504d556f">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjUtMS0xLTEtMjMyNTQ3_008a6f27-1c7c-4987-bcb0-d4c5268902c6">2,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjUtMy0xLTEtMjMyNTQ3_dd6ea883-51db-4780-9d30-d8087740bf8d">2,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjctMS0xLTEtMjMyNTQ3_5f6de32a-6152-43d4-8a2f-dcf6a55645c6">779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjctMy0xLTEtMjMyNTQ3_9056a092-10f8-41f8-8d24-8cb6b0a793bc">722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjgtMS0xLTEtMjMyNTQ3_09c40ebf-a90d-4e8a-8ec4-b1631b4dd5c2">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjgtMy0xLTEtMjMyNTQ3_1b970f2a-2630-4c66-b802-f9a6df1ec896">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjktMS0xLTEtMjMyNTQ3_51c5a76c-90ac-4c12-83e6-ffbb6e402aaa">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjktMy0xLTEtMjMyNTQ3_d29e7d00-a3ac-4e4f-8a94-2a502b475cec">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzAtMS0xLTEtMjMyNTQ3_d45fe1fe-d390-4499-b710-8966ac4cde9e">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzAtMy0xLTEtMjMyNTQ3_7989ab98-361d-43d9-a20a-5451ff0863f9">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzEtMS0xLTEtMjMyNTQ3_7918a8c2-9173-475e-8c68-9d5569b1655e">2,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzEtMy0xLTEtMjMyNTQ3_9e2d447b-408b-44c9-8b2e-6605b9f313ec">2,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzItMS0xLTEtMjMyNTQ3_a64aad93-751b-4777-8edd-9be8339932a9">1,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzItMy0xLTEtMjMyNTQ3_c555b0cf-785d-43ce-a644-10c0ef9f47eb">1,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzMtMS0xLTEtMjMyNTQ3_c350aaa0-76ad-4daa-b485-401b6bf189b4">13,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzMtMy0xLTEtMjMyNTQ3_ebd9cf2e-1bca-4e96-83f1-218dca3443ea">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzQtMS0xLTEtMjMyNTQ3_748e907e-86e3-4f23-b2a9-28ca80a61cd2">14,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzQtMy0xLTEtMjMyNTQ3_2501644b-cbe0-4ffc-9cfb-aedbc8dbbad0">11,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMy0xLTEtMS0yMzI1NDc_bc14ee36-4a63-448f-aa94-98630ee02adf">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMy0zLTEtMS0yMzI1NDc_e15890a5-94eb-4889-bed5-c639446d9fea">2,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfNS0xLTEtMS0yMzI1NDc_d21e40b7-c517-4a76-820d-44595763658e">1,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfNS0zLTEtMS0yMzI1NDc_8c2e9e12-86ed-4d8a-8042-2f4fb0b110de">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfOC0xLTEtMS0yMzI1NDc_707249de-7eeb-49cb-858d-b5d7f736c213">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfOC0zLTEtMS0yMzI1NDc_1f6c2d47-23d9-40b0-a772-ec5388043175">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:DeferredIncomeTaxesAndOtherNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTEtMS0xLTEtMjMyNTQ3_38dd6799-7b37-4f15-bcc1-66877bc7129d">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="cvs:DeferredIncomeTaxesAndOtherNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTEtMy0xLTEtMjMyNTQ3_5ebd3700-2364-4dcf-a8c2-2cc1caecbfb9">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTMtMS0xLTEtMjMyNTQ3_9be99fec-12ba-4e0c-8683-432cf2f52f28">751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTMtMy0xLTEtMjMyNTQ3_5315c241-ca77-4f53-ae92-a2708350d5ef">1,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTQtMS0xLTEtMjMyNTQ3_d6241dd1-86f4-47b3-900f-43e9b01892cd">828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTQtMy0xLTEtMjMyNTQ3_504ffbbb-47b8-4aa8-b6d2-469b9ca5ef91">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTUtMS0xLTEtMjMyNTQ3_cb0caf7d-7431-4d73-9616-a09919164ced">1,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTUtMy0xLTEtMjMyNTQ3_9eda6bcd-9dc3-40c6-9ec5-fc024ec7e242">348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTYtMS0xLTEtMjMyNTQ3_12e4a955-9bc1-4602-8a01-e065f239979c">1,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTYtMy0xLTEtMjMyNTQ3_6909803d-b162-41a4-9023-d32fbe24bfde">1,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTctMS0xLTEtMjMyNTQ3_4b4a67fd-9c3c-4ad5-961e-8bcefe59d0d9">4,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTctMy0xLTEtMjMyNTQ3_a9e262e0-1ee5-4696-8cb6-bddaf2835337">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTgtMS0xLTEtMjMyNTQ3_28898189-c4ff-4d9a-9f09-6ef153881b34">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTgtMy0xLTEtMjMyNTQ3_902ab62a-034a-40d4-a665-d935f504c317">444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTktMS0xLTEtMjMyNTQ3_41ec7f95-0f3d-417b-9105-5d0c77935d47">7,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTktMy0xLTEtMjMyNTQ3_3bcbae80-2a9f-47af-93ea-3ca58ecf0947">3,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0126d2a2d5b4cdd9ca3e3d805ece7c6_I20221231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0xLTEtMS0yMzI1NDc_6f422a26-e2a8-4030-b5fb-b4f307012a2a">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0d661cb6c0504a1fa9228d0757d805ed_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0yLTEtMS0yMzI1NDc_6c050194-16c0-477f-9fb5-b8d19017455a">458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca8df10bb3e4ef68a134deb6f91845f_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS00LTEtMS0yMzI1NDc_ca4b0262-df78-433e-bef7-8786581d587d">48,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d661cb6c0504a1fa9228d0757d805ed_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS01LTEtMS0yMzI1NDc_60714424-be32-4073-9ab4-938d817d7181">31,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3a6802840048fbb777cb7cb063f606_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS02LTEtMS0yMzI1NDc_33d8dab8-7b74-4aa0-9dbd-ce7153d73359">56,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0919e504ed6344d68c00a6acaebcde05_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS03LTEtMS0yMzI1NDc_61ef81c8-0b91-4463-aee3-8de193969576">1,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a977074046f41a89c7f4a1f6b9bcc1f_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS04LTEtMS0yMzI1NDc_15e54128-150e-4e84-a8ba-971b41dd8577">71,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie33015c34edd4999b191485b67da92a8_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS05LTEtMS0yMzI1NDc_ef09a06d-6014-42b3-9024-971b48fa6b39">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0xMC0xLTEtMjMyNTQ3_4c9d5f52-ec0a-4e75-8c13-e23402553fdb">71,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6966b4e2696f4a24ac2798c5d341762a_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi02LTEtMS0yMzI1NDc_7b9c71a8-9435-48e0-9a85-547933e92c3c">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi04LTEtMS0yMzI1NDc_8ebbd248-44fe-44f9-afc9-2f591a30ccb8">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd6ef7eeaab42469a4c1b85aecdbcbe_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi05LTEtMS0yMzI1NDc_0a2bb016-5c32-4dba-b645-34218dcb0914">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi0xMC0xLTEtMjMyNTQ3_8ad97d6b-947a-4735-ae59-5a9fdc2a9c59">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (Note 9)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca517c88528406bb73b9e7287a1467b_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNy03LTEtMS0yMzI1NDc_4871b444-3249-4971-b585-f7b35b769786">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNy04LTEtMS0yMzI1NDc_f49f48e8-5f8c-435d-9b6b-1bb4f05ad3e6">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNy0xMC0xLTEtMjMyNTQ3_4558a551-8aa3-457b-b872-16b0715d634d">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icda684d607d94e4984c89b2b79d866e6_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC0xLTEtMS0yMzI1NDc_cd1ba6d0-1cee-4155-b3d9-8f6a4dc56e52">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC00LTEtMS0yMzI1NDc_9308e9cc-7702-426d-abe9-b51cbf5ec8ee">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC04LTEtMS0yMzI1NDc_efee050f-23ba-4647-87b3-0ac544517858">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC0xMC0xLTEtMjMyNTQ3_013612a7-0fef-467c-b02e-f5f3a9aaf10f">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i607b6600b7634e74b9a25dba310ddfe6_D20230101-20230331" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0yLTEtMS0yMzI1NDc_c4b41d6b-e368-44ff-af4a-a3036171ac0b">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS00LTEtMS0yMzI1NDc_5091b64e-4ffe-460b-be4b-cda644451ed3">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i607b6600b7634e74b9a25dba310ddfe6_D20230101-20230331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS01LTEtMS0yMzI1NDc_c54fad51-69a2-43bb-97b9-e8c59b2e1614">1,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS04LTEtMS0yMzI1NDc_487ccb25-6cc4-4ccc-b4da-48d2647a9bce">1,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0xMC0xLTEtMjMyNTQ3_23ab6a6d-bf0d-4195-9a3f-2b9d08c63ab7">1,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6966b4e2696f4a24ac2798c5d341762a_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTAtNi0xLTEtMjMyNTQ3_edf79ac5-3f9f-42ec-8f4c-f34685f08d29">781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTAtOC0xLTEtMjMyNTQ3_d1b519f5-9814-4229-ae0e-786910e575fb">781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTAtMTAtMS0xLTIzMjU0Nw_bbf8794a-d305-415b-a7c3-50776083edfc">781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331" decimals="-6" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtNC0xLTEtMjMyNTQ3_9c9cc7b5-bac3-476f-a1d5-a757cc74d7cf">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331" decimals="-6" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtOC0xLTEtMjMyNTQ3_75407ef5-0e35-4cac-8c22-f21c42e92a6c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd6ef7eeaab42469a4c1b85aecdbcbe_D20230101-20230331" decimals="-6" sign="-" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtOS0xLTEtMjMyNTQ3_22a66750-c633-44b2-a8e7-3e7a3c9561dd">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtMTAtMS0xLTIzMjU0Nw_b4ae2192-426a-4e83-b729-f95afbe6a23c">99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14bff4dd44434085ac94c47f67cf0b94_I20230331" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMS0xLTEtMjMyNTQ3_217389b0-b6d0-4c9c-8a25-5c46566fed62">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib8a97180d2514a9b93e7596cf96be425_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMi0xLTEtMjMyNTQ3_bac58b12-1fef-43ba-9745-c0d784911361">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f0bf58dc2749449f2f66468faccce3_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNC0xLTEtMjMyNTQ3_68f228d6-24ee-4fb5-982a-a6c3d0e74abb">48,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a97180d2514a9b93e7596cf96be425_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNS0xLTEtMjMyNTQ3_346a8441-b914-40c1-b85c-35d5bc62cd0c">33,802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6bfce6ac5f8468eb136aac914a9ef04_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNi0xLTEtMjMyNTQ3_f40d19ae-bd19-4522-bd0f-abe1dba29a88">57,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i500c40e14a1143a3aa4e9627c448de62_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNy0xLTEtMjMyNTQ3_931da9b9-0416-4646-b80a-4acba35e7156">875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic92b2e37d0234aa2aee969f6ead4b607_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItOC0xLTEtMjMyNTQ3_a59dd4dc-1e2a-4f9a-9cf8-65c361b60c5d">71,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91059cc4e3514c71825e73b0a7423eba_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItOS0xLTEtMjMyNTQ3_89fc8175-95ff-48e2-9625-7b580ab61a12">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMTAtMS0xLTIzMjU0Nw_2c5ba9a6-4881-4561-8b34-be5b79a58579">71,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44ee7f171b49433c9fee60c78374b031_I20211231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMS0xLTEtMjMzOTQz_a19d5947-5c72-44e9-9932-309ac9bc033d">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibc256cbbfdbe4919bd580b89b5853b65_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMi0xLTEtMjMzOTQz_fdcec20a-0da2-4cba-a702-049f79ca14bf">422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5d7bc6153ed403bbf10a74c29ce4dc3_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNC0xLTEtMjMzOTQz_b9c39463-580f-4dd6-9019-a7a4fd5ac7f9">47,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc256cbbfdbe4919bd580b89b5853b65_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNS0xLTEtMjMzOTQz_45f485e3-9b46-4c82-8d3e-9d058ed4b98a">28,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a735ca1fa940769d12496008f05980_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNi0xLTEtMjMzOTQz_8196f26e-15a4-4156-96c6-3fa1bb12e8b8">54,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i769f64156cf4441d9b8d63169d946693_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNy0xLTEtMjMzOTQz_3e668b3d-29fd-4bb5-9b01-7988e22faf7b">965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1ee5670de504ce3adee519f2e40ffd2_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtOC0xLTEtMjMzOTQz_0c5bd5b6-4832-4088-9be0-44af10272282">75,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af24bdfc747494e8034faa02222d96f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtOS0xLTEtMjMzOTQz_490273b1-12c7-42ad-9162-97973aa709c0">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMTAtMS0xLTIzMzk0Mw_1f9c57ee-7ad0-43a2-b0f9-84fa498948e9">75,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of new accounting standard (Note 1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8177aa632cf4772aa7e3d0690fab4e7_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNi0xLTEtMjc5ODE0_e9b07a15-ac08-413e-805f-2b66fd5510a8">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1236f0a166354cc7b555200e4c10809a_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjc5ODE0_2aeead0b-ce92-4b84-b456-8a22a76d1c5d">631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7ec450630a5482c819c7ba9bb97985e_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjc5ODE0_835d5494-8d96-4df1-89c5-db14d9bd351c">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaaa42d004654ea98904e4011dbecabb_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTI3OTgxNA_2ae192ea-b3ef-4e45-8040-5fa42904c6d3">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ae773548b24dbf955bf39d91ac8fa8_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtNi0xLTEtMjMzOTQz_59e51c72-1ddf-4dc7-bf31-f9a9e668b27b">2,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtOC0xLTEtMjMzOTQz_aaa8ea9d-1608-4403-a417-4d1231e088ca">2,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c46457ec075463b998b7704930f1527_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtOS0xLTEtMjMzOTQz_e0eb4a62-a0e7-4216-9001-d78298f06491">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtMTAtMS0xLTIzMzk0Mw_033d5b49-59ba-48bc-83e6-448406725628">2,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 9)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia04b5afab2af4259b71dabfaa547a322_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjMzOTQz_5c5aa880-1dd8-4470-95fa-5c183c9616af">763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjMzOTQz_7e295012-a316-49db-8c91-46f6b053d767">763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTIzMzk0Mw_a1cb1a19-acd2-425c-b2aa-d4b55510e886">763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id87e905aad04499185592c649df0501d_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctMS0xLTEtMjMzOTQz_f7893f41-bc19-4390-8818-12a693e60cd9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76890c43bde24648bc18aa2102227d8d_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctNC0xLTEtMjMzOTQz_e4aa5458-f5dc-47fc-8f5c-4dba67141cac">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctOC0xLTEtMjMzOTQz_9a50458c-9da0-429f-9dc5-af06125f7029">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctMTAtMS0xLTIzMzk0Mw_742c8b41-53b4-48e1-9fe5-41360b0b3bbf">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3ffe2b44a55945b284180e30309e8aad_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMi0xLTEtMjMzOTQz_4ddd1924-457b-4a04-9c51-c099d307ce1f">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffe2b44a55945b284180e30309e8aad_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtNS0xLTEtMjMzOTQz_076ae2ba-235c-4cf0-8ff1-3b73daa62000">1,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtOC0xLTEtMjMzOTQz_0414db75-a396-4d10-adc8-40e8e5a9dab9">1,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMTAtMS0xLTIzMzk0Mw_3a2e495a-eea9-4631-8633-7daf0934ea9f">1,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ae773548b24dbf955bf39d91ac8fa8_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTktNi0xLTEtMjMzOTQz_3e3e6a91-efc6-43f4-9025-3bc8f8eb1949">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTktOC0xLTEtMjMzOTQz_cb2a2857-597b-49af-999c-a340b1a21d66">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTktMTAtMS0xLTIzMzk0Mw_b6327cf9-b76e-417b-9852-df289d3bd202">730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c46457ec075463b998b7704930f1527_D20220101-20220331" decimals="-6" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjAtOS0xLTEtMjMzOTQz_afad0bd0-20a6-4799-a7ea-070304b2ad10">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjAtMTAtMS0xLTIzMzk0Mw_2342ea8a-e452-43f8-8a99-91b74ab95f2c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i68525f7e800f4c59b752a9f19135d07d_I20220331" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMS0xLTEtMjMzOTQz_d8e5974e-5379-4cfc-a8c9-bdbf94ed829d">1,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia4688929cda745bb98a6c1e716bcf78d_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMi0xLTEtMjMzOTQz_55cc909c-b93b-412d-b0f0-4aa7a02e4690">441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75183c2d4ace4f5787e50b8f1271e1f7_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNC0xLTEtMjMzOTQz_40ae901a-05df-4b91-86cd-5b3d8a1815e0">47,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4688929cda745bb98a6c1e716bcf78d_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNS0xLTEtMjMzOTQz_6499dc29-8bea-4f59-bb31-f6b0fc576c54">30,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2fdd12e3c9442ebce0208dc0b9d3a2_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNi0xLTEtMjMzOTQz_cd32d520-0d8d-4526-a826-cb71a6d32dcb">56,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c83419b19394b2b9e56453a8077baa2_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNy0xLTEtMjMzOTQz_7252cdc2-3fbd-4fd6-b919-083f75972cce">429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19ac4c954a3448a8ad572bcd89c79da_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtOC0xLTEtMjMzOTQz_f84d28b6-59d6-45e5-9441-c9e9052f1621">73,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e44e45d682450d8e8f9d28b40f3de4_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtOS0xLTEtMjMzOTQz_bd74b3de-7c02-419a-855e-0eeda40351bf">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMTAtMS0xLTIzMzk0Mw_526b622b-f63d-42cc-8b0c-b24b6fde6fe9">74,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="cvs:TreasuryStockSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_110c3536-f415-4b93-8b86-8e97289d4e0f"><ix:nonFraction unitRef="shares" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:TreasuryStockSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_34b3efb6-84f0-4b0b-b8eb-50d171dbcda7"><ix:nonFraction unitRef="shares" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="cvs:TreasuryStockSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_d463a5ba-2cce-4abe-a5c3-2e8c8d0161fd"><ix:nonFraction unitRef="shares" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:TreasuryStockSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_dfa3abd4-e8db-4515-ae9b-c1d9032b4b48">1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_7b23fc46-b031-4b3b-89a0-116a1e3c2b57"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_9ec457b2-77a1-4c22-a23a-a9d14d6a2cee"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_b9c804d2-55ca-476a-bbce-67bb8c1f0932"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_e7ce6455-1f95-4da4-8730-0a902a5ae903">29</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of March&#160;31, 2023 and 2022 and December&#160;31, 2022 and 2021.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTU3Mw_8611c09e-89bb-4d18-b6a6-e6d2347f60fd"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTU3Mw_e110274b-efad-417e-9e9f-93e28eb2f921">18</ix:nonFraction></ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTYyMA_5d32b43d-5b93-4334-b960-3ceb1a273255"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTYyMA_f9d4d170-b5ee-4116-b798-895b96663317">17</ix:nonFraction></ix:nonFraction> million as of March&#160;31, 2022 and December&#160;31, 2021.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 944)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> during the three months ended March 31, 2023. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</span></ix:footnote></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_37"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjM_188b6197-51f0-4926-8d6f-a38b10bf7288" continuedAt="i2b56026934be44af87077d1e2107e870" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2b56026934be44af87077d1e2107e870" continuedAt="i32824cbeb303456e838d83de3c25c62e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="store" contextRef="i34ba550f20da42bf8e118610bd9d1e54_I20230331" decimals="-2" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTgy_c9b7ba06-d541-459c-a14c-96e961c02721">9,000</ix:nonFraction> retail locations, more than <ix:nonFraction unitRef="clinic" contextRef="i6efe121123d64cc4871d92d64ebb6df8_I20230331" decimals="-2" name="cvs:NumberOfWalkInMedicalClinics" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjEz_c1c80944-409d-41c4-be39-205cce80f989">1,100</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with over <ix:nonFraction unitRef="people" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:NumberOfPharmacyPlanMembers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjg3_d607cea5-d89f-46cc-aefe-a6fcfe819fcd">110</ix:nonFraction> million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:NumberOfPatientsServedPerYear" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNDEx_987ec0e0-82c4-4a36-b82f-3a113c69a418">one million</ix:nonFraction> patients per year. The Company also serves an estimated <ix:nonFraction unitRef="people" contextRef="i9b1e8e047ca74e2da7465cdbe0294566_I20230331" decimals="-6" name="cvs:NumberOfPeopleServed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNDcw_9d3d0dfd-97d2-4121-a22c-0e6883fca3da">37</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company is a leader in key segments of health care through its foundational businesses and is creating new sources of value by expanding into next generation care delivery and health services, with a goal of improving satisfaction levels for both providers and consumers. The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjQ_5259c852-cb1f-434a-aa00-bf9e0c7b5f94" continuedAt="i1ae3cf2eded84424ba70bdd5b5bff86a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Prior period segment financial information has been recast to conform with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the segment realignment described above, the Company&#8217;s <ix:nonFraction unitRef="segment" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTI4OA_f36614f1-6a64-4bdc-b809-b77224295444">four</ix:nonFraction> reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in <ix:nonFraction unitRef="state" contextRef="i4ef8067610324631a99b73d483b1c819_D20230101-20230331" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesNumberOfStates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjgzNA_8842491b-6dd9-42a4-8052-e80e51f6b03c">eight</ix:nonFraction> states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in <ix:nonFraction unitRef="state" contextRef="i686abe201e9f4a07bc66c9a037f0de35_D20230101-20230131" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjk1OA_6a9de7cd-86c7-402a-9278-ff5b936c2f40">four</ix:nonFraction> additional states effective January 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Health Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i32824cbeb303456e838d83de3c25c62e" continuedAt="i7afd7aab567244babbdfdd6830b261e3"><ix:continuation id="i1ae3cf2eded84424ba70bdd5b5bff86a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of March&#160;31, 2023, the Pharmacy &amp; Consumer Wellness segment operated more than <ix:nonFraction unitRef="store" contextRef="i34ba550f20da42bf8e118610bd9d1e54_I20230331" decimals="-2" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNTE2NQ_c9b7ba06-d541-459c-a14c-96e961c02721">9,000</ix:nonFraction> retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNTg_281bd691-f6c6-4090-95b0-2037654b631e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;2022 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNDA_91eca5aa-5146-4014-80a6-97d4f64d4ec5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMzU_a5b78abd-71cf-4274-aa02-38682a93790c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7afd7aab567244babbdfdd6830b261e3" continuedAt="i7cc3f4327806493e98c4a2b5df73fea1"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzk_88651fb4-8ac8-4428-a5bf-e7a0769d22ec" continuedAt="i73114bd61e424767bb21a3b456e45cd0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets primarily represents funds held on behalf of members and funds held in escrow in connection with agreements with accountable care organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i73114bd61e424767bb21a3b456e45cd0">All restricted cash is invested in demand deposits, time deposits and money market funds.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNTA_7a5f533a-0ad5-4bef-97c3-ce04e521237d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMS0xLTEtMS0yMzI1NDc_41ee416c-eaaf-4cda-bfda-3e1ab92d4b4e">14,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMS0zLTEtMS0yMzI1NDc_300c1f9e-7d1b-4890-8716-09c0ce261859">12,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMi0xLTEtMS0yMzI1NDc_c19f9971-f503-428f-a574-13a7e3975f69">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMi0zLTEtMS0yMzI1NDc_d106da8e-b955-49e1-95d1-073e4cd7743e">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMy0xLTEtMS0yMzI1NDc_ebc093cf-b7d2-44a4-8c00-5b04fc124c49">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMy0zLTEtMS0yMzI1NDc_4807925b-a47b-4491-8dd4-0166adae0a5b">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfNC0xLTEtMS0yMzI1NDc_fc575663-6eed-4f80-9e5c-694c0f1cec89">14,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfNC0zLTEtMS0yMzI1NDc_beb20433-ed91-4751-ac5c-3db562c21955">13,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjU_0b5f9931-1bb2-4a13-9807-a7f32b3966b6" continuedAt="i7ba61fd0f5bc4b77b909bafb2550ddb7" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ba61fd0f5bc4b77b909bafb2550ddb7">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</ix:continuation>. <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzODI_87fc1bbe-c487-4576-b70d-8383cbea4d74" continuedAt="ic46173512a4741dc8db7efd6c9d73c69" escape="true">Accounts receivable, net at March&#160;31, 2023 and December&#160;31, 2022 was composed of the following:</ix:nonNumeric></span></div><ix:continuation id="ic46173512a4741dc8db7efd6c9d73c69"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMS0xLTEtMS0yMzI1NDc_b9c25d7d-c4e9-4f5f-9467-116e390a1b4e">9,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMS0zLTEtMS0yMzI1NDc_2a3cd6a5-567e-4e90-a927-70d12bd1800d">8,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:VendorAndManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMi0xLTEtMS0yMzI1NDc_54f1430f-7419-4a49-8875-886b13160b7d">13,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:VendorAndManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMi0zLTEtMS0yMzI1NDc_248f9163-5370-41cf-a8b5-a3b8116af974">12,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMy0xLTEtMS0yMzI1NDc_b49af400-7436-400d-800e-81659ed65a35">3,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMy0zLTEtMS0yMzI1NDc_f93f6da8-65d3-4e2b-8373-287529870d7c">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNC0xLTEtMS0yMzI1NDc_52a1be93-2711-4eb4-bf75-ef1ac6e14a31">2,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNC0zLTEtMS0yMzI1NDc_073ca64a-8764-42a1-a231-8ee756f5e257">3,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNS0xLTEtMS0yMzI1NDc_6f7aafc0-37d9-4460-8a57-b023922dcc99">28,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNS0zLTEtMS0yMzI1NDc_b6d219d7-21c2-44ad-869e-7d40361c047c">27,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTAyMTA_ee6e4afc-4021-42ab-a361-0cb04504a951">211</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzODg2OA_fa080f4d-5a7a-4ac6-94b5-5453418bfa53">227</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTA0Njc_9c9d6b00-a29f-44a0-83c8-6d71f846fc2e">324</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTA0NzQ_884fffe6-8fbb-4f3f-8c8f-de7982bfd61e">333</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNjk_b7b8cc6e-76f8-455f-8e9d-7baa8bb11104" escape="true">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU1Nw_deafd8bd-511c-4f8d-8049-e507d3c78347" continuedAt="ie1710fe99f1346e0aed72dbe827d546f" escape="true">Health Care Contract Acquisition Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie1710fe99f1346e0aed72dbe827d546f">Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the unaudited condensed consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#8217;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the unaudited condensed consolidated statements of operations.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7cc3f4327806493e98c4a2b5df73fea1" continuedAt="i9d80515dae4a4855ada19b1ae4d73b79"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2Mw_a232686e-396f-4be9-8ebd-fa2d80d753ab" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of deferred acquisition costs for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMi0zLTEtMS0yNTA3OTU_a4c3ebf3-9a67-4898-a757-c3800beef294">1,219</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMi01LTEtMS0yNTA3OTU_d097f002-d570-4a91-93bc-d10bf94a2357">879</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalizations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostsAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMy0zLTEtMS0yNTA3OTU_700b1996-720e-4fe0-bba3-b6d7ce637314">135</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostsAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMy01LTEtMS0yNTA3OTU_72bcb890-43a8-45d7-bffd-612dbf7b0c72">139</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNC0zLTEtMS0yNTA3OTU_adb8268e-4ca2-49b6-81de-f45436cee2e0">64</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNC01LTEtMS0yNTA3OTU_5a17288b-2de2-49bb-a4f0-573315b4828a">47</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNi0zLTEtMS0yNTA3OTU_a9a35a96-7b28-4dd7-b9ce-0e3da6cb2b83">1,290</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNi01LTEtMS0yNTA3OTU_67e3d681-6221-49b4-ba04-4fbf6204967c">971</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU1OA_d3344adc-4136-4361-b80b-62f46beef114" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU1OQ_2681e8e1-943e-42ce-aeae-7dc617975e0a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:PolicyholderAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2MA_3bdd8070-b838-4ca8-80e9-985c567cc2dd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the unaudited condensed consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; and Note 6 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information about separate accounts.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:FuturePolicyBenefitsLiabilityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2MQ_ed83f6b3-bc36-4dc0-9a63-24216ab0cf83" continuedAt="i1cf6f4f0d04b41dcb299eba2906edbd3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Policy Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts and are recorded in other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for limited payment pension and annuity contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for long-term care insurance contracts represent the Company&#8217;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#8217;s </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9d80515dae4a4855ada19b1ae4d73b79" continuedAt="id84cecb8acec4a409794927d61043c19"><ix:continuation id="i1cf6f4f0d04b41dcb299eba2906edbd3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#8217;s future cash flows. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discounts its future policy benefit liability using a curve of spot rates derived from an upper-medium grade fixed-income investment. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot rate curve and the locked-in discount rate at each cohort&#8217;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss). In subsequent periods, the current period amount recorded in other comprehensive income (loss) will be adjusted for amounts previously recorded in accumulated other comprehensive loss.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, future policy benefits balances of $<ix:nonFraction unitRef="usd" contextRef="ibadef73562a5415eb23fb67f37c780fa_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzUzMg_efaf3f9b-4a0e-4369-b51a-a81dbe5ae805">529</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ifad147213d8945ffa73f99ae94585db9_I20230331" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzU4Mw_91a1b0be-b17c-46b1-b01d-59ec2766823f">4.6</ix:nonFraction>&#160;billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2022, future policy benefits balances of $<ix:nonFraction unitRef="usd" contextRef="i07754849794b4b5a972e925beaa2e2d0_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzYwMg_81ef35ff-3e44-42c4-9c70-fa5ea22af650">334</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i83fccfbc3a1e442bbaec480edae8a85b_I20221231" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzYyMA_14e12939-4b84-40f7-a72f-c894b38aada2">4.7</ix:nonFraction>&#160;billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information about future policy benefits.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id84cecb8acec4a409794927d61043c19" continuedAt="i7edbb3006e7e4630adf0b9163f0f81ab"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzE_065ce7a5-c822-42b6-9e93-b328d5ac1be8" continuedAt="i57767d8afc6f4b8f97fe35343fb704dc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:30.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer <br/>Wellness </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9c868143b7940b3b6159cc722b2c499_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy0xLTEtMS0yMzI1NDc_10829821-0f6c-4f6f-9745-5f32707402c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70419a8aec904963b0fc2149a92a6feb_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy0zLTEtMS0yMzI1NDc_c81f6193-b895-4d74-acb0-a3804c11ce5e">43,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb3b7119cdf445b286ff5a2b3bba733c_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy01LTEtMS0yMzI1NDc_b0d91378-a56d-4c4e-902f-5eb979fe0b10">21,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913d7229910442739c4ca1921c7d8667_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy03LTEtMS0yMzI1NDc_971e6e49-c418-49ef-bb85-0ea5a4e5647d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c623b94ee8462ebc5e118b823a3e98_D20230101-20230331" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy05LTEtMS0yMzI1NDc_631311ed-8054-4695-bdfd-9dc3c76d0764">12,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b014ab5cfd341f7ae8d078ed0c475f0_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy0xMS0xLTEtMjMyNTQ3_cbbd4315-2a04-4156-9b18-31871505ffc7">52,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7faa0d9a8c2d46d9a7fd1311b46dda78_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC0xLTEtMS0yMzI1NDc_cdc0df54-ed15-4b1b-8db8-2f2dc62d44fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3448fe5bcb4de789f0540bb778b942_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC0zLTEtMS0yMzI1NDc_16e9c464-4c97-4f8f-8dbc-ba2be3b3ee7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fde3795c73045aca5218db1a3bf0627_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC01LTEtMS0yMzI1NDc_51c5ea84-2ba2-4f80-889d-c0f8a964ee58">5,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f01a502bc824fe1bcb34881c372163e_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC03LTEtMS0yMzI1NDc_024eca49-4ac3-4ff7-991b-8082b1bf87bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed4956174e64851ad6fceaaf2191dc6_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC05LTEtMS0yMzI1NDc_3a6cab40-fdb6-47c2-b619-de2b7c8a2ecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d66e496f5549518e1bb751fee97f54_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC0xMS0xLTEtMjMyNTQ3_a0431135-f1bb-49e6-abb1-691859b21c02">5,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af16b8edb9d4671b5a7ce811f1e9a3e_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS0xLTEtMS0yMzI1NDc_01a9ffd8-34b4-4b8d-839e-69f1a039e226">24,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074bb083281146a4814aa0c3ac130d88_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS0zLTEtMS0yMzI1NDc_2655cce1-8271-42cc-86f0-99a5b70e9227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic730a4294079499a823806ec14836c28_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS01LTEtMS0yMzI1NDc_9efe7110-6232-4569-9322-ba9336ce9d6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e959c8f50844bdc9d92aa231cd7d852_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS03LTEtMS0yMzI1NDc_a779c8d9-0f32-46e4-9290-09550c7dd4ed">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a5b5bb1e9dd42a2aa9b210432135329_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS05LTEtMS0yMzI1NDc_dffe283f-6004-4f82-88ad-ee49e9967ca9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150b57bf1a274deead0798dbcbbc2bab_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS0xMS0xLTEtMjMyNTQ3_d1667624-410b-48eb-a1dc-75cc41defdd9">24,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi0xLTEtMS0yMzI1NDc_fe42237a-baf6-4569-95c6-afda1c26748a">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi0zLTEtMS0yMzI1NDc_04e81c4b-720b-4ea7-9761-d16bab732c52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi01LTEtMS0yMzI1NDc_81facbc8-46db-45fa-9d5f-744d6b31f738">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi03LTEtMS0yMzI1NDc_32784228-9225-4706-9382-0c83e49010fc">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi05LTEtMS0yMzI1NDc_b52938fe-0692-4e86-b761-705456e6c27e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi0xMS0xLTEtMjMyNTQ3_52101dd4-f42b-4c66-89ca-d4c6ca1d85f1">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21838ca5480d43e99c84c865f63fae2a_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy0xLTEtMS0yMzI1NDc_1717cad3-624f-4df2-8798-26c39a16e6a1">1,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b6e52d861e413ca3dcbe8cf24ddbe8_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy0zLTEtMS0yMzI1NDc_ce6e8fb0-50e9-48c9-bfc3-0ec847ad0d96">854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2726cf35a1549a39f68c6d870831a3a_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy01LTEtMS0yMzI1NDc_a5dfe87c-cfb7-4cbc-bb43-4b27cef8bcda">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6726b8f30277400383f48e1c4916b2ab_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy03LTEtMS0yMzI1NDc_b3c03dbf-69aa-469d-93a2-d178557239d0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d9bf2d1bfaf4038bee28037421646dc_D20230101-20230331" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy05LTEtMS0yMzI1NDc_8f10b121-2160-426a-a41a-461937ee6872">568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1599d39404424e269c1dd6dd7a2f8beb_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy0xMS0xLTEtMjMyNTQ3_19195814-991e-4f17-b543-bf256dc19e8c">2,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC0xLTEtMS0yMzI1NDc_be5e9f62-1abe-4335-8b98-b9d19aa52033">25,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC0zLTEtMS0yMzI1NDc_321e4a26-d2fe-47d9-8776-99d6bf7228dd">44,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC01LTEtMS0yMzI1NDc_432d3363-b761-48bf-a827-5a45096b39f7">27,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC03LTEtMS0yMzI1NDc_8dae308d-dab2-43f2-8111-81281fad008d">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC05LTEtMS0yMzI1NDc_4c6c475a-5166-40b4-bc5e-a1724f095831">13,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC0xMS0xLTEtMjMyNTQ3_ff87d744-c72c-4ec2-9a63-c8ba8de417fc">85,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5217fa8bc5cb48358a723612bde7d479_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTEtMy0xLTEtMjMyNTQ3_2495199f-1e9b-47d5-ba9e-d01d9a2d574d">27,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i003831bfd1e24cfc94e47ab4156fd856_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTItMy0xLTEtMjMyNTQ3_91b30d3e-783e-4430-a5d2-3f79d1f44b0d">16,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib416aea626f043fd9431aa5342e2b4c8_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTMtMy0xLTEtMjMyNTQ3_1af4e5ab-5c2c-4e20-a6ac-528b8e368057">854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTQtMy0xLTEtMjMyNTQ3_6298f807-b58d-4715-8e9b-a841c8b7090f">44,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19d1a8e74194a419ec6e6349cf88ae9_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtMS0xLTEtMjMyNTQ3_d64ed09d-86bf-43b9-ba3e-31b05e619251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea8ab3ccda94b4fb2323193afbc272e_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtMy0xLTEtMjMyNTQ3_12681823-5ae5-411b-911b-f442c37babdd">38,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60d284b94f343769d7fb6d50fda05c9_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtNS0xLTEtMjMyNTQ3_c1d129a1-5580-486b-a777-194df25f231e">19,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb268de0eb0840c6ad11a4d9d30093e4_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtNy0xLTEtMjMyNTQ3_e02a3c94-2bc3-4d9b-98be-5bd1131ed7db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i834cc79324ef46228461e0711bc261e1_D20220101-20220331" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtOS0xLTEtMjMyNTQ3_39295e5b-4fd6-483f-a8b6-c8716b2ba136">11,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5614313bb744e009682b28fbc6584fc_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtMTEtMS0xLTIzMjU0Nw_57f2b3f8-9a2b-46eb-9699-cb41329802e7">47,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d1785a62b574847bd8bd9762c88ad05_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktMS0xLTEtMjMyNTQ3_e242e674-bdc7-4b48-8593-bac2d222546b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8416ff007f2346618a642e998ffbde5f_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktMy0xLTEtMjMyNTQ3_664b3355-bc2f-42d3-81f9-f4b032344ae1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea625c13b80a41a38461b27d7dc98167_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktNS0xLTEtMjMyNTQ3_df8f2ee1-28dd-43e7-9a8c-307515ff34ae">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2ab9d4f54a4545aa1a48d8fcffe4a3_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktNy0xLTEtMjMyNTQ3_0e484942-2e95-4562-b6a3-2a62bfd36293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33693ee297b14cd1b0fd9a47d4d4f880_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktOS0xLTEtMjMyNTQ3_9dc8b3a7-8beb-4088-8472-2f0145e43575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd51d95f7ef41039d8cfa9e1d363b8f_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktMTEtMS0xLTIzMjU0Nw_6b29dfa3-7ef9-4dd3-b264-b8aa61e16872">5,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe185f8b39742e6bf6fc4a03b2c1cec_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtMS0xLTEtMjMyNTQ3_bbd7e4fd-2912-460c-92e0-ab49591b203e">21,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ided2d67f45094a79a717c8cee0eb96d0_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtMy0xLTEtMjMyNTQ3_67a0bea1-4c04-4bb5-aa60-5230cc32f41e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie000fac120824472bf6fbd96bd370915_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtNS0xLTEtMjMyNTQ3_9b20a3f6-91ca-46e9-83d9-694277113584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108159c26e0d4ad68b98ccf1c5e9a35f_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtNy0xLTEtMjMyNTQ3_be868464-936c-4239-95f8-c0bfc4cbd7c8">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d1376e4b4e47bc99fff3a44a2e7122_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtOS0xLTEtMjMyNTQ3_c595beee-083e-4568-84c5-e1e0a9021081">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04e21b8463b4e6eb6cb2ca6a5197ca2_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtMTEtMS0xLTIzMjU0Nw_39508d90-c4db-43d6-9960-66fb98e50168">21,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtMS0xLTEtMjMyNTQ3_ac2f5a64-b44d-4e16-9fdf-0a5bde6bb294">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtMy0xLTEtMjMyNTQ3_fc58c007-2afc-4e33-b9f0-494398315d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtNS0xLTEtMjMyNTQ3_56140bad-2d23-410f-8b71-e69b1e11240e">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtNy0xLTEtMjMyNTQ3_9dbb836f-5821-4963-b9b3-191612a6f297">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtOS0xLTEtMjMyNTQ3_60f5be7b-fb5d-46ed-b5ce-4d46f3fef096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtMTEtMS0xLTIzMjU0Nw_5a749e99-b56a-4c1d-b346-f6d333c5dba5">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177844ba7569439393b0dd8b1f8727ff_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItMS0xLTEtMjMyNTQ3_834072cb-1058-4e65-bd22-1ccfda0da585">1,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29b95f23f2f4497e8f422c459c2ad25c_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItMy0xLTEtMjMyNTQ3_d70245a4-9495-405c-9d0f-223d47c6b9be">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20a226c3f2ff49e2848ef2bd802993fd_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItNS0xLTEtMjMyNTQ3_fb57a8f5-9af3-4618-904a-234d79a56059">1,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbcab26d09246a984f88af308a36bde_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItNy0xLTEtMjMyNTQ3_71d43f36-1eab-4174-92b0-68bb9235b0a0">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f7b0dd6afc04d5fb6dec0b03362681a_D20220101-20220331" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItOS0xLTEtMjMyNTQ3_c8d57509-14b9-4439-a4ab-df89ca1d6605">631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbfb3606fe14686af2486fd20b1659d_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItMTEtMS0xLTIzMjU0Nw_33c3303e-5fb1-4873-a6aa-0891e5a07887">2,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtMS0xLTEtMjMyNTQ3_29d098b3-e312-4ff8-b441-3d8d7cee9716">23,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtMy0xLTEtMjMyNTQ3_2c84fa96-9c68-4ce9-b0a1-a1908f7ec1bc">39,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtNS0xLTEtMjMyNTQ3_0ff205d4-4830-47e6-a39e-2444df28cdcf">25,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtNy0xLTEtMjMyNTQ3_a1ae50b6-ff7f-43c5-a3da-73f177a9a618">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtOS0xLTEtMjMyNTQ3_de525f5d-807b-40de-b116-5f068596a7ce">11,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtMTEtMS0xLTIzMjU0Nw_dca49a45-fba0-4e29-a4f8-957bb90abfc5">76,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9544478beb4979bd59c64b69d4a6a1_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjYtMy0xLTEtMjMyNTQ3_17c82deb-2a07-42dc-835a-f1ac31d7e770">24,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5bb2b68e6b044e298527de5f04d708d_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjctMy0xLTEtMjMyNTQ3_7b586682-be74-41bf-af52-d49ffdba9678">14,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d3ac659a2774583871cc2f66cd8f09e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjgtMy0xLTEtMjMyNTQ3_685a4f6c-3bbe-464a-b5c2-1bb70043180b">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjktMy0xLTEtMjMyNTQ3_a9ee0ed5-5904-4ed6-82b2-d333b39db8eb">39,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty. Prior period financial information has been revised to conform with current period presentation. </span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="i57767d8afc6f4b8f97fe35343fb704dc" continuedAt="ie2ec248d975b4101af884270012c1539"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Health Services mail &amp; specialty is defined as specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ie2ec248d975b4101af884270012c1539"> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Prior period financial information has been revised to conform with current period presentation.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzODU_92267a17-5c60-4577-97ba-7548258459c1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and primarily include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i7edbb3006e7e4630adf0b9163f0f81ab" continuedAt="i69f9e3f473004d0cbcaaf8661e13534b"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzU_d2e4393a-6176-4f19-af36-378225f056de" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMS0xLTEtMS0yMzI1NDc_b9c25d7d-c4e9-4f5f-9467-116e390a1b4e">9,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMS0zLTEtMS0yMzI1NDc_1c482a7a-eb8a-4cca-9ed0-fd4421330b45">8,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMi0xLTEtMS0yMzI1NDc_53bb12ae-e0e7-44bf-9e03-95cddb494958">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMi0zLTEtMS0yMzI1NDc_f2794f9b-9ad8-439e-84be-aa8f36024e65">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. During the three months ended March&#160;31, 2023, the contract liabilities balance also reflects the addition of contract liabilities acquired in connection with the Company&#8217;s acquisition of Signify Health, Inc. (&#8220;Signify Health&#8221;) on March 29, 2023. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMi0xLTEtMS0yMzI1NDc_f2794f9b-9ad8-439e-84be-aa8f36024e65">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMi0zLTEtMS0yMzI1NDc_8e539c73-fe9a-4356-8d78-709463b5a9e5">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMy0xLTEtMS0yMzI1NDc_940fe97e-cba0-43b8-bd7d-2e8a61b0132a">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMy0zLTEtMS0yMzI1NDc_5a22a083-845b-4b80-b0ec-ce9bff64fda6">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNC0xLTEtMS0yMzI1NDc_a440a7ac-dd9f-4f35-9213-243f216d406f">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNC0zLTEtMS0yMzI1NDc_84985a46-9fea-4567-98d4-35e47d446ef0">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0xLTEtMS0yNzY4Mzg_eec48108-eed1-4a68-941f-a4d0f642a7f2">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0zLTEtMS0yNzY4Mzg_bcca84bc-43c9-4f9d-b170-cbd11a8857d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0xLTEtMS0yMzI1NDc_53bb12ae-e0e7-44bf-9e03-95cddb494958">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0zLTEtMS0yMzI1NDc_ee8232f2-d0aa-4f66-8618-234bbac38b74">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjE_86abb38a-f121-46ee-8d48-b5783c277c48" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTMyNjE_1aee7600-96e2-4545-bcca-0fe06aa14982">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNTQ5NzU1ODMxNTEx_22983b68-36b7-4b98-9977-3670caac78df">15</ix:nonFraction> million in the three months ended March&#160;31, 2023 and 2022, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="i4a6ae917fc994efda306a7228aff6320_I20230331" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTM2OTM_7cf97454-5811-4252-ab04-0d09da3939c3">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTM3MzE_a19e6179-5841-4078-95b7-abf48ab44d89">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTM3Mzg_83bc9af8-0ccf-4322-8e0e-02d098224afe">21</ix:nonFraction> million for pharmaceutical inventory purchases during the three months ended March&#160;31, 2023 and 2022, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzg_d9fe5c13-48fe-44a7-be46-022c5daae985" continuedAt="i8199ed910217440383641feb2cdb3b29" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944) (the &#8220;long-duration insurance standard&#8221;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented, January 1, 2021, also referred to as the &#8220;transition date&#8221;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $<ix:nonFraction unitRef="usd" contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101" decimals="-6" sign="-" name="cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY3Ng_4fbdcc97-8c63-44d9-b224-07aec91c274c"><ix:nonFraction unitRef="usd" contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY3Ng_9e94c056-f763-4921-a5a2-c1583855c284">986</ix:nonFraction></ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY5MA_1e5d26f1-0a4d-47bf-9866-457558e688ca"><ix:nonFraction unitRef="usd" contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY5MA_a967fee8-3273-4ef5-9637-9b49b1b25c03">766</ix:nonFraction></ix:nonFraction>&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. The transition date </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i69f9e3f473004d0cbcaaf8661e13534b" continuedAt="i765599cd50464ccc9c1a94287a3fee74"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8199ed910217440383641feb2cdb3b29">net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information has been  revised to reflect the adoption of the long-duration insurance standard.</ix:continuation></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2NA_7dd95b80-14ae-4201-b113-36f37d66924c" continuedAt="i29c5171ff68e4738881bf7605f2d22a0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMS0xLTEtMS0yNTY1MDE_d11824ea-fe6a-4979-868f-b994eafcbfb6">3,224</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id410b8ee1a2f45edad8defa2042f4b1b_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMS0zLTEtMS0yNTY1MDE_6c612fed-ea98-4a93-ad8f-e0d76074d54f">1,142</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb57f57ab4aa4756834cf154419fa446_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMS01LTEtMS0yNTY0ODQ_a0bab213-e9da-4bc3-82a4-a9fad3ce4e0b">480</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMi0xLTEtMS0yNTY2MDI_c0a69dfe-821b-428f-a3d6-15dfe8b903ca">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id410b8ee1a2f45edad8defa2042f4b1b_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMi0zLTEtMS0yNTY2MDI_eb7d65d1-cb1d-4de7-8f9f-5f70abea7ed3">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb57f57ab4aa4756834cf154419fa446_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMi01LTEtMS0yNTY2MDI_dce49fe0-3eda-46eb-bf80-a56e61a72472">274</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0xLTEtMS0yNTY2MDI_2b282fe9-2f0c-4a30-88a9-64941a019082">3,224</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id410b8ee1a2f45edad8defa2042f4b1b_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0zLTEtMS0yNTY2MDI_280af4fd-ed5d-47cb-ad34-4670c0631263">1,142</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb57f57ab4aa4756834cf154419fa446_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy01LTEtMS0yNTY2MDI_488b7711-9863-434d-97b3-ce0951eb6925">754</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7d3bb136a1f4e01a755060f96bc46f1_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0xLTEtMS0yNTQ5MDY_09332462-05bd-48bc-88dd-5d243fbf7ff9">604</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9884f3d8910649048241aa4449af5b47_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0zLTEtMS0yNTQ5MDY_1d29cb21-0ba6-4a93-b1f7-e2e65c253654">553</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e56abae24c4188a3a7c997d9c465c2_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy01LTEtMS0yNTQ5MDY_f4a4bcaa-d84b-4a67-a6e5-103b94b667b5">44</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Removal of shadow adjustments in accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a54fdeeb3e044288d6c4a1818ab4dee_I20201231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNi0xLTEtMS0yNTQ5MDY_bcc89083-bb63-4220-900c-4e6e4f9c7138">181</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42eb8ce2ba0b4cf0bf9748577c25dae5_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNi0zLTEtMS0yNTQ5MDY_c6e34f95-7d21-4ae3-9fbe-ab5c1009f56c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d253afd2a9475db0569365a548c9c4_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNi01LTEtMS0yNTQ5MDY_961ab663-18d0-4a4b-8bef-c543cf35097c">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNy0xLTEtMS0yNTQ5MDY_444cce7d-325b-4a4f-8367-753f18e4dd5b">3,647</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i649b9f03c30f4132b55105d20f98cd1d_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNy0zLTEtMS0yNTQ5MDY_1a70a1ae-f08f-4c0f-9db2-7470c4068b1f">1,695</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977993d8848741e6a20cfa0d2b47e0ee_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNy01LTEtMS0yNTQ5MDY_1b3687de-349d-474d-849d-e60fb399cabb">798</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOC0xLTEtMS0yNTUwOTI_d56e90bf-5a6c-449f-8dc5-1979d45d3e30">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i649b9f03c30f4132b55105d20f98cd1d_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOC0zLTEtMS0yNTQ5MDY_11e49e80-fc96-4b67-8045-e4c3bfc02139">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977993d8848741e6a20cfa0d2b47e0ee_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOC01LTEtMS0yNTQ5MDY_50113a70-833e-457c-bbd2-6b508683481e">308</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span id="i91763596c6af4e16a382b50f4b12646c_8-0-1-1-256536"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021, net of reinsurance </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOS0xLTEtMS0yNTQ5MDY_30ddbed9-8c6f-4f0a-84f8-debe4833727d">3,647</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i649b9f03c30f4132b55105d20f98cd1d_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOS0zLTEtMS0yNTQ5MDY_19123f2d-c0b7-489c-9451-ea827f30eb2c">1,695</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977993d8848741e6a20cfa0d2b47e0ee_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOS01LTEtMS0yNTQ5MDY_d4fd2c81-9a80-4d05-a827-30cf4f2ec07b">490</ix:nonFraction></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of Long-Duration Insurance Standard Adoption on Financial Statement Line Items</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of operations for the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy0xLTEtMS0yNTA4MzM_03907d12-a404-4284-baf0-57c9bcf53102">17,951</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy0zLTEtMS0yNTA4MzM_6dfd48cb-bbca-4e8d-84d7-457a4688fe6c">28</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy01LTEtMS0yNTA4MzM_0129db50-13e0-4431-959a-6a57ae77741e">17,923</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNS0xLTEtMS0yNTM2Nzc_43193850-516a-4904-bfba-49398a0fee04">9,351</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" sign="-" name="cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNS0zLTEtMS0yNTM2Nzc_72454077-8560-405f-b960-0c9c7374589e">27</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNS01LTEtMS0yNTM2Nzc_a31b1cee-de2c-4e63-ba66-8b154439d099">9,324</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOC0xLTEtMS0yNTA4MzM_a2160397-5c83-44b2-ad65-d04a5d0b4385">73,336</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOC0zLTEtMS0yNTA4MzM_2b08b558-8f9c-4b26-8008-bc776e4670cc">55</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOC01LTEtMS0yNTA4MzM_a1dc5280-e266-4427-92e0-1afe65fdc5a2">73,281</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOS0xLTEtMS0yNTA4MzM_e9e0583b-a0cc-4efa-91a8-f4be1790ea23">3,490</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy0zLTEtMS0yNTM2Nzc_a4804130-bd2f-42d6-9384-bdf4f87cbd39">55</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy01LTEtMS0yNTM2Nzc_9d303f37-b1bf-42e5-9dd1-91f134527843">3,545</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTAtMS0xLTEtMjUwODMz_148dedbb-68fa-4406-a3ae-1b36a1c1fb11">2,946</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTAtMy0xLTEtMjUwODMz_7f8f8278-0c30-48e7-aec1-89b2e88d6896">55</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTAtNS0xLTEtMjUwODMz_3d5b8126-3131-489f-9165-f3a38adf7082">3,001</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTEtMS0xLTEtMjUwODMz_84f8212f-c3b1-4f70-a6a0-2d4459708c5e">633</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTEtMy0xLTEtMjUwODMz_6cd1f5f4-73ba-4aee-a387-af24e72e1a4e">13</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTEtNS0xLTEtMjUwODMz_4264e1e8-1651-4d2e-960b-81d402f6725b">646</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMS0xLTEtMjUwODMz_f6663353-9669-4393-906a-22ee38186ade">2,313</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMy0xLTEtMjUwODMz_d9f8a516-4427-4a36-8da7-084f9c9db859">42</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtNS0xLTEtMjUwODMz_aa0d388c-7a25-4341-96b6-e65a51f972ad">2,355</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMS0xLTEtMjUwODMz_df33d1a7-aca4-4685-b6d5-e509b31c0fcd">2,312</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMy0xLTEtMjUwODMz_e98c051f-896b-4fd0-9e8e-c56e4890f343">42</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtNS0xLTEtMjUwODMz_d69ee8ed-96e6-4405-a1df-963ccbb50bf6">2,354</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMS0xLTEtMjc4MzYx_db03e20d-ebfb-4c90-a5a8-ba36adb002cb">1.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMy0xLTEtMjc4MzU5_f069a0e0-349d-4ca3-b633-0eebe6e4e293">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtNS0xLTEtMjc1OTIw_8b329685-2f7e-4062-89ac-faf3a78fecc5">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMS0xLTEtMjc4MzYx_9c1fe5a7-e6e9-4826-9c97-d035c09c379d">1.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMy0xLTEtMjc4MzU5_4f3bf6a4-9f90-4d01-85d3-b169d2a25379">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtNS0xLTEtMjc1OTIw_1223cc4d-14ee-4f4a-903a-0743d66bb84e">1.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i765599cd50464ccc9c1a94287a3fee74"><ix:continuation id="i29c5171ff68e4738881bf7605f2d22a0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated balance sheet as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMy0xLTEtMS0yNTM2OTM_c161e726-44bf-431c-a064-a64a4611f448">2,685</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMy0zLTEtMS0yNTM2OTM_0a00a0a6-bc9e-4462-873e-3530437ddac7">49</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMy01LTEtMS0yNTM2OTM_1cbbadf9-be52-41f1-9be8-d9977c67b4e6">2,636</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0xLTEtMS0yNjg2OTY_ae2bc21f-42c1-42d8-a12d-e6cb313a8f36">65,682</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0zLTEtMS0yNjg2OTY_7768127a-940f-4c94-a293-7e2e3cd7e0d9">49</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC01LTEtMS0yNjg2OTY_8f4ab013-5a20-44e2-b965-e7a1e75078ae">65,633</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0xLTEtMS0yNTM2OTM_51825f77-b750-4970-b6d4-ce348418e8c9">24,754</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0zLTEtMS0yNTM2OTM_cfff3d28-8067-44f3-98e9-9fed90424674">49</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC01LTEtMS0yNTM2OTM_1e074376-92e1-400a-b666-32e145b5eca5">24,803</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0xLTEtMS0yNTQyMzE_0e85efa1-8a7e-4503-be20-6b21da6c8d71">228,275</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0zLTEtMS0yNTQyMzE_ce14ff9d-6017-4a53-b808-1c3c013d2c19">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi01LTEtMS0yNTQyMzE_6c7849ac-fe0e-4cca-8b11-e1fd675b492a">228,275</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0xLTEtMS0yNTM2OTM_e06cc6c2-c359-475d-bd9c-0948e1f75f04">10,406</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0zLTEtMS0yNTM2OTM_ad006e7e-1d06-437a-b269-0329072e9a6a">264</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi01LTEtMS0yNTM2OTM_a9dea7d9-b3b9-46f6-bb11-b2e4aea9a902">10,142</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOC0xLTEtMS0yNTM2OTM_c96f738b-6a47-46d7-8f11-8e61d3d59c93">1,140</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOC0zLTEtMS0yNTM2OTM_36bd0755-4ffc-4ed0-b4de-084376d3450d">51</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOC01LTEtMS0yNTM2OTM_8bd206ea-2807-439f-a0e4-1d79bf9246db">1,089</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMS0xLTEtMjU3MzAy_1c4a9435-1359-4cb9-ae36-6bc5ea743e01">69,736</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMy0xLTEtMjU3MzAy_a5c9442e-c5fc-4fe9-9cb6-08419bb9aaf1">315</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtNS0xLTEtMjU3MzAy_2cb2d418-3012-48c9-90ae-6140372fad4f">69,421</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOS0xLTEtMS0yNTM2OTM_59ed9134-3faa-4c19-9dac-315d54559a07">3,880</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOS0zLTEtMS0yNTM2OTM_3c984972-bce6-483f-bbb2-aa1db87e1797">136</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOS01LTEtMS0yNTM2OTM_3340fb1c-988c-4135-b087-07705128e5a7">4,016</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTAtMS0xLTEtMjUzNjkz_1e0cf0db-1af9-4124-9a30-f2e4a3aa267b">6,108</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTAtMy0xLTEtMjUzNjkz_243e0617-0519-4dcc-b758-5aa2520d3680">273</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTAtNS0xLTEtMjUzNjkz_ee225559-4905-4f8c-b25a-25becb69d824">5,835</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTQtMS0xLTEtMjY4NzMx_3c4a68b8-39e9-4942-8e00-0bb62b63a7d9">6,732</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTQtMy0xLTEtMjY4NzMx_aff8285f-16ae-4803-b69b-25b99adaec1f">2</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTQtNS0xLTEtMjY4NzMx_7c174953-87b6-4ccd-a586-9b67896c85cd">6,730</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMS0xLTEtMjU0MjM5_0a4d0cfe-02d9-4d66-a12c-e5cdee8f014a">156,960</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" sign="-" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMy0xLTEtMjU0MjM5_4b2762f3-1068-4f4b-9387-ce3b4e91e61a">454</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItNS0xLTEtMjU0MjM5_b8374f4a-3a4e-4d58-a934-7c77dbdb7a27">156,506</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMS0xLTEtMjU0MTI2_31dea997-0f12-42a8-97a4-bebef5bc9f48">56,145</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMy0xLTEtMjU0MTM5_ccb1b5e7-4b40-4d79-9067-19591ea5b81f">253</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtNS0xLTEtMjU0MTM5_e1313fbc-cc3d-4239-bd2b-5b0babae4806">56,398</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMS0xLTEtMjUzNjkz_5487f8a4-dc98-44fa-9fbb-0e0bfb0d8bae">1,465</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMy0xLTEtMjUzNjkz_3fe0d9d9-8363-43cf-8c7e-e7a0f900aa55">201</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtNS0xLTEtMjUzNjkz_04c91ff2-c31a-4466-91fb-9393007ab49b">1,264</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMS0xLTEtMjUzNjkz_99021c44-e0f8-4dfe-b1d4-89bdf88f2f8b">71,015</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMy0xLTEtMjUzNjkz_92f5b937-c0f4-4e70-b52f-934ffb6a1117">454</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItNS0xLTEtMjUzNjkz_6043297c-32b4-4b5d-91a5-cc1ff018b914">71,469</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTMtMS0xLTEtMjUzNjkz_3406b3cc-e695-40cb-84d3-a380f5cd6251">71,315</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTMtMy0xLTEtMjUzNjkz_ae860681-12f2-4fb6-a722-5b99fedb480d">454</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTMtNS0xLTEtMjUzNjkz_1ddbdf93-d845-4d04-ab08-72d3ecc5c71f">71,769</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTgtMS0xLTEtMjc0MDcy_f37df505-65d6-4e20-8f37-974fb7d5db91">228,275</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTgtMy0xLTEtMjc0MDcy_c91587f6-1f8a-44da-9bda-8f6afcff1e83">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTgtNS0xLTEtMjc0MDcy_5f23b419-739f-4932-9a26-191540affaf8">228,275</ix:nonFraction></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of cash flows for the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNC0xLTEtMS0yNTM3NDA_bdde5f41-18ec-4ff9-a613-49b111b2fa0c">2,313</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNC0zLTEtMS0yNTM3NDA_a582f281-b393-49b4-bb16-af8713eb6f30">42</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNC01LTEtMS0yNTM3NDA_13e7a149-c11b-4f5d-97b8-b44c3e08e1e7">2,355</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNi0xLTEtMS0yNTM3NDA_d843e6ed-19a4-47f0-a41f-6518b8196c2d">1,055</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNi0zLTEtMS0yNTM3NDA_8129d0f4-8990-4dd1-9ac7-94a47b05402a">6</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNi01LTEtMS0yNTM3NDA_8116e780-987a-4bb9-9cc4-7cb9772c41bb">1,049</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" sign="-" name="cvs:DeferredIncomeTaxesAndOtherNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNy0xLTEtMS0yNTM3NDA_fcef7bd6-5462-4842-8953-1b1a4f396439">187</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" name="cvs:DeferredIncomeTaxesAndOtherNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNy0zLTEtMS0yNTM3NDA_fc2b80e8-8a12-4352-9ff9-f8f02382f984">12</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="cvs:DeferredIncomeTaxesAndOtherNoncashItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNy01LTEtMS0yNTM3NDA_1fb99384-b1c8-4769-bce3-fbb1bb5a12c1">175</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfOS0xLTEtMS0yNTM3NDA_d8ae80ad-68e5-47a7-8daa-ac5c46925f15">352</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfOS0zLTEtMS0yNTM3NDA_22c50a5f-44ec-4dce-bd48-50e20d837c0e">4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfOS01LTEtMS0yNTM3NDA_20928b48-5240-4c7e-82ce-243ef479cafe">348</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTAtMS0xLTEtMjU0Mjkz_e779597d-777b-411f-8396-487a57e0656e">1,478</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTAtMy0xLTEtMjU0Mjkz_1c101d49-ffc1-4087-bdae-1d288beb1a1f">48</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTAtNS0xLTEtMjU0Mjkz_a8d2a668-1204-44ad-88b5-de090228aea0">1,430</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTEtMS0xLTEtMjUzNzQw_36aa3e7b-08b5-4c8f-9139-24aa78b7b51c">440</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTEtMy0xLTEtMjUzNzQw_4179288c-c986-4123-8d8b-1b0652f002e0">4</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTEtNS0xLTEtMjUzNzQw_42c28260-c40a-4259-9c79-ae0321598ec6">444</ix:nonFraction>)</span></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27.22pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.72pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNjAwMg_60742919-bec9-4cc9-a401-e697059a8ff8" continuedAt="ibb7d5337100c43a1abe561b25f89843c" escape="true">Acquisitions and Assets Held for Sale</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibb7d5337100c43a1abe561b25f89843c" continuedAt="i7d5d277c18974d33b234dc8cc81b9c34"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Signify Health Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2023 (the &#8220;Signify Health Acquisition Date&#8221;), the Company acquired <ix:nonFraction unitRef="number" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU0OA_016160dc-f26c-402d-8ed3-bb5ff0d0f312">100</ix:nonFraction>% of the outstanding shares and voting interest of Signify Health for cash (&#8220;Signify Health Acquisition&#8221;). Under the terms of the merger agreement, Signify Health stockholders received $<ix:nonFraction unitRef="usdPerShare" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzI5ODUzNDkxOTUyMg_f56a90f4-fc33-4ad3-a621-d854f01b292c">30.50</ix:nonFraction> per share in cash. The Company financed the transaction with cash on hand, which included approximately $<ix:nonFraction unitRef="usd" contextRef="i1bc1e1b3223b4f1cb3c91d8f034eb45b_D20230201-20230228" decimals="-9" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzI5ODUzNDkxOTU0Mg_b6e86c84-1188-4e47-b8c1-5012b78badb4">6</ix:nonFraction>&#160;billion of proceeds from the issuance of senior unsecured notes in February 2023. Signify Health is a leader in health risk assessments, value-based care and provider enablement services. The Company will include Signify Health within the Health Services segment. The Company acquired Signify Health to advance its health care services strategy, growth in value-based care and new product offerings for other payers.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU0Ng_8be99fc0-9f05-4e58-a97b-d3252e2c5916" continuedAt="i87a7626a87db4da39648708a0b28c310" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the consideration transferred on the date of acquisition consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMS0xLTEtMS0yNjI0MDU_679a8d64-7b3d-4bf1-9a68-fb4b4cb3c1bc">7,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of replacement equity awards for pre-combination services (<ix:nonFraction unitRef="shares" contextRef="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMi0wLTEtMS0yNzM4MjQvdGV4dHJlZ2lvbjo3NGU2ODkwMDk5MmM0YWZiYjVmNWYzNjYwZTYyNzI5NF8zMjk4NTM0ODgzNDM4_5c2376d0-4937-4c3a-94bf-b01b5fc31f5f">3.2</ix:nonFraction>&#160;million shares) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMi0xLTEtMS0yNjI0MDU_35278e5a-5e97-47dc-a429-12267d7cd277">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective settlement of pre-existing relationship </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329" decimals="-6" name="cvs:BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMy0xLTEtMS0yNjI0MDU_5755e209-932b-437f-9f8e-81919237782b">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfNC0xLTEtMS0yNjI0MDU_c92924b1-8c1f-4ba3-b821-e5c52feaffae">7,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The fair value of the replacement equity awards issued by the Company was determined as of the Signify Health Acquisition Date. The fair value of the awards attributed to pre-combination services of $<ix:nonFraction unitRef="usd" contextRef="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMTY0OTI2NzQ4OTAyNw_35278e5a-5e97-47dc-a429-12267d7cd277">14</ix:nonFraction> million is included in the consideration transferred and the fair value of the awards attributed to post-combination services of $<ix:nonFraction unitRef="usd" contextRef="i7d0721ccf873491b96d1a9065be7d6f9_D20230329-20230329" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzI5ODUzNDkyMTM2Nw_b2b3821d-cb77-4a56-b3bf-dfbb9a29d8bc">167</ix:nonFraction>&#160;million has been, or will be, included in the Company&#8217;s post-combination financial statements as compensation costs.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i87a7626a87db4da39648708a0b28c310" continuedAt="ibbd53738ccaa4e948a7b2d6e417f3a63">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="ibbd53738ccaa4e948a7b2d6e417f3a63">The purchase price included $<ix:nonFraction unitRef="usd" contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329" decimals="-6" name="cvs:BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMTY0OTI2NzQ4OTAzNA_5755e209-932b-437f-9f8e-81919237782b">111</ix:nonFraction> million of effectively settled liabilities the Company owed to Signify Health from their pre-existing relationship.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction has been accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU1Mw_f0788e4b-dc3a-4b17-b636-e5fefe9a9a26" continuedAt="i2e4acfff466f4ef886e9a0753429741f" escape="true">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i2e4acfff466f4ef886e9a0753429741f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMS0xLTEtMS0yNjI0ODA_a061b113-5888-4694-9ffa-4507e20832c2">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMi0xLTEtMS0yNjI0ODA_7f2776d1-ebf4-47bf-b866-e73a8fd7844b">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets (including restricted cash of $<ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="cvs:BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMy0wLTEtMS0yNjk1NDIvdGV4dHJlZ2lvbjo5YTI1MDM1ZTFiYmE0MjkyYjc1MGIyMTEwZGQyNGEyYl8xNjQ5MjY3NDQxNzQy_2a341973-11b8-46e1-9bd6-8be1aab66377">28</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMy0xLTEtMS0yNjI0ODA_64bd1fd8-ab64-41b2-9482-ed8a59f697f6">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNC0xLTEtMS0yNjI0ODA_ec8da110-fb94-4cce-864c-12ee101ee11e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNS0xLTEtMS0yNjI0ODA_ec8c7ffd-170c-4b05-bf31-457db70c5083">5,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNi0xLTEtMS0yNjI0ODA_c3ff60e1-9bd0-4291-8b02-50494425ac7e">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNy0xLTEtMS0yNjI0ODA_3a161987-f7d7-4779-9581-279c6f634e53">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfOC0xLTEtMS0yNjI0ODA_0d7d212b-1266-462d-880d-4c1c3cc503b1">8,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTAtMS0xLTEtMjYyNDgw_13a0f617-3119-44f2-9998-03307df57b64">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (current and long-term)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTAtMS0xLTEtMjY5Nzc3_e9ffc0cd-7026-4880-805a-c3c024081d1f">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTEtMS0xLTEtMjYyNDgw_4fd75884-0c61-4ce7-8677-dbed2f789572">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTItMS0xLTEtMjYyNDgw_b0b9f6dd-ba10-4268-8a7d-d0f24ee2e8e1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTMtMS0xLTEtMjYyNDgw_398eb1cf-2905-42ed-ae49-f6b05dba13fc">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTQtMS0xLTEtMjYyNDgw_b9dd8e55-6104-4a7b-bc7f-f0c4fb272d57">7,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment of fair value is preliminary and is based on information that was available to management at the time the unaudited condensed consolidated financial statements were prepared. The most significant open items included the valuation of certain intangible assets, the estimation of certain contract assets and contract liabilities, the accounting for income taxes and the accounting for contingencies as management is awaiting additional information to complete its assessment of these matters. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date. The finalization of the Company&#8217;s purchase accounting assessment could result in changes in the valuation of assets acquired and liabilities assumed, which could be material.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i7d5d277c18974d33b234dc8cc81b9c34" continuedAt="i5e9bc530b28045ccab666cab1f841121"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents future economic benefits expected to arise from the Company&#8217;s expanded presence in the health services industry, the assembled workforce acquired, expected revenue and medical cost synergies, as well as operating efficiencies and cost savings. <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:BusinessCombinationSegmentAllocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU1NA_fb7ff572-16c7-4301-ae1e-7fd23d863bbe" continuedAt="i87dfb408b3e9409692e64aedf421e779" escape="true">The preliminary valuation of goodwill was allocated to the Company&#8217;s business segments as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i87dfb408b3e9409692e64aedf421e779"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd3ba4757bbe45faaadd9ba0c14cda5a_I20230329" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfMS0xLTEtMS0yNjI1Njg_cfdc0141-7cfd-47f1-a6a3-5efafc8e4316">3,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5520b236fefd42c6ac7b83e8db7d39d0_I20230329" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfMi0xLTEtMS0yNjI1Njg_743a0936-91ac-4ed2-ab9f-ecbf679a35d8">2,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy &amp; Consumer Wellness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28b96b93836450fbebf6c84e59a6a20_I20230329" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfMy0xLTEtMS0yNjI1Njg_a69e04e3-930c-4827-97ac-cb773822c58d">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfNC0xLTEtMS0yNjI1Njg_2560881a-f16d-4960-8144-512db38742f3">5,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $<ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-8" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODE4MDY4MQ_b1333164-558f-4da4-8533-10638e60c07e">1.7</ix:nonFraction>&#160;billion of goodwill is deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU1NQ_9e87130e-beaf-41df-a3b0-035a76d3ab2f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary fair values and weighted average useful lives for intangible assets acquired in the Signify Health Acquisition, each of which is subject to change as the Company finalizes its purchase accounting:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average useful life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted <br/>Average Useful<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4af840426f5742b98ce7a573b0ca84b1_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMS0xLTEtMS0yNjI2NTI_12541c5d-dc7c-4e42-bdfd-b19d74ec6365">1,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icfddb8845ccc4274844fac816ac10c32_D20230329-20230329" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMS0zLTEtMS0yNjI2Nzc_f8223904-4e3d-4cd3-878b-4a56541d3e2b">16.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82fb46fef07440d83a4d87da8d741a2_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMi0xLTEtMS0yNjI2NTI_be20b3c6-9f32-4bb9-a2f5-2bcdc91bb63c">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida41df4f3f8347ed801d55304618efc9_D20230329-20230329" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMi0zLTEtMS0yNjI2OTY_09fe0b62-be0b-4375-8472-5bfb92172a6e">3.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark (definite-lived)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fb2931d2f6141989e86bc6f9e479fa5_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMy0xLTEtMS0yNjI2NTI_897278b4-18e7-4b11-b833-192ae4797861">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a52af93ed8c4145bf21e078f72a0933_D20230329-20230329" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMy0zLTEtMS0yNjI3MTQ_0e8238b6-115c-4da4-8396-f699ebb6c1f0">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfNC0xLTEtMS0yNjI2NTI_ce471caa-c9a9-465f-ac69-42531a42357d">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfNC0zLTEtMS0yNjI3MTQ_e197a9c3-c637-4920-adab-6378550ec2ad">16.0</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation includes net deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODE4MTYzNg_0c726e95-ef2c-4964-9dda-c2a4cc3aa3e0">256</ix:nonFraction>&#160;million, primarily related to deferred tax liabilities established on the identifiable acquired intangible assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for Signify Health from the Signify Health Acquisition Date to March&#160;31, 2023 were immaterial to the Company&#8217;s consolidated results of operations for the three months ended March 31, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company incurred transaction costs of $<ix:nonFraction unitRef="usd" contextRef="i46c86ba47653492db774e9e6bbe191b4_I20230331" decimals="-6" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMTY0OTI2NzQ5MDIzMQ_b5c013f8-2bbf-4e01-9aa4-e45e5e240ab4">37</ix:nonFraction>&#160;million associated with the Signify Health Acquisition that were recorded within operating expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Oak Street Health Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2023, the Company acquired <ix:nonFraction unitRef="number" contextRef="i839190f328204596bd4e7f2b5c29b42b_I20230502" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzMwMjkyOQ_4738f502-588f-4b67-a782-c1412df1bbcc">100</ix:nonFraction>% of the outstanding shares and voting interest of Oak Street Health, Inc. (&#8220;Oak Street Health&#8221;) for cash. Under the terms of the merger agreement, Oak Street Health stockholders received $<ix:nonFraction unitRef="usdPerShare" contextRef="i839190f328204596bd4e7f2b5c29b42b_I20230502" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODQ0MTUy_59a43286-af90-4e4a-adab-6c8b80ccfd1a">39.00</ix:nonFraction> per share in cash. The total value of the transaction was approximately $<ix:nonFraction unitRef="usd" contextRef="ifc946f669dc44ab69a194363c6a5ce91_D20230502-20230502" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODQ0MTU5_419f2fe1-dcd6-40e6-847d-fa5ff608bd81">10.6</ix:nonFraction>&#160;billion. The Company financed the transaction with borrowings of $<ix:nonFraction unitRef="usd" contextRef="i85f8c4df47be4b3bb9037e0c92c557ba_D20230501-20230501" decimals="-8" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzMwMjkzNQ_019bb649-cc90-432d-812a-aa8d7752d30e">5.0</ix:nonFraction>&#160;billion from a term loan agreement entered into on May 1, 2023 as described in Note 7 &#8216;&#8216;Borrowings&#8217;&#8217; and cash on hand. Oak Street Health is a leading multi-payor, senior focused value-based primary care company. The Company will include Oak Street Health within the Health Services segment. The Company acquired Oak Street Health to advance its value-based care strategy and broaden its platform into primary care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Held For Sale</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> long-term care business (&#8220;LTC business&#8221;), which is included within the Pharmacy &amp; Consumer Wellness segment, was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. During 2022, the LTC business met the criteria to be classified as held for sale and the carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell. Accordingly, the Company recorded total losses on assets held for sale of $<ix:nonFraction unitRef="usd" contextRef="i327cce141c0e4abb8b30e48daa9e4ec1_D20220101-20221231" decimals="-8" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzg0ODI5MDcwOTAzMQ_d719f145-b096-4fb6-b0a1-663ad9c679a9">2.5</ix:nonFraction>&#160;billion during the year ended December&#160;31, 2022. As of March&#160;31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting. During the three months ended March&#160;31, 2023, an incremental loss on assets held for sale of $<ix:nonFraction unitRef="usd" contextRef="i0debc62e945846f3839159ee0a6f9a4d_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNzY5NjU4MTQ2MDc4NQ_c35997dd-5a76-4d85-9b61-22485b8a40ba">349</ix:nonFraction> million was recorded to write-down the carrying value of the LTC business to the Company&#8217;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. The loss on assets held for sale </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5e9bc530b28045ccab666cab1f841121"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represents the write-down of long-lived assets and was recorded in the Company&#8217;s unaudited condensed consolidated statement of operations within the Pharmacy &amp; Consumer Wellness segment. The LTC business operating income was not material for the three months ended March&#160;31, 2023 and 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC business met the criteria to be classified as held for sale at both March&#160;31, 2023 and December&#160;31, 2022, but did not meet the criteria to be classified as discontinued operations. As a result, the related assets and liabilities were included in the separate held-for-sale line items of the asset and liability sections of the unaudited condensed consolidated balance sheets. As the assets held for sale are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, they are classified in Level 3 of the fair value hierarchy. <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNjAwNg_e2276ae9-13a4-4be8-8735-7e255ae7f2ad" continuedAt="i2aae3d34c9474504a21f245cc3391193" escape="true">The following table summarizes the assets and liabilities held for sale at March&#160;31, 2023 and December&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i2aae3d34c9474504a21f245cc3391193"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMi0xLTEtMS0yMzI1NDc_037d5c41-6e6a-4c64-a289-ba7e1817f183">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMi0zLTEtMS0yNTc0NjY_f29d77fb-40eb-44b7-ad38-043c6481d5ec">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMy0xLTEtMS0yMzI1NDc_fb347b06-75fd-4cee-9cf6-15d45cdbc3bb">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMy0zLTEtMS0yNTc0NjY_13450859-c2ec-44a3-a43f-3d1a6a41deb2">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNC0xLTEtMS0yMzI1NDc_8ec3aa35-43c6-47b1-955a-d34e0ed6c0ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNC0zLTEtMS0yNTc0NjY_add1a984-407c-43e7-9b5f-344658cbf1e8">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNi0xLTEtMS0yMzI1NDc_b16cddbc-93b7-4dde-87f4-d041d76cfc82">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNS0zLTEtMS0yNTc0NjY_e369efcb-fde2-4a51-82c0-8aa42f70e3fa">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNy0xLTEtMS0yMzI1NDc_a4bb6f6e-0697-4e19-a7d8-7c9580ed3e34">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNi0zLTEtMS0yNTc0NjY_8373d94f-520b-4f4e-9044-a1605acc293e">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfOC0xLTEtMS0yMzI1NDc_e627473b-5f42-46ec-ae35-f20da1e1d866">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNy0zLTEtMS0yNTc0NjY_eda5ee93-b8ad-4c89-affa-f882e5867e37">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTEtMS0xLTEtMjMyNTQ3_5286199e-6dd6-4938-b875-3e4209dd658d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTAtMy0xLTEtMjU3NDY2_945ba96e-749c-40b2-98ea-976ead9f4c68">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTItMS0xLTEtMjMyNTQ3_71181546-1e00-4b48-8a0b-f1d951807564">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTEtMy0xLTEtMjU3NDY2_e4d2c8bb-0837-42b2-b42c-fba39232360a">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTMtMS0xLTEtMjMyNTQ3_be42ecd1-5b9e-4556-ba76-881a4d98f154">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTItMy0xLTEtMjU3NDY2_87bc6491-ff3b-4ddd-b879-c8cbb0972cd1">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTQtMS0xLTEtMjMyNTQ3_18b1a74b-0497-48e8-bb57-bead0f434ee0">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTMtMy0xLTEtMjU3NDY2_fcc029d8-23de-42fd-91c4-d32e7afd2c49">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIxMw_ef3beb99-ca60-4d86-9edb-86d16405c3cf" continuedAt="i50f6b4f31d3f4ecd92d27a8122a4b3db" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i50f6b4f31d3f4ecd92d27a8122a4b3db" continuedAt="i80329929c6484f689b22bf3f394883bc"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTMwNQ_5a35df21-8b7a-4f4d-8570-02c6f6f33fb9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb07919adac2412abcdc705eb562b3c7_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi0xLTEtMS0yMzI1NDc_bd1f5bfe-533a-4975-8b22-0cc45c5cfa89">3,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb07919adac2412abcdc705eb562b3c7_I20230331" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi0zLTEtMS0yMzI1NDc_3d8252ec-507a-4f5c-886c-81e0dab2a543">17,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb07919adac2412abcdc705eb562b3c7_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi01LTEtMS0yMzI1NDc_2a3c617a-9350-44ad-ab3c-6a69c36b188c">20,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327aba17f5014740927f4d6f30982b5d_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi03LTEtMS0yMzI1NDc_5267b894-fecb-485b-b69e-ec3f4a56ed29">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327aba17f5014740927f4d6f30982b5d_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi05LTEtMS0yMzI1NDc_eb56f440-871e-4c32-a277-d0601263a6f0">17,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327aba17f5014740927f4d6f30982b5d_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi0xMS0xLTEtMjMyNTQ3_944e02df-3be5-42ba-b532-38e56741fdb6">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id164ef0f52604d3090071179b7c674e0_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy0xLTEtMS0yMzI1NDc_632aa3c9-2baa-4877-ac67-6c5b404f8f2f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id164ef0f52604d3090071179b7c674e0_I20230331" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy0zLTEtMS0yMzI1NDc_bd02a75f-50bb-49eb-8662-2b7b35a7650e">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id164ef0f52604d3090071179b7c674e0_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy01LTEtMS0yMzI1NDc_a3acbb32-8b91-4784-bc01-25a882dd4cde">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867b324806204e6a8e1477d0e3cb2fc3_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy03LTEtMS0yMzI1NDc_ab8f9d00-cea0-43bf-82d1-3b55f1dd805f">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867b324806204e6a8e1477d0e3cb2fc3_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy05LTEtMS0yMzI1NDc_15957bdc-5e95-4729-a851-6f0861ea3e27">989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867b324806204e6a8e1477d0e3cb2fc3_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy0xMS0xLTEtMjMyNTQ3_f61a6709-38aa-4489-b99c-91dba43f9550">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb893d91703146878373e8b9e7346cb8_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC0xLTEtMS0yMzI1NDc_549f9eed-b92a-44fa-ad15-228e40bf7e64">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb893d91703146878373e8b9e7346cb8_I20230331" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC0zLTEtMS0yMzI1NDc_abe84361-89c3-41db-b5b7-31221ed75f90">2,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb893d91703146878373e8b9e7346cb8_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC01LTEtMS0yMzI1NDc_31ab8eb6-a3d3-424c-8b73-09b940e724b4">2,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e08e1c1bd8548999900b632892e8ecb_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC03LTEtMS0yMzI1NDc_1b0deb7c-3cf6-43af-b8e8-159edc9e8ec9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e08e1c1bd8548999900b632892e8ecb_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC05LTEtMS0yMzI1NDc_b673fe81-5466-4b15-8270-766f5b7eb9cd">2,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e08e1c1bd8548999900b632892e8ecb_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC0xMS0xLTEtMjMyNTQ3_ba589cf4-52cc-4e8e-b2d1-d5910a1b4ca0">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS0xLTEtMS0yMzI1NDc_cd3de390-9a66-4657-ab78-1f0d9f250ce4">3,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS0zLTEtMS0yMzI1NDc_b51e20f8-7741-4d0b-9eb0-73a17a7e940d">21,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS01LTEtMS0yMzI1NDc_96b3a9ce-cfc2-477c-a010-5600fb2fe8bc">24,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS03LTEtMS0yMzI1NDc_e78336fe-083d-491d-84b0-cb83d8731e63">2,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS05LTEtMS0yMzI1NDc_8cef23a3-3957-4ae5-96bc-98dd63f7e78e">21,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS0xMS0xLTEtMjMyNTQ3_293201a0-56c7-4c23-93c9-d1c885afd50c">23,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term investments of  $<ix:nonFraction unitRef="usd" contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMzI5ODUzNDg4OTI1OA_e4c97ea4-6e34-493b-90eb-ba2f691b183f">17</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheet at December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIxMA_7cc13a7a-2356-44c8-bf6d-c82eeba7074a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy0xLTEtMS0yMzI1NDc_8654c6d8-5561-4ff7-a08a-7376b5bcf1f5">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy0zLTEtMS0yMzI1NDc_9d080d79-5c3d-4370-9b90-a03941c7e6de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy01LTEtMS0yMzI1NDc_2df84539-dda1-4278-93c5-cb7059a8df5d">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy03LTEtMS0yMzI1NDc_97ddb424-4e94-4d97-989f-168d2b74b779">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy05LTEtMS0yMzI1NDc_d5baf8a0-b732-4e36-b26a-37ba1067ab9d">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy0xMS0xLTEtMjMyNTQ3_8ede51af-09f4-4d72-ab2c-e01bd2b91ec2">1,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC0xLTEtMS0yMzI1NDc_084b7809-6a50-4d31-a76b-b207a58e924f">2,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC0zLTEtMS0yMzI1NDc_537f82c2-0756-4c63-a7ac-290ab2c9b82f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC01LTEtMS0yMzI1NDc_0cd4a156-73c9-46b3-81c7-016174b1ce63">2,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC03LTEtMS0yMzI1NDc_77947ac2-201e-40e9-b8ce-499fca01bbec">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC05LTEtMS0yMzI1NDc_72d402c0-e84f-44ff-ab07-008c848656b6">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC0xMS0xLTEtMjMyNTQ3_3c376c6b-5e22-4ac0-9856-e4e04c8be431">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS0xLTEtMS0yMzI1NDc_06acb2c1-1293-4be1-9d76-c82c5d4608e5">9,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS0zLTEtMS0yMzI1NDc_faee14c4-4a32-4319-bc2b-c6fd1d8f8cc8">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS01LTEtMS0yMzI1NDc_b3a0673d-3b71-41fe-804a-d0979b0bd4ea">9,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS03LTEtMS0yMzI1NDc_82fa5165-7ebc-481a-a642-58d70b74a7f7">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS05LTEtMS0yMzI1NDc_43bbfcf2-4019-4ade-adc2-34c90083ec61">665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS0xMS0xLTEtMjMyNTQ3_88d3ae0b-81f6-4d41-9f64-96deef3c2478">9,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi0xLTEtMS0yMzI1NDc_522de8a7-a0ab-4214-b262-3cf28f3ff3e8">2,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi0zLTEtMS0yMzI1NDc_78edaee2-745f-4273-95a3-e392d216bd69">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi01LTEtMS0yMzI1NDc_21f56a27-690d-4752-bf2a-17f6c0c39b98">2,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi03LTEtMS0yMzI1NDc_2ef45ed3-aa64-4b80-a587-589da7f860fe">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi05LTEtMS0yMzI1NDc_5b6fc346-133e-4ce6-8ce0-1d47b16294ce">193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi0xMS0xLTEtMjMyNTQ3_f51c9aea-e2c4-4a08-aaa8-04b1285a3243">2,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy0xLTEtMS0yMzI1NDc_0b0ce2e6-7067-42e1-b17d-058ba6e3ebef">881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy0zLTEtMS0yMzI1NDc_592090de-87d6-49a2-b6d4-15959f86f35c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy01LTEtMS0yMzI1NDc_608f94b7-6d0a-4fb4-8eec-7e9d2ae52a0c">881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy03LTEtMS0yMzI1NDc_a72552af-68f4-43b5-aac0-f9f887aab549">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy05LTEtMS0yMzI1NDc_f5ea3597-1416-439a-8eb5-e9c9ca3cefdd">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy0xMS0xLTEtMjMyNTQ3_08b63373-84b6-43f9-88b9-a5d2ae951130">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC0xLTEtMS0yMzI1NDc_f22e198c-71a3-4cdc-91ed-6a909992b160">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC0zLTEtMS0yMzI1NDc_280c5dce-e28d-4f22-9c71-3270d615a612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC01LTEtMS0yMzI1NDc_245fdf80-a565-46fa-a68f-a915f817b0b5">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC03LTEtMS0yMzI1NDc_9e01c14f-c05f-43cc-a0ad-fb04c6c1d28c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC05LTEtMS0yMzI1NDc_ccae6452-24cd-49b9-b14e-a83ab2c99db9">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC0xMS0xLTEtMjMyNTQ3_fb63be69-3130-4f15-b408-6530f5777b90">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS0xLTEtMS0yMzI1NDc_034ed884-cc89-4fd0-ba76-2b21a32f756d">2,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS0zLTEtMS0yMzI1NDc_987d6b72-058f-43aa-8593-13d78f4b4bc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS01LTEtMS0yMzI1NDc_565c2fd9-06cd-478d-856e-1c3303747d12">2,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS03LTEtMS0yMzI1NDc_ea8d3540-b2d0-4082-bcca-614fec1b392e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS05LTEtMS0yMzI1NDc_810bf6a4-f7c1-4f6b-a2dd-74c0c35e2825">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS0xMS0xLTEtMjMyNTQ3_429f5f0e-3771-4252-821d-877d69c4853f">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtMS0xLTEtMjMyNTQ3_d8a230dd-bb06-4082-92b2-955ad88dad7c">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtMy0xLTEtMjMyNTQ3_0a75da50-e998-49d8-a572-404e409ae35a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtNS0xLTEtMjMyNTQ3_2ca5c6fe-c65c-4263-8a1d-e2b3ec84ec6a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtNy0xLTEtMjMyNTQ3_308307d6-8f9d-411a-aef5-6f9879e934c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtOS0xLTEtMjMyNTQ3_2ae4f93e-1602-4800-b613-e8f2fa30ebe0">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtMTEtMS0xLTIzMjU0Nw_bcfc7ea9-4bb2-4124-8788-d7091f03f1a7">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtMS0xLTEtMjMyNTQ3_44c7cb03-b19f-4066-a359-b22edf34e87a">22,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtMy0xLTEtMjMyNTQ3_21163122-5cc4-4449-b97a-41cea154592b">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtNS0xLTEtMjMyNTQ3_ece6c8a1-b994-4f81-bca1-a7c6d2672fc0">22,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtNy0xLTEtMjMyNTQ3_94fa4c31-7cbf-41eb-947a-80075ec6c745">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtOS0xLTEtMjMyNTQ3_6f2b1f24-76d4-4ca8-bd81-ab55d0d01fb0">1,393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtMTEtMS0xLTIzMjU0Nw_b5adaed9-d6e9-4ade-b1ae-9b3fc3d6a46b">20,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtMS0xLTEtMjMyNTQ3_fcb164a8-6de7-42d0-a06f-8804c2416f01">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtMy0xLTEtMjMyNTQ3_e7a4c1a7-4050-4a5d-94bd-ed87b7217745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtNS0xLTEtMjMyNTQ3_3c4f4e1e-057c-4496-801f-2e18df77fb45">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtNy0xLTEtMjMyNTQ3_3132324c-c0ab-4e6f-817d-ea7715125eb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtOS0xLTEtMjMyNTQ3_88e4e4d2-2189-4758-92cc-2a33c9b78d8c">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtMTEtMS0xLTIzMjU0Nw_eba275e1-ed11-44d8-87b3-9b999891e861">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtMS0xLTEtMjMyNTQ3_fc06b5bd-9e51-4352-bdf1-2f28faa4c826">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtMy0xLTEtMjMyNTQ3_f519821e-ccca-4331-9a22-d21b51fb3bdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtNS0xLTEtMjMyNTQ3_e4a84b3b-acce-4c19-8218-7ffbf8a32663">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtNy0xLTEtMjMyNTQ3_e30dd0aa-749d-4c76-a2b4-55a0ad7c61ae">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtOS0xLTEtMjMyNTQ3_a2eb188e-bf6b-45ac-8db7-49a089fae767">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtMTEtMS0xLTIzMjU0Nw_de3f384b-eef7-4414-ab93-bd6e76c31f83">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctMS0xLTEtMjMyNTQ3_408582b4-4357-4480-81dc-95af0f78e46e">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctMy0xLTEtMjMyNTQ3_cf532209-0e84-49d7-b68b-3eacc549b88e">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctNS0xLTEtMjMyNTQ3_86718f57-9a4a-4ecd-82c0-b810fcb04747">9,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctNy0xLTEtMjMyNTQ3_1d77bfa7-6e34-4dea-98ae-abcc24abc0ec">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctOS0xLTEtMjMyNTQ3_6de73030-1ba3-4504-8c2d-1782054cd503">903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctMTEtMS0xLTIzMjU0Nw_d8439af5-4f0c-4d0c-8aaa-4cc8e8dd45af">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtMS0xLTEtMjMyNTQ3_d71b94c2-7837-4ebf-8302-c7fddf7d17c3">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtMy0xLTEtMjMyNTQ3_437ec8e1-96fa-477a-97a7-21047c90b278">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtNS0xLTEtMjMyNTQ3_53bd05bb-1171-4337-b07b-8c15103718c5">2,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtNy0xLTEtMjMyNTQ3_de36292c-e33b-47cf-8b26-7ee189593a2f">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtOS0xLTEtMjMyNTQ3_71fea888-ed2e-4c0e-aba3-5eaa362ab7b3">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtMTEtMS0xLTIzMjU0Nw_6c718a1e-b1cb-49ae-b6fe-e64177cab7b8">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktMS0xLTEtMjMyNTQ3_87e88883-bdc7-4847-b6df-9af6ad0fcf6f">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktMy0xLTEtMjMyNTQ3_5af3103d-12e4-4cd1-9ff2-64223adb0e98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktNS0xLTEtMjMyNTQ3_89086604-ccc9-4199-9c15-03ea110d7c2c">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktNy0xLTEtMjMyNTQ3_22b3cab7-ea38-4e71-82ed-8e25c42764b1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktOS0xLTEtMjMyNTQ3_50c3d28b-4433-4b07-85dc-ac04dfc430d5">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktMTEtMS0xLTIzMjU0Nw_7ff10396-a0f7-46a4-801c-9c80ed62e219">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtMS0xLTEtMjMyNTQ3_788b54a6-2a82-4350-b2df-6a720c768923">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtMy0xLTEtMjMyNTQ3_91f1b3b4-f470-4550-a8d8-8cfcd00e86d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtNS0xLTEtMjMyNTQ3_a8634926-fea0-4eda-b7a1-cfeff93788f0">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtNy0xLTEtMjMyNTQ3_10f1657b-30c6-4829-bcb4-c00df9a089ce">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtOS0xLTEtMjMyNTQ3_3b391f65-139d-474c-9758-529b4d487c93">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtMTEtMS0xLTIzMjU0Nw_e5353f94-3312-4003-b023-b7f5daa823c9">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtMS0xLTEtMjMyNTQ3_bdca33ee-61e4-4eeb-a217-9d781acc7694">2,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtMy0xLTEtMjMyNTQ3_6389e013-cea5-43a0-9c6d-36c4163d0cb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtNS0xLTEtMjMyNTQ3_bcba018c-a0a0-492b-974d-ad3eadea82f1">2,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtNy0xLTEtMjMyNTQ3_9007ff89-bbbb-41bf-b9e9-ed6269c2153e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtOS0xLTEtMjMyNTQ3_52b02b03-70ef-4a4d-9527-d3023489bc2b">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtMTEtMS0xLTIzMjU0Nw_cbd114a3-12d2-48e2-9372-27b74d958054">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItMS0xLTEtMjMyNTQ3_50574262-95bf-48d6-a703-ea88c008255e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItMy0xLTEtMjMyNTQ3_9228e8fb-243b-4676-a4ac-a1f1ed8857b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItNS0xLTEtMjMyNTQ3_cc9a07c3-70c2-4bde-8521-53d8b68bf053">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItNy0xLTEtMjMyNTQ3_7cb07145-ca07-4266-9684-b68ea1bd5280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItOS0xLTEtMjMyNTQ3_980fae7d-e847-4894-bcc1-82510944ccfc">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItMTEtMS0xLTIzMjU0Nw_670c909d-7279-4539-a5bb-f2622856dda4">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtMS0xLTEtMjMyNTQ3_0536b8e0-0f5d-4cee-a054-9846e8d738d0">22,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtMy0xLTEtMjMyNTQ3_08acd64a-c45e-4cc4-8b4d-132ebabb0acc">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtNS0xLTEtMjMyNTQ3_0fab31cc-dbaa-4373-bcce-3066a580eb77">22,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtNy0xLTEtMjMyNTQ3_d72c5471-a1d6-4eaf-8b7e-3a9fe34317bd">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtOS0xLTEtMjMyNTQ3_80cf1e10-72dc-4706-b2ce-cb8f19f776e9">1,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtMTEtMS0xLTIzMjU0Nw_8a6712da-8d43-4199-9a7e-06ddd76b6698">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At March&#160;31, 2023, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNjc5_68a181d5-f633-49d3-a27d-a8f3b386ff8e">620</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNzE3_acb02e5e-44db-446e-a237-49e8b08ebb97">5</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNzU5_9ebf5b5e-a9d9-43ee-98d2-8527104dba6d">40</ix:nonFraction> million and at December&#160;31, 2022, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i2114bac1bd054f9bbf533d596e9ab742_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfODEw_e87aedbc-8909-41a8-9816-b1f23791f35b">609</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i2114bac1bd054f9bbf533d596e9ab742_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfODQ4_3d0926b6-f407-48a5-aece-04c62629d8ed">3</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i2114bac1bd054f9bbf533d596e9ab742_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfODkw_2768540c-911d-44a9-a98a-cbe336300a5c">59</ix:nonFraction> million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive loss.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i80329929c6484f689b22bf3f394883bc" continuedAt="i6e02eaddce9b49028e0fbafef32d75aa"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTI3OA_bed6a38d-5baa-4cdf-a8a5-634d7aafc4a4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at March&#160;31, 2023 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMi0xLTEtMS0yMzI1NDc_503d171f-8532-48bd-ad87-69e679641591">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMi0zLTEtMS0yMzI1NDc_6d3dde0d-2542-4314-a94f-1acfbed93a54">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMy0xLTEtMS0yMzI1NDc_61bdeb74-5ef5-4073-8005-ba59413533a8">6,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMy0zLTEtMS0yMzI1NDc_171a7aee-1781-4806-81f3-40fd2cf8c3fd">6,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNC0xLTEtMS0yMzI1NDc_7268ed87-05d6-4f3d-91d6-3cd9b96ccb1a">4,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNC0zLTEtMS0yMzI1NDc_b7414b88-d040-47d8-8602-7e446c2af245">4,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNS0xLTEtMS0yMzI1NDc_f4e55fb3-8526-4e58-a808-766f8e760412">4,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNS0zLTEtMS0yMzI1NDc_2c1939e9-d94f-44d7-abcc-37151e5a55c0">3,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNi0xLTEtMS0yMzI1NDc_2bbcbd5e-47e7-4107-9ab9-a43c74003b5a">881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNi0zLTEtMS0yMzI1NDc_9820b406-9b29-4f08-8277-2da5e6ed7a05">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNy0xLTEtMS0yMzI1NDc_6b4a142b-dea3-4f43-a268-69967a7eb1fa">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNy0zLTEtMS0yMzI1NDc_4049faa7-c63f-435b-8ec5-2f803540aaa2">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOC0xLTEtMS0yMzI1NDc_7ee05fe6-e7e7-47d4-825e-f0e196d92e53">2,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOC0zLTEtMS0yMzI1NDc_df797cab-6a64-4c45-bc11-5e28017277d1">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOS0xLTEtMS0yMzI1NDc_40d376aa-87aa-4576-b899-7e439f299836">22,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOS0zLTEtMS0yMzI1NDc_f408094d-4228-4a5a-8a38-20d50805a6d3">20,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6e02eaddce9b49028e0fbafef32d75aa" continuedAt="i0f20225e7a5e4690b106815bf7a2967d"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTI3MQ_1b420232-df9f-4845-8fe2-ec9fa951e001" continuedAt="i97320c1ef5f64f3c9e608316589ea2ec" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at March&#160;31, 2023 and December&#160;31, 2022 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xLTEtMS0yMzI1NDc_3c22f945-7a02-4945-b05f-98cde75855d0">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0zLTEtMS0yMzI1NDc_aefbb1b8-fe7a-4a66-8e8d-4e15f785f661">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC01LTEtMS0yMzI1NDc_bee309be-6a4b-4850-b701-714c8aaa134b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC03LTEtMS0yMzI1NDc_05ad496b-b3e1-4a06-90bc-7efd333d1912">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC05LTEtMS0yMzI1NDc_3dfcc2d6-d0c2-4a30-9a81-896adb672edc">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xMS0xLTEtMjMyNTQ3_6fa5a35a-0e57-483f-ac08-0b95b49d279f">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xMy0xLTEtMjMyNTQ3_66bcaa32-ba82-48da-84d8-fb0ef40cedae">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xNS0xLTEtMjMyNTQ3_303fc793-ef02-4b28-bc54-3db61f296ff4">1,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xNy0xLTEtMjMyNTQ3_15252f03-74f2-4cf7-bf7e-9cdaab6c8f0e">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xLTEtMS0yMzI1NDc_1852e367-13bf-4e36-9294-d7df97231ef2">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0zLTEtMS0yMzI1NDc_5c05cee4-70dd-453b-bdce-9966d6a26c4f">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS01LTEtMS0yMzI1NDc_78f4d50d-63b2-4c34-a00d-a7c3f08cd7d3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS03LTEtMS0yMzI1NDc_b56d19d0-b3ac-40c1-b16e-fda479b26f6c">583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS05LTEtMS0yMzI1NDc_62a950f1-dbe8-4854-a831-fbbf92d78c33">897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xMS0xLTEtMjMyNTQ3_fd840fdc-516a-4db6-9010-b93bce75bc04">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xMy0xLTEtMjMyNTQ3_08cda2ce-ff37-461b-9bb2-5cb798eb9e9a">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xNS0xLTEtMjMyNTQ3_74550beb-63ee-4313-b9ae-68a76eed920d">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xNy0xLTEtMjMyNTQ3_1d7f8579-88d8-4531-9b0f-ad65b32b77fd">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xLTEtMS0yMzI1NDc_13ccad29-bc31-42cf-8b44-5dc11c97702f">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0zLTEtMS0yMzI1NDc_73761fc0-1c18-440a-9972-083446980d24">3,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi01LTEtMS0yMzI1NDc_dc1dfd0c-c3c3-425b-8066-c6e6e8c7b702">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi03LTEtMS0yMzI1NDc_3e9c48ce-7811-4a10-a71a-ccda866ad9bc">3,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi05LTEtMS0yMzI1NDc_94880c8e-73a5-43e0-9650-b6734ee222fa">4,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xMS0xLTEtMjMyNTQ3_9568ccaa-473d-4c0d-b283-f42432090ae7">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xMy0xLTEtMjMyNTQ3_ddfbc31d-7bac-4893-a4f8-5e37e23398d7">5,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xNS0xLTEtMjMyNTQ3_0389664a-f66d-4468-82ee-8d587e27b256">7,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xNy0xLTEtMjMyNTQ3_79140fe9-ddf0-4185-93f2-202d21989431">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xLTEtMS0yMzI1NDc_6a77c101-c374-4abd-8e31-ea202f1addc0">653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0zLTEtMS0yMzI1NDc_f2e3957c-1d85-41d0-970a-f9dffbfdde42">946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy01LTEtMS0yMzI1NDc_125ea4ee-51fa-41e0-98f0-2a54901e7040">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy03LTEtMS0yMzI1NDc_63a11ab0-084e-469d-8f72-e009380fe8e8">787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy05LTEtMS0yMzI1NDc_c0f4de38-d5ac-401a-9b30-0d653b85f0f8">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xMS0xLTEtMjMyNTQ3_b4d7bc3b-7df7-4a52-81d3-0f6bce9ebe1c">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xMy0xLTEtMjMyNTQ3_afc878a0-4117-493e-8da2-f5efd0f62223">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xNS0xLTEtMjMyNTQ3_d49d8903-a5e4-4e9a-9dd7-a3028f783bfb">2,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xNy0xLTEtMjMyNTQ3_c8504f8b-29c2-4e17-ba25-f4a6bb103dab">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xLTEtMS0yMzI1NDc_5c09e9c7-0cfe-4d9f-9ac1-c6fca8beb0bf">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0zLTEtMS0yMzI1NDc_8be40874-bde1-4820-a041-b7699878cc48">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC01LTEtMS0yMzI1NDc_95a4b9a9-16f3-4bce-aadb-944918ce5de2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC03LTEtMS0yMzI1NDc_cd4fdca7-af3c-4766-8925-924be1dce6c2">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC05LTEtMS0yMzI1NDc_6d6b44aa-5f1a-42e2-b5f1-03c812cf63cd">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xMS0xLTEtMjMyNTQ3_a3ce6bf4-97da-4abe-a242-5ad507483238">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xMy0xLTEtMjMyNTQ3_1d92ff54-aa78-4a61-8dec-f94de91c060a">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xNS0xLTEtMjMyNTQ3_18a7773a-2a3b-451c-929f-b9de1eb96262">723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xNy0xLTEtMjMyNTQ3_faad7328-7ba6-4c9a-be98-f41cff58d759">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xLTEtMS0yMzI1NDc_71a60af6-c327-496e-9794-89fdbcd8a0fa">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0zLTEtMS0yMzI1NDc_72171f65-9feb-4000-b9c1-0435d124421a">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS01LTEtMS0yMzI1NDc_e6010303-c29f-4a05-abcd-10ebde2190b5">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS03LTEtMS0yMzI1NDc_6d679b3f-4d9e-4bd6-8c8d-a9ea20697ac1">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS05LTEtMS0yMzI1NDc_6325fc21-31ff-41d8-880f-0c42d3f70370">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xMS0xLTEtMjMyNTQ3_b6e5840d-9452-4b3a-a739-2bc02255c9a7">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xMy0xLTEtMjMyNTQ3_bf658884-350c-4be5-9519-5de1fbeeb2e5">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xNS0xLTEtMjMyNTQ3_e8f9bd7a-bd7f-4e54-b04a-489a20d1d940">932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xNy0xLTEtMjMyNTQ3_55e29a6d-1736-4a98-834c-f9a4dc823884">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMS0xLTEtMjMyNTQ3_6af9a060-79b2-44be-a894-0a11de26cee3">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMy0xLTEtMjMyNTQ3_646a849f-93f0-4ef8-8829-456f7870420c">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtNS0xLTEtMjMyNTQ3_ee1fea60-252b-41ad-b62d-9f9521668175">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtNy0xLTEtMjMyNTQ3_5f65844d-22df-4977-a87a-5ce24847476e">726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtOS0xLTEtMjMyNTQ3_28ca54b0-ec5c-436e-ba21-60227d537513">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTEtMS0xLTIzMjU0Nw_022a948d-dee4-4d8b-bb56-2a869ab31343">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTMtMS0xLTIzMjU0Nw_cb615263-b239-4267-8f77-a1ffad4beffd">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTUtMS0xLTIzMjU0Nw_66170a1d-6c65-491a-bb11-2a2785b0ef9e">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTctMS0xLTIzMjU0Nw_a2d159b3-8318-4565-91db-1f1a36c24db6">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMS0xLTEtMjMyNTQ3_6a782b35-dff9-4e0d-8bb4-c06962bf8edb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMy0xLTEtMjMyNTQ3_bda2907f-9198-4c49-92d1-dd94810ee053">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtNS0xLTEtMjMyNTQ3_b7c4e230-3494-4225-aa20-f61298c2c197">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtNy0xLTEtMjMyNTQ3_cd376fe1-6fe7-421a-a958-4db411efe383">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtOS0xLTEtMjMyNTQ3_87682c91-c1b9-4956-97b5-56be773618c9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTEtMS0xLTIzMjU0Nw_bac9944d-114f-45a0-9bc8-047187dab7dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTMtMS0xLTIzMjU0Nw_1292ebbc-cadf-4943-89da-d475fbd6f3d9">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTUtMS0xLTIzMjU0Nw_9191804d-4617-43e4-a122-c94836f41895">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTctMS0xLTIzMjU0Nw_5d687b0f-4349-4571-a45b-9d75dc0ed1dc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMS0xLTEtMjMyNTQ3_87537f55-043a-4658-ac0a-95fe014ff4dd">4,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMy0xLTEtMjMyNTQ3_e61aab38-3829-46f7-b9d3-104eb7dbb72f">7,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItNS0xLTEtMjMyNTQ3_d3aa76e9-6447-486f-8d1b-b486ad3e3680">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItNy0xLTEtMjMyNTQ3_8c1bd235-490c-4556-b9e4-9d9a7c52ed81">6,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItOS0xLTEtMjMyNTQ3_43c0b2f7-11f3-4894-8380-001ca8848604">9,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTEtMS0xLTIzMjU0Nw_7e80deb7-ac47-4422-9c6d-c0f882d90c0f">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTMtMS0xLTIzMjU0Nw_0f869c81-0a29-4705-bc37-4aa4469c6efa">11,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTUtMS0xLTIzMjU0Nw_c25d1a0a-53d7-4db1-a890-f7b1280e7b86">16,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTctMS0xLTIzMjU0Nw_8e36e3fc-a91c-4dcf-abf2-18bf82da0f85">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMS0xLTEtMjMyNTQ3_69cf0892-88d8-4b1c-9d06-0e53418701d7">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMy0xLTEtMjMyNTQ3_51677e96-6800-4c66-8bd1-50e295b8756e">1,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtNS0xLTEtMjMyNTQ3_381b0b93-7544-40c9-b842-28ff67e1ce9d">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtNy0xLTEtMjMyNTQ3_cee2ac1a-f8ac-49c1-86df-d47cc88a476b">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtOS0xLTEtMjMyNTQ3_aa448d96-6b15-4492-98af-02ccf4c4c05a">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTEtMS0xLTIzMjU0Nw_3e627bd8-9851-4d9f-8acd-c23a66761e97">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTMtMS0xLTIzMjU0Nw_8e0f4d70-f8fa-4d6d-b696-369db57b24e8">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTUtMS0xLTIzMjU0Nw_d2cd3c7c-0930-4117-ac83-49a23c7fe420">1,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTctMS0xLTIzMjU0Nw_0a0fa86d-0d45-4375-9d90-244995a68a66">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMS0xLTEtMjMyNTQ3_d3211f7d-9cc6-4182-b3cc-acf7dfe0cbc3">859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMy0xLTEtMjMyNTQ3_3d35be91-12c3-4c11-a30d-01cde6a4f239">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctNS0xLTEtMjMyNTQ3_87af3468-9351-4d2e-b87e-9038181af82c">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctNy0xLTEtMjMyNTQ3_8324f619-c623-40f3-b4a4-eaf655744f75">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctOS0xLTEtMjMyNTQ3_6cf4abaf-92b5-4d15-92fa-f6b7ba959752">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTEtMS0xLTIzMjU0Nw_4835f890-f5ff-47bb-a82c-8d1192e99c36">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTMtMS0xLTIzMjU0Nw_dceebe3d-d1e0-4cf0-bc40-9841c9e459c4">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTUtMS0xLTIzMjU0Nw_186c5920-1df6-4ff1-bd42-d6625da2c924">1,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTctMS0xLTIzMjU0Nw_7820517d-53b7-415d-86bc-cb2a065f2648">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMS0xLTEtMjMyNTQ3_f61444f5-87ce-4f56-a5aa-a6ae64eb7f12">5,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMy0xLTEtMjMyNTQ3_7ead6750-0784-4956-9338-e435477e261d">6,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtNS0xLTEtMjMyNTQ3_2e45d228-9f2a-4e86-a6df-dc3cc4a8aba1">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtNy0xLTEtMjMyNTQ3_510e15a8-3c31-48f4-b0a7-3587ab0ab150">1,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtOS0xLTEtMjMyNTQ3_c16b899a-0a85-4810-b5ef-8db835eef429">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTEtMS0xLTIzMjU0Nw_4ca1733b-29f2-46f5-ada9-77f49225858a">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTMtMS0xLTIzMjU0Nw_46e24099-763c-4820-bb4d-b04aef043751">6,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTUtMS0xLTIzMjU0Nw_2b174983-e70d-497c-a93f-af7c81df9073">8,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433e18f57964e288d423f861ddf29db_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTctMS0xLTIzMjU0Nw_4695bea4-3c90-4bf6-a6e7-6d7cdb59fbdb">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMS0xLTEtMjMyNTQ3_9115ca32-5a4c-42b5-9db4-b38ce6e4363a">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMy0xLTEtMjMyNTQ3_f3f3425a-4da0-4028-8005-e1717319b0e5">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktNS0xLTEtMjMyNTQ3_79836dee-e822-4a1a-a7e6-0b37fa2aa91b">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktNy0xLTEtMjMyNTQ3_e96036b9-140a-450b-9949-ef8e274e4693">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktOS0xLTEtMjMyNTQ3_e82997d3-e1ac-4a6a-9303-fd858f001c6e">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTEtMS0xLTIzMjU0Nw_717213de-e18c-4642-b545-065c8ef621ce">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTMtMS0xLTIzMjU0Nw_ff13a9d7-7b7e-4fcc-8aaf-00d72ecf4b4b">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTUtMS0xLTIzMjU0Nw_385c06f2-7a63-41bc-81eb-a9504aa560a2">2,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTctMS0xLTIzMjU0Nw_2348d95f-c50e-4f5b-a086-f2b38efef98b">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMS0xLTEtMjMyNTQ3_81204150-63b3-4b70-8f7e-31acf2d4ce57">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMy0xLTEtMjMyNTQ3_88e2e5d1-8957-4c72-8561-477cd60583c9">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtNS0xLTEtMjMyNTQ3_20cc911d-d9b5-48ca-8243-03eb4eded7f9">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtNy0xLTEtMjMyNTQ3_04e9adfe-1656-4b64-96db-4b79edaaccd1">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtOS0xLTEtMjMyNTQ3_22b33c16-bb46-437d-91c7-cf8bbb822764">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTEtMS0xLTIzMjU0Nw_21bf4018-8ecc-463f-a0e9-890b0cf8075c">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTMtMS0xLTIzMjU0Nw_a9affea7-f71a-4ad5-b655-f188a1497563">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTUtMS0xLTIzMjU0Nw_2ccf89a5-f34f-4ca1-bca2-8338bfeb8146">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70be69bf99746f0b1a2639e28853784_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTctMS0xLTIzMjU0Nw_16f0ca9b-6428-4fe9-9a82-97dcadc4fadb">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMS0xLTEtMjMyNTQ3_fd9908e0-66fa-4087-8124-83e676b6eeab">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMy0xLTEtMjMyNTQ3_302a9dd1-6d69-4213-93a9-49b3aae5a11d">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtNS0xLTEtMjMyNTQ3_05ea09ed-bafc-4c14-92e2-0a89be81eb09">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtNy0xLTEtMjMyNTQ3_ebe9a1b6-3368-47fc-af1f-24fca085baf0">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtOS0xLTEtMjMyNTQ3_14788603-39d9-477c-b57e-8c780e33b2af">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTEtMS0xLTIzMjU0Nw_e9f9573b-792e-434e-b40c-830818f19418">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTMtMS0xLTIzMjU0Nw_bab15ee8-ba8b-4ada-a6b4-387c48b3a777">475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTUtMS0xLTIzMjU0Nw_59f19184-1893-4f29-a279-deb26d6caeae">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTctMS0xLTIzMjU0Nw_88c59530-6276-4ae9-97b9-987718e06c15">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMS0xLTEtMjMyNTQ3_78456024-c6ef-46bb-897c-c15883e6f177">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMy0xLTEtMjMyNTQ3_eb0d1a58-fa90-409d-a816-3e11be44c3b6">1,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItNS0xLTEtMjMyNTQ3_3ee7050f-4bd7-4bdf-a938-1bb4fb7d0ac1">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItNy0xLTEtMjMyNTQ3_d26ee5b4-015f-4408-b228-6f789b667ebb">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItOS0xLTEtMjMyNTQ3_fd6b3827-b9f1-4dd6-b661-dce2a3e27830">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTEtMS0xLTIzMjU0Nw_dd57981b-6add-4f1c-8a9f-4e043c2cdf88">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTMtMS0xLTIzMjU0Nw_37101e35-9df2-4145-b145-0a96a19caec0">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTUtMS0xLTIzMjU0Nw_7b9e4949-db2f-4f28-b6e1-9cbbb9d44afc">2,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTctMS0xLTIzMjU0Nw_475e4e4b-cbba-4731-9935-09bf9fd25f60">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMS0xLTEtMjMyNTQ3_c09a5056-1eb9-4fb6-8577-03980a4b6621">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMy0xLTEtMjMyNTQ3_452c611c-d9ea-46e3-8627-1b0c3303c339">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtNS0xLTEtMjMyNTQ3_fab6ece5-c6e0-4b18-8785-a2784cef88a8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtNy0xLTEtMjMyNTQ3_9090f6c1-06da-48d0-80ed-381c0abdc54a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtOS0xLTEtMjMyNTQ3_55de394d-162f-40c5-bece-b2b88ffd5ece">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTEtMS0xLTIzMjU0Nw_22697a40-7067-4771-8840-ec200d2ee968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTMtMS0xLTIzMjU0Nw_b26b6275-b134-40de-a992-cba18805b28c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTUtMS0xLTIzMjU0Nw_d007fd4f-34bf-41dd-999d-dfe8c3a84657">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTctMS0xLTIzMjU0Nw_cb31ba08-00b7-4e83-be79-799c752e50a9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMS0xLTEtMjMyNTQ3_0b9eae9b-3325-47f9-8984-9e2b9d0aaa48">9,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMy0xLTEtMjMyNTQ3_813c4dee-6886-422f-93bb-1933dcfedb39">14,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtNS0xLTEtMjMyNTQ3_50bb90df-649f-4955-80aa-a3070850c3d7">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtNy0xLTEtMjMyNTQ3_fd587732-8aac-4fc9-8f40-02d2237b770b">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtOS0xLTEtMjMyNTQ3_752ab117-5d69-4b44-a393-e25258588db6">4,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTEtMS0xLTIzMjU0Nw_9184b538-8d73-4b46-904a-8c80d43baf62">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTMtMS0xLTIzMjU0Nw_c9315824-b529-4c43-94ee-91c5a026c6b6">12,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTUtMS0xLTIzMjU0Nw_86ed74fd-9b7a-4849-add8-ee0b035e4891">18,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTctMS0xLTIzMjU0Nw_49e84781-ec10-4940-8ee0-23115d2d9fd4">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at March&#160;31, 2023 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of March&#160;31, 2023, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0f20225e7a5e4690b106815bf7a2967d" continuedAt="if4709cbbf0364f77bbe3eee247c348df"><ix:continuation id="i97320c1ef5f64f3c9e608316589ea2ec"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at March&#160;31, 2023 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy0xLTEtMS0yMzI1NDc_5c68f07c-6e48-404f-a4ce-386ec6917b26">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy0zLTEtMS0yMzI1NDc_914db5cf-0cd9-4f7d-9631-a6ad3779804f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy01LTEtMS0yMzI1NDc_b4c0d853-5908-486b-9fcc-ac7002142035">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy03LTEtMS0yMzI1NDc_17c20dd0-c7b7-4da4-8bce-77d9f7dddf45">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy05LTEtMS0yMzI1NDc_f6056062-ebad-462e-8597-e23163ef15ce">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy0xMS0xLTEtMjMyNTQ3_794657fb-d643-4720-8414-85cc47d33032">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC0xLTEtMS0yMzI1NDc_d9fb2462-b9dc-46ee-932e-8260fd3bb313">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC0zLTEtMS0yMzI1NDc_7c93ba86-39fc-4eba-85a8-0eab875ef960">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC01LTEtMS0yMzI1NDc_de92b93d-fffc-4224-bd8c-5d0ed2d50c8e">5,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC03LTEtMS0yMzI1NDc_c2d5995d-7550-47f2-afe6-26a372fcd587">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC05LTEtMS0yMzI1NDc_359993c4-29c7-4ba7-9637-99d9e992b58a">5,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC0xMS0xLTEtMjMyNTQ3_2b85a441-ca3e-4f37-8458-6944e412e64a">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS0xLTEtMS0yMzI1NDc_34ec9104-ffe0-422d-b8a7-332dd411040a">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS0zLTEtMS0yMzI1NDc_b936db67-a5b1-4e02-895f-e3e42ef35bbf">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS01LTEtMS0yMzI1NDc_f1ceae58-c7ad-46bd-a6c1-653ef1681467">3,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS03LTEtMS0yMzI1NDc_5180223d-504d-493a-bafb-76cf2594d56d">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS05LTEtMS0yMzI1NDc_33351214-51a2-41bc-9257-5a7d78efd820">3,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS0xMS0xLTEtMjMyNTQ3_c094dfb5-cbfd-47fc-a770-d44eab91ab69">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi0xLTEtMS0yMzI1NDc_77fab225-dd9a-4a1a-8f98-078f0516d539">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi0zLTEtMS0yMzI1NDc_fb5c525b-7121-46c5-bbc4-3466c366610a">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi01LTEtMS0yMzI1NDc_559cee4d-464c-4aa6-9a9c-c11cb7b818c7">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi03LTEtMS0yMzI1NDc_7accd97d-b118-48dc-a68e-323d7aed6a24">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi05LTEtMS0yMzI1NDc_41b03207-61e5-4cd4-a6aa-3f1b5bd4bbac">3,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi0xMS0xLTEtMjMyNTQ3_692eb731-7982-4e50-93c3-90cd08505565">377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab2edb2f7584b39b2e4c10c2b4cf2bd_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy0xLTEtMS0yMzI1NDc_c547ba96-221b-4454-ac16-991d079e725e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab2edb2f7584b39b2e4c10c2b4cf2bd_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy0zLTEtMS0yMzI1NDc_06058331-68a0-4cf4-a1b9-0fe0d2a10db8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i514f278578014b3ea9214b4c5b8aa393_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy01LTEtMS0yMzI1NDc_6c76855e-19f9-4d38-b9fa-9ae3009bf480">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i514f278578014b3ea9214b4c5b8aa393_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy03LTEtMS0yMzI1NDc_808ab463-741a-4fb1-9a71-3215395e2ce8">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy05LTEtMS0yMzI1NDc_5a325032-4f1f-49ca-b1ae-42343565c09e">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy0xMS0xLTEtMjMyNTQ3_73fc6624-6cba-4070-9e37-a7dc3db64cd3">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220d86c07d6f4153933adc26fb1b8c40_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC0xLTEtMS0yMzI1NDc_9552f844-4244-4436-a47a-1789e7576b0e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220d86c07d6f4153933adc26fb1b8c40_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC0zLTEtMS0yMzI1NDc_bd3a9963-caa9-4405-8b9a-fb9c848d4c75">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11f7f0a3fb574018bd69ea4301436dc8_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC01LTEtMS0yMzI1NDc_62df6c46-c7ad-4d88-9d9c-dcbc83169a0d">909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11f7f0a3fb574018bd69ea4301436dc8_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC03LTEtMS0yMzI1NDc_9346e6fc-649b-444f-bb18-d761e41fb317">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC05LTEtMS0yMzI1NDc_0d0edb7b-6d9a-46c6-825d-a8f7662c195b">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC0xMS0xLTEtMjMyNTQ3_cebd7da3-3d80-4625-8ddf-42de68ee8a83">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c66f45a22194ea1bd25a835ded92b94_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS0xLTEtMS0yMzI1NDc_cacd2257-e7fc-415a-a386-af21de012f7d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c66f45a22194ea1bd25a835ded92b94_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS0zLTEtMS0yMzI1NDc_d7d760a2-e72c-48e1-a0ac-2d53f5519bc9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c46b634040b42af82927fa3b3a9c69e_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS01LTEtMS0yMzI1NDc_3cac11a5-5d4f-4196-915d-312fe8e4494c">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c46b634040b42af82927fa3b3a9c69e_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS03LTEtMS0yMzI1NDc_42a82e9e-c343-47e9-a5b5-a5aa4c90a220">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS05LTEtMS0yMzI1NDc_9991ae85-0a32-4dda-bb0a-2e30a66a02da">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS0xMS0xLTEtMjMyNTQ3_ce23dc22-63a1-4caf-bfac-40250ae86acf">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtMS0xLTEtMjMyNTQ3_d83d6f21-43ac-4ebb-9e7d-0b7fcd1f8041">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657b2a0824346879b134134d44a0a15_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtMy0xLTEtMjMyNTQ3_eda56d54-f881-4b5e-a357-5ef7f340ca99">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtNS0xLTEtMjMyNTQ3_77b1976b-6545-402c-b262-bd62958fc823">16,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtNy0xLTEtMjMyNTQ3_a955bea7-c700-4281-9f85-378f8942a3b5">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtOS0xLTEtMjMyNTQ3_0e8401c2-9269-4b7b-9534-9d94ec2eb420">16,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtMTEtMS0xLTIzMjU0Nw_5427458b-3467-4836-9662-8d59a004d499">1,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;<ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIxOA_e0a013e3-a832-4555-ab63-9cbce857cb3a" continuedAt="ie8e4a745fdad4fcb8a2bd818039b3cba" escape="true">During the three months ended March&#160;31, 2023 and 2022, the Company had the following activity in its mortgage loan portfolio:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie8e4a745fdad4fcb8a2bd818039b3cba"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMi0xLTEtMS0yMzI1NDc_21da16c6-b2d6-4ae8-a54b-b773ca265ac7">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMi0zLTEtMS0yMzI1NDc_eeda3149-1492-4747-9fdf-1520747f4bf3">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMy0xLTEtMS0yMzI1NDc_c3f89e39-0c53-4f4c-b0e8-b906a29f0ed5">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMy0zLTEtMS0yMzI1NDc_3227a19c-780e-4032-be44-39e344dc4778">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfNC0xLTEtMS0yMzI1NDc_1642d1dc-d251-4745-9a0b-53151877cc32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfNC0zLTEtMS0yMzI1NDc_83c0dfe8-5a6f-4724-bbb1-748e924cbc97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if4709cbbf0364f77bbe3eee247c348df"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIzMw_eb180404-8196-4c80-bb7e-8c7a15290a7c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at March&#160;31, 2023 and December&#160;31, 2022, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7071e99aae74c26818ee4fc1078006f_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0xLTEtMS0yMzI1NDc_bb7010c3-505a-4201-90d9-7e6c78ad3792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f338d30818a45c8b71f0f0dbd66b6d2_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0zLTEtMS0yMzI1NDc_21f98abc-4d56-4613-b4f9-f0670d0610bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61edd147d4fd41509a556db54902c84c_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy01LTEtMS0yMzI1NDc_4879a36e-7ce3-4e7f-bcea-320d9ffdc24b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36bbbfa3da2b4326bc60719fa6fd45ed_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy03LTEtMS0yMzI1NDc_fe3603d0-1b51-4c34-b72d-6118fffd92b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib52a1527e7b349ec89e29f3f0ba90ad4_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy05LTEtMS0yMzI1NDc_cc6294a5-973d-4f68-b77c-a8ecf83e064f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d3db81712f4239be8f0051d1d897a8_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0xMS0xLTEtMjMyNTQ3_ea4d421f-b675-46a6-8635-a339bd057467">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97b341035254171803036112d834dc3_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0xMy0xLTEtMjMyNTQ3_14e18b63-94c6-4966-8667-dabd400bbebe">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9687fc8f6c4d6db21b6785089b7e8f_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0xLTEtMS0yMzI1NDc_39df154c-167e-4743-aa87-b194713a98b7">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfdc0c8d72f342cb92f5fc2b1a42d622_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0zLTEtMS0yMzI1NDc_db147679-32df-4fd8-addd-60daaa88ede5">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64f1950f0b744460b168ac0882235a7a_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC01LTEtMS0yMzI1NDc_75df5da5-9e41-4d0e-a834-b44430a869af">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d8282968274787bf68cd11594aa0c5_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC03LTEtMS0yMzI1NDc_29dfd217-fc89-4bb4-a324-531f13198a73">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if11186980b9e4cf698fbb8587274f2dd_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC05LTEtMS0yMzI1NDc_70d5ccc5-4666-482d-bdb6-1b0239ffaf16">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3bda5d9087a4425bd1f312345cf6dcb_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0xMS0xLTEtMjMyNTQ3_60aef6bd-1b55-45e4-aa99-32b7cc0fe232">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia26be39686ba45b1acebc43952d4c3e3_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0xMy0xLTEtMjMyNTQ3_593781ce-6d56-4c5e-87e1-3adcba79b664">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied1ab1eca1634f0698b6d31cd0ccd36a_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0xLTEtMS0yMzI1NDc_32184752-8dfa-4f0a-b43a-286594c1fa3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ae3ae19a3841afaf0cd279b4c39bbe_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0zLTEtMS0yMzI1NDc_81d9974d-2d86-408a-b979-eb762ce5e55d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56aa2cf3462544d8979682eaef70c07f_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS01LTEtMS0yMzI1NDc_a73eb97d-3ccc-4d94-9c58-fc9219261f6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539fd33dac17452e8380f33c7328399a_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS03LTEtMS0yMzI1NDc_c8904b58-cb7d-423b-8df3-80eef35a2bf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2310718e6df44f9ba6d23f2c10ce4f28_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS05LTEtMS0yMzI1NDc_e81a14f4-b3ec-4423-bb39-44cd3e54d7c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a0c27fd53e74ac09581adda8572f037_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0xMS0xLTEtMjMyNTQ3_7cf988cf-555f-4058-bd1d-a67eeb5a0e6f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd736e093284b1f90094c25759f3a5d_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0xMy0xLTEtMjMyNTQ3_0eacd9b5-1202-4f91-8618-56b8888e9103">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a7c42e398848ce8ae91911c305983e_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0xLTEtMS0yMzI1NDc_38624eb3-e12a-491c-b731-5da0ecd5193f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d25dd9c66fa49e183749b9de751d7ac_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0zLTEtMS0yMzI1NDc_031b1df8-1033-430b-99b6-6d175af5967f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcaa27ca17db4c80894a80bd3c652fd5_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi01LTEtMS0yMzI1NDc_e630dda8-a407-4a28-bb33-f38b27d0c479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d38be3dbd9f47b1a656a54014fe335e_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi03LTEtMS0yMzI1NDc_ec8ec307-9f20-4a33-9221-a79c281445f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a81db5279004ab98255bc257a8b932a_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi05LTEtMS0yMzI1NDc_6627a925-e843-473e-a79f-f607e4d58688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddee2adad35a4a8192069f6cafdf1201_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0xMS0xLTEtMjMyNTQ3_c842b0f8-ac18-4c73-a115-aadc1c04b2f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ccefd85418d453d9737f46e41f5fb23_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0xMy0xLTEtMjMyNTQ3_0e06891f-ff02-466d-84f4-d3081160601e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfed1454e7274af982d6b45ba703168a_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0xLTEtMS0yMzI1NDc_c3d898d3-5d10-45c0-92a5-aa97935872ce">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fe3eeb911349678a7bf8df45f05778_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0zLTEtMS0yMzI1NDc_d8453aea-87d4-4237-858c-e1a0fc347071">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e26089b884345fc8d7fc1a31ebe1941_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy01LTEtMS0yMzI1NDc_08bdade8-4b5b-498f-80d7-a37297f46af0">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdbe7e2001e5451395afcf0f04039747_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy03LTEtMS0yMzI1NDc_10a0c444-70c9-4304-99a4-ce51534b3da2">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcc5f5ebbc94676a14ee20dd1d88ee3_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy05LTEtMS0yMzI1NDc_7dd01fe1-7607-4bf4-ac0d-e99304dbc310">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d3af566c97447eb29044226498a483_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0xMS0xLTEtMjMyNTQ3_b55b5e22-ab59-4c7a-9e46-567d8ef671ea">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a07081ff1e147c7b62955fae3341f9c_I20230331" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0xMy0xLTEtMjMyNTQ3_875daea2-2a28-451c-b2c8-8e72ab90804f">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc787c3d87de4e529b1a1214d25dd219_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtMy0xLTEtMjMyNTQ3_777999a8-93c4-4f8e-941f-73ff563a14c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42cb4a9358d245a9b06a8c263fbba453_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtNS0xLTEtMjMyNTQ3_9baa9c72-daf4-4084-82bb-c5297609e4af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639de7dfa3ed4105824a383022ae604b_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtNy0xLTEtMjMyNTQ3_6500356f-4305-41b3-9b11-1f978c85ee14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e3d483e0784d668c5fcccc53c0c0c4_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtOS0xLTEtMjMyNTQ3_71598cba-af3b-4255-940f-40e7a0e3a3e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27fd2cc36f7841a7931db67ed478f1d4_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtMTEtMS0xLTIzMjU0Nw_28858b8b-8e80-4a29-8803-f6faea3ecbd2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i925fade534304e14aa08d9d00d456adc_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtMTMtMS0xLTIzMjU0Nw_f53228e4-63a7-4f01-8350-46d83075ac89">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f043b01d8c84596bf6c16f669ae0033_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtMy0xLTEtMjMyNTQ3_b4f2ce76-2354-46e8-89f3-5086809c1fd4">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f1f3e2b054b410ebbfba28ae8d5bf9c_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtNS0xLTEtMjMyNTQ3_944070fa-101d-44f7-92af-0b30cc48c68f">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7b70ddd11a47b5b376a5b3fbcfc34a_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtNy0xLTEtMjMyNTQ3_49c855ab-348b-4619-8ea5-c1687474af65">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb066670e8741e7b46db0c89fb8f532_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtOS0xLTEtMjMyNTQ3_ca9760a3-3974-4b05-917f-9add52ebd2cd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c073aee648d483b8b99e031c637e88d_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtMTEtMS0xLTIzMjU0Nw_9e064490-db55-4c69-8c69-2c57bc43134c">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785a7204a25949809c4a78f9d83a56fc_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtMTMtMS0xLTIzMjU0Nw_76f4a20a-73ae-4188-b01b-5084136379aa">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4727e084447d41309188d3fa8292bd52_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItMy0xLTEtMjMyNTQ3_3f2a285f-445c-4613-b9da-30775067302a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9145c1132d8f4904bd34c706c2b8da19_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItNS0xLTEtMjMyNTQ3_b6fc477d-38dc-4160-9630-3348e9ef6fe9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib210e2369b7443789e3ea95a893fa4a4_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItNy0xLTEtMjMyNTQ3_cf35d686-3cbe-4fc1-90ac-fdfe2df971dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388162eb095246c8ae3b452b6fb6d79d_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItOS0xLTEtMjMyNTQ3_d560b360-6979-41b1-aef1-1d17a5bbd208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30017e91965849e3b86010cef96f9638_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItMTEtMS0xLTIzMjU0Nw_4be3aafb-4299-464c-86d0-89a57c8bd906">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6302cce667044a7c840558fd40b16281_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItMTMtMS0xLTIzMjU0Nw_15b7f1d6-ade5-491d-a278-13188c9a432d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7156bae6dfd14a4c86bad30abbbff44b_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtMy0xLTEtMjMyNTQ3_e060ea4d-10be-4ea3-9015-99b06f51d7cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd294f5249d4543b203a1badf1bd045_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtNS0xLTEtMjMyNTQ3_ce69274e-2e10-4190-8e3e-7971eafdef61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d2723b92ac44880b50abda5a89b505e_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtNy0xLTEtMjMyNTQ3_0b067acd-ff9b-4e35-8515-9aeb458759c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b68ae2c1f64fd19f95c3e5bd640eb1_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtOS0xLTEtMjMyNTQ3_14d94088-bd46-4d4b-bdcd-429f2fa1fda4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9e6f409f64046f1a01d80570a92c6dc_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtMTEtMS0xLTIzMjU0Nw_9429321e-ff6a-4769-9a72-432e5016e3e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a992fa5adc941b1a529b3cf351ef331_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtMTMtMS0xLTIzMjU0Nw_be8d1b7e-1db5-4fb5-8ab6-814fa31caa5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc1567be7a7f4866ad74e7c9bc298305_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtMy0xLTEtMjMyNTQ3_043bb2b1-a4b0-413f-acb1-816f2522eb2e">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i001598a6451343debc1eff9c7e4e32c1_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtNS0xLTEtMjMyNTQ3_dd238167-5e84-434d-94c9-523a72ee3392">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2962e842fe1042c48b78d2a92f8ba363_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtNy0xLTEtMjMyNTQ3_1e61ae51-b4b8-4d0a-8001-c0f607e1c0c7">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63617743472146bca1ddf9b17d4cd4c9_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtOS0xLTEtMjMyNTQ3_c2c0ad21-47ed-4a35-948f-9a8d57ba4cfe">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd1a57a9ec4148a9907fb88d8b662710_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtMTEtMS0xLTIzMjU0Nw_71c1f259-8977-41bb-81fe-09ea2d9b3aa2">424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913e95c8d14844cab43aae1b5ee9d5d7_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtMTMtMS0xLTIzMjU0Nw_d72634ee-368a-41ba-9838-420707a8ef5e">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIyOA_60b46f5e-beb3-46a7-bad7-8b51fa3a6f83" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.282%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1894678fde443f82f89be4a6696366_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMi0xLTEtMS0yMzI1NDc_dcb7c11c-baf7-4c98-ba28-653207799c75">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8265c25c9ead4bd99cf15809d148a000_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMi0zLTEtMS0yMzI1NDc_ec95efd5-7f9c-4213-a6c4-d8a39df1666a">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb917855ecff45e8a8e787e07790f532_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMy0xLTEtMS0yMzI1NDc_c62916e5-ef43-43ad-b44d-93f1e20263b0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec14ebc629645989483a19e0343e21c_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMy0zLTEtMS0yMzI1NDc_8aab1345-61a8-44b6-9503-ec751d259660">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88836880a6c74131ab0d5e56774644d3_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNC0xLTEtMS0yMzI1NDc_e46d81ae-5b90-4e37-8e42-303314d46858">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b7647c520143b2b49538ae9a39be8e_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNC0zLTEtMS0yMzI1NDc_cb10d7d7-c323-4980-a6d6-c1d188c67e0c">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNS0xLTEtMS0yMzI1NDc_38a6155a-20d0-40c8-9227-4c8256f81f1f">449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNS0zLTEtMS0yMzI1NDc_398bbb30-6bae-48b7-bea4-a24134ede367">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNi0xLTEtMS0yMzI1NDc_8e87e53c-1330-40ed-bbed-3ef034d37dbf">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNi0zLTEtMS0yMzI1NDc_7f9b79d5-e339-424f-bd7b-337a8835fc84">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsOrLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNy0xLTEtMS0yMzI1NDc_d37591bc-f184-4b01-9406-e74473419bb9">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsOrLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNy0zLTEtMS0yMzI1NDc_c90fa4b5-474c-4a8c-a5c5-21a5f1935378">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOC0xLTEtMS0yMzI1NDc_d38b3ae4-dd50-4bc9-9264-52d7bebc7326">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOC0zLTEtMS0yMzI1NDc_22a18566-b27d-4805-bdd1-5f552460a573">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOS0xLTEtMS0yMzI1NDc_6cbe520a-87da-46d2-806f-b2b99e544bbe">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOS0zLTEtMS0yMzI1NDc_4babc542-50d9-4db3-a731-eedd23a4e774">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include the reversal of previously recorded credit-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMTA5OTUxMTYzNDMxNA_a8061136-07eb-4fc2-be08-67e4993bded4">1</ix:nonFraction> million and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNDE5Ng_71727d15-0c42-4053-9a93-91e6030cf0b4">24</ix:nonFraction> million in the three months ended March&#160;31, 2023. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMzI5ODUzNDg4OTM2MA_3f0a7fe3-3642-4fd5-a292-3705e4177fe6">38</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNDQ5Mg_3f7ad8f6-ff9f-47af-9377-cd35dae54ce5">18</ix:nonFraction> million, respectively, in the three months ended March&#160;31, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="i8ebc837ea9594ee285981ba3f282c096_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNDc3NA_5fe1751f-a3ff-4582-9b79-20b708431286">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1dbe5953d7534e6b8caf8d57ca5ede7b_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMzI5ODUzNDg4OTQxMg_96ea9b1d-e291-4ce1-8371-d9fcc61a5218">9</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively, related to investments supporting experience-rated products.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTI1Nw_2c49a347-4452-4b64-816c-31380a17082e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMi0xLTEtMS0yMzI1NDc_af9157cc-90e8-477f-a30b-c3745bef1cad">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMi0zLTEtMS0yMzI1NDc_bcfc52cf-9fa1-4813-9bc2-756453c8d575">1,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMy0xLTEtMS0yMzI1NDc_bf47d436-60ff-496f-a3f3-837f7acd6d95">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMy0zLTEtMS0yMzI1NDc_7906cfd8-e8fd-4684-8716-5ea1548c55da">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfNC0xLTEtMS0yMzI1NDc_61ab2b28-973c-44e6-bb7d-37a2f2cf6504">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfNC0zLTEtMS0yMzI1NDc_c03c3c5e-734f-4736-981b-7cb0e8be9b7a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ2MA_2e68e570-7d95-4242-a40c-e47460605bd3" continuedAt="ibdc5b4a5cc6449748e77dbed3121508b" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibdc5b4a5cc6449748e77dbed3121508b" continuedAt="i374bcb88620e48b0ada212e79c8a323a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2022 Form 10-K.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i374bcb88620e48b0ada212e79c8a323a" continuedAt="i501a49ae570e4ea29a651fb5e0b57ad1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMTQzMg_0423879c-e13a-4882-afdd-12e54277a2e7"><ix:nonFraction unitRef="usd" contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMTQzMg_ec3895dc-4a04-4fc8-a4f9-32d8e37ae124">no</ix:nonFraction></ix:nonFraction> financial liabilities measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 or December&#160;31, 2022. <ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ3MA_d4c4cd7e-d3c7-45ec-83ad-b08fcdb4b8b1" continuedAt="ib384b2077ce64f11a8fa0697d5fc2ac4" escape="true">Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</ix:nonNumeric></span></div><ix:continuation id="ib384b2077ce64f11a8fa0697d5fc2ac4"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi0xLTEtMS0yMzI1NDc_995ac011-0e38-40dd-a35a-7cfd21998aa2">5,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi0zLTEtMS0yMzI1NDc_b1554feb-fd9b-43d2-a42b-e3b9e30b92f7">8,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi01LTEtMS0yMzI1NDc_8641cee2-5bf0-42ba-ace7-7a62c47abdfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi03LTEtMS0yMzI1NDc_42ce1176-83e3-4ae7-bdd0-625d8b91c300">14,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2cc79aa32c24877bb38fed7bb662b80_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC0xLTEtMS0yMzI1NDc_0ee6658f-79d5-4147-aca3-4a86747ebbcf">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940d96b554da411a9cba8e0f8ac4b3f8_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC0zLTEtMS0yMzI1NDc_81c5ed1b-53f0-448c-bc07-bcc49b974b3b">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccf07ea07e5473386720165a8d80e66_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC01LTEtMS0yMzI1NDc_e32062cb-ee7f-4e91-a0c3-f9685c1b4c86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f12a0b1caec43ed8a5cff4d6a9e3476_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC03LTEtMS0yMzI1NDc_afa73399-0f37-4242-b5d7-fcf1815c84b2">1,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfa4161feae48dab889801774d4b2e6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS0xLTEtMS0yMzI1NDc_c5e9e680-0723-4916-950e-f309fe3dac94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f3cbe1cfcb4a5f9a47d208546e9394_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS0zLTEtMS0yMzI1NDc_c8a2f156-7498-4e0b-9519-52fa0b2e12b7">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af15065f24c48d597eeba3d21822866_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS01LTEtMS0yMzI1NDc_65ad001d-67c2-4bad-b3b4-52d762a9f18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i018e0921466c4187bd61ec7f759a162b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS03LTEtMS0yMzI1NDc_99f06be3-17ae-4cc6-8b66-88e5e8e36840">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c8746221ad488b9529c5494d1ea6ec_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi0xLTEtMS0yMzI1NDc_d76cd6d3-6e2b-4953-915e-1ea9066b587b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa81968af7b42edb313c43eed5dac3b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi0zLTEtMS0yMzI1NDc_7c31dc74-d3f9-43a1-80cc-4a3e6a2ec601">9,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13000e7829fd4c77a7fd14783d62bd3f_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi01LTEtMS0yMzI1NDc_70f29d68-7f11-4818-9884-09b131dba0da">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff376ec3f339421eb5832e29861ce655_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi03LTEtMS0yMzI1NDc_44b94a27-2f82-4039-8457-1a2b2b25ec86">9,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a515693d5ce41788531f520d6f67ec0_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy0xLTEtMS0yMzI1NDc_8233ca37-8bbe-4d7c-83bb-ab1cd8f14162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie41a3c6e1c99451a98b32769c140d8ad_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy0zLTEtMS0yMzI1NDc_867ff00e-ced6-40a6-b0c0-496c59cf1751">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1fb2239301f45369894d81b5bef30af_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy01LTEtMS0yMzI1NDc_c14f2833-7fe8-490a-b187-8a4c681b1d2d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ddde48bac0413a905db67674a8e7bd_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy03LTEtMS0yMzI1NDc_9b3e9711-8c66-4e35-a179-c9cf005484a3">2,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i638494ab1b4746019b02aed9c1bf8d9c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC0xLTEtMS0yMzI1NDc_19db1e18-dbe6-447d-8b94-302e57010d3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4104a3224bf9493180199848515bb756_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC0zLTEtMS0yMzI1NDc_5bf03667-99ac-4d03-9ece-3899528f64ad">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bfdfa7a6f4b458dbd8ae201cba1db28_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC01LTEtMS0yMzI1NDc_bcf4ef38-b7bb-42be-9b9b-528c669338a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e4d1e5638a949eeaec6c1e059aa2887_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC03LTEtMS0yMzI1NDc_3cf9e573-fb10-4a28-8684-eadbac045dfd">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1abdb4a43b4e52a6d8356ebe217244_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS0xLTEtMS0yMzI1NDc_b8e572d3-605c-4d31-a5ff-bb2ebae805c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e5e884e58f40ecb2c2247c7abe2f3e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS0zLTEtMS0yMzI1NDc_6f8b1548-eef7-427d-ba8e-2a7eab730655">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic203ee5d324b425a8a68bfeed0a05433_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS01LTEtMS0yMzI1NDc_df73eeab-513a-41e0-9b2d-4747950424a6">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id123001a7f8d495091ca8cf8640c1149_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS03LTEtMS0yMzI1NDc_7e3b0059-e20c-4de3-b2d4-971f0ee64d6f">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae365fa794744d8889721900ea6b2235_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtMS0xLTEtMjMyNTQ3_ab800852-5d32-4b47-ae15-d77105f6e84e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c5c14abc11642c596325a01b162322f_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtMy0xLTEtMjMyNTQ3_018313fa-5370-4ed0-9e6e-80b5c69d17c8">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d88303b2f434c308ad61792e9ee3b36_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtNS0xLTEtMjMyNTQ3_2b937388-e9f2-41ce-ae91-4edc603c13f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie608b61ad1604ca986c8862e56a56332_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtNy0xLTEtMjMyNTQ3_a4bb6d08-cc60-42c9-bbc3-3e064602c9b6">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86995cf6b1d84d179178e116a1a20f11_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtMS0xLTEtMjMyNTQ3_b8320612-e171-4a94-9008-498efc514c6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cd9790208a42bea5215d04c5eb3401_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtMy0xLTEtMjMyNTQ3_48462719-2f6c-430f-b25e-0a8951053351">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc5a5cd534c4f698abae8407f367bcb_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtNS0xLTEtMjMyNTQ3_2bf155d2-268a-485c-bdda-150422987562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54953c6cd4614dc1ab7325d790cf34e5_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtNy0xLTEtMjMyNTQ3_3dbda148-ad5b-4e84-8d5f-cb6cb5e5626a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItMS0xLTEtMjMyNTQ3_c5c98022-1b36-4a61-960b-740a5c0acb68">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItMy0xLTEtMjMyNTQ3_42605a4a-6dc2-4406-b69f-f125d6e3cd17">18,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItNS0xLTEtMjMyNTQ3_24b67373-6e3a-4e8d-b1c1-1138c225bb69">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItNy0xLTEtMjMyNTQ3_05138cc4-5101-4b46-921b-ea38257d84a2">20,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtMS0xLTEtMjMyNTQ3_a416015c-dc24-43a6-a07f-59cba7267322">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtMy0xLTEtMjMyNTQ3_f9ff1ef9-cbf3-4e7c-bc99-4199907a0391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtNS0xLTEtMjMyNTQ3_998cec4f-5a71-47e3-a5ad-c67fae9b39a7">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtNy0xLTEtMjMyNTQ3_3d7f9da9-adb2-4ec2-8aee-192fb48eaf18">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtMS0xLTEtMjMyNTQ3_115dccfe-0682-4160-92ad-9b9050de4a9b">8,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtMy0xLTEtMjMyNTQ3_0bce2b67-512d-459e-8dc4-cf22e2cb4d73">27,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtNS0xLTEtMjMyNTQ3_dc47820f-3d80-42a4-a300-23996247a7e2">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtNy0xLTEtMjMyNTQ3_00158a63-15a3-43bf-93eb-b8221305e18b">35,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctMS0xLTEtMjMyNTQ3_61b8b828-40e2-4085-953e-5d805fc6da00">6,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctMy0xLTEtMjMyNTQ3_899fa51c-c53a-4eba-8dc6-b0711421fba4">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctNS0xLTEtMjMyNTQ3_9d44b902-477d-4fb0-971b-9fd066517b82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctNy0xLTEtMjMyNTQ3_f41c5747-562f-4121-944b-176e2683910a">12,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e187738c64a4f819165a5dd65b86de2_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktMS0xLTEtMjMyNTQ3_3242a309-9a98-4189-a004-7ab49f0f279e">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb701bf9661948ebac5ec92842c42cd1_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktMy0xLTEtMjMyNTQ3_fad0d25b-f820-4def-815d-0da32c44600e">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20104417b40c467083117d2e267a0d8d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktNS0xLTEtMjMyNTQ3_d656a2e9-00ee-47c7-811b-52245556d36c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b061f9764a45d58ce926b44ad26d44_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktNy0xLTEtMjMyNTQ3_8d078e90-b75c-490b-bbb6-20b87ddfa860">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c1a5f7cda7b418fb2105151c6cebdd9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtMS0xLTEtMjMyNTQ3_6e1309f2-0604-4ea8-9f06-188c30afb6dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ac657fdf5ab45fdbf03530b75c2f55a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtMy0xLTEtMjMyNTQ3_50e39989-5a26-449b-b455-e84fbae6063d">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i442caee6095c4be4950552f634b6d7a8_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtNS0xLTEtMjMyNTQ3_bc5d6780-307f-4a45-b421-56301d86bdcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e51a45df88d476ab23a4e8b55ec1e22_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtNy0xLTEtMjMyNTQ3_4c35dc59-ffba-4926-a666-c0f70e809e8e">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie42c87aeb9a142048b4d45e04a53dabf_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtMS0xLTEtMjMyNTQ3_67b449ce-0239-470f-bf1c-b4bcbcdeda22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58584562df924c35a92246868059ade9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtMy0xLTEtMjMyNTQ3_e3d2c364-1a9b-4181-a005-cd4bcd7183c4">8,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180e642f281a4428bccbf1a1d28a4863_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtNS0xLTEtMjMyNTQ3_c53b59dd-323b-4431-ba4b-04a0c67ddec8">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96a5d0edeea40438700b57fea0592cb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtNy0xLTEtMjMyNTQ3_63bf85bf-407d-4441-8543-ae64e5cc9efa">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a3623a5b404531b6aaf3bc4355290f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItMS0xLTEtMjMyNTQ3_c3cf09f3-6399-441f-aa13-a4c1e3d339ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9130e432ea74b33b7edc370ab5d3ac3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItMy0xLTEtMjMyNTQ3_319ae022-6cf9-4aee-bb69-e8ce48db8773">2,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5e7a806a404590beb00542a88de708_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItNS0xLTEtMjMyNTQ3_b149c71b-53e2-4e6a-b87f-70d860ce80e0">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0a094fa23b4862beaf7cd2379edd3a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItNy0xLTEtMjMyNTQ3_ae93f5d6-425c-42f0-b1c8-e9a3c5914628">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9302529dcf26467bbd2db62d902d4ad9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtMS0xLTEtMjMyNTQ3_c82b81f8-2926-47ff-b714-dff81387145d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7d300ceec143fb95566216335aac05_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtMy0xLTEtMjMyNTQ3_81f2512c-72b3-4020-8967-39310fb0149a">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic966dffda67f45128f343cfed0076de3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtNS0xLTEtMjMyNTQ3_2fbc6125-706d-49fa-8df2-7ffe91397eae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dadf84326ee476a8256a97b1954777b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtNy0xLTEtMjMyNTQ3_09b6517a-d2aa-4529-a37e-5a37da52c963">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e69bfca3ac4909baeee8e3bb375ac6_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtMS0xLTEtMjMyNTQ3_d8f3c9e9-b531-4927-b8fb-0b844294f100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e7e9cfafd4471d888f09553e3a8397_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtMy0xLTEtMjMyNTQ3_8b3c375a-2e51-477b-9fda-5413aad13a75">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i711edb971fdc4948ae77077c034cd4f3_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtNS0xLTEtMjMyNTQ3_61387284-055e-4fc7-96cd-27101aca45ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05330bee1a9f44669bc7deddcd19520f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtNy0xLTEtMjMyNTQ3_935bce31-bf60-4426-95aa-bfe24471cb03">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d6560e9fbc4acf849607bd7a325af1_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtMS0xLTEtMjMyNTQ3_623b9cdc-0d2c-4633-874d-06867ebb1e94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367940a0c0de44c9bc97abafd36441db_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtMy0xLTEtMjMyNTQ3_eb13f1a5-679f-4fb7-ada0-8323f95e120b">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b59adf13cdf461f9fe4939c39d5a82f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtNS0xLTEtMjMyNTQ3_cd04670f-3f75-406b-9ec4-8ac5529ef22f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db4636fab2045e79a50da511dac639e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtNy0xLTEtMjMyNTQ3_128c76c0-8525-42ab-975c-beb5474d9b70">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib837b245fbf5401cab8f7e03d387b150_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtMS0xLTEtMjMyNTQ3_f9eb2db3-eab0-4f90-8886-c06375d45e22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c3faf213d24ed792c56ec2ff526497_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtMy0xLTEtMjMyNTQ3_21e1347b-3a7f-4f26-861c-16723bf33bd4">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152425578ab245479d4240084913937c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtNS0xLTEtMjMyNTQ3_aaf68761-779a-4d85-82f2-8d1d29a51bad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d385b28a05d4c32befb019eea226fb0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtNy0xLTEtMjMyNTQ3_cae8b68e-9596-4441-b2e6-cfed942ed92b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctMS0xLTEtMjMyNTQ3_dc23117f-4627-43e7-8f18-d30c7231cca8">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctMy0xLTEtMjMyNTQ3_da93fcb0-0484-457b-ad11-c3190082b29d">18,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctNS0xLTEtMjMyNTQ3_d38c4261-5674-4d96-8cf5-fd50ccac7c45">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctNy0xLTEtMjMyNTQ3_ddaa7e30-d5df-4b5d-9db1-ca0ce11117fa">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtMS0xLTEtMjMyNTQ3_0ef9af79-bbe7-4d2f-a5f6-c694dae2e24f">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtMy0xLTEtMjMyNTQ3_4a45da89-9a79-43a4-a87b-5ed7c69bdc3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtNS0xLTEtMjMyNTQ3_934006b5-592b-44a7-9f42-2de43b3740b9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtNy0xLTEtMjMyNTQ3_b010e5f7-21cf-47bf-892e-99e109379ad9">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktMS0xLTEtMjMyNTQ3_d28e507f-0177-48d0-8c55-1366990a9a88">8,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktMy0xLTEtMjMyNTQ3_cfd0d86f-ac58-4453-9038-633011886108">24,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktNS0xLTEtMjMyNTQ3_13d01ec0-9f94-46e4-aab2-4ef9e5c5cf74">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktNy0xLTEtMjMyNTQ3_920fbbe0-3c36-4339-8501-5186a0a8aa7f">33,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i174f156a210a439ca784589516304147_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMTgwMg_4db89ce4-9266-4553-a736-573d9b427805">7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3a8530e6bd584994b387406e0a034c9f_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzI5ODUzNDg4NzA4Nw_4cd47b81-37c7-4cc8-b96f-795473f1b2e9">6</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, there were $<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMjA1Nw_759bddcc-8922-4b62-91ef-2893235eccd3">29</ix:nonFraction>&#160;million of transfers out of Level 3. During the three months ended March&#160;31, 2022, there were $<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfNDk0NzgwMjMyODYzNA_59b61a88-ad0b-4bc2-92e1-0da60c8b7aad">3</ix:nonFraction> million of transfers out of Level 3.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i501a49ae570e4ea29a651fb5e0b57ad1"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ0NQ_8a052698-67f5-4d2d-9ac2-7a5b54806961" continuedAt="i4035fbfd3ce74f3daf4a936abd91414a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC0xLTEtMS0yMzI1NDc_e8af2a07-3d1c-4d5d-af33-600d67a86f16">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC0zLTEtMS0yMzI1NDc_292ee9b6-007c-4280-b51c-05ddb32c7bd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC01LTEtMS0yMzI1NDc_35aab29e-d560-4d98-8bc3-746adff23355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC03LTEtMS0yMzI1NDc_9503e2fb-e664-40f5-90d1-6a00b189c472">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC05LTEtMS0yMzI1NDc_e076b33c-6e57-4d32-9bf6-3ba7f1ffcfa7">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNS0xLTEtMS0yMzI1NDc_e4f2fc8a-7043-49c9-8062-ea36753aea90">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC0xLTEtMS0yMzI1NDc_3584f258-1118-4767-aada-c85e398d3f76">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC0zLTEtMS0yMzI1NDc_95f66a2c-619f-44e0-a6cb-39fb2855b0ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC01LTEtMS0yMzI1NDc_171f1010-6d48-4505-a263-5a55e374f20f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC03LTEtMS0yMzI1NDc_4c39e3f1-4066-4a56-bec0-6713be288c6b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC05LTEtMS0yMzI1NDc_5f4eeae7-e0d0-4bf2-9a19-49ad471709d4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS0xLTEtMS0yMzI1NDc_9e762ed9-d344-466c-afa4-94476055b749">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS0zLTEtMS0yMzI1NDc_a9fd154f-b628-4c21-aec5-02526eba674c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS01LTEtMS0yMzI1NDc_aee03fa6-f378-41e9-9db0-1459c0e021b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS03LTEtMS0yMzI1NDc_5c0bf962-0b39-4729-8158-17125c5242f3">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS05LTEtMS0yMzI1NDc_3afd79a6-9aae-4ac6-9489-61d7191f9a0a">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtMS0xLTEtMjMyNTQ3_9f2f2438-23c6-4ea8-9ea2-a469f253d0e9">58,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtMy0xLTEtMjMyNTQ3_385f0b59-3666-42e4-8bd9-221f37b1a52b">54,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtNS0xLTEtMjMyNTQ3_e4fc0ec1-58f7-4ad8-b287-49075ba373de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtNy0xLTEtMjMyNTQ3_eb316bc2-9956-4150-ad13-0f29554a8c99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtOS0xLTEtMjMyNTQ3_347025a8-36d7-4a4d-89fa-d04545cbf68e">54,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtMS0xLTEtMjMyNTQ3_fe4dd7d5-ccb7-4854-9667-45dd3af0c21c">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtMy0xLTEtMjMyNTQ3_44a3459d-f566-488e-a678-a582148d84c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtNS0xLTEtMjMyNTQ3_f7e4447c-6094-45f3-ae80-a9873b90a278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtNy0xLTEtMjMyNTQ3_0f9e1589-3b89-40db-8529-0dfcd0f56422">978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtOS0xLTEtMjMyNTQ3_1e9d7418-2134-4258-9525-7755ca0ef104">978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTUtMS0xLTEtMjMyNTQ3_e587e4c7-9ed0-4a63-a106-8b4e66dc7cd7">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtMS0xLTEtMjMyNTQ3_67e79668-1195-4c50-a2ce-d4da953c1e4f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtMy0xLTEtMjMyNTQ3_259db3f7-8c00-4479-8ffb-d85eb88a17b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtNS0xLTEtMjMyNTQ3_39b92190-3073-46ff-91a1-e6a2f432a42e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtNy0xLTEtMjMyNTQ3_87ce3068-155f-49e7-b54a-3a098b6ffbd9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtOS0xLTEtMjMyNTQ3_16d54683-a0f9-4675-9e54-9b0c62e55ec0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktMS0xLTEtMjMyNTQ3_d109a1e9-506c-49da-8832-7bfec1b85bdc">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktMy0xLTEtMjMyNTQ3_4bb89f4a-b412-450d-8051-a55800c5f95c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktNS0xLTEtMjMyNTQ3_8907cfe1-ed89-4882-8016-9977f3577cae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktNy0xLTEtMjMyNTQ3_307904c2-e7ad-4400-bb5f-28e1310f9f22">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktOS0xLTEtMjMyNTQ3_30da259d-4333-4470-b110-c27ae85b62ba">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtMS0xLTEtMjMyNTQ3_e185686f-b7dd-4518-b772-a7af850cc914">52,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtMy0xLTEtMjMyNTQ3_25c5519f-86b3-40a8-ab26-19a0d24d93cc">47,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtNS0xLTEtMjMyNTQ3_07f14eef-3177-4fa3-9edb-246c09354ce6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtNy0xLTEtMjMyNTQ3_dfa2dfae-e146-4ee4-8cd7-48a3c1de0eb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtOS0xLTEtMjMyNTQ3_795a1e9b-9f0f-4597-9bb6-d2075e9227b3">47,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i4035fbfd3ce74f3daf4a936abd91414a" continuedAt="i518a83a6d72f4c6d9fd69a2d99d5c0ff">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i518a83a6d72f4c6d9fd69a2d99d5c0ff">Includes long-term debt of $<ix:nonFraction unitRef="usd" contextRef="ibd3f75c2d0b04f1e92ad90c558bfb862_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzI5ODUzNDg4NzE0MA_a80d3ade-b2aa-4330-aff6-987976f28a99"><ix:nonFraction unitRef="usd" contextRef="ie9216a5f76034bf488b5c23d00f7740f_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzI5ODUzNDg4NzE0MA_e60ecd1d-1606-4a13-983d-e5183893e8cf">3</ix:nonFraction></ix:nonFraction>&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;<ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ3Nw_d7fed4ad-f85a-4950-b4d2-469f2d2d0ea0" continuedAt="i420ff51ec5a54ac899ae6f16ddeb5cc3" escape="true">Separate Accounts financial assets as of March&#160;31, 2023 and December&#160;31, 2022 were as follows:</ix:nonNumeric></span></div><ix:continuation id="i420ff51ec5a54ac899ae6f16ddeb5cc3" continuedAt="iad61f51256d94bf789e7dc9a00d45248"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0477daecdf25494cb2366e0b03619181_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xLTEtMS0yMzI1NDc_5f72b135-7ee9-41c4-b4a6-27705a7de240">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f84be43c284e9ea81738a715edabe2_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0zLTEtMS0yMzI1NDc_7e39dc6a-f176-4811-8013-51b1264a435e">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6db07e1d8d6441eace2fba24d4330f2_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi01LTEtMS0yMzI1NDc_f27f16d6-5618-4d61-85f3-9148174f5d70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1683e51a0304fd1b7b78196b6cd714f_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi03LTEtMS0yMzI1NDc_d7bf38fc-5eb4-4b1d-8ae9-254a26f56b68">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd649305f8964805951ac2c94e102d7e_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi05LTEtMS0yMzI1NDc_03aabcb4-7733-487e-9286-9a0fff49eecd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82772095666435b8c2ba849a5d87d24_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xMS0xLTEtMjMyNTQ3_1888aa03-d993-42b1-8246-31821629acec">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243d234bfce84d389bc036ddb4b85c74_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xMy0xLTEtMjMyNTQ3_8994c23d-14e5-4f59-bb73-5d25af13b0ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2391cba71e9345508d7ce650a306647c_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xNS0xLTEtMjMyNTQ3_39d33856-4cf7-4f83-bf24-d61e4e1a07aa">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63539f261c8e469cb1db341cc5be5d7e_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xLTEtMS0yMzI1NDc_b1368d42-17b4-40c0-84cb-619299ead56c">699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78e7cab3f0f04b0f9ce8ce12e0f930f8_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0zLTEtMS0yMzI1NDc_3d93410d-6745-4faf-bd53-1da0192fb3ab">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecb5c351dba4689987a3a609b0cfb43_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy01LTEtMS0yMzI1NDc_728b3673-f40b-4ed4-9534-29c8a9ec0b1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767908569cc8444db0b335059e1f47f5_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy03LTEtMS0yMzI1NDc_f2c7a04e-68c5-4002-8f01-4f5b979ff088">2,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42367ec111444b5db6d88802bba1dba7_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy05LTEtMS0yMzI1NDc_df2620c0-f834-477a-a3b7-ffce3715e43c">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01151808097d494ea4b5cc15684dc01a_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xMS0xLTEtMjMyNTQ3_18eac300-e073-47e3-9692-7550cad001af">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64dbb0605566455397f86d75767eabfe_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xMy0xLTEtMjMyNTQ3_fe130fe6-6425-4853-8999-846579203db2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e5aacbdfc34e248dd6ad1cabff65bd_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xNS0xLTEtMjMyNTQ3_21e5992f-4342-47a2-bd6c-cdcec496b4c5">2,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f67171bf8fe46e184c0ac18933c3013_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xLTEtMS0yMzI1NDc_45f5ad58-43dd-46a5-b968-71f28650eaeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30887d94add43ff8de3f123add67684_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0zLTEtMS0yMzI1NDc_c28fa29f-0428-4b3c-b541-a067a4d0a6f6">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963eadfc020e4b0bb4c52e215959124d_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS01LTEtMS0yMzI1NDc_6ea0e00e-7451-4469-ade9-2e3010b20cc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3739f888e9fa4ab18bf2d985de27fe27_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS03LTEtMS0yMzI1NDc_bbcd72cf-2361-4c02-9026-d9afbda8632e">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d351d5ac104a9383183f6130aa4991_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS05LTEtMS0yMzI1NDc_7f3db367-0651-44a1-a2df-1de8a866504b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2651627654ef4f4c91f509c8eb1bb477_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xMS0xLTEtMjMyNTQ3_5be726f9-2cc4-4645-be64-1bf87e67d245">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a146d6f9c44eb0987d661df9a8f498_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xMy0xLTEtMjMyNTQ3_fa88011f-0086-49c3-9e56-c98f2556d233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0dca12fc0564290869461416690d5fa_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xNS0xLTEtMjMyNTQ3_e2bfc200-7b47-41a9-bfb8-ae03fcd1eef0">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xLTEtMS0yMzI1NDc_a4ca000b-1019-473c-95a7-6aae9d9d75bf">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0zLTEtMS0yMzI1NDc_07256bef-92e4-4efe-aea9-fed5fb6dfbce">2,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi01LTEtMS0yMzI1NDc_06927f3d-08f3-4c91-af7e-85cd2eaf81db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi03LTEtMS0yMzI1NDc_948cb266-8fda-4b68-8100-658611b4273e">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi05LTEtMS0yMzI1NDc_707e1ba8-d66d-44f7-b9c0-e6da8bf6e2f8">714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xMS0xLTEtMjMyNTQ3_5247c7b7-aaab-4dd7-9e9d-4bad02e5432f">2,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xMy0xLTEtMjMyNTQ3_b1aa437f-a4b2-459b-b628-bcaa32b18c08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xNS0xLTEtMjMyNTQ3_2160245b-ba41-44b7-8287-7ee95967c0be">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i8903f0df33854a12b5260ff32cb9efff_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzM4MQ_b9ef9ebb-7f48-4c2e-b636-ad378fd1fcef">29</ix:nonFraction> million of other receivables and $<ix:nonFraction unitRef="usd" contextRef="idf917e365bae42a0b79ce78cefbe94e4_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzM4OA_480cf1d1-6199-436c-aab0-fc0f494c7cac">85</ix:nonFraction> million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_6047313953990"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY185ODk1NjA0NjUyMjA2_40972c6e-8681-4512-9efa-c1ac5a090448" continuedAt="ie8436ac0f9634ff8858532fe5328211c" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie8436ac0f9634ff8858532fe5328211c"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY185ODk1NjA0NjUyMjA3_3a351f25-a3c4-48ad-a837-d88262268530" continuedAt="i9f122ebf62b44db788198a9667ee8aff" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the three months ended March&#160;31, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8yLTEtMS0xLTI1ODU5OA_25fc9bc3-4731-44ac-87fd-86db60094319">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8yLTMtMS0xLTI1ODU5OA_2f712dfb-7be3-4247-954d-ea98acf1a461">8,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8zLTEtMS0xLTI1ODU5OA_ecee1f1e-84ed-41c7-937e-eced66870db9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8zLTMtMS0xLTI1ODU5OA_067454bb-52e8-43cd-b389-3cfb2177c24d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTEtMS0xLTI3Nzg0NA_bf709245-7e0c-42ff-8aaf-f61b893e4611">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTMtMS0xLTI3Nzg0NA_9e192041-a17c-4ab4-b30a-b05e73fcb77d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTEtMS0xLTI1ODU5OA_3546cba2-f431-439c-ac82-f1eebb6ce808">10,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTMtMS0xLTI1ODU5OA_347fa114-1a39-4c48-b3c8-fdcaba60f136">8,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV83LTEtMS0xLTI1ODU5OA_372e4200-15e0-4f8c-a272-8203f68ae5d5">21,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV83LTMtMS0xLTI1ODU5OA_ee5f69cf-5749-4a01-bfde-ecef38fc80fe">18,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV84LTEtMS0xLTI1ODU5OA_0c18d969-8703-45fc-8869-6ba6e9304ece">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV84LTMtMS0xLTI1ODU5OA_401b95a3-28e2-42b4-8187-7da96250e435">676</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV85LTEtMS0xLTI1ODU5OA_d7eebf3a-7935-4a92-a0a2-e31ad6d756bb">20,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV85LTMtMS0xLTI1ODU5OA_a8ab0763-03b2-4b2a-af07-b92007845d31">17,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMS0xLTEtMS0yNTg1OTg_b0a1a417-0db4-4256-879a-a4cf7c4729f5">11,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMS0zLTEtMS0yNTg1OTg_2efaa94a-1985-474d-9289-117d1e9a60ca">10,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMi0xLTEtMS0yNTg1OTg_06edc49b-515d-4b6d-97b4-3b04398ea022">7,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMi0zLTEtMS0yNTg1OTg_63219107-316f-4993-bfb1-5fda670b2a5c">6,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMy0xLTEtMS0yNTg1OTg_bc9ec61d-b14d-4cec-8cb0-5ebaead46c7c">19,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMy0zLTEtMS0yNTg1OTg_ce813bde-9c92-4400-9659-0fb28f2cdc03">16,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNC0xLTEtMS0yNTg1OTg_2fd67cb0-2534-4717-a229-b4c107c4ebe0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNC0zLTEtMS0yNTg1OTg_9adbfda2-0fd1-4658-9053-98e0f52b2346">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6451d539af494cc08958d87d42063dd5_D20230101-20230331" decimals="-6" name="cvs:DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNS0xLTEtMS0yNTg1OTg_67fd54d7-bd53-44c6-b9cc-a42d826cb492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d919deafdff42c08b18845673c9987c_D20220101-20220331" decimals="-6" name="cvs:DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNS0zLTEtMS0yNTg1OTg_dc18c2e2-46bc-42ad-a1b5-fef8957f244a">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNi0xLTEtMS0yNTg1OTg_95bf1dd9-9003-49be-ae19-e2db499ed654">10,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNi0zLTEtMS0yNTg1OTg_f9ff86d7-8a0e-4839-a146-c0c308dbb8bc">10,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNy0xLTEtMS0yNTg1OTg_6d953a0b-189a-48ad-be04-9860902c328b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNy0zLTEtMS0yNTg1OTg_b912efab-c01c-493b-b8c3-324667349bd9">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOS0xLTEtMS0yNzc4NTk_4223cbed-de97-4bab-8d88-6c0b87aa0e04">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOS0zLTEtMS0yNzc4NTk_591189cb-b651-4068-aaa1-d6b9b5829996">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOC0xLTEtMS0yNTg1OTg_95622e3d-d883-4311-a1af-4747ea7d0e10">10,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOC0zLTEtMS0yNTg1OTg_3bfab2be-258e-4360-9e80-210247670ea0">10,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive loss on the unaudited condensed consolidated balance sheets. Refer to Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for further information related to the adoption of the long-duration insurance contracts accounting standard.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the three months ended March 31, 2023 and 2022 in the table above exclude $<ix:nonFraction unitRef="usd" contextRef="i4ef8067610324631a99b73d483b1c819_D20230101-20230331" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18yNjg_51b64815-b8c6-4c5e-83ef-9a54ea92a220">22</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id68cb38e243a4c0589c5dc10a30a7ad0_D20220101-20220331" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18yNzY_aef4d21b-d2c1-49a4-84e5-fde9246113e0">21</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and $<ix:nonFraction unitRef="usd" contextRef="i0643f3ad93414fdb8de5a7dd49b4a6f3_D20230101-20230331" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY180NjU_4aaeea10-9486-4ebd-97fc-192bacdedcc6">51</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id4056481f5b44ae287fa3901ab72f3a3_D20220101-20220331" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY180NzM_d25f318b-c6f8-4627-be16-708ed57ebbba">61</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. The incurred health care costs for the three months ended March&#160;31, 2022 also exclude $<ix:nonFraction unitRef="usd" contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY183Mjc_9adbfda2-0fd1-4658-9053-98e0f52b2346">13</ix:nonFraction> million for a premium deficiency reserve related to the Company&#8217;s Medicaid products.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i9f122ebf62b44db788198a9667ee8aff" continuedAt="i93927a80d9ea44edb1ba39f69e6dd154">(3)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i93927a80d9ea44edb1ba39f69e6dd154">As a result of the divestiture of the international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), the net assets associated with this business were accounted for as assets held for sale and the associated health care costs payable balance was included in accrued expenses on the unaudited condensed consolidated balance sheet at March&#160;31, 2022.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18xMjUz_0c18d969-8703-45fc-8869-6ba6e9304ece">693</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18xMjYx_401b95a3-28e2-42b4-8187-7da96250e435">676</ix:nonFraction> million, respectively, in the three months ended March&#160;31, 2023 and 2022, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-8" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18xNjQ5MjY3NDQzODU2_ec1472a2-2c4a-4237-b48b-02a33bf8b805">8.0</ix:nonFraction>&#160;billion. The majority of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at March&#160;31, 2023 related to the current year.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_3298534884531"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:InsuranceContractAcquisitionCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk0_8b4263aa-fa55-420d-bf4f-da9306a0334f" continuedAt="i28c1c28dc84a4b8f8b231a5947e04fb0" escape="true">Other Insurance Liabilities and Separate Accounts</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i28c1c28dc84a4b8f8b231a5947e04fb0" continuedAt="i117573793e10406f99b2f1703ba394ef"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Policy Benefits</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk1_b3614f0c-7b66-42c8-86b1-83e23f5fc7e3" continuedAt="iee87c0436acc4bd1a5523b0470c0e485" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yLTMtMS0xLTI0ODA1Nw_274b5a1a-2eb6-41a2-bb71-b56acd99f449">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8zLTMtMS0xLTI0ODA1Nw_8a0daf2a-fbbd-489e-8ad7-8d700e2b8510">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF80LTMtMS0xLTI0ODA1Nw_e7105662-5217-4be1-9cb8-3cbf67c375a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF81LTMtMS0xLTI0ODA1Nw_312d84a0-efcc-48dd-956e-f8278e6fd8b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF82LTMtMS0xLTI0ODA1Nw_1cc1442f-4207-43fe-8489-c6b63d72b92e">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF84LTMtMS0xLTI0ODA1Nw_80923d82-69d7-4434-b902-3433f2ef491f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF85LTMtMS0xLTI0ODA1Nw_a1c1e7ad-af68-4ef0-9c60-19e4455fc800">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xMS0zLTEtMS0yNDgwNTc_b531a311-2a2d-4493-8dc3-cd90b115d300">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xMi0zLTEtMS0yNDgwNTc_70c58dc9-4b0d-4cc6-a9b9-01de13c8950c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xMy0zLTEtMS0yNDgwNTc_1eb1010e-b1d1-424e-963a-db9aa7bc056c">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180077daf73946ae866928c89b89e292_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNS0xLTEtMS0yNTQ0MTE_f8cd94ca-bda6-4e61-b163-9703237fea18">2,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNS0zLTEtMS0yNTQ0MTE_2d6939f1-6ee3-452a-b0e0-d06e5476b0f5">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180077daf73946ae866928c89b89e292_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNi0xLTEtMS0yNTQ0MTE_665ea499-f13a-48a5-81ff-cfc14d6571a8">2,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNi0zLTEtMS0yNTQ0MTE_2499117d-7b94-40dd-b02c-d00d45ce72b2">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180077daf73946ae866928c89b89e292_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNy0xLTEtMS0yNTQ0MTE_7f0b6073-b766-4371-a074-54886ff4b28c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNy0zLTEtMS0yNTQ0MTE_88d117f3-2e0d-4e2d-8eee-547394e29733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180077daf73946ae866928c89b89e292_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOC0xLTEtMS0yNTQ0MTE_ddcd48d7-f0d1-442d-ab0d-955427329320">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOC0zLTEtMS0yNTQ0MTE_36bce630-2690-46a8-84c5-6732336e2d35">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180077daf73946ae866928c89b89e292_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOS0xLTEtMS0yNTQ0MTE_adea5e11-0c5b-488d-a418-ec8deb88be04">2,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOS0zLTEtMS0yNTQ0MTE_e0860e5d-d649-4f57-855a-16e8d69c7d21">1,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances (end of quarter)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMC0xLTEtMS0yNTQ0MTE_aaf46d8b-3f22-4615-b3a9-2c03dc3806cc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMC0zLTEtMS0yNTQ0MTE_0de5b3f6-9a59-4a06-9cc0-b0a0566aff65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMS0xLTEtMS0yNTQ0MTE_f534a443-5d34-4ca7-9949-479f5c566d29">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMS0zLTEtMS0yNTQ0MTE_92d8644f-ed6e-46c4-bed5-3aacc54a0721">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMi0xLTEtMS0yNTQ0MTE_ea9dc7f6-9293-4374-955a-0e498d9cc41a">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMi0zLTEtMS0yNTQ0MTE_9407db3b-d723-4858-851e-17181659fda4">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNC0xLTEtMS0yNTQ0MTE_ffa61762-16d3-4940-909d-9a0292bc4b43">2,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNC0zLTEtMS0yNTQ0MTE_fa220ae3-15cd-4847-9ed0-4c5056db84ad">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNS0xLTEtMS0yNTQ0MTE_cdf42abc-b203-41c7-842b-f9c3e1f4f1a0">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNS0zLTEtMS0yNTQ0MTE_d4e2fce0-41b0-49c2-976c-4586aea7ffb3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNi0xLTEtMS0yNTQ0MTE_98c44be1-3dcf-48a3-92b0-875c815867ed">2,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNi0zLTEtMS0yNTQ0MTE_c08f9683-bf24-4c3a-a52f-187c90984aa3">1,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOC0xLTEtMS0yNTQ0MTE_8e06fff3-64b7-41a9-8dfd-bc13326ae062">2,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOC0zLTEtMS0yNTQ0MTE_d6121607-4dc5-4822-9a0b-ead59833d001">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOS0xLTEtMS0yNTQ0MTE_bc374abb-e059-4049-8a7f-b55d34e08c16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOS0zLTEtMS0yNTQ0MTE_26be856c-8c6c-4f0e-a0dd-ff261b563c6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8zMC0xLTEtMS0yNTQ0MTE_a26fef60-8d7a-4617-9754-7d57cda2dfa0">2,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8zMC0zLTEtMS0yNTQ0MTE_91b466dc-c8c0-402e-a4dd-898a01af01d4">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i117573793e10406f99b2f1703ba394ef" continuedAt="i8c8231ecb2ce4efe9bb26a82f2bf8454"><ix:continuation id="iee87c0436acc4bd1a5523b0470c0e485" continuedAt="i96563e5694484f818e7c8a951aae9d09"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of the period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18yLTMtMS0xLTI0ODEwMg_c50fb4b9-69e0-4bd5-a0b5-b9ebe056352d">389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18zLTMtMS0xLTI0ODEwMg_9ae7631a-6e24-48f7-8b90-9bc75ed9f6cd">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N180LTMtMS0xLTI0ODEwMg_53514010-40b2-4b1a-9f56-0f21aace2625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N181LTMtMS0xLTI0ODEwMg_42e95e8c-0ffb-4209-9250-9796e64c676d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N182LTMtMS0xLTI0ODEwMg_41d1b4e5-291f-4cfc-a344-526a585e1d68">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N184LTMtMS0xLTI0ODEwMg_d3c40c5d-c867-43d4-9ea3-384aaab376b9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N185LTMtMS0xLTI0ODEwMg_03c3d3c9-2fc5-49ba-b975-8cc59d88e87e">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMS0zLTEtMS0yNDgxMDI_9b64dc7e-7318-40e4-bd5e-87fb75f3f4bd">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMi0zLTEtMS0yNDgxMDI_3619c70e-fbdf-46b5-a6cf-b5b2da296a91">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of the period - current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMy0zLTEtMS0yNDgxMDI_2c2c63c9-d8d0-4626-ae00-00aae8c87e4b">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of the period - current discount rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18yLTEtMS0xLTI0NzQ5NA_c955051a-6146-40df-8289-767a1dc08a6b">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18yLTMtMS0xLTI0NzUwMg_3cfdfcef-aada-4fb9-9ca8-7039bb4dee2d">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18zLTEtMS0xLTI0NzQ5NA_5b84931a-246f-483a-84dc-3bb8b4564987">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18zLTMtMS0xLTI0NzUwMg_b956bc50-4929-4495-be89-625445e17f98">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N180LTEtMS0xLTI0NzQ5NA_a7722f85-4e63-41ef-a564-f02813e37ba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N180LTMtMS0xLTI0NzUwMg_3d427408-4c79-4dac-a5de-0f9c5fc6f4ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N181LTEtMS0xLTI0NzQ5NA_b5f031d8-e584-4bff-ba89-4c30365a5355">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N181LTMtMS0xLTI0NzUwMg_cf71b55f-dfe0-40fe-8983-249adacc50fe">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N182LTEtMS0xLTI0NzQ5NA_85ed3a22-270b-4340-bf67-54eb1991dc48">2,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d33508a44c209de9379671362b7f_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N182LTMtMS0xLTI0NzUwMg_648b7065-59f9-4909-8fbb-69b7410d5e75">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances (end of quarter)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N183LTEtMS0xLTI0NzQ5NA_06d34778-36f6-4442-8d50-ea74929f32aa">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N183LTMtMS0xLTI0NzUwMg_a7241cf8-8d2b-4413-a7a0-f4e85069b746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N184LTEtMS0xLTI0NzQ5NA_cf83f976-cff6-4b71-b839-b803b5e71120">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N184LTMtMS0xLTI0NzUwMg_36d74403-aa4e-49dd-9947-1f4e0efd6b3c">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N185LTEtMS0xLTI0NzQ5NA_c338d1d4-ef76-461c-b9f8-084df52ed214">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N185LTMtMS0xLTI0NzUwMg_6d6165c3-ae5a-47af-9826-ab66e5675cfd">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMS0xLTEtMS0yNDc0OTQ_49550150-9ea4-4468-810b-4f831b3e31fa">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMS0zLTEtMS0yNDc1MDI_9debcf4d-f4fa-4f74-8506-7385078869fb">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMi0xLTEtMS0yNDc0OTQ_fc843c3c-06b4-4794-bc19-f98f051320fb">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMi0zLTEtMS0yNDc1MDI_31c8f410-78d3-4a24-9478-eba62285cbb8">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of the period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMy0xLTEtMS0yNDc0OTQ_b0f7b741-a377-4306-9667-0b08c12b9d44">2,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMy0zLTEtMS0yNDc1MDI_c8fad719-3f9f-47f0-a4f9-5302fe78f1b6">1,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNS0xLTEtMS0yNDc0OTQ_2c97abb3-1063-4262-b73d-0f84d2bb987c">2,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNS0zLTEtMS0yNDc1MDI_45d7b6cb-6d37-4828-8d55-e980c44c8ee3">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNi0xLTEtMS0yNDc0OTQ_667a604f-07c6-433e-8893-c267f83b825b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNi0zLTEtMS0yNDc1MDI_bbba18c4-9ba3-44c5-a992-5d6e5e27a1b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNy0xLTEtMS0yNDc0OTQ_b11088be-9170-426d-a14c-014af2432244">2,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNy0zLTEtMS0yNDc1MDI_98f81ebe-2671-4e96-8fc8-bd97caae23db">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8c8231ecb2ce4efe9bb26a82f2bf8454" continuedAt="ia887a040b87d4768bc5b7276a909adea"><ix:continuation id="i96563e5694484f818e7c8a951aae9d09"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8yLTEtMS0xLTI1NDM1Ng_11153af0-61c1-46e1-b474-e214ebfb2a5e">3,463</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8yLTMtMS0xLTI1NDM2Mg_21c18edb-f7cc-4178-80c1-d137c8112774">3,810</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8zLTEtMS0xLTI1NDM1Ng_b08bab16-969f-4c09-aada-a3c3c56d80d9">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8zLTMtMS0xLTI1NDM2Mg_371895a7-5922-42c6-a245-2a380aa807cd">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV82LTEtMS0xLTI1NDMzMg_19b07f0e-e2f8-4666-afd1-83c0a818e174">3,246</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV82LTMtMS0xLTI1NDMzOA_f8c93206-daca-4c2f-a084-a2218e46c81b">3,115</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV83LTEtMS0xLTI1NDMzMg_a50ae59c-1ab3-4518-823b-29a6bfdfedca">428</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV83LTMtMS0xLTI1NDMzOA_bc616b80-1418-4148-8d15-e6fb3afefd18">476</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18xLTEtMS0xLTI0ODMzMw_2025ab9b-4b3d-498a-85cd-513285e744e1">4.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18xLTEtMS0xLTI0NzY3Mg_ce4ee0fb-a0bb-4f87-8a66-606b851903d4">4.20</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18yLTEtMS0xLTI0ODMzMw_4c19bdb1-dae2-4d88-9786-3b40b0e7bbf3">4.90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18yLTEtMS0xLTI0NzY3Mg_24b4d0d1-9d36-4288-9e53-a52c6ced6872">3.54</ix:nonFraction>%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N182LTEtMS0xLTI1MzgxMg_1ed3c88e-9f4c-4f61-9390-1cd5a8b41656">5.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N182LTMtMS0xLTI1Mzg1Mg_dffcbd75-f6e7-47b7-9f09-f8ccb347eb59">5.11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N183LTEtMS0xLTI1MzgxMg_6a2f3f4f-ef09-473c-a055-a277feb1e470">5.06</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N183LTMtMS0xLTI1Mzg1Mg_190cfe22-decf-415f-8316-22687321b6d6">3.75</ix:nonFraction>%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average durations (in years) of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8xLTEtMS0xLTI0ODQ1MQ_91e1d31b-3c18-4c18-a80d-caa69f224f2b">7.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8xLTMtMS0xLTI0ODQ0MQ_4a288561-c6c7-462c-96a4-6e6b36c30719">7.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8zLTEtMS0xLTI2MzY5Mw_3dfd2d89-de2e-42fa-a1aa-5b7ef0a07971">12.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8zLTMtMS0xLTI2MzY5OQ_485b5cfd-7246-4b67-b602-83279f69e6b8">13.3</ix:nonNumeric></span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any material differences between the actual experience and expected experience for the significant assumptions used in the computation of the liability for future policy benefits.</span></div></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia887a040b87d4768bc5b7276a909adea" continuedAt="i5beb12a4848b49b598cb51793989d2a2"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:PolicyholderAccountBalanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk5_52608bb9-7b07-48ae-b715-06d07b365006" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in policyholders&#8217; funds related to long-duration insurance contracts, which are included in policyholders&#8217; funds and other long-term liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average crediting rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8yLTEtMS0xLTI1MDkzMQ_0f56361a-aaf0-4dbe-9622-0c6815a95b12">345</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8yLTMtMS0xLTI0Njk5Mg_1ab89dc1-5c53-4115-b8cf-23b29c10c129">522</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:PolicyholderAccountBalanceDepositsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF80LTEtMS0xLTI1MDkzMQ_b5f6309e-742f-4d71-83b8-8657cf69de5e">4</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:PolicyholderAccountBalanceDepositsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF80LTMtMS0xLTI0Njk5Mg_0a23a4be-97a7-4a92-be3b-579280b638ec">2</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF82LTEtMS0xLTI1MDkzMQ_6c05de3d-f295-41e7-bb7f-1f68956103bd">7</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF82LTMtMS0xLTI0Njk5Mg_b6acd020-6695-4712-8051-4c1866792a73">4</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest credited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:InterestCreditedToPolicyholdersAccountBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF85LTEtMS0xLTI1MDkzMQ_b4591f1d-c4f2-448b-91be-4dcdcffb5cb1">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:InterestCreditedToPolicyholdersAccountBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF85LTMtMS0xLTI0Njk5Mg_8f64be0c-1d32-48a9-a043-4c6107a7226e">4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0xLTEtMS0yNTk4ODI_50a6ee03-eb57-45e6-a821-6394a8a646e3">21</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0zLTEtMS0yNTk4Njk_4f8076c7-35ca-46b0-8c42-f21225a53702">72</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0xLTEtMS0yNTA5MzE_bf0374df-b6ed-4d4e-bbce-97d3bd6fd9cc">9</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0zLTEtMS0yNDY5OTI_e2395a60-5bc5-4699-bb11-07704e86fd0a">4</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, end of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMS0xLTEtMS0yNTA5MzE_7f6cad4f-455c-4520-a9d9-ca88ca764b72">349</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMS0zLTEtMS0yNDY5OTI_c0a1ce3e-236d-4cd7-83d2-2bb491a19fb6">444</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average crediting rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="4" name="us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMi0xLTEtMS0yNTA5MzE_13cf694d-b9b3-471e-ac7b-a849e1c5084e">4.55</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="4" name="us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMi0zLTEtMS0yNDY5OTI_efc4c399-a3b0-444f-861c-86747088fed4">4.65</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:PolicyholderAccountBalanceNetAmountAtRisk" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNC0xLTEtMS0yNTA5MzE_59d17ac0-9a64-4073-9f85-bec5a6608326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:PolicyholderAccountBalanceNetAmountAtRisk" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNC0zLTEtMS0yNDY5OTI_6625ce02-3fca-4bdc-b42e-dd8bf97dd124">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:CashSurrenderValueDuePolicyholdersAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNi0xLTEtMS0yNTA5MzE_c664c494-9625-454c-8d5c-c9767fc70d43">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:CashSurrenderValueDuePolicyholdersAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNi0zLTEtMS0yNDY5OTI_25b66947-4092-4727-b2c5-a963017e45d4">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><ix:continuation id="iad61f51256d94bf789e7dc9a00d45248"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452ce3dfebd34199a05e64ce393bc4c8_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8yLTEtMS0xLTI3NDU2OA_c9e7d1e5-c1f1-4af2-aea6-75192c820a17">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifacd64ecac6a4aac953d15d34d578d88_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8yLTMtMS0xLTI3NDU2OA_1c10d3ff-c362-48ce-9259-95bbc4f42e6c">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c5d299901045239a89b149c86fc62b_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV80LTEtMS0xLTI0Njg0Mg_8974cc17-3a71-4065-a3bf-43e4472fca39">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83a48cee9f5421f959a40efc914a409_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV80LTMtMS0xLTI0Njg0Mg_e45253b7-cb85-4084-ba02-b56934d19ca9">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662502d2b9824d468b5ea7e46559f0d0_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV81LTEtMS0xLTI0Njg0Mg_80bcb860-d97c-4577-bd90-85909679a9d1">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if223ef4f1cb04f89aaed72f66b1ea655_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV81LTMtMS0xLTI0Njg0Mg_39027f81-1ed5-4c2d-b064-f01b5e279cbf">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6045cebcc054f359aeda689be7966b1_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV82LTEtMS0xLTI3ODMwMw_f91c1690-571c-4425-a6ea-4f55800e9521">1,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdba47c662a241d796fcf13177996678_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV82LTMtMS0xLTI3ODI4MQ_95eb6efa-1472-4932-a028-0d01ebf50383">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9e113db05c4437a869964daf990132_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV85LTEtMS0xLTI0Njg0Mg_9c513d08-1586-41b8-8e17-00db46ffc0ad">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df477b572d04891896d991e4831089e_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV85LTMtMS0xLTI0Njg0Mg_c2767113-4e9c-4f30-82c8-3cfddfc62114">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6116e07db6564d4bbfa404e6b3bb00a2_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0xLTEtMS0yNzQ1ODE_a58bfb74-d0ab-454e-8670-9c6be6ce4b92">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee90579e8a1b4b1da229e849035d343d_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0zLTEtMS0yNzQ1ODE_d288606a-2095-4ac4-8bf0-2136757478db">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic932276a2f124dba92225829473c58a6_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0xLTEtMS0yNTA5ODk_1a4f569c-e4a4-4dca-8a91-557996e5dac2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b686b402cc4958a97490b22451eac1_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0zLTEtMS0yNDY4NjY_17a6d646-9178-4997-8ba8-3f4ebda37956">6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia094aa9bc0e247adbf9401a23f3358a1_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0xLTEtMS0yNTA5ODk_e8490134-2664-4fb8-a7e6-a882b48f5306">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b3614b59a37444c9c0ce65c076cc76b_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0zLTEtMS0yNDY4NjY_581533cf-019b-4f4d-a1ac-2514c7142fbe">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55ff9d813bee44a0965aa5d87884e5ff_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMy0xLTEtMS0yNzQ1OTY_cd6a51a9-12c0-46d9-8f9a-e7f6a58abed8">2,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d86193e1b54a5cb7daa5b1dc397607_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMy0zLTEtMS0yNzQ2MDc_c42c0f29-e41e-4afc-b305-7ecaf31c7512">2,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903d499b0d9b49e49eaa2a9bb04df017_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xNS0xLTEtMS0yNzQ2NTM_ab58e4c8-2cee-403f-beda-785b48a97b18">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8213443c893d488d8dac56b4a243aa90_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xNS0zLTEtMS0yNzQ2NzA_9192fcf5-29c4-485d-be8c-14d807bcb467">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0xLTEtMS0yNDY4NDI_8bae268e-8511-4f4e-b379-90f2b7cba1c6">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0zLTEtMS0yNDY4NDI_e2f48ebe-acd3-4dad-9379-d6e182d4a5be">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i8903f0df33854a12b5260ff32cb9efff_I20230331" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18zMjk4NTM0ODk1MTAz_b9ef9ebb-7f48-4c2e-b636-ad378fd1fcef">29</ix:nonFraction> million of other receivables and $<ix:nonFraction unitRef="usd" contextRef="idf917e365bae42a0b79ce78cefbe94e4_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18zMjk4NTM0ODk1MTEy_480cf1d1-6199-436c-aab0-fc0f494c7cac">85</ix:nonFraction> million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5beb12a4848b49b598cb51793989d2a2" continuedAt="i1a4e343247234562b0d50ebeae2f98a2"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:SeparateAccountLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk3_9b1c1a0f-5ea1-4ae8-b97e-687d87a204c5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in Separate Accounts liabilities during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8zLTEtMS0xLTI1MDk5Nw_35a384c5-8c28-40c0-953b-a9f95b7cf65a">3,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8zLTMtMS0xLTI0NjkwNg_93529c8d-ac40-4cc7-a71e-cb3c272697ae">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:SeparateAccountLiabilityPremiumAndDeposit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl80LTEtMS0xLTI1MDk5Nw_c438d69f-fbf3-40db-bf04-ebef2006fae6">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:SeparateAccountLiabilityPremiumAndDeposit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl80LTMtMS0xLTI0NjkwNg_5fd6e89f-8d24-4125-b802-ddb0056c06ec">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl82LTEtMS0xLTI1MDk5Nw_c699a37a-aca4-41de-bc00-e2079c09781b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl82LTMtMS0xLTI0NjkwNg_adbaf581-7a2c-4ec1-b7ca-b9128d0a52d2">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:SeparateAccountLiabilityBenefitPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl83LTEtMS0xLTI1MDk5Nw_2bf69720-8456-46a6-bc13-22dc73386801">260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:SeparateAccountLiabilityBenefitPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl83LTMtMS0xLTI0NjkwNg_5f1dd541-3786-4c8f-8d88-d7ac8a36abe8">236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl84LTEtMS0xLTI1MDk5Nw_1fac8636-9794-4bd0-ae51-b830763a30a8">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl84LTMtMS0xLTI0NjkwNg_3f25b2c7-4dbb-42b6-9bf2-446568336d2c">393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers from general account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl85LTEtMS0xLTI1MDk5Nw_f604c45a-1b90-49a9-97d6-1d01342028a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl85LTMtMS0xLTI0NjkwNg_1611438f-7970-4a29-8018-d91a7c5fd5bb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMC0xLTEtMS0yNTA5OTc_3ad87e67-be1a-44a3-8e5d-1eba27fe7feb">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMC0zLTEtMS0yNDY5MDY_918c457a-7958-4696-bbfa-e7cf49000256">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMS0xLTEtMS0yNTA5OTc_b9cc58ec-751e-44ee-a732-ebcebb6f0c3d">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMS0zLTEtMS0yNDY5MDY_3c4bb913-800e-4f3c-a394-f6b0ba802753">4,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value, end of the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMi0xLTEtMS0yNTA5OTc_b7a78d41-7931-4876-b218-1a0577df2a6f">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97beaa9151e94932b8318858d3577500_I20220331" decimals="-6" name="us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMi0zLTEtMS0yNDY5MDY_88922246-dec7-42bc-b831-8913b5351152">3,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1a4e343247234562b0d50ebeae2f98a2">The Company did not recognize any gains or losses on assets transferred to Separate Accounts during the three months ended March&#160;31, 2023 and 2022.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTE2Ng_aa4f5f58-6bb6-4ae8-92fe-51441465d3a3" continuedAt="i8c4f634d5e694093b46ca71401ad7f11" escape="true">Borrowings</ix:nonNumeric></span></div><div style="text-indent:-9pt"><span><br/></span></div><ix:continuation id="i8c4f634d5e694093b46ca71401ad7f11" continuedAt="i142cb5ca311343bda51cd66081634342"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTE3Mw_e46b6891-92e0-448f-a549-8f142a1b455f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at March&#160;31, 2023 and December&#160;31, 2022: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29e609944ebb4c7abcd29efc5ac7a42a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfOS0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjpjZWNjYTNlOTNlMTY0Yzg5OGE3MjVmZmJmN2YyNmFmNF80_8f57da0c-fb6b-47c9-9493-84b71d5275c5">2.8</ix:nonFraction>% senior notes due June 2023</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e609944ebb4c7abcd29efc5ac7a42a_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfOS0xLTEtMS0yMzI1NDc_d61c311c-031e-4c41-b3ec-c998b93b95d1">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fdf4d6af289497db86f4e1ef5b01c5b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfOS0zLTEtMS0yMzI1NDc_8efb068a-59cd-4798-9d55-c6b822e4b8cb">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47a06c42b0d441a9bffe6e38635b3abb_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MmE4NjliYjMwZGQ0NGZhZDlkNjBmZmI0M2QzOGFlY2NfNA_eecafc6b-b21e-4b88-93f1-94191e201b0a">4</ix:nonFraction>% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a06c42b0d441a9bffe6e38635b3abb_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTAtMS0xLTEtMjMyNTQ3_25620a2d-18e2-450c-bc6a-0ad10b85cbc2">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ec5f2382c744b1386a167b07243b1ff_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTAtMy0xLTEtMjMyNTQ3_09930dc3-72f5-49e1-9ed5-ff9321b8a0c0">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1389fe77fa0245a3b7288b5f5b6fd60a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MGNkYTY4Mzg5ZGMxNGZjYmFkOTJkZTE5NjlhMzc1MTNfNA_d56e0246-33b5-4ca3-a273-925d466dc09c">3.375</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1389fe77fa0245a3b7288b5f5b6fd60a_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTEtMS0xLTEtMjMyNTQ3_dd0f55e9-d52e-46a4-8646-099db78f162b">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8195e760c0664b8ebc5acf22c0705628_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTEtMy0xLTEtMjMyNTQ3_8f67f944-04aa-4448-b717-773b23cc7158">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4e614b3ac4b4f9b8791bb6db2978b36_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YmY2MTBiYjlkZjc2NDE3MTg5MzBiN2MwNzE5MDQyODBfNA_3f43ba43-f193-4141-946a-fa9ca6877ed9">2.625</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e614b3ac4b4f9b8791bb6db2978b36_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTItMS0xLTEtMjMyNTQ3_57440178-adb4-4841-ba42-81fe50e103d8">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6084b97edd8d4f4fbf531a21307abe4d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTItMy0xLTEtMjMyNTQ3_2d64634e-bd7d-449d-92de-b739d6892373">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e7e4e1aac0e46b59b1c064b844b1068_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NTZmYWE5YWI2ODUwNGRlY2JmNzUyODgxNTA3MjJlOTdfNA_c421f90b-8073-4f3b-b57e-79710f13e25e">3.5</ix:nonFraction>% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e7e4e1aac0e46b59b1c064b844b1068_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTMtMS0xLTEtMjMyNTQ3_fd4ec054-1f27-4c46-a220-e9d623abafe9">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee3f756fd384578983ede98c5a0fc5c_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTMtMy0xLTEtMjMyNTQ3_d14165d1-d791-4dfd-90d8-d31076af4870">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18c1afd8891d4f5c94b81a067731189a_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTQtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NGU4YzQxMGFiNWZmNGNmMGE1YzYxNDQ0MzhhMjQ3N2NfNA_25f3b8f0-b30a-4b8a-9667-2dbf161e74bf">5</ix:nonFraction>% senior notes due December 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c1afd8891d4f5c94b81a067731189a_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTQtMS0xLTEtMjMyNTQ3_ed5c2cd9-824d-486a-9a63-b0d6b736d28a">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bca211743f44200bcddc914732f3f5b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTQtMy0xLTEtMjMyNTQ3_6c6ab123-ea97-43df-b6c7-09d3a1a18f41">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63f3531d3fe74d638d45ecfa6b71c325_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTUtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YTA2ZGVmMWFiODhjNDdmZjg3NWJlZDI1MmVlMjMyMmNfNA_77ee1fb2-30ad-45bc-b7c9-966521104cb6">4.1</ix:nonFraction>% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f3531d3fe74d638d45ecfa6b71c325_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTUtMS0xLTEtMjMyNTQ3_71000357-add5-4b71-bfe2-c11b81b69f4a">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ee92e3968142fc8a1f00b97f55b501_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTUtMy0xLTEtMjMyNTQ3_ece72fd7-06af-46ec-8faa-c05ab7d198ae">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9c5c27de38b4adb9c680fe62498e820_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTYtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YWNmNzM3MGQ1Yjk4NDBhNjg1NjhmMWU3MDEzYjNmMWJfNA_f9543cc7-3263-4111-8661-2dd8e93e559d">3.875</ix:nonFraction>% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9c5c27de38b4adb9c680fe62498e820_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTYtMS0xLTEtMjMyNTQ3_f986417a-d2db-4ee7-8927-18acf85b8f78">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53af89ad853e4e88a7223062ff9de426_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTYtMy0xLTEtMjMyNTQ3_d1094303-bf4c-4a13-87bf-989edf640c3f">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e5be82f9aa84b8f82e19cbbd50d5017_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMC0xLTEtMjU4Mzc2L3RleHRyZWdpb246Y2FiNmM0NDJjMDMwNDZhNmI5MzMxNWNiMDRiNWY2ZDJfMzI5ODUzNDg4MzMzMg_3ca3e53c-7213-4bff-aae2-a4aaca5220e0">5</ix:nonFraction>% senior notes due February 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5be82f9aa84b8f82e19cbbd50d5017_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMS0xLTEtMjU4Mzkw_1daca8c1-1d4d-4642-aec6-c379f139f2c2">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93656a700a24e76938502046d84db62_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMy0xLTEtMjU4Mzkw_f01193dd-6099-4d65-bcf8-9bff348eb165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f7f76b8c0b544a3a59704c58a83c665_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MzEwZDIwMTY1MzJmNDY4ZDhmOGM1MmY3Yzk1NDNkZTJfNA_8819a6e8-2371-45dc-b602-0fc3b0a29e18">2.875</ix:nonFraction>% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f7f76b8c0b544a3a59704c58a83c665_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMS0xLTEtMjMyNTQ3_4c5e5dee-5e47-484b-ad5a-00502d59ad27">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic060d61cd4084e17b433a1b12fa6cd89_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMy0xLTEtMjMyNTQ3_e871e940-2959-492d-8b85-273d32c8d664">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide95dae98a2245b1acb066495f097ca2_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YTY0ZWM1OTIyODA3NGRiNmE5ZjQ5NTE1Y2M2ZDY4NjZfNA_257920de-3f18-4972-b595-2e1a22a7445a">3</ix:nonFraction>% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide95dae98a2245b1acb066495f097ca2_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTgtMS0xLTEtMjMyNTQ3_a860386a-d344-4764-9dfa-e1f3ad107a1e">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858a0f59e1c349d6b9a6c24cbe1894b2_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTgtMy0xLTEtMjMyNTQ3_c500e977-f46a-4e6a-b819-b0d1909b228f">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb777320df5b48f797263822df4f0e9d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDBmNTc4ZDZhYjFlNGUwM2JkOTBmNmNkMzU4MzU4NTFfNA_68e8aa9c-bfc2-4524-b56d-151ba7e1991b">3.625</ix:nonFraction>% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb777320df5b48f797263822df4f0e9d_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTktMS0xLTEtMjMyNTQ3_808246e0-f35f-4b4a-b383-5e5c0eadd2a9">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic312216e7bc34f27ae9ab07c90920b49_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTktMy0xLTEtMjMyNTQ3_3c6249e0-1bcd-4f09-95cb-cdae57b06207">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7bf61a5560341df80eaf86640920cf8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ODNlMmU1ZTE5NjljNGI0NDg4ZGZhMjAwNDFlMDI3Y2VfNA_5c105dd0-cf31-49f0-b717-0099a3758193">6.25</ix:nonFraction>% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bf61a5560341df80eaf86640920cf8_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjAtMS0xLTEtMjMyNTQ3_f7febfab-382c-4ae2-86aa-3ac8fe1d3c4f">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i619ee922ba3248eabc18dc25aa73b06f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjAtMy0xLTEtMjMyNTQ3_a4d86634-beae-4b5d-8b92-09d7e5f9eaf3">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cdf17416ddc41a6b3022410dc3d2705_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZjY5M2YwYTRjMmY1NDFkMWJjNmU0YmRjMmJlMjkxMzZfNA_87973d5e-0d76-4078-bf0c-2be286229132">1.3</ix:nonFraction>% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cdf17416ddc41a6b3022410dc3d2705_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjEtMS0xLTEtMjMyNTQ3_a1424670-ddcb-4a40-99ef-a719b858fcbc">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b29cbacf5446fdac7dcf2a511e8029_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjEtMy0xLTEtMjMyNTQ3_c908bfe4-2137-4bac-9742-c30602dcf559">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6d28f166a4b43a397fdfaabad32194b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MjhhMjE4ZDkxNTRlNDhiMjhmNDIzNGQxZWY5MTlkMjZfNA_66d8bc34-baa6-4346-b90f-40aacf3c6742">4.3</ix:nonFraction>% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d28f166a4b43a397fdfaabad32194b_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjItMS0xLTEtMjMyNTQ3_f6cf1df9-78e0-4de6-9757-fa3d1e469af9">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061715fa0d744784ba4cc2d892ac4b03_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjItMy0xLTEtMjMyNTQ3_2c0321cf-a2b3-4ae0-9028-3054ac63203e">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38635e749f46407a80cdf7fc2ea4d372_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YjZhODMyYmI2YmUzNDFhYzhmM2RmYTNjZTM1NmExZGZfNA_e0eb2fc6-f7c3-4bc4-b44b-944aeef6ec63">3.25</ix:nonFraction>% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38635e749f46407a80cdf7fc2ea4d372_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjMtMS0xLTEtMjMyNTQ3_83d2a6dc-4688-4bbc-9c9c-eab2f8dcc7dc">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a442e85b6e4b94a98823c08df1f043_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjMtMy0xLTEtMjMyNTQ3_0f8652d6-e9e0-418e-9643-288545e391e2">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b311c6d410f4978bd5331eecaecaa64_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMC0xLTEtMjU4NDIwL3RleHRyZWdpb246MzdlNzk5YjUwMjVmNGI1NmIxZWY3MDkzZmM4ZTdlM2VfMzI5ODUzNDg4MzMzMg_2a40180c-5183-4014-b229-b145359b2267">5.125</ix:nonFraction>% senior notes due February 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b311c6d410f4978bd5331eecaecaa64_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMS0xLTEtMjU4NDEz_8f9575fd-6a77-4442-8f4d-7b9977758db7">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0e5fbb301a40e6827651a423c2292d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMy0xLTEtMjU4NDEz_b13b925c-1ee3-4b41-8000-0798d196ae55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if6eb4e9251184548a1634972c55a28d0_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjQtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YmRmNzJiZDQ0NTkyNGZmZGE5NDhiZWRkYWQ5Yjk4NjFfNA_7b6bde33-9490-413b-a4e9-e1bba5b746d9">3.75</ix:nonFraction>% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6eb4e9251184548a1634972c55a28d0_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjQtMS0xLTEtMjMyNTQ3_60d06fe8-af4d-4701-a615-3c09d5d0b052">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529f1b8b3f1f4b42b2e5446768b8e87e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjQtMy0xLTEtMjMyNTQ3_e3a06b73-7cd8-4d08-9ce6-43e534bce66a">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie07bdea3da6f451c9bcba9f549201961_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZjdiNWVmMDFjNjczNDljYjk3MTBkOWY1MGEwZDgxNDNfNA_dbde9ed0-cd7a-4945-88aa-45e0fb5e16e4">1.75</ix:nonFraction>% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie07bdea3da6f451c9bcba9f549201961_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMS0xLTEtMjMyNTQ3_55d98c10-8018-48c4-8306-72a21c2f46af">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i175bb047294f462da1aa8e1333b6d0ee_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMy0xLTEtMjMyNTQ3_789a446d-b5bf-4c13-825d-92018b3ff93d">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0a02874bdf04d5b9a706cad560999ac_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjYtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YWViM2VlYWQ5NTZlNDQ4MWFkODc3MGRlY2IyODQzZjJfNA_4cc14abf-f927-41f5-8bd8-448a5cc3845e">1.875</ix:nonFraction>% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a02874bdf04d5b9a706cad560999ac_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjYtMS0xLTEtMjMyNTQ3_90065bef-372e-4b4b-89d3-9d0cbbd2926e">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8c414c1efc476fa3e1e6d77efcaa3e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjYtMy0xLTEtMjMyNTQ3_9cf03a00-b14f-4deb-8321-b815e963da67">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41089ddd19eb470282adb9570456e08e_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjctMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246N2ZkZWU0MDhmNDFlNGQxYTliMzMwYTFlODA5MDdjOGRfNA_9bdbef85-bfeb-4fda-a77c-0b03f9b4cd16">2.125</ix:nonFraction>% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41089ddd19eb470282adb9570456e08e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjctMS0xLTEtMjMyNTQ3_236b0982-6692-4a28-b7d7-4a6b0d2d4b79">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f6643ec5754faebede440568434de3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjctMy0xLTEtMjMyNTQ3_0a84219b-9ee4-4931-9866-8d0fde5e4ed7">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e8700d2108e4ab496a24690db04dcf2_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMC0xLTEtMjU4NDM1L3RleHRyZWdpb246ZDYzOGY2NWZlZjI1NDFkYzgzNDViMDlhMzc0NGE0MWRfMzI5ODUzNDg4MzM0NA_c104dfb3-7fc9-49c2-b495-96fbdbc48023">5.25</ix:nonFraction>% senior notes due February 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e8700d2108e4ab496a24690db04dcf2_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMS0xLTEtMjU4NDU0_4956cddc-c31b-4435-bde2-4da62e8e23da">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41b9178e08b45cb91563f0883c36a2a_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMy0xLTEtMjU4NDU0_e1e8cb6c-47dc-476d-a10c-19c656574645">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45cd1f1f6e8b4f41986ce9a7b9e9e696_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MWE1ZWI5MWVlNGMzNGNhZWE1YjE0ZWQ4OGQ2ZDMwZTlfNA_56b53cdb-a0ea-4877-92a1-40d327d87875">4.875</ix:nonFraction>% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cd1f1f6e8b4f41986ce9a7b9e9e696_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjgtMS0xLTEtMjMyNTQ3_1a5a8184-1f23-4e1b-845f-4c7c8c2f25e5">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b01afccbbf34ad4a1781cb89df8712b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjgtMy0xLTEtMjMyNTQ3_2dc4eeeb-bde9-4362-92f4-833f3997bc2f">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87fac5abf1e74d54a53dc666fcc47f4d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YWM3NzgxOWYwMGZjNDU2NjhkNTNjYjZjMDNhMDlkZjJfNA_a4b2c637-0dc2-4666-8cb4-f07c88ce58d6">6.625</ix:nonFraction>% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87fac5abf1e74d54a53dc666fcc47f4d_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjktMS0xLTEtMjMyNTQ3_6cf001cc-7585-4788-b9c2-f2c2208160c6">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792622491465439c87c4cca105f8d743_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjktMy0xLTEtMjMyNTQ3_9c168100-8dcf-4a5a-a814-ddcabed51021">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d5ddad65b5b4fecb1c2c210aba362c8_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YzQxY2I1ZjlhOTM0NGFjMWExZjY2MjQ5NGZlYWUyMTRfNA_e5666322-c291-4d97-bad6-382ae086df51">6.75</ix:nonFraction>% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5ddad65b5b4fecb1c2c210aba362c8_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMS0xLTEtMjMyNTQ3_46bb6941-7fb7-4e0f-9d4e-1d551a9f8104">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a596cb57ed46fab4eba2c7de95bc00_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMy0xLTEtMjMyNTQ3_9bbe29b1-59ac-42d2-ac37-2d0301bdc841">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e9459ad3944423592e566ee3f8a9f55_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ODM1YjQ3OWNmOTRjNDAzNWIyMGFlMjZmN2ZjMzMyNzNfNA_2b3ef5f4-3e1c-4ce1-9266-75d1dc7175d7">4.78</ix:nonFraction>% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9459ad3944423592e566ee3f8a9f55_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzEtMS0xLTEtMjMyNTQ3_7dbee4ec-aae2-46f8-b85c-6c4612c26f65">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e871c110bd4599ada469473b42a2e7_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzEtMy0xLTEtMjMyNTQ3_a466cd17-013a-4d76-946c-3217866b0283">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6cd1bc3205234dbc80620f09b4404f44_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NzNiNTBmZDAxZDk2NGIwMzk2ZjA1MjgwYTNhNjU0ODRfNA_47d4128a-b12b-4357-8603-968dd97c77a7">6.125</ix:nonFraction>% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd1bc3205234dbc80620f09b4404f44_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzItMS0xLTEtMjMyNTQ3_035e6b8b-3020-4f51-a2ec-a18d78f73d7e">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78517656fb3e4be49efce58b458d7215_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzItMy0xLTEtMjMyNTQ3_9ebeaae2-3340-40b8-8234-ba3c6a822b1a">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i780cead0663d47e985eb7cde37891351_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDVkYzllZmRhZmY0NDRmZmJkOWRmYjg0NDliMTczOTNfNA_069fe11f-b1b7-444b-bf4a-fc6cbbd11751">4.125</ix:nonFraction>% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i780cead0663d47e985eb7cde37891351_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzMtMS0xLTEtMjMyNTQ3_25a58fbf-7d71-4510-a882-3622434cdbc7">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39881b60def4677ad68de30d76d707e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzMtMy0xLTEtMjMyNTQ3_b3647c29-8801-4519-aadd-e20dd30440ff">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5934de2b48064b68824f5a5e12dbbb82_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzQtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NWZlNzU1Nzc5MDg2NDY4OGE1NDdjYTc0NmY1YzAzM2ZfNA_0c463440-ca81-4c45-891a-5b2d2dc27eb6">2.7</ix:nonFraction>% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5934de2b48064b68824f5a5e12dbbb82_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzQtMS0xLTEtMjMyNTQ3_9b05ad18-a361-47ca-8815-8e500d6b8b48">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245129fe18fc45cdadddd2c037c1005c_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzQtMy0xLTEtMjMyNTQ3_7e916a5c-c8e3-4d87-89c8-a140a0c823cf">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib080a75dab51499e8152c514ed6ab74c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzUtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZmVmMGQxMjE4NjE1NGNlOTlhZTIwNjQwMDlmNjc1Y2FfNA_b0e25d19-ded5-4241-b6e0-83c3b5e7a4be">5.75</ix:nonFraction>% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib080a75dab51499e8152c514ed6ab74c_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzUtMS0xLTEtMjMyNTQ3_dfc2698a-fe3a-408f-81a7-23a2d9a8c49c">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444c1838f8c64b14a5caef64a8ccd662_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzUtMy0xLTEtMjMyNTQ3_3e57e541-0aca-47f2-9b7e-0cf7cb25ecaa">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cd7de97cfdf412381d46297d5991484_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzYtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MzBhYzVhYzIwYThhNDhlMWFkYTljMWZmZWZkODk1ZDlfNA_ffffed87-f84f-46f7-a7af-a3fe5b672b42">4.5</ix:nonFraction>% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd7de97cfdf412381d46297d5991484_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzYtMS0xLTEtMjMyNTQ3_26686088-635e-4ec6-b239-6115b68a00b8">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if350f271cef34debb54ac8e3ae82abe9_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzYtMy0xLTEtMjMyNTQ3_9d5e783a-4794-4956-bcf9-178ed1453550">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c4d09214db040b5b5740899c41892e6_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzctMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Njc2YzE5NTc3NzZiNGQ1NDgwNWFiNmVkYWRlODA3Y2VfNA_94234219-5f44-4c5a-a1fa-279d923bbc23">4.125</ix:nonFraction>% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4d09214db040b5b5740899c41892e6_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzctMS0xLTEtMjMyNTQ3_8bfe8586-46b2-4f5d-9c23-e773071cdbb4">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8122b6f5dd094913857934bb5ac9998a_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzctMy0xLTEtMjMyNTQ3_c6933aef-cf29-47a5-943e-9485bd0c5d08">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e903c49671d4c7bb899e91247869f60_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NjRhZTBmYjJkNmJiNGM2YjkzZWE0Y2JlOGFmZWUxN2FfNA_d4358b32-d59d-4c0a-bd0e-a80292a792a6">5.3</ix:nonFraction>% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e903c49671d4c7bb899e91247869f60_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzgtMS0xLTEtMjMyNTQ3_6f128b2e-405a-4bec-830d-d8d029feaf2f">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791829c941b64e9cb8aac4352fd31278_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzgtMy0xLTEtMjMyNTQ3_9c794f78-9e7a-43ac-b238-b5833334a045">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48586d4589464091a486da7ecff7be86_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZGRiMTQ5NTgzNjI5NDIyMzkzYWNiN2Q4MmUyMjIxMTdfNA_f6f00f64-651b-4bdf-8f2b-529cf72197d6">4.75</ix:nonFraction>% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48586d4589464091a486da7ecff7be86_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzktMS0xLTEtMjMyNTQ3_2d731621-5a31-4bf0-b01d-3a85a385b1ce">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a52fb5322d941878151c5480cdcb452_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzktMy0xLTEtMjMyNTQ3_529da2b6-30c1-4134-8325-7c2a7f082618">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib95efcc5698746f887d004c6b539186f_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZjIyMzhlMDI4YWYzNGYyNmE4YTg0NTk2NGEwNGQ1YzlfNA_480a7a5f-f2bd-4357-96e8-fd382f4654f0">5.125</ix:nonFraction>% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95efcc5698746f887d004c6b539186f_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDAtMS0xLTEtMjMyNTQ3_80f98d49-73e9-4599-8ee9-169ed0f14be2">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5a3762af674b319552867bf484df1b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDAtMy0xLTEtMjMyNTQ3_065c32b4-2e6f-4023-bc8c-8207ec19ba58">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id09a1af1b14f4dedb5552601fe0a898b_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246OTZjY2UzZjNmMzBhNGI4ZTkyZWM5OTZkZTY1Y2MyZjhfNA_3b629e8f-70a1-4a0d-ad8c-7d2e174b221b">3.875</ix:nonFraction>% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09a1af1b14f4dedb5552601fe0a898b_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDEtMS0xLTEtMjMyNTQ3_2fe5467b-b006-48af-b2a1-c5dbc784ba0a">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fc72c0ca3044aefa6c543e50d9f5073_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDEtMy0xLTEtMjMyNTQ3_d6114181-89b5-4805-a3ac-8013f08f9d18">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a9a69c0387a4dbb9cba44bbcb236d31_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ODlkODc2YTNkZjRiNDYzMThmYTI0YzdjMmVmNmVjODNfNA_26c32f4c-300d-4fd5-a884-0b589d9fc5ec">5.05</ix:nonFraction>% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9a69c0387a4dbb9cba44bbcb236d31_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDItMS0xLTEtMjMyNTQ3_0b8db55f-f227-4a9e-90b8-153a6153be49">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad107da7cf74913a7fb43e2fa78c217_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDItMy0xLTEtMjMyNTQ3_e86e7159-542f-450a-9c86-5874217d9ca6">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i855756e5c4f640c09e72c199fabc5c3e_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NTRiYzAyYTllNTI1NDEwYzk1NjAxY2JiYTk2N2Q5NDNfNA_a852c65c-7963-4783-817c-7ce0b8f53d1d">4.25</ix:nonFraction>% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i855756e5c4f640c09e72c199fabc5c3e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDMtMS0xLTEtMjMyNTQ3_1a0f48fe-ed60-4154-97b4-be1123f469c8">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b6295bbdec46108d23d6648619dc7d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDMtMy0xLTEtMjMyNTQ3_7fde8972-68cd-4009-925a-7255769bc7b9">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i089e716c693541d38cbcfc0f339c6165_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMC0xLTEtMjU4NDc1L3RleHRyZWdpb246NmIwODFhMmQ0YjRhNDdmY2E3OWM1NzdiOWY2MWY2ZDhfMzI5ODUzNDg4MzMzMg_fc9045a7-fc9b-4c85-996b-13c733e05bdc">5.625</ix:nonFraction>% senior notes due February 2053</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i089e716c693541d38cbcfc0f339c6165_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMS0xLTEtMjU4NDg0_327cf493-f511-46c2-8a05-adee98a5cca0">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061610d07ab54236a1e052f4440a4b61_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMy0xLTEtMjU4NDg0_545f4660-b8c0-4827-b635-b6dbccc165c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_4a540ca2-c5a0-4370-9572-5e1f1b60ec25"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_effb7122-9853-4ffd-bc90-e0ef6a32ea42">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMS0xLTEtMjMyNTQ3_2f6d62ce-51f9-4f4d-9992-522252831572">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMy0xLTEtMjMyNTQ3_329c85a9-f91e-4bfd-9eef-7fdcaa7f22f3">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765e8c9bf1514d37b538d56d98f8673d_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDUtMS0xLTEtMjMyNTQ3_5adc9a69-5dff-4f97-9d58-c4c6acff987c">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i843857ee2e25408ba0949fae0a27ddc3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDUtMy0xLTEtMjMyNTQ3_81706777-8d01-4b3f-9b11-85601fe5d27f">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:LongTermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDYtMS0xLTEtMjMyNTQ3_6004167b-4ac2-4142-9594-50a7682f07f5">58,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:LongTermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDYtMy0xLTEtMjMyNTQ3_bcc70d52-d8cd-4356-bb10-232442e78578">52,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMS0xLTEtMjMyNTQ3_5c9d9299-9005-4134-b8ce-f23d8896f542">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMy0xLTEtMjMyNTQ3_e638bc68-af98-45c1-9226-b8eed783abd9">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDgtMS0xLTEtMjMyNTQ3_c32ff662-6dbb-4927-8040-19448329d48a">735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDgtMy0xLTEtMjMyNTQ3_f94bdb65-5ded-49df-9e37-52c48a9c3be5">696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDktMS0xLTEtMjMyNTQ3_a5c16583-aeae-452c-9b57-8b1cc6a8a9d7">58,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDktMy0xLTEtMjMyNTQ3_11878d5c-2507-4b44-a6aa-b850bcb315a7">52,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTItMS0xLTEtMjMyNTQ3_c2a17195-f56e-40b6-9dd9-d857c20d1594">1,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTItMy0xLTEtMjMyNTQ3_f7711a4e-2e0d-40b5-9608-fcd9e3a0b534">1,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="-6" name="cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTMtMS0xLTEtMjMyNTQ3_f3e2d740-01ed-4ce1-afeb-d700d146526c">56,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231" decimals="-6" name="cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTMtMy0xLTEtMjMyNTQ3_23004f48-c7ba-498c-a8ac-988d0c0bbbca">50,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1.95pt;font-weight:400;line-height:120%;position:relative;top:-1.05pt;vertical-align:baseline">_____________________________________________________________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $<ix:nonFraction unitRef="usd" contextRef="id93ceac7923443509811589be6f2fda6_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMzI5ODUzNDg4Njk4NQ_061d31b2-aa21-40aa-ae29-61b021716d54"><ix:nonFraction unitRef="usd" contextRef="i825b614ae6f949128593ec129680423e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMzI5ODUzNDg4Njk4NQ_c4dd4a57-89c4-48c4-83a9-ba6cb4af14f2">3</ix:nonFraction></ix:nonFraction>&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i142cb5ca311343bda51cd66081634342"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 1, 2023, the Company entered into a 364-day $<ix:nonFraction unitRef="usd" contextRef="i57dc9b642fb340ec9fbef3cdb67f4dc4_I20230501" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTY0OTI2NzQ1ODM3Nw_83e328f6-d09a-4e8f-90bd-cc1898987a84">5.0</ix:nonFraction>&#160;billion term loan agreement. The term loan agreement allows for borrowings at various rates that are dependent, in part, on the Company&#8217;s debt ratings. On May 2, 2023, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="if84cea09dba14f6bb1e7a65458f7d779_D20230502-20230502" decimals="-8" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTY0OTI2NzQ1ODM5MQ_86830c14-521a-43c4-aece-47440958cf4f">5.0</ix:nonFraction>&#160;billion under the term loan agreement to fund a portion of the Oak Street Health acquisition purchase price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2023, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i1f22263a3b694849ac61d1b0059ba4c0_I20230221" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODA2NA_31005d68-901f-4e60-ba88-775db8e41a77">1.5</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i1f22263a3b694849ac61d1b0059ba4c0_I20230221" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODA5Mg_e205b377-1b34-476c-835a-06f6dbe9eece">5.0</ix:nonFraction>% senior notes due February 2026, $<ix:nonFraction unitRef="usd" contextRef="i3088c2dbfe5d4a469e09d45deecf17d4_I20230221" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODA5OA_971dcbba-8f51-4999-b123-57e420da66c3">1.5</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i3088c2dbfe5d4a469e09d45deecf17d4_I20230221" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODExNA_bfa30063-6334-4546-b8ed-6ac1dd8dcbd0">5.125</ix:nonFraction>% senior notes due February 2030, $<ix:nonFraction unitRef="usd" contextRef="i466f42736e3c44f8a5bb7b033dc6dcc0_I20230221" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODEyMg_ffc36a87-9240-4223-8e71-45e6f3149a6c">1.75</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i466f42736e3c44f8a5bb7b033dc6dcc0_I20230221" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODEzOA_d3613aa1-0a78-4997-887c-e5c22d72e16f">5.25</ix:nonFraction>% senior notes due February 2033 and $<ix:nonFraction unitRef="usd" contextRef="i96c354a2d55441de977ed5f9a4c0d071_I20230221" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODE0Ng_12869661-7564-46eb-9be5-7cad460d4bd5">1.25</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i96c354a2d55441de977ed5f9a4c0d071_I20230221" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODE2Mg_895c24d4-e013-4ab4-8807-d85726703fc1">5.625</ix:nonFraction>% senior notes due February 2053 for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i409ce543d75747f6a86747b1e3200724_D20230221-20230221" decimals="-8" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODQ2Mw_81c61f82-60a7-4fc9-ae08-b16bfaa8d792">6.0</ix:nonFraction> billion, net of discounts and underwriting fees. The net proceeds of these offerings were used to fund general corporate purposes, including a portion of the Signify Health Acquisition purchase price.</span></div></ix:continuation><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_55"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjU5Mw_cb84463c-7059-4b93-9169-f64a9181aac7" continuedAt="i72e70270cd514c568036e5634d75ca5a" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i72e70270cd514c568036e5634d75ca5a" continuedAt="i286e735f2fc14051b9970e7625907158"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjU4Mg_72ca878e-7888-4384-8186-b2984fe78fbc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3f405559b34436a7dd9bda0df240e1_I20221117" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0xLTEtMS0yNDY0NzU_bd9b7576-29e3-48eb-bf36-749c89236238">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e778ae14014217b9adbc2e50448ccd_I20230331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0zLTEtMS0yNDY0NzU_ed6a28e7-b37f-4432-a2c3-b8318be4c5b7">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b66500cbc3494cbb2171885f5e9eaf_I20211209" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0xLTEtMS0yMzI1NDc_7ece097a-8b82-409c-b22a-3a996ddd6d7a">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8259b9e69e843db9bea20eeb8e3c4e0_I20230331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0zLTEtMS0yMzI1NDc_45d40c97-36d7-4323-a86c-3029d5779314">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time. </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company repurchased an aggregate of <ix:nonFraction unitRef="shares" contextRef="if9b17aee558d466d97018672fae58058_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg4ODczMg_7e983873-76eb-4187-9f92-6af3fea6d7ed">22.8</ix:nonFraction> million shares of common stock for approximately $<ix:nonFraction unitRef="usd" contextRef="if9b17aee558d466d97018672fae58058_D20230101-20230331" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNjMy_a21248e3-6ad1-489c-b61b-65a933189cfb">2.0</ix:nonFraction> billion and an aggregate of <ix:nonFraction unitRef="shares" contextRef="i220c5401ed2f49ac8453e559cfa0869a_D20220101-20220331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg4ODYzOQ_328a9e1e-84c4-4245-9b47-458f12957d74">19.1</ix:nonFraction> million shares of common stock for approximately $<ix:nonFraction unitRef="usd" contextRef="i220c5401ed2f49ac8453e559cfa0869a_D20220101-20220331" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDEwNQ_391e9148-ea6b-4983-8955-ef38f1f32c14">2.0</ix:nonFraction>&#160;billion, respectively, both pursuant to the 2021 Repurchase Program. This activity includes the share repurchases under the ASR transactions described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODQ4_bdf44c6d-1c21-464d-8bc9-c13815dd31fe">2.0</ix:nonFraction>&#160;billion fixed dollar ASR with Citibank, N.A. (&#8220;Citibank&#8221;). Upon payment of the $<ix:nonFraction unitRef="usd" contextRef="i356ddbd8c27d4b8c951a6be4585f1092_D20230104-20230104" decimals="-8" name="cvs:PaymentsForAcceleratedShareRepurchasesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODYy_3622190e-e707-4bd4-ad78-a0b4bec70240">2.0</ix:nonFraction>&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to <ix:nonFraction unitRef="number" contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODc2_e7ec55dd-e9e1-49ac-974a-76dc116e5bf7">80</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4OTA4_5a6791e7-01da-4468-b5be-12778bf4c16e">2.0</ix:nonFraction>&#160;billion notional amount of the ASR or approximately <ix:nonFraction unitRef="shares" contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODgx_335efb55-ebf2-48c9-ae38-a5d1b5e3ef0a">17.4</ix:nonFraction>&#160;million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODk1_6de1ae87-1180-4621-8073-4c5943f0eff8">92.19</ix:nonFraction> per share, which were placed into treasury stock in January 2023. The ASR was accounted for as an initial treasury stock transaction for $<ix:nonFraction unitRef="usd" contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104" decimals="-8" name="cvs:TransferOfSharesToTreasuryStockValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTY0OTI2NzQ0ODUwMQ_b7c41881-f495-44b1-8a44-6de32a4f04c9">1.6</ix:nonFraction>&#160;billion and a forward contract for $<ix:nonFraction unitRef="usd" contextRef="i82104008040f4e91b57c7a3d066cd708_I20230104" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDAwOQ_e50cb82f-bf17-4024-bb7b-ec855c13f2c3">0.4</ix:nonFraction>&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2023, the Company received approximately <ix:nonFraction unitRef="shares" contextRef="i165725ae3ea04060af45b3a4c66096f0_I20230228" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTY0OTI2NzQ0ODQyNg_bcebfd59-1d48-4852-a7c1-b7a5f7a9e97b">5.4</ix:nonFraction>&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining <ix:nonFraction unitRef="number" contextRef="i165725ae3ea04060af45b3a4c66096f0_I20230228" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDAyNw_a96174f4-0080-4024-bbd8-95f61cb7b3db">20</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i165725ae3ea04060af45b3a4c66096f0_I20230228" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDAzMw_1ca6b4e8-6b98-4603-9e35-8431b226366e">2.0</ix:nonFraction>&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfOTM1_4feee1ab-90f1-44bb-89aa-7f035d24cb96">1.5</ix:nonFraction>&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $<ix:nonFraction unitRef="usd" contextRef="ice6b8f5b6cc749a6a4fce5808629a093_D20220104-20220104" decimals="-8" name="cvs:PaymentsForAcceleratedShareRepurchasesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTAxMg_d18d625c-0779-4f74-9d70-19454b977bfc">1.5</ix:nonFraction>&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to <ix:nonFraction unitRef="number" contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTE0MA_05525d04-1334-45bf-b8be-d09e87469619">80</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTE1MA_41bd85a9-afbb-4e8b-938e-93ac6dfc9e2b">1.5</ix:nonFraction>&#160;billion notional amount of the ASR or approximately <ix:nonFraction unitRef="shares" contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTE5Nw_b969a49d-67a4-4a62-bfb0-f919024c57fa">11.6</ix:nonFraction>&#160;million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTIyMQ_3a170d36-4388-4dfb-ae9b-f6a0d5ed25be">103.34</ix:nonFraction> per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $<ix:nonFraction unitRef="usd" contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104" decimals="-8" name="cvs:TransferOfSharesToTreasuryStockValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTM2MQ_bb77561d-deec-4fb2-bf15-c3533d8c3ac4">1.2</ix:nonFraction>&#160;billion and a forward contract for $<ix:nonFraction unitRef="usd" contextRef="i8f99461356ba4ce58d8b75de3a097310_I20220104" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTM5MQ_c4bcb1f0-923b-4225-816d-330cbe6fb876">0.3</ix:nonFraction>&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately <ix:nonFraction unitRef="shares" contextRef="iab1e6b8b47724b91aaf561c27d054b14_I20220228" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTU0OQ_27cbe9cf-9068-4018-8c12-118986d3f378">2.7</ix:nonFraction>&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining <ix:nonFraction unitRef="number" contextRef="iab1e6b8b47724b91aaf561c27d054b14_I20220228" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTYyOA_dbcbe516-8e38-43e2-8e37-b549419cae32">20</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="iab1e6b8b47724b91aaf561c27d054b14_I20220228" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTYzOA_68160358-e69f-40ca-abec-410b07fd239b">1.5</ix:nonFraction>&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i286e735f2fc14051b9970e7625907158"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjE0OA_9204fcbb-6ee1-4388-b5cc-f8dbf1b98307">0.605</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjE1NQ_2f5effce-c1b5-4300-ae26-71b5ea2e5424">0.55</ix:nonFraction> per share in the three months ended March&#160;31, 2023 and 2022, respectively. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMTAzNw_b313dcfb-c723-4fab-9dee-aa548f4d5387" continuedAt="ia079f6f61ea849c39870dd7e149e85e1" escape="true">Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><ix:continuation id="ia079f6f61ea849c39870dd7e149e85e1" continuedAt="i46deb98220014a0e9d9c562ce0de0fea"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMTAyOA_76b356bc-b7f2-4112-8235-26c1e9187f4c" continuedAt="i6858bea9342e4b1aa1e24dc00e2febfc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:76.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.297%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9e4ce7d668647199a9963ba9223fb1e_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMy0xLTEtMS0yMzI1NDc_98cad07e-dc87-4930-8a73-7eb51a64822a">1,519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cee30098f554ffc83dd60ace24f2da1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMy0zLTEtMS0yMzI1NDc_ea8fe0a9-e358-4bb1-ae47-7ff279c57284">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i12b0bf32f4024d9a901bb71692e6457b_I20221231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yNTU1MDAvdGV4dHJlZ2lvbjo4MWUzOWU1Y2ZjNzQ0ZmM3OWVhMzFhMTBiMTE2MTNhNV8zMjk4NTM0ODgzMzk3_41ac8366-130a-4858-bb6c-6b72382e4c06">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia973432534304c319e71bd7ba226880a_I20211231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yNTU1MDAvdGV4dHJlZ2lvbjo4MWUzOWU1Y2ZjNzQ0ZmM3OWVhMzFhMTBiMTE2MTNhNV8zMjk4NTM0ODgzNDAz_a38f7500-aec0-4937-beab-9f4585bb1ca3">26</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b0bf32f4024d9a901bb71692e6457b_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0xLTEtMS0yNTU0MDM_48f6bdda-f6df-4177-88c9-c13fc3e4b76b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia973432534304c319e71bd7ba226880a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0zLTEtMS0yNTU0MDM_e6431599-c5d0-404b-b670-c0331d72f21c">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjoxYmRiYTFiYmE2MWE0MjkyOTlhNDhiODQyNDJkNjU2Nl81NQ_e243bab5-8e10-450b-9268-f0c5de0defcb">340</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjoxYmRiYTFiYmE2MWE0MjkyOTlhNDhiODQyNDJkNjU2Nl81OQ_62ece9c3-d967-401b-ba76-749ba13dffe5">1,375</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0xLTEtMS0yMzI1NDc_ce5c5aae-4dc8-47e2-ac82-ea1c1681492d">339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0zLTEtMS0yMzI1NDc_7ff73e36-b4b1-40b7-86e4-e538cfdd23c3">1,207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjpjMzkwOWYzYzIwNTM0MWM0YTUwOWNlNjE0NmJmNzgwOF83Nw_4b354967-682d-4fcd-87f1-8389cee09343">131</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjpjMzkwOWYzYzIwNTM0MWM0YTUwOWNlNjE0NmJmNzgwOF84MQ_619f6772-9af8-4cdd-b58b-f51ea2b573dc">77</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0xLTEtMS0yMzI1NDc_cf94114b-5130-4c69-abe6-3581822af709">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0zLTEtMS0yMzI1NDc_7bb1edfa-f179-49c4-a887-b0e8b8bf3f74">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNi0xLTEtMS0yMzI1NDc_e52b0beb-3edb-45e3-a027-c911670b2f19">470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNi0zLTEtMS0yMzI1NDc_b8f23e67-dd7e-42e9-bd4c-ddd2475af9a9">1,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50bde2997fe64d2fa6e63680de08d727_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNy0xLTEtMS0yMzI1NDc_51aa1b1d-405d-434f-bac9-023dee36db4d">1,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e3b16b861e34693a440d9cbeb7ff083_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNy0zLTEtMS0yMzI1NDc_3e4f25b6-664e-4d4d-afc5-ddf6e528fce5">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in discount rate on long-duration insurance reserves:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ce902132c444a37ae7bef2d65504f51_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMS0xLTEtMjU1NDU2_c5731851-df7c-4317-987c-b18c983b6e5d">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf12a3d04a2473399581bc3408cd6bb_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMy0xLTEtMjU1NDU2_dcbe0c95-bcc5-4f2d-9d5c-fe166264736f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia2a52a92c5c54930b5139ac668af203b_I20221231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMC0xLTEtMjU1NTE2L3RleHRyZWdpb246ZGNiZTY0NWI2Nzg1NDdiN2I2OWQ0YzcxMjk0YmVmZmZfMzI5ODUzNDg4MzM5Nw_d7ad2f2a-4715-451c-91fb-661892881350">0</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i2e51eab27f6049da87e49ecefc750401_I20211231" decimals="-6" sign="-" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMC0xLTEtMjU1NTE2L3RleHRyZWdpb246ZGNiZTY0NWI2Nzg1NDdiN2I2OWQ0YzcxMjk0YmVmZmZfMzI5ODUzNDg4MzQwMw_35c67028-8f6b-4ed4-9ffa-97d49eb176fe">838</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2a52a92c5c54930b5139ac668af203b_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMS0xLTEtMjU1NDU2_e924fa04-ea9f-4947-b698-ad906e376b8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e51eab27f6049da87e49ecefc750401_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMy0xLTEtMjU1NDU2_082e2404-ccd3-4c21-94ab-1c8b829514b9">651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMC0xLTEtMjU1NDI2L3RleHRyZWdpb246ZmMxMTlkMzJmZTRiNGY1NDk2ZmQzOTNhNTIxMzU4MmZfMzI5ODUzNDg4MzQyMQ_280bab8f-d497-468e-a8b5-b4fcc9def543">101</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMC0xLTEtMjU1NDI2L3RleHRyZWdpb246ZmMxMTlkMzJmZTRiNGY1NDk2ZmQzOTNhNTIxMzU4MmZfMzI5ODUzNDg4MzQzNA_f599444c-2f6e-4cea-abd4-679faf7b4e5f">475</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMS0xLTEtMjU1NDU2_27c72671-20eb-480e-bfa5-0cb1eb1bb4ee">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMy0xLTEtMjU1NDU2_ada285d9-91a2-408d-a747-f4beae5e29d4">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMS0xLTEtMjU1NDU2_abc8563e-b066-495e-ba22-4b79f3be9308">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMy0xLTEtMjU1NDU2_8a59c396-7ec8-4caa-bed1-46fc7f85ff83">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b73ef515fa74bda9625d4853a2c40af_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTUtMS0xLTEtMjU1NDU2_009bd01b-c97f-488c-894d-c3d5be904836">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc48e18e68b24845a7b17fbee590d05e_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTUtMy0xLTEtMjU1NDU2_982283f6-fe46-481d-903d-f71adc1a2367">282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4233cdd857c84c5495036af966d69c1e_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTAtMS0xLTEtMjMyNTQ3_bf7283e1-1b12-432a-b29b-0fe1f69180aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69ec3798d5e44b4d9eec0a23d4f9102b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTAtMy0xLTEtMjMyNTQ3_8eb152fd-c36e-4d21-b6f0-b6e9cfac4625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbaec47994724954be26c44f88b1be41_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMS0xLTEtMjMyNTQ3_d79e8547-4283-4e11-b201-99261386d846">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349061ce37a4635b17c190c002a1781_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMy0xLTEtMjMyNTQ3_565ea49d-cad0-4c76-9476-9983fe2e004a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbaec47994724954be26c44f88b1be41_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMS0xLTEtMjMyNTQ3_18a9a57c-8ca0-4193-b8e4-e1afdd835939">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349061ce37a4635b17c190c002a1781_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMy0xLTEtMjMyNTQ3_210cbf5e-3225-4b4f-9a98-c268d6b7adff">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c1adaa533e24a38b010ac1f6be0ca13_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMS0xLTEtMjMyNTQ3_6bdacc3d-c369-4ed3-b670-14cb1c76564f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib634cfe740504bac99546a361cf5b67c_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMy0xLTEtMjMyNTQ3_1a7131ec-6f49-4de6-becf-b7a85731bb6c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8471dc1ae7b4c3ea316bf53d8400d96_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTctMS0xLTEtMjMyNTQ3_b1b545ec-19d9-4f1f-b816-281d59ce3466">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37a9e3c8866a4ad8be85672e565cf864_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTctMy0xLTEtMjMyNTQ3_b6b459f5-5495-44c9-afdf-ef8feccbdc70">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTEzMDc5YWY0ZGMzNDZiYjkwNDM5ZDU4OTg2MDZjNDBfNTc_d69f9a22-3b83-4cb6-a549-bae607d53cb3">5</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTEzMDc5YWY0ZGMzNDZiYjkwNDM5ZDU4OTg2MDZjNDBfNjE_14e84649-ec7d-447c-9235-391242783d16">0</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMS0xLTEtMjMyNTQ3_f559d6dc-d98a-4d90-a491-a9a885999e81">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMy0xLTEtMjMyNTQ3_f000ee31-a196-4053-b754-3470d18526ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246OTYxODBmZTRkMmNjNDZjYTgzNTZlZTFkMmM5N2I3YTdfNzA_4fa52e89-9d09-480b-97b3-26f505764991">3</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246OTYxODBmZTRkMmNjNDZjYTgzNTZlZTFkMmM5N2I3YTdfNzQ_334743af-924c-4741-aa59-0b46dee1f74c">4</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMS0xLTEtMjMyNTQ3_39957cbc-3187-43ff-b0aa-c7d111a3c8ad">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMy0xLTEtMjMyNTQ3_391fefd9-1e28-4806-861a-544ba6a34763">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjAtMS0xLTEtMjMyNTQ3_2adc4940-0cdc-49c2-bd23-3a58946132bc">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjAtMy0xLTEtMjMyNTQ3_6b1ec978-8d99-4916-b8ad-5f927fa01796">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7ed44250004f0abd93cfd873764497_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjEtMS0xLTEtMjMyNTQ3_c0bdd1da-6dec-45f9-83e5-3ce062e5853d">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80edf5a59a3b4b4cbde630d40e6cf394_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjEtMy0xLTEtMjMyNTQ3_eca8d4bd-b8e1-4484-a1e2-09509c8b3e4d">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2ced1961f54c58a58691eb07a37938_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjQtMS0xLTEtMjMyNTQ3_b169a3e7-8789-469d-a316-9da0c7054084">203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24d62eb54342479d9c8f667ab299427d_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjQtMy0xLTEtMjMyNTQ3_c33396e4-5738-41ba-9fbe-f9c00e7afc61">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd2694bab621470b83d6016dd198125c_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjctMS0xLTEtMjMyNTQ3_44aa55bf-bdd0-47e6-b678-33dbffea2891">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e064e345951488e83346591a86aa59e_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjctMy0xLTEtMjMyNTQ3_3155991e-6c9a-42e8-8130-36a8fad98f20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i428c873482a54c03a2844bcfd0128950_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjgtMS0xLTEtMjMyNTQ3_922ae601-c822-45e1-9714-6580ef3401e8">203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36ecd33b2f0d4bf79158216e8e771219_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjgtMy0xLTEtMjMyNTQ3_f907bcc2-0f2d-4d4b-ae0e-7337ad10d6d0">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506d0959bcbe41b386b645d218ba7cad_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzAtMS0xLTEtMjMyNTQ3_ec5efd56-7fc2-4b56-88f7-c625c524ee5c">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b89e03562af42418df598d66e518fc3_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzAtMy0xLTEtMjMyNTQ3_aeaaa3eb-8ffe-4c03-afe1-15fe8f5522f0">965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2abc6620160466c96132f7287192b1f_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNDAtMS0xLTEtMjU1NDY5_fd35e3b5-5437-402d-9358-6c485d0a4af7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28d618aaf5d4485a9bcc280348fd703a_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNDAtMy0xLTEtMjU1NDY5_104007a2-8ee3-4be3-a7c6-6bb71564d949">631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzEtMS0xLTEtMjMyNTQ3_4eee5b7b-995b-488a-aa6e-0911d948f340">389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzEtMy0xLTEtMjMyNTQ3_eb9d3935-7ece-42b0-84e3-b72c18fe6859">763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a84c750be7040c4995da886f9ea1771_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzItMS0xLTEtMjMyNTQ3_ab6f9d45-3100-42c4-9753-3ef516e50689">875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9431e6a492f4c89b178b2b1528cc6f0_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzItMy0xLTEtMjMyNTQ3_dfb73f9f-c2cd-4c68-ad06-8f69e93ccfd7">429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMjE5OTAyMzI1NzE0NQ_e6900be7-0b3a-4d0a-abd8-725b8e9077ce">ASU 2018-12</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 944)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> during the three months ended March 31, 2023. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="i46deb98220014a0e9d9c562ce0de0fea"><ix:continuation id="i6858bea9342e4b1aa1e24dc00e2febfc"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i0e7ed44250004f0abd93cfd873764497_I20230331" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfNjkw_df825a07-8390-407d-93c0-faa1f6b10e6e">14</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></ix:continuation></ix:continuation></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_61"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfMTM3Nw_099b0fb0-4257-49d3-b861-001901016519" continuedAt="ibd92a118aac640dda45d6e8643456fba" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibd92a118aac640dda45d6e8643456fba"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. Stock options and stock appreciation rights to purchase <ix:nonFraction unitRef="shares" contextRef="i1fb588d338ae42bcbcfae34f3bc52d4b_D20230101-20230331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfNDAy_63caaa80-733f-478f-8a53-cea0ad1bbc64">4</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ic10b551416e249919ddba15b607f1f4c_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfNDk0NzgwMjMyNjY5MQ_8915eb91-f61d-42fa-aeb2-826f3ea21dc6">2</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three months ended March&#160;31, 2023 and 2022, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfMTM2Nw_90a6f84d-8911-49b9-8779-54e0acf87b0e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:74.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfNi0xLTEtMS0yMzI1NDc_eeda8040-0531-4f42-9ae8-c55b39e9d03d">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfNi0zLTEtMS0yMzI1NDc_ad8da7ea-30ea-423d-af60-002a2f6c1eed">2,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfOS0xLTEtMS0yMzI1NDc_9da5002e-8081-46bc-958b-82e0338c97f6">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfOS0zLTEtMS0yMzI1NDc_0e88b8a3-e7fb-4f0d-97aa-f0baaf5c70e2">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i578b2414d82040be9c8f73746252c42e_D20230101-20230331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTAtMS0xLTEtMjMyNTQ3_34d87d71-c977-4880-ab46-e5a02013d58c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb438f2d815843dcbab2c539cffbd7ad_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTAtMy0xLTEtMjMyNTQ3_13957e19-9eb2-429b-8cea-5c57b7df5fb3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1fb588d338ae42bcbcfae34f3bc52d4b_D20230101-20230331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTEtMS0xLTEtMjMyNTQ3_26b781be-8eca-4b73-a1ea-df3caaa163b3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic10b551416e249919ddba15b607f1f4c_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTEtMy0xLTEtMjMyNTQ3_5ce354db-cb22-4bef-b048-f221717071b6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTItMS0xLTEtMjMyNTQ3_38559511-737e-457b-ab84-7177537349e3">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTItMy0xLTEtMjMyNTQ3_dd70be0b-fa4d-49ae-a7c5-d297e1420d8b">1,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTUtMS0xLTEtMjMyNTQ3_36cd68c8-4a0e-46af-9991-851c4acc6ce9">1.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTUtMy0xLTEtMjMyNTQ3_8b329685-2f7e-4062-89ac-faf3a78fecc5">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTYtMS0xLTEtMjMyNTQ3_ca9fe2d0-bf81-4d2a-968f-7b84cb077096">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTYtMy0xLTEtMjMyNTQ3_1223cc4d-14ee-4f4a-903a-0743d66bb84e">1.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_64"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMzQ0Mzc_0e4eb9e2-fc15-49d9-bbd1-5f05451ee5c5" continuedAt="i017f801026ca479f868d9a596b9896ec" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i017f801026ca479f868d9a596b9896ec" continuedAt="i6f5e19d3cf9b4a719e14136f87c87658"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations. As of March&#160;31, 2023, the Company guaranteed <ix:nonFraction unitRef="lease" contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331" decimals="INF" name="cvs:GuarantorObligationsNumberOfLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjA1Mw_43b97c11-de97-4ff7-9eff-f2138195cc8b">64</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2034. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6f5e19d3cf9b4a719e14136f87c87658" continuedAt="i9ae087f726bc4df68ee97f96f821137b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic had on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS&#8221;), state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state Attorneys General, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the U.S. Federal Trade Commission (the &#8220;FTC&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. Other than the controlled substances litigation accruals described below, none of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors and government payors, and are based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9ae087f726bc4df68ee97f96f821137b" continuedAt="id58c2aa936704aa1b64fada09da19bf3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classes have been certified. In October 2022, one of the litigating shareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to demonstrate demand futility. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions, and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims. The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;), and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims beginning as far back as the early 2000s generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs, and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs, and other requests for information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a judgment jointly against the three defendants in the amount of $<ix:nonFraction unitRef="usd" contextRef="i834bdaa838194915943ae1dd41b66214_D20220801-20220831" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMTI4NTk_de3965c0-928c-4cff-9374-cafa4ee401ef">651</ix:nonFraction>&#160;million to be paid over <ix:nonNumeric contextRef="i30f76719657045dc97c61d48649aabd8_I20220831" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMTI4Nzg_95a22891-eaad-4e37-8e60-6e6a5bd9bd31">15</ix:nonNumeric> years, and also ordered certain injunctive relief. The Company is appealing the judgment and has not accrued a liability for this matter. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a leadership group of a number of state Attorneys General and the Plaintiffs&#8217; Executive Committee (&#8220;PEC&#8221;). The agreement would resolve substantially all opioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the settlement would be approximately $<ix:nonFraction unitRef="usd" contextRef="i73c2c711a9e144129bf8bcee89201591_D20221201-20221231" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMTY0OTI2NzQ5MDU2OA_f70b97a6-97fc-4427-9141-4af4ca676abb">4.3</ix:nonFraction>&#160;billion in opioid remediation and $<ix:nonFraction unitRef="usd" contextRef="i73c2c711a9e144129bf8bcee89201591_D20221201-20221231" decimals="-6" name="us-gaap:LegalFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDI5_a750c07c-603f-4fa3-a1f2-83b1c7b33cce">625</ix:nonFraction>&#160;million in attorneys&#8217; fees and costs and additional remediation. The amounts would be payable over <ix:nonNumeric contextRef="if91f496db0cd4ebeb4308b49828714b9_I20221231" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMwNDIwNQ_4963d655-b30e-45fa-910a-99194ddd9f50">10</ix:nonNumeric> years, beginning in 2023. The agreement also contains injunctive terms relating to the dispensing of opioid medications. The settlement agreement is available at nationalopioidsettlement.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the settlement agreement, before the Company determines whether to enter into any final settlement, it will assess the number and identities of the governmental entities that will participate in any such settlement. The settlement agreement contemplates that if certain governmental entities do not agree to the settlement, but the Company nonetheless concludes that there is sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id58c2aa936704aa1b64fada09da19bf3" continuedAt="i362dd18c59ea48c596ecffca6a390139"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. Private plaintiff litigation will also continue.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has been informed that <ix:nonFraction unitRef="state" contextRef="if91f496db0cd4ebeb4308b49828714b9_I20221231" decimals="0" name="cvs:LitigationSettlementNumberOfStatesElectedToJoin" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMwNDIxOQ_aadf6861-b86d-4013-b1a5-2c68c4e374e5">45</ix:nonFraction> states, the District of Columbia, and all eligible United States territories have elected to join the settlement. The Company has elected to proceed with the settlement process based on that level of participation. The settlement process will progress to the period during which subdivisions may elect to join. The Company has separately entered into settlement agreements with the Cherokee Nation and <ix:nonFraction unitRef="state" contextRef="if91f496db0cd4ebeb4308b49828714b9_I20221231" decimals="0" name="cvs:LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMyNzc4Mw_f916c3b9-8b21-4ef2-83fc-55c5c1bc97d9">four</ix:nonFraction> states: Florida, West Virginia, New Mexico, and Nevada.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company also agreed to a formal settlement agreement with a leadership group representing tribes throughout the United States. The agreement resolves substantially all opioid claims against Company entities by such tribes. The maximum amount payable by the Company under the settlement is $<ix:nonFraction unitRef="usd" contextRef="i9ef4e0c2d2c244c393a5cfcced1e4a15_D20221201-20221231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDQz_ed75803d-1f6a-48a4-adbb-8669966308e0">113</ix:nonFraction>&#160;million in opioid remediation and $<ix:nonFraction unitRef="usd" contextRef="i9ef4e0c2d2c244c393a5cfcced1e4a15_D20221201-20221231" decimals="-6" name="us-gaap:LegalFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDU3_5cedc078-b2e6-4706-a530-28601fd8f52e">16</ix:nonFraction>&#160;million in attorneys&#8217; fees and costs, payable over <ix:nonNumeric contextRef="ie999f8648a0f440188249767603b220a_I20221231" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMwNDIzMw_9b662f0f-2427-4de0-9f79-b6958deb1667">10</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that settlement of opioid claims by governmental entities and tribes is probable, and the loss related thereto could be reasonably estimated. As a result of that conclusion, and its assessment of certain other opioid-related claims including those for which the Company reached agreement in August and September 2022, the Company recorded pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i0692ab80d568422b875c73998e65a989_D20220101-20221231" decimals="-8" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDcw_4d0b9440-3542-4a32-aafe-9de54ac979d9">5.3</ix:nonFraction>&#160;billion during the year ended December 31, 2022. Settlement accruals expected to be paid within twelve months from the balance sheet date are classified as accrued expenses on the unaudited condensed consolidated balance sheets and settlement accruals expected to be paid greater than twelve months from the balance sheet date are classified as other long-term liabilities on the unaudited condensed consolidated balance sheets. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment requires judgments about future events. Moreover, the settlement is in its early phases, and there is no assurance that contingencies will be satisfied. The amount of ultimate loss may differ materially from this accrual. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any settlement arrangement or other resolution of all opioid-related litigation matters, including the uncertain scope of participation by governmental entities, and given that the Company continues to actively defend ongoing litigation for which it believes it has defenses and assertions that have merit, the Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time. The outcome of these legal matters could have a material effect on the Company&#8217;s business, financial condition, operating results and/or cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The DOJ subsequently served additional DEA administrative subpoenas relating to controlled substances. The DOJ also served the Company with additional CIDs relating to controlled substances. The Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Gill et al. v. CVS Health Corp. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for the Northern District of Illinois). In July 2022, the Delaware Attorney General&#8217;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The federal government and the remaining states declined to intervene on other additional theories in the relator&#8217;s complaint. The Company is defending itself against all of the claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:18pt"><span><br/></span></div><ix:continuation id="i362dd18c59ea48c596ecffca6a390139" continuedAt="ic2d4434666f94f39a9311a52459129e7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the Company&#8217;s post payment audit and collection practices). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to claims payments, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, in the &#8220;Notice of Final Payment Error Calculation for Part C Medicare Advantage Risk Adjustment Validation Data (RADV) Contract-Level Audits,&#8221; CMS revised its audit methodology for RADV contract-level audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS announced extrapolation of the error rate identified in the audit sample along with the application of a process to account for errors in the government&#8217;s traditional fee-for-service Medicare program (&#8220;FFS Adjuster&#8221;). For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract, nor did CMS propose to apply a FFS adjuster. By applying the FFS Adjuster, Medicare Advantage organizations would have been liable for repayments only to the extent that their extrapolated payment errors exceeded the error rate in Original Medicare, which could have impacted the extrapolated repayments to which Medicare Advantage organizations are subject. This revised contract-level audit methodology increased the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. In the RADV audit methodology CMS used from 2011-2013, CMS selected only a few of the Company&#8217;s Medicare Advantage contracts for various contract years for contract-level RADV audits. In October 2018, CMS in the proposed rule (&#8220;Proposed Rule&#8221;) announced a new methodology for RADV audits targeting certain health conditions and members with many diagnostic conditions along with extrapolation for the error rates identified without use of a FFS Adjuster. While the rule was under proposal, CMS initiated contract-level RADV audits for the years 2014 and 2015 with this new RADV methodology without a final rule. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ic2d4434666f94f39a9311a52459129e7" continuedAt="if73af35831ee4c05af9d0292074539e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 30, 2023, CMS released the final rule (&#8220;RADV Audit Rule&#8221;), announcing it may use extrapolation for payment years 2018 forward, for both RADV audits and OIG audits, and eliminated the application of a FFS Adjuster in Part C contract-level RADV audits of Medicare Advantage organizations. In the RADV Audit Rule, CMS indicated that it will use more than one audit methodology going forward and indicated CMS will audit contracts it believes are at the highest risk for overpayments based on its statistical modeling, citing a 2016 Governmental Accountability Office report that recommended selection of contract-level RADV audits with a focus on contracts likely to have high rates of improper payment, the highest coding intensity scores, and contracts with high levels of unsupported diagnoses from prior RADV audits.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds for years prior to 2018 or prospective adjustments to Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s minimum loss ratio rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RADV Audit Rule does not apply to the CMS Part C Improper Payment Measures audits nor the HHS-RADV programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes related to risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the U.S. Attorney&#8217;s Office for the Southern District of New York requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. Since filing, several of the cases have been consolidated, and two have resolved, including the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the dismissal of which the First Circuit affirmed in August 2022. The Company and its current and former officers and directors are defending themselves against remaining claims. The Company has moved to dismiss the amended complaint in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the court granted the Company&#8217;s motion to dismiss in February 2023 and the plaintiffs have filed a notice of appeal.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, <ix:nonFraction unitRef="claim" contextRef="i27b20e43185e4a60b4de68bbfd17424a_I20200930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMxMTg1OA_f7809272-ff50-4007-adb2-8f5745fbeb06">two</ix:nonFraction> class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases asserted a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business. In October 2022, the court granted the Company&#8217;s motion to dismiss the amended consolidated complaint with prejudice. Plaintiffs appealed this decision to the Second Circuit and later withdrew the appeal in January 2023.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in December 2021, the Company has received two demands for inspection of books and records pursuant to Delaware Corporation Law Section 220, as well as a derivative complaint (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Vladimir Gusinsky Revocable Trust v. Lynch, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) that was filed in January 2023. The demands and the complaint purport to be related to potential breaches of fiduciary duties by </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if73af35831ee4c05af9d0292074539e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Board in relation to certain matters concerning opioids. The Company and its current and former officers and directors are defending themselves against these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas, or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation, and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed, or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight, and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNTY2Mw_50346245-1ea2-4dd2-bcb5-f215642fbfe5" continuedAt="idc8981ef0d1047ecba141bb79dd68077" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="idc8981ef0d1047ecba141bb79dd68077" continuedAt="i69d3cae1f92c49a68fb43fed5a897d94"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNDE_5a64c3cc-08b9-414f-b653-8e5826ccd27c">three</ix:nonFraction> operating segments, Health Care Benefits, Health Services and Pharmacy &amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the three months ended March&#160;31, 2023 reflects the following items:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8220;Significant Accounting Policies,&#8221; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method, as described in Note 1 &#8220;Significant Accounting Policies.&#8221; </span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNTY2MA_66873257-87bb-46b2-9a7b-c42e16143f63" continuedAt="i32bddade20c449538a2f3f3f446eee59" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the three months ended March&#160;31, 2022 has been revised to conform with current period presentation for these items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43eb35c724574445b70e64a0712e5fd0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi0xLTEtMS0yNTI2Njg_3c37d192-2bd3-4f0a-bd37-5ffcc669f52e">23,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c819332a1f49149907bd79dbb6e5ee_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi0zLTEtMS0yNTI2Njg_fc27b8e6-581a-497c-8536-095af4fafca0">39,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea3c803bd92470ca456a8cbd46b65d7_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi01LTEtMS0yNTI2Njg_73384a38-af48-4cb6-9092-6e0d3573a77b">25,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id46d76788ff04d0c89d679c03b4d8113_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi03LTEtMS0yNTI2Njg_a15d6815-da90-47d9-b4aa-675581e9e334">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b33e78be95e46aa8781e4f5cd708b7b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi05LTEtMS0yNTI2Njg_17187ca8-fb20-4424-8833-2c8134876a04">11,288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi0xMS0xLTEtMjUyNjY4_5bb026ce-0baf-4854-a39d-feec945612d7">76,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icceee7f19d8144d1838edd528b32a625_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy0xLTEtMS0yNTI2Njg_f13518fd-47fc-4327-a6c7-493afc8cc841">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25124c88573450f860bbc033280cab3_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy0zLTEtMS0yNTI2Njg_fb7b747d-e8e8-420b-902a-ae44a662614d">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72d3de15fdb141208e8be43677f48e7a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy01LTEtMS0yNTI2Njg_a08abbea-b514-4045-838d-eaeec75c88f9">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf51c4d778d74146836a38c29f6f5806_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy03LTEtMS0yNTI2Njg_9e31d8c9-c6a9-4ea9-bd41-a4d42d206417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8949cbfc8744ae59620e133dc98603d_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy05LTEtMS0yNTI2Njg_ef32a30b-c8a7-4917-9331-38ba07e4a09e">619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5c687add1743e5809d22a9d77525eb_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy0xMS0xLTEtMjUyNjY4_f31e47e7-af6a-47e0-81cd-5d9590bb7795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC0xLTEtMS0yNTI2Njg_166e5f0f-b984-4be3-b901-98add35b22bf">23,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC0zLTEtMS0yNTI2Njg_f349105d-f04f-4771-a04c-88511479baeb">39,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC01LTEtMS0yNTI2Njg_933ba77a-3884-4784-92b5-8d89e4666c04">25,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC03LTEtMS0yNTI2Njg_8b432e85-9edf-42e0-9de7-000ad9ee6277">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC05LTEtMS0yNTI2Njg_cc7dc0b4-3c67-422d-ab51-132fbb9c851e">11,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC0xMS0xLTEtMjUyNjY4_ff8544f7-ed3a-41c1-a012-d140a0ea3faa">76,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43eb35c724574445b70e64a0712e5fd0_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtMS0xLTEtMjUyNjY4_abf576bf-606b-4242-911e-4e14d05967eb">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c819332a1f49149907bd79dbb6e5ee_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtMy0xLTEtMjUyNjY4_1e7dc6df-30cf-4cfa-bb19-414bcba39ba4">1,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea3c803bd92470ca456a8cbd46b65d7_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtNS0xLTEtMjUyNjY4_b02c01bb-5408-4a60-b525-09b89b2e0a22">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id46d76788ff04d0c89d679c03b4d8113_D20220101-20220331" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtNy0xLTEtMjUyNjY4_ddde87f4-51b3-4feb-a3b4-994b83bd0bb9">305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b33e78be95e46aa8781e4f5cd708b7b_D20220101-20220331" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtOS0xLTEtMjUyNjY4_dd59a713-9130-47d3-9fff-61baeb0d31ff">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtMTEtMS0xLTI1MjY2OA_14b3b2e1-0be5-4dba-bd03-cb09807ee04b">4,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icceee7f19d8144d1838edd528b32a625_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctMS0xLTEtMjUyNjY4_91925009-f404-4270-a0ae-aad8078095d3">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id25124c88573450f860bbc033280cab3_D20220101-20220331" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctMy0xLTEtMjUyNjY4_bbdec360-95c2-4878-aa1e-76e9f4edd173">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72d3de15fdb141208e8be43677f48e7a_D20220101-20220331" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctNS0xLTEtMjUyNjY4_a955570e-7661-4b78-b1f6-2d6111887022">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf51c4d778d74146836a38c29f6f5806_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctNy0xLTEtMjUyNjY4_d1d52d4d-99f4-464d-b04a-4bb676baff56">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8949cbfc8744ae59620e133dc98603d_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctOS0xLTEtMjUyNjY4_dd7dbc4f-1a93-4f0e-920f-37b269734a49">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5c687add1743e5809d22a9d77525eb_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctMTEtMS0xLTI1MjY2OA_f6fe4bf1-5acf-45ad-b35c-6d03a843e510">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtMS0xLTEtMjUyNjY4_3639a236-0cfc-49fd-b8a7-a0d7a2d7c1c3">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtMy0xLTEtMjUyNjY4_08acf7cc-d09a-4203-a5a1-f588722cd673">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtNS0xLTEtMjUyNjY4_133ef1c7-5bed-4be4-b6d8-8c2489dafaab">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtNy0xLTEtMjUyNjY4_b1e3f909-b795-48aa-81ca-1bb677247a13">298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtOS0xLTEtMjUyNjY4_d23f47af-362a-4ab0-b7fe-9448885e2730">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtMTEtMS0xLTI1MjY2OA_3db3787c-bd76-499a-b759-b3855f0c8a24">4,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Prior period financial information has been recast to conform with&#160;current period presentation. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i69d3cae1f92c49a68fb43fed5a897d94" continuedAt="if95a9edd8a29495b860109c507faf627"><ix:continuation id="i32bddade20c449538a2f3f3f446eee59" continuedAt="i40974fc42583476cbe26754b8a69ba49"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy0xLTEtMS0yMzI1NDc_e8e21331-403d-4eb4-9d46-bf6bec6df505">25,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy0zLTEtMS0yMzI1NDc_9725304b-01d6-4584-91e4-b027f99e2e78">40,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy01LTEtMS0yMzI1NDc_7b8772e6-23f7-4823-9fa7-e97b746eda5e">18,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy03LTEtMS0yMzI1NDc_0c3d146b-745a-46ce-ab72-c55e7d7f5087">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy0xMS0xLTEtMjMyNTQ3_def8bc57-e3c2-43b4-93ce-320f1d29a2ac">84,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a711f48e1345a19a731927269c49cc_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC0xLTEtMS0yMzI1NDc_fb24e211-1bc9-4ccf-b51b-edd4dcc6ba16">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73dedc2c29fd4e33a88a7a1d2a1957db_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC0zLTEtMS0yMzI1NDc_891b9c74-f197-4b9a-af31-a963809926a3">3,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b32d6ef57d9481e855325b36afb4145_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC01LTEtMS0yMzI1NDc_66df8e23-ffa5-475c-8359-aa2040d1a9cd">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC05LTEtMS0yMzI1NDc_adafebd9-167a-438e-87eb-adad25863b8b">13,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS0xLTEtMS0yMzI1NDc_fe42237a-baf6-4569-95c6-afda1c26748a">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS0zLTEtMS0yMzI1NDc_04e81c4b-720b-4ea7-9761-d16bab732c52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS01LTEtMS0yMzI1NDc_81facbc8-46db-45fa-9d5f-744d6b31f738">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS03LTEtMS0yMzI1NDc_32784228-9225-4706-9382-0c83e49010fc">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS05LTEtMS0yMzI1NDc_b52938fe-0692-4e86-b761-705456e6c27e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS0xMS0xLTEtMjMyNTQ3_52101dd4-f42b-4c66-89ca-d4c6ca1d85f1">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi0xLTEtMS0yMzI1NDc_4e8ffd4f-cf33-4196-9729-5a91c3292e72">25,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi0zLTEtMS0yMzI1NDc_f6bbd687-d2df-4094-8481-47cf7551b39c">44,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi01LTEtMS0yMzI1NDc_432d3363-b761-48bf-a827-5a45096b39f7">27,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi03LTEtMS0yMzI1NDc_be8da5a2-9caa-4cd4-a2b5-c90f951d94e4">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi05LTEtMS0yMzI1NDc_5a968d3d-7e98-44ea-8c08-f2a0d5d87e63">13,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi0xMS0xLTEtMjMyNTQ3_ad5e63cc-e6ac-4a3d-b545-6f3404d17acb">85,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy0xLTEtMS0yMzI1NDc_b66438eb-40c8-4ede-a3e9-fed933451e91">1,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy0zLTEtMS0yMzI1NDc_a029471b-6142-43f9-93ad-6c8daf791c18">1,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy01LTEtMS0yMzI1NDc_7cf61eeb-5fa6-4e0a-bc34-8291723b4cfa">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy03LTEtMS0yMzI1NDc_077b9dd3-ebf5-4782-9433-e0d65334e80e">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy05LTEtMS0yMzI1NDc_db90b9c7-d8b9-4eed-b8d3-f4b9da155a17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy0xMS0xLTEtMjMyNTQ3_4f519e86-6255-4161-b6db-058e39042586">4,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtMS0xLTEtMjMyNTQ3_14921c34-c211-4947-ae36-c2b08cdbf969">22,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtMy0xLTEtMjMyNTQ3_d9299e8e-4feb-4cb0-a0fc-90ca2fecce1b">36,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtNS0xLTEtMjMyNTQ3_6b44a164-3973-4a61-ae32-c38819a5af64">17,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtNy0xLTEtMjMyNTQ3_b965af2e-5349-4507-8bcd-c4173690d344">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtMTEtMS0xLTIzMjU0Nw_185d048b-12aa-4733-bcd0-90242013ebad">76,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eef6ef05c314ac8991556b8d8d5dd5e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtMS0xLTEtMjMyNTQ3_cda36954-d6a9-48a6-9e4a-629af1112918">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832630f4a1134a15bb6da5125d24a7d0_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtMy0xLTEtMjMyNTQ3_8821a251-4de8-4376-bd56-ea59b1db63b3">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153b35e7e97042bb9c9cb483ab1d7c90_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtNS0xLTEtMjMyNTQ3_3c7d5bfb-3c8a-403a-9b27-0b2292b27e74">8,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtOS0xLTEtMjMyNTQ3_fa36898c-b167-4fca-a203-3ed4757b5e60">11,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItMS0xLTEtMjMyNTQ3_ac2f5a64-b44d-4e16-9fdf-0a5bde6bb294">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItMy0xLTEtMjMyNTQ3_fc58c007-2afc-4e33-b9f0-494398315d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItNS0xLTEtMjMyNTQ3_56140bad-2d23-410f-8b71-e69b1e11240e">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItNy0xLTEtMjMyNTQ3_9dbb836f-5821-4963-b9b3-191612a6f297">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItOS0xLTEtMjMyNTQ3_60f5be7b-fb5d-46ed-b5ce-4d46f3fef096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItMTEtMS0xLTIzMjU0Nw_68182511-c892-46a9-b884-399efe12b076">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtMS0xLTEtMjMyNTQ3_de2c3d01-2ed5-40c5-af68-e3f7532c3ddc">23,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtMy0xLTEtMjMyNTQ3_a6510a50-3899-4929-a62a-ab379657f1d2">39,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtNS0xLTEtMjMyNTQ3_d427a6c4-706a-4129-9645-fb52d082d3ca">25,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtNy0xLTEtMjMyNTQ3_c6e80b2b-8c2f-4c53-b8b9-e88026beafca">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtOS0xLTEtMjMyNTQ3_2abdc139-62a5-4433-b497-dd7865d95757">11,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtMTEtMS0xLTIzMjU0Nw_d25a3d2a-f4c6-4380-8978-3ceebab0358c">76,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtMS0xLTEtMjMyNTQ3_234f9732-8283-4e24-a681-084fcf151687">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtMy0xLTEtMjMyNTQ3_089f05d2-3e98-4834-b648-30d982ec9ea2">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtNS0xLTEtMjMyNTQ3_2ff689e8-9df8-4adc-8318-ac244ff9ab85">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtNy0xLTEtMjMyNTQ3_57a4f056-799f-498d-9788-c94878524a38">298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtOS0xLTEtMjMyNTQ3_81b4205c-8617-4982-8140-416c4885167f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtMTEtMS0xLTIzMjU0Nw_67b79f0d-872e-4e29-b400-b352a2d6988b">4,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfMTc2MA_2c0af03f-f75f-4746-9652-85d278878ef9">4.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfMTc2Nw_1771941e-6680-4acb-a05b-d827b44d3d98">3.8</ix:nonFraction> billion of retail co-payments for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i40974fc42583476cbe26754b8a69ba49" continuedAt="i04c6c8982e80435c9df93e5323f2026b">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i04c6c8982e80435c9df93e5323f2026b">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if95a9edd8a29495b860109c507faf627"><ix:nonNumeric contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNTY2Mg_7aa257eb-25ab-42ee-8cb8-2147a35d10ff" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three months ended March&#160;31, 2023 and 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:74.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMi0xLTEtMS0yMzI1NDc_915d2f43-2dfd-49fb-aaa5-07913c5dc02d">3,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMi0zLTEtMS0yMzI1NDc_f9eaf016-0d3b-4c90-a29b-6d0b8760d5fe">3,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMy0xLTEtMS0yMzI1NDc_ecee8ac3-c41a-4a43-9db3-4299f1725b33">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMy0zLTEtMS0yMzI1NDc_f51474bb-aefb-48bf-9ca3-9d13c3447b5d">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0xLTEtMS0yNTI2MDY_865cd978-f2e0-4d29-aedb-9793ad7fc5e3">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0zLTEtMS0yNTI2MTA_e4e45bb4-ca9f-4c82-bb53-f70ab647e403">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0xLTEtMS0yNzIxNDM_c61725f9-51ec-4220-8538-55d68f94895a">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0zLTEtMS0yNzIxNDM_3a055beb-68c0-40b3-a8c2-88df8296cf34">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0xLTEtMS0yNjc5NDM_a42bbc8a-02f0-46ae-b804-cc21c24426dd">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0zLTEtMS0yNjc5NDM_c5426e9f-b7e1-49db-be56-499ad158312b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0xLTEtMS0yNDMyMzM_9825a23c-d455-49ec-ae26-0b98d022176e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0zLTEtMS0yNDMyNDE_98ea4a2a-bcbd-4078-98d3-54d5465754cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charge </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0xLTEtMS0yMzI1NDc_d61226ac-de05-48da-84b3-f5a8be7ba593">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0zLTEtMS0yMzI1NDc_5b151594-38a5-41c8-a849-248ecbbbf930">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMTItMS0xLTEtMjMyNTQ3_4f519e86-6255-4161-b6db-058e39042586">4,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMTItMy0xLTEtMjMyNTQ3_67b79f0d-872e-4e29-b400-b352a2d6988b">4,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the unaudited condensed consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the loss on assets held for sale relates to the Company&#8217;s LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. During 2022, the Company determined that its LTC business was no longer a strategic asset and committed to a plan to sell it, at which time the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. As of March 31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the first quarter of 2023, a loss on assets held for sale was recorded to write down the carrying value of the LTC business to the Company&#8217;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. During the three months ended March&#160;31, 2022, the loss on assets held for sale relates to the Company&#8217;s Thailand business, which was included in the Commercial Business reporting unit in the Health Care Benefits segment. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the acquisition-related transaction and integration costs relate to the acquisitions of Signify Health and Oak Street Health. The acquisition-related transaction and integration costs are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2022, the opioid litigation charge relates to an agreement to resolve substantially all opioid claims against the Company by the State of Florida. The opioid litigation charge is reflected within the Corporate/Other segment.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Review of Interim Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed the accompanying condensed consolidated balance sheet of CVS Health Corporation (the Company) as of March&#160;31, 2023, the related condensed consolidated statements of operations and comprehensive income for the three-month periods ended March&#160;31, 2023 and 2022, the related condensed consolidated statements of shareholders&#8217; equity for the three-month periods ended March&#160;31, 2023 and 2022, the related condensed consolidated statements of cash flows for the three-month periods ended March&#160;31, 2023 and 2022, and the related notes (collectively referred to as the &#8220;condensed consolidated interim financial statements&#8221;). Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated interim financial statements for them to be in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December&#160;31, 2022, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and cash flows for the year then ended, and the related notes (not presented herein); and in our report dated February 8, 2023, we expressed an unqualified audit opinion on those consolidated financial statements. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 1 to the Company&#8217;s condensed consolidated interim financial statements, on January 1, 2023, the Company adopted ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on a modified retrospective basis resulting in the revision of the December 31, 2022 consolidated balance sheet. We have not audited and reported on the revised condensed consolidated balance sheet reflecting the adoption of ASU 2018-12.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Review Results</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the SEC and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial statements consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;3, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;)</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a leading diversified health solutions company reshaping health care to help make healthier happen for more Americans. In an increasingly connected and digital world, CVS Health is meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company is a leader in key segments of health care through its foundational businesses and is creating new sources of value by expanding into next generation care delivery and health services, with a goal of improving satisfaction levels for both providers and consumers. The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Prior period segment financial information has been recast to conform with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the segment realignment described above, the Company&#8217;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Overview of the Health Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Pharmacy &amp; Consumer Wellness Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of March&#160;31, 2023, the Pharmacy &amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Current Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face trends and uncertainties specific to our reportable segments, certain of which are summarized below and also discussed in the review of our segment results. For the remainder of the year, the Company believes you should consider the following important information:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment is expected to continue to benefit from Medicare and Commercial membership growth, partially offset by declines in Medicaid due to the impact of redeterminations in 2023.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Services segment is expected to continue to benefit from the Company&#8217;s ability to drive further improvements in purchasing economics and strong pharmacy network volume. These increases are expected to be partially offset by continued client price improvements and regulation of pharmacy pricing, as well as a recent expansion of pharmaceutical manufacturer policies restricting 340B discounts. The dilutive impact of the acquisition of Oak Street Health, Inc. (&#8220;Oak Street Health&#8221;) is expected to be partially offset by the accretive impact of the acquisition of Signify Health, Inc. (&#8220;Signify Health&#8221;) during the remainder of the year.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy &amp; Consumer Wellness segment is expected to continue to benefit from increased prescription volume and improved generic drug purchasing, partially offset by continued pharmacy reimbursement pressure and lower contributions from coronavirus disease 2019 (&#8220;COVID-19&#8221;) vaccinations, diagnostic testing and OTC test kits as COVID-19 transitions to an endemic stage. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is expected to benefit from the continuation of its enterprise-wide cost savings initiatives, which aim to reduce the Company&#8217;s operating cost structure in a way that improves the consumer experience and is sustainable. Key drivers include:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investments in digital, technology and analytics capabilities that will streamline processes and improve outcomes, </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementing workforce and workplace strategies, and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deploying vendor and procurement strategies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company expects changes to its business environment to continue as elected and other government officials at the national and state levels continue to propose and enact significant modifications to public policy and existing laws and regulations that govern or impact the Company&#8217;s businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current expectations described above are forward-looking statements. Please see the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this Form 10-Q for information regarding important factors that may cause the Company&#8217;s actual results to differ from those currently projected and/or otherwise materially affect the Company.</span></div><div id="ifc438c7598ac4033b496900bad31bcfa_82"></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion explains the material changes in the Company&#8217;s operating results for the three months ended March&#160;31, 2023 and 2022, and the significant developments affecting the Company&#8217;s financial condition since December&#160;31, 2022. We strongly recommend that you read our audited consolidated financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.127%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,452&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">751.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,580&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">81,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">73,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,355&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(500.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended March&#160;31, 2023 vs. 2022 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $8.5 billion, or 11.0%, in the three months ended March&#160;31, 2023 compared to the prior year driven by growth across all segments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $256 million, or 2.7%, in the three months ended March&#160;31, 2023 compared to the prior year. The increase in operating expenses was primarily due to increased operating expenses to support growth in the business,  incremental investments in business operations and an increase in acquisition-related transaction and integration costs compared to the prior year. These increases were partially offset by a decrease in amortization of intangible assets compared to the prior year. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues were 11.2% in the three months ended March&#160;31, 2023, a decrease of 90 basis points compared to the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues described above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $99 million, or 2.8%, in the three months ended March&#160;31, 2023 compared to prior year primarily due to declines in the Pharmacy &amp; Consumer Wellness segment, including a $349 million loss on assets held for sale related to the write-down of the Company&#8217;s Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  long-term care business (&#8220;LTC business&#8221;), as well as acquisition-related transaction and integration costs recorded in the current year. The decrease was partially offset by the absence of a $484 million opioid litigation charge recorded in the prior year and increased operating income in the Health Services segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating results of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense remained relatively consistent, increasing $3 million, or 0.5%, in the three months ended March&#160;31, 2023 compared to the prior year. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effective income tax rate was 25.6% for the three months ended March&#160;31, 2023 compared to 21.5% for the three months ended March&#160;31, 2022. The increase in the tax rate was primarily due to the absence of the impact of certain discrete tax items concluded in the first quarter of 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 12 &#8216;&#8216;Segment Reporting&#8217;&#8217; to the unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Health Services and Pharmacy &amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the three months ended March&#160;31, 2023 reflects the following items:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; to the unaudited condensed consolidated financial statements, including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (2) of the table below.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method, as described in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; to the unaudited condensed consolidated financial statements. </span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the three months ended March&#160;31, 2022 has been recast to conform with current period presentation for these items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as previously reported</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as adjusted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,483&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $4.1 billion and $3.8 billion of retail co-payments for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income, as well as reconciliations of segment GAAP operating income to segment adjusted operating income:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:44.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.080%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the unaudited condensed consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the loss on assets held for sale relates to the Company&#8217;s LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. During 2022, the Company determined that its LTC business was no longer a strategic asset and committed to a plan to sell it, at which time the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. As of March 31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the first quarter of 2023, a loss on assets held for sale was recorded to write down the carrying value of the LTC business to the Company&#8217;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. During the three months ended March&#160;31, 2022, the loss on assets held for sale relates to the Company&#8217;s international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), which was included in the Commercial Business reporting unit in the Health Care Benefits segment. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the acquisition-related transaction and integration costs relate to the acquisitions of Signify Health and Oak Street Health. The acquisition-related transaction and integration costs are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2022, the opioid litigation charge relates to an agreement to resolve substantially all opioid claims against the Company by the State of Florida. The opioid litigation charge is reflected within the Corporate/Other segment.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_88"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.237%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,339</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,614</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,877</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,595</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,874</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,567</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,528</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,195</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,419</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Health Care Benefits segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended March&#160;31, 2023 vs. 2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $2.8 billion, or 12.1%, to $25.9 billion in the three months ended March&#160;31, 2023 compared to the prior year driven by growth across all product lines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR increased to 84.6% in the three months ended March&#160;31, 2023 compared to 83.4% in the prior year reflective of the continued progression towards normalized utilization and lower impact from favorable development of prior-years&#8217; health care cost estimates in the three months ended March&#160;31, 2023 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on assets held for sale</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended March&#160;31, 2022, the Company recorded a $41 million loss on assets held for sale on its</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thailand business, which was included in the Commercial Business reporting unit within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $307 million, or 8.6%, in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by increased operating expenses to support the growth across all product lines described above.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 15.0% in the three months ended March&#160;31, 2023 compared to 15.4% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased slightly in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by the continued progression towards normalized utilization and lower impact from favorable development of prior-years&#8217; health care cost estimates in the three months ended March&#160;31, 2023 compared to the prior year. These decreases were largely offset by higher net investment income and membership growth across all product lines in the three months ended March&#160;31, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:30.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,393&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,401&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental membership information: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of March&#160;31, 2023 of 25.5 million increased 1.1 million members compared with December&#160;31, 2022, driven by increases across all product lines including an increase of approximately 900,000 members related to the individual exchange business within the Commercial product line.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2023, the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) issued its final notice detailing final 2024 Medicare Advantage payment rates. Final 2024 Medicare Advantage rates resulted in an expected average decrease in revenue for the Medicare Advantage industry of 1.12%, excluding the CMS estimate of Medicare Advantage risk score trend.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Services Segment (formerly Pharmacy Services Segment)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Services segment&#8217;s performance for the respective periods:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:62.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,671</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,899</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,976&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,416</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,622</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel): </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,592</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,128</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,145</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,668</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566.5</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Health Services segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy network revenues relate to claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network revenues also include activity associated with Maintenance Choice, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty revenues. Prior period financial information has been revised to conform with current period presentation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mail &amp; specialty revenues relate to specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty revenues exclude Maintenance Choice activity, which is now reported within pharmacy network revenues. Prior period financial information has been revised to conform with current period presentation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended March&#160;31, 2023 vs. 2022 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $5.0 billion, or 12.6%, to $44.6 billion in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued pharmacy client price improvements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Services segment include selling, general and administrative expenses; and depreciation and amortization expense.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 1.2% and 1.4% in the three-month periods ended March&#160;31, 2023 and 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $209 million, or 14.2%, in the three months ended March&#160;31, 2023 compared to the prior year. The increase in adjusted operating income was primarily driven by improved purchasing economics, including increased contributions from the products and services of the Company&#8217;s group purchasing organization, and increased pharmacy claims volume. These increases were partially offset by continued pharmacy client price improvements and decreased COVID-19 diagnostic testing in the segment&#8217;s MinuteClinic walk-in medical clinics compared to the prior year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Health Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates, fees and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates, fees and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy claims processed represents the number of prescription claims processed through the Company&#8217;s pharmacy benefits manager and dispensed by either its retail network pharmacies or the Company&#8217;s mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy claims processed on a 30-day equivalent basis increased 3.7% in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by net new business, increased utilization and the impact of an elevated cough, cold and flu season compared to the prior year. These increases were partially offset by a decrease in COVID-19 vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, pharmacy claims processed increased 4.8% on a 30-day equivalent basis for the three months ended March&#160;31, 2023 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Health Services segment&#8217;s generic drug claims processed by its total claims processed. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Services segment&#8217;s generic dispensing rate increased to 88.4% in the three months ended March&#160;31, 2023 compared to 87.7% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in the three months ended March&#160;31, 2023 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s generic dispensing rate was 88.5% and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88.8%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Segment (formerly Retail/LTC Segment)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy &amp; Consumer Wellness segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:61.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.071%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.331%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.337%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,258</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,904</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,876</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,382</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,980</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,081</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(439)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,495</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,532</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,069</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Pharmacy &amp; Consumer Wellness segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues and prescriptions from LTC and infusion services operations. Effective January 1, 2023, same store sales also include digital sales initiated online or through mobile applications and fulfilled through the Company&#8217;s distribution centers. Prior period financial information has been revised to conform with current period presentation. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful&#160;in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended March&#160;31, 2023 vs. 2022 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $2.0 billion, or 7.8%, to $27.9 billion in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by increased prescription and front store volume, pharmacy drug mix and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure, decreased COVID-19 vaccinations and diagnostic testing and the impact of recent generic introductions.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 12.7% in the three months ended March&#160;31, 2023 compared to the prior year. The increase was primarily driven by the 5.0% increase in pharmacy same store prescription volume on a 30-day equivalent basis, pharmacy drug mix and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 7.7% in the three months ended March&#160;31, 2023 compared to the prior year. The increase was primarily due to strength in consumer health, including the impact of an elevated cough, cold and flu season compared to the prior year, as well as increased beauty product sales in the three months ended March&#160;31, 2023.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues decreased $236 million in the three months ended March&#160;31, 2023 compared to the prior year. The decrease was primarily due to decreased COVID-19 diagnostic testing in the three months ended March&#160;31, 2023 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on assets held for sale</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended March&#160;31, 2023, the Company recorded a $349 million loss on assets held for sale related to the write-down of its LTC business. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy &amp; Consumer Wellness segment include payroll, employee benefits and occupancy costs associated with the segment&#8217;s stores and pharmacy fulfillment operations; selling expenses; advertising expenses; depreciation and amortization expense and certain administrative expenses. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $101 million, or 2.0%, in the three months ended March&#160;31, 2023 compared to the prior year. The decrease was primarily due to lower expenses associated with COVID-19 vaccination administration and a decrease in amortization of intangible assets compared to the prior year. These decreases were partially offset by incremental costs associated with increased volume and increased investments in the segment&#8217;s operations and capabilities.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 17.8% in the three months ended March&#160;31, 2023 compared to 19.6% in the prior year. The decrease in operating expenses as a percentage of total revenues was driven by the increases in total revenues and decreases in operating expenses described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $439 million, or 27.9% in the three months ended March&#160;31, 2023 compared to the prior year. The decrease in adjusted operating income was primarily driven by continued pharmacy reimbursement pressure, decreased COVID-19 vaccinations and diagnostic testing and increased investments in the segment&#8217;s operations and capabilities. These decreases were partially offset by the increased prescription volume described above and improved generic drug purchasing.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy &amp; Consumer Wellness segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income has been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Pharmacy &amp; Consumer Wellness segment. If the pharmacy reimbursement pressure accelerates, the segment may not be able to grow revenues, and its adjusted operating income could be adversely affected.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand to generic drug conversions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Pharmacy &amp; Consumer Wellness segment&#8217;s retail and long-term care pharmacies and infusion services operations. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 2.5% on a 30-day equivalent basis in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by increased utilization and the impact of an elevated cough, cold and flu season compared to the prior year. These increases were partially offset by a decrease in COVID-19 vaccinations. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 4.5% on a 30-day equivalent basis for the three months ended March&#160;31, 2023 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy &amp; Consumer Wellness segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy &amp; Consumer Wellness segment&#8217;s generic dispensing rate increased to 89.4% in the three months ended March&#160;31, 2023 compared to 87.5% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in the three months ended March&#160;31, 2023 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate was 89.7% in both the three months ended March&#160;31, 2023 and 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.275%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Corporate/Other segment operating loss (GAAP measure) to adjusted operating loss, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended March&#160;31, 2023 vs. 2022 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $62 million, or 49.2%, to $188 million in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by higher average invested assets and favorable average investment yields compared to the prior year, partially offset by decreased net investment income from private equity investments compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opioid litigation charge</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended March&#160;31, 2022, the Company recorded a $484 million opioid litigation charge. See</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss decreased $30 million in the three months ended March&#160;31, 2023 compared to the prior year primarily driven by the increases in net investment income described above, partially offset by an increase in operating expenses.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of March&#160;31, 2023, the Company had approximately $14.6 billion in cash and cash equivalents, approximately $2.7 billion of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash during the three months ended March&#160;31, 2023 and 2022 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,521)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(327.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased by $3.9 billion in the three months ended March&#160;31, 2023 compared to the prior year. The increase was primarily due to the early receipt of the April CMS payment of $5.1 billion, partially offset by the timing of payments.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased by $6.5 billion in the three months ended March&#160;31, 2023 compared to the prior year primarily due to the acquisition of Signify Health in March 2023, partially offset by lower net purchases of investments. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $2.7 billion in the three months ended March&#160;31, 2023 compared to net cash used in financing activities of $2.7 billion in the prior year. The increase in cash provided by financing activities primarily related to proceeds from the issuance of $6.0 billion of long-term senior notes in the three months ended March 31, 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of March&#160;31, 2023. In connection with its commercial paper program, the Company maintains a $2.5 billion, five-year unsecured back-up revolving credit facility, which expires on May&#160;16, 2025, a $2.5 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026, and a $2.5 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2027. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of March&#160;31, 2023, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 1, 2023, the Company entered into a 364-day $5.0&#160;billion term loan agreement. The term loan agreement allows for borrowings at various rates that are dependent, in part, on the Company&#8217;s debt ratings. On May 2, 2023, the Company borrowed $5.0&#160;billion under the term loan agreement to fund a portion of the Oak Street Health acquisition purchase price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the Federal Home Loan Bank of Boston (the &#8220;FHLBB&#8221;). As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of March&#160;31, 2023 was approximately $990 million. As of March&#160;31, 2023, there were no outstanding advances from the FHLBB.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;21, 2023, the Company issued $1.5 billion aggregate principal amount of 5.0% senior notes due February 2026, $1.5 billion aggregate principal amount of 5.125% senior notes due February 2030, $1.75 billion aggregate principal amount of 5.25% senior notes due February 2033 and $1.25 billion aggregate principal amount of 5.625% senior notes due February 2053 for total proceeds of approximately $6.0 billion, net of discounts and underwriting fees. The net proceeds of these offerings were used to fund general corporate purposes, including a portion of the Signify Health Acquisition purchase price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities and unsecured senior notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of March&#160;31, 2023, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investor Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. The outlook on the Company&#8217;s long-term debt is &#8220;Stable&#8221; by both Moody&#8217;s and S&amp;P. In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time. </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company repurchased an aggregate of 22.8 million shares of common stock for approximately $2.0 billion and an aggregate of 19.1 million shares of common stock for approximately $2.0&#160;billion, respectively, both pursuant to the 2021 Repurchase Program. This activity includes the share repurchases under the ASR transactions described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $2.0&#160;billion fixed dollar ASR with Citibank, N.A. (&#8220;Citibank&#8221;). Upon payment of the $2.0&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $2.0&#160;billion notional amount of the ASR or approximately 17.4&#160;million shares at a price of $92.19 per share, which were placed into treasury stock in January 2023. The ASR was accounted for as an initial treasury stock transaction for $1.6&#160;billion and a forward contract for $0.4&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2023, the Company received approximately 5.4&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining 20% of the $2.0&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2023.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining 20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the unaudited condensed consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the unaudited condensed consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a full description of the Company&#8217;s other critical accounting policies, see &#8220;Critical Accounting Policies&#8221; in Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of the 2022 Form 10-K.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Concerning Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We want to take advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this Quarterly Report on Form 10-Q (this &#8220;report&#8221;) is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to the forward-looking information in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in Part I, Item 2 of this report. In addition, throughout this report and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the impact of COVID-19 and any new variants or viruses on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Health Services segment business, sales results and/or trends and/or operations, Pharmacy &amp; Consumer Wellness segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, statements related to possible, proposed or pending acquisitions, joint ventures, investments or combinations that involve, among other things, the timing or likelihood of receipt of regulatory approvals, the timing of completion, integration synergies, net synergies and integration risks and other costs, including those related to CVS Health&#8217;s acquisitions of Signify Health and Oak Street Health, enterprise modernization, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain additional risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and under &#8220;Risk Factors&#8221; included in Part II, Item 1A of this report; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks that may affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of this report, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_109"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not experienced any material changes in exposures to market risk since </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See the information contained in Part II, Item 7A &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the Company&#8217;s exposures to market risk. </span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_112"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Securities Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) as of March&#160;31, 2023, have concluded that as of such date the Company&#8217;s disclosure controls and procedures were adequate and effective and designed to provide reasonable assurance that material information relating to the Company and its subsidiaries would be made known to such officers on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There has been no change in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that occurred in the three months ended&#160;March&#160;31, 2023 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_115"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:40.36pt">Other Information</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_118"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Note 11 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_121"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:34.8pt">Risk Factors</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information supplements the &#8220;Risk Factors&#8221; disclosed in Part I, Item 1A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (the &#8220;2022 10-K&#8221;)  and should be read in conjunction with the risk factors described in the 2022 10-K. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Risks Relating to Our Acquisitions of Signify Health and Oak Street Health</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Our recent acquisitions of Signify Health and Oak Street Health subject us to new and additional risks beyond those to which we have been historically subject. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consummated the Signify Health, Inc. (&#8220;Signify Health&#8221;) acquisition on March 29, 2023 through which we expanded our offerings to include health risk assessments, value-based care and provider enablement services, and we also consummated the Oak Street Health, Inc. (&#8220;Oak Street Health&#8221;) acquisition on May 2, 2023 through which we will offer multi-payor, senior-focused, value-based primary care for Medicare-eligible patients, broadening our ability to provide primary care services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Signify Health and the Oak Street Health businesses are subject to many of the risks described in &#8220;Item 1A. Risk Factors&#8221; of the 2022 10-K, as well as to certain additional risks that are different from the risks of our existing businesses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional risks to which our Signify Health business is subject include, but are not limited to, the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to recruit, retain and grow its network of credentialed, high-quality physicians, physician assistants and nurse practitioners to provide clinical services in highly competitive markets for talent&#894;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful challenges to Signify Health&#8217;s treatment of health care providers as independent contractors, which could result in increased costs and subject the business to regulatory sanction; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on a concentrated number of key health plan customers; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality of the information received about plan members of such health plans for whom Signify Health will seek to provide in-home evaluations and other services, and the regulatory restrictions and requirements associated with directly contacting plan members;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to perform and ensure the quality of health risk assessments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to achieve and receive shared health care cost savings;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the regulatory and business risks associated with participation in certain government health care programs, including the Medicare Shared Savings Program through Signify Health&#8217;s Caravan accountable care organizations; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">health reform initiatives and changes in the rules governing government health care programs, including rules related to the use of in-home health risk assessments; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">use of &#8220;open source&#8221; software in its technology, which may make it easier for others to gain access or compromise its proprietary technology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional risks to which our Oak Street Health business is subject include, but are not limited to, the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to attract new Medicare-eligible patients and credentialed, high-quality physicians and other providers for senior-focused primary care in a highly competitive market for such patients and providers&#894;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfying the enrollment requirements under government health care programs for physicians and other providers in a timely manner;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on a significant portion of revenue from Medicare or Medicare Advantage plans, which subjects Oak Street Health to reductions in Medicare reimbursement rates or changes in the rules governing the Medicare program;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence for a significant portion of revenue from agreements with a limited number of key payors with whom Oak Street Health contracts to provide services under terms that may permit a payor to amend the compensation arrangements or terminate the agreements without cause;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on reimbursements from third-party payors, which can result in substantial delay, and on patients, through copayments and deductibles, which subjects Oak Street Health to additional reimbursement risk; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">under the fixed fee (or capitated) agreements Oak Street Health enters into with health plans, the assumption of the risk that the actual cost of a service it provides to a patient exceeds the reimbursement provided by the health plan; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reductions in the quality ratings of Medicare health plans Oak Street Health serves could result in a shift of patients from, or the termination of, a health plan Oak Street Health serves; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission of inaccurate, incomplete or erroneous data, including risk adjustment data, to health plans and government payors could result in inaccuracies in the revenue Oak Street Health records or receipt of overpayments, which may subject it to repayment obligations and penalties; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">geographic concentration of its primary centers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with its existing legal proceedings and litigations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws regulating the corporate practice of medicine and the associated agreements entered into with physician practice groups restrict the manner in which the Oak Street Health business is able to direct the operations and otherwise exercise control of its physician practice groups; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the legal treatment of its contractual arrangements with its physician practice groups could impact the ability to consolidate the revenue of these groups; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to maintain and enhance its reputation and brand recognition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional risks faced by Signify Health and Oak Street Health may also compound, or be heightened by, many of the other risks described in the 2022 10-K, including the risks related to adverse economic conditions in the United States and abroad, the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic or other pandemics or epidemics, cybersecurity, and compliance with applicable laws and regulations, among others. The Signify Health and the Oak Street Health businesses may also be subject to additional risks the existence or significance of which we may not have anticipated prior to the respective acquisitions of such businesses. Any risks associated with the Signify Health or the Oak Street Health business, if they materialize, could adversely affect our business, financial condition and results of operations, including our ability to timely and effectively integrate the businesses in our operations and the timing and extent of realization of synergies and other benefits that we expected in connection with the acquisitions. Our experience in managing the additional risks associated with the acquisitions is more limited than our experience in managing the risks associated with our historical businesses, and there is no assurance that we will be able to effectively manage or mitigate such risks.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_124"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Stock Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total number of shares purchased in the three months ended March&#160;31, 2023, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the share repurchase programs authorized by CVS Health Corporation&#8217;s Board of Directors on November 17, 2022 and December 9, 2021. See Note 8 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form&#160;10-Q for additional information.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Fiscal&#160;Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of&#160;Shares<br/>Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid&#160;per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;Shares<br/>Purchased&#160;as&#160;Part&#160;of<br/>Publicly&#160;Announced<br/>Plans&#160;or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Approximate&#160;Dollar<br/>Value&#160;of&#160;Shares&#160;that<br/>May&#160;Yet&#160;Be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2023 through January 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,946,836,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023 through February 28, 2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,432,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,432,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,500,000,143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023 through March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,500,000,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,787,452&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,787,452&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div><span><br/></span></div><div id="ifc438c7598ac4033b496900bad31bcfa_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in this Item 6 are filed as part of this Quarterly Report on Form 10-Q. Exhibits marked with an asterisk (*) are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan of acquisition, reorganization, arrangement, liquidation or succession</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#8224; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787123000139/ss1747226_ex0201.htm">Agreement and Plan of Merger, dated as of February 7, 2023, by and among CVS Pharmacy, Inc., Halo Merger Sub Corp., Oak Street Health, Inc. and, for the limited purposes set forth therein, CVS Health Corporation (incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Current Report on Form 8-K filed February 8, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Instruments defining the rights of security holders, including indentures</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312523043484/d392967dex41.htm">Form of the Registrant&#8217;s 2026 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on February 21, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312523043484/d392967dex42.htm">Form of the Registrant&#8217;s 2030 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on February 21, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312523043484/d392967dex43.htm">Form of the Registrant&#8217;s 2033 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed on February 21, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312523043484/d392967dex44.htm">Form of the Registrant&#8217;s 2053 Note (incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Current Report on Form 8-K filed on February 21, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Contracts</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex101.htm">Restrictive Covenant Agreement dated June 20, 2022 between the Registrant and Tilak Mandadi</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex102.htm">Change in Control Agreement effective as of August 11, 2022 between the Registrant and Tilak Mandadi</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex103.htm">Restrictive Covenant Agreement dated May 11, 2022 between the Registrant and Prem Shah</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex104.htm">Change in Control Agreement effective as of January 27, 2023 between the Registrant and Prem Shah</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex105.htm">Second Amendment to Five Year Credit Agreement dated as of March 23, 2023, to the Five Year Credit Agreement, dated as of May 16, 2019, as amended by the First Amendment to Five Year Credit Agreement, dated as of May 16, 2022, by and among the Registrant, the lenders party thereto and Bank of America N.A. as Administrative Agent.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex106.htm">Second Amendment to Five Year Credit Agreement dated as of March 23, 2023, to the Five Year Credit Agreement, dated as of May 11, 2021, as amended by the First Amendment to Five Year Credit Agreement, dated as of May 16, 2022, by and among the Registrant, the lenders party thereto and Bank of America N.A. as Administrative Agent.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex107.htm">First Amendment to Five Year Credit Agreement dated as of March 23, 2023, to the Five Year Credit Agreement, dated as of May 16, 2022, by and among the Registrant, the lenders party thereto and Bank of America N.A. as Administrative Agent.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787123000511/ss2023948_ex1001.htm">Term Loan Agreement, dated May 1, 2023, by and among the Registrant, the lenders party thereto and Barclays Bank PLC, as administrative agent (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on May 2, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787123000139/ss1747226_ex9901.htm">Form of Voting Agreement by and among CVS Pharmacy, Inc., certain stockholders of Oak Street Health, Inc. and certain members of the Oak Street Health, Inc. board of directors parties thereto (incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s Current Report on Form 8-K filed February 8, 2023).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Letter re: unaudited interim financial information</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex151.htm">Letter from Ernst &amp; Young LLP acknowledging awareness of the use of a report dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex151.htm">May</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex151.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex151.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex151.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex151.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex151.htm"> related to their reviews of interim financial information.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 13a-14(a)/15d-14(a) Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex311.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex312.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 1350 Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex321.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a03312023ex322.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the CVS Health Corporation Quarterly Report on Form 10-Q for the three months ended March 31, 2023 formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Shareholders&#8217; Equity and (vi) the related Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023, formatted in Inline XBRL (included as Exhibit 101).</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224; Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request.</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="ifc438c7598ac4033b496900bad31bcfa_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifc438c7598ac4033b496900bad31bcfa_7">Form 10-Q Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a03312023ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if70452a411e44033bfbb00e611a1b908_1"></div><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:3.9pt;padding-left:145.95pt;padding-right:145.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS Pharmacy, Inc.</font></div><div style="padding-left:145.95pt;padding-right:145.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restrictive Covenant Agreement</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.022%"><div style="margin-top:4.55pt"><font><br></font></div></div><div style="display:inline-block;max-width:3.955%;min-width:2.955%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.023%"><div><font><br></font></div></div></div><div style="padding-left:51.1pt"><font><br></font></div><div style="padding-right:5.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I,   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">                               Tilak Mandadi                      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, enter into this Restrictive Covenant       Agreement (&#8220;Agreement&#8221;) with CVS Pharmacy, Inc., on its own behalf and on behalf of its subsidiaries     and affiliates (&#8220;CVS&#8221;), which is effective as of the date I sign the Agreement (&#8220;Effective Date&#8221;).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:8.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.25pt">Consideration for Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In connection with my duties and responsibilities at CVS Health Corporation or one of its subsidiaries or affiliates, including Aetna Inc. (collectively, the &#8220;Corporation&#8221;),   the Corporation will provide me with Confidential Information and&#47;or access to the Corporation&#8217;s  customers and clients and the opportunity to develop and maintain relationships and goodwill with them.    In consideration of the foregoing and the mutual promises in this Agreement and other good and valuable consideration, I hereby agree with CVS to comply with the terms of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.8pt">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. During my employment by the Corporation and during the Non-Competition Period following the termination of my employment for any reason, I will not directly or indirectly    engage in Competition or provide Consulting or Audit Services within the Restricted Area.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:15.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.42pt">Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Engaging in &#8220;Competition&#8221; means (whether as an employee, contractor, consultant, principal, agent, partner, officer, or director) (i) working on, developing, producing,   marketing, selling, servicing, or managing (or assisting in developing, producing, marketing, selling, servicing, or managing) any product or service that is competitive with any existing or planned products   or services of the Corporation that I managed, or with which I was involved, at any time during the last twenty-four (24) months of my employment with the Corporation&#59; or (ii) accepting any position or engaging in any activity that will likely result in the disclosure of Confidential Information to a Competitor or the use of Confidential Information on behalf of a Competitor.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:6.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.75pt">Competitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A &#8220;Competitor&#8221; for purposes of this Agreement shall mean any person, corporation or other entity that competes with one or more of the business offerings of the Corporation      As of the Effective Date, the Corporation&#8217;s business offerings include&#58; (i) pharmacy benefits management (&#8220;PBM&#8221;), including&#58; (a) the administration of pharmacy benefits for businesses, government agencies      and health plans&#59; (b) mail order pharmacy&#59; (c) specialty pharmacy&#59; and (d) the procurement of     prescription drugs at a negotiated rate for dispensing&#59; (ii) retail, which includes the sale of prescription drugs, over-the-counter medications, beauty products and cosmetics, digital and traditional photo      finishing services, digital and other online offerings, seasonal and other general merchandise, greeting   cards, convenience foods and other product lines and services which are sold by the Corporation&#8217;s retail division (&#8220;Retail&#8221;)&#59; (iii) retail health clinics (&#8220;MinuteClinic&#8221;)&#59; (iv) the provision of pharmaceutical     products and ancillary services, including specialty pharmaceutical products and support services and the provision of related pharmacy consulting, data management services and medical supplies to long-term    care facilities, other healthcare service providers and recipients of services from such facilities (&#8220;Long- Term Care&#8221;)&#59; (v) the provision of prescription infusion drugs and related services (&#8220;Infusion&#8221;)&#59; (vi) the provision of kidney care services, including but not limited to caring for patients with end stage renal disease (&#8220;Kidney Care&#8221;)&#59; (vii) services relating to or supporting clinical trials (&#8220;Clinical Trials&#8221;)&#59; (viii) the provision of insurance (&#8220;Insurance&#8221;) including&#58; (a) health insurance products and services&#59; (b) managed health care products and services&#59; (c) dental, vision, and employee assistance program products and services&#59; (d) wellness products and services to employers, government agencies, health plans, other businesses or third party payers&#59; (e) Medicare Part D services&#59; and (f) other voluntary products that are excepted benefits under HIPAA&#59; (ix) the creation and provision of population health management     products and services (&#8220;Health Management&#8221;)&#59; (x) services supporting or related to the administration of   the business offerings in (i) &#8211; (ix) (&#8220;Administration&#8221;)&#59; and (xi) any other business in which Corporation is engaged or imminently will be engaged. For avoidance of doubt, Competitor shall include any business</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">unit, corporate entity, division, affiliate or part of a Competitor which offers other products or services which are or may be combined or offered as part of a suite of products or services with the Competitor&#8217;s Insurance, Health Management and&#47;or PBM offerings.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the purpose of assessing whether I am engaging in &#8220;Competition&#8221; under section 2(a)(i) above,     a person, corporation or other entity shall not be considered a Retail Competitor if such entity derives   annual gross revenues from its business in an amount which is less than 2% of the Corporation&#8217;s gross revenues from Retail, during its most recently completed fiscal year. For avoidance of doubt, this    exclusion does not apply to a determination of whether I am engaging in &#8220;Competition&#8221; as set forth in section 2(a)(ii) above.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I and the Corporation acknowledge that both the Corporation&#8217;s products and services and the  entities which compete with the Corporation&#8217;s products and services evolve over time, and that an entity  will be considered a Competitor if it provides products or services competitive with the products and services provided by the Corporation within the last two years of my employment with the Corporation.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.9pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I agree that the provisions of Section 2 of this Agreement are reasonable to protect and preserve    the Corporation&#8217;s legitimate business interests, including the protection of the Company&#8217;s Confidential Information and the Company&#8217;s substantial investment made to develop and retain its Confidential Information, clients, other business relationships, and related goodwill.</font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:8.55pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.42pt">Consulting or Audit Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#8220;Consulting or Audit Services&#8221; shall mean any activity     that involves providing audit review or other consulting or advisory services with respect to any    relationship or prospective relationship between the Corporation and any third party that is likely to result  in the use or disclosure of Confidential Information.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:43.35pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.8pt">Non-Competition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The &#8220;Non-Competition Period&#8221; shall be the period of    18 months following the termination of my employment with the Corporation for any reason.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:6.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.37pt">Restricted Area</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. &#8220;Restricted Area&#8221; refers to those states within the United States in      which the Corporation conducts its business, as well as the District of Columbia and Puerto Rico. To the extent I worked on international matters involving the Corporation&#8217;s business in Asia, Europe, or other international locations where the Corporation may conduct business, the Restricted Area includes those countries and those countries where the Corporation is actively planning to conduct business. I understand and agree that the Corporation&#8217;s business is global in nature and that its clients are located throughout the world&#59; therefore, the Restricted Territory definition is reasonable and necessary to allow the Corporation     to adequately protect its legitimate business interests, and the absence of a more restricted limitation     would not be reasonable under these circumstances. Nevertheless, the restrictions on my work during the Non-Competition Period shall only extend to those locations within the Restricted Area where such work constitutes engaging in Competition.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:9.3pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.8pt">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. During the Non-Solicitation Period, which shall be during my employment by   the Corporation and for 18 months following the termination of my employment with the Corporation for any reason, I will not, unless a duly authorized officer of the Corporation gives me written authorization    to do so&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:14.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.37pt">interfere with the Corporation&#8217;s relationship with its Business Partners by soliciting or communicating (regardless of who initiates the communication) with a Business Partner to&#58; (i) induce or encourage the Business Partner to stop doing business or reduce its business with the Corporation, or      (ii) buy a product or service that competes with a product or service offered by the Corporation&#8217;s  business. &#8220;Business Partner&#8221; means&#58; a customer (person or entity), prospective customer (person or</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:5.95pt;padding-right:6.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">entity), healthcare provider, supplier, manufacturer, agency, broker, hospital, hospital system, long-term  care facility, Insurance client&#47;customer, and&#47;or pharmaceutical manufacturer with whom the Corporation  has a business relationship and with which I had business-related contact or dealings, or about which I received Confidential Information, in the two years prior to the termination of my employment with the Corporation. A Business Partner does not include a customer, supplier, manufacturer, agency, broker, hospital, hospital system, long-term care facility and&#47;or pharmaceutical manufacturer which has fully and finally ceased doing any business with the Corporation independent of any conduct or communications by me or breach of this Agreement and such full cessation of business has been in effect for at least 1 year  prior to my separation from employment with the Corporation. Nothing in this Section 3(a) shall prevent  me from working as a staff pharmacist or in another retail position wherein I would be providing or      selling prescriptions or other products directly to consumers.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:59.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.8pt">work on a Corporation account on behalf of a Business Partner or serve as the representative of a Business Partner for the Corporation.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:14.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.42pt">interfere with the Corporation&#8217;s relationship with any employee or contractor of the Corporation by&#58; (i) soliciting or communicating with the employee or contractor to induce or encourage him or her to leave the Corporation&#8217;s employ or engagement (regardless of who first initiates the communication)&#59; (ii) helping another person or entity evaluate such employee or contractor as an employment or contractor candidate&#59; or (iii) otherwise helping any person or entity hire an employee or contractor away from the Corporation.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:42pt;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.85pt">Non-Disclosure of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:6.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.42pt">Subject to Sections 7 and 8 below, I will not at any time, whether during or after the termination of my employment, disclose to any person or entity any of the Corporation&#8217;s Confidential Information, except as may be appropriately required in the ordinary course of performing my duties as     an employee of the Corporation. The Corporation&#8217;s Confidential Information includes but is not limited      to the following non-public information&#58; trade secrets&#59; computer code generated or developed by the Corporation&#59; software or programs and related documentation&#59; strategic compilations and analysis&#59;    strategic processes&#59; business or financial methods, practices and plans&#59; non-public costs and prices&#59; operating margins&#59; marketing, merchandising and selling techniques and information&#59; customer lists&#59; provider lists&#59; details of customer or provider agreements&#59; pricing arrangements with pharmaceutical manufacturers, distributors or suppliers including but not limited to any discounts and&#47;or rebates&#59; pricing arrangements with insurance clients and customers&#59; pharmacy reimbursement rates&#59; premium     information&#59; payment rates&#59; contractual forms&#59; expansion strategies&#59; real estate strategies&#59; operating strategies&#59; sources of supply&#59; patient records&#59; business plans&#59; other financial, commercial, business or technical information related to the Corporation, and confidential information of third parties which is    given to the Corporation pursuant to an obligation or agreement to keep such information confidential (collectively, &#8220;Confidential Information&#8221;). I shall not use or attempt to use any Confidential Information    on behalf of any person or entity other than the Corporation, or in any manner which may injure or cause loss or may be calculated to injure or cause loss, whether directly or indirectly, to the Corporation. If, at    any time over the last two years of my employment at CVS, my position included access to Confidential Information, as described above, specifically related to the Corporation&#8217;s procurement of prescription   drugs, I understand and agree my employment with a pharmaceutical manufacturer, distributor or supplier (&#8220;Pharmaceutical Entity&#8221;) would place a substantial risk of use and&#47;or disclosure of Confidential Information with which I have been or will be entrusted during my employment with the Corporation. In light of this risk of disclosure, I acknowledge and agree that the Corporation will be entitled to immediate injunctive relief to prevent me from disclosing any such Confidential Information in the course of my employment with any such Pharmaceutical Entity. I agree that the disclosure of such Confidential Information to the Corporation&#8217;s PBM Competitors with which one may negotiate in the course of</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:6pt;padding-right:5.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">employment with such Pharmaceutical Entity, would cause immediate and irreparable harm to the Corporation.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:11.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.75pt">During my employment, I shall not make, use, or permit to be used, any materials of any nature relating to any matter within the scope of the business of the Corporation or concerning any of its dealings or affairs other than for the benefit of the Corporation. I shall not, after the termination of my employment, use or permit to be used any such materials and shall return same in accordance with    Section 5 below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:15.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.37pt">NOTICE OF IMMUNITY FROM LIABILITY FOR CONFIDENTIAL DISCLOSURE  OF A TRADE SECRET TO THE GOVERNMENT OR IN A COURT FILING. Pursuant to the United States Defend Trade Secrets Act of 2016 (the &#34;DTSA&#34;), the Company hereby provides the following notice to Employee&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:7.1pt;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.68pt">IMMUNITY&#58; An individual shall not be held criminally or civilly liable under      any Federal or State trade secret law for the disclosure of a trade secret that (A) is made&#58; (1) in confidence  to a Federal, State, or local government official, either directly or indirectly, or to an attorney&#59; and              (2) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font></div><div><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.08pt">USE OF TRADE SECRET INFORMATION IN ANTI-RETALIATION     LAWSUIT&#58; An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret in       the court proceeding, if the individual&#58; (A) files any document containing the trade secret under seal&#59; and     (B) does not disclose the trade secret, except pursuant to court order.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:10.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.8pt">Ownership and Return of the Corporation&#8217;s Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. On or before my final date of  employment with the Corporation, I shall return to the Corporation all property of the Corporation in my possession, custody or control, including but not limited to the originals and copies of any information provided to or acquired by me in connection with the performance of my duties for the Corporation, such  as files, correspondence, communications, memoranda, e-mails, slides, records, and all other documents,  no matter how produced or reproduced, all computer equipment, communication devices (including but  not limited to any mobile phone or other portable digital assistant or device), computer programs and&#47;or files, and all office keys and access cards. I agree that all the items described in this Section are the sole property of the Corporation.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.85pt">Rights to Inventions, Works</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:7.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.42pt">Assignment of Inventions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether patentable or otherwise protectable under similar law, made, conceived or developed by me, whether alone or jointly  with others, from the date of my initial employment by the Corporation and continuing until the end of    any period during which I am employed by the Corporation, relating or pertaining in any way to my employment with or the business of the Corporation (collectively referred to as &#8220;Inventions&#8221;) shall be promptly disclosed in writing to the Corporation. I hereby assign to the Corporation, or its designee, all       of my rights, title and interest to such Inventions. All original works of authorship which are made by me (solely or jointly with others) within the scope of and during the period of my employment with the Corporation and which are protectable by copyright are &#8220;works made for hire,&#8221; as that term is defined in   the United States Copyright Act and as such are the sole property of the Corporation. The decision    whether to commercialize or market any Invention developed by me solely or jointly with others is within</font></div><div><font><br></font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:6pt;padding-right:10.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Corporation&#8217;s sole discretion and for the Corporation&#8217;s sole benefit and no royalty will be due to me    as a result of the Corporation&#8217;s efforts to commercialize or market any such Invention.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:12.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.75pt">Inventions Retained and Licensed. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I have attached hereto as Exhibit A, a list     specifically describing all inventions, original works of authorship, developments, improvements, and  trade secrets that were made by me prior to my employment with the Corporation (&#8220;Prior Inventions&#8221;), which belong to me and are not assigned to the Corporation hereunder. If no such list is attached, I represent that there are no such Prior Inventions. I will not incorporate, or permit to be incorporated, any Prior Invention owned by me or in which I have an interest into a Corporation product, process or    machine without the Corporation&#8217;s prior written consent. Notwithstanding the foregoing sentence, if, in   the course of my employment with the Corporation, I incorporate into a Corporation product, process or machine a Prior Invention owned by me or in which I have an interest, the Corporation is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have    made, modify, use and sell such Prior Invention as part of or in connection with such product, process or machine.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:9.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.42pt">Patent and Copyright Registrations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I will assist the Corporation, or its designee, at        the Corporation&#8217;s expense, in every proper way to secure the Corporation&#8217;s rights in the Inventions and    any copyrights, patents, mask work rights or other intellectual property rights relating thereto, including, but not limited to, the disclosure to the Corporation of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments    which the Corporation shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Corporation, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. My obligation to execute or cause to be executed, when it is     in my power to do so, any such instrument or papers shall continue after my employment ends for any reason and&#47;or after the termination of this Agreement. If the Corporation is unable because of my mental    or physical incapacity or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Corporation as above, then I hereby irrevocably designate    and appoint the Corporation and its duly authorized officers and agents as my agent and attorney in fact,     to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully   permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by me.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:15.5pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.8pt">Exception to Assignments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. I understand that if I am an employee in Illinois, Kansas, North Carolina, Utah or Minnesota, I should refer to Exhibit B (incorporated herein for all purposes) for important limitations on the scope of the provisions of this Agreement concerning assignment of Inventions. I will advise the Corporation promptly in writing of any inventions that I believe meet the criteria in Exhibit B and that are not otherwise disclosed on Exhibit A.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.8pt">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:7.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.37pt">In the event I receive a subpoena, deposition notice, interview request, or other process        or order to testify or produce Confidential Information or any other information or property of the Corporation, I shall promptly&#58; (i) notify the Corporation of the item, document, or information sought by such subpoena, deposition notice, interview request, or other process or order&#59; (ii) furnish the Corporation with a copy of said subpoena, deposition notice, interview request, or other process or order&#59; and             (iii) provide reasonable cooperation with respect to any procedure that the Corporation may initiate to protect Confidential Information or other interests. If the Corporation objects to the subpoena, deposition notice, interview request, process, or order, I shall cooperate to ensure that there shall be no disclosure</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:6pt;padding-right:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">until the court or other applicable entity has ruled upon the objection, and then only in accordance with    the ruling so made. If no such objection is made despite a reasonable opportunity to do so, I shall be    entitled to comply with the subpoena, deposition, notice, interview request, or other process or order, provided that I have fulfilled the above obligations.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:10.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.75pt">I will cooperate fully with the Corporation, its affiliates, and their legal counsel in connection with any action, proceeding, or dispute arising out of matters with which I was directly or indirectly involved while serving as an employee of the Corporation, its predecessors, subsidiaries or affiliates. This cooperation shall include, but shall not be limited to, meeting with, and providing information to, the Corporation and its legal counsel, maintaining the confidentiality of any past or future privileged communications with the Corporation&#8217;s legal counsel (outside and in-house), and making   myself available to testify truthfully by affidavit, in depositions, or in any other forum on behalf of the Corporation. The Corporation agrees to reimburse me for any reasonable and necessary out-of-pocket    costs associated with my cooperation.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.37pt">Notice of New Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a representative of the Corporation, during or following    my employment, requests that I identify the company or business to which I will be or am providing services, or with which I will be or am employed, and requests that I provide information about the    services that I am or will be providing to such entity, I shall provide the Corporation with a written   statement that identifies the entity and describes the nature of the services that I am or will be providing to such entity with sufficient detail to allow the Corporation to independently assess whether I am or will be    in violation of this Agreement. Such statement shall be delivered to the Corporation&#8217;s Chief People     Officer or his or her authorized delegate via personal delivery or overnight delivery within five calendar days of my receipt of such request.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.8pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.8pt">Limitation on Restrictions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nothing in this Agreement is intended to or shall interfere with my   right to file charges or participate in a proceeding with any appropriate federal, state or local government agency, including the Occupational Safety and Health Administration (&#8220;OSHA&#8221;), National Labor    Relations Board (&#8220;NLRB&#8221;) or the Securities and Exchange Commission (&#8220;SEC&#8221;)&#59; to exercise rights under Section 7 of the National Labor Relations Act (&#8220;NLRA&#8221;)&#59; or to file a charge or complaint with or    participate or cooperate in an investigation or proceeding with the US Equal Employment Opportunity Commission (&#8220;EEOC&#8221;) or comparable state or local agencies. Such agencies have authority to carry out   their statutory duties by investigating a charge, issuing a determination, filing a lawsuit, or taking any    other action authorized by law. I retain the right to participate in any such action and retain the right to communicate with the NLRB, SEC, EEOC, OSHA and comparable state or local agencies and such communication shall not be limited by any provision in this Agreement. Nothing in this Agreement limits my right to receive an award for information provided to a government agency such as the SEC and    OSHA. In addition, nothing in this Agreement is intended to interfere with or restrain the immunity   provided under 18 U.S.C. &#167; 1833(b) for confidential disclosures of trade secrets to government officials or lawyers, solely for the purpose of reporting or investigating a suspected violation of law, or in a sealed   filing in court or other proceeding.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:9.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:21.75pt">Eligibility for Severance Pay. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If my employment with the Corporation terminates under circumstances in which I am eligible for severance under the applicable severance plan (the &#8220;Severance Plan&#8221;), the Corporation will offer me severance in accordance with the Severance Plan. I acknowledge    that I must meet certain requirements in order to receive severance, including but not limited to execution  of a separation agreement and release of claims in a form acceptable to CVS Health Corporation and any other requirements set forth in the Severance Plan. In the event that the Corporation fails to comply with   its obligations to offer me severance according to the Severance Plan, then Section 2 of this Agreement shall be of no further effect. I agree that if I decline the Corporation&#8217;s offer of severance, I shall continue    to be subject to the restrictions in Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 6</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:6pt;padding-right:9.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.25pt">Injunctive Relief and Other Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any breach of this Agreement by me will cause   irreparable damage to the Corporation and, in the event of such breach, the Corporation shall have, in addition to any and all remedies of law, the right to an injunction, specific performance or other equitable relief to prevent the violation of my obligations hereunder, and without providing a bond to the extent permitted by the applicable rules of civil procedure. Nothing contained in this Agreement shall be   construed to prohibit the Corporation from pursuing any other remedy available to the Corporation at law   or in equity, the parties having agreed that all remedies are cumulative.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:29.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.25pt">No Right of Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement does not create an obligation on the Corporation or any other person or entity to continue my employment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:10.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.25pt">No Conflicting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. I represent that the performance of my job duties with the   Corporation and my compliance with all of the terms of this Agreement does not and will not breach or conflict with any other agreement, covenant, obligation or restriction to which I am bound including but   not limited to any agreement to keep in confidence proprietary information acquired by me in confidence  or in trust prior to my employment by the Corporation.</font></div><div style="margin-top:0.45pt;text-indent:36pt"><font><br></font></div><div style="padding-left:6pt;padding-right:6.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.25pt">Entire Agreement&#47;No Reliance&#47;No Modifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and any compensation,    benefit or equity plan or agreement referred to herein or under which equity was granted, to the extent    those other agreements apply to me, set forth the entire agreement between the parties hereto and fully supersede any and all prior and&#47;or supplemental understandings, whether written or oral, between the   parties concerning the subject matter of this Agreement. This agreement shall not have any effect on any prior existing agreements between Corporation and me regarding the arbitration of workplace legal    disputes and any such agreements remain in full force and effect. I agree and acknowledge that I have not relied on any representations, promises or agreements of any kind in connection with my decision to     accept the terms of this Agreement, except for the representations, promises and agreements herein. Any modification to this Agreement must be made in writing and signed by me and the Corporation&#8217;s Chief People Officer or his or her authorized representative.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.25pt">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any waiver by the Corporation of a breach of any provision of this Agreement, or of   any other similar agreement with any other current or former employee of the Corporation, shall not    operate or be construed as a waiver of any subsequent breach of such provision or any other provision hereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:16pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The parties hereby agree that each provision herein shall be treated as a separate     and independent clause, and the unenforceability of any one clause shall in no way impair the enforceability of any of the other clauses herein. Moreover, if one or more of the provisions of this Agreement are for any reason held to be excessively broad as to scope, activity, duration, subject or otherwise so as to be unenforceable at law, the parties consent to such provision or provisions being modified in any way necessary or limited by the appropriate judicial body (where allowed by applicable law), so as to be enforceable to the maximum extent compatible with the applicable law.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:20.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Survival of Employee&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. My obligations under this Agreement shall survive the termination of my employment regardless of the manner of such termination and shall be binding upon my heirs, personal representatives, executors, administrators and legal representatives.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:8.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Corporation&#8217;s Right to Assign Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Corporation has the right to assign this    Agreement to its successors and assigns without the need for further agreement or consent by me, and all covenants and agreements hereunder shall inure to the benefit of and be enforceable by said successors or assigns.</font></div><div><font><br></font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 7</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:6pt;padding-right:8.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.25pt">Non-Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. I shall not assign my rights and obligations under this Agreement, in whole or     in part, whether by operation of law or otherwise, without the prior written consent of the Corporation,    and any such assignment contrary to the terms hereof shall be null and void and of no force or effect.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement shall be governed by and construed in accordance with the      laws of the state of Rhode Island excluding its choice of law rules or principles that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:6.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Personal Jurisdiction and Venue. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I agree that any State or Federal court located within the State    of Rhode Island shall have personal jurisdiction over me with regard to any claim or dispute arising out of    or related to this Agreement or the subject matter of this Agreement. I agree that unless otherwise   prohibited by applicable law, any claim or dispute arising out of or related to this Agreement or the     subject matter of this Agreement shall be exclusively brought and resolved in a State or Federal court located within the state of Rhode Island.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:9.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Consultation with Legal Counsel&#59; Time to Consider Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I acknowledge that CVS   advises me to consult with an attorney before signing this Agreement. I also acknowledge that CVS has given me fourteen (14) days from the date I received this Agreement to consider whether to sign this Agreement. I further acknowledge that if I choose to do so voluntarily, I may sign this Agreement before the expiration of the 14-day consideration period.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:24.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Headings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:12.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any party to this Agreement breaches any terms of this Agreement, then that party shall pay to the non-breaching party all of the non-breaching party&#8217;s costs and expenses, including attorneys&#8217; fees, incurred by that party in enforcing the terms of this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:6.4pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.3pt">Tolling. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event I violate one of the time-limited restrictions in Sections 2 and&#47;or 3 of this Agreement, I agree that the time period for such violated restriction shall be extended by one day for each day I have violated the restriction, up to a maximum extension equal to the length of the original period of the restricted covenant.</font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:10.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this Agreement as a sealed instrument as of the date set forth below.</font></div><div><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font><br></font></div><div style="padding-left:8.3pt;padding-right:8.3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.438%"><tr><td style="width:1.0%"></td><td style="width:5.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Tilak Mandadi</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Laurie P. Havanec</font></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Laurie Havanec</font></td></tr><tr><td colspan="6" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXXXXXX</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Chief People Officer</font></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee ID</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;CVS Pharmacy, Inc.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">06&#47;20&#47;2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-right:92.75pt"><font><br></font></div><div style="padding-right:92.75pt"><font><br></font></div><div style="padding-right:92.75pt"><font><br></font></div><div style="padding-right:92.75pt"><font><br></font></div><div style="padding-right:92.75pt"><font><br></font></div><div style="padding-right:92.75pt"><font><br></font></div><div><font><br></font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 8</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:145.95pt;padding-right:145.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">List of Prior Inventions &#8211; See Section 6</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:3.9pt;padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font><br></font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 9</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72.92pt;padding-right:72.92pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT B</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:145.97pt;padding-right:145.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Notice Regarding Invention Assignment</font></div><div><font><br></font></div><div style="padding-left:33pt;text-indent:-27.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.8pt">For an employee residing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Illinois, Kansas, or North Carolina</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, you are hereby advised&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:32.95pt;padding-right:5.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No provision in this Agreement requires you to assign any of your rights to an invention for which no equipment, supplies, facility, or trade secret information of the Corporation was used and which was developed entirely on your own time, unless (a) the invention relates (i) to the business of the Corporation or (ii) to the Corporation&#8217;s actual or demonstrably anticipated research or development, or (b) the invention results from any work performed by you for the Corporation.  Illinois 765ILCS1060&#47;1-3, &#8220;Employees Patent Act&#8221;&#59; Kansas Statutes Section 44-130&#59; North Carolina General Statutes Article 10A, Chapter 66, Commerce and Business, Section 66-57.1.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:33pt;text-indent:-24.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.05pt">For an employee residing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Utah</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, you are hereby advised&#58;</font></div><div><font><br></font></div><div style="padding-left:32.95pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No provision in this Agreement requires you to assign any of your rights to an invention which was created entirely on your own time, and which is not (a) conceived, developed, reduced to practice, or created by you (i) within the scope of your employment with the Corporation, (ii) on the Corporation&#8217;s time, or (iii) with the aid, assistance, or use of any of the Corporation&#8217;s property, equipment, facilities, supplies, resources, or patents, trade secrets, know-how, technology,  confidential information, ideas, copy rights, trademarks and service marks and any and all rights, applications and registrations relating to them, (b) the results of any work, services, or duties performed by you for the Corporation, (c) related to the industry or trade of the Corporation, or (d) related to the current or demonstrably anticipated business, research, or development of the Corporation. Utah Code Sections 34-39-1 through 34-39-3, &#8220;Employee Inventions Act.&#8221;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:33.35pt;text-indent:-27.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.2pt">For an employee residing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Minnesota</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, you are hereby advised&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:33.35pt;padding-right:5.6pt;text-align:justify;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Notice.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No provision in this Agreement requires you to assign any of your rights to an invention for which no equipment, supplies, facility, or trade secret information of the Corporation was used, and which was developed entirely on your own time, and (a) which does not relate (i) directly to the business of the Corporation, or (ii) to the Corporation&#8217;s actual or demonstrably anticipated research   or development, or (b) which does not result from any work performed by you for the Corporation. Minnesota Statutes 13A Section 181.78.</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 10</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022 </font></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a03312023ex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic107c15ed5fa44d1aa54744da092b3e2_1"></div><div style="min-height:90.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14.5pt;font-weight:400;line-height:100%">  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">_______________________________________________________________________________________</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:7.25pt;padding-left:82.62pt;padding-right:82.62pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:82.8pt;padding-right:82.8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:400;line-height:120%">Change in Control Agreement for</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:3pt;padding-left:82.75pt;padding-right:82.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Tilak Mandadi</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">_______________________________________________________________________________________</font></div><div style="margin-top:0.15pt;text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="height:35.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:31.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CONFIDENTIAL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revised 2020</font></td></tr></table></div></div></div><div id="ic107c15ed5fa44d1aa54744da092b3e2_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:185.95pt;padding-right:185.95pt;text-align:center;text-indent:-0.36pt"><font><br></font></div><div style="padding-left:6.34pt;padding-right:6.34pt;text-align:center;text-indent:-0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:486.00pt"><tr><td style="width:1.0pt"></td><td style="width:23.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:412.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitions.................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term of Agreement.....................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Entitlement to Severance Benefit...............................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidentiality&#59; Cooperation with Regard to Litigation&#59; Non-disparagement..............................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-solicitation...........................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remedies...................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Agreement on Other Benefits.......................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not an Employment Agreement.................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resolution of Disputes...............................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assignability&#59; Binding Nature.....................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Representation...........................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment or Waiver&#59; Section 409A........................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severability.................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Survivorship...............................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beneficiaries&#47;References...........................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governing Law&#47;Jurisdiction........................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices.......................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Headings....................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Counterparts..............................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></td></tr></table></div><div style="height:35.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ic107c15ed5fa44d1aa54744da092b3e2_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:7pt;padding-right:18.5pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Change in Control Agreement (&#34;Agreement&#34;) is made and entered into as of August 11,  2022, between CVS Pharmacy, Inc., a wholly owned subsidiary of CVS Health Corporation and Tilak Mandadi (the &#34;Executive&#34;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:7pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Board of Directors (the &#34;Board&#34;) of CVS Health Corporation (&#34;CVS&#34; or the &#8220;Company&#8221;) believes it is necessary and desirable for the Company to be able to rely upon Executive to continue serving in Executive&#8217;s position with the Company in the event of a pending or actual change in  control of CVS&#59;</font></div><div><font><br></font></div><div style="padding-left:7pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Executive is employed by CVS Pharmacy, Inc., a Subsidiary of CVS, and this Agreement shall not alter Executive's status as an employee at will&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:7pt;padding-right:18.5pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the promises and mutual covenants contained   herein and for other good and valuable consideration, the receipt of which is mutually acknowledged,   CVS and the Executive (individually a &#34;Party&#34; and together the &#34;Parties&#8221;) agree as follows&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:28pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Base Salary&#34; shall mean Executive's annual rate of base salary at the time of Executive&#8217;s termination of employment or, if greater, as in effect immediately prior to a Change in Control.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt">&#34;Cause&#34; shall exist if&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;text-indent:-41.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.11pt">Executive willfully and materially breaches Sections 4 or 5 of this Agreement&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;text-indent:-43.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.04pt">Executive is convicted of a felony involving moral turpitude&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:13.8pt;text-indent:-45.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.07pt">Executive engages in conduct that constitutes willful gross neglect or willful gross misconduct in carrying out Executive&#8217;s duties under this Agreement, resulting, in either case, in material harm to the financial condition or reputation of the Company.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:12.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Agreement, an act or failure to act on Executive's part shall   be considered &#34;willful&#34; if it was done or omitted to be done by Executive not in   good faith, and shall not include any act or failure to act resulting from any incapacity of Executive. A termination for Cause shall not take effect absent compliance with the provisions of this paragraph. Executive shall be given written notice by the Company of its intention to terminate Executive&#8217;s employment for Cause, such notice (A) to state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Cause is based and (B) to be given within 90 days of the Company's learning of such act or acts or failure or failures to act. Executive shall have 20 days after the date that such written notice has been given to Executive in which to cure such conduct, to extent such cure is possible. If Executive fails to cure such conduct, Executive shall then be entitled to a hearing before the Committee, or an officer    or officers designated by the Committee, at which Executive is entitled to appear. Such hearing shall be held within 25 days of such notice to Executive, provided Executive requests such hearing within 10 days of the written notice from the Company of the intention to terminate Executive for Cause. If, within five days following such hearing, Executive is furnished written notice by the Committee confirming that, in its judgment, grounds for Cause on the basis of the original notice exist, Executive shall thereupon be terminated for Cause. Executive's right  to cure in accordance with this provision applies only in the event of a Change in</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:115pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Control as defined in Section 1(c) below and does not alter Executive's &#34;at will&#34; employment status.</font></div><div><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.28pt">A &#8220;Change in Control&#8221; shall be deemed to have occurred if&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:15.15pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.17pt">any Person (other than (a) the Company, (b) any trustee or other    fiduciary holding securities under any employee benefit plan of the Company, (c) any company owned, directly or indirectly, by the stockholders of the Company immediately after the occurrence with respect to which the evaluation is being made in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such occurrence or (d) any surviving or resulting  entity from a merger or consolidation referred to in clause (iii) below that does not constitute a Change of Control under clause (iii) below)   becomes the Beneficial Owner (except that a Person shall be deemed to be the Beneficial Owner of all shares that any such Person has the right   to acquire pursuant to any agreement or arrangement or upon exercise    of conversion rights, warrants or options or otherwise, without regard to  the sixty day period referred to in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company or of any subsidiary owning directly or indirectly all or substantially all of the consolidated assets of the Company (a &#34;Significant Subsidiary&#34;), representing 30% or more of the combined voting power of the Company's or such Significant Subsidiary's then outstanding securities&#59;</font></div><div><font><br></font></div><div style="padding-left:151.05pt;padding-right:18.35pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.95pt">during any period of twelve (12) consecutive months, individuals who at the beginning of such period constitute the Board, and any new director whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the twelve (12) month period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:18.35pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">the consummation of a merger or consolidation of the Company or any Significant Subsidiary with any other entity, other than a merger or consolidation which would result in the voting securities of the Company or a Significant Subsidiary outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving or resulting entity) more than 50% of the combined voting power of the surviving or resulting entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:18.35pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.17pt">the consummation of a transaction (or series of transactions within a 12 month period) which constitutes the sale or disposition of all or substantially all of the consolidated assets of the Company but in no  event assets having a gross fair market value of less than 40% of the  total gross fair market value of all of the consolidated assets of the Company (other than such a sale or disposition immediately after which such assets will be owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such sale or disposition).</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this definition&#58;</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:187.05pt;padding-right:18.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">The term &#34;Beneficial Owner&#34; shall have the meaning ascribed to such term in Rule 13d-3 under the Exchange Act (including any successor to such Rule).</font></div><div><font><br></font></div><div style="padding-left:187.05pt;padding-right:18.55pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">The term &#34;Exchange Act&#34; means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:187.05pt;padding-right:15.15pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">The term &#34;Person&#34; shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including &#34;group&#34; as defined in Section 13(d) thereof.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:79pt;padding-right:21.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Committee&#34; shall mean the Management Planning and Development Committee of the Board, or the corresponding committee of the board of directors of a successor to CVS.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt">&#34;Company&#34; shall mean, collectively, CVS and any Subsidiary or affiliate of CVS.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.51pt">&#34;Confidential Information&#34; shall have the meaning set forth in Section 4 below.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;padding-right:28.8pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Constructive Termination Without Cause&#34; shall mean a termination of the Executive's employment at Executive&#8217;s initiative following the occurrence, without the Executive's written consent, of one or more of the following events (except as a result of a prior termination)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:38.95pt;text-indent:-41.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.06pt">an assignment of any duties to Executive that is materially inconsistent with Executive&#8217;s status as a member of the senior management of CVS&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;padding-right:18.95pt;text-indent:-43.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.99pt">a material decrease in Executive's annual base salary or target annual incentive award opportunity&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:16.2pt;text-indent:-45.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.07pt">any failure to secure the agreement of any successor to CVS to fully assume the Company&#8217;s material obligations under this Agreement&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:115pt;padding-right:33.45pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">a relocation of Executive's principal place of employment more than 35 miles from Executive&#8217;s place of employment before such relocation.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;padding-right:13.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In all cases, no Constructive Termination Without Cause shall be deemed to have   occurred unless (a) the Executive provides written notice to the Company that an event described in subsections i. through iv. has occurred, and such notice identifies such     event and is provided within 30 days of the initial occurrence of such event, (b) a cure period of 45 days following the Company&#8217;s receipt of such notice expires and the   Company has not cured such event within such cure period and (c) the Executive actually terminates his&#47;her employment within 30 days of the expiration of the cure period.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:35.8pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Disability&#34; shall mean disability as that term is defined in the Company's Long-Term Disability Plan.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.06pt">&#34;Effective Date&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.06pt">&#34;Original Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.28pt">&#34;Renewal Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:79pt;padding-right:40.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">&#34;Severance Period&#34; shall mean the period of 18 months following the termination of Executive's employment with the Company.</font></div><div><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.95pt">&#34;Subsidiary&#34; shall have the meaning set forth in Section 4 below.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt">&#34;Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;padding-right:27.5pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#8220;termination of employment&#8221;, &#8220;employment is terminated&#8221; and other similar words shall mean with respect to Executive</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:12.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.12pt">for any plan or arrangement that is subject to the rules of Section 409A of the  Internal Revenue Code (the &#8220;Code&#8221;) a &#8220;Separation from Service&#8221; as such term is defined    in the Income Tax Regulations under Section 409A (the &#8220;409A Regulations&#8221;) of the Code   as modified by the rules described below&#58;</font></div><div><font><br></font></div><div style="padding-left:151.05pt;padding-right:9.15pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">except in the case where Executive is on a bona fide leave of absence pursuant to the Company&#8217;s policies as provided below, Executive is  deemed to have incurred a Separation from Service on a date if the company and Executive reasonably anticipate that the level of services to be performed by Executive after such date would be permanently reduced to 20% or less of the average services rendered by Executive during the immediately preceding 36-month period (or the total period of employment, if less than 36 months), disregarding periods during which Executive was  on a bona fide leave of absence&#59;</font></div><div><font><br></font></div><div style="padding-left:151.05pt;padding-right:11.9pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">if Executive is absent from work due to military leave, sick leave, or other bona fide leave of absence pursuant to the Company&#8217;s policies, Executive shall incur a Separation from Service on the first date that the rules of (A), above, are satisfied following the later of (i) the six-month anniversary of the commencement of the leave or (ii) the expiration of Executive&#8217;s right,    if any, to reemployment under statute, contract or Company policy&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:11.9pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.17pt">Executive shall be considered to continue employment and to not have a Separation from Service while on a bona fide leave of absence pursuant   to the Company&#8217;s policies if the leave does not exceed 6 consecutive months (12) months for a disability leave of absence) or, if longer, so long as the Executive retains a right to reemployment with the Company or an Affiliate under an applicable statute, contract or Company policy. For this purpose, a &#8220;disability leave of absence&#8221; is an absence due to any medically determinable physical or mental impairment of Executive that can be expected to result in death or can be expected to last for a continuous period of not less than 6 months, where such impairment causes   Executive to be unable to perform the duties of Executive&#8217;s job or a substantially similar job&#59;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:151.05pt;padding-right:12.15pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.17pt">for purposes of determining whether another organization is an Affiliate of the Company, common ownership of at least 50% shall be determinative&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:151.05pt;padding-right:13.2pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">the Company specifically reserves the right to determine whether a sale   or other disposition of substantial assets to an unrelated party constitutes  a Separation from Service with respect to Executive providing services to the seller immediately prior to the transaction and providing services to   the buyer after the transaction. Such determination shall be made in accordance with the requirements of Section 409A of the Code&#59; or</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:115pt;padding-right:14.6pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">for any plan or arrangement that is not subject to the rules of Section 409A of the Code, the complete cessation of providing service to the Company or any     Affiliate as an employee.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Term of Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of this Agreement shall commence on the date of this Agreement (the &#34;Effective Date&#34;) and end on the third anniversary of such date (the &#34;Original Term&#34;). The Original Term shall be automatically renewed for successive one-year terms (the &#34;Renewal Terms&#34;) unless at least 180 days prior to the expiration of the Original Term or any Renewal Term, either Party notifies the  other Party in writing that he&#47;she or it is electing to terminate this Agreement at the expiration of   the then current Term. &#34;Term&#34; shall mean the Original Term and all Renewal Terms. If a Change     in Control shall have occurred during the Term, notwithstanding any other provision of this     Section 2, the Term shall not expire earlier than two years after such Change in Control.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Entitlement to Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:18.85pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event Executive's employment with the Company is   Terminated Without Cause, other than due to death, or Disability, or in the event there is   a Constructive Termination Without Cause, in each case within two years following a Change in Control, Executive shall be entitled to receive&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:26.65pt;text-indent:-41.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.06pt">Base Salary through the date of termination of Executive's employment, which shall be paid in a cash lump sum not later than 15 days following Executive's termination of employment&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:12.35pt;text-indent:-43.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.99pt">An amount equal to 1.5 times Executive's Base Salary in effect on the date of termination of Executive's employment (or in the event a reduction in Base Salary  is a basis for a Constructive Termination Without Cause, then the Base Salary in effect immediately prior to such reduction), payable in a cash lump sum following Executive's termination of employment&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:14.35pt;text-indent:-45.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.07pt">An amount equal to the most recently established target annual cash incentive bonus amount, prorated based on the portion of the performance year that Executive has worked as of the date of Executive&#8217;s termination. Such payment of  a pro rata annual cash incentive bonus will be payable in a cash lump sum following Executive's termination of employment&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:115pt;padding-right:48.5pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">An amount equal to 1.5 times the most recently established target annual incentive cash bonus amount, payable in a cash lump sum following the Executive's termination of employment&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:18.2pt;text-indent:-43.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.03pt">Elimination of all restrictions on any restricted stock or restricted stock unit  awards outstanding at the time of termination of employment (other than awards under the Company's Partnership Equity Program, which shall be governed by  the terms of such awards)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:17.6pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">Immediate vesting of all outstanding stock options and the right to exercise such stock options for the remainder of the full term of such option (other than awards under the Company's Partnership Equity Program, which shall be governed by  the terms of such awards)&#59;</font></div><div><font><br></font></div><div style="padding-left:115pt;padding-right:15.9pt;text-indent:-48.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.04pt">The balance of any incentive awards earned as of December 31 of the prior year but not yet paid, which shall be paid in a single lump sum not later than 15 days following Executive's termination of employment&#59;</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:115pt;padding-right:26.5pt;text-indent:-50.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">viii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.97pt">Settlement of all deferred compensation arrangements in accordance with any then applicable deferred compensation plan or election form&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:13.7pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ix.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">Continued participation in all medical, health and life insurance plans at the same benefit level at which Executive was participating on the date of termination of Executive&#8217;s employment until the earlier of&#58;</font></div><div><font><br></font></div><div style="padding-left:169.05pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">the end of the Severance Period&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:169.05pt;padding-right:28.85pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">the date, or dates, Executive receives equivalent coverage and benefits under the plans and programs of a subsequent employer (such coverage and benefits to be determined on a coverage-by- coverage, or benefit-by-benefit, basis)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:115pt;padding-right:18.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that (1) if Executive is precluded from continuing Executive&#8217;s participation in any employee benefit plan or program as provided in this clause (ix) of this Section 3.a, Executive shall receive cash payments equal on an after- tax basis to the cost to Executive of obtaining the benefits provided under the    plan or program in which Executive is unable to participate for the period    specified in this clause (ix) of this Section 3.a, (2) such cost shall be deemed to    be the lowest reasonable cost that would be incurred by Executive in obtaining such benefit on an individual basis, and (3) payment of such amounts shall be made quarterly in advance&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:115pt;padding-right:33.75pt;text-indent:-43.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.03pt">other or additional benefits then due or earned in accordance with applicable plans and programs of the Company.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:79pt;padding-right:24.7pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Change in Control Best Payments Determination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event the Severance Benefits described in Section 3(a) are payable to Executive in connection with a Change in Control and, if paid, could subject Executive to an excise tax under Section 4999 of the Internal Revenue Code (the &#8220;Excise Tax&#8221;), then notwithstanding the provisions of Section 3(a) the Company shall reduce the Severance Benefits (the &#8220;Benefit Reduction&#8221;) under Section 3(a) by the amount necessary to result in the Executive not being subject to the Excise Tax, if such reduction would result in the Executive&#8217;s &#8220;Net After-Tax Amount&#8221; attributable to the Severance Benefits described in Section 3(a) being greater than it   would be if no Benefit Reduction was effected. For this purpose &#8220;Net After-Tax Amount&#8221; shall mean the net amount of Severance Benefits Executive is entitled to receive under  this Agreement after giving effect to all Federal, state and local taxes which would be applicable to such payments, including, but not limited to, the Excise Tax. The determination of whether any such Benefit Reduction shall be effected shall be made by    a nationally recognized public accounting firm selected by the Company (the &#8220;Accounting Firm&#8221;) prior to the occurrence of the Change in Control and such determination shall be binding on both Executive and the Company. In the event it is determined that a Benefit Reduction is required, such reduction of items described in Section 3(a) above shall be done first by reducing cash severance determined in accordance with Section 3(a)(ii), 3(a)(iii) and 3(a)(iv)&#59; to the extent a further Benefit Reduction is necessary, then   Severance Benefits will be reduced from the amounts determined in accordance with Section 3(a)(v) and 3(a)(vi), all as determined by the Accounting Firm.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:79pt;padding-right:30.8pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt;text-decoration:underline">No Mitigation&#59; No Offset</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of any termination of employment under this Section 3, Executive shall be under no obligation to seek other employment, and the amounts due Executive under this Agreement shall not be offset by any remuneration attributable to any subsequent employment that Executive may obtain.</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:79pt;padding-right:30.8pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Nature of Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any amounts due under this Section 3 are in the nature of severance payments considered to be reasonable by the Company and are not in the nature of a penalty.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;padding-right:12.6pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Exclusivity of Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon termination of Executive's employment during the Term, Executive shall not be entitled to any severance payments or severance benefits  from the Company, or any other payments by the Company, other than the Severance Benefit provided in this Section 3, except as required by law.</font></div><div><font><br></font></div><div style="padding-left:79pt;padding-right:16.5pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.46pt;text-decoration:underline">General Release of Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Executive agrees, as a condition of payment of the   Severance Benefit provided for in this Section 3, that Executive will execute within 60   days of Executive&#8217;s termination of employment a separation agreement, in a form reasonably satisfactory to the Company, that includes a general release of any and all claims arising out of Executive's employment or termination of employment with the Company, other than claims for (i) enforcement of this Agreement, (ii) enforcement of Executive's rights under any of the Company's incentive compensation, equity and&#47;or employee benefit plans and programs to which Executive is entitled under this   Agreement, and (iii) any tort for personal injury not arising out of or related to Executive&#8217;s employment or termination of employment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:14.7pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Subject to the provisions of Section 12(b), all payments to be made pursuant to this  Section 3 upon the termination of employment of Executive shall be made or commence, as the case may be, within 75 days after the Executive&#8217;s termination of employment provided, however, that if such termination of employment is after October 15 of a year,   the payout or first payment, as the case may be, shall be made at the end of such 75 day period.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Confidentiality&#59; Cooperation with Regard to Litigation&#59; Non-disparagement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:15.25pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">During the Term and thereafter, Executive shall not, without the prior written consent of   the Company, disclose to anyone (except in good faith in the ordinary course of business  to a person who will be advised by Executive to keep such information confidential) or make use of any confidential information except in the performance of Executive&#8217;s duties hereunder or when required to do so by legal process, by any governmental agency  having supervisory authority over the business of the Company or by any administrative   or legislative body (including a committee thereof) that requires Executive to divulge, disclose or make accessible such information. In the event that Executive is so ordered, Executive shall give prompt written notice to the Company in order to allow the Company the opportunity to object to or otherwise resist such order.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:12.25pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">During the Term and thereafter, Executive shall not disclose the existence or contents of  this Agreement beyond what is disclosed in the proxy statement or documents filed with   the government unless and to the extent such disclosure is required by law, by a governmental agency, or in a document required by law to be filed with a governmental agency or in connection with enforcement of Executive&#8217;s rights under this Agreement. In  the event that disclosure is so required, Executive shall give prompt written notice to the Company in order to allow the Company the opportunity to object to or otherwise resist such requirement. This restriction shall not apply to such disclosure by Executive to members of Executive&#8217;s immediate family, Executive&#8217;s tax, legal or financial advisors, any lender, or tax authorities, or to potential future employers to the extent necessary, each of whom shall be advised not to disclose such information.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;padding-right:18.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">Confidential Information&#34; shall mean all information concerning the business of the Company or any Subsidiary relating to any of their products, product development, trade secrets, customers, suppliers, finances, and business plans and strategies. Excluded  from the definition of Confidential Information is information (i) that is or becomes part of</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:79pt;padding-right:12.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the public domain, other than through the breach of this Agreement by Executive or (ii) regarding the Company's business or industry properly acquired by Executive in the   course of Executive&#8217;s career as an Executive in the Company's industry and independent  of Executive's employment by the Company. For this purpose, information known or available generally within the trade or industry of the Company or any Subsidiary shall be deemed to be known or available to the public.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;padding-right:34.9pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Subsidiary&#34; shall mean any corporation or other business entity owned or controlled directly or indirectly by CVS.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:79pt;padding-right:15.45pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Executive agrees to cooperate with the Company, during the Term and thereafter  (including following Executive's termination of employment for any reason), by being reasonably available to testify on behalf of the Company or any Subsidiary in any action, suit, or proceeding, whether civil, criminal, administrative, or investigative, and to assist   the Company, or any Subsidiary, in any such action, suit, or proceeding, by providing information and meeting and consulting with the Board or its representatives or counsel,   or representatives or counsel to the Company, or any Subsidiary as requested&#59; provided, however that the same does not materially interfere with Executive&#8217;s then current professional activities. The Company agrees to reimburse Executive on an after tax    basis, for all reasonable expenses actually incurred in connection with Executive&#8217;s provision of testimony or assistance.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;padding-right:18.2pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.46pt">Executive agrees that, during the Term and thereafter (including following Executive's termination of employment for any reason) Executive will not make statements or representations, or otherwise communicate, directly or indirectly, in writing, orally, or otherwise, or take any action which may, directly or indirectly, disparage or be damaging  to the Company or any Subsidiary or their respective officers, directors, employees, advisors, businesses or reputations. Notwithstanding the foregoing, nothing in this Agreement shall preclude Executive from making truthful statements or disclosures that are required by applicable law, regulation or legal process.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Non-solicitation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:14.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period beginning with the Effective Date and ending 18 months following the   termination of Executive's employment with the Company, Executive, whether acting on  Executive&#8217;s own behalf or by, through or on behalf of any third party, shall not (a) hire any employees of the Company or any Subsidiary, or recruit or solicit any such employees or encourage them to terminate their employment with the Company or any Subsidiary&#59; (b) accept business from any customers of the Company or any Subsidiary, or solicit or encourage any customers, joint venture partners or investors of the Company or any Subsidiary to terminate or diminish their relationship with the Company or any Subsidiary or to violate any agreement with   the Company or any Subsidiary. For purposes of subsection 5(a), an employee of the Company    or any Subsidiary means any person who was employed by the Company or any Subsidiary    within 180 days of such hiring, recruitment, solicitation or encouragement. Executive agrees to make any employer with whom Executive becomes employed during the 18-month period   following Executive's termination with the Company aware of this non-solicitation obligation upon commencing employment with such subsequent entity.</font></div><div><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to whatever other rights and remedies the Company may have at equity or in law, the Company (a) shall have the right to immediately terminate all payments and benefits due under  this Agreement if Executive breaches any of the provisions contained in Sections 4 or 5 above,   and (b) shall have the right to seek injunctive relief in any court of competent jurisdiction if Executive breaches or threatens to breach any of the provisions contained in Sections 4 or 5 above. Executive acknowledges that such a breach would cause irreparable injury and that</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:43pt;padding-right:18.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">money damages would not provide an adequate remedy for the Company&#59; provided, however,   the foregoing shall not prevent Executive from contesting the issuance of any such injunction on the ground that no violation or threatened violation of Sections 4 or 5 has occurred.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Effect of Agreement on Other Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as specifically provided in this Agreement, the existence of this Agreement shall not be interpreted to preclude, prohibit or restrict the Executive's participation in any other employee benefit or other plans or programs in which he &#47;she currently participates.</font></div><div><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Not an Employment Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:12.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement is not, and nothing herein shall be deemed to create, a contract of employment between Executive and the Company. The Company may terminate the employment of Executive  at any time and for any reason, subject to the terms of any employment agreement between the Company and Executive that may then be in effect.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Resolution of Disputes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:12.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any controversy or claim arising out of or relating to this Agreement or any breach or asserted breach hereof or questioning the validity and binding effect hereof arising under or in connection with this Agreement, other than seeking injunctive relief under Sections 4 or 5, shall be resolved    by binding arbitration, to be held at an office closest to the Company&#8217;s principal offices in accordance with the rules and procedures of the American Arbitration Association. Judgment     upon the award rendered by the arbitrator(s) may be entered in any court having jurisdiction  thereof. Pending the resolution of any arbitration or court proceeding, the company shall continue payment of all amounts and benefits due Executive under this Agreement. All reasonable costs   and expenses of any arbitration or court proceeding (including fees and disbursements of    counsel) shall be paid on behalf of or reimbursed to Executive promptly by the Company&#59;    provided, however, that no reimbursement shall be made of such expenses if and to the extent     the arbitrator(s) determine(s) that any of Executive&#8217;s litigation assertions or defenses were in bad faith or frivolous.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Assignability&#59; Binding Nature</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:13.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors, heirs (in the case of Executive) and permitted assigns. No rights or obligations of the Company under this Agreement may be assigned or transferred by the Company except that     such rights or obligations may be assigned or transferred in connection with the sale or transfer of all or substantially all of the assets of the Company, provided that the assignee or transferee is     the successor to all or substantially all of the assets of the Company and such assignee or transferee assumes the liabilities, obligations and duties of the Company, as contained in this agreement, either contractually or as a matter of law. The Company further agrees that, in the  event of a sale or transfer of assets as described in the preceding sentence, it shall take whatever action it legally can in order to cause such assignee or transferee to expressly assume the liabilities, obligations and duties of the Company hereunder. No rights or obligations of Executive under this Agreement may be assigned or transferred by Executive other than Executive&#8217;s rights    to compensation and benefits, which may be transferred only by will or operation of law, except     as provided in Section 15 below.</font></div><div><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Representation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company represents and warrants that it is fully authorized and empowered to enter into this Agreement and that the performance of its obligations under this Agreement will not violate any agreement between it and any other person, firm or organization.</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Amendment or Waiver&#59; Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:15.4pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">No provision in this Agreement may be amended unless such amendment is agreed to in writing and signed by Executive and an authorized officer of the Company. No waiver by either Party of any breach by the other Party of any condition or provision contained in   this Agreement to be performed by such other Party shall be deemed a waiver of a    similar or dissimilar condition or provision at the same or any prior or subsequent time.   Any waiver must be in writing and signed by Executive or an authorized officer of the Company, as the case may be.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:79pt;padding-right:15.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive and Company agree that it is the intent of the Parties that this Agreement not violate any applicable provision of, or result in any additional tax or penalty under,    Section 409A of the Code, as amended, and that to the extent any provisions of this Agreement do not comply with such Code Section 409A the Parties will make such changes as are mutually agreed upon in order to comply with Code Section 409A. In all events, to the extent required to avoid a violation of the applicable rules under all Section 409A by reason of Code Section 409A(a)(2)(B)(i), payment of any amounts subject to Code Section 409A shall be delayed until the relevant date of payment that will result in compliance with the rules of Code Section 409A(a)(2)(B)(i).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:18.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, in whole or in part, the remaining provisions of this Agreement   shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by law.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Survivorship</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective rights and obligations of the Parties hereunder shall survive any termination of Executive's employment to the extent necessary to the intended preservation of such rights and obligations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Beneficiaries&#47;References</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:12.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive shall be entitled, to the extent permitted under any applicable law, to select and change   a beneficiary or beneficiaries to receive any compensation or benefit payable hereunder following Executive's death by giving the Company written notice thereof. In the event of Executive's death  or a judicial determination of Executive&#8217;s incompetence, references in this Agreement to      Executive shall be deemed, where appropriate, to refer to Executive&#8217;s beneficiary, estate or other   legal representative.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Governing Law&#47;Jurisdiction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:14.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement shall be governed by and construed and interpreted in accordance with the laws   of Rhode Island without reference to principles of conflict of laws. Subject to Section 6, the Company and Executive hereby consent to the jurisdiction of any or all of the following courts for purposes of resolving any dispute under this Agreement&#58; (i) the United States District Court for Rhode Island or (ii) any of the courts of the State of Rhode Island. The Company and Executive further agree that any service of process or notice requirements in such proceeding shall be satisfied if the rules of such court relating thereto have been substantially satisfied. The Company and Executive hereby waive, to the fullest extent permitted by applicable law, any objection which   it or he&#47;she may now or hereafter have to such jurisdiction and any defense of inconvenient    forum.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:18.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any notice given to a Party shall be in writing and shall be deemed to have been given when delivered personally or sent by certified or registered mail, postage prepaid, return receipt requested, duly addressed to the Party concerned at the address indicated below or to such changed address as such Party may subsequently give written notice of&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:61pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to CVS&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:117pt;padding-right:264.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Pharmacy, Inc.</font></div><div style="padding-left:117pt;padding-right:264.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One CVS Drive </font></div><div style="padding-left:117pt;padding-right:264.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Woonsocket, RI 02895</font></div><div style="padding-left:117pt;padding-right:233.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Corporate Secretary </font></div><div style="padding-right:233.75pt"><font><br></font></div><div style="padding-left:58.5pt;padding-right:233.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to Executive&#58;</font></div><div style="padding-left:115pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tilak Mandadi</font></div><div style="padding-left:115pt;padding-right:253.45pt"><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XXXX XXXXXXXX XXX XX  </font></div><div style="padding-left:115pt;padding-right:253.45pt"><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XXXXXXXX, XX XXXXX</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:18.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement may be executed in two or more counterparts.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:43pt;padding-right:14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first  written above.</font></div><div><font><br></font></div><div style="margin-top:8.1pt;padding-left:288pt;padding-right:67.05pt;text-align:right;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:251.25pt"><tr><td style="width:1.0pt"></td><td style="width:24.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:187.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVS Pharmacy, Inc. </font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laurie P. Havanec</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laurie Havenec</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief People</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="9" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Tilak Mandadi</font></td></tr></table></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a03312023ex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6b5a5634721a45e19404f2bf924b61ee_1"></div><div style="min-height:79.92pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div></div><div style="margin-top:3.75pt;padding-left:68.12pt;padding-right:68.12pt;text-align:center"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CVS Pharmacy, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inc.</font></div><div style="margin-top:1pt;padding-left:144.6pt;padding-right:144.6pt;text-align:center"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restrictive Covenant Agreement</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:6.5pt;padding-left:21.15pt;padding-right:8.55pt;text-indent:0.25pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">I, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%;text-decoration:underline">        PREM SHAH                     </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%"> enter into this </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Restrictive </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Covenant </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Agreement </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">(&#34;'Agreement&#34;)                 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">with CVS Pharmacy, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Inc., </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">on its own behalf and on behalf of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">its </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">subsidiaries and </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">affiliates (&#34;CVS&#34;),                     </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">which </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">is </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">effective as of the date I sign the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Agreement (&#34;Effective </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Date&#34;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:20.85pt;padding-right:7.05pt;text-indent:0.15pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%">1.</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%;padding-left:7.5pt">Consideration for </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%">Agreement. </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">In </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">connection with </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">my </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">duties and </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">responsibilities </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">at CVS Health Corporation or one of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">its </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">subsidiaries or affiliates, including Aetna Inc. </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">(</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">collectively, </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">&#34;Corporation&#34;),         </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Corporation </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">will provide me with Confidential Information and&#47;or access to the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Corporation's          </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">customers and clients and the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">opportunity </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">to develop and maintain relationships and goodwill </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">with them.          </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">In </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">consideration of </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">foregoing and the mutual promises in this </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Agreement </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">and </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">other </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">good and </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">valuable </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">consideration, I hereby </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">agree with </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">CVS </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">comply </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">with </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the terms of </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">this </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Agreement.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:20.85pt;padding-right:7.8pt;text-indent:0.6pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">2.</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:7.05pt">Non</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">-</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Competition. </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">During my employment by </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the Corporation </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and during </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Non-Competition          Period following the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">termination </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">of my </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">employment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">for any reason, </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">I will </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">not directly or indirectly            engage </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Competition or provide </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Consulting </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">or Audit Services within the Restricted Area.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:20.75pt;padding-right:14.2pt;text-indent:35.3pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">a.</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:9.02pt">Competition. </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Engaging </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">in </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">&#34;Competition&#34; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">means </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(whether </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">as an employee, contractor,   consultant, principal, agent</font><font style="color:#707070;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">partner, officer, or director) </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(i) </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">working </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">on, developing, producing,          marketing</font><font style="color:#707070;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">selling, servicing, or managing </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(or </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">assisting </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">in </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">developing, producing, marketing, selling,  servicing, or managing) any product or service that </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">is </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">competitive with any existing or planned products          or services of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Corporation that I managed, or with which </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">I </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">was </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">involved</font><font style="color:#707070;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">at any time during the last twenty-four (24) months of my employment with the Corporation&#59; or </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(ii) accepting </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">any position or       engaging in any activity that will likely result in </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">disclosure of Confidential Infom1ation </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">a        Competitor or the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">use </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">of Confidential Information on behalf of a </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Competitor.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:20.8pt;padding-right:5.6pt;text-indent:35.6pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">b.</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:8.1pt">Competitor. </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">A </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">&#34;Competitor&#34; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">for purposes of this Agreement shall mean any person,        corporation or other entity </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">that </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">competes with one or more of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">business offerings of </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Corporation             </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">As </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">of the Effective Date, the Corporation</font><font style="color:#707070;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">'</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">s business offerings include&#58; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(i) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">pharmacy benefits management (&#34;PBM&#34;), including&#58; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(a) </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">administration of pharmacy benefits for businesses</font><font style="color:#707070;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">government agencies               </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">health plans&#59; (b) mail order pharmacy&#59; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(c) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">specialty pharmacy&#59; and </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(d) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the procurement of            prescription drugs at a negotiated </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">rate </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">for </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">dispensing&#59; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">ii</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">) </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">retail, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">which includes the </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">sale </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">prescription         drugs, over-the-counter medications, beauty products and cosmetics, digital and traditional photo             finishing services, digital and other online offerings</font><font style="color:#707070;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">seasonal </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and other </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">general </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">merchandise, greeting          cards, convenience foods and other product </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">lines </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and services which are </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">sold </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">by the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Corporation's </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">retail     division (&#34;Retail&#34;)&#59; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(iii) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">retail health clinics </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(&#34;MinuteClinic&#34;)&#59; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(iv) the provision </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">pharmaceutical            products and ancillary services, including specialty pharmaceutical products and support </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">services </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">provision of </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">related </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">pharmacy consulting, data management </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">services </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and medical supplies </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">to </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">long-term          care facilities, other healthcare service providers and recipients of services from </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">such </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">facilities </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(&#34;Long-         </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Term Care&#34;)&#59; (v) the </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">provision </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">of prescription infusion drugs and related </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">services </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(&#34;Infusion&#34;)&#59; </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(vi) the    provision of kidney </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">care </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">services, including </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">but </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">not </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">limited to caring </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">for </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">patients </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">with </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">end stage renal          </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">disease </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(&#34;Kidney Care&#34;)&#59; (vii) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">services </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">relating </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">to or supporting clinical trials </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(&#34;Clinical </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Trials&#34;)&#59; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(viii) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">provision </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">of insurance </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(&#34;Insurance&#34;) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">including&#58; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(a) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">health </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">insurance </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">products </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and services&#59; </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(b) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">managed        health care </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">products </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">services&#59; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(c) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">dental, vision</font><font style="color:#707070;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">, </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and employee assistance program products and            services&#59; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(d) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">wellness </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">product</font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">s </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and services to employers, government agencies, health plans, other       businesses or third party payers&#59; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(e) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Medicare Part D services&#59; and </font><font style="color:#5d5d5d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(f) </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">other </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">voluntary products that are    excepted benefits under </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:122%">HIP</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:122%">AA</font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:122%">&#59; </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(ix) </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">the creation </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">and </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">provision of population </font><font style="color:#4d4d4d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">health </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">management</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><div id="i6b5a5634721a45e19404f2bf924b61ee_4"></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.7pt;padding-left:19.2pt;padding-right:0.05pt;text-indent:0.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">products and services (&#34;Health Management&#34;)&#59; (x) services supporting or related to the administration of            the business offerings in (i)-(ix) (''Administration&#34;)&#59; and (xi) any other business in which Corporation is      engaged or imminently will be engaged. For avoidance of doubt, Competitor shall include any business             unit, corporate entity, division, affiliate or part of a Competitor which offers other products or services            which are or may be combined or offered as part of a suite of products or services with the Competitor's    Insurance, Health Management and&#47;or PBM offerings.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:19.3pt;padding-right:8.55pt;text-indent:35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%">For the purpose of assessing whether I am engaging in &#34;Competition&#34; under section 2(a)(i) above,           a person, corporation or other entity shall not be considered a Retail Competitor if such entity derives          annual gross revenues from its business in an amount which is less than 2% of the Corporation's gross      revenues from Retail, during its most recently completed fiscal year. For avoidance of doubt, this           exclusion does not apply to a determination of whether I am engaging in &#34;Competition&#34; as set forth in       section 2(a)(ii) above.</font></div><div><font><br></font></div><div style="padding-left:19.3pt;padding-right:8.55pt;text-indent:35.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">I and the Corporation acknowledge that both the Corporation's products and services and the        entities which compete with the Corporation's products and services evolve over time, and that an entity          will be considered a Competitor if it provides products or services competitive with the products and        services provided by the Corporation within the last two years of my employment with the Corporation.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:19.55pt;padding-right:10.8pt;text-indent:35.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">I agree that the provisions of Section 2 of this Agreement are reasonable to protect and preserve         the Corporation's legitimate business interests, including the protection of the Company's Confidential Information and the Company's substantial investment made to develop and retain its Confidential    Information, clients, other business relationships, and related goodwill.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:19.7pt;padding-right:9pt;text-indent:34.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:124%;padding-left:10.47pt">Consulting or Audit Services. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">&#34;Consulting or Audit Services&#34; shall mean any activity                that involves providing audit review or other consulting or advisory services with respect to any          relationship or prospective relationship between the Corporation and any third party that is likely to result         in the use or disclosure of Confidential Information.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:19.6pt;padding-right:42.95pt;text-indent:35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:126%;padding-left:9.9pt">Non-Competition Period. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%">The &#34;Non-Competition Period&#34; shall be the period of               18 months following the termination of my employment with the Corporation for any reason.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:19.4pt;padding-right:7.05pt;text-indent:35.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:10.52pt">Restricted Area. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">&#183;'Restricted Area&#34; refers to those states within the United States in                  which the Corporation conducts its business, as well as the District of Columbia and Puerto Rico. To the      extent I worked on international matters involving the Corporation's business in Asia, Europe, or other international locations where the Corporation may conduct business, the Restricted Area includes those countries and those countries where the Corporation is actively planning to conduct business. I understand and agree that the Corporation's business is global in nature and that its clients are located throughout the world&#59; therefore, the Restricted Territory definition is reasonable and necessary to allow the Corporation      to adequately protect its legitimate business interests, and the absence of a more restricted limitation       would not be reasonable under these circumstances. Nevertheless, the restrictions on my work during the Non-Competition Period shall only extend to those locations within the Restricted Area where such work constitutes engaging in Competition.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:19.45pt;padding-right:9.6pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:124%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:124%;padding-left:8.9pt">Non-Solicitation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">During the Non-Solicitation Period, which shall be during my employment by          the Corporation and for 18 months following the termination of my employment with the Corporation for any reason, I will not, unless a duly authorized officer of the Corporation gives me written authorization      to do so&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:19.45pt;padding-right:15pt;text-indent:35.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%;padding-left:10.47pt">interfere with the Corporation's relationship with its Business Partners by soliciting or communicating (regardless of who initiates the communication) with a Business Partner to&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:131%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">induce or</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><div id="i6b5a5634721a45e19404f2bf924b61ee_7"></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.75pt;padding-left:18.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">encourage the Business Partner to stop doing business or reduce its business with the Corporation, or                  (ii) buy a product or service that competes with a product or service offered by the Corporation's                business. &#34;Business Partner&#34; means&#58; a customer (person or entity), prospective customer (person or                entity), healthcare provider, supplier, manufacturer, agency, broker, hospital, hospital system, long-term            care facility, Insurance client&#47;customer, and&#47;or pharmaceutical manufacturer with whom the Corporation            has a business relationship and with which I had business-related contact or dealings, or about which I         received Confidential Information, in the two years prior to the termination of my employment with the Corporation. A Business Partner does not include a customer, supplier, manufacturer, agency, broker,         hospital, hospital system, long-term care facility and&#47;or pharmaceutical manufacturer which has fully and       finally ceased doing any business with the Corporation independent of any conduct or communications by          me or breach of this Agreement and such full cessation of business has been in effect for at least 1 year            prior to my separation from employment with the Corporation. Nothing in this Section 3(a) shall prevent            me from working as a staff pharmacist or in another retail position wherein I would be providing or                selling prescriptions or other products directly to consumers.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:19.2pt;padding-right:58.4pt;text-indent:35.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%;padding-left:10.05pt">work on a Corporation account on behalf of a Business Partner or serve as the representative of a Business Partner for the Corporation.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:18.9pt;padding-right:15.85pt;text-indent:35.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%;padding-left:11.02pt">interfere with the Corporation's relationship with any employee or contractor of the         Corporation by&#58; (i) soliciting or communicating with the employee or contractor to induce or encourage       him or her to leave the Corporation's employ or engagement (regardless of who first initiates the communication)&#59; (ii) helping another person or entity evaluate such employee or contractor as an    employment or contractor candidate&#59; or (iii) otherwise helping any person or entity hire an employee or    contractor away from the Corporation.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:54.35pt;text-indent:-35.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%;padding-left:27.48pt">Non-Disclosure of Confidential Information.</font></div><div><font><br></font></div><div style="padding-left:18.95pt;padding-right:7.65pt;text-indent:35.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%;padding-left:10.97pt">Subject to Sections 7 and 8 below, 1 will not at any time, whether during or after the           termination of my employment, disclose to any person or entity any of the Corporation's Confidential Information, except as may be appropriately required in the ordinary course of performing my duties as              an employee of the Corporation. The Corporation's Confidential Information includes but is not limited             to the following non-public information&#58; trade secrets&#59; computer code generated or developed by the Corporation&#59; software or programs and related documentation&#59; strategic compilations and analysis&#59;            strategic processes&#59; business or financial methods, practices and plans&#59; non-public costs and prices&#59;         operating margins&#59; marketing, merchandising and selling techniques and information&#59; customer lists&#59;        provider lists&#59; details of customer or provider agreements&#59; pricing arrangements with pharmaceutical manufacturers, distributors or suppliers including but not limited to any discounts and&#47;or rebates&#59; pricing arrangements with insurance clients and customers&#59; pharmacy reimbursement rates&#59; premium                 information&#59; payment rates&#59; contractual forms&#59; expansion strategies&#59; real estate strategies&#59; operating       strategies&#59; sources of supply&#59; patient records&#59; business plans&#59; other financial, commercial, business or      technical information related to the Corporation, and confidential information of third parties which is           given to the Corporation pursuant to an obligation or agreement to keep such information confidential (collectively, &#34;Confidential Information&#34;). I shall not use or attempt to use any Confidential Information            on behalf of any person or entity other than the Corporation, or in any manner which may injure or cause         loss or may be calculated to injure or cause loss, whether directly or indirectly, to the Corporation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:123%">If, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">at           any time over the last two years of my employment at CVS, my position included access to Confidential Information, as described above, specifically related to the Corporation's procurement of prescription           drugs, I understand and agree my employment with a pharmaceutical manufacturer, distributor or supplier (&#34;Pharmaceutical Entity&#34;) would place a substantial risk of use and&#47;or disclosure of Confidential          Information with which I have been or will be entrusted during my employment with the Corporation. In        light of this risk of disclosure, I acknowledge and agree that the Corporation will be entitled to immediate</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><div id="i6b5a5634721a45e19404f2bf924b61ee_10"></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.25pt;padding-left:17.95pt;padding-right:8.55pt;text-indent:0.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">injunctive relief to prevent me from disclosing any such Confidential Information in the course of my employment with any such Pharmaceutical Entity. I agree that the disclosure of such Confidential       Information to the Corporation's PBM Competitors with which one may negotiate in the course of     employment with such Pharmaceutical Entity, would cause immediate and irreparable harm to the      Corporation.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:18.2pt;padding-right:13.55pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%;padding-left:11pt">During my employment, I shall not make, use, or permit to be used, any materials of any      nature relating to any matter within the scope of the business of the Corporation or concerning any of its dealings or affairs other than for the benefit of the Corporation. I shall not, after the termination of my employment, use or permit to be used any such materials and shall return same in accordance with          Section 5 below.</font></div><div><font><br></font></div><div style="padding-left:18.45pt;padding-right:17.4pt;text-indent:34.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%;padding-left:11.97pt">NOTICE OF IMMUNITY FROM LIABILITY FOR CONFIDENTIAL DISCLOSURE           OF A TRADE SECRET TO THE GOVERNMENT OR IN A COURT FILING. Pursuant to the United    States Defend Trade Secrets Act of 2016 (the &#34;DTSA&#34;), the Company hereby provides the following         notice to Employee&#58;</font></div><div style="margin-top:9.55pt;padding-left:18.25pt;padding-right:9pt;text-indent:69.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%;padding-left:10.77pt">IMMUNITY&#58; An individual shall not be held criminally or civilly liable under              any Federal or State trade secret law for the disclosure of a trade secret that (A) is made&#58; (1) in confidence          to a Federal, State, or local government official, either directly or indirectly, or to an attorney&#59; and                     (2) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a   complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:18pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt">USE OF TRADE SECRET INFORMATION IN ANTI-RETALIATION              LAWSUIT&#58; An individual who files a lawsuit for retaliation by an employer for reporting a suspected         violation of law may disclose the trade secret to the attorney of the individual and use the trade secret in               the court proceeding, if the individual&#58; (A) files any document containing the trade secret under seal&#59; and             (B) does not disclose the trade secret, except pursuant to court order.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:18.45pt;padding-right:12.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%;padding-left:9.68pt">Ownership and Return of the Corporation's Property. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">On or before my final date of         employment with the Corporation, I shall return to the Corporation all property of the Corporation in my possession, custody or control, including but not limited to the originals and copies of any information    provided to or acquired by me in connection with the performance of my duties for the Corporation, such          as files, correspondence, communications, memoranda, e-mails, slides, records, and all other documents,          no matter how produced or reproduced, all computer equipment, communication devices (including but         not limited to any mobile phone or other portable digital assistant or device), computer programs and&#47;or       files, and all office keys and access cards. I agree that all the items described in this Section are the sole property of the Corporation.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:53.8pt;text-indent:-35.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%;padding-left:27.58pt">Rights to Inventions, Works.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:18.4pt;padding-right:9.35pt;text-indent:35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%;padding-left:11.47pt">Assignment of Inventions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">All inventions, original works of authorship, developments,   concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether patentable or otherwise protectable under similar law, made, conceived or developed by me, whether alone or jointly          with others, from the date of my initial employment by the Corporation and continuing until the end of           any period during which I am employed by the Corporation, relating or pertaining in any way to my employment with or the business of the Corporation (collectively referred to as &#34;Inventions&#34;) shall be     promptly disclosed in writing to the Corporation. I hereby assign to the Corporation, or its designee, all              of my rights, title and interest to such Inventions. All original works of authorship which are made by me   (solely or jointly with others) within the scope of and during the period of my employment with the    Corporation and which are protectable by copyright are &#34;works made for hire,&#34; as that term is defined in</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><div id="i6b5a5634721a45e19404f2bf924b61ee_13"></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.7pt;padding-left:18pt;padding-right:8.55pt;text-indent:0.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">the United States Copyright Act and as such are the sole property of the Corporation. The decision           whether to commercialize or market any Invention developed by me solely or jointly with others is within        the Corporation's sole discretion and for the Corporation's sole benefit and no royalty will be due to me             as a result of the Corporation's efforts to commercialize or market any such Invention.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:17.85pt;padding-right:14.5pt;text-indent:35.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:10.95pt">Inventions Retained and Licensed. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">I have attached hereto as Exhibit A, a list               specifically describing all inventions, original works of authorship, developments, improvements, and         trade secrets that were made by me prior to my employment with the Corporation (&#34;Prior Inventions&#34;),      which belong to me and are not assigned to the Corporation hereunder. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">If </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">no such list is attached, I       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:122%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">represent that there are no such Prior Inventions. I will not incorporate, or permit to be incorporated, any     Prior Invention owned </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:122%">by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">me or in which l have an interest into a Corporation product, process or          machine without the Corporation's prior written consent. Notwithstanding the foregoing sentence, if, in          the course of my employment with the Corporation, I incorporate into a Corporation product, process or machine a Prior Invention owned by me or in which I have an interest, the Corporation is hereby granted       and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make. have           made, modify, use and sell such Prior Invention as part of or in connection with such product, process or machine.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:18.25pt;padding-right:11.7pt;text-indent:34.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%;padding-left:11.92pt">Patent and Copyright Registrations. 1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">will assist the Corporation, or its designee, at                 the Corporation's expense, in every proper way to secure the Corporation's rights in the Inventions and           any copyrights, patents, mask work rights or other intellectual property rights relating thereto, including,         but not limited to, the disclosure to the Corporation of all pertinent information and data with respect        thereto, the execution of all applications, specifications, oaths, assignments and all other instruments          which the Corporation shall deem necessary in order to apply for and obtain such rights and in order to       assign and convey to the Corporation, its successors, assigns, and nominees the sole and exclusive rights,       title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other       intellectual property rights relating thereto. My obligation to execute or cause to be executed, when it is            in my power to do so, any such instrument or papers shall continue after my employment ends for any        reason and&#47;or after the te1mination of this Agreement. If the Corporation is unable because of my mental         or physical incapacity or for any other reason to secure my signature to apply for or to pursue any        application for any United States or foreign patents or copyright registrations covering Inventions or         original works of authorship assigned to the Corporation as above, then I hereby irrevocably designate           and appoint the Corporation and its duly authorized officers and agents as my agent and attorney in fact,           to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon         with the same legal force and effect as if executed by me. </font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:18.45pt;padding-right:17.3pt;text-indent:34.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.35pt">Exception to Assignments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I understand that if I am an employee in Illinois, Kansas,          North Carolina, Utah or Minnesota, I should refer to Exhibit B (incorporated herein for all purposes) for important limitations on the scope of the provisions of this Agreement concerning assignment of       Inventions. I </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">advise the Corporation promptly in writing of any inventions that l believe meet the     criteria in Exhibit Band that are not otherwise disclosed on Exhibit A.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:53.6pt;text-indent:-35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:27.7pt">Cooperation.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:18.3pt;padding-right:10pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%;padding-left:11.47pt">In the event I receive a subpoena, deposition notice, interview request, or other process                  or order to testify or produce Confidential Information or any other information or property of the     Corporation, I shall promptly&#58; (i) notify the Corporation of the item, document, or information sought by       such subpoena, deposition notice, interview request, or other process or order&#59; (ii) furnish the Corporation      with a copy of said subpoena, deposition notice, interview request, or other process or order&#59; and                     (iii) provide reasonable cooperation with respect to any procedure that the Corporation may initiate to</font></div><div><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.7pt;padding-left:18.25pt;padding-right:8.55pt;text-indent:0.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">protect Confidential Information or other interests. If the Corporation objects to the subpoena, deposition    notice, interview request, process, or order, I shall cooperate to ensure that there shall be no disclosure            until the court or other applicable entity has ruled upon the objection, and then only in accordance with             the ruling so made. If no such objection is made despite a reasonable opportunity to do so, I shall be            entitled to comply with the subpoena, deposition, notice, interview request, or other process or order,       provided that I have fulfilled the above obligations.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:18.45pt;padding-right:11.9pt;text-indent:35.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%;padding-left:10.5pt">I will cooperate fully with the Corporation, its affiliates, and their legal counsel in           connection with any action, proceeding, or dispute arising out of matters with which I was directly or      indirectly involved while serving as an employee of the Corporation, its predecessors, subsidiaries or     affiliates. This cooperation shall include, but shall not be limited to, meeting with, and providing        information to, the Corporation and its legal counsel, maintaining the confidentiality of any past or future privileged communications with the Corporation's legal counsel (outside and in-house), and making           myself available to testify truthfully by affidavit, in depositions, or in any other forum on behalf of the Corporation. The Corporation agrees to reimburse me for any reasonable and necessary out-of-pocket           costs associated with my cooperation.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:18.3pt;padding-right:8.05pt;text-indent:35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%;padding-left:11.47pt">Notice of New Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">If a representative of the Corporation, during or following            my employment, requests that I identify the company or business to which I will be or am providing         services, or with which I will be or am employed, and requests that I provide information about the             services that I am or will be providing to such entity, I shall provide the Corporation with a written          statement that identifies the entity and describes the nature of the services that I am or will be providing to      such entity with sufficient detail to allow the Corporation to independently assess whether I am or will be           in violation of this Agreement. Such statement shall be delivered to the Corporation's Chief People            Officer or his or her authorized delegate via personal delivery or overnight delivery within five calendar         days of my receipt of such request.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:18.4pt;padding-right:8.1pt;text-indent:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%;padding-left:9.68pt">Limitation on Restrictions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Nothing in this Agreement is intended to or shall interfere with my            right to file charges or participate in a proceeding with any appropriate federal, state or local government   agency, including the Occupational Safety and Health Administration (&#34;OSHA&#34;), National Labor            Relations Board (&#34;NLRB&#34;) or the Securities and Exchange Commission (&#34;SEC&#34;)&#59; to exercise rights under Section 7 of the National Labor Relations Act (&#34;NLRA&#34;)&#59; or to file a charge or complaint with or           participate or cooperate in an investigation or proceeding with the US Equal Employment Opportunity Commission (&#34;EEOC&#34;) or comparable state or local agencies. Such agencies have authority to carry out          their statutory duties by investigating a charge, issuing a determination, filing a lawsuit, or taking any            other action authorized by law. I retain the right to participate in any such action and retain the right to communicate with the NLRB, SEC, EEOC, OSHA and comparable state or local agencies and such communication shall not be limited by any provision in this Agreement. Nothing in this Agreement limits         my right to receive an award for information provided to a government agency such as the SEC and          OSHA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:122%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">In</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:122%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">addition, nothing in this Agreement is intended to interfere with or restrain the immunity         provided under 18 U.S.C. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:122%">&#167; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">I833(b) for confidential disclosures of trade secrets to government officials or lawyers. solely for the purpose of reporting or investigating a suspected violation of law, or in a sealed          filing in court or other proceeding.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:18.25pt;padding-right:11.05pt;text-indent:0.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%;padding-left:9.63pt">Eligibility for Severance Pay. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">If my employment with the Corporation terminates under           circumstances in which I am eligible for severance under the applicable severance plan (the &#34;Severance      Plan&#34;), the Corporation will offer me severance in accordance with the Severance Plan. I acknowledge            that I must meet certain requirements in order to receive severance, including but not limited to execution        of a separation agreement and release of claims in a form acceptable to CVS Health Corporation and any     other requirements set forth in the Severance Plan. In the event that the Corporation fails to comply with          its obligations to offer me severance according to the Severance Plan, then Section 2 of this Agreement</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  6</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><div id="i6b5a5634721a45e19404f2bf924b61ee_16"></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.25pt;padding-left:17.75pt;padding-right:8.55pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:146%">shall be of no further effect. I agree that if I decline the Corporation's offer of severance, I shall continue            to be subject to the restrictions in Section 2.</font></div><div style="margin-top:7.65pt;padding-left:18pt;padding-right:11.6pt;text-indent:-0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%;padding-left:5.23pt">Injunctive Relief and Other Remedies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Any breach of this Agreement by me will cause          irreparable damage to the Corporation and, in the event of such breach, the Corporation shall have, in      addition to any and all remedies of law, the right to an injunction, specific performance or other equitable    relief to prevent the violation of my obligations hereunder, and without providing a bond to the extent   permitted by the applicable rules of civil procedure. Nothing contained in this Agreement shall be          construed to prohibit the Corporation from pursuing any other remedy available to the Corporation at law         or in equity, the parties having agreed that all remedies are cumulative.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:17.95pt;padding-right:30.55pt;text-indent:-0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:129%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:129%;padding-left:5.28pt">No Right of Continued Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:129%">This Agreement does not create an obligation on the Corporation or any other person or entity to continue my employment.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:17.95pt;padding-right:12.9pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:122%;padding-left:4.78pt">No Conflicting Agreements. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">I represent that the performance of my job duties with the           Corporation and my compliance with all of the terms of this Agreement does not and will not breach or    conflict with any other agreement, covenant, obligation or restriction to which I am bound including but         not limited to any agreement to keep in confidence proprietary information acquired by me in confidence         or in trust prior to my employment by the Corporation.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:17.85pt;padding-right:7.85pt;text-indent:0.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%;padding-left:4.78pt">Entire Agreement&#47;No Reliance&#47;No Modifications. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">This Agreement and any compensation,            benefit or equity plan or agreement referred to herein or under which equity was granted, to the extent           those other agreements apply to me, set forth the entire agreement between the parties hereto and fully    supersede any and all prior and&#47;or supplemental understandings, whether written or oral, between the          parties concerning the subject matter of this Agreement. This agreement shall not have any effect on any        prior existing agreements between Corporation and me regarding the arbitration of workplace legal           disputes and any such agreements remain in full force and effect. I agree and acknowledge that I have not     relied on any representations, promises or agreements of any kind in connection with my decision to            accept the terms of this Agreement, except for the representations, promises and agreements herein. Any modification to this Agreement must be made </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:123%">in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">writing and signed by me and the Corporation's Chief       People Officer or his or her authorized representative.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:18pt;padding-right:8.2pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:124%;padding-left:4.78pt">No Waiver. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">Any waiver by the Corporation of a breach of any provision of this Agreement, or of            any other similar agreement with any other current or former employee of the Corporation, shall not           operate or be construed as a waiver of any subsequent breach of such provision or any other provision         hereof.</font></div><div style="margin-top:9.85pt;padding-left:17.95pt;padding-right:17.75pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%;padding-left:4.78pt">Severability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">The parties hereby agree that each provision herein shall be treated as a separate              and independent clause, and the unenforceability of any one clause shall in no way impair the       enforceability of any of the other clauses herein. Moreover, if one or more of the provisions of this     Agreement are for any reason held to be excessively broad as to scope, activity, duration, subject or    otherwise so as to be unenforceable at law, the parties consent to such provision or provisions being     modified in any way necessary or limited by the appropriate judicial body (where allowed by applicable     law), so as to be enforceable to the maximum extent compatible with the applicable law.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:18.25pt;padding-right:22.35pt;text-align:justify;text-indent:-0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:123%;padding-left:4.78pt">Survival of Employee's Obligations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">My obligations under this Agreement shall survive the termination of my employment regardless of the manner of such termination and shall be binding upon       my heirs, personal representatives, executors, administrators and legal representatives.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:18.25pt;padding-right:13.75pt;text-indent:-0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:119%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:119%;padding-left:4.78pt">Corporation's Right to Assign Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:119%">The Corporation has the right to assign this          Agreement to its successors and assigns without the need for further agreement or consent by me, and all</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  7</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><div id="i6b5a5634721a45e19404f2bf924b61ee_19"></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.25pt;padding-left:18pt;padding-right:8.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">covenants and agreements hereunder shall inure to the benefit of and be enforceable by said successors or assigns.</font></div><div style="margin-top:8.7pt;padding-left:18pt;padding-right:10.4pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:126%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:126%;padding-left:5.35pt">Non-Assignment. l </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%">shall not assign my rights and obligations under this Agreement, in whole or                in part, whether by operation of law or otherwise, without the prior written consent of the Corporation,            and any such assignment contrary to the terms hereof shall be null and void and of no force or effect.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:18pt;padding-right:10.75pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:124%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:124%;padding-left:5.35pt">Governing Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">This Agreement shall be governed by and construed in accordance with the                 laws of the state of Rhode Island excluding its choice of law rules or principles that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:18pt;padding-right:8.45pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:5.4pt">Personal Jurisdiction and Venue. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">I agree that any State or Federal court located within the State               of Rhode Island shall have personal jurisdiction over me with regard to any claim or dispute arising out of          or related to this Agreement or the subject matter of this Agreement. I agree that unless otherwise          prohibited by applicable law, any claim or dispute arising out of or related to this Agreement or the             subject matter of this Agreement shall be exclusively brought and resolved in a State or Federal court         located within the state of Rhode Island.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:18.45pt;padding-right:10.7pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%;padding-left:5.45pt">Consultation with Legal Counsel&#59; Time to Consider Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">I acknowledge that CVS             advises me to consult with an attorney before signing this Agreement. I also acknowledge that CVS has       given me fourteen (14) days from the date I received this Agreement to consider whether to sign this Agreement. I further acknowledge that if I choose to do so voluntarily, I may sign this Agreement before         the expiration of the 14-day consideration period.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:18.45pt;padding-right:25.05pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:126%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:126%;padding-left:4.95pt">Headings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:126%">The headings of the sections contained in this Agreement are for convenience only             and shall not be deemed to control or affect the meaning or construction of any provision of this         Agreement.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:18.5pt;padding-right:8.25pt;text-align:justify;text-indent:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%;padding-left:4.95pt">Attorneys' Fees. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">If any party to this Agreement breaches any terms of this Agreement, then that            party shall pay to the non-breaching party all of the non-breaching party's costs and expenses, including attorneys' fees, incurred by that party in enforcing the terms of this Agreement.</font></div><div><font><br></font></div><div style="padding-left:18.5pt;padding-right:8.25pt;text-indent:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%;padding-left:4.95pt">Tolling. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">In the event I violate one of the time-limited restrictions in Sections 2 and&#47;or 3 of this     Agreement, I agree that the time period for such violated restriction shall be extended by one day for each        day I have violated the restriction, up to a maximum extension equal to the length of the original period of        the restricted covenant.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:18.5pt;padding-right:8.55pt;text-indent:0.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">IN WITNESS WHEREOF, the undersigned has executed this Agreement as a sealed instrument as of the           date set forth below.</font></div><div style="padding-left:288pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">                     </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.189%"><tr><td style="width:1.0%"></td><td style="width:5.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.745%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.745%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Prem Shah</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Laurie P. Havanec</font></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Laurie Havanec</font></td></tr><tr><td colspan="6" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXXXXXX</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Chief People Officer</font></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employee ID</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;CVS Pharmacy, Inc.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">05&#47;11&#47;2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  8</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><div id="i6b5a5634721a45e19404f2bf924b61ee_22"></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.7pt;padding-left:72.52pt;padding-right:72.52pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div><font><br></font></div><div style="padding-left:148.4pt;padding-right:148.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">List of Prior Inventions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">See Section 6</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:3.7pt;padding-left:149pt;padding-right:149pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font><br></font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  9</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72.75pt;padding-right:72.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT B</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:149.12pt;padding-right:149.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice Regarding Invention Assignment</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:42.75pt;text-indent:-25.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.15pt">For an employee residing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Illinois, Kansas, or North Carolina, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">you are hereby advised&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:42.55pt;padding-right:9.25pt;text-align:justify;text-indent:0.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Notice.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No provision in this Agreement requires you to assign any of your rights to an invention for  which no equipment, supplies, facility, or trade secret information of the Corporation was used and    which was developed entirely on your own time, unless (a) the invention relates (i) to the business of     the Corporation or (ii) to the Corporation's actual or demonstrably anticipated research or       development, or (b) the invention results from any work performed by you for the Corporation.        Illinois 765ILCS1060&#47;1-3, &#34;Employees Patent Act&#34;&#59; Kansas Statutes Section 44-130&#59; North Carolina General Statutes Article 10A, Chapter 66, Commerce and Business, Section 66-57.1.</font></div><div><font><br></font></div><div style="padding-left:42.75pt;text-indent:-23.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.75pt">For an employee residing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Utah, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">you are hereby advised&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:42.55pt;padding-right:9.35pt;text-align:justify;text-indent:0.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%;text-decoration:underline">Notice.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">No provision in this Agreement requires you to assign any of your rights to an invention        which was created entirely on your own time, and which is not (a) conceived, developed, reduced to practice, or created by you </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:123%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">within the scope of your employment with the Corporation, (ii) on the Corporation's time, or (iii) with the aid, assistance, or use of any of the Corporation's property,    equipment, facilities, supplies, resources, or patents, trade secrets, know-how, technology,        confidential information, ideas, copy rights, trademarks and service marks and any and all rights, applications and registrations relating to them, (b) the results of any work, services, or duties       performed by you for the Corporation, (c) related to the industry or trade of the Corporation, or (d)    related to the current or demonstrably anticipated business, research, or development of the     Corporation. Utah Code Sections 34-39-1 through 34-39-3, &#34;Employee Inventions Act.&#34;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:42.75pt;text-indent:-26.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.8pt">For an employee residing in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Minnesota, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">you are hereby advised&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:42.55pt;padding-right:9.4pt;text-align:justify;text-indent:0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%;text-decoration:underline">Notice.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:123%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">No provision in this Agreement requires you to assign any of your rights to an invention for   which no equipment, supplies, facility, or trade secret information of the Corporation was used, and   which was developed entirely on your own time, and (a) which does not relate (i) directly to the     business of the Corporation, or (ii) to the Corporation's actual or demonstrably anticipated research          or development, or (b) which does not result from any work performed by you for the Corporation. Minnesota Statutes 13A Section 181.78.</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.441%"><tr><td style="width:1.0%"></td><td style="width:32.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page  10</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EVP SVP US NC NS ND March 2022</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>a03312023ex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icff3fa9b61bf4c66abcc4459b9353208_1"></div><div style="min-height:90.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">_______________________________________________________________________________________</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="margin-top:4.25pt;padding-left:80.82pt;padding-right:80.82pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:400;line-height:100%">CVS HEALTH CORPORATION</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41.2pt;padding-right:41.2pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:400;line-height:100%">Change in Control Agreement for</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:80.75pt;padding-right:80.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:100%">Prem Shah</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">_______________________________________________________________________________________</font></div><div style="margin-top:0.25pt;text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:7pt"><font><br></font></div><div style="height:35.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CONFIDENTIAL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revised 2020</font></td></tr></table></div></div></div><div id="icff3fa9b61bf4c66abcc4459b9353208_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:7.9pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:0.62pt;padding-right:0.62pt;text-align:center;text-indent:-12.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:482.25pt"><tr><td style="width:1.0pt"></td><td style="width:23.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:414.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:38.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitions...................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term of Agreement.....................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Entitlement to Severance Benefit...............................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidentiality&#59; Cooperation with Regard to Litigation&#59; Non-disparagement..............................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-solicitation...........................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remedies....................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Agreement on Other Benefits.......................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not an Employment Agreement..................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resolution of Disputes................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assignability&#59; Binding Nature......................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Representation...........................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment or Waiver&#59; Section 409A.........................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severability.................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Survivorship................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beneficiaries&#47;References............................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Governing Law&#47;Jurisdiction.........................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notices........................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Headings.....................................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Counterparts...............................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></td></tr></table></div><div style="height:35.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="icff3fa9b61bf4c66abcc4459b9353208_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:7pt;padding-right:10.7pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Change in Control Agreement (&#34;Agreement&#34;) is made and entered into as of January 27, 2023, between CVS Pharmacy, Inc., a wholly owned subsidiary of CVS Health Corporation, and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prem Shah </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the &#34;Executive&#34;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:7pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Board of Directors (the &#34;Board&#34;) of CVS Health Corporation (&#34;CVS&#34; or the &#8220;Company&#8221;) believes it is necessary and desirable for the Company to be able to rely upon Executive to continue serving in Executive&#8217;s position with the Company in the event of a pending or actual change in control of CVS&#59;</font></div><div><font><br></font></div><div style="padding-left:7pt;padding-right:13.7pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Executive is employed by Caremark and this Agreement shall not alter Executive's status as an employee at will&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:7pt;padding-right:13.7pt;text-indent:53.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the promises and mutual covenants contained   herein and for other good and valuable consideration, the receipt of which is mutually acknowledged,    CVS and the Executive (individually a &#34;Party&#34; and together the &#34;Parties&#8221;) agree as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:23.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Base Salary&#34; shall mean Executive's annual rate of base salary at the time of Executive&#8217;s termination of employment or, if greater, as in effect immediately prior to a Change in Control.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt">&#34;Cause&#34; shall exist if&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;text-indent:-41.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.11pt">Executive willfully and materially breaches Sections 4 or 5 of this Agreement&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;text-indent:-43.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.04pt">Executive is convicted of a felony involving moral turpitude&#59; or</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;padding-right:9.75pt;text-indent:-45.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.07pt">Executive engages in conduct that constitutes willful gross neglect or willful gross misconduct in carrying out Executive&#8217;s duties under this Agreement, resulting, in either case, in material harm to the financial condition or reputation of the Company.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:115pt;padding-right:8.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Agreement, an act or failure to act on Executive's part shall    be considered &#34;willful&#34; if it was done or omitted to be done by Executive not in    good faith, and shall not include any act or failure to act resulting from any incapacity of Executive. A termination for Cause shall not take effect absent compliance with the provisions of this paragraph. Executive shall be given written notice by the Company of its intention to terminate Executive&#8217;s employment for Cause, such notice (A) to state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Cause is based and (B) to be given within 90 days of the Company's learning of such act or acts or failure or failures to act. Executive shall have 20 days after the date that such written notice has been given to Executive in which to cure such conduct, to extent such cure is possible. If Executive fails to cure such conduct, Executive shall then be entitled to a hearing before the Committee, or an officer    or officers designated by the Committee, at which Executive is entitled to appear. Such hearing shall be held within 25 days of such notice to Executive, provided Executive requests such hearing within 10 days of the written notice from the Company of the intention to terminate Executive for Cause. If, within five days following such hearing, Executive is furnished written notice by the Committee confirming that, in its judgment, grounds for Cause on the basis of the original notice exist, Executive shall thereupon be terminated for Cause. Executive's right   to cure in accordance with this provision applies only in the event of a Change in</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.85pt;padding-left:115pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Control as defined in Section 1(c) below and does not alter Executive's &#34;at will&#34; employment status.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.28pt">A &#8220;Change in Control&#8221; shall be deemed to have occurred if&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:11pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.17pt">any Person (other than (a) the Company, (b) any trustee or other     fiduciary holding securities under any employee benefit plan of the Company, (c) any company owned, directly or indirectly, by the stockholders of the Company immediately after the occurrence with respect to which the evaluation is being made in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such occurrence or (d) any surviving or resulting   entity from a merger or consolidation referred to in clause (iii) below that does not constitute a Change of Control under clause (iii) below)    becomes the Beneficial Owner (except that a Person shall be deemed to be the Beneficial Owner of all shares that any such Person has the right    to acquire pursuant to any agreement or arrangement or upon exercise    of conversion rights, warrants or options or otherwise, without regard to   the sixty day period referred to in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company or of any subsidiary owning directly or indirectly all or substantially all of the consolidated assets of the Company (a &#34;Significant Subsidiary&#34;), representing 30% or more of the combined voting power of the Company's or such Significant Subsidiary's then outstanding securities&#59;</font></div><div><font><br></font></div><div style="padding-left:151.05pt;padding-right:14.3pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.95pt">during any period of twelve (12) consecutive months, individuals who at the beginning of such period constitute the Board, and any new director whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the twelve (12) month period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:14.35pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">the consummation of a merger or consolidation of the Company or any Significant Subsidiary with any other entity, other than a merger or consolidation which would result in the voting securities of the Company or a Significant Subsidiary outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving or resulting entity) more than 50% of the combined voting power of the surviving or resulting entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:14.4pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.17pt">the consummation of a transaction (or series of transactions within a 12 month period) which constitutes the sale or disposition of all or substantially all of the consolidated assets of the Company but in no   event assets having a gross fair market value of less than 40% of the  total gross fair market value of all of the consolidated assets of the Company (other than such a sale or disposition immediately after which such assets will be owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such sale or disposition).</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this definition&#58;</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:187.05pt;padding-right:14.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">The term &#34;Beneficial Owner&#34; shall have the meaning ascribed to such term in Rule 13d-3 under the Exchange Act (including any successor to such Rule).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:187.05pt;padding-right:14.6pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">The term &#34;Exchange Act&#34; means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:187.05pt;padding-right:11.05pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">The term &#34;Person&#34; shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including &#34;group&#34; as defined in Section 13(d) thereof.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;padding-right:17.95pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Committee&#34; shall mean the Management Planning and Development Committee of the Board, or the corresponding committee of the board of directors of a successor to CVS.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt">&#34;Company&#34; shall mean, collectively, CVS and any Subsidiary or affiliate of CVS.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.51pt">&#34;Confidential Information&#34; shall have the meaning set forth in Section 4 below.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;padding-right:25.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Constructive Termination Without Cause&#34; shall mean a termination of the Executive's employment at Executive&#8217;s initiative following the occurrence, without the Executive's written consent, of one or more of the following events (except as a result of a prior termination)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:34.9pt;text-indent:-41.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.06pt">an assignment of any duties to Executive that is materially inconsistent with Executive&#8217;s status as a member of the senior management of CVS&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;padding-right:15pt;text-indent:-43.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.99pt">a material decrease in Executive's annual base salary or target annual incentive award opportunity&#59;</font></div><div><font><br></font></div><div style="padding-left:115pt;padding-right:12.45pt;text-indent:-45.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.07pt">any failure to secure the agreement of any successor to CVS to fully assume the Company&#8217;s material obligations under this Agreement&#59; or</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:115pt;padding-right:29.4pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">a relocation of Executive's principal place of employment more than 35 miles from Executive&#8217;s place of employment before such relocation.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;padding-right:9.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In all cases, no Constructive Termination Without Cause shall be deemed to have    occurred unless (a) the Executive provides written notice to the Company that an event described in subsections i. through iv. has occurred, and such notice identifies such     event and is provided within 30 days of the initial occurrence of such event, (b) a cure period of 45 days following the Company&#8217;s receipt of such notice expires and the    Company has not cured such event within such cure period and (c) the Executive actually terminates his&#47;her employment within 30 days of the expiration of the cure period.</font></div><div><font><br></font></div><div style="padding-left:79pt;padding-right:31.9pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Disability&#34; shall mean disability as that term is defined in the Company's Long-Term Disability Plan.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.06pt">&#34;Effective Date&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.06pt">&#34;Original Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.28pt">&#34;Renewal Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:79pt;padding-right:36.85pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">&#34;Severance Period&#34; shall mean the period of 18 months following the termination of Executive's employment with the Company.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.95pt">&#34;Subsidiary&#34; shall have the meaning set forth in Section 4 below.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:79pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt">&#34;Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:79pt;padding-right:23.45pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#8220;termination of employment&#8221;, &#8220;employment is terminated&#8221; and other similar words shall mean with respect to Executive</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:7.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.12pt">for any plan or arrangement that is subject to the rules of Section 409A of the  Internal Revenue Code (the &#8220;Code&#8221;) a &#8220;Separation from Service&#8221; as such term is defined    in the Income Tax Regulations under Section 409A (the &#8220;409A Regulations&#8221;) of the Code   as modified by the rules described below&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:5.3pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">except in the case where Executive is on a bona fide leave of absence pursuant to the Company&#8217;s policies as provided below, Executive is   deemed to have incurred a Separation from Service on a date if the company and Executive reasonably anticipate that the level of services to be performed by Executive after such date would be permanently reduced to 20% or less of the average services rendered by Executive during the immediately preceding 36-month period (or the total period of employment, if less than 36 months), disregarding periods during which Executive was   on a bona fide leave of absence&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:151.05pt;padding-right:8pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">if Executive is absent from work due to military leave, sick leave, or other bona fide leave of absence pursuant to the Company&#8217;s policies, Executive shall incur a Separation from Service on the first date that the rules of (A), above, are satisfied following the later of (i) the six-month anniversary of the commencement of the leave or (ii) the expiration of Executive&#8217;s right,    if any, to reemployment under statute, contract or Company policy&#59;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:151.05pt;padding-right:7.75pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.17pt">Executive shall be considered to continue employment and to not have a Separation from Service while on a bona fide leave of absence pursuant    to the Company&#8217;s policies if the leave does not exceed 6 consecutive months (12) months for a disability leave of absence) or, if longer, so long as the Executive retains a right to reemployment with the Company or an Affiliate under an applicable statute, contract or Company policy. For this purpose, a &#8220;disability leave of absence&#8221; is an absence due to any medically determinable physical or mental impairment of Executive that can be expected to result in death or can be expected to last for a continuous period of not less than 6 months, where such impairment causes    Executive to be unable to perform the duties of Executive&#8217;s job or a substantially similar job&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:8.2pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.17pt">for purposes of determining whether another organization is an Affiliate of the Company, common ownership of at least 50% shall be determinative&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:151.05pt;padding-right:9.2pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.73pt">the Company specifically reserves the right to determine whether a sale    or other disposition of substantial assets to an unrelated party constitutes  a Separation from Service with respect to Executive providing services to the seller immediately prior to the transaction and providing services to   the buyer after the transaction. Such determination shall be made in accordance with the requirements of Section 409A of the Code&#59; or</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:115pt;padding-right:10.55pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">for any plan or arrangement that is not subject to the rules of Section 409A of the Code, the complete cessation of providing service to the Company or any     Affiliate as an employee.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Term of Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:10.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of this Agreement shall commence on the date of this Agreement (the &#34;Effective Date&#34;) and end on the third anniversary of such date (the &#34;Original Term&#34;). The Original Term shall be automatically renewed for successive one-year terms (the &#34;Renewal Terms&#34;) unless at least 180 days prior to the expiration of the Original Term or any Renewal Term, either Party notifies the   other Party in writing that he&#47;she or it is electing to terminate this Agreement at the expiration of   the then current Term. &#34;Term&#34; shall mean the Original Term and all Renewal Terms. If a Change     in Control shall have occurred during the Term, notwithstanding any other provision of this    Section 2, the Term shall not expire earlier than two years after such Change in Control.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Entitlement to Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:14.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event Executive's employment with the Company is   Terminated Without Cause, other than due to death, or Disability, or in the event there is    a Constructive Termination Without Cause, in each case within two years following a Change in Control, Executive shall be entitled to receive&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:22.55pt;text-indent:-41.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.06pt">Base Salary through the date of termination of Executive's employment, which shall be paid in a cash lump sum not later than 15 days following Executive's termination of employment&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;padding-right:8pt;text-indent:-43.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.99pt">An amount equal to 1.5 times Executive's Base Salary in effect on the date of termination of Executive's employment (or in the event a reduction in Base Salary    is a basis for a Constructive Termination Without Cause, then the Base Salary in effect immediately prior to such reduction), payable in a cash lump sum following Executive's termination of employment&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:10.35pt;text-indent:-45.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.07pt">An amount equal to the most recently established target annual cash incentive bonus amount, prorated based on the portion of the performance year that Executive has worked as of the date of Executive&#8217;s termination. Such payment of   a pro rata annual cash incentive bonus will be payable in a cash lump sum following Executive's termination of employment&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:44.5pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">An amount equal to 1.5 times the most recently established target annual incentive cash bonus amount, payable in a cash lump sum following the Executive's termination of employment&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:14.25pt;text-indent:-43.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.03pt">Elimination of all restrictions on any restricted stock or restricted stock unit   awards outstanding at the time of termination of employment (other than awards under the Company's Partnership Equity Program, which shall be governed by   the terms of such awards)&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:115pt;padding-right:13.6pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">Immediate vesting of all outstanding stock options and the right to exercise such stock options for the remainder of the full term of such option (other than awards under the Company's Partnership Equity Program, which shall be governed by   the terms of such awards)&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:115pt;padding-right:11.9pt;text-indent:-48.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.04pt">The balance of any incentive awards earned as of December 31 of the prior year but not yet paid, which shall be paid in a single lump sum not later than 15 days following Executive's termination of employment&#59;</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:115pt;padding-right:22.15pt;text-indent:-50.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">viii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.97pt">Settlement of all deferred compensation arrangements in accordance with any then applicable deferred compensation plan or election form&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;padding-right:9.45pt;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ix.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.01pt">Continued participation in all medical, health and life insurance plans at the same benefit level at which Executive was participating on the date of termination of Executive&#8217;s employment until the earlier of&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:169.05pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">the end of the Severance Period&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:169.05pt;padding-right:25.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">the date, or dates, Executive receives equivalent coverage and benefits under the plans and programs of a subsequent employer (such coverage and benefits to be determined on a coverage-by- coverage, or benefit-by-benefit, basis)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that (1) if Executive is precluded from continuing Executive&#8217;s   participation in any employee benefit plan or program as provided in this clause (ix) of this Section 3.a, Executive shall receive cash payments equal on an after- tax basis to the cost to Executive of obtaining the benefits provided under the    plan or program in which Executive is unable to participate for the period    specified in this clause (ix) of this Section 3.a, (2) such cost shall be deemed to   be the lowest reasonable cost that would be incurred by Executive in obtaining such benefit on an individual basis, and (3) payment of such amounts shall be made quarterly in advance&#59; and</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;padding-right:29.6pt;text-indent:-43.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:36.03pt">other or additional benefits then due or earned in accordance with applicable plans and programs of the Company.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:79pt;padding-right:20.7pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Change in Control Best Payments Determination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event the Severance Benefits described in Section 3(a) are payable to Executive in connection with a Change in Control and, if paid, could subject Executive to an excise tax under Section 4999 of the Internal Revenue Code (the &#8220;Excise Tax&#8221;), then notwithstanding the provisions of Section 3(a) the Company shall reduce the Severance Benefits (the &#8220;Benefit Reduction&#8221;) under Section 3(a) by the amount necessary to result in the Executive not being subject to the Excise Tax, if such reduction would result in the Executive&#8217;s &#8220;Net After-Tax Amount&#8221; attributable to the Severance Benefits described in Section 3(a) being greater than it    would be if no Benefit Reduction was effected. For this purpose &#8220;Net After-Tax Amount&#8221; shall mean the net amount of Severance Benefits Executive is entitled to receive under   this Agreement after giving effect to all Federal, state and local taxes which would be applicable to such payments, including, but not limited to, the Excise Tax. The determination of whether any such Benefit Reduction shall be effected shall be made by    a nationally recognized public accounting firm selected by the Company (the &#8220;Accounting Firm&#8221;) prior to the occurrence of the Change in Control and such determination shall be binding on both Executive and the Company. In the event it is determined that a Benefit Reduction is required, such reduction of items described in Section 3(a) above shall be done first by reducing cash severance determined in accordance with Section 3(a)(ii), 3(a)(iii) and 3(a)(iv)&#59; to the extent a further Benefit Reduction is necessary, then    Severance Benefits will be reduced from the amounts determined in accordance with Section 3(a)(v) and 3(a)(vi), all as determined by the Accounting Firm.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:79pt;padding-right:26.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt;text-decoration:underline">No Mitigation&#59; No Offset</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of any termination of employment under this Section 3, Executive shall be under no obligation to seek other employment, and the amounts due Executive under this Agreement shall not be offset by any remuneration attributable to any subsequent employment that Executive may obtain.</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:79pt;padding-right:26.7pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Nature of Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any amounts due under this Section 3 are in the nature of severance payments considered to be reasonable by the Company and are not in the nature of a penalty.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:79pt;padding-right:8.6pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Exclusivity of Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon termination of Executive's employment during the Term, Executive shall not be entitled to any severance payments or severance benefits from the Company, or any other payments by the Company, other than the Severance Benefit provided in this Section 3, except as required by law.</font></div><div><font><br></font></div><div style="padding-left:79pt;padding-right:12.45pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.46pt;text-decoration:underline">General Release of Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Executive agrees, as a condition of payment of the   Severance Benefit provided for in this Section 3, that Executive will execute within 60    days of Executive&#8217;s termination of employment a separation agreement, in a form reasonably satisfactory to the Company, that includes a general release of any and all claims arising out of Executive's employment or termination of employment with the Company, other than claims for (i) enforcement of this Agreement, (ii) enforcement of Executive's rights under any of the Company's incentive compensation, equity and&#47;or employee benefit plans and programs to which Executive is entitled under this    Agreement, and (iii) any tort for personal injury not arising out of or related to Executive&#8217;s employment or termination of employment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:10.6pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Subject to the provisions of Section 12(b), all payments to be made pursuant to this Section 3 upon the termination of employment of Executive shall be made or commence, as the case may be, within 75 days after the Executive&#8217;s termination of employment provided, however, that if such termination of employment is after October 15 of a year,   the payout or first payment, as the case may be, shall be made at the end of such 75 day period.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Confidentiality&#59; Cooperation with Regard to Litigation&#59; Non-disparagement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:11.3pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">During the Term and thereafter, Executive shall not, without the prior written consent of   the Company, disclose to anyone (except in good faith in the ordinary course of business to a person who will be advised by Executive to keep such information confidential) or make use of any confidential information except in the performance of Executive&#8217;s duties hereunder or when required to do so by legal process, by any governmental agency   having supervisory authority over the business of the Company or by any administrative   or legislative body (including a committee thereof) that requires Executive to divulge, disclose or make accessible such information. In the event that Executive is so ordered, Executive shall give prompt written notice to the Company in order to allow the Company the opportunity to object to or otherwise resist such order.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:8.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">During the Term and thereafter, Executive shall not disclose the existence or contents of this Agreement beyond what is disclosed in the proxy statement or documents filed with   the government unless and to the extent such disclosure is required by law, by a governmental agency, or in a document required by law to be filed with a governmental agency or in connection with enforcement of Executive&#8217;s rights under this Agreement. In   the event that disclosure is so required, Executive shall give prompt written notice to the Company in order to allow the Company the opportunity to object to or otherwise resist such requirement. This restriction shall not apply to such disclosure by Executive to members of Executive&#8217;s immediate family, Executive&#8217;s tax, legal or financial advisors, any lender, or tax authorities, or to potential future employers to the extent necessary, each of whom shall be advised not to disclose such information.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:14.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">Confidential Information&#34; shall mean all information concerning the business of the Company or any Subsidiary relating to any of their products, product development, trade secrets, customers, suppliers, finances, and business plans and strategies. Excluded   from the definition of Confidential Information is information (i) that is or becomes part of</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:79pt;padding-right:8.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the public domain, other than through the breach of this Agreement by Executive or (ii) regarding the Company's business or industry properly acquired by Executive in the    course of Executive&#8217;s career as an Executive in the Company's industry and independent    of Executive's employment by the Company. For this purpose, information known or available generally within the trade or industry of the Company or any Subsidiary shall be deemed to be known or available to the public.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:30.9pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Subsidiary&#34; shall mean any corporation or other business entity owned or controlled directly or indirectly by CVS.</font></div><div><font><br></font></div><div style="padding-left:79pt;padding-right:11.85pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Executive agrees to cooperate with the Company, during the Term and thereafter (including following Executive's termination of employment for any reason), by being reasonably available to testify on behalf of the Company or any Subsidiary in any action, suit, or proceeding, whether civil, criminal, administrative, or investigative, and to assist   the Company, or any Subsidiary, in any such action, suit, or proceeding, by providing information and meeting and consulting with the Board or its representatives or counsel,   or representatives or counsel to the Company, or any Subsidiary as requested&#59; provided, however that the same does not materially interfere with Executive&#8217;s then current professional activities. The Company agrees to reimburse Executive on an after tax    basis, for all reasonable expenses actually incurred in connection with Executive&#8217;s provision of testimony or assistance.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:14pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.46pt">Executive agrees that, during the Term and thereafter (including following Executive's termination of employment for any reason) Executive will not make statements or representations, or otherwise communicate, directly or indirectly, in writing, orally, or otherwise, or take any action which may, directly or indirectly, disparage or be damaging  to the Company or any Subsidiary or their respective officers, directors, employees, advisors, businesses or reputations. Notwithstanding the foregoing, nothing in this Agreement shall preclude Executive from making truthful statements or disclosures that are required by applicable law, regulation or legal process.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Non-solicitation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:10.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period beginning with the Effective Date and ending 18 months following the  termination of Executive's employment with the Company, Executive, whether acting on  Executive&#8217;s own behalf or by, through or on behalf of any third party, shall not (a) hire any employees of the Company or any Subsidiary, or recruit or solicit any such employees or encourage them to terminate their employment with the Company or any Subsidiary&#59; (b) accept business from any customers of the Company or any Subsidiary, or solicit or encourage any customers, joint venture partners or investors of the Company or any Subsidiary to terminate or diminish their relationship with the Company or any Subsidiary or to violate any agreement with   the Company or any Subsidiary. For purposes of subsection 5(a), an employee of the Company    or any Subsidiary means any person who was employed by the Company or any Subsidiary    within 180 days of such hiring, recruitment, solicitation or encouragement. Executive agrees to make any employer with whom Executive becomes employed during the 18-month period  following Executive's termination with the Company aware of this non-solicitation obligation upon commencing employment with such subsequent entity.</font></div><div><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to whatever other rights and remedies the Company may have at equity or in law, the Company (a) shall have the right to immediately terminate all payments and benefits due under this Agreement if Executive breaches any of the provisions contained in Sections 4 or 5 above, and (b) shall have the right to seek injunctive relief in any court of competent jurisdiction if Executive breaches or threatens to breach any of the provisions contained in Sections 4 or 5 above. Executive acknowledges that such a breach would cause irreparable injury and that</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:43pt;padding-right:10.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">money damages would not provide an adequate remedy for the Company&#59; provided, however,    the foregoing shall not prevent Executive from contesting the issuance of any such injunction on the ground that no violation or threatened violation of Sections 4 or 5 has occurred.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Effect of Agreement on Other Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as specifically provided in this Agreement, the existence of this Agreement shall not be interpreted to preclude, prohibit or restrict the Executive's participation in any other employee benefit or other plans or programs in which he &#47;she currently participates.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Not an Employment Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:8.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement is not, and nothing herein shall be deemed to create, a contract of employment between Executive and the Company. The Company may terminate the employment of Executive   at any time and for any reason, subject to the terms of any employment agreement between the Company and Executive that may then be in effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.72pt;text-decoration:underline">Resolution of Disputes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:8.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any controversy or claim arising out of or relating to this Agreement or any breach or asserted breach hereof or questioning the validity and binding effect hereof arising under or in connection with this Agreement, other than seeking injunctive relief under Sections 4 or 5, shall be resolved    by binding arbitration, to be held at an office closest to the Company&#8217;s principal offices in accordance with the rules and procedures of the American Arbitration Association. Judgment     upon the award rendered by the arbitrator(s) may be entered in any court having jurisdiction   thereof. Pending the resolution of any arbitration or court proceeding, the company shall continue payment of all amounts and benefits due Executive under this Agreement. All reasonable costs   and expenses of any arbitration or court proceeding (including fees and disbursements of    counsel) shall be paid on behalf of or reimbursed to Executive promptly by the Company&#59;    provided, however, that no reimbursement shall be made of such expenses if and to the extent    the arbitrator(s) determine(s) that any of Executive&#8217;s litigation assertions or defenses were in bad   faith or frivolous.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Assignability&#59; Binding Nature</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:8.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors, heirs (in the case of Executive) and permitted assigns. No rights or obligations of the Company under this Agreement may be assigned or transferred by the Company except that     such rights or obligations may be assigned or transferred in connection with the sale or transfer of all or substantially all of the assets of the Company, provided that the assignee or transferee is     the successor to all or substantially all of the assets of the Company and such assignee or transferee assumes the liabilities, obligations and duties of the Company, as contained in this agreement, either contractually or as a matter of law. The Company further agrees that, in the   event of a sale or transfer of assets as described in the preceding sentence, it shall take whatever action it legally can in order to cause such assignee or transferee to expressly assume the liabilities, obligations and duties of the Company hereunder. No rights or obligations of Executive under this Agreement may be assigned or transferred by Executive other than Executive&#8217;s rights    to compensation and benefits, which may be transferred only by will or operation of law, except     as provided in Section 15 below.</font></div><div><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Representation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:10.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company represents and warrants that it is fully authorized and empowered to enter into this Agreement and that the performance of its obligations under this Agreement will not violate any agreement between it and any other person, firm or organization.</font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Amendment or Waiver&#59; Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:79pt;padding-right:11.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">No provision in this Agreement may be amended unless such amendment is agreed to in writing and signed by Executive and an authorized officer of the Company. No waiver by either Party of any breach by the other Party of any condition or provision contained in   this Agreement to be performed by such other Party shall be deemed a waiver of a     similar or dissimilar condition or provision at the same or any prior or subsequent time.   Any waiver must be in writing and signed by Executive or an authorized officer of the Company, as the case may be.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:79pt;padding-right:11.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive and Company agree that it is the intent of the Parties that this Agreement not violate any applicable provision of, or result in any additional tax or penalty under,     Section 409A of the Code, as amended, and that to the extent any provisions of this Agreement do not comply with such Code Section 409A the Parties will make such changes as are mutually agreed upon in order to comply with Code Section 409A. In all events, to the extent required to avoid a violation of the applicable rules under all Section 409A by reason of Code Section 409A(a)(2)(B)(i), payment of any amounts subject to Code Section 409A shall be delayed until the relevant date of payment that will result in compliance with the rules of Code Section 409A(a)(2)(B)(i).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, in whole or in part, the remaining provisions of this Agreement   shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by law.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Survivorship</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective rights and obligations of the Parties hereunder shall survive any termination of Executive's employment to the extent necessary to the intended preservation of such rights and obligations.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Beneficiaries&#47;References</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:8.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive shall be entitled, to the extent permitted under any applicable law, to select and change   a beneficiary or beneficiaries to receive any compensation or benefit payable hereunder following Executive's death by giving the Company written notice thereof. In the event of Executive's death   or a judicial determination of Executive&#8217;s incompetence, references in this Agreement to     Executive shall be deemed, where appropriate, to refer to Executive&#8217;s beneficiary, estate or other legal representative.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Governing Law&#47;Jurisdiction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:9.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement shall be governed by and construed and interpreted in accordance with the laws    of Rhode Island without reference to principles of conflict of laws. Subject to Section 6, the Company and Executive hereby consent to the jurisdiction of any or all of the following courts for purposes of resolving any dispute under this Agreement&#58; (i) the United States District Court for Rhode Island or (ii) any of the courts of the State of Rhode Island. The Company and Executive further agree that any service of process or notice requirements in such proceeding shall be satisfied if the rules of such court relating thereto have been substantially satisfied. The Company and Executive hereby waive, to the fullest extent permitted by applicable law, any objection which    it or he&#47;she may now or hereafter have to such jurisdiction and any defense of inconvenient    forum.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any notice given to a Party shall be in writing and shall be deemed to have been given when delivered personally or sent by certified or registered mail, postage prepaid, return receipt    requested, duly addressed to the Party concerned at the address indicated below or to such    changed address as such Party may subsequently give written notice of&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:61pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to the Company&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115pt;padding-right:242.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c&#47;o CVS Health Corporation</font></div><div style="padding-left:115pt;padding-right:242.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One CVS Drive </font></div><div style="padding-left:117pt;padding-right:242.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Woonsocket, RI 02895</font></div><div style="padding-left:61pt;padding-right:229.75pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Corporate Secretary </font></div><div style="padding-right:229.75pt"><font><br></font></div><div style="padding-left:61pt;padding-right:229.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to the Executive&#58;</font></div><div style="padding-left:115pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prem Shah</font></div><div style="padding-left:115pt;padding-right:253.45pt"><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XXXX XXXXXXXX XXX XX  </font></div><div style="padding-left:115pt;padding-right:253.45pt"><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XXXXXXXX, XX XXXXX</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt;padding-right:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:43pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.16pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:43pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement may be executed in two or more counterparts.</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:43pt;padding-right:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first written above.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:8.3pt;padding-right:8.3pt;text-align:center"><font><br></font></div><div style="padding-right:16.6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">        </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:243.75pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:186.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom">CVS Pharmacy, Inc.</td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laurie P. Havanec      </font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laurie P. Havanec</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief People Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive</font></td></tr><tr style="height:14pt"><td colspan="9" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Prem S. Shah</font></td></tr><tr style="height:14pt"><td colspan="9" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prem S. Shah</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Pharmacy Officer and</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-President- CVS Pharmacy</font></td></tr></table></div><div style="padding-left:8.3pt;padding-right:8.3pt;text-align:center"><font><br></font></div><div style="padding-left:8.3pt;padding-right:8.3pt;text-align:center"><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>a03312023ex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2a57e2754daa4b1a8518584c6f52ba5c_1"></div><div style="min-height:31.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-bottom:3pt;padding-right:36.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div><div style="padding-right:36.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="margin-top:3.3pt;padding-right:36.8pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:108.42pt;padding-right:108.42pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SECOND AMENDMENT TO FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECOND AMENDMENT TO FIVE YEAR CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), dated                               as of March 23, 2023, is entered into among CVS Health Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Lenders party hereto and Bank of America, N.A., as Administrative Agent. Except as otherwise provided herein, capitalized terms used herein which are not defined herein shall have the meanings set forth in the Credit Agreement (as defined below).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower, the Lenders and the Administrative Agent entered into that certain Five Year Credit Agreement, dated as of May 16, 2019, as amended by that certain First Amendment to Five Year Credit Agreement, dated as of May 16, 2022 (and as further amended, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower has requested that the Lenders amend the Credit Agreement as set forth       below.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">NOW, THEREFORE, in consideration of the covenants, conditions and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and pursuant to Section 11.1 of the Credit Agreement, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Amendments to the Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Credit Agreement is hereby amended as follows&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:37.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.8pt">The definition of &#8220;Aggregate Commitment Amount&#8221; in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:145pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Aggregate Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;&#58; at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement. The Aggregate Commitment Amount on the Second Amendment Effective Date is $2,500,000,000.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:73pt;padding-right:38.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.18pt">The following definition is hereby added to Section 1.01 of the Credit Agreement in the appropriate alphabetical order to read as follows&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:181pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Second Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means March 23, 2023.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:73pt;padding-right:46.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.8pt">Section 2.6(d)(1) of the Credit Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:145pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">immediately after giving effect thereto, the sum of all increases in the Aggregate Commitment Amount made subsequent to the Second Amendment Effective Date pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed $500,000,000&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:55.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.18pt">Exhibit A (List of Commitments) to the Credit Agreement is hereby amended and restated in its entirety to read as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%"> attached hereto.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.75pt;text-decoration:underline">Conditions Precedent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Amendment shall become effective on and as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Second Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section 2. Upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968405v5</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:37pt;padding-right:29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2, the Administrative Agent shall promptly provide the Borrower and the Lenders with written confirmation that this Amendment has become effective.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt;text-decoration:underline">Counterparts of this Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Receipt by the Administrative Agent of counterparts of this Amendment executed by the Borrower and the Lenders.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt;text-decoration:underline">Corporate Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a certificate,   dated the Second Amendment Effective Date, of the Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Amendment, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Amendment and the other Loan Documents, and any other certificates, requests, notices or other documents required hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary of State of the State of Delaware.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt;text-decoration:underline">Opinions of Counsel to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received (i) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the Second Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent, and (ii) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the Second Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt;text-decoration:underline">No Default and Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a certificate, dated the Second Amendment Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the representations and warranties contained in this Amendment are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the Second Amendment Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:22.8pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Administrative Agent shall have received all fees and other amounts   due and payable to it on the Second Amendment Effective Date, including the upfront fees payable to the Lenders, in respect of this Amendment.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.02pt;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (i) Each Lender shall have received    such documents and information as it may have requested in order to comply with &#8220;know-your- customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the Second Amendment Effective Date, and (ii) at least five Domestic Business Days prior to the Second Amendment Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:145pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Borrower hereby represents and warrants as follows&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37.1pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:24.63pt">The Borrower has taken all necessary corporate action to authorize the execution, delivery and performance of this Amendment.</font></div><div style="padding-left:37pt;padding-right:37.1pt;text-indent:108pt"><font><br></font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968405v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:37pt;padding-right:37.1pt"><font><br></font></div><div style="margin-top:3.9pt;padding-left:37pt;padding-right:37.1pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.58pt">This Amendment has been duly executed and delivered by the Borrower and constitutes the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37.1pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.53pt">No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery, and performance by the Borrower of this Amendment or is required as a condition to the enforceability of this Amendment against the Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:36.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">The Borrower represents and warrants to the Lenders that the representations and warranties of the Borrower set forth in Section 4 of the Credit Agreement (as amended by this Amendment) are true and correct in all material respects on the date hereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language is true and correct (after giving effect to any qualification therein) in all respects on the date hereof), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt">Except as expressly amended hereby, the Credit Agreement and the other Loan Documents shall remain in full force and effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">On and after the Second Amendment Effective Date, each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221; or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to &#8220;the Credit Agreement&#8221;, &#8220;thereunder&#8221;, &#8220;thereof&#8221; or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement as modified hereby. This Amendment shall constitute a Loan Document.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt">Subject to Section 11.8 of the Credit Agreement, this Amendment may be in the form of an Electronic Record and may be executed using Electronic Signatures (including facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Amendment may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same agreement.</font></div><div><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">This Amendment and the rights and obligations of the parties hereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div><font><br></font></div><div style="padding-left:108.3pt;padding-right:108.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;signature pages follow&#93;</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div style="margin-top:0.65pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968405v5</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_7"></div><hr style="page-break-after:always"><div style="min-height:84.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.55pt;padding-left:86.25pt"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">parties have caused this Amendment to be du</font><font style="color:#1d1d1d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">l</font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">y executed as of </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the date </font><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">fir</font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">st </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">written </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">above.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:258.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Carol A. DeNale                                     </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Carol A. DeNale</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President and Treasurer&#160;&#160;&#160;&#160;</font></div><div style="padding-left:1.08pt"><font><br></font></div><div style="padding-left:1.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_13"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kyle D Harding                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kyle D Harding</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_16"></div><hr style="page-break-after:always"><div style="min-height:43.92pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer, the</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Swing Line Lender and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joseph L. Corah                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joseph L. Corah</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_19"></div><hr style="page-break-after:always"><div style="min-height:69.84pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Christopher M. Aitkin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Christopher M. Aitkin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_22"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; William E. Briggs IV                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William E. Briggs IV</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:46.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_25"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issuer and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Gregory T. Martin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Gregory T. Martin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_28"></div><hr style="page-break-after:always"><div style="min-height:2.16pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as an Issuer and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Darin Mullis                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Darin Mullis</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_31"></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CITIBANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kevin Ciok                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kevin Ciok</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:51.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_34"></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CREDIT SUISSE AG, NEW YORK</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Doreen Barr                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Doreen Barr</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Wesley Cronin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Wesley Cronin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:46.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_37"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIZUHO BANK LTD., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Tracy Rahn                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Tracy Rahn</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_40"></div><hr style="page-break-after:always"><div style="min-height:79.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROYAL BANK OF CANADA, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Scott MacVicar                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Scott MacVicar</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:61.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_43"></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRUIST BANK, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Jonathan Hart                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Jonathan Hart</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_46"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">U.S. BANK NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joyce P. Dorsett                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joyce P. Dorsett</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_49"></div><hr style="page-break-after:always"><div style="min-height:0pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIFTH THIRD BANK NATIONAL</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Todd Robinson                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Todd Robinson</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director, SVP</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_52"></div><hr style="page-break-after:always"><div style="min-height:77.76pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MORGAN STANLEY BANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Michael King                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Michael King</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_55"></div><hr style="page-break-after:always"><div style="min-height:45.36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PNC BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; William P. Herold                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William P. Herold</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_58"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CORPORATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Cindy Hwee                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Cindy Hwee</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_61"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE BANK OF NEW YORK MELLON, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Luke Daly                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Luke Daly</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF CHINA, NEW YORK BRANCH,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Raymond Qiao                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Raymond Qiao</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_64"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:252pt;padding-right:29pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INDUSTRIAL AND COMMERCIAL BANK</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OF CHINA LIMITED, NEW YORK </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Yuanyuan Peng                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Yuanyuan Peng</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Lindsay Du                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Lindsay Du</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_67"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KEYBANK NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Marianne T. Meil                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  MARIANNE T MEIL</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    SR. VICE PRESIDENT</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_70"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TD BANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Bernadette Collins                                     </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Bernadette Collins</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;padding-left:54.15pt;padding-right:54.15pt;text-align:center"><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">&#91;Second Amendment </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">to </font><font style="color:#525254;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">2025 </font><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%">Facility&#93;</font></div></div></div><div id="i2a57e2754daa4b1a8518584c6f52ba5c_73"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.05pt;padding-left:108.3pt;padding-right:108.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:5.95pt;padding-left:108.37pt;padding-right:108.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIST OF COMMITMENTS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:3.55pt;padding-right:3.55pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:534.00pt"><tr><td style="width:1.0pt"></td><td style="width:253.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:96.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:78.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:39pt"><td colspan="3" style="background-color:#cccccc;border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:92.82pt;padding-right:92.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:111%">Lender</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27.65pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">Commitment Amount</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-6.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">Letter of Credit Commitment</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.67pt;padding-right:1.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">Commercial Letter of Credit Commitment</font></div></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Bank of America, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.75pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$50,000,000</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Barclays Bank PLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$0</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goldman Sachs Bank USA</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$0</font></div></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMorgan Chase Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$50,000,000</font></div></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Wells Fargo Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$50,000,000</font></div></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Citibank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Credit Suisse AG, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mizuho Bank, Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Royal Bank of Canada</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Truist Bank</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">U.S. Bank National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Fifth Third Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Morgan Stanley Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">PNC Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Sumitomo Mitsui Banking Corporation</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">The Bank of New York Mellon</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$74,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Bank of China, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:32pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;padding-right:0.55pt;text-indent:-2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Industrial and Commercial Bank of China Limited, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">KeyBank National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TD Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TOTAL</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.05pt;padding-right:12.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">$2,500,000,000</font></div></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.3pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$250,000,000</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.8pt;padding-right:0.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">$150,000,000</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:37pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968405v5</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>a03312023ex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifceeb01d33e24562a4792dc6307d5399_1"></div><div style="min-height:31.68pt;width:100%"><div><font><br></font></div><div style="margin-top:3.5pt;padding-right:36.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.6</font></div><div style="padding-right:36.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="margin-top:3.3pt;padding-right:36.8pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90.27pt;padding-right:90.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SECOND AMENDMENT TO FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECOND AMENDMENT TO FIVE YEAR CREDIT AGREEMENT  (this  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;),  dated as of March 23, 2023, is entered into among CVS Health Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Lenders party hereto and Bank of America, N.A., as Administrative Agent. Except as otherwise provided herein, capitalized terms used herein which are not defined herein shall have the meanings set forth in the Credit Agreement (as defined below).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower, the Lenders and the Administrative Agent entered into that certain Five Year Credit Agreement, dated as of May 11, 2021, as amended by that certain First Amendment to Five Year Credit Agreement, dated as of May 16, 2022 (and as further amended, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower has requested that the Lenders amend the Credit Agreement as set forth      below.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">NOW, THEREFORE, in consideration of the covenants, conditions and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and pursuant to Section 11.1 of the Credit Agreement, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Amendments to the Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Credit Agreement is hereby amended as follows&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:37.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.8pt">The definition of &#8220;Aggregate Commitment Amount&#8221; in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:145pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Aggregate Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;&#58; at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement. The Aggregate  Commitment  Amount  on  the  Second  Amendment  Effective  Date is $2,500,000,000.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:73pt;padding-right:38.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.18pt">The following definition is hereby added to Section 1.01 of the Credit Agreement in the appropriate alphabetical order to read as follows&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:181pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Second Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means March 23, 2023.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:73pt;padding-right:46.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.8pt">Section 2.6(d)(1) of the Credit Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:145pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">immediately after giving effect thereto, the sum of all increases in the Aggregate Commitment Amount made subsequent to the Second Amendment Effective Date pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed $500,000,000&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:37.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.18pt">Exhibit A (List of Commitments) to the Credit Agreement is hereby amended and restated in its entirety to read as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%"> attached hereto.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.75pt;text-decoration:underline">Conditions Precedent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Amendment shall become effective on and as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Second Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section 2. Upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this  Section</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">1</font></div><div style="margin-top:0.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968403v5</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:37pt;padding-right:29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2, the Administrative Agent shall promptly provide the Borrower and the Lenders with written confirmation that this Amendment has become effective.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt;text-decoration:underline">Counterparts of this Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Receipt by the Administrative Agent of counterparts of this Amendment executed by the Borrower and the Lenders.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt;text-decoration:underline">Corporate Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a certificate,  dated the Second Amendment Effective Date, of the Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Amendment, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Amendment and the other Loan Documents, and any other certificates, requests, notices or other documents required hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary of State of the State of Delaware.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt;text-decoration:underline">Opinions of Counsel to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received (i) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the Second Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent, and (ii) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the Second Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt;text-decoration:underline">No Default and Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a certificate, dated the Second Amendment Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the representations and warranties contained in this Amendment are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the Second Amendment Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:22.8pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">.        The Administrative Agent shall have received all fees and other amounts due and payable to it on the Second Amendment Effective Date, including the upfront fees payable to the Lenders, in respect of this Amendment.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.02pt;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.    (i) Each Lender shall have received such documents and information as it may have requested in order to comply with &#8220;know-your- customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the Second Amendment Effective Date, and (ii) at least five Domestic Business Days prior to the Second Amendment Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:145pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Borrower hereby represents and warrants as follows&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37.1pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:24.63pt">The Borrower has taken all necessary corporate action to authorize the execution, delivery and performance of this Amendment.</font></div><div style="padding-left:37pt;padding-right:37.1pt;text-indent:108pt"><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">2</font></div><div style="margin-top:0.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968403v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:37pt;padding-right:37.1pt"><font><br></font></div><div style="margin-top:3.9pt;padding-left:37pt;padding-right:37.1pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.58pt">This Amendment has been duly executed and delivered by the Borrower and constitutes the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37.1pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.53pt">No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery, and performance by the Borrower of this Amendment or is required as a condition to the enforceability of this Amendment against the Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:36.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">The Borrower represents and warrants to the Lenders that the representations and warranties of the Borrower set forth in Section 4 of the Credit Agreement (as amended by this Amendment) are true and correct in all material respects on the date hereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language is true and correct (after giving effect to any qualification therein) in all respects on the date hereof), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt">Except as expressly amended hereby, the Credit Agreement and the other Loan Documents shall remain in full force and effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">On and after the Second Amendment Effective Date, each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221; or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to &#8220;the Credit Agreement&#8221;, &#8220;thereunder&#8221;, &#8220;thereof&#8221; or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement as modified hereby. This Amendment shall constitute a Loan Document.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt">Subject to Section 11.8 of the Credit Agreement, this Amendment may be in the form of an Electronic Record and may be executed using Electronic Signatures (including facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Amendment may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same agreement.</font></div><div><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">This Amendment and the rights and obligations of the parties hereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div><font><br></font></div><div style="padding-left:108.3pt;padding-right:108.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;signature pages follow&#93;</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">3</font></div><div style="margin-top:0.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968403v5</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_7"></div><hr style="page-break-after:always"><div style="min-height:87.12pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.25pt;padding-left:85.5pt"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">The parties have ca</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">u</font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">sed </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">this Amendme</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">t to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">b</font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">e </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">du</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">l</font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">y executed </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">as of the date first written </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">above.</font></div><div><font><br></font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Carol A. DeNale                                     </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Carol A. DeNale</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President and Treasurer&#160;&#160;&#160;&#160;</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_13"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kyle D Harding                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kyle D Harding</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer, the</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Swing Line Lender and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joseph L. Corah                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joseph L. Corah</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_16"></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Christopher M. Aitkin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Christopher M. Aitkin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_19"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; William E. Briggs IV                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William E. Briggs IV</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issuer and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Gregory T. Martin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Gregory T. Martin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_22"></div><hr style="page-break-after:always"><div style="min-height:46.8pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as an Issuer and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Darin Mullis                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Darin Mullis</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_25"></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CITIBANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kevin Ciok                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kevin Ciok</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:51.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_28"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CREDIT SUISSE AG, NEW YORK</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Doreen Barr                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Doreen Barr</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Wesley Cronin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Wesley Cronin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_31"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIZUHO BANK LTD., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Tracy Rahn                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Tracy Rahn</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_34"></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROYAL BANK OF CANADA, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Scott MacVicar                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Scott MacVicar</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRUIST BANK, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Jonathan Hart                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Jonathan Hart</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:46.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_40"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">U.S. BANK NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joyce P. Dorsett                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joyce P. Dorsett</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_43"></div><hr style="page-break-after:always"><div style="min-height:0pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIFTH THIRD BANK NATIONAL</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Todd Robinson                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Todd Robinson</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director, SVP</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_46"></div><hr style="page-break-after:always"><div style="min-height:77.04pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MORGAN STANLEY BANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Michael King                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Michael King</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_49"></div><hr style="page-break-after:always"><div style="min-height:2.16pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PNC BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; William P. Herold                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William P. Herold</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> </font></div><div style="height:46.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_55"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CORPORATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Cindy Hwee                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Cindy Hwee</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_58"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE BANK OF NEW YORK MELLON, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Luke Daly                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Luke Daly</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_61"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF CHINA, NEW YORK BRANCH,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Raymond Qiao                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Raymond Qiao</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_64"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:252pt;padding-right:29pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INDUSTRIAL AND COMMERCIAL BANK</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OF CHINA LIMITED, NEW YORK </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Yuanyuan Peng                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Yuanyuan Peng</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Lindsay Du                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Lindsay Du</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_67"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KEYBANK NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Marianne T. Meil                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  MARIANNE T. MEIL</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    SR. VICE PRESIDENT</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_70"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TD BANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Bernadette Collins                                     </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Bernadette Collins</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.6pt;text-align:center"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#91;Seco</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">n</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">d </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Amendment </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">to </font><font style="color:#565757;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">2026 </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">Faci</font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">l</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%">ity&#93;</font></div></div></div><div id="ifceeb01d33e24562a4792dc6307d5399_73"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.05pt;padding-left:108.3pt;padding-right:108.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:5.95pt;padding-left:108.37pt;padding-right:108.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIST OF COMMITMENTS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:3.55pt;padding-right:3.55pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:538.50pt"><tr><td style="width:1.0pt"></td><td style="width:253.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:96.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:81.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:99.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:39pt"><td colspan="3" style="background-color:#cccccc;border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:106.32pt;padding-right:106.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:111%">Lender</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27.65pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">Commitment Amount</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-6.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">Letter of Credit Commitment</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.67pt;padding-right:1.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">Commercial Letter of Credit Commitment</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Bank of America, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.75pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.42pt;padding-right:1.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$50,000,000</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Barclays Bank PLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$0</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goldman Sachs Bank USA</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$0</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMorgan Chase Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$50,000,000</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Wells Fargo Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 15.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$50,000,000</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$50,000,000</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Citibank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Credit Suisse AG, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mizuho Bank, Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Royal Bank of Canada</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Truist Bank</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">U.S. Bank National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Fifth Third Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Morgan Stanley Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">PNC Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Sumitomo Mitsui Banking Corporation</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">The Bank of New York Mellon</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$74,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Bank of China, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:32pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;padding-right:0.55pt;text-indent:-2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Industrial and Commercial Bank of China Limited, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">KeyBank National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TD Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TOTAL</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.05pt;padding-right:12.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">$2,500,000,000</font></div></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.3pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">$250,000,000</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1pt solid #000000;border-right:1.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.8pt;padding-right:0.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">$150,000,000</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:37pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968403v5</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>8
<FILENAME>a03312023ex107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_1"></div><div style="min-height:41.76pt;width:100%"><div><font><br></font></div><div style="margin-top:3.5pt;padding-right:36.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.7</font></div><div style="margin-top:3.5pt;padding-right:36.8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="margin-top:3.5pt;padding-right:36.8pt;text-align:right"><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:93.65pt;padding-right:93.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">FIRST AMENDMENT TO FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">FIRST AMENDMENT TO FIVE YEAR CREDIT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), dated as  of March 23, 2023, is entered into among CVS Health Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Lenders party hereto and Bank of America, N.A., as Administrative Agent. Except as otherwise provided herein, capitalized terms used herein which are not defined herein shall have the meanings set forth in the Credit Agreement (as defined below).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower, the Lenders and the Administrative Agent entered into that certain Five Year Credit Agreement, dated as of May 16, 2022 (as amended, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:37pt;padding-right:37.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower has requested that the Lenders amend the Credit Agreement as set forth       below.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">NOW, THEREFORE, in consideration of the covenants, conditions and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and pursuant to Section 11.1 of the Credit Agreement, the parties hereto hereby agree as follows&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Amendments to the Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Credit Agreement is hereby amended as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:37.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt">The definition of &#8220;Aggregate Commitment Amount&#8221; in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:145pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Aggregate Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;&#58; at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement. The Aggregate Commitment Amount on the First Amendment Effective Date is $2,500,000,000.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:73pt;padding-right:38.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">The following definition is hereby added to Section 1.01 of the Credit Agreement in the appropriate alphabetical order to read as follows&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:181pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">First Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means March 23, 2023.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:73pt;padding-right:46.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.8pt">Section 2.6(d)(1) of the Credit Agreement is hereby amended and restated in its entirety to read as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:145pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:22.18pt">immediately after giving effect thereto, the sum of all increases in the Aggregate Commitment Amount made subsequent to the First Amendment Effective Date pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> shall not exceed $500,000,000&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:55.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.18pt">Exhibit A (List of Commitments) to the Credit Agreement is hereby amended and restated in its entirety to read as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%"> attached hereto.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:37pt;padding-right:37.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.75pt;text-decoration:underline">Conditions Precedent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Amendment shall become effective on and as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section 2. Upon satisfaction (or waiver in accordance with Section 11.1 of the Credit Agreement) of the conditions precedent set forth in this Section 2, the Administrative Agent shall promptly provide the Borrower and the Lenders with written confirmation that this Amendment has become effective.</font></div><div style="height:30.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968406v5</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt;text-decoration:underline">Counterparts of this Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Receipt by the Administrative Agent of counterparts of this Amendment executed by the Borrower and the Lenders.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt;text-decoration:underline">Corporate Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a certificate,   dated the First Amendment Effective Date, of the Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Amendment, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Amendment and the other Loan Documents, and any other certificates, requests, notices or other documents required hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary of State  of the State of Delaware.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt;text-decoration:underline">Opinions of Counsel to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have  received (i) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the  First Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent,  and (ii) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the First Amendment Effective Date, in a form reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:73pt;padding-right:36.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt;text-decoration:underline">No Default and Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a certificate, dated the First Amendment Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the representations  and warranties contained in this Amendment are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the First Amendment Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received all fees and other amounts    due and payable to it on the First Amendment Effective Date, including the upfront fees payable to the Lenders, in respect of this Amendment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.02pt;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (i) Each Lender shall have received     such documents and information as it may have requested in order to comply with &#8220;know-your- customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the First Amendment Effective Date, and (ii) at least five Domestic Business Days prior to the First Amendment Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:145pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Borrower hereby represents and warrants as follows&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:37pt;padding-right:50.75pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:24.63pt">The Borrower has taken all necessary corporate action to authorize the execution, delivery and performance of this Amendment.</font></div><div><font><br></font></div><div style="padding-left:37pt;padding-right:37.15pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.58pt">This Amendment has been duly executed and delivered by the Borrower and constitutes the valid and legally binding obligations of the Borrower, enforceable against the Borrower</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.65pt;padding-left:1pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968406v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.9pt;padding-left:37pt;padding-right:37.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:37pt;padding-right:37.1pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.53pt">No consent or approval of, or other action by, shareholders of the  Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery, and performance by the Borrower of this Amendment or is required as a condition to the enforceability of this Amendment against the Borrower.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:73pt;padding-right:36.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">The Borrower represents and warrants to the Lenders that the representations and warranties of the Borrower set forth in Section 4 of the Credit Agreement (as amended by this Amendment) are true and correct in all material respects on the date hereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language is true and correct (after giving effect to any qualification therein) in all respects on the date hereof), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:73pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:73pt;padding-right:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:22.8pt">Except as expressly amended hereby, the Credit Agreement and the other Loan Documents shall remain in full force and effect.</font></div><div><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">On and after the First Amendment Effective Date, each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221; or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to &#8220;the Credit Agreement&#8221;, &#8220;thereunder&#8221;, &#8220;thereof&#8221; or words of like import referring to the Credit Agreement, shall mean and  be a reference to the Credit Agreement as modified hereby. This Amendment shall constitute a         Loan Document.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:73pt;padding-right:37.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.8pt">Subject to Section 11.8 of the Credit Agreement, this Amendment may be in the form of an Electronic Record and may be executed using Electronic Signatures (including facsimile and .pdf) and shall be considered an original, and shall have the same legal effect, validity and enforceability as a paper record. This Amendment may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same agreement.</font></div><div><font><br></font></div><div style="padding-left:73pt;padding-right:37.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.18pt">This Amendment and the rights and obligations of the parties hereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:115pt;padding-right:115pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;signature pages follow&#93;</font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.65pt;padding-left:1pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968406v5</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_7"></div><hr style="page-break-after:always"><div style="min-height:84.24pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.6pt;padding-left:86.6pt"><font style="color:#4d4d4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The </font><font style="color:#3b3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">parties have </font><font style="color:#4d4d4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">caused </font><font style="color:#3b3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">this Amendment to be duly executed as of </font><font style="color:#4d4d4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the </font><font style="color:#3b3d3d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">date </font><font style="color:#4d4d4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">first written abov</font><font style="color:#646767;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e</font><font style="color:#4d4d4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Carol A. DeNale                                     </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Carol A. DeNale</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President and Treasurer&#160;&#160;&#160;&#160;</font></div><div style="height:64.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_10"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Administrative Agent</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kyle D Harding                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kyle D Harding</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_13"></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer, the</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Swing Line Lender and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joseph L. Corah                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joseph L. Corah</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_16"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="text-indent:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BARCLAYS BANK PLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as an Issuer and a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Christopher M. Aitkin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Christopher M. Aitkin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_19"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:289.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as an Issuer</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; William E. Briggs IV                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William E. Briggs IV</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_22"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Issuer and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Gregory T. Martin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Gregory T. Martin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="margin-top:0.7pt;padding-left:289.45pt"><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_25"></div><hr style="page-break-after:always"><div style="min-height:2.16pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as an Issuer and a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Darin Mullis                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Darin Mullis</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director</font></div><div style="margin-top:0.65pt;padding-left:283.15pt"><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_31"></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CITIBANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Kevin Ciok                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kevin Ciok</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:51.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_34"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CREDIT SUISSE AG, NEW YORK</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Doreen Barr                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Doreen Barr</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Wesley Cronin                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Wesley Cronin</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div><font><br></font></div><div style="height:43.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_37"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIZUHO BANK LTD., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Tracy Rahn                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Tracy Rahn</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_40"></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROYAL BANK OF CANADA, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Scott MacVicar                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Scott MacVicar</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_43"></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRUIST BANK, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Jonathan Hart                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Jonathan Hart</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_46"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">U.S. BANK NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Joyce P. Dorsett                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Joyce P. Dorsett</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_49"></div><hr style="page-break-after:always"><div style="min-height:0pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIFTH THIRD BANK NATIONAL</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Todd Robinson                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Todd Robinson</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director, SVP</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_52"></div><hr style="page-break-after:always"><div style="min-height:77.04pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MORGAN STANLEY BANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Michael King                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Michael King</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="padding-left:471.75pt"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_58"></div><hr style="page-break-after:always"><div style="min-height:51.84pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.45pt;text-indent:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PNC BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; William P. Herold                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  William P. Herold</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> </font></div><div style="height:46.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_61"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CORPORATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Cindy Hwee                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Cindy Hwee</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%"> </font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_64"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE BANK OF NEW YORK MELLON, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Luke Daly                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Luke Daly</font></div><div style="margin-bottom:120pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_2199023256162"></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-indent:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BANK OF CHINA, NEW YORK BRANCH,</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Raymond Qiao                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Raymond Qiao</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Vice President</font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_67"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INDUSTRIAL AND COMMERCIAL BANK</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OF CHINA LIMITED, NEW YORK </font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Yuanyuan Peng                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Yuanyuan Peng</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Lindsay Du                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Lindsay Du</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_70"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KEYBANK NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as</font></div><div style="margin-bottom:36pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Marianne T. Meil                                 </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  MARIANNE T. MEIL</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    SR. VICE PRESIDENT</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="height:46.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_73"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TD BANK, N.A., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">       &#47;s&#47; Bernadette Collins                                     </font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Bernadette Collins</font></div><div style="margin-bottom:24pt;padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Authorized Signatory</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%">&#91;First Amendment to 2027 Facility&#93;</font></div></div></div><div id="ic57d6a1bd6ce487db4d6dfed3043d66e_76"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:115pt;padding-right:115pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:115.07pt;padding-right:115.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIST OF COMMITMENTS</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:3.52pt;padding-right:3.52pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:539.25pt"><tr><td style="width:1.0pt"></td><td style="width:253.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:96.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:80.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:100.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:39pt"><td colspan="3" style="background-color:#cccccc;border-left:2.5pt double #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:107.07pt;padding-right:107.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:111%">Lender</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27.65pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">Commitment Amount</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-6.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:118%">Letter of Credit Commitment</font></div></td><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.55pt;padding-right:3.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">Commercial Letter of Credit Commitment</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Bank of America, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:12.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$30,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.55pt;padding-right:3.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$40,000,000</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Barclays Bank PLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:12.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$30,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$0</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Goldman Sachs Bank USA</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:12.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$30,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.52pt;padding-right:3.52pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$0</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMorgan Chase Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:12.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$30,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.55pt;padding-right:3.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$40,000,000</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Wells Fargo Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$198,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:12.2pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$30,000,000</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.55pt;padding-right:3.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$40,000,000</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Citibank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.8pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Credit Suisse AG, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.9pt;padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mizuho Bank, Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Royal Bank of Canada</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Truist Bank</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">U.S. Bank National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;padding-right:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$142,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Fifth Third Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Morgan Stanley Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">PNC Bank, National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Sumitomo Mitsui Banking Corporation</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$92,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">The Bank of New York Mellon</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$74,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Bank of China, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;padding-right:0.55pt;text-indent:-2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Industrial and Commercial Bank of China Limited, New York Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">KeyBank National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">TD Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.02pt;padding-right:12.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">$54,000,000</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfbfbf;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:58pt;padding-right:58pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">TOTAL</font></div></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12.05pt;padding-right:12.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$2,500,000,000</font></div></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$150,000,000</font></div></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:1pt solid #000000;border-right:2.5pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.35pt;padding-right:3.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$120,000,000</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:37pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHAR1&#92;1968406v5</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>9
<FILENAME>a03312023ex151.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i10e4bd74ccc54948b62c0640509a0ca8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 15.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter re&#58; Unaudited Interim Financial Information</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">May&#160;3, 2023 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-238506 and Form S-8 Nos. 333-271582, 333-270936, 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated May&#160;3, 2023, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that is included in its Form 10-Q for the quarter ended March&#160;31, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>a03312023ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie6acce70419b44f6997aaa29f782d288_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:8pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>a03312023ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia7fc8217c72e4939ab0e3565ea9e055d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>a03312023ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i95c48fb55a1e400c912770132b1d4fed_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>a03312023ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iaf8a07e4ba6d4c908ef5610f5adee9cd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial&#160;Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>cvs-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a5201116-fa32-47d9-bf67-a4b1f9934cb7,g:676c592e-810f-43b8-9a45-1cf85e252b17-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>0000005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited_1" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSale" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSale">
        <link:definition>0000010 - Disclosure - Acquisition and Assets Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>0000011 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>0000012 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>0000013 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccounts" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts">
        <link:definition>0000014 - Disclosure - Other Insurance Liabilities and Separate Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://www.cvshealth.com/role/Borrowings">
        <link:definition>0000015 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>0000016 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLoss" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss">
        <link:definition>0000017 - Disclosure - Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.cvshealth.com/role/EarningsPerShare">
        <link:definition>0000018 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>0000019 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>0000020 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000021 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>0000022 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSaleTables" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables">
        <link:definition>0000023 - Disclosure - Acquisition and Assets Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>0000024 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>0000025 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>0000026 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsTables" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables">
        <link:definition>0000027 - Disclosure - Other Insurance Liabilities and Separate Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://www.cvshealth.com/role/BorrowingsTables">
        <link:definition>0000028 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables">
        <link:definition>0000029 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLossTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossTables">
        <link:definition>0000030 - Disclosure - Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsPerShareTables">
        <link:definition>0000031 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>0000032 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000033 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails">
        <link:definition>0000034 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>0000035 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDeferredAcquisitionCostsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails">
        <link:definition>0000036 - Disclosure - Significant Accounting Policies - Deferred Acquisition Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>0000037 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails">
        <link:definition>0000038 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>0000039 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails">
        <link:definition>0000040 - Disclosure - Significant Accounting Policies - New Accounting Pronouncements Recently Adopted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails">
        <link:definition>0000041 - Disclosure - Significant Accounting Policies - Changes in balances of long-duration insurance liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails">
        <link:definition>0000042 - Disclosure - Significant Accounting Policies - Adjustments Resulting From Applying New Accounting Standard (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSaleNarrativeDetails" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails">
        <link:definition>0000043 - Disclosure - Acquisition and Assets Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails">
        <link:definition>0000044 - Disclosure - Acquisition and Assets Held for Sale - Schedule of Fair Value of Consideration Transferred (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>0000045 - Disclosure - Acquisition and Assets Held for Sale - Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails">
        <link:definition>0000046 - Disclosure - Acquisition and Assets Held for Sale - Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails">
        <link:definition>0000047 - Disclosure - Acquisition and Assets Held for Sale - Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>0000048 - Disclosure - Acquisition and Assets Held for Sale - Summary of Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTotalInvestmentScheduleDetails" roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails">
        <link:definition>0000049 - Disclosure - Investments - Total Investment Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>0000050 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails_1" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1">
        <link:definition>0000050 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>0000051 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>0000052 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>0000053 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>0000054 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>0000055 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>0000056 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>0000057 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementonaRecurringBasisDetails" roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails">
        <link:definition>0000058 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails">
        <link:definition>0000059 - Disclosure - Fair Value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>0000060 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>0000061 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
        <link:definition>0000062 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>0000063 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails">
        <link:definition>0000064 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails">
        <link:definition>0000065 - Disclosure - Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails">
        <link:definition>0000066 - Disclosure - Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails">
        <link:definition>0000067 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails">
        <link:definition>0000068 - Disclosure - Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails">
        <link:definition>0000069 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsScheduleofBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails">
        <link:definition>0000070 - Disclosure - Borrowings - Schedule of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsNarrativeDetails" roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails">
        <link:definition>0000071 - Disclosure - Borrowings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails">
        <link:definition>0000072 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAcceleratedShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails">
        <link:definition>0000073 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDividendsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails">
        <link:definition>0000074 - Disclosure - Shareholders' Equity - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLossDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails">
        <link:definition>0000075 - Disclosure - Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails">
        <link:definition>0000076 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000077 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>0000078 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails">
        <link:definition>0000079 - Disclosure - Segment Reporting - Retrospective Adjustments to Segment Composition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
        <link:definition>0000080 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails">
        <link:definition>0000081 - Disclosure - Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueJuly2025Member" abstract="true" name="SeniorNotes3.875DueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" abstract="true" name="HealthCareandOtherInsuranceLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes5DueDecember2024Member" abstract="true" name="SeniorNotes5DueDecember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PreCombinationServicesMember" abstract="true" name="PreCombinationServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfWalkInMedicalClinics" abstract="false" name="NumberOfWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_OtherLongTermInsuranceLiabilitiesMember" abstract="true" name="OtherLongTermInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesNumberOfStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SettlementFrameworkMember" abstract="true" name="SettlementFrameworkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes3.375DueAugust2024Member" abstract="true" name="SeniorNotes3.375DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherReceivablesMember" abstract="true" name="OtherReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes50DueFebruary2026Member" abstract="true" name="SeniorNotes50DueFebruary2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueNovember2024Member" abstract="true" name="SeniorNotes3.5DueNovember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DeferredIncomeTaxesAndOtherNoncashItems" abstract="false" name="DeferredIncomeTaxesAndOtherNoncashItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherPayablesMember" abstract="true" name="OtherPayablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" abstract="false" name="BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.75DueApril2030Member" abstract="true" name="SeniorNotes3.75DueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LegalSettlementPeriodOfPayment" abstract="false" name="LegalSettlementPeriodOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" abstract="false" name="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TransferOfSharesToTreasuryStockValue" abstract="false" name="TransferOfSharesToTreasuryStockValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PaymentsForAcceleratedShareRepurchasesAmount" abstract="false" name="PaymentsForAcceleratedShareRepurchasesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollingInterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.875DueJuly2035Member" abstract="true" name="SeniorNotes4.875DueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.625DueApril2027Member" abstract="true" name="SeniorNotes3.625DueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LongTermCareMember" abstract="true" name="LongTermCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.125DueJuly2045Member" abstract="true" name="SeniorNotes5.125DueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_TermLoanAgreement364DayMember" abstract="true" name="TermLoanAgreement364DayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PaymentsForInsuranceBenefits" abstract="false" name="PaymentsForInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfPatientsServedPerYear" abstract="false" name="NumberOfPatientsServedPerYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.125DueSeptember2039Member" abstract="true" name="SeniorNotes6.125DueSeptember2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes27DueAugust2040Member" abstract="true" name="SeniorNotes27DueAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.1DueMarch2025Member" abstract="true" name="SeniorNotes4.1DueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" abstract="false" name="OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes13DueAugust2027Member" abstract="true" name="SeniorNotes13DueAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" abstract="true" name="RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VendorAndManufacturerReceivables" abstract="false" name="VendorAndManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OfficeRealEstateOptimizationCharges" abstract="false" name="OfficeRealEstateOptimizationCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.5DueMay2042Member" abstract="true" name="SeniorNotes4.5DueMay2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" abstract="true" name="EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueNovember2042Member" abstract="true" name="SeniorNotes4.125DueNovember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_A2021RepurchaseProgramMember" abstract="true" name="A2021RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.25DueAugust2029Member" abstract="true" name="SeniorNotes3.25DueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" abstract="false" name="DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" abstract="true" name="EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5625DueFebruary2053Member" abstract="true" name="SeniorNotes5625DueFebruary2053Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberOfLeases" abstract="false" name="GuarantorObligationsNumberOfLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PostCombinationServicesMember" abstract="true" name="PostCombinationServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthServicesSegmentMember" abstract="true" name="HealthServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" abstract="true" name="SettlementFrameworkAndOtherOpioidRelatedClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueAugust2047Member" abstract="true" name="SeniorNotes3.875DueAugust2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldInTrust" abstract="false" name="TreasuryStockSharesHeldInTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_NumberOfPeopleServed" abstract="false" name="NumberOfPeopleServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_StockOptionsAndStockAppreciationRightsMember" abstract="true" name="StockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" abstract="true" name="RadcliffeAndFlaimVAetnaIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfPharmacyPlanMembers" abstract="false" name="NumberOfPharmacyPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes5.75DueMay2041Member" abstract="true" name="SeniorNotes5.75DueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OakStreetHealthIncMember" abstract="true" name="OakStreetHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.625DueAugust2024Member" abstract="true" name="SeniorNotes2.625DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2125PercentDueSeptember2031Member" abstract="true" name="SeniorNotes2125PercentDueSeptember2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeparateAccountOtherAssetBackedSecuritiesMember" abstract="true" name="SeparateAccountOtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueApril2040Member" abstract="true" name="SeniorNotes4.125DueApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" abstract="true" name="ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueMarch2044Member" abstract="true" name="SeniorNotes4.75DueMarch2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsOrLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJune2023Member" abstract="true" name="SeniorNotes2.8DueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" abstract="false" name="PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FederalCourtInOhioJudgmentMember" abstract="true" name="FederalCourtInOhioJudgmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LitigationSettlementNumberOfStatesElectedToJoin" abstract="false" name="LitigationSettlementNumberOfStatesElectedToJoin" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes175DueAugust2030Member" abstract="true" name="SeniorNotes175DueAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.3DueDecember2043Member" abstract="true" name="SeniorNotes5.3DueDecember2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" abstract="false" name="BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" abstract="false" name="LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.3DueMarch2028Member" abstract="true" name="SeniorNotes4.3DueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5125DueFebruary2030Member" abstract="true" name="SeniorNotes5125DueFebruary2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesAgreementAmount" abstract="false" name="AcceleratedShareRepurchasesAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" abstract="false" name="PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ThailandBusinessMember" abstract="true" name="ThailandBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.25DueApril2050Member" abstract="true" name="SeniorNotes4.25DueApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LongTermInvestmentsIncludingAssetsHeldForSale" abstract="false" name="LongTermInvestmentsIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_Categories5and6Member" abstract="true" name="Categories5and6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes525DueFebruary2033Member" abstract="true" name="SeniorNotes525DueFebruary2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TribalEntitiesMember" abstract="true" name="TribalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes1875DueFebruary2031Member" abstract="true" name="SeniorNotes1875DueFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PolicyholderAccountBalanceDepositsReceived" abstract="false" name="PolicyholderAccountBalanceDepositsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_A2022RepurchaseProgramMember" abstract="true" name="A2022RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes3DueAugust2026Member" abstract="true" name="SeniorNotes3DueAugust2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.75DueDecember2037Member" abstract="true" name="SeniorNotes6.75DueDecember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_BarclaysBankMember" abstract="true" name="BarclaysBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LongTermDebtGrossAndLeaseObligation" abstract="false" name="LongTermDebtGrossAndLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" abstract="false" name="AcceleratedShareRepurchasesNumberOfSharesRepurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_PharmacyAndConsumerHealthSegmentMember" abstract="true" name="PharmacyAndConsumerHealthSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OmnicareLongTermCareBusinessMember" abstract="true" name="OmnicareLongTermCareBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyClaimsAndDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsAndDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CitibankNAMember" abstract="true" name="CitibankNAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractwithCustomerLiabilityRedemptionandBreakage" abstract="false" name="ContractwithCustomerLiabilityRedemptionandBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.05DueMarch2048Member" abstract="true" name="SeniorNotes5.05DueMarch2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" abstract="false" name="LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" abstract="true" name="AOCIChangeInDiscountRateOnInsuranceReservesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.78DueMarch2038Member" abstract="true" name="SeniorNotes4.78DueMarch2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" abstract="false" name="LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_LargeCasePensionsMember" abstract="true" name="LargeCasePensionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" abstract="false" name="LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" abstract="false" name="AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesMember" abstract="true" name="OtherInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4DueDecember2023Member" abstract="true" name="SeniorNotes4DueDecember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.25DueJune2027Member" abstract="true" name="SeniorNotes6.25DueJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SignifyHealthIncMember" abstract="true" name="SignifyHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.875DueJune2026Member" abstract="true" name="SeniorNotes2.875DueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.625DueJune2036Member" abstract="true" name="SeniorNotes6.625DueJune2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CorporateOtherMember" abstract="true" name="CorporateOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" abstract="false" name="DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ChangeinContractwithCustomerLiabilityRollForward" abstract="true" name="ChangeinContractwithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>cvs-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a5201116-fa32-47d9-bf67-a4b1f9934cb7,g:676c592e-810f-43b8-9a45-1cf85e252b17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6435f160-3486-4c3d-aac0-5f4287ab4126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f5af058a-bde3-4032-aae5-9e8bb4b04a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6435f160-3486-4c3d-aac0-5f4287ab4126" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f5af058a-bde3-4032-aae5-9e8bb4b04a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_774aba90-942e-4d01-8a9e-7711e87691ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6435f160-3486-4c3d-aac0-5f4287ab4126" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_774aba90-942e-4d01-8a9e-7711e87691ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c31d64de-5a40-4885-87b7-f4118df89530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f9ffaded-54fa-46fd-ab1b-75d98294582f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c31d64de-5a40-4885-87b7-f4118df89530" xlink:to="loc_us-gaap_CostsAndExpenses_f9ffaded-54fa-46fd-ab1b-75d98294582f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6fa48988-ef11-4388-a9b9-4cd6932c69a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c31d64de-5a40-4885-87b7-f4118df89530" xlink:to="loc_us-gaap_Revenues_6fa48988-ef11-4388-a9b9-4cd6932c69a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f73cd826-7ce5-4b42-83eb-f607982c7778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_309b842b-b1cb-443a-858e-19c3da660d82" xlink:href="cvs-20230331.xsd#cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f73cd826-7ce5-4b42-83eb-f607982c7778" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_309b842b-b1cb-443a-858e-19c3da660d82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f679edd1-ddd9-4126-ae89-3f12ad6d1a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f73cd826-7ce5-4b42-83eb-f607982c7778" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f679edd1-ddd9-4126-ae89-3f12ad6d1a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_8e313727-2d30-48dc-8e1d-0b94396b5aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f73cd826-7ce5-4b42-83eb-f607982c7778" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_8e313727-2d30-48dc-8e1d-0b94396b5aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_d62368f5-8aa6-47c0-8645-f7853e461645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f73cd826-7ce5-4b42-83eb-f607982c7778" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_d62368f5-8aa6-47c0-8645-f7853e461645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_8d5b92d6-2c91-4f61-901a-12b43ad36e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f73cd826-7ce5-4b42-83eb-f607982c7778" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_8d5b92d6-2c91-4f61-901a-12b43ad36e43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_63576a9f-ed1c-40b7-b072-f520459e28ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bc7c617e-4a8a-4f5c-9ec1-d49bdbfbb1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_63576a9f-ed1c-40b7-b072-f520459e28ac" xlink:to="loc_us-gaap_OperatingIncomeLoss_bc7c617e-4a8a-4f5c-9ec1-d49bdbfbb1da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8b302577-d3cb-4a95-871d-eb6a1e901028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_63576a9f-ed1c-40b7-b072-f520459e28ac" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8b302577-d3cb-4a95-871d-eb6a1e901028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_64c4704f-d125-460f-85c3-519e4238443a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_63576a9f-ed1c-40b7-b072-f520459e28ac" xlink:to="loc_us-gaap_InterestExpense_64c4704f-d125-460f-85c3-519e4238443a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3c3a48fc-ddc7-42ec-a05a-7dfa4238cb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_adcd95bd-d4c0-4bf7-841e-de0285a24b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_3c3a48fc-ddc7-42ec-a05a-7dfa4238cb2f" xlink:to="loc_us-gaap_NetInvestmentIncome_adcd95bd-d4c0-4bf7-841e-de0285a24b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_f55f7e63-c20f-4c59-8789-5292eb61bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_3c3a48fc-ddc7-42ec-a05a-7dfa4238cb2f" xlink:to="loc_us-gaap_PremiumsEarnedNet_f55f7e63-c20f-4c59-8789-5292eb61bea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce65d6aa-13ac-405c-ae99-b3dab4a91546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_3c3a48fc-ddc7-42ec-a05a-7dfa4238cb2f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce65d6aa-13ac-405c-ae99-b3dab4a91546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c9d4f5df-81e8-4b25-bb1b-195e01347201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d37e7109-5bab-4132-a935-09a1fedc5d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c9d4f5df-81e8-4b25-bb1b-195e01347201" xlink:to="loc_us-gaap_ProfitLoss_d37e7109-5bab-4132-a935-09a1fedc5d6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_930a57e8-a5ab-41b4-8f2e-4521926e8f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c9d4f5df-81e8-4b25-bb1b-195e01347201" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_930a57e8-a5ab-41b4-8f2e-4521926e8f69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7a36e6a5-a9c0-4473-9882-8eba0d9dc559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d5e80aa7-cf55-4f66-b160-d7e5647e585e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7a36e6a5-a9c0-4473-9882-8eba0d9dc559" xlink:to="loc_us-gaap_ProfitLoss_d5e80aa7-cf55-4f66-b160-d7e5647e585e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_943ef7d1-9ebf-4356-aaee-7d15040132e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7a36e6a5-a9c0-4473-9882-8eba0d9dc559" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_943ef7d1-9ebf-4356-aaee-7d15040132e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9b20a085-f7f9-49ae-9a2c-83415fe59f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e552bb6a-f3b6-4d7e-b332-a08e69b5b1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9b20a085-f7f9-49ae-9a2c-83415fe59f1d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e552bb6a-f3b6-4d7e-b332-a08e69b5b1d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9d1051a6-5fa1-4e3d-a15e-e795030e3fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9b20a085-f7f9-49ae-9a2c-83415fe59f1d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9d1051a6-5fa1-4e3d-a15e-e795030e3fbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_68f1ae1e-ade5-4810-b992-e586629797fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_ada04475-020b-4267-b063-bd4717e02912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_68f1ae1e-ade5-4810-b992-e586629797fd" xlink:to="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_ada04475-020b-4267-b063-bd4717e02912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bc5496d7-0cd8-4a7e-848f-434eba04775b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_68f1ae1e-ade5-4810-b992-e586629797fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bc5496d7-0cd8-4a7e-848f-434eba04775b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c7f474d3-4388-4017-83f4-0cdc87ee9c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_68f1ae1e-ade5-4810-b992-e586629797fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_c7f474d3-4388-4017-83f4-0cdc87ee9c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_47ca379a-9a7e-4069-aa32-e172760bf750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_68f1ae1e-ade5-4810-b992-e586629797fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_47ca379a-9a7e-4069-aa32-e172760bf750" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84530830-95aa-4270-bb4d-6e91c091e213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_cba9c5e2-907e-45d4-94f9-aa784bce069e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84530830-95aa-4270-bb4d-6e91c091e213" xlink:to="loc_us-gaap_PreferredStockValue_cba9c5e2-907e-45d4-94f9-aa784bce069e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_95524042-dee5-49b5-a077-a52d42c6ca6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84530830-95aa-4270-bb4d-6e91c091e213" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_95524042-dee5-49b5-a077-a52d42c6ca6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_f77cc68a-f7c6-4a8a-97e9-a7a1410afd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84530830-95aa-4270-bb4d-6e91c091e213" xlink:to="loc_us-gaap_TreasuryStockValue_f77cc68a-f7c6-4a8a-97e9-a7a1410afd5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0626a848-ab5e-48d8-be1a-25ef9c0a98eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84530830-95aa-4270-bb4d-6e91c091e213" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0626a848-ab5e-48d8-be1a-25ef9c0a98eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d20e509a-9d53-4cbf-a576-9fdd4f27f39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84530830-95aa-4270-bb4d-6e91c091e213" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d20e509a-9d53-4cbf-a576-9fdd4f27f39d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_e5814970-8cb7-40c7-b2c8-12328e3211c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_LongTermInvestments_e5814970-8cb7-40c7-b2c8-12328e3211c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4f1b3a0e-f089-4ada-8717-9bce17e082fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4f1b3a0e-f089-4ada-8717-9bce17e082fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ac4359bf-1b5b-4c17-b9e2-70c541e8fc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ac4359bf-1b5b-4c17-b9e2-70c541e8fc52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e927e213-d966-4d82-9864-17b18452b420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_Goodwill_e927e213-d966-4d82-9864-17b18452b420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_21de727d-c5bf-4634-bab9-8f57b395e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_21de727d-c5bf-4634-bab9-8f57b395e1bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_86aa64f5-f715-4c88-b154-4691ac322dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_SeparateAccountAssets_86aa64f5-f715-4c88-b154-4691ac322dfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c9a706ba-9176-4468-a1c7-9758a0aba9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c9a706ba-9176-4468-a1c7-9758a0aba9a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_68c54135-11e5-461c-abdf-c35c523defb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e84b4ec-ac27-48f8-915d-1f73b7d8fee5" xlink:to="loc_us-gaap_AssetsCurrent_68c54135-11e5-461c-abdf-c35c523defb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b0172773-6cd8-4914-a791-8582e3ee77ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:to="loc_us-gaap_LiabilitiesCurrent_b0172773-6cd8-4914-a791-8582e3ee77ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c4f6b543-ba1c-4824-aa73-86bf628d5cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c4f6b543-ba1c-4824-aa73-86bf628d5cbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d817baec-8477-494b-9437-c2c440979377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d817baec-8477-494b-9437-c2c440979377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_10caf6e1-3053-41e9-8d23-eb9240c22a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_10caf6e1-3053-41e9-8d23-eb9240c22a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_f03b8908-50eb-48b9-8536-d289b322a244" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_f03b8908-50eb-48b9-8536-d289b322a244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ec7d643c-d227-494b-afe5-57ce20e558d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ec7d643c-d227-494b-afe5-57ce20e558d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_abfd9f4f-1282-4848-bf43-221dbe2cc708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_161c4fd4-fba9-4213-81b3-5d0aac76390b" xlink:to="loc_us-gaap_SeparateAccountsLiability_abfd9f4f-1282-4848-bf43-221dbe2cc708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a099ccad-3731-4a76-ba8a-0a4f367340f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d1ce34c1-044d-4af7-9c99-e9ceb4d1fe5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a099ccad-3731-4a76-ba8a-0a4f367340f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d1ce34c1-044d-4af7-9c99-e9ceb4d1fe5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_f4be7055-9777-49d5-ba99-be3b70751085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a099ccad-3731-4a76-ba8a-0a4f367340f0" xlink:to="loc_us-gaap_ShortTermInvestments_f4be7055-9777-49d5-ba99-be3b70751085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dc874927-1b50-4d4c-90d5-e0c3937d3395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a099ccad-3731-4a76-ba8a-0a4f367340f0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dc874927-1b50-4d4c-90d5-e0c3937d3395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_17caf0f2-0385-4209-b4e7-3a731ad84b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a099ccad-3731-4a76-ba8a-0a4f367340f0" xlink:to="loc_us-gaap_InventoryNet_17caf0f2-0385-4209-b4e7-3a731ad84b83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0c44c589-fd4b-4a95-aedb-1ae3007378c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a099ccad-3731-4a76-ba8a-0a4f367340f0" xlink:to="loc_us-gaap_OtherAssetsCurrent_0c44c589-fd4b-4a95-aedb-1ae3007378c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_863bc31e-26d6-4840-bd6d-a54bb8e0af18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a099ccad-3731-4a76-ba8a-0a4f367340f0" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_863bc31e-26d6-4840-bd6d-a54bb8e0af18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e52c9620-0640-4a43-afa1-4f9f8393e463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b2cddb91-dc7f-4ba4-979b-17e7fc4cd95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e52c9620-0640-4a43-afa1-4f9f8393e463" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b2cddb91-dc7f-4ba4-979b-17e7fc4cd95a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_141730b5-51cf-4391-b328-740cb478aabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e52c9620-0640-4a43-afa1-4f9f8393e463" xlink:to="loc_us-gaap_Liabilities_141730b5-51cf-4391-b328-740cb478aabd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2cfbde2f-de50-49eb-8557-b92fe2de7c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2cfbde2f-de50-49eb-8557-b92fe2de7c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ce6014f1-eddf-49fd-9397-7ec9fca0fc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ce6014f1-eddf-49fd-9397-7ec9fca0fc43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_03476708-7dfc-4922-9e3e-2417e9167c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_03476708-7dfc-4922-9e3e-2417e9167c3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_c971edfb-7970-4502-b412-3690d8f81ed1" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_c971edfb-7970-4502-b412-3690d8f81ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_c7f14ca0-31fe-418d-8025-a3a4a813a494" xlink:href="cvs-20230331.xsd#cvs_PharmacyClaimsAndDiscountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_c7f14ca0-31fe-418d-8025-a3a4a813a494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_af5f4911-74d8-41b6-a1ba-be0870cf104d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_af5f4911-74d8-41b6-a1ba-be0870cf104d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_3a634fa9-ac22-4eb9-a7c7-a44331948a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_us-gaap_OtherPolicyholderFunds_3a634fa9-ac22-4eb9-a7c7-a44331948a42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_33a23876-4937-4fe4-9d25-9264f242c700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_33a23876-4937-4fe4-9d25-9264f242c700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_57fda15d-747c-4f84-8af5-9a39ad3efe23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0024fb16-8978-49b2-9707-4b1fead79056" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_57fda15d-747c-4f84-8af5-9a39ad3efe23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04febe4e-3631-4810-b7a4-425d78bef7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7985c9a5-2ff5-44bc-b9da-0e04ed8a1c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04febe4e-3631-4810-b7a4-425d78bef7cb" xlink:to="loc_us-gaap_StockholdersEquity_7985c9a5-2ff5-44bc-b9da-0e04ed8a1c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_bddfb463-f6a1-4e47-898c-711810674999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_04febe4e-3631-4810-b7a4-425d78bef7cb" xlink:to="loc_us-gaap_MinorityInterest_bddfb463-f6a1-4e47-898c-711810674999" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dcb95e1-387a-4bbe-9caf-35525b44164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_11aa6a94-b1d6-4200-8956-021da810d124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dcb95e1-387a-4bbe-9caf-35525b44164d" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_11aa6a94-b1d6-4200-8956-021da810d124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4d4a7b7a-a8ca-494f-875f-231d925201f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dcb95e1-387a-4bbe-9caf-35525b44164d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4d4a7b7a-a8ca-494f-875f-231d925201f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a372f033-341a-41c3-b27b-e5d1bba3d708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dcb95e1-387a-4bbe-9caf-35525b44164d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a372f033-341a-41c3-b27b-e5d1bba3d708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_71ca8d52-625b-4636-81ff-e99caee94431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dcb95e1-387a-4bbe-9caf-35525b44164d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_71ca8d52-625b-4636-81ff-e99caee94431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0dd23d05-4ab8-45d5-bdc6-e0143b33f5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3dcb95e1-387a-4bbe-9caf-35525b44164d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0dd23d05-4ab8-45d5-bdc6-e0143b33f5eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a0ccf6f5-2adf-412b-9dc5-66b6b8daf99f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_ProfitLoss_a0ccf6f5-2adf-412b-9dc5-66b6b8daf99f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_772b24b0-1325-417f-965a-d762043e65e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_ShareBasedCompensation_772b24b0-1325-417f-965a-d762043e65e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_149c6417-a47c-4d2a-a428-51bf2f417ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_149c6417-a47c-4d2a-a428-51bf2f417ae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_cfcfe8c6-1005-499c-92c7-f159f627a759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_cfcfe8c6-1005-499c-92c7-f159f627a759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b0f2cdce-bd43-49ad-ba79-2f2bce0599bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b0f2cdce-bd43-49ad-ba79-2f2bce0599bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_84e831ec-b50b-4a63-8609-829b2681432a" xlink:href="cvs-20230331.xsd#cvs_DeferredIncomeTaxesAndOtherNoncashItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_84e831ec-b50b-4a63-8609-829b2681432a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3e2b1105-7bc6-4fa2-a13e-c6d8bdb5a1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3e2b1105-7bc6-4fa2-a13e-c6d8bdb5a1b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_44aed3dc-017b-4430-9de8-3682fa90d299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_44aed3dc-017b-4430-9de8-3682fa90d299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fc803441-08cb-4852-afd3-6e1f365152de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fc803441-08cb-4852-afd3-6e1f365152de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f474e1e7-381a-4121-bed4-0dac310b2325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47c27a89-a676-44e3-b528-ee7b36906ecd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f474e1e7-381a-4121-bed4-0dac310b2325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_5aca26d1-48a2-4912-a02c-c6e3dd560e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:to="loc_us-gaap_PaymentsOfDividends_5aca26d1-48a2-4912-a02c-c6e3dd560e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c95ed724-3404-4748-93c6-2ce673d53194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c95ed724-3404-4748-93c6-2ce673d53194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_08fb31cd-a8dd-4664-8a0f-1f400802b2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_08fb31cd-a8dd-4664-8a0f-1f400802b2b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2ee702ac-c9ae-4ac8-8892-3729c8b05134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2ee702ac-c9ae-4ac8-8892-3729c8b05134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c520d64c-f63c-4f30-87db-e78bb805c170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c520d64c-f63c-4f30-87db-e78bb805c170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a4011e87-8d82-4216-8bb3-1afc15830ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a4011e87-8d82-4216-8bb3-1afc15830ec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_03665fc3-2400-4fa4-842e-99b0bb9cd5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_60f7d7e7-e109-4369-946e-b37bf19f27de" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_03665fc3-2400-4fa4-842e-99b0bb9cd5f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_26f0f11a-e92d-42f7-83ca-b2821cfb685b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e25da19c-c3de-476b-bdef-605410aae231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_26f0f11a-e92d-42f7-83ca-b2821cfb685b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e25da19c-c3de-476b-bdef-605410aae231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c19e0dda-e6ff-4962-8ef1-70ceb7ddb261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_26f0f11a-e92d-42f7-83ca-b2821cfb685b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c19e0dda-e6ff-4962-8ef1-70ceb7ddb261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1406e9a6-a17b-415a-9cd9-409b14441512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_26f0f11a-e92d-42f7-83ca-b2821cfb685b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1406e9a6-a17b-415a-9cd9-409b14441512" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f817c464-3409-4456-9a36-cd686b4e4498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:to="loc_us-gaap_InterestPaidNet_f817c464-3409-4456-9a36-cd686b4e4498" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_5deadb44-c8e5-4670-bd63-45f95e8a23ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_5deadb44-c8e5-4670-bd63-45f95e8a23ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_ee1bafc2-fb91-4e5c-89fe-f8d00d6b5039" xlink:href="cvs-20230331.xsd#cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:to="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_ee1bafc2-fb91-4e5c-89fe-f8d00d6b5039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_f531f4b4-ce94-42c7-9095-8058106de911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:to="loc_us-gaap_ProceedsFromCustomers_f531f4b4-ce94-42c7-9095-8058106de911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInsuranceBenefits_977e903f-a7b0-4715-891c-77d09ea3f44f" xlink:href="cvs-20230331.xsd#cvs_PaymentsForInsuranceBenefits"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:to="loc_cvs_PaymentsForInsuranceBenefits_977e903f-a7b0-4715-891c-77d09ea3f44f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_dfbca82e-6211-44a5-941c-153f32293c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_dfbca82e-6211-44a5-941c-153f32293c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_076108e9-5c26-4ff1-a5b9-6dd95e5d3770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcda90a8-a552-48fd-8906-0222cda7203a" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_076108e9-5c26-4ff1-a5b9-6dd95e5d3770" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efc9c58e-45b0-4d07-84ad-88da803dbfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b41e804a-c257-48ed-8522-98c666b14ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efc9c58e-45b0-4d07-84ad-88da803dbfd5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b41e804a-c257-48ed-8522-98c666b14ab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_81f327be-8bc3-4077-84bf-ec77fa7f3eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efc9c58e-45b0-4d07-84ad-88da803dbfd5" xlink:to="loc_us-gaap_RestrictedCashCurrent_81f327be-8bc3-4077-84bf-ec77fa7f3eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_b3b8ced4-30d9-4c5d-92dd-e78c06deffc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efc9c58e-45b0-4d07-84ad-88da803dbfd5" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_b3b8ced4-30d9-4c5d-92dd-e78c06deffc3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_ee2a2e66-a60d-4b5c-82a1-28eefbaa3a8d" xlink:href="cvs-20230331.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_02e410d7-6d4b-4205-83dc-a6d3a55a75de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_ee2a2e66-a60d-4b5c-82a1-28eefbaa3a8d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_02e410d7-6d4b-4205-83dc-a6d3a55a75de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAndManufacturerReceivables_6524c613-eaad-4703-964d-4f009254be85" xlink:href="cvs-20230331.xsd#cvs_VendorAndManufacturerReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_ee2a2e66-a60d-4b5c-82a1-28eefbaa3a8d" xlink:to="loc_cvs_VendorAndManufacturerReceivables_6524c613-eaad-4703-964d-4f009254be85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_a92e445e-bd31-43ca-a580-2db6becee4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_ee2a2e66-a60d-4b5c-82a1-28eefbaa3a8d" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_a92e445e-bd31-43ca-a580-2db6becee4b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_c6e78cf7-6719-4afb-8910-e4a8a7d0e24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_ee2a2e66-a60d-4b5c-82a1-28eefbaa3a8d" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_c6e78cf7-6719-4afb-8910-e4a8a7d0e24b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2dd5a015-7137-481c-8171-9987d02730e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_29b5ac63-b016-46e9-a662-5b15257e0d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2dd5a015-7137-481c-8171-9987d02730e7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_29b5ac63-b016-46e9-a662-5b15257e0d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_f1199970-5bf3-42e0-9ecd-bbce1df604e1" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2dd5a015-7137-481c-8171-9987d02730e7" xlink:to="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_f1199970-5bf3-42e0-9ecd-bbce1df604e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8b99f592-4238-4423-9ea6-48bcd7d0d40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2dd5a015-7137-481c-8171-9987d02730e7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8b99f592-4238-4423-9ea6-48bcd7d0d40c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_424a2154-e84f-4d6f-a832-ff9e6e9b0f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_424a2154-e84f-4d6f-a832-ff9e6e9b0f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2a6b5e58-daa1-4f3f-a7e3-82371330f10d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_2a6b5e58-daa1-4f3f-a7e3-82371330f10d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_ae9668a0-2756-4a19-8999-48c861390dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_ae9668a0-2756-4a19-8999-48c861390dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_50b869d0-3db8-4bbe-8841-5a091f5ab917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_50b869d0-3db8-4bbe-8841-5a091f5ab917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d5a2cad7-0637-401c-a28a-594fb3bd1174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d5a2cad7-0637-401c-a28a-594fb3bd1174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_01015feb-dc2e-4606-8430-85d61c7d1996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_01015feb-dc2e-4606-8430-85d61c7d1996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_75ca679d-c1c8-40c9-aec7-6fdad5b28d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4bb7473c-69c6-40a7-90b0-24b8669b8217" xlink:to="loc_us-gaap_Goodwill_75ca679d-c1c8-40c9-aec7-6fdad5b28d83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_cd1338a4-0193-4924-8af7-aa831aa71d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_41ad102b-2a1c-4fc6-bb3d-53269f9f2ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_cd1338a4-0193-4924-8af7-aa831aa71d77" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_41ad102b-2a1c-4fc6-bb3d-53269f9f2ddd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_03e3e4b6-26ac-4f5c-8bdd-801f0e7a9289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_cd1338a4-0193-4924-8af7-aa831aa71d77" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_03e3e4b6-26ac-4f5c-8bdd-801f0e7a9289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc60baee-9e04-4076-ad22-40b49e1b09d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a38d59db-820d-4a74-9de2-aea0b14c6c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc60baee-9e04-4076-ad22-40b49e1b09d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a38d59db-820d-4a74-9de2-aea0b14c6c90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_79ef6506-f106-400b-b53c-c8c52dbc8d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc60baee-9e04-4076-ad22-40b49e1b09d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_79ef6506-f106-400b-b53c-c8c52dbc8d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_2a603c97-2162-4d0f-a222-a2bccff4523f" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc60baee-9e04-4076-ad22-40b49e1b09d2" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_2a603c97-2162-4d0f-a222-a2bccff4523f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_24546b8d-3c0b-465a-a7da-744dadb9d04e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc60baee-9e04-4076-ad22-40b49e1b09d2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_24546b8d-3c0b-465a-a7da-744dadb9d04e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a64d761d-4d81-4c6b-8496-f5ffcf00acf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b8e45226-dacc-43a7-9992-7da1b1cac203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a64d761d-4d81-4c6b-8496-f5ffcf00acf0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_b8e45226-dacc-43a7-9992-7da1b1cac203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_c411eacf-7471-46a6-83c7-3e70b23d871b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a64d761d-4d81-4c6b-8496-f5ffcf00acf0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_c411eacf-7471-46a6-83c7-3e70b23d871b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9c558f1e-c7f6-4fef-bab9-f147f5b46d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a64d761d-4d81-4c6b-8496-f5ffcf00acf0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9c558f1e-c7f6-4fef-bab9-f147f5b46d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_f50cbb95-15c6-49a5-94ee-d03bd68c2da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a64d761d-4d81-4c6b-8496-f5ffcf00acf0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_f50cbb95-15c6-49a5-94ee-d03bd68c2da0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_68e22e73-eccd-4f01-b5a7-9765854b097e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a64d761d-4d81-4c6b-8496-f5ffcf00acf0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_68e22e73-eccd-4f01-b5a7-9765854b097e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ab51b99-0d10-45b5-954b-f4cb8bfea952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_897a822d-aec8-43b4-b4ae-8aa18673ba8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ab51b99-0d10-45b5-954b-f4cb8bfea952" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_897a822d-aec8-43b4-b4ae-8aa18673ba8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_3b37dc03-a668-4e8b-bf96-a3c2e393e838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ab51b99-0d10-45b5-954b-f4cb8bfea952" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_3b37dc03-a668-4e8b-bf96-a3c2e393e838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_74808482-5137-4274-8b73-f9b71b857856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_9ab51b99-0d10-45b5-954b-f4cb8bfea952" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_74808482-5137-4274-8b73-f9b71b857856" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_38cf3a66-dcc8-4479-92c0-8e3a44d04838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_6b018695-2d07-4fec-845e-71bbc7312436" xlink:href="cvs-20230331.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_38cf3a66-dcc8-4479-92c0-8e3a44d04838" xlink:to="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_6b018695-2d07-4fec-845e-71bbc7312436" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ba9c95ae-d356-4c10-adf6-b029fbf2cdcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_38cf3a66-dcc8-4479-92c0-8e3a44d04838" xlink:to="loc_us-gaap_ShortTermInvestments_ba9c95ae-d356-4c10-adf6-b029fbf2cdcc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_02979d1d-5cc9-449a-b123-88a7a8cce8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5ee8dcb7-694b-494f-b77d-1b9d761f2e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_02979d1d-5cc9-449a-b123-88a7a8cce8cf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5ee8dcb7-694b-494f-b77d-1b9d761f2e3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8cfa510d-fa8f-4006-a704-825893dd90e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_02979d1d-5cc9-449a-b123-88a7a8cce8cf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8cfa510d-fa8f-4006-a704-825893dd90e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1718c442-df62-47df-8557-d85db4caf452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ab37773e-94f6-4392-b3af-e4219fe582da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1718c442-df62-47df-8557-d85db4caf452" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ab37773e-94f6-4392-b3af-e4219fe582da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ef91be5-874d-4a23-833d-1252e4ee0881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1718c442-df62-47df-8557-d85db4caf452" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ef91be5-874d-4a23-833d-1252e4ee0881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7c700e39-1ac9-4b81-a108-30503d919860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_1718c442-df62-47df-8557-d85db4caf452" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7c700e39-1ac9-4b81-a108-30503d919860" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_04a317a7-bba3-4e6c-a92c-e02abe2e4dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_33a479f6-df19-40ca-a841-33dffdb5e2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_04a317a7-bba3-4e6c-a92c-e02abe2e4dfa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_33a479f6-df19-40ca-a841-33dffdb5e2dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_9914ceec-2d7f-431d-9cba-49cacb33c3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_04a317a7-bba3-4e6c-a92c-e02abe2e4dfa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_9914ceec-2d7f-431d-9cba-49cacb33c3ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_797436d0-519a-4516-b3d3-d5cc821f97e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_04a317a7-bba3-4e6c-a92c-e02abe2e4dfa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_797436d0-519a-4516-b3d3-d5cc821f97e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_df23973a-9eaf-4664-a871-2355a615c9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_04a317a7-bba3-4e6c-a92c-e02abe2e4dfa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_df23973a-9eaf-4664-a871-2355a615c9c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_ccd86f37-85d0-4495-b2b1-2fdd8ab48301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_04a317a7-bba3-4e6c-a92c-e02abe2e4dfa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_ccd86f37-85d0-4495-b2b1-2fdd8ab48301" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c4691b3-2dd7-4a2b-a241-52ef82019350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_164f7a77-b0af-421a-bcc2-78a459a4c085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c4691b3-2dd7-4a2b-a241-52ef82019350" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_164f7a77-b0af-421a-bcc2-78a459a4c085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_42fce3da-2004-4a00-9a89-85e764fa318f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c4691b3-2dd7-4a2b-a241-52ef82019350" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_42fce3da-2004-4a00-9a89-85e764fa318f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5d1a37ef-ae53-4bcd-be65-3d0c85e83a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c4691b3-2dd7-4a2b-a241-52ef82019350" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5d1a37ef-ae53-4bcd-be65-3d0c85e83a0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7f88865e-1d4b-4fd6-812b-5af4a694359f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c4691b3-2dd7-4a2b-a241-52ef82019350" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_7f88865e-1d4b-4fd6-812b-5af4a694359f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ddf297d1-c986-4810-8269-e9b7713edbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5c4691b3-2dd7-4a2b-a241-52ef82019350" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ddf297d1-c986-4810-8269-e9b7713edbdf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4c8597eb-f7cc-4191-9978-7c23fcf40276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_5599d35a-ae33-42a6-9db8-7ad7b2d5a5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4c8597eb-f7cc-4191-9978-7c23fcf40276" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_5599d35a-ae33-42a6-9db8-7ad7b2d5a5de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dd6d14e2-9524-407a-ab2f-3dae879f4bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4c8597eb-f7cc-4191-9978-7c23fcf40276" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_dd6d14e2-9524-407a-ab2f-3dae879f4bb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_14b02447-745d-4aa2-9125-1ac776d9b8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_5599dec1-e4fb-4aa4-80bd-649ad6342aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_14b02447-745d-4aa2-9125-1ac776d9b8fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_5599dec1-e4fb-4aa4-80bd-649ad6342aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_e079a47c-96c4-4f8f-9931-1eaf94bb93e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_14b02447-745d-4aa2-9125-1ac776d9b8fb" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_e079a47c-96c4-4f8f-9931-1eaf94bb93e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d6b0c3ea-2501-4ef3-88c8-9e805b96cb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1281464d-762c-4474-8c7e-38b0853eea99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d6b0c3ea-2501-4ef3-88c8-9e805b96cb71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1281464d-762c-4474-8c7e-38b0853eea99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_413ff829-089f-4e9f-a2ed-09fe90b19db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d6b0c3ea-2501-4ef3-88c8-9e805b96cb71" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_413ff829-089f-4e9f-a2ed-09fe90b19db8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fc524751-0bd2-4711-8bf0-26fdae34e90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_17c1caff-0984-47f4-a8f4-37763d8017b7" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fc524751-0bd2-4711-8bf0-26fdae34e90e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_17c1caff-0984-47f4-a8f4-37763d8017b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_6557335f-c09d-44d1-a774-5fc3642809be" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fc524751-0bd2-4711-8bf0-26fdae34e90e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_6557335f-c09d-44d1-a774-5fc3642809be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_52a08499-6eb0-4882-81ce-06bdde09f310" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fc524751-0bd2-4711-8bf0-26fdae34e90e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_52a08499-6eb0-4882-81ce-06bdde09f310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_70aff18c-92ef-41bd-8137-93bdac335062" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fc524751-0bd2-4711-8bf0-26fdae34e90e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_70aff18c-92ef-41bd-8137-93bdac335062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_1fecaf21-e5cd-45bf-b0a3-37bad457d48e" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fc524751-0bd2-4711-8bf0-26fdae34e90e" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_1fecaf21-e5cd-45bf-b0a3-37bad457d48e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_eeb26f1b-f5f2-4084-a8cf-529865b9646f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_008c47a9-61f8-4816-aa26-fb374ffec49c" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_eeb26f1b-f5f2-4084-a8cf-529865b9646f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_008c47a9-61f8-4816-aa26-fb374ffec49c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_95e54ec0-5f39-4ec0-b635-03cc67ab29c1" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_eeb26f1b-f5f2-4084-a8cf-529865b9646f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_95e54ec0-5f39-4ec0-b635-03cc67ab29c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_cb6f60e0-ceaf-48a8-bff0-48f961631735" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_eeb26f1b-f5f2-4084-a8cf-529865b9646f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_cb6f60e0-ceaf-48a8-bff0-48f961631735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_837853fa-b83e-4ab6-9bfd-adeb388ed711" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_eeb26f1b-f5f2-4084-a8cf-529865b9646f" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_837853fa-b83e-4ab6-9bfd-adeb388ed711" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_94b1dfe0-28e1-4e0a-8c7e-2bc9188ce15c" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_eeb26f1b-f5f2-4084-a8cf-529865b9646f" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_94b1dfe0-28e1-4e0a-8c7e-2bc9188ce15c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_a859ee01-92c7-46e2-b00a-b977a282060d" xlink:href="cvs-20230331.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_051d12d0-dba2-45df-aca5-9c6efd1bac6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_a859ee01-92c7-46e2-b00a-b977a282060d" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_051d12d0-dba2-45df-aca5-9c6efd1bac6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_b649c680-14f7-4938-a5eb-2ca194ed446b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_a859ee01-92c7-46e2-b00a-b977a282060d" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_b649c680-14f7-4938-a5eb-2ca194ed446b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_b2770366-4200-41f2-8aed-c56203908aec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_e6447084-0744-4877-9491-0db1da21d6dd" xlink:href="cvs-20230331.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_b2770366-4200-41f2-8aed-c56203908aec" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_e6447084-0744-4877-9491-0db1da21d6dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_3674df9c-2175-4a41-acf2-808722fff7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_b2770366-4200-41f2-8aed-c56203908aec" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_3674df9c-2175-4a41-acf2-808722fff7a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_fdc07482-4858-4cff-bb75-e47ba17f327b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_14741835-d177-404e-b7f9-ad8c4fd6da41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_fdc07482-4858-4cff-bb75-e47ba17f327b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_14741835-d177-404e-b7f9-ad8c4fd6da41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ad5e68c7-c779-4340-bc96-88cbace3b232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_fdc07482-4858-4cff-bb75-e47ba17f327b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ad5e68c7-c779-4340-bc96-88cbace3b232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6b167a98-e150-4978-8cf5-82da9719ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_fdc07482-4858-4cff-bb75-e47ba17f327b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6b167a98-e150-4978-8cf5-82da9719ed1d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_625c452f-d0ad-4285-a0ac-c50910f46b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_9504fc1d-60ec-42f1-92ad-56fcd572aead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_625c452f-d0ad-4285-a0ac-c50910f46b25" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_9504fc1d-60ec-42f1-92ad-56fcd572aead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_3229b921-a62d-4f61-8172-68157f1b630e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_625c452f-d0ad-4285-a0ac-c50910f46b25" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_3229b921-a62d-4f61-8172-68157f1b630e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_3acaa21b-d048-4d68-822b-113f56b38b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_625c452f-d0ad-4285-a0ac-c50910f46b25" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_3acaa21b-d048-4d68-822b-113f56b38b6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_92f0424e-f35e-4758-b9a1-83516e90efd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_4215ff52-03bc-4bbb-82d5-7fbfc94aa99c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_92f0424e-f35e-4758-b9a1-83516e90efd8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_4215ff52-03bc-4bbb-82d5-7fbfc94aa99c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2a941ac5-d03d-4a5b-a0b6-95837bbe438f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_92f0424e-f35e-4758-b9a1-83516e90efd8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_2a941ac5-d03d-4a5b-a0b6-95837bbe438f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1c7c70a7-211c-4d39-bdcb-76a1b1038b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_05d12e7b-4daf-44ad-b84d-6445e6850d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1c7c70a7-211c-4d39-bdcb-76a1b1038b01" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_05d12e7b-4daf-44ad-b84d-6445e6850d94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_64e2ce01-b5f9-4724-aa9c-883a8ac0d343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1c7c70a7-211c-4d39-bdcb-76a1b1038b01" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_64e2ce01-b5f9-4724-aa9c-883a8ac0d343" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_3a6b75c0-894a-43e4-b50b-38cc03e977c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_37897d7b-5c7e-4798-9f18-e8e982b1530b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_3a6b75c0-894a-43e4-b50b-38cc03e977c7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_37897d7b-5c7e-4798-9f18-e8e982b1530b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_3e90a34a-aef6-4883-b90e-9170a62a7417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_3a6b75c0-894a-43e4-b50b-38cc03e977c7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_3e90a34a-aef6-4883-b90e-9170a62a7417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_2963f43a-e5be-4fda-8938-fca9d05f3469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_3a6b75c0-894a-43e4-b50b-38cc03e977c7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_2963f43a-e5be-4fda-8938-fca9d05f3469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_f70a82e8-9cef-4252-ad17-122185e0fd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_bcc88593-e581-4e38-ac83-f4634ff29234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_f70a82e8-9cef-4252-ad17-122185e0fd43" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_bcc88593-e581-4e38-ac83-f4634ff29234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_bd6c5f80-686e-4f7f-b11e-7196b080bb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_f70a82e8-9cef-4252-ad17-122185e0fd43" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_bd6c5f80-686e-4f7f-b11e-7196b080bb47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_93bce848-fa1d-488d-abc4-a89fc02e6d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_f70a82e8-9cef-4252-ad17-122185e0fd43" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_93bce848-fa1d-488d-abc4-a89fc02e6d83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_dcc803d9-6657-423d-af1c-45b434391971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_057fce7b-0846-411d-8d15-a6d83fb4a6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_dcc803d9-6657-423d-af1c-45b434391971" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_057fce7b-0846-411d-8d15-a6d83fb4a6d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_196b58e3-5736-4db1-a956-4df88ac2c1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_dcc803d9-6657-423d-af1c-45b434391971" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_196b58e3-5736-4db1-a956-4df88ac2c1d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_daa88a1a-959f-41e6-b43f-e04eb6cf12f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_2e8e6950-7d57-4e0a-932a-2bba840c1ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_daa88a1a-959f-41e6-b43f-e04eb6cf12f4" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_2e8e6950-7d57-4e0a-932a-2bba840c1ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_6eab42d8-7459-41ac-a86c-82ad39934c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_daa88a1a-959f-41e6-b43f-e04eb6cf12f4" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_6eab42d8-7459-41ac-a86c-82ad39934c0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_9567c993-2c8e-409c-b898-29f7b8a02e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_b50da8f3-93fe-4659-961e-c0f648874cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_9567c993-2c8e-409c-b898-29f7b8a02e01" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_b50da8f3-93fe-4659-961e-c0f648874cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_2abfeb4d-e714-4fb5-b02b-a9ad04d2c8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_9567c993-2c8e-409c-b898-29f7b8a02e01" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_2abfeb4d-e714-4fb5-b02b-a9ad04d2c8c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_38da9e9b-c444-4472-8dfe-e72eddbea0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_4da30017-75e8-403b-804e-7a8d687ead96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_38da9e9b-c444-4472-8dfe-e72eddbea0b3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_4da30017-75e8-403b-804e-7a8d687ead96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_ae069ede-566e-4006-8348-4957d16d1ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_38da9e9b-c444-4472-8dfe-e72eddbea0b3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_ae069ede-566e-4006-8348-4957d16d1ee4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_842d4be5-8747-4330-a693-74c130e679ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_58efcb9a-07c3-4084-9a6d-1f5741095dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_842d4be5-8747-4330-a693-74c130e679ca" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_58efcb9a-07c3-4084-9a6d-1f5741095dd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_5f2af995-2f9a-48c6-b7ae-e12ee5d76281" xlink:href="cvs-20230331.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_842d4be5-8747-4330-a693-74c130e679ca" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_5f2af995-2f9a-48c6-b7ae-e12ee5d76281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtGrossAndLeaseObligation_1ca53402-6d95-4a4e-844f-302851c5078c" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtGrossAndLeaseObligation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_842d4be5-8747-4330-a693-74c130e679ca" xlink:to="loc_cvs_LongTermDebtGrossAndLeaseObligation_1ca53402-6d95-4a4e-844f-302851c5078c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtGrossAndLeaseObligation_752744c8-e37d-48b5-a84b-255c623087b4" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtGrossAndLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2c18b2d4-3943-43bc-9562-379680c5fc77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongTermDebtGrossAndLeaseObligation_752744c8-e37d-48b5-a84b-255c623087b4" xlink:to="loc_us-gaap_FinanceLeaseLiability_2c18b2d4-3943-43bc-9562-379680c5fc77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_054c1135-8988-496a-a8ed-4ab2aac5a1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongTermDebtGrossAndLeaseObligation_752744c8-e37d-48b5-a84b-255c623087b4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_054c1135-8988-496a-a8ed-4ab2aac5a1b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_232a7849-42ec-413a-8738-78400a9e3a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b9f9f329-24b6-4f19-8b5c-36d154080fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_232a7849-42ec-413a-8738-78400a9e3a6f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b9f9f329-24b6-4f19-8b5c-36d154080fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f1c1f729-fc34-4d9c-bc5b-2e6377efa92f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_232a7849-42ec-413a-8738-78400a9e3a6f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f1c1f729-fc34-4d9c-bc5b-2e6377efa92f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ced090b-1528-463c-8641-c71fe33bc37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_dbde7990-167d-4f82-b6d7-5d9da465b65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ced090b-1528-463c-8641-c71fe33bc37a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_dbde7990-167d-4f82-b6d7-5d9da465b65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_96c09356-9b55-49a7-b1bd-8fcdd8339bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8ced090b-1528-463c-8641-c71fe33bc37a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_96c09356-9b55-49a7-b1bd-8fcdd8339bea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_087c9dec-8b53-4f97-890f-c2cc01b7de38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_196f8545-bc3f-448a-9d07-049001afeca6" xlink:href="cvs-20230331.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_087c9dec-8b53-4f97-890f-c2cc01b7de38" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_196f8545-bc3f-448a-9d07-049001afeca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_593d08a1-bd8f-44e4-866b-cb72cc5e07ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_087c9dec-8b53-4f97-890f-c2cc01b7de38" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_593d08a1-bd8f-44e4-866b-cb72cc5e07ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_d8cdb422-4473-4f72-b3a7-42162fdb0ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_087c9dec-8b53-4f97-890f-c2cc01b7de38" xlink:to="loc_us-gaap_NetInvestmentIncome_d8cdb422-4473-4f72-b3a7-42162fdb0ca5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>cvs-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a5201116-fa32-47d9-bf67-a4b1f9934cb7,g:676c592e-810f-43b8-9a45-1cf85e252b17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="id1ac913c0eea4e7fbe4de931982e9ef6_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cca2f58d-bddc-4054-a4c3-b64d7ccb6a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cca2f58d-bddc-4054-a4c3-b64d7ccb6a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_325fefe1-b8f1-4502-862b-757a018344d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_PremiumsEarnedNet_325fefe1-b8f1-4502-862b-757a018344d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_3f48309b-d8ee-4662-b1af-703d215c920a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_NetInvestmentIncome_3f48309b-d8ee-4662-b1af-703d215c920a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4e82bfae-464c-41cc-9d6a-6efe20532ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_Revenues_4e82bfae-464c-41cc-9d6a-6efe20532ffe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3bd1e509-2a80-48cc-93c9-f94401ca1f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3bd1e509-2a80-48cc-93c9-f94401ca1f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_516c0976-1c18-4ea5-8994-6bc0f7bdccb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_516c0976-1c18-4ea5-8994-6bc0f7bdccb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c2b71e28-d7e2-41ea-858b-6f9357a708ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c2b71e28-d7e2-41ea-858b-6f9357a708ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ba8e09a1-fd54-4457-b021-3dc2e411ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ba8e09a1-fd54-4457-b021-3dc2e411ed1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_27ff0916-4622-491b-9dfc-17d7573eb25d" xlink:href="cvs-20230331.xsd#cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_27ff0916-4622-491b-9dfc-17d7573eb25d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_739c6dbe-1513-410b-8e6d-99536212c8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_CostsAndExpenses_739c6dbe-1513-410b-8e6d-99536212c8da" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fce77972-2cc0-4d23-b75f-cafddd1004eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_OperatingIncomeLoss_fce77972-2cc0-4d23-b75f-cafddd1004eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f7f09e79-6327-4573-b626-2df32a26460e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_InterestExpense_f7f09e79-6327-4573-b626-2df32a26460e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c0a2b59d-e8dd-45c1-b048-7bd63b9c8994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c0a2b59d-e8dd-45c1-b048-7bd63b9c8994" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15c6944d-a6ca-4f72-8d90-589b94129d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15c6944d-a6ca-4f72-8d90-589b94129d05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_10f1a3ee-d2e0-49df-99d8-44ac0b699571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_10f1a3ee-d2e0-49df-99d8-44ac0b699571" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7901254d-2016-40e1-a0bb-fd5059238435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_ProfitLoss_7901254d-2016-40e1-a0bb-fd5059238435" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3d8ad674-1b97-4eb7-ad3d-0066992efd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3d8ad674-1b97-4eb7-ad3d-0066992efd75" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f79e0af-7157-4f01-b641-32a719029827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_NetIncomeLoss_7f79e0af-7157-4f01-b641-32a719029827" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b1b1e9d3-8322-49dd-8778-075021430932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:to="loc_us-gaap_EarningsPerShareBasic_b1b1e9d3-8322-49dd-8778-075021430932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_26b6bb73-6bb3-47f8-9cdc-652dd0aa9f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_26b6bb73-6bb3-47f8-9cdc-652dd0aa9f09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19336dda-d836-40c9-b6f9-5dc248faf261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19336dda-d836-40c9-b6f9-5dc248faf261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7f4a543-e08e-4c4b-a05e-c510f221c366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7f4a543-e08e-4c4b-a05e-c510f221c366" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_6fdc7c22-623c-4982-806f-8ab7fd07b072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_6fdc7c22-623c-4982-806f-8ab7fd07b072" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_c2dce359-c0ca-4a0c-9609-a4a880d4fb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_c2dce359-c0ca-4a0c-9609-a4a880d4fb3b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d5b9a936-beed-4551-9640-470eb6971328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_StatementTable_d5b9a936-beed-4551-9640-470eb6971328" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d5b9a936-beed-4551-9640-470eb6971328" xlink:to="loc_srt_ProductOrServiceAxis_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721" xlink:to="loc_srt_ProductsAndServicesDomain_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721" xlink:to="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_d9795fcd-718e-4d0e-bf47-b0529a13e836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:to="loc_us-gaap_ProductMember_d9795fcd-718e-4d0e-bf47-b0529a13e836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_0dc061b5-b800-4571-b56d-6e3e9b62f24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:to="loc_us-gaap_ServiceMember_0dc061b5-b800-4571-b56d-6e3e9b62f24f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended" id="i4642b724b630477da0d9a4e8b7003d23_CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d8641284-a86b-4f21-a9be-0f353b500837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d8641284-a86b-4f21-a9be-0f353b500837" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_061322ca-4d93-437a-b406-f70b5799e82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_SharesOutstanding_061322ca-4d93-437a-b406-f70b5799e82b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6e7711e3-9553-40b1-aebf-d6eacb89dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6e7711e3-9553-40b1-aebf-d6eacb89dac7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff1aeae4-7f24-47f1-b16a-129fc12ee9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff1aeae4-7f24-47f1-b16a-129fc12ee9c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3287680f-a25f-4a14-82ae-ba7fd84d869a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_ProfitLoss_3287680f-a25f-4a14-82ae-ba7fd84d869a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a0b6ca82-dd1e-4721-9825-9f2b2fc9d71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a0b6ca82-dd1e-4721-9825-9f2b2fc9d71f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c1648361-9ed9-4886-a24c-2a4b20bd38e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c1648361-9ed9-4886-a24c-2a4b20bd38e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c288d181-51f0-40af-afe1-90a5ae28dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c288d181-51f0-40af-afe1-90a5ae28dbcf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_251ce38d-84f9-4eaf-bab4-caa7fb72967c" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_251ce38d-84f9-4eaf-bab4-caa7fb72967c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce92592e-7aeb-4c6f-9c10-0ee5ebd06f14" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce92592e-7aeb-4c6f-9c10-0ee5ebd06f14" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_016520e7-2335-4276-af2b-f522e6dd1644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_DividendsCommonStock_016520e7-2335-4276-af2b-f522e6dd1644" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_5b0fcf41-d44d-44bf-87c6-390ad039f6ff" xlink:href="cvs-20230331.xsd#cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_5b0fcf41-d44d-44bf-87c6-390ad039f6ff" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_28879577-09aa-49a5-bf56-be60ccb09121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_67879137-8980-4363-a84f-267214789437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3188c94-2e2c-46f9-b5a1-1ce72e6a11f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d8641284-a86b-4f21-a9be-0f353b500837" xlink:to="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b" xlink:to="loc_us-gaap_EquityComponentDomain_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b" xlink:to="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:to="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d808c6f3-16a2-494f-94d9-e28673315ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_CommonStockMember_d808c6f3-16a2-494f-94d9-e28673315ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_41d448a4-69f7-4de8-b2ee-a5ba1edd6867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_TreasuryStockCommonMember_41d448a4-69f7-4de8-b2ee-a5ba1edd6867" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_c0dd9b48-22d0-45e1-9bd3-3412fe1e712f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_c0dd9b48-22d0-45e1-9bd3-3412fe1e712f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_818c1002-8cb5-4d68-b47d-9b51bede720b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_RetainedEarningsMember_818c1002-8cb5-4d68-b47d-9b51bede720b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6852ce50-7283-4527-a62d-abe8294c4d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6852ce50-7283-4527-a62d-abe8294c4d9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_df1e8600-dbf1-42ba-b2a4-764ac656c661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:to="loc_us-gaap_NoncontrollingInterestMember_df1e8600-dbf1-42ba-b2a4-764ac656c661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ffda15e2-2d03-4d88-b5c3-cfe05bb63390" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ffda15e2-2d03-4d88-b5c3-cfe05bb63390" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ffda15e2-2d03-4d88-b5c3-cfe05bb63390_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ffda15e2-2d03-4d88-b5c3-cfe05bb63390" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ffda15e2-2d03-4d88-b5c3-cfe05bb63390_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_653ba323-76f3-42ab-9e08-3cb773d1c4ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ffda15e2-2d03-4d88-b5c3-cfe05bb63390" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_653ba323-76f3-42ab-9e08-3cb773d1c4ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e7c35927-c617-4d71-8fa2-063af724f058" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_653ba323-76f3-42ab-9e08-3cb773d1c4ce" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e7c35927-c617-4d71-8fa2-063af724f058" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i970939709e9b4ef2b326b58d744dc787_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_0db807bc-10c5-44ea-8f20-ced25d645de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_NumberOfStores_0db807bc-10c5-44ea-8f20-ced25d645de1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfWalkInMedicalClinics_d2ec50fb-a4a3-4ad8-918b-379e847a677a" xlink:href="cvs-20230331.xsd#cvs_NumberOfWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfWalkInMedicalClinics_d2ec50fb-a4a3-4ad8-918b-379e847a677a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPharmacyPlanMembers_5aff6332-1e23-43d9-9162-88a9c91d633a" xlink:href="cvs-20230331.xsd#cvs_NumberOfPharmacyPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfPharmacyPlanMembers_5aff6332-1e23-43d9-9162-88a9c91d633a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPatientsServedPerYear_92679766-4f71-42a2-9844-bdd5d2c45be3" xlink:href="cvs-20230331.xsd#cvs_NumberOfPatientsServedPerYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfPatientsServedPerYear_92679766-4f71-42a2-9844-bdd5d2c45be3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_d3684fb3-d416-41b1-83ab-296de8b96a71" xlink:href="cvs-20230331.xsd#cvs_NumberOfPeopleServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfPeopleServed_d3684fb3-d416-41b1-83ab-296de8b96a71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_14dac28e-0f93-431c-b507-2dfe3133db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_NumberOfReportableSegments_14dac28e-0f93-431c-b507-2dfe3133db9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_f88b4c6a-0e13-4d01-a08e-e2e41cc514a5" xlink:href="cvs-20230331.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_f88b4c6a-0e13-4d01-a08e-e2e41cc514a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_5e758912-a811-4d88-a7ca-9956e5c9539f" xlink:href="cvs-20230331.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_5e758912-a811-4d88-a7ca-9956e5c9539f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ce06bfc9-9992-4f83-9613-3a555c46c3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ce06bfc9-9992-4f83-9613-3a555c46c3ef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_05f8e68e-a9e8-4949-be19-55d910c51370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_05f8e68e-a9e8-4949-be19-55d910c51370" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_29901616-e559-45c2-8302-ac173792f7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_29901616-e559-45c2-8302-ac173792f7ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_db8cc450-6869-4d21-87cc-43fe560882f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_db8cc450-6869-4d21-87cc-43fe560882f2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_32ea70aa-5bdf-4f6b-9656-18d78998c290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_32ea70aa-5bdf-4f6b-9656-18d78998c290" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b5b8cc75-ffb7-41c1-b21e-9c948176bd08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b5b8cc75-ffb7-41c1-b21e-9c948176bd08" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2a32cc89-6eb7-4696-b0da-d80e2a237c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2a32cc89-6eb7-4696-b0da-d80e2a237c39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2a32cc89-6eb7-4696-b0da-d80e2a237c39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2a32cc89-6eb7-4696-b0da-d80e2a237c39" xlink:to="loc_us-gaap_SegmentDomain_2a32cc89-6eb7-4696-b0da-d80e2a237c39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2a32cc89-6eb7-4696-b0da-d80e2a237c39" xlink:to="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a32cdfe1-530a-4da1-bae5-c26075092bd5" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a32cdfe1-530a-4da1-bae5-c26075092bd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_a509f9e8-e777-44b7-b1f7-3cb92db69dbb" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:to="loc_cvs_HealthServicesSegmentMember_a509f9e8-e777-44b7-b1f7-3cb92db69dbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_a7adeffb-51cf-46c9-b5ff-0e6a0259e0d8" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_a7adeffb-51cf-46c9-b5ff-0e6a0259e0d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_20df56e5-3244-412b-aa0e-c2b9dc12cc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_20df56e5-3244-412b-aa0e-c2b9dc12cc03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_20df56e5-3244-412b-aa0e-c2b9dc12cc03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_20df56e5-3244-412b-aa0e-c2b9dc12cc03" xlink:to="loc_us-gaap_RelatedPartyDomain_20df56e5-3244-412b-aa0e-c2b9dc12cc03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bdf9c216-0b17-4493-9b8b-5594c16b6839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_20df56e5-3244-412b-aa0e-c2b9dc12cc03" xlink:to="loc_us-gaap_RelatedPartyDomain_bdf9c216-0b17-4493-9b8b-5594c16b6839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_a253480b-a8b2-4fee-8c3b-8ea2f5511c6c" xlink:href="cvs-20230331.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_bdf9c216-0b17-4493-9b8b-5594c16b6839" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_a253480b-a8b2-4fee-8c3b-8ea2f5511c6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_81a006c6-f3a0-43ad-9763-eeb169bb5f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_81a006c6-f3a0-43ad-9763-eeb169bb5f9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_81a006c6-f3a0-43ad-9763-eeb169bb5f9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_81a006c6-f3a0-43ad-9763-eeb169bb5f9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_81a006c6-f3a0-43ad-9763-eeb169bb5f9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_81a006c6-f3a0-43ad-9763-eeb169bb5f9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_3af962a1-1c79-4286-86b7-d46ba375d089" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_3af962a1-1c79-4286-86b7-d46ba375d089" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_f64fea54-9102-45cb-a1cf-d4217e7c1468" xlink:href="cvs-20230331.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_f64fea54-9102-45cb-a1cf-d4217e7c1468" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended" id="icbd8eae8c448440f9184c5e98f2e28ec_SignificantAccountingPoliciesAccountsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a0fc545c-d76c-4076-8ccc-64112cedc420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a0fc545c-d76c-4076-8ccc-64112cedc420" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAndManufacturerReceivables_75c43731-b71a-4eac-a9e8-1f69fccfc9f4" xlink:href="cvs-20230331.xsd#cvs_VendorAndManufacturerReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_cvs_VendorAndManufacturerReceivables_75c43731-b71a-4eac-a9e8-1f69fccfc9f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_1b5183a7-1593-4769-b100-df7e73fad7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_1b5183a7-1593-4769-b100-df7e73fad7c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_4aad1e42-0f07-483a-8e13-bf8a0c6e2e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_4aad1e42-0f07-483a-8e13-bf8a0c6e2e7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_67fd9cb4-a24a-48f4-b2e5-a7b231624c6d" xlink:href="cvs-20230331.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_67fd9cb4-a24a-48f4-b2e5-a7b231624c6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2ee50f06-2704-4352-be18-b7afd6c6bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2ee50f06-2704-4352-be18-b7afd6c6bfb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56909ae3-b890-4f61-8abd-d829e2c8f562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56909ae3-b890-4f61-8abd-d829e2c8f562" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b362b526-762a-4a34-8740-3e6fef179d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56909ae3-b890-4f61-8abd-d829e2c8f562" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b362b526-762a-4a34-8740-3e6fef179d7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b362b526-762a-4a34-8740-3e6fef179d7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b362b526-762a-4a34-8740-3e6fef179d7f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b362b526-762a-4a34-8740-3e6fef179d7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bf4dfd1b-9b9f-4fcf-bad2-16f9b6e8a237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b362b526-762a-4a34-8740-3e6fef179d7f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bf4dfd1b-9b9f-4fcf-bad2-16f9b6e8a237" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e0d96a18-8cc2-4530-8afd-5ae7d57c2bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bf4dfd1b-9b9f-4fcf-bad2-16f9b6e8a237" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e0d96a18-8cc2-4530-8afd-5ae7d57c2bfe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="i2bab1c3ff1e34ea48d2268a312de2f03_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f399d0e0-88b7-4443-bd07-fbb9dcff6616" xlink:href="cvs-20230331.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f399d0e0-88b7-4443-bd07-fbb9dcff6616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_897faf1e-bc9e-45fe-a290-84fd9a299016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:to="loc_us-gaap_NetInvestmentIncome_897faf1e-bc9e-45fe-a290-84fd9a299016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7c0beb3d-e8ca-4ee8-b859-826887434117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:to="loc_us-gaap_Revenues_7c0beb3d-e8ca-4ee8-b859-826887434117" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ebbc4888-4f28-4f76-b87d-0bb3340ee707" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_srt_ConsolidationItemsAxis_ebbc4888-4f28-4f76-b87d-0bb3340ee707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ebbc4888-4f28-4f76-b87d-0bb3340ee707_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ebbc4888-4f28-4f76-b87d-0bb3340ee707" xlink:to="loc_srt_ConsolidationItemsDomain_ebbc4888-4f28-4f76-b87d-0bb3340ee707_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ebbc4888-4f28-4f76-b87d-0bb3340ee707" xlink:to="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7cf6e05-823f-494b-9af4-fb7d912cdcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7cf6e05-823f-494b-9af4-fb7d912cdcaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ccbf0f19-79c9-4ed8-992f-cdcda1b7a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ccbf0f19-79c9-4ed8-992f-cdcda1b7a3c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_8a39c7ba-ddf6-4a61-830b-865799ab787a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:to="loc_us-gaap_IntersegmentEliminationMember_8a39c7ba-ddf6-4a61-830b-865799ab787a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62d8b646-d0da-472e-a365-96ea4f09c25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62d8b646-d0da-472e-a365-96ea4f09c25d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_62d8b646-d0da-472e-a365-96ea4f09c25d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62d8b646-d0da-472e-a365-96ea4f09c25d" xlink:to="loc_us-gaap_SegmentDomain_62d8b646-d0da-472e-a365-96ea4f09c25d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62d8b646-d0da-472e-a365-96ea4f09c25d" xlink:to="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e13f3092-c102-432e-9bd1-21fef2af8909" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e13f3092-c102-432e-9bd1-21fef2af8909" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_1e2befaa-2745-4577-af85-4f695cce034c" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:to="loc_cvs_HealthServicesSegmentMember_1e2befaa-2745-4577-af85-4f695cce034c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_648aaf91-3b74-4993-84b8-a9c5176edeaf" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_648aaf91-3b74-4993-84b8-a9c5176edeaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_srt_ProductOrServiceAxis_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7" xlink:to="loc_srt_ProductsAndServicesDomain_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7" xlink:to="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_95d26735-8694-46ed-97a9-d6305284f531" xlink:href="cvs-20230331.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_cvs_PharmacyRevenueMember_95d26735-8694-46ed-97a9-d6305284f531" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_be935b95-eebd-4856-a0c9-f0c36ff19b7e" xlink:href="cvs-20230331.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_cvs_FrontStoreRevenueMember_be935b95-eebd-4856-a0c9-f0c36ff19b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_83b749c2-3df5-4cae-8c79-ffea5f37dd5d" xlink:href="cvs-20230331.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_cvs_PremiumsMember_83b749c2-3df5-4cae-8c79-ffea5f37dd5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_6a65245d-252d-4aeb-b72c-d08b7d0f01ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_6a65245d-252d-4aeb-b72c-d08b7d0f01ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ad52ac02-6bd1-483f-812a-494215edf19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ad52ac02-6bd1-483f-812a-494215edf19f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ad52ac02-6bd1-483f-812a-494215edf19f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ad52ac02-6bd1-483f-812a-494215edf19f" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ad52ac02-6bd1-483f-812a-494215edf19f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ad52ac02-6bd1-483f-812a-494215edf19f" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_4f390b78-d55b-4520-9e63-21ba56ee7824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_4f390b78-d55b-4520-9e63-21ba56ee7824" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_acd9f6ba-e979-4975-9703-41706a9f6ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_acd9f6ba-e979-4975-9703-41706a9f6ad0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_1ccf507d-60ba-49df-8301-0a23a9e8faa9" xlink:href="cvs-20230331.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:to="loc_cvs_SalesChannelOtherMember_1ccf507d-60ba-49df-8301-0a23a9e8faa9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails" xlink:type="extended" id="i1714d56fed8644cdbdaa06876de03175_SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_45a71675-89f5-4093-a9f1-48f1799e3324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_45a71675-89f5-4093-a9f1-48f1799e3324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_ab520aba-6828-47e9-91f7-3aa8fb99dd73" xlink:href="cvs-20230331.xsd#cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_ab520aba-6828-47e9-91f7-3aa8fb99dd73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_dcce8560-c23e-4810-ad64-ab3ee6d5f7c8" xlink:href="cvs-20230331.xsd#cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_dcce8560-c23e-4810-ad64-ab3ee6d5f7c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_316845fb-c569-48a9-8027-647b0a2094b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_316845fb-c569-48a9-8027-647b0a2094b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130" xlink:to="loc_us-gaap_TypeOfAdoptionMember_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_476f384b-7d23-4bc5-babe-3f2a60b4b0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130" xlink:to="loc_us-gaap_TypeOfAdoptionMember_476f384b-7d23-4bc5-babe-3f2a60b4b0f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201812Member_b8585c6b-bd4f-4764-bd7f-dc703865d350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201812Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_476f384b-7d23-4bc5-babe-3f2a60b4b0f6" xlink:to="loc_us-gaap_AccountingStandardsUpdate201812Member_b8585c6b-bd4f-4764-bd7f-dc703865d350" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bbccb2ca-21ba-4e72-a9a8-9730db8227aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bbccb2ca-21ba-4e72-a9a8-9730db8227aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bbccb2ca-21ba-4e72-a9a8-9730db8227aa_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bbccb2ca-21ba-4e72-a9a8-9730db8227aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bbccb2ca-21ba-4e72-a9a8-9730db8227aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0741ddf2-b059-44a5-b57d-7b04bce9cf99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bbccb2ca-21ba-4e72-a9a8-9730db8227aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0741ddf2-b059-44a5-b57d-7b04bce9cf99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4d1c4785-22df-448b-a88c-6fdfe157f890" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0741ddf2-b059-44a5-b57d-7b04bce9cf99" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4d1c4785-22df-448b-a88c-6fdfe157f890" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails" xlink:type="extended" id="i5955cb60223a4c39bc7cebfe72266bdd_SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d95ae7c1-5a7a-451e-99df-088c4460e58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d95ae7c1-5a7a-451e-99df-088c4460e58f" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_0b50beb7-bf4a-423b-9c60-eecf30eb7c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_0b50beb7-bf4a-423b-9c60-eecf30eb7c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_d176c329-c440-4853-b8a5-2d603fc924e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_d176c329-c440-4853-b8a5-2d603fc924e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_9e238499-e984-40a3-8698-143b0f048d48" xlink:href="cvs-20230331.xsd#cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_9e238499-e984-40a3-8698-143b0f048d48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_11f23003-4377-465c-b145-c42eb6b3d460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_11f23003-4377-465c-b145-c42eb6b3d460" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_6468a261-27f0-4581-a99b-def5d3040072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_6468a261-27f0-4581-a99b-def5d3040072" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_b84a573f-d577-4e1f-b93d-0fd92d23e686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_887e9f5e-b9ec-467f-97ef-30131033f1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d95ae7c1-5a7a-451e-99df-088c4460e58f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8a68994b-8f1c-43cb-97cb-b437dee56a47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:to="loc_srt_ProductOrServiceAxis_8a68994b-8f1c-43cb-97cb-b437dee56a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8a68994b-8f1c-43cb-97cb-b437dee56a47_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8a68994b-8f1c-43cb-97cb-b437dee56a47" xlink:to="loc_srt_ProductsAndServicesDomain_8a68994b-8f1c-43cb-97cb-b437dee56a47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8a68994b-8f1c-43cb-97cb-b437dee56a47" xlink:to="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_49c06a22-14ca-49a9-bbf0-c0742eac58ee" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:to="loc_cvs_LargeCasePensionsMember_49c06a22-14ca-49a9-bbf0-c0742eac58ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_a2fd8404-b49b-4ad9-ba32-bc1c92167983" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:to="loc_cvs_LongTermCareMember_a2fd8404-b49b-4ad9-ba32-bc1c92167983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_5ea6e63c-83c5-4ef6-8690-89b9ba374a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_5ea6e63c-83c5-4ef6-8690-89b9ba374a46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_614e6bbd-ec56-473c-919e-9eb6beae73b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:to="loc_srt_RestatementAxis_614e6bbd-ec56-473c-919e-9eb6beae73b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_614e6bbd-ec56-473c-919e-9eb6beae73b9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_614e6bbd-ec56-473c-919e-9eb6beae73b9" xlink:to="loc_srt_RestatementDomain_614e6bbd-ec56-473c-919e-9eb6beae73b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_614e6bbd-ec56-473c-919e-9eb6beae73b9" xlink:to="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1a54249f-fa6e-4111-b67c-5b535df74fed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1a54249f-fa6e-4111-b67c-5b535df74fed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_7ecfb1ac-d020-4828-82fb-2f0f1fe80e5d" xlink:href="cvs-20230331.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_7ecfb1ac-d020-4828-82fb-2f0f1fe80e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_ce4b06d5-c1dd-403e-bd9d-54d488e74641" xlink:href="cvs-20230331.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_ce4b06d5-c1dd-403e-bd9d-54d488e74641" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="extended" id="i8923159f689d4c229d922e4d232fb81a_SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:to="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_92a0ce11-58ac-43b8-98b7-7b9d19a5c73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_92a0ce11-58ac-43b8-98b7-7b9d19a5c73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_b6afe8f9-3231-4bc1-9f41-9c694643bfaa" xlink:href="cvs-20230331.xsd#cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_b6afe8f9-3231-4bc1-9f41-9c694643bfaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1b25cb43-8ef0-461e-9eb7-24a4e24574b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_CostsAndExpenses_1b25cb43-8ef0-461e-9eb7-24a4e24574b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f9cc827b-ab0d-46f2-872c-e458bdf1dcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_OperatingIncomeLoss_f9cc827b-ab0d-46f2-872c-e458bdf1dcdb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9c6a6ddc-23ae-4b49-851c-734bbdfeb577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9c6a6ddc-23ae-4b49-851c-734bbdfeb577" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4577be73-9afa-41ac-9084-94b40d58080a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4577be73-9afa-41ac-9084-94b40d58080a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c488e514-90f0-4336-ab90-6fa01832a37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_ProfitLoss_c488e514-90f0-4336-ab90-6fa01832a37d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ac42b5c2-82e2-4c1c-85db-610e8f6563b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_NetIncomeLoss_ac42b5c2-82e2-4c1c-85db-610e8f6563b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8b399247-cc7c-4e6b-8da4-4a11c139372a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:to="loc_us-gaap_EarningsPerShareBasic_8b399247-cc7c-4e6b-8da4-4a11c139372a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7b909221-4680-4625-a8c4-6ade78828ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7b909221-4680-4625-a8c4-6ade78828ac2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4aacee7a-9684-436e-a909-bd12297bae85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_OtherAssetsCurrent_4aacee7a-9684-436e-a909-bd12297bae85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_24be6c96-497e-4553-a679-4b956165b89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_AssetsCurrent_24be6c96-497e-4553-a679-4b956165b89a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c03f0b79-8d14-4001-bdbe-741c28654288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c03f0b79-8d14-4001-bdbe-741c28654288" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_80b084c6-6ef5-4e10-b5da-f1e4110be23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_Assets_80b084c6-6ef5-4e10-b5da-f1e4110be23f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_bf988fcf-5abd-4d18-aeac-cf2561d97bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_bf988fcf-5abd-4d18-aeac-cf2561d97bc5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_02372ed7-46ab-4da0-bedb-2723fdd96ed1" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_02372ed7-46ab-4da0-bedb-2723fdd96ed1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9cdb5931-248d-4f95-8190-30959b6a016b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_LiabilitiesCurrent_9cdb5931-248d-4f95-8190-30959b6a016b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f1f689f9-1155-489f-84f7-6402607e6c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f1f689f9-1155-489f-84f7-6402607e6c5d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_bf9e0243-cf26-4cb5-aa3b-02c6e68543fd" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_bf9e0243-cf26-4cb5-aa3b-02c6e68543fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ad9e4bca-1832-477d-b08e-1c1496804a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ad9e4bca-1832-477d-b08e-1c1496804a99" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dac083d2-c3fb-4413-a4b6-748f1122a24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_Liabilities_dac083d2-c3fb-4413-a4b6-748f1122a24f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bb286007-800d-4995-b04f-7fb4d12e22b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bb286007-800d-4995-b04f-7fb4d12e22b0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e3107ee-f757-4a6c-bef2-dd5e57833bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e3107ee-f757-4a6c-bef2-dd5e57833bf2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7529b1ae-e67e-455b-a2df-dc97f2cf5f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_StockholdersEquity_7529b1ae-e67e-455b-a2df-dc97f2cf5f78" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_967342fb-4518-41cf-b5df-ace51a880b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_967342fb-4518-41cf-b5df-ace51a880b2b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c808ad7-25c1-4429-bd87-201a346842e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c808ad7-25c1-4429-bd87-201a346842e8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_26b16841-9e33-4861-8558-d822c4003a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_26b16841-9e33-4861-8558-d822c4003a61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_20d24993-ecf4-47cb-ba61-0203f3e2b6e8" xlink:href="cvs-20230331.xsd#cvs_DeferredIncomeTaxesAndOtherNoncashItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_20d24993-ecf4-47cb-ba61-0203f3e2b6e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c6bb11b9-b47f-4d8e-922b-12b33d9c2c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c6bb11b9-b47f-4d8e-922b-12b33d9c2c6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ff85b72d-8fb8-49b4-801f-ffc48f5c8ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ff85b72d-8fb8-49b4-801f-ffc48f5c8ff5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fddb7ace-1d9b-4df3-a038-746b785738e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fddb7ace-1d9b-4df3-a038-746b785738e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e04e1d82-af3c-4e58-8f9b-de1720f1ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e04e1d82-af3c-4e58-8f9b-de1720f1ce37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e04e1d82-af3c-4e58-8f9b-de1720f1ce37" xlink:to="loc_srt_RestatementAxis_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2" xlink:to="loc_srt_RestatementDomain_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2" xlink:to="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_4b2ca8c1-a0cc-401f-bc51-4effbc1f8f23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_4b2ca8c1-a0cc-401f-bc51-4effbc1f8f23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_4de18dda-7c38-4562-82c7-9920cfa1db3c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_4de18dda-7c38-4562-82c7-9920cfa1db3c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails" xlink:type="extended" id="i10d1a91f4f904b55ae1e59092872b63c_AcquisitionandAssetsHeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_93dfe219-4d8d-4958-bc56-4707634e89cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_93dfe219-4d8d-4958-bc56-4707634e89cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_76be3a42-8bb9-4206-bdf5-da4c0e469f70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_76be3a42-8bb9-4206-bdf5-da4c0e469f70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_14dc974f-7bb5-4106-9a8a-438e278d73e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_14dc974f-7bb5-4106-9a8a-438e278d73e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc73c2fc-ae55-4503-8e59-eb78c63833d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc73c2fc-ae55-4503-8e59-eb78c63833d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f0bd28ec-9041-45cc-97bb-bfeedcedd1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f0bd28ec-9041-45cc-97bb-bfeedcedd1fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f50909e6-2471-492e-b31d-d9f7fba69960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f50909e6-2471-492e-b31d-d9f7fba69960" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_029ae5a5-a1e1-4b16-abcc-0449e48b8aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_029ae5a5-a1e1-4b16-abcc-0449e48b8aa8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_da44815e-ce60-4755-b773-9c0ee63b0d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_da44815e-ce60-4755-b773-9c0ee63b0d01" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4f8d3d6f-d048-4db5-8c43-cfe45a680e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4f8d3d6f-d048-4db5-8c43-cfe45a680e71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4f8d3d6f-d048-4db5-8c43-cfe45a680e71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4f8d3d6f-d048-4db5-8c43-cfe45a680e71" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4f8d3d6f-d048-4db5-8c43-cfe45a680e71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9f02b8e6-dfad-41c3-859f-15eaef91a745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4f8d3d6f-d048-4db5-8c43-cfe45a680e71" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9f02b8e6-dfad-41c3-859f-15eaef91a745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7649b6e5-078f-44bd-9f5a-828db50c06dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9f02b8e6-dfad-41c3-859f-15eaef91a745" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7649b6e5-078f-44bd-9f5a-828db50c06dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aea7e389-21a1-4f50-8541-7204e20bd98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aea7e389-21a1-4f50-8541-7204e20bd98a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aea7e389-21a1-4f50-8541-7204e20bd98a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aea7e389-21a1-4f50-8541-7204e20bd98a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aea7e389-21a1-4f50-8541-7204e20bd98a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0100a1bd-294d-46e9-9ae9-e17c4b484fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aea7e389-21a1-4f50-8541-7204e20bd98a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0100a1bd-294d-46e9-9ae9-e17c4b484fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember_58939811-d8bc-43cf-b58b-537f9074884e" xlink:href="cvs-20230331.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0100a1bd-294d-46e9-9ae9-e17c4b484fdd" xlink:to="loc_cvs_OmnicareLongTermCareBusinessMember_58939811-d8bc-43cf-b58b-537f9074884e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_35eda846-7fe7-488d-9442-a1fd49f9a314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_35eda846-7fe7-488d-9442-a1fd49f9a314" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35eda846-7fe7-488d-9442-a1fd49f9a314_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35eda846-7fe7-488d-9442-a1fd49f9a314" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35eda846-7fe7-488d-9442-a1fd49f9a314_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35eda846-7fe7-488d-9442-a1fd49f9a314" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_c99435a3-2237-48d0-a88c-3137bd3f4a02" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:to="loc_cvs_SignifyHealthIncMember_c99435a3-2237-48d0-a88c-3137bd3f4a02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember_f69b3af3-0e2e-44d6-ba13-7f09af66b6c1" xlink:href="cvs-20230331.xsd#cvs_OakStreetHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:to="loc_cvs_OakStreetHealthIncMember_f69b3af3-0e2e-44d6-ba13-7f09af66b6c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aa0d5e47-8740-438a-a59b-82822f3f7bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aa0d5e47-8740-438a-a59b-82822f3f7bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7af8dcf7-9e39-458e-b7df-95adb12f732e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aa0d5e47-8740-438a-a59b-82822f3f7bd2" xlink:to="loc_us-gaap_SubsequentEventMember_7af8dcf7-9e39-458e-b7df-95adb12f732e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4" xlink:to="loc_us-gaap_SegmentDomain_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_33074e0c-723e-4c80-b624-50df45e2e60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4" xlink:to="loc_us-gaap_SegmentDomain_33074e0c-723e-4c80-b624-50df45e2e60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a9f3977c-df5b-4822-9a79-f67bd0637e6f" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33074e0c-723e-4c80-b624-50df45e2e60b" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a9f3977c-df5b-4822-9a79-f67bd0637e6f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails" xlink:type="extended" id="ic24e0b0afbad41ad9e298002c711d4dd_AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d255dce-07cc-4eff-85b3-3d2f434c3772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d255dce-07cc-4eff-85b3-3d2f434c3772" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_efa9e1a8-a4cc-4834-a2ae-dfbb02bc32f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_efa9e1a8-a4cc-4834-a2ae-dfbb02bc32f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_fb2d60c2-b59c-4c0e-a38f-71e0c8acfde9" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_fb2d60c2-b59c-4c0e-a38f-71e0c8acfde9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3cbf24e4-6aac-470e-b454-47d92f1b2691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3cbf24e4-6aac-470e-b454-47d92f1b2691" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f587ac86-1208-4b9c-a6c1-60512482dcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f587ac86-1208-4b9c-a6c1-60512482dcb9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9d0a1e9d-a742-415c-8db3-febd9d55075d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9d0a1e9d-a742-415c-8db3-febd9d55075d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d0a1e9d-a742-415c-8db3-febd9d55075d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9d0a1e9d-a742-415c-8db3-febd9d55075d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d0a1e9d-a742-415c-8db3-febd9d55075d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_837d1193-e202-41cf-87ed-4fb8a79a2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9d0a1e9d-a742-415c-8db3-febd9d55075d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_837d1193-e202-41cf-87ed-4fb8a79a2fc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_8a1ca499-c044-4fe6-bcb4-99835c786902" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_837d1193-e202-41cf-87ed-4fb8a79a2fc7" xlink:to="loc_cvs_SignifyHealthIncMember_8a1ca499-c044-4fe6-bcb4-99835c786902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_d8391049-7ebd-4901-9e4b-46d60000a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_d8391049-7ebd-4901-9e4b-46d60000a6eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_d8391049-7ebd-4901-9e4b-46d60000a6eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_d8391049-7ebd-4901-9e4b-46d60000a6eb" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_d8391049-7ebd-4901-9e4b-46d60000a6eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_d8391049-7ebd-4901-9e4b-46d60000a6eb" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PreCombinationServicesMember_779170b8-2097-4c62-9c60-9107f91f738a" xlink:href="cvs-20230331.xsd#cvs_PreCombinationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:to="loc_cvs_PreCombinationServicesMember_779170b8-2097-4c62-9c60-9107f91f738a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PostCombinationServicesMember_65ef1a73-455b-4196-91b2-f42a1d70026c" xlink:href="cvs-20230331.xsd#cvs_PostCombinationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:to="loc_cvs_PostCombinationServicesMember_65ef1a73-455b-4196-91b2-f42a1d70026c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i4fd0a126cedb4856a7a6433c79c00270_AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c3adedf6-205f-4dad-b12b-0205eb17b826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c3adedf6-205f-4dad-b12b-0205eb17b826" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b5fc913e-878a-4f22-989d-fbd669d72dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b5fc913e-878a-4f22-989d-fbd669d72dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_aca8dcda-a8db-411c-acd6-b2c61d5066bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_aca8dcda-a8db-411c-acd6-b2c61d5066bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72829963-88a2-4627-af4e-c898ee9e65e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72829963-88a2-4627-af4e-c898ee9e65e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e25f3f44-1d90-4869-ad4d-61fed5e6df44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_Goodwill_e25f3f44-1d90-4869-ad4d-61fed5e6df44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f156be72-007f-4e41-8891-7131015e8e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f156be72-007f-4e41-8891-7131015e8e4f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ca330d7e-bd34-4ea8-b0c9-29424d3aa837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ca330d7e-bd34-4ea8-b0c9-29424d3aa837" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cbd29037-b37f-4eb3-b057-78b2a1febc32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cbd29037-b37f-4eb3-b057-78b2a1febc32" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a6883d6e-4fa7-40d4-8564-557855816a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a6883d6e-4fa7-40d4-8564-557855816a05" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_199248ee-1442-479f-aff1-3df9e3149e33" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_199248ee-1442-479f-aff1-3df9e3149e33" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee597960-1ce1-412a-b706-91c780f02671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee597960-1ce1-412a-b706-91c780f02671" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ab672b42-19f3-4e75-8a75-b5e96f230e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ab672b42-19f3-4e75-8a75-b5e96f230e42" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a3056d14-f343-419e-af3a-5c01cc6f65b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a3056d14-f343-419e-af3a-5c01cc6f65b4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_49b321f2-e328-4278-941d-39120a7de226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_49b321f2-e328-4278-941d-39120a7de226" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_fab58f0f-797d-4911-868e-729be43b3da8" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_fab58f0f-797d-4911-868e-729be43b3da8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fdbc2d9-8844-4d6e-915a-400f609d0507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fdbc2d9-8844-4d6e-915a-400f609d0507" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fdbc2d9-8844-4d6e-915a-400f609d0507" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7be46500-e7df-43dd-816f-b66b5fcbde85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7be46500-e7df-43dd-816f-b66b5fcbde85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_2ea88c7b-6bd3-4798-85db-431b995b6083" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7be46500-e7df-43dd-816f-b66b5fcbde85" xlink:to="loc_cvs_SignifyHealthIncMember_2ea88c7b-6bd3-4798-85db-431b995b6083" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails" xlink:type="extended" id="ib3ea852aabb54812b84983eb73606f65_AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4ad05ca8-13a5-4348-9a87-9f482410dd23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95034fa4-ad8c-4b60-a20b-82363a799c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4ad05ca8-13a5-4348-9a87-9f482410dd23" xlink:to="loc_us-gaap_Goodwill_95034fa4-ad8c-4b60-a20b-82363a799c62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4ad05ca8-13a5-4348-9a87-9f482410dd23" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_915a0689-3bf6-4be9-be85-60d627381f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_915a0689-3bf6-4be9-be85-60d627381f9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_915a0689-3bf6-4be9-be85-60d627381f9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_915a0689-3bf6-4be9-be85-60d627381f9c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_915a0689-3bf6-4be9-be85-60d627381f9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d861342-8e4d-496f-9029-239015b8b39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_915a0689-3bf6-4be9-be85-60d627381f9c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d861342-8e4d-496f-9029-239015b8b39d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_171183ab-6139-4a6b-88fb-be0bdabc1af1" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d861342-8e4d-496f-9029-239015b8b39d" xlink:to="loc_cvs_SignifyHealthIncMember_171183ab-6139-4a6b-88fb-be0bdabc1af1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b7db9458-83eb-4ff9-b671-6e60a4c74d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b7db9458-83eb-4ff9-b671-6e60a4c74d6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b7db9458-83eb-4ff9-b671-6e60a4c74d6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b7db9458-83eb-4ff9-b671-6e60a4c74d6a" xlink:to="loc_us-gaap_SegmentDomain_b7db9458-83eb-4ff9-b671-6e60a4c74d6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b7db9458-83eb-4ff9-b671-6e60a4c74d6a" xlink:to="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_b087b1bb-5bc1-4c94-9075-e9ab200378df" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:to="loc_cvs_HealthServicesSegmentMember_b087b1bb-5bc1-4c94-9075-e9ab200378df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_89f7a30c-bc28-4ee0-9394-80208ed38e77" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_89f7a30c-bc28-4ee0-9394-80208ed38e77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_32af0e6a-579a-4eae-9121-49d861aa989f" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_32af0e6a-579a-4eae-9121-49d861aa989f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails" xlink:type="extended" id="i8316bdf393f6411a834871e89e63e2ab_AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7563b5da-070f-4f8e-b9cc-8b2f7b1b3100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7563b5da-070f-4f8e-b9cc-8b2f7b1b3100" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_7681a240-1c6e-4655-9483-c0836b00b5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_7681a240-1c6e-4655-9483-c0836b00b5e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_708c77a6-5fc2-42fb-88fe-14fd085bf1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_708c77a6-5fc2-42fb-88fe-14fd085bf1d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_708c77a6-5fc2-42fb-88fe-14fd085bf1d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_708c77a6-5fc2-42fb-88fe-14fd085bf1d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_708c77a6-5fc2-42fb-88fe-14fd085bf1d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_708c77a6-5fc2-42fb-88fe-14fd085bf1d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d1c44286-1747-443d-ad2d-fdd6794393c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d1c44286-1747-443d-ad2d-fdd6794393c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4b2cce80-4ac0-4040-9d42-10635fa73712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4b2cce80-4ac0-4040-9d42-10635fa73712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_0d5a074f-0eb1-49d5-9e83-756077a1efb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:to="loc_us-gaap_TrademarksMember_0d5a074f-0eb1-49d5-9e83-756077a1efb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b073b8ab-7045-4829-885a-c6664d27e7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b073b8ab-7045-4829-885a-c6664d27e7ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_8e72eb86-10a4-4ce1-a3ef-fedaf3c27557" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b073b8ab-7045-4829-885a-c6664d27e7ba" xlink:to="loc_cvs_SignifyHealthIncMember_8e72eb86-10a4-4ce1-a3ef-fedaf3c27557" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="i6cb2440e3a964850b3d3a88f0320e5a9_AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_497a441d-632c-4e6d-b01c-07e276f79d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_497a441d-632c-4e6d-b01c-07e276f79d04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6d7b3ab4-0a07-44e0-a3bf-e3e8c7beddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6d7b3ab4-0a07-44e0-a3bf-e3e8c7beddb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9b39ea0d-c3f6-4e33-9371-6aae37bdecba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9b39ea0d-c3f6-4e33-9371-6aae37bdecba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3f0a72b2-6af0-4ff1-9d22-76b8984a841f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3f0a72b2-6af0-4ff1-9d22-76b8984a841f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb2b1571-26c7-42a8-b9d8-f325da24b22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb2b1571-26c7-42a8-b9d8-f325da24b22c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_df2981d8-2602-493b-a567-349f5af9c310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_df2981d8-2602-493b-a567-349f5af9c310" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_d9028f8b-de1a-4181-8f84-be2c6372f9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_d9028f8b-de1a-4181-8f84-be2c6372f9d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_309d13a0-1c03-4b47-842e-3953213a3b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_309d13a0-1c03-4b47-842e-3953213a3b7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_33e0c779-a86b-49fb-9c1f-fcecf4f99a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_33e0c779-a86b-49fb-9c1f-fcecf4f99a61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_79533dda-f273-4061-8cd6-89a964f50e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_79533dda-f273-4061-8cd6-89a964f50e19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c1dce9b6-24ef-42cf-b051-45baa23039d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c1dce9b6-24ef-42cf-b051-45baa23039d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7c748877-5d27-4ddd-b88f-9cbf0245947b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c1dce9b6-24ef-42cf-b051-45baa23039d3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7c748877-5d27-4ddd-b88f-9cbf0245947b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7c748877-5d27-4ddd-b88f-9cbf0245947b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7c748877-5d27-4ddd-b88f-9cbf0245947b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7c748877-5d27-4ddd-b88f-9cbf0245947b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c5bfdc1f-9838-4079-97f9-95726ae59910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7c748877-5d27-4ddd-b88f-9cbf0245947b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c5bfdc1f-9838-4079-97f9-95726ae59910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6ad2d60d-3baa-4341-8070-228ab4556910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c5bfdc1f-9838-4079-97f9-95726ae59910" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6ad2d60d-3baa-4341-8070-228ab4556910" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended" id="i1f1ac4bafc5d4d168b0b2888aaed255f_InvestmentsTotalInvestmentScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_245ecde6-a107-4839-9cde-617aa8943f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:to="loc_us-gaap_ShortTermInvestments_245ecde6-a107-4839-9cde-617aa8943f37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_741162b7-7200-4c78-9836-f2a3a15100a3" xlink:href="cvs-20230331.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:to="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_741162b7-7200-4c78-9836-f2a3a15100a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_62617704-6d0f-4ed0-b075-5a373f7331d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:to="loc_us-gaap_Investments_62617704-6d0f-4ed0-b075-5a373f7331d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:to="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:to="loc_cvs_TotalInvestmentsAxis_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8_default" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8" xlink:to="loc_cvs_TotalInvestmentsDomain_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8" xlink:to="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_56c98592-3071-4a89-91af-144d3a1cc323" xlink:href="cvs-20230331.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_56c98592-3071-4a89-91af-144d3a1cc323" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_5b719f84-f9aa-43a2-a7fa-6ebd7a660fb6" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:to="loc_cvs_MortgageLoansMember_5b719f84-f9aa-43a2-a7fa-6ebd7a660fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_312c657b-5349-4c72-afe6-488bd95254ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:to="loc_us-gaap_OtherInvestmentsMember_312c657b-5349-4c72-afe6-488bd95254ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9029cc8e-4995-48c8-b043-eeae9686b791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9029cc8e-4995-48c8-b043-eeae9686b791" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a19cc6e2-5a09-4e12-ab2a-b9e988f7b91e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9029cc8e-4995-48c8-b043-eeae9686b791" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a19cc6e2-5a09-4e12-ab2a-b9e988f7b91e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="iffe0910f500f4ff0bc3e3dc07fe51879_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1c9d250-0120-4403-9c76-acb9c28f1a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1c9d250-0120-4403-9c76-acb9c28f1a48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2a338a75-c8f2-4d2c-82e1-c8b336982aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2a338a75-c8f2-4d2c-82e1-c8b336982aa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_c7cb4170-23c3-45e1-b3aa-9031ba89a04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_c7cb4170-23c3-45e1-b3aa-9031ba89a04c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e81d0983-4b80-4a47-94d7-166888b50151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e81d0983-4b80-4a47-94d7-166888b50151" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f1f40169-ef05-4ace-92a5-de0da05277fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f1f40169-ef05-4ace-92a5-de0da05277fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3d9c1996-4d29-4381-b97c-fe7fadfae0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3d9c1996-4d29-4381-b97c-fe7fadfae0c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e4102930-4650-4039-9d95-7d3cce7f358f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e4102930-4650-4039-9d95-7d3cce7f358f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4102930-4650-4039-9d95-7d3cce7f358f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4102930-4650-4039-9d95-7d3cce7f358f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4102930-4650-4039-9d95-7d3cce7f358f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_29ce47d5-ca13-4142-9293-a2d3b71c7d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4102930-4650-4039-9d95-7d3cce7f358f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_29ce47d5-ca13-4142-9293-a2d3b71c7d6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_29ce47d5-ca13-4142-9293-a2d3b71c7d6b" xlink:to="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_17d80723-bc7a-42ba-af8b-05b8dada66cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_17d80723-bc7a-42ba-af8b-05b8dada66cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f90bdd01-5b8b-4f7e-8bd1-e3352d53a7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f90bdd01-5b8b-4f7e-8bd1-e3352d53a7d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_9a145edd-d0ca-4d11-b05d-6bd641fe17cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_9a145edd-d0ca-4d11-b05d-6bd641fe17cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3f75a9e8-0972-49bc-a533-9cca6f11056a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3f75a9e8-0972-49bc-a533-9cca6f11056a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d1afe64a-bda9-46ed-be49-432602297286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d1afe64a-bda9-46ed-be49-432602297286" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_486fe40b-0505-44aa-8bf5-9bd9cfa92197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_486fe40b-0505-44aa-8bf5-9bd9cfa92197" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_07d8e8d3-449a-422b-bdbb-181d03b878b7" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_07d8e8d3-449a-422b-bdbb-181d03b878b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_459f6fa7-7b39-4125-83da-83310c781cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_459f6fa7-7b39-4125-83da-83310c781cc4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_be9c5830-d8af-4768-bef4-a1168d771f43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:to="loc_srt_ProductOrServiceAxis_be9c5830-d8af-4768-bef4-a1168d771f43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_be9c5830-d8af-4768-bef4-a1168d771f43_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_be9c5830-d8af-4768-bef4-a1168d771f43" xlink:to="loc_srt_ProductsAndServicesDomain_be9c5830-d8af-4768-bef4-a1168d771f43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bdfac330-5006-4d46-926a-0dd1b964692b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_be9c5830-d8af-4768-bef4-a1168d771f43" xlink:to="loc_srt_ProductsAndServicesDomain_bdfac330-5006-4d46-926a-0dd1b964692b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_58e19ee0-da06-495c-b65f-d71315b8e916" xlink:href="cvs-20230331.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bdfac330-5006-4d46-926a-0dd1b964692b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_58e19ee0-da06-495c-b65f-d71315b8e916" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="ic11ca992d9a14d24a158d041d4a2c8de_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_caab7d9b-e164-4ee6-93d9-42206be43e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_caab7d9b-e164-4ee6-93d9-42206be43e6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_d98161fa-a51b-4acc-a035-fa3d4cc9c0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_d98161fa-a51b-4acc-a035-fa3d4cc9c0f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_7fd528d5-c2a3-447f-8c12-7787d8142ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_7fd528d5-c2a3-447f-8c12-7787d8142ec0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ac17c286-486d-4166-b797-e04767fe5b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ac17c286-486d-4166-b797-e04767fe5b27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_aa4ed1e3-2799-4402-8252-79bd1e9a4913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_aa4ed1e3-2799-4402-8252-79bd1e9a4913" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_41cad5aa-c481-4520-8045-ac60cbc7124f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_41cad5aa-c481-4520-8045-ac60cbc7124f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d19b6cf8-f825-4dcb-a2be-c96edd3452d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d19b6cf8-f825-4dcb-a2be-c96edd3452d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_06b7b9fc-dd71-454b-a876-ab2b33e3bd55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_06b7b9fc-dd71-454b-a876-ab2b33e3bd55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_580e9df1-bcdc-4422-bba4-8b36def6e225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_580e9df1-bcdc-4422-bba4-8b36def6e225" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_85f0904a-a67c-47ff-9aa9-dff88bce6028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_85f0904a-a67c-47ff-9aa9-dff88bce6028" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_8a5748eb-c268-4006-afab-9db527e87fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_8a5748eb-c268-4006-afab-9db527e87fcb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_926f63ce-abaf-4a52-b3fd-63160dac3433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_926f63ce-abaf-4a52-b3fd-63160dac3433" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf813598-024d-4a61-b61f-9871aa4f344f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf813598-024d-4a61-b61f-9871aa4f344f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_663ce673-a035-40c7-ae3d-87a793cfcf98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf813598-024d-4a61-b61f-9871aa4f344f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_663ce673-a035-40c7-ae3d-87a793cfcf98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_663ce673-a035-40c7-ae3d-87a793cfcf98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_663ce673-a035-40c7-ae3d-87a793cfcf98" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_663ce673-a035-40c7-ae3d-87a793cfcf98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_663ce673-a035-40c7-ae3d-87a793cfcf98" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_71c00c6b-9487-4d54-97a6-94878fd56e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_71c00c6b-9487-4d54-97a6-94878fd56e2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c40b24f2-afb2-4c38-9e69-c0763f98b94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c40b24f2-afb2-4c38-9e69-c0763f98b94b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c7177569-5d3f-4bf1-bc2c-bb4999ac3a03" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c7177569-5d3f-4bf1-bc2c-bb4999ac3a03" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="id3312a5f4a684a54b0b36c9a6ec3b75e_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_9a080adb-7131-4f6a-87a2-64a153effc38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_9a080adb-7131-4f6a-87a2-64a153effc38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_37cc2e52-7596-4eb8-87a0-42d603da8f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_37cc2e52-7596-4eb8-87a0-42d603da8f7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_2ee2f28e-fac2-43b5-9118-1f29df1edc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_2ee2f28e-fac2-43b5-9118-1f29df1edc8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ac7247e8-11ac-49d7-bd71-10ac8dddf820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ac7247e8-11ac-49d7-bd71-10ac8dddf820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_e9742ea2-91ee-4d13-a7a7-df1e912229f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_e9742ea2-91ee-4d13-a7a7-df1e912229f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a88af0e-a0a3-4331-8995-590379f3f61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a88af0e-a0a3-4331-8995-590379f3f61f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b5b76251-b9b8-43ed-a9e1-f45a9b590018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b5b76251-b9b8-43ed-a9e1-f45a9b590018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abce7ec8-0867-466d-8157-f0f51732f07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abce7ec8-0867-466d-8157-f0f51732f07c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_369ed6c4-03f2-407f-bf86-8e409deb5c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_369ed6c4-03f2-407f-bf86-8e409deb5c03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cee37634-0127-40cc-a65d-ed6b0a4efb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cee37634-0127-40cc-a65d-ed6b0a4efb1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_51fc6253-482e-4ca9-acee-1ddea14b0c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cee37634-0127-40cc-a65d-ed6b0a4efb1b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_51fc6253-482e-4ca9-acee-1ddea14b0c43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_51fc6253-482e-4ca9-acee-1ddea14b0c43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_51fc6253-482e-4ca9-acee-1ddea14b0c43" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_51fc6253-482e-4ca9-acee-1ddea14b0c43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_51fc6253-482e-4ca9-acee-1ddea14b0c43" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a0af12cf-0173-4d71-b19a-f3212addfac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a0af12cf-0173-4d71-b19a-f3212addfac9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5c2a502d-fda5-4cfe-a59b-8b477926f91c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5c2a502d-fda5-4cfe-a59b-8b477926f91c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ba69b504-21d2-4d4a-9c40-63f8969796f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ba69b504-21d2-4d4a-9c40-63f8969796f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5f289914-1711-40d2-b551-5ddcd3a66d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5f289914-1711-40d2-b551-5ddcd3a66d57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d295eb3e-25d7-40a8-b311-9561633038f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d295eb3e-25d7-40a8-b311-9561633038f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2f12b63c-7e80-4b37-b0cb-1aeb55472ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2f12b63c-7e80-4b37-b0cb-1aeb55472ed3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d1d65011-e04a-40ed-af70-829aec6bdc5b" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d1d65011-e04a-40ed-af70-829aec6bdc5b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_4893ed69-fd67-4a09-93e0-79dbc35c5c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_4893ed69-fd67-4a09-93e0-79dbc35c5c8b" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="i14910fb81a404abbbef21d098d196d8c_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_fa3776ca-60d1-46e0-9226-1cc1b05378b4" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_fa3776ca-60d1-46e0-9226-1cc1b05378b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1a7d0d44-74dd-4a43-bf4e-d9ec1a9b2284" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1a7d0d44-74dd-4a43-bf4e-d9ec1a9b2284" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_34755ab1-2813-4692-9d4b-0b5e6c9a5fab" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_34755ab1-2813-4692-9d4b-0b5e6c9a5fab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3649c3dc-0272-407f-9825-f9163ac044f6" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3649c3dc-0272-407f-9825-f9163ac044f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_549f3125-1dbb-41ba-b850-b33b70d0fa21" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_549f3125-1dbb-41ba-b850-b33b70d0fa21" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5fc6db79-b798-4847-a6b8-edb645c3002e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5fc6db79-b798-4847-a6b8-edb645c3002e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_bb6a444c-a25d-4f55-8c50-f9a9743da9d8" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_bb6a444c-a25d-4f55-8c50-f9a9743da9d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f15e3064-3825-4492-af8b-00c66486572f" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f15e3064-3825-4492-af8b-00c66486572f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_6650686d-f4a5-407e-a4cb-25f6116d6390" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_6650686d-f4a5-407e-a4cb-25f6116d6390" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_7cd720d7-b84e-4030-854c-3ca45bb37840" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_7cd720d7-b84e-4030-854c-3ca45bb37840" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_37ffb0c3-eee9-4d5d-9f82-5b116fe8421d" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_37ffb0c3-eee9-4d5d-9f82-5b116fe8421d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_6f448061-8ec5-41ed-af59-46fb5aa8ba2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_6f448061-8ec5-41ed-af59-46fb5aa8ba2d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35228351-1fc4-4ebe-94cd-e2219f071404" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:to="loc_srt_ProductOrServiceAxis_35228351-1fc4-4ebe-94cd-e2219f071404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_35228351-1fc4-4ebe-94cd-e2219f071404_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_35228351-1fc4-4ebe-94cd-e2219f071404" xlink:to="loc_srt_ProductsAndServicesDomain_35228351-1fc4-4ebe-94cd-e2219f071404_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_35228351-1fc4-4ebe-94cd-e2219f071404" xlink:to="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_4f732cb4-a11c-403e-80e5-90f32738a35e" xlink:href="cvs-20230331.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_4f732cb4-a11c-403e-80e5-90f32738a35e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_904d9c6a-1987-4807-9e1e-969b6c1a7bc9" xlink:href="cvs-20230331.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:to="loc_cvs_SupportingRemainingProductsMember_904d9c6a-1987-4807-9e1e-969b6c1a7bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_46a3497d-f72a-4944-88e7-71310e08c164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_46a3497d-f72a-4944-88e7-71310e08c164" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46a3497d-f72a-4944-88e7-71310e08c164_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_46a3497d-f72a-4944-88e7-71310e08c164" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46a3497d-f72a-4944-88e7-71310e08c164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_46a3497d-f72a-4944-88e7-71310e08c164" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_578e08b6-e12b-4fc6-b2c8-7cfc02804b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_578e08b6-e12b-4fc6-b2c8-7cfc02804b9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0f3be44c-d73f-41fe-a7fb-908161928604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0f3be44c-d73f-41fe-a7fb-908161928604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_3178878f-4e7f-4dd0-844b-16c39b00962c" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_3178878f-4e7f-4dd0-844b-16c39b00962c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="i47a21eb251e74045ab3b5bf1c589b52b_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a9421598-6d67-466f-a9d2-fb6096ec9c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a9421598-6d67-466f-a9d2-fb6096ec9c34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_9163f970-1815-4fa4-bae2-5518df79c5ee" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_9163f970-1815-4fa4-bae2-5518df79c5ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_8b77b2d8-32b3-4ae2-b80a-057bd3dfde58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_8b77b2d8-32b3-4ae2-b80a-057bd3dfde58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_74d67025-19f1-4260-916d-19c8ca6361a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_74d67025-19f1-4260-916d-19c8ca6361a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c2f8994e-08b9-4aa2-ade8-9870277e3232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_74d67025-19f1-4260-916d-19c8ca6361a9" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c2f8994e-08b9-4aa2-ade8-9870277e3232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_c2f8994e-08b9-4aa2-ade8-9870277e3232_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c2f8994e-08b9-4aa2-ade8-9870277e3232" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_c2f8994e-08b9-4aa2-ade8-9870277e3232_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d43c0431-05d1-47a1-8a44-642254d885ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c2f8994e-08b9-4aa2-ade8-9870277e3232" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d43c0431-05d1-47a1-8a44-642254d885ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_0b30a203-975f-4efb-be38-2a39ceff6f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d43c0431-05d1-47a1-8a44-642254d885ca" xlink:to="loc_us-gaap_CommercialRealEstateMember_0b30a203-975f-4efb-be38-2a39ceff6f72" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="ib2c8a345e541417f8356ff536d9979a5_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_07d4d8bf-54df-4849-b3e8-73b0ef825633" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_07c2dcee-6e9b-4037-b17a-750b89bf8e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_07d4d8bf-54df-4849-b3e8-73b0ef825633" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_07c2dcee-6e9b-4037-b17a-750b89bf8e6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_07d4d8bf-54df-4849-b3e8-73b0ef825633" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0c740a91-7172-4f09-bc5a-8e58984c3529" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0c740a91-7172-4f09-bc5a-8e58984c3529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0c740a91-7172-4f09-bc5a-8e58984c3529_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0c740a91-7172-4f09-bc5a-8e58984c3529" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0c740a91-7172-4f09-bc5a-8e58984c3529_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f1f08ae-155b-4200-ac9f-a2707d5f2530" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0c740a91-7172-4f09-bc5a-8e58984c3529" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f1f08ae-155b-4200-ac9f-a2707d5f2530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_04d1fe65-c82b-4e36-a55e-1472ba6a7769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f1f08ae-155b-4200-ac9f-a2707d5f2530" xlink:to="loc_us-gaap_CommercialRealEstateMember_04d1fe65-c82b-4e36-a55e-1472ba6a7769" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_1cfbefbd-b249-455a-b731-b26241f417e1" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_1cfbefbd-b249-455a-b731-b26241f417e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1cfbefbd-b249-455a-b731-b26241f417e1_default" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_1cfbefbd-b249-455a-b731-b26241f417e1" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_1cfbefbd-b249-455a-b731-b26241f417e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_1cfbefbd-b249-455a-b731-b26241f417e1" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_aacf8af9-1f0c-43ed-9a71-2b90238a2cbd" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_aacf8af9-1f0c-43ed-9a71-2b90238a2cbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_da05eaf1-f3a4-4612-904e-ca1b8b01c95a" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_da05eaf1-f3a4-4612-904e-ca1b8b01c95a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_df273ae3-8fc5-474a-baf8-b6e35ac9026b" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_df273ae3-8fc5-474a-baf8-b6e35ac9026b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_dc7aea08-1868-4f55-bd15-ea175c3421d2" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_dc7aea08-1868-4f55-bd15-ea175c3421d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_6b6aa7f2-5bde-44e0-adcf-8288d0060c58" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_6b6aa7f2-5bde-44e0-adcf-8288d0060c58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_c9c3cce9-0a4c-4790-8546-c6fbe68c2094" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_c9c3cce9-0a4c-4790-8546-c6fbe68c2094" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_a92fab84-4f2f-4110-b0b3-fdc3e60477f2" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_a92fab84-4f2f-4110-b0b3-fdc3e60477f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_a92fab84-4f2f-4110-b0b3-fdc3e60477f2_default" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_a92fab84-4f2f-4110-b0b3-fdc3e60477f2" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_a92fab84-4f2f-4110-b0b3-fdc3e60477f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_a92fab84-4f2f-4110-b0b3-fdc3e60477f2" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_d96fd845-ae7b-42af-beee-fc6a84aa73c9" xlink:href="cvs-20230331.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Category1Member_d96fd845-ae7b-42af-beee-fc6a84aa73c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_4e63bfbd-f4bc-4609-8ee8-36effa3d842c" xlink:href="cvs-20230331.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Category2To4Member_4e63bfbd-f4bc-4609-8ee8-36effa3d842c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_6dc2bbc1-30fc-4ad9-8be9-0995e40524d6" xlink:href="cvs-20230331.xsd#cvs_Categories5and6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Categories5and6Member_6dc2bbc1-30fc-4ad9-8be9-0995e40524d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_7e46350e-57c1-45d3-9443-527deb4c5c82" xlink:href="cvs-20230331.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Category7Member_7e46350e-57c1-45d3-9443-527deb4c5c82" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="i7faf9f5462ba42aaab5fb06f6889e225_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_a672be7b-ece1-4ee4-b3df-54aff89824fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_a672be7b-ece1-4ee4-b3df-54aff89824fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_680b7916-a23b-4847-a0ae-26254d2de7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_680b7916-a23b-4847-a0ae-26254d2de7af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_a8c8253d-cb8f-4c69-8ad8-68f5a415174f" xlink:href="cvs-20230331.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_a8c8253d-cb8f-4c69-8ad8-68f5a415174f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_99d0de14-7848-4891-a108-afcfdf8c87f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_99d0de14-7848-4891-a108-afcfdf8c87f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_f7fc7e27-9cf5-4f2b-be7a-d1526b74e519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_InvestmentIncomeNet_f7fc7e27-9cf5-4f2b-be7a-d1526b74e519" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4827f52-de47-4cca-9993-6d80d310179b" xlink:href="cvs-20230331.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4827f52-de47-4cca-9993-6d80d310179b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f5d57d58-5877-4984-b7fc-bbd73b633fc7" xlink:href="cvs-20230331.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f5d57d58-5877-4984-b7fc-bbd73b633fc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c2a527e1-92e9-471e-b630-699699499d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:to="loc_us-gaap_InvestmentTypeAxis_c2a527e1-92e9-471e-b630-699699499d1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c2a527e1-92e9-471e-b630-699699499d1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_c2a527e1-92e9-471e-b630-699699499d1a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c2a527e1-92e9-471e-b630-699699499d1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_c2a527e1-92e9-471e-b630-699699499d1a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_20ffd221-cbc4-4edf-8678-fafbdc269fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:to="loc_us-gaap_DebtSecuritiesMember_20ffd221-cbc4-4edf-8678-fafbdc269fa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_4535919b-9f6b-4d51-bea8-a7e68cb339e6" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:to="loc_cvs_MortgageLoansMember_4535919b-9f6b-4d51-bea8-a7e68cb339e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_bbee1790-78ec-498b-ad6f-59be55140d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:to="loc_us-gaap_OtherInvestmentsMember_bbee1790-78ec-498b-ad6f-59be55140d98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_71d74695-6d9c-44ea-aeb1-008bf1cca037" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:to="loc_srt_ProductOrServiceAxis_71d74695-6d9c-44ea-aeb1-008bf1cca037" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_71d74695-6d9c-44ea-aeb1-008bf1cca037_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_71d74695-6d9c-44ea-aeb1-008bf1cca037" xlink:to="loc_srt_ProductsAndServicesDomain_71d74695-6d9c-44ea-aeb1-008bf1cca037_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad834ac3-6f53-4cc8-9e18-a429f4a70e30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_71d74695-6d9c-44ea-aeb1-008bf1cca037" xlink:to="loc_srt_ProductsAndServicesDomain_ad834ac3-6f53-4cc8-9e18-a429f4a70e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_138e493f-0fc4-458c-b68e-0afd18457eea" xlink:href="cvs-20230331.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad834ac3-6f53-4cc8-9e18-a429f4a70e30" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_138e493f-0fc4-458c-b68e-0afd18457eea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended" id="i515c349c341d40d6b9e8467439f5b06c_FairValueMeasurementonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_e9723f38-cd03-4565-ba7b-bf534d5497bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_e9723f38-cd03-4565-ba7b-bf534d5497bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_75d12ac2-35da-4c87-af9e-8d3df29434bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_75d12ac2-35da-4c87-af9e-8d3df29434bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a710e341-377f-4564-a9d5-3edd65f2024d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a710e341-377f-4564-a9d5-3edd65f2024d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c68ffdaa-f0bd-422f-b032-990475a4b9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c68ffdaa-f0bd-422f-b032-990475a4b9d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_dcbc0b0f-1061-47e1-8e58-650f6c2e051a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_dcbc0b0f-1061-47e1-8e58-650f6c2e051a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0da0d253-30f7-4685-b0dd-e2235236fc26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0da0d253-30f7-4685-b0dd-e2235236fc26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0da0d253-30f7-4685-b0dd-e2235236fc26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0da0d253-30f7-4685-b0dd-e2235236fc26" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0da0d253-30f7-4685-b0dd-e2235236fc26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_30a4f2a4-af03-4dea-bd66-6ad8cc670481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0da0d253-30f7-4685-b0dd-e2235236fc26" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_30a4f2a4-af03-4dea-bd66-6ad8cc670481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7d3480f8-15b1-42c7-aecb-2f552369ba0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_30a4f2a4-af03-4dea-bd66-6ad8cc670481" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7d3480f8-15b1-42c7-aecb-2f552369ba0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1e8c752b-31ae-4ac0-af29-01b8a794e532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1e8c752b-31ae-4ac0-af29-01b8a794e532" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1e8c752b-31ae-4ac0-af29-01b8a794e532_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1e8c752b-31ae-4ac0-af29-01b8a794e532" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1e8c752b-31ae-4ac0-af29-01b8a794e532_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1e8c752b-31ae-4ac0-af29-01b8a794e532" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4fbfcc64-829d-4587-bac5-60c1ee856d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4fbfcc64-829d-4587-bac5-60c1ee856d01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5008e0a9-030e-4d55-a926-88cdc82bce14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5008e0a9-030e-4d55-a926-88cdc82bce14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ec309a77-c680-4e4d-974e-4eaf587a0858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ec309a77-c680-4e4d-974e-4eaf587a0858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fa4d7d01-ffc7-4e2f-8b33-a09a4c06fa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fa4d7d01-ffc7-4e2f-8b33-a09a4c06fa8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3d0c704f-576e-447f-9ea3-d7d54044e9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3d0c704f-576e-447f-9ea3-d7d54044e9a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ab015a79-7110-4dce-b018-7305c097b2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ab015a79-7110-4dce-b018-7305c097b2b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_8138ab44-6a80-4aa5-b97a-fcf4937a61ad" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_8138ab44-6a80-4aa5-b97a-fcf4937a61ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_97d0e674-6f1e-4d1f-b6a9-eeed1de4cc61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_97d0e674-6f1e-4d1f-b6a9-eeed1de4cc61" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c064a502-c182-4786-b14c-f439f15dd7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c064a502-c182-4786-b14c-f439f15dd7bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c064a502-c182-4786-b14c-f439f15dd7bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c064a502-c182-4786-b14c-f439f15dd7bd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c064a502-c182-4786-b14c-f439f15dd7bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c064a502-c182-4786-b14c-f439f15dd7bd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fdb7951d-22df-4921-9dac-89d1bbd98d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fdb7951d-22df-4921-9dac-89d1bbd98d6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_78b0ddf6-e908-4d85-8e73-cec0f962b4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_78b0ddf6-e908-4d85-8e73-cec0f962b4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a2fe921c-a0b1-4ea0-aabf-667a375f4dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a2fe921c-a0b1-4ea0-aabf-667a375f4dfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ec206afe-49a1-4671-a6fc-822ef6ff74f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ec206afe-49a1-4671-a6fc-822ef6ff74f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ec206afe-49a1-4671-a6fc-822ef6ff74f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ec206afe-49a1-4671-a6fc-822ef6ff74f0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ec206afe-49a1-4671-a6fc-822ef6ff74f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0738ff3c-4a89-4079-bbc3-67ad3302a2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ec206afe-49a1-4671-a6fc-822ef6ff74f0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0738ff3c-4a89-4079-bbc3-67ad3302a2b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50f74c2-7ddf-470f-8d40-7fb794484894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0738ff3c-4a89-4079-bbc3-67ad3302a2b9" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50f74c2-7ddf-470f-8d40-7fb794484894" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="ic8b28e0f6d33456abcc2964a5c0c6800_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_dde77a38-43db-4d79-9bf0-30bddc76cbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_dde77a38-43db-4d79-9bf0-30bddc76cbce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1800e336-b12a-4d12-b0fc-2781cf4bc9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1800e336-b12a-4d12-b0fc-2781cf4bc9ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_325bc0b9-8188-4f2a-9da1-336eb191ff40" xlink:href="cvs-20230331.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_325bc0b9-8188-4f2a-9da1-336eb191ff40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_786b4037-347d-419e-b9dc-14d13228db5f" xlink:href="cvs-20230331.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_786b4037-347d-419e-b9dc-14d13228db5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f03473fa-daa0-4dc2-8214-24f265ef0f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f03473fa-daa0-4dc2-8214-24f265ef0f8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b453c96-aeb3-4b57-b89f-a02a970bcbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b453c96-aeb3-4b57-b89f-a02a970bcbf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8b453c96-aeb3-4b57-b89f-a02a970bcbf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b453c96-aeb3-4b57-b89f-a02a970bcbf0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8b453c96-aeb3-4b57-b89f-a02a970bcbf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_92e281c1-46e5-4d89-90e3-dcfe6103d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b453c96-aeb3-4b57-b89f-a02a970bcbf0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_92e281c1-46e5-4d89-90e3-dcfe6103d6b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_a1c0f55e-29d5-45dd-9e4e-221430e72f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_92e281c1-46e5-4d89-90e3-dcfe6103d6b8" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_a1c0f55e-29d5-45dd-9e4e-221430e72f91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7535fedf-5d54-452c-895e-36d365c9895f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7535fedf-5d54-452c-895e-36d365c9895f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7535fedf-5d54-452c-895e-36d365c9895f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7535fedf-5d54-452c-895e-36d365c9895f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7535fedf-5d54-452c-895e-36d365c9895f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7535fedf-5d54-452c-895e-36d365c9895f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_870a2dc9-0dcf-446b-9115-d84c79f08cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_870a2dc9-0dcf-446b-9115-d84c79f08cbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_477c6efd-0359-47db-b3d9-e39054a6a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_477c6efd-0359-47db-b3d9-e39054a6a03c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_87d42844-c95d-460a-91c0-7dd8293779bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_87d42844-c95d-460a-91c0-7dd8293779bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_737cb023-8735-4257-abce-1494b37b1c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_737cb023-8735-4257-abce-1494b37b1c3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_737cb023-8735-4257-abce-1494b37b1c3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_737cb023-8735-4257-abce-1494b37b1c3b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_737cb023-8735-4257-abce-1494b37b1c3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1774494d-19bf-4d65-8ca5-398baed3861e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_737cb023-8735-4257-abce-1494b37b1c3b" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1774494d-19bf-4d65-8ca5-398baed3861e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1774494d-19bf-4d65-8ca5-398baed3861e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa9f2102-b56c-4108-a48e-bd8bdc4235b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa9f2102-b56c-4108-a48e-bd8bdc4235b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_92b76f53-c0dd-4baa-97b8-5056159f21b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_92b76f53-c0dd-4baa-97b8-5056159f21b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_36b1b413-17ba-4dc2-9a04-1d246a130584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_36b1b413-17ba-4dc2-9a04-1d246a130584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_317cdb24-6719-43c9-b985-d90bfdca470e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_36b1b413-17ba-4dc2-9a04-1d246a130584" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_317cdb24-6719-43c9-b985-d90bfdca470e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="iac4414fbd94c40ce9f66fab031b786dd_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_5b6b3386-332a-45c5-8f81-a365e73c5c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:to="loc_us-gaap_SeparateAccountAssets_5b6b3386-332a-45c5-8f81-a365e73c5c63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_d1350d97-0736-43fa-bd86-40dc098d5cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:to="loc_us-gaap_SeparateAccountsLiability_d1350d97-0736-43fa-bd86-40dc098d5cd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_57f7ff2c-0e37-4734-ac0d-9e0132211d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_57f7ff2c-0e37-4734-ac0d-9e0132211d1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_57f7ff2c-0e37-4734-ac0d-9e0132211d1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_57f7ff2c-0e37-4734-ac0d-9e0132211d1d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_57f7ff2c-0e37-4734-ac0d-9e0132211d1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5da9b013-c908-4fa7-9aae-d58914ae9323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_57f7ff2c-0e37-4734-ac0d-9e0132211d1d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5da9b013-c908-4fa7-9aae-d58914ae9323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a2781ce3-9ad0-44e2-9356-9daa8b039408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5da9b013-c908-4fa7-9aae-d58914ae9323" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a2781ce3-9ad0-44e2-9356-9daa8b039408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8762bf68-19fd-4f75-9b06-0fd6d5db98b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8762bf68-19fd-4f75-9b06-0fd6d5db98b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1cb1ce38-ef8e-4532-a9f1-f262f2ff2c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1cb1ce38-ef8e-4532-a9f1-f262f2ff2c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6d41847b-5d74-44aa-b6cd-874b55e99f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6d41847b-5d74-44aa-b6cd-874b55e99f93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f2282924-9b04-4b81-ad17-a4a1e3e4a050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_InvestmentTypeAxis_f2282924-9b04-4b81-ad17-a4a1e3e4a050" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f2282924-9b04-4b81-ad17-a4a1e3e4a050_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_f2282924-9b04-4b81-ad17-a4a1e3e4a050" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f2282924-9b04-4b81-ad17-a4a1e3e4a050_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_f2282924-9b04-4b81-ad17-a4a1e3e4a050" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_cc574661-38b3-4378-aa92-d8e26d493e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_cc574661-38b3-4378-aa92-d8e26d493e96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_f0ad0fec-3074-4b17-8470-8a8c8b144eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:to="loc_us-gaap_DebtSecuritiesMember_f0ad0fec-3074-4b17-8470-8a8c8b144eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_7412e409-009b-41a0-9466-56032388f1b6" xlink:href="cvs-20230331.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_7412e409-009b-41a0-9466-56032388f1b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_24933c4f-7998-4a1a-b2ab-0b4c7dda192c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_24933c4f-7998-4a1a-b2ab-0b4c7dda192c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_24933c4f-7998-4a1a-b2ab-0b4c7dda192c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_24933c4f-7998-4a1a-b2ab-0b4c7dda192c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_24933c4f-7998-4a1a-b2ab-0b4c7dda192c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_24933c4f-7998-4a1a-b2ab-0b4c7dda192c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_6ad2aab4-3dbd-485f-962d-3cb1d300937c" xlink:href="cvs-20230331.xsd#cvs_OtherReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:to="loc_cvs_OtherReceivablesMember_6ad2aab4-3dbd-485f-962d-3cb1d300937c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherPayablesMember_a0362113-a2b6-4e00-bdd4-12273443f798" xlink:href="cvs-20230331.xsd#cvs_OtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:to="loc_cvs_OtherPayablesMember_a0362113-a2b6-4e00-bdd4-12273443f798" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended" id="i4d056fb5db7e4e39bf707fbc7bc9aec3_HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b019fa8e-0394-4135-94a7-bb9e6caae5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b019fa8e-0394-4135-94a7-bb9e6caae5e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1aa496ee-d1c2-48cf-8d8b-675b8d6bb409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1aa496ee-d1c2-48cf-8d8b-675b8d6bb409" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_0c061485-c1a2-4520-a82d-adc8db390af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_0c061485-c1a2-4520-a82d-adc8db390af7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ceb5e872-a0df-47d2-916d-d6e4ebef2aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ceb5e872-a0df-47d2-916d-d6e4ebef2aac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6035b0c3-0f68-46d5-b4ef-0c4dd6dbcdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6035b0c3-0f68-46d5-b4ef-0c4dd6dbcdfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8a6d84df-4809-46e5-a100-d9d4136a706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8a6d84df-4809-46e5-a100-d9d4136a706e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_082e7e83-40ef-42bb-8a36-970786128df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_082e7e83-40ef-42bb-8a36-970786128df8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_af519e0d-d9ac-45d8-bd33-9aa56a5a0c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_af519e0d-d9ac-45d8-bd33-9aa56a5a0c1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_eb95d9ae-320b-41aa-ab7a-d89bdcf5f5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_eb95d9ae-320b-41aa-ab7a-d89bdcf5f5b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f450b3b1-7726-44cb-8b46-99e34f9ebea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f450b3b1-7726-44cb-8b46-99e34f9ebea2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_999568ea-a7dd-4ea1-8016-2853de3a8521" xlink:href="cvs-20230331.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_999568ea-a7dd-4ea1-8016-2853de3a8521" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_193225fb-7765-486c-b6df-d8a67e159171" xlink:href="cvs-20230331.xsd#cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_193225fb-7765-486c-b6df-d8a67e159171" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8d0ee979-96c6-40d1-84ea-a05150ad9711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_fa43fc90-58a4-4033-a35b-394a8dcdf348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_8aa2282e-edc5-45a9-bf8c-c661ce1fb6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_04082978-9cd0-4a4d-afb0-ce80bbe9f855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_b2e111b1-93bb-4ce5-adc4-a48a5e3aabe4" xlink:href="cvs-20230331.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_b2e111b1-93bb-4ce5-adc4-a48a5e3aabe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_4f0e5e94-3cba-4604-ad49-2749e13a7ed4" xlink:href="cvs-20230331.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:to="loc_srt_ProductOrServiceAxis_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030" xlink:to="loc_srt_ProductsAndServicesDomain_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d0ffd228-6ab8-4ef3-a146-6b89abdbb803" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030" xlink:to="loc_srt_ProductsAndServicesDomain_d0ffd228-6ab8-4ef3-a146-6b89abdbb803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_c4b2e326-497f-4232-805d-73b8e0b9b048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d0ffd228-6ab8-4ef3-a146-6b89abdbb803" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_c4b2e326-497f-4232-805d-73b8e0b9b048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_60b51c30-2f51-4287-a21e-27082177b72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_60b51c30-2f51-4287-a21e-27082177b72c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_60b51c30-2f51-4287-a21e-27082177b72c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60b51c30-2f51-4287-a21e-27082177b72c" xlink:to="loc_us-gaap_SegmentDomain_60b51c30-2f51-4287-a21e-27082177b72c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60b51c30-2f51-4287-a21e-27082177b72c" xlink:to="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_f6654135-e17e-43b1-bce2-071416f96a4a" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_f6654135-e17e-43b1-bce2-071416f96a4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_9bd04902-cd44-4065-9bb9-dec6a3d5b858" xlink:href="cvs-20230331.xsd#cvs_CorporateOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:to="loc_cvs_CorporateOtherMember_9bd04902-cd44-4065-9bb9-dec6a3d5b858" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_25f134e2-2038-49ab-957b-4a2d04cc74cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_25f134e2-2038-49ab-957b-4a2d04cc74cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_25f134e2-2038-49ab-957b-4a2d04cc74cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_25f134e2-2038-49ab-957b-4a2d04cc74cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_25f134e2-2038-49ab-957b-4a2d04cc74cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_512b9567-5e0e-4608-a152-e5c807699751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_25f134e2-2038-49ab-957b-4a2d04cc74cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_512b9567-5e0e-4608-a152-e5c807699751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember_e4742f97-a83a-4005-8adf-391300475487" xlink:href="cvs-20230331.xsd#cvs_ThailandBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_512b9567-5e0e-4608-a152-e5c807699751" xlink:to="loc_cvs_ThailandBusinessMember_e4742f97-a83a-4005-8adf-391300475487" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="i16f65d2dc7fe4a738f9170844983d52f_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_42a3545b-9565-4ef9-9916-764d5af02b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_42a3545b-9565-4ef9-9916-764d5af02b35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_bec1050f-88f5-42ed-be1b-14f8f3ad8a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_bec1050f-88f5-42ed-be1b-14f8f3ad8a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_01a899d2-9185-42bb-a2a2-3d68bd83ef9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_01a899d2-9185-42bb-a2a2-3d68bd83ef9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_01a899d2-9185-42bb-a2a2-3d68bd83ef9c" xlink:to="loc_srt_ProductOrServiceAxis_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca" xlink:to="loc_srt_ProductsAndServicesDomain_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_11579084-c49e-4b90-935c-4d63b4ea014c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca" xlink:to="loc_srt_ProductsAndServicesDomain_11579084-c49e-4b90-935c-4d63b4ea014c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_b709a590-8484-45f4-b0b3-47672b158bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_11579084-c49e-4b90-935c-4d63b4ea014c" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_b709a590-8484-45f4-b0b3-47672b158bc5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="extended" id="i63bc0d8c87b0412487116d7726c718f4_OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_722dbbb3-e53a-470c-b437-bf80075651ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_722dbbb3-e53a-470c-b437-bf80075651ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_1afd2a41-eaa2-4707-91a1-f3e0c41f8e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_1afd2a41-eaa2-4707-91a1-f3e0c41f8e11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_d974b32e-309b-49d8-959a-2cd6ac8a5c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_d974b32e-309b-49d8-959a-2cd6ac8a5c86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_7833e7e2-e9a5-42fe-b6c4-2923e5151f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_7833e7e2-e9a5-42fe-b6c4-2923e5151f8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_61cd56cf-53c7-44e9-93ca-cac135ab8608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_61cd56cf-53c7-44e9-93ca-cac135ab8608" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_f11cdb7e-71cd-40d7-9924-f5b7d3201eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_f11cdb7e-71cd-40d7-9924-f5b7d3201eb8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_eb507ce5-a2a9-4ac9-806f-dc6003cef176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_eb507ce5-a2a9-4ac9-806f-dc6003cef176" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_d7ea9935-1b43-4c19-b14e-4c1df6cf9258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_822aaaae-2739-4642-a201-623385d7bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_822aaaae-2739-4642-a201-623385d7bd1c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_2144008a-ea85-4330-8dca-b421ed791cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_16ebdbf2-deb5-4993-89d7-14feb0b2c02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_16ebdbf2-deb5-4993-89d7-14feb0b2c02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_4e7c7c49-8189-4008-a1af-371383100ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_4e7c7c49-8189-4008-a1af-371383100ef7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ffbd1225-5680-4e1c-b6aa-00dc3f7005a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ffbd1225-5680-4e1c-b6aa-00dc3f7005a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_56cf1932-a1e2-46b6-b8ac-1bcf8a13bc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_56cf1932-a1e2-46b6-b8ac-1bcf8a13bc89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_d0dcac38-d849-414d-a4d0-97e476ba35f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_d0dcac38-d849-414d-a4d0-97e476ba35f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_7be0a6fe-4ad0-4b8f-8385-8f38589fad94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_7be0a6fe-4ad0-4b8f-8385-8f38589fad94" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_079d019e-3cdf-4616-934c-23a889b3794d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_079d019e-3cdf-4616-934c-23a889b3794d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_65ecc09d-752c-41aa-b104-729376f99bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_65ecc09d-752c-41aa-b104-729376f99bc6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_14bc683e-31a6-438b-931f-1856163ea5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_bb36a6c3-8b8e-41b4-8d9a-d89a8f382b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_bb36a6c3-8b8e-41b4-8d9a-d89a8f382b3d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_7fcffc0b-7695-471d-b1c0-7a7956a0c736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_0edc5766-da1e-489b-96b5-57b607549ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_0edc5766-da1e-489b-96b5-57b607549ba8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_9552c7c1-341e-49d2-ae0b-e8eab0ce322f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_9552c7c1-341e-49d2-ae0b-e8eab0ce322f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_2c85a41b-baca-4810-9865-cb9654f2d944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_2c85a41b-baca-4810-9865-cb9654f2d944" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_7ddc26aa-6b7b-4887-9424-3d0876417769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_7ddc26aa-6b7b-4887-9424-3d0876417769" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cce8fff6-f186-45b7-b5a6-e17fa38c8eae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_7ddc26aa-6b7b-4887-9424-3d0876417769" xlink:to="loc_srt_ProductOrServiceAxis_cce8fff6-f186-45b7-b5a6-e17fa38c8eae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cce8fff6-f186-45b7-b5a6-e17fa38c8eae_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_cce8fff6-f186-45b7-b5a6-e17fa38c8eae" xlink:to="loc_srt_ProductsAndServicesDomain_cce8fff6-f186-45b7-b5a6-e17fa38c8eae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_cce8fff6-f186-45b7-b5a6-e17fa38c8eae" xlink:to="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_3ad03c78-2535-46bb-94cb-5c7bfc052ba1" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:to="loc_cvs_LargeCasePensionsMember_3ad03c78-2535-46bb-94cb-5c7bfc052ba1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_472c732e-f925-4f90-aa7a-5fabb41e7203" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:to="loc_cvs_LongTermCareMember_472c732e-f925-4f90-aa7a-5fabb41e7203" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="extended" id="icb8bafec37ce499faa93e3d01964d741_OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_5970e18f-feca-44e0-97d7-bfcfdb15141e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_5970e18f-feca-44e0-97d7-bfcfdb15141e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_4b11ed53-7d40-490e-8837-1c3c9bb3a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_4b11ed53-7d40-490e-8837-1c3c9bb3a5dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_352df556-26fd-41fb-a955-60704c7e8d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_352df556-26fd-41fb-a955-60704c7e8d05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_352df556-26fd-41fb-a955-60704c7e8d05" xlink:to="loc_srt_ProductOrServiceAxis_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36" xlink:to="loc_srt_ProductsAndServicesDomain_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36" xlink:to="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_c03008dc-03d9-40fd-a5a6-c5474282451a" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:to="loc_cvs_LargeCasePensionsMember_c03008dc-03d9-40fd-a5a6-c5474282451a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_34d2f8b8-fc16-48c7-bd58-26b98c49b5c1" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:to="loc_cvs_LongTermCareMember_34d2f8b8-fc16-48c7-bd58-26b98c49b5c1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="extended" id="i7a4f4a5d49144347b997e69b7a68e697_OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_84c849b2-5008-406e-86c8-e25420ae42f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_84c849b2-5008-406e-86c8-e25420ae42f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_f378453a-a9e2-4c25-b73b-8c800f9c5e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_f378453a-a9e2-4c25-b73b-8c800f9c5e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_509be9c7-36ee-4f46-9d0b-878c56c100b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_509be9c7-36ee-4f46-9d0b-878c56c100b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_a720284d-06d6-4b20-9760-75aa57a6ab08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_a720284d-06d6-4b20-9760-75aa57a6ab08" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_a720284d-06d6-4b20-9760-75aa57a6ab08" xlink:to="loc_srt_ProductOrServiceAxis_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988" xlink:to="loc_srt_ProductsAndServicesDomain_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988" xlink:to="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_2d0dc149-ed3d-47d6-9ce7-1cd8ed4a1ab5" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:to="loc_cvs_LargeCasePensionsMember_2d0dc149-ed3d-47d6-9ce7-1cd8ed4a1ab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_9d5b7501-3b67-49e2-95b1-cd0af07cbb3b" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:to="loc_cvs_LongTermCareMember_9d5b7501-3b67-49e2-95b1-cd0af07cbb3b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="extended" id="i041acf4c59d24ff6b3b6148eca6ad1ff_OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_0f6590e7-64d0-4309-8f48-4e7ec509c973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:to="loc_us-gaap_SeparateAccountAssets_0f6590e7-64d0-4309-8f48-4e7ec509c973" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_5870e5ab-903f-4a54-b9a4-e3ba88777a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:to="loc_us-gaap_SeparateAccountsLiability_5870e5ab-903f-4a54-b9a4-e3ba88777a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_3ab68e7f-4a27-45fc-8459-ccabe384dbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_3ab68e7f-4a27-45fc-8459-ccabe384dbe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_3ab68e7f-4a27-45fc-8459-ccabe384dbe7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_3ab68e7f-4a27-45fc-8459-ccabe384dbe7" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_3ab68e7f-4a27-45fc-8459-ccabe384dbe7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_3ab68e7f-4a27-45fc-8459-ccabe384dbe7" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_feaa5f39-3260-467a-893d-e8088703d9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_feaa5f39-3260-467a-893d-e8088703d9db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountDebtSecurityMember_4a0f88d8-f937-4d7b-a96b-375dd38ec3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_us-gaap_SeparateAccountDebtSecurityMember_4a0f88d8-f937-4d7b-a96b-375dd38ec3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_7a885210-2a7f-4280-af1e-915d626754a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountMortgageBackedSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_7a885210-2a7f-4280-af1e-915d626754a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_1af39a21-d085-4f1f-ba18-d43444edef27" xlink:href="cvs-20230331.xsd#cvs_SeparateAccountOtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_1af39a21-d085-4f1f-ba18-d43444edef27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_fbfd0152-7b7a-4edc-9d60-bf4da03facbe" xlink:href="cvs-20230331.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_fbfd0152-7b7a-4edc-9d60-bf4da03facbe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_08a09435-e6b5-4772-a96b-24a8de9a4a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_08a09435-e6b5-4772-a96b-24a8de9a4a07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_08a09435-e6b5-4772-a96b-24a8de9a4a07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_08a09435-e6b5-4772-a96b-24a8de9a4a07" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_08a09435-e6b5-4772-a96b-24a8de9a4a07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_08a09435-e6b5-4772-a96b-24a8de9a4a07" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_18d4c8de-cd81-4286-aa64-1ddd0c0e920b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_18d4c8de-cd81-4286-aa64-1ddd0c0e920b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0eba0b61-7225-44dc-b1f5-76e469e8bc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0eba0b61-7225-44dc-b1f5-76e469e8bc0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e82ae6af-4a3b-4917-8b0e-dff75fb022bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e82ae6af-4a3b-4917-8b0e-dff75fb022bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_87903222-9dca-46cd-9f5e-9bea2bdbf30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_87903222-9dca-46cd-9f5e-9bea2bdbf30c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6ceed0ef-44c3-4fd8-902e-41eb59f5ff45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6ceed0ef-44c3-4fd8-902e-41eb59f5ff45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db89d93b-ef73-45e4-85ad-95fdc9238238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db89d93b-ef73-45e4-85ad-95fdc9238238" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b6864ac4-0022-444b-a3f8-c48e31ed00d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b6864ac4-0022-444b-a3f8-c48e31ed00d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b6864ac4-0022-444b-a3f8-c48e31ed00d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b6864ac4-0022-444b-a3f8-c48e31ed00d4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b6864ac4-0022-444b-a3f8-c48e31ed00d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b6864ac4-0022-444b-a3f8-c48e31ed00d4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_35f7da92-fe91-4f7b-b5fb-43136384a031" xlink:href="cvs-20230331.xsd#cvs_OtherReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:to="loc_cvs_OtherReceivablesMember_35f7da92-fe91-4f7b-b5fb-43136384a031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherPayablesMember_2c8a4720-3076-41a0-b734-20ade9662f6f" xlink:href="cvs-20230331.xsd#cvs_OtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:to="loc_cvs_OtherPayablesMember_2c8a4720-3076-41a0-b734-20ade9662f6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3da88e40-faa1-46cb-9e8f-5fc3b97d9b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3da88e40-faa1-46cb-9e8f-5fc3b97d9b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_cb0edc22-e61e-4460-9a31-dfaf74414e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3da88e40-faa1-46cb-9e8f-5fc3b97d9b39" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_cb0edc22-e61e-4460-9a31-dfaf74414e8f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended" id="ica93da510b22410882547ce58afe9c4f_BorrowingsScheduleofBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04629c02-8321-4f5e-85e9-b757d2259ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04629c02-8321-4f5e-85e9-b757d2259ec7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ee48cc98-0f51-4d41-8b90-146a3922925e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ee48cc98-0f51-4d41-8b90-146a3922925e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_88c72251-4479-4979-8d26-38d93f587db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_FinanceLeaseLiability_88c72251-4479-4979-8d26-38d93f587db4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtGrossAndLeaseObligation_9038135b-a419-4423-8b71-6760d26bb253" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtGrossAndLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_cvs_LongTermDebtGrossAndLeaseObligation_9038135b-a419-4423-8b71-6760d26bb253" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_9f7b2b92-f4a0-4fe9-9616-1b7686a707ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_9f7b2b92-f4a0-4fe9-9616-1b7686a707ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_ae2b54ab-0af1-4d71-af32-fc4a39265b59" xlink:href="cvs-20230331.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_ae2b54ab-0af1-4d71-af32-fc4a39265b59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_01eba74e-69c5-4a61-8cdf-7a2abec361cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_01eba74e-69c5-4a61-8cdf-7a2abec361cd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_df31b0ab-a996-449d-86f0-92222a164c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_df31b0ab-a996-449d-86f0-92222a164c43" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_24eb988d-3430-4184-abbd-fe9e0327e0e7" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_24eb988d-3430-4184-abbd-fe9e0327e0e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_bb4bb332-555b-49a7-9d04-1e45f1161348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_bb4bb332-555b-49a7-9d04-1e45f1161348" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5a1a04c7-4e7e-4adf-bf25-ecd933b41776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5a1a04c7-4e7e-4adf-bf25-ecd933b41776" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5a1a04c7-4e7e-4adf-bf25-ecd933b41776_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5a1a04c7-4e7e-4adf-bf25-ecd933b41776" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5a1a04c7-4e7e-4adf-bf25-ecd933b41776_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5a1a04c7-4e7e-4adf-bf25-ecd933b41776" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_91b81bcf-6430-413b-9fc6-9a72b53d46e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:to="loc_us-gaap_SeniorNotesMember_91b81bcf-6430-413b-9fc6-9a72b53d46e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_92d78c58-5503-4934-bb7f-c7ac4bd91904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_92d78c58-5503-4934-bb7f-c7ac4bd91904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b187e304-6fef-417b-b46a-24bbca4070a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:to="loc_us-gaap_DebtInstrumentAxis_b187e304-6fef-417b-b46a-24bbca4070a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b187e304-6fef-417b-b46a-24bbca4070a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b187e304-6fef-417b-b46a-24bbca4070a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b187e304-6fef-417b-b46a-24bbca4070a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b187e304-6fef-417b-b46a-24bbca4070a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_9112999b-783e-47f2-87e1-ed5c4649ed58" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_9112999b-783e-47f2-87e1-ed5c4649ed58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_373d5381-335d-478a-bec4-862c45581fdc" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_373d5381-335d-478a-bec4-862c45581fdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_dee7562f-ad74-4331-bc55-4a6a289e2f25" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_dee7562f-ad74-4331-bc55-4a6a289e2f25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_066e8dac-5fad-46bf-8883-8bebd5d23f2b" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_066e8dac-5fad-46bf-8883-8bebd5d23f2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_95f7dd99-619f-46f9-a86d-a2f53d8e463c" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_95f7dd99-619f-46f9-a86d-a2f53d8e463c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_69ecd4c1-b4b0-4947-8bb1-316198b1eeeb" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_69ecd4c1-b4b0-4947-8bb1-316198b1eeeb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_a124a8c5-a8e4-48ec-b90d-24b18558bec5" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_a124a8c5-a8e4-48ec-b90d-24b18558bec5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_cde53900-4355-4362-b9aa-747277c1fb82" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_cde53900-4355-4362-b9aa-747277c1fb82" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes50DueFebruary2026Member_c2a56fdd-733b-4dc7-9706-f0e9cd2b0096" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes50DueFebruary2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes50DueFebruary2026Member_c2a56fdd-733b-4dc7-9706-f0e9cd2b0096" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_16c7ae3c-bb12-42b1-9f35-4d3c3260ae6f" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_16c7ae3c-bb12-42b1-9f35-4d3c3260ae6f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_506a3444-2785-41c9-a03d-b7fe82c1cbc3" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_506a3444-2785-41c9-a03d-b7fe82c1cbc3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_e07a520f-6428-4abb-b1af-b0183d3013cf" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_e07a520f-6428-4abb-b1af-b0183d3013cf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_2f310eaa-90d0-4ed8-bff4-3cff880df2e7" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_2f310eaa-90d0-4ed8-bff4-3cff880df2e7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_b0d09189-8155-4c7e-b6ae-b8ba889b9e9f" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_b0d09189-8155-4c7e-b6ae-b8ba889b9e9f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_039c597a-b326-4f45-bd70-b88c433064d7" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_039c597a-b326-4f45-bd70-b88c433064d7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_599adf94-ea1e-4a2f-86ac-b14b52fa47f4" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_599adf94-ea1e-4a2f-86ac-b14b52fa47f4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5125DueFebruary2030Member_dcbd0e1a-237b-4a8a-8745-6778e2ecade4" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5125DueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5125DueFebruary2030Member_dcbd0e1a-237b-4a8a-8745-6778e2ecade4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_2d5b8b68-702d-43f1-9e1b-08c968f7997b" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_2d5b8b68-702d-43f1-9e1b-08c968f7997b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_b7565db0-3154-4a58-b2e0-97fe188de624" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_b7565db0-3154-4a58-b2e0-97fe188de624" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_37300696-8cda-433f-aca1-af8478694c3e" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_37300696-8cda-433f-aca1-af8478694c3e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_29df568e-b063-4ceb-9105-0ea059e5e1f8" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2125PercentDueSeptember2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_29df568e-b063-4ceb-9105-0ea059e5e1f8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes525DueFebruary2033Member_4480b91a-949a-4fad-bfc0-2755ea3442d0" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes525DueFebruary2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes525DueFebruary2033Member_4480b91a-949a-4fad-bfc0-2755ea3442d0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_682d6c8f-8710-48a0-a79f-c71f5b9aa83c" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_682d6c8f-8710-48a0-a79f-c71f5b9aa83c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_6a173892-08a6-452a-84c9-d88cdc12046d" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_6a173892-08a6-452a-84c9-d88cdc12046d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_99b86ed6-090a-4433-9b13-77f3d3d6f6a2" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_99b86ed6-090a-4433-9b13-77f3d3d6f6a2" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_98ae9339-fab1-469e-adcc-a5522f6c1b83" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_98ae9339-fab1-469e-adcc-a5522f6c1b83" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_28c64ae0-abc9-4d9e-9f69-9841dbc62300" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_28c64ae0-abc9-4d9e-9f69-9841dbc62300" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_92cdb1cc-4040-40ae-a6e9-9412dc1c7005" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_92cdb1cc-4040-40ae-a6e9-9412dc1c7005" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_d17798dd-4006-44c7-9d6c-e97e56e3fef0" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_d17798dd-4006-44c7-9d6c-e97e56e3fef0" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_f138f85c-ceaf-4b93-940d-e8715e0f5795" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_f138f85c-ceaf-4b93-940d-e8715e0f5795" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_85aa0342-71f4-4e82-881c-32d92213d4de" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_85aa0342-71f4-4e82-881c-32d92213d4de" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_2f685e78-840e-43af-99bc-deb769a229a9" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_2f685e78-840e-43af-99bc-deb769a229a9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_d8fef234-4374-40b9-bf86-3fe27a99a0ce" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_d8fef234-4374-40b9-bf86-3fe27a99a0ce" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_2052b870-abca-45d2-a553-6f5e5aa4c837" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_2052b870-abca-45d2-a553-6f5e5aa4c837" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_e7738c1a-ff24-4e25-9cb9-149c97e8e476" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_e7738c1a-ff24-4e25-9cb9-149c97e8e476" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_6ac3ed17-168d-4f99-9742-58b84ad923be" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_6ac3ed17-168d-4f99-9742-58b84ad923be" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_1c2cffb8-3535-4e31-9298-c88d3c1ed58b" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_1c2cffb8-3535-4e31-9298-c88d3c1ed58b" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_48c0df9f-3c2d-4776-856e-a99079044904" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_48c0df9f-3c2d-4776-856e-a99079044904" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5625DueFebruary2053Member_b24ca0bc-a91b-4850-bc59-0f5ef6afd388" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5625DueFebruary2053Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5625DueFebruary2053Member_b24ca0bc-a91b-4850-bc59-0f5ef6afd388" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_61a61d45-e24b-45ec-af56-8959aeee942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_61a61d45-e24b-45ec-af56-8959aeee942d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_61a61d45-e24b-45ec-af56-8959aeee942d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_61a61d45-e24b-45ec-af56-8959aeee942d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_61a61d45-e24b-45ec-af56-8959aeee942d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7dff1b01-8a85-46a8-aa71-0e227a89ec03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_61a61d45-e24b-45ec-af56-8959aeee942d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7dff1b01-8a85-46a8-aa71-0e227a89ec03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_dfa87741-660a-43e5-9147-2d296a4551f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7dff1b01-8a85-46a8-aa71-0e227a89ec03" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_dfa87741-660a-43e5-9147-2d296a4551f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#BorrowingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended" id="icc9fc67732f9479b9fd2901766ba9404_BorrowingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2572e3a0-fc87-48fb-8204-3ce3d99d54cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2572e3a0-fc87-48fb-8204-3ce3d99d54cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_90099ff0-36e9-42da-9b2e-6dd68861e36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_90099ff0-36e9-42da-9b2e-6dd68861e36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d63f0d8c-8827-43e1-8ac8-d6dd9d8a2a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d63f0d8c-8827-43e1-8ac8-d6dd9d8a2a4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:to="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3f7074f3-d576-4c4e-87b3-e4879d312093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3f7074f3-d576-4c4e-87b3-e4879d312093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3f7074f3-d576-4c4e-87b3-e4879d312093_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3f7074f3-d576-4c4e-87b3-e4879d312093" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3f7074f3-d576-4c4e-87b3-e4879d312093_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a326ed72-0487-4a71-9371-8ccacd3a5ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3f7074f3-d576-4c4e-87b3-e4879d312093" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a326ed72-0487-4a71-9371-8ccacd3a5ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_04c4773f-ab9e-4da0-9200-d0bc6a8ee495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a326ed72-0487-4a71-9371-8ccacd3a5ac5" xlink:to="loc_us-gaap_LineOfCreditMember_04c4773f-ab9e-4da0-9200-d0bc6a8ee495" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_511adb8a-caf2-4ca0-90af-44ca6b1d4794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_511adb8a-caf2-4ca0-90af-44ca6b1d4794" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_511adb8a-caf2-4ca0-90af-44ca6b1d4794_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_511adb8a-caf2-4ca0-90af-44ca6b1d4794" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_511adb8a-caf2-4ca0-90af-44ca6b1d4794_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_70ca9cc3-7096-4e32-8609-92c8a1973ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_511adb8a-caf2-4ca0-90af-44ca6b1d4794" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_70ca9cc3-7096-4e32-8609-92c8a1973ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_e9efe63b-321c-4f9b-833b-04834a0d6b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70ca9cc3-7096-4e32-8609-92c8a1973ac5" xlink:to="loc_us-gaap_SeniorNotesMember_e9efe63b-321c-4f9b-833b-04834a0d6b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d100ccb2-77fa-4f85-8a1b-08f113172658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_DebtInstrumentAxis_d100ccb2-77fa-4f85-8a1b-08f113172658" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d100ccb2-77fa-4f85-8a1b-08f113172658_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d100ccb2-77fa-4f85-8a1b-08f113172658" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d100ccb2-77fa-4f85-8a1b-08f113172658_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d100ccb2-77fa-4f85-8a1b-08f113172658" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TermLoanAgreement364DayMember_64be3214-c1e4-48ec-9050-55dfa3c29e97" xlink:href="cvs-20230331.xsd#cvs_TermLoanAgreement364DayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_TermLoanAgreement364DayMember_64be3214-c1e4-48ec-9050-55dfa3c29e97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes50DueFebruary2026Member_148c2040-fa41-4510-8e25-64abebf3af21" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes50DueFebruary2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes50DueFebruary2026Member_148c2040-fa41-4510-8e25-64abebf3af21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5125DueFebruary2030Member_85a41b89-87dd-4b13-a8fa-668c0413341c" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5125DueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes5125DueFebruary2030Member_85a41b89-87dd-4b13-a8fa-668c0413341c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes525DueFebruary2033Member_6c60ff1f-3e99-4b9b-b4aa-9a5ad0f84bfa" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes525DueFebruary2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes525DueFebruary2033Member_6c60ff1f-3e99-4b9b-b4aa-9a5ad0f84bfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5625DueFebruary2053Member_f5aad391-0d54-4f1c-89ec-c56b308fc996" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5625DueFebruary2053Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes5625DueFebruary2053Member_f5aad391-0d54-4f1c-89ec-c56b308fc996" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_06304d52-3928-42fd-b99d-2be8a3c39c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_06304d52-3928-42fd-b99d-2be8a3c39c43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_06304d52-3928-42fd-b99d-2be8a3c39c43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_06304d52-3928-42fd-b99d-2be8a3c39c43" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_06304d52-3928-42fd-b99d-2be8a3c39c43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1fae562b-fefd-4143-a7fc-3ef23e77a5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_06304d52-3928-42fd-b99d-2be8a3c39c43" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1fae562b-fefd-4143-a7fc-3ef23e77a5c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_79fea16b-fa62-490c-858e-15db21dca4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1fae562b-fefd-4143-a7fc-3ef23e77a5c9" xlink:to="loc_us-gaap_SubsequentEventMember_79fea16b-fa62-490c-858e-15db21dca4e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended" id="idd0e071cd9344649aa7380f70d84071d_ShareholdersEquityShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1b606287-516d-412a-aa1e-a4b32bcd0549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1b606287-516d-412a-aa1e-a4b32bcd0549" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b4d2ffed-c901-493e-b0f4-c2c6fc8752ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b4d2ffed-c901-493e-b0f4-c2c6fc8752ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0031a87c-d9c4-4e95-bb26-d91354f8a7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0031a87c-d9c4-4e95-bb26-d91354f8a7b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7a61a604-94f6-4b74-b097-1a6ecc6d7018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7a61a604-94f6-4b74-b097-1a6ecc6d7018" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_b0e90bea-9d95-405d-92ba-5cb0ad10d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_b0e90bea-9d95-405d-92ba-5cb0ad10d77a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_b0e90bea-9d95-405d-92ba-5cb0ad10d77a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2022RepurchaseProgramMember_a9c6551a-1877-452f-bb5b-16ca23907e33" xlink:href="cvs-20230331.xsd#cvs_A2022RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:to="loc_cvs_A2022RepurchaseProgramMember_a9c6551a-1877-452f-bb5b-16ca23907e33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_6522e1cd-e119-4efe-8dd6-e1d7e4cb78c0" xlink:href="cvs-20230331.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:to="loc_cvs_A2021RepurchaseProgramMember_6522e1cd-e119-4efe-8dd6-e1d7e4cb78c0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended" id="i696606cd64114e91ada99fd1747402f3_ShareholdersEquityAcceleratedShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_c24fba42-3663-4a0a-9593-089e4ab96725" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_c24fba42-3663-4a0a-9593-089e4ab96725" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_2df377a1-d801-4b26-bdb4-60f52292b3cf" xlink:href="cvs-20230331.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_2df377a1-d801-4b26-bdb4-60f52292b3cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_f0c34376-3a9e-407e-b5c6-98eeefa07ec7" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_f0c34376-3a9e-407e-b5c6-98eeefa07ec7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_3bb1fc85-94bc-40ac-b211-0595c714226c" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_3bb1fc85-94bc-40ac-b211-0595c714226c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_7b78a867-7b46-4e03-8196-35ed35f23ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_us-gaap_SharePrice_7b78a867-7b46-4e03-8196-35ed35f23ae1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue_99fbd79a-48b3-41a7-9255-69c1b8c66754" xlink:href="cvs-20230331.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_TransferOfSharesToTreasuryStockValue_99fbd79a-48b3-41a7-9255-69c1b8c66754" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e1d7a7f6-193d-40af-a801-c04d412d3ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e1d7a7f6-193d-40af-a801-c04d412d3ba7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_bb674304-c5db-494b-a6d9-0f07e47a84a5" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_bb674304-c5db-494b-a6d9-0f07e47a84a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e4ade164-1924-4e54-b1c5-2936edcb6913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e4ade164-1924-4e54-b1c5-2936edcb6913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e4ade164-1924-4e54-b1c5-2936edcb6913_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e4ade164-1924-4e54-b1c5-2936edcb6913" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e4ade164-1924-4e54-b1c5-2936edcb6913_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_dc4c956a-d877-4b57-8f28-656afeb04d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e4ade164-1924-4e54-b1c5-2936edcb6913" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_dc4c956a-d877-4b57-8f28-656afeb04d10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_621307c7-19e5-4e98-80f0-cd49ea8e7dca" xlink:href="cvs-20230331.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_dc4c956a-d877-4b57-8f28-656afeb04d10" xlink:to="loc_cvs_A2021RepurchaseProgramMember_621307c7-19e5-4e98-80f0-cd49ea8e7dca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5574defa-5814-4011-a098-475fec3e12bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:to="loc_srt_CounterpartyNameAxis_5574defa-5814-4011-a098-475fec3e12bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5574defa-5814-4011-a098-475fec3e12bd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5574defa-5814-4011-a098-475fec3e12bd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5574defa-5814-4011-a098-475fec3e12bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5574defa-5814-4011-a098-475fec3e12bd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CitibankNAMember_e993754c-4200-408c-a517-1c276a02236b" xlink:href="cvs-20230331.xsd#cvs_CitibankNAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:to="loc_cvs_CitibankNAMember_e993754c-4200-408c-a517-1c276a02236b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_176f8b18-1374-438f-bdaa-2e396bcc277f" xlink:href="cvs-20230331.xsd#cvs_BarclaysBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:to="loc_cvs_BarclaysBankMember_176f8b18-1374-438f-bdaa-2e396bcc277f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_15ac8a7f-408c-4867-98f4-4223e9845eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_15ac8a7f-408c-4867-98f4-4223e9845eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_e3bf69e0-02b4-450d-99a7-16e7917aa0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_15ac8a7f-408c-4867-98f4-4223e9845eb4" xlink:to="loc_us-gaap_ForwardContractsMember_e3bf69e0-02b4-450d-99a7-16e7917aa0da" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i822a5ec3bad94e6cbe536ca106aeb95b_OtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d9dba3de-3266-4408-885a-b58364d2bd25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d9dba3de-3266-4408-885a-b58364d2bd25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6bd0db9f-87c7-454d-806b-5df70db95dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6bd0db9f-87c7-454d-806b-5df70db95dc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b2d734ef-d375-4560-8589-314e3ee37881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b2d734ef-d375-4560-8589-314e3ee37881" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81ab5cf8-d058-4a6e-bb5b-9bdc9eac721e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81ab5cf8-d058-4a6e-bb5b-9bdc9eac721e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02282325-e0eb-475a-b2ad-7c6ceef33327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_5a68651c-9b82-4747-8dd4-1cfe6bc1dd74" xlink:href="cvs-20230331.xsd#cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_5a68651c-9b82-4747-8dd4-1cfe6bc1dd74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2c205e89-8b96-40ad-9694-54157e5f9748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2c205e89-8b96-40ad-9694-54157e5f9748" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_4ff48130-566c-441e-b80a-5cc57b6a537e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_4ff48130-566c-441e-b80a-5cc57b6a537e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_855e399a-fada-49dc-8c7a-0a33add0b846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_855e399a-fada-49dc-8c7a-0a33add0b846" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3c952147-f25b-4ca4-af71-d81a589c1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3c952147-f25b-4ca4-af71-d81a589c1a1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_208469c2-77f6-4d65-9317-e708464d41fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_208469c2-77f6-4d65-9317-e708464d41fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_208469c2-77f6-4d65-9317-e708464d41fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_208469c2-77f6-4d65-9317-e708464d41fa" xlink:to="loc_us-gaap_EquityComponentDomain_208469c2-77f6-4d65-9317-e708464d41fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_208469c2-77f6-4d65-9317-e708464d41fa" xlink:to="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4da819f3-2b97-4e0f-a032-efb5afc084a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4da819f3-2b97-4e0f-a032-efb5afc084a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_b7904565-bb19-4516-a9f3-f74986920cf9" xlink:href="cvs-20230331.xsd#cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_b7904565-bb19-4516-a9f3-f74986920cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_699ec14a-ae32-4c00-97e3-a6650301488a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_699ec14a-ae32-4c00-97e3-a6650301488a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_375ce83d-16d1-4c87-b9fa-5922c075d114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_375ce83d-16d1-4c87-b9fa-5922c075d114" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_ef058bef-e3bf-4134-8add-db24c4ab339c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_ef058bef-e3bf-4134-8add-db24c4ab339c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_35b4ac0d-b700-4630-b785-54c5b4637d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_35b4ac0d-b700-4630-b785-54c5b4637d10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a40cddb-7c5e-471c-9fde-c71611555aca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a40cddb-7c5e-471c-9fde-c71611555aca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3a40cddb-7c5e-471c-9fde-c71611555aca_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a40cddb-7c5e-471c-9fde-c71611555aca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3a40cddb-7c5e-471c-9fde-c71611555aca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f52c7a58-6bda-4e99-bda5-7c834fbec07a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a40cddb-7c5e-471c-9fde-c71611555aca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f52c7a58-6bda-4e99-bda5-7c834fbec07a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbaf584e-ba5f-4099-a611-85732f483e61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f52c7a58-6bda-4e99-bda5-7c834fbec07a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbaf584e-ba5f-4099-a611-85732f483e61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended" id="i988400701a9345298092cea81b6dc4c7_EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ddd75bae-064d-4ac6-bc62-ef800ce1ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ddd75bae-064d-4ac6-bc62-ef800ce1ad8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b627a5c8-04d2-4b8c-9396-2ea8cb0e9de6" xlink:href="cvs-20230331.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b627a5c8-04d2-4b8c-9396-2ea8cb0e9de6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0b87eedc-fc8e-4e98-881b-60939a6a6180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b627a5c8-04d2-4b8c-9396-2ea8cb0e9de6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0b87eedc-fc8e-4e98-881b-60939a6a6180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:href="cvs-20230331.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6636beb-05f9-4a93-afb4-159ddd8a78b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6636beb-05f9-4a93-afb4-159ddd8a78b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7c8cac2a-600d-4821-94cb-850c86814d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7c8cac2a-600d-4821-94cb-850c86814d1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2382e5b0-4d30-47fd-aae2-3ac7121ccd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2382e5b0-4d30-47fd-aae2-3ac7121ccd5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:href="cvs-20230331.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f33d3bdd-1e20-49d9-87d0-b36db5784053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:to="loc_us-gaap_EarningsPerShareBasic_f33d3bdd-1e20-49d9-87d0-b36db5784053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a4e38cd4-249a-4762-a8dd-a739679f512f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a4e38cd4-249a-4762-a8dd-a739679f512f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_dd6ba9dd-35ce-432a-88fe-fae3bf8945e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_dd6ba9dd-35ce-432a-88fe-fae3bf8945e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ae97acd5-db65-4511-af02-8f953827ea75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_dd6ba9dd-35ce-432a-88fe-fae3bf8945e1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ae97acd5-db65-4511-af02-8f953827ea75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae97acd5-db65-4511-af02-8f953827ea75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ae97acd5-db65-4511-af02-8f953827ea75" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae97acd5-db65-4511-af02-8f953827ea75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ae97acd5-db65-4511-af02-8f953827ea75" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_0dfc1ed8-1474-4430-8d9a-5be23f749aed" xlink:href="cvs-20230331.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:to="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_0dfc1ed8-1474-4430-8d9a-5be23f749aed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember_0b6183a5-7d4e-4713-9832-f28735d55696" xlink:href="cvs-20230331.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:to="loc_cvs_StockOptionsAndStockAppreciationRightsMember_0b6183a5-7d4e-4713-9832-f28735d55696" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ice514de412514ec0bfc7114a891f5e4d_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_2faf4765-6331-4850-8b56-b8c18e635828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_2faf4765-6331-4850-8b56-b8c18e635828" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_40fb4601-2924-4d2e-9aae-0537418da93a" xlink:href="cvs-20230331.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_40fb4601-2924-4d2e-9aae-0537418da93a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_f8362cf9-e5f7-4b64-a02a-ab9dcdbacb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_LegalFees_f8362cf9-e5f7-4b64-a02a-ab9dcdbacb15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_7815145f-40b1-4883-bff1-10ad2ab0f29f" xlink:href="cvs-20230331.xsd#cvs_LitigationSettlementNumberOfStatesElectedToJoin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_7815145f-40b1-4883-bff1-10ad2ab0f29f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements_82c6a596-47ce-4890-ba7a-b92f4f41e2a1" xlink:href="cvs-20230331.xsd#cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements_82c6a596-47ce-4890-ba7a-b92f4f41e2a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_b707c8aa-ce0e-4649-8e5c-29ccaa73017b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_b707c8aa-ce0e-4649-8e5c-29ccaa73017b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_836e3af1-296a-42e2-bfcb-5809407732e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_836e3af1-296a-42e2-bfcb-5809407732e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8bc5df1d-a572-40dc-829d-fdde84eefacb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:to="loc_srt_LitigationCaseAxis_8bc5df1d-a572-40dc-829d-fdde84eefacb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8bc5df1d-a572-40dc-829d-fdde84eefacb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8bc5df1d-a572-40dc-829d-fdde84eefacb" xlink:to="loc_srt_LitigationCaseTypeDomain_8bc5df1d-a572-40dc-829d-fdde84eefacb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8bc5df1d-a572-40dc-829d-fdde84eefacb" xlink:to="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FederalCourtInOhioJudgmentMember_3ef745c2-70d7-49c5-8733-d1d4fc381d84" xlink:href="cvs-20230331.xsd#cvs_FederalCourtInOhioJudgmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_FederalCourtInOhioJudgmentMember_3ef745c2-70d7-49c5-8733-d1d4fc381d84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkMember_441d37d6-4298-4e8c-92ee-5dc02ea3a33a" xlink:href="cvs-20230331.xsd#cvs_SettlementFrameworkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_SettlementFrameworkMember_441d37d6-4298-4e8c-92ee-5dc02ea3a33a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_b55a2c79-c180-4017-a53c-ca7a61344854" xlink:href="cvs-20230331.xsd#cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_b55a2c79-c180-4017-a53c-ca7a61344854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_01919206-012e-418b-8694-ce420909dd40" xlink:href="cvs-20230331.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_01919206-012e-418b-8694-ce420909dd40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7cc5330a-b20e-4ecb-91eb-81700fca33c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:to="loc_us-gaap_LitigationStatusAxis_7cc5330a-b20e-4ecb-91eb-81700fca33c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7cc5330a-b20e-4ecb-91eb-81700fca33c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_7cc5330a-b20e-4ecb-91eb-81700fca33c8" xlink:to="loc_us-gaap_LitigationStatusDomain_7cc5330a-b20e-4ecb-91eb-81700fca33c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_65cf06ce-92de-44ee-aad2-052ee30c01d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_7cc5330a-b20e-4ecb-91eb-81700fca33c8" xlink:to="loc_us-gaap_LitigationStatusDomain_65cf06ce-92de-44ee-aad2-052ee30c01d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_b59ccefc-e887-409a-9bd9-a4aa1aa7ff02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_65cf06ce-92de-44ee-aad2-052ee30c01d6" xlink:to="loc_us-gaap_PendingLitigationMember_b59ccefc-e887-409a-9bd9-a4aa1aa7ff02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d941a249-e943-40ed-83c4-f53f0c4a0130" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:to="loc_srt_CounterpartyNameAxis_d941a249-e943-40ed-83c4-f53f0c4a0130" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d941a249-e943-40ed-83c4-f53f0c4a0130_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d941a249-e943-40ed-83c4-f53f0c4a0130" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d941a249-e943-40ed-83c4-f53f0c4a0130_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76b2f89e-42ef-406c-8075-8758ea139636" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d941a249-e943-40ed-83c4-f53f0c4a0130" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76b2f89e-42ef-406c-8075-8758ea139636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TribalEntitiesMember_d9b85bf6-b637-492c-8317-f454bdafb563" xlink:href="cvs-20230331.xsd#cvs_TribalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76b2f89e-42ef-406c-8075-8758ea139636" xlink:to="loc_cvs_TribalEntitiesMember_d9b85bf6-b637-492c-8317-f454bdafb563" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="extended" id="i552325a6be4043d7bbb0fe2e2a2bb97d_SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9888254b-45e3-43a1-a65d-2c8511cf81ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:to="loc_us-gaap_Revenues_9888254b-45e3-43a1-a65d-2c8511cf81ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_6267b5e0-603a-4989-b96a-0ef0904ecc26" xlink:href="cvs-20230331.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_6267b5e0-603a-4989-b96a-0ef0904ecc26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e4e2ee88-1bf0-45fc-afa2-5f162699243c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:to="loc_srt_RestatementAxis_e4e2ee88-1bf0-45fc-afa2-5f162699243c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e4e2ee88-1bf0-45fc-afa2-5f162699243c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_e4e2ee88-1bf0-45fc-afa2-5f162699243c" xlink:to="loc_srt_RestatementDomain_e4e2ee88-1bf0-45fc-afa2-5f162699243c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_e4e2ee88-1bf0-45fc-afa2-5f162699243c" xlink:to="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_3fa4bd6b-6ab2-442c-b245-e4d11b759a08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_3fa4bd6b-6ab2-442c-b245-e4d11b759a08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_820ee566-01fe-4433-9457-85a2d0af7018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:to="loc_srt_RestatementAdjustmentMember_820ee566-01fe-4433-9457-85a2d0af7018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d94d396b-7d84-42ac-955e-6de15fc541f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d94d396b-7d84-42ac-955e-6de15fc541f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d94d396b-7d84-42ac-955e-6de15fc541f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d94d396b-7d84-42ac-955e-6de15fc541f8" xlink:to="loc_us-gaap_SegmentDomain_d94d396b-7d84-42ac-955e-6de15fc541f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d94d396b-7d84-42ac-955e-6de15fc541f8" xlink:to="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ffd64300-cd36-4419-a302-ebd14ad13752" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ffd64300-cd36-4419-a302-ebd14ad13752" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_4440b534-5adb-4cc2-aa77-bf96b65570f3" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:to="loc_cvs_HealthServicesSegmentMember_4440b534-5adb-4cc2-aa77-bf96b65570f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_c2eee53c-1772-4212-accf-dead55a36fa3" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_c2eee53c-1772-4212-accf-dead55a36fa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_17fa3935-664a-4efa-9e76-80ba124172fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:to="loc_srt_ConsolidationItemsAxis_17fa3935-664a-4efa-9e76-80ba124172fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_17fa3935-664a-4efa-9e76-80ba124172fc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_17fa3935-664a-4efa-9e76-80ba124172fc" xlink:to="loc_srt_ConsolidationItemsDomain_17fa3935-664a-4efa-9e76-80ba124172fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_17fa3935-664a-4efa-9e76-80ba124172fc" xlink:to="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7e49c230-4779-488d-868b-fa639b760313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:to="loc_us-gaap_OperatingSegmentsMember_7e49c230-4779-488d-868b-fa639b760313" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c9d04683-f4b0-4f92-8013-e75c73483163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c9d04683-f4b0-4f92-8013-e75c73483163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_218b501e-a38f-4c2e-8543-49ba14a7dc47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:to="loc_us-gaap_IntersegmentEliminationMember_218b501e-a38f-4c2e-8543-49ba14a7dc47" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended" id="idcca3170af714936936909f73890ae15_SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_7828b36f-66cf-480c-8847-b0e0abc0c8b8" xlink:href="cvs-20230331.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_7828b36f-66cf-480c-8847-b0e0abc0c8b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58f5b166-ed88-440b-9132-c8e679bd41ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58f5b166-ed88-440b-9132-c8e679bd41ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_97b10ab5-bc94-4866-8414-b750b687fc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_us-gaap_NetInvestmentIncome_97b10ab5-bc94-4866-8414-b750b687fc2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0b7bbc74-bccc-4139-a88a-0fa248da01af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_us-gaap_Revenues_0b7bbc74-bccc-4139-a88a-0fa248da01af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_f9fd890b-e44a-4276-95c2-115786b11ac4" xlink:href="cvs-20230331.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_f9fd890b-e44a-4276-95c2-115786b11ac4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_44b62548-e0d8-42cf-a808-dbe6676acb8d" xlink:href="cvs-20230331.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_44b62548-e0d8-42cf-a808-dbe6676acb8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e4857fc5-d984-4863-94a3-861b1db72dcf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:to="loc_srt_ConsolidationItemsAxis_e4857fc5-d984-4863-94a3-861b1db72dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e4857fc5-d984-4863-94a3-861b1db72dcf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e4857fc5-d984-4863-94a3-861b1db72dcf" xlink:to="loc_srt_ConsolidationItemsDomain_e4857fc5-d984-4863-94a3-861b1db72dcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e4857fc5-d984-4863-94a3-861b1db72dcf" xlink:to="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_47d394f9-96a7-4bd1-816b-e2f843e1abc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:to="loc_us-gaap_OperatingSegmentsMember_47d394f9-96a7-4bd1-816b-e2f843e1abc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a8cfc088-f692-4c14-8492-7b1cffa8784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a8cfc088-f692-4c14-8492-7b1cffa8784b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_0dc04796-f0b3-4bc3-91b1-668de1e9e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:to="loc_us-gaap_IntersegmentEliminationMember_0dc04796-f0b3-4bc3-91b1-668de1e9e05a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c" xlink:to="loc_us-gaap_SegmentDomain_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c" xlink:to="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_494fb942-f696-4c93-b6ed-cb7c2ba0eae1" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_494fb942-f696-4c93-b6ed-cb7c2ba0eae1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_e34b2992-b9d9-4a90-a6c8-ade05d62cb32" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:to="loc_cvs_HealthServicesSegmentMember_e34b2992-b9d9-4a90-a6c8-ade05d62cb32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_f154276a-d422-497e-b9bc-787c06fbae75" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_f154276a-d422-497e-b9bc-787c06fbae75" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>cvs-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a5201116-fa32-47d9-bf67-a4b1f9934cb7,g:676c592e-810f-43b8-9a45-1cf85e252b17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_14da988e-a3fa-4eb6-914d-254c64394f74_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_c50e2b90-7633-47aa-8d7b-3d5eac250731_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1529850e-a5e7-4ca1-b578-6f14cc7b16f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_0b523b33-d73c-4d06-9bde-4d8069a41096_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d79fa8ce-6bc2-4241-be2a-832ce26e7dd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_abfe5bf8-cc97-446e-97ef-8df108968ed7_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_e097a5b5-432b-45a8-98f8-796d698ab4c2_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2d61f078-65a9-46d4-8892-42583e6dedd9_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2be8f2aa-635a-4a34-8986-5be3d3789643_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_436a8675-5529-4432-b9e9-975033e2cad8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_77f52457-a01c-4f7a-b249-3d8354ccbb0d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_279171ed-b2aa-4d05-aa01-1b33bc31dd77_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_69a4d1bf-3db8-49b4-9a7b-1128a224058c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_544a472c-cc8f-49e3-a41a-26a18faa9ffd_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Impact of discount rate on long-duration insurance reserves</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_15c1299a-c65e-464a-8cf0-f1052f34515e_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Impact of discount rate on long-duration insurance reserves</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_3728d459-ae98-4fac-95d4-47133aadbaaf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_label_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:to="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_91b5dd39-f0d7-4fd3-a805-7215a1a203dd_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_6b3700c9-3c9f-4b79-885c-32e355230624_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3b767058-32da-4dd2-8083-c04dceadab9b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_0bd32157-d179-4376-996a-374ee3e31f30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Change in Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy_6dcc2240-80be-4857-be47-571c2a6847bd_terseLabel_en-US" xlink:label="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Policy Benefits</link:label>
    <link:label id="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy_label_en-US" xlink:label="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FuturePolicyBenefitsLiabilityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:to="lab_us-gaap_FuturePolicyBenefitsLiabilityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_96225d75-6fe1-426e-945f-c4b7982f5b1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_304a141d-173a-4103-935e-4c3ea4117160_terseLabel_en-US" xlink:label="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework and Other Opioid-Related Claims</link:label>
    <link:label id="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_label_en-US" xlink:label="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework And Other Opioid-Related Claims [Member]</link:label>
    <link:label id="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_documentation_en-US" xlink:label="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework And Other Opioid-Related Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:href="cvs-20230331.xsd#cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:to="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_92c8f08f-7ca9-4872-b3f0-a4dd062a19b7_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_c28ef375-1476-479d-9ba9-83e69dec08a7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d1ec38ea-fb9c-4618-955b-25087e5e1fc9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5ab6093a-7488-48ac-a446-3c4b534262bf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_86d756b0-d4d3-4fa5-ae2f-e320a61b5d16_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_041f686b-d0e1-4cd7-93a1-c6174b46826c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_7918d448-e27c-4cf2-807d-e4a678aa3d1b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.05% senior notes due March 2048</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:to="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_1f2704bf-c3cc-4a3c-9b80-5b01fd88280c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_8dfc3ed5-7f35-4b10-b5fa-2d7334ef5b71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surrenders and withdrawals</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Surrender and Withdrawal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:to="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_01c1d91a-01ee-436a-9130-5fdaf98f4deb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_0d5b6a6c-5c1e-4254-993c-2052930682ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_8f4d10e2-f507-4717-8017-5faa402c5acf_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_6dad9aba-215b-42ac-920f-de93a16ee77c_terseLabel_en-US" xlink:label="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in discount rate on long-duration insurance reserves</link:label>
    <link:label id="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_label_en-US" xlink:label="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:to="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_d59ca319-b9a1-4724-b7e9-4ef20e28437f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_aa4bb9d3-1eed-4bc3-bddf-f0b1c2005c72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b3217fe-fab7-4cd9-8872-6c96dddaa0fe_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_3f7cae5a-f929-4edd-b601-0d889bb1cea7_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20230331.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_620b7d82-d2bf-4b1b-8f77-3641392b12cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ThailandBusinessMember_bdb20424-c6eb-43dc-a4e1-a4665030e677_terseLabel_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business</link:label>
    <link:label id="lab_cvs_ThailandBusinessMember_label_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business [Member]</link:label>
    <link:label id="lab_cvs_ThailandBusinessMember_documentation_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember" xlink:href="cvs-20230331.xsd#cvs_ThailandBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ThailandBusinessMember" xlink:to="lab_cvs_ThailandBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ca718920-2492-4ea1-8642-dfec9b0a5054_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountDebtSecurityMember_d8d14f58-8783-4ded-8758-6e3f3ac36bc6_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountDebtSecurityMember_label_en-US" xlink:label="lab_us-gaap_SeparateAccountDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Debt Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountDebtSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountDebtSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountDebtSecurityMember" xlink:to="lab_us-gaap_SeparateAccountDebtSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_ef1f5382-15b3-4a41-a8da-aa4f6ac50aa6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_fb6d7177-652e-4f99-8713-7fbcb8c74df4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a88b4260-077f-4594-b3f8-4342bdb4de3d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_79802b57-89f0-490f-9654-fee30293f713_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_ef9f4c58-9d7a-4413-98be-1deaa3153365_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_9fabeea9-6d40-40c2-abd2-66aa68d5d468_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for prescriptions dispensed and health services rendered</link:label>
    <link:label id="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:href="cvs-20230331.xsd#cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_75db0281-bc3f-4aed-8a62-3933813f3d6e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_42a154a8-8861-412b-8e13-2e4a53eb2c9d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_61df2263-56c8-4400-8fdb-41ff0f0a124a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_439cd68b-27fa-48c0-9d4c-3c5039c69872_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_807bca87-e288-49fe-8481-133ff4376251_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_ca85d937-28ff-4219-9b00-4233025abfc0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_4a779aea-6c5a-4d7e-b11b-7f8fd002b6ad_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_01592ac4-3a8a-49ae-8532-4bbaafdc2de5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_d8638bc3-34e6-41b7-b703-1deee57afb2e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_a3845a77-4155-4234-a4cc-27cd2b68d2b0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_7ed83e57-4cf1-493d-9a19-a2efbb4f73f2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_6834a85c-683a-48b3-a74b-cfd7245612de_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (loss)</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f53ceb8e-0a9a-43ba-9261-0d1f1fb2d6e8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_152bbe33-67a1-4ae4-b8f9-0f98b95df643_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4fdff553-321b-45af-8193-6c51fe30af28_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_df11c458-cdc2-49db-bfa9-38cb4131180d_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount at risk</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Net Amount at Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceNetAmountAtRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:to="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_c6dc613e-f43f-496b-8789-080820a1d9a0_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20230331.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_94b4e2a1-da1b-44a3-9ba6-b1560c559eff_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_76a64f14-387e-47af-a623-e819e186509c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_0d3f509a-0c69-49a8-804f-4f37cdaf8917_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR percent of notional amount received in shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_b002a2a8-db96-4f71-8191-47e0c3aa7546_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, beginning of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_2c2be59a-2345-425c-8f87-f491adbf5cd6_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, end of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_46d4e412-2602-4e56-9867-b223f442add4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_79877666-9076-4db8-adfa-ad880b72986a_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20230331.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_2fe39018-89c9-492b-90ea-6bfab05a103c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.125% senior notes due September 2039</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:to="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_76da02bf-026f-4f43-8d42-b5a4166b22d5_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.625DueApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.625DueApril2027Member" xlink:to="lab_cvs_SeniorNotes3.625DueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_6e0cf6b2-e600-4fea-a4b6-2042cb0877ca_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_598d7cbe-a703-4888-9b88-eb2c97c8a8c2_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_05d24dea-2b88-4f4e-ab6e-7a433cce1f2b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2020, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_2dc1b50f-aa6a-4502-b882-d204dd125546_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance at January 1, 2021, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_9802670a-34c9-40fd-b5ac-ad5215a1a78c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net liability for future policy benefits, net of reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, after Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f22c6f8a-6ea6-4658-99a9-2fcc9eaccba0_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_label_en-US" xlink:label="lab_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Cash</link:label>
    <link:label id="lab_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:to="lab_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_93a21a98-fd0d-4827-abde-e3434cd99793_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_2c951c57-757d-433c-b747-f702f156d92b_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_1116e88f-8ea8-4beb-88ae-2e9cf706d241_periodStartLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts liability, beginning of the period</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_bcc52513-310d-4b98-bea0-7b54c6b2b2f2_periodEndLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts liability, end of the period</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8df9f967-4144-4d78-905a-af91ab70da34_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_03f4823a-9b2e-437c-a8e4-d96a61900ab6_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_85d831c7-11d4-4d78-87a9-dfdde73bd36d_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_0203e199-731b-4093-8618-5914c9597eb4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash to be received by shareholders in proposed acquisition (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_267376fe-794b-43db-a07a-451fb5c9ce8c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease obligation</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherReceivablesMember_a126b1b1-fbe5-4eb3-b2dc-65c92372135d_terseLabel_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_label_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables [Member]</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_documentation_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember" xlink:href="cvs-20230331.xsd#cvs_OtherReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherReceivablesMember" xlink:to="lab_cvs_OtherReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_f05b5d02-7c89-4ac0-9a6b-f84cc87c6624_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20230331.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_28189afb-4e99-4a4a-8b08-e70ae460b5a9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_67c3aea7-8d62-43e5-8785-c5ef5368c6df_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_0d2ede5c-78fa-44fd-9d36-d3246d07de9f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_9fa84970-4d77-4d83-8467-f666e7453785_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected gross premiums</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_4a22565d-97c9-4f4b-8114-98bf7571fb88_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR agreement, amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:to="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SignifyHealthIncMember_8ea8acd5-1928-4b8f-bced-e92f579b0660_terseLabel_en-US" xlink:label="lab_cvs_SignifyHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Signify Health, Inc.</link:label>
    <link:label id="lab_cvs_SignifyHealthIncMember_label_en-US" xlink:label="lab_cvs_SignifyHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Signify Health, Inc. [Member]</link:label>
    <link:label id="lab_cvs_SignifyHealthIncMember_documentation_en-US" xlink:label="lab_cvs_SignifyHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Signify Health, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SignifyHealthIncMember" xlink:to="lab_cvs_SignifyHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_d566e43b-c80e-41d4-8b38-1d6e69456a37_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_5361de04-9fdd-4553-a6d9-ec9134593833_terseLabel_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and performance stock units</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_label_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) [Member]</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_documentation_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:href="cvs-20230331.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:to="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SettlementFrameworkMember_411850bb-bb21-4fa4-afb3-853134d88c14_terseLabel_en-US" xlink:label="lab_cvs_SettlementFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework</link:label>
    <link:label id="lab_cvs_SettlementFrameworkMember_label_en-US" xlink:label="lab_cvs_SettlementFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework [Member]</link:label>
    <link:label id="lab_cvs_SettlementFrameworkMember_documentation_en-US" xlink:label="lab_cvs_SettlementFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkMember" xlink:href="cvs-20230331.xsd#cvs_SettlementFrameworkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SettlementFrameworkMember" xlink:to="lab_cvs_SettlementFrameworkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f20532a5-0d2c-4804-b1be-c756123b088f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_46d40fdd-1d0b-4bb3-b5a5-0c247cb22a17_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_81628b06-55ef-4b92-a933-9643133e3269_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_508d0151-8407-49ed-be73-ec3c1185c1aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_0c7699cc-5dff-4cad-993e-47aada33ae1b_terseLabel_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and stock appreciation rights</link:label>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Stock Appreciation Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:href="cvs-20230331.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:to="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f571f4c2-c041-4992-8176-9d636a45a223_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_72e605c7-e9e6-4720-a4ea-a6b301f30366_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future benefit payments</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_57e441d5-090d-41f0-b6bd-f7584492086b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_1b576e82-6652-4b7a-9681-b0303a12bda4_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment earnings</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Increase (Decrease) from Invested Performance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:to="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e72c8e9f-4afa-42f8-8d9c-ecd176cc1ffb_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_f79227a3-3c20-4083-b073-45b7d37c0489_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,759 shares issued and 1,279 shares outstanding at March&#160;31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December&#160;31, 2022 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d8a43da6-a404-47cc-a730-53ecc9fd3520_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b5af8ab0-ef4b-4bc0-86c9-006f65a7a415_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_47f11ff6-373e-4e7e-a326-0dcbbc6e58d9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_7444e180-60b2-455e-aa03-c4898b41df52_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c29d1945-50e0-4d00-bd76-6032565b44ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_7479a8d4-4ee4-4f78-8547-79f7ea9469f5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f7d4eb81-383d-4268-a71b-f4c283aa1e64_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20230331.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_6f70c353-86d0-4dd0-9fbc-349957c0807f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities Available For Sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent_d86cd16f-8658-4991-a839-59c18d6042ca_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims And Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims And Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:href="cvs-20230331.xsd#cvs_PharmacyClaimsAndDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_41eb294b-c67b-4693-b4bd-9eb4bb088591_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20230331.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_381eb535-227f-48ec-9fc0-e2c93d22135e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.3% senior notes due December 2043</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:to="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_a05d2845-26f5-4112-8008-cd8b717f0123_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due August 2029</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:to="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_da592d3c-ad77-4d05-b809-b16af5cd009d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6b30e246-c0b6-40b8-bc9e-2d8be241c317_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_30b05ba9-c08b-4f1d-ab35-304b24a0df8a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityTableTextBlock_4fbd1ca8-781e-48ed-ace5-ea82e9306cb8_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Roll Forward of Separate Accounts</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:to="lab_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_a03c8899-4ab4-44df-813b-455815badeeb_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due December 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:to="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ab1b4b1c-ffb8-4d11-bb28-89872ce25897_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4dab1340-d4c2-4e8d-9f5f-112ecda90892_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_79e543eb-5578-40f2-a129-1a40934e5973_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_448d4c95-c4e6-4113-8816-65e24f711673_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_164f7df9-6d87-49d7-ae3b-e24594f73290_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_553ab0ef-a9a6-4f39-9652-36ced08975f7_terseLabel_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember" xlink:href="cvs-20230331.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2021RepurchaseProgramMember" xlink:to="lab_cvs_A2021RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9ea3c0e7-0271-474c-814c-1d2c2ea7b4b4_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7e1bde22-7c1d-4cd0-b3f2-d9dfdb9a2a55_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f7283850-0a01-4d9f-9e62-d2629dc249f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_63b97755-dd1b-404f-99e0-622f3e90960f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_0daf0705-6b09-4288-b72f-6f4fa5ffffa8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_af4286f5-549f-4bbf-a71b-6891e0f55d33_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_21c97706-d43e-49df-94f5-c35e040f6247_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b0325372-29ca-4982-a838-6f64a212d531_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e4cf7741-33b1-41b0-afc0-ac56f934fc61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_57f686fd-9fd3-4aa1-8467-816198d4befb_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_19d3afc9-859f-49a0-8fbd-a42646b11588_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_384ea1cd-e491-42b6-865a-0d22b379698e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_53ec2502-6439-4b13-8fb4-19dc83bfc50c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherPayablesMember_03413056-e8e6-4999-88b3-520d039ccda5_terseLabel_en-US" xlink:label="lab_cvs_OtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payables</link:label>
    <link:label id="lab_cvs_OtherPayablesMember_label_en-US" xlink:label="lab_cvs_OtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payables [Member]</link:label>
    <link:label id="lab_cvs_OtherPayablesMember_documentation_en-US" xlink:label="lab_cvs_OtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherPayablesMember" xlink:href="cvs-20230331.xsd#cvs_OtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherPayablesMember" xlink:to="lab_cvs_OtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_1c8e48a5-0148-4fdc-afd8-103b57fe1945_terseLabel_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:href="cvs-20230331.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:to="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_3d4242f7-f8bc-47b4-906f-222e838621cc_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_cf841fac-d0f6-4dbb-8200-acd06845ddfc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Statement of Cash Flows:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_4ca0ada5-d9de-4d47-afe5-ec43b27c3dc8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_03f092ac-118e-43f3-90d7-cb8c72c16164_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a861366e-f126-4729-94b8-754bed1c6d6e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_d4d9a32b-1f0e-46e8-9bf9-018be3b48c18_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5and6Member_2c313576-ce39-4a60-92a9-c7b8f8317fef_terseLabel_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 and 6</link:label>
    <link:label id="lab_cvs_Categories5and6Member_label_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5and6Member_documentation_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member" xlink:href="cvs-20230331.xsd#cvs_Categories5and6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5and6Member" xlink:to="lab_cvs_Categories5and6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_98ab0a78-7b3e-495d-b353-1d8610376b2e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5d47a11b-6cb1-4df5-8536-8df1fe007080_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermDebtGrossAndLeaseObligation_04a3328c-03a7-4d6e-a61d-0153dde46bc9_totalLabel_en-US" xlink:label="lab_cvs_LongTermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongTermDebtGrossAndLeaseObligation_label_en-US" xlink:label="lab_cvs_LongTermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross And Lease Obligation</link:label>
    <link:label id="lab_cvs_LongTermDebtGrossAndLeaseObligation_documentation_en-US" xlink:label="lab_cvs_LongTermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross And Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtGrossAndLeaseObligation" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtGrossAndLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermDebtGrossAndLeaseObligation" xlink:to="lab_cvs_LongTermDebtGrossAndLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_b46c70ee-f3ee-4828-803b-f7406e65c25a_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_ac7daeb7-64be-4493-8169-a74bfc033949_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_69b21b70-f58e-4ba9-9e77-73de6fed45cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_03e51905-3296-40e3-a8e7-a63cb3c51bf2_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_46458025-5561-4886-826f-f55701d7d599_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_823d2169-2382-4a6d-8a51-1ffc3e34c3e7_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_a93bdd68-cff1-42ce-9dd9-d3eb7b5d0166_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c2c25a33-c605-4634-85e4-71cfd1ef6c2e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Replacement equity awards for pre-combination services (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_f8db0fa3-5c3e-4c7a-9f74-a66df8fa9d20_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3% senior notes due August 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:to="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_d6d25a24-ec3a-422d-bc52-be96270c4ccd_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% senior notes due July 2035</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:to="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_23777870-48b9-4910-9ff0-a8f0302a24b6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements_039fdef2-77f8-471b-b003-6478b72273ac_terseLabel_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states under separate settlement agreements</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements_label_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Under Separate Settlement Agreements</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements_documentation_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Under Separate Settlement Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" xlink:href="cvs-20230331.xsd#cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" xlink:to="lab_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_9d7d4c8f-c6ec-4ad8-aa9b-6b0687559812_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_f8b7cb2b-ba84-4f07-8d57-0dcb83f23ccb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8b88fb2b-0de1-4100-9127-fa115584786b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_96c83748-7671-41fb-afdd-3284b8d581f1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables and contract liabilities from contracts with customers</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_1532b66a-65af-4d25-a898-7a697368c8b3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_f67d6312-eaab-420f-94ce-cd2a2cc9b47a_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.25% senior notes due June 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:to="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_1334d1e2-9f54-4c31-b0f7-2a9231d25211_terseLabel_en-US" xlink:label="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting standard, pre-tax</link:label>
    <link:label id="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_label_en-US" xlink:label="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax</link:label>
    <link:label id="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_documentation_en-US" xlink:label="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:href="cvs-20230331.xsd#cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:to="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_a532f2c0-7991-483e-b1d2-89347192a4bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_7f2f3de2-ad72-43ae-ab25-2cd7c3d8db94_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.75DueApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.75DueApril2030Member" xlink:to="lab_cvs_SeniorNotes3.75DueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_d348d01e-e335-4a5c-bead-64479ec10432_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_5e656001-747d-4b66-8851-e57ee66c602c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Contract Acquisition Costs</link:label>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_label_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_6b38d980-b9cb-487f-b458-36e8460fa58a_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_484c4379-a162-40f6-b9cc-36481c0d5358_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberOfLeases_756ee727-338b-4101-b3b5-6c6e03546070_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, number of leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberOfLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number Of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberOfLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number Of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberOfLeases" xlink:href="cvs-20230331.xsd#cvs_GuarantorObligationsNumberOfLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberOfLeases" xlink:to="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f93d371c-7de2-43f2-80a1-68e68f4b5860_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ce813be5-a29e-4007-a528-cea5f9a42c8c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_0e971cd3-898d-4176-8f95-3b86cb9f908b_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c5ad1003-2e73-40ee-b791-29527f5a2fc7_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_5cf593c6-75fd-45fb-9e24-ff099a3472ff_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20230331.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_aed03b25-1339-448a-bb2b-c9052aaeb8cd_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueApril2040Member" xlink:to="lab_cvs_SeniorNotes4.125DueApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_413bf98c-1d7d-488a-bb4d-80fcffd9c7c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2fe5ab13-03db-4b18-8ffa-dbb782a02feb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_edb41d5e-063b-48bb-acd1-f6a160afda3c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_070eec25-1194-4c23-96aa-0553b5ee92d6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_8314e759-d3d9-48cb-9d83-a9ace8a450c4_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_dc52882c-3af7-4e79-97e3-aeda74ecc348_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_2cc3801d-d56b-4c6f-a5b9-84f3e8292ca0_terseLabel_en-US" xlink:label="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers from general account</link:label>
    <link:label id="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_label_en-US" xlink:label="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to (from) Policyholder Account Balance (to) from Separate Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:to="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e48f3661-f357-48f4-b17c-8442a2666477_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_e1ca4fc2-64f4-436e-86be-8717496a2d1c_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20230331.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_8fb42d7c-f41d-4175-b0e6-2a7fbb74d37a_totalLabel_en-US" xlink:label="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale</link:label>
    <link:label id="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:href="cvs-20230331.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:to="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_88b92758-69f1-43f6-8522-f7ac9c72be57_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_b0cb23d7-a485-44ec-b8dd-46c1007e3a79_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7f27dae8-19b7-461a-ac9d-f72e2574a482_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_a62d7f4e-a7c6-42c7-b574-6bbdc10ec53e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:to="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_bda7ea2a-c29b-43ba-80a1-1904058d79e3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_ede63539-34c9-4867-9695-7845e6a15047_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_665a8868-002d-4012-940b-32b8ec23573b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0cc0485a-2fe2-4e21-add2-b85e59df231d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_4969e02c-6d22-4608-9786-ec2068f29943_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_92a78f6d-c801-4662-8f12-1a52107242e6_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_5f0ae13b-3663-4535-8774-29d411438cc0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_40b94f8f-ce09-4892-8cde-64074ee91c83_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_e8f2d378-cc11-4cf4-ae56-78035899269d_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contract</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_a915752b-a7f7-4900-9e40-c60335da1ada_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_cd1f2998-7d3f-4352-802b-74158a645730_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_7bef6b90-baed-46b7-82ce-5f1f5f0c236a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_6f8339ee-a2b6-4ea2-a726-8b947b6acffd_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience-rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20230331.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bd4aed10-1085-4a6d-916c-63951e1271e0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_deaa12d3-7e8d-4e17-9a4f-6727c6b5f35c_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8702d055-5033-45ae-9aca-1d937e17af3c_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_948fd341-17aa-40ca-b9d1-292514743772_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in cash flow assumptions</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_a7799f51-2b46-4bd8-ba3a-28686a1d1638_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and deposits</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Premium and Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityPremiumAndDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:to="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_76474efc-f940-4add-9274-1a7ca7cb01ee_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_07d914ce-9b0b-4b4b-9eb1-bf5a398c387e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_f3206d88-f145-417c-88d6-382a060a1936_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_0658e072-2f6a-4477-9470-497168eb2ab6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_af28a313-3d38-4c46-bc9f-4ed504f36f06_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_acd663ba-9e69-4428-b0bd-ffaa90d11b1b_terseLabel_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_label_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_documentation_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:href="cvs-20230331.xsd#cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:to="lab_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_6f34be87-3107-4e37-b7e4-3c4aa5ea2833_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9131582d-a699-4491-939d-219c11029ff3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_10bd74ed-4c22-4a2a-8349-ef8177aedc69_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_2149fa0d-ebe4-43ba-b582-0fb11d1786a1_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20230331.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_cb05f4a4-f275-4162-bea7-170be38c35ad_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_c705ebee-e6dd-4cfa-a1cd-70fd1676cec6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances (end of quarter)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_e8cb0c8e-cb15-41fd-aa1b-92961214f05c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_1583753a-367d-4105-a899-887ec12aa0ed_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% senior notes due June 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:to="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_501ab263-67ca-49af-aa8a-77565d633046_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_06c2aead-558d-46ab-bb3b-d81df706514d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_14b25ed3-a9b6-4491-9b5a-841788141b11_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_e3004ea0-fec6-4b77-9fa1-b4e5a129cd4f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions_bf5c21d5-8055-4282-9ff8-fe5ecb794dd2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalizations</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost, Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a6db31a3-a810-4e74-bb49-69a20c9e7c6f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_e4a14b4e-9ab1-4aca-943b-9a1f7a6918a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but not reported (IBNR) claims liability, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_07d7c31d-081e-40e0-a444-e52d4ad02eb3_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fe55ef1e-30a4-44e7-bb4f-dce3c4ae44f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a1ea2abd-1a31-493b-bd32-0379d5aa7637_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d4ebfc53-8834-46ea-9b15-e79e562a3cdb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_b7d60ebb-e214-4b2d-ba37-b150d5838d00_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_840c0868-6492-4a99-a2da-4b2597b97aeb_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f246af58-dfc8-424f-a09f-29d0e04f8beb_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_ca1b7f82-5395-412f-bd25-8f6720983d82_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20230331.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_a3faa3a7-05fa-4db6-bbd9-c88d0c3a9d1b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_c8d8f673-f395-4328-aa02-02aec1fa42f2_terseLabel_en-US" xlink:label="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments, Including Assets Held For Sale</link:label>
    <link:label id="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments, Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:href="cvs-20230331.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:to="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_d4852785-7982-481a-9312-de19b81bd8c0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_7a70de9f-bb7f-4013-b28e-c827de2887ea_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due March 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:to="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_812ac8b6-0aa0-43a2-9fe1-3f683f9b2155_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_3757aa1b-8865-42fe-ab23-f0b7b08f7d79_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7156d005-824b-4c3d-98c5-f13397489433_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_65c72b68-ccf4-41ee-80dc-7fbafe82eaac_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_9ce592ce-42f7-456b-9e81-d4322cc8a6ad_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_55036a01-92f2-4c85-ae7c-e5ecb7ec50a0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_de1b590a-4637-48dd-972f-633cc469386c_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs, beginning of the period</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_b2bb76a5-d674-4b56-8415-47910f16aac8_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs, end of the period</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d42c193c-299a-48f3-b14f-90f9df43e184_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_824444c5-5627-4ee5-b324-597362acf6cb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_b2480e81-eff6-4424-b790-59316778ed84_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due August 2047</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:to="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3245523e-c16e-478a-bc2d-40031c2a71af_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_88c63501-5bbe-4789-ad39-45dd61ef505c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_98bd7757-0a25-4679-8b94-949e6005670b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_6ea38847-29c5-4fe2-9f6a-8937b1d0b3e1_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_39358e0c-06a6-481c-8c23-b6ab50d5173d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_366b6a59-12bc-48af-b390-7f8ac0ce2d2f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_68ff2b8c-3891-4758-a894-661c1caf4588_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_337d6409-f0e7-4c5a-83a4-af80cb87b2c9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_f1739768-92dd-4aec-ae50-3b7fcce6d5f4_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_c930a08c-278b-4feb-92ff-87a7c55b9032_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares outstanding, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_511f19d2-2b65-4272-ac21-f1773f621763_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares outstanding, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_f5e4e3d5-d1ea-46f8-90de-c9364c9b1a01_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_ffe63164-51be-4c0c-8d4d-1bbce85c5257_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due July 2045</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:to="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_2b7ab00e-d20c-45ae-a099-a36e523344b9_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPatientsServedPerYear_0be341b8-b47d-4874-888d-31e34131a9c0_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPatientsServedPerYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year (more than)</link:label>
    <link:label id="lab_cvs_NumberOfPatientsServedPerYear_label_en-US" xlink:label="lab_cvs_NumberOfPatientsServedPerYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patients Served per Year</link:label>
    <link:label id="lab_cvs_NumberOfPatientsServedPerYear_documentation_en-US" xlink:label="lab_cvs_NumberOfPatientsServedPerYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patients Served per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPatientsServedPerYear" xlink:href="cvs-20230331.xsd#cvs_NumberOfPatientsServedPerYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPatientsServedPerYear" xlink:to="lab_cvs_NumberOfPatientsServedPerYear" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FederalCourtInOhioJudgmentMember_77ab451e-bb88-4584-bea8-34846074038a_terseLabel_en-US" xlink:label="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Court in Ohio Judgment</link:label>
    <link:label id="lab_cvs_FederalCourtInOhioJudgmentMember_label_en-US" xlink:label="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Court In Ohio Judgment [Member]</link:label>
    <link:label id="lab_cvs_FederalCourtInOhioJudgmentMember_documentation_en-US" xlink:label="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Court In Ohio Judgment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FederalCourtInOhioJudgmentMember" xlink:href="cvs-20230331.xsd#cvs_FederalCourtInOhioJudgmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FederalCourtInOhioJudgmentMember" xlink:to="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2022RepurchaseProgramMember_ed8392f8-f17c-4186-8d59-a9812cd40f89_terseLabel_en-US" xlink:label="lab_cvs_A2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2022RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2022RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2022RepurchaseProgramMember" xlink:href="cvs-20230331.xsd#cvs_A2022RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2022RepurchaseProgramMember" xlink:to="lab_cvs_A2022RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2bafa1b9-d565-4feb-9a6d-cb8110f147a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_482c489a-b67a-4f35-836e-7dca8a7e8015_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_4642b3b8-59f1-4b64-887f-a0b97cb94bc0_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_b43bfe09-7020-470d-b0af-85eb49e43335_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_80840f5d-433e-48b4-97f6-5b8835611cd0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PolicyholderAccountBalanceDepositsReceived_b8b38e19-ff76-4259-bdc0-a970782e60d8_negatedTerseLabel_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits received</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceDepositsReceived_label_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Deposits Received</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceDepositsReceived_documentation_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Deposits Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:href="cvs-20230331.xsd#cvs_PolicyholderAccountBalanceDepositsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:to="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock_36169860-a7e9-4228-ba14-c3b13f70273e_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Roll Forward of Policyholders' Funds</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:to="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d59de42f-c461-48ef-99fb-90cf6d3c8648_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_1763c39b-ef68-4e11-ab4a-16cd76fcced3_terseLabel_en-US" xlink:label="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_label_en-US" xlink:label="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Lease Obligation, Including Liabilities Held For Sale</link:label>
    <link:label id="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_documentation_en-US" xlink:label="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of long-term debt and lease obligation, including liabilities held for sale, classified as noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:to="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_82e41e20-2b72-441d-9212-50e2ab8b1b28_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_8e38857f-01ae-4ed9-a779-45d8c29570b7_terseLabel_en-US" xlink:label="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Other Asset-Backed Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:href="cvs-20230331.xsd#cvs_SeparateAccountOtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3c4f2eee-bc8a-4e88-9318-bceaeb39164f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_9a0a341b-b21b-4519-94fc-a5b84160c209_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_e11d8762-7c4b-4e35-880c-d67ef0615be9_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_f9ee7ce2-e0f2-40b6-9a93-b8db1ecd186b_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f8e29e5c-6037-4bb9-b236-4c3fcc5e2090_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_748aa750-479c-4b0f-8870-04b9b53bc44f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_e04d60ac-505f-4bfe-b5e0-bdabc7ea6404_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_be81cf2d-b227-42c2-a176-1e1bab3506ad_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_91874247-198e-409a-889a-b4f4960c8f00_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TermLoanAgreement364DayMember_74925f1b-184b-4876-948f-11cc751ddab2_terseLabel_en-US" xlink:label="lab_cvs_TermLoanAgreement364DayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement, 364-Day</link:label>
    <link:label id="lab_cvs_TermLoanAgreement364DayMember_label_en-US" xlink:label="lab_cvs_TermLoanAgreement364DayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement, 364-Day [Member]</link:label>
    <link:label id="lab_cvs_TermLoanAgreement364DayMember_documentation_en-US" xlink:label="lab_cvs_TermLoanAgreement364DayMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement, 364-Day</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TermLoanAgreement364DayMember" xlink:href="cvs-20230331.xsd#cvs_TermLoanAgreement364DayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TermLoanAgreement364DayMember" xlink:to="lab_cvs_TermLoanAgreement364DayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_90230f32-4caa-4069-b0a5-08a6857fcb48_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% senior notes due June 2036</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:to="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_7c0d8a7b-9fee-4adf-94d5-09c4a5e0993b_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20230331.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_99ee2eae-6a80-431d-8298-072488ca6e59_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which the Company has entered the individual public health insurance exchange</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number of States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:href="cvs-20230331.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_0650bcf5-2da2-4dba-b8c6-48d77524642d_terseLabel_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:href="cvs-20230331.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_bc4221e1-5160-475e-b1c3-42b2240e56ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_95276b84-b709-4c5d-94c5-b2e8f8eb42db_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_a19136e3-386e-41d5-81c0-32146dbc761c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average duration of long-duration insurance liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Weighted-Average Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_0c128481-9f24-4214-b288-043cf0651c77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_57c0d7cb-ffb3-42c9-bc5d-a0158668cf9b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ce08217b-8a9c-4189-9926-52c284815d21_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2c4e3fcc-34d3-4445-b093-2b14d78b49fe_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_544e6774-3bc0-484a-8681-d2047449db59_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accretion rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_21ced6c3-feca-44ca-a355-65092aa12b9b_negatedTerseLabel_en-US" xlink:label="lab_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:label id="lab_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_documentation_en-US" xlink:label="lab_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="cvs-20230331.xsd#cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_4b004173-71e3-4c5e-bba4-1fddd6e17664_negatedTerseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective settlement of pre-existing relationship</link:label>
    <link:label id="lab_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_label_en-US" xlink:label="lab_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Effective Settlement Of Pre-Existing Relationship</link:label>
    <link:label id="lab_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Effective Settlement Of Pre-Existing Relationship</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" xlink:to="lab_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d0adc938-12c6-4289-a132-5ba601ff91c2_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_de5aef45-b288-4c29-8b44-a4e961dd7cac_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_4e8d067d-6ee8-435a-b01c-89f0b85223bc_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_09d1d333-1e85-4c1b-9372-a5b14af03ae7_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_e895c4a6-942d-4b99-8f10-f7afbe6faf38_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredIncomeTaxesAndOtherNoncashItems_abe95104-84c7-4403-8f2a-c87ae577e1e1_terseLabel_en-US" xlink:label="lab_cvs_DeferredIncomeTaxesAndOtherNoncashItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_DeferredIncomeTaxesAndOtherNoncashItems_label_en-US" xlink:label="lab_cvs_DeferredIncomeTaxesAndOtherNoncashItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes And Other Noncash Items</link:label>
    <link:label id="lab_cvs_DeferredIncomeTaxesAndOtherNoncashItems_documentation_en-US" xlink:label="lab_cvs_DeferredIncomeTaxesAndOtherNoncashItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems" xlink:href="cvs-20230331.xsd#cvs_DeferredIncomeTaxesAndOtherNoncashItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems" xlink:to="lab_cvs_DeferredIncomeTaxesAndOtherNoncashItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_65ff247f-ba71-4b4a-8f95-8daf2a30cd11_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_37023789-91d3-46e5-8ade-5805dfded721_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_758ec4f6-2b06-4fe1-9192-39b50fc24875_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_73fe77b1-2388-41c8-9983-d12548ecfc28_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_c5847b09-dda6-4980-8e95-d61570a89b9c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_5409c6ad-f3ce-4711-8432-baa88dc7e951_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_14a24dab-3b51-4da2-a235-60e5e94e503b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_c70498ac-d03d-4139-ae05-128485f0aee6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_2b8afc30-3eb9-4bd8-acc2-c2f9e10e10b6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit Activity [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit Activity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_d7ac25e8-c556-40ab-a7e7-42a51389d940_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_17297a4b-7601-4273-819f-29c5dd5dd212_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_760dc81c-df40-4dfb-a94a-16076fe3558b_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains Or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains Or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:href="cvs-20230331.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_a0cf9ff4-e024-4b42-ad58-c3876b0b0ce9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityBenefitPayment_3c300827-7f18-41e7-8052-22f8c01b9d25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityBenefitPayment_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Benefit Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityBenefitPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:to="lab_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_cc85c35a-c9cc-46e0-bbe5-f2c993a6cc6d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_46227c2a-fe20-48b4-a431-e0f135693f06_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock_c814f3c8-4bb1-409f-9be6-c54bed2375fe_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities and Separate Accounts</link:label>
    <link:label id="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock_label_en-US" xlink:label="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contract, Acquisition Cost [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractAcquisitionCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:to="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0bdf6b8e-ef12-44a3-aa06-a2088eff1f97_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_2f4833ad-f46b-41de-bcd3-963255bd475d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_fbf6a6f8-eff6-4bcc-9663-356b80f4a6a8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin_8d2bd61d-f7e6-4f17-bc0f-e64b6bf3926a_terseLabel_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that elected to join the settlement</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin_label_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Elected To Join</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin_documentation_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Elected To Join</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:href="cvs-20230331.xsd#cvs_LitigationSettlementNumberOfStatesElectedToJoin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:to="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CorporateOtherMember_3edb8487-d362-4ab7-b72d-72bc65e93bf5_terseLabel_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_label_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_documentation_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember" xlink:href="cvs-20230331.xsd#cvs_CorporateOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CorporateOtherMember" xlink:to="lab_cvs_CorporateOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_ebee2b99-2841-447a-8910-aee597a3dabc_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_20d009ac-511d-4f31-97d1-5f788c7ef863_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid litigation charge</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_8c6b347e-efa4-4379-93a0-3f6743a0d5ca_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_686405e9-5b8d-4efe-b537-e52452f7774c_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_05358aae-d22d-4e19-9aa0-6894538500db_verboseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20230331.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_6a306ef9-f40c-43e4-9b16-8902511ea25c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_f39ffa27-f936-4b9e-ac46-1ba778d78b55_terseLabel_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for ASR, amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_label_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Accelerated Share Repurchases, Amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_documentation_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Accelerated Share Repurchases, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:href="cvs-20230331.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:to="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_df025a1e-cbc4-42f6-a2c2-609906d7dabe_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_379890a7-f7f3-40b4-be9e-b7ecbbcfb4e7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_19367a1b-3bab-4d55-96eb-01017e7699dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OmnicareLongTermCareBusinessMember_0ff1b926-58ab-45eb-ba91-ced1edb18f52_terseLabel_en-US" xlink:label="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnicare Long-Term Care Business</link:label>
    <link:label id="lab_cvs_OmnicareLongTermCareBusinessMember_label_en-US" xlink:label="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnicare Long-Term Care Business [Member]</link:label>
    <link:label id="lab_cvs_OmnicareLongTermCareBusinessMember_documentation_en-US" xlink:label="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnicare Long-Term Care Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember" xlink:href="cvs-20230331.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OmnicareLongTermCareBusinessMember" xlink:to="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3f654cb0-bbc0-4d50-bf0c-8b31fde37df0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_81c7e2b0-5743-48c7-a066-b298645e63da_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_40d46b43-0d56-4ca7-af33-610962281911_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LargeCasePensionsMember_719bb641-471e-4335-91b8-83eeb22ebc7d_terseLabel_en-US" xlink:label="lab_cvs_LargeCasePensionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Large Case Pensions</link:label>
    <link:label id="lab_cvs_LargeCasePensionsMember_label_en-US" xlink:label="lab_cvs_LargeCasePensionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Large Case Pensions [Member]</link:label>
    <link:label id="lab_cvs_LargeCasePensionsMember_documentation_en-US" xlink:label="lab_cvs_LargeCasePensionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Large Case Pensions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LargeCasePensionsMember" xlink:to="lab_cvs_LargeCasePensionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9622d325-09ca-4598-b5b9-7b6abfaf81bd_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_dc3b7714-bbd7-4bea-969d-168f7892a10b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_0468618b-ec14-414e-b787-45521e128c0d_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2f0f95a6-f034-456e-be27-97dbcad2a428_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_3ca3162c-f6e4-4cf9-958b-354e6d78827f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase programs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_5e02289a-dc44-4b7a-a5ad-314fb0ff31a4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c7626009-437b-4c34-8df2-dfcbc3868a4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8de04ece-bfbc-484b-8dd5-bece955b5f65_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances_4f5368f6-928b-47d9-a854-6cc7f0b6f093_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest credited</link:label>
    <link:label id="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances_label_en-US" xlink:label="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCreditedToPolicyholdersAccountBalances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:to="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_01a9daf6-a6c1-4cfd-a76f-7c54040d9e1b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f71d0235-e500-40c3-98e4-07235e04eda1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_400dd4e0-9b7a-4c69-97ab-5f02390d4fa7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_e437a423-6fc0-48ec-a1da-3b27c820b60e_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_3fa23f11-0da9-4c4b-9f8f-d3e614601f24_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_02430b96-caee-4f88-bda6-6ef0ee5d51d7_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_35089901-b709-49a8-993c-632808c54cf2_terseLabel_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_label_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_documentation_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:href="cvs-20230331.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:to="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_aa7b0898-10f4-4698-a34b-07c593e6026a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount_ba9e5579-b1fc-4c09-8307-0952edce7507_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Cash Surrender Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueDuePolicyholdersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:to="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_103ab266-1bc3-4598-b023-bf57b8c765dd_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_e6e32536-73ff-412d-b2ef-c3f8fa55fd0a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fb7b6917-e485-40b1-84a1-b80fcb7cdc16_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bbcd1a3f-4de2-4f90-a851-019cad9127c4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c2d027ae-c7d2-4311-9a3c-2abc526966b0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForInsuranceBenefits_cd02e728-0260-475b-b9b3-68c0344030c4_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsForInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsForInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsForInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsForInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsForInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInsuranceBenefits" xlink:href="cvs-20230331.xsd#cvs_PaymentsForInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForInsuranceBenefits" xlink:to="lab_cvs_PaymentsForInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_e19efd99-4abc-41a2-bcc0-cc4eed4dad76_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value, end of the period</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Cash Surrender Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:to="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_93d15c3a-7261-43f6-95ee-bf5a479e7293_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_d225532a-10d5-4779-bf40-9a5f2919a1cc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of expected future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_0955f763-914a-4c87-96ec-14f808d92344_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes525DueFebruary2033Member_f9d579cf-15a5-495e-9aa8-dc8226966d03_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes525DueFebruary2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% senior notes due February 2033</link:label>
    <link:label id="lab_cvs_SeniorNotes525DueFebruary2033Member_label_en-US" xlink:label="lab_cvs_SeniorNotes525DueFebruary2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.25%, Due February 2033 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes525DueFebruary2033Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes525DueFebruary2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.25%, Due February 2033</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes525DueFebruary2033Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes525DueFebruary2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes525DueFebruary2033Member" xlink:to="lab_cvs_SeniorNotes525DueFebruary2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_76264561-a6ca-49f9-afd8-c16ce517802c_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_093497e4-357e-4221-923b-7baa58dd6aa7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2587dd20-9d9c-4940-9c5c-1060b5f4f048_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_7a4de4c2-4ba6-432d-b48a-fb2bdcdbc78a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_420f6067-bbd8-446f-8204-455217a4cd42_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4464f7a8-7372-405a-a655-524912c1ca7c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_3482a826-bcf6-4adb-9d75-566e7f2bed03_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_22ba197b-b476-4bdd-9df5-9c2567bc8187_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average crediting rate</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Weighted Average Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:to="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_a2587a50-fae8-4c92-88bd-8fd74dafa3b5_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_564c9074-14e1-4c48-acec-d693f8682508_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a519fa59-bfea-42b2-b48b-36634fe64f8f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d05cb936-af3e-4924-8385-930375fc4362_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyAndConsumerHealthSegmentMember_433d1877-b6e5-4d9b-a458-b90cf12b1161_terseLabel_en-US" xlink:label="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy &amp; Consumer Wellness</link:label>
    <link:label id="lab_cvs_PharmacyAndConsumerHealthSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy And Consumer Health Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyAndConsumerHealthSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy And Consumer Health Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:to="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2327d3de-48c9-4dba-968f-2b977ba6b209_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7a20fd6e-c5f5-4d07-adae-cecc116657dc_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5d83b486-6698-411b-96e9-e2e7ddd451db_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b754605d-08fd-4845-8b54-9f504c7fdfc7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0b81a9be-a31f-4706-9928-a0ce760e6205_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_f5c53b73-4235-4b3c-8715-34ff0257e2b1_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_cece8973-18c6-4119-9b5c-cc9948ae8591_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TribalEntitiesMember_8727c7d6-3a65-402b-9cba-52b229fed014_terseLabel_en-US" xlink:label="lab_cvs_TribalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tribal Entities</link:label>
    <link:label id="lab_cvs_TribalEntitiesMember_label_en-US" xlink:label="lab_cvs_TribalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tribal Entities [Member]</link:label>
    <link:label id="lab_cvs_TribalEntitiesMember_documentation_en-US" xlink:label="lab_cvs_TribalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tribal Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TribalEntitiesMember" xlink:href="cvs-20230331.xsd#cvs_TribalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TribalEntitiesMember" xlink:to="lab_cvs_TribalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_37303d05-1ff2-4e76-8f4a-f803ad97c762_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201812Member_e0fc7579-f505-4a08-a01c-5c2aec0fb80d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201812Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-12</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201812Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201812Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-12 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201812Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201812Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201812Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201812Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2b68ccab-5dab-4cd4-b995-e906cdd216d9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d57e0a87-ba6d-4f6f-9b23-143526ff853b_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_5684308e-7315-484c-b08e-752a5043f0a9_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_cf2380b0-d2e0-4845-9fe4-097497129b29_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet:</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_71f1f0e0-2fdb-4c50-ae15-bb7889471b6c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_e8b0c01b-1def-4a2a-b55f-29ee71a7590e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_963d0cc5-fa88-4ba8-93c6-09421fe73c61_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20230331.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_7d0f697d-8c6f-4435-94b3-b820f4bb899f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec27b20d-aba1-4bfa-a2fd-42a560bca11a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ebf52b97-6425-48dc-9de8-244422aec6d1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_c89d8479-bb47-4c20-8ef1-496e99af213e_terseLabel_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_label_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_documentation_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:href="cvs-20230331.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:to="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_9f617301-91b2-49c3-82ca-96ee2a0b9ef3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_f2126b36-5eda-4610-ae08-839b81157e19_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Segment Allocation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSegmentAllocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:to="lab_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_c20236d7-5949-4e28-857e-6bd59c14fb42_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5f03063c-0173-4e38-88b5-52f2c9e2a1d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_56c365da-2b6f-4b51-8a47-0b4725fce0a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_39cbf31e-fd09-481e-9f1f-24ad978670c5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_a3e7bc7b-2fc3-44c6-b78f-727875008ece_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Liability for Future Policy Benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_4b1fe15a-2bce-4167-9782-e362bb055b83_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_a2dba7b8-fb31-40f2-b307-18ee99248106_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_98420498-f131-4b52-ad4b-59440b8114f5_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_7e323217-a8a9-47da-acbf-d93d426ad0cd_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ed244e2-2e84-490b-92a5-a0262ef3b40f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_193b2a45-7c4f-4c8d-9caa-8949d454d470_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_f288e8da-6580-4b47-809c-3f7637dee37c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_bd0e4b77-d3af-4be6-8139-3036c4652ca3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_57f7b37f-862e-445a-a980-336b446ecc13_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, beginning of period - current discount rate</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_label_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_documentation_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:href="cvs-20230331.xsd#cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:to="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7f385289-0d5f-4efa-b12a-fe03ca088352_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of adjustments resulting from applying new accounting standard</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_dd34cbaa-0c59-4467-9100-da146009d051_terseLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_label_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:to="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_73fbb97d-cf5b-462d-9166-350ebccae506_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_61ca045a-00a1-48e4-9a95-28c101af17b6_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_c5a76d65-a1b2-48d1-9c33-8044316d1cbb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4b473608-6c98-4051-858a-c2ee0db8c2cd_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPharmacyPlanMembers_004e7748-a770-4fa0-82f8-f69293328264_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pharmacy plan members</link:label>
    <link:label id="lab_cvs_NumberOfPharmacyPlanMembers_label_en-US" xlink:label="lab_cvs_NumberOfPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Pharmacy Plan Members</link:label>
    <link:label id="lab_cvs_NumberOfPharmacyPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberOfPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Pharmacy Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPharmacyPlanMembers" xlink:href="cvs-20230331.xsd#cvs_NumberOfPharmacyPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPharmacyPlanMembers" xlink:to="lab_cvs_NumberOfPharmacyPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_50a693b8-03a2-47db-a691-675257081b4e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_c21fd1c0-0c5f-47bf-a612-12acd8aeec40_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875% senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_2cbd9508-b751-447f-9c63-570382d83206_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_7569ab30-ff4b-41ea-99b1-88bcbdd0941f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4% senior notes due December 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:to="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_509def0a-8e02-4b56-9132-ee235112df35_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20230331.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_0af9549d-076a-407e-895f-6e49bc34acd8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_b171adfd-05ac-4d97-bca7-1bae04304bb7_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_404b4c96-18ca-472c-ab11-80a52ec3a7c9_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_51f935bc-f368-4195-9a78-82d978e1d11c_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital losses</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_56ec50de-6b7e-44bd-9217-85b08744fbd5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital losses</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_22485562-2909-498f-a949-6fe5e1c91d2a_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_37233253-46c5-4bec-ac03-dbb0fd289ab2_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_a34cdbbf-fa62-4cbb-ac53-e76873b0f344_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20230331.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_4d552ce1-a30a-45be-bdfa-96fd71235d89_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail &amp; specialty</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OakStreetHealthIncMember_5630fea8-d455-46d2-8c16-0818882e9901_terseLabel_en-US" xlink:label="lab_cvs_OakStreetHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oak Street Health Inc.</link:label>
    <link:label id="lab_cvs_OakStreetHealthIncMember_label_en-US" xlink:label="lab_cvs_OakStreetHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oak Street Health Inc. [Member]</link:label>
    <link:label id="lab_cvs_OakStreetHealthIncMember_documentation_en-US" xlink:label="lab_cvs_OakStreetHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oak Street Health Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember" xlink:href="cvs-20230331.xsd#cvs_OakStreetHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OakStreetHealthIncMember" xlink:to="lab_cvs_OakStreetHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_835095d5-7fcc-494b-9a4a-989ee37cc450_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_3f269e78-6736-4eca-9ae9-28d67917db85_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_8a939e38-676b-4478-9dde-24dba155ee50_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_e9a8ffe9-415f-4224-8b2f-db703094f7ed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_31d8134a-16a0-4f25-9887-8fee45a80ad3_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR, shares to be received at the end of program as a percent of notional amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e20491f9-b7fa-4055-a7b6-5c69853a0bd3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b41d8448-7358-4e85-b742-75c05abe4aec_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4fbdc0fc-05f7-41c0-8d69-babfe1758b19_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorAndManufacturerReceivables_dcef9641-7ca9-4f5b-a2d5-229bb103a2c4_terseLabel_en-US" xlink:label="lab_cvs_VendorAndManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorAndManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorAndManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor And Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorAndManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorAndManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor And Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAndManufacturerReceivables" xlink:href="cvs-20230331.xsd#cvs_VendorAndManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorAndManufacturerReceivables" xlink:to="lab_cvs_VendorAndManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a6d293fe-c482-4c60-863a-de271a7fa54f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_022ed02d-eebc-4813-b86e-74b854347a0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6762f7a8-5ef8-4cb6-972b-4201acf6e770_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_16eb1d3a-3954-4e56-a1a9-2aaa663c59de_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_33ce9574-707a-4657-9ef0-a8f96520bdcd_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermCareMember_b9ed5aea-b8fb-4da5-bfd6-1726a18634df_terseLabel_en-US" xlink:label="lab_cvs_LongTermCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care</link:label>
    <link:label id="lab_cvs_LongTermCareMember_label_en-US" xlink:label="lab_cvs_LongTermCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Care [Member]</link:label>
    <link:label id="lab_cvs_LongTermCareMember_documentation_en-US" xlink:label="lab_cvs_LongTermCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermCareMember" xlink:to="lab_cvs_LongTermCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_adbf81de-7ab2-40b2-aa28-0a9ae4c09f80_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_f128cd07-ee56-4a55-9f25-f1969cda691e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0aaada62-3a15-43e8-9ee6-f9144a73d806_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_71e0a5f8-9863-4701-b7cd-4a82596b82ea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_a5089d8e-e972-433a-85db-ff0d231ddd08_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:to="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_ac3ef528-6d91-4fc3-8410-7b8fb7f928c0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_ed2f4021-2950-4161-9db1-7343ed54c46e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock and Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_e7b3b681-6361-4f8b-8323-17a7e79f8f97_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1cb8ac38-019c-4b2c-ab92-af8d77ca603d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_eca06a09-d4e2-4882-a868-f1df2db20030_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, end of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_0c06636e-a48c-42ae-a574-8c6dfdf5f6b4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due March 2044</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:to="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_bfbc1993-fd72-45e1-85bf-7ac3bef82a17_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities In An Unrealized Capital Loss Position</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_6a61a493-3c5e-4d94-a5fa-d099c574c20c_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_cff5f26f-90cb-4427-9aed-a707493fb8c7_negatedTerseLabel_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferred financing costs</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_label_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_documentation_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:href="cvs-20230331.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:to="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_994ac6cd-cd9b-4db8-8032-0de326817bdf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_075aa0e4-d271-4b4d-bf7f-5ead83ab29c3_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_a984911e-8a0f-4a78-a1b6-4e263b9f652f_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7e42540c-5cd4-43d7-b20b-a3e48a5ef173_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b7e97de2-87f6-43fd-af6b-0797860fa430_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_873b12b4-7486-4b1c-a24f-02956e9a5835_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of actual variances from expected experience</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldInTrust_c0b99aa8-5b5d-408a-b529-f71dbaef2258_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldInTrust" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_5898d2db-0e5d-4e11-b29c-954f690ad047_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_a9b8132b-3867-456e-ab8e-0b962df63fb7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_596b1d40-feea-4936-8e86-9eb658d55b05_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1d3064d4-2507-48a3-bfdc-2b50704691e0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca3de804-0d53-4096-ae05-a3c6a132d7dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_7df16dcf-770c-4816-9cd0-07754d9d1e2e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_4403dd38-9f70-4df7-b380-d2235fd54cfb_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_781c5505-9961-4018-a490-aba54bc8a99a_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Increase (Decrease) from Other Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:to="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_6b6a0ab0-69ba-47a9-a94a-5cb192771ea6_terseLabel_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in discount rate assumptions</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_label_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions [Member]</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_documentation_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:href="cvs-20230331.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:to="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_70da7c4c-4a3e-4051-b1fd-c511374562fa_terseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_9ef3e050-2da8-4e85-961f-140a6ce022ce_verboseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20230331.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_7c7f3460-c0ef-4a1c-bf2a-9d01cd5f62cf_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:to="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_b716e1b5-19a7-4560-9acf-18ad62ed6daa_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and Assets Held for Sale</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_8b144469-50ad-4458-a491-511e5aae3b81_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9076bccb-c3f7-4ffa-b6ca-0bc806399939_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Financial Information Of Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2a47674a-a30b-4dd7-9c5d-63558bcbe436_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_b29fd853-2e2a-4166-b718-6dcd6efceb6c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on assets held for sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_99bb40ed-3b90-4c87-b166-c2d6e773cd45_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on assets held for sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3cc2b411-8d5c-4cdb-9d39-8abffa918457_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_41aa9767-2347-4055-8ab0-6210b36904f8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_5a78280c-e2c0-4163-a2d6-07eba1d113bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_8cbd5d4d-2967-4e0f-9ba3-bcb5638250ec_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_108b6e4d-b4a2-4466-8cea-5d0c1caae178_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_bba1977d-699f-4d43-b7c2-453379f52e09_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_0890c3e5-b32e-4d9e-a5dd-8fdb4154bc85_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_752b7f62-56bf-4544-8e4a-e800ccfb841f_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_d9113695-ff68-4bd9-93cf-3c1b1f7e35f9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_d1ac22ad-ed6e-4ef1-9957-1b80e1730030_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Current Weighted-Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BarclaysBankMember_33adf66a-1666-4f70-a726-e008f43728ed_terseLabel_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_label_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank [Member]</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_documentation_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember" xlink:href="cvs-20230331.xsd#cvs_BarclaysBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BarclaysBankMember" xlink:to="lab_cvs_BarclaysBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_0196ef79-04a2-4828-bf78-e7983594e0e6_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f7a22ffc-922f-42e6-9a07-1c65a2ecd71e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Estimated Fair Values of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_742800f4-9ea7-481f-ad02-98f7671ea6a5_verboseLabel_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS [Abstract]</link:label>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="cvs-20230331.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_4f96d729-6885-4ba1-ac1b-708296d4fecb_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_75cf4275-f5a9-4461-9e16-9c43a82f6ffa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_df09d6c7-bd6f-4807-8615-a9c501ef5d17_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_48329604-c379-4451-b436-fd6f633bd5a6_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increases (decreases) in noncontrolling interests</link:label>
    <link:label id="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20230331.xsd#cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_a75de95b-ce0e-46a5-a23e-a539a08c7705_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_68f84fef-6cb5-44a0-9dcc-507c823dba25_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_a7b4e448-37b3-473d-b05d-2168e0243875_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_172470c4-691c-4aaa-93ca-bc37fa7d0049_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums (actual)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c3664d73-99a4-4f4c-8e3c-64e7eaf21be0_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_8c1c97f4-869b-41dc-b602-2e10a08291e7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_525b619c-c4f2-4681-9751-d68c3fcfd08c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_9472e5b8-7b71-4f81-a824-296f699000ec_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20230331.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_cf11a809-c565-43b4-8d96-c1cfb1495f6b_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_4b8a721a-3e2e-4f27-bbcd-31249c6082da_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of expected net premiums</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_786fe5f1-80bc-439a-baa1-1b916251f0ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_5b105dbf-8166-484c-bd31-46762e2f148e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_8916ddcf-d741-4868-8e48-1a3747ec9cd5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 480 shares at March&#160;31, 2023 and 458 shares at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_5d7d1b40-b6d3-4405-9402-7383fddb10b7_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member_ffea235a-7c6d-4fa8-86dc-9189cfdc94c7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due September 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125 Percent, Due September 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125 Percent, Due September 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2125PercentDueSeptember2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:to="lab_cvs_SeniorNotes2125PercentDueSeptember2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes50DueFebruary2026Member_bdf5b6e6-7e07-440a-aaf1-05e3950c33e3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes50DueFebruary2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due February 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes50DueFebruary2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes50DueFebruary2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.0%, Due February 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes50DueFebruary2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes50DueFebruary2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.0%, Due February 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes50DueFebruary2026Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes50DueFebruary2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes50DueFebruary2026Member" xlink:to="lab_cvs_SeniorNotes50DueFebruary2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a90878a6-e577-4cb6-82bf-3c4fd98a6802_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3a664bc6-3f43-45a4-8655-9a9913a297ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_9661f95e-3f08-49bf-a89c-4e5993b3217b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_c3df6ef6-bac0-47d4-b1d7-4ffec20545d1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_15085e60-405a-49bd-b529-fdafe94446df_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_d221d1e8-d749-4566-89f2-8e2e083c1c27_terseLabel_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of shares to treasury stock value</link:label>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_label_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Shares to Treasury Stock Value</link:label>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_documentation_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Shares to Treasury Stock Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue" xlink:href="cvs-20230331.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TransferOfSharesToTreasuryStockValue" xlink:to="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_da78a370-b2e6-48b1-8364-6ce1881f9124_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_57cfec1d-586d-45d6-8dc2-03836d8e1b85_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_531ce9df-0c49-4179-a697-f34f19d36a74_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction to accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_872080e3-8775-437d-aced-f96584c150de_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_e97024f7-f002-4282-a445-617074089a80_terseLabel_en-US" xlink:label="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_label_en-US" xlink:label="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:to="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderFunds_26e7a04b-d891-4f12-927a-a030ea898289_periodStartLabel_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds, beginning of the period</link:label>
    <link:label id="lab_us-gaap_PolicyholderFunds_d96b7b28-7000-42af-969b-bf5048fd26e1_periodEndLabel_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds, end of the period</link:label>
    <link:label id="lab_us-gaap_PolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderFunds" xlink:to="lab_us-gaap_PolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8cf7c68b-50d0-4abc-bdc9-799d3395aad8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_aa2b19bf-8ae6-4438-a9df-12e8069cce49_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_12c3d5db-f5b3-4dac-ac5e-5079ec17faf3_negatedTerseLabel_en-US" xlink:label="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction to accumulated other comprehensive income (loss), before tax</link:label>
    <link:label id="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Before Tax</link:label>
    <link:label id="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_documentation_en-US" xlink:label="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:href="cvs-20230331.xsd#cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b7fd8c56-dbcd-410e-b62b-0e3a6f82cd0f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_67ba332c-c964-4640-9f05-c3e91b9cc1ff_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_7fde2d62-57af-4db1-b115-1b187bb97d81_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_a90edf54-03c0-4a7c-a8ef-1686ecf66692_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% senior notes due December 2037</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:to="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_4922ff28-6dfa-406e-9767-9f1092612fa6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_923c729d-7b84-4017-a87a-6cf14a768fb8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due June 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:to="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_80d87d97-7b93-4b3f-abf2-00cc142ce6ea_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in cash flow assumptions</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_f99a262a-e250-46ed-b449-bf9b19e10ebd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_30c044af-dd4b-4e15-8ab0-d17ba10fad55_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OfficeRealEstateOptimizationCharges_69d5e7b7-4425-44bf-9493-7ecfb4e0b03d_terseLabel_en-US" xlink:label="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office real estate optimization charges</link:label>
    <link:label id="lab_cvs_OfficeRealEstateOptimizationCharges_label_en-US" xlink:label="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Real Estate Optimization Charges</link:label>
    <link:label id="lab_cvs_OfficeRealEstateOptimizationCharges_documentation_en-US" xlink:label="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges" xlink:href="cvs-20230331.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OfficeRealEstateOptimizationCharges" xlink:to="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_a64e9a10-973a-45f4-998e-086b7d69615c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_b14c8755-e42f-4548-96d8-f66bb7d4f0cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_610fbccb-ebec-4258-a177-3e2d67ea9c52_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_95791227-b9da-4066-ba28-9694300ad1e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_169332a7-e769-419c-abc1-1117527a1737_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_584f9319-8f44-4bcb-82ae-0f670668e74f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of actual variances from expected experience</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_2ad0c61a-521c-443f-af05-a372f8c15409_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_7fd2a424-97bb-474b-b695-4953643ec87c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_2f219300-717d-4508-b5db-e50d23c34f1d_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountsPolicy" xlink:to="lab_us-gaap_PolicyholderAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_b4f185e8-c1e4-43c7-91c4-4d17c38771c6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net liability for future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_5266ff50-fb7c-4537-802c-db127c0ae249_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_9e698c60-ab04-4ef9-a82e-d4c2381f14c7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due July 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:to="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_17fb517c-f165-4e4e-b2e9-b0acb2cf537b_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_5a6c2dac-977c-44a0-b028-530fcdcf2f4a_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_cc979956-e052-4c02-aa19-8124ecd55746_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PostCombinationServicesMember_cf6689c1-a0f2-4929-9cb4-c02114ffb9cf_terseLabel_en-US" xlink:label="lab_cvs_PostCombinationServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination services</link:label>
    <link:label id="lab_cvs_PostCombinationServicesMember_label_en-US" xlink:label="lab_cvs_PostCombinationServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-Combination Services [Member]</link:label>
    <link:label id="lab_cvs_PostCombinationServicesMember_documentation_en-US" xlink:label="lab_cvs_PostCombinationServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-Combination Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PostCombinationServicesMember" xlink:href="cvs-20230331.xsd#cvs_PostCombinationServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PostCombinationServicesMember" xlink:to="lab_cvs_PostCombinationServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_644b875a-3ba9-4940-9ea8-1afc9a42a4ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_d77a7cb8-f44e-4bbe-810f-2ad1b042db27_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_00b5b37d-dbfd-4d06-a047-b87bd229b502_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_83eb5640-b711-4715-b318-64864d0a9cfc_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_052e0831-79f0-46e0-aa9f-de3bf7a821b7_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_0c129719-ed77-412d-b134-69e66be393cb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of retail locations (more than)</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7d9466ea-3378-4d4b-80df-36d72bd05a78_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_07db33b1-b750-41ce-844d-92f970d5595c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_916c934c-c6e0-49f1-b2e0-04f108b6f2ae_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased under ASR agreement (in shares)</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Number of Shares Repurchased</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Number of Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:to="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_3d1f3c47-0a81-478f-b92f-afeb43f12b39_terseLabel_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Removal of shadow adjustments in accumulated other comprehensive income</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_documentation_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:href="cvs-20230331.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_593a3e21-b4b9-477c-9d54-d7783ce37bc7_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_3fa5f3dc-85e7-410c-b9e0-1363bd20e29b_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_afed063e-0fba-43cb-b3e6-b343df48bd69_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_label_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_documentation_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:href="cvs-20230331.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:to="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPeopleServed_70990f87-8beb-40c0-bfec-109eaf6fd5d6_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_label_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_documentation_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed" xlink:href="cvs-20230331.xsd#cvs_NumberOfPeopleServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPeopleServed" xlink:to="lab_cvs_NumberOfPeopleServed" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfWalkInMedicalClinics_c5e6d480-b147-42ca-b415-715913a34500_terseLabel_en-US" xlink:label="lab_cvs_NumberOfWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk in medical clinics (more than)</link:label>
    <link:label id="lab_cvs_NumberOfWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberOfWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberOfWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberOfWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfWalkInMedicalClinics" xlink:href="cvs-20230331.xsd#cvs_NumberOfWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfWalkInMedicalClinics" xlink:to="lab_cvs_NumberOfWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_b8326bfa-fc74-4fe7-82dd-e1ff495680e0_terseLabel_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_label_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al [Member]</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_documentation_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:href="cvs-20230331.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:to="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_82f19c98-b6a7-4bc4-beab-990c5674768f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_6352498d-f616-46ba-b0ed-ffcd133bd505_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_0c7f8613-e0e0-4a66-b751-411b3b15d145_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_698da8b8-c333-4cc7-9c2a-7e01bce39b56_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_3de1c0ef-409d-4f13-a31d-9bdfcdf8f727_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_8ca02c50-ed55-4308-8d10-d0b5b85600b2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_aa7068ff-43d8-4cb0-be49-99b181b41299_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Separate Accounts by Major Category of Investment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_8c04ae49-dfd9-41ad-a3ee-f8d3660e40b3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Separate Account Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_48ac5b90-8981-4320-be51-41118331ee1e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_88390867-9f2b-4cd0-9551-99bd4b0c777e_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_e6d3d681-9908-45f7-864a-0831f8219999_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20230331.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_8d1723c1-75db-44e4-8395-a59b9b4f31a9_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_23606b78-b2c0-4fc2-a510-39fff12a1345_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due November 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:to="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_6965be3c-1d74-47ed-a330-dcff4896a3ff_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_66e506fa-4616-48af-8b2b-0c73563d5d68_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_54b99fd3-1946-422d-b286-b0d467ab0a15_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_c9ae2953-203b-4913-8c64-c7d251f65d09_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.1% senior notes due March 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:to="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_3731b538-c01b-4b4a-9382-ab96bc6cf2a4_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_71fe911c-c0dd-46e5-b5a3-797a753c27d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d1a807d9-11d1-45a3-a1ac-b36b03dee8ee_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_a27ab2b6-1a3b-4288-9d60-49192b9a0b88_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8a11b6e6-eb69-40d0-9b73-517c18a7820f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_88f48aa1-cf62-470b-80de-61bf56dc1988_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_d94cc7e9-9fef-4183-9701-2602940670e6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal settlement awarded to other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6528193c-a8ef-4e59-a1f6-2661ed848e87_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a9b317c2-aee9-4852-8cd2-f1a618ebc1c9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_823d31ed-cfa7-41db-9b1b-319cc50d12f4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_8122b55c-a8e5-4582-a626-a3bc24bf1828_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceRollForward_57ce2fcf-c58b-456f-a190-e4ce375f3a95_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceRollForward_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward" xlink:to="lab_us-gaap_PolicyholderAccountBalanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_717583bc-4c7b-49ec-8f60-46b0b07625bb_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_e0b1a68a-5348-4256-b60a-84244651ec30_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20230331.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3a94a8c9-84f6-4b8a-9a42-a8cf1735ad37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_fcbd168b-8f34-4eb5-b09a-b3d6bac6f602_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_539c4e0b-24ec-4bf5-b263-ed56dfc951a5_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_66fec7a4-443b-4503-be13-078d38ecd249_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3944711e-0ff8-45e8-8539-ba9501e06e8d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_933f1920-70f4-4e3e-b22d-8c985d9723f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_3ae7e4b4-2096-46a4-a425-d168e127d178_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share held in trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_d6ece81f-8947-409a-bce9-d25654fb174e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due November 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due November 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2042 with a coupon rate of 4.125%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:to="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_b8439fd1-e2b2-428c-9269-52cca209e4f6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_6204b456-c4cb-4136-95bf-a909668361c1_negatedLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_a601e49c-3e7d-430e-a46b-972a3f929dfa_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Copayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20230331.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_29e2a64c-ae45-4eff-9c77-f9dba27dc9d9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_c129a05c-175e-4bca-a682-b66095f11665_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_3ce24fac-c82c-47e1-a05b-f4a8ee3b918b_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_575cb961-4c3f-4afc-aca1-be2a7d14b9ee_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, after tax</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_label_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, After Reinsurance, Net Of Tax</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_documentation_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, After Reinsurance, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:href="cvs-20230331.xsd#cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:to="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b9f7dad9-a27d-450f-af28-045999cb010f_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Useful Life (years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_7ca6300e-05c2-4dfc-8f2d-bc4227963ab1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_c398ccf5-b993-4230-a889-c5c1617a9250_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_5142bb7a-4653-40db-a671-3b92ba912567_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contract, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_714b4317-2daa-480b-86c9-bf61ba4632b4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_18d44770-a6e3-4dc3-86f8-9395ccf411b3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_b80fa7d4-afa5-4660-997a-6b840ec04469_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20230331.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_e43d4356-c724-4147-a3e0-d2a4a7bfa55c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_30a7f17b-df80-4aa9-8ea5-d785f78bf068_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other current assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_2271a9df-db17-4567-a01f-95c0366959e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4c5f14b9-8c99-4198-be16-11a60bc4daec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_77112802-be80-4973-96f5-039082bb52fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_8cd11ff9-c8c9-4414-b3a8-d059e2104262_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c37e820-2b5e-439b-b584-d3672dfbea62_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06431565-a91a-4b78-a715-332fdbf53298_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8fa63903-d6f9-4ddc-aaa0-18012d81ad2a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replacement equity awards for pre-combination services</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_8aaa8742-eea3-4b1e-9e03-1b49486f1b56_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_7ab91b88-0d3e-405e-b532-6b3abcc95e8e_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PreCombinationServicesMember_43863eb2-6b19-4225-81d8-5cfc91f61b13_terseLabel_en-US" xlink:label="lab_cvs_PreCombinationServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-combination services</link:label>
    <link:label id="lab_cvs_PreCombinationServicesMember_label_en-US" xlink:label="lab_cvs_PreCombinationServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Combination Services [Member]</link:label>
    <link:label id="lab_cvs_PreCombinationServicesMember_documentation_en-US" xlink:label="lab_cvs_PreCombinationServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Combination Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PreCombinationServicesMember" xlink:href="cvs-20230331.xsd#cvs_PreCombinationServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PreCombinationServicesMember" xlink:to="lab_cvs_PreCombinationServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f20bca8b-f00d-453a-b060-8ea65a57d9a0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_b60cde68-61cb-449a-954b-fd632ba255e6_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2292c52d-1177-4ce4-8fdc-e5f6f4b53f26_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_aabc5703-d32f-4e7a-8637-8b2c1da57cbf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_7d3235cd-a4fc-4437-bddf-662f3b838297_terseLabel_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net unrealized gains (losses)</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_label_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Change In Net Unrealized Gains (Losses)</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_documentation_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Change In Net Unrealized Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:href="cvs-20230331.xsd#cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:to="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_de894ba2-a260-4c13-a309-207ccd9fdbfe_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember_2df49fd2-bfb5-445c-8d2e-f9f7f68636ff_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2690819b-b102-4504-8dd5-919d599e3a54_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_18344e64-e24f-49ed-9035-7fb9d63c9bdd_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_a4847f05-7a45-42f2-bfc3-9020f5113147_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Long-Lived Assets Held-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:to="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_e6e0a545-c3f1-4385-b95e-a02a05e644b9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_1c5c53d4-3822-4adb-8f89-6323b35017bf_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of states in which the Company entered the individual public health insurance exchange</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number of Additional States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number of Additional States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:href="cvs-20230331.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_7efbeff1-7586-4264-9c54-5eb66aad3cdb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_0bc3a63d-0847-416c-8a7a-cc72c585d975_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_fb8c3ceb-5c45-418c-850e-22fc8eaf25d0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_caf05846-3cc1-4495-8e22-ea29caf75b58_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.25DueApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.25DueApril2050Member" xlink:to="lab_cvs_SeniorNotes4.25DueApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5625DueFebruary2053Member_ab4f01ca-a43d-4315-b9b1-2fd1e2e24887_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5625DueFebruary2053Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.625% senior notes due February 2053</link:label>
    <link:label id="lab_cvs_SeniorNotes5625DueFebruary2053Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5625DueFebruary2053Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.625%, Due February 2053 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5625DueFebruary2053Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5625DueFebruary2053Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.625%, Due February 2053</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5625DueFebruary2053Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5625DueFebruary2053Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5625DueFebruary2053Member" xlink:to="lab_cvs_SeniorNotes5625DueFebruary2053Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ae49e92b-08de-4b92-b824-12eb8664b6cc_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f78c4743-69dd-4ea5-bd3a-b56406616bf3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_402f8a41-2034-4135-95cd-4ee03258b283_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_3da00f05-1ae6-4e4b-9db2-41f0bbe3474e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_1d8d28c7-fb84-4b57-a56e-10b91cd53a4e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_cfada458-c90c-42f4-8dbb-a8fad2ef0ab8_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_f8e03a5a-79c9-49c4-bba2-4a307870909c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ca844f41-6840-4112-a213-c809f94ebe06_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4ed2992c-8ac1-4414-8d1f-6ec875e75978_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_22d8dc14-f884-42f8-9076-c0b29ca87b82_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_56fea93c-9af2-4757-ba8d-732cbecc2223_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surrenders and withdrawals</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Surrender and Withdrawal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:to="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d6e444ff-59c3-45d5-bde5-04133766b4d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b545383d-4724-4951-9389-082064110548_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bea3d969-038c-49fa-a0bf-fe4f493fc261_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_526c75f5-b45d-4838-82d8-7aaa8bb06dc3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_97420286-3b1a-4957-94d5-1f288aa05449_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20230331.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_e9a7cd89-3cd4-4d80-96ca-3a7c1dc7a2fd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for income tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_2350c49b-613e-4369-bb9f-dc28721f09dd_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Consolidated Operating Income to Adjusted Operating Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_2aaa7603-d176-4256-9506-f2c8809c8e89_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalIncomeStatementElementsAbstract_42160263-0043-4a33-8bf4-a414de946e4a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Statement of Operations:</link:label>
    <link:label id="lab_us-gaap_SupplementalIncomeStatementElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Income Statement Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:to="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_a1eff1e9-3257-459c-9fef-c9ae3149bc97_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_910b3dca-6040-4e4d-a529-a108d7262777_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_becab4a8-2675-4977-aaff-971075476db1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_c3f778b2-1639-4866-9938-51b16b6d3369_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a2b14923-0417-4223-838d-3fdc006cefa5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_aef4f1e7-1ff4-443a-a4a0-e4ea49a2e711_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets (including restricted cash of $28)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_12366f69-ded0-4b9e-a8cd-8cdcf43b0bc9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_42e543fe-5f57-4ebb-8dfe-ad63f8cac3b6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c1eccb8a-8a5b-4c3f-aa16-00475d43c6ce_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_2cee8c1b-88a5-4d5c-829c-5056531d5a5d_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20230331.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_15476de9-8448-4e3d-84ba-e9cf8de16983_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% senior notes due May 2041</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:to="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_acf35a13-0a70-4a09-8a57-3db95da5f069_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_e039553d-57bd-4207-84dc-a7eae18f7f57_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_937438e1-6111-44ca-9430-61f8dba0b786_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0df3018f-9a50-475e-911f-d9cb145f45fe_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_bd8bf248-6cb5-40fa-aa80-4bc462536ac4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e9daf927-7136-4df7-a951-055045226031_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_ad6e3277-d4cd-434c-913e-fb325ae767ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_baf64f13-cc53-4ab5-a2bd-c94394a49a61_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accrual (using locked-in discount rate)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8cb46bd0-d02c-4bb6-a92f-c6a54c189c62_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_83decb36-cd96-4986-9d85-bfadadcfd242_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_bb3beafb-1095-49a0-9a1b-182c3d3cb764_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_dbba6c8a-72bd-434d-93ea-0810ac53ebb5_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f973c3b3-a4c6-40c3-8b77-0c4507253aac_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_8ac8e240-a067-4a09-ace2-1f1820a23598_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before reclassifications, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_dad0066a-2a05-4417-b25f-bf0d5a48fce2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_ce54f158-5985-4c70-bf2d-8e0315412aef_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a063e54d-333d-4d4b-971f-07fe6be36612_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_17f23d14-6f34-4f99-8ee9-4b4c7d93e57e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.78% senior notes due March 2038</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:to="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b54cb80a-b313-4021-87c5-078506df0c6f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_f4dd0830-1a10-4f8b-ab36-ef17e83cee65_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_1d899178-cf19-4e34-9c8b-bedcaf0a90d4_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, end of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_31d80f10-2f47-482e-a8ad-6368996d2920_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, beginning of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_09ef1e08-bd13-4359-910f-93a8560cbdae_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, end of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_f688201c-df6b-4d93-8226-eee8ea1334f9_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt (current and long-term)</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:to="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_0e959644-7797-4cc9-92c3-a467824934ce_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_10bed8cd-8db7-48e4-b177-41e7c8d43d41_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0826fb47-d777-4d22-b4f8-3c04578e4eee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_70e8a080-08fe-4bd6-8d2e-2923239be597_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f1a29c4c-278c-4a7b-af79-ef2ac8d89f23_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_aec6559f-14cf-4cb2-85f3-682a9a533445_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_b0bc5db2-0d46-4b8c-80da-91790506d034_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_77e08fad-b2dd-446a-a695-b2d94af22100_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_539c1948-c92c-45e8-88c3-a18ea9eb9fa1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_55dc703e-f65c-4bb8-ba28-b932a10c8d29_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthServicesSegmentMember_ed0ac2c7-d35f-44bc-addc-82194b9d3dcb_terseLabel_en-US" xlink:label="lab_cvs_HealthServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Services</link:label>
    <link:label id="lab_cvs_HealthServicesSegmentMember_label_en-US" xlink:label="lab_cvs_HealthServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Services Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Services Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthServicesSegmentMember" xlink:to="lab_cvs_HealthServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_a8659242-20aa-4b8e-b98a-d4255324731a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_146b7d6c-5c2e-4e3f-a3c0-3abfa61b7cbe_terseLabel_en-US" xlink:label="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in discount rate on long-duration insurance reserves</link:label>
    <link:label id="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_label_en-US" xlink:label="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Change In Discount Rate On Insurance Reserves [Member]</link:label>
    <link:label id="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_documentation_en-US" xlink:label="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Change In Discount Rate On Insurance Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:href="cvs-20230331.xsd#cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:to="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_25b135f0-245a-466e-8d9c-ecdf0fd02932_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_56fca602-981c-49b6-9b52-c4b03791e9de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_a4481ec9-4ab9-4030-8b0c-984c258a91e9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_b2a64fc1-8eae-45a3-a59a-03e7c609c130_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_29bb1faf-a164-408a-a363-ddfcaf72a059_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_58a559dc-63c3-4f7a-a4b7-8031be469a07_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_0e66a6a7-963a-44f8-9b12-4ba8574a9370_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_cf658d5d-c318-4755-b7f7-041da2f8a367_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Mortgage Loan Portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20230331.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_13a9e037-7fae-471a-a580-0b639e76b158_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_79d6303c-c8e5-4e45-bfd9-88b896a4404a_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9370d96b-c25e-4331-858f-b77db638f5e1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_870311ca-f8c4-4457-bfe4-7e926d0d780c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_44314f5e-9e03-4cf0-ad35-4e0b15b40038_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables (included in accounts receivable, net)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember_28aca2f7-d23f-4350-9d27-c75e2220dfe7_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember_label_en-US" xlink:label="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Mortgage-Backed Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountMortgageBackedSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:to="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1070d0ef-866e-4ea9-88c1-38881f3964bd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_00f8ca34-cbe4-4e99-a379-46a710de127f_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Increase (Decrease) from Other Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:to="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_93bbd0c1-90db-4d20-aa12-831c91d48176_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20230331.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_93e401cd-9a96-4699-b2e7-0baaf928bd13_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_ccfce474-7e81-4f0c-b1ef-ccb355c80c03_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ebe4c4a9-03e5-4dcf-b480-a19de8a63646_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_c3900768-eb26-485d-8da3-a0b38105e3a2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_c7b64e5a-3637-4cb0-bca6-3d575f7e74e6_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityRollForward_9f9bee4c-d9b8-45e0-91f9-fe20dabfbf8c_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityRollForward_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward" xlink:to="lab_us-gaap_SeparateAccountLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_9baab634-5de8-4b9c-856f-911a2fbfcff5_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_ebd532bb-684c-4346-b573-97201a13273d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_5a1a9f72-e4aa-4c63-be41-8a013906f7bf_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4a4252c6-f941-4b30-91e7-0e66728bf350_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_5acc49a6-a017-46ef-bae7-d5f5d41afd58_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of proposed acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_8bba35d4-dd11-48a5-97eb-dfb833dec988_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_8354ec86-8bd1-4513-b80b-16ef6eb93a9b_terseLabel_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal settlement, period of payment</link:label>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_label_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Settlement, Period Of Payment</link:label>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_documentation_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Settlement, Period Of Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment" xlink:href="cvs-20230331.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LegalSettlementPeriodOfPayment" xlink:to="lab_cvs_LegalSettlementPeriodOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_9fe59d33-06c4-4657-8eff-0c5152e92397_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_7d2fed5a-4d3b-4b12-bbce-79aef9254014_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_32d294a2-b9d6-48cb-9937-806fe9330c21_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_45b81621-ae07-41bc-a6f5-b2c2c1b339ea_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_712cfbfe-d50e-4bad-85ae-8446f9d48ce3_terseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attorneys' fees and costs</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_86951c3c-dac6-41ee-828c-d9ab6b7dc85c_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CitibankNAMember_59407b73-ff19-42df-b1c1-2d06e9d68f2a_terseLabel_en-US" xlink:label="lab_cvs_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A.</link:label>
    <link:label id="lab_cvs_CitibankNAMember_label_en-US" xlink:label="lab_cvs_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A. [Member]</link:label>
    <link:label id="lab_cvs_CitibankNAMember_documentation_en-US" xlink:label="lab_cvs_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CitibankNAMember" xlink:href="cvs-20230331.xsd#cvs_CitibankNAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CitibankNAMember" xlink:to="lab_cvs_CitibankNAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b1b04621-e6c6-4f0e-9462-0c8ca595be0c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_5b3a684c-5f00-4261-9e77-49f39ff7c360_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_954dbb84-ed1f-4366-8ea8-3186c4a66df2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_f2389b04-256c-4bd2-94d3-e6abe082b95d_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20230331.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_9cbefe8b-c2ba-4f1e-92bf-b70a6286fd51_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_07e6249b-78f0-45ca-989a-ec31e9cee68d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% senior notes due May 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:to="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9568158e-4921-47d7-bac7-2c21c763f68d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_f293c6fd-c20e-453a-8dad-7124aeb151fa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5125DueFebruary2030Member_c9edb7bb-2af8-4e51-a5da-876b65908bdb_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5125DueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due February 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes5125DueFebruary2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5125DueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due February 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5125DueFebruary2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5125DueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due February 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5125DueFebruary2030Member" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5125DueFebruary2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5125DueFebruary2030Member" xlink:to="lab_cvs_SeniorNotes5125DueFebruary2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_e9b3d93d-c44f-4bee-b7e4-5d2f67839245_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_55045d30-5b29-4e8f-aa31-9096acf32fc0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b414905f-24f5-46b3-8361-1da91bd4b089_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8554d4d1-aafb-4a15-b528-0684e25fefa5_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_552c5e45-c8be-460e-9700-6d27fd8961b4_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_cce5622c-38b2-4a4a-90a5-33bb841a4572_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_29ee5165-0932-4863-bff5-2f389f79cb5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_109f0176-adb3-4702-91f0-a97773495000_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_791e17fe-4d86-4a94-b1b3-07b5c663e1b4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_747bb04b-1fe4-4b0d-8040-4653e700a26b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments (actual)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_77250ca3-e2b6-42e7-b49c-2fcbad011801_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9be7b4ab-2033-444e-8cab-76c8bf24fe25_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_a655c981-71b3-42be-98e3-0ce28d91c8d3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2eaec1e5-9ae3-4a5e-9c1c-1f8e9c7aadd7_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_17d49530-1b8c-4957-98e1-3b6b76ea55ae_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_5674665a-fa94-4e20-9635-37d3a019d9f3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accrual (using locked-in discount rate)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_393e9605-9871-4835-9016-806be94dea83_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>cvs-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a5201116-fa32-47d9-bf67-a4b1f9934cb7,g:676c592e-810f-43b8-9a45-1cf85e252b17-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a2ac6658-7a0e-44d3-8b59-82fcec773456" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_DocumentType_a2ac6658-7a0e-44d3-8b59-82fcec773456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_daa66892-5c45-45c7-b156-57f8ab426b42" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_DocumentQuarterlyReport_daa66892-5c45-45c7-b156-57f8ab426b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_47d4a9e0-d3ea-4ca5-a8a5-de59e0155579" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_DocumentPeriodEndDate_47d4a9e0-d3ea-4ca5-a8a5-de59e0155579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a226810f-2232-4d79-9249-30d5d79f4055" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_DocumentTransitionReport_a226810f-2232-4d79-9249-30d5d79f4055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9b54bfa5-f053-4d50-9348-64e75cafa638" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityFileNumber_9b54bfa5-f053-4d50-9348-64e75cafa638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8a83906f-d03a-490f-8362-4751482c84eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityRegistrantName_8a83906f-d03a-490f-8362-4751482c84eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2f1cef00-f205-4ce8-a41c-dbad9a10b6b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2f1cef00-f205-4ce8-a41c-dbad9a10b6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_78a404ae-7275-4d93-bed2-612ba5e078f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityTaxIdentificationNumber_78a404ae-7275-4d93-bed2-612ba5e078f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_879fa721-7cd3-45bf-9d33-2e499c00d26c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityAddressAddressLine1_879fa721-7cd3-45bf-9d33-2e499c00d26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_075ea928-6575-4bfe-b308-e7735149c0e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityAddressCityOrTown_075ea928-6575-4bfe-b308-e7735149c0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5d55910c-09ca-4a2e-95d0-e1631c105a1e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityAddressStateOrProvince_5d55910c-09ca-4a2e-95d0-e1631c105a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_04526d43-19c4-4983-92ab-13f9ed5a28f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityAddressPostalZipCode_04526d43-19c4-4983-92ab-13f9ed5a28f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_77ecccca-390b-4431-aa06-8781d56fd4d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_CityAreaCode_77ecccca-390b-4431-aa06-8781d56fd4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_601cd074-9074-42ab-ab88-e70268a794be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_LocalPhoneNumber_601cd074-9074-42ab-ab88-e70268a794be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8a6d1f89-50c6-421f-8a9b-8b0164123854" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_Security12bTitle_8a6d1f89-50c6-421f-8a9b-8b0164123854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_21c6b644-805d-4802-bf82-e64f2181fff0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_TradingSymbol_21c6b644-805d-4802-bf82-e64f2181fff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7d7f72ba-d2d6-451f-a75c-918ea1d73abe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_SecurityExchangeName_7d7f72ba-d2d6-451f-a75c-918ea1d73abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_787e5ca3-a352-4646-85fe-e017d930f0a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityCurrentReportingStatus_787e5ca3-a352-4646-85fe-e017d930f0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_64450397-d55a-4417-bc8f-1256ef085286" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityInteractiveDataCurrent_64450397-d55a-4417-bc8f-1256ef085286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ee8f4b81-6394-4ae9-bd9d-66b405108186" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityFilerCategory_ee8f4b81-6394-4ae9-bd9d-66b405108186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_ddf04c23-b4cd-4314-a759-4dd9c095a77d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntitySmallBusiness_ddf04c23-b4cd-4314-a759-4dd9c095a77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a37e143c-b288-4453-a5b1-cf310d0c6d05" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityEmergingGrowthCompany_a37e143c-b288-4453-a5b1-cf310d0c6d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_dd8f9fb3-d969-42d3-92e8-ea2ea81521eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityShellCompany_dd8f9fb3-d969-42d3-92e8-ea2ea81521eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2ed019bf-048a-4929-b38c-e211ebc09021" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2ed019bf-048a-4929-b38c-e211ebc09021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_925c99ff-9cf3-47a0-9066-f14546794a9e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_EntityCentralIndexKey_925c99ff-9cf3-47a0-9066-f14546794a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0efa7339-4feb-4862-b8db-368adb346887" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_CurrentFiscalYearEndDate_0efa7339-4feb-4862-b8db-368adb346887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_cbfc66bb-9577-4048-bd92-d324a679e28d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_DocumentFiscalYearFocus_cbfc66bb-9577-4048-bd92-d324a679e28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d4bd0f26-9e87-4309-8257-6b9ec1d75d21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d4bd0f26-9e87-4309-8257-6b9ec1d75d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_00330f64-bab2-4d65-a34c-b0b012bf7f6e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bf59d412-75a1-4ffd-8cbf-8ef0568d4bff" xlink:to="loc_dei_AmendmentFlag_00330f64-bab2-4d65-a34c-b0b012bf7f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_96be4c0a-bfa4-4b57-b470-63f34360edaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d5b9a936-beed-4551-9640-470eb6971328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_96be4c0a-bfa4-4b57-b470-63f34360edaf" xlink:to="loc_us-gaap_StatementTable_d5b9a936-beed-4551-9640-470eb6971328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d5b9a936-beed-4551-9640-470eb6971328" xlink:to="loc_srt_ProductOrServiceAxis_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e7de3ce7-f3b4-4ed6-b4b1-85c0dc8bf721" xlink:to="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_d9795fcd-718e-4d0e-bf47-b0529a13e836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:to="loc_us-gaap_ProductMember_d9795fcd-718e-4d0e-bf47-b0529a13e836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_0dc061b5-b800-4571-b56d-6e3e9b62f24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6adde5cb-ab6a-4adf-9615-792adcac3ce6" xlink:to="loc_us-gaap_ServiceMember_0dc061b5-b800-4571-b56d-6e3e9b62f24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d5b9a936-beed-4551-9640-470eb6971328" xlink:to="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cca2f58d-bddc-4054-a4c3-b64d7ccb6a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cca2f58d-bddc-4054-a4c3-b64d7ccb6a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_325fefe1-b8f1-4502-862b-757a018344d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_PremiumsEarnedNet_325fefe1-b8f1-4502-862b-757a018344d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_3f48309b-d8ee-4662-b1af-703d215c920a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_NetInvestmentIncome_3f48309b-d8ee-4662-b1af-703d215c920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4e82bfae-464c-41cc-9d6a-6efe20532ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_69db0151-882d-4038-b3ac-7418b6c26e9f" xlink:to="loc_us-gaap_Revenues_4e82bfae-464c-41cc-9d6a-6efe20532ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3bd1e509-2a80-48cc-93c9-f94401ca1f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3bd1e509-2a80-48cc-93c9-f94401ca1f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_516c0976-1c18-4ea5-8994-6bc0f7bdccb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_516c0976-1c18-4ea5-8994-6bc0f7bdccb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c2b71e28-d7e2-41ea-858b-6f9357a708ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c2b71e28-d7e2-41ea-858b-6f9357a708ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ba8e09a1-fd54-4457-b021-3dc2e411ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ba8e09a1-fd54-4457-b021-3dc2e411ed1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_27ff0916-4622-491b-9dfc-17d7573eb25d" xlink:href="cvs-20230331.xsd#cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_27ff0916-4622-491b-9dfc-17d7573eb25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_739c6dbe-1513-410b-8e6d-99536212c8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_433eb44d-e10d-4025-b1b4-52926c058916" xlink:to="loc_us-gaap_CostsAndExpenses_739c6dbe-1513-410b-8e6d-99536212c8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fce77972-2cc0-4d23-b75f-cafddd1004eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_OperatingIncomeLoss_fce77972-2cc0-4d23-b75f-cafddd1004eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f7f09e79-6327-4573-b626-2df32a26460e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_InterestExpense_f7f09e79-6327-4573-b626-2df32a26460e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c0a2b59d-e8dd-45c1-b048-7bd63b9c8994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c0a2b59d-e8dd-45c1-b048-7bd63b9c8994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15c6944d-a6ca-4f72-8d90-589b94129d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15c6944d-a6ca-4f72-8d90-589b94129d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_10f1a3ee-d2e0-49df-99d8-44ac0b699571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_10f1a3ee-d2e0-49df-99d8-44ac0b699571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7901254d-2016-40e1-a0bb-fd5059238435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_ProfitLoss_7901254d-2016-40e1-a0bb-fd5059238435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3d8ad674-1b97-4eb7-ad3d-0066992efd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3d8ad674-1b97-4eb7-ad3d-0066992efd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f79e0af-7157-4f01-b641-32a719029827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_NetIncomeLoss_7f79e0af-7157-4f01-b641-32a719029827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b1b1e9d3-8322-49dd-8778-075021430932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:to="loc_us-gaap_EarningsPerShareBasic_b1b1e9d3-8322-49dd-8778-075021430932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_26b6bb73-6bb3-47f8-9cdc-652dd0aa9f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c05145f-adf4-44e5-a985-850f51865edf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_26b6bb73-6bb3-47f8-9cdc-652dd0aa9f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19336dda-d836-40c9-b6f9-5dc248faf261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19336dda-d836-40c9-b6f9-5dc248faf261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7f4a543-e08e-4c4b-a05e-c510f221c366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d2365c4-06da-43d5-aecc-fbeda846d7d6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7f4a543-e08e-4c4b-a05e-c510f221c366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_6fdc7c22-623c-4982-806f-8ab7fd07b072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_6fdc7c22-623c-4982-806f-8ab7fd07b072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_c2dce359-c0ca-4a0c-9609-a4a880d4fb3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b32ed4ee-b30c-48dc-a52b-a367ba850ac0" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_c2dce359-c0ca-4a0c-9609-a4a880d4fb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ddda9039-7f1d-4b1e-acec-437d83eb39c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6c2c3021-389f-4351-9391-f400e0a42f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ddda9039-7f1d-4b1e-acec-437d83eb39c3" xlink:to="loc_us-gaap_ProfitLoss_6c2c3021-389f-4351-9391-f400e0a42f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_78674a76-16ca-4e3a-9589-54b6da825d62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ddda9039-7f1d-4b1e-acec-437d83eb39c3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_78674a76-16ca-4e3a-9589-54b6da825d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3e8a1d1c-fee7-4aa0-8c86-f8755d492a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_78674a76-16ca-4e3a-9589-54b6da825d62" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3e8a1d1c-fee7-4aa0-8c86-f8755d492a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_76ae185f-bf8e-4630-8a4e-b73191fbf81b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_78674a76-16ca-4e3a-9589-54b6da825d62" xlink:to="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_76ae185f-bf8e-4630-8a4e-b73191fbf81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2860b51c-8b91-436a-a1f4-ede4a44f875a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_78674a76-16ca-4e3a-9589-54b6da825d62" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2860b51c-8b91-436a-a1f4-ede4a44f875a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_080ce551-1f61-4023-87e7-196141987b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_78674a76-16ca-4e3a-9589-54b6da825d62" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_080ce551-1f61-4023-87e7-196141987b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e618866f-d7b3-4918-bd63-8e234c712fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_78674a76-16ca-4e3a-9589-54b6da825d62" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e618866f-d7b3-4918-bd63-8e234c712fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cfa613b5-b87f-4c68-bee2-1a7789368b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ddda9039-7f1d-4b1e-acec-437d83eb39c3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cfa613b5-b87f-4c68-bee2-1a7789368b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c0b1ef8a-09fb-4b4a-b4ef-4c34f6a220cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ddda9039-7f1d-4b1e-acec-437d83eb39c3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c0b1ef8a-09fb-4b4a-b4ef-4c34f6a220cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f85af7ce-4526-4183-8764-f670911217d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ddda9039-7f1d-4b1e-acec-437d83eb39c3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f85af7ce-4526-4183-8764-f670911217d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cbc14d69-f9ac-417c-b41c-bccdaf4ad537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cbc14d69-f9ac-417c-b41c-bccdaf4ad537" xlink:to="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_450e384a-98c1-4453-98eb-37a820490e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_450e384a-98c1-4453-98eb-37a820490e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7e2aefcd-6bb1-4b04-a8cb-ca2a3aef4384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_ShortTermInvestments_7e2aefcd-6bb1-4b04-a8cb-ca2a3aef4384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e4111b13-eb63-47d8-a72a-2e48cbc10de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e4111b13-eb63-47d8-a72a-2e48cbc10de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a336abf9-9998-477b-a6a4-ad7bf09e69cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_InventoryNet_a336abf9-9998-477b-a6a4-ad7bf09e69cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_8f6ad7df-7260-4721-be8c-1e087b5f1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_8f6ad7df-7260-4721-be8c-1e087b5f1e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_f6e3e54e-a816-4c76-8164-b31d42f400fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_OtherAssetsCurrent_f6e3e54e-a816-4c76-8164-b31d42f400fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f994d3b2-fac3-44b2-93f7-2d5c5dc4062d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_AssetsCurrent_f994d3b2-fac3-44b2-93f7-2d5c5dc4062d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_534a6f17-c255-44ab-9039-908faf418252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_LongTermInvestments_534a6f17-c255-44ab-9039-908faf418252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ac0932e1-7ada-4b36-88e3-33a88067eb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ac0932e1-7ada-4b36-88e3-33a88067eb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fccd7867-a67c-4b7c-9085-352c51584430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fccd7867-a67c-4b7c-9085-352c51584430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c1efae19-32dd-4686-bc80-62d0aa7b4a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_Goodwill_c1efae19-32dd-4686-bc80-62d0aa7b4a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c34b5999-33f3-4c38-9db5-f8730310b28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c34b5999-33f3-4c38-9db5-f8730310b28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_37731a2e-6aae-44e4-aed5-756099ca8ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_SeparateAccountAssets_37731a2e-6aae-44e4-aed5-756099ca8ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d9e0c956-4cce-46ae-82a9-3b09e23f28a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d9e0c956-4cce-46ae-82a9-3b09e23f28a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3539051d-f5fd-457e-8148-68703202bddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c892bf70-437f-4c33-9fe0-d453c48c3c80" xlink:to="loc_us-gaap_Assets_3539051d-f5fd-457e-8148-68703202bddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cbc14d69-f9ac-417c-b41c-bccdaf4ad537" xlink:to="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_3d8a0e4c-10d5-472c-9e38-f0d037e14010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_3d8a0e4c-10d5-472c-9e38-f0d037e14010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_b22200e8-5cc0-4acf-83df-280f97b704ac" xlink:href="cvs-20230331.xsd#cvs_PharmacyClaimsAndDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_b22200e8-5cc0-4acf-83df-280f97b704ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1f095874-dc30-4afc-bb9d-443f09e1a5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1f095874-dc30-4afc-bb9d-443f09e1a5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_1efb9300-b333-4cea-98aa-9cdd7e42357c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_OtherPolicyholderFunds_1efb9300-b333-4cea-98aa-9cdd7e42357c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_309a90b1-d54d-46b8-88d5-3453993143aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_309a90b1-d54d-46b8-88d5-3453993143aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_e8c6fc9a-7a22-46e7-b983-01fd519d43b5" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_e8c6fc9a-7a22-46e7-b983-01fd519d43b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9622cf16-3591-4e00-99e5-70b09e325f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9622cf16-3591-4e00-99e5-70b09e325f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a85c379a-5171-43d9-89d3-68fbc4eb3318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a85c379a-5171-43d9-89d3-68fbc4eb3318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_f50425fd-f9b2-4df2-b833-2174461a80b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_f50425fd-f9b2-4df2-b833-2174461a80b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1b701102-aa41-4588-bb88-29dce4cc1411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_LiabilitiesCurrent_1b701102-aa41-4588-bb88-29dce4cc1411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6dd7ee46-36df-4e7f-9eb6-dc3a0f8473a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6dd7ee46-36df-4e7f-9eb6-dc3a0f8473a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d3605864-030f-417b-a25b-3a6ba70de0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_d3605864-030f-417b-a25b-3a6ba70de0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_aad693d9-4695-4917-843f-271429419f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_aad693d9-4695-4917-843f-271429419f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_df1775b6-5dd3-4893-983a-2d4017ca7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_SeparateAccountsLiability_df1775b6-5dd3-4893-983a-2d4017ca7da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c0dbc1ef-77c7-450d-8b79-fd395bfb8d8d" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c0dbc1ef-77c7-450d-8b79-fd395bfb8d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ca04f593-d440-43e1-9470-721377da87ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ca04f593-d440-43e1-9470-721377da87ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7052a769-447b-437a-8345-7c1170942b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c295576a-0e17-4e1b-bfe2-9aaa73c91c76" xlink:to="loc_us-gaap_Liabilities_7052a769-447b-437a-8345-7c1170942b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cbc14d69-f9ac-417c-b41c-bccdaf4ad537" xlink:to="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e23e52ff-8b5a-4107-8f6f-1ad54fc9a252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:to="loc_us-gaap_PreferredStockValue_e23e52ff-8b5a-4107-8f6f-1ad54fc9a252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_9e4019c0-286c-45c3-b8bf-2439b72e6cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_9e4019c0-286c-45c3-b8bf-2439b72e6cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_cd56260a-cb7c-42ca-8570-852d55ddf149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:to="loc_us-gaap_TreasuryStockValue_cd56260a-cb7c-42ca-8570-852d55ddf149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_786bd591-e740-435c-b426-4c8af3db3e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_786bd591-e740-435c-b426-4c8af3db3e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1ea7dc80-3a74-4fd1-bbe9-4f14537b07fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1ea7dc80-3a74-4fd1-bbe9-4f14537b07fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d84a1ad-7197-46b8-9455-87f13c3ef507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_659565d3-8001-4316-af72-851ad8cca26d" xlink:to="loc_us-gaap_StockholdersEquity_2d84a1ad-7197-46b8-9455-87f13c3ef507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_65196e3b-808f-4594-a64d-5298d245612b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cbc14d69-f9ac-417c-b41c-bccdaf4ad537" xlink:to="loc_us-gaap_MinorityInterest_65196e3b-808f-4594-a64d-5298d245612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05d50b1e-26a1-4da9-8214-5235158284bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cbc14d69-f9ac-417c-b41c-bccdaf4ad537" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05d50b1e-26a1-4da9-8214-5235158284bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c2fd46e1-c189-44f9-b259-a51c508aded1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cbc14d69-f9ac-417c-b41c-bccdaf4ad537" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c2fd46e1-c189-44f9-b259-a51c508aded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ae6981b6-1c02-4ceb-bed6-6afc1b2ee286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ae6981b6-1c02-4ceb-bed6-6afc1b2ee286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_aa5570f1-2a1d-4e35-bbde-7159a971f6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_aa5570f1-2a1d-4e35-bbde-7159a971f6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_86a1e8b5-7ac7-459e-aa63-03b9c2e86a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_86a1e8b5-7ac7-459e-aa63-03b9c2e86a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9f90e6bf-a8da-4769-ad4c-695d27aa585f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9f90e6bf-a8da-4769-ad4c-695d27aa585f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_96b33bcc-1ffe-4f8f-a07e-daaaed191262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_96b33bcc-1ffe-4f8f-a07e-daaaed191262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9c80dfef-a177-4c31-96ab-23a0be825ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9c80dfef-a177-4c31-96ab-23a0be825ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8174645c-c61c-4437-bd13-ee65f9763bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_CommonStockSharesIssued_8174645c-c61c-4437-bd13-ee65f9763bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b2d19620-0358-4ac4-8821-f8495aaf9121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b2d19620-0358-4ac4-8821-f8495aaf9121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_fedc4393-48b0-4fa1-8042-4f81069f9622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_792d4bdb-a901-4679-8ce6-3dd34ad2d7c9" xlink:to="loc_us-gaap_TreasuryStockShares_fedc4393-48b0-4fa1-8042-4f81069f9622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_27881fb5-b683-49fe-8bbf-40cfaa7eda5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_us-gaap_ProceedsFromCustomers_27881fb5-b683-49fe-8bbf-40cfaa7eda5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_dd48ca29-c442-429e-9944-70d2828e564b" xlink:href="cvs-20230331.xsd#cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_dd48ca29-c442-429e-9944-70d2828e564b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInsuranceBenefits_458a6040-c51f-4101-9773-52bee1f2fce3" xlink:href="cvs-20230331.xsd#cvs_PaymentsForInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_cvs_PaymentsForInsuranceBenefits_458a6040-c51f-4101-9773-52bee1f2fce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_741f5285-ec8a-4452-9b58-cf1f67307476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_741f5285-ec8a-4452-9b58-cf1f67307476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_bb60db0d-804a-41e7-ad03-df12487ba8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_bb60db0d-804a-41e7-ad03-df12487ba8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e2035b1c-5e90-4e30-b20a-8fc6351248f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_us-gaap_InterestPaidNet_e2035b1c-5e90-4e30-b20a-8fc6351248f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_bc6d0807-2f2f-466d-97d1-5a1cff8d5b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_bc6d0807-2f2f-466d-97d1-5a1cff8d5b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_72c0f761-2a2b-4f82-a52b-ea442a0c8343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_758bba6b-f6f2-4d84-8f0a-b152224e29c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_72c0f761-2a2b-4f82-a52b-ea442a0c8343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_5ac2df91-a0e4-45c3-bdcc-53a85f128e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_5ac2df91-a0e4-45c3-bdcc-53a85f128e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_33da51a2-00f5-4f5a-b613-4861aa31de27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_33da51a2-00f5-4f5a-b613-4861aa31de27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e07e5f1a-797c-4233-8c71-63c2c6c33cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e07e5f1a-797c-4233-8c71-63c2c6c33cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22048217-0e7c-4a18-89eb-ffce4714c41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_22048217-0e7c-4a18-89eb-ffce4714c41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ade2d03f-d0ec-4907-8022-541386fa0510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ade2d03f-d0ec-4907-8022-541386fa0510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a807ce28-86a2-448b-9b94-f0d36088efbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2a5d127-8e52-4145-8c86-33ce2d3e0bc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a807ce28-86a2-448b-9b94-f0d36088efbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f5be80d-0cdd-4b75-9b40-e2268e7f4cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f5be80d-0cdd-4b75-9b40-e2268e7f4cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_68f8f2cd-3e23-47f7-83bc-b7fde85502b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_68f8f2cd-3e23-47f7-83bc-b7fde85502b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_de08fc11-2558-4cc8-8c13-ebe9dd1e5f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_de08fc11-2558-4cc8-8c13-ebe9dd1e5f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_3af55df6-09a6-441c-85bc-e62ed30c6371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_PaymentsOfDividends_3af55df6-09a6-441c-85bc-e62ed30c6371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_5121ca94-2c13-4d9c-8e4f-5d6c60e30d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_5121ca94-2c13-4d9c-8e4f-5d6c60e30d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e97ec5e7-6999-44f9-a67c-c6113ac5d607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e97ec5e7-6999-44f9-a67c-c6113ac5d607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9b61097d-6aee-401a-9bd4-0856b95d896e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9b61097d-6aee-401a-9bd4-0856b95d896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19acec56-c42e-4aa0-8673-6133167425ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c2fc267-3818-4931-80ab-83502cb3e9fa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19acec56-c42e-4aa0-8673-6133167425ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_888908c6-e333-464e-a1f8-b05b4f565187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_888908c6-e333-464e-a1f8-b05b4f565187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfc314e4-ae7c-499c-a43d-e31d8192010f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfc314e4-ae7c-499c-a43d-e31d8192010f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3348ba33-e8ee-40c7-95d3-73af4ade2970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3348ba33-e8ee-40c7-95d3-73af4ade2970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b2eb0bde-8ed3-4e64-abf7-3e130ddc063f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a07ef008-e9e0-4582-8555-a24f75babd00" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b2eb0bde-8ed3-4e64-abf7-3e130ddc063f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_978553bd-2bf9-4e5f-81b9-eae0a0b37059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b2eb0bde-8ed3-4e64-abf7-3e130ddc063f" xlink:to="loc_us-gaap_ProfitLoss_978553bd-2bf9-4e5f-81b9-eae0a0b37059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd3effbf-f43c-4632-bdf0-ce235a8d4e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b2eb0bde-8ed3-4e64-abf7-3e130ddc063f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd3effbf-f43c-4632-bdf0-ce235a8d4e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a39a0638-a534-4581-a684-86b1fb5638da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd3effbf-f43c-4632-bdf0-ce235a8d4e65" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a39a0638-a534-4581-a684-86b1fb5638da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_341d3eb8-872f-4561-ae82-180ee41de0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd3effbf-f43c-4632-bdf0-ce235a8d4e65" xlink:to="loc_us-gaap_ShareBasedCompensation_341d3eb8-872f-4561-ae82-180ee41de0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_7bcb285a-482b-4779-97d3-61550c898f56" xlink:href="cvs-20230331.xsd#cvs_DeferredIncomeTaxesAndOtherNoncashItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd3effbf-f43c-4632-bdf0-ce235a8d4e65" xlink:to="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_7bcb285a-482b-4779-97d3-61550c898f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:href="cvs-20230331.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd3effbf-f43c-4632-bdf0-ce235a8d4e65" xlink:to="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a487228a-af58-43ec-a37d-1262c9fc3338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a487228a-af58-43ec-a37d-1262c9fc3338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_fb50852c-7c95-4339-85a0-136933001253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_fb50852c-7c95-4339-85a0-136933001253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e0c41786-5d08-4464-98ba-0726e6c92f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e0c41786-5d08-4464-98ba-0726e6c92f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_29d4ad17-4cc9-4a33-8cf0-0a4287cc5f75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_29d4ad17-4cc9-4a33-8cf0-0a4287cc5f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_08559b9f-4a55-4552-b202-a381eee54d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_08559b9f-4a55-4552-b202-a381eee54d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6120aa50-f9ad-4cff-8742-67392cea8fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6120aa50-f9ad-4cff-8742-67392cea8fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e41eedba-3c2c-438b-aecf-1d20e056d995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_931d2e91-e733-4ac9-9909-2d23cf7495cb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e41eedba-3c2c-438b-aecf-1d20e056d995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_eacc9b00-54e9-4c88-8edb-d21fdfd71928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_eacc9b00-54e9-4c88-8edb-d21fdfd71928" xlink:to="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e3b3ec51-f7ba-4e5d-b3b1-b87f47f0895b" xlink:to="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:to="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d808c6f3-16a2-494f-94d9-e28673315ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_CommonStockMember_d808c6f3-16a2-494f-94d9-e28673315ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_41d448a4-69f7-4de8-b2ee-a5ba1edd6867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_TreasuryStockCommonMember_41d448a4-69f7-4de8-b2ee-a5ba1edd6867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_c0dd9b48-22d0-45e1-9bd3-3412fe1e712f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_c0dd9b48-22d0-45e1-9bd3-3412fe1e712f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_818c1002-8cb5-4d68-b47d-9b51bede720b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_RetainedEarningsMember_818c1002-8cb5-4d68-b47d-9b51bede720b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6852ce50-7283-4527-a62d-abe8294c4d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d54c2c16-aaf2-41b4-9492-2f1f3ad76a9b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6852ce50-7283-4527-a62d-abe8294c4d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_df1e8600-dbf1-42ba-b2a4-764ac656c661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c8011c99-639e-4fa3-81c0-d66423680c56" xlink:to="loc_us-gaap_NoncontrollingInterestMember_df1e8600-dbf1-42ba-b2a4-764ac656c661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ffda15e2-2d03-4d88-b5c3-cfe05bb63390" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ffda15e2-2d03-4d88-b5c3-cfe05bb63390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_653ba323-76f3-42ab-9e08-3cb773d1c4ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_ffda15e2-2d03-4d88-b5c3-cfe05bb63390" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_653ba323-76f3-42ab-9e08-3cb773d1c4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e7c35927-c617-4d71-8fa2-063af724f058" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_653ba323-76f3-42ab-9e08-3cb773d1c4ce" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e7c35927-c617-4d71-8fa2-063af724f058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d8641284-a86b-4f21-a9be-0f353b500837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8f1977e7-a501-4764-aac1-e9f8cbc6fca6" xlink:to="loc_us-gaap_StatementLineItems_d8641284-a86b-4f21-a9be-0f353b500837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d8641284-a86b-4f21-a9be-0f353b500837" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_061322ca-4d93-437a-b406-f70b5799e82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_SharesOutstanding_061322ca-4d93-437a-b406-f70b5799e82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6e7711e3-9553-40b1-aebf-d6eacb89dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6e7711e3-9553-40b1-aebf-d6eacb89dac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff1aeae4-7f24-47f1-b16a-129fc12ee9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ff1aeae4-7f24-47f1-b16a-129fc12ee9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3287680f-a25f-4a14-82ae-ba7fd84d869a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_ProfitLoss_3287680f-a25f-4a14-82ae-ba7fd84d869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a0b6ca82-dd1e-4721-9825-9f2b2fc9d71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a0b6ca82-dd1e-4721-9825-9f2b2fc9d71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c1648361-9ed9-4886-a24c-2a4b20bd38e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c1648361-9ed9-4886-a24c-2a4b20bd38e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c288d181-51f0-40af-afe1-90a5ae28dbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c288d181-51f0-40af-afe1-90a5ae28dbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_251ce38d-84f9-4eaf-bab4-caa7fb72967c" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_251ce38d-84f9-4eaf-bab4-caa7fb72967c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce92592e-7aeb-4c6f-9c10-0ee5ebd06f14" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_ce92592e-7aeb-4c6f-9c10-0ee5ebd06f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_016520e7-2335-4276-af2b-f522e6dd1644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_DividendsCommonStock_016520e7-2335-4276-af2b-f522e6dd1644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_5b0fcf41-d44d-44bf-87c6-390ad039f6ff" xlink:href="cvs-20230331.xsd#cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_5b0fcf41-d44d-44bf-87c6-390ad039f6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_28879577-09aa-49a5-bf56-be60ccb09121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_SharesOutstanding_28879577-09aa-49a5-bf56-be60ccb09121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_67879137-8980-4363-a84f-267214789437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_TreasuryStockCommonShares_67879137-8980-4363-a84f-267214789437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3188c94-2e2c-46f9-b5a1-1ce72e6a11f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f07397ad-6508-43b2-b2e1-9ac9f89b7804" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3188c94-2e2c-46f9-b5a1-1ce72e6a11f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="simple" xlink:href="cvs-20230331.xsd#CondensedConsolidatedStatementsofShareholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3da1b133-d522-48d8-b3a2-75045c030715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldInTrust_7a3c42d2-9b26-4d8c-8dc3-b5f5d212225d" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockSharesHeldInTrust"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3da1b133-d522-48d8-b3a2-75045c030715" xlink:to="loc_cvs_TreasuryStockSharesHeldInTrust_7a3c42d2-9b26-4d8c-8dc3-b5f5d212225d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_e4938e6f-8d66-4279-a355-7a87cbd771f6" xlink:href="cvs-20230331.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3da1b133-d522-48d8-b3a2-75045c030715" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_e4938e6f-8d66-4279-a355-7a87cbd771f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1e7972c2-8dd7-4c2e-a17d-0d988e150d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3da1b133-d522-48d8-b3a2-75045c030715" xlink:to="loc_us-gaap_CommonStockValue_1e7972c2-8dd7-4c2e-a17d-0d988e150d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0beb06b1-1daa-46ea-9e65-2d3b28273d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f485746f-e232-4c89-8366-3fe8cf9428ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0beb06b1-1daa-46ea-9e65-2d3b28273d5c" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f485746f-e232-4c89-8366-3fe8cf9428ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSale" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSale"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2ccc20f3-f72d-48ff-a91c-6b468a64882e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_7d8e6753-72fe-450a-92e3-e72a5efc1d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2ccc20f3-f72d-48ff-a91c-6b468a64882e" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_7d8e6753-72fe-450a-92e3-e72a5efc1d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20230331.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b63f1fe3-81bc-4fad-9694-77b45d812ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_89450a5a-fff8-4930-8e52-8a54e6a58926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b63f1fe3-81bc-4fad-9694-77b45d812ad8" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_89450a5a-fff8-4930-8e52-8a54e6a58926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e2095cbd-d3f6-4c50-80fd-b8d9c1ffcefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b078b6f6-952f-40cd-8014-1abeb2e10a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e2095cbd-d3f6-4c50-80fd-b8d9c1ffcefe" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b078b6f6-952f-40cd-8014-1abeb2e10a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20230331.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_20480aed-54ec-4920-8254-95f824846244" xlink:href="cvs-20230331.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_6e876f6f-60e3-4063-9bf1-d6663ba0e086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_20480aed-54ec-4920-8254-95f824846244" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_6e876f6f-60e3-4063-9bf1-d6663ba0e086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccounts"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_7f68a503-24be-4f34-843c-cbe6a5609c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock_ca9b5354-876d-43e7-959d-c736b029e3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractAcquisitionCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7f68a503-24be-4f34-843c-cbe6a5609c17" xlink:to="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock_ca9b5354-876d-43e7-959d-c736b029e3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Borrowings" xlink:type="simple" xlink:href="cvs-20230331.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_40496a3d-356a-4580-9fa2-8bf23332dd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_b041a41e-6399-4f3d-86dc-e2d2e56a32fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40496a3d-356a-4580-9fa2-8bf23332dd8d" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_b041a41e-6399-4f3d-86dc-e2d2e56a32fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20230331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c9473abc-8cc6-4f2c-9ac2-079959712dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3dc2d325-67d9-44a6-8922-567a91dd4d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c9473abc-8cc6-4f2c-9ac2-079959712dff" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3dc2d325-67d9-44a6-8922-567a91dd4d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_382d796a-74a3-4505-9058-efe960e3ca28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_88cff657-77c9-4b05-b84e-b203b08c3fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_382d796a-74a3-4505-9058-efe960e3ca28" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_88cff657-77c9-4b05-b84e-b203b08c3fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20230331.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_51572f92-3ae5-43c3-b590-be15738e7ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7d5aa427-81f0-4e7f-96e5-9ffee4d494f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51572f92-3ae5-43c3-b590-be15738e7ff0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7d5aa427-81f0-4e7f-96e5-9ffee4d494f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_888c2422-6720-4808-bc19-7fd347d63e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b9a43aab-b43e-48b7-bfc1-5e0ce6230921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_888c2422-6720-4808-bc19-7fd347d63e03" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b9a43aab-b43e-48b7-bfc1-5e0ce6230921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_62a31df9-bfa5-40a9-8b3b-937fb79e1b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c27c7b80-85ba-44f2-90a0-f42cbe42def6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_62a31df9-bfa5-40a9-8b3b-937fb79e1b0c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c27c7b80-85ba-44f2-90a0-f42cbe42def6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_75435507-761d-4744-af84-8a7a73a6efc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_75435507-761d-4744-af84-8a7a73a6efc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_52b88a6f-f885-46be-81ec-fd09ec2ba68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_52b88a6f-f885-46be-81ec-fd09ec2ba68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_04d53229-04e0-4fa7-b5c5-0e03f62dc98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_04d53229-04e0-4fa7-b5c5-0e03f62dc98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_39d5e37d-1556-486a-8fee-e9aee85dc57b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_39d5e37d-1556-486a-8fee-e9aee85dc57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_7cd8982d-6c36-49e8-83e1-98c69c75c94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_7cd8982d-6c36-49e8-83e1-98c69c75c94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_2a7fc19a-ccf7-4c9e-bbfa-ca97e0e0cbec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_2a7fc19a-ccf7-4c9e-bbfa-ca97e0e0cbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_4920034e-47f2-4fdf-8108-d1fb27d88565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_4920034e-47f2-4fdf-8108-d1fb27d88565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_3d8f7a2f-9c1e-45df-b0e3-efc87be9fcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_3d8f7a2f-9c1e-45df-b0e3-efc87be9fcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_87ea5bdb-ad10-4859-b5c6-eebc7080b281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_87ea5bdb-ad10-4859-b5c6-eebc7080b281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_3dd58a7c-6141-45c9-be91-114ce51e66d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_3dd58a7c-6141-45c9-be91-114ce51e66d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy_7913debb-07ea-4053-949e-579a957b5fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_PolicyholderAccountsPolicy_7913debb-07ea-4053-949e-579a957b5fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy_1f8a34bb-8cd9-4274-b9fa-ba2b71554957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FuturePolicyBenefitsLiabilityPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_FuturePolicyBenefitsLiabilityPolicy_1f8a34bb-8cd9-4274-b9fa-ba2b71554957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5a4703fc-9a25-413c-b579-b1525456aa2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5a4703fc-9a25-413c-b579-b1525456aa2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_1b13386a-d80e-468d-a125-a39023b2dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_1b13386a-d80e-468d-a125-a39023b2dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_026d4d92-f4fd-4b5b-be4a-3686ef6127a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46fd0a5a-7682-44c7-99da-a5f22948d507" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_026d4d92-f4fd-4b5b-be4a-3686ef6127a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f45f2df7-599c-41b9-ba42-6b9bce72b985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_956638a5-c12b-43f2-946e-145c306c325c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f45f2df7-599c-41b9-ba42-6b9bce72b985" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_956638a5-c12b-43f2-946e-145c306c325c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_ac155171-69b6-40fb-9d5e-d4b3d87ebd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f45f2df7-599c-41b9-ba42-6b9bce72b985" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_ac155171-69b6-40fb-9d5e-d4b3d87ebd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_be6ba536-8668-4ae4-87dd-452018eef0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f45f2df7-599c-41b9-ba42-6b9bce72b985" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_be6ba536-8668-4ae4-87dd-452018eef0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1250915e-538b-42b8-850d-fb78dcfe671e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f45f2df7-599c-41b9-ba42-6b9bce72b985" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1250915e-538b-42b8-850d-fb78dcfe671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_04267d30-1d2f-45cc-ac11-7d586a869244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f45f2df7-599c-41b9-ba42-6b9bce72b985" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_04267d30-1d2f-45cc-ac11-7d586a869244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1ac4ecd2-3711-43ac-9498-c7deefaa2269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f45f2df7-599c-41b9-ba42-6b9bce72b985" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1ac4ecd2-3711-43ac-9498-c7deefaa2269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d22bf84-c58b-4c2c-a5de-d87e8d2941b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f8aa0b54-1242-4cbb-a593-dcbccda6812c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d22bf84-c58b-4c2c-a5de-d87e8d2941b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f8aa0b54-1242-4cbb-a593-dcbccda6812c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_41282e58-dd77-42f2-9431-cdb13bedef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d22bf84-c58b-4c2c-a5de-d87e8d2941b3" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_41282e58-dd77-42f2-9431-cdb13bedef3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_f701de3d-463a-4347-b27a-ed3a828cd79b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSegmentAllocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d22bf84-c58b-4c2c-a5de-d87e8d2941b3" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock_f701de3d-463a-4347-b27a-ed3a828cd79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_d280f56c-0f7f-4a84-bef5-d83395ceb5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d22bf84-c58b-4c2c-a5de-d87e8d2941b3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_d280f56c-0f7f-4a84-bef5-d83395ceb5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_34f9968f-df47-4433-827c-350e8cdbd1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d22bf84-c58b-4c2c-a5de-d87e8d2941b3" xlink:to="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_34f9968f-df47-4433-827c-350e8cdbd1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_b5768c5f-ef12-4f1e-8c91-686279e4a5d0" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_b5768c5f-ef12-4f1e-8c91-686279e4a5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_c293c8e8-0bfa-4a1f-9bb6-8169125a192a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_c293c8e8-0bfa-4a1f-9bb6-8169125a192a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_bbc2a559-b30b-4797-9276-693528245f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_bbc2a559-b30b-4797-9276-693528245f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_b95d6f75-fcbe-4b31-bb25-b9722f12b612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_b95d6f75-fcbe-4b31-bb25-b9722f12b612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_4002d200-3dbc-49f2-addd-3d6e98cc5471" xlink:href="cvs-20230331.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_4002d200-3dbc-49f2-addd-3d6e98cc5471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_f32909d5-6623-414d-a03a-48f521256d39" xlink:href="cvs-20230331.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_f32909d5-6623-414d-a03a-48f521256d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_121fc044-68c6-4d3a-b8f9-761a02c3ced6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_121fc044-68c6-4d3a-b8f9-761a02c3ced6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_d1ed20ac-15be-49a8-a7ad-e45866250ecb" xlink:href="cvs-20230331.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7ea49c01-51d4-4425-a7ec-2cad091ee814" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_d1ed20ac-15be-49a8-a7ad-e45866250ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_33de75ac-88b3-42f7-9f69-e3d19cc9a0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d65d550c-2110-4966-af2e-14c0c648340a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33de75ac-88b3-42f7-9f69-e3d19cc9a0e1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d65d550c-2110-4966-af2e-14c0c648340a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_398fc39b-b29b-4652-9009-1cc9ebb10cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33de75ac-88b3-42f7-9f69-e3d19cc9a0e1" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_398fc39b-b29b-4652-9009-1cc9ebb10cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_6024402b-d61b-456d-83f7-7daf4b1d0662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_33de75ac-88b3-42f7-9f69-e3d19cc9a0e1" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_6024402b-d61b-456d-83f7-7daf4b1d0662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_965c073f-b3a6-49fe-be96-3b9302009721" xlink:href="cvs-20230331.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b04a8750-0e19-469d-b8db-fccc88b9b7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_965c073f-b3a6-49fe-be96-3b9302009721" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b04a8750-0e19-469d-b8db-fccc88b9b7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_de3f658b-1318-40f3-8135-3aa6fb7d6067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_fac1fb03-3ad9-4cc1-b7c5-1f412420c5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_de3f658b-1318-40f3-8135-3aa6fb7d6067" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_fac1fb03-3ad9-4cc1-b7c5-1f412420c5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock_21d8e1a5-3a2c-42cb-a21e-92f1156d286e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_de3f658b-1318-40f3-8135-3aa6fb7d6067" xlink:to="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock_21d8e1a5-3a2c-42cb-a21e-92f1156d286e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_90ba8392-c6bb-498c-953f-3fcb6f0b1b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_de3f658b-1318-40f3-8135-3aa6fb7d6067" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_90ba8392-c6bb-498c-953f-3fcb6f0b1b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityTableTextBlock_e92d8208-49a1-4f2e-990a-1c3299e32c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_de3f658b-1318-40f3-8135-3aa6fb7d6067" xlink:to="loc_us-gaap_SeparateAccountLiabilityTableTextBlock_e92d8208-49a1-4f2e-990a-1c3299e32c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0a77f840-0ef3-4ae1-920f-6fcc91ed2b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_91a90c58-1ef9-43a2-bfa5-67b2d6772c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0a77f840-0ef3-4ae1-920f-6fcc91ed2b6a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_91a90c58-1ef9-43a2-bfa5-67b2d6772c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_eb6c4ba7-751a-4d75-872f-edf5f1d443e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_c4a82166-2923-4f58-88eb-30c68163bcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_eb6c4ba7-751a-4d75-872f-edf5f1d443e6" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_c4a82166-2923-4f58-88eb-30c68163bcb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_22366b7b-a225-42d8-b3cb-0ef2509e84ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_90afeb1d-58e0-40c7-9951-3589e29c259a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_22366b7b-a225-42d8-b3cb-0ef2509e84ea" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_90afeb1d-58e0-40c7-9951-3589e29c259a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_252df51a-03ef-46c5-942f-d943f844434e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_91e36999-5e30-4835-bd3a-4bbdb43ecce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_252df51a-03ef-46c5-942f-d943f844434e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_91e36999-5e30-4835-bd3a-4bbdb43ecce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_675b96a1-b86e-49c6-b064-cb99d3fb6ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f7b12dcb-3103-47a0-b815-dc0585aca619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_675b96a1-b86e-49c6-b064-cb99d3fb6ebf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f7b12dcb-3103-47a0-b815-dc0585aca619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_44e7cac5-bf66-4fc0-9d14-5be953313964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_675b96a1-b86e-49c6-b064-cb99d3fb6ebf" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_44e7cac5-bf66-4fc0-9d14-5be953313964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_04f9a676-60ec-45b1-8b4a-b11fd7f15111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_04f9a676-60ec-45b1-8b4a-b11fd7f15111" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2a32cc89-6eb7-4696-b0da-d80e2a237c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2a32cc89-6eb7-4696-b0da-d80e2a237c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2a32cc89-6eb7-4696-b0da-d80e2a237c39" xlink:to="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a32cdfe1-530a-4da1-bae5-c26075092bd5" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a32cdfe1-530a-4da1-bae5-c26075092bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_a509f9e8-e777-44b7-b1f7-3cb92db69dbb" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:to="loc_cvs_HealthServicesSegmentMember_a509f9e8-e777-44b7-b1f7-3cb92db69dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_a7adeffb-51cf-46c9-b5ff-0e6a0259e0d8" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5a4243ad-e240-4e19-b1aa-b772d13533e9" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_a7adeffb-51cf-46c9-b5ff-0e6a0259e0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_20df56e5-3244-412b-aa0e-c2b9dc12cc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_20df56e5-3244-412b-aa0e-c2b9dc12cc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bdf9c216-0b17-4493-9b8b-5594c16b6839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_20df56e5-3244-412b-aa0e-c2b9dc12cc03" xlink:to="loc_us-gaap_RelatedPartyDomain_bdf9c216-0b17-4493-9b8b-5594c16b6839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_a253480b-a8b2-4fee-8c3b-8ea2f5511c6c" xlink:href="cvs-20230331.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_bdf9c216-0b17-4493-9b8b-5594c16b6839" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_a253480b-a8b2-4fee-8c3b-8ea2f5511c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_81a006c6-f3a0-43ad-9763-eeb169bb5f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_81a006c6-f3a0-43ad-9763-eeb169bb5f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_81a006c6-f3a0-43ad-9763-eeb169bb5f9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_3af962a1-1c79-4286-86b7-d46ba375d089" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_3af962a1-1c79-4286-86b7-d46ba375d089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_f64fea54-9102-45cb-a1cf-d4217e7c1468" xlink:href="cvs-20230331.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8ec4379-72c4-49da-84c1-b42fc1f96201" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_f64fea54-9102-45cb-a1cf-d4217e7c1468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f6c620b3-8797-4fbe-aa99-4fe67cb38aea" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_0db807bc-10c5-44ea-8f20-ced25d645de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_NumberOfStores_0db807bc-10c5-44ea-8f20-ced25d645de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfWalkInMedicalClinics_d2ec50fb-a4a3-4ad8-918b-379e847a677a" xlink:href="cvs-20230331.xsd#cvs_NumberOfWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfWalkInMedicalClinics_d2ec50fb-a4a3-4ad8-918b-379e847a677a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPharmacyPlanMembers_5aff6332-1e23-43d9-9162-88a9c91d633a" xlink:href="cvs-20230331.xsd#cvs_NumberOfPharmacyPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfPharmacyPlanMembers_5aff6332-1e23-43d9-9162-88a9c91d633a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPatientsServedPerYear_92679766-4f71-42a2-9844-bdd5d2c45be3" xlink:href="cvs-20230331.xsd#cvs_NumberOfPatientsServedPerYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfPatientsServedPerYear_92679766-4f71-42a2-9844-bdd5d2c45be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_d3684fb3-d416-41b1-83ab-296de8b96a71" xlink:href="cvs-20230331.xsd#cvs_NumberOfPeopleServed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_NumberOfPeopleServed_d3684fb3-d416-41b1-83ab-296de8b96a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_14dac28e-0f93-431c-b507-2dfe3133db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_NumberOfReportableSegments_14dac28e-0f93-431c-b507-2dfe3133db9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_f88b4c6a-0e13-4d01-a08e-e2e41cc514a5" xlink:href="cvs-20230331.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_f88b4c6a-0e13-4d01-a08e-e2e41cc514a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_5e758912-a811-4d88-a7ca-9956e5c9539f" xlink:href="cvs-20230331.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_5e758912-a811-4d88-a7ca-9956e5c9539f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ce06bfc9-9992-4f83-9613-3a555c46c3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ce06bfc9-9992-4f83-9613-3a555c46c3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_05f8e68e-a9e8-4949-be19-55d910c51370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_05f8e68e-a9e8-4949-be19-55d910c51370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_29901616-e559-45c2-8302-ac173792f7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_29901616-e559-45c2-8302-ac173792f7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_db8cc450-6869-4d21-87cc-43fe560882f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_db8cc450-6869-4d21-87cc-43fe560882f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_32ea70aa-5bdf-4f6b-9656-18d78998c290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_32ea70aa-5bdf-4f6b-9656-18d78998c290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b5b8cc75-ffb7-41c1-b21e-9c948176bd08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_887fb4b2-68f4-4d72-9499-e997927c6291" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b5b8cc75-ffb7-41c1-b21e-9c948176bd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_af18c241-de62-48b6-a708-7733bcfec80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7dff478b-4c89-4055-9c96-b7d77f4afc27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af18c241-de62-48b6-a708-7733bcfec80d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7dff478b-4c89-4055-9c96-b7d77f4afc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_2d54eefe-3c99-4b5a-a3ad-c821d98e9e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af18c241-de62-48b6-a708-7733bcfec80d" xlink:to="loc_us-gaap_RestrictedCashCurrent_2d54eefe-3c99-4b5a-a3ad-c821d98e9e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_895038d4-5c8c-4754-8fd4-2d6b771eef8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af18c241-de62-48b6-a708-7733bcfec80d" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_895038d4-5c8c-4754-8fd4-2d6b771eef8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ca9ef46-a50e-475d-af42-ccb5f24a6c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_af18c241-de62-48b6-a708-7733bcfec80d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ca9ef46-a50e-475d-af42-ccb5f24a6c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6a86bf85-e57a-4ea4-baac-25e6f3e7523e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56909ae3-b890-4f61-8abd-d829e2c8f562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a86bf85-e57a-4ea4-baac-25e6f3e7523e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56909ae3-b890-4f61-8abd-d829e2c8f562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b362b526-762a-4a34-8740-3e6fef179d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56909ae3-b890-4f61-8abd-d829e2c8f562" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b362b526-762a-4a34-8740-3e6fef179d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bf4dfd1b-9b9f-4fcf-bad2-16f9b6e8a237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b362b526-762a-4a34-8740-3e6fef179d7f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bf4dfd1b-9b9f-4fcf-bad2-16f9b6e8a237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e0d96a18-8cc2-4530-8afd-5ae7d57c2bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bf4dfd1b-9b9f-4fcf-bad2-16f9b6e8a237" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e0d96a18-8cc2-4530-8afd-5ae7d57c2bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_56909ae3-b890-4f61-8abd-d829e2c8f562" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a0fc545c-d76c-4076-8ccc-64112cedc420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_a0fc545c-d76c-4076-8ccc-64112cedc420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAndManufacturerReceivables_75c43731-b71a-4eac-a9e8-1f69fccfc9f4" xlink:href="cvs-20230331.xsd#cvs_VendorAndManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_cvs_VendorAndManufacturerReceivables_75c43731-b71a-4eac-a9e8-1f69fccfc9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_1b5183a7-1593-4769-b100-df7e73fad7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_1b5183a7-1593-4769-b100-df7e73fad7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_4aad1e42-0f07-483a-8e13-bf8a0c6e2e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_4aad1e42-0f07-483a-8e13-bf8a0c6e2e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_67fd9cb4-a24a-48f4-b2e5-a7b231624c6d" xlink:href="cvs-20230331.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_67fd9cb4-a24a-48f4-b2e5-a7b231624c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2ee50f06-2704-4352-be18-b7afd6c6bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_d346e164-f50c-481e-b4cc-69fe5328bca3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_2ee50f06-2704-4352-be18-b7afd6c6bfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b4b29713-6143-4ef4-8517-73b3e7789fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_eb667dea-0e23-4401-8643-5c6bcae22c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b4b29713-6143-4ef4-8517-73b3e7789fbc" xlink:to="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_eb667dea-0e23-4401-8643-5c6bcae22c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_660fc0f1-9638-46f3-a8a8-31cc0e189a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_eb667dea-0e23-4401-8643-5c6bcae22c50" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_660fc0f1-9638-46f3-a8a8-31cc0e189a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions_26d96135-22b2-40a7-bfb3-febdb7e997f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_eb667dea-0e23-4401-8643-5c6bcae22c50" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions_26d96135-22b2-40a7-bfb3-febdb7e997f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_8e490558-10e2-41f2-84a7-a42aaa192477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_eb667dea-0e23-4401-8643-5c6bcae22c50" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_8e490558-10e2-41f2-84a7-a42aaa192477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_cf019812-d1de-44e9-a6d4-4c5655ed416d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_eb667dea-0e23-4401-8643-5c6bcae22c50" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_cf019812-d1de-44e9-a6d4-4c5655ed416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2352689e-766c-44bf-ad9e-d12e3b8afbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2352689e-766c-44bf-ad9e-d12e3b8afbe5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ebbc4888-4f28-4f76-b87d-0bb3340ee707" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_srt_ConsolidationItemsAxis_ebbc4888-4f28-4f76-b87d-0bb3340ee707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ebbc4888-4f28-4f76-b87d-0bb3340ee707" xlink:to="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7cf6e05-823f-494b-9af4-fb7d912cdcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7cf6e05-823f-494b-9af4-fb7d912cdcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_ccbf0f19-79c9-4ed8-992f-cdcda1b7a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:to="loc_us-gaap_CorporateNonSegmentMember_ccbf0f19-79c9-4ed8-992f-cdcda1b7a3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_8a39c7ba-ddf6-4a61-830b-865799ab787a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_be1eb0ea-37e9-4761-9ef7-b37bd1a23c27" xlink:to="loc_us-gaap_IntersegmentEliminationMember_8a39c7ba-ddf6-4a61-830b-865799ab787a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62d8b646-d0da-472e-a365-96ea4f09c25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62d8b646-d0da-472e-a365-96ea4f09c25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62d8b646-d0da-472e-a365-96ea4f09c25d" xlink:to="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e13f3092-c102-432e-9bd1-21fef2af8909" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e13f3092-c102-432e-9bd1-21fef2af8909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_1e2befaa-2745-4577-af85-4f695cce034c" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:to="loc_cvs_HealthServicesSegmentMember_1e2befaa-2745-4577-af85-4f695cce034c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_648aaf91-3b74-4993-84b8-a9c5176edeaf" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0892c3d9-e8ff-41ab-8348-980cd3603795" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_648aaf91-3b74-4993-84b8-a9c5176edeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_srt_ProductOrServiceAxis_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_03b1ce3f-ef71-4a27-8589-9577bd5cc5e7" xlink:to="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_95d26735-8694-46ed-97a9-d6305284f531" xlink:href="cvs-20230331.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_cvs_PharmacyRevenueMember_95d26735-8694-46ed-97a9-d6305284f531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_be935b95-eebd-4856-a0c9-f0c36ff19b7e" xlink:href="cvs-20230331.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_cvs_FrontStoreRevenueMember_be935b95-eebd-4856-a0c9-f0c36ff19b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_83b749c2-3df5-4cae-8c79-ffea5f37dd5d" xlink:href="cvs-20230331.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_cvs_PremiumsMember_83b749c2-3df5-4cae-8c79-ffea5f37dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_6a65245d-252d-4aeb-b72c-d08b7d0f01ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_91ee8e98-ebb5-47a1-912b-bd1e1efba533" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_6a65245d-252d-4aeb-b72c-d08b7d0f01ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ad52ac02-6bd1-483f-812a-494215edf19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ad52ac02-6bd1-483f-812a-494215edf19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_ad52ac02-6bd1-483f-812a-494215edf19f" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_4f390b78-d55b-4520-9e63-21ba56ee7824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_4f390b78-d55b-4520-9e63-21ba56ee7824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_acd9f6ba-e979-4975-9703-41706a9f6ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_acd9f6ba-e979-4975-9703-41706a9f6ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_1ccf507d-60ba-49df-8301-0a23a9e8faa9" xlink:href="cvs-20230331.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7d2879a9-304b-4bae-965f-2c12d4d8854f" xlink:to="loc_cvs_SalesChannelOtherMember_1ccf507d-60ba-49df-8301-0a23a9e8faa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b47665-ee75-43b4-8b5c-db733df7a59d" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f399d0e0-88b7-4443-bd07-fbb9dcff6616" xlink:href="cvs-20230331.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f399d0e0-88b7-4443-bd07-fbb9dcff6616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_897faf1e-bc9e-45fe-a290-84fd9a299016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:to="loc_us-gaap_NetInvestmentIncome_897faf1e-bc9e-45fe-a290-84fd9a299016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7c0beb3d-e8ca-4ee8-b859-826887434117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3425cf56-12ff-4f8c-9614-594e3eb4d343" xlink:to="loc_us-gaap_Revenues_7c0beb3d-e8ca-4ee8-b859-826887434117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b7611ffd-fc94-45f8-91f3-030cb8412661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_27cf08ad-09fd-499f-8d9f-93af8cfe4912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7611ffd-fc94-45f8-91f3-030cb8412661" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_27cf08ad-09fd-499f-8d9f-93af8cfe4912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4588d807-be84-43ea-bbdb-4df11e3f3129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7611ffd-fc94-45f8-91f3-030cb8412661" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4588d807-be84-43ea-bbdb-4df11e3f3129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_32fb278f-8b16-4a38-8e65-11191dfa4bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e98f0efe-0590-4356-aaf4-89598457df66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_32fb278f-8b16-4a38-8e65-11191dfa4bee" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e98f0efe-0590-4356-aaf4-89598457df66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_b8061b71-4a56-4d97-ad89-f8ab3bac66a3" xlink:href="cvs-20230331.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e98f0efe-0590-4356-aaf4-89598457df66" xlink:to="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_b8061b71-4a56-4d97-ad89-f8ab3bac66a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0cb334fe-8def-43c9-b8bf-df1d8d875066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_b8061b71-4a56-4d97-ad89-f8ab3bac66a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0cb334fe-8def-43c9-b8bf-df1d8d875066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_08eab155-e4ee-445a-ad72-070dc018f7c7" xlink:href="cvs-20230331.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_b8061b71-4a56-4d97-ad89-f8ab3bac66a3" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_08eab155-e4ee-445a-ad72-070dc018f7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_09668f98-76c1-4df2-b7e8-2e68b8bd18af" xlink:href="cvs-20230331.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_b8061b71-4a56-4d97-ad89-f8ab3bac66a3" xlink:to="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_09668f98-76c1-4df2-b7e8-2e68b8bd18af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_585f05ac-8f3a-428f-a2dc-04a42ee08658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_b8061b71-4a56-4d97-ad89-f8ab3bac66a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_585f05ac-8f3a-428f-a2dc-04a42ee08658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4c7e8d07-3e25-4ad2-ae03-4828eb3a5ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_b8061b71-4a56-4d97-ad89-f8ab3bac66a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4c7e8d07-3e25-4ad2-ae03-4828eb3a5ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7edbdb07-11ee-4b60-a67e-d0d3d2bde211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7edbdb07-11ee-4b60-a67e-d0d3d2bde211" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_476f384b-7d23-4bc5-babe-3f2a60b4b0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3037d7e-1cf3-45b0-8b16-8e4bdc5c1130" xlink:to="loc_us-gaap_TypeOfAdoptionMember_476f384b-7d23-4bc5-babe-3f2a60b4b0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201812Member_b8585c6b-bd4f-4764-bd7f-dc703865d350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201812Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_476f384b-7d23-4bc5-babe-3f2a60b4b0f6" xlink:to="loc_us-gaap_AccountingStandardsUpdate201812Member_b8585c6b-bd4f-4764-bd7f-dc703865d350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bbccb2ca-21ba-4e72-a9a8-9730db8227aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bbccb2ca-21ba-4e72-a9a8-9730db8227aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0741ddf2-b059-44a5-b57d-7b04bce9cf99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bbccb2ca-21ba-4e72-a9a8-9730db8227aa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0741ddf2-b059-44a5-b57d-7b04bce9cf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4d1c4785-22df-448b-a88c-6fdfe157f890" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0741ddf2-b059-44a5-b57d-7b04bce9cf99" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4d1c4785-22df-448b-a88c-6fdfe157f890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_72afcf65-c054-42a7-91f8-f71233262f45" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_45a71675-89f5-4093-a9f1-48f1799e3324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_45a71675-89f5-4093-a9f1-48f1799e3324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_ab520aba-6828-47e9-91f7-3aa8fb99dd73" xlink:href="cvs-20230331.xsd#cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_ab520aba-6828-47e9-91f7-3aa8fb99dd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_dcce8560-c23e-4810-ad64-ab3ee6d5f7c8" xlink:href="cvs-20230331.xsd#cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_dcce8560-c23e-4810-ad64-ab3ee6d5f7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_316845fb-c569-48a9-8027-647b0a2094b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e349f171-489c-44ce-b37f-12fc0d1810e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_316845fb-c569-48a9-8027-647b0a2094b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c266b28e-a7ee-4180-9341-61ab3cf58eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c266b28e-a7ee-4180-9341-61ab3cf58eb2" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8a68994b-8f1c-43cb-97cb-b437dee56a47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:to="loc_srt_ProductOrServiceAxis_8a68994b-8f1c-43cb-97cb-b437dee56a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8a68994b-8f1c-43cb-97cb-b437dee56a47" xlink:to="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_49c06a22-14ca-49a9-bbf0-c0742eac58ee" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:to="loc_cvs_LargeCasePensionsMember_49c06a22-14ca-49a9-bbf0-c0742eac58ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_a2fd8404-b49b-4ad9-ba32-bc1c92167983" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:to="loc_cvs_LongTermCareMember_a2fd8404-b49b-4ad9-ba32-bc1c92167983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_5ea6e63c-83c5-4ef6-8690-89b9ba374a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_189ad28b-bcd2-49d0-a77e-beb701840afd" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_5ea6e63c-83c5-4ef6-8690-89b9ba374a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_614e6bbd-ec56-473c-919e-9eb6beae73b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:to="loc_srt_RestatementAxis_614e6bbd-ec56-473c-919e-9eb6beae73b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_614e6bbd-ec56-473c-919e-9eb6beae73b9" xlink:to="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1a54249f-fa6e-4111-b67c-5b535df74fed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1a54249f-fa6e-4111-b67c-5b535df74fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_7ecfb1ac-d020-4828-82fb-2f0f1fe80e5d" xlink:href="cvs-20230331.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_7ecfb1ac-d020-4828-82fb-2f0f1fe80e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_ce4b06d5-c1dd-403e-bd9d-54d488e74641" xlink:href="cvs-20230331.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_aacbf28f-f5f3-4bea-b8d1-59355f37feb8" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_ce4b06d5-c1dd-403e-bd9d-54d488e74641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d95ae7c1-5a7a-451e-99df-088c4460e58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_44607f00-6658-4ef1-8ecf-f704fa6160c1" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d95ae7c1-5a7a-451e-99df-088c4460e58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d95ae7c1-5a7a-451e-99df-088c4460e58f" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_0b50beb7-bf4a-423b-9c60-eecf30eb7c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_0b50beb7-bf4a-423b-9c60-eecf30eb7c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_d176c329-c440-4853-b8a5-2d603fc924e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_d176c329-c440-4853-b8a5-2d603fc924e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_9e238499-e984-40a3-8698-143b0f048d48" xlink:href="cvs-20230331.xsd#cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_9e238499-e984-40a3-8698-143b0f048d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_11f23003-4377-465c-b145-c42eb6b3d460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_11f23003-4377-465c-b145-c42eb6b3d460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_6468a261-27f0-4581-a99b-def5d3040072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_6468a261-27f0-4581-a99b-def5d3040072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_b84a573f-d577-4e1f-b93d-0fd92d23e686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_b84a573f-d577-4e1f-b93d-0fd92d23e686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_887e9f5e-b9ec-467f-97ef-30131033f1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_fc9a6763-5967-4f10-b656-0817fb33a6fb" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_887e9f5e-b9ec-467f-97ef-30131033f1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c44c70c5-ccc5-49e4-9995-f3dffd655b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e04e1d82-af3c-4e58-8f9b-de1720f1ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c44c70c5-ccc5-49e4-9995-f3dffd655b64" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e04e1d82-af3c-4e58-8f9b-de1720f1ce37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e04e1d82-af3c-4e58-8f9b-de1720f1ce37" xlink:to="loc_srt_RestatementAxis_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_848acacc-1e8b-4fb5-b5ae-9ff26f6f17b2" xlink:to="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_4b2ca8c1-a0cc-401f-bc51-4effbc1f8f23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_4b2ca8c1-a0cc-401f-bc51-4effbc1f8f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_4de18dda-7c38-4562-82c7-9920cfa1db3c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_80fc90d3-9965-491a-9e38-62a58df945b3" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_4de18dda-7c38-4562-82c7-9920cfa1db3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e04e1d82-af3c-4e58-8f9b-de1720f1ce37" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:to="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_92a0ce11-58ac-43b8-98b7-7b9d19a5c73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_92a0ce11-58ac-43b8-98b7-7b9d19a5c73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_b6afe8f9-3231-4bc1-9f41-9c694643bfaa" xlink:href="cvs-20230331.xsd#cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_b6afe8f9-3231-4bc1-9f41-9c694643bfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1b25cb43-8ef0-461e-9eb7-24a4e24574b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_CostsAndExpenses_1b25cb43-8ef0-461e-9eb7-24a4e24574b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f9cc827b-ab0d-46f2-872c-e458bdf1dcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_OperatingIncomeLoss_f9cc827b-ab0d-46f2-872c-e458bdf1dcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9c6a6ddc-23ae-4b49-851c-734bbdfeb577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9c6a6ddc-23ae-4b49-851c-734bbdfeb577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4577be73-9afa-41ac-9084-94b40d58080a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4577be73-9afa-41ac-9084-94b40d58080a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c488e514-90f0-4336-ab90-6fa01832a37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_ProfitLoss_c488e514-90f0-4336-ab90-6fa01832a37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ac42b5c2-82e2-4c1c-85db-610e8f6563b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_NetIncomeLoss_ac42b5c2-82e2-4c1c-85db-610e8f6563b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_12c48343-8f8c-402f-9aae-e040004819a7" xlink:to="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8b399247-cc7c-4e6b-8da4-4a11c139372a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:to="loc_us-gaap_EarningsPerShareBasic_8b399247-cc7c-4e6b-8da4-4a11c139372a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7b909221-4680-4625-a8c4-6ade78828ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d7017cdb-7938-42c5-9516-30b23d0df55b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7b909221-4680-4625-a8c4-6ade78828ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4aacee7a-9684-436e-a909-bd12297bae85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_OtherAssetsCurrent_4aacee7a-9684-436e-a909-bd12297bae85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_24be6c96-497e-4553-a679-4b956165b89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_AssetsCurrent_24be6c96-497e-4553-a679-4b956165b89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c03f0b79-8d14-4001-bdbe-741c28654288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c03f0b79-8d14-4001-bdbe-741c28654288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_80b084c6-6ef5-4e10-b5da-f1e4110be23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_Assets_80b084c6-6ef5-4e10-b5da-f1e4110be23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_bf988fcf-5abd-4d18-aeac-cf2561d97bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_bf988fcf-5abd-4d18-aeac-cf2561d97bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_02372ed7-46ab-4da0-bedb-2723fdd96ed1" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_02372ed7-46ab-4da0-bedb-2723fdd96ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9cdb5931-248d-4f95-8190-30959b6a016b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_LiabilitiesCurrent_9cdb5931-248d-4f95-8190-30959b6a016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f1f689f9-1155-489f-84f7-6402607e6c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f1f689f9-1155-489f-84f7-6402607e6c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_bf9e0243-cf26-4cb5-aa3b-02c6e68543fd" xlink:href="cvs-20230331.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_bf9e0243-cf26-4cb5-aa3b-02c6e68543fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ad9e4bca-1832-477d-b08e-1c1496804a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ad9e4bca-1832-477d-b08e-1c1496804a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dac083d2-c3fb-4413-a4b6-748f1122a24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_Liabilities_dac083d2-c3fb-4413-a4b6-748f1122a24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bb286007-800d-4995-b04f-7fb4d12e22b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bb286007-800d-4995-b04f-7fb4d12e22b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e3107ee-f757-4a6c-bef2-dd5e57833bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e3107ee-f757-4a6c-bef2-dd5e57833bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7529b1ae-e67e-455b-a2df-dc97f2cf5f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_StockholdersEquity_7529b1ae-e67e-455b-a2df-dc97f2cf5f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_967342fb-4518-41cf-b5df-ace51a880b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_967342fb-4518-41cf-b5df-ace51a880b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c808ad7-25c1-4429-bd87-201a346842e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8a650fa3-63fc-4480-abe4-5aeac076c518" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c808ad7-25c1-4429-bd87-201a346842e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_27de5a3d-e416-457a-b697-5003b08a2463" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_26b16841-9e33-4861-8558-d822c4003a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_26b16841-9e33-4861-8558-d822c4003a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_20d24993-ecf4-47cb-ba61-0203f3e2b6e8" xlink:href="cvs-20230331.xsd#cvs_DeferredIncomeTaxesAndOtherNoncashItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_cvs_DeferredIncomeTaxesAndOtherNoncashItems_20d24993-ecf4-47cb-ba61-0203f3e2b6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c6bb11b9-b47f-4d8e-922b-12b33d9c2c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c6bb11b9-b47f-4d8e-922b-12b33d9c2c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ff85b72d-8fb8-49b4-801f-ffc48f5c8ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ff85b72d-8fb8-49b4-801f-ffc48f5c8ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fddb7ace-1d9b-4df3-a038-746b785738e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f2911eef-58c9-4778-aa34-8e7d8952ceca" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fddb7ace-1d9b-4df3-a038-746b785738e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_44b08c71-3bfc-4354-9fb5-f40d1481628e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_44b08c71-3bfc-4354-9fb5-f40d1481628e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4f8d3d6f-d048-4db5-8c43-cfe45a680e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4f8d3d6f-d048-4db5-8c43-cfe45a680e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9f02b8e6-dfad-41c3-859f-15eaef91a745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4f8d3d6f-d048-4db5-8c43-cfe45a680e71" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9f02b8e6-dfad-41c3-859f-15eaef91a745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7649b6e5-078f-44bd-9f5a-828db50c06dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9f02b8e6-dfad-41c3-859f-15eaef91a745" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_7649b6e5-078f-44bd-9f5a-828db50c06dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aea7e389-21a1-4f50-8541-7204e20bd98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aea7e389-21a1-4f50-8541-7204e20bd98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0100a1bd-294d-46e9-9ae9-e17c4b484fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aea7e389-21a1-4f50-8541-7204e20bd98a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0100a1bd-294d-46e9-9ae9-e17c4b484fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember_58939811-d8bc-43cf-b58b-537f9074884e" xlink:href="cvs-20230331.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0100a1bd-294d-46e9-9ae9-e17c4b484fdd" xlink:to="loc_cvs_OmnicareLongTermCareBusinessMember_58939811-d8bc-43cf-b58b-537f9074884e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_35eda846-7fe7-488d-9442-a1fd49f9a314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_35eda846-7fe7-488d-9442-a1fd49f9a314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35eda846-7fe7-488d-9442-a1fd49f9a314" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_c99435a3-2237-48d0-a88c-3137bd3f4a02" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:to="loc_cvs_SignifyHealthIncMember_c99435a3-2237-48d0-a88c-3137bd3f4a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember_f69b3af3-0e2e-44d6-ba13-7f09af66b6c1" xlink:href="cvs-20230331.xsd#cvs_OakStreetHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4abb5596-0ac8-40dc-ae75-9cf71fe8ae17" xlink:to="loc_cvs_OakStreetHealthIncMember_f69b3af3-0e2e-44d6-ba13-7f09af66b6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aa0d5e47-8740-438a-a59b-82822f3f7bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdfd60b5-fcab-4a4a-a366-6cbbddbdd3fa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aa0d5e47-8740-438a-a59b-82822f3f7bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7af8dcf7-9e39-458e-b7df-95adb12f732e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aa0d5e47-8740-438a-a59b-82822f3f7bd2" xlink:to="loc_us-gaap_SubsequentEventMember_7af8dcf7-9e39-458e-b7df-95adb12f732e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_33074e0c-723e-4c80-b624-50df45e2e60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_62a2e18b-891b-4e86-b26b-38b1d6eb9ec4" xlink:to="loc_us-gaap_SegmentDomain_33074e0c-723e-4c80-b624-50df45e2e60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a9f3977c-df5b-4822-9a79-f67bd0637e6f" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33074e0c-723e-4c80-b624-50df45e2e60b" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a9f3977c-df5b-4822-9a79-f67bd0637e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_be10574e-5f31-4d9e-b41a-11c3c466e74f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_93dfe219-4d8d-4958-bc56-4707634e89cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_93dfe219-4d8d-4958-bc56-4707634e89cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_76be3a42-8bb9-4206-bdf5-da4c0e469f70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_76be3a42-8bb9-4206-bdf5-da4c0e469f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_14dc974f-7bb5-4106-9a8a-438e278d73e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_14dc974f-7bb5-4106-9a8a-438e278d73e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc73c2fc-ae55-4503-8e59-eb78c63833d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dc73c2fc-ae55-4503-8e59-eb78c63833d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f0bd28ec-9041-45cc-97bb-bfeedcedd1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f0bd28ec-9041-45cc-97bb-bfeedcedd1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f50909e6-2471-492e-b31d-d9f7fba69960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f50909e6-2471-492e-b31d-d9f7fba69960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_029ae5a5-a1e1-4b16-abcc-0449e48b8aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_029ae5a5-a1e1-4b16-abcc-0449e48b8aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_da44815e-ce60-4755-b773-9c0ee63b0d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4097170e-b100-4882-b5c4-2cf244fb8c2c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_da44815e-ce60-4755-b773-9c0ee63b0d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18b381f6-ac6e-4d0b-98a5-02df2cbad56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18b381f6-ac6e-4d0b-98a5-02df2cbad56d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9d0a1e9d-a742-415c-8db3-febd9d55075d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9d0a1e9d-a742-415c-8db3-febd9d55075d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_837d1193-e202-41cf-87ed-4fb8a79a2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9d0a1e9d-a742-415c-8db3-febd9d55075d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_837d1193-e202-41cf-87ed-4fb8a79a2fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_8a1ca499-c044-4fe6-bcb4-99835c786902" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_837d1193-e202-41cf-87ed-4fb8a79a2fc7" xlink:to="loc_cvs_SignifyHealthIncMember_8a1ca499-c044-4fe6-bcb4-99835c786902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_d8391049-7ebd-4901-9e4b-46d60000a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_d8391049-7ebd-4901-9e4b-46d60000a6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_d8391049-7ebd-4901-9e4b-46d60000a6eb" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PreCombinationServicesMember_779170b8-2097-4c62-9c60-9107f91f738a" xlink:href="cvs-20230331.xsd#cvs_PreCombinationServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:to="loc_cvs_PreCombinationServicesMember_779170b8-2097-4c62-9c60-9107f91f738a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PostCombinationServicesMember_65ef1a73-455b-4196-91b2-f42a1d70026c" xlink:href="cvs-20230331.xsd#cvs_PostCombinationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a1e314d8-0352-4588-9f30-8e1682216c48" xlink:to="loc_cvs_PostCombinationServicesMember_65ef1a73-455b-4196-91b2-f42a1d70026c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59581388-d682-4dac-b5e7-5603be7262ba" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d255dce-07cc-4eff-85b3-3d2f434c3772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d255dce-07cc-4eff-85b3-3d2f434c3772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_efa9e1a8-a4cc-4834-a2ae-dfbb02bc32f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_efa9e1a8-a4cc-4834-a2ae-dfbb02bc32f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_fb2d60c2-b59c-4c0e-a38f-71e0c8acfde9" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship_fb2d60c2-b59c-4c0e-a38f-71e0c8acfde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3cbf24e4-6aac-470e-b454-47d92f1b2691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3cbf24e4-6aac-470e-b454-47d92f1b2691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f587ac86-1208-4b9c-a6c1-60512482dcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb66f213-04bc-4b9a-9ce3-32aff50000a1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f587ac86-1208-4b9c-a6c1-60512482dcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_aed61f0e-6ffd-45b9-8172-39edc22e51e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fdbc2d9-8844-4d6e-915a-400f609d0507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_aed61f0e-6ffd-45b9-8172-39edc22e51e8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fdbc2d9-8844-4d6e-915a-400f609d0507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fdbc2d9-8844-4d6e-915a-400f609d0507" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7be46500-e7df-43dd-816f-b66b5fcbde85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6cc5d3f-5691-4cc6-98a5-85f3fdb8569b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7be46500-e7df-43dd-816f-b66b5fcbde85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_2ea88c7b-6bd3-4798-85db-431b995b6083" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7be46500-e7df-43dd-816f-b66b5fcbde85" xlink:to="loc_cvs_SignifyHealthIncMember_2ea88c7b-6bd3-4798-85db-431b995b6083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fdbc2d9-8844-4d6e-915a-400f609d0507" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c3adedf6-205f-4dad-b12b-0205eb17b826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c3adedf6-205f-4dad-b12b-0205eb17b826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b5fc913e-878a-4f22-989d-fbd669d72dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b5fc913e-878a-4f22-989d-fbd669d72dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_aca8dcda-a8db-411c-acd6-b2c61d5066bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_aca8dcda-a8db-411c-acd6-b2c61d5066bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72829963-88a2-4627-af4e-c898ee9e65e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72829963-88a2-4627-af4e-c898ee9e65e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e25f3f44-1d90-4869-ad4d-61fed5e6df44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_Goodwill_e25f3f44-1d90-4869-ad4d-61fed5e6df44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f156be72-007f-4e41-8891-7131015e8e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f156be72-007f-4e41-8891-7131015e8e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ca330d7e-bd34-4ea8-b0c9-29424d3aa837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ca330d7e-bd34-4ea8-b0c9-29424d3aa837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cbd29037-b37f-4eb3-b057-78b2a1febc32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cbd29037-b37f-4eb3-b057-78b2a1febc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a6883d6e-4fa7-40d4-8564-557855816a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a6883d6e-4fa7-40d4-8564-557855816a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_199248ee-1442-479f-aff1-3df9e3149e33" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_199248ee-1442-479f-aff1-3df9e3149e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee597960-1ce1-412a-b706-91c780f02671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ee597960-1ce1-412a-b706-91c780f02671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ab672b42-19f3-4e75-8a75-b5e96f230e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_ab672b42-19f3-4e75-8a75-b5e96f230e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a3056d14-f343-419e-af3a-5c01cc6f65b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a3056d14-f343-419e-af3a-5c01cc6f65b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_49b321f2-e328-4278-941d-39120a7de226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_49b321f2-e328-4278-941d-39120a7de226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_fab58f0f-797d-4911-868e-729be43b3da8" xlink:href="cvs-20230331.xsd#cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_db7482ad-3d92-41cb-bb36-2944e67ed26e" xlink:to="loc_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_fab58f0f-797d-4911-868e-729be43b3da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b0cb870f-1d90-4ce6-8822-378d4fb1a655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b0cb870f-1d90-4ce6-8822-378d4fb1a655" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_915a0689-3bf6-4be9-be85-60d627381f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_915a0689-3bf6-4be9-be85-60d627381f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d861342-8e4d-496f-9029-239015b8b39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_915a0689-3bf6-4be9-be85-60d627381f9c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d861342-8e4d-496f-9029-239015b8b39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_171183ab-6139-4a6b-88fb-be0bdabc1af1" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9d861342-8e4d-496f-9029-239015b8b39d" xlink:to="loc_cvs_SignifyHealthIncMember_171183ab-6139-4a6b-88fb-be0bdabc1af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b7db9458-83eb-4ff9-b671-6e60a4c74d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b7db9458-83eb-4ff9-b671-6e60a4c74d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b7db9458-83eb-4ff9-b671-6e60a4c74d6a" xlink:to="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_b087b1bb-5bc1-4c94-9075-e9ab200378df" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:to="loc_cvs_HealthServicesSegmentMember_b087b1bb-5bc1-4c94-9075-e9ab200378df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_89f7a30c-bc28-4ee0-9394-80208ed38e77" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_89f7a30c-bc28-4ee0-9394-80208ed38e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_32af0e6a-579a-4eae-9121-49d861aa989f" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_23eef663-728c-44e7-84c3-9f36150ab083" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_32af0e6a-579a-4eae-9121-49d861aa989f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4ad05ca8-13a5-4348-9a87-9f482410dd23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_576a6f5e-3b4f-4f42-805a-b04418221f6e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4ad05ca8-13a5-4348-9a87-9f482410dd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95034fa4-ad8c-4b60-a20b-82363a799c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4ad05ca8-13a5-4348-9a87-9f482410dd23" xlink:to="loc_us-gaap_Goodwill_95034fa4-ad8c-4b60-a20b-82363a799c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_90bf7d28-62ad-466e-a435-ddd7f8fb9b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_90bf7d28-62ad-466e-a435-ddd7f8fb9b18" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_708c77a6-5fc2-42fb-88fe-14fd085bf1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_708c77a6-5fc2-42fb-88fe-14fd085bf1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_708c77a6-5fc2-42fb-88fe-14fd085bf1d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d1c44286-1747-443d-ad2d-fdd6794393c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d1c44286-1747-443d-ad2d-fdd6794393c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4b2cce80-4ac0-4040-9d42-10635fa73712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4b2cce80-4ac0-4040-9d42-10635fa73712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_0d5a074f-0eb1-49d5-9e83-756077a1efb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9ab10fc-e210-4ccf-8316-5582fbb664a6" xlink:to="loc_us-gaap_TrademarksMember_0d5a074f-0eb1-49d5-9e83-756077a1efb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b073b8ab-7045-4829-885a-c6664d27e7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e9880acb-f2ae-4254-80bb-10f3ed9b1ce5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b073b8ab-7045-4829-885a-c6664d27e7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_8e72eb86-10a4-4ce1-a3ef-fedaf3c27557" xlink:href="cvs-20230331.xsd#cvs_SignifyHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b073b8ab-7045-4829-885a-c6664d27e7ba" xlink:to="loc_cvs_SignifyHealthIncMember_8e72eb86-10a4-4ce1-a3ef-fedaf3c27557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_12b1e341-edad-4544-8d68-94b9b6aa2aa8" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7563b5da-070f-4f8e-b9cc-8b2f7b1b3100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7563b5da-070f-4f8e-b9cc-8b2f7b1b3100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_7681a240-1c6e-4655-9483-c0836b00b5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1b236d2c-6f67-4901-b2ab-5bb30352610a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_7681a240-1c6e-4655-9483-c0836b00b5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a65df93b-889b-4d3b-9c06-11dcb55c5515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c1dce9b6-24ef-42cf-b051-45baa23039d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a65df93b-889b-4d3b-9c06-11dcb55c5515" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c1dce9b6-24ef-42cf-b051-45baa23039d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7c748877-5d27-4ddd-b88f-9cbf0245947b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c1dce9b6-24ef-42cf-b051-45baa23039d3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7c748877-5d27-4ddd-b88f-9cbf0245947b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c5bfdc1f-9838-4079-97f9-95726ae59910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7c748877-5d27-4ddd-b88f-9cbf0245947b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c5bfdc1f-9838-4079-97f9-95726ae59910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6ad2d60d-3baa-4341-8070-228ab4556910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c5bfdc1f-9838-4079-97f9-95726ae59910" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6ad2d60d-3baa-4341-8070-228ab4556910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c1dce9b6-24ef-42cf-b051-45baa23039d3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_497a441d-632c-4e6d-b01c-07e276f79d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_497a441d-632c-4e6d-b01c-07e276f79d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6d7b3ab4-0a07-44e0-a3bf-e3e8c7beddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6d7b3ab4-0a07-44e0-a3bf-e3e8c7beddb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9b39ea0d-c3f6-4e33-9371-6aae37bdecba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9b39ea0d-c3f6-4e33-9371-6aae37bdecba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3f0a72b2-6af0-4ff1-9d22-76b8984a841f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_3f0a72b2-6af0-4ff1-9d22-76b8984a841f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb2b1571-26c7-42a8-b9d8-f325da24b22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_eb2b1571-26c7-42a8-b9d8-f325da24b22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_df2981d8-2602-493b-a567-349f5af9c310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_fd800330-af75-4a87-86e4-44970e3ed207" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_df2981d8-2602-493b-a567-349f5af9c310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_66080345-fc41-41c7-bf7f-d43d4fb5762d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_d9028f8b-de1a-4181-8f84-be2c6372f9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_d9028f8b-de1a-4181-8f84-be2c6372f9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_309d13a0-1c03-4b47-842e-3953213a3b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_309d13a0-1c03-4b47-842e-3953213a3b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_33e0c779-a86b-49fb-9c1f-fcecf4f99a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_33e0c779-a86b-49fb-9c1f-fcecf4f99a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_79533dda-f273-4061-8cd6-89a964f50e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_4fe7b11b-f938-41a8-9cdd-f8d7b638b4d2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_79533dda-f273-4061-8cd6-89a964f50e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_79594cd4-710c-4428-bee3-c6e0c7292c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_79594cd4-710c-4428-bee3-c6e0c7292c0f" xlink:to="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:to="loc_cvs_TotalInvestmentsAxis_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_add53cd6-7866-4dd0-a3a8-638ba4f5c3f8" xlink:to="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_56c98592-3071-4a89-91af-144d3a1cc323" xlink:href="cvs-20230331.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_56c98592-3071-4a89-91af-144d3a1cc323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_5b719f84-f9aa-43a2-a7fa-6ebd7a660fb6" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:to="loc_cvs_MortgageLoansMember_5b719f84-f9aa-43a2-a7fa-6ebd7a660fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_312c657b-5349-4c72-afe6-488bd95254ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_0af7f9d2-4f13-4854-9cfb-e16f3ea641c9" xlink:to="loc_us-gaap_OtherInvestmentsMember_312c657b-5349-4c72-afe6-488bd95254ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9029cc8e-4995-48c8-b043-eeae9686b791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d1f9a1f2-fd96-4c5d-86de-b809044ecb9d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9029cc8e-4995-48c8-b043-eeae9686b791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a19cc6e2-5a09-4e12-ab2a-b9e988f7b91e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9029cc8e-4995-48c8-b043-eeae9686b791" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a19cc6e2-5a09-4e12-ab2a-b9e988f7b91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:href="cvs-20230331.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_5c297818-ba12-4bdc-9b16-034b7a378c14" xlink:to="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_245ecde6-a107-4839-9cde-617aa8943f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:to="loc_us-gaap_ShortTermInvestments_245ecde6-a107-4839-9cde-617aa8943f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_741162b7-7200-4c78-9836-f2a3a15100a3" xlink:href="cvs-20230331.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:to="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_741162b7-7200-4c78-9836-f2a3a15100a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_62617704-6d0f-4ed0-b075-5a373f7331d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_80453187-ff0d-4db1-914d-852c923abd0f" xlink:to="loc_us-gaap_Investments_62617704-6d0f-4ed0-b075-5a373f7331d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_87c0e95e-a30e-4bdc-9e61-a0de08c58e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_87c0e95e-a30e-4bdc-9e61-a0de08c58e55" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e4102930-4650-4039-9d95-7d3cce7f358f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e4102930-4650-4039-9d95-7d3cce7f358f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_29ce47d5-ca13-4142-9293-a2d3b71c7d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e4102930-4650-4039-9d95-7d3cce7f358f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_29ce47d5-ca13-4142-9293-a2d3b71c7d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_29ce47d5-ca13-4142-9293-a2d3b71c7d6b" xlink:to="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_17d80723-bc7a-42ba-af8b-05b8dada66cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_17d80723-bc7a-42ba-af8b-05b8dada66cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f90bdd01-5b8b-4f7e-8bd1-e3352d53a7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f90bdd01-5b8b-4f7e-8bd1-e3352d53a7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_9a145edd-d0ca-4d11-b05d-6bd641fe17cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_9a145edd-d0ca-4d11-b05d-6bd641fe17cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3f75a9e8-0972-49bc-a533-9cca6f11056a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3f75a9e8-0972-49bc-a533-9cca6f11056a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d1afe64a-bda9-46ed-be49-432602297286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d1afe64a-bda9-46ed-be49-432602297286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_486fe40b-0505-44aa-8bf5-9bd9cfa92197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_486fe40b-0505-44aa-8bf5-9bd9cfa92197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_07d8e8d3-449a-422b-bdbb-181d03b878b7" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_07d8e8d3-449a-422b-bdbb-181d03b878b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_459f6fa7-7b39-4125-83da-83310c781cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_e8b1a13e-4e33-4c6a-8280-a70093052684" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_459f6fa7-7b39-4125-83da-83310c781cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_be9c5830-d8af-4768-bef4-a1168d771f43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:to="loc_srt_ProductOrServiceAxis_be9c5830-d8af-4768-bef4-a1168d771f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bdfac330-5006-4d46-926a-0dd1b964692b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_be9c5830-d8af-4768-bef4-a1168d771f43" xlink:to="loc_srt_ProductsAndServicesDomain_bdfac330-5006-4d46-926a-0dd1b964692b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_58e19ee0-da06-495c-b65f-d71315b8e916" xlink:href="cvs-20230331.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bdfac330-5006-4d46-926a-0dd1b964692b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_58e19ee0-da06-495c-b65f-d71315b8e916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0c04e065-1d7e-4a08-932b-d3fbd05a0511" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1c9d250-0120-4403-9c76-acb9c28f1a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f1c9d250-0120-4403-9c76-acb9c28f1a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2a338a75-c8f2-4d2c-82e1-c8b336982aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_2a338a75-c8f2-4d2c-82e1-c8b336982aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_c7cb4170-23c3-45e1-b3aa-9031ba89a04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_c7cb4170-23c3-45e1-b3aa-9031ba89a04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e81d0983-4b80-4a47-94d7-166888b50151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e81d0983-4b80-4a47-94d7-166888b50151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f1f40169-ef05-4ace-92a5-de0da05277fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f1f40169-ef05-4ace-92a5-de0da05277fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3d9c1996-4d29-4381-b97c-fe7fadfae0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f52cc4dc-b106-46c9-8202-6b0683418ccd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3d9c1996-4d29-4381-b97c-fe7fadfae0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_f81960fd-a0e5-4838-a1b3-3140be5669bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf813598-024d-4a61-b61f-9871aa4f344f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f81960fd-a0e5-4838-a1b3-3140be5669bf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf813598-024d-4a61-b61f-9871aa4f344f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_663ce673-a035-40c7-ae3d-87a793cfcf98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf813598-024d-4a61-b61f-9871aa4f344f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_663ce673-a035-40c7-ae3d-87a793cfcf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_663ce673-a035-40c7-ae3d-87a793cfcf98" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_71c00c6b-9487-4d54-97a6-94878fd56e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_71c00c6b-9487-4d54-97a6-94878fd56e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c40b24f2-afb2-4c38-9e69-c0763f98b94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c40b24f2-afb2-4c38-9e69-c0763f98b94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c7177569-5d3f-4bf1-bc2c-bb4999ac3a03" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46069771-8316-4061-80f3-c98b3de78235" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c7177569-5d3f-4bf1-bc2c-bb4999ac3a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf813598-024d-4a61-b61f-9871aa4f344f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_caab7d9b-e164-4ee6-93d9-42206be43e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_caab7d9b-e164-4ee6-93d9-42206be43e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_d98161fa-a51b-4acc-a035-fa3d4cc9c0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_d98161fa-a51b-4acc-a035-fa3d4cc9c0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_7fd528d5-c2a3-447f-8c12-7787d8142ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_7fd528d5-c2a3-447f-8c12-7787d8142ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ac17c286-486d-4166-b797-e04767fe5b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_ac17c286-486d-4166-b797-e04767fe5b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_aa4ed1e3-2799-4402-8252-79bd1e9a4913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_aa4ed1e3-2799-4402-8252-79bd1e9a4913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_41cad5aa-c481-4520-8045-ac60cbc7124f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_2a652a85-614c-4e8c-8ff9-29c78627cb13" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_41cad5aa-c481-4520-8045-ac60cbc7124f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fc7c659c-e2d3-4006-92c6-330ccc680754" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d19b6cf8-f825-4dcb-a2be-c96edd3452d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d19b6cf8-f825-4dcb-a2be-c96edd3452d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_06b7b9fc-dd71-454b-a876-ab2b33e3bd55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_06b7b9fc-dd71-454b-a876-ab2b33e3bd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_580e9df1-bcdc-4422-bba4-8b36def6e225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_580e9df1-bcdc-4422-bba4-8b36def6e225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_85f0904a-a67c-47ff-9aa9-dff88bce6028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_85f0904a-a67c-47ff-9aa9-dff88bce6028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_8a5748eb-c268-4006-afab-9db527e87fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_8a5748eb-c268-4006-afab-9db527e87fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_926f63ce-abaf-4a52-b3fd-63160dac3433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_17b4de5a-45d0-487a-aada-b264ab6cbfef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_926f63ce-abaf-4a52-b3fd-63160dac3433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_80fea188-db5d-4cb0-aed2-1a7801e1be5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cee37634-0127-40cc-a65d-ed6b0a4efb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_80fea188-db5d-4cb0-aed2-1a7801e1be5d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cee37634-0127-40cc-a65d-ed6b0a4efb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_51fc6253-482e-4ca9-acee-1ddea14b0c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cee37634-0127-40cc-a65d-ed6b0a4efb1b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_51fc6253-482e-4ca9-acee-1ddea14b0c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_51fc6253-482e-4ca9-acee-1ddea14b0c43" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a0af12cf-0173-4d71-b19a-f3212addfac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a0af12cf-0173-4d71-b19a-f3212addfac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5c2a502d-fda5-4cfe-a59b-8b477926f91c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5c2a502d-fda5-4cfe-a59b-8b477926f91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ba69b504-21d2-4d4a-9c40-63f8969796f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ba69b504-21d2-4d4a-9c40-63f8969796f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5f289914-1711-40d2-b551-5ddcd3a66d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_5f289914-1711-40d2-b551-5ddcd3a66d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d295eb3e-25d7-40a8-b311-9561633038f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d295eb3e-25d7-40a8-b311-9561633038f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2f12b63c-7e80-4b37-b0cb-1aeb55472ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_2f12b63c-7e80-4b37-b0cb-1aeb55472ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d1d65011-e04a-40ed-af70-829aec6bdc5b" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d1d65011-e04a-40ed-af70-829aec6bdc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_4893ed69-fd67-4a09-93e0-79dbc35c5c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8d0af0c-eb79-4f7f-8f09-e48fde4a56a8" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_4893ed69-fd67-4a09-93e0-79dbc35c5c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cee37634-0127-40cc-a65d-ed6b0a4efb1b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_9a080adb-7131-4f6a-87a2-64a153effc38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_9a080adb-7131-4f6a-87a2-64a153effc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_37cc2e52-7596-4eb8-87a0-42d603da8f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_37cc2e52-7596-4eb8-87a0-42d603da8f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_2ee2f28e-fac2-43b5-9118-1f29df1edc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_a8627471-1355-4ebb-af06-a2d660fd4e7e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_2ee2f28e-fac2-43b5-9118-1f29df1edc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ac7247e8-11ac-49d7-bd71-10ac8dddf820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ac7247e8-11ac-49d7-bd71-10ac8dddf820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_e9742ea2-91ee-4d13-a7a7-df1e912229f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_e9742ea2-91ee-4d13-a7a7-df1e912229f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a88af0e-a0a3-4331-8995-590379f3f61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c21d9d92-bc73-4f39-b96d-f10bc4ae4d98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a88af0e-a0a3-4331-8995-590379f3f61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9d7f826f-b9df-4edb-b058-2d65254e1059" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b5b76251-b9b8-43ed-a9e1-f45a9b590018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b5b76251-b9b8-43ed-a9e1-f45a9b590018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abce7ec8-0867-466d-8157-f0f51732f07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abce7ec8-0867-466d-8157-f0f51732f07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_369ed6c4-03f2-407f-bf86-8e409deb5c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_07fa1f40-0a83-420d-ade2-a90a03283d23" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_369ed6c4-03f2-407f-bf86-8e409deb5c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_99a61710-4b0d-43a0-bfca-76c49acf0c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_99a61710-4b0d-43a0-bfca-76c49acf0c31" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_35228351-1fc4-4ebe-94cd-e2219f071404" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:to="loc_srt_ProductOrServiceAxis_35228351-1fc4-4ebe-94cd-e2219f071404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_35228351-1fc4-4ebe-94cd-e2219f071404" xlink:to="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_4f732cb4-a11c-403e-80e5-90f32738a35e" xlink:href="cvs-20230331.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_4f732cb4-a11c-403e-80e5-90f32738a35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_904d9c6a-1987-4807-9e1e-969b6c1a7bc9" xlink:href="cvs-20230331.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6e432f4d-9e9f-4478-8aae-b3eb2a7111fd" xlink:to="loc_cvs_SupportingRemainingProductsMember_904d9c6a-1987-4807-9e1e-969b6c1a7bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_46a3497d-f72a-4944-88e7-71310e08c164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_46a3497d-f72a-4944-88e7-71310e08c164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_46a3497d-f72a-4944-88e7-71310e08c164" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_578e08b6-e12b-4fc6-b2c8-7cfc02804b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_578e08b6-e12b-4fc6-b2c8-7cfc02804b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0f3be44c-d73f-41fe-a7fb-908161928604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0f3be44c-d73f-41fe-a7fb-908161928604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_3178878f-4e7f-4dd0-844b-16c39b00962c" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776021e1-97e0-429c-8906-3371e3a186a5" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_3178878f-4e7f-4dd0-844b-16c39b00962c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_97eebdef-cdf3-4253-8bf9-692f2ff023a0" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_fa3776ca-60d1-46e0-9226-1cc1b05378b4" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_fa3776ca-60d1-46e0-9226-1cc1b05378b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1a7d0d44-74dd-4a43-bf4e-d9ec1a9b2284" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_1a7d0d44-74dd-4a43-bf4e-d9ec1a9b2284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_34755ab1-2813-4692-9d4b-0b5e6c9a5fab" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_34755ab1-2813-4692-9d4b-0b5e6c9a5fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3649c3dc-0272-407f-9825-f9163ac044f6" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_3649c3dc-0272-407f-9825-f9163ac044f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_549f3125-1dbb-41ba-b850-b33b70d0fa21" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_549f3125-1dbb-41ba-b850-b33b70d0fa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5fc6db79-b798-4847-a6b8-edb645c3002e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_0e49e703-05d0-41be-a43f-6e8b9bdc7808" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5fc6db79-b798-4847-a6b8-edb645c3002e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_18b61512-4941-49bc-9527-416c5c89124d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_bb6a444c-a25d-4f55-8c50-f9a9743da9d8" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_bb6a444c-a25d-4f55-8c50-f9a9743da9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f15e3064-3825-4492-af8b-00c66486572f" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f15e3064-3825-4492-af8b-00c66486572f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_6650686d-f4a5-407e-a4cb-25f6116d6390" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_6650686d-f4a5-407e-a4cb-25f6116d6390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_7cd720d7-b84e-4030-854c-3ca45bb37840" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_7cd720d7-b84e-4030-854c-3ca45bb37840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_37ffb0c3-eee9-4d5d-9f82-5b116fe8421d" xlink:href="cvs-20230331.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_37ffb0c3-eee9-4d5d-9f82-5b116fe8421d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_6f448061-8ec5-41ed-af59-46fb5aa8ba2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a48e4eab-6b2c-4dbd-8efa-23cdc450b1fd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_6f448061-8ec5-41ed-af59-46fb5aa8ba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_2a2f1bbc-cb01-4b01-994f-836c313f5df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_74d67025-19f1-4260-916d-19c8ca6361a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2a2f1bbc-cb01-4b01-994f-836c313f5df9" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_74d67025-19f1-4260-916d-19c8ca6361a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c2f8994e-08b9-4aa2-ade8-9870277e3232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_74d67025-19f1-4260-916d-19c8ca6361a9" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c2f8994e-08b9-4aa2-ade8-9870277e3232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d43c0431-05d1-47a1-8a44-642254d885ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c2f8994e-08b9-4aa2-ade8-9870277e3232" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d43c0431-05d1-47a1-8a44-642254d885ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_0b30a203-975f-4efb-be38-2a39ceff6f72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d43c0431-05d1-47a1-8a44-642254d885ca" xlink:to="loc_us-gaap_CommercialRealEstateMember_0b30a203-975f-4efb-be38-2a39ceff6f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_74d67025-19f1-4260-916d-19c8ca6361a9" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a9421598-6d67-466f-a9d2-fb6096ec9c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a9421598-6d67-466f-a9d2-fb6096ec9c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_9163f970-1815-4fa4-bae2-5518df79c5ee" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_9163f970-1815-4fa4-bae2-5518df79c5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_8b77b2d8-32b3-4ae2-b80a-057bd3dfde58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_27930aee-edb6-49bc-bc73-1b24529388ee" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_8b77b2d8-32b3-4ae2-b80a-057bd3dfde58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_6e8bafda-4173-4b75-aba3-c39adce9272b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_6e8bafda-4173-4b75-aba3-c39adce9272b" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0c740a91-7172-4f09-bc5a-8e58984c3529" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0c740a91-7172-4f09-bc5a-8e58984c3529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f1f08ae-155b-4200-ac9f-a2707d5f2530" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0c740a91-7172-4f09-bc5a-8e58984c3529" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f1f08ae-155b-4200-ac9f-a2707d5f2530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_04d1fe65-c82b-4e36-a55e-1472ba6a7769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_3f1f08ae-155b-4200-ac9f-a2707d5f2530" xlink:to="loc_us-gaap_CommercialRealEstateMember_04d1fe65-c82b-4e36-a55e-1472ba6a7769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_1cfbefbd-b249-455a-b731-b26241f417e1" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_1cfbefbd-b249-455a-b731-b26241f417e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_1cfbefbd-b249-455a-b731-b26241f417e1" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_aacf8af9-1f0c-43ed-9a71-2b90238a2cbd" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_aacf8af9-1f0c-43ed-9a71-2b90238a2cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_da05eaf1-f3a4-4612-904e-ca1b8b01c95a" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_da05eaf1-f3a4-4612-904e-ca1b8b01c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_df273ae3-8fc5-474a-baf8-b6e35ac9026b" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_df273ae3-8fc5-474a-baf8-b6e35ac9026b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_dc7aea08-1868-4f55-bd15-ea175c3421d2" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_dc7aea08-1868-4f55-bd15-ea175c3421d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_6b6aa7f2-5bde-44e0-adcf-8288d0060c58" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_6b6aa7f2-5bde-44e0-adcf-8288d0060c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_c9c3cce9-0a4c-4790-8546-c6fbe68c2094" xlink:href="cvs-20230331.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_f0821694-8f21-4eb9-817e-25786d9354ed" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_c9c3cce9-0a4c-4790-8546-c6fbe68c2094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_a92fab84-4f2f-4110-b0b3-fdc3e60477f2" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_a92fab84-4f2f-4110-b0b3-fdc3e60477f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_a92fab84-4f2f-4110-b0b3-fdc3e60477f2" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_d96fd845-ae7b-42af-beee-fc6a84aa73c9" xlink:href="cvs-20230331.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Category1Member_d96fd845-ae7b-42af-beee-fc6a84aa73c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_4e63bfbd-f4bc-4609-8ee8-36effa3d842c" xlink:href="cvs-20230331.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Category2To4Member_4e63bfbd-f4bc-4609-8ee8-36effa3d842c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_6dc2bbc1-30fc-4ad9-8be9-0995e40524d6" xlink:href="cvs-20230331.xsd#cvs_Categories5and6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Categories5and6Member_6dc2bbc1-30fc-4ad9-8be9-0995e40524d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_7e46350e-57c1-45d3-9443-527deb4c5c82" xlink:href="cvs-20230331.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_472d4172-9dba-4254-bd21-9b0bfda8dc1b" xlink:to="loc_cvs_Category7Member_7e46350e-57c1-45d3-9443-527deb4c5c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_07d4d8bf-54df-4849-b3e8-73b0ef825633" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_e83184d5-dbd7-413d-aaf4-fe2e51022d30" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_07d4d8bf-54df-4849-b3e8-73b0ef825633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_07c2dcee-6e9b-4037-b17a-750b89bf8e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_07d4d8bf-54df-4849-b3e8-73b0ef825633" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_07c2dcee-6e9b-4037-b17a-750b89bf8e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_496d8083-b1da-4166-a020-5df9b4ea19ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_496d8083-b1da-4166-a020-5df9b4ea19ad" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_c2a527e1-92e9-471e-b630-699699499d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:to="loc_us-gaap_InvestmentTypeAxis_c2a527e1-92e9-471e-b630-699699499d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_c2a527e1-92e9-471e-b630-699699499d1a" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_20ffd221-cbc4-4edf-8678-fafbdc269fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:to="loc_us-gaap_DebtSecuritiesMember_20ffd221-cbc4-4edf-8678-fafbdc269fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_4535919b-9f6b-4d51-bea8-a7e68cb339e6" xlink:href="cvs-20230331.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:to="loc_cvs_MortgageLoansMember_4535919b-9f6b-4d51-bea8-a7e68cb339e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_bbee1790-78ec-498b-ad6f-59be55140d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a857b206-05ce-4bf6-b9bd-4764ec500c36" xlink:to="loc_us-gaap_OtherInvestmentsMember_bbee1790-78ec-498b-ad6f-59be55140d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_71d74695-6d9c-44ea-aeb1-008bf1cca037" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:to="loc_srt_ProductOrServiceAxis_71d74695-6d9c-44ea-aeb1-008bf1cca037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad834ac3-6f53-4cc8-9e18-a429f4a70e30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_71d74695-6d9c-44ea-aeb1-008bf1cca037" xlink:to="loc_srt_ProductsAndServicesDomain_ad834ac3-6f53-4cc8-9e18-a429f4a70e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_138e493f-0fc4-458c-b68e-0afd18457eea" xlink:href="cvs-20230331.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad834ac3-6f53-4cc8-9e18-a429f4a70e30" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_138e493f-0fc4-458c-b68e-0afd18457eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_01799cca-bf40-42d3-a2a7-39704e137630" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_a672be7b-ece1-4ee4-b3df-54aff89824fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_a672be7b-ece1-4ee4-b3df-54aff89824fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_680b7916-a23b-4847-a0ae-26254d2de7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_680b7916-a23b-4847-a0ae-26254d2de7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_a8c8253d-cb8f-4c69-8ad8-68f5a415174f" xlink:href="cvs-20230331.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_a8c8253d-cb8f-4c69-8ad8-68f5a415174f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_99d0de14-7848-4891-a108-afcfdf8c87f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_99d0de14-7848-4891-a108-afcfdf8c87f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_f7fc7e27-9cf5-4f2b-be7a-d1526b74e519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_us-gaap_InvestmentIncomeNet_f7fc7e27-9cf5-4f2b-be7a-d1526b74e519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4827f52-de47-4cca-9993-6d80d310179b" xlink:href="cvs-20230331.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4827f52-de47-4cca-9993-6d80d310179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f5d57d58-5877-4984-b7fc-bbd73b633fc7" xlink:href="cvs-20230331.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_f047f5f0-5dec-479b-b543-4d115aa510e2" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_f5d57d58-5877-4984-b7fc-bbd73b633fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_3c8629f4-d385-4fef-ad3c-fbb5691eb711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_51ddaf65-bc6d-4576-b1dc-c6fae49f14bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3c8629f4-d385-4fef-ad3c-fbb5691eb711" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_51ddaf65-bc6d-4576-b1dc-c6fae49f14bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_6605bfe2-b653-4ead-8e63-e445fa861e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3c8629f4-d385-4fef-ad3c-fbb5691eb711" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_6605bfe2-b653-4ead-8e63-e445fa861e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_7f44bf46-299c-4ae6-a46b-b3288a97602f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3c8629f4-d385-4fef-ad3c-fbb5691eb711" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_7f44bf46-299c-4ae6-a46b-b3288a97602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ef6324aa-5202-41bf-ad12-ff29b7e17fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ef6324aa-5202-41bf-ad12-ff29b7e17fc0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0da0d253-30f7-4685-b0dd-e2235236fc26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0da0d253-30f7-4685-b0dd-e2235236fc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_30a4f2a4-af03-4dea-bd66-6ad8cc670481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0da0d253-30f7-4685-b0dd-e2235236fc26" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_30a4f2a4-af03-4dea-bd66-6ad8cc670481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7d3480f8-15b1-42c7-aecb-2f552369ba0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_30a4f2a4-af03-4dea-bd66-6ad8cc670481" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7d3480f8-15b1-42c7-aecb-2f552369ba0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1e8c752b-31ae-4ac0-af29-01b8a794e532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1e8c752b-31ae-4ac0-af29-01b8a794e532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1e8c752b-31ae-4ac0-af29-01b8a794e532" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4fbfcc64-829d-4587-bac5-60c1ee856d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4fbfcc64-829d-4587-bac5-60c1ee856d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5008e0a9-030e-4d55-a926-88cdc82bce14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5008e0a9-030e-4d55-a926-88cdc82bce14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ec309a77-c680-4e4d-974e-4eaf587a0858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_ec309a77-c680-4e4d-974e-4eaf587a0858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fa4d7d01-ffc7-4e2f-8b33-a09a4c06fa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_fa4d7d01-ffc7-4e2f-8b33-a09a4c06fa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3d0c704f-576e-447f-9ea3-d7d54044e9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3d0c704f-576e-447f-9ea3-d7d54044e9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ab015a79-7110-4dce-b018-7305c097b2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ab015a79-7110-4dce-b018-7305c097b2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_8138ab44-6a80-4aa5-b97a-fcf4937a61ad" xlink:href="cvs-20230331.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_8138ab44-6a80-4aa5-b97a-fcf4937a61ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_97d0e674-6f1e-4d1f-b6a9-eeed1de4cc61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8db5d983-7ad1-424e-9b81-f5ff1abc946b" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_97d0e674-6f1e-4d1f-b6a9-eeed1de4cc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c064a502-c182-4786-b14c-f439f15dd7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c064a502-c182-4786-b14c-f439f15dd7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c064a502-c182-4786-b14c-f439f15dd7bd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fdb7951d-22df-4921-9dac-89d1bbd98d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fdb7951d-22df-4921-9dac-89d1bbd98d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_78b0ddf6-e908-4d85-8e73-cec0f962b4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_78b0ddf6-e908-4d85-8e73-cec0f962b4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a2fe921c-a0b1-4ea0-aabf-667a375f4dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e3bad2-2dbb-4f51-8e01-0ce1455d716c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a2fe921c-a0b1-4ea0-aabf-667a375f4dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ec206afe-49a1-4671-a6fc-822ef6ff74f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ec206afe-49a1-4671-a6fc-822ef6ff74f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0738ff3c-4a89-4079-bbc3-67ad3302a2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ec206afe-49a1-4671-a6fc-822ef6ff74f0" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0738ff3c-4a89-4079-bbc3-67ad3302a2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50f74c2-7ddf-470f-8d40-7fb794484894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0738ff3c-4a89-4079-bbc3-67ad3302a2b9" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d50f74c2-7ddf-470f-8d40-7fb794484894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fc13ba9-d458-49cd-bf86-bcbeafe51e43" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_e9723f38-cd03-4565-ba7b-bf534d5497bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_e9723f38-cd03-4565-ba7b-bf534d5497bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_75d12ac2-35da-4c87-af9e-8d3df29434bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_75d12ac2-35da-4c87-af9e-8d3df29434bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a710e341-377f-4564-a9d5-3edd65f2024d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a710e341-377f-4564-a9d5-3edd65f2024d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c68ffdaa-f0bd-422f-b032-990475a4b9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c68ffdaa-f0bd-422f-b032-990475a4b9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_dcbc0b0f-1061-47e1-8e58-650f6c2e051a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4191d307-db31-4ab8-a52b-968875cf9390" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_dcbc0b0f-1061-47e1-8e58-650f6c2e051a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d0337795-b467-427b-bc90-430120d5a291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_4a5e674d-4954-465b-b143-af2f8b62529f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d0337795-b467-427b-bc90-430120d5a291" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_4a5e674d-4954-465b-b143-af2f8b62529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_239e5816-e780-4a42-9101-d1087144134c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_239e5816-e780-4a42-9101-d1087144134c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b453c96-aeb3-4b57-b89f-a02a970bcbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b453c96-aeb3-4b57-b89f-a02a970bcbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_92e281c1-46e5-4d89-90e3-dcfe6103d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b453c96-aeb3-4b57-b89f-a02a970bcbf0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_92e281c1-46e5-4d89-90e3-dcfe6103d6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_a1c0f55e-29d5-45dd-9e4e-221430e72f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_92e281c1-46e5-4d89-90e3-dcfe6103d6b8" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_a1c0f55e-29d5-45dd-9e4e-221430e72f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7535fedf-5d54-452c-895e-36d365c9895f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7535fedf-5d54-452c-895e-36d365c9895f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7535fedf-5d54-452c-895e-36d365c9895f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_870a2dc9-0dcf-446b-9115-d84c79f08cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_870a2dc9-0dcf-446b-9115-d84c79f08cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_477c6efd-0359-47db-b3d9-e39054a6a03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_477c6efd-0359-47db-b3d9-e39054a6a03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_87d42844-c95d-460a-91c0-7dd8293779bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_507a2711-cc37-4b9b-aa9f-4a31326c9052" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_87d42844-c95d-460a-91c0-7dd8293779bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_737cb023-8735-4257-abce-1494b37b1c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_737cb023-8735-4257-abce-1494b37b1c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1774494d-19bf-4d65-8ca5-398baed3861e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_737cb023-8735-4257-abce-1494b37b1c3b" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1774494d-19bf-4d65-8ca5-398baed3861e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_1774494d-19bf-4d65-8ca5-398baed3861e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa9f2102-b56c-4108-a48e-bd8bdc4235b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa9f2102-b56c-4108-a48e-bd8bdc4235b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_92b76f53-c0dd-4baa-97b8-5056159f21b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b3959d78-28ae-4f14-a901-c7fd7d091c66" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_92b76f53-c0dd-4baa-97b8-5056159f21b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_36b1b413-17ba-4dc2-9a04-1d246a130584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b4a0aae-315a-4fc8-92e6-fc0cb719eac5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_36b1b413-17ba-4dc2-9a04-1d246a130584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_317cdb24-6719-43c9-b985-d90bfdca470e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_36b1b413-17ba-4dc2-9a04-1d246a130584" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_317cdb24-6719-43c9-b985-d90bfdca470e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8784c79a-099f-4c7c-bfb7-5f43bfb9abcc" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_dde77a38-43db-4d79-9bf0-30bddc76cbce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_dde77a38-43db-4d79-9bf0-30bddc76cbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1800e336-b12a-4d12-b0fc-2781cf4bc9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_fff5f91b-7179-4527-839b-463e3db3d762" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1800e336-b12a-4d12-b0fc-2781cf4bc9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4f08d808-c807-4495-a0b6-0617ac452d20" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_325bc0b9-8188-4f2a-9da1-336eb191ff40" xlink:href="cvs-20230331.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_325bc0b9-8188-4f2a-9da1-336eb191ff40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_786b4037-347d-419e-b9dc-14d13228db5f" xlink:href="cvs-20230331.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_786b4037-347d-419e-b9dc-14d13228db5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_f03473fa-daa0-4dc2-8214-24f265ef0f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_23aacc60-95ce-40a5-ae43-c06291997736" xlink:to="loc_us-gaap_DebtInstrumentFairValue_f03473fa-daa0-4dc2-8214-24f265ef0f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6b87e64a-c4d6-4e58-9e2f-e1e3c61277d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6b87e64a-c4d6-4e58-9e2f-e1e3c61277d5" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_57f7ff2c-0e37-4734-ac0d-9e0132211d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_57f7ff2c-0e37-4734-ac0d-9e0132211d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5da9b013-c908-4fa7-9aae-d58914ae9323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_57f7ff2c-0e37-4734-ac0d-9e0132211d1d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5da9b013-c908-4fa7-9aae-d58914ae9323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a2781ce3-9ad0-44e2-9356-9daa8b039408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5da9b013-c908-4fa7-9aae-d58914ae9323" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a2781ce3-9ad0-44e2-9356-9daa8b039408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51e3f517-d5bb-4fc7-8cc1-09d7a16acab6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8762bf68-19fd-4f75-9b06-0fd6d5db98b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8762bf68-19fd-4f75-9b06-0fd6d5db98b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1cb1ce38-ef8e-4532-a9f1-f262f2ff2c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1cb1ce38-ef8e-4532-a9f1-f262f2ff2c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6d41847b-5d74-44aa-b6cd-874b55e99f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_74199b2e-87fb-48b9-abff-ca653512049b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6d41847b-5d74-44aa-b6cd-874b55e99f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f2282924-9b04-4b81-ad17-a4a1e3e4a050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_InvestmentTypeAxis_f2282924-9b04-4b81-ad17-a4a1e3e4a050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_f2282924-9b04-4b81-ad17-a4a1e3e4a050" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_cc574661-38b3-4378-aa92-d8e26d493e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_cc574661-38b3-4378-aa92-d8e26d493e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_f0ad0fec-3074-4b17-8470-8a8c8b144eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:to="loc_us-gaap_DebtSecuritiesMember_f0ad0fec-3074-4b17-8470-8a8c8b144eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_7412e409-009b-41a0-9466-56032388f1b6" xlink:href="cvs-20230331.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2e0df0dd-8638-4028-9c84-8347f2c08d51" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_7412e409-009b-41a0-9466-56032388f1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_24933c4f-7998-4a1a-b2ab-0b4c7dda192c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_24933c4f-7998-4a1a-b2ab-0b4c7dda192c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_24933c4f-7998-4a1a-b2ab-0b4c7dda192c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_6ad2aab4-3dbd-485f-962d-3cb1d300937c" xlink:href="cvs-20230331.xsd#cvs_OtherReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:to="loc_cvs_OtherReceivablesMember_6ad2aab4-3dbd-485f-962d-3cb1d300937c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherPayablesMember_a0362113-a2b6-4e00-bdd4-12273443f798" xlink:href="cvs-20230331.xsd#cvs_OtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c3913f70-7eb6-4b58-bae7-e8232c2c2a7d" xlink:to="loc_cvs_OtherPayablesMember_a0362113-a2b6-4e00-bdd4-12273443f798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_5922df7e-1b74-43cf-b13b-a0f0333a70c9" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_5b6b3386-332a-45c5-8f81-a365e73c5c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:to="loc_us-gaap_SeparateAccountAssets_5b6b3386-332a-45c5-8f81-a365e73c5c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_d1350d97-0736-43fa-bd86-40dc098d5cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f8580ab7-c81d-4956-836a-a1fd75c55c41" xlink:to="loc_us-gaap_SeparateAccountsLiability_d1350d97-0736-43fa-bd86-40dc098d5cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_e513cc7b-0d2e-41e3-af28-0e3f31074591" xlink:href="cvs-20230331.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_e513cc7b-0d2e-41e3-af28-0e3f31074591" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:to="loc_srt_ProductOrServiceAxis_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d0ffd228-6ab8-4ef3-a146-6b89abdbb803" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_58ce0bfa-5ccd-49fc-a98b-a9cb5bd24030" xlink:to="loc_srt_ProductsAndServicesDomain_d0ffd228-6ab8-4ef3-a146-6b89abdbb803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_c4b2e326-497f-4232-805d-73b8e0b9b048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d0ffd228-6ab8-4ef3-a146-6b89abdbb803" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_c4b2e326-497f-4232-805d-73b8e0b9b048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_60b51c30-2f51-4287-a21e-27082177b72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_60b51c30-2f51-4287-a21e-27082177b72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_60b51c30-2f51-4287-a21e-27082177b72c" xlink:to="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_f6654135-e17e-43b1-bce2-071416f96a4a" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_f6654135-e17e-43b1-bce2-071416f96a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_9bd04902-cd44-4065-9bb9-dec6a3d5b858" xlink:href="cvs-20230331.xsd#cvs_CorporateOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f90ee02-0ebf-4190-9ac6-5b4c87f06480" xlink:to="loc_cvs_CorporateOtherMember_9bd04902-cd44-4065-9bb9-dec6a3d5b858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_25f134e2-2038-49ab-957b-4a2d04cc74cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_25f134e2-2038-49ab-957b-4a2d04cc74cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_512b9567-5e0e-4608-a152-e5c807699751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_25f134e2-2038-49ab-957b-4a2d04cc74cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_512b9567-5e0e-4608-a152-e5c807699751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember_e4742f97-a83a-4005-8adf-391300475487" xlink:href="cvs-20230331.xsd#cvs_ThailandBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_512b9567-5e0e-4608-a152-e5c807699751" xlink:to="loc_cvs_ThailandBusinessMember_e4742f97-a83a-4005-8adf-391300475487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_42e38805-e50d-41be-9a4c-c9c4f4008a39" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b019fa8e-0394-4135-94a7-bb9e6caae5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b019fa8e-0394-4135-94a7-bb9e6caae5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1aa496ee-d1c2-48cf-8d8b-675b8d6bb409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1aa496ee-d1c2-48cf-8d8b-675b8d6bb409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_0c061485-c1a2-4520-a82d-adc8db390af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_0c061485-c1a2-4520-a82d-adc8db390af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ceb5e872-a0df-47d2-916d-d6e4ebef2aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ceb5e872-a0df-47d2-916d-d6e4ebef2aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6035b0c3-0f68-46d5-b4ef-0c4dd6dbcdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6035b0c3-0f68-46d5-b4ef-0c4dd6dbcdfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8a6d84df-4809-46e5-a100-d9d4136a706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_8a6d84df-4809-46e5-a100-d9d4136a706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_082e7e83-40ef-42bb-8a36-970786128df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_5b660af0-df31-475e-a7a0-dcf169267943" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_082e7e83-40ef-42bb-8a36-970786128df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_af519e0d-d9ac-45d8-bd33-9aa56a5a0c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_af519e0d-d9ac-45d8-bd33-9aa56a5a0c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_eb95d9ae-320b-41aa-ab7a-d89bdcf5f5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_eb95d9ae-320b-41aa-ab7a-d89bdcf5f5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f450b3b1-7726-44cb-8b46-99e34f9ebea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_469b82e0-24de-4906-b0d3-90dca8ec0ab1" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f450b3b1-7726-44cb-8b46-99e34f9ebea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_999568ea-a7dd-4ea1-8016-2853de3a8521" xlink:href="cvs-20230331.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_999568ea-a7dd-4ea1-8016-2853de3a8521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_193225fb-7765-486c-b6df-d8a67e159171" xlink:href="cvs-20230331.xsd#cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_193225fb-7765-486c-b6df-d8a67e159171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8d0ee979-96c6-40d1-84ea-a05150ad9711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8d0ee979-96c6-40d1-84ea-a05150ad9711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_fa43fc90-58a4-4033-a35b-394a8dcdf348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_fa43fc90-58a4-4033-a35b-394a8dcdf348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_8aa2282e-edc5-45a9-bf8c-c661ce1fb6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_8aa2282e-edc5-45a9-bf8c-c661ce1fb6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_04082978-9cd0-4a4d-afb0-ce80bbe9f855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_3ccad16e-9da3-442e-be5f-fa733bcd1d90" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_04082978-9cd0-4a4d-afb0-ce80bbe9f855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_b2e111b1-93bb-4ce5-adc4-a48a5e3aabe4" xlink:href="cvs-20230331.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_b2e111b1-93bb-4ce5-adc4-a48a5e3aabe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_4f0e5e94-3cba-4604-ad49-2749e13a7ed4" xlink:href="cvs-20230331.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_bbdbe52b-21ae-4b87-ba58-b7cbd6da6920" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_4f0e5e94-3cba-4604-ad49-2749e13a7ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_27cc2613-d0c3-453f-b45e-db2ae1030394" xlink:href="cvs-20230331.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_01a899d2-9185-42bb-a2a2-3d68bd83ef9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_27cc2613-d0c3-453f-b45e-db2ae1030394" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_01a899d2-9185-42bb-a2a2-3d68bd83ef9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_01a899d2-9185-42bb-a2a2-3d68bd83ef9c" xlink:to="loc_srt_ProductOrServiceAxis_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_11579084-c49e-4b90-935c-4d63b4ea014c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_70faabbd-fd4e-4d77-8f60-a6e7c817c4ca" xlink:to="loc_srt_ProductsAndServicesDomain_11579084-c49e-4b90-935c-4d63b4ea014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_b709a590-8484-45f4-b0b3-47672b158bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_11579084-c49e-4b90-935c-4d63b4ea014c" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_b709a590-8484-45f4-b0b3-47672b158bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_01a899d2-9185-42bb-a2a2-3d68bd83ef9c" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_42a3545b-9565-4ef9-9916-764d5af02b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_42a3545b-9565-4ef9-9916-764d5af02b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_bec1050f-88f5-42ed-be1b-14f8f3ad8a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_ba1cf670-7d5b-45da-ac9d-36c0444f5642" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_bec1050f-88f5-42ed-be1b-14f8f3ad8a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_d1533f82-5a1f-4174-8e5d-8198035ad257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_7ddc26aa-6b7b-4887-9424-3d0876417769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_d1533f82-5a1f-4174-8e5d-8198035ad257" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_7ddc26aa-6b7b-4887-9424-3d0876417769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cce8fff6-f186-45b7-b5a6-e17fa38c8eae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_7ddc26aa-6b7b-4887-9424-3d0876417769" xlink:to="loc_srt_ProductOrServiceAxis_cce8fff6-f186-45b7-b5a6-e17fa38c8eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_cce8fff6-f186-45b7-b5a6-e17fa38c8eae" xlink:to="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_3ad03c78-2535-46bb-94cb-5c7bfc052ba1" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:to="loc_cvs_LargeCasePensionsMember_3ad03c78-2535-46bb-94cb-5c7bfc052ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_472c732e-f925-4f90-aa7a-5fabb41e7203" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9f536aa8-9cbe-4e1f-98de-2a2619857e7a" xlink:to="loc_cvs_LongTermCareMember_472c732e-f925-4f90-aa7a-5fabb41e7203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_7ddc26aa-6b7b-4887-9424-3d0876417769" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_722dbbb3-e53a-470c-b437-bf80075651ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_722dbbb3-e53a-470c-b437-bf80075651ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_1afd2a41-eaa2-4707-91a1-f3e0c41f8e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_1afd2a41-eaa2-4707-91a1-f3e0c41f8e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_d974b32e-309b-49d8-959a-2cd6ac8a5c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_d974b32e-309b-49d8-959a-2cd6ac8a5c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_7833e7e2-e9a5-42fe-b6c4-2923e5151f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_7833e7e2-e9a5-42fe-b6c4-2923e5151f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_61cd56cf-53c7-44e9-93ca-cac135ab8608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_61cd56cf-53c7-44e9-93ca-cac135ab8608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_f11cdb7e-71cd-40d7-9924-f5b7d3201eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_f11cdb7e-71cd-40d7-9924-f5b7d3201eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_eb507ce5-a2a9-4ac9-806f-dc6003cef176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_eb507ce5-a2a9-4ac9-806f-dc6003cef176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_d7ea9935-1b43-4c19-b14e-4c1df6cf9258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_d7ea9935-1b43-4c19-b14e-4c1df6cf9258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_822aaaae-2739-4642-a201-623385d7bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_822aaaae-2739-4642-a201-623385d7bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_2144008a-ea85-4330-8dca-b421ed791cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_d9202839-2b59-4433-9b57-44c1fd6a44d6" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_2144008a-ea85-4330-8dca-b421ed791cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_16ebdbf2-deb5-4993-89d7-14feb0b2c02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_16ebdbf2-deb5-4993-89d7-14feb0b2c02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_4e7c7c49-8189-4008-a1af-371383100ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_4e7c7c49-8189-4008-a1af-371383100ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ffbd1225-5680-4e1c-b6aa-00dc3f7005a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ffbd1225-5680-4e1c-b6aa-00dc3f7005a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_56cf1932-a1e2-46b6-b8ac-1bcf8a13bc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_56cf1932-a1e2-46b6-b8ac-1bcf8a13bc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_d0dcac38-d849-414d-a4d0-97e476ba35f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_d0dcac38-d849-414d-a4d0-97e476ba35f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_7be0a6fe-4ad0-4b8f-8385-8f38589fad94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_7be0a6fe-4ad0-4b8f-8385-8f38589fad94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_079d019e-3cdf-4616-934c-23a889b3794d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_079d019e-3cdf-4616-934c-23a889b3794d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_65ecc09d-752c-41aa-b104-729376f99bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_65ecc09d-752c-41aa-b104-729376f99bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_14bc683e-31a6-438b-931f-1856163ea5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_14bc683e-31a6-438b-931f-1856163ea5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_bb36a6c3-8b8e-41b4-8d9a-d89a8f382b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_bb36a6c3-8b8e-41b4-8d9a-d89a8f382b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_7fcffc0b-7695-471d-b1c0-7a7956a0c736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_9cbceaac-42c3-4417-b348-41d70fa86a16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_7fcffc0b-7695-471d-b1c0-7a7956a0c736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_0edc5766-da1e-489b-96b5-57b607549ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_0edc5766-da1e-489b-96b5-57b607549ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_9552c7c1-341e-49d2-ae0b-e8eab0ce322f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_9552c7c1-341e-49d2-ae0b-e8eab0ce322f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_2c85a41b-baca-4810-9865-cb9654f2d944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_50915f06-ed0f-4a08-8f38-15d9a7154b16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_2c85a41b-baca-4810-9865-cb9654f2d944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_38ed0508-d887-4f17-bcdb-fb5956d382f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_352df556-26fd-41fb-a955-60704c7e8d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_38ed0508-d887-4f17-bcdb-fb5956d382f3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_352df556-26fd-41fb-a955-60704c7e8d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_352df556-26fd-41fb-a955-60704c7e8d05" xlink:to="loc_srt_ProductOrServiceAxis_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6cb18acd-7ca0-4b17-af3d-3ae6c774ec36" xlink:to="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_c03008dc-03d9-40fd-a5a6-c5474282451a" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:to="loc_cvs_LargeCasePensionsMember_c03008dc-03d9-40fd-a5a6-c5474282451a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_34d2f8b8-fc16-48c7-bd58-26b98c49b5c1" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9c0ea349-054e-4b83-b391-e7d87517f3aa" xlink:to="loc_cvs_LongTermCareMember_34d2f8b8-fc16-48c7-bd58-26b98c49b5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_352df556-26fd-41fb-a955-60704c7e8d05" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_5970e18f-feca-44e0-97d7-bfcfdb15141e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_5970e18f-feca-44e0-97d7-bfcfdb15141e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_4b11ed53-7d40-490e-8837-1c3c9bb3a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_a347d906-724f-46b6-9471-4d729fdeece3" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_4b11ed53-7d40-490e-8837-1c3c9bb3a5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e931143b-8a74-4381-914e-0c827fc6b900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_a720284d-06d6-4b20-9760-75aa57a6ab08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e931143b-8a74-4381-914e-0c827fc6b900" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_a720284d-06d6-4b20-9760-75aa57a6ab08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_a720284d-06d6-4b20-9760-75aa57a6ab08" xlink:to="loc_srt_ProductOrServiceAxis_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_52f04e6a-4d00-4d12-ae7f-dcf7b7b11988" xlink:to="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_2d0dc149-ed3d-47d6-9ce7-1cd8ed4a1ab5" xlink:href="cvs-20230331.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:to="loc_cvs_LargeCasePensionsMember_2d0dc149-ed3d-47d6-9ce7-1cd8ed4a1ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_9d5b7501-3b67-49e2-95b1-cd0af07cbb3b" xlink:href="cvs-20230331.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4c80967e-71d5-4168-9f83-532b57b16237" xlink:to="loc_cvs_LongTermCareMember_9d5b7501-3b67-49e2-95b1-cd0af07cbb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_a720284d-06d6-4b20-9760-75aa57a6ab08" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_84c849b2-5008-406e-86c8-e25420ae42f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_84c849b2-5008-406e-86c8-e25420ae42f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_f378453a-a9e2-4c25-b73b-8c800f9c5e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_f378453a-a9e2-4c25-b73b-8c800f9c5e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_509be9c7-36ee-4f46-9d0b-878c56c100b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_0bc25b1a-931d-4a38-95c8-4050549185b8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_509be9c7-36ee-4f46-9d0b-878c56c100b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_d2ead05e-b47c-4b72-b5bd-68debf2ae8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_d2ead05e-b47c-4b72-b5bd-68debf2ae8c2" xlink:to="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds_bc5d5301-46d0-46f3-a7d5-601d886c5db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:to="loc_us-gaap_PolicyholderFunds_bc5d5301-46d0-46f3-a7d5-601d886c5db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceDepositsReceived_b98cbac5-6d73-4640-b607-48a9e5fe2dba" xlink:href="cvs-20230331.xsd#cvs_PolicyholderAccountBalanceDepositsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:to="loc_cvs_PolicyholderAccountBalanceDepositsReceived_b98cbac5-6d73-4640-b607-48a9e5fe2dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_89fd4f67-59c7-482e-a55d-d6be188d4b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:to="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_89fd4f67-59c7-482e-a55d-d6be188d4b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances_f756e13d-242b-4d9d-aeff-0dfe0b470104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCreditedToPolicyholdersAccountBalances"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:to="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances_f756e13d-242b-4d9d-aeff-0dfe0b470104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_d8c8c2ad-eb55-4793-b2a5-bfd1ee493d39" xlink:href="cvs-20230331.xsd#cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:to="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_d8c8c2ad-eb55-4793-b2a5-bfd1ee493d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_6a63e96a-fa24-41cd-9c93-e37c11f9c479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:to="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_6a63e96a-fa24-41cd-9c93-e37c11f9c479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds_08f80d0f-e110-443e-bd98-6279eb9e44a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_79555e70-b943-4fec-9cc7-28a2a3e5500d" xlink:to="loc_us-gaap_PolicyholderFunds_08f80d0f-e110-443e-bd98-6279eb9e44a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_ad29c8ea-4698-4f32-bd33-d12406d5a26c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_d2ead05e-b47c-4b72-b5bd-68debf2ae8c2" xlink:to="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_ad29c8ea-4698-4f32-bd33-d12406d5a26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_458e6caa-971f-4408-9140-9aa0c1090cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceNetAmountAtRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_d2ead05e-b47c-4b72-b5bd-68debf2ae8c2" xlink:to="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_458e6caa-971f-4408-9140-9aa0c1090cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_c8164fac-fe44-4deb-8c74-1cfc3e84cc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueDuePolicyholdersAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_d2ead05e-b47c-4b72-b5bd-68debf2ae8c2" xlink:to="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_c8164fac-fe44-4deb-8c74-1cfc3e84cc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_16faa6c8-d310-4083-a952-f92cb37a917d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_16faa6c8-d310-4083-a952-f92cb37a917d" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_3ab68e7f-4a27-45fc-8459-ccabe384dbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_3ab68e7f-4a27-45fc-8459-ccabe384dbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_3ab68e7f-4a27-45fc-8459-ccabe384dbe7" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_feaa5f39-3260-467a-893d-e8088703d9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_feaa5f39-3260-467a-893d-e8088703d9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountDebtSecurityMember_4a0f88d8-f937-4d7b-a96b-375dd38ec3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountDebtSecurityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_us-gaap_SeparateAccountDebtSecurityMember_4a0f88d8-f937-4d7b-a96b-375dd38ec3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_7a885210-2a7f-4280-af1e-915d626754a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountMortgageBackedSecurityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_7a885210-2a7f-4280-af1e-915d626754a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_1af39a21-d085-4f1f-ba18-d43444edef27" xlink:href="cvs-20230331.xsd#cvs_SeparateAccountOtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_1af39a21-d085-4f1f-ba18-d43444edef27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_fbfd0152-7b7a-4edc-9d60-bf4da03facbe" xlink:href="cvs-20230331.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_97b98c68-8d17-4dfb-8315-4d2f5c5a3a57" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_fbfd0152-7b7a-4edc-9d60-bf4da03facbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_08a09435-e6b5-4772-a96b-24a8de9a4a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_08a09435-e6b5-4772-a96b-24a8de9a4a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_08a09435-e6b5-4772-a96b-24a8de9a4a07" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_18d4c8de-cd81-4286-aa64-1ddd0c0e920b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_18d4c8de-cd81-4286-aa64-1ddd0c0e920b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0eba0b61-7225-44dc-b1f5-76e469e8bc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_0eba0b61-7225-44dc-b1f5-76e469e8bc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e82ae6af-4a3b-4917-8b0e-dff75fb022bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e82ae6af-4a3b-4917-8b0e-dff75fb022bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_87903222-9dca-46cd-9f5e-9bea2bdbf30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_87903222-9dca-46cd-9f5e-9bea2bdbf30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6ceed0ef-44c3-4fd8-902e-41eb59f5ff45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6ceed0ef-44c3-4fd8-902e-41eb59f5ff45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db89d93b-ef73-45e4-85ad-95fdc9238238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_768d2088-c883-4c38-857a-708beeea6b80" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_db89d93b-ef73-45e4-85ad-95fdc9238238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b6864ac4-0022-444b-a3f8-c48e31ed00d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b6864ac4-0022-444b-a3f8-c48e31ed00d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b6864ac4-0022-444b-a3f8-c48e31ed00d4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_35f7da92-fe91-4f7b-b5fb-43136384a031" xlink:href="cvs-20230331.xsd#cvs_OtherReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:to="loc_cvs_OtherReceivablesMember_35f7da92-fe91-4f7b-b5fb-43136384a031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherPayablesMember_2c8a4720-3076-41a0-b734-20ade9662f6f" xlink:href="cvs-20230331.xsd#cvs_OtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaaafffd-bf60-48de-b068-a1d7ef119d85" xlink:to="loc_cvs_OtherPayablesMember_2c8a4720-3076-41a0-b734-20ade9662f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3da88e40-faa1-46cb-9e8f-5fc3b97d9b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d556a1e1-2e09-4dec-b6a7-bb503b0b5d08" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3da88e40-faa1-46cb-9e8f-5fc3b97d9b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_cb0edc22-e61e-4460-9a31-dfaf74414e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3da88e40-faa1-46cb-9e8f-5fc3b97d9b39" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_cb0edc22-e61e-4460-9a31-dfaf74414e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_a9342bc3-6dee-46c1-ae7f-238e422106a1" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_0f6590e7-64d0-4309-8f48-4e7ec509c973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:to="loc_us-gaap_SeparateAccountAssets_0f6590e7-64d0-4309-8f48-4e7ec509c973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_5870e5ab-903f-4a54-b9a4-e3ba88777a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_adbea505-fbe1-41ad-8773-7adca572a46a" xlink:to="loc_us-gaap_SeparateAccountsLiability_5870e5ab-903f-4a54-b9a4-e3ba88777a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_a718b691-7b1c-487b-995d-f01e5f10080a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a718b691-7b1c-487b-995d-f01e5f10080a" xlink:to="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_7e52b699-73df-4f19-8b29-c8d5c6c4ca20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_SeparateAccountsLiability_7e52b699-73df-4f19-8b29-c8d5c6c4ca20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_fdbdc5c7-88fb-4beb-9136-a838fdfbdec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityPremiumAndDeposit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_fdbdc5c7-88fb-4beb-9136-a838fdfbdec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_606a32ce-a980-42a8-bbc4-51a7dc8165c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_606a32ce-a980-42a8-bbc4-51a7dc8165c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityBenefitPayment_ae1d10ad-3e65-44a1-8066-d712e3050a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityBenefitPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_SeparateAccountLiabilityBenefitPayment_ae1d10ad-3e65-44a1-8066-d712e3050a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_454bf903-6f02-4e13-acd5-d257fdcdb781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_454bf903-6f02-4e13-acd5-d257fdcdb781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_2f10fa12-85b7-4e99-8b42-68bb7d44fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_2f10fa12-85b7-4e99-8b42-68bb7d44fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_6c536eb4-1071-4e74-9a72-57ca664e77e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_6c536eb4-1071-4e74-9a72-57ca664e77e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_26da20d8-0190-4c2f-83f8-626767e586b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_0647663d-04b7-41c6-8ca3-b59c83349f58" xlink:to="loc_us-gaap_SeparateAccountsLiability_26da20d8-0190-4c2f-83f8-626767e586b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_1135180b-1b97-4dfa-b712-a2c4b66fe267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a718b691-7b1c-487b-995d-f01e5f10080a" xlink:to="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_1135180b-1b97-4dfa-b712-a2c4b66fe267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#BorrowingsScheduleofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_530f297e-3e66-4d73-aae8-63de92bb979b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_530f297e-3e66-4d73-aae8-63de92bb979b" xlink:to="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5a1a04c7-4e7e-4adf-bf25-ecd933b41776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5a1a04c7-4e7e-4adf-bf25-ecd933b41776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5a1a04c7-4e7e-4adf-bf25-ecd933b41776" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_91b81bcf-6430-413b-9fc6-9a72b53d46e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:to="loc_us-gaap_SeniorNotesMember_91b81bcf-6430-413b-9fc6-9a72b53d46e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_92d78c58-5503-4934-bb7f-c7ac4bd91904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_538a7fc3-bd12-4105-90c6-f8510b75433a" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_92d78c58-5503-4934-bb7f-c7ac4bd91904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b187e304-6fef-417b-b46a-24bbca4070a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:to="loc_us-gaap_DebtInstrumentAxis_b187e304-6fef-417b-b46a-24bbca4070a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b187e304-6fef-417b-b46a-24bbca4070a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_9112999b-783e-47f2-87e1-ed5c4649ed58" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_9112999b-783e-47f2-87e1-ed5c4649ed58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_373d5381-335d-478a-bec4-862c45581fdc" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_373d5381-335d-478a-bec4-862c45581fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_dee7562f-ad74-4331-bc55-4a6a289e2f25" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_dee7562f-ad74-4331-bc55-4a6a289e2f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_066e8dac-5fad-46bf-8883-8bebd5d23f2b" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_066e8dac-5fad-46bf-8883-8bebd5d23f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_95f7dd99-619f-46f9-a86d-a2f53d8e463c" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_95f7dd99-619f-46f9-a86d-a2f53d8e463c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_69ecd4c1-b4b0-4947-8bb1-316198b1eeeb" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_69ecd4c1-b4b0-4947-8bb1-316198b1eeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_a124a8c5-a8e4-48ec-b90d-24b18558bec5" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_a124a8c5-a8e4-48ec-b90d-24b18558bec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_cde53900-4355-4362-b9aa-747277c1fb82" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_cde53900-4355-4362-b9aa-747277c1fb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes50DueFebruary2026Member_c2a56fdd-733b-4dc7-9706-f0e9cd2b0096" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes50DueFebruary2026Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes50DueFebruary2026Member_c2a56fdd-733b-4dc7-9706-f0e9cd2b0096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_16c7ae3c-bb12-42b1-9f35-4d3c3260ae6f" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_16c7ae3c-bb12-42b1-9f35-4d3c3260ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_506a3444-2785-41c9-a03d-b7fe82c1cbc3" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_506a3444-2785-41c9-a03d-b7fe82c1cbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.625DueApril2027Member_e07a520f-6428-4abb-b1af-b0183d3013cf" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.625DueApril2027Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.625DueApril2027Member_e07a520f-6428-4abb-b1af-b0183d3013cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_2f310eaa-90d0-4ed8-bff4-3cff880df2e7" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_2f310eaa-90d0-4ed8-bff4-3cff880df2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_b0d09189-8155-4c7e-b6ae-b8ba889b9e9f" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_b0d09189-8155-4c7e-b6ae-b8ba889b9e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_039c597a-b326-4f45-bd70-b88c433064d7" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_039c597a-b326-4f45-bd70-b88c433064d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_599adf94-ea1e-4a2f-86ac-b14b52fa47f4" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_599adf94-ea1e-4a2f-86ac-b14b52fa47f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5125DueFebruary2030Member_dcbd0e1a-237b-4a8a-8745-6778e2ecade4" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5125DueFebruary2030Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5125DueFebruary2030Member_dcbd0e1a-237b-4a8a-8745-6778e2ecade4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.75DueApril2030Member_2d5b8b68-702d-43f1-9e1b-08c968f7997b" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.75DueApril2030Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.75DueApril2030Member_2d5b8b68-702d-43f1-9e1b-08c968f7997b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_b7565db0-3154-4a58-b2e0-97fe188de624" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_b7565db0-3154-4a58-b2e0-97fe188de624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_37300696-8cda-433f-aca1-af8478694c3e" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_37300696-8cda-433f-aca1-af8478694c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_29df568e-b063-4ceb-9105-0ea059e5e1f8" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes2125PercentDueSeptember2031Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes2125PercentDueSeptember2031Member_29df568e-b063-4ceb-9105-0ea059e5e1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes525DueFebruary2033Member_4480b91a-949a-4fad-bfc0-2755ea3442d0" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes525DueFebruary2033Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes525DueFebruary2033Member_4480b91a-949a-4fad-bfc0-2755ea3442d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_682d6c8f-8710-48a0-a79f-c71f5b9aa83c" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_682d6c8f-8710-48a0-a79f-c71f5b9aa83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_6a173892-08a6-452a-84c9-d88cdc12046d" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_6a173892-08a6-452a-84c9-d88cdc12046d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_99b86ed6-090a-4433-9b13-77f3d3d6f6a2" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_99b86ed6-090a-4433-9b13-77f3d3d6f6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_98ae9339-fab1-469e-adcc-a5522f6c1b83" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_98ae9339-fab1-469e-adcc-a5522f6c1b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_28c64ae0-abc9-4d9e-9f69-9841dbc62300" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_28c64ae0-abc9-4d9e-9f69-9841dbc62300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueApril2040Member_92cdb1cc-4040-40ae-a6e9-9412dc1c7005" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.125DueApril2040Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.125DueApril2040Member_92cdb1cc-4040-40ae-a6e9-9412dc1c7005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_d17798dd-4006-44c7-9d6c-e97e56e3fef0" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_d17798dd-4006-44c7-9d6c-e97e56e3fef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_f138f85c-ceaf-4b93-940d-e8715e0f5795" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_f138f85c-ceaf-4b93-940d-e8715e0f5795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_85aa0342-71f4-4e82-881c-32d92213d4de" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_85aa0342-71f4-4e82-881c-32d92213d4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_2f685e78-840e-43af-99bc-deb769a229a9" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_2f685e78-840e-43af-99bc-deb769a229a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_d8fef234-4374-40b9-bf86-3fe27a99a0ce" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_d8fef234-4374-40b9-bf86-3fe27a99a0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_2052b870-abca-45d2-a553-6f5e5aa4c837" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_2052b870-abca-45d2-a553-6f5e5aa4c837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_e7738c1a-ff24-4e25-9cb9-149c97e8e476" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_e7738c1a-ff24-4e25-9cb9-149c97e8e476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_6ac3ed17-168d-4f99-9742-58b84ad923be" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_6ac3ed17-168d-4f99-9742-58b84ad923be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_1c2cffb8-3535-4e31-9298-c88d3c1ed58b" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_1c2cffb8-3535-4e31-9298-c88d3c1ed58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.25DueApril2050Member_48c0df9f-3c2d-4776-856e-a99079044904" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes4.25DueApril2050Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes4.25DueApril2050Member_48c0df9f-3c2d-4776-856e-a99079044904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5625DueFebruary2053Member_b24ca0bc-a91b-4850-bc59-0f5ef6afd388" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5625DueFebruary2053Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e0fb7635-df39-4da9-a1c3-d3cbc4858cd9" xlink:to="loc_cvs_SeniorNotes5625DueFebruary2053Member_b24ca0bc-a91b-4850-bc59-0f5ef6afd388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_61a61d45-e24b-45ec-af56-8959aeee942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_61a61d45-e24b-45ec-af56-8959aeee942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7dff1b01-8a85-46a8-aa71-0e227a89ec03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_61a61d45-e24b-45ec-af56-8959aeee942d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7dff1b01-8a85-46a8-aa71-0e227a89ec03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_dfa87741-660a-43e5-9147-2d296a4551f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7dff1b01-8a85-46a8-aa71-0e227a89ec03" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_dfa87741-660a-43e5-9147-2d296a4551f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_202beb96-07c8-4d51-9afe-e8f9c5870030" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04629c02-8321-4f5e-85e9-b757d2259ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_04629c02-8321-4f5e-85e9-b757d2259ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ee48cc98-0f51-4d41-8b90-146a3922925e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ee48cc98-0f51-4d41-8b90-146a3922925e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_88c72251-4479-4979-8d26-38d93f587db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_FinanceLeaseLiability_88c72251-4479-4979-8d26-38d93f587db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtGrossAndLeaseObligation_9038135b-a419-4423-8b71-6760d26bb253" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_cvs_LongTermDebtGrossAndLeaseObligation_9038135b-a419-4423-8b71-6760d26bb253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_9f7b2b92-f4a0-4fe9-9616-1b7686a707ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_9f7b2b92-f4a0-4fe9-9616-1b7686a707ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_ae2b54ab-0af1-4d71-af32-fc4a39265b59" xlink:href="cvs-20230331.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_ae2b54ab-0af1-4d71-af32-fc4a39265b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_01eba74e-69c5-4a61-8cdf-7a2abec361cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_01eba74e-69c5-4a61-8cdf-7a2abec361cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_df31b0ab-a996-449d-86f0-92222a164c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_df31b0ab-a996-449d-86f0-92222a164c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_24eb988d-3430-4184-abbd-fe9e0327e0e7" xlink:href="cvs-20230331.xsd#cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_24eb988d-3430-4184-abbd-fe9e0327e0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_bb4bb332-555b-49a7-9d04-1e45f1161348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ca5f8ff4-5a55-4115-abd0-819bcf06505a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_bb4bb332-555b-49a7-9d04-1e45f1161348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#BorrowingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f93c4c6b-9ad2-4248-8612-ea629e242bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f93c4c6b-9ad2-4248-8612-ea629e242bb3" xlink:to="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3f7074f3-d576-4c4e-87b3-e4879d312093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3f7074f3-d576-4c4e-87b3-e4879d312093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_a326ed72-0487-4a71-9371-8ccacd3a5ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3f7074f3-d576-4c4e-87b3-e4879d312093" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_a326ed72-0487-4a71-9371-8ccacd3a5ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_04c4773f-ab9e-4da0-9200-d0bc6a8ee495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_a326ed72-0487-4a71-9371-8ccacd3a5ac5" xlink:to="loc_us-gaap_LineOfCreditMember_04c4773f-ab9e-4da0-9200-d0bc6a8ee495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_511adb8a-caf2-4ca0-90af-44ca6b1d4794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_511adb8a-caf2-4ca0-90af-44ca6b1d4794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_70ca9cc3-7096-4e32-8609-92c8a1973ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_511adb8a-caf2-4ca0-90af-44ca6b1d4794" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_70ca9cc3-7096-4e32-8609-92c8a1973ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_e9efe63b-321c-4f9b-833b-04834a0d6b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70ca9cc3-7096-4e32-8609-92c8a1973ac5" xlink:to="loc_us-gaap_SeniorNotesMember_e9efe63b-321c-4f9b-833b-04834a0d6b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d100ccb2-77fa-4f85-8a1b-08f113172658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_DebtInstrumentAxis_d100ccb2-77fa-4f85-8a1b-08f113172658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d100ccb2-77fa-4f85-8a1b-08f113172658" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TermLoanAgreement364DayMember_64be3214-c1e4-48ec-9050-55dfa3c29e97" xlink:href="cvs-20230331.xsd#cvs_TermLoanAgreement364DayMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_TermLoanAgreement364DayMember_64be3214-c1e4-48ec-9050-55dfa3c29e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes50DueFebruary2026Member_148c2040-fa41-4510-8e25-64abebf3af21" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes50DueFebruary2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes50DueFebruary2026Member_148c2040-fa41-4510-8e25-64abebf3af21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5125DueFebruary2030Member_85a41b89-87dd-4b13-a8fa-668c0413341c" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5125DueFebruary2030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes5125DueFebruary2030Member_85a41b89-87dd-4b13-a8fa-668c0413341c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes525DueFebruary2033Member_6c60ff1f-3e99-4b9b-b4aa-9a5ad0f84bfa" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes525DueFebruary2033Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes525DueFebruary2033Member_6c60ff1f-3e99-4b9b-b4aa-9a5ad0f84bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5625DueFebruary2053Member_f5aad391-0d54-4f1c-89ec-c56b308fc996" xlink:href="cvs-20230331.xsd#cvs_SeniorNotes5625DueFebruary2053Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc12feb3-6ec4-4a3d-8127-72f68b1d8e90" xlink:to="loc_cvs_SeniorNotes5625DueFebruary2053Member_f5aad391-0d54-4f1c-89ec-c56b308fc996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_06304d52-3928-42fd-b99d-2be8a3c39c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_06304d52-3928-42fd-b99d-2be8a3c39c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1fae562b-fefd-4143-a7fc-3ef23e77a5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_06304d52-3928-42fd-b99d-2be8a3c39c43" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1fae562b-fefd-4143-a7fc-3ef23e77a5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_79fea16b-fa62-490c-858e-15db21dca4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1fae562b-fefd-4143-a7fc-3ef23e77a5c9" xlink:to="loc_us-gaap_SubsequentEventMember_79fea16b-fa62-490c-858e-15db21dca4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e4b6cd53-8d1f-4818-b881-ea02182ddb1a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2572e3a0-fc87-48fb-8204-3ce3d99d54cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2572e3a0-fc87-48fb-8204-3ce3d99d54cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_90099ff0-36e9-42da-9b2e-6dd68861e36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_90099ff0-36e9-42da-9b2e-6dd68861e36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d63f0d8c-8827-43e1-8ac8-d6dd9d8a2a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3b1ae2d-4242-4550-8844-668a9d46050b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d63f0d8c-8827-43e1-8ac8-d6dd9d8a2a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_07c3f72d-8270-41c8-b490-8a043778f2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_b0e90bea-9d95-405d-92ba-5cb0ad10d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_07c3f72d-8270-41c8-b490-8a043778f2bb" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_b0e90bea-9d95-405d-92ba-5cb0ad10d77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_b0e90bea-9d95-405d-92ba-5cb0ad10d77a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_83cd1f7c-cdf9-4cde-bdb3-27ba48919dbb" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2022RepurchaseProgramMember_a9c6551a-1877-452f-bb5b-16ca23907e33" xlink:href="cvs-20230331.xsd#cvs_A2022RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:to="loc_cvs_A2022RepurchaseProgramMember_a9c6551a-1877-452f-bb5b-16ca23907e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_6522e1cd-e119-4efe-8dd6-e1d7e4cb78c0" xlink:href="cvs-20230331.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_31c8f375-142f-4dc8-a4e2-22b6a23fbd2e" xlink:to="loc_cvs_A2021RepurchaseProgramMember_6522e1cd-e119-4efe-8dd6-e1d7e4cb78c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_b0e90bea-9d95-405d-92ba-5cb0ad10d77a" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1b606287-516d-412a-aa1e-a4b32bcd0549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1b606287-516d-412a-aa1e-a4b32bcd0549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b4d2ffed-c901-493e-b0f4-c2c6fc8752ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b4d2ffed-c901-493e-b0f4-c2c6fc8752ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0031a87c-d9c4-4e95-bb26-d91354f8a7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0031a87c-d9c4-4e95-bb26-d91354f8a7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_7a61a604-94f6-4b74-b097-1a6ecc6d7018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_11f7f53a-be67-411b-8bf1-ccbd8d26b19d" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_7a61a604-94f6-4b74-b097-1a6ecc6d7018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_07da92cd-1371-4ecc-8074-f3f9e09d5f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_07da92cd-1371-4ecc-8074-f3f9e09d5f97" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e4ade164-1924-4e54-b1c5-2936edcb6913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e4ade164-1924-4e54-b1c5-2936edcb6913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_dc4c956a-d877-4b57-8f28-656afeb04d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e4ade164-1924-4e54-b1c5-2936edcb6913" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_dc4c956a-d877-4b57-8f28-656afeb04d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_621307c7-19e5-4e98-80f0-cd49ea8e7dca" xlink:href="cvs-20230331.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_dc4c956a-d877-4b57-8f28-656afeb04d10" xlink:to="loc_cvs_A2021RepurchaseProgramMember_621307c7-19e5-4e98-80f0-cd49ea8e7dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5574defa-5814-4011-a098-475fec3e12bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:to="loc_srt_CounterpartyNameAxis_5574defa-5814-4011-a098-475fec3e12bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5574defa-5814-4011-a098-475fec3e12bd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CitibankNAMember_e993754c-4200-408c-a517-1c276a02236b" xlink:href="cvs-20230331.xsd#cvs_CitibankNAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:to="loc_cvs_CitibankNAMember_e993754c-4200-408c-a517-1c276a02236b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_176f8b18-1374-438f-bdaa-2e396bcc277f" xlink:href="cvs-20230331.xsd#cvs_BarclaysBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a1d28861-d966-49cc-aafb-8ffe588ccbc1" xlink:to="loc_cvs_BarclaysBankMember_176f8b18-1374-438f-bdaa-2e396bcc277f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_15ac8a7f-408c-4867-98f4-4223e9845eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3fdd5f21-b0b8-4b01-af9e-ef5154d8c176" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_15ac8a7f-408c-4867-98f4-4223e9845eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_e3bf69e0-02b4-450d-99a7-16e7917aa0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_15ac8a7f-408c-4867-98f4-4223e9845eb4" xlink:to="loc_us-gaap_ForwardContractsMember_e3bf69e0-02b4-450d-99a7-16e7917aa0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_492b9144-73b3-48b7-90bd-1c90c9626277" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_c24fba42-3663-4a0a-9593-089e4ab96725" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_c24fba42-3663-4a0a-9593-089e4ab96725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_2df377a1-d801-4b26-bdb4-60f52292b3cf" xlink:href="cvs-20230331.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_2df377a1-d801-4b26-bdb4-60f52292b3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_f0c34376-3a9e-407e-b5c6-98eeefa07ec7" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_f0c34376-3a9e-407e-b5c6-98eeefa07ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_3bb1fc85-94bc-40ac-b211-0595c714226c" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_3bb1fc85-94bc-40ac-b211-0595c714226c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_7b78a867-7b46-4e03-8196-35ed35f23ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_us-gaap_SharePrice_7b78a867-7b46-4e03-8196-35ed35f23ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue_99fbd79a-48b3-41a7-9255-69c1b8c66754" xlink:href="cvs-20230331.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_TransferOfSharesToTreasuryStockValue_99fbd79a-48b3-41a7-9255-69c1b8c66754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e1d7a7f6-193d-40af-a801-c04d412d3ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e1d7a7f6-193d-40af-a801-c04d412d3ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_bb674304-c5db-494b-a6d9-0f07e47a84a5" xlink:href="cvs-20230331.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3e2bf90b-12d1-4333-ad95-8d203aff54cf" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_bb674304-c5db-494b-a6d9-0f07e47a84a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#ShareholdersEquityDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0e2d242a-ac5d-4471-97c7-cdeca4547430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_aebdaecf-9811-437e-87c4-9c92ab619e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0e2d242a-ac5d-4471-97c7-cdeca4547430" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_aebdaecf-9811-437e-87c4-9c92ab619e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f0c527cd-0667-4c57-885a-9279a32de21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f0c527cd-0667-4c57-885a-9279a32de21d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_208469c2-77f6-4d65-9317-e708464d41fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_208469c2-77f6-4d65-9317-e708464d41fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_208469c2-77f6-4d65-9317-e708464d41fa" xlink:to="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4da819f3-2b97-4e0f-a032-efb5afc084a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4da819f3-2b97-4e0f-a032-efb5afc084a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_b7904565-bb19-4516-a9f3-f74986920cf9" xlink:href="cvs-20230331.xsd#cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_b7904565-bb19-4516-a9f3-f74986920cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_699ec14a-ae32-4c00-97e3-a6650301488a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_699ec14a-ae32-4c00-97e3-a6650301488a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_375ce83d-16d1-4c87-b9fa-5922c075d114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_375ce83d-16d1-4c87-b9fa-5922c075d114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_ef058bef-e3bf-4134-8add-db24c4ab339c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_ef058bef-e3bf-4134-8add-db24c4ab339c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_35b4ac0d-b700-4630-b785-54c5b4637d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_86b396eb-393f-44a9-b2f2-4e8e9fbe8bb1" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_35b4ac0d-b700-4630-b785-54c5b4637d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a40cddb-7c5e-471c-9fde-c71611555aca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a40cddb-7c5e-471c-9fde-c71611555aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f52c7a58-6bda-4e99-bda5-7c834fbec07a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3a40cddb-7c5e-471c-9fde-c71611555aca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f52c7a58-6bda-4e99-bda5-7c834fbec07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbaf584e-ba5f-4099-a611-85732f483e61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f52c7a58-6bda-4e99-bda5-7c834fbec07a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbaf584e-ba5f-4099-a611-85732f483e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_8ee9ad84-9a0f-4206-bde8-bae137574a83" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d9dba3de-3266-4408-885a-b58364d2bd25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d9dba3de-3266-4408-885a-b58364d2bd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6bd0db9f-87c7-454d-806b-5df70db95dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6bd0db9f-87c7-454d-806b-5df70db95dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b2d734ef-d375-4560-8589-314e3ee37881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b2d734ef-d375-4560-8589-314e3ee37881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81ab5cf8-d058-4a6e-bb5b-9bdc9eac721e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_81ab5cf8-d058-4a6e-bb5b-9bdc9eac721e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02282325-e0eb-475a-b2ad-7c6ceef33327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_c3d0e02b-ffc4-4550-9078-36fdb9357bf2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_02282325-e0eb-475a-b2ad-7c6ceef33327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_5a68651c-9b82-4747-8dd4-1cfe6bc1dd74" xlink:href="cvs-20230331.xsd#cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_5a68651c-9b82-4747-8dd4-1cfe6bc1dd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2c205e89-8b96-40ad-9694-54157e5f9748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2c205e89-8b96-40ad-9694-54157e5f9748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_4ff48130-566c-441e-b80a-5cc57b6a537e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_4ff48130-566c-441e-b80a-5cc57b6a537e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_855e399a-fada-49dc-8c7a-0a33add0b846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_855e399a-fada-49dc-8c7a-0a33add0b846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3c952147-f25b-4ca4-af71-d81a589c1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_60934232-2f29-47d9-bf23-e6ecca41aea6" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3c952147-f25b-4ca4-af71-d81a589c1a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4832d7c2-1c96-4a30-aee1-eb107eec7451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_dd6ba9dd-35ce-432a-88fe-fae3bf8945e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4832d7c2-1c96-4a30-aee1-eb107eec7451" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_dd6ba9dd-35ce-432a-88fe-fae3bf8945e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ae97acd5-db65-4511-af02-8f953827ea75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_dd6ba9dd-35ce-432a-88fe-fae3bf8945e1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ae97acd5-db65-4511-af02-8f953827ea75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ae97acd5-db65-4511-af02-8f953827ea75" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_0dfc1ed8-1474-4430-8d9a-5be23f749aed" xlink:href="cvs-20230331.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:to="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_0dfc1ed8-1474-4430-8d9a-5be23f749aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember_0b6183a5-7d4e-4713-9832-f28735d55696" xlink:href="cvs-20230331.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4680d23e-ad83-4af5-9efe-5c92f2b930d3" xlink:to="loc_cvs_StockOptionsAndStockAppreciationRightsMember_0b6183a5-7d4e-4713-9832-f28735d55696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_dd6ba9dd-35ce-432a-88fe-fae3bf8945e1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ddd75bae-064d-4ac6-bc62-ef800ce1ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ddd75bae-064d-4ac6-bc62-ef800ce1ad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b627a5c8-04d2-4b8c-9396-2ea8cb0e9de6" xlink:href="cvs-20230331.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b627a5c8-04d2-4b8c-9396-2ea8cb0e9de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0b87eedc-fc8e-4e98-881b-60939a6a6180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b627a5c8-04d2-4b8c-9396-2ea8cb0e9de6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0b87eedc-fc8e-4e98-881b-60939a6a6180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:href="cvs-20230331.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6636beb-05f9-4a93-afb4-159ddd8a78b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6636beb-05f9-4a93-afb4-159ddd8a78b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7c8cac2a-600d-4821-94cb-850c86814d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7c8cac2a-600d-4821-94cb-850c86814d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2382e5b0-4d30-47fd-aae2-3ac7121ccd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_9dcc4539-fec2-42be-9de2-0cbc4a635fdc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2382e5b0-4d30-47fd-aae2-3ac7121ccd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:href="cvs-20230331.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a5303f78-0346-41c0-aac7-4457a6e2cfe5" xlink:to="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f33d3bdd-1e20-49d9-87d0-b36db5784053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:to="loc_us-gaap_EarningsPerShareBasic_f33d3bdd-1e20-49d9-87d0-b36db5784053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a4e38cd4-249a-4762-a8dd-a739679f512f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_d8398c3c-5078-41af-a751-1c4a5446fbd2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a4e38cd4-249a-4762-a8dd-a739679f512f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1087a68f-1972-4214-9d0c-26e55b61ede4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberOfLeases_69f61e38-3f9d-4f95-bd49-f3970443497e" xlink:href="cvs-20230331.xsd#cvs_GuarantorObligationsNumberOfLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1087a68f-1972-4214-9d0c-26e55b61ede4" xlink:to="loc_cvs_GuarantorObligationsNumberOfLeases_69f61e38-3f9d-4f95-bd49-f3970443497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1087a68f-1972-4214-9d0c-26e55b61ede4" xlink:to="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8bc5df1d-a572-40dc-829d-fdde84eefacb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:to="loc_srt_LitigationCaseAxis_8bc5df1d-a572-40dc-829d-fdde84eefacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8bc5df1d-a572-40dc-829d-fdde84eefacb" xlink:to="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FederalCourtInOhioJudgmentMember_3ef745c2-70d7-49c5-8733-d1d4fc381d84" xlink:href="cvs-20230331.xsd#cvs_FederalCourtInOhioJudgmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_FederalCourtInOhioJudgmentMember_3ef745c2-70d7-49c5-8733-d1d4fc381d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkMember_441d37d6-4298-4e8c-92ee-5dc02ea3a33a" xlink:href="cvs-20230331.xsd#cvs_SettlementFrameworkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_SettlementFrameworkMember_441d37d6-4298-4e8c-92ee-5dc02ea3a33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_b55a2c79-c180-4017-a53c-ca7a61344854" xlink:href="cvs-20230331.xsd#cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_b55a2c79-c180-4017-a53c-ca7a61344854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_01919206-012e-418b-8694-ce420909dd40" xlink:href="cvs-20230331.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_20782491-e43d-44eb-b673-31e289e20012" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_01919206-012e-418b-8694-ce420909dd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7cc5330a-b20e-4ecb-91eb-81700fca33c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:to="loc_us-gaap_LitigationStatusAxis_7cc5330a-b20e-4ecb-91eb-81700fca33c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_65cf06ce-92de-44ee-aad2-052ee30c01d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_7cc5330a-b20e-4ecb-91eb-81700fca33c8" xlink:to="loc_us-gaap_LitigationStatusDomain_65cf06ce-92de-44ee-aad2-052ee30c01d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_b59ccefc-e887-409a-9bd9-a4aa1aa7ff02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_65cf06ce-92de-44ee-aad2-052ee30c01d6" xlink:to="loc_us-gaap_PendingLitigationMember_b59ccefc-e887-409a-9bd9-a4aa1aa7ff02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d941a249-e943-40ed-83c4-f53f0c4a0130" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:to="loc_srt_CounterpartyNameAxis_d941a249-e943-40ed-83c4-f53f0c4a0130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76b2f89e-42ef-406c-8075-8758ea139636" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d941a249-e943-40ed-83c4-f53f0c4a0130" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76b2f89e-42ef-406c-8075-8758ea139636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TribalEntitiesMember_d9b85bf6-b637-492c-8317-f454bdafb563" xlink:href="cvs-20230331.xsd#cvs_TribalEntitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_76b2f89e-42ef-406c-8075-8758ea139636" xlink:to="loc_cvs_TribalEntitiesMember_d9b85bf6-b637-492c-8317-f454bdafb563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0b8c3fd1-8498-42d9-bd85-21209228a6a6" xlink:to="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_2faf4765-6331-4850-8b56-b8c18e635828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_2faf4765-6331-4850-8b56-b8c18e635828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_40fb4601-2924-4d2e-9aae-0537418da93a" xlink:href="cvs-20230331.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_40fb4601-2924-4d2e-9aae-0537418da93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_f8362cf9-e5f7-4b64-a02a-ab9dcdbacb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_LegalFees_f8362cf9-e5f7-4b64-a02a-ab9dcdbacb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_7815145f-40b1-4883-bff1-10ad2ab0f29f" xlink:href="cvs-20230331.xsd#cvs_LitigationSettlementNumberOfStatesElectedToJoin"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_7815145f-40b1-4883-bff1-10ad2ab0f29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements_82c6a596-47ce-4890-ba7a-b92f4f41e2a1" xlink:href="cvs-20230331.xsd#cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements_82c6a596-47ce-4890-ba7a-b92f4f41e2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_b707c8aa-ce0e-4649-8e5c-29ccaa73017b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_b707c8aa-ce0e-4649-8e5c-29ccaa73017b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_836e3af1-296a-42e2-bfcb-5809407732e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8a218e72-b027-4750-aa51-69c66ea8d062" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_836e3af1-296a-42e2-bfcb-5809407732e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d3fc6134-1657-4143-920c-ee60759e6f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_6582edae-4100-4a1f-99f9-4e6335be0b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d3fc6134-1657-4143-920c-ee60759e6f76" xlink:to="loc_us-gaap_NumberOfOperatingSegments_6582edae-4100-4a1f-99f9-4e6335be0b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_02dbdfb7-4a08-4143-8c04-4c9424ca1747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_02dbdfb7-4a08-4143-8c04-4c9424ca1747" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e4e2ee88-1bf0-45fc-afa2-5f162699243c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:to="loc_srt_RestatementAxis_e4e2ee88-1bf0-45fc-afa2-5f162699243c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_e4e2ee88-1bf0-45fc-afa2-5f162699243c" xlink:to="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_3fa4bd6b-6ab2-442c-b245-e4d11b759a08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_3fa4bd6b-6ab2-442c-b245-e4d11b759a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_820ee566-01fe-4433-9457-85a2d0af7018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_67c3c49a-c37d-456e-9a9e-8ee417920fac" xlink:to="loc_srt_RestatementAdjustmentMember_820ee566-01fe-4433-9457-85a2d0af7018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d94d396b-7d84-42ac-955e-6de15fc541f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d94d396b-7d84-42ac-955e-6de15fc541f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d94d396b-7d84-42ac-955e-6de15fc541f8" xlink:to="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ffd64300-cd36-4419-a302-ebd14ad13752" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ffd64300-cd36-4419-a302-ebd14ad13752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_4440b534-5adb-4cc2-aa77-bf96b65570f3" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:to="loc_cvs_HealthServicesSegmentMember_4440b534-5adb-4cc2-aa77-bf96b65570f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_c2eee53c-1772-4212-accf-dead55a36fa3" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_710c936d-9fc6-4ccd-a7dd-742ce6a3f139" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_c2eee53c-1772-4212-accf-dead55a36fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_17fa3935-664a-4efa-9e76-80ba124172fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:to="loc_srt_ConsolidationItemsAxis_17fa3935-664a-4efa-9e76-80ba124172fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_17fa3935-664a-4efa-9e76-80ba124172fc" xlink:to="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7e49c230-4779-488d-868b-fa639b760313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:to="loc_us-gaap_OperatingSegmentsMember_7e49c230-4779-488d-868b-fa639b760313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c9d04683-f4b0-4f92-8013-e75c73483163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c9d04683-f4b0-4f92-8013-e75c73483163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_218b501e-a38f-4c2e-8543-49ba14a7dc47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8e0511f3-3475-4d8b-b29e-e07bd62f87ac" xlink:to="loc_us-gaap_IntersegmentEliminationMember_218b501e-a38f-4c2e-8543-49ba14a7dc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_3dc7c805-9a15-44b8-986a-ef2553f4f2dd" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9888254b-45e3-43a1-a65d-2c8511cf81ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:to="loc_us-gaap_Revenues_9888254b-45e3-43a1-a65d-2c8511cf81ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_6267b5e0-603a-4989-b96a-0ef0904ecc26" xlink:href="cvs-20230331.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_39b77298-4060-4823-9fe4-18a0b8156184" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_6267b5e0-603a-4989-b96a-0ef0904ecc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_439ce168-a1b6-42c1-a170-692e5ce53686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_439ce168-a1b6-42c1-a170-692e5ce53686" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e4857fc5-d984-4863-94a3-861b1db72dcf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:to="loc_srt_ConsolidationItemsAxis_e4857fc5-d984-4863-94a3-861b1db72dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e4857fc5-d984-4863-94a3-861b1db72dcf" xlink:to="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_47d394f9-96a7-4bd1-816b-e2f843e1abc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:to="loc_us-gaap_OperatingSegmentsMember_47d394f9-96a7-4bd1-816b-e2f843e1abc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a8cfc088-f692-4c14-8492-7b1cffa8784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a8cfc088-f692-4c14-8492-7b1cffa8784b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_0dc04796-f0b3-4bc3-91b1-668de1e9e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_40bcc60b-88c0-4211-a050-c03c99577249" xlink:to="loc_us-gaap_IntersegmentEliminationMember_0dc04796-f0b3-4bc3-91b1-668de1e9e05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8dd052e-7aa4-4ccd-9cc8-1d18d0d5a44c" xlink:to="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_494fb942-f696-4c93-b6ed-cb7c2ba0eae1" xlink:href="cvs-20230331.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_494fb942-f696-4c93-b6ed-cb7c2ba0eae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_e34b2992-b9d9-4a90-a6c8-ade05d62cb32" xlink:href="cvs-20230331.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:to="loc_cvs_HealthServicesSegmentMember_e34b2992-b9d9-4a90-a6c8-ade05d62cb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_f154276a-d422-497e-b9bc-787c06fbae75" xlink:href="cvs-20230331.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d754a71-41f5-40bd-b7f1-09217b240287" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_f154276a-d422-497e-b9bc-787c06fbae75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_7896cb14-9aea-455c-a765-ea3a00ebcbb0" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_7828b36f-66cf-480c-8847-b0e0abc0c8b8" xlink:href="cvs-20230331.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_7828b36f-66cf-480c-8847-b0e0abc0c8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58f5b166-ed88-440b-9132-c8e679bd41ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_58f5b166-ed88-440b-9132-c8e679bd41ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_97b10ab5-bc94-4866-8414-b750b687fc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_us-gaap_NetInvestmentIncome_97b10ab5-bc94-4866-8414-b750b687fc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0b7bbc74-bccc-4139-a88a-0fa248da01af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_us-gaap_Revenues_0b7bbc74-bccc-4139-a88a-0fa248da01af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_f9fd890b-e44a-4276-95c2-115786b11ac4" xlink:href="cvs-20230331.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_f9fd890b-e44a-4276-95c2-115786b11ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_44b62548-e0d8-42cf-a808-dbe6676acb8d" xlink:href="cvs-20230331.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_30b855ac-bf63-421b-b7ed-bf8ec0455c53" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_44b62548-e0d8-42cf-a808-dbe6676acb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20230331.xsd#SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_000a2c8e-a527-4181-8ea2-c3ba4ddcc580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_us-gaap_OperatingIncomeLoss_000a2c8e-a527-4181-8ea2-c3ba4ddcc580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_59fd704c-cc4b-428e-a01e-8a30e91c563f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_59fd704c-cc4b-428e-a01e-8a30e91c563f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_c04dab32-6200-4b7b-b089-6a38cf8ea810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_c04dab32-6200-4b7b-b089-6a38cf8ea810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_79f37c7b-3672-4ec5-a169-5649e02dabc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_79f37c7b-3672-4ec5-a169-5649e02dabc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_91519357-8f3d-4ea1-8786-ea53251a03ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_91519357-8f3d-4ea1-8786-ea53251a03ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges_79f86ce6-5d5e-4108-864f-9e78aeba903b" xlink:href="cvs-20230331.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_cvs_OfficeRealEstateOptimizationCharges_79f86ce6-5d5e-4108-864f-9e78aeba903b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_3b64e5c4-4cda-4028-9d52-e87e758b7544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_3b64e5c4-4cda-4028-9d52-e87e758b7544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_49b8bbb5-20f8-40fc-92c9-329c81f68f43" xlink:href="cvs-20230331.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba63e3c2-3197-4ece-93a9-13a3ec370ba1" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_49b8bbb5-20f8-40fc-92c9-329c81f68f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cvs-20230331_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20230331_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153414972576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,282,025,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409073952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 24,352<span></span>
</td>
<td class="nump">$ 21,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">85,278<span></span>
</td>
<td class="nump">76,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">51,455<span></span>
</td>
<td class="nump">45,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">20,448<span></span>
</td>
<td class="nump">17,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="nump">9,580<span></span>
</td>
<td class="nump">9,324<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">81,832<span></span>
</td>
<td class="nump">73,281<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,446<span></span>
</td>
<td class="nump">3,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">2,879<span></span>
</td>
<td class="nump">3,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">737<span></span>
</td>
<td class="nump">646<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">2,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 2,136<span></span>
</td>
<td class="nump">$ 2,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">1,283<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">1,291<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.605<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 58,147<span></span>
</td>
<td class="nump">$ 52,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 2,445<span></span>
</td>
<td class="nump">$ 2,505<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153413459504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,142<span></span>
</td>
<td class="nump">$ 2,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains (losses)</a></td>
<td class="nump">470<span></span>
</td>
<td class="num">(1,132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax', window );">Change in discount rate on long-duration insurance reserves</a></td>
<td class="num">(74)<span></span>
</td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">389<span></span>
</td>
<td class="num">(763)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to CVS Health</a></td>
<td class="nump">$ 2,525<span></span>
</td>
<td class="nump">$ 1,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of unrealized gain (loss) from (increase) decrease in liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (m)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409036704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 14,618<span></span>
</td>
<td class="nump">$ 12,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">3,102<span></span>
</td>
<td class="nump">2,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">28,331<span></span>
</td>
<td class="nump">27,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">18,263<span></span>
</td>
<td class="nump">19,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">3,767<span></span>
</td>
<td class="nump">2,636<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">68,706<span></span>
</td>
<td class="nump">65,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">21,612<span></span>
</td>
<td class="nump">21,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,872<span></span>
</td>
<td class="nump">12,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">17,660<span></span>
</td>
<td class="nump">17,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">84,057<span></span>
</td>
<td class="nump">78,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">26,368<span></span>
</td>
<td class="nump">24,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">3,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,824<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">239,330<span></span>
</td>
<td class="nump">228,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">12,527<span></span>
</td>
<td class="nump">14,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PharmacyClaimsAndDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">20,047<span></span>
</td>
<td class="nump">19,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="nump">10,895<span></span>
</td>
<td class="nump">10,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">21,515<span></span>
</td>
<td class="nump">18,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">4,974<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">75,054<span></span>
</td>
<td class="nump">69,421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">16,571<span></span>
</td>
<td class="nump">16,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">56,450<span></span>
</td>
<td class="nump">50,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">3,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">5,678<span></span>
</td>
<td class="nump">5,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">6,671<span></span>
</td>
<td class="nump">6,730<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">167,750<span></span>
</td>
<td class="nump">156,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,759 shares issued and 1,279 shares outstanding at March&#160;31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December&#160;31, 2022 and capital surplus</a></td>
<td class="nump">48,306<span></span>
</td>
<td class="nump">48,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 480 shares at March&#160;31, 2023 and 458 shares at December&#160;31, 2022</a></td>
<td class="num">(33,802)<span></span>
</td>
<td class="num">(31,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">57,753<span></span>
</td>
<td class="nump">56,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(875)<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">71,382<span></span>
</td>
<td class="nump">71,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">71,580<span></span>
</td>
<td class="nump">71,769<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 239,330<span></span>
</td>
<td class="nump">$ 228,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsAndDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims And Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsAndDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405266448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,759,000,000<span></span>
</td>
<td class="nump">1,758,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,279,000,000<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">480,000,000<span></span>
</td>
<td class="nump">458,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409063808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 87,798<span></span>
</td>
<td class="nump">$ 74,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies', window );">Cash paid for prescriptions dispensed and health services rendered</a></td>
<td class="num">(50,223)<span></span>
</td>
<td class="num">(44,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(19,757)<span></span>
</td>
<td class="num">(16,616)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(9,958)<span></span>
</td>
<td class="num">(8,969)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(773)<span></span>
</td>
<td class="num">(782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">7,438<span></span>
</td>
<td class="nump">3,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">1,891<span></span>
</td>
<td class="nump">2,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(2,358)<span></span>
</td>
<td class="num">(3,474)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(984)<span></span>
</td>
<td class="num">(1,051)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(7,094)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(8,514)<span></span>
</td>
<td class="num">(1,993)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">5,951<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(362)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(2,018)<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(779)<span></span>
</td>
<td class="num">(722)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">2,726<span></span>
</td>
<td class="num">(2,650)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">1,650<span></span>
</td>
<td class="num">(1,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">13,305<span></span>
</td>
<td class="nump">12,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">14,955<span></span>
</td>
<td class="nump">11,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">2,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredIncomeTaxesAndOtherNoncashItems', window );">Deferred income taxes and other noncash items</a></td>
<td class="nump">155<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(751)<span></span>
</td>
<td class="num">(1,967)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">828<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(1,255)<span></span>
</td>
<td class="num">(348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="num">(1,203)<span></span>
</td>
<td class="nump">1,974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">4,382<span></span>
</td>
<td class="nump">1,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">2,036<span></span>
</td>
<td class="num">(444)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 7,438<span></span>
</td>
<td class="nump">$ 3,563<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredIncomeTaxesAndOtherNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredIncomeTaxesAndOtherNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409456224">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Total CVS Health Shareholders&#8217; Equity</div></th>
<th class="th">
<div>Total CVS Health Shareholders&#8217; Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Common Shares</div></th>
<th class="th" colspan="2"><div>Treasury Stock</div></th>
<th class="th" colspan="2"><div>Common Stock and Capital Surplus</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th">
<div>Accumulated Other Comprehensive Income (Loss) </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 75,381<span></span>
</td>
<td colspan="2" class="num">$ (540)<span></span>
</td>
<td class="nump">$ 75,075<span></span>
</td>
<td colspan="2" class="num">$ (540)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 47,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 54,906<span></span>
</td>
<td colspan="2" class="nump">$ 91<span></span>
</td>
<td class="nump">$ 965<span></span>
</td>
<td colspan="2" class="num">$ (631)<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,355<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,354<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,354<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(763)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(763)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(763)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,972)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(1,972)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,972)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(730)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(730)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(730)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,034<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">73,724<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">47,677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">56,621<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(429)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(458)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,769<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">71,469<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,858)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">48,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">56,398<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,142<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,136<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,136<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">389<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">122<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">122<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,962)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(1,962)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,944)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(781)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(781)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(781)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(99)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, balance at end of period (in shares) at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(480)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 71,580<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,382<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33,802)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 48,306<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 57,753<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">$ (875)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
</tr>
<tr><td colspan="19"></td></tr>
<tr><td colspan="19"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of March&#160;31, 2023 and 2022 and December&#160;31, 2022 and 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 944)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> during the three months ended March 31, 2023. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $18 million as of March&#160;31, 2023 and December&#160;31, 2022 and $17 million as of March&#160;31, 2022 and December&#160;31, 2021.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412524480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldInTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury share held in trust</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held In Trust</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153415885648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company is a leader in key segments of health care through its foundational businesses and is creating new sources of value by expanding into next generation care delivery and health services, with a goal of improving satisfaction levels for both providers and consumers. The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Prior period segment financial information has been recast to conform with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the segment realignment described above, the Company&#8217;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Health Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of March&#160;31, 2023, the Pharmacy &amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;2022 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets primarily represents funds held on behalf of members and funds held in escrow in connection with agreements with accountable care organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All restricted cash is invested in demand deposits, time deposits and money market funds. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net at March&#160;31, 2023 and December&#160;31, 2022 was composed of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes accounts receivable of $211&#160;million and $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $324 million and $333 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Contract Acquisition Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the unaudited condensed consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#8217;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the unaudited condensed consolidated statements of operations. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of deferred acquisition costs for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalizations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the unaudited condensed consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; and Note 6 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information about separate accounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Policy Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts and are recorded in other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for limited payment pension and annuity contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for long-term care insurance contracts represent the Company&#8217;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#8217;s </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#8217;s future cash flows. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discounts its future policy benefit liability using a curve of spot rates derived from an upper-medium grade fixed-income investment. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot rate curve and the locked-in discount rate at each cohort&#8217;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss). In subsequent periods, the current period amount recorded in other comprehensive income (loss) will be adjusted for amounts previously recorded in accumulated other comprehensive loss.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, future policy benefits balances of $529&#160;million and $4.6&#160;billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2022, future policy benefits balances of $334&#160;million and $4.7&#160;billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information about future policy benefits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:30.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.196%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer <br/>Wellness </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,732)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty. Prior period financial information has been revised to conform with current period presentation. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Health Services mail &amp; specialty is defined as specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Prior period financial information has been revised to conform with current period presentation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and primarily include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. During the three months ended March&#160;31, 2023, the contract liabilities balance also reflects the addition of contract liabilities acquired in connection with the Company&#8217;s acquisition of Signify Health, Inc. (&#8220;Signify Health&#8221;) on March 29, 2023. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $17 million and $15 million in the three months ended March&#160;31, 2023 and 2022, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $21 million for pharmaceutical inventory purchases during the three months ended March&#160;31, 2023 and 2022, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944) (the &#8220;long-duration insurance standard&#8221;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented, January 1, 2021, also referred to as the &#8220;transition date&#8221;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $986&#160;million ($766&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. The transition date </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information has been  revised to reflect the adoption of the long-duration insurance standard.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Removal of shadow adjustments in accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span id="i91763596c6af4e16a382b50f4b12646c_8-0-1-1-256536"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021, net of reinsurance </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of Long-Duration Insurance Standard Adoption on Financial Statement Line Items</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of operations for the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,923</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,351</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,324</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,336</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,281</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,490</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,312</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,354</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated balance sheet as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,682</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,633</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,754</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,803</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,736</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,421</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,880</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,108</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,730</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,960</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,506</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,465)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,469</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,315</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,769</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of cash flows for the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153415902944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisition and Assets Held for Sale</a></td>
<td class="text">Acquisitions and Assets Held for Sale<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Signify Health Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2023 (the &#8220;Signify Health Acquisition Date&#8221;), the Company acquired 100% of the outstanding shares and voting interest of Signify Health for cash (&#8220;Signify Health Acquisition&#8221;). Under the terms of the merger agreement, Signify Health stockholders received $30.50 per share in cash. The Company financed the transaction with cash on hand, which included approximately $6&#160;billion of proceeds from the issuance of senior unsecured notes in February 2023. Signify Health is a leader in health risk assessments, value-based care and provider enablement services. The Company will include Signify Health within the Health Services segment. The Company acquired Signify Health to advance its health care services strategy, growth in value-based care and new product offerings for other payers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the consideration transferred on the date of acquisition consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of replacement equity awards for pre-combination services (3.2&#160;million shares) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective settlement of pre-existing relationship </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The fair value of the replacement equity awards issued by the Company was determined as of the Signify Health Acquisition Date. The fair value of the awards attributed to pre-combination services of $14 million is included in the consideration transferred and the fair value of the awards attributed to post-combination services of $167&#160;million has been, or will be, included in the Company&#8217;s post-combination financial statements as compensation costs.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The purchase price included $111 million of effectively settled liabilities the Company owed to Signify Health from their pre-existing relationship. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction has been accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets (including restricted cash of $28)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,590&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (current and long-term)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assessment of fair value is preliminary and is based on information that was available to management at the time the unaudited condensed consolidated financial statements were prepared. The most significant open items included the valuation of certain intangible assets, the estimation of certain contract assets and contract liabilities, the accounting for income taxes and the accounting for contingencies as management is awaiting additional information to complete its assessment of these matters. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date. The finalization of the Company&#8217;s purchase accounting assessment could result in changes in the valuation of assets acquired and liabilities assumed, which could be material.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents future economic benefits expected to arise from the Company&#8217;s expanded presence in the health services industry, the assembled workforce acquired, expected revenue and medical cost synergies, as well as operating efficiencies and cost savings. The preliminary valuation of goodwill was allocated to the Company&#8217;s business segments as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy &amp; Consumer Wellness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $1.7&#160;billion of goodwill is deductible for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary fair values and weighted average useful lives for intangible assets acquired in the Signify Health Acquisition, each of which is subject to change as the Company finalizes its purchase accounting:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average useful life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted <br/>Average Useful<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark (definite-lived)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation includes net deferred tax liabilities of $256&#160;million, primarily related to deferred tax liabilities established on the identifiable acquired intangible assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for Signify Health from the Signify Health Acquisition Date to March&#160;31, 2023 were immaterial to the Company&#8217;s consolidated results of operations for the three months ended March 31, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company incurred transaction costs of $37&#160;million associated with the Signify Health Acquisition that were recorded within operating expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Oak Street Health Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2023, the Company acquired 100% of the outstanding shares and voting interest of Oak Street Health, Inc. (&#8220;Oak Street Health&#8221;) for cash. Under the terms of the merger agreement, Oak Street Health stockholders received $39.00 per share in cash. The total value of the transaction was approximately $10.6&#160;billion. The Company financed the transaction with borrowings of $5.0&#160;billion from a term loan agreement entered into on May 1, 2023 as described in Note 7 &#8216;&#8216;Borrowings&#8217;&#8217; and cash on hand. Oak Street Health is a leading multi-payor, senior focused value-based primary care company. The Company will include Oak Street Health within the Health Services segment. The Company acquired Oak Street Health to advance its value-based care strategy and broaden its platform into primary care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Held For Sale</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> long-term care business (&#8220;LTC business&#8221;), which is included within the Pharmacy &amp; Consumer Wellness segment, was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. During 2022, the LTC business met the criteria to be classified as held for sale and the carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell. Accordingly, the Company recorded total losses on assets held for sale of $2.5&#160;billion during the year ended December&#160;31, 2022. As of March&#160;31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting. During the three months ended March&#160;31, 2023, an incremental loss on assets held for sale of $349 million was recorded to write-down the carrying value of the LTC business to the Company&#8217;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. The loss on assets held for sale </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represents the write-down of long-lived assets and was recorded in the Company&#8217;s unaudited condensed consolidated statement of operations within the Pharmacy &amp; Consumer Wellness segment. The LTC business operating income was not material for the three months ended March&#160;31, 2023 and 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC business met the criteria to be classified as held for sale at both March&#160;31, 2023 and December&#160;31, 2022, but did not meet the criteria to be classified as discontinued operations. As a result, the related assets and liabilities were included in the separate held-for-sale line items of the asset and liability sections of the unaudited condensed consolidated balance sheets. As the assets held for sale are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, they are classified in Level 3 of the fair value hierarchy. The following table summarizes the assets and liabilities held for sale at March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153415885648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,891&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term investments of  $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheet at December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At March&#160;31, 2023, debt securities with a fair value of $620 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $40 million and at December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of $59 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive loss.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at March&#160;31, 2023 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at March&#160;31, 2023 and December&#160;31, 2022 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,374&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at March&#160;31, 2023 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of March&#160;31, 2023, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at March&#160;31, 2023 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the three months ended March&#160;31, 2023 and 2022, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at March&#160;31, 2023 and December&#160;31, 2022, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include the reversal of previously recorded credit-related impairment losses on debt securities of $1 million and yield-related impairment losses on debt securities of $24 million in the three months ended March&#160;31, 2023. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $38 million and $18 million, respectively, in the three months ended March&#160;31, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $8 million and $9 million for the three months ended March&#160;31, 2023 and 2022, respectively, related to investments supporting experience-rated products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153415877936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2022 Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 or December&#160;31, 2022. Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,407&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes cash and cash equivalents of $7&#160;million and $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, there were $29&#160;million of transfers out of Level 3. During the three months ended March&#160;31, 2022, there were $3 million of transfers out of Level 3.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153415944896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the three months ended March&#160;31, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,895&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive loss on the unaudited condensed consolidated balance sheets. Refer to Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for further information related to the adoption of the long-duration insurance contracts accounting standard.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the three months ended March 31, 2023 and 2022 in the table above exclude $22 million and $21 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and $51 million and $61 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. The incurred health care costs for the three months ended March&#160;31, 2022 also exclude $13 million for a premium deficiency reserve related to the Company&#8217;s Medicaid products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As a result of the divestiture of the international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), the net assets associated with this business were accounted for as assets held for sale and the associated health care costs payable balance was included in accrued expenses on the unaudited condensed consolidated balance sheet at March&#160;31, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $693 million and $676 million, respectively, in the three months ended March&#160;31, 2023 and 2022, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $8.0&#160;billion. The majority of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at March&#160;31, 2023 related to the current year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -URI https://asc.fasb.org/subtopic&amp;trid=2560295<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409868736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceContractAcquisitionCostTextBlock', window );">Other Insurance Liabilities and Separate Accounts</a></td>
<td class="text">Other Insurance Liabilities and Separate Accounts<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Policy Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances (end of quarter)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of the period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of the period - current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of the period - current discount rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances (end of quarter)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of the period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,463</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,115</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average durations (in years) of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any material differences between the actual experience and expected experience for the significant assumptions used in the computation of the liability for future policy benefits.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in policyholders&#8217; funds related to long-duration insurance contracts, which are included in policyholders&#8217; funds and other long-term liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average crediting rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest credited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, end of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average crediting rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.55%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.65%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in Separate Accounts liabilities during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers from general account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value, end of the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The Company did not recognize any gains or losses on assets transferred to Separate Accounts during the three months ended March&#160;31, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceContractAcquisitionCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cost related directly to successful acquisition of new and renewal of insurance contract. Includes, but is not limited to, deferred policy acquisition cost, deferred sale inducement cost, and present value of future profit of insurance contract acquired in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=4737841<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceContractAcquisitionCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153507799056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">Borrowings<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at March&#160;31, 2023 and December&#160;31, 2022: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due December 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due February 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due February 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.25% senior notes due February 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.625% senior notes due February 2053</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_4a540ca2-c5a0-4370-9572-5e1f1b60ec25"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_effb7122-9853-4ffd-bc90-e0ef6a32ea42">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(735)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1.95pt;font-weight:400;line-height:120%;position:relative;top:-1.05pt;vertical-align:baseline">_____________________________________________________________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 1, 2023, the Company entered into a 364-day $5.0&#160;billion term loan agreement. The term loan agreement allows for borrowings at various rates that are dependent, in part, on the Company&#8217;s debt ratings. On May 2, 2023, the Company borrowed $5.0&#160;billion under the term loan agreement to fund a portion of the Oak Street Health acquisition purchase price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2023, the Company issued $1.5 billion aggregate principal amount of 5.0% senior notes due February 2026, $1.5 billion aggregate principal amount of 5.125% senior notes due February 2030, $1.75 billion aggregate principal amount of 5.25% senior notes due February 2033 and $1.25 billion aggregate principal amount of 5.625% senior notes due February 2053 for total proceeds of approximately $6.0 billion, net of discounts and underwriting fees. The net proceeds of these offerings were used to fund general corporate purposes, including a portion of the Signify Health Acquisition purchase price.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153406265824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time. </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the Company repurchased an aggregate of 22.8 million shares of common stock for approximately $2.0 billion and an aggregate of 19.1 million shares of common stock for approximately $2.0&#160;billion, respectively, both pursuant to the 2021 Repurchase Program. This activity includes the share repurchases under the ASR transactions described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $2.0&#160;billion fixed dollar ASR with Citibank, N.A. (&#8220;Citibank&#8221;). Upon payment of the $2.0&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $2.0&#160;billion notional amount of the ASR or approximately 17.4&#160;million shares at a price of $92.19 per share, which were placed into treasury stock in January 2023. The ASR was accounted for as an initial treasury stock transaction for $1.6&#160;billion and a forward contract for $0.4&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2023, the Company received approximately 5.4&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining 20% of the $2.0&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining 20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $0.605 and $0.55 per share in the three months ended March&#160;31, 2023 and 2022, respectively. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412247264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income (Loss)</a></td>
<td class="text">Other Comprehensive Income (Loss)<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$0 and $26 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$340 and $(1,375) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$131 and $77 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,049)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in discount rate on long-duration insurance reserves:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$0 and $(838) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(101) and $475 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(5) and $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(3) and $(4) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(875)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMjE5OTAyMzI1NzE0NQ_e6900be7-0b3a-4d0a-abd8-725b8e9077ce">ASU 2018-12</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 944)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> during the three months ended March 31, 2023. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$14 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412245872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. Stock options and stock appreciation rights to purchase 4 million and 2 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three months ended March&#160;31, 2023 and 2022, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153416069408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations. As of March&#160;31, 2023, the Company guaranteed 64 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2034. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic had on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS&#8221;), state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state Attorneys General, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the U.S. Federal Trade Commission (the &#8220;FTC&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. Other than the controlled substances litigation accruals described below, none of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors and government payors, and are based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classes have been certified. In October 2022, one of the litigating shareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to demonstrate demand futility. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions, and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims. The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;), and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims beginning as far back as the early 2000s generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs, and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs, and other requests for information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a judgment jointly against the three defendants in the amount of $651&#160;million to be paid over 15 years, and also ordered certain injunctive relief. The Company is appealing the judgment and has not accrued a liability for this matter. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a leadership group of a number of state Attorneys General and the Plaintiffs&#8217; Executive Committee (&#8220;PEC&#8221;). The agreement would resolve substantially all opioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the settlement would be approximately $4.3&#160;billion in opioid remediation and $625&#160;million in attorneys&#8217; fees and costs and additional remediation. The amounts would be payable over 10 years, beginning in 2023. The agreement also contains injunctive terms relating to the dispensing of opioid medications. The settlement agreement is available at nationalopioidsettlement.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the settlement agreement, before the Company determines whether to enter into any final settlement, it will assess the number and identities of the governmental entities that will participate in any such settlement. The settlement agreement contemplates that if certain governmental entities do not agree to the settlement, but the Company nonetheless concludes that there is sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. Private plaintiff litigation will also continue.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has been informed that 45 states, the District of Columbia, and all eligible United States territories have elected to join the settlement. The Company has elected to proceed with the settlement process based on that level of participation. The settlement process will progress to the period during which subdivisions may elect to join. The Company has separately entered into settlement agreements with the Cherokee Nation and four states: Florida, West Virginia, New Mexico, and Nevada.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company also agreed to a formal settlement agreement with a leadership group representing tribes throughout the United States. The agreement resolves substantially all opioid claims against Company entities by such tribes. The maximum amount payable by the Company under the settlement is $113&#160;million in opioid remediation and $16&#160;million in attorneys&#8217; fees and costs, payable over 10 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that settlement of opioid claims by governmental entities and tribes is probable, and the loss related thereto could be reasonably estimated. As a result of that conclusion, and its assessment of certain other opioid-related claims including those for which the Company reached agreement in August and September 2022, the Company recorded pre-tax charges of $5.3&#160;billion during the year ended December 31, 2022. Settlement accruals expected to be paid within twelve months from the balance sheet date are classified as accrued expenses on the unaudited condensed consolidated balance sheets and settlement accruals expected to be paid greater than twelve months from the balance sheet date are classified as other long-term liabilities on the unaudited condensed consolidated balance sheets. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment requires judgments about future events. Moreover, the settlement is in its early phases, and there is no assurance that contingencies will be satisfied. The amount of ultimate loss may differ materially from this accrual. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any settlement arrangement or other resolution of all opioid-related litigation matters, including the uncertain scope of participation by governmental entities, and given that the Company continues to actively defend ongoing litigation for which it believes it has defenses and assertions that have merit, the Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time. The outcome of these legal matters could have a material effect on the Company&#8217;s business, financial condition, operating results and/or cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The DOJ subsequently served additional DEA administrative subpoenas relating to controlled substances. The DOJ also served the Company with additional CIDs relating to controlled substances. The Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Gill et al. v. CVS Health Corp. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for the Northern District of Illinois). In July 2022, the Delaware Attorney General&#8217;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The federal government and the remaining states declined to intervene on other additional theories in the relator&#8217;s complaint. The Company is defending itself against all of the claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the Company&#8217;s post payment audit and collection practices). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to claims payments, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, in the &#8220;Notice of Final Payment Error Calculation for Part C Medicare Advantage Risk Adjustment Validation Data (RADV) Contract-Level Audits,&#8221; CMS revised its audit methodology for RADV contract-level audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS announced extrapolation of the error rate identified in the audit sample along with the application of a process to account for errors in the government&#8217;s traditional fee-for-service Medicare program (&#8220;FFS Adjuster&#8221;). For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract, nor did CMS propose to apply a FFS adjuster. By applying the FFS Adjuster, Medicare Advantage organizations would have been liable for repayments only to the extent that their extrapolated payment errors exceeded the error rate in Original Medicare, which could have impacted the extrapolated repayments to which Medicare Advantage organizations are subject. This revised contract-level audit methodology increased the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. In the RADV audit methodology CMS used from 2011-2013, CMS selected only a few of the Company&#8217;s Medicare Advantage contracts for various contract years for contract-level RADV audits. In October 2018, CMS in the proposed rule (&#8220;Proposed Rule&#8221;) announced a new methodology for RADV audits targeting certain health conditions and members with many diagnostic conditions along with extrapolation for the error rates identified without use of a FFS Adjuster. While the rule was under proposal, CMS initiated contract-level RADV audits for the years 2014 and 2015 with this new RADV methodology without a final rule. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 30, 2023, CMS released the final rule (&#8220;RADV Audit Rule&#8221;), announcing it may use extrapolation for payment years 2018 forward, for both RADV audits and OIG audits, and eliminated the application of a FFS Adjuster in Part C contract-level RADV audits of Medicare Advantage organizations. In the RADV Audit Rule, CMS indicated that it will use more than one audit methodology going forward and indicated CMS will audit contracts it believes are at the highest risk for overpayments based on its statistical modeling, citing a 2016 Governmental Accountability Office report that recommended selection of contract-level RADV audits with a focus on contracts likely to have high rates of improper payment, the highest coding intensity scores, and contracts with high levels of unsupported diagnoses from prior RADV audits.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds for years prior to 2018 or prospective adjustments to Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s minimum loss ratio rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RADV Audit Rule does not apply to the CMS Part C Improper Payment Measures audits nor the HHS-RADV programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes related to risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the U.S. Attorney&#8217;s Office for the Southern District of New York requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. Since filing, several of the cases have been consolidated, and two have resolved, including the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the dismissal of which the First Circuit affirmed in August 2022. The Company and its current and former officers and directors are defending themselves against remaining claims. The Company has moved to dismiss the amended complaint in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the court granted the Company&#8217;s motion to dismiss in February 2023 and the plaintiffs have filed a notice of appeal.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases asserted a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business. In October 2022, the court granted the Company&#8217;s motion to dismiss the amended consolidated complaint with prejudice. Plaintiffs appealed this decision to the Second Circuit and later withdrew the appeal in January 2023.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in December 2021, the Company has received two demands for inspection of books and records pursuant to Delaware Corporation Law Section 220, as well as a derivative complaint (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Vladimir Gusinsky Revocable Trust v. Lynch, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) that was filed in January 2023. The demands and the complaint purport to be related to potential breaches of fiduciary duties by </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Board in relation to certain matters concerning opioids. The Company and its current and former officers and directors are defending themselves against these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas, or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation, and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed, or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight, and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153505803584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Health Services and Pharmacy &amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the three months ended March&#160;31, 2023 reflects the following items:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8220;Significant Accounting Policies,&#8221; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method, as described in Note 1 &#8220;Significant Accounting Policies.&#8221; </span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the three months ended March&#160;31, 2022 has been revised to conform with current period presentation for these items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,288)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Prior period financial information has been recast to conform with&#160;current period presentation. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:29.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $4.1 billion and $3.8 billion of retail co-payments for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three months ended March&#160;31, 2023 and 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charge </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the unaudited condensed consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the loss on assets held for sale relates to the Company&#8217;s LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. During 2022, the Company determined that its LTC business was no longer a strategic asset and committed to a plan to sell it, at which time the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. As of March 31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the first quarter of 2023, a loss on assets held for sale was recorded to write down the carrying value of the LTC business to the Company&#8217;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. During the three months ended March&#160;31, 2022, the loss on assets held for sale relates to the Company&#8217;s Thailand business, which was included in the Commercial Business reporting unit in the Health Care Benefits segment. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the acquisition-related transaction and integration costs relate to the acquisitions of Signify Health and Oak Street Health. The acquisition-related transaction and integration costs are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2022, the opioid litigation charge relates to an agreement to resolve substantially all opioid claims against the Company by the State of Florida. The opioid litigation charge is reflected within the Corporate/Other segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153404079376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Prior period segment financial information has been recast to conform with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the segment realignment described above, the Company&#8217;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Health Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of March&#160;31, 2023, the Pharmacy &amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#8220;2022 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets primarily represents funds held on behalf of members and funds held in escrow in connection with agreements with accountable care organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. </span></div>All restricted cash is invested in demand deposits, time deposits and money market funds.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable, Allowance for Credit Losses</a></td>
<td class="text">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy', window );">Health Care Contract Acquisition Costs</a></td>
<td class="text">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the unaudited condensed consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#8217;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountsPolicy', window );">Separate Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the unaudited condensed consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FuturePolicyBenefitsLiabilityPolicy', window );">Future Policy Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Policy Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts and are recorded in other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for limited payment pension and annuity contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for long-term care insurance contracts represent the Company&#8217;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#8217;s </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#8217;s future cash flows. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discounts its future policy benefit liability using a curve of spot rates derived from an upper-medium grade fixed-income investment. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot rate curve and the locked-in discount rate at each cohort&#8217;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss). In subsequent periods, the current period amount recorded in other comprehensive income (loss) will be adjusted for amounts previously recorded in accumulated other comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and primarily include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $17 million and $15 million in the three months ended March&#160;31, 2023 and 2022, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $21 million for pharmaceutical inventory purchases during the three months ended March&#160;31, 2023 and 2022, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Recently Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944) (the &#8220;long-duration insurance standard&#8221;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented, January 1, 2021, also referred to as the &#8220;transition date&#8221;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $986&#160;million ($766&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. The transition date </span></div>net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information has been  revised to reflect the adoption of the long-duration insurance standard.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FuturePolicyBenefitsLiabilityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for liability for future benefit to be paid to or on behalf of policyholder. Includes, but is not limited to, input, judgment, assumption, and method used in measuring liability and change in input, judgment, and assumption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14937-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FuturePolicyBenefitsLiabilityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409649824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of reconciliation of cash and cash equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable, net</a></td>
<td class="text">Accounts receivable, net at March&#160;31, 2023 and December&#160;31, 2022 was composed of the following:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes accounts receivable of $211&#160;million and $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock', window );">Rollforward of deferred acquisition costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of deferred acquisition costs for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalizations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the three months ended March 31, 2023 and 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:30.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.196%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer <br/>Wellness </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,732)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty. Prior period financial information has been revised to conform with current period presentation. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Health Services mail &amp; specialty is defined as specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Prior period financial information has been revised to conform with current period presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of receivables and contract liabilities from contracts with customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 and 2022, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. During the three months ended March&#160;31, 2023, the contract liabilities balance also reflects the addition of contract liabilities acquired in connection with the Company&#8217;s acquisition of Signify Health, Inc. (&#8220;Signify Health&#8221;) on March 29, 2023. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of adjustments resulting from applying new accounting standard</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Removal of shadow adjustments in accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span id="i91763596c6af4e16a382b50f4b12646c_8-0-1-1-256536"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021, net of reinsurance </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of Long-Duration Insurance Standard Adoption on Financial Statement Line Items</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of operations for the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,923</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,351</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,324</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,336</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,281</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,490</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,312</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,354</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated balance sheet as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,682</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,633</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,754</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,803</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,736</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,421</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,880</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,108</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,730</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,960</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,506</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,465)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,469</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,315</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,769</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of cash flows for the three months ended March&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the movement in deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412463200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Fair Value of Consideration Transferred</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the consideration transferred on the date of acquisition consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of replacement equity awards for pre-combination services (3.2&#160;million shares) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective settlement of pre-existing relationship </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The fair value of the replacement equity awards issued by the Company was determined as of the Signify Health Acquisition Date. The fair value of the awards attributed to pre-combination services of $14 million is included in the consideration transferred and the fair value of the awards attributed to post-combination services of $167&#160;million has been, or will be, included in the Company&#8217;s post-combination financial statements as compensation costs.</span></div>(2)The purchase price included $111 million of effectively settled liabilities the Company owed to Signify Health from their pre-existing relationship.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of Estimated Fair Values of Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets (including restricted cash of $28)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,590&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (current and long-term)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock', window );">Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments</a></td>
<td class="text">The preliminary valuation of goodwill was allocated to the Company&#8217;s business segments as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy &amp; Consumer Wellness</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary fair values and weighted average useful lives for intangible assets acquired in the Signify Health Acquisition, each of which is subject to change as the Company finalizes its purchase accounting:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average useful life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted <br/>Average Useful<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark (definite-lived)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock', window );">Summary of Assets and Liabilities Held for Sale</a></td>
<td class="text">The following table summarizes the assets and liabilities held for sale at March&#160;31, 2023 and December&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSegmentAllocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSegmentAllocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409709712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Schedule of Total Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,891&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term investments of  $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheet at December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities Available For Sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,393)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At March&#160;31, 2023, debt securities with a fair value of $620 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $40 million and at December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of $59 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Net Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net amortized cost and fair value of debt securities at March&#160;31, 2023 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of Debt Securities In An Unrealized Capital Loss Position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at March&#160;31, 2023 and December&#160;31, 2022 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,374&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at March&#160;31, 2023 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Schedule of Activity in Mortgage Loan Portfolio</a></td>
<td class="text">During the three months ended March&#160;31, 2023 and 2022, the Company had the following activity in its mortgage loan portfolio:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at March&#160;31, 2023 and December&#160;31, 2022, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Schedule of Net Investment Income</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include the reversal of previously recorded credit-related impairment losses on debt securities of $1 million and yield-related impairment losses on debt securities of $24 million in the three months ended March&#160;31, 2023. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $38 million and $18 million, respectively, in the three months ended March&#160;31, 2022. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $8 million and $9 million for the three months ended March&#160;31, 2023 and 2022, respectively, related to investments supporting experience-rated products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153414768640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022 were as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,407&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes cash and cash equivalents of $7&#160;million and $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at March&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</span></div>(2)Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Schedule of Fair Value of Separate Accounts by Major Category of Investment</a></td>
<td class="text">Separate Accounts financial assets as of March&#160;31, 2023 and December&#160;31, 2022 were as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153416134928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Components of Change in Health Care Costs Payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the three months ended March&#160;31, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,828&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,895&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive loss on the unaudited condensed consolidated balance sheets. Refer to Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for further information related to the adoption of the long-duration insurance contracts accounting standard.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the three months ended March 31, 2023 and 2022 in the table above exclude $22 million and $21 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and $51 million and $61 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. The incurred health care costs for the three months ended March&#160;31, 2022 also exclude $13 million for a premium deficiency reserve related to the Company&#8217;s Medicaid products.</span></div>(3)As a result of the divestiture of the international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), the net assets associated with this business were accounted for as assets held for sale and the associated health care costs payable balance was included in accrued expenses on the unaudited condensed consolidated balance sheet at March&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153414940464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock', window );">Schedule of Changes in Liability for Future Policy Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances (end of quarter)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of the period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of the period - current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of the period - current discount rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances (end of quarter)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of the period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,463</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,115</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.54%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average durations (in years) of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceTableTextBlock', window );">Roll Forward of Policyholders' Funds</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in policyholders&#8217; funds related to long-duration insurance contracts, which are included in policyholders&#8217; funds and other long-term liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average crediting rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest credited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, end of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average crediting rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.55%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.65%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Summary of Separate Account Assets</a></td>
<td class="text">Separate Accounts financial assets as of March&#160;31, 2023 and December&#160;31, 2022 were as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.932%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.257%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of March&#160;31, 2023 and December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityTableTextBlock', window );">Roll Forward of Separate Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in Separate Accounts liabilities during the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers from general account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value, end of the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about policyholder account balance, including, but not limited to change in liability and related cash surrender value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about separate account liability, including, but not limited to change in liability and related cash surrender value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153410271520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Company's Borrowings</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings at March&#160;31, 2023 and December&#160;31, 2022: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due December 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due February 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due February 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.25% senior notes due February 2033</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.625% senior notes due February 2053</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_4a540ca2-c5a0-4370-9572-5e1f1b60ec25"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_effb7122-9853-4ffd-bc90-e0ef6a32ea42">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(735)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1.95pt;font-weight:400;line-height:120%;position:relative;top:-1.05pt;vertical-align:baseline">_____________________________________________________________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#8216;&#8216;Acquisitions and Assets Held for Sale&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153410375328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Share repurchase programs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412563136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:76.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.297%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$0 and $26 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$340 and $(1,375) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$131 and $77 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,049)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in discount rate on long-duration insurance reserves:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$0 and $(838) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$(101) and $475 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(5) and $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(3) and $(4) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(875)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMjE5OTAyMzI1NzE0NQ_e6900be7-0b3a-4d0a-abd8-725b8e9077ce">ASU 2018-12</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 944)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> during the three months ended March 31, 2023. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$14 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153410307664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153414908864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Financial Information Of Segments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the three months ended March&#160;31, 2022 has been revised to conform with current period presentation for these items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,288)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Prior period financial information has been recast to conform with&#160;current period presentation. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:29.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.488%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.079%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,922&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $4.1 billion and $3.8 billion of retail co-payments for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div>(2)Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Consolidated Operating Income to Adjusted Operating Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three months ended March&#160;31, 2023 and 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charge </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the unaudited condensed consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the loss on assets held for sale relates to the Company&#8217;s LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. During 2022, the Company determined that its LTC business was no longer a strategic asset and committed to a plan to sell it, at which time the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. As of March 31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the first quarter of 2023, a loss on assets held for sale was recorded to write down the carrying value of the LTC business to the Company&#8217;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. During the three months ended March&#160;31, 2022, the loss on assets held for sale relates to the Company&#8217;s Thailand business, which was included in the Commercial Business reporting unit in the Health Care Benefits segment. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the acquisition-related transaction and integration costs relate to the acquisitions of Signify Health and Oak Street Health. The acquisition-related transaction and integration costs are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2023, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three months ended March&#160;31, 2022, the opioid litigation charge relates to an agreement to resolve substantially all opioid claims against the Company by the State of Florida. The opioid litigation charge is reflected within the Corporate/Other segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153404747120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> people in Millions, patient in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>state</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>people </div>
<div>clinic </div>
<div>patient </div>
<div>state </div>
<div>store </div>
<div>Segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfPharmacyPlanMembers', window );">Number of pharmacy plan members | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfPatientsServedPerYear', window );">Number of patients served per year (more than) | patient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Other revenues from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember', window );">Other Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember', window );">Other Long-Term Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember', window );">Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of retail locations (more than) | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember', window );">Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfWalkInMedicalClinics', window );">Number of walk in medical clinics (more than) | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfPeopleServed', window );">Number of people served | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates', window );">Number of states in which the Company has entered the individual public health insurance exchange | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates', window );">Additional number of states in which the Company entered the individual public health insurance exchange | state</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Number of Additional States</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Number of States</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPatientsServedPerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Patients Served per Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPatientsServedPerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPeopleServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of People Served</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPeopleServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPharmacyPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Pharmacy Plan Members</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPharmacyPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of reinsurance, of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153413439104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 14,618<span></span>
</td>
<td class="nump">$ 12,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash (included in other current assets)</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the statements of cash flows</a></td>
<td class="nump">$ 14,955<span></span>
</td>
<td class="nump">$ 13,305<span></span>
</td>
<td class="nump">$ 11,611<span></span>
</td>
<td class="nump">$ 12,691<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405694464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 9,229<span></span>
</td>
<td class="nump">$ 8,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_VendorAndManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">13,357<span></span>
</td>
<td class="nump">12,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">3,636<span></span>
</td>
<td class="nump">2,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2,320<span></span>
</td>
<td class="nump">3,449<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale', window );">Total accounts receivable, net</a></td>
<td class="nump">28,542<span></span>
</td>
<td class="nump">27,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">324<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 211<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorAndManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vendor And Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorAndManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405148080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Deferred Acquisition Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward', window );"><strong>Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs, beginning of the period</a></td>
<td class="nump">$ 1,219<span></span>
</td>
<td class="nump">$ 879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostsAdditions', window );">Capitalizations</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense', window );">Amortization expense</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs, end of the period</a></td>
<td class="nump">$ 1,290<span></span>
</td>
<td class="nump">$ 971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6480726&amp;loc=d3e6691-158385<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized on contract remaining in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124506110&amp;loc=d3e32546-158582<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153406172800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 84,944<span></span>
</td>
<td class="nump">$ 76,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">85,278<span></span>
</td>
<td class="nump">76,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">52,500<span></span>
</td>
<td class="nump">47,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,597<span></span>
</td>
<td class="nump">5,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">24,352<span></span>
</td>
<td class="nump">21,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,495<span></span>
</td>
<td class="nump">2,662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">25,692<span></span>
</td>
<td class="nump">22,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25,877<span></span>
</td>
<td class="nump">23,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">24,339<span></span>
</td>
<td class="nump">21,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,374<span></span>
</td>
<td class="nump">1,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">40,811<span></span>
</td>
<td class="nump">36,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">44,591<span></span>
</td>
<td class="nump">39,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Pharmacy network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">27,592<span></span>
</td>
<td class="nump">24,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Mail &amp; specialty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">16,145<span></span>
</td>
<td class="nump">14,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">854<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">43,737<span></span>
</td>
<td class="nump">38,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">854<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">18,426<span></span>
</td>
<td class="nump">17,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">27,922<span></span>
</td>
<td class="nump">25,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">21,495<span></span>
</td>
<td class="nump">19,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,597<span></span>
</td>
<td class="nump">5,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">1,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(13,300)<span></span>
</td>
<td class="num">(11,907)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(12,732)<span></span>
</td>
<td class="num">(11,276)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (568)<span></span>
</td>
<td class="num">$ (631)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412269984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables and Contracted Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables (included in accounts receivable, net)</a></td>
<td class="nump">$ 9,229<span></span>
</td>
<td class="nump">$ 8,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405745968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ChangeinContractwithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, beginning of the period</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage', window );">Redemption and breakage</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination', window );">Acquired contract liabilities</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, end of the period</a></td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinContractwithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinContractwithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer Liability Redemption and Breakage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractwithCustomerLiabilityRedemptionandBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409675344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - New Accounting Pronouncements Recently Adopted (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Reduction to accumulated other comprehensive income (loss)</a></td>
<td class="nump">$ 875<span></span>
</td>
<td class="nump">$ 1,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201812Member', window );">Accounting Standards Update 2018-12 | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax', window );">Reduction to accumulated other comprehensive income (loss), before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax', window );">Liability for future policy benefits, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Reduction to accumulated other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, After Reinsurance, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of reinsurance, of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201812Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201812Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153402184416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Changes in balances of long-duration insurance liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Balance at December 31, 2020, net of reinsurance</a></td>
<td class="nump">$ 2,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">2,270<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions | As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Balance at December 31, 2020, net of reinsurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions | Change in discount rate assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions | Removal of shadow adjustments in accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Balance at December 31, 2020, net of reinsurance</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">$ 1,625<span></span>
</td>
<td class="nump">$ 1,566<span></span>
</td>
<td class="nump">$ 1,772<span></span>
</td>
<td class="nump">$ 1,991<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care | As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Balance at December 31, 2020, net of reinsurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care | Change in discount rate assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care | Removal of shadow adjustments in accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Balance at December 31, 2020, net of reinsurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Balance at December 31, 2020, net of reinsurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Change in discount rate assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Removal of shadow adjustments in accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of reinsurance, of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from cash flow assumption change for future cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405336032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Adjustments Resulting From Applying New Accounting Standard (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalIncomeStatementElementsAbstract', window );"><strong>Condensed Consolidated Statement of Operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">$ 20,448<span></span>
</td>
<td class="nump">$ 17,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="nump">9,580<span></span>
</td>
<td class="nump">9,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">81,832<span></span>
</td>
<td class="nump">73,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,446<span></span>
</td>
<td class="nump">3,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">2,879<span></span>
</td>
<td class="nump">3,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">737<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,142<span></span>
</td>
<td class="nump">2,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 2,136<span></span>
</td>
<td class="nump">$ 2,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Condensed Consolidated Balance Sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 3,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">68,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">26,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">239,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="nump">10,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">4,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">75,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">5,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">6,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">167,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">57,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">71,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">71,580<span></span>
</td>
<td class="nump">$ 74,034<span></span>
</td>
<td class="nump">71,769<span></span>
</td>
<td class="nump">$ 75,381<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">239,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Condensed Consolidated Statement of Cash Flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredIncomeTaxesAndOtherNoncashItems', window );">Deferred income taxes and other noncash items</a></td>
<td class="nump">155<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(1,255)<span></span>
</td>
<td class="num">(348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">4,382<span></span>
</td>
<td class="nump">1,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">$ 2,036<span></span>
</td>
<td class="num">(444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalIncomeStatementElementsAbstract', window );"><strong>Condensed Consolidated Statement of Operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Condensed Consolidated Balance Sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,465)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Condensed Consolidated Statement of Cash Flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredIncomeTaxesAndOtherNoncashItems', window );">Deferred income taxes and other noncash items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(352)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalIncomeStatementElementsAbstract', window );"><strong>Condensed Consolidated Statement of Operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Condensed Consolidated Balance Sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(315)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Condensed Consolidated Statement of Cash Flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredIncomeTaxesAndOtherNoncashItems', window );">Deferred income taxes and other noncash items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredIncomeTaxesAndOtherNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredIncomeTaxesAndOtherNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalIncomeStatementElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalIncomeStatementElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153404697728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Mar. 29, 2023</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash to be received by shareholders in proposed acquisition (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total value of proposed acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for income tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_OakStreetHealthIncMember', window );">Oak Street Health Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash to be received by shareholders in proposed acquisition (in dollars per share)</a></td>
<td class="nump">$ 39.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total value of proposed acquisition</a></td>
<td class="nump">$ 10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Omnicare Long-Term Care Business | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_OakStreetHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_OakStreetHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_OmnicareLongTermCareBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_OmnicareLongTermCareBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412308544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale - Schedule of Fair Value of Consideration Transferred (Details) - Signify Health, Inc.<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 29, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">$ 7,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship', window );">Effective settlement of pre-existing relationship</a></td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration transferred</a></td>
<td class="nump">7,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Pre-combination services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of replacement equity awards for pre-combination services</a></td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Replacement equity awards for pre-combination services (in shares) | shares</a></td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Post-combination services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of replacement equity awards for pre-combination services</a></td>
<td class="nump">$ 167<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Effective Settlement Of Pre-Existing Relationship</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=cvs_PreCombinationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=cvs_PreCombinationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=cvs_PostCombinationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=cvs_PostCombinationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153408937456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale - Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 29, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 84,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets (including restricted cash of $28)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Debt (current and long-term)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combinations, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153406171856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale - Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 29, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 84,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc. | Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc. | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc. | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153411938768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale - Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired (Details) - Signify Health, Inc.<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 29, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Gross Fair Value</a></td>
<td class="nump">$ 1,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Useful Life (years)</a></td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Gross Fair Value</a></td>
<td class="nump">$ 1,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Useful Life (years)</a></td>
<td class="text">16 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Gross Fair Value</a></td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Useful Life (years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Gross Fair Value</a></td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Useful Life (years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153411954608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition and Assets Held for Sale - Summary of Assets and Liabilities Held for Sale (Details) - Disposal Group, Held-for-sale, Not Discontinued Operations - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">$ 211<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets', window );">Deferred income taxes</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 213<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409015808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Total Investment Schedule (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">$ 3,102<span></span>
</td>
<td class="nump">$ 2,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">21,612<span></span>
</td>
<td class="nump">21,113<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">24,714<span></span>
</td>
<td class="nump">23,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">3,061<span></span>
</td>
<td class="nump">2,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">17,761<span></span>
</td>
<td class="nump">17,562<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">20,822<span></span>
</td>
<td class="nump">20,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">2,813<span></span>
</td>
<td class="nump">2,562<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 2,815<span></span>
</td>
<td class="nump">$ 2,567<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Investments, Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongTermInvestmentsIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153406354464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">$ 22,117<span></span>
</td>
<td class="nump">$ 22,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">22,114<span></span>
</td>
<td class="nump">22,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,393)<span></span>
</td>
<td class="num">(1,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">20,822<span></span>
</td>
<td class="nump">20,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">620<span></span>
</td>
<td class="nump">609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,071<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,071<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,935<span></span>
</td>
<td class="nump">1,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,322<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,322<span></span>
</td>
<td class="nump">2,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">9,983<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">9,981<span></span>
</td>
<td class="nump">9,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(665)<span></span>
</td>
<td class="num">(903)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,364<span></span>
</td>
<td class="nump">8,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,765<span></span>
</td>
<td class="nump">2,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,764<span></span>
</td>
<td class="nump">2,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(193)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,592<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,901<span></span>
</td>
<td class="nump">2,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,901<span></span>
</td>
<td class="nump">2,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405676432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Less than one year</a></td>
<td class="nump">$ 1,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">One year through five years</a></td>
<td class="nump">6,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">After five years through ten years</a></td>
<td class="nump">4,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Greater than ten years</a></td>
<td class="nump">4,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">22,114<span></span>
</td>
<td class="nump">$ 22,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">6,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">4,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">3,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">20,822<span></span>
</td>
<td class="nump">20,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Net Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,901<span></span>
</td>
<td class="nump">2,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,818<span></span>
</td>
<td class="nump">$ 2,810<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153404465392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">4,797<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">6,231<span></span>
</td>
<td class="nump">2,784<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">11,028<span></span>
</td>
<td class="nump">12,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 7,374<span></span>
</td>
<td class="nump">$ 14,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">9,572<span></span>
</td>
<td class="nump">4,264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">16,946<span></span>
</td>
<td class="nump">18,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">1,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1,393<span></span>
</td>
<td class="nump">$ 1,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">476<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 473<span></span>
</td>
<td class="nump">$ 1,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,616<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">884<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 513<span></span>
</td>
<td class="nump">$ 1,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">897<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">1,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">2,675<span></span>
</td>
<td class="nump">5,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">5,975<span></span>
</td>
<td class="nump">6,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 3,640<span></span>
</td>
<td class="nump">$ 6,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">4,116<span></span>
</td>
<td class="nump">1,822<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">7,756<span></span>
</td>
<td class="nump">8,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 665<span></span>
</td>
<td class="nump">$ 903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">653<span></span>
</td>
<td class="nump">1,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 946<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,109<span></span>
</td>
<td class="nump">2,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 362<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">723<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">632<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">527<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">726<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,126<span></span>
</td>
<td class="nump">$ 1,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">1,257<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,383<span></span>
</td>
<td class="nump">2,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153413274256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 1,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">5,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">3,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">3,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">16,946<span></span>
</td>
<td class="nump">$ 18,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1,393<span></span>
</td>
<td class="nump">1,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">723<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,383<span></span>
</td>
<td class="nump">2,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">5,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">3,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">2,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">16,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412527712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405858592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 1,077<span></span>
</td>
<td class="nump">$ 1,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2023 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2023 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2023 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2023 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">333<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">333<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">405<span></span>
</td>
<td class="nump">424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153406177776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 449<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses', window );">Net investment income (excluding net realized capital losses)</a></td>
<td class="nump">439<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital losses</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains Or Losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsOrLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412593936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 1,341<span></span>
</td>
<td class="nump">$ 1,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153402538112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 20,822<span></span>
</td>
<td class="nump">$ 20,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,935<span></span>
</td>
<td class="nump">1,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,364<span></span>
</td>
<td class="nump">8,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,592<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">14,625<span></span>
</td>
<td class="nump">12,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">20,822<span></span>
</td>
<td class="nump">20,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">35,681<span></span>
</td>
<td class="nump">33,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">5,946<span></span>
</td>
<td class="nump">6,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="nump">1,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">8,017<span></span>
</td>
<td class="nump">8,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">8,679<span></span>
</td>
<td class="nump">6,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">18,866<span></span>
</td>
<td class="nump">18,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">27,545<span></span>
</td>
<td class="nump">24,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,935<span></span>
</td>
<td class="nump">1,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="nump">1,860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,364<span></span>
</td>
<td class="nump">8,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,332<span></span>
</td>
<td class="nump">8,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,592<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,584<span></span>
</td>
<td class="nump">2,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412208864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409006832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 1,077<span></span>
</td>
<td class="nump">$ 1,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">58,231<span></span>
</td>
<td class="nump">52,257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">54,960<span></span>
</td>
<td class="nump">47,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">54,960<span></span>
</td>
<td class="nump">47,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 3 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153402773808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 3,231<span></span>
</td>
<td class="nump">$ 3,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">$ 4,670<span></span>
</td>
<td class="nump">$ 5,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,202<span></span>
</td>
<td class="nump">3,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,645<span></span>
</td>
<td class="nump">2,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">699<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,502<span></span>
</td>
<td class="nump">2,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,946<span></span>
</td>
<td class="nump">1,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405688144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of the period</a></td>
<td class="nump">$ 10,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of the period</a></td>
<td class="nump">10,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember', window );">Corporate / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of the period</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">8,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Less: Impact of discount rate on long-duration insurance reserves</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">10,129<span></span>
</td>
<td class="nump">8,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">21,068<span></span>
</td>
<td class="nump">18,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(693)<span></span>
</td>
<td class="num">(676)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">20,375<span></span>
</td>
<td class="nump">17,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">11,957<span></span>
</td>
<td class="nump">10,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">7,645<span></span>
</td>
<td class="nump">6,183<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">19,602<span></span>
</td>
<td class="nump">16,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">10,902<span></span>
</td>
<td class="nump">10,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Add: Impact of discount rate on long-duration insurance reserves</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of the period</a></td>
<td class="nump">10,895<span></span>
</td>
<td class="nump">10,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line | Thailand Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Other</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Liability for Unpaid Claims and Claims Adjustment Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_ThailandBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_ThailandBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153412527552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Incurred but not reported (IBNR) claims liability, net</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Decrease in prior years' healthcare costs payable</a></td>
<td class="nump">$ 693<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153404671424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="nump">$ 2,253<span></span>
</td>
<td class="nump">$ 3,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Beginning liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">2,425<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience', window );">Effect of actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange', window );">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,428<span></span>
</td>
<td class="nump">2,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance', window );">Issuances (end of quarter)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense', window );">Interest accrual (using locked-in discount rate)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits', window );">Benefit payments (actual)</a></td>
<td class="num">(73)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">2,385<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Effect of changes in discount rate assumptions</a></td>
<td class="num">(115)<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">2,270<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Net liability for future policy benefits</a></td>
<td class="nump">2,270<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Less: Reinsurance recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Net liability for future policy benefits, net of reinsurance recoverable</a></td>
<td class="nump">2,270<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward', window );"><strong>Present value of expected net premiums</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Beginning liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience', window );">Effect of actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange', window );">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome', window );">Interest accrual (using locked-in discount rate)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected', window );">Net premiums (actual)</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax', window );">Effect of changes in discount rate assumptions</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Beginning liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience', window );">Effect of actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange', window );">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,611<span></span>
</td>
<td class="nump">$ 1,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance', window );">Issuances (end of quarter)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense', window );">Interest accrual (using locked-in discount rate)</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits', window );">Benefit payments (actual)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Effect of changes in discount rate assumptions</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">1,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Net liability for future policy benefits</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Less: Reinsurance recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Net liability for future policy benefits, net of reinsurance recoverable</a></td>
<td class="nump">$ 1,324<span></span>
</td>
<td class="nump">$ 1,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,695<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from increase (decrease) in expected net premium component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of reinsurance, of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected future benefit and expense component for liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from cash flow assumption change for future cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in expected future policy benefit and expense component of liability for future policy benefit from contract issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and current period update of cash flow assumption, of expected future policy benefit and expense component of liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected net premium component of liability for future policy benefit from cash flow assumption change for future cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected net premium component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income for expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of premium collected from policyholder to fund expected benefit payment for expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected net premium component for liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153411861104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance', window );">Expected future benefit payments</a></td>
<td class="nump">$ 3,463<span></span>
</td>
<td class="nump">$ 3,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance', window );">Expected gross premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance', window );">Expected future benefit payments</a></td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">3,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance', window );">Expected gross premiums</a></td>
<td class="nump">$ 428<span></span>
</td>
<td class="nump">$ 476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of undiscounted balance for expected future gross premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of undiscounted balance for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153406244704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate', window );">Interest accretion rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate', window );">Current discount rate</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">3.54%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration', window );">Weighted-average duration of long-duration insurance liabilities</a></td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate', window );">Interest accretion rate</a></td>
<td class="nump">5.11%<span></span>
</td>
<td class="nump">5.11%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate', window );">Current discount rate</a></td>
<td class="nump">5.06%<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration', window );">Weighted-average duration of long-duration insurance liabilities</a></td>
<td class="text">12 years 6 months<span></span>
</td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current weighted-average discount rate used to measure liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average duration of liability for future policy benefit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original weighted-average discount rate at contract issue date used to measure liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405789824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceRollForward', window );"><strong>Policyholder Account Balance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholders&#8217; funds, beginning of the period</a></td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PolicyholderAccountBalanceDepositsReceived', window );">Deposits received</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal', window );">Surrenders and withdrawals</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCreditedToPolicyholdersAccountBalances', window );">Interest credited</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses', window );">Change in net unrealized gains (losses)</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange', window );">Other</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholders&#8217; funds, end of the period</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate', window );">Weighted average crediting rate</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="nump">4.65%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk', window );">Net amount at risk</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueDuePolicyholdersAmount', window );">Cash surrender value</a></td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">$ 342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Account Balance, Change In Net Unrealized Gains (Losses)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PolicyholderAccountBalanceDepositsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Account Balance, Deposits Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PolicyholderAccountBalanceDepositsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueDuePolicyholdersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash to be paid to policyholder upon termination and surrender of long-duration contract issued by insurance entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueDuePolicyholdersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCreditedToPolicyholdersAccountBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for allocation to policyholder account balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13J<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783734-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6480726&amp;loc=d3e6691-158385<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCreditedToPolicyholdersAccountBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in liability for policyholder account balance from change, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of guaranteed benefit in excess of current account balance of policyholder account balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceNetAmountAtRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in liability for policyholder account balance from contract redemption and withdrawal of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average crediting rate for liability for policyholder account balance, calculated at a point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholder. Includes, but is not limited to, unpaid policy dividend, retrospective refund, and undistributed earnings on participating business. Excludes future policy benefit and claim expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153402360992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 3,231<span></span>
</td>
<td class="nump">$ 3,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">$ 4,670<span></span>
</td>
<td class="nump">$ 5,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,202<span></span>
</td>
<td class="nump">3,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember', window );">Other Receivables | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherPayablesMember', window );">Other Payables | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,645<span></span>
</td>
<td class="nump">2,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | U.S. government securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | States, municipalities and political subdivisions | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | U.S. corporate securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,642<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | Foreign securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember', window );">Mortgage-backed securities | Residential mortgage-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember', window );">Mortgage-backed securities | Commercial mortgage-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountOtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember', window );">Common/collective trusts | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 397<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountOtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountOtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153404151088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityRollForward', window );"><strong>Separate Account, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate Accounts liability, beginning of the period</a></td>
<td class="nump">$ 3,228<span></span>
</td>
<td class="nump">$ 5,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityPremiumAndDeposit', window );">Premiums and deposits</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal', window );">Surrenders and withdrawals</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityBenefitPayment', window );">Benefit payments</a></td>
<td class="num">(260)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance', window );">Investment earnings</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(393)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount', window );">Net transfers from general account</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange', window );">Other</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate Accounts liability, end of the period</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">4,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount', window );">Cash surrender value, end of the period</a></td>
<td class="nump">$ 2,142<span></span>
</td>
<td class="nump">$ 3,204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityBenefitPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to separate account policyholder from benefit payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityBenefitPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of separate account liability payable to policyholder upon surrender of contract before maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in separate account liability from performance of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount increase (decrease) in separate account liability from change, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityPremiumAndDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow to separate account liability from premium and deposit from cash received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityPremiumAndDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in separate account liability from contract redemption and withdrawal of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer to (from) liability for policyholder account balance (to) from liability for separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13J<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783734-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153402105792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Schedule of Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">$ 1,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,465<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">58,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet', window );">Debt discounts and deferred financing costs</a></td>
<td class="num">(735)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(696)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term debt and lease obligation</a></td>
<td class="nump">58,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(1,778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,778)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale', window );">Long-term debt</a></td>
<td class="nump">$ 56,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Long-term debt<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due June 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.375% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024 | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due July 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due February 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.875% senior notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.25% senior notes due June 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due February 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875% senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.25% senior notes due February 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.25%<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% senior notes due July 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.625% senior notes due June 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% senior notes due December 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.78% senior notes due March 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.125% senior notes due September 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% senior notes due May 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.5% senior notes due May 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due November 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.3% senior notes due December 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due March 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due July 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due August 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.05% senior notes due March 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.625% senior notes due February 2053</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.625%<span></span>
</td>
<td class="nump">5.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including liabilities held for sale, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongTermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongTermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes50DueFebruary2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes50DueFebruary2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.625DueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5125DueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5125DueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.75DueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueSeptember2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2125PercentDueSeptember2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes525DueFebruary2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes525DueFebruary2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.25DueApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5625DueFebruary2053Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5625DueFebruary2053Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153406323024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000,000<span></span>
</td>
<td class="nump">$ 6,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due February 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due February 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.25% senior notes due February 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.625% senior notes due February 2053</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Term Loan Agreement, 364-Day | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="nump">$ 5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes50DueFebruary2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes50DueFebruary2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5125DueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5125DueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes525DueFebruary2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes525DueFebruary2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5625DueFebruary2053Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5625DueFebruary2053Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_TermLoanAgreement364DayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_TermLoanAgreement364DayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405719600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Share Repurchases (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Nov. 17, 2022</div></th>
<th class="th"><div>Dec. 09, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2022RepurchaseProgramMember', window );">2022 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">2021 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 4,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="nump">22.8<span></span>
</td>
<td class="nump">19.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period, value</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2022RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2022RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153413337664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Accelerated Share Repurchases (Details) - 2021 Repurchase Program - USD ($)<br> $ / shares in Units, shares in Millions, $ in Billions</strong></div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Jan. 04, 2022</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">Citibank, N.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesAgreementAmount', window );">ASR agreement, amount</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount', window );">Payments for ASR, amount</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares', window );">ASR percent of notional amount received in shares</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased', window );">Shares repurchased under ASR agreement (in shares)</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 92.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TransferOfSharesToTreasuryStockValue', window );">Transfer of shares to treasury stock value</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram', window );">ASR, shares to be received at the end of program as a percent of notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">Citibank, N.A. | Forward contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Forward contract, notional amount</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">Barclays Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesAgreementAmount', window );">ASR agreement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount', window );">Payments for ASR, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares', window );">ASR percent of notional amount received in shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased', window );">Shares repurchased under ASR agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TransferOfSharesToTreasuryStockValue', window );">Transfer of shares to treasury stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram', window );">ASR, shares to be received at the end of program as a percent of notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">Barclays Bank | Forward contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Forward contract, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Number of Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Accelerated Share Repurchases, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForAcceleratedShareRepurchasesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TransferOfSharesToTreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer of Shares to Treasury Stock Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TransferOfSharesToTreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_CitibankNAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_CitibankNAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_BarclaysBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_BarclaysBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409048960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Dividends (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.605<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405994640">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 71,769<span></span>
</td>
<td class="nump">$ 75,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">389<span></span>
</td>
<td class="num">(763)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 71,580<span></span>
</td>
<td class="nump">74,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Accounting Standards Update 2018-12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(540)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,519)<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">339<span></span>
</td>
<td class="num">(1,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">131<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">470<span></span>
</td>
<td class="num">(1,132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,049)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">340<span></span>
</td>
<td class="num">(1,375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">131<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses) | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax', window );">Adoption of new accounting standard, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember', window );">Change in discount rate on long-duration insurance reserves</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">219<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(74)<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(74)<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">145<span></span>
</td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(101)<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember', window );">Change in discount rate on long-duration insurance reserves | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax', window );">Adoption of new accounting standard, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (838)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">239<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">233<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and other postretirement benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(203)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(203)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,264)<span></span>
</td>
<td class="nump">965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(875)<span></span>
</td>
<td class="num">(429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 944)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> during the three months ended March 31, 2023. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153409566704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 2,136<span></span>
</td>
<td class="nump">$ 2,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,283<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,291<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings (loss) per share, basic (in dollars per share)</a></td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings (loss) per share, diluted (in dollars per share)</a></td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember', window );">Restricted stock units and performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember', window );">Stock options and stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic and Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153414993440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberOfLeases', window );">Guarantor obligations, number of leases | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_FederalCourtInOhioJudgmentMember', window );">Federal Court in Ohio Judgment | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Legal settlement awarded to other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkMember', window );">Settlement Framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Legal settlement awarded to other party</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Attorneys' fees and costs</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LitigationSettlementNumberOfStatesElectedToJoin', window );">Number of states that elected to join the settlement | state</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements', window );">Number of states under separate settlement agreements | state</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkMember', window );">Settlement Framework | Tribal Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Legal settlement awarded to other party</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Attorneys' fees and costs</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember', window );">Settlement Framework and Other Opioid-Related Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember', window );">Radcliffe and Flaim v. Aetna Inc., et al | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number Of Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LegalSettlementPeriodOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Legal Settlement, Period Of Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LegalSettlementPeriodOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LitigationSettlementNumberOfStatesElectedToJoin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Number Of States Elected To Join</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LitigationSettlementNumberOfStatesElectedToJoin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Number Of States Under Separate Settlement Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_FederalCourtInOhioJudgmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_FederalCourtInOhioJudgmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_SettlementFrameworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_TribalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_TribalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153416147696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405088368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Retrospective Adjustments to Segment Composition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 85,278<span></span>
</td>
<td class="nump">$ 76,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">4,370<span></span>
</td>
<td class="nump">4,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(268)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(13,300)<span></span>
</td>
<td class="num">(11,907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25,877<span></span>
</td>
<td class="nump">23,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,824<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember', window );">Health Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">44,591<span></span>
</td>
<td class="nump">39,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,680<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember', window );">Pharmacy &amp; Consumer Wellness | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">27,922<span></span>
</td>
<td class="nump">25,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">$ 1,134<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,288)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Health Care Benefits | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Health Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,636<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Pharmacy &amp; Consumer Wellness | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Health Care Benefits | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Health Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Pharmacy &amp; Consumer Wellness | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405974032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 84,944<span></span>
</td>
<td class="nump">$ 76,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">85,278<span></span>
</td>
<td class="nump">76,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">4,370<span></span>
</td>
<td class="nump">4,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">25,692<span></span>
</td>
<td class="nump">22,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25,877<span></span>
</td>
<td class="nump">23,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,824<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">40,811<span></span>
</td>
<td class="nump">36,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">44,591<span></span>
</td>
<td class="nump">39,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,680<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Copayments</a></td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">18,426<span></span>
</td>
<td class="nump">17,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">27,922<span></span>
</td>
<td class="nump">25,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(268)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="num">(13,300)<span></span>
</td>
<td class="num">(11,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(13,300)<span></span>
</td>
<td class="num">(11,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">3,780<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">$ 9,499<span></span>
</td>
<td class="nump">$ 8,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140153405154080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="nump">$ 3,446<span></span>
</td>
<td class="nump">$ 3,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">402<span></span>
</td>
<td class="nump">462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital losses</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related integration costs</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OfficeRealEstateOptimizationCharges', window );">Office real estate optimization charges</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">$ 4,370<span></span>
</td>
<td class="nump">$ 4,607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OfficeRealEstateOptimizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OfficeRealEstateOptimizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>cvs-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20230331.xsd" xlink:type="simple"/>
    <context id="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i91b26ed1eaac4b94ac243c6f30365065_I20230426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="i1c4d4c6f963c4f73bc0cc280e69d641b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifcc0efcf324e4c67accd1041ac8b9ce1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i28dec895582849b98979be68d4b8999a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic4ff0943b4f746ffb566b7dab6c56ede_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i80e4bbee9f2f48ff8554d030ba033144_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i745cd9060f244c0591aa68a99e2834de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97beaa9151e94932b8318858d3577500_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id0126d2a2d5b4cdd9ca3e3d805ece7c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d661cb6c0504a1fa9228d0757d805ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ca8df10bb3e4ef68a134deb6f91845f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f3a6802840048fbb777cb7cb063f606_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0919e504ed6344d68c00a6acaebcde05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a977074046f41a89c7f4a1f6b9bcc1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie33015c34edd4999b191485b67da92a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6966b4e2696f4a24ac2798c5d341762a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iebd6ef7eeaab42469a4c1b85aecdbcbe_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5ca517c88528406bb73b9e7287a1467b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icda684d607d94e4984c89b2b79d866e6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i607b6600b7634e74b9a25dba310ddfe6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i14bff4dd44434085ac94c47f67cf0b94_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib8a97180d2514a9b93e7596cf96be425_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i18f0bf58dc2749449f2f66468faccce3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic6bfce6ac5f8468eb136aac914a9ef04_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i500c40e14a1143a3aa4e9627c448de62_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic92b2e37d0234aa2aee969f6ead4b607_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i91059cc4e3514c71825e73b0a7423eba_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i44ee7f171b49433c9fee60c78374b031_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc256cbbfdbe4919bd580b89b5853b65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5d7bc6153ed403bbf10a74c29ce4dc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8a735ca1fa940769d12496008f05980_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i769f64156cf4441d9b8d63169d946693_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1ee5670de504ce3adee519f2e40ffd2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7af24bdfc747494e8034faa02222d96f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8177aa632cf4772aa7e3d0690fab4e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1236f0a166354cc7b555200e4c10809a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7ec450630a5482c819c7ba9bb97985e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icaaa42d004654ea98904e4011dbecabb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24ae773548b24dbf955bf39d91ac8fa8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c46457ec075463b998b7704930f1527_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia04b5afab2af4259b71dabfaa547a322_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id87e905aad04499185592c649df0501d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i76890c43bde24648bc18aa2102227d8d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ffe2b44a55945b284180e30309e8aad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i68525f7e800f4c59b752a9f19135d07d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia4688929cda745bb98a6c1e716bcf78d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i75183c2d4ace4f5787e50b8f1271e1f7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iea2fdd12e3c9442ebce0208dc0b9d3a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9c83419b19394b2b9e56453a8077baa2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie19ac4c954a3448a8ad572bcd89c79da_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if4e44e45d682450d8e8f9d28b40f3de4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i34ba550f20da42bf8e118610bd9d1e54_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6efe121123d64cc4871d92d64ebb6df8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b1e8e047ca74e2da7465cdbe0294566_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4ef8067610324631a99b73d483b1c819_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i686abe201e9f4a07bc66c9a037f0de35_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i477ed67917444c06928e6bdfe4442b96_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibadef73562a5415eb23fb67f37c780fa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifad147213d8945ffa73f99ae94585db9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i07754849794b4b5a972e925beaa2e2d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83fccfbc3a1e442bbaec480edae8a85b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9c868143b7940b3b6159cc722b2c499_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i70419a8aec904963b0fc2149a92a6feb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibb3b7119cdf445b286ff5a2b3bba733c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i913d7229910442739c4ca1921c7d8667_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i27c623b94ee8462ebc5e118b823a3e98_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6b014ab5cfd341f7ae8d078ed0c475f0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7faa0d9a8c2d46d9a7fd1311b46dda78_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0a3448fe5bcb4de789f0540bb778b942_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1fde3795c73045aca5218db1a3bf0627_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f01a502bc824fe1bcb34881c372163e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9ed4956174e64851ad6fceaaf2191dc6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i69d66e496f5549518e1bb751fee97f54_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7af16b8edb9d4671b5a7ce811f1e9a3e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i074bb083281146a4814aa0c3ac130d88_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic730a4294079499a823806ec14836c28_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9e959c8f50844bdc9d92aa231cd7d852_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9a5b5bb1e9dd42a2aa9b210432135329_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i150b57bf1a274deead0798dbcbbc2bab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic7e9712c1179476e90472386d3884dae_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i21838ca5480d43e99c84c865f63fae2a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i12b6e52d861e413ca3dcbe8cf24ddbe8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia2726cf35a1549a39f68c6d870831a3a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6726b8f30277400383f48e1c4916b2ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2d9bf2d1bfaf4038bee28037421646dc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1599d39404424e269c1dd6dd7a2f8beb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5217fa8bc5cb48358a723612bde7d479_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i003831bfd1e24cfc94e47ab4156fd856_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib416aea626f043fd9431aa5342e2b4c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia19d1a8e74194a419ec6e6349cf88ae9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ea8ab3ccda94b4fb2323193afbc272e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib60d284b94f343769d7fb6d50fda05c9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icb268de0eb0840c6ad11a4d9d30093e4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i834cc79324ef46228461e0711bc261e1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie5614313bb744e009682b28fbc6584fc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d1785a62b574847bd8bd9762c88ad05_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8416ff007f2346618a642e998ffbde5f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iea625c13b80a41a38461b27d7dc98167_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0d2ab9d4f54a4545aa1a48d8fcffe4a3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i33693ee297b14cd1b0fd9a47d4d4f880_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5fd51d95f7ef41039d8cfa9e1d363b8f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1fe185f8b39742e6bf6fc4a03b2c1cec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ided2d67f45094a79a717c8cee0eb96d0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie000fac120824472bf6fbd96bd370915_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i108159c26e0d4ad68b98ccf1c5e9a35f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i79d1376e4b4e47bc99fff3a44a2e7122_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if04e21b8463b4e6eb6cb2ca6a5197ca2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i177844ba7569439393b0dd8b1f8727ff_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i29b95f23f2f4497e8f422c459c2ad25c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20a226c3f2ff49e2848ef2bd802993fd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idcbcab26d09246a984f88af308a36bde_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3f7b0dd6afc04d5fb6dec0b03362681a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8dbfb3606fe14686af2486fd20b1659d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7b9544478beb4979bd59c64b69d4a6a1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5bb2b68e6b044e298527de5f04d708d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4d3ac659a2774583871cc2f66cd8f09e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a6ae917fc994efda306a7228aff6320_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd36720f2ede47418003c3eca8540ff9_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201812Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id410b8ee1a2f45edad8defa2042f4b1b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb57f57ab4aa4756834cf154419fa446_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7d3bb136a1f4e01a755060f96bc46f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9884f3d8910649048241aa4449af5b47_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04e56abae24c4188a3a7c997d9c465c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a54fdeeb3e044288d6c4a1818ab4dee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42eb8ce2ba0b4cf0bf9748577c25dae5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81d253afd2a9475db0569365a548c9c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i649b9f03c30f4132b55105d20f98cd1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i977993d8848741e6a20cfa0d2b47e0ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab7538367b4d402aad244c6c69df822b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i43c26daacfb34ea994d687550fd86388_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i65bb2f8cfc394124a9e9de093bf7e693_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i59381ee9dfea4532add1e4bb94d27155_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i92b1cc55a9704aeea04b6939f5195e76_I20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="i1bc1e1b3223b4f1cb3c91d8f034eb45b_D20230201-20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">cvs:PreCombinationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="i7d0721ccf873491b96d1a9065be7d6f9_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">cvs:PostCombinationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="icd3ba4757bbe45faaadd9ba0c14cda5a_I20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="i5520b236fefd42c6ac7b83e8db7d39d0_I20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="ib28b96b93836450fbebf6c84e59a6a20_I20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="i4af840426f5742b98ce7a573b0ca84b1_I20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="icfddb8845ccc4274844fac816ac10c32_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="ic82fb46fef07440d83a4d87da8d741a2_I20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="ida41df4f3f8347ed801d55304618efc9_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="i3fb2931d2f6141989e86bc6f9e479fa5_I20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="i3a52af93ed8c4145bf21e078f72a0933_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="i46c86ba47653492db774e9e6bbe191b4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i839190f328204596bd4e7f2b5c29b42b_I20230502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="ifc946f669dc44ab69a194363c6a5ce91_D20230502-20230502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="i85f8c4df47be4b3bb9037e0c92c557ba_D20230501-20230501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="i327cce141c0e4abb8b30e48daa9e4ec1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0debc62e945846f3839159ee0a6f9a4d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifb07919adac2412abcdc705eb562b3c7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i327aba17f5014740927f4d6f30982b5d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id164ef0f52604d3090071179b7c674e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i867b324806204e6a8e1477d0e3cb2fc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb893d91703146878373e8b9e7346cb8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7e08e1c1bd8548999900b632892e8ecb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b1e23607d9b4a6091501bbce5031d11_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie78c8e3b7926431fa4a031ff1b43afff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic36a1c6051fe46d29e86c02619938c15_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7d0df874b4644f05949c4d3711ac6210_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic991c189663c4129a0fde857c5cebba3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibfd177924cc3495f977df5f06e848f4a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib08b48c8d45a411fadb58b9f97850fbb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaee54db0edd84b02b83911d676d2521a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i03a42f31cb6c4a84bff5f04071d84127_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4256325af2f4601ba2bc2b417b0cc41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3433e18f57964e288d423f861ddf29db_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb3983d4da1c4a63b445b21520061727_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if70be69bf99746f0b1a2639e28853784_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb23d1e2a799483fbe06ff074abe16d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2657b2a0824346879b134134d44a0a15_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2114bac1bd054f9bbf533d596e9ab742_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ff23176b1c647b08e43d79fec054b16_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaab2edb2f7584b39b2e4c10c2b4cf2bd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i514f278578014b3ea9214b4c5b8aa393_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i220d86c07d6f4153933adc26fb1b8c40_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11f7f0a3fb574018bd69ea4301436dc8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c66f45a22194ea1bd25a835ded92b94_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6c46b634040b42af82927fa3b3a9c69e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie7071e99aae74c26818ee4fc1078006f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f338d30818a45c8b71f0f0dbd66b6d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i61edd147d4fd41509a556db54902c84c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i36bbbfa3da2b4326bc60719fa6fd45ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib52a1527e7b349ec89e29f3f0ba90ad4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i71d3db81712f4239be8f0051d1d897a8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie97b341035254171803036112d834dc3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaf9687fc8f6c4d6db21b6785089b7e8f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibfdc0c8d72f342cb92f5fc2b1a42d622_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i64f1950f0b744460b168ac0882235a7a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i68d8282968274787bf68cd11594aa0c5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if11186980b9e4cf698fbb8587274f2dd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie3bda5d9087a4425bd1f312345cf6dcb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia26be39686ba45b1acebc43952d4c3e3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied1ab1eca1634f0698b6d31cd0ccd36a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib7ae3ae19a3841afaf0cd279b4c39bbe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i56aa2cf3462544d8979682eaef70c07f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i539fd33dac17452e8380f33c7328399a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2310718e6df44f9ba6d23f2c10ce4f28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a0c27fd53e74ac09581adda8572f037_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9dd736e093284b1f90094c25759f3a5d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie4a7c42e398848ce8ae91911c305983e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2d25dd9c66fa49e183749b9de751d7ac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibcaa27ca17db4c80894a80bd3c652fd5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4d38be3dbd9f47b1a656a54014fe335e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a81db5279004ab98255bc257a8b932a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iddee2adad35a4a8192069f6cafdf1201_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0ccefd85418d453d9737f46e41f5fb23_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibfed1454e7274af982d6b45ba703168a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i57fe3eeb911349678a7bf8df45f05778_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9e26089b884345fc8d7fc1a31ebe1941_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icdbe7e2001e5451395afcf0f04039747_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifbcc5f5ebbc94676a14ee20dd1d88ee3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i44d3af566c97447eb29044226498a483_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8a07081ff1e147c7b62955fae3341f9c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icc787c3d87de4e529b1a1214d25dd219_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i42cb4a9358d245a9b06a8c263fbba453_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i639de7dfa3ed4105824a383022ae604b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16e3d483e0784d668c5fcccc53c0c0c4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27fd2cc36f7841a7931db67ed478f1d4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i925fade534304e14aa08d9d00d456adc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f043b01d8c84596bf6c16f669ae0033_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7f1f3e2b054b410ebbfba28ae8d5bf9c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb7b70ddd11a47b5b376a5b3fbcfc34a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifbb066670e8741e7b46db0c89fb8f532_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c073aee648d483b8b99e031c637e88d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i785a7204a25949809c4a78f9d83a56fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4727e084447d41309188d3fa8292bd52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9145c1132d8f4904bd34c706c2b8da19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib210e2369b7443789e3ea95a893fa4a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i388162eb095246c8ae3b452b6fb6d79d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30017e91965849e3b86010cef96f9638_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6302cce667044a7c840558fd40b16281_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7156bae6dfd14a4c86bad30abbbff44b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3cd294f5249d4543b203a1badf1bd045_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d2723b92ac44880b50abda5a89b505e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47b68ae2c1f64fd19f95c3e5bd640eb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9e6f409f64046f1a01d80570a92c6dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a992fa5adc941b1a529b3cf351ef331_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc1567be7a7f4866ad74e7c9bc298305_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i001598a6451343debc1eff9c7e4e32c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2962e842fe1042c48b78d2a92f8ba363_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63617743472146bca1ddf9b17d4cd4c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd1a57a9ec4148a9907fb88d8b662710_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i913e95c8d14844cab43aae1b5ee9d5d7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b1894678fde443f82f89be4a6696366_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8265c25c9ead4bd99cf15809d148a000_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb917855ecff45e8a8e787e07790f532_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibec14ebc629645989483a19e0343e21c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i88836880a6c74131ab0d5e56774644d3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia3b7647c520143b2b49538ae9a39be8e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ebc837ea9594ee285981ba3f282c096_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1dbe5953d7534e6b8caf8d57ca5ede7b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i13296d918c654fd9985778c3de5b1aeb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e6a6329197e4602bc28dcb00294a999_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifbcb7186ed06424e99a7e02812bf766d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib2cc79aa32c24877bb38fed7bb662b80_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i940d96b554da411a9cba8e0f8ac4b3f8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibccf07ea07e5473386720165a8d80e66_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f12a0b1caec43ed8a5cff4d6a9e3476_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9cfa4161feae48dab889801774d4b2e6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i41f3cbe1cfcb4a5f9a47d208546e9394_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1af15065f24c48d597eeba3d21822866_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i018e0921466c4187bd61ec7f759a162b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i36c8746221ad488b9529c5494d1ea6ec_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iffa81968af7b42edb313c43eed5dac3b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i13000e7829fd4c77a7fd14783d62bd3f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iff376ec3f339421eb5832e29861ce655_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a515693d5ce41788531f520d6f67ec0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie41a3c6e1c99451a98b32769c140d8ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1fb2239301f45369894d81b5bef30af_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i75ddde48bac0413a905db67674a8e7bd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i638494ab1b4746019b02aed9c1bf8d9c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4104a3224bf9493180199848515bb756_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5bfdfa7a6f4b458dbd8ae201cba1db28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5e4d1e5638a949eeaec6c1e059aa2887_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2b1abdb4a43b4e52a6d8356ebe217244_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie2e5e884e58f40ecb2c2247c7abe2f3e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic203ee5d324b425a8a68bfeed0a05433_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id123001a7f8d495091ca8cf8640c1149_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iae365fa794744d8889721900ea6b2235_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2c5c14abc11642c596325a01b162322f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0d88303b2f434c308ad61792e9ee3b36_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie608b61ad1604ca986c8862e56a56332_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86995cf6b1d84d179178e116a1a20f11_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia6cd9790208a42bea5215d04c5eb3401_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2bc5a5cd534c4f698abae8407f367bcb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i54953c6cd4614dc1ab7325d790cf34e5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8d69ccacd09d405b9d774c898769ad31_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5f28276f9544efdb371f2ddf105d27b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e915bd1e3b34f25ae6de550809d67f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e187738c64a4f819165a5dd65b86de2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb701bf9661948ebac5ec92842c42cd1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20104417b40c467083117d2e267a0d8d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i38b061f9764a45d58ce926b44ad26d44_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c1a5f7cda7b418fb2105151c6cebdd9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ac657fdf5ab45fdbf03530b75c2f55a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i442caee6095c4be4950552f634b6d7a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e51a45df88d476ab23a4e8b55ec1e22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie42c87aeb9a142048b4d45e04a53dabf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58584562df924c35a92246868059ade9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i180e642f281a4428bccbf1a1d28a4863_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if96a5d0edeea40438700b57fea0592cb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66a3623a5b404531b6aaf3bc4355290f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9130e432ea74b33b7edc370ab5d3ac3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d5e7a806a404590beb00542a88de708_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a0a094fa23b4862beaf7cd2379edd3a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9302529dcf26467bbd2db62d902d4ad9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c7d300ceec143fb95566216335aac05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic966dffda67f45128f343cfed0076de3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1dadf84326ee476a8256a97b1954777b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29e69bfca3ac4909baeee8e3bb375ac6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51e7e9cfafd4471d888f09553e3a8397_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i711edb971fdc4948ae77077c034cd4f3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05330bee1a9f44669bc7deddcd19520f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i65d6560e9fbc4acf849607bd7a325af1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i367940a0c0de44c9bc97abafd36441db_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b59adf13cdf461f9fe4939c39d5a82f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3db4636fab2045e79a50da511dac639e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib837b245fbf5401cab8f7e03d387b150_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i03c3faf213d24ed792c56ec2ff526497_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i152425578ab245479d4240084913937c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d385b28a05d4c32befb019eea226fb0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i174f156a210a439ca784589516304147_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3a8530e6bd584994b387406e0a034c9f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id949c9b2b95046068211c24d3d40a4e2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i95b279c3a46845edac9bcef54ebf51b5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id9580fad210c4bd8811feeca4fa82016_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e3ce116f77d4736ad8797c395b90826_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1530c22fff264f3083979c2e12ffcde9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35bd935f9c8045c1baaeabbec9492fe0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8cf824a61ec042a2b9b0f1108219276e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd3f75c2d0b04f1e92ad90c558bfb862_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9216a5f76034bf488b5c23d00f7740f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0477daecdf25494cb2366e0b03619181_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i73f84be43c284e9ea81738a715edabe2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if6db07e1d8d6441eace2fba24d4330f2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie1683e51a0304fd1b7b78196b6cd714f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idd649305f8964805951ac2c94e102d7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie82772095666435b8c2ba849a5d87d24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i243d234bfce84d389bc036ddb4b85c74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2391cba71e9345508d7ce650a306647c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63539f261c8e469cb1db341cc5be5d7e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i78e7cab3f0f04b0f9ce8ce12e0f930f8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2ecb5c351dba4689987a3a609b0cfb43_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i767908569cc8444db0b335059e1f47f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i42367ec111444b5db6d88802bba1dba7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01151808097d494ea4b5cc15684dc01a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64dbb0605566455397f86d75767eabfe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i44e5aacbdfc34e248dd6ad1cabff65bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f67171bf8fe46e184c0ac18933c3013_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie30887d94add43ff8de3f123add67684_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i963eadfc020e4b0bb4c52e215959124d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3739f888e9fa4ab18bf2d985de27fe27_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib0d351d5ac104a9383183f6130aa4991_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2651627654ef4f4c91f509c8eb1bb477_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i75a146d6f9c44eb0987d661df9a8f498_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0dca12fc0564290869461416690d5fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8903f0df33854a12b5260ff32cb9efff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idf917e365bae42a0b79ce78cefbe94e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i791de71b848e4eaab8372e1b5f61e096_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2ddedc311f014abe8cb88591cd05edb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib8eb0165ec524ac69eafcbce65d1384d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4a92f64233d34b92b691ec5e6b31bc87_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6451d539af494cc08958d87d42063dd5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6d919deafdff42c08b18845673c9987c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id68cb38e243a4c0589c5dc10a30a7ad0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0643f3ad93414fdb8de5a7dd49b4a6f3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id4056481f5b44ae287fa3901ab72f3a3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0b28e0a23a584695a4622d30105683e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i180077daf73946ae866928c89b89e292_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i68a2a42d2c314267a6ba9a48f7231396_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie123d33508a44c209de9379671362b7f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5bd67553bffa4d42b6ad807eec4e0947_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i452ce3dfebd34199a05e64ce393bc4c8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifacd64ecac6a4aac953d15d34d578d88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86c5d299901045239a89b149c86fc62b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if83a48cee9f5421f959a40efc914a409_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i662502d2b9824d468b5ea7e46559f0d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if223ef4f1cb04f89aaed72f66b1ea655_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia6045cebcc054f359aeda689be7966b1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibdba47c662a241d796fcf13177996678_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4a9e113db05c4437a869964daf990132_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7df477b572d04891896d991e4831089e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6116e07db6564d4bbfa404e6b3bb00a2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iee90579e8a1b4b1da229e849035d343d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic932276a2f124dba92225829473c58a6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic0b686b402cc4958a97490b22451eac1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia094aa9bc0e247adbf9401a23f3358a1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3b3614b59a37444c9c0ce65c076cc76b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i55ff9d813bee44a0965aa5d87884e5ff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i18d86193e1b54a5cb7daa5b1dc397607_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i903d499b0d9b49e49eaa2a9bb04df017_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8213443c893d488d8dac56b4a243aa90_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29e609944ebb4c7abcd29efc5ac7a42a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6fdf4d6af289497db86f4e1ef5b01c5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47a06c42b0d441a9bffe6e38635b3abb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1ec5f2382c744b1386a167b07243b1ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1389fe77fa0245a3b7288b5f5b6fd60a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8195e760c0664b8ebc5acf22c0705628_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4e614b3ac4b4f9b8791bb6db2978b36_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6084b97edd8d4f4fbf531a21307abe4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e7e4e1aac0e46b59b1c064b844b1068_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2ee3f756fd384578983ede98c5a0fc5c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18c1afd8891d4f5c94b81a067731189a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5bca211743f44200bcddc914732f3f5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63f3531d3fe74d638d45ecfa6b71c325_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11ee92e3968142fc8a1f00b97f55b501_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9c5c27de38b4adb9c680fe62498e820_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i53af89ad853e4e88a7223062ff9de426_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e5be82f9aa84b8f82e19cbbd50d5017_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes50DueFebruary2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id93656a700a24e76938502046d84db62_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes50DueFebruary2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f7f76b8c0b544a3a59704c58a83c665_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic060d61cd4084e17b433a1b12fa6cd89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide95dae98a2245b1acb066495f097ca2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i858a0f59e1c349d6b9a6c24cbe1894b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb777320df5b48f797263822df4f0e9d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic312216e7bc34f27ae9ab07c90920b49_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia7bf61a5560341df80eaf86640920cf8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i619ee922ba3248eabc18dc25aa73b06f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cdf17416ddc41a6b3022410dc3d2705_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i31b29cbacf5446fdac7dcf2a511e8029_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib6d28f166a4b43a397fdfaabad32194b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i061715fa0d744784ba4cc2d892ac4b03_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i38635e749f46407a80cdf7fc2ea4d372_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i84a442e85b6e4b94a98823c08df1f043_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b311c6d410f4978bd5331eecaecaa64_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5125DueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7f0e5fbb301a40e6827651a423c2292d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5125DueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6eb4e9251184548a1634972c55a28d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i529f1b8b3f1f4b42b2e5446768b8e87e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.75DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie07bdea3da6f451c9bcba9f549201961_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i175bb047294f462da1aa8e1333b6d0ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie0a02874bdf04d5b9a706cad560999ac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d8c414c1efc476fa3e1e6d77efcaa3e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41089ddd19eb470282adb9570456e08e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i63f6643ec5754faebede440568434de3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e8700d2108e4ab496a24690db04dcf2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes525DueFebruary2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib41b9178e08b45cb91563f0883c36a2a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes525DueFebruary2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i45cd1f1f6e8b4f41986ce9a7b9e9e696_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8b01afccbbf34ad4a1781cb89df8712b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87fac5abf1e74d54a53dc666fcc47f4d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i792622491465439c87c4cca105f8d743_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6d5ddad65b5b4fecb1c2c210aba362c8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i97a596cb57ed46fab4eba2c7de95bc00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e9459ad3944423592e566ee3f8a9f55_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i52e871c110bd4599ada469473b42a2e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cd1bc3205234dbc80620f09b4404f44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i78517656fb3e4be49efce58b458d7215_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i780cead0663d47e985eb7cde37891351_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id39881b60def4677ad68de30d76d707e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5934de2b48064b68824f5a5e12dbbb82_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i245129fe18fc45cdadddd2c037c1005c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib080a75dab51499e8152c514ed6ab74c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i444c1838f8c64b14a5caef64a8ccd662_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3cd7de97cfdf412381d46297d5991484_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if350f271cef34debb54ac8e3ae82abe9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c4d09214db040b5b5740899c41892e6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8122b6f5dd094913857934bb5ac9998a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e903c49671d4c7bb899e91247869f60_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i791829c941b64e9cb8aac4352fd31278_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i48586d4589464091a486da7ecff7be86_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9a52fb5322d941878151c5480cdcb452_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib95efcc5698746f887d004c6b539186f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ife5a3762af674b319552867bf484df1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id09a1af1b14f4dedb5552601fe0a898b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6fc72c0ca3044aefa6c543e50d9f5073_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8a9a69c0387a4dbb9cba44bbcb236d31_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icad107da7cf74913a7fb43e2fa78c217_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i855756e5c4f640c09e72c199fabc5c3e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i38b6295bbdec46108d23d6648619dc7d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.25DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i089e716c693541d38cbcfc0f339c6165_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5625DueFebruary2053Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i061610d07ab54236a1e052f4440a4b61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5625DueFebruary2053Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i765e8c9bf1514d37b538d56d98f8673d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i843857ee2e25408ba0949fae0a27ddc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id93ceac7923443509811589be6f2fda6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i825b614ae6f949128593ec129680423e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i57dc9b642fb340ec9fbef3cdb67f4dc4_I20230501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:TermLoanAgreement364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-01</instant>
        </period>
    </context>
    <context id="if84cea09dba14f6bb1e7a65458f7d779_D20230502-20230502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:TermLoanAgreement364DayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="i1f22263a3b694849ac61d1b0059ba4c0_I20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes50DueFebruary2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="i3088c2dbfe5d4a469e09d45deecf17d4_I20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5125DueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="i466f42736e3c44f8a5bb7b033dc6dcc0_I20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes525DueFebruary2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="i96c354a2d55441de977ed5f9a4c0d071_I20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5625DueFebruary2053Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="i409ce543d75747f6a86747b1e3200724_D20230221-20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2023-02-21</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <context id="i1d3f405559b34436a7dd9bda0df240e1_I20221117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-17</instant>
        </period>
    </context>
    <context id="i33e778ae14014217b9adbc2e50448ccd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24b66500cbc3494cbb2171885f5e9eaf_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="ia8259b9e69e843db9bea20eeb8e3c4e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if9b17aee558d466d97018672fae58058_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i220c5401ed2f49ac8453e559cfa0869a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic891f32373a24150b07a0e2e79451ecf_I20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="i356ddbd8c27d4b8c951a6be4585f1092_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="i82104008040f4e91b57c7a3d066cd708_I20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="i165725ae3ea04060af45b3a4c66096f0_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="ifdb54f39d1c8482b9e757ee875b765cb_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="ice6b8f5b6cc749a6a4fce5808629a093_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="i8f99461356ba4ce58d8b75de3a097310_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="iab1e6b8b47724b91aaf561c27d054b14_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="ie9e4ce7d668647199a9963ba9223fb1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cee30098f554ffc83dd60ace24f2da1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12b0bf32f4024d9a901bb71692e6457b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia973432534304c319e71bd7ba226880a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i50bde2997fe64d2fa6e63680de08d727_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4e3b16b861e34693a440d9cbeb7ff083_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5ce902132c444a37ae7bef2d65504f51_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieaf12a3d04a2473399581bc3408cd6bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2a52a92c5c54930b5139ac668af203b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e51eab27f6049da87e49ecefc750401_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1b73ef515fa74bda9625d4853a2c40af_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc48e18e68b24845a7b17fbee590d05e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4233cdd857c84c5495036af966d69c1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i69ec3798d5e44b4d9eec0a23d4f9102b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbaec47994724954be26c44f88b1be41_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5349061ce37a4635b17c190c002a1781_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3c1adaa533e24a38b010ac1f6be0ca13_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib634cfe740504bac99546a361cf5b67c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id8471dc1ae7b4c3ea316bf53d8400d96_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37a9e3c8866a4ad8be85672e565cf864_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0e7ed44250004f0abd93cfd873764497_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i80edf5a59a3b4b4cbde630d40e6cf394_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1a2ced1961f54c58a58691eb07a37938_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24d62eb54342479d9c8f667ab299427d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd2694bab621470b83d6016dd198125c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0e064e345951488e83346591a86aa59e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i428c873482a54c03a2844bcfd0128950_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i36ecd33b2f0d4bf79158216e8e771219_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i506d0959bcbe41b386b645d218ba7cad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b89e03562af42418df598d66e518fc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2abc6620160466c96132f7287192b1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i28d618aaf5d4485a9bcc280348fd703a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a84c750be7040c4995da886f9ea1771_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie9431e6a492f4c89b178b2b1528cc6f0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1fb588d338ae42bcbcfae34f3bc52d4b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic10b551416e249919ddba15b607f1f4c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i578b2414d82040be9c8f73746252c42e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibb438f2d815843dcbab2c539cffbd7ad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i834bdaa838194915943ae1dd41b66214_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i30f76719657045dc97c61d48649aabd8_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i73c2c711a9e144129bf8bcee89201591_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if91f496db0cd4ebeb4308b49828714b9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ef4e0c2d2c244c393a5cfcced1e4a15_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie999f8648a0f440188249767603b220a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0692ab80d568422b875c73998e65a989_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i27b20e43185e4a60b4de68bbfd17424a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i43eb35c724574445b70e64a0712e5fd0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia6c819332a1f49149907bd79dbb6e5ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5ea3c803bd92470ca456a8cbd46b65d7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id46d76788ff04d0c89d679c03b4d8113_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9b33e78be95e46aa8781e4f5cd708b7b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icceee7f19d8144d1838edd528b32a625_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id25124c88573450f860bbc033280cab3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i72d3de15fdb141208e8be43677f48e7a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf51c4d778d74146836a38c29f6f5806_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie8949cbfc8744ae59620e133dc98603d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8f5c687add1743e5809d22a9d77525eb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5a711f48e1345a19a731927269c49cc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i73dedc2c29fd4e33a88a7a1d2a1957db_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4b32d6ef57d9481e855325b36afb4145_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9eef6ef05c314ac8991556b8d8d5dd5e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i832630f4a1134a15bb6da5125d24a7d0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i153b35e7e97042bb9c9cb483ab1d7c90_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="people">
        <measure>cvs:people</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="lease">
        <measure>cvs:lease</measure>
    </unit>
    <unit id="claim">
        <measure>cvs:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF8zLTEtMS0xLTIzMjU0Nw_9b281632-4622-4096-80db-32f411543a32">0000064803</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF80LTEtMS0xLTIzMjU0Nw_6cd9f7d3-ab36-465b-bcc2-ce8980d22a23">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF81LTEtMS0xLTIzMjU0Nw_5e923756-312d-4633-870b-f58575adddde">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF82LTEtMS0xLTIzMjU0Nw_283ade20-6b1b-466e-88cb-8d76a728f1a5">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80L2ZyYWc6NWE2NzVkMDRmMTIyNDRiMmFiZWNhNzQzNjJkYmU2OTUvdGFibGU6ZWRmYmUyOGY0ODNmNGNlYjg3MzhmN2E5YjI3M2E4ZjgvdGFibGVyYW5nZTplZGZiZTI4ZjQ4M2Y0Y2ViODczOGY3YTliMjczYThmOF83LTEtMS0xLTIzMjU0Nw_8e687914-24e1-41ef-b352-bfef29d8166a">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0wLTEtMS0yMzI1NDc_112c1de1-6ac2-4f44-a85c-ce76b5723e12">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0wLTEtMS0yMzI1NDc_251d0c44-9e0d-4edc-a097-0115cf0f41fb">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_4a540ca2-c5a0-4370-9572-5e1f1b60ec25">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_effb7122-9853-4ffd-bc90-e0ef6a32ea42">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMjE5OTAyMzI1NzE0NQ_e6900be7-0b3a-4d0a-abd8-725b8e9077ce">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV84Ng_2e45f684-5f70-4141-b933-6c3ec8fee55d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI2_f7ae20f9-4c5b-4560-9588-21686e98d15c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMjQ_1d70c69d-ee0a-47ce-b09b-85790d289e4e">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI3_1e8d33be-4a36-4f8d-857b-0f2d1fae1f5e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI4_8e54eb90-d670-4020-918c-3a7b8b386801">001-01011</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDI5_b9417f6e-d037-4369-973a-f96bdc8854c3">CVS HEALTH CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6NzBkZTA0NGU1NDE2NGFjNTg5YzFkOGIzOWJmN2E4ZGMvdGFibGVyYW5nZTo3MGRlMDQ0ZTU0MTY0YWM1ODljMWQ4YjM5YmY3YThkY18wLTAtMS0xLTIzMjU0Nw_5f04f0c7-7a58-4b7a-af67-dd78cc93888a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6NzBkZTA0NGU1NDE2NGFjNTg5YzFkOGIzOWJmN2E4ZGMvdGFibGVyYW5nZTo3MGRlMDQ0ZTU0MTY0YWM1ODljMWQ4YjM5YmY3YThkY18wLTItMS0xLTIzMjU0Nw_a00c147c-0dde-4c83-9f8a-8ba417c6c171">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTEtMS0xLTIzMjU0Nw_afeac430-cfed-4a03-86bd-464b8f9afb80">One CVS Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTItMS0xLTIzMjU0Nw_0700b350-734a-4538-b955-185b9c5698d7">Woonsocket,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTMtMS0xLTIzMjU0Nw_89e82fd8-7f29-42a5-b75f-5b6c7a2c1e4c">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8wLTUtMS0xLTIzMjU0Nw_4d39f74e-4581-4dd4-95ea-2eb96b14a433">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8zLTUtMS0xLTIzMjU0Nw_38516939-c3b9-4ae3-9a74-838879a1d5ee">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6MzIzODIwYTE1MGYxNDA3NjhjODkyNzQ3YjMzYWJkZDQvdGFibGVyYW5nZTozMjM4MjBhMTUwZjE0MDc2OGM4OTI3NDdiMzNhYmRkNF8zLTYtMS0xLTIzMjU0Nw_3f3d4e75-f1a3-4930-ba51-86dc8817dc0c">765-1500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZWY4NTAxNGUzMTEwNDA5ZDk2NDdjMTcwM2VmYTIyMmYvdGFibGVyYW5nZTplZjg1MDE0ZTMxMTA0MDlkOTY0N2MxNzAzZWZhMjIyZl8xLTAtMS0xLTIzMjU0Nw_1754c9c8-9b89-4515-97b2-ff8f3fb1ff3d">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZWY4NTAxNGUzMTEwNDA5ZDk2NDdjMTcwM2VmYTIyMmYvdGFibGVyYW5nZTplZjg1MDE0ZTMxMTA0MDlkOTY0N2MxNzAzZWZhMjIyZl8xLTEtMS0xLTIzMjU0Nw_cc9212b5-ef87-493a-8e94-63560c250718">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZWY4NTAxNGUzMTEwNDA5ZDk2NDdjMTcwM2VmYTIyMmYvdGFibGVyYW5nZTplZjg1MDE0ZTMxMTA0MDlkOTY0N2MxNzAzZWZhMjIyZl8xLTItMS0xLTIzMjU0Nw_055de72b-d94e-4848-bf34-bc749d9bfd81">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDMw_e2fb1289-d7e5-4f55-b45d-ecfc565dcd38">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDMx_8e9b9a61-e248-4209-ae64-fab022ff0448">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZTMwYjMyZGFiYTkzNGNjZGI3ODIwMzk1NWFhMWI4NDAvdGFibGVyYW5nZTplMzBiMzJkYWJhOTM0Y2NkYjc4MjAzOTU1YWExYjg0MF8wLTAtMS0xLTIzMjU0Nw_1e8a2a3a-344c-46f0-9e35-421506efd24f">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZTMwYjMyZGFiYTkzNGNjZGI3ODIwMzk1NWFhMWI4NDAvdGFibGVyYW5nZTplMzBiMzJkYWJhOTM0Y2NkYjc4MjAzOTU1YWExYjg0MF8xLTMtMS0xLTIzMjU0Nw_ee241baf-7eaf-4d4f-95a4-793e87ce4107">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGFibGU6ZTMwYjMyZGFiYTkzNGNjZGI3ODIwMzk1NWFhMWI4NDAvdGFibGVyYW5nZTplMzBiMzJkYWJhOTM0Y2NkYjc4MjAzOTU1YWExYjg0MF8yLTMtMS0xLTIzMjU0Nw_bc908718-487b-4a47-9786-fc029f122835">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8yMDMy_6ac19bb8-785c-4de9-939d-ef8773308612">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i91b26ed1eaac4b94ac243c6f30365065_I20230426"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xL2ZyYWc6ZTI5Yjc2MTVmZjAwNGE3MTk5ZDM3NTA2OTNkM2RlNzUvdGV4dHJlZ2lvbjplMjliNzYxNWZmMDA0YTcxOTlkMzc1MDY5M2QzZGU3NV8xOTc4_e5b214da-01c5-48ab-b0ee-03f0bc821cf1"
      unitRef="shares">1282025283</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c4d4c6f963c4f73bc0cc280e69d641b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMy0xLTEtMS0yMzI1NDc_b9a52f88-92cb-4567-9b13-d6f69b05c17f"
      unitRef="usd">58147000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcc0efcf324e4c67accd1041ac8b9ce1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMy0zLTEtMS0yMzI1NDc_d5c4b317-18b8-4e93-8939-ae590a55171b"
      unitRef="usd">52522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNC0xLTEtMS0yMzI1NDc_c9a5afa4-a1e7-4959-bfbe-2e3d08588630"
      unitRef="usd">24352000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNC0zLTEtMS0yMzI1NDc_21f23924-1caf-4a9d-8116-b6e153f97418"
      unitRef="usd">21631000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28dec895582849b98979be68d4b8999a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNS0xLTEtMS0yMzI1NDc_1f3285d7-21bb-45a6-bc57-9bd0edc2fda2"
      unitRef="usd">2445000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4ff0943b4f746ffb566b7dab6c56ede_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNS0zLTEtMS0yMzI1NDc_9d4c1a3f-ef5f-4d14-9f88-91711f9387e1"
      unitRef="usd">2505000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNi0xLTEtMS0yMzI1NDc_8ad1fc94-8369-4f36-a823-f9081963da25"
      unitRef="usd">334000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNi0zLTEtMS0yMzI1NDc_68182511-c892-46a9-b884-399efe12b076"
      unitRef="usd">168000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNy0xLTEtMS0yMzI1NDc_d36a3845-e09f-417e-a8e3-15643f8c2bc3"
      unitRef="usd">85278000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNy0zLTEtMS0yMzI1NDc_5ad70118-e0dc-4397-908a-14022f940851"
      unitRef="usd">76826000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0xLTEtMS0yMzI1NDc_65d0aef6-de3b-4d53-b182-62023c7109f1"
      unitRef="usd">51455000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfOS0zLTEtMS0yMzI1NDc_2352de72-775a-47c5-a78c-79487382cee0"
      unitRef="usd">45509000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTAtMS0xLTEtMjMyNTQ3_42c7f528-9907-495f-b4ee-6b1e00750a7a"
      unitRef="usd">20448000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTAtMy0xLTEtMjMyNTQ3_af123d43-513b-44ba-a71b-946aacfecb82"
      unitRef="usd">17923000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTEtMS0xLTEtMjMyNTQ3_a0f43641-dbe1-42a5-8373-4ccecd64040b"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTEtMy0xLTEtMjMyNTQ3_0826074a-ba48-497a-bcc8-9acb906daa5e"
      unitRef="usd">-484000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTItMS0xLTEtMjMyNTQ3_c679066b-96d9-452b-ba8e-a7ecea508eb3"
      unitRef="usd">349000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTItMy0xLTEtMjMyNTQ3_6e6b1b42-86d9-49b3-be1f-dbacb1771b5d"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTQtMS0xLTEtMjMyNTQ3_72a04fe3-f13c-409d-b9a4-480fbf0ef4bc"
      unitRef="usd">9580000000</cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTQtMy0xLTEtMjMyNTQ3_5cfa9f8f-0d16-4b6c-9eca-882984f5a753"
      unitRef="usd">9324000000</cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <us-gaap:CostsAndExpenses
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTUtMS0xLTEtMjMyNTQ3_2763243d-bd5c-4bb3-8f56-a8577583737c"
      unitRef="usd">81832000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTUtMy0xLTEtMjMyNTQ3_b435b4b6-e9cb-4c0f-b8bc-9c3d033224b3"
      unitRef="usd">73281000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTYtMS0xLTEtMjMyNTQ3_db9e4611-6bf8-4762-b824-3af94278c473"
      unitRef="usd">3446000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTYtMy0xLTEtMjMyNTQ3_f9eaf016-0d3b-4c90-a29b-6d0b8760d5fe"
      unitRef="usd">3545000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTctMS0xLTEtMjMyNTQ3_c1dca56a-ac30-46de-819a-9dd0990794f1"
      unitRef="usd">589000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTctMy0xLTEtMjMyNTQ3_cf1f2ed7-2384-42fa-bedd-881b17eca10b"
      unitRef="usd">586000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTktMS0xLTEtMjMyNTQ3_ecf8635d-ede4-46d9-af56-3fb24a7b7151"
      unitRef="usd">22000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMTktMy0xLTEtMjMyNTQ3_91cb0730-e117-46ba-b43f-ae9dd25afcae"
      unitRef="usd">42000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjAtMS0xLTEtMjMyNTQ3_26befb4a-294f-464d-b370-02815f9b1c3e"
      unitRef="usd">2879000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjAtMy0xLTEtMjMyNTQ3_4220c23a-266f-49d4-9216-69e6e087f323"
      unitRef="usd">3001000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjEtMS0xLTEtMjMyNTQ3_201a2647-a274-4361-b119-c1eeab61c999"
      unitRef="usd">737000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjEtMy0xLTEtMjMyNTQ3_4de42585-7a61-4e23-b064-95764b36f079"
      unitRef="usd">646000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjQtMS0xLTEtMjMyNTQ3_c62d34ee-711f-4b87-aabb-5584188c25a4"
      unitRef="usd">2142000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjQtMy0xLTEtMjMyNTQ3_f78b4905-8d7d-425d-a80c-62ed90fac177"
      unitRef="usd">2355000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjUtMS0xLTEtMjMyNTQ3_9c6fe787-bec4-4189-bb05-c8cf0892f1d6"
      unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjUtMy0xLTEtMjMyNTQ3_f3f3d65f-5257-4df7-8e74-6ee2b70ccb9f"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjYtMS0xLTEtMjMyNTQ3_5c03c564-3352-4370-99f5-a77c9f73c5f3"
      unitRef="usd">2136000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjYtMy0xLTEtMjMyNTQ3_818b7541-6262-4bff-9e70-465a719dc1da"
      unitRef="usd">2354000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjktMS0xLTEtMjMyNTQ3_36cd68c8-4a0e-46af-9991-851c4acc6ce9"
      unitRef="usdPerShare">1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMjktMy0xLTEtMjMyNTQ3_8b329685-2f7e-4062-89ac-faf3a78fecc5"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzAtMS0xLTEtMjMyNTQ3_ca9fe2d0-bf81-4d2a-968f-7b84cb077096"
      unitRef="usdPerShare">1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzAtMy0xLTEtMjMyNTQ3_1223cc4d-14ee-4f4a-903a-0743d66bb84e"
      unitRef="usdPerShare">1.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzItMS0xLTEtMjMyNTQ3_9da5002e-8081-46bc-958b-82e0338c97f6"
      unitRef="shares">1283000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzItMy0xLTEtMjMyNTQ3_0e88b8a3-e7fb-4f0d-97aa-f0baaf5c70e2"
      unitRef="shares">1312000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzMtMS0xLTEtMjMyNTQ3_38559511-737e-457b-ab84-7177537349e3"
      unitRef="shares">1291000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfMzMtMy0xLTEtMjMyNTQ3_dd70be0b-fa4d-49ae-a7c5-d297e1420d8b"
      unitRef="shares">1328000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNDQtMS0xLTEtMjMyNTQ3_380a0392-0805-482e-8f69-ebc38b20e1e5"
      unitRef="usdPerShare">0.605</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8xOS9mcmFnOjE4NzMwYjE1NDg0MjRhNWM4NTllYTgwNjQ4MjBiYzQ1L3RhYmxlOmZlNzBhZDY0MDAwNTQzNjBiYWMyZWMzNDM5MTI3ZjcyL3RhYmxlcmFuZ2U6ZmU3MGFkNjQwMDA1NDM2MGJhYzJlYzM0MzkxMjdmNzJfNDQtMy0xLTEtMjMyNTQ3_e1860c3e-2fec-4383-a31c-66f80569d6b3"
      unitRef="usdPerShare">0.55</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMi0xLTEtMS0yMzI1NDc_c62d34ee-711f-4b87-aabb-5584188c25a4"
      unitRef="usd">2142000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMi0zLTEtMS0yMzI1NDc_f78b4905-8d7d-425d-a80c-62ed90fac177"
      unitRef="usd">2355000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNC0xLTEtMS0yMzI1NDc_6cd06882-b028-483c-a5f5-1246a9b513ae"
      unitRef="usd">470000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNC0zLTEtMS0yMzI1NDc_a778011f-f4fb-480a-8d5f-e13b22595cd3"
      unitRef="usd">-1132000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0xLTEtMS0yNTUzNjY_18ac345f-7951-4f76-ba84-0fe852fdcb6a"
      unitRef="usd">-74000000</us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax>
    <us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0zLTEtMS0yNTUzNjY_f99282de-feee-412a-baaf-8df7ed0d3b4a"
      unitRef="usd">369000000</us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0xLTEtMS0yMzI1NDc_2273207f-5b9c-4d26-8cdd-269d1b4e7489"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNS0zLTEtMS0yMzI1NDc_2e064b4e-5b81-498b-b181-c1394fbfccb2"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNi0xLTEtMS0yMzI1NDc_1c9fe3d8-19cf-474d-8093-6d410ffb69a0"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfNi0zLTEtMS0yMzI1NDc_723ffca7-3a93-48d0-99b0-93e48b0c2f4e"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOC0xLTEtMS0yMzI1NDc_4c27407e-f669-43bf-86bc-26d05b744422"
      unitRef="usd">389000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOC0zLTEtMS0yMzI1NDc_e6eaf794-78af-4d43-ac12-1e788911a08d"
      unitRef="usd">-763000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOS0xLTEtMS0yMzI1NDc_2737ef5c-1355-42ba-b00d-9651c88e22a0"
      unitRef="usd">2531000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfOS0zLTEtMS0yMzI1NDc_45a9cffe-0d64-41e3-80c2-87437ffc8a56"
      unitRef="usd">1592000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTAtMS0xLTEtMjMyNTQ3_9c6fe787-bec4-4189-bb05-c8cf0892f1d6"
      unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTAtMy0xLTEtMjMyNTQ3_b9946ba6-d394-4477-aabd-a2630aa0012a"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTEtMS0xLTEtMjMyNTQ3_bc4b29bd-cd21-480b-8605-6534dcfa8f64"
      unitRef="usd">2525000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yMi9mcmFnOjVjMzlkODEzMmRlMzRhOTU4NzYwNGM3OGIzYWNkYThiL3RhYmxlOmJhM2VhZjUyMzFkNTRmMTU4NjRjMmEzNmE5OTE2NWU1L3RhYmxlcmFuZ2U6YmEzZWFmNTIzMWQ1NGYxNTg2NGMyYTM2YTk5MTY1ZTVfMTEtMy0xLTEtMjMyNTQ3_e64f8473-060c-4654-9c42-9b75fa62faea"
      unitRef="usd">1591000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMi0xLTEtMS0yMzI1NDc_41ee416c-eaaf-4cda-bfda-3e1ab92d4b4e"
      unitRef="usd">14618000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMi0zLTEtMS0yMzI1NDc_300c1f9e-7d1b-4890-8716-09c0ce261859"
      unitRef="usd">12945000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMy0xLTEtMS0yMzI1NDc_34afa4ed-0715-4975-a5a6-98aeab2290b1"
      unitRef="usd">3102000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMy0zLTEtMS0yMzI1NDc_7641b8d1-e225-4e59-8a88-de94d02a9d23"
      unitRef="usd">2778000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNC0xLTEtMS0yMzI1NDc_5832cacc-1ac1-452b-ae5f-f7236168d763"
      unitRef="usd">28331000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNC0zLTEtMS0yMzI1NDc_6f43ca95-bca4-494f-8f26-54fb7a208e10"
      unitRef="usd">27276000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNS0xLTEtMS0yMzI1NDc_0ff249f3-2087-4ca6-a39c-66733e71223c"
      unitRef="usd">18263000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNS0zLTEtMS0yMzI1NDc_1990705d-fbb4-4f1b-8861-602c983ee5f5"
      unitRef="usd">19090000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNi0xLTEtMS0yMzI1NDc_ea562812-d681-4c16-8925-0bc8d8b69901"
      unitRef="usd">625000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNi0zLTEtMS0yMzI1NDc_a26a97c5-4610-4af7-99f6-7e3433627b7e"
      unitRef="usd">908000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNy0xLTEtMS0yMzI1NDc_a9a6b2db-bd1e-41cd-bd63-c21d12639def"
      unitRef="usd">3767000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNy0zLTEtMS0yMzI1NDc_7c51a329-af02-4134-977d-06cf71ea8e5c"
      unitRef="usd">2636000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOC0xLTEtMS0yMzI1NDc_09c44bdf-00d8-4042-a35f-b9686762b3c7"
      unitRef="usd">68706000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOC0zLTEtMS0yMzI1NDc_48343724-c8aa-4a77-b3f9-c0bc092b6e12"
      unitRef="usd">65633000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOS0xLTEtMS0yMzI1NDc_726d64e3-af2d-4b41-83de-e3891e8c6642"
      unitRef="usd">21612000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfOS0zLTEtMS0yMzI1NDc_877cc319-dacc-4885-9b2f-281270662870"
      unitRef="usd">21096000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTAtMS0xLTEtMjMyNTQ3_ea857df9-8590-46fd-80d5-9c0f2d0413df"
      unitRef="usd">12872000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTAtMy0xLTEtMjMyNTQ3_69bb66dd-ae92-4cc0-889b-fa5791d1d3b4"
      unitRef="usd">12873000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTEtMS0xLTEtMjMyNTQ3_e2f3d64e-e037-453a-b655-e61e02cc2c29"
      unitRef="usd">17660000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTEtMy0xLTEtMjMyNTQ3_8851dc37-c330-4da1-ae21-9836ca107a12"
      unitRef="usd">17872000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTItMS0xLTEtMjMyNTQ3_8b5fd314-67cf-4e3e-bca1-6e188690586a"
      unitRef="usd">84057000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTItMy0xLTEtMjMyNTQ3_0648735d-dfd6-4225-8542-34a4417ff98f"
      unitRef="usd">78150000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTMtMS0xLTEtMjMyNTQ3_199c2b1f-0c9a-44fc-a10f-2aaf4f475086"
      unitRef="usd">26368000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTMtMy0xLTEtMjMyNTQ3_adbd7d5a-a921-4cbe-b7f9-de71376210a3"
      unitRef="usd">24803000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTQtMS0xLTEtMjMyNTQ3_e2dd235d-978a-459c-b4a3-346260a67d70"
      unitRef="usd">3231000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTQtMy0xLTEtMjMyNTQ3_c6f04f8c-3013-4cf0-bc21-33a471a3fdfb"
      unitRef="usd">3228000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTUtMS0xLTEtMjMyNTQ3_290993c9-a51d-4100-81ea-b1ea510e10d4"
      unitRef="usd">4824000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTUtMy0xLTEtMjMyNTQ3_f27219a9-2e62-4133-994c-04b434ca6d5f"
      unitRef="usd">4620000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTYtMS0xLTEtMjMyNTQ3_127d95cc-05ba-4045-97ce-a64c6aad1e0b"
      unitRef="usd">239330000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTYtMy0xLTEtMjMyNTQ3_047de142-3ba4-41e9-8239-c5b123707b99"
      unitRef="usd">228275000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTktMS0xLTEtMjMyNTQ3_5196cfe7-a7d4-41d7-8ba6-60f58b00e4bc"
      unitRef="usd">12527000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMTktMy0xLTEtMjMyNTQ3_e7db1a7c-8a20-425a-9579-ba755b62a36d"
      unitRef="usd">14838000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsAndDiscountsPayableCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjAtMS0xLTEtMjMyNTQ3_dde0a226-804f-4550-ac9a-5aba901ed77f"
      unitRef="usd">20047000000</cvs:PharmacyClaimsAndDiscountsPayableCurrent>
    <cvs:PharmacyClaimsAndDiscountsPayableCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjAtMy0xLTEtMjMyNTQ3_a806592d-9ceb-431f-a08f-f111bd1a1cc8"
      unitRef="usd">19423000000</cvs:PharmacyClaimsAndDiscountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjEtMS0xLTEtMjMyNTQ3_fd034af5-3d06-4735-92d8-1a720abe13c0"
      unitRef="usd">10895000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjEtMy0xLTEtMjMyNTQ3_1b87b921-220c-4c90-80c6-e4b9194fe255"
      unitRef="usd">10142000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjItMS0xLTEtMjMyNTQ3_40d3e99b-9d9d-4f0c-a650-ec2f15f84ca7"
      unitRef="usd">1426000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjItMy0xLTEtMjMyNTQ3_a6a029f1-d78c-4bcf-9b27-444faa20a925"
      unitRef="usd">1500000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjMtMS0xLTEtMjMyNTQ3_3c6a1c67-89df-4b40-8ad6-6828d99a697e"
      unitRef="usd">21515000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjMtMy0xLTEtMjMyNTQ3_d5b7cdb9-fabe-4fac-903b-03e168bc8dbd"
      unitRef="usd">18745000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjQtMS0xLTEtMjMyNTQ3_f0c8bdeb-1525-47c7-81a3-0c3ea5a48a2f"
      unitRef="usd">4974000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjQtMy0xLTEtMjMyNTQ3_67d4d027-bfa8-4a12-a445-1c27169937dc"
      unitRef="usd">1089000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjUtMS0xLTEtMjMyNTQ3_9976844a-dbb0-4b3f-97a6-cdfca5fdb58d"
      unitRef="usd">1679000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjUtMy0xLTEtMjMyNTQ3_7042cfb9-5bf4-490b-9119-514ef5ab698b"
      unitRef="usd">1678000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjctMS0xLTEtMjMyNTQ3_d0d04b99-c5d7-4f12-8017-cbd78b0547ae"
      unitRef="usd">1778000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjctMy0xLTEtMjMyNTQ3_0500d774-d5c9-4488-bb72-b2eb583ec23a"
      unitRef="usd">1778000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjgtMS0xLTEtMjMyNTQ3_30d41041-4c69-4d2a-8a47-3f255b80479d"
      unitRef="usd">213000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjgtMy0xLTEtMjMyNTQ3_f48e5b63-7300-4fe4-a122-904f567ba0a1"
      unitRef="usd">228000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjktMS0xLTEtMjMyNTQ3_832ccb2c-1131-424a-80b2-9cd053165835"
      unitRef="usd">75054000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMjktMy0xLTEtMjMyNTQ3_a675def8-5727-43cd-bd6e-9f2e47829cb2"
      unitRef="usd">69421000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzAtMS0xLTEtMjMyNTQ3_a1c63492-365a-453d-b491-6f0cd7228924"
      unitRef="usd">16571000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzAtMy0xLTEtMjMyNTQ3_78300935-e8a0-47d6-9683-92f74fa987e3"
      unitRef="usd">16800000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzEtMS0xLTEtMjMyNTQ3_47625641-975b-4d78-8837-264bc7c6f2d5"
      unitRef="usd">56450000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzEtMy0xLTEtMjMyNTQ3_94c07124-1c68-427b-a97a-2baac1008072"
      unitRef="usd">50476000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzItMS0xLTEtMjMyNTQ3_fc584574-fc6a-4d38-bcd6-770794bcecb7"
      unitRef="usd">4095000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzItMy0xLTEtMjMyNTQ3_9cf67eca-2087-441f-91cf-aca4213e2a14"
      unitRef="usd">4016000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzMtMS0xLTEtMjMyNTQ3_eb01d0db-7a32-4a83-85de-8ec96ec27226"
      unitRef="usd">3231000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzMtMy0xLTEtMjMyNTQ3_0cbc51ad-f239-40bd-b379-7706dac3fbc0"
      unitRef="usd">3228000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzQtMS0xLTEtMjMyNTQ3_e9d07c73-4c65-4807-ab1d-0aa9ba962ec1"
      unitRef="usd">5678000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzQtMy0xLTEtMjMyNTQ3_2c1413a1-1792-47f1-b8e8-1f9be215e518"
      unitRef="usd">5835000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzUtMS0xLTEtMjMyNTQ3_8a702d02-6834-41e7-9842-9293b1f30e16"
      unitRef="usd">6671000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzUtMy0xLTEtMjMyNTQ3_c4a6f5ff-b533-4973-a6b7-5c94ef420264"
      unitRef="usd">6730000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzYtMS0xLTEtMjMyNTQ3_e7b11ad9-017c-4a13-822b-b41b4bcab741"
      unitRef="usd">167750000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzYtMy0xLTEtMjMyNTQ3_845eeef1-2c0e-43a7-9e4b-37f4a2eb4804"
      unitRef="usd">156506000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzE_0bab64e1-9ecb-461c-8d07-e4091e1c193b"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzE_3218c8c2-2c65-4a5c-88a1-2516da28dfc7"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzU_3e58aba6-b73f-46e9-9bc6-4999c0fd00da"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfMzU_74ba2298-ce33-4681-a165-49eed5295a9d"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_16193b71-8df7-486a-b5fb-212480c0a448"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_3f74eeac-1ca4-436c-81a5-57e63ceaaf84"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_48e1eea2-7db3-4043-bc3a-e881af3c35fd"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDIxMWMxMjg2NmIxNDYxZmI0YjViN2ViNGFiNzMyZDdfNTc_b5debfa6-faba-4ae8-9a9c-089ddddb00d0"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMS0xLTEtMjMyNTQ3_ae8f08f6-8f4c-4508-bae8-a56f0f358873"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfMzktMy0xLTEtMjMyNTQ3_5850144c-d7d3-4ee3-b38d-60a33a66e571"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMjg_3656a802-1cf7-4dfe-8590-cb089d14b586"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMjg_f5506cdf-6712-4a2e-9cd2-305c52948c3c"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMzI_1335ac0b-5705-4a68-bc66-e08bbb9dd60a"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMzI_c69c6caa-e8f2-4118-ae71-e115cbcf2087"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfNTQ_7987d1d4-8801-4170-b4fe-132725b92412"
      unitRef="shares">1759000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfNzU_1631d98e-5e4f-48e4-b325-f98128993e16"
      unitRef="shares">1279000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMTA3_d8526503-b02d-4dd6-9e1c-516f0d234a4a"
      unitRef="shares">1758000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Mjk5ZTY0NDIwNzkwNGRiYThkNTMyNzg3OTdhNGI4NjlfMTI4_3692e92c-8732-4f6b-a187-d2363b49ab22"
      unitRef="shares">1300000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMS0xLTEtMjMyNTQ3_74028079-cbd8-46e3-b22d-559f35fb0590"
      unitRef="usd">48306000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDAtMy0xLTEtMjMyNTQ3_33640132-a2ea-44b4-8aa4-8640f385affc"
      unitRef="usd">48193000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTliYzBiNGEzMDQ1NDFhOTlhMWE5ODM3ZDUxMjc2YjNfMjk_57bc6cc9-3ccd-4b34-8f1b-f8108ace13bb"
      unitRef="shares">480000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTliYzBiNGEzMDQ1NDFhOTlhMWE5ODM3ZDUxMjc2YjNfNDk_89951800-aad8-4a45-8213-bb4b31d960e7"
      unitRef="shares">458000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMS0xLTEtMjMyNTQ3_c9c414c3-1b63-4e6f-8d35-93c98afedb57"
      unitRef="usd">33802000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDEtMy0xLTEtMjMyNTQ3_1c757777-b172-4dd5-84ba-365a384cf40c"
      unitRef="usd">31858000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDItMS0xLTEtMjMyNTQ3_330a2be3-0457-4d57-941b-4c52856305fb"
      unitRef="usd">57753000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDItMy0xLTEtMjMyNTQ3_6f33730e-c4a3-45c6-a7c6-e0199e6dd408"
      unitRef="usd">56398000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDMtMS0xLTEtMjMyNTQ3_81a6cdcb-9ab9-4978-b5e9-c8d700969f88"
      unitRef="usd">-875000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDMtMy0xLTEtMjMyNTQ3_5a79ef76-9a0c-4275-9caf-219ad05560c7"
      unitRef="usd">-1264000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDQtMS0xLTEtMjMyNTQ3_ac758b1a-4fd9-40d9-a9e1-014bd9e936b4"
      unitRef="usd">71382000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDQtMy0xLTEtMjMyNTQ3_854173a0-78c0-4c97-a194-ac94f423e20f"
      unitRef="usd">71469000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDUtMS0xLTEtMjMyNTQ3_bff3a22b-4c03-4135-8348-ee7fb3ec3299"
      unitRef="usd">198000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDUtMy0xLTEtMjMyNTQ3_c53d577d-9f74-4b6b-b478-74627640c1d9"
      unitRef="usd">300000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDYtMS0xLTEtMjMyNTQ3_c4a28e2d-d7b5-4e51-9ade-6a8b136cac4a"
      unitRef="usd">71580000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDYtMy0xLTEtMjMyNTQ3_76a2af78-6f99-4e14-8f69-4c40a5c9269d"
      unitRef="usd">71769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDctMS0xLTEtMjMyNTQ3_811f4b3a-e8e8-40da-bd06-f62e6164af4e"
      unitRef="usd">239330000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yNS9mcmFnOmM5NmRhZmY1YTkwMjQ3NDE5NWQ1ZmMyYWNhYTU1YjllL3RhYmxlOmExNTgzOGI2ZTY2OTQxOTliNjE5Y2M4ZDAzMGU4MWViL3RhYmxlcmFuZ2U6YTE1ODM4YjZlNjY5NDE5OWI2MTljYzhkMDMwZTgxZWJfNDctMy0xLTEtMjMyNTQ3_d72743fa-8ba7-42a4-b9d0-e30cd61d850e"
      unitRef="usd">228275000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMy0xLTEtMS0yMzI1NDc_49d5f9ea-23df-470c-a810-04e9e595389b"
      unitRef="usd">87798000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMy0zLTEtMS0yMzI1NDc_9828c5f0-963a-4c2c-b92d-b31847543d66"
      unitRef="usd">74192000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNC0xLTEtMS0yMzI1NDc_4c1bca05-241a-4341-8bc7-4bc71b2e36e7"
      unitRef="usd">50223000000</cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies>
    <cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNC0zLTEtMS0yMzI1NDc_cfd6a6ff-f83b-4713-8e61-336fb6170d45"
      unitRef="usd">44365000000</cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies>
    <cvs:PaymentsForInsuranceBenefits
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNS0xLTEtMS0yMzI1NDc_24351f2d-1f39-4230-87d2-87613a8908f0"
      unitRef="usd">19757000000</cvs:PaymentsForInsuranceBenefits>
    <cvs:PaymentsForInsuranceBenefits
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNS0zLTEtMS0yMzI1NDc_02d78f0a-844d-4a82-bffd-5b2a219ce6a0"
      unitRef="usd">16616000000</cvs:PaymentsForInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNi0xLTEtMS0yMzI1NDc_9ebe4954-5e3c-41e7-ba95-12bed8a694a3"
      unitRef="usd">9958000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNi0zLTEtMS0yMzI1NDc_f74c2152-f70b-43ff-8598-cd8b122b105c"
      unitRef="usd">8969000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNy0xLTEtMS0yMzI1NDc_6f42f96c-cb07-46bc-9922-defb17f70677"
      unitRef="usd">426000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfNy0zLTEtMS0yMzI1NDc_03d950dd-4cb0-44a3-81e6-4c8dd42bc3e0"
      unitRef="usd">199000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOC0xLTEtMS0yMzI1NDc_7da870db-e268-4240-9f2b-18952a7028e2"
      unitRef="usd">773000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOC0zLTEtMS0yMzI1NDc_b26a7753-7ba7-4f8d-8b53-cf845c08c316"
      unitRef="usd">782000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOS0xLTEtMS0yMzI1NDc_8a7e5c83-ea75-433f-aa64-3fb9f0433e05"
      unitRef="usd">75000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfOS0zLTEtMS0yMzI1NDc_471a7793-7788-48fb-84c2-c2c97baf3642"
      unitRef="usd">96000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTAtMS0xLTEtMjMyNTQ3_125c1f39-5d0a-48e5-b0a3-d38bbf605f16"
      unitRef="usd">7438000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTAtMy0xLTEtMjMyNTQ3_4dc6650e-2052-4b6e-8c9a-00e8c1f25ce1"
      unitRef="usd">3563000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTMtMS0xLTEtMjMyNTQ3_802f1131-063e-4fd8-99ff-2becef4e2bed"
      unitRef="usd">1891000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTMtMy0xLTEtMjMyNTQ3_df95f42c-1020-45e7-9542-4f60dbf9655b"
      unitRef="usd">2570000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTQtMS0xLTEtMjMyNTQ3_dcbbe042-7381-4db8-b9a3-b228c28411b3"
      unitRef="usd">2358000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTQtMy0xLTEtMjMyNTQ3_cc828ca1-1d60-4802-9aae-44de1c52125a"
      unitRef="usd">3474000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTUtMS0xLTEtMjMyNTQ3_16b08f09-38b8-455e-8ef9-019cf18fb127"
      unitRef="usd">984000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTUtMy0xLTEtMjMyNTQ3_d8272b4d-27fd-4d3a-ab5d-2f21775c2f58"
      unitRef="usd">1051000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTYtMS0xLTEtMjMyNTQ3_44b5973c-a06d-40a4-a657-3e1c524eb6d6"
      unitRef="usd">7094000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTYtMy0xLTEtMjMyNTQ3_b88dd388-01ac-4ede-96b1-683351b1a640"
      unitRef="usd">7000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTgtMS0xLTEtMjMyNTQ3_eb7198af-7c97-4fa6-8bc7-765cce2885aa"
      unitRef="usd">-31000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTgtMy0xLTEtMjMyNTQ3_b420bcf5-fd92-4bc0-a920-0c4e7858f5a3"
      unitRef="usd">31000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTktMS0xLTEtMjMyNTQ3_c5229e73-6fc2-4ad5-9e97-70c316b14817"
      unitRef="usd">-8514000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMTktMy0xLTEtMjMyNTQ3_515704f9-527a-4b9b-a6ec-181e405c560e"
      unitRef="usd">-1993000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjMtMS0xLTEtMjMyNTQ3_2e333c31-ea2a-4409-b5c0-444b6b534c78"
      unitRef="usd">5951000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjMtMy0xLTEtMjMyNTQ3_d91ca827-097e-4c8d-adab-25785e461ffe"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjQtMS0xLTEtMjMyNTQ3_cbd07ca3-0f05-4530-9355-cd2537318cde"
      unitRef="usd">362000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjQtMy0xLTEtMjMyNTQ3_b3b4f7c3-13ee-4a44-b925-8078504d556f"
      unitRef="usd">14000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjUtMS0xLTEtMjMyNTQ3_008a6f27-1c7c-4987-bcb0-d4c5268902c6"
      unitRef="usd">2018000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjUtMy0xLTEtMjMyNTQ3_dd6ea883-51db-4780-9d30-d8087740bf8d"
      unitRef="usd">2000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjctMS0xLTEtMjMyNTQ3_5f6de32a-6152-43d4-8a2f-dcf6a55645c6"
      unitRef="usd">779000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjctMy0xLTEtMjMyNTQ3_9056a092-10f8-41f8-8d24-8cb6b0a793bc"
      unitRef="usd">722000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjgtMS0xLTEtMjMyNTQ3_09c40ebf-a90d-4e8a-8ec4-b1631b4dd5c2"
      unitRef="usd">96000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjgtMy0xLTEtMjMyNTQ3_1b970f2a-2630-4c66-b802-f9a6df1ec896"
      unitRef="usd">297000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjktMS0xLTEtMjMyNTQ3_51c5a76c-90ac-4c12-83e6-ffbb6e402aaa"
      unitRef="usd">34000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMjktMy0xLTEtMjMyNTQ3_d29e7d00-a3ac-4e4f-8a94-2a502b475cec"
      unitRef="usd">62000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzAtMS0xLTEtMjMyNTQ3_d45fe1fe-d390-4499-b710-8966ac4cde9e"
      unitRef="usd">-128000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzAtMy0xLTEtMjMyNTQ3_7989ab98-361d-43d9-a20a-5451ff0863f9"
      unitRef="usd">-149000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzEtMS0xLTEtMjMyNTQ3_7918a8c2-9173-475e-8c68-9d5569b1655e"
      unitRef="usd">2726000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzEtMy0xLTEtMjMyNTQ3_9e2d447b-408b-44c9-8b2e-6605b9f313ec"
      unitRef="usd">-2650000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzItMS0xLTEtMjMyNTQ3_a64aad93-751b-4777-8edd-9be8339932a9"
      unitRef="usd">1650000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzItMy0xLTEtMjMyNTQ3_c555b0cf-785d-43ce-a644-10c0ef9f47eb"
      unitRef="usd">-1080000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzMtMS0xLTEtMjMyNTQ3_c350aaa0-76ad-4daa-b485-401b6bf189b4"
      unitRef="usd">13305000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzMtMy0xLTEtMjMyNTQ3_ebd9cf2e-1bca-4e96-83f1-218dca3443ea"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzQtMS0xLTEtMjMyNTQ3_748e907e-86e3-4f23-b2a9-28ca80a61cd2"
      unitRef="usd">14955000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOjBkYWQxYTM4MWFhMjQxMzc5YWRhOWQ3ODIzYWUxYjJlL3RhYmxlcmFuZ2U6MGRhZDFhMzgxYWEyNDEzNzlhZGE5ZDc4MjNhZTFiMmVfMzQtMy0xLTEtMjMyNTQ3_2501644b-cbe0-4ffc-9cfb-aedbc8dbbad0"
      unitRef="usd">11611000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMy0xLTEtMS0yMzI1NDc_bc14ee36-4a63-448f-aa94-98630ee02adf"
      unitRef="usd">2142000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMy0zLTEtMS0yMzI1NDc_e15890a5-94eb-4889-bed5-c639446d9fea"
      unitRef="usd">2355000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfNS0xLTEtMS0yMzI1NDc_d21e40b7-c517-4a76-820d-44595763658e"
      unitRef="usd">1001000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfNS0zLTEtMS0yMzI1NDc_8c2e9e12-86ed-4d8a-8042-2f4fb0b110de"
      unitRef="usd">1049000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfOC0xLTEtMS0yMzI1NDc_707249de-7eeb-49cb-858d-b5d7f736c213"
      unitRef="usd">103000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfOC0zLTEtMS0yMzI1NDc_1f6c2d47-23d9-40b0-a772-ec5388043175"
      unitRef="usd">89000000</us-gaap:ShareBasedCompensation>
    <cvs:DeferredIncomeTaxesAndOtherNoncashItems
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTEtMS0xLTEtMjMyNTQ3_38dd6799-7b37-4f15-bcc1-66877bc7129d"
      unitRef="usd">155000000</cvs:DeferredIncomeTaxesAndOtherNoncashItems>
    <cvs:DeferredIncomeTaxesAndOtherNoncashItems
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTEtMy0xLTEtMjMyNTQ3_5ebd3700-2364-4dcf-a8c2-2cc1caecbfb9"
      unitRef="usd">-175000000</cvs:DeferredIncomeTaxesAndOtherNoncashItems>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTMtMS0xLTEtMjMyNTQ3_9be99fec-12ba-4e0c-8683-432cf2f52f28"
      unitRef="usd">751000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTMtMy0xLTEtMjMyNTQ3_5315c241-ca77-4f53-ae92-a2708350d5ef"
      unitRef="usd">1967000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTQtMS0xLTEtMjMyNTQ3_d6241dd1-86f4-47b3-900f-43e9b01892cd"
      unitRef="usd">-828000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTQtMy0xLTEtMjMyNTQ3_504ffbbb-47b8-4aa8-b6d2-469b9ca5ef91"
      unitRef="usd">400000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTUtMS0xLTEtMjMyNTQ3_cb0caf7d-7431-4d73-9616-a09919164ced"
      unitRef="usd">1255000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTUtMy0xLTEtMjMyNTQ3_9eda6bcd-9dc3-40c6-9ec5-fc024ec7e242"
      unitRef="usd">348000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTYtMS0xLTEtMjMyNTQ3_12e4a955-9bc1-4602-8a01-e065f239979c"
      unitRef="usd">-1203000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTYtMy0xLTEtMjMyNTQ3_6909803d-b162-41a4-9023-d32fbe24bfde"
      unitRef="usd">1974000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTctMS0xLTEtMjMyNTQ3_4b4a67fd-9c3c-4ad5-961e-8bcefe59d0d9"
      unitRef="usd">4382000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTctMy0xLTEtMjMyNTQ3_a9e262e0-1ee5-4696-8cb6-bddaf2835337"
      unitRef="usd">1430000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTgtMS0xLTEtMjMyNTQ3_28898189-c4ff-4d9a-9f09-6ef153881b34"
      unitRef="usd">2036000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTgtMy0xLTEtMjMyNTQ3_902ab62a-034a-40d4-a665-d935f504c317"
      unitRef="usd">-444000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTktMS0xLTEtMjMyNTQ3_41ec7f95-0f3d-417b-9105-5d0c77935d47"
      unitRef="usd">7438000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8yOC9mcmFnOjc3OTZkYWViYzAzMjQzY2Y5YmNiODVmODIwYjU5OTM5L3RhYmxlOmYyZjFkNTQ0ZmQ0ZTRiYzJiY2ViZjMyNWRkZGRlNWNkL3RhYmxlcmFuZ2U6ZjJmMWQ1NDRmZDRlNGJjMmJjZWJmMzI1ZGRkZGU1Y2RfMTktMy0xLTEtMjMyNTQ3_3bcbae80-2a9f-47af-93ea-3ca58ecf0947"
      unitRef="usd">3563000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="id0126d2a2d5b4cdd9ca3e3d805ece7c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0xLTEtMS0yMzI1NDc_6f422a26-e2a8-4030-b5fb-b4f307012a2a"
      unitRef="shares">1758000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i0d661cb6c0504a1fa9228d0757d805ed_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0yLTEtMS0yMzI1NDc_6c050194-16c0-477f-9fb5-b8d19017455a"
      unitRef="shares">458000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ca8df10bb3e4ef68a134deb6f91845f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS00LTEtMS0yMzI1NDc_ca4b0262-df78-433e-bef7-8786581d587d"
      unitRef="usd">48193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d661cb6c0504a1fa9228d0757d805ed_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS01LTEtMS0yMzI1NDc_60714424-be32-4073-9ab4-938d817d7181"
      unitRef="usd">-31858000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f3a6802840048fbb777cb7cb063f606_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS02LTEtMS0yMzI1NDc_33d8dab8-7b74-4aa0-9dbd-ce7153d73359"
      unitRef="usd">56398000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0919e504ed6344d68c00a6acaebcde05_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS03LTEtMS0yMzI1NDc_61ef81c8-0b91-4463-aee3-8de193969576"
      unitRef="usd">-1264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a977074046f41a89c7f4a1f6b9bcc1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS04LTEtMS0yMzI1NDc_15e54128-150e-4e84-a8ba-971b41dd8577"
      unitRef="usd">71469000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie33015c34edd4999b191485b67da92a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS05LTEtMS0yMzI1NDc_ef09a06d-6014-42b3-9024-971b48fa6b39"
      unitRef="usd">300000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0xMC0xLTEtMjMyNTQ3_4c9d5f52-ec0a-4e75-8c13-e23402553fdb"
      unitRef="usd">71769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i6966b4e2696f4a24ac2798c5d341762a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi02LTEtMS0yMzI1NDc_7b9c71a8-9435-48e0-9a85-547933e92c3c"
      unitRef="usd">2136000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi04LTEtMS0yMzI1NDc_8ebbd248-44fe-44f9-afc9-2f591a30ccb8"
      unitRef="usd">2136000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iebd6ef7eeaab42469a4c1b85aecdbcbe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi05LTEtMS0yMzI1NDc_0a2bb016-5c32-4dba-b645-34218dcb0914"
      unitRef="usd">6000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNi0xMC0xLTEtMjMyNTQ3_8ad97d6b-947a-4735-ae59-5a9fdc2a9c59"
      unitRef="usd">2142000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ca517c88528406bb73b9e7287a1467b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNy03LTEtMS0yMzI1NDc_4871b444-3249-4971-b585-f7b35b769786"
      unitRef="usd">389000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNy04LTEtMS0yMzI1NDc_f49f48e8-5f8c-435d-9b6b-1bb4f05ad3e6"
      unitRef="usd">389000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNy0xMC0xLTEtMjMyNTQ3_4558a551-8aa3-457b-b872-16b0715d634d"
      unitRef="usd">389000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="icda684d607d94e4984c89b2b79d866e6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC0xLTEtMS0yMzI1NDc_cd1ba6d0-1cee-4155-b3d9-8f6a4dc56e52"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC00LTEtMS0yMzI1NDc_9308e9cc-7702-426d-abe9-b51cbf5ec8ee"
      unitRef="usd">122000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC04LTEtMS0yMzI1NDc_efee050f-23ba-4647-87b3-0ac544517858"
      unitRef="usd">122000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC0xMC0xLTEtMjMyNTQ3_013612a7-0fef-467c-b02e-f5f3a9aaf10f"
      unitRef="usd">122000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i607b6600b7634e74b9a25dba310ddfe6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0yLTEtMS0yMzI1NDc_c4b41d6b-e368-44ff-af4a-a3036171ac0b"
      unitRef="shares">22000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS00LTEtMS0yMzI1NDc_5091b64e-4ffe-460b-be4b-cda644451ed3"
      unitRef="usd">18000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i607b6600b7634e74b9a25dba310ddfe6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS01LTEtMS0yMzI1NDc_c54fad51-69a2-43bb-97b9-e8c59b2e1614"
      unitRef="usd">1944000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS04LTEtMS0yMzI1NDc_487ccb25-6cc4-4ccc-b4da-48d2647a9bce"
      unitRef="usd">1962000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0xMC0xLTEtMjMyNTQ3_23ab6a6d-bf0d-4195-9a3f-2b9d08c63ab7"
      unitRef="usd">1962000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i6966b4e2696f4a24ac2798c5d341762a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTAtNi0xLTEtMjMyNTQ3_edf79ac5-3f9f-42ec-8f4c-f34685f08d29"
      unitRef="usd">781000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTAtOC0xLTEtMjMyNTQ3_d1b519f5-9814-4229-ae0e-786910e575fb"
      unitRef="usd">781000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTAtMTAtMS0xLTIzMjU0Nw_bbf8794a-d305-415b-a7c3-50776083edfc"
      unitRef="usd">781000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="i12b8af2f5b1649969d4dc6910ff0cd0a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtNC0xLTEtMjMyNTQ3_9c9cc7b5-bac3-476f-a1d5-a757cc74d7cf"
      unitRef="usd">9000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="i0ace68007d0f47a9af5bb9109dd6e366_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtOC0xLTEtMjMyNTQ3_75407ef5-0e35-4cac-8c22-f21c42e92a6c"
      unitRef="usd">9000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="iebd6ef7eeaab42469a4c1b85aecdbcbe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtOS0xLTEtMjMyNTQ3_22a66750-c633-44b2-a8e7-3e7a3c9561dd"
      unitRef="usd">-108000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTEtMTAtMS0xLTIzMjU0Nw_b4ae2192-426a-4e83-b729-f95afbe6a23c"
      unitRef="usd">-99000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i14bff4dd44434085ac94c47f67cf0b94_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMS0xLTEtMjMyNTQ3_217389b0-b6d0-4c9c-8a25-5c46566fed62"
      unitRef="shares">1759000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ib8a97180d2514a9b93e7596cf96be425_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMi0xLTEtMjMyNTQ3_bac58b12-1fef-43ba-9745-c0d784911361"
      unitRef="shares">480000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i18f0bf58dc2749449f2f66468faccce3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNC0xLTEtMjMyNTQ3_68f228d6-24ee-4fb5-982a-a6c3d0e74abb"
      unitRef="usd">48306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8a97180d2514a9b93e7596cf96be425_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNS0xLTEtMjMyNTQ3_346a8441-b914-40c1-b85c-35d5bc62cd0c"
      unitRef="usd">-33802000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6bfce6ac5f8468eb136aac914a9ef04_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNi0xLTEtMjMyNTQ3_f40d19ae-bd19-4522-bd0f-abe1dba29a88"
      unitRef="usd">57753000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i500c40e14a1143a3aa4e9627c448de62_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNy0xLTEtMjMyNTQ3_931da9b9-0416-4646-b80a-4acba35e7156"
      unitRef="usd">-875000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic92b2e37d0234aa2aee969f6ead4b607_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItOC0xLTEtMjMyNTQ3_a59dd4dc-1e2a-4f9a-9cf8-65c361b60c5d"
      unitRef="usd">71382000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91059cc4e3514c71825e73b0a7423eba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItOS0xLTEtMjMyNTQ3_89fc8175-95ff-48e2-9625-7b580ab61a12"
      unitRef="usd">198000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMTAtMS0xLTIzMjU0Nw_2c5ba9a6-4881-4561-8b34-be5b79a58579"
      unitRef="usd">71580000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i44ee7f171b49433c9fee60c78374b031_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMS0xLTEtMjMzOTQz_a19d5947-5c72-44e9-9932-309ac9bc033d"
      unitRef="shares">1744000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ibc256cbbfdbe4919bd580b89b5853b65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMi0xLTEtMjMzOTQz_fdcec20a-0da2-4cba-a702-049f79ca14bf"
      unitRef="shares">422000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5d7bc6153ed403bbf10a74c29ce4dc3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNC0xLTEtMjMzOTQz_b9c39463-580f-4dd6-9019-a7a4fd5ac7f9"
      unitRef="usd">47377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc256cbbfdbe4919bd580b89b5853b65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNS0xLTEtMjMzOTQz_45f485e3-9b46-4c82-8d3e-9d058ed4b98a"
      unitRef="usd">-28173000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8a735ca1fa940769d12496008f05980_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNi0xLTEtMjMzOTQz_8196f26e-15a4-4156-96c6-3fa1bb12e8b8"
      unitRef="usd">54906000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i769f64156cf4441d9b8d63169d946693_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNy0xLTEtMjMzOTQz_3e668b3d-29fd-4bb5-9b01-7988e22faf7b"
      unitRef="usd">965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1ee5670de504ce3adee519f2e40ffd2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtOC0xLTEtMjMzOTQz_0c5bd5b6-4832-4088-9be0-44af10272282"
      unitRef="usd">75075000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7af24bdfc747494e8034faa02222d96f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtOS0xLTEtMjMzOTQz_490273b1-12c7-42ad-9162-97973aa709c0"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMTAtMS0xLTIzMzk0Mw_1f9c57ee-7ad0-43a2-b0f9-84fa498948e9"
      unitRef="usd">75381000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8177aa632cf4772aa7e3d0690fab4e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNi0xLTEtMjc5ODE0_e9b07a15-ac08-413e-805f-2b66fd5510a8"
      unitRef="usd">91000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1236f0a166354cc7b555200e4c10809a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjc5ODE0_2aeead0b-ce92-4b84-b456-8a22a76d1c5d"
      unitRef="usd">-631000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7ec450630a5482c819c7ba9bb97985e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjc5ODE0_835d5494-8d96-4df1-89c5-db14d9bd351c"
      unitRef="usd">-540000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icaaa42d004654ea98904e4011dbecabb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTI3OTgxNA_2ae192ea-b3ef-4e45-8040-5fa42904c6d3"
      unitRef="usd">-540000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i24ae773548b24dbf955bf39d91ac8fa8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtNi0xLTEtMjMzOTQz_59e51c72-1ddf-4dc7-bf31-f9a9e668b27b"
      unitRef="usd">2354000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtOC0xLTEtMjMzOTQz_aaa8ea9d-1608-4403-a417-4d1231e088ca"
      unitRef="usd">2354000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c46457ec075463b998b7704930f1527_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtOS0xLTEtMjMzOTQz_e0eb4a62-a0e7-4216-9001-d78298f06491"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTUtMTAtMS0xLTIzMzk0Mw_033d5b49-59ba-48bc-83e6-448406725628"
      unitRef="usd">2355000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia04b5afab2af4259b71dabfaa547a322_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjMzOTQz_5c5aa880-1dd8-4470-95fa-5c183c9616af"
      unitRef="usd">-763000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjMzOTQz_7e295012-a316-49db-8c91-46f6b053d767"
      unitRef="usd">-763000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTIzMzk0Mw_a1cb1a19-acd2-425c-b2aa-d4b55510e886"
      unitRef="usd">-763000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id87e905aad04499185592c649df0501d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctMS0xLTEtMjMzOTQz_f7893f41-bc19-4390-8818-12a693e60cd9"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i76890c43bde24648bc18aa2102227d8d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctNC0xLTEtMjMzOTQz_e4aa5458-f5dc-47fc-8f5c-4dba67141cac"
      unitRef="usd">300000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctOC0xLTEtMjMzOTQz_9a50458c-9da0-429f-9dc5-af06125f7029"
      unitRef="usd">300000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctMTAtMS0xLTIzMzk0Mw_742c8b41-53b4-48e1-9fe5-41360b0b3bbf"
      unitRef="usd">300000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i3ffe2b44a55945b284180e30309e8aad_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMi0xLTEtMjMzOTQz_4ddd1924-457b-4a04-9c51-c099d307ce1f"
      unitRef="shares">19000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i3ffe2b44a55945b284180e30309e8aad_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtNS0xLTEtMjMzOTQz_076ae2ba-235c-4cf0-8ff1-3b73daa62000"
      unitRef="usd">1972000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtOC0xLTEtMjMzOTQz_0414db75-a396-4d10-adc8-40e8e5a9dab9"
      unitRef="usd">1972000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMTAtMS0xLTIzMzk0Mw_3a2e495a-eea9-4631-8633-7daf0934ea9f"
      unitRef="usd">1972000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i24ae773548b24dbf955bf39d91ac8fa8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTktNi0xLTEtMjMzOTQz_3e3e6a91-efc6-43f4-9025-3bc8f8eb1949"
      unitRef="usd">730000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i4c5d6315357146eb8271c996a3968a6e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTktOC0xLTEtMjMzOTQz_cb2a2857-597b-49af-999c-a340b1a21d66"
      unitRef="usd">730000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTktMTAtMS0xLTIzMzk0Mw_b6327cf9-b76e-417b-9852-df289d3bd202"
      unitRef="usd">730000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="i8c46457ec075463b998b7704930f1527_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjAtOS0xLTEtMjMzOTQz_afad0bd0-20a6-4799-a7ea-070304b2ad10"
      unitRef="usd">3000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjAtMTAtMS0xLTIzMzk0Mw_2342ea8a-e452-43f8-8a99-91b74ab95f2c"
      unitRef="usd">3000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i68525f7e800f4c59b752a9f19135d07d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMS0xLTEtMjMzOTQz_d8e5974e-5379-4cfc-a8c9-bdbf94ed829d"
      unitRef="shares">1747000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia4688929cda745bb98a6c1e716bcf78d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMi0xLTEtMjMzOTQz_55cc909c-b93b-412d-b0f0-4aa7a02e4690"
      unitRef="shares">441000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75183c2d4ace4f5787e50b8f1271e1f7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNC0xLTEtMjMzOTQz_40ae901a-05df-4b91-86cd-5b3d8a1815e0"
      unitRef="usd">47677000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4688929cda745bb98a6c1e716bcf78d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNS0xLTEtMjMzOTQz_6499dc29-8bea-4f59-bb31-f6b0fc576c54"
      unitRef="usd">-30145000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea2fdd12e3c9442ebce0208dc0b9d3a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNi0xLTEtMjMzOTQz_cd32d520-0d8d-4526-a826-cb71a6d32dcb"
      unitRef="usd">56621000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c83419b19394b2b9e56453a8077baa2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNy0xLTEtMjMzOTQz_7252cdc2-3fbd-4fd6-b919-083f75972cce"
      unitRef="usd">-429000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie19ac4c954a3448a8ad572bcd89c79da_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtOC0xLTEtMjMzOTQz_f84d28b6-59d6-45e5-9441-c9e9052f1621"
      unitRef="usd">73724000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4e44e45d682450d8e8f9d28b40f3de4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtOS0xLTEtMjMzOTQz_bd74b3de-7c02-419a-855e-0eeda40351bf"
      unitRef="usd">310000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMTAtMS0xLTIzMzk0Mw_526b622b-f63d-42cc-8b0c-b24b6fde6fe9"
      unitRef="usd">74034000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldInTrust
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_110c3536-f415-4b93-8b86-8e97289d4e0f"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldInTrust>
    <cvs:TreasuryStockSharesHeldInTrust
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_34b3efb6-84f0-4b0b-b8eb-50d171dbcda7"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldInTrust>
    <cvs:TreasuryStockSharesHeldInTrust
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_d463a5ba-2cce-4abe-a5c3-2e8c8d0161fd"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldInTrust>
    <cvs:TreasuryStockSharesHeldInTrust
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMTcy_dfa3abd4-e8db-4515-ae9b-c1d9032b4b48"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_7b23fc46-b031-4b3b-89a0-116a1e3c2b57"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_9ec457b2-77a1-4c22-a23a-a9d14d6a2cee"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_b9c804d2-55ca-476a-bbce-67bb8c1f0932"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjI0_e7ce6455-1f95-4da4-8730-0a902a5ae903"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTU3Mw_8611c09e-89bb-4d18-b6a6-e6d2347f60fd"
      unitRef="usd">18000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTU3Mw_e110274b-efad-417e-9e9f-93e28eb2f921"
      unitRef="usd">18000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTYyMA_5d32b43d-5b93-4334-b960-3ceb1a273255"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMzI5ODUzNDg4NTYyMA_f9d4d170-b5ee-4116-b798-895b96663317"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjM_188b6197-51f0-4926-8d6f-a38b10bf7288">Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation, together with its subsidiaries (collectively, &#x201c;CVS Health&#x201d; or the &#x201c;Company&#x201d;), has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company is a leader in key segments of health care through its foundational businesses and is creating new sources of value by expanding into next generation care delivery and health services, with a goal of improving satisfaction levels for both providers and consumers. The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#x201c;CODM&#x201d;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, also delivers health care services in the Company&#x2019;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp;amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#x2019;s specialty and mail order pharmacy offerings. Prior period segment financial information has been recast to conform with the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Following the segment realignment described above, the Company&#x2019;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp;amp; Consumer Wellness and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Health Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy &amp;amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#x2019;s specialty and mail order pharmacy offerings. As of March&#160;31, 2023, the Pharmacy &amp;amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#x201c;2022 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets primarily represents funds held on behalf of members and funds held in escrow in connection with agreements with accountable care organizations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;All restricted cash is invested in demand deposits, time deposits and money market funds. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net at March&#160;31, 2023 and December&#160;31, 2022 was composed of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes accounts receivable of $211&#160;million and $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $324 million and $333 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Contract Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the unaudited condensed consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#x2019;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the unaudited condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of deferred acquisition costs for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the unaudited condensed consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 4 &#x2018;&#x2018;Fair Value&#x2019;&#x2019; and Note 6 &#x2018;&#x2018;Other Insurance Liabilities and Separate Accounts&#x2019;&#x2019; for additional information about separate accounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts and are recorded in other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for limited payment pension and annuity contracts represent the Company&#x2019;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for long-term care insurance contracts represent the Company&#x2019;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#x2019;s &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#x2019;s future cash flows. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company discounts its future policy benefit liability using a curve of spot rates derived from an upper-medium grade fixed-income investment. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot rate curve and the locked-in discount rate at each cohort&#x2019;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss). In subsequent periods, the current period amount recorded in other comprehensive income (loss) will be adjusted for amounts previously recorded in accumulated other comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, future policy benefits balances of $529&#160;million and $4.6&#160;billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2022, future policy benefits balances of $334&#160;million and $4.7&#160;billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 &#x2018;&#x2018;Other Insurance Liabilities and Separate Accounts&#x2019;&#x2019; for additional information about future policy benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer &lt;br/&gt;Wellness &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp;amp; specialty. Prior period financial information has been revised to conform with current period presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Health Services mail &amp;amp; specialty is defined as specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp;amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp;amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Prior period financial information has been revised to conform with current period presentation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and primarily include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. During the three months ended March&#160;31, 2023, the contract liabilities balance also reflects the addition of contract liabilities acquired in connection with the Company&#x2019;s acquisition of Signify Health, Inc. (&#x201c;Signify Health&#x201d;) on March 29, 2023. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $17 million and $15 million in the three months ended March&#160;31, 2023 and 2022, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $21 million for pharmaceutical inventory purchases during the three months ended March&#160;31, 2023 and 2022, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944) (the &#x201c;long-duration insurance standard&#x201d;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented, January 1, 2021, also referred to as the &#x201c;transition date&#x201d;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $986&#160;million ($766&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. The transition date &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information has been  revised to reflect the adoption of the long-duration insurance standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Removal of shadow adjustments in accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span id="i91763596c6af4e16a382b50f4b12646c_8-0-1-1-256536"/&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021, net of reinsurance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact of Long-Duration Insurance Standard Adoption on Financial Statement Line Items&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of operations for the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Condensed Consolidated Statement of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,923&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,324&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,336&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,281&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,490&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,946&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,312&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,354&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to CVS Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated balance sheet as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Condensed Consolidated Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,636&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,682&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,754&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,406&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,736&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,880&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,835&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,960&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,465)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CVS Health shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,469&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,315&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,769&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of cash flows for the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Condensed Consolidated Statement of Cash Flows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation of net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments required to reconcile net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes and other noncash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities, net of effects from acquisitions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable and other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="i34ba550f20da42bf8e118610bd9d1e54_I20230331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTgy_c9b7ba06-d541-459c-a14c-96e961c02721"
      unitRef="store">9000</us-gaap:NumberOfStores>
    <cvs:NumberOfWalkInMedicalClinics
      contextRef="i6efe121123d64cc4871d92d64ebb6df8_I20230331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjEz_c1c80944-409d-41c4-be39-205cce80f989"
      unitRef="clinic">1100</cvs:NumberOfWalkInMedicalClinics>
    <cvs:NumberOfPharmacyPlanMembers
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjg3_d607cea5-d89f-46cc-aefe-a6fcfe819fcd"
      unitRef="people">110000000</cvs:NumberOfPharmacyPlanMembers>
    <cvs:NumberOfPatientsServedPerYear
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNDEx_987ec0e0-82c4-4a36-b82f-3a113c69a418"
      unitRef="patient">1000000</cvs:NumberOfPatientsServedPerYear>
    <cvs:NumberOfPeopleServed
      contextRef="i9b1e8e047ca74e2da7465cdbe0294566_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNDcw_9d3d0dfd-97d2-4121-a22c-0e6883fca3da"
      unitRef="people">37000000</cvs:NumberOfPeopleServed>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjQ_5259c852-cb1f-434a-aa00-bf9e0c7b5f94">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#x201c;CODM&#x201d;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, also delivers health care services in the Company&#x2019;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp;amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#x2019;s specialty and mail order pharmacy offerings. Prior period segment financial information has been recast to conform with the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Following the segment realignment described above, the Company&#x2019;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp;amp; Consumer Wellness and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Health Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy &amp;amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#x2019;s specialty and mail order pharmacy offerings. As of March&#160;31, 2023, the Pharmacy &amp;amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTI4OA_f36614f1-6a64-4bdc-b809-b77224295444"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <cvs:IndividualPublicHealthInsuranceExchangesNumberOfStates
      contextRef="i4ef8067610324631a99b73d483b1c819_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjgzNA_8842491b-6dd9-42a4-8052-e80e51f6b03c"
      unitRef="state">8</cvs:IndividualPublicHealthInsuranceExchangesNumberOfStates>
    <cvs:IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates
      contextRef="i686abe201e9f4a07bc66c9a037f0de35_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjk1OA_6a9de7cd-86c7-402a-9278-ff5b936c2f40"
      unitRef="state">4</cvs:IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates>
    <us-gaap:NumberOfStores
      contextRef="i34ba550f20da42bf8e118610bd9d1e54_I20230331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNTE2NQ_c9b7ba06-d541-459c-a14c-96e961c02721"
      unitRef="store">9000</us-gaap:NumberOfStores>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNTg_281bd691-f6c6-4090-95b0-2037654b631e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (the &#x201c;2022 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNDA_91eca5aa-5146-4014-80a6-97d4f64d4ec5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMzU_a5b78abd-71cf-4274-aa02-38682a93790c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzk_88651fb4-8ac8-4428-a5bf-e7a0769d22ec">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Restricted cash included in other current assets on the unaudited condensed consolidated balance sheets primarily represents funds held on behalf of members and funds held in escrow in connection with agreements with accountable care organizations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. &lt;/span&gt;&lt;/div&gt;All restricted cash is invested in demand deposits, time deposits and money market funds.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNTA_7a5f533a-0ad5-4bef-97c3-ce04e521237d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMS0xLTEtMS0yMzI1NDc_41ee416c-eaaf-4cda-bfda-3e1ab92d4b4e"
      unitRef="usd">14618000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMS0zLTEtMS0yMzI1NDc_300c1f9e-7d1b-4890-8716-09c0ce261859"
      unitRef="usd">12945000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMi0xLTEtMS0yMzI1NDc_c19f9971-f503-428f-a574-13a7e3975f69"
      unitRef="usd">107000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMi0zLTEtMS0yMzI1NDc_d106da8e-b955-49e1-95d1-073e4cd7743e"
      unitRef="usd">144000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMy0xLTEtMS0yMzI1NDc_ebc093cf-b7d2-44a4-8c00-5b04fc124c49"
      unitRef="usd">230000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfMy0zLTEtMS0yMzI1NDc_4807925b-a47b-4491-8dd4-0166adae0a5b"
      unitRef="usd">216000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfNC0xLTEtMS0yMzI1NDc_fc575663-6eed-4f80-9e5c-694c0f1cec89"
      unitRef="usd">14955000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmEyZWEyY2Q2NTBiZDQ2OGY4MjBiZGQzNTM4ZjdlM2M5L3RhYmxlcmFuZ2U6YTJlYTJjZDY1MGJkNDY4ZjgyMGJkZDM1MzhmN2UzYzlfNC0zLTEtMS0yMzI1NDc_beb20433-ed91-4751-ac5c-3db562c21955"
      unitRef="usd">13305000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjU_0b5f9931-1bb2-4a13-9807-a7f32b3966b6">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzODI_87fc1bbe-c487-4576-b70d-8383cbea4d74">Accounts receivable, net at March&#160;31, 2023 and December&#160;31, 2022 was composed of the following:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes accounts receivable of $211&#160;million and $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMS0xLTEtMS0yMzI1NDc_b9c25d7d-c4e9-4f5f-9467-116e390a1b4e"
      unitRef="usd">9229000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMS0zLTEtMS0yMzI1NDc_2a3cd6a5-567e-4e90-a927-70d12bd1800d"
      unitRef="usd">8983000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorAndManufacturerReceivables
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMi0xLTEtMS0yMzI1NDc_54f1430f-7419-4a49-8875-886b13160b7d"
      unitRef="usd">13357000000</cvs:VendorAndManufacturerReceivables>
    <cvs:VendorAndManufacturerReceivables
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMi0zLTEtMS0yMzI1NDc_248f9163-5370-41cf-a8b5-a3b8116af974"
      unitRef="usd">12395000000</cvs:VendorAndManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMy0xLTEtMS0yMzI1NDc_b49af400-7436-400d-800e-81659ed65a35"
      unitRef="usd">3636000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfMy0zLTEtMS0yMzI1NDc_f93f6da8-65d3-4e2b-8373-287529870d7c"
      unitRef="usd">2676000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNC0xLTEtMS0yMzI1NDc_52a1be93-2711-4eb4-bf75-ef1ac6e14a31"
      unitRef="usd">2320000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNC0zLTEtMS0yMzI1NDc_073ca64a-8764-42a1-a231-8ee756f5e257"
      unitRef="usd">3449000000</us-gaap:OtherReceivablesNetCurrent>
    <cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNS0xLTEtMS0yMzI1NDc_6f7aafc0-37d9-4460-8a57-b023922dcc99"
      unitRef="usd">28542000000</cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale>
    <cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjBlMTk2Yzg1ZTE4MzRjYjlhNmU1ZGJhMGE2ZTNlM2VjL3RhYmxlcmFuZ2U6MGUxOTZjODVlMTgzNGNiOWE2ZTVkYmEwYTZlM2UzZWNfNS0zLTEtMS0yMzI1NDc_b6d219d7-21c2-44ad-869e-7d40361c047c"
      unitRef="usd">27503000000</cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale>
    <cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTAyMTA_ee6e4afc-4021-42ab-a361-0cb04504a951"
      unitRef="usd">211000000</cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale>
    <cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzODg2OA_fa080f4d-5a7a-4ac6-94b5-5453418bfa53"
      unitRef="usd">227000000</cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTA0Njc_9c9d6b00-a29f-44a0-83c8-6d71f846fc2e"
      unitRef="usd">324000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTA0NzQ_884fffe6-8fbb-4f3f-8c8f-de7982bfd61e"
      unitRef="usd">333000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNjk_b7b8cc6e-76f8-455f-8e9d-7baa8bb11104">When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU1Nw_deafd8bd-511c-4f8d-8049-e507d3c78347">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the unaudited condensed consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#x2019;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the unaudited condensed consolidated statements of operations.</us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy>
    <us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2Mw_a232686e-396f-4be9-8ebd-fa2d80d753ab">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of deferred acquisition costs for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMi0zLTEtMS0yNTA3OTU_a4c3ebf3-9a67-4898-a757-c3800beef294"
      unitRef="usd">1219000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMi01LTEtMS0yNTA3OTU_d097f002-d570-4a91-93bc-d10bf94a2357"
      unitRef="usd">879000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCostsAdditions
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMy0zLTEtMS0yNTA3OTU_700b1996-720e-4fe0-bba3-b6d7ce637314"
      unitRef="usd">135000000</us-gaap:DeferredPolicyAcquisitionCostsAdditions>
    <us-gaap:DeferredPolicyAcquisitionCostsAdditions
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfMy01LTEtMS0yNTA3OTU_72bcb890-43a8-45d7-bffd-612dbf7b0c72"
      unitRef="usd">139000000</us-gaap:DeferredPolicyAcquisitionCostsAdditions>
    <us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNC0zLTEtMS0yNTA3OTU_adb8268e-4ca2-49b6-81de-f45436cee2e0"
      unitRef="usd">64000000</us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense>
    <us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNC01LTEtMS0yNTA3OTU_5a17288b-2de2-49bb-a4f0-573315b4828a"
      unitRef="usd">47000000</us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNi0zLTEtMS0yNTA3OTU_a9a35a96-7b28-4dd7-b9ce-0e3da6cb2b83"
      unitRef="usd">1290000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQzMjk2YjdiMzQxYzQ0M2VhOTNmMDJkNWJiODdjZThjL3RhYmxlcmFuZ2U6NDMyOTZiN2IzNDFjNDQzZWE5M2YwMmQ1YmI4N2NlOGNfNi01LTEtMS0yNTA3OTU_67e3d681-6221-49b4-ba04-4fbf6204967c"
      unitRef="usd">971000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU1OA_d3344adc-4136-4361-b80b-62f46beef114">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU1OQ_2681e8e1-943e-42ce-aeae-7dc617975e0a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:PolicyholderAccountsPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2MA_3bdd8070-b838-4ca8-80e9-985c567cc2dd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the unaudited condensed consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.&lt;/span&gt;&lt;/div&gt;</us-gaap:PolicyholderAccountsPolicy>
    <us-gaap:FuturePolicyBenefitsLiabilityPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2MQ_ed83f6b3-bc36-4dc0-9a63-24216ab0cf83">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts and are recorded in other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for limited payment pension and annuity contracts represent the Company&#x2019;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for long-term care insurance contracts represent the Company&#x2019;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#x2019;s &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#x2019;s future cash flows. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company discounts its future policy benefit liability using a curve of spot rates derived from an upper-medium grade fixed-income investment. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot rate curve and the locked-in discount rate at each cohort&#x2019;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss). In subsequent periods, the current period amount recorded in other comprehensive income (loss) will be adjusted for amounts previously recorded in accumulated other comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:FuturePolicyBenefitsLiabilityPolicy>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="ibadef73562a5415eb23fb67f37c780fa_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzUzMg_efaf3f9b-4a0e-4369-b51a-a81dbe5ae805"
      unitRef="usd">529000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="ifad147213d8945ffa73f99ae94585db9_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzU4Mw_91a1b0be-b17c-46b1-b01d-59ec2766823f"
      unitRef="usd">4600000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i07754849794b4b5a972e925beaa2e2d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzYwMg_81ef35ff-3e44-42c4-9c70-fa5ea22af650"
      unitRef="usd">334000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i83fccfbc3a1e442bbaec480edae8a85b_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMzI5ODUzNDkzNzYyMA_14e12939-4b84-40f7-a72f-c894b38aada2"
      unitRef="usd">4700000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzE_065ce7a5-c822-42b6-9e93-b328d5ac1be8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer &lt;br/&gt;Wellness &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp;amp; specialty. Prior period financial information has been revised to conform with current period presentation. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Health Services mail &amp;amp; specialty is defined as specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt; claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp;amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp;amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Prior period financial information has been revised to conform with current period presentation.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9c868143b7940b3b6159cc722b2c499_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy0xLTEtMS0yMzI1NDc_10829821-0f6c-4f6f-9745-5f32707402c9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70419a8aec904963b0fc2149a92a6feb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy0zLTEtMS0yMzI1NDc_c81f6193-b895-4d74-acb0-a3804c11ce5e"
      unitRef="usd">43737000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb3b7119cdf445b286ff5a2b3bba733c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy01LTEtMS0yMzI1NDc_b0d91378-a56d-4c4e-902f-5eb979fe0b10"
      unitRef="usd">21495000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i913d7229910442739c4ca1921c7d8667_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy03LTEtMS0yMzI1NDc_971e6e49-c418-49ef-bb85-0ea5a4e5647d"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27c623b94ee8462ebc5e118b823a3e98_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy05LTEtMS0yMzI1NDc_631311ed-8054-4695-bdfd-9dc3c76d0764"
      unitRef="usd">-12732000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b014ab5cfd341f7ae8d078ed0c475f0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMy0xMS0xLTEtMjMyNTQ3_cbbd4315-2a04-4156-9b18-31871505ffc7"
      unitRef="usd">52500000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7faa0d9a8c2d46d9a7fd1311b46dda78_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC0xLTEtMS0yMzI1NDc_cdc0df54-ed15-4b1b-8db8-2f2dc62d44fe"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a3448fe5bcb4de789f0540bb778b942_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC0zLTEtMS0yMzI1NDc_16e9c464-4c97-4f8f-8dbc-ba2be3b3ee7a"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fde3795c73045aca5218db1a3bf0627_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC01LTEtMS0yMzI1NDc_51c5ea84-2ba2-4f80-889d-c0f8a964ee58"
      unitRef="usd">5597000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f01a502bc824fe1bcb34881c372163e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC03LTEtMS0yMzI1NDc_024eca49-4ac3-4ff7-991b-8082b1bf87bf"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ed4956174e64851ad6fceaaf2191dc6_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC05LTEtMS0yMzI1NDc_3a6cab40-fdb6-47c2-b619-de2b7c8a2ecd"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69d66e496f5549518e1bb751fee97f54_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNC0xMS0xLTEtMjMyNTQ3_a0431135-f1bb-49e6-abb1-691859b21c02"
      unitRef="usd">5597000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7af16b8edb9d4671b5a7ce811f1e9a3e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS0xLTEtMS0yMzI1NDc_01a9ffd8-34b4-4b8d-839e-69f1a039e226"
      unitRef="usd">24339000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i074bb083281146a4814aa0c3ac130d88_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS0zLTEtMS0yMzI1NDc_2655cce1-8271-42cc-86f0-99a5b70e9227"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic730a4294079499a823806ec14836c28_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS01LTEtMS0yMzI1NDc_9efe7110-6232-4569-9322-ba9336ce9d6b"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e959c8f50844bdc9d92aa231cd7d852_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS03LTEtMS0yMzI1NDc_a779c8d9-0f32-46e4-9290-09550c7dd4ed"
      unitRef="usd">13000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a5b5bb1e9dd42a2aa9b210432135329_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS05LTEtMS0yMzI1NDc_dffe283f-6004-4f82-88ad-ee49e9967ca9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i150b57bf1a274deead0798dbcbbc2bab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNS0xMS0xLTEtMjMyNTQ3_d1667624-410b-48eb-a1dc-75cc41defdd9"
      unitRef="usd">24352000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi0xLTEtMS0yMzI1NDc_fe42237a-baf6-4569-95c6-afda1c26748a"
      unitRef="usd">164000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi0zLTEtMS0yMzI1NDc_04e81c4b-720b-4ea7-9761-d16bab732c52"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi01LTEtMS0yMzI1NDc_81facbc8-46db-45fa-9d5f-744d6b31f738"
      unitRef="usd">-3000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi03LTEtMS0yMzI1NDc_32784228-9225-4706-9382-0c83e49010fc"
      unitRef="usd">173000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi05LTEtMS0yMzI1NDc_b52938fe-0692-4e86-b761-705456e6c27e"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNi0xMS0xLTEtMjMyNTQ3_52101dd4-f42b-4c66-89ca-d4c6ca1d85f1"
      unitRef="usd">334000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21838ca5480d43e99c84c865f63fae2a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy0xLTEtMS0yMzI1NDc_1717cad3-624f-4df2-8798-26c39a16e6a1"
      unitRef="usd">1374000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12b6e52d861e413ca3dcbe8cf24ddbe8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy0zLTEtMS0yMzI1NDc_ce6e8fb0-50e9-48c9-bfc3-0ec847ad0d96"
      unitRef="usd">854000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2726cf35a1549a39f68c6d870831a3a_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy01LTEtMS0yMzI1NDc_a5dfe87c-cfb7-4cbc-bb43-4b27cef8bcda"
      unitRef="usd">833000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6726b8f30277400383f48e1c4916b2ab_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy03LTEtMS0yMzI1NDc_b3c03dbf-69aa-469d-93a2-d178557239d0"
      unitRef="usd">2000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d9bf2d1bfaf4038bee28037421646dc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy05LTEtMS0yMzI1NDc_8f10b121-2160-426a-a41a-461937ee6872"
      unitRef="usd">-568000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1599d39404424e269c1dd6dd7a2f8beb_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfNy0xMS0xLTEtMjMyNTQ3_19195814-991e-4f17-b543-bf256dc19e8c"
      unitRef="usd">2495000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC0xLTEtMS0yMzI1NDc_be5e9f62-1abe-4335-8b98-b9d19aa52033"
      unitRef="usd">25877000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC0zLTEtMS0yMzI1NDc_321e4a26-d2fe-47d9-8776-99d6bf7228dd"
      unitRef="usd">44591000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC01LTEtMS0yMzI1NDc_432d3363-b761-48bf-a827-5a45096b39f7"
      unitRef="usd">27922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC03LTEtMS0yMzI1NDc_8dae308d-dab2-43f2-8111-81281fad008d"
      unitRef="usd">188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC05LTEtMS0yMzI1NDc_4c6c475a-5166-40b4-bc5e-a1724f095831"
      unitRef="usd">-13300000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfOC0xMS0xLTEtMjMyNTQ3_ff87d744-c72c-4ec2-9a63-c8ba8de417fc"
      unitRef="usd">85278000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5217fa8bc5cb48358a723612bde7d479_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTEtMy0xLTEtMjMyNTQ3_2495199f-1e9b-47d5-ba9e-d01d9a2d574d"
      unitRef="usd">27592000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i003831bfd1e24cfc94e47ab4156fd856_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTItMy0xLTEtMjMyNTQ3_91b30d3e-783e-4430-a5d2-3f79d1f44b0d"
      unitRef="usd">16145000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib416aea626f043fd9431aa5342e2b4c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTMtMy0xLTEtMjMyNTQ3_1af4e5ab-5c2c-4e20-a6ac-528b8e368057"
      unitRef="usd">854000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTQtMy0xLTEtMjMyNTQ3_6298f807-b58d-4715-8e9b-a841c8b7090f"
      unitRef="usd">44591000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia19d1a8e74194a419ec6e6349cf88ae9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtMS0xLTEtMjMyNTQ3_d64ed09d-86bf-43b9-ba3e-31b05e619251"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ea8ab3ccda94b4fb2323193afbc272e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtMy0xLTEtMjMyNTQ3_12681823-5ae5-411b-911b-f442c37babdd"
      unitRef="usd">38796000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib60d284b94f343769d7fb6d50fda05c9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtNS0xLTEtMjMyNTQ3_c1d129a1-5580-486b-a777-194df25f231e"
      unitRef="usd">19532000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb268de0eb0840c6ad11a4d9d30093e4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtNy0xLTEtMjMyNTQ3_e02a3c94-2bc3-4d9b-98be-5bd1131ed7db"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i834cc79324ef46228461e0711bc261e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtOS0xLTEtMjMyNTQ3_39295e5b-4fd6-483f-a8b6-c8716b2ba136"
      unitRef="usd">-11276000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5614313bb744e009682b28fbc6584fc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTgtMTEtMS0xLTIzMjU0Nw_57f2b3f8-9a2b-46eb-9699-cb41329802e7"
      unitRef="usd">47052000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d1785a62b574847bd8bd9762c88ad05_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktMS0xLTEtMjMyNTQ3_e242e674-bdc7-4b48-8593-bac2d222546b"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8416ff007f2346618a642e998ffbde5f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktMy0xLTEtMjMyNTQ3_664b3355-bc2f-42d3-81f9-f4b032344ae1"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea625c13b80a41a38461b27d7dc98167_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktNS0xLTEtMjMyNTQ3_df8f2ee1-28dd-43e7-9a8c-307515ff34ae"
      unitRef="usd">5313000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d2ab9d4f54a4545aa1a48d8fcffe4a3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktNy0xLTEtMjMyNTQ3_0e484942-2e95-4562-b6a3-2a62bfd36293"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33693ee297b14cd1b0fd9a47d4d4f880_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktOS0xLTEtMjMyNTQ3_9dc8b3a7-8beb-4088-8472-2f0145e43575"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fd51d95f7ef41039d8cfa9e1d363b8f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMTktMTEtMS0xLTIzMjU0Nw_6b29dfa3-7ef9-4dd3-b264-b8aa61e16872"
      unitRef="usd">5313000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fe185f8b39742e6bf6fc4a03b2c1cec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtMS0xLTEtMjMyNTQ3_bbd7e4fd-2912-460c-92e0-ab49591b203e"
      unitRef="usd">21614000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ided2d67f45094a79a717c8cee0eb96d0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtMy0xLTEtMjMyNTQ3_67a0bea1-4c04-4bb5-aa60-5230cc32f41e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie000fac120824472bf6fbd96bd370915_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtNS0xLTEtMjMyNTQ3_9b20a3f6-91ca-46e9-83d9-694277113584"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i108159c26e0d4ad68b98ccf1c5e9a35f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtNy0xLTEtMjMyNTQ3_be868464-936c-4239-95f8-c0bfc4cbd7c8"
      unitRef="usd">17000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79d1376e4b4e47bc99fff3a44a2e7122_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtOS0xLTEtMjMyNTQ3_c595beee-083e-4568-84c5-e1e0a9021081"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if04e21b8463b4e6eb6cb2ca6a5197ca2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjAtMTEtMS0xLTIzMjU0Nw_39508d90-c4db-43d6-9960-66fb98e50168"
      unitRef="usd">21631000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtMS0xLTEtMjMyNTQ3_ac2f5a64-b44d-4e16-9fdf-0a5bde6bb294"
      unitRef="usd">89000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtMy0xLTEtMjMyNTQ3_fc58c007-2afc-4e33-b9f0-494398315d53"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtNS0xLTEtMjMyNTQ3_56140bad-2d23-410f-8b71-e69b1e11240e"
      unitRef="usd">-16000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtNy0xLTEtMjMyNTQ3_9dbb836f-5821-4963-b9b3-191612a6f297"
      unitRef="usd">95000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtOS0xLTEtMjMyNTQ3_60f5be7b-fb5d-46ed-b5ce-4d46f3fef096"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjEtMTEtMS0xLTIzMjU0Nw_5a749e99-b56a-4c1d-b346-f6d333c5dba5"
      unitRef="usd">168000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i177844ba7569439393b0dd8b1f8727ff_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItMS0xLTEtMjMyNTQ3_834072cb-1058-4e65-bd22-1ccfda0da585"
      unitRef="usd">1391000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29b95f23f2f4497e8f422c459c2ad25c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItMy0xLTEtMjMyNTQ3_d70245a4-9495-405c-9d0f-223d47c6b9be"
      unitRef="usd">819000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20a226c3f2ff49e2848ef2bd802993fd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItNS0xLTEtMjMyNTQ3_fb57a8f5-9af3-4618-904a-234d79a56059"
      unitRef="usd">1069000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcbcab26d09246a984f88af308a36bde_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItNy0xLTEtMjMyNTQ3_71d43f36-1eab-4174-92b0-68bb9235b0a0"
      unitRef="usd">14000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f7b0dd6afc04d5fb6dec0b03362681a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItOS0xLTEtMjMyNTQ3_c8d57509-14b9-4439-a4ab-df89ca1d6605"
      unitRef="usd">-631000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8dbfb3606fe14686af2486fd20b1659d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjItMTEtMS0xLTIzMjU0Nw_33c3303e-5fb1-4873-a6aa-0891e5a07887"
      unitRef="usd">2662000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtMS0xLTEtMjMyNTQ3_29d098b3-e312-4ff8-b441-3d8d7cee9716"
      unitRef="usd">23094000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtMy0xLTEtMjMyNTQ3_2c84fa96-9c68-4ce9-b0a1-a1908f7ec1bc"
      unitRef="usd">39615000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtNS0xLTEtMjMyNTQ3_0ff205d4-4830-47e6-a39e-2444df28cdcf"
      unitRef="usd">25898000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtNy0xLTEtMjMyNTQ3_a1ae50b6-ff7f-43c5-a3da-73f177a9a618"
      unitRef="usd">126000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtOS0xLTEtMjMyNTQ3_de525f5d-807b-40de-b116-5f068596a7ce"
      unitRef="usd">-11907000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjMtMTEtMS0xLTIzMjU0Nw_dca49a45-fba0-4e29-a4f8-957bb90abfc5"
      unitRef="usd">76826000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7b9544478beb4979bd59c64b69d4a6a1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjYtMy0xLTEtMjMyNTQ3_17c82deb-2a07-42dc-835a-f1ac31d7e770"
      unitRef="usd">24128000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id5bb2b68e6b044e298527de5f04d708d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjctMy0xLTEtMjMyNTQ3_7b586682-be74-41bf-af52-d49ffdba9678"
      unitRef="usd">14668000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d3ac659a2774583871cc2f66cd8f09e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjgtMy0xLTEtMjMyNTQ3_685a4f6c-3bbe-464a-b5c2-1bb70043180b"
      unitRef="usd">819000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIyMDg4ZDkwZDBlNTRmMTBiNzlhY2ZlNjkxNmMwZTdmL3RhYmxlcmFuZ2U6YjIwODhkOTBkMGU1NGYxMGI3OWFjZmU2OTE2YzBlN2ZfMjktMy0xLTEtMjMyNTQ3_a9ee0ed5-5904-4ed6-82b2-d333b39db8eb"
      unitRef="usd">39615000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzODU_92267a17-5c60-4577-97ba-7548258459c1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and primarily include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzU_d2e4393a-6176-4f19-af36-378225f056de">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. During the three months ended March&#160;31, 2023, the contract liabilities balance also reflects the addition of contract liabilities acquired in connection with the Company&#x2019;s acquisition of Signify Health, Inc. (&#x201c;Signify Health&#x201d;) on March 29, 2023. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMS0xLTEtMS0yMzI1NDc_b9c25d7d-c4e9-4f5f-9467-116e390a1b4e"
      unitRef="usd">9229000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMS0zLTEtMS0yMzI1NDc_1c482a7a-eb8a-4cca-9ed0-fd4421330b45"
      unitRef="usd">8983000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMi0xLTEtMS0yMzI1NDc_53bb12ae-e0e7-44bf-9e03-95cddb494958"
      unitRef="usd">136000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmIzMDA0OTEyMTQyYzRhOTVhM2UxYmFkMGJlYzMwNDNlL3RhYmxlcmFuZ2U6YjMwMDQ5MTIxNDJjNGE5NWEzZTFiYWQwYmVjMzA0M2VfMi0zLTEtMS0yMzI1NDc_f2794f9b-9ad8-439e-84be-aa8f36024e65"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMi0xLTEtMS0yMzI1NDc_f2794f9b-9ad8-439e-84be-aa8f36024e65"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMi0zLTEtMS0yMzI1NDc_8e539c73-fe9a-4356-8d78-709463b5a9e5"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMy0xLTEtMS0yMzI1NDc_940fe97e-cba0-43b8-bd7d-2e8a61b0132a"
      unitRef="usd">82000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfMy0zLTEtMS0yMzI1NDc_5a22a083-845b-4b80-b0ec-ce9bff64fda6"
      unitRef="usd">80000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNC0xLTEtMS0yMzI1NDc_a440a7ac-dd9f-4f35-9213-243f216d406f"
      unitRef="usd">85000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNC0zLTEtMS0yMzI1NDc_84985a46-9fea-4567-98d4-35e47d446ef0"
      unitRef="usd">87000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0xLTEtMS0yNzY4Mzg_eec48108-eed1-4a68-941f-a4d0f642a7f2"
      unitRef="usd">68000000</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0zLTEtMS0yNzY4Mzg_bcca84bc-43c9-4f9d-b170-cbd11a8857d2"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0xLTEtMS0yMzI1NDc_53bb12ae-e0e7-44bf-9e03-95cddb494958"
      unitRef="usd">136000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQxZjFjZTA1YzNiODRkMTJhOTEyMWQ5YmY0ZDhkNDBjL3RhYmxlcmFuZ2U6NDFmMWNlMDVjM2I4NGQxMmE5MTIxZDliZjRkOGQ0MGNfNS0zLTEtMS0yMzI1NDc_ee8232f2-d0aa-4f66-8618-234bbac38b74"
      unitRef="usd">80000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzMjE_86abb38a-f121-46ee-8d48-b5783c277c48">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $17 million and $15 million in the three months ended March&#160;31, 2023 and 2022, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $21 million for pharmaceutical inventory purchases during the three months ended March&#160;31, 2023 and 2022, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTMyNjE_1aee7600-96e2-4545-bcca-0fe06aa14982"
      unitRef="usd">17000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfNTQ5NzU1ODMxNTEx_22983b68-36b7-4b98-9977-3670caac78df"
      unitRef="usd">15000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i4a6ae917fc994efda306a7228aff6320_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTM2OTM_7cf97454-5811-4252-ab04-0d09da3939c3"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTM3MzE_a19e6179-5841-4078-95b7-abf48ab44d89"
      unitRef="usd">19000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTM3Mzg_83bc9af8-0ccf-4322-8e0e-02d098224afe"
      unitRef="usd">21000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTYzNzg_d9fe5c13-48fe-44a7-be46-022c5daae985">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944) (the &#x201c;long-duration insurance standard&#x201d;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented, January 1, 2021, also referred to as the &#x201c;transition date&#x201d;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $986&#160;million ($766&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets. The transition date &lt;/span&gt;&lt;/div&gt;net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information has been  revised to reflect the adoption of the long-duration insurance standard.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax
      contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY3Ng_4fbdcc97-8c63-44d9-b224-07aec91c274c"
      unitRef="usd">-986000000</cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY3Ng_9e94c056-f763-4921-a5a2-c1583855c284"
      unitRef="usd">986000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY5MA_1e5d26f1-0a4d-47bf-9866-457558e688ca"
      unitRef="usd">-766000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <cvs:LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax
      contextRef="ifd36720f2ede47418003c3eca8540ff9_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMTY0OTI2NzQ5ODY5MA_a967fee8-3273-4ef5-9637-9b49b1b25c03"
      unitRef="usd">766000000</cvs:LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RleHRyZWdpb246MDA2YzY0OWE2ZDdmNDY5Zjk0NTQ0NWNkNWEyYTZlY2RfMjE5OTAyMzMyODU2NA_7dd95b80-14ae-4201-b113-36f37d66924c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Removal of shadow adjustments in accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span id="i91763596c6af4e16a382b50f4b12646c_8-0-1-1-256536"/&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021, net of reinsurance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact of Long-Duration Insurance Standard Adoption on Financial Statement Line Items&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of operations for the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Condensed Consolidated Statement of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,923&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,324&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,336&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,281&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,490&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,946&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,312&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,354&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to CVS Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated balance sheet as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Condensed Consolidated Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,636&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,682&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,754&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,406&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,736&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,880&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,835&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,960&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,465)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CVS Health shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,469&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,315&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,769&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the unaudited condensed consolidated statement of cash flows for the three months ended March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Condensed Consolidated Statement of Cash Flows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation of net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments required to reconcile net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes and other noncash items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities, net of effects from acquisitions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable and other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMS0xLTEtMS0yNTY1MDE_d11824ea-fe6a-4979-868f-b994eafcbfb6"
      unitRef="usd">3224000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="id410b8ee1a2f45edad8defa2042f4b1b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMS0zLTEtMS0yNTY1MDE_6c612fed-ea98-4a93-ad8f-e0d76074d54f"
      unitRef="usd">1142000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="idb57f57ab4aa4756834cf154419fa446_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMS01LTEtMS0yNTY0ODQ_a0bab213-e9da-4bc3-82a4-a9fad3ce4e0b"
      unitRef="usd">480000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMi0xLTEtMS0yNTY2MDI_c0a69dfe-821b-428f-a3d6-15dfe8b903ca"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="id410b8ee1a2f45edad8defa2042f4b1b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMi0zLTEtMS0yNTY2MDI_eb7d65d1-cb1d-4de7-8f9f-5f70abea7ed3"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="idb57f57ab4aa4756834cf154419fa446_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMi01LTEtMS0yNTY2MDI_dce49fe0-3eda-46eb-bf80-a56e61a72472"
      unitRef="usd">274000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange
      contextRef="i4e37cccc858e4f118a4ec053a4b54bb0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0xLTEtMS0yNTY2MDI_2b282fe9-2f0c-4a30-88a9-64941a019082"
      unitRef="usd">3224000000</cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange>
    <cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange
      contextRef="id410b8ee1a2f45edad8defa2042f4b1b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0zLTEtMS0yNTY2MDI_280af4fd-ed5d-47cb-ad34-4670c0631263"
      unitRef="usd">1142000000</cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange>
    <cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange
      contextRef="idb57f57ab4aa4756834cf154419fa446_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy01LTEtMS0yNTY2MDI_488b7711-9863-434d-97b3-ce0951eb6925"
      unitRef="usd">754000000</cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="id7d3bb136a1f4e01a755060f96bc46f1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0xLTEtMS0yNTQ5MDY_09332462-05bd-48bc-88dd-5d243fbf7ff9"
      unitRef="usd">604000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i9884f3d8910649048241aa4449af5b47_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy0zLTEtMS0yNTQ5MDY_1d29cb21-0ba6-4a93-b1f7-e2e65c253654"
      unitRef="usd">553000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i04e56abae24c4188a3a7c997d9c465c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfMy01LTEtMS0yNTQ5MDY_f4a4bcaa-d84b-4a67-a6e5-103b94b667b5"
      unitRef="usd">44000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i1a54fdeeb3e044288d6c4a1818ab4dee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNi0xLTEtMS0yNTQ5MDY_bcc89083-bb63-4220-900c-4e6e4f9c7138"
      unitRef="usd">-181000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i42eb8ce2ba0b4cf0bf9748577c25dae5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNi0zLTEtMS0yNTQ5MDY_c6e34f95-7d21-4ae3-9fbe-ab5c1009f56c"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i81d253afd2a9475db0569365a548c9c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNi01LTEtMS0yNTQ5MDY_961ab663-18d0-4a4b-8bef-c543cf35097c"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNy0xLTEtMS0yNTQ5MDY_444cce7d-325b-4a4f-8367-753f18e4dd5b"
      unitRef="usd">3647000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i649b9f03c30f4132b55105d20f98cd1d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNy0zLTEtMS0yNTQ5MDY_1a70a1ae-f08f-4c0f-9db2-7470c4068b1f"
      unitRef="usd">1695000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i977993d8848741e6a20cfa0d2b47e0ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfNy01LTEtMS0yNTQ5MDY_1b3687de-349d-474d-849d-e60fb399cabb"
      unitRef="usd">798000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOC0xLTEtMS0yNTUwOTI_d56e90bf-5a6c-449f-8dc5-1979d45d3e30"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i649b9f03c30f4132b55105d20f98cd1d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOC0zLTEtMS0yNTQ5MDY_11e49e80-fc96-4b67-8045-e4c3bfc02139"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i977993d8848741e6a20cfa0d2b47e0ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOC01LTEtMS0yNTQ5MDY_50113a70-833e-457c-bbd2-6b508683481e"
      unitRef="usd">308000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOS0xLTEtMS0yNTQ5MDY_30ddbed9-8c6f-4f0a-84f8-debe4833727d"
      unitRef="usd">3647000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i649b9f03c30f4132b55105d20f98cd1d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOS0zLTEtMS0yNTQ5MDY_19123f2d-c0b7-489c-9451-ea827f30eb2c"
      unitRef="usd">1695000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i977993d8848741e6a20cfa0d2b47e0ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjkxNzYzNTk2YzZhZjRlMTZhMzgyYjUwZjRiMTI2NDZjL3RhYmxlcmFuZ2U6OTE3NjM1OTZjNmFmNGUxNmEzODJiNTBmNGIxMjY0NmNfOS01LTEtMS0yNTQ5MDY_d4fd2c81-9a80-4d05-a827-30cf4f2ec07b"
      unitRef="usd">490000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy0xLTEtMS0yNTA4MzM_03907d12-a404-4284-baf0-57c9bcf53102"
      unitRef="usd">17951000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy0zLTEtMS0yNTA4MzM_6dfd48cb-bbca-4e8d-84d7-457a4688fe6c"
      unitRef="usd">-28000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy01LTEtMS0yNTA4MzM_0129db50-13e0-4431-959a-6a57ae77741e"
      unitRef="usd">17923000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNS0xLTEtMS0yNTM2Nzc_43193850-516a-4904-bfba-49398a0fee04"
      unitRef="usd">9351000000</cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNS0zLTEtMS0yNTM2Nzc_72454077-8560-405f-b960-0c9c7374589e"
      unitRef="usd">-27000000</cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNS01LTEtMS0yNTM2Nzc_a31b1cee-de2c-4e63-ba66-8b154439d099"
      unitRef="usd">9324000000</cvs:OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <us-gaap:CostsAndExpenses
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOC0xLTEtMS0yNTA4MzM_a2160397-5c83-44b2-ad65-d04a5d0b4385"
      unitRef="usd">73336000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOC0zLTEtMS0yNTA4MzM_2b08b558-8f9c-4b26-8008-bc776e4670cc"
      unitRef="usd">-55000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOC01LTEtMS0yNTA4MzM_a1dc5280-e266-4427-92e0-1afe65fdc5a2"
      unitRef="usd">73281000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfOS0xLTEtMS0yNTA4MzM_e9e0583b-a0cc-4efa-91a8-f4be1790ea23"
      unitRef="usd">3490000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy0zLTEtMS0yNTM2Nzc_a4804130-bd2f-42d6-9384-bdf4f87cbd39"
      unitRef="usd">55000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfNy01LTEtMS0yNTM2Nzc_9d303f37-b1bf-42e5-9dd1-91f134527843"
      unitRef="usd">3545000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTAtMS0xLTEtMjUwODMz_148dedbb-68fa-4406-a3ae-1b36a1c1fb11"
      unitRef="usd">2946000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTAtMy0xLTEtMjUwODMz_7f8f8278-0c30-48e7-aec1-89b2e88d6896"
      unitRef="usd">55000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTAtNS0xLTEtMjUwODMz_3d5b8126-3131-489f-9165-f3a38adf7082"
      unitRef="usd">3001000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTEtMS0xLTEtMjUwODMz_84f8212f-c3b1-4f70-a6a0-2d4459708c5e"
      unitRef="usd">633000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTEtMy0xLTEtMjUwODMz_6cd1f5f4-73ba-4aee-a387-af24e72e1a4e"
      unitRef="usd">13000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTEtNS0xLTEtMjUwODMz_4264e1e8-1651-4d2e-960b-81d402f6725b"
      unitRef="usd">646000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMS0xLTEtMjUwODMz_f6663353-9669-4393-906a-22ee38186ade"
      unitRef="usd">2313000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMy0xLTEtMjUwODMz_d9f8a516-4427-4a36-8da7-084f9c9db859"
      unitRef="usd">42000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtNS0xLTEtMjUwODMz_aa0d388c-7a25-4341-96b6-e65a51f972ad"
      unitRef="usd">2355000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMS0xLTEtMjUwODMz_df33d1a7-aca4-4685-b6d5-e509b31c0fcd"
      unitRef="usd">2312000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMy0xLTEtMjUwODMz_e98c051f-896b-4fd0-9e8e-c56e4890f343"
      unitRef="usd">42000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtNS0xLTEtMjUwODMz_d69ee8ed-96e6-4405-a1df-963ccbb50bf6"
      unitRef="usd">2354000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMS0xLTEtMjc4MzYx_db03e20d-ebfb-4c90-a5a8-ba36adb002cb"
      unitRef="usdPerShare">1.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtMy0xLTEtMjc4MzU5_f069a0e0-349d-4ca3-b633-0eebe6e4e293"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTMtNS0xLTEtMjc1OTIw_8b329685-2f7e-4062-89ac-faf3a78fecc5"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMS0xLTEtMjc4MzYx_9c1fe5a7-e6e9-4826-9c97-d035c09c379d"
      unitRef="usdPerShare">1.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtMy0xLTEtMjc4MzU5_4f3bf6a4-9f90-4d01-85d3-b169d2a25379"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjRlYWYxYWYxOGQxYjQyYThiYjYwNWNjN2UxMzYwZDQ3L3RhYmxlcmFuZ2U6NGVhZjFhZjE4ZDFiNDJhOGJiNjA1Y2M3ZTEzNjBkNDdfMTQtNS0xLTEtMjc1OTIw_1223cc4d-14ee-4f4a-903a-0743d66bb84e"
      unitRef="usdPerShare">1.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:OtherAssetsCurrent
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMy0xLTEtMS0yNTM2OTM_c161e726-44bf-431c-a064-a64a4611f448"
      unitRef="usd">2685000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMy0zLTEtMS0yNTM2OTM_0a00a0a6-bc9e-4462-873e-3530437ddac7"
      unitRef="usd">-49000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMy01LTEtMS0yNTM2OTM_1cbbadf9-be52-41f1-9be8-d9977c67b4e6"
      unitRef="usd">2636000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0xLTEtMS0yNjg2OTY_ae2bc21f-42c1-42d8-a12d-e6cb313a8f36"
      unitRef="usd">65682000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0zLTEtMS0yNjg2OTY_7768127a-940f-4c94-a293-7e2e3cd7e0d9"
      unitRef="usd">-49000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC01LTEtMS0yNjg2OTY_8f4ab013-5a20-44e2-b965-e7a1e75078ae"
      unitRef="usd">65633000000</us-gaap:AssetsCurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0xLTEtMS0yNTM2OTM_51825f77-b750-4970-b6d4-ce348418e8c9"
      unitRef="usd">24754000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC0zLTEtMS0yNTM2OTM_cfff3d28-8067-44f3-98e9-9fed90424674"
      unitRef="usd">49000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNC01LTEtMS0yNTM2OTM_1e074376-92e1-400a-b666-32e145b5eca5"
      unitRef="usd">24803000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Assets
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0xLTEtMS0yNTQyMzE_0e85efa1-8a7e-4503-be20-6b21da6c8d71"
      unitRef="usd">228275000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0zLTEtMS0yNTQyMzE_ce14ff9d-6017-4a53-b808-1c3c013d2c19"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi01LTEtMS0yNTQyMzE_6c7849ac-fe0e-4cca-8b11-e1fd675b492a"
      unitRef="usd">228275000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0xLTEtMS0yNTM2OTM_e06cc6c2-c359-475d-bd9c-0948e1f75f04"
      unitRef="usd">10406000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi0zLTEtMS0yNTM2OTM_ad006e7e-1d06-437a-b269-0329072e9a6a"
      unitRef="usd">-264000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfNi01LTEtMS0yNTM2OTM_a9dea7d9-b3b9-46f6-bb11-b2e4aea9a902"
      unitRef="usd">10142000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOC0xLTEtMS0yNTM2OTM_c96f738b-6a47-46d7-8f11-8e61d3d59c93"
      unitRef="usd">1140000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOC0zLTEtMS0yNTM2OTM_36bd0755-4ffc-4ed0-b4de-084376d3450d"
      unitRef="usd">-51000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOC01LTEtMS0yNTM2OTM_8bd206ea-2807-439f-a0e4-1d79bf9246db"
      unitRef="usd">1089000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMS0xLTEtMjU3MzAy_1c4a9435-1359-4cb9-ae36-6bc5ea743e01"
      unitRef="usd">69736000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMy0xLTEtMjU3MzAy_a5c9442e-c5fc-4fe9-9cb6-08419bb9aaf1"
      unitRef="usd">-315000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtNS0xLTEtMjU3MzAy_2cb2d418-3012-48c9-90ae-6140372fad4f"
      unitRef="usd">69421000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOS0xLTEtMS0yNTM2OTM_59ed9134-3faa-4c19-9dac-315d54559a07"
      unitRef="usd">3880000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOS0zLTEtMS0yNTM2OTM_3c984972-bce6-483f-bbb2-aa1db87e1797"
      unitRef="usd">136000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfOS01LTEtMS0yNTM2OTM_3340fb1c-988c-4135-b087-07705128e5a7"
      unitRef="usd">4016000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTAtMS0xLTEtMjUzNjkz_1e0cf0db-1af9-4124-9a30-f2e4a3aa267b"
      unitRef="usd">6108000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTAtMy0xLTEtMjUzNjkz_243e0617-0519-4dcc-b758-5aa2520d3680"
      unitRef="usd">-273000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTAtNS0xLTEtMjUzNjkz_ee225559-4905-4f8c-b25a-25becb69d824"
      unitRef="usd">5835000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTQtMS0xLTEtMjY4NzMx_3c4a68b8-39e9-4942-8e00-0bb62b63a7d9"
      unitRef="usd">6732000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTQtMy0xLTEtMjY4NzMx_aff8285f-16ae-4803-b69b-25b99adaec1f"
      unitRef="usd">-2000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTQtNS0xLTEtMjY4NzMx_7c174953-87b6-4ccd-a586-9b67896c85cd"
      unitRef="usd">6730000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMS0xLTEtMjU0MjM5_0a4d0cfe-02d9-4d66-a12c-e5cdee8f014a"
      unitRef="usd">156960000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMy0xLTEtMjU0MjM5_4b2762f3-1068-4f4b-9387-ce3b4e91e61a"
      unitRef="usd">-454000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItNS0xLTEtMjU0MjM5_b8374f4a-3a4e-4d58-a934-7c77dbdb7a27"
      unitRef="usd">156506000000</us-gaap:Liabilities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMS0xLTEtMjU0MTI2_31dea997-0f12-42a8-97a4-bebef5bc9f48"
      unitRef="usd">56145000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMy0xLTEtMjU0MTM5_ccb1b5e7-4b40-4d79-9067-19591ea5b81f"
      unitRef="usd">253000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtNS0xLTEtMjU0MTM5_e1313fbc-cc3d-4239-bd2b-5b0babae4806"
      unitRef="usd">56398000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMS0xLTEtMjUzNjkz_5487f8a4-dc98-44fa-9fbb-0e0bfb0d8bae"
      unitRef="usd">-1465000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtMy0xLTEtMjUzNjkz_3fe0d9d9-8363-43cf-8c7e-e7a0f900aa55"
      unitRef="usd">201000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTEtNS0xLTEtMjUzNjkz_04c91ff2-c31a-4466-91fb-9393007ab49b"
      unitRef="usd">-1264000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMS0xLTEtMjUzNjkz_99021c44-e0f8-4dfe-b1d4-89bdf88f2f8b"
      unitRef="usd">71015000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItMy0xLTEtMjUzNjkz_92f5b937-c0f4-4e70-b52f-934ffb6a1117"
      unitRef="usd">454000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTItNS0xLTEtMjUzNjkz_6043297c-32b4-4b5d-91a5-cc1ff018b914"
      unitRef="usd">71469000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTMtMS0xLTEtMjUzNjkz_3406b3cc-e695-40cb-84d3-a380f5cd6251"
      unitRef="usd">71315000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTMtMy0xLTEtMjUzNjkz_ae860681-12f2-4fb6-a722-5b99fedb480d"
      unitRef="usd">454000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTMtNS0xLTEtMjUzNjkz_1ddbdf93-d845-4d04-ab08-72d3ecc5c71f"
      unitRef="usd">71769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i65bb2f8cfc394124a9e9de093bf7e693_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTgtMS0xLTEtMjc0MDcy_f37df505-65d6-4e20-8f37-974fb7d5db91"
      unitRef="usd">228275000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i59381ee9dfea4532add1e4bb94d27155_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTgtMy0xLTEtMjc0MDcy_c91587f6-1f8a-44da-9bda-8f6afcff1e83"
      unitRef="usd">0</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOmJkZWJjN2ZhMzYxYzQ0MTNhNTZjNzIyZjExMzY2YzVhL3RhYmxlcmFuZ2U6YmRlYmM3ZmEzNjFjNDQxM2E1NmM3MjJmMTEzNjZjNWFfMTgtNS0xLTEtMjc0MDcy_5f23b419-739f-4932-9a26-191540affaf8"
      unitRef="usd">228275000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNC0xLTEtMS0yNTM3NDA_bdde5f41-18ec-4ff9-a613-49b111b2fa0c"
      unitRef="usd">2313000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNC0zLTEtMS0yNTM3NDA_a582f281-b393-49b4-bb16-af8713eb6f30"
      unitRef="usd">42000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNC01LTEtMS0yNTM3NDA_13e7a149-c11b-4f5d-97b8-b44c3e08e1e7"
      unitRef="usd">2355000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNi0xLTEtMS0yNTM3NDA_d843e6ed-19a4-47f0-a41f-6518b8196c2d"
      unitRef="usd">1055000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNi0zLTEtMS0yNTM3NDA_8129d0f4-8990-4dd1-9ac7-94a47b05402a"
      unitRef="usd">-6000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNi01LTEtMS0yNTM3NDA_8116e780-987a-4bb9-9cc4-7cb9772c41bb"
      unitRef="usd">1049000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:DeferredIncomeTaxesAndOtherNoncashItems
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNy0xLTEtMS0yNTM3NDA_fcef7bd6-5462-4842-8953-1b1a4f396439"
      unitRef="usd">-187000000</cvs:DeferredIncomeTaxesAndOtherNoncashItems>
    <cvs:DeferredIncomeTaxesAndOtherNoncashItems
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNy0zLTEtMS0yNTM3NDA_fc2b80e8-8a12-4352-9ff9-f8f02382f984"
      unitRef="usd">12000000</cvs:DeferredIncomeTaxesAndOtherNoncashItems>
    <cvs:DeferredIncomeTaxesAndOtherNoncashItems
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfNy01LTEtMS0yNTM3NDA_1fb99384-b1c8-4769-bce3-fbb1bb5a12c1"
      unitRef="usd">-175000000</cvs:DeferredIncomeTaxesAndOtherNoncashItems>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfOS0xLTEtMS0yNTM3NDA_d8ae80ad-68e5-47a7-8daa-ac5c46925f15"
      unitRef="usd">352000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfOS0zLTEtMS0yNTM3NDA_22c50a5f-44ec-4dce-bd48-50e20d837c0e"
      unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfOS01LTEtMS0yNTM3NDA_20928b48-5240-4c7e-82ce-243ef479cafe"
      unitRef="usd">348000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTAtMS0xLTEtMjU0Mjkz_e779597d-777b-411f-8396-487a57e0656e"
      unitRef="usd">1478000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTAtMy0xLTEtMjU0Mjkz_1c101d49-ffc1-4087-bdae-1d288beb1a1f"
      unitRef="usd">-48000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTAtNS0xLTEtMjU0Mjkz_a8d2a668-1204-44ad-88b5-de090228aea0"
      unitRef="usd">1430000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTEtMS0xLTEtMjUzNzQw_36aa3e7b-08b5-4c8f-9139-24aa78b7b51c"
      unitRef="usd">-440000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i43c26daacfb34ea994d687550fd86388_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTEtMy0xLTEtMjUzNzQw_4179288c-c986-4123-8d8b-1b0652f002e0"
      unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zNy9mcmFnOjAwNmM2NDlhNmQ3ZjQ2OWY5NDU0NDVjZDVhMmE2ZWNkL3RhYmxlOjQ5ZjNlMDc0MzZhMDQyZmViOTJiYzNkNjkwMzEwY2UxL3RhYmxlcmFuZ2U6NDlmM2UwNzQzNmEwNDJmZWI5MmJjM2Q2OTAzMTBjZTFfMTEtNS0xLTEtMjUzNzQw_42c28260-c40a-4259-9c79-ae0321598ec6"
      unitRef="usd">-444000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNjAwMg_60742919-bec9-4cc9-a401-e697059a8ff8">Acquisitions and Assets Held for Sale&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Signify Health Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 29, 2023 (the &#x201c;Signify Health Acquisition Date&#x201d;), the Company acquired 100% of the outstanding shares and voting interest of Signify Health for cash (&#x201c;Signify Health Acquisition&#x201d;). Under the terms of the merger agreement, Signify Health stockholders received $30.50 per share in cash. The Company financed the transaction with cash on hand, which included approximately $6&#160;billion of proceeds from the issuance of senior unsecured notes in February 2023. Signify Health is a leader in health risk assessments, value-based care and provider enablement services. The Company will include Signify Health within the Health Services segment. The Company acquired Signify Health to advance its health care services strategy, growth in value-based care and new product offerings for other payers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the consideration transferred on the date of acquisition consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of replacement equity awards for pre-combination services (3.2&#160;million shares) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective settlement of pre-existing relationship &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The fair value of the replacement equity awards issued by the Company was determined as of the Signify Health Acquisition Date. The fair value of the awards attributed to pre-combination services of $14 million is included in the consideration transferred and the fair value of the awards attributed to post-combination services of $167&#160;million has been, or will be, included in the Company&#x2019;s post-combination financial statements as compensation costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The purchase price included $111 million of effectively settled liabilities the Company owed to Signify Health from their pre-existing relationship. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction has been accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets (including restricted cash of $28)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assessment of fair value is preliminary and is based on information that was available to management at the time the unaudited condensed consolidated financial statements were prepared. The most significant open items included the valuation of certain intangible assets, the estimation of certain contract assets and contract liabilities, the accounting for income taxes and the accounting for contingencies as management is awaiting additional information to complete its assessment of these matters. Measurement period adjustments will be recorded in the period in which they are determined, as if they had been completed at the acquisition date. The finalization of the Company&#x2019;s purchase accounting assessment could result in changes in the valuation of assets acquired and liabilities assumed, which could be material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents future economic benefits expected to arise from the Company&#x2019;s expanded presence in the health services industry, the assembled workforce acquired, expected revenue and medical cost synergies, as well as operating efficiencies and cost savings. The preliminary valuation of goodwill was allocated to the Company&#x2019;s business segments as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy &amp;amp; Consumer Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately $1.7&#160;billion of goodwill is deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary fair values and weighted average useful lives for intangible assets acquired in the Signify Health Acquisition, each of which is subject to change as the Company finalizes its purchase accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except weighted average useful life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted &lt;br/&gt;Average Useful&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark (definite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price allocation includes net deferred tax liabilities of $256&#160;million, primarily related to deferred tax liabilities established on the identifiable acquired intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Results of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for Signify Health from the Signify Health Acquisition Date to March&#160;31, 2023 were immaterial to the Company&#x2019;s consolidated results of operations for the three months ended March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the Company incurred transaction costs of $37&#160;million associated with the Signify Health Acquisition that were recorded within operating expenses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Oak Street Health Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 2, 2023, the Company acquired 100% of the outstanding shares and voting interest of Oak Street Health, Inc. (&#x201c;Oak Street Health&#x201d;) for cash. Under the terms of the merger agreement, Oak Street Health stockholders received $39.00 per share in cash. The total value of the transaction was approximately $10.6&#160;billion. The Company financed the transaction with borrowings of $5.0&#160;billion from a term loan agreement entered into on May 1, 2023 as described in Note 7 &#x2018;&#x2018;Borrowings&#x2019;&#x2019; and cash on hand. Oak Street Health is a leading multi-payor, senior focused value-based primary care company. The Company will include Oak Street Health within the Health Services segment. The Company acquired Oak Street Health to advance its value-based care strategy and broaden its platform into primary care.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Held For Sale&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its Omnicare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; long-term care business (&#x201c;LTC business&#x201d;), which is included within the Pharmacy &amp;amp; Consumer Wellness segment, was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. During 2022, the LTC business met the criteria to be classified as held for sale and the carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell. Accordingly, the Company recorded total losses on assets held for sale of $2.5&#160;billion during the year ended December&#160;31, 2022. As of March&#160;31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting. During the three months ended March&#160;31, 2023, an incremental loss on assets held for sale of $349 million was recorded to write-down the carrying value of the LTC business to the Company&#x2019;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. The loss on assets held for sale &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represents the write-down of long-lived assets and was recorded in the Company&#x2019;s unaudited condensed consolidated statement of operations within the Pharmacy &amp;amp; Consumer Wellness segment. The LTC business operating income was not material for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The LTC business met the criteria to be classified as held for sale at both March&#160;31, 2023 and December&#160;31, 2022, but did not meet the criteria to be classified as discontinued operations. As a result, the related assets and liabilities were included in the separate held-for-sale line items of the asset and liability sections of the unaudited condensed consolidated balance sheets. As the assets held for sale are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, they are classified in Level 3 of the fair value hierarchy. The following table summarizes the assets and liabilities held for sale at March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU0OA_016160dc-f26c-402d-8ed3-bb5ff0d0f312"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzI5ODUzNDkxOTUyMg_f56a90f4-fc33-4ad3-a621-d854f01b292c"
      unitRef="usdPerShare">30.50</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i1bc1e1b3223b4f1cb3c91d8f034eb45b_D20230201-20230228"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzI5ODUzNDkxOTU0Mg_b6e86c84-1188-4e47-b8c1-5012b78badb4"
      unitRef="usd">6000000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU0Ng_8be99fc0-9f05-4e58-a97b-d3252e2c5916">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the consideration transferred on the date of acquisition consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of replacement equity awards for pre-combination services (3.2&#160;million shares) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective settlement of pre-existing relationship &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The fair value of the replacement equity awards issued by the Company was determined as of the Signify Health Acquisition Date. The fair value of the awards attributed to pre-combination services of $14 million is included in the consideration transferred and the fair value of the awards attributed to post-combination services of $167&#160;million has been, or will be, included in the Company&#x2019;s post-combination financial statements as compensation costs.&lt;/span&gt;&lt;/div&gt;(2)The purchase price included $111 million of effectively settled liabilities the Company owed to Signify Health from their pre-existing relationship.</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMS0xLTEtMS0yNjI0MDU_679a8d64-7b3d-4bf1-9a68-fb4b4cb3c1bc"
      unitRef="usd">7450000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMi0wLTEtMS0yNzM4MjQvdGV4dHJlZ2lvbjo3NGU2ODkwMDk5MmM0YWZiYjVmNWYzNjYwZTYyNzI5NF8zMjk4NTM0ODgzNDM4_5c2376d0-4937-4c3a-94bf-b01b5fc31f5f"
      unitRef="shares">3200000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMi0xLTEtMS0yNjI0MDU_35278e5a-5e97-47dc-a429-12267d7cd277"
      unitRef="usd">14000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <cvs:BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship
      contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfMy0xLTEtMS0yNjI0MDU_5755e209-932b-437f-9f8e-81919237782b"
      unitRef="usd">111000000</cvs:BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmIxYmRhNDA5ZTFiNjQ3OGY4NmNlZWYxNWRmMTZlMWJjL3RhYmxlcmFuZ2U6YjFiZGE0MDllMWI2NDc4Zjg2Y2VlZjE1ZGYxNmUxYmNfNC0xLTEtMS0yNjI0MDU_c92924b1-8c1f-4ba3-b821-e5c52feaffae"
      unitRef="usd">7353000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic631e9c5f9164a64ac5d001fd51e6b92_D20230329-20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMTY0OTI2NzQ4OTAyNw_35278e5a-5e97-47dc-a429-12267d7cd277"
      unitRef="usd">14000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i7d0721ccf873491b96d1a9065be7d6f9_D20230329-20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzI5ODUzNDkyMTM2Nw_b2b3821d-cb77-4a56-b3bf-dfbb9a29d8bc"
      unitRef="usd">167000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <cvs:BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship
      contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMTY0OTI2NzQ4OTAzNA_5755e209-932b-437f-9f8e-81919237782b"
      unitRef="usd">111000000</cvs:BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU1Mw_f0788e4b-dc3a-4b17-b636-e5fefe9a9a26">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets (including restricted cash of $28)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMS0xLTEtMS0yNjI0ODA_a061b113-5888-4694-9ffa-4507e20832c2"
      unitRef="usd">376000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMi0xLTEtMS0yNjI0ODA_7f2776d1-ebf4-47bf-b866-e73a8fd7844b"
      unitRef="usd">190000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <cvs:BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMy0wLTEtMS0yNjk1NDIvdGV4dHJlZ2lvbjo5YTI1MDM1ZTFiYmE0MjkyYjc1MGIyMTEwZGQyNGEyYl8xNjQ5MjY3NDQxNzQy_2a341973-11b8-46e1-9bd6-8be1aab66377"
      unitRef="usd">28000000</cvs:BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMy0xLTEtMS0yNjI0ODA_64bd1fd8-ab64-41b2-9482-ed8a59f697f6"
      unitRef="usd">149000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNC0xLTEtMS0yNjI0ODA_ec8da110-fb94-4cce-864c-12ee101ee11e"
      unitRef="usd">25000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNS0xLTEtMS0yNjI0ODA_ec8c7ffd-170c-4b05-bf31-457db70c5083"
      unitRef="usd">5907000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNi0xLTEtMS0yNjI0ODA_c3ff60e1-9bd0-4291-8b02-50494425ac7e"
      unitRef="usd">1920000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfNy0xLTEtMS0yNjI0ODA_3a161987-f7d7-4779-9581-279c6f634e53"
      unitRef="usd">23000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfOC0xLTEtMS0yNjI0ODA_0d7d212b-1266-462d-880d-4c1c3cc503b1"
      unitRef="usd">8590000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTAtMS0xLTEtMjYyNDgw_13a0f617-3119-44f2-9998-03307df57b64"
      unitRef="usd">609000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTAtMS0xLTEtMjY5Nzc3_e9ffc0cd-7026-4880-805a-c3c024081d1f"
      unitRef="usd">346000000</cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTEtMS0xLTEtMjYyNDgw_4fd75884-0c61-4ce7-8677-dbed2f789572"
      unitRef="usd">256000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTItMS0xLTEtMjYyNDgw_b0b9f6dd-ba10-4268-8a7d-d0f24ee2e8e1"
      unitRef="usd">26000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTMtMS0xLTEtMjYyNDgw_398eb1cf-2905-42ed-ae49-f6b05dba13fc"
      unitRef="usd">1237000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmZiMGJiNDgzMDhmZTQ4MjlhYWUzYTY3NmNlZWQ1ODg0L3RhYmxlcmFuZ2U6ZmIwYmI0ODMwOGZlNDgyOWFhZTNhNjc2Y2VlZDU4ODRfMTQtMS0xLTEtMjYyNDgw_b9dd8e55-6104-4a7b-bc7f-f0c4fb272d57"
      unitRef="usd">7353000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationSegmentAllocationTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU1NA_fb7ff572-16c7-4301-ae1e-7fd23d863bbe">The preliminary valuation of goodwill was allocated to the Company&#x2019;s business segments as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy &amp;amp; Consumer Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessCombinationSegmentAllocationTableTextBlock>
    <us-gaap:Goodwill
      contextRef="icd3ba4757bbe45faaadd9ba0c14cda5a_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfMS0xLTEtMS0yNjI1Njg_cfdc0141-7cfd-47f1-a6a3-5efafc8e4316"
      unitRef="usd">3404000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5520b236fefd42c6ac7b83e8db7d39d0_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfMi0xLTEtMS0yNjI1Njg_743a0936-91ac-4ed2-ab9f-ecbf679a35d8"
      unitRef="usd">2473000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib28b96b93836450fbebf6c84e59a6a20_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfMy0xLTEtMS0yNjI1Njg_a69e04e3-930c-4827-97ac-cb773822c58d"
      unitRef="usd">30000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOjllNWU5YWI3OWY5MTQyY2Q5YWRiM2U3YzgxOGQ3MDgzL3RhYmxlcmFuZ2U6OWU1ZTlhYjc5ZjkxNDJjZDlhZGIzZTdjODE4ZDcwODNfNC0xLTEtMS0yNjI1Njg_2560881a-f16d-4960-8144-512db38742f3"
      unitRef="usd">5907000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODE4MDY4MQ_b1333164-558f-4da4-8533-10638e60c07e"
      unitRef="usd">1700000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzI5OTU1NQ_9e87130e-beaf-41df-a3b0-035a76d3ab2f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary fair values and weighted average useful lives for intangible assets acquired in the Signify Health Acquisition, each of which is subject to change as the Company finalizes its purchase accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except weighted average useful life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted &lt;br/&gt;Average Useful&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark (definite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4af840426f5742b98ce7a573b0ca84b1_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMS0xLTEtMS0yNjI2NTI_12541c5d-dc7c-4e42-bdfd-b19d74ec6365"
      unitRef="usd">1810000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icfddb8845ccc4274844fac816ac10c32_D20230329-20230329"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMS0zLTEtMS0yNjI2Nzc_f8223904-4e3d-4cd3-878b-4a56541d3e2b">P16Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic82fb46fef07440d83a4d87da8d741a2_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMi0xLTEtMS0yNjI2NTI_be20b3c6-9f32-4bb9-a2f5-2bcdc91bb63c"
      unitRef="usd">50000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ida41df4f3f8347ed801d55304618efc9_D20230329-20230329"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMi0zLTEtMS0yNjI2OTY_09fe0b62-be0b-4375-8472-5bfb92172a6e">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3fb2931d2f6141989e86bc6f9e479fa5_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMy0xLTEtMS0yNjI2NTI_897278b4-18e7-4b11-b833-192ae4797861"
      unitRef="usd">60000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3a52af93ed8c4145bf21e078f72a0933_D20230329-20230329"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfMy0zLTEtMS0yNjI3MTQ_0e8238b6-115c-4da4-8396-f699ebb6c1f0">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfNC0xLTEtMS0yNjI2NTI_ce471caa-c9a9-465f-ac69-42531a42357d"
      unitRef="usd">1920000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmMyNzJiZDA0M2I0OTRkNGU5YWFlNTBiMDJkMTkxZGJkL3RhYmxlcmFuZ2U6YzI3MmJkMDQzYjQ5NGQ0ZTlhYWU1MGIwMmQxOTFkYmRfNC0zLTEtMS0yNjI3MTQ_e197a9c3-c637-4920-adab-6378550ec2ad">P16Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i92b1cc55a9704aeea04b6939f5195e76_I20230329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODE4MTYzNg_0c726e95-ef2c-4964-9dda-c2a4cc3aa3e0"
      unitRef="usd">256000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i46c86ba47653492db774e9e6bbe191b4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMTY0OTI2NzQ5MDIzMQ_b5c013f8-2bbf-4e01-9aa4-e45e5e240ab4"
      unitRef="usd">37000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i839190f328204596bd4e7f2b5c29b42b_I20230502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzMwMjkyOQ_4738f502-588f-4b67-a782-c1412df1bbcc"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i839190f328204596bd4e7f2b5c29b42b_I20230502"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODQ0MTUy_59a43286-af90-4e4a-adab-6c8b80ccfd1a"
      unitRef="usdPerShare">39.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ifc946f669dc44ab69a194363c6a5ce91_D20230502-20230502"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNTQ5NzU1ODQ0MTU5_419f2fe1-dcd6-40e6-847d-fa5ff608bd81"
      unitRef="usd">10600000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i85f8c4df47be4b3bb9037e0c92c557ba_D20230501-20230501"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMjE5OTAyMzMwMjkzNQ_019bb649-cc90-432d-812a-aa8d7752d30e"
      unitRef="usd">5000000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i327cce141c0e4abb8b30e48daa9e4ec1_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfMzg0ODI5MDcwOTAzMQ_d719f145-b096-4fb6-b0a1-663ad9c679a9"
      unitRef="usd">2500000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i0debc62e945846f3839159ee0a6f9a4d_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNzY5NjU4MTQ2MDc4NQ_c35997dd-5a76-4d85-9b61-22485b8a40ba"
      unitRef="usd">349000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RleHRyZWdpb246OTYyNmNmYmY1NDQxNDgwODhmODE0NDgxZmZmYjc2OTZfNjAwNg_e2276ae9-13a4-4be8-8735-7e255ae7f2ad">The following table summarizes the assets and liabilities held for sale at March&#160;31, 2023 and December&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMi0xLTEtMS0yMzI1NDc_037d5c41-6e6a-4c64-a289-ba7e1817f183"
      unitRef="usd">211000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMi0zLTEtMS0yNTc0NjY_f29d77fb-40eb-44b7-ad38-043c6481d5ec"
      unitRef="usd">227000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMy0xLTEtMS0yMzI1NDc_fb347b06-75fd-4cee-9cf6-15d45cdbc3bb"
      unitRef="usd">183000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMy0zLTEtMS0yNTc0NjY_13450859-c2ec-44a3-a43f-3d1a6a41deb2"
      unitRef="usd">188000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNC0xLTEtMS0yMzI1NDc_8ec3aa35-43c6-47b1-955a-d34e0ed6c0ed"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNC0zLTEtMS0yNTc0NjY_add1a984-407c-43e7-9b5f-344658cbf1e8"
      unitRef="usd">244000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNi0xLTEtMS0yMzI1NDc_b16cddbc-93b7-4dde-87f4-d041d76cfc82"
      unitRef="usd">214000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNS0zLTEtMS0yNTc0NjY_e369efcb-fde2-4a51-82c0-8aa42f70e3fa"
      unitRef="usd">131000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNy0xLTEtMS0yMzI1NDc_a4bb6f6e-0697-4e19-a7d8-7c9580ed3e34"
      unitRef="usd">17000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNi0zLTEtMS0yNTc0NjY_8373d94f-520b-4f4e-9044-a1605acc293e"
      unitRef="usd">118000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfOC0xLTEtMS0yMzI1NDc_e627473b-5f42-46ec-ae35-f20da1e1d866"
      unitRef="usd">625000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfNy0zLTEtMS0yNTc0NjY_eda5ee93-b8ad-4c89-affa-f882e5867e37"
      unitRef="usd">908000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTEtMS0xLTEtMjMyNTQ3_5286199e-6dd6-4938-b875-3e4209dd658d"
      unitRef="usd">84000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTAtMy0xLTEtMjU3NDY2_945ba96e-749c-40b2-98ea-976ead9f4c68"
      unitRef="usd">86000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTItMS0xLTEtMjMyNTQ3_71181546-1e00-4b48-8a0b-f1d951807564"
      unitRef="usd">58000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTEtMy0xLTEtMjU3NDY2_e4d2c8bb-0837-42b2-b42c-fba39232360a"
      unitRef="usd">71000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTMtMS0xLTEtMjMyNTQ3_be42ecd1-5b9e-4556-ba76-881a4d98f154"
      unitRef="usd">71000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTItMy0xLTEtMjU3NDY2_87bc6491-ff3b-4ddd-b879-c8cbb0972cd1"
      unitRef="usd">71000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i477ed67917444c06928e6bdfe4442b96_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTQtMS0xLTEtMjMyNTQ3_18b1a74b-0497-48e8-bb57-bead0f434ee0"
      unitRef="usd">213000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80MC9mcmFnOjk2MjZjZmJmNTQ0MTQ4MDg4ZjgxNDQ4MWZmZmI3Njk2L3RhYmxlOmM4MzAzZjVkNDRiZDQ1NTY5YTY0Yjc4ODMwNGNkNWIxL3RhYmxlcmFuZ2U6YzgzMDNmNWQ0NGJkNDU1NjlhNjRiNzg4MzA0Y2Q1YjFfMTMtMy0xLTEtMjU3NDY2_fcc029d8-23de-42fd-91c4-d32e7afd2c49"
      unitRef="usd">228000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIxMw_ef3beb99-ca60-4d86-9edb-86d16405c3cf">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term investments of  $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheet at December&#160;31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At March&#160;31, 2023, debt securities with a fair value of $620 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $40 million and at December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of $59 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net amortized cost and fair value of debt securities at March&#160;31, 2023 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at March&#160;31, 2023 and December&#160;31, 2022 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. Unrealized capital losses at March&#160;31, 2023 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of March&#160;31, 2023, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the three months ended March&#160;31, 2023 and 2022, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at March&#160;31, 2023 and December&#160;31, 2022, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include the reversal of previously recorded credit-related impairment losses on debt securities of $1 million and yield-related impairment losses on debt securities of $24 million in the three months ended March&#160;31, 2023. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $38 million and $18 million, respectively, in the three months ended March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $8 million and $9 million for the three months ended March&#160;31, 2023 and 2022, respectively, related to investments supporting experience-rated products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTMwNQ_5a35df21-8b7a-4f4d-8570-02c6f6f33fb9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term investments of  $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheet at December&#160;31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="ifb07919adac2412abcdc705eb562b3c7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi0xLTEtMS0yMzI1NDc_bd1f5bfe-533a-4975-8b22-0cc45c5cfa89"
      unitRef="usd">3061000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="ifb07919adac2412abcdc705eb562b3c7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi0zLTEtMS0yMzI1NDc_3d8252ec-507a-4f5c-886c-81e0dab2a543"
      unitRef="usd">17761000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="ifb07919adac2412abcdc705eb562b3c7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi01LTEtMS0yMzI1NDc_2a3c617a-9350-44ad-ab3c-6a69c36b188c"
      unitRef="usd">20822000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i327aba17f5014740927f4d6f30982b5d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi03LTEtMS0yMzI1NDc_5267b894-fecb-485b-b69e-ec3f4a56ed29"
      unitRef="usd">2718000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i327aba17f5014740927f4d6f30982b5d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi05LTEtMS0yMzI1NDc_eb56f440-871e-4c32-a277-d0601263a6f0"
      unitRef="usd">17562000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i327aba17f5014740927f4d6f30982b5d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMi0xMS0xLTEtMjMyNTQ3_944e02df-3be5-42ba-b532-38e56741fdb6"
      unitRef="usd">20280000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="id164ef0f52604d3090071179b7c674e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy0xLTEtMS0yMzI1NDc_632aa3c9-2baa-4877-ac67-6c5b404f8f2f"
      unitRef="usd">39000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="id164ef0f52604d3090071179b7c674e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy0zLTEtMS0yMzI1NDc_bd02a75f-50bb-49eb-8662-2b7b35a7650e"
      unitRef="usd">1038000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="id164ef0f52604d3090071179b7c674e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy01LTEtMS0yMzI1NDc_a3acbb32-8b91-4784-bc01-25a882dd4cde"
      unitRef="usd">1077000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i867b324806204e6a8e1477d0e3cb2fc3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy03LTEtMS0yMzI1NDc_ab8f9d00-cea0-43bf-82d1-3b55f1dd805f"
      unitRef="usd">55000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i867b324806204e6a8e1477d0e3cb2fc3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy05LTEtMS0yMzI1NDc_15957bdc-5e95-4729-a851-6f0861ea3e27"
      unitRef="usd">989000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i867b324806204e6a8e1477d0e3cb2fc3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfMy0xMS0xLTEtMjMyNTQ3_f61a6709-38aa-4489-b99c-91dba43f9550"
      unitRef="usd">1044000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ifb893d91703146878373e8b9e7346cb8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC0xLTEtMS0yMzI1NDc_549f9eed-b92a-44fa-ad15-228e40bf7e64"
      unitRef="usd">2000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="ifb893d91703146878373e8b9e7346cb8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC0zLTEtMS0yMzI1NDc_abe84361-89c3-41db-b5b7-31221ed75f90"
      unitRef="usd">2813000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="ifb893d91703146878373e8b9e7346cb8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC01LTEtMS0yMzI1NDc_31ab8eb6-a3d3-424c-8b73-09b940e724b4"
      unitRef="usd">2815000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i7e08e1c1bd8548999900b632892e8ecb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC03LTEtMS0yMzI1NDc_1b0deb7c-3cf6-43af-b8e8-159edc9e8ec9"
      unitRef="usd">5000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i7e08e1c1bd8548999900b632892e8ecb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC05LTEtMS0yMzI1NDc_b673fe81-5466-4b15-8270-766f5b7eb9cd"
      unitRef="usd">2562000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i7e08e1c1bd8548999900b632892e8ecb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNC0xMS0xLTEtMjMyNTQ3_ba589cf4-52cc-4e8e-b2d1-d5910a1b4ca0"
      unitRef="usd">2567000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS0xLTEtMS0yMzI1NDc_cd3de390-9a66-4657-ab78-1f0d9f250ce4"
      unitRef="usd">3102000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS0zLTEtMS0yMzI1NDc_b51e20f8-7741-4d0b-9eb0-73a17a7e940d"
      unitRef="usd">21612000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS01LTEtMS0yMzI1NDc_96b3a9ce-cfc2-477c-a010-5600fb2fe8bc"
      unitRef="usd">24714000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS03LTEtMS0yMzI1NDc_e78336fe-083d-491d-84b0-cb83d8731e63"
      unitRef="usd">2778000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS05LTEtMS0yMzI1NDc_8cef23a3-3957-4ae5-96bc-98dd63f7e78e"
      unitRef="usd">21113000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjAyMTQyYjhhZDRkYjRkYTk5YjM5ZTJlYTQ1NWRiZWJiL3RhYmxlcmFuZ2U6MDIxNDJiOGFkNGRiNGRhOTliMzllMmVhNDU1ZGJlYmJfNS0xMS0xLTEtMjMyNTQ3_293201a0-56c7-4c23-93c9-d1c885afd50c"
      unitRef="usd">23891000000</us-gaap:Investments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i2cd4b5608b584505baa69c6d8dfe4c4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMzI5ODUzNDg4OTI1OA_e4c97ea4-6e34-493b-90eb-ba2f691b183f"
      unitRef="usd">17000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIxMA_7cc13a7a-2356-44c8-bf6d-c82eeba7074a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At March&#160;31, 2023, debt securities with a fair value of $620 million, gross unrealized capital gains of $5 million and gross unrealized capital losses of $40 million and at December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of $59 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy0xLTEtMS0yMzI1NDc_8654c6d8-5561-4ff7-a08a-7376b5bcf1f5"
      unitRef="usd">2071000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy0zLTEtMS0yMzI1NDc_9d080d79-5c3d-4370-9b90-a03941c7e6de"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy01LTEtMS0yMzI1NDc_2df84539-dda1-4278-93c5-cb7059a8df5d"
      unitRef="usd">2071000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy03LTEtMS0yMzI1NDc_97ddb424-4e94-4d97-989f-168d2b74b779"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy05LTEtMS0yMzI1NDc_d5baf8a0-b732-4e36-b26a-37ba1067ab9d"
      unitRef="usd">140000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMy0xMS0xLTEtMjMyNTQ3_8ede51af-09f4-4d72-ab2c-e01bd2b91ec2"
      unitRef="usd">1935000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC0xLTEtMS0yMzI1NDc_084b7809-6a50-4d31-a76b-b207a58e924f"
      unitRef="usd">2322000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC0zLTEtMS0yMzI1NDc_537f82c2-0756-4c63-a7ac-290ab2c9b82f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC01LTEtMS0yMzI1NDc_0cd4a156-73c9-46b3-81c7-016174b1ce63"
      unitRef="usd">2322000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC03LTEtMS0yMzI1NDc_77947ac2-201e-40e9-b8ce-499fca01bbec"
      unitRef="usd">18000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC05LTEtMS0yMzI1NDc_72d402c0-e84f-44ff-ab07-008c848656b6"
      unitRef="usd">86000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNC0xMS0xLTEtMjMyNTQ3_3c376c6b-5e22-4ac0-9856-e4e04c8be431"
      unitRef="usd">2254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS0xLTEtMS0yMzI1NDc_06acb2c1-1293-4be1-9d76-c82c5d4608e5"
      unitRef="usd">9983000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS0zLTEtMS0yMzI1NDc_faee14c4-4a32-4319-bc2b-c6fd1d8f8cc8"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS01LTEtMS0yMzI1NDc_b3a0673d-3b71-41fe-804a-d0979b0bd4ea"
      unitRef="usd">9981000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS03LTEtMS0yMzI1NDc_82fa5165-7ebc-481a-a642-58d70b74a7f7"
      unitRef="usd">48000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS05LTEtMS0yMzI1NDc_43bbfcf2-4019-4ade-adc2-34c90083ec61"
      unitRef="usd">665000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNS0xMS0xLTEtMjMyNTQ3_88d3ae0b-81f6-4d41-9f64-96deef3c2478"
      unitRef="usd">9364000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi0xLTEtMS0yMzI1NDc_522de8a7-a0ab-4214-b262-3cf28f3ff3e8"
      unitRef="usd">2765000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi0zLTEtMS0yMzI1NDc_78edaee2-745f-4273-95a3-e392d216bd69"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi01LTEtMS0yMzI1NDc_21f56a27-690d-4752-bf2a-17f6c0c39b98"
      unitRef="usd">2764000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi03LTEtMS0yMzI1NDc_2ef45ed3-aa64-4b80-a587-589da7f860fe"
      unitRef="usd">21000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi05LTEtMS0yMzI1NDc_5b6fc346-133e-4ce6-8ce0-1d47b16294ce"
      unitRef="usd">193000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNi0xMS0xLTEtMjMyNTQ3_f51c9aea-e2c4-4a08-aaa8-04b1285a3243"
      unitRef="usd">2592000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy0xLTEtMS0yMzI1NDc_0b0ce2e6-7067-42e1-b17d-058ba6e3ebef"
      unitRef="usd">881000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy0zLTEtMS0yMzI1NDc_592090de-87d6-49a2-b6d4-15959f86f35c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy01LTEtMS0yMzI1NDc_608f94b7-6d0a-4fb4-8eec-7e9d2ae52a0c"
      unitRef="usd">881000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy03LTEtMS0yMzI1NDc_a72552af-68f4-43b5-aac0-f9f887aab549"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy05LTEtMS0yMzI1NDc_f5ea3597-1416-439a-8eb5-e9c9ca3cefdd"
      unitRef="usd">71000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfNy0xMS0xLTEtMjMyNTQ3_08b63373-84b6-43f9-88b9-a5d2ae951130"
      unitRef="usd">812000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC0xLTEtMS0yMzI1NDc_f22e198c-71a3-4cdc-91ed-6a909992b160"
      unitRef="usd">1173000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC0zLTEtMS0yMzI1NDc_280c5dce-e28d-4f22-9c71-3270d615a612"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC01LTEtMS0yMzI1NDc_245fdf80-a565-46fa-a68f-a915f817b0b5"
      unitRef="usd">1173000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC03LTEtMS0yMzI1NDc_9e01c14f-c05f-43cc-a0ad-fb04c6c1d28c"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC05LTEtMS0yMzI1NDc_ccae6452-24cd-49b9-b14e-a83ab2c99db9"
      unitRef="usd">146000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOC0xMS0xLTEtMjMyNTQ3_fb63be69-3130-4f15-b408-6530f5777b90"
      unitRef="usd">1028000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS0xLTEtMS0yMzI1NDc_034ed884-cc89-4fd0-ba76-2b21a32f756d"
      unitRef="usd">2901000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS0zLTEtMS0yMzI1NDc_987d6b72-058f-43aa-8593-13d78f4b4bc0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS01LTEtMS0yMzI1NDc_565c2fd9-06cd-478d-856e-1c3303747d12"
      unitRef="usd">2901000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS03LTEtMS0yMzI1NDc_ea8d3540-b2d0-4082-bcca-614fec1b392e"
      unitRef="usd">7000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS05LTEtMS0yMzI1NDc_810bf6a4-f7c1-4f6b-a2dd-74c0c35e2825"
      unitRef="usd">90000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfOS0xMS0xLTEtMjMyNTQ3_429f5f0e-3771-4252-821d-877d69c4853f"
      unitRef="usd">2818000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtMS0xLTEtMjMyNTQ3_d8a230dd-bb06-4082-92b2-955ad88dad7c"
      unitRef="usd">21000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtMy0xLTEtMjMyNTQ3_0a75da50-e998-49d8-a572-404e409ae35a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtNS0xLTEtMjMyNTQ3_2ca5c6fe-c65c-4263-8a1d-e2b3ec84ec6a"
      unitRef="usd">21000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtNy0xLTEtMjMyNTQ3_308307d6-8f9d-411a-aef5-6f9879e934c7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtOS0xLTEtMjMyNTQ3_2ae4f93e-1602-4800-b613-e8f2fa30ebe0"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTAtMTEtMS0xLTIzMjU0Nw_bcfc7ea9-4bb2-4124-8788-d7091f03f1a7"
      unitRef="usd">19000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtMS0xLTEtMjMyNTQ3_44c7cb03-b19f-4066-a359-b22edf34e87a"
      unitRef="usd">22117000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtMy0xLTEtMjMyNTQ3_21163122-5cc4-4449-b97a-41cea154592b"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtNS0xLTEtMjMyNTQ3_ece6c8a1-b994-4f81-bca1-a7c6d2672fc0"
      unitRef="usd">22114000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtNy0xLTEtMjMyNTQ3_94fa4c31-7cbf-41eb-947a-80075ec6c745"
      unitRef="usd">101000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtOS0xLTEtMjMyNTQ3_6f2b1f24-76d4-4ca8-bd81-ab55d0d01fb0"
      unitRef="usd">1393000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTEtMTEtMS0xLTIzMjU0Nw_b5adaed9-d6e9-4ade-b1ae-9b3fc3d6a46b"
      unitRef="usd">20822000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtMS0xLTEtMjMyNTQ3_fcb164a8-6de7-42d0-a06f-8804c2416f01"
      unitRef="usd">2074000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtMy0xLTEtMjMyNTQ3_e7a4c1a7-4050-4a5d-94bd-ed87b7217745"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtNS0xLTEtMjMyNTQ3_3c4f4e1e-057c-4496-801f-2e18df77fb45"
      unitRef="usd">2074000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtNy0xLTEtMjMyNTQ3_3132324c-c0ab-4e6f-817d-ea7715125eb3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtOS0xLTEtMjMyNTQ3_88e4e4d2-2189-4758-92cc-2a33c9b78d8c"
      unitRef="usd">182000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTUtMTEtMS0xLTIzMjU0Nw_eba275e1-ed11-44d8-87b3-9b999891e861"
      unitRef="usd">1892000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtMS0xLTEtMjMyNTQ3_fc06b5bd-9e51-4352-bdf1-2f28faa4c826"
      unitRef="usd">2393000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtMy0xLTEtMjMyNTQ3_f519821e-ccca-4331-9a22-d21b51fb3bdc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtNS0xLTEtMjMyNTQ3_e4a84b3b-acce-4c19-8218-7ffbf8a32663"
      unitRef="usd">2393000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtNy0xLTEtMjMyNTQ3_e30dd0aa-749d-4c76-a2b4-55a0ad7c61ae"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtOS0xLTEtMjMyNTQ3_a2eb188e-bf6b-45ac-8db7-49a089fae767"
      unitRef="usd">129000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTYtMTEtMS0xLTIzMjU0Nw_de3f384b-eef7-4414-ab93-bd6e76c31f83"
      unitRef="usd">2272000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctMS0xLTEtMjMyNTQ3_408582b4-4357-4480-81dc-95af0f78e46e"
      unitRef="usd">9838000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctMy0xLTEtMjMyNTQ3_cf532209-0e84-49d7-b68b-3eacc549b88e"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctNS0xLTEtMjMyNTQ3_86718f57-9a4a-4ecd-82c0-b810fcb04747"
      unitRef="usd">9835000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctNy0xLTEtMjMyNTQ3_1d77bfa7-6e34-4dea-98ae-abcc24abc0ec"
      unitRef="usd">26000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctOS0xLTEtMjMyNTQ3_6de73030-1ba3-4504-8c2d-1782054cd503"
      unitRef="usd">903000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTctMTEtMS0xLTIzMjU0Nw_d8439af5-4f0c-4d0c-8aaa-4cc8e8dd45af"
      unitRef="usd">8958000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtMS0xLTEtMjMyNTQ3_d71b94c2-7837-4ebf-8302-c7fddf7d17c3"
      unitRef="usd">2780000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtMy0xLTEtMjMyNTQ3_437ec8e1-96fa-477a-97a7-21047c90b278"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtNS0xLTEtMjMyNTQ3_53bd05bb-1171-4337-b07b-8c15103718c5"
      unitRef="usd">2779000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtNy0xLTEtMjMyNTQ3_de36292c-e33b-47cf-8b26-7ee189593a2f"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtOS0xLTEtMjMyNTQ3_71fea888-ed2e-4c0e-aba3-5eaa362ab7b3"
      unitRef="usd">244000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTgtMTEtMS0xLTIzMjU0Nw_6c718a1e-b1cb-49ae-b6fe-e64177cab7b8"
      unitRef="usd">2550000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktMS0xLTEtMjMyNTQ3_87e88883-bdc7-4847-b6df-9af6ad0fcf6f"
      unitRef="usd">845000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktMy0xLTEtMjMyNTQ3_5af3103d-12e4-4cd1-9ff2-64223adb0e98"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktNS0xLTEtMjMyNTQ3_89086604-ccc9-4199-9c15-03ea110d7c2c"
      unitRef="usd">845000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktNy0xLTEtMjMyNTQ3_22b3cab7-ea38-4e71-82ed-8e25c42764b1"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktOS0xLTEtMjMyNTQ3_50c3d28b-4433-4b07-85dc-ac04dfc430d5"
      unitRef="usd">89000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMTktMTEtMS0xLTIzMjU0Nw_7ff10396-a0f7-46a4-801c-9c80ed62e219"
      unitRef="usd">757000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtMS0xLTEtMjMyNTQ3_788b54a6-2a82-4350-b2df-6a720c768923"
      unitRef="usd">1172000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtMy0xLTEtMjMyNTQ3_91f1b3b4-f470-4550-a8d8-8cfcd00e86d8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtNS0xLTEtMjMyNTQ3_a8634926-fea0-4eda-b7a1-cfeff93788f0"
      unitRef="usd">1172000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtNy0xLTEtMjMyNTQ3_10f1657b-30c6-4829-bcb4-c00df9a089ce"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtOS0xLTEtMjMyNTQ3_3b391f65-139d-474c-9758-529b4d487c93"
      unitRef="usd">155000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjAtMTEtMS0xLTIzMjU0Nw_e5353f94-3312-4003-b023-b7f5daa823c9"
      unitRef="usd">1018000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtMS0xLTEtMjMyNTQ3_bdca33ee-61e4-4eeb-a217-9d781acc7694"
      unitRef="usd">2940000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtMy0xLTEtMjMyNTQ3_6389e013-cea5-43a0-9c6d-36c4163d0cb6"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtNS0xLTEtMjMyNTQ3_bcba018c-a0a0-492b-974d-ad3eadea82f1"
      unitRef="usd">2940000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtNy0xLTEtMjMyNTQ3_9007ff89-bbbb-41bf-b9e9-ed6269c2153e"
      unitRef="usd">6000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtOS0xLTEtMjMyNTQ3_52b02b03-70ef-4a4d-9527-d3023489bc2b"
      unitRef="usd">136000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjEtMTEtMS0xLTIzMjU0Nw_cbd114a3-12d2-48e2-9372-27b74d958054"
      unitRef="usd">2810000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItMS0xLTEtMjMyNTQ3_50574262-95bf-48d6-a703-ea88c008255e"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItMy0xLTEtMjMyNTQ3_9228e8fb-243b-4676-a4ac-a1f1ed8857b9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItNS0xLTEtMjMyNTQ3_cc9a07c3-70c2-4bde-8521-53d8b68bf053"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItNy0xLTEtMjMyNTQ3_7cb07145-ca07-4266-9684-b68ea1bd5280"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItOS0xLTEtMjMyNTQ3_980fae7d-e847-4894-bcc1-82510944ccfc"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjItMTEtMS0xLTIzMjU0Nw_670c909d-7279-4539-a5bb-f2622856dda4"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtMS0xLTEtMjMyNTQ3_0536b8e0-0f5d-4cee-a054-9846e8d738d0"
      unitRef="usd">22067000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtMy0xLTEtMjMyNTQ3_08acd64a-c45e-4cc4-8b4d-132ebabb0acc"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtNS0xLTEtMjMyNTQ3_0fab31cc-dbaa-4373-bcce-3066a580eb77"
      unitRef="usd">22063000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtNy0xLTEtMjMyNTQ3_d72c5471-a1d6-4eaf-8b7e-3a9fe34317bd"
      unitRef="usd">57000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtOS0xLTEtMjMyNTQ3_80cf1e10-72dc-4706-b2ce-cb8f19f776e9"
      unitRef="usd">1840000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjgxM2NiMzA1MzE3OTRjYWQ4ZmJhMjE3NTE1NTM0YWU3L3RhYmxlcmFuZ2U6ODEzY2IzMDUzMTc5NGNhZDhmYmEyMTc1MTU1MzRhZTdfMjMtMTEtMS0xLTIzMjU0Nw_8a6712da-8d43-4199-9a7e-06ddd76b6698"
      unitRef="usd">20280000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNjc5_68a181d5-f633-49d3-a27d-a8f3b386ff8e"
      unitRef="usd">620000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNzE3_acb02e5e-44db-446e-a237-49e8b08ebb97"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNzU5_9ebf5b5e-a9d9-43ee-98d2-8527104dba6d"
      unitRef="usd">40000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2114bac1bd054f9bbf533d596e9ab742_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfODEw_e87aedbc-8909-41a8-9816-b1f23791f35b"
      unitRef="usd">609000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2114bac1bd054f9bbf533d596e9ab742_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfODQ4_3d0926b6-f407-48a5-aece-04c62629d8ed"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2114bac1bd054f9bbf533d596e9ab742_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfODkw_2768540c-911d-44a9-a98a-cbe336300a5c"
      unitRef="usd">59000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTI3OA_bed6a38d-5baa-4cdf-a8a5-634d7aafc4a4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net amortized cost and fair value of debt securities at March&#160;31, 2023 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMi0xLTEtMS0yMzI1NDc_503d171f-8532-48bd-ad87-69e679641591"
      unitRef="usd">1412000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMi0zLTEtMS0yMzI1NDc_6d3dde0d-2542-4314-a94f-1acfbed93a54"
      unitRef="usd">1395000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMy0xLTEtMS0yMzI1NDc_61bdeb74-5ef5-4073-8005-ba59413533a8"
      unitRef="usd">6823000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfMy0zLTEtMS0yMzI1NDc_171a7aee-1781-4806-81f3-40fd2cf8c3fd"
      unitRef="usd">6510000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNC0xLTEtMS0yMzI1NDc_7268ed87-05d6-4f3d-91d6-3cd9b96ccb1a"
      unitRef="usd">4627000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNC0zLTEtMS0yMzI1NDc_b7414b88-d040-47d8-8602-7e446c2af245"
      unitRef="usd">4299000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNS0xLTEtMS0yMzI1NDc_f4e55fb3-8526-4e58-a808-766f8e760412"
      unitRef="usd">4297000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNS0zLTEtMS0yMzI1NDc_2c1939e9-d94f-44d7-abcc-37151e5a55c0"
      unitRef="usd">3960000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNi0xLTEtMS0yMzI1NDc_2bbcbd5e-47e7-4107-9ab9-a43c74003b5a"
      unitRef="usd">881000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNi0zLTEtMS0yMzI1NDc_9820b406-9b29-4f08-8277-2da5e6ed7a05"
      unitRef="usd">812000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNy0xLTEtMS0yMzI1NDc_6b4a142b-dea3-4f43-a268-69967a7eb1fa"
      unitRef="usd">1173000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfNy0zLTEtMS0yMzI1NDc_4049faa7-c63f-435b-8ec5-2f803540aaa2"
      unitRef="usd">1028000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOC0xLTEtMS0yMzI1NDc_7ee05fe6-e7e7-47d4-825e-f0e196d92e53"
      unitRef="usd">2901000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOC0zLTEtMS0yMzI1NDc_df797cab-6a64-4c45-bc11-5e28017277d1"
      unitRef="usd">2818000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOS0xLTEtMS0yMzI1NDc_40d376aa-87aa-4576-b899-7e439f299836"
      unitRef="usd">22114000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjJhNTY0ZWJjMGUxNzRiM2M4MGI3NTVjMDNjM2ZiZDY5L3RhYmxlcmFuZ2U6MmE1NjRlYmMwZTE3NGIzYzgwYjc1NWMwM2MzZmJkNjlfOS0zLTEtMS0yMzI1NDc_f408094d-4228-4a5a-8a38-20d50805a6d3"
      unitRef="usd">20822000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTI3MQ_1b420232-df9f-4845-8fe2-ec9fa951e001">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at March&#160;31, 2023 and December&#160;31, 2022 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at March&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xLTEtMS0yMzI1NDc_3c22f945-7a02-4945-b05f-98cde75855d0"
      unitRef="security">153</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0zLTEtMS0yMzI1NDc_aefbb1b8-fe7a-4a66-8e8d-4e15f785f661"
      unitRef="usd">473000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC01LTEtMS0yMzI1NDc_bee309be-6a4b-4850-b701-714c8aaa134b"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC03LTEtMS0yMzI1NDc_05ad496b-b3e1-4a06-90bc-7efd333d1912"
      unitRef="security">323</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC05LTEtMS0yMzI1NDc_3dfcc2d6-d0c2-4a30-9a81-896adb672edc"
      unitRef="usd">1143000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xMS0xLTEtMjMyNTQ3_6fa5a35a-0e57-483f-ac08-0b95b49d279f"
      unitRef="usd">120000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xMy0xLTEtMjMyNTQ3_66bcaa32-ba82-48da-84d8-fb0ef40cedae"
      unitRef="security">476</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xNS0xLTEtMjMyNTQ3_303fc793-ef02-4b28-bc54-3db61f296ff4"
      unitRef="usd">1616000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i4b1e23607d9b4a6091501bbce5031d11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNC0xNy0xLTEtMjMyNTQ3_15252f03-74f2-4cf7-bf7e-9cdaab6c8f0e"
      unitRef="usd">140000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xLTEtMS0yMzI1NDc_1852e367-13bf-4e36-9294-d7df97231ef2"
      unitRef="security">301</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0zLTEtMS0yMzI1NDc_5c05cee4-70dd-453b-bdce-9966d6a26c4f"
      unitRef="usd">513000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS01LTEtMS0yMzI1NDc_78f4d50d-63b2-4c34-a00d-a7c3f08cd7d3"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS03LTEtMS0yMzI1NDc_b56d19d0-b3ac-40c1-b16e-fda479b26f6c"
      unitRef="security">583</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS05LTEtMS0yMzI1NDc_62a950f1-dbe8-4854-a831-fbbf92d78c33"
      unitRef="usd">897000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xMS0xLTEtMjMyNTQ3_fd840fdc-516a-4db6-9010-b93bce75bc04"
      unitRef="usd">74000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xMy0xLTEtMjMyNTQ3_08cda2ce-ff37-461b-9bb2-5cb798eb9e9a"
      unitRef="security">884</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xNS0xLTEtMjMyNTQ3_74550beb-63ee-4313-b9ae-68a76eed920d"
      unitRef="usd">1410000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie78c8e3b7926431fa4a031ff1b43afff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNS0xNy0xLTEtMjMyNTQ3_1d7f8579-88d8-4531-9b0f-ad65b32b77fd"
      unitRef="usd">86000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xLTEtMS0yMzI1NDc_13ccad29-bc31-42cf-8b44-5dc11c97702f"
      unitRef="security">2675</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0zLTEtMS0yMzI1NDc_73761fc0-1c18-440a-9972-083446980d24"
      unitRef="usd">3640000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi01LTEtMS0yMzI1NDc_dc1dfd0c-c3c3-425b-8066-c6e6e8c7b702"
      unitRef="usd">167000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi03LTEtMS0yMzI1NDc_3e9c48ce-7811-4a10-a71a-ccda866ad9bc"
      unitRef="security">3300</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi05LTEtMS0yMzI1NDc_94880c8e-73a5-43e0-9650-b6734ee222fa"
      unitRef="usd">4116000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xMS0xLTEtMjMyNTQ3_9568ccaa-473d-4c0d-b283-f42432090ae7"
      unitRef="usd">498000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xMy0xLTEtMjMyNTQ3_ddfbc31d-7bac-4893-a4f8-5e37e23398d7"
      unitRef="security">5975</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xNS0xLTEtMjMyNTQ3_0389664a-f66d-4468-82ee-8d587e27b256"
      unitRef="usd">7756000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic36a1c6051fe46d29e86c02619938c15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNi0xNy0xLTEtMjMyNTQ3_79140fe9-ddf0-4185-93f2-202d21989431"
      unitRef="usd">665000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xLTEtMS0yMzI1NDc_6a77c101-c374-4abd-8e31-ea202f1addc0"
      unitRef="security">653</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0zLTEtMS0yMzI1NDc_f2e3957c-1d85-41d0-970a-f9dffbfdde42"
      unitRef="usd">946000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy01LTEtMS0yMzI1NDc_125ea4ee-51fa-41e0-98f0-2a54901e7040"
      unitRef="usd">34000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy03LTEtMS0yMzI1NDc_63a11ab0-084e-469d-8f72-e009380fe8e8"
      unitRef="security">787</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy05LTEtMS0yMzI1NDc_c0f4de38-d5ac-401a-9b30-0d653b85f0f8"
      unitRef="usd">1163000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xMS0xLTEtMjMyNTQ3_b4d7bc3b-7df7-4a52-81d3-0f6bce9ebe1c"
      unitRef="usd">159000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xMy0xLTEtMjMyNTQ3_afc878a0-4117-493e-8da2-f5efd0f62223"
      unitRef="security">1440</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xNS0xLTEtMjMyNTQ3_d49d8903-a5e4-4e9a-9dd7-a3028f783bfb"
      unitRef="usd">2109000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7d0df874b4644f05949c4d3711ac6210_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfNy0xNy0xLTEtMjMyNTQ3_c8504f8b-29c2-4e17-ba25-f4a6bb103dab"
      unitRef="usd">193000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xLTEtMS0yMzI1NDc_5c09e9c7-0cfe-4d9f-9ac1-c6fca8beb0bf"
      unitRef="security">350</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0zLTEtMS0yMzI1NDc_8be40874-bde1-4820-a041-b7699878cc48"
      unitRef="usd">362000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC01LTEtMS0yMzI1NDc_95a4b9a9-16f3-4bce-aadb-944918ce5de2"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC03LTEtMS0yMzI1NDc_cd4fdca7-af3c-4766-8925-924be1dce6c2"
      unitRef="security">183</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC05LTEtMS0yMzI1NDc_6d6b44aa-5f1a-42e2-b5f1-03c812cf63cd"
      unitRef="usd">361000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xMS0xLTEtMjMyNTQ3_a3ce6bf4-97da-4abe-a242-5ad507483238"
      unitRef="usd">59000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xMy0xLTEtMjMyNTQ3_1d92ff54-aa78-4a61-8dec-f94de91c060a"
      unitRef="security">533</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xNS0xLTEtMjMyNTQ3_18a7773a-2a3b-451c-929f-b9de1eb96262"
      unitRef="usd">723000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOC0xNy0xLTEtMjMyNTQ3_faad7328-7ba6-4c9a-be98-f41cff58d759"
      unitRef="usd">71000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xLTEtMS0yMzI1NDc_71a60af6-c327-496e-9794-89fdbcd8a0fa"
      unitRef="security">131</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0zLTEtMS0yMzI1NDc_72171f65-9feb-4000-b9c1-0435d124421a"
      unitRef="usd">300000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS01LTEtMS0yMzI1NDc_e6010303-c29f-4a05-abcd-10ebde2190b5"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS03LTEtMS0yMzI1NDc_6d679b3f-4d9e-4bd6-8c8d-a9ea20697ac1"
      unitRef="security">328</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS05LTEtMS0yMzI1NDc_6325fc21-31ff-41d8-880f-0c42d3f70370"
      unitRef="usd">632000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xMS0xLTEtMjMyNTQ3_b6e5840d-9452-4b3a-a739-2bc02255c9a7"
      unitRef="usd">128000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xMy0xLTEtMjMyNTQ3_bf658884-350c-4be5-9519-5de1fbeeb2e5"
      unitRef="security">459</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xNS0xLTEtMjMyNTQ3_e8f9bd7a-bd7f-4e54-b04a-489a20d1d940"
      unitRef="usd">932000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfOS0xNy0xLTEtMjMyNTQ3_55e29a6d-1736-4a98-834c-f9a4dc823884"
      unitRef="usd">146000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMS0xLTEtMjMyNTQ3_6af9a060-79b2-44be-a894-0a11de26cee3"
      unitRef="security">527</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMy0xLTEtMjMyNTQ3_646a849f-93f0-4ef8-8829-456f7870420c"
      unitRef="usd">1126000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtNS0xLTEtMjMyNTQ3_ee1fea60-252b-41ad-b62d-9f9521668175"
      unitRef="usd">23000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtNy0xLTEtMjMyNTQ3_5f65844d-22df-4977-a87a-5ce24847476e"
      unitRef="security">726</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtOS0xLTEtMjMyNTQ3_28ca54b0-ec5c-436e-ba21-60227d537513"
      unitRef="usd">1257000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTEtMS0xLTIzMjU0Nw_022a948d-dee4-4d8b-bb56-2a869ab31343"
      unitRef="usd">67000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTMtMS0xLTIzMjU0Nw_cb615263-b239-4267-8f77-a1ffad4beffd"
      unitRef="security">1253</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTUtMS0xLTIzMjU0Nw_66170a1d-6c65-491a-bb11-2a2785b0ef9e"
      unitRef="usd">2383000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTAtMTctMS0xLTIzMjU0Nw_a2d159b3-8318-4565-91db-1f1a36c24db6"
      unitRef="usd">90000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMS0xLTEtMjMyNTQ3_6a782b35-dff9-4e0d-8bb4-c06962bf8edb"
      unitRef="security">7</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMy0xLTEtMjMyNTQ3_bda2907f-9198-4c49-92d1-dd94810ee053"
      unitRef="usd">14000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtNS0xLTEtMjMyNTQ3_b7c4e230-3494-4225-aa20-f61298c2c197"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtNy0xLTEtMjMyNTQ3_cd376fe1-6fe7-421a-a958-4db411efe383"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtOS0xLTEtMjMyNTQ3_87682c91-c1b9-4956-97b5-56be773618c9"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTEtMS0xLTIzMjU0Nw_bac9944d-114f-45a0-9bc8-047187dab7dc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTMtMS0xLTIzMjU0Nw_1292ebbc-cadf-4943-89da-d475fbd6f3d9"
      unitRef="security">8</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTUtMS0xLTIzMjU0Nw_9191804d-4617-43e4-a122-c94836f41895"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaee54db0edd84b02b83911d676d2521a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTEtMTctMS0xLTIzMjU0Nw_5d687b0f-4349-4571-a45b-9d75dc0ed1dc"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMS0xLTEtMjMyNTQ3_87537f55-043a-4658-ac0a-95fe014ff4dd"
      unitRef="security">4797</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMy0xLTEtMjMyNTQ3_e61aab38-3829-46f7-b9d3-104eb7dbb72f"
      unitRef="usd">7374000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItNS0xLTEtMjMyNTQ3_d3aa76e9-6447-486f-8d1b-b486ad3e3680"
      unitRef="usd">288000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItNy0xLTEtMjMyNTQ3_8c1bd235-490c-4556-b9e4-9d9a7c52ed81"
      unitRef="security">6231</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItOS0xLTEtMjMyNTQ3_43c0b2f7-11f3-4894-8380-001ca8848604"
      unitRef="usd">9572000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTEtMS0xLTIzMjU0Nw_7e80deb7-ac47-4422-9c6d-c0f882d90c0f"
      unitRef="usd">1105000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTMtMS0xLTIzMjU0Nw_0f869c81-0a29-4705-bc37-4aa4469c6efa"
      unitRef="security">11028</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTUtMS0xLTIzMjU0Nw_c25d1a0a-53d7-4db1-a890-f7b1280e7b86"
      unitRef="usd">16946000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTItMTctMS0xLTIzMjU0Nw_8e36e3fc-a91c-4dcf-abf2-18bf82da0f85"
      unitRef="usd">1393000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMS0xLTEtMjMyNTQ3_69cf0892-88d8-4b1c-9d06-0e53418701d7"
      unitRef="security">519</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMy0xLTEtMjMyNTQ3_51677e96-6800-4c66-8bd1-50e295b8756e"
      unitRef="usd">1620000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtNS0xLTEtMjMyNTQ3_381b0b93-7544-40c9-b842-28ff67e1ce9d"
      unitRef="usd">164000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtNy0xLTEtMjMyNTQ3_cee2ac1a-f8ac-49c1-86df-d47cc88a476b"
      unitRef="security">35</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtOS0xLTEtMjMyNTQ3_aa448d96-6b15-4492-98af-02ccf4c4c05a"
      unitRef="usd">191000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTEtMS0xLTIzMjU0Nw_3e627bd8-9851-4d9f-8acd-c23a66761e97"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTMtMS0xLTIzMjU0Nw_8e0f4d70-f8fa-4d6d-b696-369db57b24e8"
      unitRef="security">554</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTUtMS0xLTIzMjU0Nw_d2cd3c7c-0930-4117-ac83-49a23c7fe420"
      unitRef="usd">1811000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i03a42f31cb6c4a84bff5f04071d84127_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTYtMTctMS0xLTIzMjU0Nw_0a0fa86d-0d45-4375-9d90-244995a68a66"
      unitRef="usd">182000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMS0xLTEtMjMyNTQ3_d3211f7d-9cc6-4182-b3cc-acf7dfe0cbc3"
      unitRef="security">859</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMy0xLTEtMjMyNTQ3_3d35be91-12c3-4c11-a30d-01cde6a4f239"
      unitRef="usd">1370000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctNS0xLTEtMjMyNTQ3_87af3468-9351-4d2e-b87e-9038181af82c"
      unitRef="usd">95000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctNy0xLTEtMjMyNTQ3_8324f619-c623-40f3-b4a4-eaf655744f75"
      unitRef="security">196</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctOS0xLTEtMjMyNTQ3_6cf4abaf-92b5-4d15-92fa-f6b7ba959752"
      unitRef="usd">322000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTEtMS0xLTIzMjU0Nw_4835f890-f5ff-47bb-a82c-8d1192e99c36"
      unitRef="usd">34000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTMtMS0xLTIzMjU0Nw_dceebe3d-d1e0-4cf0-bc40-9841c9e459c4"
      unitRef="security">1055</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTUtMS0xLTIzMjU0Nw_186c5920-1df6-4ff1-bd42-d6625da2c924"
      unitRef="usd">1692000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id4256325af2f4601ba2bc2b417b0cc41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTctMTctMS0xLTIzMjU0Nw_7820517d-53b7-415d-86bc-cb2a065f2648"
      unitRef="usd">129000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMS0xLTEtMjMyNTQ3_f61444f5-87ce-4f56-a5aa-a6ae64eb7f12"
      unitRef="security">5193</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMy0xLTEtMjMyNTQ3_7ead6750-0784-4956-9338-e435477e261d"
      unitRef="usd">6537000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtNS0xLTEtMjMyNTQ3_2e45d228-9f2a-4e86-a6df-dc3cc4a8aba1"
      unitRef="usd">622000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtNy0xLTEtMjMyNTQ3_510e15a8-3c31-48f4-b0a7-3587ab0ab150"
      unitRef="security">1479</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtOS0xLTEtMjMyNTQ3_c16b899a-0a85-4810-b5ef-8db835eef429"
      unitRef="usd">1822000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTEtMS0xLTIzMjU0Nw_4ca1733b-29f2-46f5-ada9-77f49225858a"
      unitRef="usd">281000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTMtMS0xLTIzMjU0Nw_46e24099-763c-4820-bb4d-b04aef043751"
      unitRef="security">6672</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTUtMS0xLTIzMjU0Nw_2b174983-e70d-497c-a93f-af7c81df9073"
      unitRef="usd">8359000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3433e18f57964e288d423f861ddf29db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTgtMTctMS0xLTIzMjU0Nw_4695bea4-3c90-4bf6-a6e7-6d7cdb59fbdb"
      unitRef="usd">903000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMS0xLTEtMjMyNTQ3_9115ca32-5a4c-42b5-9db4-b38ce6e4363a"
      unitRef="security">1168</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMy0xLTEtMjMyNTQ3_f3f3425a-4da0-4028-8005-e1717319b0e5"
      unitRef="usd">1715000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktNS0xLTEtMjMyNTQ3_79836dee-e822-4a1a-a7e6-0b37fa2aa91b"
      unitRef="usd">147000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktNy0xLTEtMjMyNTQ3_e96036b9-140a-450b-9949-ef8e274e4693"
      unitRef="security">403</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktOS0xLTEtMjMyNTQ3_e82997d3-e1ac-4a6a-9303-fd858f001c6e"
      unitRef="usd">592000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTEtMS0xLTIzMjU0Nw_717213de-e18c-4642-b545-065c8ef621ce"
      unitRef="usd">97000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTMtMS0xLTIzMjU0Nw_ff13a9d7-7b7e-4fcc-8aaf-00d72ecf4b4b"
      unitRef="security">1571</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTUtMS0xLTIzMjU0Nw_385c06f2-7a63-41bc-81eb-a9504aa560a2"
      unitRef="usd">2307000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ieb3983d4da1c4a63b445b21520061727_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMTktMTctMS0xLTIzMjU0Nw_2348d95f-c50e-4f5b-a086-f2b38efef98b"
      unitRef="usd">244000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMS0xLTEtMjMyNTQ3_81204150-63b3-4b70-8f7e-31acf2d4ce57"
      unitRef="security">452</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMy0xLTEtMjMyNTQ3_88e2e5d1-8957-4c72-8561-477cd60583c9"
      unitRef="usd">464000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtNS0xLTEtMjMyNTQ3_20cc911d-d9b5-48ca-8243-03eb4eded7f9"
      unitRef="usd">39000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtNy0xLTEtMjMyNTQ3_04e9adfe-1656-4b64-96db-4b79edaaccd1"
      unitRef="security">91</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtOS0xLTEtMjMyNTQ3_22b33c16-bb46-437d-91c7-cf8bbb822764"
      unitRef="usd">257000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTEtMS0xLTIzMjU0Nw_21bf4018-8ecc-463f-a0e9-890b0cf8075c"
      unitRef="usd">50000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTMtMS0xLTIzMjU0Nw_a9affea7-f71a-4ad5-b655-f188a1497563"
      unitRef="security">543</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTUtMS0xLTIzMjU0Nw_2ccf89a5-f34f-4ca1-bca2-8338bfeb8146"
      unitRef="usd">721000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if70be69bf99746f0b1a2639e28853784_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjAtMTctMS0xLTIzMjU0Nw_16f0ca9b-6428-4fe9-9a82-97dcadc4fadb"
      unitRef="usd">89000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMS0xLTEtMjMyNTQ3_fd9908e0-66fa-4087-8124-83e676b6eeab"
      unitRef="security">288</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMy0xLTEtMjMyNTQ3_302a9dd1-6d69-4213-93a9-49b3aae5a11d"
      unitRef="usd">611000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtNS0xLTEtMjMyNTQ3_05ea09ed-bafc-4c14-92e2-0a89be81eb09"
      unitRef="usd">69000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtNy0xLTEtMjMyNTQ3_ebe9a1b6-3368-47fc-af1f-24fca085baf0"
      unitRef="security">187</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtOS0xLTEtMjMyNTQ3_14788603-39d9-477c-b57e-8c780e33b2af"
      unitRef="usd">381000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTEtMS0xLTIzMjU0Nw_e9f9573b-792e-434e-b40c-830818f19418"
      unitRef="usd">86000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTMtMS0xLTIzMjU0Nw_bab15ee8-ba8b-4ada-a6b4-387c48b3a777"
      unitRef="security">475</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTUtMS0xLTIzMjU0Nw_59f19184-1893-4f29-a279-deb26d6caeae"
      unitRef="usd">992000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib71e7222f0c84675b7a4e485bb1ebd88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjEtMTctMS0xLTIzMjU0Nw_88c59530-6276-4ae9-97b9-987718e06c15"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMS0xLTEtMjMyNTQ3_78456024-c6ef-46bb-897c-c15883e6f177"
      unitRef="security">1008</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMy0xLTEtMjMyNTQ3_eb0d1a58-fa90-409d-a816-3e11be44c3b6"
      unitRef="usd">1893000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItNS0xLTEtMjMyNTQ3_3ee7050f-4bd7-4bdf-a938-1bb4fb7d0ac1"
      unitRef="usd">88000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItNy0xLTEtMjMyNTQ3_d26ee5b4-015f-4408-b228-6f789b667ebb"
      unitRef="security">391</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItOS0xLTEtMjMyNTQ3_fd6b3827-b9f1-4dd6-b661-dce2a3e27830"
      unitRef="usd">694000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTEtMS0xLTIzMjU0Nw_dd57981b-6add-4f1c-8a9f-4e043c2cdf88"
      unitRef="usd">48000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTMtMS0xLTIzMjU0Nw_37101e35-9df2-4145-b145-0a96a19caec0"
      unitRef="security">1399</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTUtMS0xLTIzMjU0Nw_7b9e4949-db2f-4f28-b6e1-9cbbb9d44afc"
      unitRef="usd">2587000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ifb23d1e2a799483fbe06ff074abe16d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjItMTctMS0xLTIzMjU0Nw_475e4e4b-cbba-4731-9935-09bf9fd25f60"
      unitRef="usd">136000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMS0xLTEtMjMyNTQ3_c09a5056-1eb9-4fb6-8577-03980a4b6621"
      unitRef="security">13</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMy0xLTEtMjMyNTQ3_452c611c-d9ea-46e3-8627-1b0c3303c339"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtNS0xLTEtMjMyNTQ3_fab6ece5-c6e0-4b18-8785-a2784cef88a8"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtNy0xLTEtMjMyNTQ3_9090f6c1-06da-48d0-80ed-381c0abdc54a"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtOS0xLTEtMjMyNTQ3_55de394d-162f-40c5-bece-b2b88ffd5ece"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTEtMS0xLTIzMjU0Nw_22697a40-7067-4771-8840-ec200d2ee968"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTMtMS0xLTIzMjU0Nw_b26b6275-b134-40de-a992-cba18805b28c"
      unitRef="security">15</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTUtMS0xLTIzMjU0Nw_d007fd4f-34bf-41dd-999d-dfe8c3a84657"
      unitRef="usd">23000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i16da4f6eea4a41358459c0d06fcf2d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjMtMTctMS0xLTIzMjU0Nw_cb31ba08-00b7-4e83-be79-799c752e50a9"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMS0xLTEtMjMyNTQ3_0b9eae9b-3325-47f9-8984-9e2b9d0aaa48"
      unitRef="security">9500</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMy0xLTEtMjMyNTQ3_813c4dee-6886-422f-93bb-1933dcfedb39"
      unitRef="usd">14228000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtNS0xLTEtMjMyNTQ3_50bb90df-649f-4955-80aa-a3070850c3d7"
      unitRef="usd">1226000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtNy0xLTEtMjMyNTQ3_fd587732-8aac-4fc9-8f40-02d2237b770b"
      unitRef="security">2784</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtOS0xLTEtMjMyNTQ3_752ab117-5d69-4b44-a393-e25258588db6"
      unitRef="usd">4264000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTEtMS0xLTIzMjU0Nw_9184b538-8d73-4b46-904a-8c80d43baf62"
      unitRef="usd">614000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTMtMS0xLTIzMjU0Nw_c9315824-b529-4c43-94ee-91c5a026c6b6"
      unitRef="security">12284</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTUtMS0xLTIzMjU0Nw_86ed74fd-9b7a-4849-add8-ee0b035e4891"
      unitRef="usd">18492000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjY4YjZiZmY1NDI5OTQ3MzE5MGQ0NzQ3NDNhZDExNTc3L3RhYmxlcmFuZ2U6NjhiNmJmZjU0Mjk5NDczMTkwZDQ3NDc0M2FkMTE1NzdfMjQtMTctMS0xLTIzMjU0Nw_49e84781-ec10-4940-8ee0-23115d2d9fd4"
      unitRef="usd">1840000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy0xLTEtMS0yMzI1NDc_5c68f07c-6e48-404f-a4ce-386ec6917b26"
      unitRef="usd">22000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy0zLTEtMS0yMzI1NDc_914db5cf-0cd9-4f7d-9631-a6ad3779804f"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy01LTEtMS0yMzI1NDc_b4c0d853-5908-486b-9fcc-ac7002142035"
      unitRef="usd">1200000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy03LTEtMS0yMzI1NDc_17c20dd0-c7b7-4da4-8bce-77d9f7dddf45"
      unitRef="usd">18000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy05LTEtMS0yMzI1NDc_f6056062-ebad-462e-8597-e23163ef15ce"
      unitRef="usd">1222000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMy0xMS0xLTEtMjMyNTQ3_794657fb-d643-4720-8414-85cc47d33032"
      unitRef="usd">18000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC0xLTEtMS0yMzI1NDc_d9fb2462-b9dc-46ee-932e-8260fd3bb313"
      unitRef="usd">125000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC0zLTEtMS0yMzI1NDc_7c93ba86-39fc-4eba-85a8-0eab875ef960"
      unitRef="usd">3000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC01LTEtMS0yMzI1NDc_de92b93d-fffc-4224-bd8c-5d0ed2d50c8e"
      unitRef="usd">5238000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC03LTEtMS0yMzI1NDc_c2d5995d-7550-47f2-afe6-26a372fcd587"
      unitRef="usd">330000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC05LTEtMS0yMzI1NDc_359993c4-29c7-4ba7-9637-99d9e992b58a"
      unitRef="usd">5363000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNC0xMS0xLTEtMjMyNTQ3_2b85a441-ca3e-4f37-8458-6944e412e64a"
      unitRef="usd">333000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS0xLTEtMS0yMzI1NDc_34ec9104-ffe0-422d-b8a7-332dd411040a"
      unitRef="usd">120000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS0zLTEtMS0yMzI1NDc_b936db67-a5b1-4e02-895f-e3e42ef35bbf"
      unitRef="usd">12000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS01LTEtMS0yMzI1NDc_f1ceae58-c7ad-46bd-a6c1-653ef1681467"
      unitRef="usd">3171000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS03LTEtMS0yMzI1NDc_5180223d-504d-493a-bafb-76cf2594d56d"
      unitRef="usd">346000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS05LTEtMS0yMzI1NDc_33351214-51a2-41bc-9257-5a7d78efd820"
      unitRef="usd">3291000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNS0xMS0xLTEtMjMyNTQ3_c094dfb5-cbfd-47fc-a770-d44eab91ab69"
      unitRef="usd">358000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi0xLTEtMS0yMzI1NDc_77fab225-dd9a-4a1a-8f98-078f0516d539"
      unitRef="usd">197000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi0zLTEtMS0yMzI1NDc_fb5c525b-7121-46c5-bbc4-3466c366610a"
      unitRef="usd">20000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi01LTEtMS0yMzI1NDc_559cee4d-464c-4aa6-9a9c-c11cb7b818c7"
      unitRef="usd">2835000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi03LTEtMS0yMzI1NDc_7accd97d-b118-48dc-a68e-323d7aed6a24"
      unitRef="usd">357000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi05LTEtMS0yMzI1NDc_41b03207-61e5-4cd4-a6aa-3f1b5bd4bbac"
      unitRef="usd">3032000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNi0xMS0xLTEtMjMyNTQ3_692eb731-7982-4e50-93c3-90cd08505565"
      unitRef="usd">377000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="iaab2edb2f7584b39b2e4c10c2b4cf2bd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy0xLTEtMS0yMzI1NDc_c547ba96-221b-4454-ac16-991d079e725e"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="iaab2edb2f7584b39b2e4c10c2b4cf2bd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy0zLTEtMS0yMzI1NDc_06058331-68a0-4cf4-a1b9-0fe0d2a10db8"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i514f278578014b3ea9214b4c5b8aa393_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy01LTEtMS0yMzI1NDc_6c76855e-19f9-4d38-b9fa-9ae3009bf480"
      unitRef="usd">712000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i514f278578014b3ea9214b4c5b8aa393_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy03LTEtMS0yMzI1NDc_808ab463-741a-4fb1-9a71-3215395e2ce8"
      unitRef="usd">70000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy05LTEtMS0yMzI1NDc_5a325032-4f1f-49ca-b1ae-42343565c09e"
      unitRef="usd">723000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="ic991c189663c4129a0fde857c5cebba3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfNy0xMS0xLTEtMjMyNTQ3_73fc6624-6cba-4070-9e37-a7dc3db64cd3"
      unitRef="usd">71000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i220d86c07d6f4153933adc26fb1b8c40_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC0xLTEtMS0yMzI1NDc_9552f844-4244-4436-a47a-1789e7576b0e"
      unitRef="usd">23000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i220d86c07d6f4153933adc26fb1b8c40_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC0zLTEtMS0yMzI1NDc_bd3a9963-caa9-4405-8b9a-fb9c848d4c75"
      unitRef="usd">3000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i11f7f0a3fb574018bd69ea4301436dc8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC01LTEtMS0yMzI1NDc_62df6c46-c7ad-4d88-9d9c-dcbc83169a0d"
      unitRef="usd">909000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i11f7f0a3fb574018bd69ea4301436dc8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC03LTEtMS0yMzI1NDc_9346e6fc-649b-444f-bb18-d761e41fb317"
      unitRef="usd">143000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC05LTEtMS0yMzI1NDc_0d0edb7b-6d9a-46c6-825d-a8f7662c195b"
      unitRef="usd">932000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="ibfd177924cc3495f977df5f06e848f4a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOC0xMS0xLTEtMjMyNTQ3_cebd7da3-3d80-4625-8ddf-42de68ee8a83"
      unitRef="usd">146000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i2c66f45a22194ea1bd25a835ded92b94_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS0xLTEtMS0yMzI1NDc_cacd2257-e7fc-415a-a386-af21de012f7d"
      unitRef="usd">17000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i2c66f45a22194ea1bd25a835ded92b94_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS0zLTEtMS0yMzI1NDc_d7d760a2-e72c-48e1-a0ac-2d53f5519bc9"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i6c46b634040b42af82927fa3b3a9c69e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS01LTEtMS0yMzI1NDc_3cac11a5-5d4f-4196-915d-312fe8e4494c"
      unitRef="usd">2366000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i6c46b634040b42af82927fa3b3a9c69e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS03LTEtMS0yMzI1NDc_42a82e9e-c343-47e9-a5b5-a5aa4c90a220"
      unitRef="usd">89000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS05LTEtMS0yMzI1NDc_9991ae85-0a32-4dda-bb0a-2e30a66a02da"
      unitRef="usd">2383000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="ib08b48c8d45a411fadb58b9f97850fbb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfOS0xMS0xLTEtMjMyNTQ3_ce23dc22-63a1-4caf-bfac-40250ae86acf"
      unitRef="usd">90000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtMS0xLTEtMjMyNTQ3_d83d6f21-43ac-4ebb-9e7d-0b7fcd1f8041"
      unitRef="usd">515000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2657b2a0824346879b134134d44a0a15_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtMy0xLTEtMjMyNTQ3_eda56d54-f881-4b5e-a357-5ef7f340ca99"
      unitRef="usd">40000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtNS0xLTEtMjMyNTQ3_77b1976b-6545-402c-b262-bd62958fc823"
      unitRef="usd">16431000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i8ff23176b1c647b08e43d79fec054b16_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtNy0xLTEtMjMyNTQ3_a955bea7-c700-4281-9f85-378f8942a3b5"
      unitRef="usd">1353000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtOS0xLTEtMjMyNTQ3_0e8401c2-9269-4b7b-9534-9d94ec2eb420"
      unitRef="usd">16946000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjljZDQ1YTMzOGM4MTQ5Y2I4ZWJjM2VlMDQ0NmU3NWIyL3RhYmxlcmFuZ2U6OWNkNDVhMzM4YzgxNDljYjhlYmMzZWUwNDQ2ZTc1YjJfMTAtMTEtMS0xLTIzMjU0Nw_5427458b-3467-4836-9662-8d59a004d499"
      unitRef="usd">1393000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIxOA_e0a013e3-a832-4555-ab63-9cbce857cb3a">During the three months ended March&#160;31, 2023 and 2022, the Company had the following activity in its mortgage loan portfolio:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMi0xLTEtMS0yMzI1NDc_21da16c6-b2d6-4ae8-a54b-b773ca265ac7"
      unitRef="usd">55000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMi0zLTEtMS0yMzI1NDc_eeda3149-1492-4747-9fdf-1520747f4bf3"
      unitRef="usd">59000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMy0xLTEtMS0yMzI1NDc_c3f89e39-0c53-4f4c-b0e8-b906a29f0ed5"
      unitRef="usd">14000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfMy0zLTEtMS0yMzI1NDc_3227a19c-780e-4032-be44-39e344dc4778"
      unitRef="usd">35000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfNC0xLTEtMS0yMzI1NDc_1642d1dc-d251-4745-9a0b-53151877cc32"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ia88b843c07924a7bbb87112e6d7b5b9e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjc1OGJmNDBjMDY2ZTRiYjViNWFmOGNhNTcyMTE1YTA4L3RhYmxlcmFuZ2U6NzU4YmY0MGMwNjZlNGJiNWI1YWY4Y2E1NzIxMTVhMDhfNC0zLTEtMS0yMzI1NDc_83c0dfe8-5a6f-4724-bbb1-748e924cbc97"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIzMw_eb180404-8196-4c80-bb7e-8c7a15290a7c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at March&#160;31, 2023 and December&#160;31, 2022, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie7071e99aae74c26818ee4fc1078006f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0xLTEtMS0yMzI1NDc_bb7010c3-505a-4201-90d9-7e6c78ad3792"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3f338d30818a45c8b71f0f0dbd66b6d2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0zLTEtMS0yMzI1NDc_21f98abc-4d56-4613-b4f9-f0670d0610bd"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i61edd147d4fd41509a556db54902c84c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy01LTEtMS0yMzI1NDc_4879a36e-7ce3-4e7f-bcea-320d9ffdc24b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i36bbbfa3da2b4326bc60719fa6fd45ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy03LTEtMS0yMzI1NDc_fe3603d0-1b51-4c34-b72d-6118fffd92b8"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib52a1527e7b349ec89e29f3f0ba90ad4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy05LTEtMS0yMzI1NDc_cc6294a5-973d-4f68-b77c-a8ecf83e064f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i71d3db81712f4239be8f0051d1d897a8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0xMS0xLTEtMjMyNTQ3_ea4d421f-b675-46a6-8635-a339bd057467"
      unitRef="usd">14000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie97b341035254171803036112d834dc3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMy0xMy0xLTEtMjMyNTQ3_14e18b63-94c6-4966-8667-dabd400bbebe"
      unitRef="usd">14000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaf9687fc8f6c4d6db21b6785089b7e8f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0xLTEtMS0yMzI1NDc_39df154c-167e-4743-aa87-b194713a98b7"
      unitRef="usd">44000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibfdc0c8d72f342cb92f5fc2b1a42d622_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0zLTEtMS0yMzI1NDc_db147679-32df-4fd8-addd-60daaa88ede5"
      unitRef="usd">333000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i64f1950f0b744460b168ac0882235a7a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC01LTEtMS0yMzI1NDc_75df5da5-9e41-4d0e-a834-b44430a869af"
      unitRef="usd">248000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i68d8282968274787bf68cd11594aa0c5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC03LTEtMS0yMzI1NDc_29dfd217-fc89-4bb4-a324-531f13198a73"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if11186980b9e4cf698fbb8587274f2dd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC05LTEtMS0yMzI1NDc_70d5ccc5-4666-482d-bdb6-1b0239ffaf16"
      unitRef="usd">11000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie3bda5d9087a4425bd1f312345cf6dcb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0xMS0xLTEtMjMyNTQ3_60aef6bd-1b55-45e4-aa99-32b7cc0fe232"
      unitRef="usd">385000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia26be39686ba45b1acebc43952d4c3e3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNC0xMy0xLTEtMjMyNTQ3_593781ce-6d56-4c5e-87e1-3adcba79b664"
      unitRef="usd">1057000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ied1ab1eca1634f0698b6d31cd0ccd36a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0xLTEtMS0yMzI1NDc_32184752-8dfa-4f0a-b43a-286594c1fa3f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib7ae3ae19a3841afaf0cd279b4c39bbe_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0zLTEtMS0yMzI1NDc_81d9974d-2d86-408a-b979-eb762ce5e55d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i56aa2cf3462544d8979682eaef70c07f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS01LTEtMS0yMzI1NDc_a73eb97d-3ccc-4d94-9c58-fc9219261f6e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i539fd33dac17452e8380f33c7328399a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS03LTEtMS0yMzI1NDc_c8904b58-cb7d-423b-8df3-80eef35a2bf9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2310718e6df44f9ba6d23f2c10ce4f28_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS05LTEtMS0yMzI1NDc_e81a14f4-b3ec-4423-bb39-44cd3e54d7c6"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0a0c27fd53e74ac09581adda8572f037_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0xMS0xLTEtMjMyNTQ3_7cf988cf-555f-4058-bd1d-a67eeb5a0e6f"
      unitRef="usd">6000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9dd736e093284b1f90094c25759f3a5d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNS0xMy0xLTEtMjMyNTQ3_0eacd9b5-1202-4f91-8618-56b8888e9103"
      unitRef="usd">6000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie4a7c42e398848ce8ae91911c305983e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0xLTEtMS0yMzI1NDc_38624eb3-e12a-491c-b731-5da0ecd5193f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2d25dd9c66fa49e183749b9de751d7ac_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0zLTEtMS0yMzI1NDc_031b1df8-1033-430b-99b6-6d175af5967f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibcaa27ca17db4c80894a80bd3c652fd5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi01LTEtMS0yMzI1NDc_e630dda8-a407-4a28-bb33-f38b27d0c479"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4d38be3dbd9f47b1a656a54014fe335e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi03LTEtMS0yMzI1NDc_ec8ec307-9f20-4a33-9221-a79c281445f7"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0a81db5279004ab98255bc257a8b932a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi05LTEtMS0yMzI1NDc_6627a925-e843-473e-a79f-f607e4d58688"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iddee2adad35a4a8192069f6cafdf1201_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0xMS0xLTEtMjMyNTQ3_c842b0f8-ac18-4c73-a115-aadc1c04b2f1"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0ccefd85418d453d9737f46e41f5fb23_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNi0xMy0xLTEtMjMyNTQ3_0e06891f-ff02-466d-84f4-d3081160601e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibfed1454e7274af982d6b45ba703168a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0xLTEtMS0yMzI1NDc_c3d898d3-5d10-45c0-92a5-aa97935872ce"
      unitRef="usd">44000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i57fe3eeb911349678a7bf8df45f05778_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0zLTEtMS0yMzI1NDc_d8453aea-87d4-4237-858c-e1a0fc347071"
      unitRef="usd">333000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9e26089b884345fc8d7fc1a31ebe1941_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy01LTEtMS0yMzI1NDc_08bdade8-4b5b-498f-80d7-a37297f46af0"
      unitRef="usd">248000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icdbe7e2001e5451395afcf0f04039747_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy03LTEtMS0yMzI1NDc_10a0c444-70c9-4304-99a4-ce51534b3da2"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifbcc5f5ebbc94676a14ee20dd1d88ee3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy05LTEtMS0yMzI1NDc_7dd01fe1-7607-4bf4-ac0d-e99304dbc310"
      unitRef="usd">11000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i44d3af566c97447eb29044226498a483_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0xMS0xLTEtMjMyNTQ3_b55b5e22-ab59-4c7a-9e46-567d8ef671ea"
      unitRef="usd">405000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8a07081ff1e147c7b62955fae3341f9c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfNy0xMy0xLTEtMjMyNTQ3_875daea2-2a28-451c-b2c8-8e72ab90804f"
      unitRef="usd">1077000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icc787c3d87de4e529b1a1214d25dd219_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtMy0xLTEtMjMyNTQ3_777999a8-93c4-4f8e-941f-73ff563a14c5"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i42cb4a9358d245a9b06a8c263fbba453_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtNS0xLTEtMjMyNTQ3_9baa9c72-daf4-4084-82bb-c5297609e4af"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i639de7dfa3ed4105824a383022ae604b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtNy0xLTEtMjMyNTQ3_6500356f-4305-41b3-9b11-1f978c85ee14"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i16e3d483e0784d668c5fcccc53c0c0c4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtOS0xLTEtMjMyNTQ3_71598cba-af3b-4255-940f-40e7a0e3a3e6"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i27fd2cc36f7841a7931db67ed478f1d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtMTEtMS0xLTIzMjU0Nw_28858b8b-8e80-4a29-8803-f6faea3ecbd2"
      unitRef="usd">15000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i925fade534304e14aa08d9d00d456adc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTAtMTMtMS0xLTIzMjU0Nw_f53228e4-63a7-4f01-8350-46d83075ac89"
      unitRef="usd">15000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1f043b01d8c84596bf6c16f669ae0033_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtMy0xLTEtMjMyNTQ3_b4f2ce76-2354-46e8-89f3-5086809c1fd4"
      unitRef="usd">326000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7f1f3e2b054b410ebbfba28ae8d5bf9c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtNS0xLTEtMjMyNTQ3_944070fa-101d-44f7-92af-0b30cc48c68f"
      unitRef="usd">247000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icb7b70ddd11a47b5b376a5b3fbcfc34a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtNy0xLTEtMjMyNTQ3_49c855ab-348b-4619-8ea5-c1687474af65"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifbb066670e8741e7b46db0c89fb8f532_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtOS0xLTEtMjMyNTQ3_ca9760a3-3974-4b05-917f-9add52ebd2cd"
      unitRef="usd">11000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0c073aee648d483b8b99e031c637e88d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtMTEtMS0xLTIzMjU0Nw_9e064490-db55-4c69-8c69-2c57bc43134c"
      unitRef="usd">402000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i785a7204a25949809c4a78f9d83a56fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTEtMTMtMS0xLTIzMjU0Nw_76f4a20a-73ae-4188-b01b-5084136379aa"
      unitRef="usd">1022000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4727e084447d41309188d3fa8292bd52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItMy0xLTEtMjMyNTQ3_3f2a285f-445c-4613-b9da-30775067302a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9145c1132d8f4904bd34c706c2b8da19_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItNS0xLTEtMjMyNTQ3_b6fc477d-38dc-4160-9630-3348e9ef6fe9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib210e2369b7443789e3ea95a893fa4a4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItNy0xLTEtMjMyNTQ3_cf35d686-3cbe-4fc1-90ac-fdfe2df971dc"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i388162eb095246c8ae3b452b6fb6d79d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItOS0xLTEtMjMyNTQ3_d560b360-6979-41b1-aef1-1d17a5bbd208"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i30017e91965849e3b86010cef96f9638_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItMTEtMS0xLTIzMjU0Nw_4be3aafb-4299-464c-86d0-89a57c8bd906"
      unitRef="usd">7000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6302cce667044a7c840558fd40b16281_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTItMTMtMS0xLTIzMjU0Nw_15b7f1d6-ade5-491d-a278-13188c9a432d"
      unitRef="usd">7000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7156bae6dfd14a4c86bad30abbbff44b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtMy0xLTEtMjMyNTQ3_e060ea4d-10be-4ea3-9015-99b06f51d7cf"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3cd294f5249d4543b203a1badf1bd045_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtNS0xLTEtMjMyNTQ3_ce69274e-2e10-4190-8e3e-7971eafdef61"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4d2723b92ac44880b50abda5a89b505e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtNy0xLTEtMjMyNTQ3_0b067acd-ff9b-4e35-8515-9aeb458759c4"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i47b68ae2c1f64fd19f95c3e5bd640eb1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtOS0xLTEtMjMyNTQ3_14d94088-bd46-4d4b-bdcd-429f2fa1fda4"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id9e6f409f64046f1a01d80570a92c6dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtMTEtMS0xLTIzMjU0Nw_9429321e-ff6a-4769-9a72-432e5016e3e4"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1a992fa5adc941b1a529b3cf351ef331_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTMtMTMtMS0xLTIzMjU0Nw_be8d1b7e-1db5-4fb5-8ab6-814fa31caa5c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icc1567be7a7f4866ad74e7c9bc298305_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtMy0xLTEtMjMyNTQ3_043bb2b1-a4b0-413f-acb1-816f2522eb2e"
      unitRef="usd">326000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i001598a6451343debc1eff9c7e4e32c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtNS0xLTEtMjMyNTQ3_dd238167-5e84-434d-94c9-523a72ee3392"
      unitRef="usd">247000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2962e842fe1042c48b78d2a92f8ba363_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtNy0xLTEtMjMyNTQ3_1e61ae51-b4b8-4d0a-8001-c0f607e1c0c7"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i63617743472146bca1ddf9b17d4cd4c9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtOS0xLTEtMjMyNTQ3_c2c0ad21-47ed-4a35-948f-9a8d57ba4cfe"
      unitRef="usd">11000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icd1a57a9ec4148a9907fb88d8b662710_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtMTEtMS0xLTIzMjU0Nw_71c1f259-8977-41bb-81fe-09ea2d9b3aa2"
      unitRef="usd">424000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i913e95c8d14844cab43aae1b5ee9d5d7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjFmY2MyNTI0MGZlYzQwZjhhMmNhNjQ1MTcxMWFkZDhhL3RhYmxlcmFuZ2U6MWZjYzI1MjQwZmVjNDBmOGEyY2E2NDUxNzExYWRkOGFfMTQtMTMtMS0xLTIzMjU0Nw_d72634ee-368a-41ba-9838-420707a8ef5e"
      unitRef="usd">1044000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTIyOA_60b46f5e-beb3-46a7-bad7-8b51fa3a6f83">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include the reversal of previously recorded credit-related impairment losses on debt securities of $1 million and yield-related impairment losses on debt securities of $24 million in the three months ended March&#160;31, 2023. Net realized capital losses include credit-related and yield-related impairment losses on debt securities of $38 million and $18 million, respectively, in the three months ended March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $8 million and $9 million for the three months ended March&#160;31, 2023 and 2022, respectively, related to investments supporting experience-rated products.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i1b1894678fde443f82f89be4a6696366_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMi0xLTEtMS0yMzI1NDc_dcb7c11c-baf7-4c98-ba28-653207799c75"
      unitRef="usd">191000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i8265c25c9ead4bd99cf15809d148a000_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMi0zLTEtMS0yMzI1NDc_ec95efd5-7f9c-4213-a6c4-d8a39df1666a"
      unitRef="usd">164000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ibb917855ecff45e8a8e787e07790f532_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMy0xLTEtMS0yMzI1NDc_c62916e5-ef43-43ad-b44d-93f1e20263b0"
      unitRef="usd">13000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ibec14ebc629645989483a19e0343e21c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfMy0zLTEtMS0yMzI1NDc_8aab1345-61a8-44b6-9503-ec751d259660"
      unitRef="usd">11000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i88836880a6c74131ab0d5e56774644d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNC0xLTEtMS0yMzI1NDc_e46d81ae-5b90-4e37-8e42-303314d46858"
      unitRef="usd">245000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia3b7647c520143b2b49538ae9a39be8e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNC0zLTEtMS0yMzI1NDc_cb10d7d7-c323-4980-a6d6-c1d188c67e0c"
      unitRef="usd">77000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNS0xLTEtMS0yMzI1NDc_38a6155a-20d0-40c8-9227-4c8256f81f1f"
      unitRef="usd">449000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNS0zLTEtMS0yMzI1NDc_398bbb30-6bae-48b7-bea4-a24134ede367"
      unitRef="usd">252000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNi0xLTEtMS0yMzI1NDc_8e87e53c-1330-40ed-bbed-3ef034d37dbf"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNi0zLTEtMS0yMzI1NDc_7f9b79d5-e339-424f-bd7b-337a8835fc84"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsOrLosses
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNy0xLTEtMS0yMzI1NDc_d37591bc-f184-4b01-9406-e74473419bb9"
      unitRef="usd">439000000</cvs:InvestmentIncomeExcludingCapitalGainsOrLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsOrLosses
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfNy0zLTEtMS0yMzI1NDc_c90fa4b5-474c-4a8c-a5c5-21a5f1935378"
      unitRef="usd">243000000</cvs:InvestmentIncomeExcludingCapitalGainsOrLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOC0xLTEtMS0yMzI1NDc_d38b3ae4-dd50-4bc9-9264-52d7bebc7326"
      unitRef="usd">-105000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOC0zLTEtMS0yMzI1NDc_22a18566-b27d-4805-bdd1-5f552460a573"
      unitRef="usd">-75000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOS0xLTEtMS0yMzI1NDc_6cbe520a-87da-46d2-806f-b2b99e544bbe"
      unitRef="usd">334000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjk5YWIxZTc3ZTZlZTRlYWY5YzQ5MDZjMzhjOThjYzU1L3RhYmxlcmFuZ2U6OTlhYjFlNzdlNmVlNGVhZjljNDkwNmMzOGM5OGNjNTVfOS0zLTEtMS0yMzI1NDc_4babc542-50d9-4db3-a731-eedd23a4e774"
      unitRef="usd">168000000</us-gaap:InvestmentIncomeNet>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMTA5OTUxMTYzNDMxNA_a8061136-07eb-4fc2-be08-67e4993bded4"
      unitRef="usd">1000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNDE5Ng_71727d15-0c42-4053-9a93-91e6030cf0b4"
      unitRef="usd">24000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMzI5ODUzNDg4OTM2MA_3f0a7fe3-3642-4fd5-a292-3705e4177fe6"
      unitRef="usd">38000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNDQ5Mg_3f7ad8f6-ff9f-47af-9377-cd35dae54ce5"
      unitRef="usd">18000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="i8ebc837ea9594ee285981ba3f282c096_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNDc3NA_5fe1751f-a3ff-4582-9b79-20b708431286"
      unitRef="usd">8000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i1dbe5953d7534e6b8caf8d57ca5ede7b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfMzI5ODUzNDg4OTQxMg_96ea9b1d-e291-4ce1-8371-d9fcc61a5218"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RleHRyZWdpb246M2YxNzlmOGZkMTExNGQ0N2E1ZDExN2E1M2U2YmM0ZjBfNTI1Nw_2c49a347-4452-4b64-816c-31380a17082e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMi0xLTEtMS0yMzI1NDc_af9157cc-90e8-477f-a30b-c3745bef1cad"
      unitRef="usd">1341000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMi0zLTEtMS0yMzI1NDc_bcfc52cf-9fa1-4813-9bc2-756453c8d575"
      unitRef="usd">1911000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMy0xLTEtMS0yMzI1NDc_bf47d436-60ff-496f-a3f3-837f7acd6d95"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfMy0zLTEtMS0yMzI1NDc_7906cfd8-e8fd-4684-8716-5ea1548c55da"
      unitRef="usd">14000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfNC0xLTEtMS0yMzI1NDc_61ab2b28-973c-44e6-bb7d-37a2f2cf6504"
      unitRef="usd">111000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80My9mcmFnOjNmMTc5ZjhmZDExMTRkNDdhNWQxMTdhNTNlNmJjNGYwL3RhYmxlOjQyMWQyN2ViNzMyMjRmZGJhNmNhYmJkZTg1ODQ5NGMyL3RhYmxlcmFuZ2U6NDIxZDI3ZWI3MzIyNGZkYmE2Y2FiYmRlODU4NDk0YzJfNC0zLTEtMS0yMzI1NDc_c03c3c5e-734f-4736-981b-7cb0e8be9b7a"
      unitRef="usd">35000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ2MA_2e68e570-7d95-4242-a40c-e47460605bd3">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#x2019;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#x201c;Fair Value&#x201d; in the 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 or December&#160;31, 2022. Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes cash and cash equivalents of $7&#160;million and $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, there were $29&#160;million of transfers out of Level 3. During the three months ended March&#160;31, 2022, there were $3 million of transfers out of Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMTQzMg_0423879c-e13a-4882-afdd-12e54277a2e7"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMTQzMg_ec3895dc-4a04-4fc8-a4f9-32d8e37ae124"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ3MA_d4c4cd7e-d3c7-45ec-83ad-b08fcdb4b8b1">Financial assets measured at fair value on a recurring basis on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes cash and cash equivalents of $7&#160;million and $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the unaudited condensed consolidated balance sheets at March&#160;31, 2023 and December&#160;31, 2022, respectively. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi0xLTEtMS0yMzI1NDc_995ac011-0e38-40dd-a35a-7cfd21998aa2"
      unitRef="usd">5946000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi0zLTEtMS0yMzI1NDc_b1554feb-fd9b-43d2-a42b-e3b9e30b92f7"
      unitRef="usd">8679000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi01LTEtMS0yMzI1NDc_8641cee2-5bf0-42ba-ace7-7a62c47abdfd"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMi03LTEtMS0yMzI1NDc_42ce1176-83e3-4ae7-bdd0-625d8b91c300"
      unitRef="usd">14625000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib2cc79aa32c24877bb38fed7bb662b80_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC0xLTEtMS0yMzI1NDc_0ee6658f-79d5-4147-aca3-4a86747ebbcf"
      unitRef="usd">1903000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i940d96b554da411a9cba8e0f8ac4b3f8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC0zLTEtMS0yMzI1NDc_81c5ed1b-53f0-448c-bc07-bcc49b974b3b"
      unitRef="usd">32000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibccf07ea07e5473386720165a8d80e66_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC01LTEtMS0yMzI1NDc_e32062cb-ee7f-4e91-a0c3-f9685c1b4c86"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f12a0b1caec43ed8a5cff4d6a9e3476_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNC03LTEtMS0yMzI1NDc_afa73399-0f37-4242-b5d7-fcf1815c84b2"
      unitRef="usd">1935000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9cfa4161feae48dab889801774d4b2e6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS0xLTEtMS0yMzI1NDc_c5e9e680-0723-4916-950e-f309fe3dac94"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i41f3cbe1cfcb4a5f9a47d208546e9394_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS0zLTEtMS0yMzI1NDc_c8a2f156-7498-4e0b-9519-52fa0b2e12b7"
      unitRef="usd">2254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1af15065f24c48d597eeba3d21822866_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS01LTEtMS0yMzI1NDc_65ad001d-67c2-4bad-b3b4-52d762a9f18e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i018e0921466c4187bd61ec7f759a162b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNS03LTEtMS0yMzI1NDc_99f06be3-17ae-4cc6-8b66-88e5e8e36840"
      unitRef="usd">2254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i36c8746221ad488b9529c5494d1ea6ec_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi0xLTEtMS0yMzI1NDc_d76cd6d3-6e2b-4953-915e-1ea9066b587b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iffa81968af7b42edb313c43eed5dac3b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi0zLTEtMS0yMzI1NDc_7c31dc74-d3f9-43a1-80cc-4a3e6a2ec601"
      unitRef="usd">9332000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i13000e7829fd4c77a7fd14783d62bd3f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi01LTEtMS0yMzI1NDc_70f29d68-7f11-4818-9884-09b131dba0da"
      unitRef="usd">32000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iff376ec3f339421eb5832e29861ce655_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNi03LTEtMS0yMzI1NDc_44b94a27-2f82-4039-8457-1a2b2b25ec86"
      unitRef="usd">9364000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0a515693d5ce41788531f520d6f67ec0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy0xLTEtMS0yMzI1NDc_8233ca37-8bbe-4d7c-83bb-ab1cd8f14162"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie41a3c6e1c99451a98b32769c140d8ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy0zLTEtMS0yMzI1NDc_867ff00e-ced6-40a6-b0c0-496c59cf1751"
      unitRef="usd">2584000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic1fb2239301f45369894d81b5bef30af_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy01LTEtMS0yMzI1NDc_c14f2833-7fe8-490a-b187-8a4c681b1d2d"
      unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75ddde48bac0413a905db67674a8e7bd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfNy03LTEtMS0yMzI1NDc_9b3e9711-8c66-4e35-a179-c9cf005484a3"
      unitRef="usd">2592000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i638494ab1b4746019b02aed9c1bf8d9c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC0xLTEtMS0yMzI1NDc_19db1e18-dbe6-447d-8b94-302e57010d3e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4104a3224bf9493180199848515bb756_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC0zLTEtMS0yMzI1NDc_5bf03667-99ac-4d03-9ece-3899528f64ad"
      unitRef="usd">812000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5bfdfa7a6f4b458dbd8ae201cba1db28_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC01LTEtMS0yMzI1NDc_bcf4ef38-b7bb-42be-9b9b-528c669338a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e4d1e5638a949eeaec6c1e059aa2887_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOC03LTEtMS0yMzI1NDc_3cf9e573-fb10-4a28-8684-eadbac045dfd"
      unitRef="usd">812000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b1abdb4a43b4e52a6d8356ebe217244_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS0xLTEtMS0yMzI1NDc_b8e572d3-605c-4d31-a5ff-bb2ebae805c8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie2e5e884e58f40ecb2c2247c7abe2f3e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS0zLTEtMS0yMzI1NDc_6f8b1548-eef7-427d-ba8e-2a7eab730655"
      unitRef="usd">1015000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic203ee5d324b425a8a68bfeed0a05433_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS01LTEtMS0yMzI1NDc_df73eeab-513a-41e0-9b2d-4747950424a6"
      unitRef="usd">13000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id123001a7f8d495091ca8cf8640c1149_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfOS03LTEtMS0yMzI1NDc_7e3b0059-e20c-4de3-b2d4-971f0ee64d6f"
      unitRef="usd">1028000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae365fa794744d8889721900ea6b2235_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtMS0xLTEtMjMyNTQ3_ab800852-5d32-4b47-ae15-d77105f6e84e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2c5c14abc11642c596325a01b162322f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtMy0xLTEtMjMyNTQ3_018313fa-5370-4ed0-9e6e-80b5c69d17c8"
      unitRef="usd">2818000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0d88303b2f434c308ad61792e9ee3b36_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtNS0xLTEtMjMyNTQ3_2b937388-e9f2-41ce-ae91-4edc603c13f1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie608b61ad1604ca986c8862e56a56332_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTAtNy0xLTEtMjMyNTQ3_a4bb6d08-cc60-42c9-bbc3-3e064602c9b6"
      unitRef="usd">2818000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i86995cf6b1d84d179178e116a1a20f11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtMS0xLTEtMjMyNTQ3_b8320612-e171-4a94-9008-498efc514c6f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia6cd9790208a42bea5215d04c5eb3401_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtMy0xLTEtMjMyNTQ3_48462719-2f6c-430f-b25e-0a8951053351"
      unitRef="usd">19000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2bc5a5cd534c4f698abae8407f367bcb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtNS0xLTEtMjMyNTQ3_2bf155d2-268a-485c-bdda-150422987562"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i54953c6cd4614dc1ab7325d790cf34e5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTEtNy0xLTEtMjMyNTQ3_3dbda148-ad5b-4e84-8d5f-cb6cb5e5626a"
      unitRef="usd">19000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItMS0xLTEtMjMyNTQ3_c5c98022-1b36-4a61-960b-740a5c0acb68"
      unitRef="usd">1903000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItMy0xLTEtMjMyNTQ3_42605a4a-6dc2-4406-b69f-f125d6e3cd17"
      unitRef="usd">18866000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItNS0xLTEtMjMyNTQ3_24b67373-6e3a-4e8d-b1c1-1138c225bb69"
      unitRef="usd">53000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTItNy0xLTEtMjMyNTQ3_05138cc4-5101-4b46-921b-ea38257d84a2"
      unitRef="usd">20822000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtMS0xLTEtMjMyNTQ3_a416015c-dc24-43a6-a07f-59cba7267322"
      unitRef="usd">168000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtMy0xLTEtMjMyNTQ3_f9ff1ef9-cbf3-4e7c-bc99-4199907a0391"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtNS0xLTEtMjMyNTQ3_998cec4f-5a71-47e3-a5ad-c67fae9b39a7"
      unitRef="usd">66000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTMtNy0xLTEtMjMyNTQ3_3d7f9da9-adb2-4ec2-8aee-192fb48eaf18"
      unitRef="usd">234000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtMS0xLTEtMjMyNTQ3_115dccfe-0682-4160-92ad-9b9050de4a9b"
      unitRef="usd">8017000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtMy0xLTEtMjMyNTQ3_0bce2b67-512d-459e-8dc4-cf22e2cb4d73"
      unitRef="usd">27545000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtNS0xLTEtMjMyNTQ3_dc47820f-3d80-42a4-a300-23996247a7e2"
      unitRef="usd">119000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTQtNy0xLTEtMjMyNTQ3_00158a63-15a3-43bf-93eb-b8221305e18b"
      unitRef="usd">35681000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctMS0xLTEtMjMyNTQ3_61b8b828-40e2-4085-953e-5d805fc6da00"
      unitRef="usd">6902000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctMy0xLTEtMjMyNTQ3_899fa51c-c53a-4eba-8dc6-b0711421fba4"
      unitRef="usd">6049000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctNS0xLTEtMjMyNTQ3_9d44b902-477d-4fb0-971b-9fd066517b82"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTctNy0xLTEtMjMyNTQ3_f41c5747-562f-4121-944b-176e2683910a"
      unitRef="usd">12951000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4e187738c64a4f819165a5dd65b86de2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktMS0xLTEtMjMyNTQ3_3242a309-9a98-4189-a004-7ab49f0f279e"
      unitRef="usd">1860000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifb701bf9661948ebac5ec92842c42cd1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktMy0xLTEtMjMyNTQ3_fad0d25b-f820-4def-815d-0da32c44600e"
      unitRef="usd">32000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20104417b40c467083117d2e267a0d8d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktNS0xLTEtMjMyNTQ3_d656a2e9-00ee-47c7-811b-52245556d36c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i38b061f9764a45d58ce926b44ad26d44_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMTktNy0xLTEtMjMyNTQ3_8d078e90-b75c-490b-bbb6-20b87ddfa860"
      unitRef="usd">1892000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8c1a5f7cda7b418fb2105151c6cebdd9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtMS0xLTEtMjMyNTQ3_6e1309f2-0604-4ea8-9f06-188c30afb6dd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5ac657fdf5ab45fdbf03530b75c2f55a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtMy0xLTEtMjMyNTQ3_50e39989-5a26-449b-b455-e84fbae6063d"
      unitRef="usd">2272000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i442caee6095c4be4950552f634b6d7a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtNS0xLTEtMjMyNTQ3_bc5d6780-307f-4a45-b421-56301d86bdcf"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e51a45df88d476ab23a4e8b55ec1e22_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjAtNy0xLTEtMjMyNTQ3_4c35dc59-ffba-4926-a666-c0f70e809e8e"
      unitRef="usd">2272000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie42c87aeb9a142048b4d45e04a53dabf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtMS0xLTEtMjMyNTQ3_67b449ce-0239-470f-bf1c-b4bcbcdeda22"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i58584562df924c35a92246868059ade9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtMy0xLTEtMjMyNTQ3_e3d2c364-1a9b-4181-a005-cd4bcd7183c4"
      unitRef="usd">8897000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i180e642f281a4428bccbf1a1d28a4863_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtNS0xLTEtMjMyNTQ3_c53b59dd-323b-4431-ba4b-04a0c67ddec8"
      unitRef="usd">61000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if96a5d0edeea40438700b57fea0592cb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjEtNy0xLTEtMjMyNTQ3_63bf85bf-407d-4441-8543-ae64e5cc9efa"
      unitRef="usd">8958000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i66a3623a5b404531b6aaf3bc4355290f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItMS0xLTEtMjMyNTQ3_c3cf09f3-6399-441f-aa13-a4c1e3d339ef"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9130e432ea74b33b7edc370ab5d3ac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItMy0xLTEtMjMyNTQ3_319ae022-6cf9-4aee-bb69-e8ce48db8773"
      unitRef="usd">2542000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d5e7a806a404590beb00542a88de708_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItNS0xLTEtMjMyNTQ3_b149c71b-53e2-4e6a-b87f-70d860ce80e0"
      unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6a0a094fa23b4862beaf7cd2379edd3a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjItNy0xLTEtMjMyNTQ3_ae93f5d6-425c-42f0-b1c8-e9a3c5914628"
      unitRef="usd">2550000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9302529dcf26467bbd2db62d902d4ad9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtMS0xLTEtMjMyNTQ3_c82b81f8-2926-47ff-b714-dff81387145d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9c7d300ceec143fb95566216335aac05_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtMy0xLTEtMjMyNTQ3_81f2512c-72b3-4020-8967-39310fb0149a"
      unitRef="usd">757000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic966dffda67f45128f343cfed0076de3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtNS0xLTEtMjMyNTQ3_2fbc6125-706d-49fa-8df2-7ffe91397eae"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1dadf84326ee476a8256a97b1954777b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjMtNy0xLTEtMjMyNTQ3_09b6517a-d2aa-4529-a37e-5a37da52c963"
      unitRef="usd">757000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29e69bfca3ac4909baeee8e3bb375ac6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtMS0xLTEtMjMyNTQ3_d8f3c9e9-b531-4927-b8fb-0b844294f100"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i51e7e9cfafd4471d888f09553e3a8397_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtMy0xLTEtMjMyNTQ3_8b3c375a-2e51-477b-9fda-5413aad13a75"
      unitRef="usd">1018000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i711edb971fdc4948ae77077c034cd4f3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtNS0xLTEtMjMyNTQ3_61387284-055e-4fc7-96cd-27101aca45ba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05330bee1a9f44669bc7deddcd19520f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjQtNy0xLTEtMjMyNTQ3_935bce31-bf60-4426-95aa-bfe24471cb03"
      unitRef="usd">1018000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i65d6560e9fbc4acf849607bd7a325af1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtMS0xLTEtMjMyNTQ3_623b9cdc-0d2c-4633-874d-06867ebb1e94"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i367940a0c0de44c9bc97abafd36441db_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtMy0xLTEtMjMyNTQ3_eb13f1a5-679f-4fb7-ada0-8323f95e120b"
      unitRef="usd">2810000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b59adf13cdf461f9fe4939c39d5a82f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtNS0xLTEtMjMyNTQ3_cd04670f-3f75-406b-9ec4-8ac5529ef22f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3db4636fab2045e79a50da511dac639e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjUtNy0xLTEtMjMyNTQ3_128c76c0-8525-42ab-975c-beb5474d9b70"
      unitRef="usd">2810000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib837b245fbf5401cab8f7e03d387b150_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtMS0xLTEtMjMyNTQ3_f9eb2db3-eab0-4f90-8886-c06375d45e22"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03c3faf213d24ed792c56ec2ff526497_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtMy0xLTEtMjMyNTQ3_21e1347b-3a7f-4f26-861c-16723bf33bd4"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i152425578ab245479d4240084913937c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtNS0xLTEtMjMyNTQ3_aaf68761-779a-4d85-82f2-8d1d29a51bad"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d385b28a05d4c32befb019eea226fb0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjYtNy0xLTEtMjMyNTQ3_cae8b68e-9596-4441-b2e6-cfed942ed92b"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctMS0xLTEtMjMyNTQ3_dc23117f-4627-43e7-8f18-d30c7231cca8"
      unitRef="usd">1860000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctMy0xLTEtMjMyNTQ3_da93fcb0-0484-457b-ad11-c3190082b29d"
      unitRef="usd">18351000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctNS0xLTEtMjMyNTQ3_d38c4261-5674-4d96-8cf5-fd50ccac7c45"
      unitRef="usd">69000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjctNy0xLTEtMjMyNTQ3_ddaa7e30-d5df-4b5d-9db1-ca0ce11117fa"
      unitRef="usd">20280000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtMS0xLTEtMjMyNTQ3_0ef9af79-bbe7-4d2f-a5f6-c694dae2e24f"
      unitRef="usd">116000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtMy0xLTEtMjMyNTQ3_4a45da89-9a79-43a4-a87b-5ed7c69bdc3c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtNS0xLTEtMjMyNTQ3_934006b5-592b-44a7-9f42-2de43b3740b9"
      unitRef="usd">60000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjgtNy0xLTEtMjMyNTQ3_b010e5f7-21cf-47bf-892e-99e109379ad9"
      unitRef="usd">176000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktMS0xLTEtMjMyNTQ3_d28e507f-0177-48d0-8c55-1366990a9a88"
      unitRef="usd">8878000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktMy0xLTEtMjMyNTQ3_cfd0d86f-ac58-4453-9038-633011886108"
      unitRef="usd">24400000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktNS0xLTEtMjMyNTQ3_13d01ec0-9f94-46e4-aab2-4ef9e5c5cf74"
      unitRef="usd">129000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjY3ZTVjZjQyMDllOTRkYWQ5Y2NkMzM3MTUwODRkMmEwL3RhYmxlcmFuZ2U6NjdlNWNmNDIwOWU5NGRhZDljY2QzMzcxNTA4NGQyYTBfMjktNy0xLTEtMjMyNTQ3_920fbbe0-3c36-4339-8501-5186a0a8aa7f"
      unitRef="usd">33407000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i174f156a210a439ca784589516304147_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMTgwMg_4db89ce4-9266-4553-a736-573d9b427805"
      unitRef="usd">7000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3a8530e6bd584994b387406e0a034c9f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzI5ODUzNDg4NzA4Nw_4cd47b81-37c7-4cc8-b96f-795473f1b2e9"
      unitRef="usd">6000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMjA1Nw_759bddcc-8922-4b62-91ef-2893235eccd3"
      unitRef="usd">29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfNDk0NzgwMjMyODYzNA_59b61a88-ad0b-4bc2-92e1-0da60c8b7aad"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ0NQ_8a052698-67f5-4d2d-9ac2-7a5b54806961">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the unaudited condensed consolidated balance sheets at adjusted cost or contract value at March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.&lt;/span&gt;&lt;/div&gt;(2)Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC0xLTEtMS0yMzI1NDc_e8af2a07-3d1c-4d5d-af33-600d67a86f16"
      unitRef="usd">1077000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC0zLTEtMS0yMzI1NDc_292ee9b6-007c-4280-b51c-05ddb32c7bd0"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC01LTEtMS0yMzI1NDc_35aab29e-d560-4d98-8bc3-746adff23355"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC03LTEtMS0yMzI1NDc_9503e2fb-e664-40f5-90d1-6a00b189c472"
      unitRef="usd">1037000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNC05LTEtMS0yMzI1NDc_e076b33c-6e57-4d32-9bf6-3ba7f1ffcfa7"
      unitRef="usd">1037000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfNS0xLTEtMS0yMzI1NDc_e4f2fc8a-7043-49c9-8062-ea36753aea90"
      unitRef="usd">412000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC0xLTEtMS0yMzI1NDc_3584f258-1118-4767-aada-c85e398d3f76"
      unitRef="usd">2000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC0zLTEtMS0yMzI1NDc_95f66a2c-619f-44e0-a6cb-39fb2855b0ca"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC01LTEtMS0yMzI1NDc_171f1010-6d48-4505-a263-5a55e374f20f"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC03LTEtMS0yMzI1NDc_4c39e3f1-4066-4a56-bec0-6713be288c6b"
      unitRef="usd">2000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOC05LTEtMS0yMzI1NDc_5f4eeae7-e0d0-4bf2-9a19-49ad471709d4"
      unitRef="usd">2000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS0xLTEtMS0yMzI1NDc_9e762ed9-d344-466c-afa4-94476055b749"
      unitRef="usd">327000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS0zLTEtMS0yMzI1NDc_a9fd154f-b628-4c21-aec5-02526eba674c"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS01LTEtMS0yMzI1NDc_aee03fa6-f378-41e9-9db0-1459c0e021b6"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS03LTEtMS0yMzI1NDc_5c0bf962-0b39-4729-8158-17125c5242f3"
      unitRef="usd">300000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfOS05LTEtMS0yMzI1NDc_3afd79a6-9aae-4ac6-9489-61d7191f9a0a"
      unitRef="usd">300000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id949c9b2b95046068211c24d3d40a4e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtMS0xLTEtMjMyNTQ3_9f2f2438-23c6-4ea8-9ea2-a469f253d0e9"
      unitRef="usd">58231000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iba3a036e4bcf4f16ab3c9ddf445b78da_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtMy0xLTEtMjMyNTQ3_385f0b59-3666-42e4-8bd9-221f37b1a52b"
      unitRef="usd">54960000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i95b279c3a46845edac9bcef54ebf51b5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtNS0xLTEtMjMyNTQ3_e4fc0ec1-58f7-4ad8-b287-49075ba373de"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i32a6c5b79d3b425aa0c88c19c841cab9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtNy0xLTEtMjMyNTQ3_eb316bc2-9956-4150-ad13-0f29554a8c99"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id9580fad210c4bd8811feeca4fa82016_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTAtOS0xLTEtMjMyNTQ3_347025a8-36d7-4a4d-89fa-d04545cbf68e"
      unitRef="usd">54960000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtMS0xLTEtMjMyNTQ3_fe4dd7d5-ccb7-4854-9667-45dd3af0c21c"
      unitRef="usd">1044000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtMy0xLTEtMjMyNTQ3_44a3459d-f566-488e-a678-a582148d84c1"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtNS0xLTEtMjMyNTQ3_f7e4447c-6094-45f3-ae80-a9873b90a278"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtNy0xLTEtMjMyNTQ3_0f9e1589-3b89-40db-8529-0dfcd0f56422"
      unitRef="usd">978000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTQtOS0xLTEtMjMyNTQ3_1e9d7418-2134-4258-9525-7755ca0ef104"
      unitRef="usd">978000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTUtMS0xLTEtMjMyNTQ3_e587e4c7-9ed0-4a63-a106-8b4e66dc7cd7"
      unitRef="usd">411000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtMS0xLTEtMjMyNTQ3_67e79668-1195-4c50-a2ce-d4da953c1e4f"
      unitRef="usd">3000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtMy0xLTEtMjMyNTQ3_259db3f7-8c00-4479-8ffb-d85eb88a17b1"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtNS0xLTEtMjMyNTQ3_39b92190-3073-46ff-91a1-e6a2f432a42e"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtNy0xLTEtMjMyNTQ3_87ce3068-155f-49e7-b54a-3a098b6ffbd9"
      unitRef="usd">3000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTgtOS0xLTEtMjMyNTQ3_16d54683-a0f9-4675-9e54-9b0c62e55ec0"
      unitRef="usd">3000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktMS0xLTEtMjMyNTQ3_d109a1e9-506c-49da-8832-7bfec1b85bdc"
      unitRef="usd">332000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktMy0xLTEtMjMyNTQ3_4bb89f4a-b412-450d-8051-a55800c5f95c"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktNS0xLTEtMjMyNTQ3_8907cfe1-ed89-4882-8016-9977f3577cae"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktNy0xLTEtMjMyNTQ3_307904c2-e7ad-4400-bb5f-28e1310f9f22"
      unitRef="usd">305000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMTktOS0xLTEtMjMyNTQ3_30da259d-4333-4470-b110-c27ae85b62ba"
      unitRef="usd">305000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i478a09cc5f3349bdbcdd13d689a1d7bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtMS0xLTEtMjMyNTQ3_e185686f-b7dd-4518-b772-a7af850cc914"
      unitRef="usd">52257000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8e3ce116f77d4736ad8797c395b90826_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtMy0xLTEtMjMyNTQ3_25c5519f-86b3-40a8-ab26-19a0d24d93cc"
      unitRef="usd">47653000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1530c22fff264f3083979c2e12ffcde9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtNS0xLTEtMjMyNTQ3_07f14eef-3177-4fa3-9edb-246c09354ce6"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i35bd935f9c8045c1baaeabbec9492fe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtNy0xLTEtMjMyNTQ3_dfa2dfae-e146-4ee4-8cd7-48a3c1de0eb7"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8cf824a61ec042a2b9b0f1108219276e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOjQ5MmIxYTUyNzVhNTQ4YTZiOTFkZjk3ODYyM2Q0NTQzL3RhYmxlcmFuZ2U6NDkyYjFhNTI3NWE1NDhhNmI5MWRmOTc4NjIzZDQ1NDNfMjAtOS0xLTEtMjMyNTQ3_795a1e9b-9f0f-4597-9bb6-d2075e9227b3"
      unitRef="usd">47653000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibd3f75c2d0b04f1e92ad90c558bfb862_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzI5ODUzNDg4NzE0MA_a80d3ade-b2aa-4330-aff6-987976f28a99"
      unitRef="usd">3000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie9216a5f76034bf488b5c23d00f7740f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzI5ODUzNDg4NzE0MA_e60ecd1d-1606-4a13-983d-e5183893e8cf"
      unitRef="usd">3000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzQ3Nw_d7fed4ad-f85a-4950-b4d2-469f2d2d0ea0">Separate Accounts financial assets as of March&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="i0477daecdf25494cb2366e0b03619181_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xLTEtMS0yMzI1NDc_5f72b135-7ee9-41c4-b4a6-27705a7de240"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i73f84be43c284e9ea81738a715edabe2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0zLTEtMS0yMzI1NDc_7e39dc6a-f176-4811-8013-51b1264a435e"
      unitRef="usd">159000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if6db07e1d8d6441eace2fba24d4330f2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi01LTEtMS0yMzI1NDc_f27f16d6-5618-4d61-85f3-9148174f5d70"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie1683e51a0304fd1b7b78196b6cd714f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi03LTEtMS0yMzI1NDc_d7bf38fc-5eb4-4b1d-8ae9-254a26f56b68"
      unitRef="usd">160000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="idd649305f8964805951ac2c94e102d7e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi05LTEtMS0yMzI1NDc_03aabcb4-7733-487e-9286-9a0fff49eecd"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie82772095666435b8c2ba849a5d87d24_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xMS0xLTEtMjMyNTQ3_1888aa03-d993-42b1-8246-31821629acec"
      unitRef="usd">154000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i243d234bfce84d389bc036ddb4b85c74_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xMy0xLTEtMjMyNTQ3_8994c23d-14e5-4f59-bb73-5d25af13b0ac"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2391cba71e9345508d7ce650a306647c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMi0xNS0xLTEtMjMyNTQ3_39d33856-4cf7-4f83-bf24-d61e4e1a07aa"
      unitRef="usd">156000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i63539f261c8e469cb1db341cc5be5d7e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xLTEtMS0yMzI1NDc_b1368d42-17b4-40c0-84cb-619299ead56c"
      unitRef="usd">699000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i78e7cab3f0f04b0f9ce8ce12e0f930f8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0zLTEtMS0yMzI1NDc_3d93410d-6745-4faf-bd53-1da0192fb3ab"
      unitRef="usd">1946000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2ecb5c351dba4689987a3a609b0cfb43_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy01LTEtMS0yMzI1NDc_728b3673-f40b-4ed4-9534-29c8a9ec0b1d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i767908569cc8444db0b335059e1f47f5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy03LTEtMS0yMzI1NDc_f2c7a04e-68c5-4002-8f01-4f5b979ff088"
      unitRef="usd">2645000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i42367ec111444b5db6d88802bba1dba7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy05LTEtMS0yMzI1NDc_df2620c0-f834-477a-a3b7-ffce3715e43c"
      unitRef="usd">712000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i01151808097d494ea4b5cc15684dc01a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xMS0xLTEtMjMyNTQ3_18eac300-e073-47e3-9692-7550cad001af"
      unitRef="usd">1965000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i64dbb0605566455397f86d75767eabfe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xMy0xLTEtMjMyNTQ3_fe130fe6-6425-4853-8999-846579203db2"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i44e5aacbdfc34e248dd6ad1cabff65bd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfMy0xNS0xLTEtMjMyNTQ3_21e5992f-4342-47a2-bd6c-cdcec496b4c5"
      unitRef="usd">2677000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1f67171bf8fe46e184c0ac18933c3013_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xLTEtMS0yMzI1NDc_45f5ad58-43dd-46a5-b968-71f28650eaeb"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie30887d94add43ff8de3f123add67684_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0zLTEtMS0yMzI1NDc_c28fa29f-0428-4b3c-b541-a067a4d0a6f6"
      unitRef="usd">397000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i963eadfc020e4b0bb4c52e215959124d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS01LTEtMS0yMzI1NDc_6ea0e00e-7451-4469-ade9-2e3010b20cc4"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3739f888e9fa4ab18bf2d985de27fe27_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS03LTEtMS0yMzI1NDc_bbcd72cf-2361-4c02-9026-d9afbda8632e"
      unitRef="usd">397000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib0d351d5ac104a9383183f6130aa4991_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS05LTEtMS0yMzI1NDc_7f3db367-0651-44a1-a2df-1de8a866504b"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2651627654ef4f4c91f509c8eb1bb477_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xMS0xLTEtMjMyNTQ3_5be726f9-2cc4-4645-be64-1bf87e67d245"
      unitRef="usd">480000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i75a146d6f9c44eb0987d661df9a8f498_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xMy0xLTEtMjMyNTQ3_fa88011f-0086-49c3-9e56-c98f2556d233"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia0dca12fc0564290869461416690d5fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNS0xNS0xLTEtMjMyNTQ3_e2bfc200-7b47-41a9-bfb8-ae03fcd1eef0"
      unitRef="usd">480000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2e6a6329197e4602bc28dcb00294a999_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xLTEtMS0yMzI1NDc_a4ca000b-1019-473c-95a7-6aae9d9d75bf"
      unitRef="usd">700000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia8e6d32b155c4b588ef8f74ac700b39c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0zLTEtMS0yMzI1NDc_07256bef-92e4-4efe-aea9-fed5fb6dfbce"
      unitRef="usd">2502000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifbcb7186ed06424e99a7e02812bf766d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi01LTEtMS0yMzI1NDc_06927f3d-08f3-4c91-af7e-85cd2eaf81db"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi03LTEtMS0yMzI1NDc_948cb266-8fda-4b68-8100-658611b4273e"
      unitRef="usd">3202000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8d69ccacd09d405b9d774c898769ad31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi05LTEtMS0yMzI1NDc_707e1ba8-d66d-44f7-b9c0-e6da8bf6e2f8"
      unitRef="usd">714000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic5f28276f9544efdb371f2ddf105d27b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xMS0xLTEtMjMyNTQ3_5247c7b7-aaab-4dd7-9e9d-4bad02e5432f"
      unitRef="usd">2599000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2e915bd1e3b34f25ae6de550809d67f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xMy0xLTEtMjMyNTQ3_b1aa437f-a4b2-459b-b628-bcaa32b18c08"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RhYmxlOmM3MDBkMDMyYTJhMzQ3ODdhZmZiNzY3MDkyOGYzNWYyL3RhYmxlcmFuZ2U6YzcwMGQwMzJhMmEzNDc4N2FmZmI3NjcwOTI4ZjM1ZjJfNi0xNS0xLTEtMjMyNTQ3_2160245b-ba41-44b7-8287-7ee95967c0be"
      unitRef="usd">3313000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8903f0df33854a12b5260ff32cb9efff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzM4MQ_b9ef9ebb-7f48-4c2e-b636-ad378fd1fcef"
      unitRef="usd">29000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountsLiability
      contextRef="idf917e365bae42a0b79ce78cefbe94e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV80Ni9mcmFnOjJlN2ZiNDMxZDFjMjQwZmRhNDllM2FlNDMxN2Y4Mzk2L3RleHRyZWdpb246MmU3ZmI0MzFkMWMyNDBmZGE0OWUzYWU0MzE3ZjgzOTZfMzM4OA_480cf1d1-6199-436c-aab0-fc0f494c7cac"
      unitRef="usd">85000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY185ODk1NjA0NjUyMjA2_40972c6e-8681-4512-9efa-c1ac5a090448">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive loss on the unaudited condensed consolidated balance sheets. Refer to Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for further information related to the adoption of the long-duration insurance contracts accounting standard.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the three months ended March 31, 2023 and 2022 in the table above exclude $22 million and $21 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and $51 million and $61 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. The incurred health care costs for the three months ended March&#160;31, 2022 also exclude $13 million for a premium deficiency reserve related to the Company&#x2019;s Medicaid products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;As a result of the divestiture of the international health care business domiciled in Thailand (&#x201c;Thailand business&#x201d;), the net assets associated with this business were accounted for as assets held for sale and the associated health care costs payable balance was included in accrued expenses on the unaudited condensed consolidated balance sheet at March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $693 million and $676 million, respectively, in the three months ended March&#160;31, 2023 and 2022, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, the Company&#x2019;s liabilities for the ultimate cost of (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#x201c;IBNR&#x201d;) plus expected development on reported claims totaled approximately $8.0&#160;billion. The majority of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at March&#160;31, 2023 related to the current year.&lt;/span&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY185ODk1NjA0NjUyMjA3_3a351f25-a3c4-48ad-a837-d88262268530">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive loss on the unaudited condensed consolidated balance sheets. Refer to Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for further information related to the adoption of the long-duration insurance contracts accounting standard.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the three months ended March 31, 2023 and 2022 in the table above exclude $22 million and $21 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets and $51 million and $61 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the unaudited condensed consolidated balance sheets. The incurred health care costs for the three months ended March&#160;31, 2022 also exclude $13 million for a premium deficiency reserve related to the Company&#x2019;s Medicaid products.&lt;/span&gt;&lt;/div&gt;(3)As a result of the divestiture of the international health care business domiciled in Thailand (&#x201c;Thailand business&#x201d;), the net assets associated with this business were accounted for as assets held for sale and the associated health care costs payable balance was included in accrued expenses on the unaudited condensed consolidated balance sheet at March&#160;31, 2022.</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8yLTEtMS0xLTI1ODU5OA_25fc9bc3-4731-44ac-87fd-86db60094319"
      unitRef="usd">10142000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8yLTMtMS0xLTI1ODU5OA_2f712dfb-7be3-4247-954d-ea98acf1a461"
      unitRef="usd">8678000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8zLTEtMS0xLTI1ODU5OA_ecee1f1e-84ed-41c7-937e-eced66870db9"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8zLTMtMS0xLTI1ODU5OA_067454bb-52e8-43cd-b389-3cfb2177c24d"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTEtMS0xLTI3Nzg0NA_bf709245-7e0c-42ff-8aaf-f61b893e4611"
      unitRef="usd">-8000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTMtMS0xLTI3Nzg0NA_9e192041-a17c-4ab4-b30a-b05e73fcb77d"
      unitRef="usd">0</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i791de71b848e4eaab8372e1b5f61e096_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTEtMS0xLTI1ODU5OA_3546cba2-f431-439c-ac82-f1eebb6ce808"
      unitRef="usd">10129000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2ddedc311f014abe8cb88591cd05edb1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV80LTMtMS0xLTI1ODU5OA_347fa114-1a39-4c48-b3c8-fdcaba60f136"
      unitRef="usd">8670000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV83LTEtMS0xLTI1ODU5OA_372e4200-15e0-4f8c-a272-8203f68ae5d5"
      unitRef="usd">21068000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV83LTMtMS0xLTI1ODU5OA_ee5f69cf-5749-4a01-bfde-ecef38fc80fe"
      unitRef="usd">18504000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV84LTEtMS0xLTI1ODU5OA_0c18d969-8703-45fc-8869-6ba6e9304ece"
      unitRef="usd">-693000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV84LTMtMS0xLTI1ODU5OA_401b95a3-28e2-42b4-8187-7da96250e435"
      unitRef="usd">-676000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV85LTEtMS0xLTI1ODU5OA_d7eebf3a-7935-4a92-a0a2-e31ad6d756bb"
      unitRef="usd">20375000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV85LTMtMS0xLTI1ODU5OA_a8ab0763-03b2-4b2a-af07-b92007845d31"
      unitRef="usd">17828000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMS0xLTEtMS0yNTg1OTg_b0a1a417-0db4-4256-879a-a4cf7c4729f5"
      unitRef="usd">11957000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMS0zLTEtMS0yNTg1OTg_2efaa94a-1985-474d-9289-117d1e9a60ca"
      unitRef="usd">10225000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMi0xLTEtMS0yNTg1OTg_06edc49b-515d-4b6d-97b4-3b04398ea022"
      unitRef="usd">7645000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMi0zLTEtMS0yNTg1OTg_63219107-316f-4993-bfb1-5fda670b2a5c"
      unitRef="usd">6183000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMy0xLTEtMS0yNTg1OTg_bc9ec61d-b14d-4cec-8cb0-5ebaead46c7c"
      unitRef="usd">19602000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xMy0zLTEtMS0yNTg1OTg_ce813bde-9c92-4400-9659-0fb28f2cdc03"
      unitRef="usd">16408000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNC0xLTEtMS0yNTg1OTg_2fd67cb0-2534-4717-a229-b4c107c4ebe0"
      unitRef="usd">0</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNC0zLTEtMS0yNTg1OTg_9adbfda2-0fd1-4658-9053-98e0f52b2346"
      unitRef="usd">13000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i6451d539af494cc08958d87d42063dd5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNS0xLTEtMS0yNTg1OTg_67fd54d7-bd53-44c6-b9cc-a42d826cb492"
      unitRef="usd">0</cvs:DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <cvs:DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i6d919deafdff42c08b18845673c9987c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNS0zLTEtMS0yNTg1OTg_dc18c2e2-46bc-42ad-a1b5-fef8957f244a"
      unitRef="usd">13000000</cvs:DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNi0xLTEtMS0yNTg1OTg_95bf1dd9-9003-49be-ae19-e2db499ed654"
      unitRef="usd">10902000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNi0zLTEtMS0yNTg1OTg_f9ff86d7-8a0e-4839-a146-c0c308dbb8bc"
      unitRef="usd">10090000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNy0xLTEtMS0yNTg1OTg_6d953a0b-189a-48ad-be04-9860902c328b"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xNy0zLTEtMS0yNTg1OTg_b912efab-c01c-493b-b8c3-324667349bd9"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOS0xLTEtMS0yNzc4NTk_4223cbed-de97-4bab-8d88-6c0b87aa0e04"
      unitRef="usd">12000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOS0zLTEtMS0yNzc4NTk_591189cb-b651-4068-aaa1-d6b9b5829996"
      unitRef="usd">-7000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib8eb0165ec524ac69eafcbce65d1384d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOC0xLTEtMS0yNTg1OTg_95622e3d-d883-4311-a1af-4747ea7d0e10"
      unitRef="usd">10895000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGFibGU6ODBkODQ0NzM5MzBhNDQ2YjhhYjBiNTlmNGUxMDA2MDUvdGFibGVyYW5nZTo4MGQ4NDQ3MzkzMGE0NDZiOGFiMGI1OWY0ZTEwMDYwNV8xOC0zLTEtMS0yNTg1OTg_3bfab2be-258e-4360-9e80-210247670ea0"
      unitRef="usd">10105000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i4ef8067610324631a99b73d483b1c819_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18yNjg_51b64815-b8c6-4c5e-83ef-9a54ea92a220"
      unitRef="usd">22000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="id68cb38e243a4c0589c5dc10a30a7ad0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18yNzY_aef4d21b-d2c1-49a4-84e5-fde9246113e0"
      unitRef="usd">21000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i0643f3ad93414fdb8de5a7dd49b4a6f3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY180NjU_4aaeea10-9486-4ebd-97fc-192bacdedcc6"
      unitRef="usd">51000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="id4056481f5b44ae287fa3901ab72f3a3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY180NzM_d25f318b-c6f8-4627-be16-708ed57ebbba"
      unitRef="usd">61000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i4a92f64233d34b92b691ec5e6b31bc87_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY183Mjc_9adbfda2-0fd1-4658-9053-98e0f52b2346"
      unitRef="usd">13000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ia8e6a9817f7941eebba766a3fb2b5dfe_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18xMjUz_0c18d969-8703-45fc-8869-6ba6e9304ece"
      unitRef="usd">-693000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ia664d6f32cde48b99292bf1fca7fd9a9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18xMjYx_401b95a3-28e2-42b4-8187-7da96250e435"
      unitRef="usd">-676000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MDQ3MzEzOTUzOTkwL2ZyYWc6MTVjOWY3OTQ1MjMzNDNkOWI1MTgxOGQ4ZDI4NmU4MmMvdGV4dHJlZ2lvbjoxNWM5Zjc5NDUyMzM0M2Q5YjUxODE4ZDhkMjg2ZTgyY18xNjQ5MjY3NDQzODU2_ec1472a2-2c4a-4237-b48b-02a33bf8b805"
      unitRef="usd">8000000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:InsuranceContractAcquisitionCostTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk0_8b4263aa-fa55-420d-bf4f-da9306a0334f">Other Insurance Liabilities and Separate Accounts&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances (end of quarter)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances (end of quarter)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,246&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.06%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average durations (in years) of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any material differences between the actual experience and expected experience for the significant assumptions used in the computation of the liability for future policy benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in policyholders&#x2019; funds related to long-duration insurance contracts, which are included in policyholders&#x2019; funds and other long-term liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest credited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in net unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.65%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount at risk&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of March&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $29 million of other receivables and $85 million of other payables at March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in Separate Accounts liabilities during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums and deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers from general account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company did not recognize any gains or losses on assets transferred to Separate Accounts during the three months ended March&#160;31, 2023 and 2022.</us-gaap:InsuranceContractAcquisitionCostTextBlock>
    <us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk1_b3614f0c-7b66-42c8-86b1-83e23f5fc7e3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances (end of quarter)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances (end of quarter)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of the period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,246&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.54%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.06%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average durations (in years) of the long-duration insurance liabilities as of March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yLTMtMS0xLTI0ODA1Nw_274b5a1a-2eb6-41a2-bb71-b56acd99f449"
      unitRef="usd">300000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8zLTMtMS0xLTI0ODA1Nw_8a0daf2a-fbbd-489e-8ad7-8d700e2b8510"
      unitRef="usd">302000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF80LTMtMS0xLTI0ODA1Nw_e7105662-5217-4be1-9cb8-3cbf67c375a3"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF81LTMtMS0xLTI0ODA1Nw_312d84a0-efcc-48dd-956e-f8278e6fd8b1"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF82LTMtMS0xLTI0ODA1Nw_1cc1442f-4207-43fe-8489-c6b63d72b92e"
      unitRef="usd">302000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome
      contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF84LTMtMS0xLTI0ODA1Nw_80923d82-69d7-4434-b902-3433f2ef491f"
      unitRef="usd">4000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected
      contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF85LTMtMS0xLTI0ODA1Nw_a1c1e7ad-af68-4ef0-9c60-19e4455fc800"
      unitRef="usd">10000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xMS0zLTEtMS0yNDgwNTc_b531a311-2a2d-4493-8dc3-cd90b115d300"
      unitRef="usd">296000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xMi0zLTEtMS0yNDgwNTc_70c58dc9-4b0d-4cc6-a9b9-01de13c8950c"
      unitRef="usd">5000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xMy0zLTEtMS0yNDgwNTc_1eb1010e-b1d1-424e-963a-db9aa7bc056c"
      unitRef="usd">301000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i180077daf73946ae866928c89b89e292_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNS0xLTEtMS0yNTQ0MTE_f8cd94ca-bda6-4e61-b163-9703237fea18"
      unitRef="usd">2253000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNS0zLTEtMS0yNTQ0MTE_2d6939f1-6ee3-452a-b0e0-d06e5476b0f5"
      unitRef="usd">1566000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i180077daf73946ae866928c89b89e292_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNi0xLTEtMS0yNTQ0MTE_665ea499-f13a-48a5-81ff-cfc14d6571a8"
      unitRef="usd">2425000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNi0zLTEtMS0yNTQ0MTE_2499117d-7b94-40dd-b02c-d00d45ce72b2"
      unitRef="usd">1613000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i180077daf73946ae866928c89b89e292_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNy0xLTEtMS0yNTQ0MTE_7f0b6073-b766-4371-a074-54886ff4b28c"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xNy0zLTEtMS0yNTQ0MTE_88d117f3-2e0d-4e2d-8eee-547394e29733"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i180077daf73946ae866928c89b89e292_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOC0xLTEtMS0yNTQ0MTE_ddcd48d7-f0d1-442d-ab0d-955427329320"
      unitRef="usd">3000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOC0zLTEtMS0yNTQ0MTE_36bce630-2690-46a8-84c5-6732336e2d35"
      unitRef="usd">-2000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i180077daf73946ae866928c89b89e292_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOS0xLTEtMS0yNTQ0MTE_adea5e11-0c5b-488d-a418-ec8deb88be04"
      unitRef="usd">2428000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i47bc4531d7e44e98b030b96e37d5d8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8xOS0zLTEtMS0yNTQ0MTE_e0860e5d-d649-4f57-855a-16e8d69c7d21"
      unitRef="usd">1611000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMC0xLTEtMS0yNTQ0MTE_aaf46d8b-3f22-4615-b3a9-2c03dc3806cc"
      unitRef="usd">5000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMC0zLTEtMS0yNTQ0MTE_0de5b3f6-9a59-4a06-9cc0-b0a0566aff65"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMS0xLTEtMS0yNTQ0MTE_f534a443-5d34-4ca7-9949-479f5c566d29"
      unitRef="usd">25000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMS0zLTEtMS0yNTQ0MTE_92d8644f-ed6e-46c4-bed5-3aacc54a0721"
      unitRef="usd">20000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i7b801721abff47d4985ea94fcb267f2e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMi0xLTEtMS0yNTQ0MTE_ea9dc7f6-9293-4374-955a-0e498d9cc41a"
      unitRef="usd">73000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i2f936cb30bbf40919a0e4a0c3c0ad5fc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yMi0zLTEtMS0yNTQ0MTE_9407db3b-d723-4858-851e-17181659fda4"
      unitRef="usd">18000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNC0xLTEtMS0yNTQ0MTE_ffa61762-16d3-4940-909d-9a0292bc4b43"
      unitRef="usd">2385000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNC0zLTEtMS0yNTQ0MTE_fa220ae3-15cd-4847-9ed0-4c5056db84ad"
      unitRef="usd">1613000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNS0xLTEtMS0yNTQ0MTE_cdf42abc-b203-41c7-842b-f9c3e1f4f1a0"
      unitRef="usd">115000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNS0zLTEtMS0yNTQ0MTE_d4e2fce0-41b0-49c2-976c-4586aea7ffb3"
      unitRef="usd">-12000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNi0xLTEtMS0yNTQ0MTE_98c44be1-3dcf-48a3-92b0-875c815867ed"
      unitRef="usd">2270000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yNi0zLTEtMS0yNTQ0MTE_c08f9683-bf24-4c3a-a52f-187c90984aa3"
      unitRef="usd">1625000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOC0xLTEtMS0yNTQ0MTE_8e06fff3-64b7-41a9-8dfd-bc13326ae062"
      unitRef="usd">2270000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOC0zLTEtMS0yNTQ0MTE_d6121607-4dc5-4822-9a0b-ead59833d001"
      unitRef="usd">1324000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOS0xLTEtMS0yNTQ0MTE_bc374abb-e059-4049-8a7f-b55d34e08c16"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8yOS0zLTEtMS0yNTQ0MTE_26be856c-8c6c-4f0e-a0dd-ff261b563c6f"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8zMC0xLTEtMS0yNTQ0MTE_a26fef60-8d7a-4617-9754-7d57cda2dfa0"
      unitRef="usd">2270000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6NDU1MTNhZTJiNjQwNGM0NmI2NzBjNTFlYTc0YTczZjgvdGFibGVyYW5nZTo0NTUxM2FlMmI2NDA0YzQ2YjY3MGM1MWVhNzRhNzNmOF8zMC0zLTEtMS0yNTQ0MTE_91b466dc-c8c0-402e-a4dd-898a01af01d4"
      unitRef="usd">1324000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18yLTMtMS0xLTI0ODEwMg_c50fb4b9-69e0-4bd5-a0b5-b9ebe056352d"
      unitRef="usd">389000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18zLTMtMS0xLTI0ODEwMg_9ae7631a-6e24-48f7-8b90-9bc75ed9f6cd"
      unitRef="usd">323000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N180LTMtMS0xLTI0ODEwMg_53514010-40b2-4b1a-9f56-0f21aace2625"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N181LTMtMS0xLTI0ODEwMg_42e95e8c-0ffb-4209-9250-9796e64c676d"
      unitRef="usd">5000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N182LTMtMS0xLTI0ODEwMg_41d1b4e5-291f-4cfc-a344-526a585e1d68"
      unitRef="usd">328000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome
      contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N184LTMtMS0xLTI0ODEwMg_d3c40c5d-c867-43d4-9ea3-384aaab376b9"
      unitRef="usd">4000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected
      contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N185LTMtMS0xLTI0ODEwMg_03c3d3c9-2fc5-49ba-b975-8cc59d88e87e"
      unitRef="usd">10000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMS0zLTEtMS0yNDgxMDI_9b64dc7e-7318-40e4-bd5e-87fb75f3f4bd"
      unitRef="usd">322000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMi0zLTEtMS0yNDgxMDI_3619c70e-fbdf-46b5-a6cf-b5b2da296a91"
      unitRef="usd">37000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMy0zLTEtMS0yNDgxMDI_2c2c63c9-d8d0-4626-ae00-00aae8c87e4b"
      unitRef="usd">359000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18yLTEtMS0xLTI0NzQ5NA_c955051a-6146-40df-8289-767a1dc08a6b"
      unitRef="usd">3034000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18yLTMtMS0xLTI0NzUwMg_3cfdfcef-aada-4fb9-9ca8-7039bb4dee2d"
      unitRef="usd">1991000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18zLTEtMS0xLTI0NzQ5NA_5b84931a-246f-483a-84dc-3bb8b4564987"
      unitRef="usd">2650000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18zLTMtMS0xLTI0NzUwMg_b956bc50-4929-4495-be89-625445e17f98"
      unitRef="usd">1480000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N180LTEtMS0xLTI0NzQ5NA_a7722f85-4e63-41ef-a564-f02813e37ba5"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N180LTMtMS0xLTI0NzUwMg_3d427408-4c79-4dac-a5de-0f9c5fc6f4ce"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N181LTEtMS0xLTI0NzQ5NA_b5f031d8-e584-4bff-ba89-4c30365a5355"
      unitRef="usd">-4000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N181LTMtMS0xLTI0NzUwMg_cf71b55f-dfe0-40fe-8983-249adacc50fe"
      unitRef="usd">6000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i76f2269fcecc4b23aa91465bd2eca8d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N182LTEtMS0xLTI0NzQ5NA_85ed3a22-270b-4340-bf67-54eb1991dc48"
      unitRef="usd">2646000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="ie123d33508a44c209de9379671362b7f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N182LTMtMS0xLTI0NzUwMg_648b7065-59f9-4909-8fbb-69b7410d5e75"
      unitRef="usd">1486000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N183LTEtMS0xLTI0NzQ5NA_06d34778-36f6-4442-8d50-ea74929f32aa"
      unitRef="usd">2000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N183LTMtMS0xLTI0NzUwMg_a7241cf8-8d2b-4413-a7a0-f4e85069b746"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N184LTEtMS0xLTI0NzQ5NA_cf83f976-cff6-4b71-b839-b803b5e71120"
      unitRef="usd">27000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N184LTMtMS0xLTI0NzUwMg_36d74403-aa4e-49dd-9947-1f4e0efd6b3c"
      unitRef="usd">19000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i9769a4d1860d4f339ecacd7f5f530a81_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N185LTEtMS0xLTI0NzQ5NA_c338d1d4-ef76-461c-b9f8-084df52ed214"
      unitRef="usd">75000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i2565d8970b754f778d2a48a7f76ed9c6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N185LTMtMS0xLTI0NzUwMg_6d6165c3-ae5a-47af-9826-ab66e5675cfd"
      unitRef="usd">16000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMS0xLTEtMS0yNDc0OTQ_49550150-9ea4-4468-810b-4f831b3e31fa"
      unitRef="usd">2600000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMS0zLTEtMS0yNDc1MDI_9debcf4d-f4fa-4f74-8506-7385078869fb"
      unitRef="usd">1489000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMi0xLTEtMS0yNDc0OTQ_fc843c3c-06b4-4794-bc19-f98f051320fb"
      unitRef="usd">-140000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMi0zLTEtMS0yNDc1MDI_31c8f410-78d3-4a24-9478-eba62285cbb8"
      unitRef="usd">-283000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMy0xLTEtMS0yNDc0OTQ_b0f7b741-a377-4306-9667-0b08c12b9d44"
      unitRef="usd">2740000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xMy0zLTEtMS0yNDc1MDI_c8fad719-3f9f-47f0-a4f9-5302fe78f1b6"
      unitRef="usd">1772000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNS0xLTEtMS0yNDc0OTQ_2c97abb3-1063-4262-b73d-0f84d2bb987c"
      unitRef="usd">2740000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNS0zLTEtMS0yNDc1MDI_45d7b6cb-6d37-4828-8d55-e980c44c8ee3"
      unitRef="usd">1413000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNi0xLTEtMS0yNDc0OTQ_667a604f-07c6-433e-8893-c267f83b825b"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNi0zLTEtMS0yNDc1MDI_bbba18c4-9ba3-44c5-a992-5d6e5e27a1b8"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNy0xLTEtMS0yNDc0OTQ_b11088be-9170-426d-a14c-014af2432244"
      unitRef="usd">2740000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGY2Y2JhNzNlZGFjNGEzNjgxZGI1ZTM1OTU5MzM1NTcvdGFibGVyYW5nZTowZjZjYmE3M2VkYWM0YTM2ODFkYjVlMzU5NTkzMzU1N18xNy0zLTEtMS0yNDc1MDI_98f81ebe-2671-4e96-8fc8-bd97caae23db"
      unitRef="usd">1413000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8yLTEtMS0xLTI1NDM1Ng_11153af0-61c1-46e1-b474-e214ebfb2a5e"
      unitRef="usd">3463000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8yLTMtMS0xLTI1NDM2Mg_21c18edb-f7cc-4178-80c1-d137c8112774"
      unitRef="usd">3810000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8zLTEtMS0xLTI1NDM1Ng_b08bab16-969f-4c09-aada-a3c3c56d80d9"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV8zLTMtMS0xLTI1NDM2Mg_371895a7-5922-42c6-a245-2a380aa807cd"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV82LTEtMS0xLTI1NDMzMg_19b07f0e-e2f8-4666-afd1-83c0a818e174"
      unitRef="usd">3246000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV82LTMtMS0xLTI1NDMzOA_f8c93206-daca-4c2f-a084-a2218e46c81b"
      unitRef="usd">3115000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV83LTEtMS0xLTI1NDMzMg_a50ae59c-1ab3-4518-823b-29a6bfdfedca"
      unitRef="usd">428000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6YjVmMWJlMWEwNjM4NGUyNWExMjhlOWUwODJiNWM3MWEvdGFibGVyYW5nZTpiNWYxYmUxYTA2Mzg0ZTI1YTEyOGU5ZTA4MmI1YzcxYV83LTMtMS0xLTI1NDMzOA_bc616b80-1418-4148-8d15-e6fb3afefd18"
      unitRef="usd">476000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18xLTEtMS0xLTI0ODMzMw_2025ab9b-4b3d-498a-85cd-513285e744e1"
      unitRef="number">0.0420</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18xLTEtMS0xLTI0NzY3Mg_ce4ee0fb-a0bb-4f87-8a66-606b851903d4"
      unitRef="number">0.0420</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18yLTEtMS0xLTI0ODMzMw_4c19bdb1-dae2-4d88-9786-3b40b0e7bbf3"
      unitRef="number">0.0490</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N18yLTEtMS0xLTI0NzY3Mg_24b4d0d1-9d36-4288-9e53-a52c6ced6872"
      unitRef="number">0.0354</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N182LTEtMS0xLTI1MzgxMg_1ed3c88e-9f4c-4f61-9390-1cd5a8b41656"
      unitRef="number">0.0511</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N182LTMtMS0xLTI1Mzg1Mg_dffcbd75-f6e7-47b7-9f09-f8ccb347eb59"
      unitRef="number">0.0511</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N183LTEtMS0xLTI1MzgxMg_6a2f3f4f-ef09-473c-a055-a277feb1e470"
      unitRef="number">0.0506</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MGVlZjcwZGM5ZDU4NDNjZTgzMjhjOGQyOGY1MDFjNTcvdGFibGVyYW5nZTowZWVmNzBkYzlkNTg0M2NlODMyOGM4ZDI4ZjUwMWM1N183LTMtMS0xLTI1Mzg1Mg_190cfe22-decf-415f-8316-22687321b6d6"
      unitRef="number">0.0375</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i68a2a42d2c314267a6ba9a48f7231396_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8xLTEtMS0xLTI0ODQ1MQ_91e1d31b-3c18-4c18-a80d-caa69f224f2b">P7Y4M24D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i5bd67553bffa4d42b6ad807eec4e0947_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8xLTMtMS0xLTI0ODQ0MQ_4a288561-c6c7-462c-96a4-6e6b36c30719">P7Y7M6D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i0b28e0a23a584695a4622d30105683e0_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8zLTEtMS0xLTI2MzY5Mw_3dfd2d89-de2e-42fa-a1aa-5b7ef0a07971">P12Y6M</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="ia7ce0c85ffa342ddbbc55f81f49c231f_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MmNmZjc5OWYxYzE5NDJjZDkxNTNlODg2Mjc2NDZhYTYvdGFibGVyYW5nZToyY2ZmNzk5ZjFjMTk0MmNkOTE1M2U4ODYyNzY0NmFhNl8zLTMtMS0xLTI2MzY5OQ_485b5cfd-7246-4b67-b602-83279f69e6b8">P13Y3M18D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:PolicyholderAccountBalanceTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk5_52608bb9-7b07-48ae-b715-06d07b365006">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in policyholders&#x2019; funds related to long-duration insurance contracts, which are included in policyholders&#x2019; funds and other long-term liabilities on the unaudited condensed consolidated balance sheets, during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest credited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in net unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.65%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount at risk&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PolicyholderAccountBalanceTableTextBlock>
    <us-gaap:PolicyholderFunds
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8yLTEtMS0xLTI1MDkzMQ_0f56361a-aaf0-4dbe-9622-0c6815a95b12"
      unitRef="usd">345000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8yLTMtMS0xLTI0Njk5Mg_1ab89dc1-5c53-4115-b8cf-23b29c10c129"
      unitRef="usd">522000000</us-gaap:PolicyholderFunds>
    <cvs:PolicyholderAccountBalanceDepositsReceived
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF80LTEtMS0xLTI1MDkzMQ_b5f6309e-742f-4d71-83b8-8657cf69de5e"
      unitRef="usd">4000000</cvs:PolicyholderAccountBalanceDepositsReceived>
    <cvs:PolicyholderAccountBalanceDepositsReceived
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF80LTMtMS0xLTI0Njk5Mg_0a23a4be-97a7-4a92-be3b-579280b638ec"
      unitRef="usd">2000000</cvs:PolicyholderAccountBalanceDepositsReceived>
    <us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF82LTEtMS0xLTI1MDkzMQ_6c05de3d-f295-41e7-bb7f-1f68956103bd"
      unitRef="usd">7000000</us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal>
    <us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF82LTMtMS0xLTI0Njk5Mg_b6acd020-6695-4712-8051-4c1866792a73"
      unitRef="usd">4000000</us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal>
    <us-gaap:InterestCreditedToPolicyholdersAccountBalances
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF85LTEtMS0xLTI1MDkzMQ_b4591f1d-c4f2-448b-91be-4dcdcffb5cb1"
      unitRef="usd">3000000</us-gaap:InterestCreditedToPolicyholdersAccountBalances>
    <us-gaap:InterestCreditedToPolicyholdersAccountBalances
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF85LTMtMS0xLTI0Njk5Mg_8f64be0c-1d32-48a9-a043-4c6107a7226e"
      unitRef="usd">4000000</us-gaap:InterestCreditedToPolicyholdersAccountBalances>
    <cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0xLTEtMS0yNTk4ODI_50a6ee03-eb57-45e6-a821-6394a8a646e3"
      unitRef="usd">21000000</cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses>
    <cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0zLTEtMS0yNTk4Njk_4f8076c7-35ca-46b0-8c42-f21225a53702"
      unitRef="usd">-72000000</cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses>
    <us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0xLTEtMS0yNTA5MzE_bf0374df-b6ed-4d4e-bbce-97d3bd6fd9cc"
      unitRef="usd">-9000000</us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange>
    <us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMC0zLTEtMS0yNDY5OTI_e2395a60-5bc5-4699-bb11-07704e86fd0a"
      unitRef="usd">-4000000</us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange>
    <us-gaap:PolicyholderFunds
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMS0xLTEtMS0yNTA5MzE_7f6cad4f-455c-4520-a9d9-ca88ca764b72"
      unitRef="usd">349000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMS0zLTEtMS0yNDY5OTI_c0a1ce3e-236d-4cd7-83d2-2bb491a19fb6"
      unitRef="usd">444000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMi0xLTEtMS0yNTA5MzE_13cf694d-b9b3-471e-ac7b-a849e1c5084e"
      unitRef="number">0.0455</us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate>
    <us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xMi0zLTEtMS0yNDY5OTI_efc4c399-a3b0-444f-861c-86747088fed4"
      unitRef="number">0.0465</us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate>
    <us-gaap:PolicyholderAccountBalanceNetAmountAtRisk
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNC0xLTEtMS0yNTA5MzE_59d17ac0-9a64-4073-9f85-bec5a6608326"
      unitRef="usd">0</us-gaap:PolicyholderAccountBalanceNetAmountAtRisk>
    <us-gaap:PolicyholderAccountBalanceNetAmountAtRisk
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNC0zLTEtMS0yNDY5OTI_6625ce02-3fca-4bdc-b42e-dd8bf97dd124"
      unitRef="usd">0</us-gaap:PolicyholderAccountBalanceNetAmountAtRisk>
    <us-gaap:CashSurrenderValueDuePolicyholdersAmount
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNi0xLTEtMS0yNTA5MzE_c664c494-9625-454c-8d5c-c9767fc70d43"
      unitRef="usd">332000000</us-gaap:CashSurrenderValueDuePolicyholdersAmount>
    <us-gaap:CashSurrenderValueDuePolicyholdersAmount
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MDUxNjM4NTRiNDY0NDQ1M2JkZjYyN2ZmN2VlZjNmNzQvdGFibGVyYW5nZTowNTE2Mzg1NGI0NjQ0NDUzYmRmNjI3ZmY3ZWVmM2Y3NF8xNi0zLTEtMS0yNDY5OTI_25b66947-4092-4727-b2c5-a963017e45d4"
      unitRef="usd">342000000</us-gaap:CashSurrenderValueDuePolicyholdersAmount>
    <us-gaap:SeparateAccountAssets
      contextRef="i452ce3dfebd34199a05e64ce393bc4c8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8yLTEtMS0xLTI3NDU2OA_c9e7d1e5-c1f1-4af2-aea6-75192c820a17"
      unitRef="usd">160000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifacd64ecac6a4aac953d15d34d578d88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8yLTMtMS0xLTI3NDU2OA_1c10d3ff-c362-48ce-9259-95bbc4f42e6c"
      unitRef="usd">156000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i86c5d299901045239a89b149c86fc62b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV80LTEtMS0xLTI0Njg0Mg_8974cc17-3a71-4065-a3bf-43e4472fca39"
      unitRef="usd">705000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if83a48cee9f5421f959a40efc914a409_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV80LTMtMS0xLTI0Njg0Mg_e45253b7-cb85-4084-ba02-b56934d19ca9"
      unitRef="usd">717000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i662502d2b9824d468b5ea7e46559f0d0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV81LTEtMS0xLTI0Njg0Mg_80bcb860-d97c-4577-bd90-85909679a9d1"
      unitRef="usd">29000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if223ef4f1cb04f89aaed72f66b1ea655_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV81LTMtMS0xLTI0Njg0Mg_39027f81-1ed5-4c2d-b064-f01b5e279cbf"
      unitRef="usd">27000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia6045cebcc054f359aeda689be7966b1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV82LTEtMS0xLTI3ODMwMw_f91c1690-571c-4425-a6ea-4f55800e9521"
      unitRef="usd">1642000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibdba47c662a241d796fcf13177996678_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV82LTMtMS0xLTI3ODI4MQ_95eb6efa-1472-4932-a028-0d01ebf50383"
      unitRef="usd">1667000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4a9e113db05c4437a869964daf990132_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV85LTEtMS0xLTI0Njg0Mg_9c513d08-1586-41b8-8e17-00db46ffc0ad"
      unitRef="usd">204000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7df477b572d04891896d991e4831089e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV85LTMtMS0xLTI0Njg0Mg_c2767113-4e9c-4f30-82c8-3cfddfc62114"
      unitRef="usd">201000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6116e07db6564d4bbfa404e6b3bb00a2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0xLTEtMS0yNzQ1ODE_a58bfb74-d0ab-454e-8670-9c6be6ce4b92"
      unitRef="usd">39000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iee90579e8a1b4b1da229e849035d343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0zLTEtMS0yNzQ1ODE_d288606a-2095-4ac4-8bf0-2136757478db"
      unitRef="usd">41000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic932276a2f124dba92225829473c58a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0xLTEtMS0yNTA5ODk_1a4f569c-e4a4-4dca-8a91-557996e5dac2"
      unitRef="usd">6000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic0b686b402cc4958a97490b22451eac1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMC0zLTEtMS0yNDY4NjY_17a6d646-9178-4997-8ba8-3f4ebda37956"
      unitRef="usd">6000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia094aa9bc0e247adbf9401a23f3358a1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0xLTEtMS0yNTA5ODk_e8490134-2664-4fb8-a7e6-a882b48f5306"
      unitRef="usd">20000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3b3614b59a37444c9c0ce65c076cc76b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0zLTEtMS0yNDY4NjY_581533cf-019b-4f4d-a1ac-2514c7142fbe"
      unitRef="usd">18000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i55ff9d813bee44a0965aa5d87884e5ff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMy0xLTEtMS0yNzQ1OTY_cd6a51a9-12c0-46d9-8f9a-e7f6a58abed8"
      unitRef="usd">2645000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i18d86193e1b54a5cb7daa5b1dc397607_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMy0zLTEtMS0yNzQ2MDc_c42c0f29-e41e-4afc-b305-7ecaf31c7512"
      unitRef="usd">2677000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i903d499b0d9b49e49eaa2a9bb04df017_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xNS0xLTEtMS0yNzQ2NTM_ab58e4c8-2cee-403f-beda-785b48a97b18"
      unitRef="usd">397000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8213443c893d488d8dac56b4a243aa90_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xNS0zLTEtMS0yNzQ2NzA_9192fcf5-29c4-485d-be8c-14d807bcb467"
      unitRef="usd">480000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5c6811cb34424e92bc1f0f67791ec9a6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0xLTEtMS0yNDY4NDI_8bae268e-8511-4f4e-b379-90f2b7cba1c6"
      unitRef="usd">3202000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i13296d918c654fd9985778c3de5b1aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MTk2ZjJhMDhlZTAzNGE0M2FkMjgzMGIxMzgwMzg5MzUvdGFibGVyYW5nZToxOTZmMmEwOGVlMDM0YTQzYWQyODMwYjEzODAzODkzNV8xMi0zLTEtMS0yNDY4NDI_e2f48ebe-acd3-4dad-9379-d6e182d4a5be"
      unitRef="usd">3313000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8903f0df33854a12b5260ff32cb9efff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18zMjk4NTM0ODk1MTAz_b9ef9ebb-7f48-4c2e-b636-ad378fd1fcef"
      unitRef="usd">29000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountsLiability
      contextRef="idf917e365bae42a0b79ce78cefbe94e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18zMjk4NTM0ODk1MTEy_480cf1d1-6199-436c-aab0-fc0f494c7cac"
      unitRef="usd">85000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountLiabilityTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGV4dHJlZ2lvbjpjOTdkMWJiZjdhYWU0ZWQ0OTRhNTA3ZmFmZmZjMjU1M18yMTk5MDIzMjYzNzk3_9b1c1a0f-5ea1-4ae8-b97e-687d87a204c5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in Separate Accounts liabilities during the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums and deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers from general account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SeparateAccountLiabilityTableTextBlock>
    <us-gaap:SeparateAccountsLiability
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8zLTEtMS0xLTI1MDk5Nw_35a384c5-8c28-40c0-953b-a9f95b7cf65a"
      unitRef="usd">3228000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i745cd9060f244c0591aa68a99e2834de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8zLTMtMS0xLTI0NjkwNg_93529c8d-ac40-4cc7-a71e-cb3c272697ae"
      unitRef="usd">5087000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountLiabilityPremiumAndDeposit
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl80LTEtMS0xLTI1MDk5Nw_c438d69f-fbf3-40db-bf04-ebef2006fae6"
      unitRef="usd">246000000</us-gaap:SeparateAccountLiabilityPremiumAndDeposit>
    <us-gaap:SeparateAccountLiabilityPremiumAndDeposit
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl80LTMtMS0xLTI0NjkwNg_5fd6e89f-8d24-4125-b802-ddb0056c06ec"
      unitRef="usd">216000000</us-gaap:SeparateAccountLiabilityPremiumAndDeposit>
    <us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl82LTEtMS0xLTI1MDk5Nw_c699a37a-aca4-41de-bc00-e2079c09781b"
      unitRef="usd">0</us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal>
    <us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl82LTMtMS0xLTI0NjkwNg_adbaf581-7a2c-4ec1-b7ca-b9128d0a52d2"
      unitRef="usd">4000000</us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal>
    <us-gaap:SeparateAccountLiabilityBenefitPayment
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl83LTEtMS0xLTI1MDk5Nw_2bf69720-8456-46a6-bc13-22dc73386801"
      unitRef="usd">260000000</us-gaap:SeparateAccountLiabilityBenefitPayment>
    <us-gaap:SeparateAccountLiabilityBenefitPayment
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl83LTMtMS0xLTI0NjkwNg_5f1dd541-3786-4c8f-8d88-d7ac8a36abe8"
      unitRef="usd">236000000</us-gaap:SeparateAccountLiabilityBenefitPayment>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl84LTEtMS0xLTI1MDk5Nw_1fac8636-9794-4bd0-ae51-b830763a30a8"
      unitRef="usd">23000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl84LTMtMS0xLTI0NjkwNg_3f25b2c7-4dbb-42b6-9bf2-446568336d2c"
      unitRef="usd">-393000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance>
    <us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl85LTEtMS0xLTI1MDk5Nw_f604c45a-1b90-49a9-97d6-1d01342028a9"
      unitRef="usd">0</us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount>
    <us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl85LTMtMS0xLTI0NjkwNg_1611438f-7970-4a29-8018-d91a7c5fd5bb"
      unitRef="usd">5000000</us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMC0xLTEtMS0yNTA5OTc_3ad87e67-be1a-44a3-8e5d-1eba27fe7feb"
      unitRef="usd">-6000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMC0zLTEtMS0yNDY5MDY_918c457a-7958-4696-bbfa-e7cf49000256"
      unitRef="usd">-5000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange>
    <us-gaap:SeparateAccountsLiability
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMS0xLTEtMS0yNTA5OTc_b9cc58ec-751e-44ee-a732-ebcebb6f0c3d"
      unitRef="usd">3231000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMS0zLTEtMS0yNDY5MDY_3c4bb913-800e-4f3c-a394-f6b0ba802753"
      unitRef="usd">4670000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMi0xLTEtMS0yNTA5OTc_b7a78d41-7931-4876-b218-1a0577df2a6f"
      unitRef="usd">2142000000</us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount>
    <us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount
      contextRef="i97beaa9151e94932b8318858d3577500_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMjk4NTM0ODg0NTMxL2ZyYWc6Yzk3ZDFiYmY3YWFlNGVkNDk0YTUwN2ZhZmZmYzI1NTMvdGFibGU6MzJkMTNhYTliMTNiNGE3YmExZjA5NTRjNmM3MzQ4NmIvdGFibGVyYW5nZTozMmQxM2FhOWIxM2I0YTdiYTFmMDk1NGM2YzczNDg2Yl8xMi0zLTEtMS0yNDY5MDY_88922246-dec7-42bc-b831-8913b5351152"
      unitRef="usd">3204000000</us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTE2Ng_aa4f5f58-6bb6-4ae8-92fe-51441465d3a3">Borrowings&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at March&#160;31, 2023 and December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due February 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.25% senior notes due February 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.625% senior notes due February 2053&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_4a540ca2-c5a0-4370-9572-5e1f1b60ec25"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_effb7122-9853-4ffd-bc90-e0ef6a32ea42"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1.95pt;font-weight:400;line-height:120%;position:relative;top:-1.05pt;vertical-align:baseline"&gt;_____________________________________________________________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Borrowings &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 1, 2023, the Company entered into a 364-day $5.0&#160;billion term loan agreement. The term loan agreement allows for borrowings at various rates that are dependent, in part, on the Company&#x2019;s debt ratings. On May 2, 2023, the Company borrowed $5.0&#160;billion under the term loan agreement to fund a portion of the Oak Street Health acquisition purchase price.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term Borrowings &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 21, 2023, the Company issued $1.5 billion aggregate principal amount of 5.0% senior notes due February 2026, $1.5 billion aggregate principal amount of 5.125% senior notes due February 2030, $1.75 billion aggregate principal amount of 5.25% senior notes due February 2033 and $1.25 billion aggregate principal amount of 5.625% senior notes due February 2053 for total proceeds of approximately $6.0 billion, net of discounts and underwriting fees. The net proceeds of these offerings were used to fund general corporate purposes, including a portion of the Signify Health Acquisition purchase price.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTE3Mw_e46b6891-92e0-448f-a549-8f142a1b455f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings at March&#160;31, 2023 and December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due February 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.25% senior notes due February 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.625% senior notes due February 2053&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_4a540ca2-c5a0-4370-9572-5e1f1b60ec25"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMC0xLTEtMjMyNTQ3_effb7122-9853-4ffd-bc90-e0ef6a32ea42"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1.95pt;font-weight:400;line-height:120%;position:relative;top:-1.05pt;vertical-align:baseline"&gt;_____________________________________________________________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the unaudited condensed consolidated balance sheets at both March&#160;31, 2023 and December&#160;31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions and Assets Held for Sale&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i29e609944ebb4c7abcd29efc5ac7a42a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfOS0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjpjZWNjYTNlOTNlMTY0Yzg5OGE3MjVmZmJmN2YyNmFmNF80_8f57da0c-fb6b-47c9-9493-84b71d5275c5"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i29e609944ebb4c7abcd29efc5ac7a42a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfOS0xLTEtMS0yMzI1NDc_d61c311c-031e-4c41-b3ec-c998b93b95d1"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6fdf4d6af289497db86f4e1ef5b01c5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfOS0zLTEtMS0yMzI1NDc_8efb068a-59cd-4798-9d55-c6b822e4b8cb"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i47a06c42b0d441a9bffe6e38635b3abb_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MmE4NjliYjMwZGQ0NGZhZDlkNjBmZmI0M2QzOGFlY2NfNA_eecafc6b-b21e-4b88-93f1-94191e201b0a"
      unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i47a06c42b0d441a9bffe6e38635b3abb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTAtMS0xLTEtMjMyNTQ3_25620a2d-18e2-450c-bc6a-0ad10b85cbc2"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1ec5f2382c744b1386a167b07243b1ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTAtMy0xLTEtMjMyNTQ3_09930dc3-72f5-49e1-9ed5-ff9321b8a0c0"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1389fe77fa0245a3b7288b5f5b6fd60a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MGNkYTY4Mzg5ZGMxNGZjYmFkOTJkZTE5NjlhMzc1MTNfNA_d56e0246-33b5-4ca3-a273-925d466dc09c"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1389fe77fa0245a3b7288b5f5b6fd60a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTEtMS0xLTEtMjMyNTQ3_dd0f55e9-d52e-46a4-8646-099db78f162b"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8195e760c0664b8ebc5acf22c0705628_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTEtMy0xLTEtMjMyNTQ3_8f67f944-04aa-4448-b717-773b23cc7158"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic4e614b3ac4b4f9b8791bb6db2978b36_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YmY2MTBiYjlkZjc2NDE3MTg5MzBiN2MwNzE5MDQyODBfNA_3f43ba43-f193-4141-946a-fa9ca6877ed9"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic4e614b3ac4b4f9b8791bb6db2978b36_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTItMS0xLTEtMjMyNTQ3_57440178-adb4-4841-ba42-81fe50e103d8"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6084b97edd8d4f4fbf531a21307abe4d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTItMy0xLTEtMjMyNTQ3_2d64634e-bd7d-449d-92de-b739d6892373"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3e7e4e1aac0e46b59b1c064b844b1068_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NTZmYWE5YWI2ODUwNGRlY2JmNzUyODgxNTA3MjJlOTdfNA_c421f90b-8073-4f3b-b57e-79710f13e25e"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3e7e4e1aac0e46b59b1c064b844b1068_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTMtMS0xLTEtMjMyNTQ3_fd4ec054-1f27-4c46-a220-e9d623abafe9"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2ee3f756fd384578983ede98c5a0fc5c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTMtMy0xLTEtMjMyNTQ3_d14165d1-d791-4dfd-90d8-d31076af4870"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i18c1afd8891d4f5c94b81a067731189a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTQtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NGU4YzQxMGFiNWZmNGNmMGE1YzYxNDQ0MzhhMjQ3N2NfNA_25f3b8f0-b30a-4b8a-9667-2dbf161e74bf"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i18c1afd8891d4f5c94b81a067731189a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTQtMS0xLTEtMjMyNTQ3_ed5c2cd9-824d-486a-9a63-b0d6b736d28a"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5bca211743f44200bcddc914732f3f5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTQtMy0xLTEtMjMyNTQ3_6c6ab123-ea97-43df-b6c7-09d3a1a18f41"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i63f3531d3fe74d638d45ecfa6b71c325_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTUtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YTA2ZGVmMWFiODhjNDdmZjg3NWJlZDI1MmVlMjMyMmNfNA_77ee1fb2-30ad-45bc-b7c9-966521104cb6"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i63f3531d3fe74d638d45ecfa6b71c325_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTUtMS0xLTEtMjMyNTQ3_71000357-add5-4b71-bfe2-c11b81b69f4a"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i11ee92e3968142fc8a1f00b97f55b501_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTUtMy0xLTEtMjMyNTQ3_ece72fd7-06af-46ec-8faa-c05ab7d198ae"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia9c5c27de38b4adb9c680fe62498e820_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTYtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YWNmNzM3MGQ1Yjk4NDBhNjg1NjhmMWU3MDEzYjNmMWJfNA_f9543cc7-3263-4111-8661-2dd8e93e559d"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia9c5c27de38b4adb9c680fe62498e820_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTYtMS0xLTEtMjMyNTQ3_f986417a-d2db-4ee7-8927-18acf85b8f78"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i53af89ad853e4e88a7223062ff9de426_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTYtMy0xLTEtMjMyNTQ3_d1094303-bf4c-4a13-87bf-989edf640c3f"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8e5be82f9aa84b8f82e19cbbd50d5017_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMC0xLTEtMjU4Mzc2L3RleHRyZWdpb246Y2FiNmM0NDJjMDMwNDZhNmI5MzMxNWNiMDRiNWY2ZDJfMzI5ODUzNDg4MzMzMg_3ca3e53c-7213-4bff-aae2-a4aaca5220e0"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8e5be82f9aa84b8f82e19cbbd50d5017_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMS0xLTEtMjU4Mzkw_1daca8c1-1d4d-4642-aec6-c379f139f2c2"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id93656a700a24e76938502046d84db62_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMy0xLTEtMjU4Mzkw_f01193dd-6099-4d65-bcf8-9bff348eb165"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2f7f76b8c0b544a3a59704c58a83c665_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MzEwZDIwMTY1MzJmNDY4ZDhmOGM1MmY3Yzk1NDNkZTJfNA_8819a6e8-2371-45dc-b602-0fc3b0a29e18"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2f7f76b8c0b544a3a59704c58a83c665_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMS0xLTEtMjMyNTQ3_4c5e5dee-5e47-484b-ad5a-00502d59ad27"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic060d61cd4084e17b433a1b12fa6cd89_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTctMy0xLTEtMjMyNTQ3_e871e940-2959-492d-8b85-273d32c8d664"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ide95dae98a2245b1acb066495f097ca2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YTY0ZWM1OTIyODA3NGRiNmE5ZjQ5NTE1Y2M2ZDY4NjZfNA_257920de-3f18-4972-b595-2e1a22a7445a"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ide95dae98a2245b1acb066495f097ca2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTgtMS0xLTEtMjMyNTQ3_a860386a-d344-4764-9dfa-e1f3ad107a1e"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i858a0f59e1c349d6b9a6c24cbe1894b2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTgtMy0xLTEtMjMyNTQ3_c500e977-f46a-4e6a-b819-b0d1909b228f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifb777320df5b48f797263822df4f0e9d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDBmNTc4ZDZhYjFlNGUwM2JkOTBmNmNkMzU4MzU4NTFfNA_68e8aa9c-bfc2-4524-b56d-151ba7e1991b"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifb777320df5b48f797263822df4f0e9d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTktMS0xLTEtMjMyNTQ3_808246e0-f35f-4b4a-b383-5e5c0eadd2a9"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic312216e7bc34f27ae9ab07c90920b49_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMTktMy0xLTEtMjMyNTQ3_3c6249e0-1bcd-4f09-95cb-cdae57b06207"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia7bf61a5560341df80eaf86640920cf8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ODNlMmU1ZTE5NjljNGI0NDg4ZGZhMjAwNDFlMDI3Y2VfNA_5c105dd0-cf31-49f0-b717-0099a3758193"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia7bf61a5560341df80eaf86640920cf8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjAtMS0xLTEtMjMyNTQ3_f7febfab-382c-4ae2-86aa-3ac8fe1d3c4f"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i619ee922ba3248eabc18dc25aa73b06f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjAtMy0xLTEtMjMyNTQ3_a4d86634-beae-4b5d-8b92-09d7e5f9eaf3"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2cdf17416ddc41a6b3022410dc3d2705_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZjY5M2YwYTRjMmY1NDFkMWJjNmU0YmRjMmJlMjkxMzZfNA_87973d5e-0d76-4078-bf0c-2be286229132"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2cdf17416ddc41a6b3022410dc3d2705_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjEtMS0xLTEtMjMyNTQ3_a1424670-ddcb-4a40-99ef-a719b858fcbc"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i31b29cbacf5446fdac7dcf2a511e8029_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjEtMy0xLTEtMjMyNTQ3_c908bfe4-2137-4bac-9742-c30602dcf559"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib6d28f166a4b43a397fdfaabad32194b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MjhhMjE4ZDkxNTRlNDhiMjhmNDIzNGQxZWY5MTlkMjZfNA_66d8bc34-baa6-4346-b90f-40aacf3c6742"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib6d28f166a4b43a397fdfaabad32194b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjItMS0xLTEtMjMyNTQ3_f6cf1df9-78e0-4de6-9757-fa3d1e469af9"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i061715fa0d744784ba4cc2d892ac4b03_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjItMy0xLTEtMjMyNTQ3_2c0321cf-a2b3-4ae0-9028-3054ac63203e"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i38635e749f46407a80cdf7fc2ea4d372_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YjZhODMyYmI2YmUzNDFhYzhmM2RmYTNjZTM1NmExZGZfNA_e0eb2fc6-f7c3-4bc4-b44b-944aeef6ec63"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i38635e749f46407a80cdf7fc2ea4d372_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjMtMS0xLTEtMjMyNTQ3_83d2a6dc-4688-4bbc-9c9c-eab2f8dcc7dc"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i84a442e85b6e4b94a98823c08df1f043_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjMtMy0xLTEtMjMyNTQ3_0f8652d6-e9e0-418e-9643-288545e391e2"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7b311c6d410f4978bd5331eecaecaa64_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMC0xLTEtMjU4NDIwL3RleHRyZWdpb246MzdlNzk5YjUwMjVmNGI1NmIxZWY3MDkzZmM4ZTdlM2VfMzI5ODUzNDg4MzMzMg_2a40180c-5183-4014-b229-b145359b2267"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7b311c6d410f4978bd5331eecaecaa64_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMS0xLTEtMjU4NDEz_8f9575fd-6a77-4442-8f4d-7b9977758db7"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7f0e5fbb301a40e6827651a423c2292d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMy0xLTEtMjU4NDEz_b13b925c-1ee3-4b41-8000-0798d196ae55"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if6eb4e9251184548a1634972c55a28d0_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjQtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YmRmNzJiZDQ0NTkyNGZmZGE5NDhiZWRkYWQ5Yjk4NjFfNA_7b6bde33-9490-413b-a4e9-e1bba5b746d9"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if6eb4e9251184548a1634972c55a28d0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjQtMS0xLTEtMjMyNTQ3_60d06fe8-af4d-4701-a615-3c09d5d0b052"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i529f1b8b3f1f4b42b2e5446768b8e87e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjQtMy0xLTEtMjMyNTQ3_e3a06b73-7cd8-4d08-9ce6-43e534bce66a"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie07bdea3da6f451c9bcba9f549201961_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZjdiNWVmMDFjNjczNDljYjk3MTBkOWY1MGEwZDgxNDNfNA_dbde9ed0-cd7a-4945-88aa-45e0fb5e16e4"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie07bdea3da6f451c9bcba9f549201961_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMS0xLTEtMjMyNTQ3_55d98c10-8018-48c4-8306-72a21c2f46af"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i175bb047294f462da1aa8e1333b6d0ee_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjUtMy0xLTEtMjMyNTQ3_789a446d-b5bf-4c13-825d-92018b3ff93d"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie0a02874bdf04d5b9a706cad560999ac_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjYtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YWViM2VlYWQ5NTZlNDQ4MWFkODc3MGRlY2IyODQzZjJfNA_4cc14abf-f927-41f5-8bd8-448a5cc3845e"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie0a02874bdf04d5b9a706cad560999ac_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjYtMS0xLTEtMjMyNTQ3_90065bef-372e-4b4b-89d3-9d0cbbd2926e"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9d8c414c1efc476fa3e1e6d77efcaa3e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjYtMy0xLTEtMjMyNTQ3_9cf03a00-b14f-4deb-8321-b815e963da67"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i41089ddd19eb470282adb9570456e08e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjctMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246N2ZkZWU0MDhmNDFlNGQxYTliMzMwYTFlODA5MDdjOGRfNA_9bdbef85-bfeb-4fda-a77c-0b03f9b4cd16"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i41089ddd19eb470282adb9570456e08e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjctMS0xLTEtMjMyNTQ3_236b0982-6692-4a28-b7d7-4a6b0d2d4b79"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i63f6643ec5754faebede440568434de3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjctMy0xLTEtMjMyNTQ3_0a84219b-9ee4-4931-9866-8d0fde5e4ed7"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2e8700d2108e4ab496a24690db04dcf2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMC0xLTEtMjU4NDM1L3RleHRyZWdpb246ZDYzOGY2NWZlZjI1NDFkYzgzNDViMDlhMzc0NGE0MWRfMzI5ODUzNDg4MzM0NA_c104dfb3-7fc9-49c2-b495-96fbdbc48023"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2e8700d2108e4ab496a24690db04dcf2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMS0xLTEtMjU4NDU0_4956cddc-c31b-4435-bde2-4da62e8e23da"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib41b9178e08b45cb91563f0883c36a2a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMy0xLTEtMjU4NDU0_e1e8cb6c-47dc-476d-a10c-19c656574645"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i45cd1f1f6e8b4f41986ce9a7b9e9e696_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MWE1ZWI5MWVlNGMzNGNhZWE1YjE0ZWQ4OGQ2ZDMwZTlfNA_56b53cdb-a0ea-4877-92a1-40d327d87875"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i45cd1f1f6e8b4f41986ce9a7b9e9e696_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjgtMS0xLTEtMjMyNTQ3_1a5a8184-1f23-4e1b-845f-4c7c8c2f25e5"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8b01afccbbf34ad4a1781cb89df8712b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjgtMy0xLTEtMjMyNTQ3_2dc4eeeb-bde9-4362-92f4-833f3997bc2f"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87fac5abf1e74d54a53dc666fcc47f4d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YWM3NzgxOWYwMGZjNDU2NjhkNTNjYjZjMDNhMDlkZjJfNA_a4b2c637-0dc2-4666-8cb4-f07c88ce58d6"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i87fac5abf1e74d54a53dc666fcc47f4d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjktMS0xLTEtMjMyNTQ3_6cf001cc-7585-4788-b9c2-f2c2208160c6"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i792622491465439c87c4cca105f8d743_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMjktMy0xLTEtMjMyNTQ3_9c168100-8dcf-4a5a-a814-ddcabed51021"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6d5ddad65b5b4fecb1c2c210aba362c8_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246YzQxY2I1ZjlhOTM0NGFjMWExZjY2MjQ5NGZlYWUyMTRfNA_e5666322-c291-4d97-bad6-382ae086df51"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6d5ddad65b5b4fecb1c2c210aba362c8_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMS0xLTEtMjMyNTQ3_46bb6941-7fb7-4e0f-9d4e-1d551a9f8104"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i97a596cb57ed46fab4eba2c7de95bc00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzAtMy0xLTEtMjMyNTQ3_9bbe29b1-59ac-42d2-ac37-2d0301bdc841"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e9459ad3944423592e566ee3f8a9f55_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ODM1YjQ3OWNmOTRjNDAzNWIyMGFlMjZmN2ZjMzMyNzNfNA_2b3ef5f4-3e1c-4ce1-9266-75d1dc7175d7"
      unitRef="number">0.0478</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4e9459ad3944423592e566ee3f8a9f55_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzEtMS0xLTEtMjMyNTQ3_7dbee4ec-aae2-46f8-b85c-6c4612c26f65"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i52e871c110bd4599ada469473b42a2e7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzEtMy0xLTEtMjMyNTQ3_a466cd17-013a-4d76-946c-3217866b0283"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6cd1bc3205234dbc80620f09b4404f44_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NzNiNTBmZDAxZDk2NGIwMzk2ZjA1MjgwYTNhNjU0ODRfNA_47d4128a-b12b-4357-8603-968dd97c77a7"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6cd1bc3205234dbc80620f09b4404f44_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzItMS0xLTEtMjMyNTQ3_035e6b8b-3020-4f51-a2ec-a18d78f73d7e"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i78517656fb3e4be49efce58b458d7215_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzItMy0xLTEtMjMyNTQ3_9ebeaae2-3340-40b8-8234-ba3c6a822b1a"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i780cead0663d47e985eb7cde37891351_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NDVkYzllZmRhZmY0NDRmZmJkOWRmYjg0NDliMTczOTNfNA_069fe11f-b1b7-444b-bf4a-fc6cbbd11751"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i780cead0663d47e985eb7cde37891351_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzMtMS0xLTEtMjMyNTQ3_25a58fbf-7d71-4510-a882-3622434cdbc7"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id39881b60def4677ad68de30d76d707e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzMtMy0xLTEtMjMyNTQ3_b3647c29-8801-4519-aadd-e20dd30440ff"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5934de2b48064b68824f5a5e12dbbb82_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzQtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NWZlNzU1Nzc5MDg2NDY4OGE1NDdjYTc0NmY1YzAzM2ZfNA_0c463440-ca81-4c45-891a-5b2d2dc27eb6"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5934de2b48064b68824f5a5e12dbbb82_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzQtMS0xLTEtMjMyNTQ3_9b05ad18-a361-47ca-8815-8e500d6b8b48"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i245129fe18fc45cdadddd2c037c1005c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzQtMy0xLTEtMjMyNTQ3_7e916a5c-c8e3-4d87-89c8-a140a0c823cf"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib080a75dab51499e8152c514ed6ab74c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzUtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZmVmMGQxMjE4NjE1NGNlOTlhZTIwNjQwMDlmNjc1Y2FfNA_b0e25d19-ded5-4241-b6e0-83c3b5e7a4be"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib080a75dab51499e8152c514ed6ab74c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzUtMS0xLTEtMjMyNTQ3_dfc2698a-fe3a-408f-81a7-23a2d9a8c49c"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i444c1838f8c64b14a5caef64a8ccd662_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzUtMy0xLTEtMjMyNTQ3_3e57e541-0aca-47f2-9b7e-0cf7cb25ecaa"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3cd7de97cfdf412381d46297d5991484_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzYtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246MzBhYzVhYzIwYThhNDhlMWFkYTljMWZmZWZkODk1ZDlfNA_ffffed87-f84f-46f7-a7af-a3fe5b672b42"
      unitRef="number">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3cd7de97cfdf412381d46297d5991484_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzYtMS0xLTEtMjMyNTQ3_26686088-635e-4ec6-b239-6115b68a00b8"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if350f271cef34debb54ac8e3ae82abe9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzYtMy0xLTEtMjMyNTQ3_9d5e783a-4794-4956-bcf9-178ed1453550"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5c4d09214db040b5b5740899c41892e6_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzctMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246Njc2YzE5NTc3NzZiNGQ1NDgwNWFiNmVkYWRlODA3Y2VfNA_94234219-5f44-4c5a-a1fa-279d923bbc23"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5c4d09214db040b5b5740899c41892e6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzctMS0xLTEtMjMyNTQ3_8bfe8586-46b2-4f5d-9c23-e773071cdbb4"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8122b6f5dd094913857934bb5ac9998a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzctMy0xLTEtMjMyNTQ3_c6933aef-cf29-47a5-943e-9485bd0c5d08"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3e903c49671d4c7bb899e91247869f60_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NjRhZTBmYjJkNmJiNGM2YjkzZWE0Y2JlOGFmZWUxN2FfNA_d4358b32-d59d-4c0a-bd0e-a80292a792a6"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3e903c49671d4c7bb899e91247869f60_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzgtMS0xLTEtMjMyNTQ3_6f128b2e-405a-4bec-830d-d8d029feaf2f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i791829c941b64e9cb8aac4352fd31278_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzgtMy0xLTEtMjMyNTQ3_9c794f78-9e7a-43ac-b238-b5833334a045"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i48586d4589464091a486da7ecff7be86_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZGRiMTQ5NTgzNjI5NDIyMzkzYWNiN2Q4MmUyMjIxMTdfNA_f6f00f64-651b-4bdf-8f2b-529cf72197d6"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i48586d4589464091a486da7ecff7be86_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzktMS0xLTEtMjMyNTQ3_2d731621-5a31-4bf0-b01d-3a85a385b1ce"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9a52fb5322d941878151c5480cdcb452_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfMzktMy0xLTEtMjMyNTQ3_529da2b6-30c1-4134-8325-7c2a7f082618"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib95efcc5698746f887d004c6b539186f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDAtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZjIyMzhlMDI4YWYzNGYyNmE4YTg0NTk2NGEwNGQ1YzlfNA_480a7a5f-f2bd-4357-96e8-fd382f4654f0"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib95efcc5698746f887d004c6b539186f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDAtMS0xLTEtMjMyNTQ3_80f98d49-73e9-4599-8ee9-169ed0f14be2"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ife5a3762af674b319552867bf484df1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDAtMy0xLTEtMjMyNTQ3_065c32b4-2e6f-4023-bc8c-8207ec19ba58"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id09a1af1b14f4dedb5552601fe0a898b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDEtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246OTZjY2UzZjNmMzBhNGI4ZTkyZWM5OTZkZTY1Y2MyZjhfNA_3b629e8f-70a1-4a0d-ad8c-7d2e174b221b"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id09a1af1b14f4dedb5552601fe0a898b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDEtMS0xLTEtMjMyNTQ3_2fe5467b-b006-48af-b2a1-c5dbc784ba0a"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6fc72c0ca3044aefa6c543e50d9f5073_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDEtMy0xLTEtMjMyNTQ3_d6114181-89b5-4805-a3ac-8013f08f9d18"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8a9a69c0387a4dbb9cba44bbcb236d31_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDItMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ODlkODc2YTNkZjRiNDYzMThmYTI0YzdjMmVmNmVjODNfNA_26c32f4c-300d-4fd5-a884-0b589d9fc5ec"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8a9a69c0387a4dbb9cba44bbcb236d31_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDItMS0xLTEtMjMyNTQ3_0b8db55f-f227-4a9e-90b8-153a6153be49"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icad107da7cf74913a7fb43e2fa78c217_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDItMy0xLTEtMjMyNTQ3_e86e7159-542f-450a-9c86-5874217d9ca6"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i855756e5c4f640c09e72c199fabc5c3e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDMtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246NTRiYzAyYTllNTI1NDEwYzk1NjAxY2JiYTk2N2Q5NDNfNA_a852c65c-7963-4783-817c-7ce0b8f53d1d"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i855756e5c4f640c09e72c199fabc5c3e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDMtMS0xLTEtMjMyNTQ3_1a0f48fe-ed60-4154-97b4-be1123f469c8"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i38b6295bbdec46108d23d6648619dc7d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDMtMy0xLTEtMjMyNTQ3_7fde8972-68cd-4009-925a-7255769bc7b9"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i089e716c693541d38cbcfc0f339c6165_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMC0xLTEtMjU4NDc1L3RleHRyZWdpb246NmIwODFhMmQ0YjRhNDdmY2E3OWM1NzdiOWY2MWY2ZDhfMzI5ODUzNDg4MzMzMg_fc9045a7-fc9b-4c85-996b-13c733e05bdc"
      unitRef="number">0.05625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i089e716c693541d38cbcfc0f339c6165_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMS0xLTEtMjU4NDg0_327cf493-f511-46c2-8a05-adee98a5cca0"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i061610d07ab54236a1e052f4440a4b61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMy0xLTEtMjU4NDg0_545f4660-b8c0-4827-b635-b6dbccc165c4"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMS0xLTEtMjMyNTQ3_2f6d62ce-51f9-4f4d-9992-522252831572"
      unitRef="usd">1483000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDQtMy0xLTEtMjMyNTQ3_329c85a9-f91e-4bfd-9eef-7fdcaa7f22f3"
      unitRef="usd">1465000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i765e8c9bf1514d37b538d56d98f8673d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDUtMS0xLTEtMjMyNTQ3_5adc9a69-5dff-4f97-9d58-c4c6acff987c"
      unitRef="usd">311000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i843857ee2e25408ba0949fae0a27ddc3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDUtMy0xLTEtMjMyNTQ3_81706777-8d01-4b3f-9b11-85601fe5d27f"
      unitRef="usd">314000000</us-gaap:DebtInstrumentCarryingAmount>
    <cvs:LongTermDebtGrossAndLeaseObligation
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDYtMS0xLTEtMjMyNTQ3_6004167b-4ac2-4142-9594-50a7682f07f5"
      unitRef="usd">58768000000</cvs:LongTermDebtGrossAndLeaseObligation>
    <cvs:LongTermDebtGrossAndLeaseObligation
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDYtMy0xLTEtMjMyNTQ3_bcc70d52-d8cd-4356-bb10-232442e78578"
      unitRef="usd">52753000000</cvs:LongTermDebtGrossAndLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMS0xLTEtMjMyNTQ3_5c9d9299-9005-4134-b8ce-f23d8896f542"
      unitRef="usd">198000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDctMy0xLTEtMjMyNTQ3_e638bc68-af98-45c1-9226-b8eed783abd9"
      unitRef="usd">200000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDgtMS0xLTEtMjMyNTQ3_c32ff662-6dbb-4927-8040-19448329d48a"
      unitRef="usd">735000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDgtMy0xLTEtMjMyNTQ3_f94bdb65-5ded-49df-9e37-52c48a9c3be5"
      unitRef="usd">696000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDktMS0xLTEtMjMyNTQ3_a5c16583-aeae-452c-9b57-8b1cc6a8a9d7"
      unitRef="usd">58231000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNDktMy0xLTEtMjMyNTQ3_11878d5c-2507-4b44-a6aa-b850bcb315a7"
      unitRef="usd">52257000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTItMS0xLTEtMjMyNTQ3_c2a17195-f56e-40b6-9dd9-d857c20d1594"
      unitRef="usd">1778000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTItMy0xLTEtMjMyNTQ3_f7711a4e-2e0d-40b5-9608-fcd9e3a0b534"
      unitRef="usd">1778000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTMtMS0xLTEtMjMyNTQ3_f3e2d740-01ed-4ce1-afeb-d700d146526c"
      unitRef="usd">56453000000</cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale>
    <cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale
      contextRef="ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RhYmxlOmQxZGU4YjcyZjcyMDQ5MGNiMDRmYjJhMDhmMTM2NDQwL3RhYmxlcmFuZ2U6ZDFkZThiNzJmNzIwNDkwY2IwNGZiMmEwOGYxMzY0NDBfNTMtMy0xLTEtMjMyNTQ3_23004f48-c7ba-498c-a8ac-988d0c0bbbca"
      unitRef="usd">50479000000</cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id93ceac7923443509811589be6f2fda6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMzI5ODUzNDg4Njk4NQ_061d31b2-aa21-40aa-ae29-61b021716d54"
      unitRef="usd">3000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i825b614ae6f949128593ec129680423e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMzI5ODUzNDg4Njk4NQ_c4dd4a57-89c4-48c4-83a9-ba6cb4af14f2"
      unitRef="usd">3000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i57dc9b642fb340ec9fbef3cdb67f4dc4_I20230501"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTY0OTI2NzQ1ODM3Nw_83e328f6-d09a-4e8f-90bd-cc1898987a84"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="if84cea09dba14f6bb1e7a65458f7d779_D20230502-20230502"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfMTY0OTI2NzQ1ODM5MQ_86830c14-521a-43c4-aece-47440958cf4f"
      unitRef="usd">5000000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1f22263a3b694849ac61d1b0059ba4c0_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODA2NA_31005d68-901f-4e60-ba88-775db8e41a77"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f22263a3b694849ac61d1b0059ba4c0_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODA5Mg_e205b377-1b34-476c-835a-06f6dbe9eece"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3088c2dbfe5d4a469e09d45deecf17d4_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODA5OA_971dcbba-8f51-4999-b123-57e420da66c3"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3088c2dbfe5d4a469e09d45deecf17d4_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODExNA_bfa30063-6334-4546-b8ed-6ac1dd8dcbd0"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i466f42736e3c44f8a5bb7b033dc6dcc0_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODEyMg_ffc36a87-9240-4223-8e71-45e6f3149a6c"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i466f42736e3c44f8a5bb7b033dc6dcc0_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODEzOA_d3613aa1-0a78-4997-887c-e5c22d72e16f"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i96c354a2d55441de977ed5f9a4c0d071_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODE0Ng_12869661-7564-46eb-9be5-7cad460d4bd5"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i96c354a2d55441de977ed5f9a4c0d071_I20230221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODE2Mg_895c24d4-e013-4ab4-8807-d85726703fc1"
      unitRef="number">0.05625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i409ce543d75747f6a86747b1e3200724_D20230221-20230221"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81Mi9mcmFnOjljN2U1ZTAwNmJiOTQxMTlhZTU1MzFmMzE1YjBkZWY5L3RleHRyZWdpb246OWM3ZTVlMDA2YmI5NDExOWFlNTUzMWYzMTViMGRlZjlfNDk0NzgwMjMyODQ2Mw_81c61f82-60a7-4fc9-ae08-b16bfaa8d792"
      unitRef="usd">6000000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjU5Mw_cb84463c-7059-4b93-9169-f64a9181aac7">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase programs have been authorized by CVS Health Corporation&#x2019;s Board of Directors (the &#x201c;Board&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 17, 2022 (&#x201c;2022 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#x201c;ASR&#x201d;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 and 2022, the Company repurchased an aggregate of 22.8 million shares of common stock for approximately $2.0 billion and an aggregate of 19.1 million shares of common stock for approximately $2.0&#160;billion, respectively, both pursuant to the 2021 Repurchase Program. This activity includes the share repurchases under the ASR transactions described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $2.0&#160;billion fixed dollar ASR with Citibank, N.A. (&#x201c;Citibank&#x201d;). Upon payment of the $2.0&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#x2019;s common stock equal to 80% of the $2.0&#160;billion notional amount of the ASR or approximately 17.4&#160;million shares at a price of $92.19 per share, which were placed into treasury stock in January 2023. The ASR was accounted for as an initial treasury stock transaction for $1.6&#160;billion and a forward contract for $0.4&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2023, the Company received approximately 5.4&#160;million shares of CVS Health Corporation&#x2019;s common stock, representing the remaining 20% of the $2.0&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#x201c;Barclays&#x201d;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#x2019;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#x2019;s common stock, representing the remaining 20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury and the forward contract was reclassified from capital surplus to treasury stock in February 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quarterly cash dividend declared by the Board was $0.605 and $0.55 per share in the three months ended March&#160;31, 2023 and 2022, respectively. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjU4Mg_72ca878e-7888-4384-8186-b2984fe78fbc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase programs have been authorized by CVS Health Corporation&#x2019;s Board of Directors (the &#x201c;Board&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 17, 2022 (&#x201c;2022 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i1d3f405559b34436a7dd9bda0df240e1_I20221117"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0xLTEtMS0yNDY0NzU_bd9b7576-29e3-48eb-bf36-749c89236238"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i33e778ae14014217b9adbc2e50448ccd_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0zLTEtMS0yNDY0NzU_ed6a28e7-b37f-4432-a2c3-b8318be4c5b7"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i24b66500cbc3494cbb2171885f5e9eaf_I20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0xLTEtMS0yMzI1NDc_7ece097a-8b82-409c-b22a-3a996ddd6d7a"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ia8259b9e69e843db9bea20eeb8e3c4e0_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RhYmxlOmYzZjVjODE5ZmZmMzQwODc4NjlkZTIzNjA3YmIxYjhlL3RhYmxlcmFuZ2U6ZjNmNWM4MTlmZmYzNDA4Nzg2OWRlMjM2MDdiYjFiOGVfMS0zLTEtMS0yMzI1NDc_45d40c97-36d7-4323-a86c-3029d5779314"
      unitRef="usd">4500000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="if9b17aee558d466d97018672fae58058_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg4ODczMg_7e983873-76eb-4187-9f92-6af3fea6d7ed"
      unitRef="shares">22800000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if9b17aee558d466d97018672fae58058_D20230101-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNjMy_a21248e3-6ad1-489c-b61b-65a933189cfb"
      unitRef="usd">2000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i220c5401ed2f49ac8453e559cfa0869a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg4ODYzOQ_328a9e1e-84c4-4245-9b47-458f12957d74"
      unitRef="shares">19100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i220c5401ed2f49ac8453e559cfa0869a_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDEwNQ_391e9148-ea6b-4983-8955-ef38f1f32c14"
      unitRef="usd">2000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODQ4_bdf44c6d-1c21-464d-8bc9-c13815dd31fe"
      unitRef="usd">2000000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:PaymentsForAcceleratedShareRepurchasesAmount
      contextRef="i356ddbd8c27d4b8c951a6be4585f1092_D20230104-20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODYy_3622190e-e707-4bd4-ad78-a0b4bec70240"
      unitRef="usd">2000000000</cvs:PaymentsForAcceleratedShareRepurchasesAmount>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares
      contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODc2_e7ec55dd-e9e1-49ac-974a-76dc116e5bf7"
      unitRef="number">0.80</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4OTA4_5a6791e7-01da-4468-b5be-12778bf4c16e"
      unitRef="usd">2000000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODgx_335efb55-ebf2-48c9-ae38-a5d1b5e3ef0a"
      unitRef="shares">17400000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <us-gaap:SharePrice
      contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfNTQ5NzU1ODE4ODk1_6de1ae87-1180-4621-8073-4c5943f0eff8"
      unitRef="usdPerShare">92.19</us-gaap:SharePrice>
    <cvs:TransferOfSharesToTreasuryStockValue
      contextRef="ic891f32373a24150b07a0e2e79451ecf_I20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTY0OTI2NzQ0ODUwMQ_b7c41881-f495-44b1-8a44-6de32a4f04c9"
      unitRef="usd">1600000000</cvs:TransferOfSharesToTreasuryStockValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i82104008040f4e91b57c7a3d066cd708_I20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDAwOQ_e50cb82f-bf17-4024-bb7b-ec855c13f2c3"
      unitRef="usd">400000000</us-gaap:DerivativeNotionalAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="i165725ae3ea04060af45b3a4c66096f0_I20230228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTY0OTI2NzQ0ODQyNg_bcebfd59-1d48-4852-a7c1-b7a5f7a9e97b"
      unitRef="shares">5400000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram
      contextRef="i165725ae3ea04060af45b3a4c66096f0_I20230228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDAyNw_a96174f4-0080-4024-bbd8-95f61cb7b3db"
      unitRef="number">0.20</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i165725ae3ea04060af45b3a4c66096f0_I20230228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMzI5ODUzNDg5MDAzMw_1ca6b4e8-6b98-4603-9e35-8431b226366e"
      unitRef="usd">2000000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfOTM1_4feee1ab-90f1-44bb-89aa-7f035d24cb96"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:PaymentsForAcceleratedShareRepurchasesAmount
      contextRef="ice6b8f5b6cc749a6a4fce5808629a093_D20220104-20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTAxMg_d18d625c-0779-4f74-9d70-19454b977bfc"
      unitRef="usd">1500000000</cvs:PaymentsForAcceleratedShareRepurchasesAmount>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares
      contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTE0MA_05525d04-1334-45bf-b8be-d09e87469619"
      unitRef="number">0.80</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTE1MA_41bd85a9-afbb-4e8b-938e-93ac6dfc9e2b"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTE5Nw_b969a49d-67a4-4a62-bfb0-f919024c57fa"
      unitRef="shares">11600000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <us-gaap:SharePrice
      contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTIyMQ_3a170d36-4388-4dfb-ae9b-f6a0d5ed25be"
      unitRef="usdPerShare">103.34</us-gaap:SharePrice>
    <cvs:TransferOfSharesToTreasuryStockValue
      contextRef="ifdb54f39d1c8482b9e757ee875b765cb_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTM2MQ_bb77561d-deec-4fb2-bf15-c3533d8c3ac4"
      unitRef="usd">1200000000</cvs:TransferOfSharesToTreasuryStockValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8f99461356ba4ce58d8b75de3a097310_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTM5MQ_c4bcb1f0-923b-4225-816d-330cbe6fb876"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="iab1e6b8b47724b91aaf561c27d054b14_I20220228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTU0OQ_27cbe9cf-9068-4018-8c12-118986d3f378"
      unitRef="shares">2700000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram
      contextRef="iab1e6b8b47724b91aaf561c27d054b14_I20220228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTYyOA_dbcbe516-8e38-43e2-8e37-b549419cae32"
      unitRef="number">0.20</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="iab1e6b8b47724b91aaf561c27d054b14_I20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMTYzOA_68160358-e69f-40ca-abec-410b07fd239b"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjE0OA_9204fcbb-6ee1-4388-b5cc-f8dbf1b98307"
      unitRef="usdPerShare">0.605</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81NS9mcmFnOjdkNjcyZGIyNWZjZDQ5NTFhNzNiY2FlMjc1NDFhNzVjL3RleHRyZWdpb246N2Q2NzJkYjI1ZmNkNDk1MWE3M2JjYWUyNzU0MWE3NWNfMjE1NQ_2f5effce-c1b5-4300-ae26-71b5ea2e5424"
      unitRef="usdPerShare">0.55</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMTAzNw_b313dcfb-c723-4fab-9dee-aa548f4d5387">Other Comprehensive Income (Loss)&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income (loss) for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$0 and $26 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$340 and $(1,375) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$131 and $77 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in discount rate on long-duration insurance reserves:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$0 and $(838) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$(101) and $475 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(5) and $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(3) and $(4) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the adoption of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMjE5OTAyMzI1NzE0NQ_e6900be7-0b3a-4d0a-abd8-725b8e9077ce"&gt;ASU 2018-12&lt;/span&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Topic 944)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; during the three months ended March 31, 2023. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$14 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMTAyOA_76b356bc-b7f2-4112-8235-26c1e9187f4c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income (loss) for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$0 and $26 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$340 and $(1,375) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$131 and $77 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in discount rate on long-duration insurance reserves:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$0 and $(838) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$(101) and $475 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(5) and $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(3) and $(4) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:0.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the adoption of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfMjE5OTAyMzI1NzE0NQ_e6900be7-0b3a-4d0a-abd8-725b8e9077ce"&gt;ASU 2018-12&lt;/span&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Topic 944)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; during the three months ended March 31, 2023. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$14 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie9e4ce7d668647199a9963ba9223fb1e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMy0xLTEtMS0yMzI1NDc_98cad07e-dc87-4930-8a73-7eb51a64822a"
      unitRef="usd">-1519000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cee30098f554ffc83dd60ace24f2da1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMy0zLTEtMS0yMzI1NDc_ea8fe0a9-e358-4bb1-ae47-7ff279c57284"
      unitRef="usd">778000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="i12b0bf32f4024d9a901bb71692e6457b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yNTU1MDAvdGV4dHJlZ2lvbjo4MWUzOWU1Y2ZjNzQ0ZmM3OWVhMzFhMTBiMTE2MTNhNV8zMjk4NTM0ODgzMzk3_41ac8366-130a-4858-bb6c-6b72382e4c06"
      unitRef="usd">0</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="ia973432534304c319e71bd7ba226880a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yNTU1MDAvdGV4dHJlZ2lvbjo4MWUzOWU1Y2ZjNzQ0ZmM3OWVhMzFhMTBiMTE2MTNhNV8zMjk4NTM0ODgzNDAz_a38f7500-aec0-4937-beab-9f4585bb1ca3"
      unitRef="usd">26000000</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12b0bf32f4024d9a901bb71692e6457b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0xLTEtMS0yNTU0MDM_48f6bdda-f6df-4177-88c9-c13fc3e4b76b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia973432534304c319e71bd7ba226880a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0zLTEtMS0yNTU0MDM_e6431599-c5d0-404b-b670-c0331d72f21c"
      unitRef="usd">20000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjoxYmRiYTFiYmE2MWE0MjkyOTlhNDhiODQyNDJkNjU2Nl81NQ_e243bab5-8e10-450b-9268-f0c5de0defcb"
      unitRef="usd">340000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjoxYmRiYTFiYmE2MWE0MjkyOTlhNDhiODQyNDJkNjU2Nl81OQ_62ece9c3-d967-401b-ba76-749ba13dffe5"
      unitRef="usd">-1375000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0xLTEtMS0yMzI1NDc_ce5c5aae-4dc8-47e2-ac82-ea1c1681492d"
      unitRef="usd">339000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNC0zLTEtMS0yMzI1NDc_7ff73e36-b4b1-40b7-86e4-e538cfdd23c3"
      unitRef="usd">-1207000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjpjMzkwOWYzYzIwNTM0MWM0YTUwOWNlNjE0NmJmNzgwOF83Nw_4b354967-682d-4fcd-87f1-8389cee09343"
      unitRef="usd">131000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0wLTEtMS0yMzI1NDcvdGV4dHJlZ2lvbjpjMzkwOWYzYzIwNTM0MWM0YTUwOWNlNjE0NmJmNzgwOF84MQ_619f6772-9af8-4cdd-b58b-f51ea2b573dc"
      unitRef="usd">77000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0xLTEtMS0yMzI1NDc_cf94114b-5130-4c69-abe6-3581822af709"
      unitRef="usd">-131000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNS0zLTEtMS0yMzI1NDc_7bb1edfa-f179-49c4-a887-b0e8b8bf3f74"
      unitRef="usd">-75000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i808b9f3adfe942ef8f31ec4261b5e656_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNi0xLTEtMS0yMzI1NDc_e52b0beb-3edb-45e3-a027-c911670b2f19"
      unitRef="usd">470000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e978d84e7ad4d6381bfdffbe9cbd1dd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNi0zLTEtMS0yMzI1NDc_b8f23e67-dd7e-42e9-bd4c-ddd2475af9a9"
      unitRef="usd">-1132000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50bde2997fe64d2fa6e63680de08d727_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNy0xLTEtMS0yMzI1NDc_51aa1b1d-405d-434f-bac9-023dee36db4d"
      unitRef="usd">-1049000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e3b16b861e34693a440d9cbeb7ff083_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNy0zLTEtMS0yMzI1NDc_3e4f25b6-664e-4d4d-afc5-ddf6e528fce5"
      unitRef="usd">-334000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ce902132c444a37ae7bef2d65504f51_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMS0xLTEtMjU1NDU2_c5731851-df7c-4317-987c-b18c983b6e5d"
      unitRef="usd">219000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieaf12a3d04a2473399581bc3408cd6bb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMy0xLTEtMjU1NDU2_dcbe0c95-bcc5-4f2d-9d5c-fe166264736f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="ia2a52a92c5c54930b5139ac668af203b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMC0xLTEtMjU1NTE2L3RleHRyZWdpb246ZGNiZTY0NWI2Nzg1NDdiN2I2OWQ0YzcxMjk0YmVmZmZfMzI5ODUzNDg4MzM5Nw_d7ad2f2a-4715-451c-91fb-661892881350"
      unitRef="usd">0</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="i2e51eab27f6049da87e49ecefc750401_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMC0xLTEtMjU1NTE2L3RleHRyZWdpb246ZGNiZTY0NWI2Nzg1NDdiN2I2OWQ0YzcxMjk0YmVmZmZfMzI5ODUzNDg4MzQwMw_35c67028-8f6b-4ed4-9ffa-97d49eb176fe"
      unitRef="usd">-838000000</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2a52a92c5c54930b5139ac668af203b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMS0xLTEtMjU1NDU2_e924fa04-ea9f-4947-b698-ad906e376b8e"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e51eab27f6049da87e49ecefc750401_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTItMy0xLTEtMjU1NDU2_082e2404-ccd3-4c21-94ab-1c8b829514b9"
      unitRef="usd">-651000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMC0xLTEtMjU1NDI2L3RleHRyZWdpb246ZmMxMTlkMzJmZTRiNGY1NDk2ZmQzOTNhNTIxMzU4MmZfMzI5ODUzNDg4MzQyMQ_280bab8f-d497-468e-a8b5-b4fcc9def543"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMC0xLTEtMjU1NDI2L3RleHRyZWdpb246ZmMxMTlkMzJmZTRiNGY1NDk2ZmQzOTNhNTIxMzU4MmZfMzI5ODUzNDg4MzQzNA_f599444c-2f6e-4cea-abd4-679faf7b4e5f"
      unitRef="usd">475000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMS0xLTEtMjU1NDU2_27c72671-20eb-480e-bfa5-0cb1eb1bb4ee"
      unitRef="usd">-74000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMy0xLTEtMjU1NDU2_ada285d9-91a2-408d-a747-f4beae5e29d4"
      unitRef="usd">369000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7f14b0f7bbb0455d87c140a92653d45b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMS0xLTEtMjU1NDU2_abc8563e-b066-495e-ba22-4b79f3be9308"
      unitRef="usd">-74000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib7b866faedc04dd8a3e6facfc944c722_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMy0xLTEtMjU1NDU2_8a59c396-7ec8-4caa-bed1-46fc7f85ff83"
      unitRef="usd">369000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b73ef515fa74bda9625d4853a2c40af_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTUtMS0xLTEtMjU1NDU2_009bd01b-c97f-488c-894d-c3d5be904836"
      unitRef="usd">145000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc48e18e68b24845a7b17fbee590d05e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTUtMy0xLTEtMjU1NDU2_982283f6-fe46-481d-903d-f71adc1a2367"
      unitRef="usd">-282000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4233cdd857c84c5495036af966d69c1e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTAtMS0xLTEtMjMyNTQ3_bf7283e1-1b12-432a-b29b-0fe1f69180aa"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69ec3798d5e44b4d9eec0a23d4f9102b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTAtMy0xLTEtMjMyNTQ3_8eb152fd-c36e-4d21-b6f0-b6e9cfac4625"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icbaec47994724954be26c44f88b1be41_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMS0xLTEtMjMyNTQ3_d79e8547-4283-4e11-b201-99261386d846"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5349061ce37a4635b17c190c002a1781_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTEtMy0xLTEtMjMyNTQ3_565ea49d-cad0-4c76-9476-9983fe2e004a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icbaec47994724954be26c44f88b1be41_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMS0xLTEtMjMyNTQ3_18a9a57c-8ca0-4193-b8e4-e1afdd835939"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5349061ce37a4635b17c190c002a1781_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTMtMy0xLTEtMjMyNTQ3_210cbf5e-3225-4b4f-9a98-c268d6b7adff"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c1adaa533e24a38b010ac1f6be0ca13_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMS0xLTEtMjMyNTQ3_6bdacc3d-c369-4ed3-b670-14cb1c76564f"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib634cfe740504bac99546a361cf5b67c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTQtMy0xLTEtMjMyNTQ3_1a7131ec-6f49-4de6-becf-b7a85731bb6c"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8471dc1ae7b4c3ea316bf53d8400d96_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTctMS0xLTEtMjMyNTQ3_b1b545ec-19d9-4f1f-b816-281d59ce3466"
      unitRef="usd">239000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37a9e3c8866a4ad8be85672e565cf864_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTctMy0xLTEtMjMyNTQ3_b6b459f5-5495-44c9-afdf-ef8feccbdc70"
      unitRef="usd">222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTEzMDc5YWY0ZGMzNDZiYjkwNDM5ZDU4OTg2MDZjNDBfNTc_d69f9a22-3b83-4cb6-a549-bae607d53cb3"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246ZTEzMDc5YWY0ZGMzNDZiYjkwNDM5ZDU4OTg2MDZjNDBfNjE_14e84649-ec7d-447c-9235-391242783d16"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMS0xLTEtMjMyNTQ3_f559d6dc-d98a-4d90-a491-a9a885999e81"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTgtMy0xLTEtMjMyNTQ3_f000ee31-a196-4053-b754-3470d18526ea"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246OTYxODBmZTRkMmNjNDZjYTgzNTZlZTFkMmM5N2I3YTdfNzA_4fa52e89-9d09-480b-97b3-26f505764991"
      unitRef="usd">-3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMC0xLTEtMjMyNTQ3L3RleHRyZWdpb246OTYxODBmZTRkMmNjNDZjYTgzNTZlZTFkMmM5N2I3YTdfNzQ_334743af-924c-4741-aa59-0b46dee1f74c"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMS0xLTEtMjMyNTQ3_39957cbc-3187-43ff-b0aa-c7d111a3c8ad"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMTktMy0xLTEtMjMyNTQ3_391fefd9-1e28-4806-861a-544ba6a34763"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3085f405e614b6a99ca4f0c8313216b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjAtMS0xLTEtMjMyNTQ3_2adc4940-0cdc-49c2-bd23-3a58946132bc"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibadf3a6be63d4640bc91c8a0bb0fe440_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjAtMy0xLTEtMjMyNTQ3_6b1ec978-8d99-4916-b8ad-5f927fa01796"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e7ed44250004f0abd93cfd873764497_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjEtMS0xLTEtMjMyNTQ3_c0bdd1da-6dec-45f9-83e5-3ce062e5853d"
      unitRef="usd">233000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80edf5a59a3b4b4cbde630d40e6cf394_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjEtMy0xLTEtMjMyNTQ3_eca8d4bd-b8e1-4484-a1e2-09509c8b3e4d"
      unitRef="usd">219000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a2ced1961f54c58a58691eb07a37938_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjQtMS0xLTEtMjMyNTQ3_b169a3e7-8789-469d-a316-9da0c7054084"
      unitRef="usd">-203000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24d62eb54342479d9c8f667ab299427d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjQtMy0xLTEtMjMyNTQ3_c33396e4-5738-41ba-9fbe-f9c00e7afc61"
      unitRef="usd">-35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd2694bab621470b83d6016dd198125c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjctMS0xLTEtMjMyNTQ3_44aa55bf-bdd0-47e6-b678-33dbffea2891"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0e064e345951488e83346591a86aa59e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjctMy0xLTEtMjMyNTQ3_3155991e-6c9a-42e8-8130-36a8fad98f20"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i428c873482a54c03a2844bcfd0128950_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjgtMS0xLTEtMjMyNTQ3_922ae601-c822-45e1-9714-6580ef3401e8"
      unitRef="usd">-203000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36ecd33b2f0d4bf79158216e8e771219_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMjgtMy0xLTEtMjMyNTQ3_f907bcc2-0f2d-4d4b-ae0e-7337ad10d6d0"
      unitRef="usd">-35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i506d0959bcbe41b386b645d218ba7cad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzAtMS0xLTEtMjMyNTQ3_ec5efd56-7fc2-4b56-88f7-c625c524ee5c"
      unitRef="usd">-1264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b89e03562af42418df598d66e518fc3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzAtMy0xLTEtMjMyNTQ3_aeaaa3eb-8ffe-4c03-afe1-15fe8f5522f0"
      unitRef="usd">965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2abc6620160466c96132f7287192b1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNDAtMS0xLTEtMjU1NDY5_fd35e3b5-5437-402d-9358-6c485d0a4af7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28d618aaf5d4485a9bcc280348fd703a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfNDAtMy0xLTEtMjU1NDY5_104007a2-8ee3-4be3-a7c6-6bb71564d949"
      unitRef="usd">-631000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzEtMS0xLTEtMjMyNTQ3_4eee5b7b-995b-488a-aa6e-0911d948f340"
      unitRef="usd">389000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzEtMy0xLTEtMjMyNTQ3_eb9d3935-7ece-42b0-84e3-b72c18fe6859"
      unitRef="usd">-763000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a84c750be7040c4995da886f9ea1771_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzItMS0xLTEtMjMyNTQ3_ab6f9d45-3100-42c4-9753-3ef516e50689"
      unitRef="usd">-875000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie9431e6a492f4c89b178b2b1528cc6f0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RhYmxlOjI4YWVmZjJhZTJiNTRjMzc4ZWI1NmMxODc2MDhiOWUwL3RhYmxlcmFuZ2U6MjhhZWZmMmFlMmI1NGMzNzhlYjU2YzE4NzYwOGI5ZTBfMzItMy0xLTEtMjMyNTQ3_dfb73f9f-c2cd-4c68-ad06-8f69e93ccfd7"
      unitRef="usd">-429000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i0e7ed44250004f0abd93cfd873764497_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV81OC9mcmFnOjA5YmY5OTljNzJjODQ1ZjZhNTkzZDk4NzM4MzZmYzAyL3RleHRyZWdpb246MDliZjk5OWM3MmM4NDVmNmE1OTNkOTg3MzgzNmZjMDJfNjkw_df825a07-8390-407d-93c0-faa1f6b10e6e"
      unitRef="usd">14000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfMTM3Nw_099b0fb0-4257-49d3-b861-001901016519">Earnings Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the treasury stock method. Stock options and stock appreciation rights to purchase 4 million and 2 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three months ended March&#160;31, 2023 and 2022, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1fb588d338ae42bcbcfae34f3bc52d4b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfNDAy_63caaa80-733f-478f-8a53-cea0ad1bbc64"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic10b551416e249919ddba15b607f1f4c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfNDk0NzgwMjMyNjY5MQ_8915eb91-f61d-42fa-aeb2-826f3ea21dc6"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RleHRyZWdpb246MDExNDRmODgwNDk4NDYyYThkZDgyNzYzNzJlZDA0ZjJfMTM2Nw_90a6f84d-8911-49b9-8779-54e0acf87b0e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfNi0xLTEtMS0yMzI1NDc_eeda8040-0531-4f42-9ae8-c55b39e9d03d"
      unitRef="usd">2136000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfNi0zLTEtMS0yMzI1NDc_ad8da7ea-30ea-423d-af60-002a2f6c1eed"
      unitRef="usd">2354000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfOS0xLTEtMS0yMzI1NDc_9da5002e-8081-46bc-958b-82e0338c97f6"
      unitRef="shares">1283000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfOS0zLTEtMS0yMzI1NDc_0e88b8a3-e7fb-4f0d-97aa-f0baaf5c70e2"
      unitRef="shares">1312000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i578b2414d82040be9c8f73746252c42e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTAtMS0xLTEtMjMyNTQ3_34d87d71-c977-4880-ab46-e5a02013d58c"
      unitRef="shares">5000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibb438f2d815843dcbab2c539cffbd7ad_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTAtMy0xLTEtMjMyNTQ3_13957e19-9eb2-429b-8cea-5c57b7df5fb3"
      unitRef="shares">10000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1fb588d338ae42bcbcfae34f3bc52d4b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTEtMS0xLTEtMjMyNTQ3_26b781be-8eca-4b73-a1ea-df3caaa163b3"
      unitRef="shares">3000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic10b551416e249919ddba15b607f1f4c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTEtMy0xLTEtMjMyNTQ3_5ce354db-cb22-4bef-b048-f221717071b6"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTItMS0xLTEtMjMyNTQ3_38559511-737e-457b-ab84-7177537349e3"
      unitRef="shares">1291000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTItMy0xLTEtMjMyNTQ3_dd70be0b-fa4d-49ae-a7c5-d297e1420d8b"
      unitRef="shares">1328000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTUtMS0xLTEtMjMyNTQ3_36cd68c8-4a0e-46af-9991-851c4acc6ce9"
      unitRef="usdPerShare">1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTUtMy0xLTEtMjMyNTQ3_8b329685-2f7e-4062-89ac-faf3a78fecc5"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTYtMS0xLTEtMjMyNTQ3_ca9fe2d0-bf81-4d2a-968f-7b84cb077096"
      unitRef="usdPerShare">1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82MS9mcmFnOjAxMTQ0Zjg4MDQ5ODQ2MmE4ZGQ4Mjc2MzcyZWQwNGYyL3RhYmxlOjdlM2ExZTdiYzU5NzRiNzFiNDRiZGU1MGU3ZmRhYmQ3L3RhYmxlcmFuZ2U6N2UzYTFlN2JjNTk3NGI3MWI0NGJkZTUwZTdmZGFiZDdfMTYtMy0xLTEtMjMyNTQ3_1223cc4d-14ee-4f4a-903a-0743d66bb84e"
      unitRef="usdPerShare">1.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMzQ0Mzc_0e4eb9e2-fc15-49d9-bbd1-5f05451ee5c5">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations. As of March&#160;31, 2023, the Company guaranteed 64 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2034. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic had on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS&#x201d;), state insurance and health and welfare departments, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the U.S. Department of Justice (the &#x201c;DOJ&#x201d;), &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;state Attorneys General, the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;), the U.S. Federal Trade Commission (the &#x201c;FTC&#x201d;) and other governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. Other than the controlled substances litigation accruals described below, none of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#x2019;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Pricing Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits that allege that the Company&#x2019;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors and government payors, and are based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;classes have been certified. In October 2022, one of the litigating shareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to demonstrate demand futility. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions, and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims. The Company has also received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;), and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims beginning as far back as the early 2000s generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs, and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs, and other requests for information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a judgment jointly against the three defendants in the amount of $651&#160;million to be paid over 15 years, and also ordered certain injunctive relief. The Company is appealing the judgment and has not accrued a liability for this matter. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a leadership group of a number of state Attorneys General and the Plaintiffs&#x2019; Executive Committee (&#x201c;PEC&#x201d;). The agreement would resolve substantially all opioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the settlement would be approximately $4.3&#160;billion in opioid remediation and $625&#160;million in attorneys&#x2019; fees and costs and additional remediation. The amounts would be payable over 10 years, beginning in 2023. The agreement also contains injunctive terms relating to the dispensing of opioid medications. The settlement agreement is available at nationalopioidsettlement.com.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the settlement agreement, before the Company determines whether to enter into any final settlement, it will assess the number and identities of the governmental entities that will participate in any such settlement. The settlement agreement contemplates that if certain governmental entities do not agree to the settlement, but the Company nonetheless concludes that there is sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. Private plaintiff litigation will also continue.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has been informed that 45 states, the District of Columbia, and all eligible United States territories have elected to join the settlement. The Company has elected to proceed with the settlement process based on that level of participation. The settlement process will progress to the period during which subdivisions may elect to join. The Company has separately entered into settlement agreements with the Cherokee Nation and four states: Florida, West Virginia, New Mexico, and Nevada.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company also agreed to a formal settlement agreement with a leadership group representing tribes throughout the United States. The agreement resolves substantially all opioid claims against Company entities by such tribes. The maximum amount payable by the Company under the settlement is $113&#160;million in opioid remediation and $16&#160;million in attorneys&#x2019; fees and costs, payable over 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has concluded that settlement of opioid claims by governmental entities and tribes is probable, and the loss related thereto could be reasonably estimated. As a result of that conclusion, and its assessment of certain other opioid-related claims including those for which the Company reached agreement in August and September 2022, the Company recorded pre-tax charges of $5.3&#160;billion during the year ended December 31, 2022. Settlement accruals expected to be paid within twelve months from the balance sheet date are classified as accrued expenses on the unaudited condensed consolidated balance sheets and settlement accruals expected to be paid greater than twelve months from the balance sheet date are classified as other long-term liabilities on the unaudited condensed consolidated balance sheets. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment requires judgments about future events. Moreover, the settlement is in its early phases, and there is no assurance that contingencies will be satisfied. The amount of ultimate loss may differ materially from this accrual. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with any settlement arrangement or other resolution of all opioid-related litigation matters, including the uncertain scope of participation by governmental entities, and given that the Company continues to actively defend ongoing litigation for which it believes it has defenses and assertions that have merit, the Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time. The outcome of these legal matters could have a material effect on the Company&#x2019;s business, financial condition, operating results and/or cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The DOJ subsequently served additional DEA administrative subpoenas relating to controlled substances. The DOJ also served the Company with additional CIDs relating to controlled substances. The Company is providing documents and information in response to these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed a complaint-in-intervention in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Gill et al. v. CVS Health Corp. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (U.S. District Court for the Northern District of Illinois). In July 2022, the Delaware Attorney General&#x2019;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The federal government and the remaining states declined to intervene on other additional theories in the relator&#x2019;s complaint. The Company is defending itself against all of the claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the Company&#x2019;s post payment audit and collection practices). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to claims payments, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#x201c;OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, in the &#x201c;Notice of Final Payment Error Calculation for Part C Medicare Advantage Risk Adjustment Validation Data (RADV) Contract-Level Audits,&#x201d; CMS revised its audit methodology for RADV contract-level audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS announced extrapolation of the error rate identified in the audit sample along with the application of a process to account for errors in the government&#x2019;s traditional fee-for-service Medicare program (&#x201c;FFS Adjuster&#x201d;). For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract, nor did CMS propose to apply a FFS adjuster. By applying the FFS Adjuster, Medicare Advantage organizations would have been liable for repayments only to the extent that their extrapolated payment errors exceeded the error rate in Original Medicare, which could have impacted the extrapolated repayments to which Medicare Advantage organizations are subject. This revised contract-level audit methodology increased the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. In the RADV audit methodology CMS used from 2011-2013, CMS selected only a few of the Company&#x2019;s Medicare Advantage contracts for various contract years for contract-level RADV audits. In October 2018, CMS in the proposed rule (&#x201c;Proposed Rule&#x201d;) announced a new methodology for RADV audits targeting certain health conditions and members with many diagnostic conditions along with extrapolation for the error rates identified without use of a FFS Adjuster. While the rule was under proposal, CMS initiated contract-level RADV audits for the years 2014 and 2015 with this new RADV methodology without a final rule. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 30, 2023, CMS released the final rule (&#x201c;RADV Audit Rule&#x201d;), announcing it may use extrapolation for payment years 2018 forward, for both RADV audits and OIG audits, and eliminated the application of a FFS Adjuster in Part C contract-level RADV audits of Medicare Advantage organizations. In the RADV Audit Rule, CMS indicated that it will use more than one audit methodology going forward and indicated CMS will audit contracts it believes are at the highest risk for overpayments based on its statistical modeling, citing a 2016 Governmental Accountability Office report that recommended selection of contract-level RADV audits with a focus on contracts likely to have high rates of improper payment, the highest coding intensity scores, and contracts with high levels of unsupported diagnoses from prior RADV audits.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds for years prior to 2018 or prospective adjustments to Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#x2019;s minimum loss ratio rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RADV Audit Rule does not apply to the CMS Part C Improper Payment Measures audits nor the HHS-RADV programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes related to risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Southern District of New York requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit. Since filing, several of the cases have been consolidated, and two have resolved, including the first-filed federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Miami Fire Fighters&#x2019; and Police Officers&#x2019; Retirement Trust, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), the dismissal of which the First Circuit affirmed in August 2022. The Company and its current and former officers and directors are defending themselves against remaining claims. The Company has moved to dismiss the amended complaint in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Act Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Waterford&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Warren&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freundlich&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), the court granted the Company&#x2019;s motion to dismiss in February 2023 and the plaintiffs have filed a notice of appeal.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#x201c;ERISA&#x201d;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. The plaintiffs in these cases asserted a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business. In October 2022, the court granted the Company&#x2019;s motion to dismiss the amended consolidated complaint with prejudice. Plaintiffs appealed this decision to the Second Circuit and later withdrew the appeal in January 2023.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Beginning in December 2021, the Company has received two demands for inspection of books and records pursuant to Delaware Corporation Law Section 220, as well as a derivative complaint (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Vladimir Gusinsky Revocable Trust v. Lynch, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) that was filed in January 2023. The demands and the complaint purport to be related to potential breaches of fiduciary duties by &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;the Board in relation to certain matters concerning opioids. The Company and its current and former officers and directors are defending themselves against these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas, or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation, and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed, or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight, and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cvs:GuarantorObligationsNumberOfLeases
      contextRef="i80e4bbee9f2f48ff8554d030ba033144_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjA1Mw_43b97c11-de97-4ff7-9eff-f2138195cc8b"
      unitRef="lease">64</cvs:GuarantorObligationsNumberOfLeases>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i834bdaa838194915943ae1dd41b66214_D20220801-20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMTI4NTk_de3965c0-928c-4cff-9374-cafa4ee401ef"
      unitRef="usd">651000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="i30f76719657045dc97c61d48649aabd8_I20220831"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMTI4Nzg_95a22891-eaad-4e37-8e60-6e6a5bd9bd31">P15Y</cvs:LegalSettlementPeriodOfPayment>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i73c2c711a9e144129bf8bcee89201591_D20221201-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMTY0OTI2NzQ5MDU2OA_f70b97a6-97fc-4427-9141-4af4ca676abb"
      unitRef="usd">4300000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LegalFees
      contextRef="i73c2c711a9e144129bf8bcee89201591_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDI5_a750c07c-603f-4fa3-a1f2-83b1c7b33cce"
      unitRef="usd">625000000</us-gaap:LegalFees>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="if91f496db0cd4ebeb4308b49828714b9_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMwNDIwNQ_4963d655-b30e-45fa-910a-99194ddd9f50">P10Y</cvs:LegalSettlementPeriodOfPayment>
    <cvs:LitigationSettlementNumberOfStatesElectedToJoin
      contextRef="if91f496db0cd4ebeb4308b49828714b9_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMwNDIxOQ_aadf6861-b86d-4013-b1a5-2c68c4e374e5"
      unitRef="state">45</cvs:LitigationSettlementNumberOfStatesElectedToJoin>
    <cvs:LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements
      contextRef="if91f496db0cd4ebeb4308b49828714b9_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMyNzc4Mw_f916c3b9-8b21-4ef2-83fc-55c5c1bc97d9"
      unitRef="state">4</cvs:LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9ef4e0c2d2c244c393a5cfcced1e4a15_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDQz_ed75803d-1f6a-48a4-adbb-8669966308e0"
      unitRef="usd">113000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LegalFees
      contextRef="i9ef4e0c2d2c244c393a5cfcced1e4a15_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDU3_5cedc078-b2e6-4706-a530-28601fd8f52e"
      unitRef="usd">16000000</us-gaap:LegalFees>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="ie999f8648a0f440188249767603b220a_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMwNDIzMw_9b662f0f-2427-4de0-9f79-b6958deb1667">P10Y</cvs:LegalSettlementPeriodOfPayment>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i0692ab80d568422b875c73998e65a989_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfNTQ5NzU1ODU1MDcw_4d0b9440-3542-4a32-aafe-9de54ac979d9"
      unitRef="usd">-5300000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i27b20e43185e4a60b4de68bbfd17424a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82NC9mcmFnOjNjYzg4NTU4OGMyNjQ0N2M5ZmMxNTE2M2Q4ODA4ZGNiL3RleHRyZWdpb246M2NjODg1NTg4YzI2NDQ3YzlmYzE1MTYzZDg4MDhkY2JfMjE5OTAyMzMxMTg1OA_f7809272-ff50-4007-adb2-8f5745fbeb06"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNTY2Mw_50346245-1ea2-4dd2-bcb5-f215642fbfe5">Segment Reporting&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three operating segments, Health Care Benefits, Health Services and Pharmacy &amp;amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the CODM evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment financial information for the three months ended March&#160;31, 2023 reflects the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The realignment of the Company&#x2019;s segments to correspond with changes made to its operating model as described in Note 1 &#x201c;Significant Accounting Policies,&#x201d; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method, as described in Note 1 &#x201c;Significant Accounting Policies.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment financial information for the three months ended March&#160;31, 2022 has been revised to conform with current period presentation for these items, the impact of which are reflected in the &#x201c;Adjustments&#x201d; lines of the table below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp;amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp;amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Prior period financial information has been recast to conform with&#160;current period presentation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Health Services segment include approximately $4.1 billion and $3.8 billion of retail co-payments for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on assets held for sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related transaction and integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office real estate optimization charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid litigation charge &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the unaudited condensed consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#x2019;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023, the loss on assets held for sale relates to the Company&#x2019;s LTC reporting unit within the Pharmacy &amp;amp; Consumer Wellness segment. During 2022, the Company determined that its LTC business was no longer a strategic asset and committed to a plan to sell it, at which time the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. As of March 31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the first quarter of 2023, a loss on assets held for sale was recorded to write down the carrying value of the LTC business to the Company&#x2019;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. During the three months ended March&#160;31, 2022, the loss on assets held for sale relates to the Company&#x2019;s Thailand business, which was included in the Commercial Business reporting unit in the Health Care Benefits segment. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023, the acquisition-related transaction and integration costs relate to the acquisitions of Signify Health and Oak Street Health. The acquisition-related transaction and integration costs are reflected in the Company&#x2019;s unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#x2019;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#x2019;s unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2022, the opioid litigation charge relates to an agreement to resolve substantially all opioid claims against the Company by the State of Florida. The opioid litigation charge is reflected within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNDE_5a64c3cc-08b9-414f-b653-8e5826ccd27c"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNTY2MA_66873257-87bb-46b2-9a7b-c42e16143f63">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment financial information for the three months ended March&#160;31, 2022 has been revised to conform with current period presentation for these items, the impact of which are reflected in the &#x201c;Adjustments&#x201d; lines of the table below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp;amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp;amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Prior period financial information has been recast to conform with&#160;current period presentation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Health Services segment include approximately $4.1 billion and $3.8 billion of retail co-payments for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;(2)Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i43eb35c724574445b70e64a0712e5fd0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi0xLTEtMS0yNTI2Njg_3c37d192-2bd3-4f0a-bd37-5ffcc669f52e"
      unitRef="usd">23109000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6c819332a1f49149907bd79dbb6e5ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi0zLTEtMS0yNTI2Njg_fc27b8e6-581a-497c-8536-095af4fafca0"
      unitRef="usd">39461000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5ea3c803bd92470ca456a8cbd46b65d7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi01LTEtMS0yNTI2Njg_73384a38-af48-4cb6-9092-6e0d3573a77b"
      unitRef="usd">25418000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id46d76788ff04d0c89d679c03b4d8113_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi03LTEtMS0yNTI2Njg_a15d6815-da90-47d9-b4aa-675581e9e334"
      unitRef="usd">126000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b33e78be95e46aa8781e4f5cd708b7b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi05LTEtMS0yNTI2Njg_17187ca8-fb20-4424-8833-2c8134876a04"
      unitRef="usd">-11288000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNi0xMS0xLTEtMjUyNjY4_5bb026ce-0baf-4854-a39d-feec945612d7"
      unitRef="usd">76826000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icceee7f19d8144d1838edd528b32a625_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy0xLTEtMS0yNTI2Njg_f13518fd-47fc-4327-a6c7-493afc8cc841"
      unitRef="usd">-15000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id25124c88573450f860bbc033280cab3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy0zLTEtMS0yNTI2Njg_fb7b747d-e8e8-420b-902a-ae44a662614d"
      unitRef="usd">154000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72d3de15fdb141208e8be43677f48e7a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy01LTEtMS0yNTI2Njg_a08abbea-b514-4045-838d-eaeec75c88f9"
      unitRef="usd">480000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf51c4d778d74146836a38c29f6f5806_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy03LTEtMS0yNTI2Njg_9e31d8c9-c6a9-4ea9-bd41-a4d42d206417"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8949cbfc8744ae59620e133dc98603d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy05LTEtMS0yNTI2Njg_ef32a30b-c8a7-4917-9331-38ba07e4a09e"
      unitRef="usd">-619000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8f5c687add1743e5809d22a9d77525eb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfNy0xMS0xLTEtMjUyNjY4_f31e47e7-af6a-47e0-81cd-5d9590bb7795"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC0xLTEtMS0yNTI2Njg_166e5f0f-b984-4be3-b901-98add35b22bf"
      unitRef="usd">23094000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC0zLTEtMS0yNTI2Njg_f349105d-f04f-4771-a04c-88511479baeb"
      unitRef="usd">39615000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC01LTEtMS0yNTI2Njg_933ba77a-3884-4784-92b5-8d89e4666c04"
      unitRef="usd">25898000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC03LTEtMS0yNTI2Njg_8b432e85-9edf-42e0-9de7-000ad9ee6277"
      unitRef="usd">126000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC05LTEtMS0yNTI2Njg_cc7dc0b4-3c67-422d-ab51-132fbb9c851e"
      unitRef="usd">-11907000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfOC0xMS0xLTEtMjUyNjY4_ff8544f7-ed3a-41c1-a012-d140a0ea3faa"
      unitRef="usd">76826000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i43eb35c724574445b70e64a0712e5fd0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtMS0xLTEtMjUyNjY4_abf576bf-606b-4242-911e-4e14d05967eb"
      unitRef="usd">1751000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia6c819332a1f49149907bd79dbb6e5ee_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtMy0xLTEtMjUyNjY4_1e7dc6df-30cf-4cfa-bb19-414bcba39ba4"
      unitRef="usd">1636000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5ea3c803bd92470ca456a8cbd46b65d7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtNS0xLTEtMjUyNjY4_b02c01bb-5408-4a60-b525-09b89b2e0a22"
      unitRef="usd">1605000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id46d76788ff04d0c89d679c03b4d8113_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtNy0xLTEtMjUyNjY4_ddde87f4-51b3-4feb-a3b4-994b83bd0bb9"
      unitRef="usd">-305000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9b33e78be95e46aa8781e4f5cd708b7b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtOS0xLTEtMjUyNjY4_dd59a713-9130-47d3-9fff-61baeb0d31ff"
      unitRef="usd">-204000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iab7538367b4d402aad244c6c69df822b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjYtMTEtMS0xLTI1MjY2OA_14b3b2e1-0be5-4dba-bd03-cb09807ee04b"
      unitRef="usd">4483000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="icceee7f19d8144d1838edd528b32a625_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctMS0xLTEtMjUyNjY4_91925009-f404-4270-a0ae-aad8078095d3"
      unitRef="usd">110000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id25124c88573450f860bbc033280cab3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctMy0xLTEtMjUyNjY4_bbdec360-95c2-4878-aa1e-76e9f4edd173"
      unitRef="usd">-165000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i72d3de15fdb141208e8be43677f48e7a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctNS0xLTEtMjUyNjY4_a955570e-7661-4b78-b1f6-2d6111887022"
      unitRef="usd">-32000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iaf51c4d778d74146836a38c29f6f5806_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctNy0xLTEtMjUyNjY4_d1d52d4d-99f4-464d-b04a-4bb676baff56"
      unitRef="usd">7000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie8949cbfc8744ae59620e133dc98603d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctOS0xLTEtMjUyNjY4_dd7dbc4f-1a93-4f0e-920f-37b269734a49"
      unitRef="usd">204000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i8f5c687add1743e5809d22a9d77525eb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjctMTEtMS0xLTI1MjY2OA_f6fe4bf1-5acf-45ad-b35c-6d03a843e510"
      unitRef="usd">124000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtMS0xLTEtMjUyNjY4_3639a236-0cfc-49fd-b8a7-a0d7a2d7c1c3"
      unitRef="usd">1861000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtMy0xLTEtMjUyNjY4_08acf7cc-d09a-4203-a5a1-f588722cd673"
      unitRef="usd">1471000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtNS0xLTEtMjUyNjY4_133ef1c7-5bed-4be4-b6d8-8c2489dafaab"
      unitRef="usd">1573000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtNy0xLTEtMjUyNjY4_b1e3f909-b795-48aa-81ca-1bb677247a13"
      unitRef="usd">-298000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtOS0xLTEtMjUyNjY4_d23f47af-362a-4ab0-b7fe-9448885e2730"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjBhODE3NWZmMjlkYjQ2YTc4MTEzNDFhNjU1M2I1OTY5L3RhYmxlcmFuZ2U6MGE4MTc1ZmYyOWRiNDZhNzgxMTM0MWE2NTUzYjU5NjlfMjgtMTEtMS0xLTI1MjY2OA_3db3787c-bd76-499a-b759-b3855f0c8a24"
      unitRef="usd">4607000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy0xLTEtMS0yMzI1NDc_e8e21331-403d-4eb4-9d46-bf6bec6df505"
      unitRef="usd">25692000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy0zLTEtMS0yMzI1NDc_9725304b-01d6-4584-91e4-b027f99e2e78"
      unitRef="usd">40811000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy01LTEtMS0yMzI1NDc_7b8772e6-23f7-4823-9fa7-e97b746eda5e"
      unitRef="usd">18426000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy03LTEtMS0yMzI1NDc_0c3d146b-745a-46ce-ab72-c55e7d7f5087"
      unitRef="usd">15000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMy0xMS0xLTEtMjMyNTQ3_def8bc57-e3c2-43b4-93ce-320f1d29a2ac"
      unitRef="usd">84944000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5a711f48e1345a19a731927269c49cc_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC0xLTEtMS0yMzI1NDc_fb24e211-1bc9-4ccf-b51b-edd4dcc6ba16"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73dedc2c29fd4e33a88a7a1d2a1957db_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC0zLTEtMS0yMzI1NDc_891b9c74-f197-4b9a-af31-a963809926a3"
      unitRef="usd">3780000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b32d6ef57d9481e855325b36afb4145_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC01LTEtMS0yMzI1NDc_66df8e23-ffa5-475c-8359-aa2040d1a9cd"
      unitRef="usd">9499000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNC05LTEtMS0yMzI1NDc_adafebd9-167a-438e-87eb-adad25863b8b"
      unitRef="usd">-13300000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS0xLTEtMS0yMzI1NDc_fe42237a-baf6-4569-95c6-afda1c26748a"
      unitRef="usd">164000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS0zLTEtMS0yMzI1NDc_04e81c4b-720b-4ea7-9761-d16bab732c52"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS01LTEtMS0yMzI1NDc_81facbc8-46db-45fa-9d5f-744d6b31f738"
      unitRef="usd">-3000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS03LTEtMS0yMzI1NDc_32784228-9225-4706-9382-0c83e49010fc"
      unitRef="usd">173000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS05LTEtMS0yMzI1NDc_b52938fe-0692-4e86-b761-705456e6c27e"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNS0xMS0xLTEtMjMyNTQ3_52101dd4-f42b-4c66-89ca-d4c6ca1d85f1"
      unitRef="usd">334000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi0xLTEtMS0yMzI1NDc_4e8ffd4f-cf33-4196-9729-5a91c3292e72"
      unitRef="usd">25877000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi0zLTEtMS0yMzI1NDc_f6bbd687-d2df-4094-8481-47cf7551b39c"
      unitRef="usd">44591000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi01LTEtMS0yMzI1NDc_432d3363-b761-48bf-a827-5a45096b39f7"
      unitRef="usd">27922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi03LTEtMS0yMzI1NDc_be8da5a2-9caa-4cd4-a2b5-c90f951d94e4"
      unitRef="usd">188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi05LTEtMS0yMzI1NDc_5a968d3d-7e98-44ea-8c08-f2a0d5d87e63"
      unitRef="usd">-13300000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNi0xMS0xLTEtMjMyNTQ3_ad5e63cc-e6ac-4a3d-b545-6f3404d17acb"
      unitRef="usd">85278000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic26cf364ab3c429b8180553a13a77a75_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy0xLTEtMS0yMzI1NDc_b66438eb-40c8-4ede-a3e9-fed933451e91"
      unitRef="usd">1824000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy0zLTEtMS0yMzI1NDc_a029471b-6142-43f9-93ad-6c8daf791c18"
      unitRef="usd">1680000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic7e9712c1179476e90472386d3884dae_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy01LTEtMS0yMzI1NDc_7cf61eeb-5fa6-4e0a-bc34-8291723b4cfa"
      unitRef="usd">1134000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib63110e713f04eb3a37042fc30e89c0e_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy03LTEtMS0yMzI1NDc_077b9dd3-ebf5-4782-9433-e0d65334e80e"
      unitRef="usd">-268000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i88fabf566648406c8e21b1cc8eaaa4be_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy05LTEtMS0yMzI1NDc_db90b9c7-d8b9-4eed-b8d3-f4b9da155a17"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfNy0xMS0xLTEtMjMyNTQ3_4f519e86-6255-4161-b6db-058e39042586"
      unitRef="usd">4370000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtMS0xLTEtMjMyNTQ3_14921c34-c211-4947-ae36-c2b08cdbf969"
      unitRef="usd">22985000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtMy0xLTEtMjMyNTQ3_d9299e8e-4feb-4cb0-a0fc-90ca2fecce1b"
      unitRef="usd">36311000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtNS0xLTEtMjMyNTQ3_6b44a164-3973-4a61-ae32-c38819a5af64"
      unitRef="usd">17331000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtNy0xLTEtMjMyNTQ3_b965af2e-5349-4507-8bcd-c4173690d344"
      unitRef="usd">31000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTAtMTEtMS0xLTIzMjU0Nw_185d048b-12aa-4733-bcd0-90242013ebad"
      unitRef="usd">76658000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9eef6ef05c314ac8991556b8d8d5dd5e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtMS0xLTEtMjMyNTQ3_cda36954-d6a9-48a6-9e4a-629af1112918"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i832630f4a1134a15bb6da5125d24a7d0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtMy0xLTEtMjMyNTQ3_8821a251-4de8-4376-bd56-ea59b1db63b3"
      unitRef="usd">3304000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i153b35e7e97042bb9c9cb483ab1d7c90_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtNS0xLTEtMjMyNTQ3_3c7d5bfb-3c8a-403a-9b27-0b2292b27e74"
      unitRef="usd">8583000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTEtOS0xLTEtMjMyNTQ3_fa36898c-b167-4fca-a203-3ed4757b5e60"
      unitRef="usd">-11907000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItMS0xLTEtMjMyNTQ3_ac2f5a64-b44d-4e16-9fdf-0a5bde6bb294"
      unitRef="usd">89000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItMy0xLTEtMjMyNTQ3_fc58c007-2afc-4e33-b9f0-494398315d53"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItNS0xLTEtMjMyNTQ3_56140bad-2d23-410f-8b71-e69b1e11240e"
      unitRef="usd">-16000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItNy0xLTEtMjMyNTQ3_9dbb836f-5821-4963-b9b3-191612a6f297"
      unitRef="usd">95000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItOS0xLTEtMjMyNTQ3_60f5be7b-fb5d-46ed-b5ce-4d46f3fef096"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTItMTEtMS0xLTIzMjU0Nw_68182511-c892-46a9-b884-399efe12b076"
      unitRef="usd">168000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtMS0xLTEtMjMyNTQ3_de2c3d01-2ed5-40c5-af68-e3f7532c3ddc"
      unitRef="usd">23094000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtMy0xLTEtMjMyNTQ3_a6510a50-3899-4929-a62a-ab379657f1d2"
      unitRef="usd">39615000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtNS0xLTEtMjMyNTQ3_d427a6c4-706a-4129-9645-fb52d082d3ca"
      unitRef="usd">25898000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtNy0xLTEtMjMyNTQ3_c6e80b2b-8c2f-4c53-b8b9-e88026beafca"
      unitRef="usd">126000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtOS0xLTEtMjMyNTQ3_2abdc139-62a5-4433-b497-dd7865d95757"
      unitRef="usd">-11907000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTMtMTEtMS0xLTIzMjU0Nw_d25a3d2a-f4c6-4380-8978-3ceebab0358c"
      unitRef="usd">76826000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie6a713612aa244efa98c2aba0b4bcf2b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtMS0xLTEtMjMyNTQ3_234f9732-8283-4e24-a681-084fcf151687"
      unitRef="usd">1861000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtMy0xLTEtMjMyNTQ3_089f05d2-3e98-4834-b648-30d982ec9ea2"
      unitRef="usd">1471000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9623fed018aa4253a3a3a44aadd44007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtNS0xLTEtMjMyNTQ3_2ff689e8-9df8-4adc-8318-ac244ff9ab85"
      unitRef="usd">1573000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if53e40fe942046bd9d774657a5424fe5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtNy0xLTEtMjMyNTQ3_57a4f056-799f-498d-9788-c94878524a38"
      unitRef="usd">-298000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iae7c8f69010d4009bbf12ba59a956a31_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtOS0xLTEtMjMyNTQ3_81b4205c-8617-4982-8140-416c4885167f"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjI2NmFkNGNmM2IwOTQ0NTNhMjQ0OGNiODZlYWI3YjdjL3RhYmxlcmFuZ2U6MjY2YWQ0Y2YzYjA5NDQ1M2EyNDQ4Y2I4NmVhYjdiN2NfMTQtMTEtMS0xLTIzMjU0Nw_67b79f0d-872e-4e29-b400-b352a2d6988b"
      unitRef="usd">4607000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i66374446ee7f468eaf7348b312bb3668_D20230101-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfMTc2MA_2c0af03f-f75f-4746-9652-85d278878ef9"
      unitRef="usd">4100000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i12aea7ae891342b9b67833b53bb8fafd_D20220101-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfMTc2Nw_1771941e-6680-4acb-a05b-d827b44d3d98"
      unitRef="usd">3800000000</cvs:NetRevenuesRetailCoPayments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RleHRyZWdpb246NDI1NTI1M2ZjZTU2NDNjNDhmN2NlNGY4MDNiN2FjZjJfNTY2Mg_7aa257eb-25ab-42ee-8cb8-2147a35d10ff">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three months ended March&#160;31, 2023 and 2022:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on assets held for sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related transaction and integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office real estate optimization charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid litigation charge &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the unaudited condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the unaudited condensed consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#x2019;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023, the loss on assets held for sale relates to the Company&#x2019;s LTC reporting unit within the Pharmacy &amp;amp; Consumer Wellness segment. During 2022, the Company determined that its LTC business was no longer a strategic asset and committed to a plan to sell it, at which time the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. As of March 31, 2023, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the first quarter of 2023, a loss on assets held for sale was recorded to write down the carrying value of the LTC business to the Company&#x2019;s best estimate of the ultimate selling price which reflects its estimated fair value less costs to sell. During the three months ended March&#160;31, 2022, the loss on assets held for sale relates to the Company&#x2019;s Thailand business, which was included in the Commercial Business reporting unit in the Health Care Benefits segment. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023, the acquisition-related transaction and integration costs relate to the acquisitions of Signify Health and Oak Street Health. The acquisition-related transaction and integration costs are reflected in the Company&#x2019;s unaudited condensed consolidated statement of operations in operating expenses within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2023, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#x2019;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#x2019;s unaudited condensed consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three months ended March&#160;31, 2022, the opioid litigation charge relates to an agreement to resolve substantially all opioid claims against the Company by the State of Florida. The opioid litigation charge is reflected within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMi0xLTEtMS0yMzI1NDc_915d2f43-2dfd-49fb-aaa5-07913c5dc02d"
      unitRef="usd">3446000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMi0zLTEtMS0yMzI1NDc_f9eaf016-0d3b-4c90-a29b-6d0b8760d5fe"
      unitRef="usd">3545000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMy0xLTEtMS0yMzI1NDc_ecee8ac3-c41a-4a43-9db3-4299f1725b33"
      unitRef="usd">402000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMy0zLTEtMS0yMzI1NDc_f51474bb-aefb-48bf-9ca3-9d13c3447b5d"
      unitRef="usd">462000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0xLTEtMS0yNTI2MDY_865cd978-f2e0-4d29-aedb-9793ad7fc5e3"
      unitRef="usd">-105000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0zLTEtMS0yNTI2MTA_e4e45bb4-ca9f-4c82-bb53-f70ab647e403"
      unitRef="usd">-75000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0xLTEtMS0yNzIxNDM_c61725f9-51ec-4220-8538-55d68f94895a"
      unitRef="usd">349000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0zLTEtMS0yNzIxNDM_3a055beb-68c0-40b3-a8c2-88df8296cf34"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0xLTEtMS0yNjc5NDM_a42bbc8a-02f0-46ae-b804-cc21c24426dd"
      unitRef="usd">43000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNS0zLTEtMS0yNjc5NDM_c5426e9f-b7e1-49db-be56-499ad158312b"
      unitRef="usd">0</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0xLTEtMS0yNDMyMzM_9825a23c-d455-49ec-ae26-0b98d022176e"
      unitRef="usd">25000000</cvs:OfficeRealEstateOptimizationCharges>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0zLTEtMS0yNDMyNDE_98ea4a2a-bcbd-4078-98d3-54d5465754cb"
      unitRef="usd">0</cvs:OfficeRealEstateOptimizationCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0xLTEtMS0yMzI1NDc_d61226ac-de05-48da-84b3-f5a8be7ba593"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfNC0zLTEtMS0yMzI1NDc_5b151594-38a5-41c8-a849-248ecbbbf930"
      unitRef="usd">-484000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMTItMS0xLTEtMjMyNTQ3_4f519e86-6255-4161-b6db-058e39042586"
      unitRef="usd">4370000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i663d023f4cc34784b53d9242913faeb7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV82Ny9mcmFnOjQyNTUyNTNmY2U1NjQzYzQ4ZjdjZTRmODAzYjdhY2YyL3RhYmxlOjRjOTQzYzcxODE0NTRmOTI5ZDhmYzcwMDk2ZDkxNDkyL3RhYmxlcmFuZ2U6NGM5NDNjNzE4MTQ1NGY5MjlkOGZjNzAwOTZkOTE0OTJfMTItMy0xLTEtMjMyNTQ3_67b79f0d-872e-4e29-b400-b352a2d6988b"
      unitRef="usd">4607000000</cvs:AdjustedOperatingIncomeLoss>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNS0xLTEtMjMzOTQz_45f485e3-9b46-4c82-8d3e-9d058ed4b98a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNS0xLTEtMjMzOTQz_45f485e3-9b46-4c82-8d3e-9d058ed4b98a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS01LTEtMS0yMzI1NDc_60714424-be32-4073-9ab4-938d817d7181"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS01LTEtMS0yMzI1NDc_60714424-be32-4073-9ab4-938d817d7181"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMi0xLTEtMjMzOTQz_55cc909c-b93b-412d-b0f0-4aa7a02e4690"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMi0xLTEtMjMzOTQz_55cc909c-b93b-412d-b0f0-4aa7a02e4690"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMi0xLTEtMjMzOTQz_fdcec20a-0da2-4cba-a702-049f79ca14bf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMi0xLTEtMjMzOTQz_fdcec20a-0da2-4cba-a702-049f79ca14bf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMi0xLTEtMjMyNTQ3_bac58b12-1fef-43ba-9745-c0d784911361"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMi0xLTEtMjMyNTQ3_bac58b12-1fef-43ba-9745-c0d784911361"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMi0xLTEtMjMzOTQz_4ddd1924-457b-4a04-9c51-c099d307ce1f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMi0xLTEtMjMzOTQz_4ddd1924-457b-4a04-9c51-c099d307ce1f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNS0xLTEtMjMyNTQ3_346a8441-b914-40c1-b85c-35d5bc62cd0c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNS0xLTEtMjMyNTQ3_346a8441-b914-40c1-b85c-35d5bc62cd0c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNS0xLTEtMjMzOTQz_6499dc29-8bea-4f59-bb31-f6b0fc576c54"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNS0xLTEtMjMzOTQz_6499dc29-8bea-4f59-bb31-f6b0fc576c54"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS01LTEtMS0yMzI1NDc_c54fad51-69a2-43bb-97b9-e8c59b2e1614"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS01LTEtMS0yMzI1NDc_c54fad51-69a2-43bb-97b9-e8c59b2e1614"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtNS0xLTEtMjMzOTQz_076ae2ba-235c-4cf0-8ff1-3b73daa62000"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtNS0xLTEtMjMzOTQz_076ae2ba-235c-4cf0-8ff1-3b73daa62000"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0yLTEtMS0yMzI1NDc_6c050194-16c0-477f-9fb5-b8d19017455a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0yLTEtMS0yMzI1NDc_6c050194-16c0-477f-9fb5-b8d19017455a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0yLTEtMS0yMzI1NDc_c4b41d6b-e368-44ff-af4a-a3036171ac0b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0yLTEtMS0yMzI1NDc_c4b41d6b-e368-44ff-af4a-a3036171ac0b"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of March&#160;31, 2023 and 2022 and December&#160;31, 2022 and 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNS0xLTEtMjMzOTQz_45f485e3-9b46-4c82-8d3e-9d058ed4b98a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS01LTEtMS0yMzI1NDc_60714424-be32-4073-9ab4-938d817d7181"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtMi0xLTEtMjMzOTQz_55cc909c-b93b-412d-b0f0-4aa7a02e4690"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtMi0xLTEtMjMzOTQz_fdcec20a-0da2-4cba-a702-049f79ca14bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItMi0xLTEtMjMyNTQ3_bac58b12-1fef-43ba-9745-c0d784911361"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtMi0xLTEtMjMzOTQz_4ddd1924-457b-4a04-9c51-c099d307ce1f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNS0xLTEtMjMyNTQ3_346a8441-b914-40c1-b85c-35d5bc62cd0c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNS0xLTEtMjMzOTQz_6499dc29-8bea-4f59-bb31-f6b0fc576c54"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS01LTEtMS0yMzI1NDc_c54fad51-69a2-43bb-97b9-e8c59b2e1614"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTgtNS0xLTEtMjMzOTQz_076ae2ba-235c-4cf0-8ff1-3b73daa62000"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS0yLTEtMS0yMzI1NDc_6c050194-16c0-477f-9fb5-b8d19017455a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOS0yLTEtMS0yMzI1NDc_c4b41d6b-e368-44ff-af4a-a3036171ac0b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfODc5_908f011e-fcb5-4511-a8ef-d5e447057069"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjc5ODE0_2aeead0b-ce92-4b84-b456-8a22a76d1c5d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjc5ODE0_2aeead0b-ce92-4b84-b456-8a22a76d1c5d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNi0xLTEtMjc5ODE0_e9b07a15-ac08-413e-805f-2b66fd5510a8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNi0xLTEtMjc5ODE0_e9b07a15-ac08-413e-805f-2b66fd5510a8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjc5ODE0_835d5494-8d96-4df1-89c5-db14d9bd351c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjc5ODE0_835d5494-8d96-4df1-89c5-db14d9bd351c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTI3OTgxNA_2ae192ea-b3ef-4e45-8040-5fa42904c6d3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTI3OTgxNA_2ae192ea-b3ef-4e45-8040-5fa42904c6d3"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-12, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 944)</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> during the three months ended March 31, 2023. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNy0xLTEtMjc5ODE0_2aeead0b-ce92-4b84-b456-8a22a76d1c5d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtNi0xLTEtMjc5ODE0_e9b07a15-ac08-413e-805f-2b66fd5510a8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtOC0xLTEtMjc5ODE0_835d5494-8d96-4df1-89c5-db14d9bd351c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTYtMTAtMS0xLTI3OTgxNA_2ae192ea-b3ef-4e45-8040-5fa42904c6d3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Nw_ee8842fc-90b5-4a2e-9772-6b9e86baedc4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctNC0xLTEtMjMzOTQz_e4aa5458-f5dc-47fc-8f5c-4dba67141cac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctNC0xLTEtMjMzOTQz_e4aa5458-f5dc-47fc-8f5c-4dba67141cac"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS00LTEtMS0yMzI1NDc_ca4b0262-df78-433e-bef7-8786581d587d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS00LTEtMS0yMzI1NDc_ca4b0262-df78-433e-bef7-8786581d587d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNC0xLTEtMjMyNTQ3_68f228d6-24ee-4fb5-982a-a6c3d0e74abb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNC0xLTEtMjMyNTQ3_68f228d6-24ee-4fb5-982a-a6c3d0e74abb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNC0xLTEtMjMzOTQz_b9c39463-580f-4dd6-9019-a7a4fd5ac7f9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNC0xLTEtMjMzOTQz_b9c39463-580f-4dd6-9019-a7a4fd5ac7f9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNC0xLTEtMjMzOTQz_40ae901a-05df-4b91-86cd-5b3d8a1815e0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNC0xLTEtMjMzOTQz_40ae901a-05df-4b91-86cd-5b3d8a1815e0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC00LTEtMS0yMzI1NDc_9308e9cc-7702-426d-abe9-b51cbf5ec8ee"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC00LTEtMS0yMzI1NDc_9308e9cc-7702-426d-abe9-b51cbf5ec8ee"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $18 million as of March&#160;31, 2023 and December&#160;31, 2022 and $17 million as of March&#160;31, 2022 and December&#160;31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTctNC0xLTEtMjMzOTQz_e4aa5458-f5dc-47fc-8f5c-4dba67141cac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfNS00LTEtMS0yMzI1NDc_ca4b0262-df78-433e-bef7-8786581d587d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTItNC0xLTEtMjMyNTQ3_68f228d6-24ee-4fb5-982a-a6c3d0e74abb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMTQtNC0xLTEtMjMzOTQz_b9c39463-580f-4dd6-9019-a7a4fd5ac7f9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfMjEtNC0xLTEtMjMzOTQz_40ae901a-05df-4b91-86cd-5b3d8a1815e0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RhYmxlOjVlOTViZDY3ZjhkYzQ1MzQ5YTQzNTgxZDkxMWZiZTVlL3RhYmxlcmFuZ2U6NWU5NWJkNjdmOGRjNDUzNDlhNDM1ODFkOTExZmJlNWVfOC00LTEtMS0yMzI1NDc_9308e9cc-7702-426d-abe9-b51cbf5ec8ee"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmZjNDM4Yzc1OThhYzQwMzNiNDk2OTAwYmFkMzFiY2ZhL3NlYzpmYzQzOGM3NTk4YWM0MDMzYjQ5NjkwMGJhZDMxYmNmYV8zMS9mcmFnOjg3MmI1OTg5Njk2MTQwOGE5YmNjYWMyMjQ4ZGQ0MmY5L3RleHRyZWdpb246ODcyYjU5ODk2OTYxNDA4YTliY2NhYzIyNDhkZDQyZjlfMjc0ODc3OTA3MTk4Ng_dac81a81-12f5-4714-8153-d530ddf7552d"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>102
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M))=K)V+H:)"QA=DAI2K4 &I#1@AY6\$.:E5+FVV@![^S541>OCNU5SR7M>.
M&.I#?NJ;$<$6X*7:^69JNI%*F+B\<CK?F$NZ3==%;&7/)94,=(W(\!_R\]\-
MR[=ZLW\"W- %M]_D.J629 "N84,4>2?;U_I(1N$E.\7;*[H_=>!;*20I,[6X
MW1/,2[(G3[ S63L.@N%<Y.=<,\$:[]UILCD5HA3WT^20PG" >I&A7N2GWNZL
M\F&T612B">QC=$BIUF\ H^%:Y.?:&[9C&2TS 3*Z4/->P37UZX3ET(R2=K<K
M%W%@K8?46@_!Q2#E&39&?C;66]/7X*[9F *U ,"#FFYL0<$?[YZE/FG5!?@C
M$_)/)WB_]=:NBR7G_TGU^)3,$#OV$[L'Q\RO>O(YV9FL'3MJ.@ ,?^! T-L]
MG.SIF:P=>VJZ!NS?PMY[SK5:U6ZC$J4P[/>W+C$4H8'BA3N'LG[^;E>0&]IY
M3V7_CV-9;+@?AS\PV[Q]P\F>GLG:L:>F;<#^3;1WMD6.,^BP7[]=4E'0K]_C
MSB5,0:M5?3<EP()O2]G<4AR^'NZ_WM:W/KWO,W@Y;VZQC)GF4NV65"M6"I#3
MI3(97"0*6-7<4S4ODF_JJYY'+B4OZL<U)1FMM(#Z_Y)SN7_1 QQN"Z?_ %!+
M P04    " #4-*-6'.#H?<@#  ""#   &    'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;*U776_;-A3]*X16# W01%^6/S);0.*N:!_2!C72/0Q[H"5:XDJ1
M'DG9Z7[]+BE%L65:Z8"\6"1U[]$Y]Y*\U_.]D-]528A&CQ7C:N&56F^O?5]E
M):FPNA);PN'-1L@*:YC*PE=;27!NG2KF1T$P]BM,N9?.[=J]3.>BUHQR<B^1
MJJL*RQ^WA(G]P@N]IX6OM"BU6?#3^1879$7TP_9>PLSO4'):$:ZHX$B2S<*[
M":^786P<K,4W2O;J8(R,E+40W\WD4[[P L.(,))I X'AL2-+PIA! A[_M*!>
M]TWC>#A^0O]@Q8.8-59D*=@?--?EPIMZ*"<;7#/]5>P_DE908O RP93]1?O6
M-O!05BLMJM89&%24-T_\V ;BP %PW Y1ZQ#U'49G'.+6P4;.;YA96>^QQNE<
MBCV2QAK0S,#&QGJ#&LI-&E=:PEL*?CI="IY#4DB.8*0$HSG6,%EI>$"VM$)B
M Z\JV".E2=Z.H$\\$Q5!;Q\XKG,*UA?H$CVLWJ.W;R[0&T0YNJ.,08[4W-=
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MYA: (N(;)1NU-4;&RKT0#V;R.9Y:CE%$&(FTH<#PLR8SPIAA AV_*E*K/M,
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M\@Q*&T)I%I0V@M(<*,U#T?(?G]GG=*G5KQZ#/VS)A86[(XTH^_(,-'$,2NM
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MPF>Z4+E0OH5)$BZRG]/ GP11N@'ICR%=5&W^2 V\A-'W[*+G]O]02P,$%
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MH?'UL<T,_X& -  <GPNA-X%Y@IK_--%?4$L#!!0    ( -0THU;;,=>[,B4
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M5^24&&*6QQ) 6U7DAKDO% HKCNB/K2FEM(ZSRBL"F-R2&%I-*"W+7#>H+?^
MWE-)W-8F#PY<EK<*A8=JMQS282A6<C38:T,=VVG=<%/.!P*NQ+%V5,&6B';O
M.HT8V%,*QP!!.#<X*.AZ1AH+V!XVL&3W) 8KB>PJ*EN Z% 9)-YUT4>&VV,Q
M$E%#%B+CHFF;D;ZA1@4T\.C#V-FIO(H9(.X[>&_U"6IXPPG:<GP=OVCV:\6"
MN.I$FQ"=5+PH[[":ZUD4#FJJC,A!)  /X# W\>N;[VTNK]\<9ZRVV"'3]5
MN[H'GSK'<!WI2PL'%XE6>7&.6EB"/.L?N+8.M.(.>0,YT?4H,<^:%905"Q2V
M$) RY@C1.C(-%EG1K*-SG1&%,(\LW'V(/+D^<0 8@^C[!#7CU)Q=R;A<$_=0
M4(_AYZS@NG!!1=_W!.'T@A(LB+F\BJQ##1K<4\!,&&.C1<U>)F%]M^6V(Q<
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M<@,I]MRQU.CVRM!#2WP\;O5XVOA,WY7RS:QN&M$]C)3+MZ." ]3N6HZV^F;
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MZ^B TKN_UGC5'%M)-X*3LJFU99#WS\934#\3^#M9G)_0R1;28SIX,@?%AX/
M)>@RT7MNX\%D,L2S*/#?9'+>]RO6E\XOCN\4A'W7]-,@Q+O\X^/F;J!_NOV*
M?['</LZ_^PX\NL'^E%RMX=7A8#Y]%E3\6^K\H2GW]/OEJ[)IRAU=;NFG>_$!
M^'Y=EHW^@!.8'[3_[G\!4$L#!!0    ( -0THU8.O3M9%PT  %\F   9
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M6]S5V.=O7V=?:^UTT%"5B]?.*>_$SZK(!4PN/LE"O3SS.(G6GV61ZIM =72
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M[T3)OM-R[3:QM=$KAZJ,M6T2'YN$-J!CV6X'$$KGK2< CN9HY*']X*1GU7&
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M6YU#N58@2W@'^4HXQ2X1(J]"]FLH'M.IZ(&NXV.Z[N1  +&?UEBH+:O&AG4
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MZWW/J(7IJ=39%\C?(C<\W_--(9 5A/5!-=3[&^$*0:=Y5I>U1!QTVB>62,E
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M(3A,H 6X/E/*MC](P.IUFJO_ 5!+ P04    " #4-*-6X]I( H@&   8$P
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MA$-NWBA>(&G:DB9>+V6S?TK"-+##]_;OGH(' @RQO4:]U*U[P5$VOG$=Y1=
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M@<87WE6_&L:IBI-RXPQ&%=:YLYM<&)GK(I/&?D<OWS?*K4\F#L@\/DE;E(N
MDNQ!F='/NG*YI9=5)K/M]1-8U)N5=&9=) \"_BQ,1+-X3,DTF3V -^O=G'F\
MV1Z\X!C]?CZWSH )?]SG8X XN!^"J^.9K44J3T>@OY7F3H[.'G\3/YD^?\#
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M-/PQ$$N_'[L]G!6!*N 0N^PSQF'8$W-+J0!1))4Z4PL%FP#N.&25MQ"L9)A
M/>'(AP^QB>A%8Y@R/(HX24;P@B59L AR@]1U>M-9D(RW\K!Q'-@HAN72R"63
M$R%.DN@8\NP)'.+DN8E$E/S Z?06M69(U"BK#ZH,47^4@#DM[?VFN[#QTRC^
M>[!CF&WK0+9B/:8YAQI^V$94SE,GA/V^:$>0"&7#P<D2HJJT:#*8L"'XD)$-
M0FG\&/BPE6%DWJ9&S3E#W 9$=+5C@=@J^0W2'LNV$R,K4 #8J@*:V([J0GW
M2 :9$\;;M5*L5\JIN:ANQ_0V.H]Z'G>/.S)']*X&1BW6:$-<5]I;^ .Y5"ER
M5M&/HFK0WM!!(-,NAU*)3"#35#5>;0"Z2>PG)'4K[_)](PJ.W_'TVWM-JS0O
MQAQ1ZF9C/@?A(\K$1]'!+M&X?CJW%O3H:1+%3UF?POB85KE"T:P0>JH+G(MM
M AQZ0]L@ ,%,M8D(AR/RQXY/A&!JI6P:EGH66RX :#N4J-C%&?#)3WX41T^V
M:X<?K[CP4Y0V'_)AWA2>M?.B]LS;F<:6I(6P-DA*,$.&8U-5:!@:GW[>A*<B
MA]JP:C"5X%XJ:N5@,(RMBP9RAK/LE9R;WN=]%-C*P.''"?@R0G"E^\:D<IW2
MF?ZH3+Z8(]YH(Z&HB!/7?0>*,1]'*SL[]U. 0^;VA1R!V 3='V<[D:1[V;05
MVJ^L)#%.]8>5Y (G1R'6:'>@&W3UTV4O)MW()\1DN,6GQ.2C ^GKBLG0M"\2
M$R[-A\4DGLZBV<'?59/DGU23Y#/59/;?JLE>#FRE((F._B4U^3R2_"_4!'0Z
M#ZUWVT_+=;"F"W((?4<I-F>AV%T_7KM!^>&O*9SWP+.PZ_(QD#5IUY@SFFZ<
M=8#JW\'02'&'"6M34:1-P:MXXLI_8.!,WZ$?7\H^76UZ!SC,U+FP*O4V9JIH
M>)T4AK-G-U6'MAB=788>.+P-0@0,!!#\287-L3 ,HGU#;,UN?\U11ST\F1[Z
M;7!Y>+C!9L^_M-L>MJK1'K;B=10>")5MVPALA&7=N4 6S2J_M2)(_E41VCHO
M$) TU$U$KQK7P,K>QU:7P3^0&1[7_%!7PV+K"Z6+Y+CGF.$"1X$PPMBSHDJ9
M(Z!HIEPG*N$U:"'"VS#&+/;FN!J\8]WQ(38,<'3?9X7)X%-/*<W2?]!B+-1;
M^.K3/^V_F9V'3T6;Z>&#&]*PA"!1(1=8.HV.#D=DPD>L<.-T[3\<X9W!Z=)?
MYE+ 8IZ \876KKOA#?HOB6=_ 5!+ P04    " #4-*-6N%%?LHH%   ,$
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MZ,T+RYK^9*#Q%^B\TMH=-][ \+=E_0-02P,$%     @ U#2C5B4MWWQW*@
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M8S ,L) P(2_P4-D\OH SQ#=E%".F",T\1MW@H[@3(OEQ#@A>B(L0&6V&;N,
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MO[=9E=VZY"P$K))C$ZRD)!O#V=@:/ QRHE")P 9C)$CY%X!+A_L]A*5586D
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MOCP'FW'8KPA,(G_M,=-]2@0F\W.O :&WSGKFJ=\'2ELJT+\"%7)+A\F%IS0
M/>:MM=,S((0>*#.1<$;)0 !W6B0Q.HGA&0NBF_JE59\6D7$U/#@JK-&89SC5
M$+J'? G[Z5XE29]PK#<TSY!(]G1U@U/G*U&[O506::!,ZAT"L0+3?UE^3NR5
M\D7<IK/O)T(/(4571K,<PW3 \K!+>(8_/S46#^!++BNW J/,]1B7!%&,R2MU
MUZM=U1B2RQ @XJXX'JL7$$IM<\'^DIS=/99#>8BOL6ML5 3DC-3M=WM^L)(<
M+&^D]KW4\:14!G4\N1L3<X<-:J49A("V0^HHMXGISH9P_,0.[]?W)EHWU.8D
MN3V/=?(JS9^OV(&=#6=9Z-(7AR[]RISNM_ !;"I"&VH@U1T\!'L'<I'S?!R;
MR8_N)4=E$E#364[>#+TVP(CH.:^MU>Y)%!5B:O-1/#EOVF&L11JHX#A2O,SG
MZ7A% LAO5Z-8/I46,G0L!0U/7QB.@X@W$V[1Q".LX]@MCEOI^A$>'+.1%Y0%
M=\($X2R -PE1IDO0.;+2.X=>6<_N'EZ>=%()BQ9W*"Y<CC2EDPN4>Q"QGS9D
M*'J6Q8=9N0,=.CHT.RQ7ELT"SY!/0U%N<M-9.:)8\I>AHBO8P+:.!5\/<B0Z
MEL\-=C]25J# C\1(&VWV&!CHH1X<6Y=_PW-'77\HUM.OXK&+I$(F<7OQ1FJ%
M0R&*>N*2B?.?TQ4DL5?#P8)3[6\Q57:JY\[SDM.[$N=R)H2ND&>KLHR%);/0
M3D)+^TL-$F6.%6^5@I#)\V#IV7<)W$5"AHJ8&7'MB!EE^^/.4L(Y.XR=U(1_
MIAL+/5L##WJR-L4O^?YFB>U1&XW)G-K8K;_?>AXEO+^_I,LW-VBT2%OBWW)<
M'W,97( X*0RF(TZA()^+&6>:$8$P2[_1A.4<OEBYT*0B!-Y5F?EP>2'''9)4
M]+]!?5LN,@_ZP_:J:,@ !CN6U7CR"@<,;VDQH])F;2JPAM:O%3QC@,,("_R-
M\7EMG!(@\(%3E6DH11J:*3R+UI4Z3LUWX82>:IKD@)ZH"NKBPIWU].Z@8!$T
M;<36S7>9R,)LJ977K$" W7-GPVB6]8RWJ.9<?8@>\RQOW":HY2Z+'5?U\J&L
MH-@I.!D*+ZF^B"+C\0JD:::'*U=KXI@ C>?$9$Y3.?[(RDFNYL**1L]<CX,&
MM2V7K?.(\G&B$2R-1N9#J5J "UQ!W4ZT]TUHDY,STT6-59&@FF0#<7KAQ^NK
M:_D:5:KN$9AOUMWA=*#,/T02O=134+:!ID7]#X!ID\4@N7SL])"4Y'$G!&94
MLD0$4U*;CYPWHEHNJ!&*.F_")<):T;?"4T/YA*2N( Q$T79>N#XXY^+H]F'$
ME&*GV(:')2QI3G1 QL@UD&,CJ,AGM'-HZ% ]VG[ ,:A3%(^H;6$D^B!5MP*3
MWE]<_1D[8K!^ RE3Q7!HTU.&"XG!Z;/<<CVL01Z/D9@ZBWG)&5&B-!TIRO8I
M\+Y&OX,D9X#R:ZE*\V/NYS83E!0:5YATACI,[0UBIQ<]^6@&.ER%%MR81'.-
MEPU;QBI)W#<A,#B::.Y O)+C+,'WRYW2WV)#E]\&L$[[36'>O?XU[C\B)LPA
M(1\<@GTCS@H)"CWH((9_,5;_HT8,E*KTT;;A,E__JH%CS.0(& \'K9@[I4?@
MV?E,0QZRD+>N%R*]HDJN:[%I+[L.2 5N>R5VEC03.7R74_Q-344OHN3\&84&
M>WL7#U!D'G(('_CW^ \J5>&S"3,AI>"&K:6S6;U0%#88E$OM&K?DBE$<*1C[
M8ZYY48R1JB9F/I]6/QS4QA3.5&>(8H] K#.I0*&*K+2$3N>8S&PFY<&Y8\3[
MU#I,WF$"&\;?2'9#V<\0H>ED9*++M8"+".#+-9:FEIA%CBZSF/N05 Q1FU%E
M%ST@1+JBHQU8$R85\./"&&I[*=AHW_U7 7CUZD:VVW31.7PU)J./39N1H$R1
M&+M5>AA=8Z1&T#1(D\Z$8;$%1D=#D.4%E> X (#TP,IKG)GHD.ZD>,%M$W<J
ME^F\9U/\X+HE"-Y_!%O>QMP?N2]2XKT@+RBH,]<VNS!=[-[;!_?2=NDR0PME
MW15L&V%JB4NGK- 6[SJ[))'42<[V.RGRP12]/7U.,CNL,:0;/[O:I#F>G 11
M3I\2MTPP(_J9TGZ@M[@S?=*S5<43OL*=3+OB(? ',=Y#'@>,F)AVPYIA?VX"
MW*63$?+A,?SO,3.CUXH[VD2,QMT>LLD3](L^![*$VO^1"*3*10@89^I'I[OQ
MP!_.2^15&)S:623UX?KM>_@V:<VEFJ8L6EC&I.)438GU/WT*1+3%;\26U$-*
ML2BJ':J&$!P'9B.[-BJG7,UI]#25[!%HQ>"9U%R4F8"F'?EH_7@,@Q,23!<\
M$,W$TNY3A^D<9L*;@F<D:87PQU/5JA@9!,+172GU=):EU#OC9$Z*=S%!__A4
M>Y:S#6NB+,0[,OC(MB_;P)GN(*<7"%@A7?8)JEHD+.4'-5/<B)*:&:5KQX4B
M4-"^>^27-9;;B]73]B3="61',?YW4#AU- _HF%Q6(PUT'ZGR76O_M)0<B1"[
MF&)Z<%_(\_)IC=?R8#@T%P73;5%HTR(6ZKK*+LO*+E=884J@C2*/:?HJ:BIL
M=XSXVO/9B37X-0T%B"H&@B6E((I?T[*<"S;->@1&0"H?857_!!2@M%J(KX#!
MJ/%ARFLJ 3 _><]QB8W]:-@ZD<7 I8D48KQ:4@/*4+-L^>)P8"JM]3A97^&[
M+682L,RB+30NS8L&'MJ(T45A&*^NO\UUT5Z.+3:CC V:0D,HLF02:K]3(8<*
M,57PU)-"&BOC@Z6R+9X.X@Q1W[E2#SNQA<(;]\',#](2A]P*:A\8T.]!SW_L
M!U&/CMQ/Y5EI==$BGG?0V5 4+CY)"I"PQT%)A4D>SZ*U2=NY>YBQN:VY"X^Z
M\_C4Q)HN;,MI%#U]-.GM811L:21Y@9*),Y J+A).)GX$ %N##@L>C>-?8!KC
MB Z*KF-_")C'^G@[E@>NI7" Z&@/E&)9V4+>O-PVRW$[9KB1!Q#9);_GI+B@
M%ZCP-"@F;0[M3G2KB??3\*QHXD#QO+P8B3\KKH<YZ&3LG<:D5:\Q%!:*^,\)
MY,R"/Y@F/-*@0]334Y3"T"Y6C7-U-.IK;<@PRU1M2 /0L?O91/,C5A#4\(][
M4R&TBJW_[M'?.Q;"A<C_?B$=:XZ1)8E)+O8(5+R D<2"O5:MI\[N&[#6 [VU
MA^G3"E+X[;>;8QH]]HD*PA/C=[;^@JJI++-"U5\QY4\]0*[DH(5N$E:33::-
ME6GS+/&A<)*\B@#KOGN-^XG#F&<J)T-@J5 R_D)2^H([A1Q,%O_?S@!CX -I
M2B#C33E5>?%-%0!W%V3=JP(@*WF4G$]63Y-%G0-!)SB@,W8]'T"V^$$'.G?%
M\IT8;.8$___C+/U-[ZJ/W*L*MHHK;5^DIRO3;B8_SF+#I*Q;<-I\*'E!2CG9
MHVK&)W^Y/@X=2.V1E/2A.'0$3;TDE3J)#*VI>A&91&*IW)\D]&=/1@Y-8Z5;
M&-5'YVV/J/2<H0@OCW=/<YZQ9S)W:^=^;VI1M:5[4KL5<MS)Z7 RE2'X'*2:
M?+VD=4IH6)B?5TT3=@=4S1\?+F.[?6Q2#'MM\?J%97"L70"T6JH<M3U+CCY(
MEO96P*OV,-ZK]K2=[X_EW6EZRI[>274IN;XWMES;XA6"EE?T$HB89:"F4/C&
M((T8QY_>&PP]$;]_Z$ AQ@8_O/5@7:2SO =,4'8?@=S27%M:H?$RXV&>5SA3
MF%57#9CXA^?1^<.\!\ H(:_IS?MRGO3=7X272)FU-W3&3)D[5LX=:E3%98(8
M3N5U"%1FIR26A,*\N6W)7IGC3>35B[QIS 3M_D+<@"_%*;BX\?-CWCV>[OI?
M)9*,J/.J,R!,#>[#P[3'PI+>#S8=M5H[/:.K5,C5TOGC$(1/Y)PX56MPVQ!>
MYQ8)W-OIP*$M+/&_=:/*HZC 7P+5W0ZP9L*6KULZN2"4V>EK@<Y^_/Y)B#:\
M?/_Z)K1^3U7@/3K%Y(=@V0!5& C1TXAACV;%A>G;,N]"-\&S1ML>8-OHR+*,
M\33:!$^CT<)6X-: $QHAUH>R(>16MJ4<M@E=%'XJWI=UU>!I'ZS I8&HNCN(
M+S$$Y:>G?[^/YJ;MO4MW?XE2GNOAOH6MAXI>WE@/X22C:9?EDO<+3.[*SBUW
MMBJ!(-6^GDY?-J%[S(M\<GKVX.-#[$71!LHR?-3SA)7V]T+K'-KIQ?-_,X)4
M3, H"#.QT:1-Z,20&\/*KS >$VTOOU9N<^V5'*U+^E=*"R]J3VI.DH8=(KKT
M,*H KD*#7P*%^&*N.NIT; 1#9P=QQ+H#="C1-<-M8)(S/8]/<LB3'E8^NZ.G
M#VH)[0[(C6PX",'X'U\CK&\ZX+AY^K[-4,6=-*XK_BAO<1WT]SGNYV>Q5/&@
M^+,I:]CNKO@5-\Q_W(%BVCHN0"%SB=+UQZZM5D&P'C+W8Q@WJ*"<'A]6L?&A
M*M?X4'W=@KX?+K!7/#XDHD22N"=-<@":6Y\2-&U"'X91"^84J<M)I__C=KG/
MS^AP\1^_3 -'NL?[7:STF"P+[HD6WJ.SWRE\_SS.':]-L"U&?%0A)4'EC"]E
MR,_Y#B.?@'LT)4V;L"I6JA1#)3KZ:9I>R5\\$HO]@ON5-7;Z0$2]BPJI6Y-U
MGPY.&>;ENTS)SLL:*T;1[FF6BL.!"T.(FLX/-EJK,1.VW&/*W2P4)H933;-1
M5YBD'0SU_S\>%\:% LG]ZDAT>)?8[WPF[[2B0A%ZRRWV"L$W-[260:IT[)4L
MW3?5P,Y";JX(Q;I]-U ;UG%]K"1^$MMPS %VN5/4@+P*151<&#Z$>Q]B:UM?
MR<MKZ$!9?#<H@I$E!L(T\%/'=V7#8N(4/&U<PCX(9V #$7WT_+J5Y,B9E*V%
M20SQT.A,6\?&;E<S"J13==S 3 @/!!'-7I^$UIY@'G%C6J.;=YP^R,Z\(G(*
M0RG[U+MH,(>>J/4)-^ SYY]"#P;I=3=^)PH *\S$3);E27VKFVK%$[=TEKSI
MI]G%8%L,\8].GL9L1#H<M20WL0)BC!;25VZ^T")N;Y:<#UETX;3HZ-5Q&WRK
MI^?@*Z8[*A3?Q=!@P#G415*\6J[C.BE]Q4 Y21WNRXN1\<ZCGUN#RME)E]6U
MJVT\Z:ZOI* KZ$ ])LUCP9>D#B8(^TV1V9Q'*,<2*X^<GAR/1Q%XE;97(\$#
M8/PT[<^C;WPMTW<TAFXVL4R12I ITCO?Y<'T\/8I!F!)1;A;:,]UK5"8+NJ>
M6GY2'1?> 9>^"I=!%J.0< # @FH%=;=_&%PNUWJ] ]V0)3G"52#R.L590=W2
M_Z.U?.KT9&_>8=.<9W'5-M$KD;FM:HR&+<&@;\/9*T&HJ1W*BX)!6>#+5N^G
MVO>NXA?;59+?^M^G]<.7BK/HC2N@^O%155*_AM20!(=2)28ZXHF3>$A'-S;D
M0$#4#!]<2/NCW\?PT%LL(X^$(R_27AQ/00ST(L&]'\*I>;TU;GY2"9H0/NMX
MKH&LL 1IMIUM0@NK<;<CRK,'7(7&.QQ-MJV^,1K(#-+6X0YX\(U\RLVJ<K7"
M/OUM"^I!$NH>)5V2R>2,*^TGUY66,QTZI?10NO1@ER:\1UOB(5F?/>J?/WMD
M/?RO@O]@Q?!_ZJB"]8G/G\%\E^82[+/T(/[EZ.PH^183?+\<79S]='%^] CN
MC)<_?[:!#7E38C,J?%/B FX]/?G^Z1&_&4<_]&Z#0V)I!A"'_EQ1,RF\ 'Y?
M.# 3\@$?0'N!TWO^OP!02P,$%     @ U#2C5JA4^44D#P  *S,  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C N>&ULW5OYC]LV%OY7B&G0G0":&<N6KUS
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M"O4E3BN6!;&DP5%<$H/8/PSL=]8!W9.RLI5>I(H%X,5A6.&Z5!L8A<:L;!>
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M(=%7A;+A_5#V0$ =B0\^MK@4!16=*E"K^'8B^3,'E<E\2* Z"&8AX^XLB#C
M<-!I47<6!?,HZ@51*X:A& 53A#H$R_F\#7CA*!@-!FW,^P4)E<[NE(L>^P%!
MA).HG3G"/?"_OA^-HGL!D^/A="JB*!C/0S&<!G/D$.%LUJXZ&P?#Z>S!2$2A
M!P$+,0\;"(,02UT.)[.6ZR@830?WLY5SA#L,YC.2XF@2C)QPI\%H1!?\3RM<
M1/#)>'9,N -!&XK$+!C/1AWA^@3@+.'.NEJ9/!7S<7,?3F8'LG79A\\]?.9!
M>4>SZ)DYAP_K+JB[D.X">BO;KPOF]Q@^'9E\Q05PS//"?-' & 7<>Q)=AV+A
MG);1_<GH>M8\X/C!P24V5[G<.0@XOW E@F0I 74*?463[J[9D?_<J<@^_+H*
MXI'=K/)47'F\#I[UH647L7DT^_6[!QIK\-T@BB;\.X[&XO;!YB>9:S08BF@R
M9!\]J"A](4F&$2+MGH[%SWC"J8&CL%9IPKNV$F0)&T?17$0A:ER$5%<A7SF+
M2;JQWK>A2[7RM7ML+#&$7#YJ@>3=<DE)&;$E !YD=E3_;^I-Q5 \-48ND>0/
M6]AXEVNC$U1\I5YU!Z+,Z;CW[%0E\,1#Z]?G]'W'!K(52M<YUO).^5Y_6\F2
M8:XR?:)SW>8MKL/GTJ_.$JXSP7WPMN/@BF?NNB%YR0M 3J$!.813A4P4;C^C
MYJNC!;=<J8MC;UB-9)-KG=,(<T=9<6FYD^?;E:I4\%L5KS.3FM4NP +FCMI[
MU+'@@US6/!TJ<.+<]".9;T[!OJ.V/^K^JQ2PE/1M'&[K&_NDNCNW<UV0B3"
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MSTEK.,<^$#IM*EO9/1XP@@!% 7FV65\UU+>%(T:V@/\UX;:>"(QV]Z1%][D
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M%+B8LM6*1@UE4O<^?D,@9BN2]L<#W X5/WE=UODG!C$0QDFU U <6S(230&
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M!3V';" ,W9T->):=^*2)!*P%QBH2#9Y#HX7$CD@+46C%N/?G;,"W'#<^8@.
M[H,,Q'W/J.'O^;!HG]WM/F-(C$B#,)*,8$Y:\!PGM4+THALMPF1+S%)LV[%J
M;AI:*%LM X%4 )X-MGL+%,$/GV]&MR[8=ZN5!C'L[P"FO'ED)K993]GFA:Q[
MW"5U:R4'9T!?-9BDB/F00VYH&B&U4J#J9E-#!9;!>LAQ98Y$+XI\G5/*2(N<
MC&T+!,9*!;!4_4>J()GRAI4C8E29IDV^U>D7R:'NUAN:4;"ZR7!Z&0C?"\A
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M2;?)6%I42%FJ!.P@T]4I^Y0BS9,$RQ 3;F+699/><.05AM6ZM<@2N!/T8)F
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MQ-&UR+4YVM$9#OM8& G'[1VG>B2G#/J<,IB<4][2X2DA'#CNSU4^%A#U/7K
M9EJ,)9!')QA/(-]!%L SI630OU)=,J7H9'$L0]3[ 5OI9)1P7YL,48L&[*=(
M\%;#HR&Q[I;P$M9,4PX/,[=LBB?E$/5)/6U3H3U&E]0##[YS\C1O:,]&EV,4
M78'$W3?@[F-X DS765=W/:+(L%=D.%F1V\H;J<COX%336OR]H;CXC-4GB(=U
M48ZI]^BTX^I]&]$BVX.CW4TK,HNJ.NFH4FM^IX2?157*VS.#2?Y6[>J+MHR
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M1\L"M+\RU!K:"1O8_9B:_0E02P,$%     @ U#2C5A,!?05G"0  H28  !D
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MXI-_; UBY5,?1M/I(T"^<<SI)&R/^7:SS;@'!Z**8\X=A">W ])[O#L&L.F
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M5D[4+D<'KD_KI/1;J=)HX[,A*"IS^W&4)M:LZ@NBU=W5]U=7U6='Z^;5QUL
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MLD(6QJ/X@9W3Z(F=TW \1EN#]/BVGT!W CEXDO7]A!.' L5'%,F$"@]T;[J
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M"X#YC00CM#]V@?X2O/H/4$L#!!0    ( -0THU;V[@MHK0(  /L%   9
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M7'E =:NI%UJ6KKQCJ4VS<-/,=&<D:V#.5U+JW<(&:/O]^!]02P,$%     @
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MB=J=(]RC_M?WHU'T"# 9#Z=3$47!>!Z*X328HX<(9[.6ZVP<#*>S)Y&(H >
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MEHJ%GP0ZIQU!!YY]3 '&,6310L2\7'$7*^@\!%VM-BRZBPE&,%MMZ!WO]%.
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M6DA:@/=+8\KZAA@TO\*\^1]02P,$%     @ U#2C5OT;'=,R!P  .SD  !D
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M$"PI-F4S"0E7)\C?UXR)IQT5H%XON?@/4$L#!!0    ( -0THU:;,%9?$P,
M #@+   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;*V676_:,!2&_XJ5
M55,K=<UW^C&(U +3=E$)E76[F'9AP@&L.C:S#73_?K:3ID!-1#5NB)V<]\WQ
MX_AP.FLNGN0<0*'GDC+9]>9*+6Y\7Q9S*+&\X M@^LF4BQ(K/14S7RX$X(D5
ME=2/@B#S2TR8EW?LO:'(.WRI*&$P%$@NRQ*+OW= ^;KKA=[+C0<RFRMSP\\[
M"SR#$:C'Q5#HF=^X3$@)3!+.D(!IU[L-;P:9B;<!/PBLY<88F96,.7\RDV^3
MKA>8A(!"H8P#UI<5](!28Z33^%-[>LTKC7!S_.+^Q:Y=KV6,)?0X_4DF:M[U
MKCPT@2E>4O7 UU^A7D]J_ I.I?U%ZSHV\%"QE(J7M5AG4!)67?%SS6%#$"9[
M!%$MB X5Q+4@/E20U(+D4$%:"^S2_6KM%EP?*YQW!%\C8:*UFQE8^E:M>1%F
MOI.1$OHIT3J5C\B,D2DI,%/HMBCXDBG"9FC(*2D(2/0)];"<(\PFU6#P9TE6
MF )3\AP]@%2"% HF^Z/0:1\4)E2>::_'41^=GIRA$T08NB>4ZF]%=GRE%V+2
M\8LZZ;LJZ6A/TO=87* X/$=1$,4.>:]=WH>BD4<.>?_PM[OD@\/?'F[+?;UY
MS0Y&S0Y&UB_>X^?:M5^W8[TS^A#^=L&M_!*WGRE,-W*!"^AZNO)($"OP\H\?
MPBSX[$)]3+/^,<T&1S+;VI2XV92XS3UOCD-A!O!Z'%S[45EEULK4]54>)EEX
MU?%7FZ =4=%UDFY']5O3>B_!(YEM$4P:@DDKP8W:8AF>$E;0Y41/=>G@:@Y"
MET<A-%.$I00ESUQHJW>DF]""RQVPCI@DV<':FNM[L1[); MKVF!-_Q=K"\[T
M#:HH#G9P.F+"; =G:X[OQ7DDLRV<68,S:\7YG2M,+<GS-T?=GG^QPUM3UI"1
M5%A!::/XM'HRU2V;LSQDCO)PG>X<_)XC*HZ#W?+@B JS,-R.&CBBHNSZ-:I"
MY6]T'::GU/^+,\(DHC#5NN#B4F^,J/JT:J+XPC8B8ZYT6V.'<]W:@C !^OF4
M<_4R,;U-TRSG_P!02P,$%     @ U#2C5AH<;_M? P  8 L  !D   !X;"]W
M;W)K<VAE971S+W-H965T,S4N>&ULO99M;]LV$,>_"J$50PLDD439LIW9 M(8
M?0#Z8"1M]V+8"T8ZVT0I4B,IN_OV.\JR*MNRL@'&WD@B>??G[XXB>=.MTM_-
M&L"2'[F09N:MK2UN?=^D:\B9N5$%2!Q9*ITSBTV]\DVA@6654RY\&@2QGS,N
MO61:]2UT,E6E%5S"0A-3YCG3?[\&H;8S+_3V'0]\M;:NPT^F!5O!(]BOQ4)C
MRV]4,IZ#-%Q)HF$Y\^["V_NP<J@LOG'8FM8W<:$\*?7=-=YG,R]P1" @M4Z"
MX6L#]R"$4T*.OVI1KYG3.;:_]^IOJN QF"=FX%Z)WWEFUS-O[)$,EJP4]D%M
MWT$=T-#II4J8ZDFVM6W@D;0T5N6U,Q+D7.[>[$>=B)9#.#CC0&L'^F\=HMHA
MJ@+=D55AS9EER52K+='.&M7<1Y6;RANCX=(MXZ/5.,K1SR:/?"7YDJ=,6G*7
MIJJ4ELL562C!4PZ&7.][#7F %/B&/0D@+^=@&1?F%8Y_?9R3ER]>D1>$2_*1
M"X&K8Z:^13@WA9_6(*]W(/0,R$>F;T@47A$:T*C#_;[??0YIXTX/W7U,29,7
MVN2%5GK1&;U]U%?DD[* KP^*24.8S,@;+IE,799:&?GC PJ0]Q9R\V=7\+O9
M!MVSN;UZ:PJ6PLS#S6A ;\!+?OTEC(/?NE)Q(;&#Q$1-8J(^]>2+9AG@!MY'
MWKG4.XFXDG 'R2:94#J9^IMV%*=&X\DX:HP.Z 8-W:"7[AO(3.EJF7(FRR6>
M$J4&_1SO3G380@FC:#@Z NZPHM%DV$T\;(B'O<0+#3DO\^<(AR=S1W$4'P&>
M&M%X%'?SQ0U?W,OWV:Z?SU]\.G%$@R.Z4Z-H,)ATTXT:NE'_WZ@L$W@7U$?4
M3\PK(L%VH8Y.4<?# 3UB[; :#8,S/^>X@1WWPMX)O#3QZ ""UR])-63<$J&,
MZ4[J^#1?='#$V6$3G:&<-)237LHY-X4RF-6W6I7%%7D'(KM&X&OL@^HX)&B2
M*G=1E)"1SP5H9L\=^KUS_==S[T)B!VD)@Y\W9?"_7@GU=!?*S:74#I/3*B/"
M"V_$6K!]_M,P//J_NXSHZ.@']UOECZL]L918<5P9 4OT"FY&N#_TKIS;-:PJ
MJHKH25FLKZK/-9; H)T!CB\5+G#=<$564U0G_P!02P,$%     @ U#2C5@^-
M2LOG @   @@  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULK57;;MLP
M#/T5P2N&#FAKQ\ZE[1(#2;IA>R@0-.CV,.Q!L>E8J"RYDI*T^_I1LN.FJ9,-
MPUYL7<C#PR.)'&ZD>M Y@"%/!1=ZY.7&E->^KY,<"JHO9 D"=S*I"FIPJI:^
M+A70U#D5W ^#H.\7E DO'KJUF8J'<F4X$S!31*^*@JKG"7"Y&7D=;[MPQY:Y
ML0M^/"SI$N9@[LN9PIG?H*2L *&9%$1!-O+&G>OIP-H[@V\,-GIG3&PF"RD?
M[.1K.O("2P@X),8B4/RM80J<6R"D\5AC>DU(Z[@[WJ)_=KEC+@NJ82KY=Y::
M?.1=>B2%C*ZXN9.;+U#GT[-XB>3:?<FFM@T\DJRTD47MC P*)JH_?:IUV'%
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M)@W*&N!^)J793FR INW'OP%02P,$%     @ U#2C5O::KG*K"@  ^V$  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULM9U1;^,V$L>_BN KBBYP68ND
M1%+;),!NMD47Z+;!YGI].-R#UF$<H;+DDY2D!>[#5Y(=CRA1HT@A7W839S@:
MCL;RCW]1X_.GO/BCO%>J\O[<I5EYL;JOJOV[];K<W*M=7+[-]RJK_W*7%[NX
MJG\MMNMR7ZCXMAVT2]?4]_EZ%R?9ZO*\?>VZN#S/'ZHTR=1UX94/NUU<_/5!
MI?G3Q8JLGE_XDFSOJ^:%]>7Y/MZJ&U7]MK\NZM_6)R^WR4YE99)G7J'N+E;O
MR;LK0MH1K<F_$_54=G[VFKE\S?,_FE\^W5ZL_"8DE:I-U?B(Z_\>U95*T\95
M'<C_CEY7IX,V [L_/WO_L9U]/9NO<:FN\O3WY+:ZOUC)E7>K[N*'M/J2/_VD
MCC,*&W^;/"W;?[VGHZV_\C8/997OCH/K"'9)=O@__O.8B<Z VH]Y #T.H/T!
MP<@ =AS VHD>(FNG]3&NXLOS(G_RBL:Z]M;\T.:F'5W/)LF:\WA3%?5?DWI<
M=7F3;+/D+MG$6>6]WVSRAZQ*LJUWG:?))E&E=^9]3,IXNRW4-F[SGM]Y7]2C
MRAZ4]]U'5<5)6KZIK7Z[^>A]]\T;[QLOR;S/29K6MN7YNJI#; ZTWAS#^7 (
MAXZ$P[S/>5;=E]X/V:VZU<>OZZF=YD>?Y_>!H@X_Q\5;CY%_>M2GS!#/U<N'
M4R0<=DHW:_VQ$7_CR?S/S[6I]ZE2N_*_IKP=_ 9FO\V[_5VYCS?J8E6_G4M5
M/*K5Y;?_(-S_WC1I2\ZT% 2G% 28]\OCA(W%<1C)VY'-%>CQ4@91$)RO'[O1
M#ZT$YZ$\66EAA:>P0C2L7^IK9I(]JK*JKU+-CYM\5Y=XFI?E&U.H!V]A)PC&
M^H$.;0@?"9.?PN1HF/_*JSBM+Z#C.>2#@\J0"MD+;6@EN*3<')PX!2?0X*[O
MX_K*NOG+%!8Z<F[]6G*F35*>)BD=O86ES118<J:E(#JE(%K\%HX&A172T/=[
MY3>T"H0?4G/Y$1\^S'PTL!^+^M/#NZGR0AD_>]#1<\^ +6_Z7#L?W,11'1X=
MVTJ#)6]Z&BBD@2ZNQ>-0K1C#2/1JT63%"!NI1?BD)^BGZ.5UH7;)P\X<F-5/
M<UO>](G"YSD)7!4B2@JSTV#)FYX&X >" P1:B$,2H 'K7.^.,S"8$<[(2"D"
M,Q <&GZM[E5AC L=-_L$6/*FSQ+@@PA7=6@53FQYT], >$+0CWZ\#J6A#J.P
M7X8&*\['/IP!&@A.#;_N51&WJ\L;M6T@N_3^[_VDXK2Z]Z[B0GD?5*;NDLH<
M.>I[]BFRY$U?D@*F4-]1I5*K!&/+FYX&(!B*H@%:J<>A6@V&/.I?,4UF-)*A
MN58I4 7%J6+N:I .&8+P_G+08"2CD4@!,RB.&=,+PJ,#/952]#'(9,;\*!@)
M$/" XNO]%[_MZY>Q!21^F-FE[P(6*, "#5U= 5 *F9T&2][T- "84!Q,T"O
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M#H*HW0!ZGBAE7SONZ% =+6=_ 5!+ P04    " #4-*-6?^SS,:H(  "48
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MZD^Q*1G/Y9> ?M[]50[UCJ T'TH34)I$T9K[B;&EO/GPY=YJ?3E+CZ3Y4)J
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MVVA:T1JZ:?OZ#ZW!I<%"?^MC7$-.^B'MK3O1%4MPZ=&UTJBVZ,5O7H6SX.T
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MTP.BB!\-V10/2%'F9C<QUIZ0*++-?D7HR+TA'IOK70?&>S\'GRE3A4WJQN;
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M:<W=&U&OMP\\WM5"U.7VY0//EKSI!/+[^[H6W]]TSU >GIF=_P]02P,$%
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M:$BRU]E74XTKX!G26.FT,?G'36G6JOM*TY@ K<OR*U)9Z:@N)QQ'K9XZ!P5
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M O+]FE+Q?*,./:M#[MF_4$L#!!0    ( -0THU::E*"&M0L  #M=   9
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M(2BB;.X@-W3.?>O=J&H(7V<"J 91BMDB36XXF[OSXEZ<S:.FQV-)&VY>,6Z
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M5<^.NN"+$/@BQ%?HAH>^4+,XQ_NS [PV4S6 $"&.$,.BAH8@*._/^/&:3)4
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M&R'A"T(B/+PRI28750'%+MY'4YVS<.ML&AXDG%-U0J+16Q(&832@9_;W\/"
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M@!@Q5VD2?1GI\$))FN#$ "D$C11M2VJ7/K3KY!DPL<TB.A]P,2DX"=[/PI@
M& $ (^8*3F)<<")-<&* $V)4<-)_$(EUPX0K&AXDH(DP*3@)5F[ABH9+ =PB
MY@I.HB\XN2(\;$6=T8 &+X DQ*B0Y RM9VC7R;-@8B=$ I5(DT*29"46KFBX
M%$ L<JZ0),>%)-($)P;\($?5(8=<S]#^DZ?!Q#Z'!"B1)M4AR8HM7-%P*0!;
MY%QU2/;5H?XE4FLT<(F4G8_5CJH^#KV>H0-,G@L3NQT2\$2:5'TD*\1P1<.E
M (B1<U4?.:[ZD"8X,4 *.2KE.$/K&=IU\@R8V.B0@"?2I)0C60&&*QK^5#L
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M0O"EAB#J[P!+"$.-I'A\S4&M8DSM>/K\COY3&KP*YH4(6++P3QK(W=R:6"B
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M971S+W-H965T-3<N>&ULK55=;],P%/TK5IC0)D'3)&V DD9:.S;V,*G:-'A
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MJ. PF<]CHN&!3'^G<I2@EJZ@:I+)E3#U'6Q'VYI][DK5P?@$:WE=>I]HZH<
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MH)J8KD\&(/Y  &FO@P_TD18.T?8.%46PO(GGS%#$GQ>*^*@H@N5-W(#!4"2
M4<0JJ0.5'\(TB*2\UEA%J6NH/08,-(+1ZS6!AAM2UY?[I[%*(M-6%@87 0P7
M@V[=@<H-))*?NG5&Q# U! PM A@MC+?N0"6%Q"7R;*6S2F+#*E? [0""@4*=
ML#QM'W$W_TQ1/@H8K 3SVO\3H"(,EC<Q> QA KBV93=AJ3M]DBB6EP(T5I$;
MI(;49KP0C%ZH"#0+%4D2*3.JSLPW/0\%C!8"F!:&35EJ 4=^K@1-Q+ZQNWH
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M3CWLUUKH8(I5MX2!8#*OLF*"2H=8WL3@,3I,1N]E3@:]4Z^Q,K]3GS  2V
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M/:KC(_)?2_D][=F+:T\C3<YKD\^KD$JPU<DG04=>GQQ!H%RG/:[> S16YGL
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MYH5%Y>T#. DP^OS'#L>7>37J\0KN@S92[S@:ZU&8MT][/>;#S=B/VB3+<YS
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M%J!_GW*N7@ZREQ3*EU(&_P-02P,$%     @ U#2C5GAYU];K!P  LUH  !D
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M=] NU&YJT_--N'U"SN$[A?\-M/\-7"NYZ7&WE.Q<YP4.W5F&T@2*9F9(F^N
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M7!NHWV\9D_L;/4!U5#[_%U!+ P04    " #4-*-6/6H)\?P"  #Q"   &0
M 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6R]5E%/VS 0_BNG#&T@,1(2:!EK
M(]'"1"5 %8CM8=J#FUQ;#\?.;(?"O]_9:;/"0K5-:"^)[?B^N^^S[RZ]A=)W
M9HYHX:$0TO2#N;7E<1B:;(X%,WNJ1$E?IDH7S-)4ST)3:F2Y-RI$&$=1)RP8
MET':\VMCG?949067.-9@JJ)@^G& 0BWZP7ZP6KCFL[EU"V':*]D,;]#>EF--
ML[!!R7F!TG E0>.T'YSL'P^[;K_?\)GCPJR-P3&9*'7G)J.\'T0N(!2868?
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M*O346W-[?9R]!*4C4&JREX*/^-:IN/G^7#+GT#UZ?P"I-?F^9I0>Y0>:3Z!
M U0MAE*3?1),PX> &OUMA3O.Z(\NM2,\]E03#5%CW450H@&J%D.IR2X*J.';
MJ<:?M#FJVS1:9* 0!HL,40:+0&$%J%H,I29;)'B%;P<6'VE=GZ//--LM+S&:
M5G>4);>YN>F,M3.NF7(P)+)GY>P(I%KLVU"&?)H%?O#M_.'8EO 6E;0;GIB#
M(_K,WM12#%&&E@())6:@:K&A!B0,QH]8([B#;P</'ZMR>?HW906:)LQ\@D%9
M :A:!*HV U6+H=3DU6+!'[#WQ,6PMHWQ0Q;9IC"./1ARWC\%58M U6:@:C&4
MFFRX(!S83CA>924,ZWB#J#.PJ2EH<J;TM?;:.#L)"D&@U&0G!03!AR#(ZRR'
M81V-$ ^K9AJ",%'-!.4GH&HQE)ILIN G^  _>=::F%W<N2\&W82"=1RC+HL=
M#HFA<I+M$4@$'XM$GK4T9C^*LT^@&T>P3F,TG_20D>K32R 1+) (MB.1UUX@
MLZ?C;"BD6H1U,J/UVS-3D+J.%D/E)9LJ" FV$Q*(11FL,Y! '<(.AD3V1)T'
M,%!& J4FFR08";8SDC_WI@O6Y1BL@X]37[LW/"(HLF?D[ 8H'X%2D]T0* 4?
MV,KQ&LLQV$!+SD+520.0P.J*M+TVSDZ"$A4H-=E)05ZPG;P\?S$&Z]L@U)48
M0PA1EZ/M>3I[! I1H-3D;>("HA#[)HX77H@A^I8.XOF*A::@D3J;MM?#>4<X
M*!>!4I,]%%R$^$\$8<<OQQ!(O# %58M U6:@:C&4FFR] "G$#E)>!8D1'9#X
MHU =+4U19V>^VHQ!.0JH6@RE)GNY]Y,=.T=Y+2A&=&3AA[ZZJ\@4%4S4^UA[
ME9SMA/VASDMP%R*X"WG"5I2CL9A=W+D_!L4MY#!N.1P20^4DVR-P"['C%B L
M9C^*LT^@%(7H@.14A2B&&'67,512LE$"H1 [0GEM+F9/Q]E12+6H5POEKMM7
M/35$!1/-UI> +D1 %V*'+FZ[Q\GA72F'0R)[2LZC%2AU@5*3[1#4A=BI"P2H
M) :HHKFDQ_C:5 \4J8"JQ5!JLDT"J1 [4G':/4YT-'+J3U1#3$&AZ@@H0 %5
MBZ'4Y!]D"X 2V '*J^#*0"<DAEMV4U2@;4NPU\?Y9]:@( 5*3?92@)3 OL'D
M^< RT#>&^.I^ T,,GJC[#>R9.KL$RCR@U&27!/,(()C'DY%E8. 8H?8K*%/4
M>*PN#MAKXNPB*.V 4I-=%+0CL-..Y^P=#PQL@F!U4=04%:B=9F1/T]DB4((!
MI29;M/>P$3O!<-X['AR<]4\/AT3VK)P=@52+K>G+IUF0B,!.(EYR[WB@/[/#
MU%(,48:6 OI#&%"UV%2#\&RD6#/<>TA70=FR>YQ:C;KQ8/N<JMVGNT>VO>\>
M5*9\?NV?3[</7A,RV^? ?4H8O[^K44X77-)[-^:)L>VCU;9OFFK=/0KLMFJ:
MJNA>KF@RIZP-X-\OJJIY>-,>8/> NZO_ 5!+ P04    " #4-*-6XS1,6P,#
M  !O"@  &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6R]5F%OVC 0_2M6
M5DVMU#8A@0 =1&KINE5J-536[<.T#R8YP*IC9[8#Y=_/=D($-*!.BO:%V,F]
ME_?.=^$&*RY>Y ) H=>4,CET%DIE5ZXKXP6D6%[R#)A^,N,BQ4IOQ=R5F0"<
M6%!*7=_S0C?%A#G1P-X;BVC <T4)@[% ,D]3+-8W0/EJZ+2<S8TG,E\H<\.-
M!AF>PP34<S86>N=6+ E)@4G"&1(P&SK7K:M1W\3;@!\$5G)KC8R3*><O9G.?
M#!W/" (*L3(,6%^6, )*#9&6\:?D=*I7&N#V>L-^9[UK+U,L8<3I3Y*HQ=#I
M.2B!&<ZI>N*KKU#ZZ1B^F%-I?]&JC/4<%.=2\;0$:P4I8<45OY9YV *TV@<
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MUZTW"".@OV\X5\>)V:!IYA=_ U!+ P04    " #4-*-6.]6)/> &  "A1
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M7\33!U[MD%_PYF*3EY_D:;]MX _(?)<KD5;!>@1IDNV_XQ_5@3@(\-H":!5
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M?2(HFI>CZ4^@XU8&*J6N4<4".PV\$OH'W5)VP&R% IH(AH-ZTHV8C4F'1/-
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M,0V5$B5H\Y'</JVX?2&?R0U?\Q)D:<C9#5C&A3E'ZWM"B7$ DU&+P1T%+=I
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MZ.S7-^A7E.;H4YIEK')45X.:983+#>+VHI/-1?$+%R7H4Y'7BPH%>4(3.?V
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MK7<S]\;:P*SX2LE.5JZ1IK+B_$4//D=3IZ<](HR$2D-@^'LE<\*81@(__BE
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MOT%IDF9HU'V!-YLJD 7>[+\K\&.U-U:[?OGY5-J1;?$TFY^AI>EI!05V0V)
M'P"7+U_,KY,/%[0N)JV+2^SE_2#VH)%JD)M*?T=.K8GZS5-:(]M58//C>2BS
MG!S.!9"SUA&@VS @!E5JD#9VT;0[S> JMMY?]SC [H):)@WBT#AH,GOGXNHX
M%-&PJ@^-N%?6M758=NX= >T=W'FCE#T9/L#T,I5_ %!+ P04    " #4-*-6
M-/A"P.T'  !_10  &0   'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6S%G&MO
MVS84AO\*X15%"]2U>)6=)@8:=T,++&C0K.N'81]4F[&UZN))3-("^_&C9,44
M+8DQ*QKZTOI"OCKGF,=\]436^4.:?<LWG OP/8Z2_&*T$6)[-IGDRPV/@_QU
MNN6)?.<VS>) R*?9>I)O,QZLRDEQ-$&>QR9Q$":C^7GYVG4V/T_O1!0F_#H#
M^5T<!]F/2QZE#Q<C.'I\X5.XWHCBA<G\?!NL^0T7G[?7F7PVV:NLPI@G>9@F
M(..W%Z.W\&SAXV)".>+/D#_DM<>@2.5KFGXKGGQ878R\(B(>\:4H) +YWSU?
M\"@JE&0<_U:BH_TQBXGUQX_JOY7)RV2^!CE?I-&7<"4V%Z/I"*SX;7 7B4_I
MPWM>)40+O64:Y>6_X*$:ZXW \BX7:5Q-EA'$8;+[/_A>%:(V0>JT3T#5!'0X
M@71,P-6$LG*3761E6N\"$<S/L_0!9,5HJ58\*&M3SI;9A$GQ,=Z(3+X;RGEB
M?L/7\D,1X!/?IID(DS48R\<B2_,M+RL,WJ[^D6$4@W(@4O X89'&VS0/R\_B
MQ3LN@C#*7\K)GV_>@1?/7H)G($S 51A%<D!^/A$RUN*(DV45U^4N+M01%P97
M:2(V.?@U6?&5/G\B<]PGBAX3O41&P:L@>PTP? 60AW!+/(OCIR-#.'A?=USJ
MX6/K_@I\%!N>@9MPG82WX3(HWURFR3*,BH_E@^ Q^.MW*5,^S/]NJ^GNF*3]
MF,4WPEF^#9;\8B1;/N?9/1_-G_\"F?>FK2".Q+3RD'UYB$E]_D<J@DA^3=SS
MY(ZW+I_=?%;.+[ZK[N=3BOSI^>2^GD-SE,^FB.U':<'1?7#4&-RN(_@*R"_3
M+"B;)DR6:<S!BRC-\Y=MX>X4:2T0@GWO(-J60<SSVX-E^V"9,=A%FLD5%@@^
MV2VPMN","K;+QI&8EJR_3]8?H*M\E^5Q)*:59[HOS[1G5TT;*Q!.#WNJ94Q7
M1\WV@<V<=]2L$<88L<-8VP;-INW!0D_MF9XQW ^)X%E>K;5?HU#NRX'HW.>,
M6K;+QY6:GGG-+< !&JPZJ*L2.5+32X14B5#/)JL$M%4),?8.MX/6<7#6M2-
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M6XH"@LI_#VS!XKA DCR^U:"3YIU%P_WK)_3W9>=E9[[0G"UX_#E:B<W%))B
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MK#"0OZ\Y%T\WQ0N:LX7S_P!02P,$%     @ U#2C5E8I;$V! P  FPH  !D
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M2X.MB1MNL7L$90WP^49*<YS8%[3]Z.)?4$L#!!0    ( -0THU:[N%XW3@,
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MM2BR6A19+8JL:Q19U_]3UE_>[S\Y?G[6@^O&EWPV_Q_]^C=02P$"% ,4
M" #4-*-6!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( -0THU9,DIH3[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -0THU:97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ U#2C5NCXW@?1!0  S1X  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -0THU9!ABK<
M& 8  #D<   8              " @10.  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " #4-*-6'.#H?<@#  ""#   &
M@(%B%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ U#2C
M5A"Z,6+"!P  W"(  !@              ("!8!@  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( -0THU9H-6M,( ,  "0+   8
M      " @5@@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" #4-*-6J932]Q,(   &)   &               @(&N(P  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ U#2C5J/:\_XV#P  L8P  !@
M             ("!]RL  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( -0THU;1D_$_N0(  -\(   8              " @6,[  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #4-*-6VS'7NS(E  #<
M?@  &               @(%2/@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ U#2C5@Z].UD7#0  7R8  !D              ("!NF,
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #4-*-6N-6[
M#'D/  " +@  &0              @($(<0  >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( -0THU9GKK=P= D  ) =   9
M  " @;B   !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
MU#2C5I+7FH'C!@  ,Q,  !D              ("!8XH  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " #4-*-603^)PN((  !:(P  &0
M            @(%]D0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( -0THU;CVD@"B 8  !@3   9              " @9::  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ U#2C5OKKR.? !@
M510  !D              ("!5:$  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " #4-*-6N%%?LHH%   ,$   &0              @(%,
MJ   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( -0THU;1
M_1P\MP,  ,((   9              " @0VN  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ U#2C5B4MWWQW*@  YH8  !D
M     ("!^[$  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -0THU8L[W?\B T  .$K   9              "
M@2(; 0!X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ U#2C
M5@30\29Y!P  ,!@  !D              ("!X2@! 'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " #4-*-64I5510,%  !8#0  &0
M        @(&1, $ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( -0THU83 7T%9PD  *$F   9              " @<LU 0!X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ U#2C5E^JB/Y'!0  $ \
M !D              ("!:3\! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " #4-*-6]NX+:*T"  #[!0  &0              @('G1 $
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( -0THU93HJ!V
MG04   00   9              " @<M' 0!X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ U#2C5AL5FA # P  Z 8  !D
M ("!GTT! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " #4
M-*-6'8,Z:/P,  "1*0  &0              @('94 $ >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( -0THU;]&QW3,@<  #LY   9
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M970S-RYX;6Q02P$"% ,4    " #4-*-6>(V<P[8"  !K"   &0
M    @(%5>@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M -0THU9 X0:=$0,  )P(   9              " @4)] 0!X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ U#2C5JTMCM]R P  9@X  !D
M             ("!BH ! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " #4-*-6?^SS,:H(  "48   &0              @($SA $ >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( -0THU;BV)9#D \
M *R<   9              " @12- 0!X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ U#2C5DA)P9(>!P  :4,  !D              ("!
MVYP! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " #4-*-6
M#"'?)3L#  !K"@  &0              @($PI $ >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( -0THU8OPCJPS@0  )L9   9
M      " @:*G 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ U#2C5@C 'YVX P  &14  !D              ("!IZP! 'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #4-*-6&!<<&T0#  "A#
M&0              @(&6L $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+
M 0(4 Q0    ( -0THU9]&8<;>@,  -L+   9              " @1&T 0!X
M;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ U#2C5JPKE6(0
M!   +A0  !D              ("!PK<! 'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6Q02P$"% ,4    " #4-*-6D<77#EP(   _.P  &0
M@($)O $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( -0T
MHU8 GXD*^ 0  / >   9              " @9S$ 0!X;"]W;W)K<VAE971S
M+W-H965T-3$N>&UL4$L! A0#%     @ U#2C5IJ4H(:U"P  .UT  !D
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M=#4V+GAM;%!+ 0(4 Q0    ( -0THU9XC973E0(  .T&   9
M  " @5_O 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @
MU#2C5M]ZO2Q]#0  -Y$  !D              ("!*_(! 'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6Q02P$"% ,4    " #4-*-6].H8OUL"  "G!0  &0
M            @('?_P$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4
M Q0    ( -0THU:Y.?_W7P4  * B   9              " @7$" @!X;"]W
M;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ U#2C5GAYU];K!P
MLUH  !D              ("!!P@" 'AL+W=O<FMS:&5E=',O<VAE970V,2YX
M;6Q02P$"% ,4    " #4-*-6G!GAH>,%   V'P  &0              @($I
M$ ( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( -0THU8]
M:@GQ_ (  /$(   9              " @4,6 @!X;"]W;W)K<VAE971S+W-H
M965T-C,N>&UL4$L! A0#%     @ U#2C5B/=&8#M"   [$X  !D
M     ("!=AD" 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -0THU;C/76)B@,  $ +   9              "
M@60T @!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ U#2C
M5IUO&3\T$@  F,P  !D              ("!)3@" 'AL+W=O<FMS:&5E=',O
M<VAE970W,"YX;6Q02P$"% ,4    " #4-*-6,91[1'D%   T,@  &0
M        @(&02@( >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0
M   ( -0THU:-B2P6O0,  $\4   9              " @4!0 @!X;"]W;W)K
M<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ U#2C5D1XV\J0!0  K2@
M !D              ("!-%0" 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q0
M2P$"% ,4    " #4-*-6'K1[/ET"  "W!0  &0              @('[60(
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( -0THU;)E%&.
MS H  )!?   9              " @8]< @!X;"]W;W)K<VAE971S+W-H965T
M-S4N>&UL4$L! A0#%     @ U#2C5KTF;MYA!   G!(  !D
M ("!DF<" 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " #4
M-*-6ZDL$?^$&   6/@  &0              @($J; ( >&PO=V]R:W-H965T
M<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( -0THU9H&N(R'P(  *4$   9
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M;',O+G)E;'-02P$"% ,4    " #4-*-6PE36H](%  "J-0  #P
M    @ &5C ( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ U#2C5JN<,4MN
M @  VB\  !H              ( !E)(" 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ U#2C5D3DWU@> @  ERX  !,
M ( !.I4" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %D 60!F&   B9<"
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>603</ContextCount>
  <ElementCount>438</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>152</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Acquisition and Assets Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSale</Role>
      <ShortName>Acquisition and Assets Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Other Insurance Liabilities and Separate Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss</Role>
      <ShortName>Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Acquisition and Assets Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables</Role>
      <ShortName>Acquisition and Assets Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSale</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Other Insurance Liabilities and Separate Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Borrowings</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeLossTables</Role>
      <ShortName>Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails</Role>
      <ShortName>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Significant Accounting Policies - Deferred Acquisition Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails</Role>
      <ShortName>Significant Accounting Policies - Deferred Acquisition Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables and Contracted Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Significant Accounting Policies - New Accounting Pronouncements Recently Adopted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails</Role>
      <ShortName>Significant Accounting Policies - New Accounting Pronouncements Recently Adopted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Significant Accounting Policies - Changes in balances of long-duration insurance liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails</Role>
      <ShortName>Significant Accounting Policies - Changes in balances of long-duration insurance liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Significant Accounting Policies - Adjustments Resulting From Applying New Accounting Standard (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails</Role>
      <ShortName>Significant Accounting Policies - Adjustments Resulting From Applying New Accounting Standard (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Acquisition and Assets Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails</Role>
      <ShortName>Acquisition and Assets Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Acquisition and Assets Held for Sale - Schedule of Fair Value of Consideration Transferred (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails</Role>
      <ShortName>Acquisition and Assets Held for Sale - Schedule of Fair Value of Consideration Transferred (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Acquisition and Assets Held for Sale - Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisition and Assets Held for Sale - Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Acquisition and Assets Held for Sale - Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails</Role>
      <ShortName>Acquisition and Assets Held for Sale - Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Acquisition and Assets Held for Sale - Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails</Role>
      <ShortName>Acquisition and Assets Held for Sale - Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Acquisition and Assets Held for Sale - Summary of Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Acquisition and Assets Held for Sale - Summary of Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Investments - Total Investment Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails</Role>
      <ShortName>Investments - Total Investment Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails</Role>
      <ShortName>Fair Value - Measurement on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Fair Value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueNarrativeDetails</Role>
      <ShortName>Fair Value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Borrowings - Schedule of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails</Role>
      <ShortName>Borrowings - Schedule of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Borrowings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsNarrativeDetails</Role>
      <ShortName>Borrowings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Accelerated Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Shareholders' Equity - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails</Role>
      <ShortName>Shareholders' Equity - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeLossTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Segment Reporting - Retrospective Adjustments to Segment Composition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails</Role>
      <ShortName>Segment Reporting - Retrospective Adjustments to Segment Composition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cvs-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cvs-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cvs-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cvs-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="cvs-20230331.htm">cvs-20230331.htm</File>
    <File>a03312023ex101.htm</File>
    <File>a03312023ex102.htm</File>
    <File>a03312023ex103.htm</File>
    <File>a03312023ex104.htm</File>
    <File>a03312023ex105.htm</File>
    <File>a03312023ex106.htm</File>
    <File>a03312023ex107.htm</File>
    <File>a03312023ex151.htm</File>
    <File>a03312023ex311.htm</File>
    <File>a03312023ex312.htm</File>
    <File>a03312023ex321.htm</File>
    <File>a03312023ex322.htm</File>
    <File>cvs-20230331.xsd</File>
    <File>cvs-20230331_cal.xml</File>
    <File>cvs-20230331_def.xml</File>
    <File>cvs-20230331_lab.xml</File>
    <File>cvs-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1659">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>108
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20230331.htm": {
   "axisCustom": 3,
   "axisStandard": 32,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1659,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 603,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 760,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 5,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 10
   },
   "keyCustom": 72,
   "keyStandard": 366,
   "memberCustom": 92,
   "memberStandard": 57,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Acquisition and Assets Held for Sale",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSale",
     "shortName": "Acquisition and Assets Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Fair Value",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Health Care Costs Payable",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceContractAcquisitionCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Other Insurance Liabilities and Separate Accounts",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts",
     "shortName": "Other Insurance Liabilities and Separate Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceContractAcquisitionCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Borrowings",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.cvshealth.com/role/Borrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Shareholders' Equity",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Other Comprehensive Income (Loss)",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss",
     "shortName": "Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.cvshealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Segment Reporting",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "21",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Acquisition and Assets Held for Sale (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables",
     "shortName": "Acquisition and Assets Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Fair Value (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Health Care Costs Payable (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Other Insurance Liabilities and Separate Accounts (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables",
     "shortName": "Other Insurance Liabilities and Separate Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Borrowings (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.cvshealth.com/role/BorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Other Comprehensive Income (Loss) (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossTables",
     "shortName": "Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.cvshealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Segment Reporting (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberOfPharmacyPlanMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "people",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberOfPharmacyPlanMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "people",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails",
     "shortName": "Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorAndManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredPolicyAcquisitionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Significant Accounting Policies - Deferred Acquisition Costs (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails",
     "shortName": "Significant Accounting Policies - Deferred Acquisition Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredPolicyAcquisitionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i6b014ab5cfd341f7ae8d078ed0c475f0_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails",
     "shortName": "Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Significant Accounting Policies - New Accounting Pronouncements Recently Adopted (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails",
     "shortName": "Significant Accounting Policies - New Accounting Pronouncements Recently Adopted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax",
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ifd36720f2ede47418003c3eca8540ff9_I20210101",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i68a2a42d2c314267a6ba9a48f7231396_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Significant Accounting Policies - Changes in balances of long-duration insurance liabilities (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails",
     "shortName": "Significant Accounting Policies - Changes in balances of long-duration insurance liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia31fd2c5b89f4c77b1dc17cf2213ac74_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Significant Accounting Policies - Adjustments Resulting From Applying New Accounting Standard (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
     "shortName": "Significant Accounting Policies - Adjustments Resulting From Applying New Accounting Standard (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "iab7538367b4d402aad244c6c69df822b_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i409ce543d75747f6a86747b1e3200724_D20230221-20230221",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Acquisition and Assets Held for Sale - Narrative (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
     "shortName": "Acquisition and Assets Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i92b1cc55a9704aeea04b6939f5195e76_I20230329",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Acquisition and Assets Held for Sale - Schedule of Fair Value of Consideration Transferred (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails",
     "shortName": "Acquisition and Assets Held for Sale - Schedule of Fair Value of Consideration Transferred (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia977cadc675147a6b4b7c76159416cd6_D20230329-20230329",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Acquisition and Assets Held for Sale - Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisition and Assets Held for Sale - Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i92b1cc55a9704aeea04b6939f5195e76_I20230329",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Acquisition and Assets Held for Sale - Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails",
     "shortName": "Acquisition and Assets Held for Sale - Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "icd3ba4757bbe45faaadd9ba0c14cda5a_I20230329",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i92b1cc55a9704aeea04b6939f5195e76_I20230329",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Acquisition and Assets Held for Sale - Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails",
     "shortName": "Acquisition and Assets Held for Sale - Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i92b1cc55a9704aeea04b6939f5195e76_I20230329",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i477ed67917444c06928e6bdfe4442b96_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Acquisition and Assets Held for Sale - Summary of Assets and Liabilities Held for Sale (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Acquisition and Assets Held for Sale - Summary of Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i477ed67917444c06928e6bdfe4442b96_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Investments - Total Investment Schedule (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails",
     "shortName": "Investments - Total Investment Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LongTermInvestmentsIncludingAssetsHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Investments - Debt Securities (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Investments - Mortgage Loans (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i48bf33e31ca8411e9359d8f0c7e3ca2f_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i8a07081ff1e147c7b62955fae3341f9c_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i8a07081ff1e147c7b62955fae3341f9c_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Investments - Net Investment Income (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Investments - Realized Gains (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
     "shortName": "Fair Value - Measurement on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i5c6811cb34424e92bc1f0f67791ec9a6_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Fair Value - Narrative (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.cvshealth.com/role/FairValueNarrativeDetails",
     "shortName": "Fair Value - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "id949c9b2b95046068211c24d3d40a4e2_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "id949c9b2b95046068211c24d3d40a4e2_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie1683e51a0304fd1b7b78196b6cd714f_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i4ef8067610324631a99b73d483b1c819_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i180077daf73946ae866928c89b89e292_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i180077daf73946ae866928c89b89e292_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i68a2a42d2c314267a6ba9a48f7231396_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i68a2a42d2c314267a6ba9a48f7231396_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i68a2a42d2c314267a6ba9a48f7231396_I20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i68a2a42d2c314267a6ba9a48f7231396_I20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PolicyholderAccountBalanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PolicyholderFunds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PolicyholderAccountBalanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PolicyholderFunds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i452ce3dfebd34199a05e64ce393bc4c8_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SeparateAccountLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountsLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SeparateAccountLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountLiabilityPremiumAndDeposit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i44ee7f171b49433c9fee60c78374b031_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i44ee7f171b49433c9fee60c78374b031_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Borrowings - Schedule of Borrowings (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
     "shortName": "Borrowings - Schedule of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i409ce543d75747f6a86747b1e3200724_D20230221-20230221",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Borrowings - Narrative (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
     "shortName": "Borrowings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i1f22263a3b694849ac61d1b0059ba4c0_I20230221",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i1d3f405559b34436a7dd9bda0df240e1_I20221117",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Shareholders' Equity - Share Repurchases (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i1d3f405559b34436a7dd9bda0df240e1_I20221117",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ic891f32373a24150b07a0e2e79451ecf_I20230104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ic891f32373a24150b07a0e2e79451ecf_I20230104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Shareholders' Equity - Dividends (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
     "shortName": "Shareholders' Equity - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ia07e4fe6ef454e7b88b2d59a3c705b31_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
     "shortName": "Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie9e4ce7d668647199a9963ba9223fb1e_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.cvshealth.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberOfLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberOfLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Segment Reporting - Narrative (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Segment Reporting - Retrospective Adjustments to Segment Composition (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
     "shortName": "Segment Reporting - Retrospective Adjustments to Segment Composition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "iab7538367b4d402aad244c6c69df822b_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldInTrust",
       "cvs:TreasuryStockSharesHeldInTrust",
       "cvs:TreasuryStockSharesHeldInTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldInTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldInTrust",
       "cvs:TreasuryStockSharesHeldInTrust",
       "cvs:TreasuryStockSharesHeldInTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i80e4bbee9f2f48ff8554d030ba033144_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldInTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
     "shortName": "Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "i66374446ee7f468eaf7348b312bb3668_D20230101-20230331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "cvs:NetRevenuesRetailCoPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation of Consolidated Operating Income to Adjusted Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230331.htm",
      "contextRef": "ie760767cad2040b7ae8d8319e04f2e47_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 152,
   "tag": {
    "cvs_A2021RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Repurchase Program",
        "label": "2021 Repurchase Program [Member]",
        "terseLabel": "2021 Repurchase Program"
       }
      }
     },
     "localname": "A2021RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_A2022RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Repurchase Program",
        "label": "2022 Repurchase Program [Member]",
        "terseLabel": "2022 Repurchase Program"
       }
      }
     },
     "localname": "A2022RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Change In Discount Rate On Insurance Reserves",
        "label": "AOCI, Change In Discount Rate On Insurance Reserves [Member]",
        "terseLabel": "Change in discount rate on long-duration insurance reserves"
       }
      }
     },
     "localname": "AOCIChangeInDiscountRateOnInsuranceReservesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AcceleratedShareRepurchasesAgreementAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases Agreement, Amount",
        "label": "Accelerated Share Repurchases Agreement, Amount",
        "terseLabel": "ASR agreement, amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAgreementAmount",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Number of Shares Repurchased",
        "label": "Accelerated Share Repurchases, Number of Shares Repurchased",
        "terseLabel": "Shares repurchased under ASR agreement (in shares)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesNumberOfSharesRepurchased",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program",
        "label": "Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program",
        "terseLabel": "ASR, shares to be received at the end of program as a percent of notional amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent of Notional Amount Received in Shares",
        "label": "Accelerated Share Repurchases, Percent of Notional Amount Received in Shares",
        "terseLabel": "ASR percent of notional amount received in shares"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale",
        "label": "Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Before Tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Before Tax",
        "negatedTerseLabel": "Reduction to accumulated other comprehensive income (loss), before tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity in mortgage loan portfolio [Table Text Block]",
        "verboseLabel": "Schedule of Activity in Mortgage Loan Portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "terseLabel": "Adjusted operating income (loss)",
        "verboseLabel": "Adjusted operating income"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BarclaysBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays Bank",
        "label": "Barclays Bank [Member]",
        "terseLabel": "Barclays Bank"
       }
      }
     },
     "localname": "BarclaysBankMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Effective Settlement Of Pre-Existing Relationship",
        "label": "Business Combination, Consideration Transferred, Effective Settlement Of Pre-Existing Relationship",
        "negatedTerseLabel": "Effective settlement of pre-existing relationship"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEffectiveSettlementOfPreExistingRelationship",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "terseLabel": "Debt (current and long-term)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Cash",
        "label": "Business Combinations, Recognized Identifiable Assets Acquired And Liabilities Assumed, Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "BusinessCombinationsRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Categories5and6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 and 6 [Member]",
        "terseLabel": "5 and 6"
       }
      }
     },
     "localname": "Categories5and6Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 to 4 [Member]",
        "terseLabel": "2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ChangeinContractwithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability [Roll Forward]",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeinContractwithCustomerLiabilityRollForward",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "label": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_CitibankNAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Citibank, N.A.",
        "label": "Citibank, N.A. [Member]",
        "terseLabel": "Citibank, N.A."
       }
      }
     },
     "localname": "CitibankNAMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common and Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractwithCustomerLiabilityRedemptionandBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer Liability Redemption and Breakage",
        "label": "Contract with Customer Liability Redemption and Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractwithCustomerLiabilityRedemptionandBreakage",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CorporateOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate / Other [Member]",
        "label": "Corporate / Other [Member]",
        "terseLabel": "Corporate / Other"
       }
      }
     },
     "localname": "CorporateOtherMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "label": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt discounts and deferred financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss",
        "label": "Debt Securities, Available-For-sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredIncomeTaxesAndOtherNoncashItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Deferred Income Taxes And Other Noncash Items",
        "terseLabel": "Deferred income taxes and other noncash items"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherNoncashItems",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Liability for Unpaid Claims and Claims Adjustment Expense",
        "label": "Disposal Group, Liability for Unpaid Claims and Claims Adjustment Expense",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DisposalGroupLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic and Diluted EPS",
        "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]",
        "verboseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions",
        "label": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions [Member]",
        "terseLabel": "Change in discount rate assumptions"
       }
      }
     },
     "localname": "EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income",
        "label": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Removal of shadow adjustments in accumulated other comprehensive income"
       }
      }
     },
     "localname": "EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FederalCourtInOhioJudgmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Court In Ohio Judgment",
        "label": "Federal Court In Ohio Judgment [Member]",
        "terseLabel": "Federal Court in Ohio Judgment"
       }
      }
     },
     "localname": "FederalCourtInOhioJudgmentMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberOfLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Number Of Leases",
        "label": "Guarantor Obligations, Number Of Leases",
        "terseLabel": "Guarantor obligations, number of leases"
       }
      }
     },
     "localname": "GuarantorObligationsNumberOfLeases",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareandOtherInsuranceLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care and Other Insurance Liabilities [Abstract]",
        "label": "Health Care and Other Insurance Liabilities [Abstract]",
        "terseLabel": "Health Care and Other Insurance Liabilities [Abstract]"
       }
      }
     },
     "localname": "HealthCareandOtherInsuranceLiabilitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cvs_HealthServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Services Segment",
        "label": "Health Services Segment [Member]",
        "terseLabel": "Health Services"
       }
      }
     },
     "localname": "HealthServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Number of Additional States",
        "label": "Individual Public Health Insurance Exchanges, Number of Additional States",
        "terseLabel": "Additional number of states in which the Company entered the individual public health insurance exchange"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Number of States",
        "label": "Individual Public Health Insurance Exchanges, Number of States",
        "terseLabel": "Number of states in which the Company has entered the individual public health insurance exchange"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesNumberOfStates",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsOrLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains Or Losses",
        "label": "Investment Income, Excluding Capital Gains Or Losses",
        "totalLabel": "Net investment income (excluding net realized capital losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsOrLosses",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LargeCasePensionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Large Case Pensions",
        "label": "Large Case Pensions [Member]",
        "terseLabel": "Large Case Pensions"
       }
      }
     },
     "localname": "LargeCasePensionsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LegalSettlementPeriodOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Settlement, Period Of Payment",
        "label": "Legal Settlement, Period Of Payment",
        "terseLabel": "Legal settlement, period of payment"
       }
      }
     },
     "localname": "LegalSettlementPeriodOfPayment",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, After Reinsurance, Net Of Tax",
        "label": "Liability For Future Policy Benefit, After Reinsurance, Net Of Tax",
        "terseLabel": "Liability for future policy benefits, after tax"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change",
        "terseLabel": "Liability for future policy benefits, beginning of period - current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LitigationSettlementNumberOfStatesElectedToJoin": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Number Of States Elected To Join",
        "label": "Litigation Settlement, Number Of States Elected To Join",
        "terseLabel": "Number of states that elected to join the settlement"
       }
      }
     },
     "localname": "LitigationSettlementNumberOfStatesElectedToJoin",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Number Of States Under Separate Settlement Agreements",
        "label": "Litigation Settlement, Number Of States Under Separate Settlement Agreements",
        "terseLabel": "Number of states under separate settlement agreements"
       }
      }
     },
     "localname": "LitigationSettlementNumberOfStatesUnderSeparateSettlementAgreements",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_LongTermCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Care",
        "label": "Long Term Care [Member]",
        "terseLabel": "Long-Term Care"
       }
      }
     },
     "localname": "LongTermCareMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including liabilities held for sale, classified as noncurrent.",
        "label": "Long-Term Debt And Lease Obligation, Including Liabilities Held For Sale",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LongTermDebtGrossAndLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Gross And Lease Obligation",
        "label": "Long-Term Debt, Gross And Lease Obligation",
        "totalLabel": "Total debt principal"
       }
      }
     },
     "localname": "LongTermDebtGrossAndLeaseObligation",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LongTermInvestmentsIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Investments, Including Assets Held For Sale",
        "label": "Long-Term Investments, Including Assets Held For Sale",
        "terseLabel": "Long-term"
       }
      }
     },
     "localname": "LongTermInvestmentsIncludingAssetsHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorAxis",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorDomain",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Copayments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling Interest, Other Period Increase (Decrease)",
        "terseLabel": "Other increases (decreases) in noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberOfPatientsServedPerYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Patients Served per Year",
        "label": "Number Of Patients Served per Year",
        "terseLabel": "Number of patients served per year (more than)"
       }
      }
     },
     "localname": "NumberOfPatientsServedPerYear",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPeopleServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Served",
        "label": "Number Of People Served",
        "terseLabel": "Number of people served"
       }
      }
     },
     "localname": "NumberOfPeopleServed",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPharmacyPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Pharmacy Plan Members",
        "label": "Number Of Pharmacy Plan Members",
        "terseLabel": "Number of pharmacy plan members"
       }
      }
     },
     "localname": "NumberOfPharmacyPlanMembers",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Walk In Medical Clinics",
        "label": "Number Of Walk In Medical Clinics",
        "terseLabel": "Number of walk in medical clinics (more than)"
       }
      }
     },
     "localname": "NumberOfWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OakStreetHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oak Street Health Inc.",
        "label": "Oak Street Health Inc. [Member]",
        "terseLabel": "Oak Street Health Inc."
       }
      }
     },
     "localname": "OakStreetHealthIncMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OfficeRealEstateOptimizationCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment",
        "label": "Office Real Estate Optimization Charges",
        "terseLabel": "Office real estate optimization charges"
       }
      }
     },
     "localname": "OfficeRealEstateOptimizationCharges",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OmnicareLongTermCareBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omnicare Long-Term Care Business",
        "label": "Omnicare Long-Term Care Business [Member]",
        "terseLabel": "Omnicare Long-Term Care Business"
       }
      }
     },
     "localname": "OmnicareLongTermCareBusinessMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Excluding Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement",
        "label": "Operating Expenses, Excluding Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities [Member]",
        "label": "Other Insurance Liabilities [Member]",
        "terseLabel": "Other Insurance Liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherLongTermInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long-Term Insurance Liabilities [Member]",
        "label": "Other Long-Term Insurance Liabilities [Member]",
        "terseLabel": "Other Long-Term Insurance Liabilities"
       }
      }
     },
     "localname": "OtherLongTermInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Payables",
        "label": "Other Payables [Member]",
        "terseLabel": "Other Payables"
       }
      }
     },
     "localname": "OtherPayablesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Receivables",
        "label": "Other Receivables [Member]",
        "terseLabel": "Other Receivables"
       }
      }
     },
     "localname": "OtherReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsForAcceleratedShareRepurchasesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Accelerated Share Repurchases, Amount",
        "label": "Payments for Accelerated Share Repurchases, Amount",
        "terseLabel": "Payments for ASR, amount"
       }
      }
     },
     "localname": "PaymentsForAcceleratedShareRepurchasesAmount",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsForInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Insurance Benefits",
        "label": "Payments For Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsForInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies",
        "label": "Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for prescriptions dispensed and health services rendered"
       }
      }
     },
     "localname": "PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyAndConsumerHealthSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy And Consumer Health Segment",
        "label": "Pharmacy And Consumer Health Segment [Member]",
        "terseLabel": "Pharmacy &amp; Consumer Wellness"
       }
      }
     },
     "localname": "PharmacyAndConsumerHealthSegmentMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyClaimsAndDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims And Discounts Payable, Current",
        "label": "Pharmacy Claims And Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsAndDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Change In Net Unrealized Gains (Losses)",
        "label": "Policyholder Account Balance, Change In Net Unrealized Gains (Losses)",
        "terseLabel": "Change in net unrealized gains (losses)"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PolicyholderAccountBalanceDepositsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Deposits Received",
        "label": "Policyholder Account Balance, Deposits Received",
        "negatedTerseLabel": "Deposits received"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceDepositsReceived",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PostCombinationServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post-Combination Services",
        "label": "Post-Combination Services [Member]",
        "terseLabel": "Post-combination services"
       }
      }
     },
     "localname": "PostCombinationServicesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PreCombinationServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-Combination Services",
        "label": "Pre-Combination Services [Member]",
        "terseLabel": "Pre-combination services"
       }
      }
     },
     "localname": "PreCombinationServicesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Revenues from external customers"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_RadcliffeAndFlaimVAetnaIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Radcliffe and Flaim v. Aetna Inc., et al",
        "label": "Radcliffe and Flaim v. Aetna Inc., et al [Member]",
        "terseLabel": "Radcliffe and Flaim v. Aetna Inc., et al"
       }
      }
     },
     "localname": "RadcliffeAndFlaimVAetnaIncEtAlMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) and Performance Stock Units (PSUs)",
        "label": "Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) [Member]",
        "terseLabel": "Restricted stock units and performance stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SeniorNotes13DueAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.3%, Due August 2027",
        "label": "Senior Notes, 1.3%, Due August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes13DueAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes175DueAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.75%, Due August 2030",
        "label": "Senior Notes, 1.75%, Due August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes175DueAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1875DueFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.875%, Due February 2031",
        "label": "Senior Notes, 1.875%, Due February 2031 [Member]",
        "terseLabel": "1.875% senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1875DueFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.625DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "label": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "terseLabel": "2.625% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes2.625DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.875DueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "label": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "terseLabel": "2.875% senior notes due June 2026"
       }
      }
     },
     "localname": "SeniorNotes2.875DueJune2026Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "label": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "terseLabel": "2.8% senior notes due June 2023"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJune2023Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2125PercentDueSeptember2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.125 Percent, Due September 2031",
        "label": "Senior Notes, 2.125 Percent, Due September 2031 [Member]",
        "terseLabel": "2.125% senior notes due September 2031"
       }
      }
     },
     "localname": "SeniorNotes2125PercentDueSeptember2031Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes27DueAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.7%, Due August 2040",
        "label": "Senior Notes, 2.7%, Due August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes27DueAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.25DueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "label": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "terseLabel": "3.25% senior notes due August 2029"
       }
      }
     },
     "localname": "SeniorNotes3.25DueAugust2029Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.375DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "label": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "terseLabel": "3.375% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes3.375DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueNovember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "label": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "terseLabel": "3.5% senior notes due November 2024"
       }
      }
     },
     "localname": "SeniorNotes3.5DueNovember2024Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.625DueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "label": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3.625DueApril2027Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.75DueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "label": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes3.75DueApril2030Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueAugust2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "label": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "terseLabel": "3.875% senior notes due August 2047"
       }
      }
     },
     "localname": "SeniorNotes3.875DueAugust2047Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "label": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "terseLabel": "3.875% senior notes due July 2025"
       }
      }
     },
     "localname": "SeniorNotes3.875DueJuly2025Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3DueAugust2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3%, Due August 2026 [Member]",
        "label": "Senior Notes, 3%, Due August 2026 [Member]",
        "terseLabel": "3% senior notes due August 2026"
       }
      }
     },
     "localname": "SeniorNotes3DueAugust2026Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "label": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4.125DueApril2040Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueNovember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2042 with a coupon rate of 4.125%.",
        "label": "Senior Notes, 4.125%, Due November 2042 [Member]",
        "terseLabel": "4.125% senior notes due November 2042"
       }
      }
     },
     "localname": "SeniorNotes4.125DueNovember2042Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.1DueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "label": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "terseLabel": "4.1% senior notes due March 2025"
       }
      }
     },
     "localname": "SeniorNotes4.1DueMarch2025Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.25DueApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "label": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes4.25DueApril2050Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.3DueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "label": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "terseLabel": "4.3% senior notes due March 2028"
       }
      }
     },
     "localname": "SeniorNotes4.3DueMarch2028Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.5DueMay2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "label": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "terseLabel": "4.5% senior notes due May 2042"
       }
      }
     },
     "localname": "SeniorNotes4.5DueMay2042Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueMarch2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "label": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "terseLabel": "4.75% senior notes due March 2044"
       }
      }
     },
     "localname": "SeniorNotes4.75DueMarch2044Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.78DueMarch2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "label": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "terseLabel": "4.78% senior notes due March 2038"
       }
      }
     },
     "localname": "SeniorNotes4.78DueMarch2038Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.875DueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "label": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "terseLabel": "4.875% senior notes due July 2035"
       }
      }
     },
     "localname": "SeniorNotes4.875DueJuly2035Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4DueDecember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4%, Due December 2023 [Member]",
        "label": "Senior Notes, 4%, Due December 2023 [Member]",
        "terseLabel": "4% senior notes due December 2023"
       }
      }
     },
     "localname": "SeniorNotes4DueDecember2023Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.05DueMarch2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "label": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "terseLabel": "5.05% senior notes due March 2048"
       }
      }
     },
     "localname": "SeniorNotes5.05DueMarch2048Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.125DueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "label": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "terseLabel": "5.125% senior notes due July 2045"
       }
      }
     },
     "localname": "SeniorNotes5.125DueJuly2045Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.3DueDecember2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "label": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "terseLabel": "5.3% senior notes due December 2043"
       }
      }
     },
     "localname": "SeniorNotes5.3DueDecember2043Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.75DueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "label": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "terseLabel": "5.75% senior notes due May 2041"
       }
      }
     },
     "localname": "SeniorNotes5.75DueMay2041Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes50DueFebruary2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.0%, Due February 2026",
        "label": "Senior Notes, 5.0%, Due February 2026 [Member]",
        "terseLabel": "5% senior notes due February 2026"
       }
      }
     },
     "localname": "SeniorNotes50DueFebruary2026Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5125DueFebruary2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due February 2030",
        "label": "Senior Notes, 5.125%, Due February 2030 [Member]",
        "terseLabel": "5.125% senior notes due February 2030"
       }
      }
     },
     "localname": "SeniorNotes5125DueFebruary2030Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes525DueFebruary2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.25%, Due February 2033",
        "label": "Senior Notes, 5.25%, Due February 2033 [Member]",
        "terseLabel": "5.25% senior notes due February 2033"
       }
      }
     },
     "localname": "SeniorNotes525DueFebruary2033Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5625DueFebruary2053Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.625%, Due February 2053",
        "label": "Senior Notes, 5.625%, Due February 2053 [Member]",
        "terseLabel": "5.625% senior notes due February 2053"
       }
      }
     },
     "localname": "SeniorNotes5625DueFebruary2053Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5DueDecember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5%, Due December 2024 [Member]",
        "label": "Senior Notes, 5%, Due December 2024 [Member]",
        "terseLabel": "5% senior notes due December 2024"
       }
      }
     },
     "localname": "SeniorNotes5DueDecember2024Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.125DueSeptember2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "label": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "terseLabel": "6.125% senior notes due September 2039"
       }
      }
     },
     "localname": "SeniorNotes6.125DueSeptember2039Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.25DueJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "label": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "terseLabel": "6.25% senior notes due June 2027"
       }
      }
     },
     "localname": "SeniorNotes6.25DueJune2027Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.625DueJune2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "label": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "terseLabel": "6.625% senior notes due June 2036"
       }
      }
     },
     "localname": "SeniorNotes6.625DueJune2036Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.75DueDecember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "label": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "terseLabel": "6.75% senior notes due December 2037"
       }
      }
     },
     "localname": "SeniorNotes6.75DueDecember2037Member",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeparateAccountOtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate Account, Other Asset-Backed Securities",
        "label": "Separate Account, Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "SeparateAccountOtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement Framework And Other Opioid-Related Claims",
        "label": "Settlement Framework And Other Opioid-Related Claims [Member]",
        "terseLabel": "Settlement Framework and Other Opioid-Related Claims"
       }
      }
     },
     "localname": "SettlementFrameworkAndOtherOpioidRelatedClaimsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SettlementFrameworkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement Framework",
        "label": "Settlement Framework [Member]",
        "terseLabel": "Settlement Framework"
       }
      }
     },
     "localname": "SettlementFrameworkMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SignifyHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Signify Health, Inc.",
        "label": "Signify Health, Inc. [Member]",
        "terseLabel": "Signify Health, Inc."
       }
      }
     },
     "localname": "SignifyHealthIncMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options and Stock Appreciation Rights",
        "label": "Stock Options and Stock Appreciation Rights [Member]",
        "terseLabel": "Stock options and stock appreciation rights"
       }
      }
     },
     "localname": "StockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax",
        "label": "Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax",
        "terseLabel": "Adoption of new accounting standard, pre-tax"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience-rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TermLoanAgreement364DayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Agreement, 364-Day",
        "label": "Term Loan Agreement, 364-Day [Member]",
        "terseLabel": "Term Loan Agreement, 364-Day"
       }
      }
     },
     "localname": "TermLoanAgreement364DayMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ThailandBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Thailand Business",
        "label": "Thailand Business [Member]",
        "terseLabel": "Thailand Business"
       }
      }
     },
     "localname": "ThailandBusinessMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Schedule of Total Investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TransferOfSharesToTreasuryStockValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer of Shares to Treasury Stock Value",
        "label": "Transfer of Shares to Treasury Stock Value",
        "terseLabel": "Transfer of shares to treasury stock value"
       }
      }
     },
     "localname": "TransferOfSharesToTreasuryStockValue",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchases of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldInTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held In Trust",
        "label": "Treasury Stock, Shares, Held In Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury share held in trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TribalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tribal Entities",
        "label": "Tribal Entities [Member]",
        "terseLabel": "Tribal Entities"
       }
      }
     },
     "localname": "TribalEntitiesMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VendorAndManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor And Manufacturer Receivables",
        "label": "Vendor And Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorAndManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Five [Member]",
        "label": "Year Of Origination, Period Five [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Four [Member]",
        "label": "Year Of Origination, Period Four [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period One [Member]",
        "label": "Year Of Origination, Period One [Member]",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Three [Member]",
        "label": "Year Of Origination, Period Three [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Two [Member]",
        "label": "Year Of Origination, Period Two [Member]",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Prior To Period Five [Member]",
        "label": "Year Of Origination, Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20230331",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r285",
      "r327",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r355",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r441",
      "r443",
      "r444",
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r285",
      "r327",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r355",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r441",
      "r443",
      "r444",
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r283",
      "r284",
      "r449",
      "r476",
      "r757",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r228",
      "r289",
      "r297",
      "r304",
      "r388",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r544",
      "r547",
      "r549",
      "r550",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r228",
      "r289",
      "r297",
      "r304",
      "r388",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r544",
      "r547",
      "r549",
      "r550",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r228",
      "r289",
      "r297",
      "r304",
      "r388",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r544",
      "r547",
      "r549",
      "r550",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r739",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r357",
      "r633",
      "r775",
      "r792",
      "r869",
      "r870",
      "r876",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r357",
      "r633",
      "r775",
      "r792",
      "r869",
      "r870",
      "r876",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r283",
      "r284",
      "r449",
      "r476",
      "r758",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r299",
      "r300",
      "r320",
      "r549",
      "r550",
      "r834",
      "r835",
      "r837",
      "r838",
      "r840",
      "r843",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r229",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r320",
      "r389",
      "r390",
      "r523",
      "r545",
      "r549",
      "r550",
      "r551",
      "r589",
      "r598",
      "r599",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r229",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r320",
      "r389",
      "r390",
      "r523",
      "r545",
      "r549",
      "r550",
      "r551",
      "r589",
      "r598",
      "r599",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r229",
      "r290",
      "r291",
      "r297",
      "r304",
      "r389",
      "r390",
      "r523",
      "r545",
      "r551",
      "r589",
      "r598",
      "r599",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r229",
      "r286",
      "r288",
      "r290",
      "r291",
      "r294",
      "r295",
      "r303",
      "r320",
      "r523",
      "r545",
      "r549",
      "r550",
      "r589",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r860",
      "r861",
      "r883",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "As Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201812Member": {
     "auth_ref": [
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-12 Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts.",
        "label": "Accounting Standards Update 2018-12 [Member]",
        "terseLabel": "Accounting Standards Update 2018-12"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201812Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r290",
      "r291",
      "r292",
      "r365",
      "r366",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r527",
      "r528",
      "r529",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r582",
      "r583",
      "r586",
      "r587",
      "r588",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r14",
      "r26"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r362",
      "r363"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r40",
      "r44",
      "r162",
      "r259",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r39",
      "r44",
      "r162",
      "r259",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r253",
      "r259",
      "r536",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r253",
      "r259",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r242",
      "r670",
      "r709",
      "r713"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "negatedLabel": "Reduction to accumulated other comprehensive income (loss)",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r41",
      "r44",
      "r162",
      "r599",
      "r704",
      "r705",
      "r816",
      "r817",
      "r818",
      "r831",
      "r832",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted Average Useful Life (years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Condensed Consolidated Statement of Cash Flows:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r290",
      "r291",
      "r292",
      "r293",
      "r304",
      "r365",
      "r366",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r514",
      "r515",
      "r516",
      "r520",
      "r521",
      "r522",
      "r523",
      "r527",
      "r528",
      "r529",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r582",
      "r583",
      "r586",
      "r587",
      "r588",
      "r589",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r635",
      "r636",
      "r637",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r243",
      "r364",
      "r391",
      "r393",
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r70",
      "r107",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r41",
      "r44",
      "r162",
      "r816",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax": {
     "auth_ref": [
      "r799",
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax",
        "negatedPeriodEndLabel": "Add: Impact of discount rate on long-duration insurance reserves",
        "negatedPeriodStartLabel": "Less: Impact of discount rate on long-duration insurance reserves",
        "negatedTerseLabel": "Effect of changes in discount rate assumptions"
       }
      }
     },
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax": {
     "auth_ref": [
      "r799",
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from increase (decrease) in expected net premium component of liability for future policy benefit from change in discount rate.",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax",
        "terseLabel": "Effect of changes in discount rate assumptions"
       }
      }
     },
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r187",
      "r204",
      "r240",
      "r281",
      "r335",
      "r347",
      "r353",
      "r384",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r440",
      "r442",
      "r444",
      "r445",
      "r532",
      "r537",
      "r565",
      "r789",
      "r872",
      "r873",
      "r891"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r234",
      "r246",
      "r281",
      "r384",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r440",
      "r442",
      "r444",
      "r445",
      "r532",
      "r537",
      "r565",
      "r789",
      "r872",
      "r873",
      "r891"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Total current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r173"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118",
      "r232",
      "r233"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r116",
      "r118",
      "r232",
      "r233"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r368",
      "r399"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Gross Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r97",
      "r372",
      "r661"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r97",
      "r371",
      "r660"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r97",
      "r373",
      "r662"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Net Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r97",
      "r370",
      "r659"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r102",
      "r663"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r94",
      "r367",
      "r399",
      "r652"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r166",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Condensed Consolidated Balance Sheet:"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r526",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r140",
      "r141",
      "r526",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Replacement equity awards for pre-combination services (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for income tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Cash to be received by shareholders in proposed acquisition (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r148",
      "r149",
      "r150"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total value of proposed acquisition",
        "totalLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r148",
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Fair value of replacement equity awards for pre-combination services"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Acquisition-related integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets (including restricted cash of $28)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r142",
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Gross Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r142",
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSegmentAllocationTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill in a business combination.",
        "label": "Business Combination, Segment Allocation [Table Text Block]",
        "terseLabel": "Summary of the Preliminary Valuation of Goodwill Allocated to Business Segments"
       }
      }
     },
     "localname": "BusinessCombinationSegmentAllocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]",
        "terseLabel": "Health Care Contract Acquisition Costs"
       }
      }
     },
     "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r175",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r72",
      "r236",
      "r754"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r73",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r65",
      "r72",
      "r75"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r65",
      "r178"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueDuePolicyholdersAmount": {
     "auth_ref": [
      "r699",
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash to be paid to policyholder upon termination and surrender of long-duration contract issued by insurance entity.",
        "label": "Policyholder Account Balance, Cash Surrender Value",
        "terseLabel": "Cash surrender value"
       }
      }
     },
     "localname": "CashSurrenderValueDuePolicyholdersAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r102",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r766",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r121",
      "r428",
      "r429",
      "r743",
      "r871"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock and Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r831",
      "r832",
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r20",
      "r21",
      "r132"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,759 shares issued and 1,279 shares outstanding at March\u00a031, 2023 and 1,758 shares issued and 1,300 shares outstanding at December\u00a031, 2022 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r45",
      "r256",
      "r258",
      "r266",
      "r656",
      "r676"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r157",
      "r165",
      "r256",
      "r258",
      "r265",
      "r655",
      "r675"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r55",
      "r264",
      "r654",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r159",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables and contract liabilities from contracts with customers"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r490",
      "r492",
      "r503"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables",
        "verboseLabel": "Trade receivables (included in accounts receivable, net)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r490",
      "r491",
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Contract liabilities, end of the period",
        "periodStartLabel": "Contract liabilities, beginning of the period",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "terseLabel": "Acquired contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r781",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r781",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r88",
      "r346",
      "r347",
      "r348",
      "r349",
      "r355",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r50",
      "r633"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "terseLabel": "Total operating costs",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r279",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r462",
      "r469",
      "r470",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Borrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r188",
      "r189",
      "r202",
      "r285",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r585",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r18",
      "r189",
      "r202",
      "r473"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "cvs_LongTermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r180",
      "r182",
      "r446",
      "r585",
      "r770",
      "r771"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r460",
      "r564",
      "r770",
      "r771"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r31",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r32",
      "r285",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r585",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r32",
      "r128",
      "r129",
      "r130",
      "r131",
      "r179",
      "r180",
      "r182",
      "r199",
      "r285",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r458",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r471",
      "r585",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r179",
      "r182",
      "r874"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r369",
      "r399",
      "r406",
      "r407"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r853"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss",
        "totalLabel": "Net Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r380",
      "r404",
      "r767"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r380",
      "r404"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r863"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r380",
      "r404",
      "r767"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r380",
      "r404"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r863"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "terseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities Available For Sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r377",
      "r400",
      "r767"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r378",
      "r401"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r379",
      "r402"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r517",
      "r518"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": {
     "auth_ref": [
      "r666",
      "r678",
      "r681",
      "r682",
      "r707",
      "r791",
      "r826"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.",
        "label": "Deferred Policy Acquisition Costs, Amortization Expense",
        "negatedTerseLabel": "Amortization expense"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCostAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCosts": {
     "auth_ref": [
      "r671",
      "r682",
      "r683",
      "r707",
      "r722",
      "r791"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.",
        "label": "Deferred Policy Acquisition Cost",
        "periodEndLabel": "Deferred acquisition costs, end of the period",
        "periodStartLabel": "Deferred acquisition costs, beginning of the period"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCostsAdditions": {
     "auth_ref": [
      "r791",
      "r896",
      "r903"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred policy acquisition cost capitalized.",
        "label": "Deferred Policy Acquisition Cost, Capitalization",
        "terseLabel": "Capitalizations"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCostsAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock": {
     "auth_ref": [
      "r217",
      "r684",
      "r707",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the movement in deferred policy acquisition costs.",
        "label": "Deferred Policy Acquisition Costs [Table Text Block]",
        "terseLabel": "Rollforward of deferred acquisition costs"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r70",
      "r330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r167",
      "r168",
      "r170",
      "r171",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r879",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Forward contract, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r502",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).",
        "label": "Disclosure of Long-Lived Assets Held-for-sale [Table Text Block]",
        "terseLabel": "Summary of Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r114",
      "r119",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r132",
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r93",
      "r784",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to CVS Health:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r267",
      "r294",
      "r295",
      "r297",
      "r298",
      "r299",
      "r305",
      "r308",
      "r314",
      "r315",
      "r316",
      "r320",
      "r550",
      "r551",
      "r657",
      "r677",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings (loss) per share, basic (in dollars per share)",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r267",
      "r294",
      "r295",
      "r297",
      "r298",
      "r299",
      "r308",
      "r314",
      "r315",
      "r316",
      "r320",
      "r550",
      "r551",
      "r657",
      "r677",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings (loss) per share, diluted (in dollars per share)",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r127",
      "r228",
      "r259",
      "r260",
      "r261",
      "r286",
      "r287",
      "r288",
      "r291",
      "r300",
      "r303",
      "r322",
      "r388",
      "r489",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r549",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r580",
      "r599",
      "r704",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]",
        "terseLabel": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]",
        "terseLabel": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r64",
      "r104",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r241",
      "r562",
      "r756"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r460",
      "r564",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r553",
      "r554",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r173",
      "r175",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r173",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r460",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r554",
      "r606",
      "r607",
      "r608",
      "r770",
      "r771",
      "r782",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r460",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r553",
      "r554",
      "r555",
      "r556",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r460",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r460",
      "r505",
      "r510",
      "r554",
      "r606",
      "r782",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r460",
      "r505",
      "r510",
      "r554",
      "r607",
      "r770",
      "r771",
      "r782",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r460",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r554",
      "r608",
      "r770",
      "r771",
      "r782",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r460",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r606",
      "r607",
      "r608",
      "r770",
      "r771",
      "r782",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r553",
      "r554",
      "r555",
      "r556",
      "r558",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r559",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r591",
      "r593"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "cvs_LongTermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r375",
      "r376",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r403",
      "r405",
      "r408",
      "r471",
      "r487",
      "r539",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r767",
      "r856",
      "r857",
      "r858",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r634",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r108",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r93",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward contract"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FuturePolicyBenefitsLiabilityPolicy": {
     "auth_ref": [
      "r692",
      "r694",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for liability for future benefit to be paid to or on behalf of policyholder. Includes, but is not limited to, input, judgment, assumption, and method used in measuring liability and change in input, judgment, and assumption.",
        "label": "Liability for Future Policy Benefit [Policy Text Block]",
        "terseLabel": "Future Policy Benefits"
       }
      }
     },
     "localname": "FuturePolicyBenefitsLiabilityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r866"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Opioid litigation charge"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r238",
      "r409",
      "r651",
      "r768",
      "r789",
      "r864",
      "r865"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r419",
      "r420",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r70",
      "r115"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Loss on assets held for sale",
        "verboseLabel": "Loss on assets held for sale"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r47",
      "r184",
      "r194",
      "r213",
      "r335",
      "r346",
      "r352",
      "r355",
      "r658",
      "r765"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income tax provision",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r10",
      "r11",
      "r12",
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r282",
      "r302",
      "r303",
      "r333",
      "r519",
      "r524",
      "r525",
      "r679"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Shareholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r316",
      "r512"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceContractAcquisitionCostTextBlock": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cost related directly to successful acquisition of new and renewal of insurance contract. Includes, but is not limited to, deferred policy acquisition cost, deferred sale inducement cost, and present value of future profit of insurance contract acquired in business combination.",
        "label": "Insurance Contract, Acquisition Cost [Text Block]",
        "terseLabel": "Other Insurance Liabilities and Separate Accounts"
       }
      }
     },
     "localname": "InsuranceContractAcquisitionCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r106",
      "r111"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCreditedToPolicyholdersAccountBalances": {
     "auth_ref": [
      "r665",
      "r801",
      "r803",
      "r895",
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for allocation to policyholder account balance.",
        "label": "Policyholder Account Balance, Interest Expense",
        "terseLabel": "Interest credited"
       }
      }
     },
     "localname": "InterestCreditedToPolicyholdersAccountBalances",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r181",
      "r196",
      "r262",
      "r329",
      "r584"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r272",
      "r277",
      "r278"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r327",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r244",
      "r755",
      "r789"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsOrLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r54",
      "r214"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsOrLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r52",
      "r53"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Schedule of Net Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Schedule of Net Amortized Cost and Fair Value of Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r185",
      "r197",
      "r225",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "terseLabel": "Attorneys' fees and costs"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r28",
      "r281",
      "r384",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r440",
      "r442",
      "r444",
      "r445",
      "r533",
      "r537",
      "r538",
      "r565",
      "r764",
      "r872",
      "r891",
      "r892"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r25",
      "r191",
      "r207",
      "r789",
      "r829",
      "r859",
      "r885"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r235",
      "r281",
      "r384",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r440",
      "r442",
      "r444",
      "r445",
      "r533",
      "r537",
      "r538",
      "r565",
      "r789",
      "r872",
      "r891",
      "r892"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Total current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r118",
      "r232",
      "r233"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r8",
      "r116",
      "r118",
      "r232",
      "r233"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r218",
      "r221"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of the period",
        "periodStartLabel": "Health care costs payable, beginning of the period",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Future Policy Benefit, Activity [Line Items]",
        "terseLabel": "Liability for Future Policy Benefit, Activity [Line Items]"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitActivityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityTable": {
     "auth_ref": [
      "r687",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about activity for liability for future policy benefit. Includes, but is not limited to, beginning and ending balance, issuance, interest income (expense), net premium collected, benefit payment, derecognition, experience adjustment, change in cash flow assumption, and change in discount rate assumption.",
        "label": "Liability for Future Policy Benefit Activity [Table]",
        "terseLabel": "Liability for Future Policy Benefit Activity [Table]"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitActivityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock": {
     "auth_ref": [
      "r687",
      "r707",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit.",
        "label": "Liability for Future Policy Benefit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Changes in Liability for Future Policy Benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance": {
     "auth_ref": [
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of reinsurance, of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, after Reinsurance",
        "periodEndLabel": "Adjusted balance at January 1, 2021, net of reinsurance",
        "terseLabel": "Balance at December 31, 2020, net of reinsurance",
        "totalLabel": "Net liability for future policy benefits, net of reinsurance recoverable",
        "verboseLabel": "Liability for future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitAfterReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate": {
     "auth_ref": [
      "r692",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current weighted-average discount rate used to measure liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Current Weighted-Average Discount Rate",
        "terseLabel": "Current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange": {
     "auth_ref": [
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected future benefit and expense component for liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change",
        "totalLabel": "Adjusted beginning liability for future policy benefits - original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance": {
     "auth_ref": [
      "r688",
      "r802"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future gross premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance",
        "terseLabel": "Expected gross premiums"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange": {
     "auth_ref": [
      "r687",
      "r688",
      "r707",
      "r802"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefits",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change",
        "periodEndLabel": "Liability for future policy benefits, end of period - current discount rate",
        "periodStartLabel": "Liability for future policy benefits, beginning of period - current discount rate",
        "verboseLabel": "Liability for future policy benefits, end of period - current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange": {
     "auth_ref": [
      "r798",
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from cash flow assumption change for future cash flows.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change",
        "terseLabel": "Effect of changes in cash flow assumptions"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience": {
     "auth_ref": [
      "r689",
      "r797",
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience",
        "terseLabel": "Effect of actual variances from expected experience"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense": {
     "auth_ref": [
      "r794",
      "r802",
      "r899",
      "r903"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense",
        "terseLabel": "Interest accrual (using locked-in discount rate)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance": {
     "auth_ref": [
      "r793",
      "r802",
      "r899",
      "r903"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in expected future policy benefit and expense component of liability for future policy benefit from contract issuance.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance",
        "terseLabel": "Issuances (end of quarter)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "auth_ref": [
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected future policy benefit and expense component of liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance",
        "periodEndLabel": "Ending liability for future policy benefits at original (locked-in) discount rate",
        "periodStartLabel": "Beginning liability for future policy benefits at original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]",
        "terseLabel": "Present value of expected future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance": {
     "auth_ref": [
      "r688",
      "r802"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance",
        "terseLabel": "Expected future benefit payments"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange": {
     "auth_ref": [
      "r687",
      "r688",
      "r707",
      "r802"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change",
        "periodEndLabel": "Liability for future policy benefits, end of period - current discount rate",
        "periodStartLabel": "Liability for future policy benefits, beginning of period - current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange": {
     "auth_ref": [
      "r798",
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected net premium component of liability for future policy benefit from cash flow assumption change for future cash flows.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change",
        "terseLabel": "Effect of changes in cash flow assumptions"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience": {
     "auth_ref": [
      "r689",
      "r797",
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected net premium component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience",
        "terseLabel": "Effect of actual variances from expected experience"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome": {
     "auth_ref": [
      "r794",
      "r802",
      "r899",
      "r903"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income for expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Interest Income",
        "terseLabel": "Interest accrual (using locked-in discount rate)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected": {
     "auth_ref": [
      "r795",
      "r802",
      "r899",
      "r903"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of premium collected from policyholder to fund expected benefit payment for expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected",
        "negatedTerseLabel": "Net premiums (actual)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "auth_ref": [
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance",
        "periodEndLabel": "Ending liability for future policy benefits at original (locked-in) discount rate",
        "periodStartLabel": "Beginning liability for future policy benefits at original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange": {
     "auth_ref": [
      "r802",
      "r899",
      "r903"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected net premium component for liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change",
        "totalLabel": "Adjusted beginning liability for future policy benefits - original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]",
        "terseLabel": "Present value of expected net premiums"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance": {
     "auth_ref": [
      "r687",
      "r690",
      "r707",
      "r802"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance",
        "periodEndLabel": "Less: Reinsurance recoverable",
        "terseLabel": "Less: Reinsurance recoverable",
        "verboseLabel": "Add: Reinsurance recoverable"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average duration of liability for future policy benefit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Liability for Future Policy Benefit, Weighted-Average Duration",
        "terseLabel": "Weighted-average duration of long-duration insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitWeightedAverageDuration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate": {
     "auth_ref": [
      "r692",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Original weighted-average discount rate at contract issue date used to measure liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate",
        "terseLabel": "Interest accretion rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "auth_ref": [
      "r667",
      "r687",
      "r693",
      "r707",
      "r802"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "totalLabel": "Net liability for future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits": {
     "auth_ref": [
      "r796",
      "r802",
      "r825",
      "r899",
      "r903"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment",
        "negatedTerseLabel": "Benefit payments (actual)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsPaymentForBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r201",
      "r218",
      "r221"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of the period, net",
        "periodStartLabel": "Health care costs payable, beginning of the period, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Legal settlement awarded to other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Current portion of long-term debt",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term debt and lease obligation"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r237"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r32",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r122",
      "r123",
      "r430",
      "r431",
      "r432",
      "r867",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r867",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r13",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisition and Assets Held for Sale"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r37",
      "r190",
      "r206",
      "r281",
      "r384",
      "r433",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r565"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r738"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r740"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r740"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]",
        "terseLabel": "Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]"
       }
      }
     },
     "localname": "MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r65",
      "r68",
      "r71"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r48",
      "r71",
      "r195",
      "r212",
      "r233",
      "r254",
      "r257",
      "r261",
      "r281",
      "r290",
      "r294",
      "r295",
      "r297",
      "r298",
      "r302",
      "r303",
      "r312",
      "r335",
      "r346",
      "r352",
      "r355",
      "r384",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r440",
      "r442",
      "r444",
      "r445",
      "r551",
      "r565",
      "r765",
      "r872"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to CVS Health",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r160",
      "r164",
      "r254",
      "r257",
      "r302",
      "r303",
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r294",
      "r295",
      "r297",
      "r298",
      "r305",
      "r306",
      "r313",
      "r316",
      "r335",
      "r346",
      "r352",
      "r355",
      "r765"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income (loss)",
        "verboseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]",
        "verboseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r77",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r297",
      "r304",
      "r320",
      "r365",
      "r366",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r514",
      "r515",
      "r516",
      "r520",
      "r521",
      "r522",
      "r523",
      "r527",
      "r528",
      "r529",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r582",
      "r583",
      "r586",
      "r587",
      "r588",
      "r589",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r635",
      "r636",
      "r637",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Significant Accounting Policies",
        "verboseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r155",
      "r489",
      "r831",
      "r832",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of retail locations (more than)"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax": {
     "auth_ref": [
      "r251",
      "r252"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of unrealized gain (loss) from (increase) decrease in liability for future policy benefit from change in discount rate.",
        "label": "OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax",
        "terseLabel": "Change in discount rate on long-duration insurance reserves"
       }
      }
     },
     "localname": "OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating costs:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r335",
      "r346",
      "r352",
      "r355",
      "r765"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r245",
      "r789"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r157",
      "r158",
      "r161"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r44",
      "r260",
      "r574",
      "r576",
      "r580",
      "r816"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before reclassifications, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r44",
      "r46",
      "r260",
      "r574",
      "r576",
      "r580",
      "r816"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r247",
      "r252"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r46",
      "r127",
      "r255",
      "r258",
      "r264",
      "r574",
      "r579",
      "r580",
      "r654",
      "r673",
      "r816",
      "r817"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r854",
      "r862",
      "r878",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r67",
      "r220"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r819",
      "r820"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r57",
      "r530"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r276",
      "r823",
      "r824"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange": {
     "auth_ref": [
      "r803",
      "r900"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in liability for policyholder account balance from change, classified as other.",
        "label": "Policyholder Account Balance, Increase (Decrease) from Other Change",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalanceNetAmountAtRisk": {
     "auth_ref": [
      "r698",
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of guaranteed benefit in excess of current account balance of policyholder account balance.",
        "label": "Policyholder Account Balance, Net Amount at Risk",
        "terseLabel": "Net amount at risk"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceNetAmountAtRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalanceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Policyholder Account Balance [Roll Forward]",
        "terseLabel": "Policyholder Account Balance [Roll Forward]"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal": {
     "auth_ref": [
      "r803",
      "r900"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in liability for policyholder account balance from contract redemption and withdrawal of funds.",
        "label": "Policyholder Account Balance, Surrender and Withdrawal",
        "negatedTerseLabel": "Surrenders and withdrawals"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceSurrenderAndWithdrawal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalanceTableTextBlock": {
     "auth_ref": [
      "r803",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about policyholder account balance, including, but not limited to change in liability and related cash surrender value.",
        "label": "Policyholder Account Balance [Table Text Block]",
        "terseLabel": "Roll Forward of Policyholders' Funds"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate": {
     "auth_ref": [
      "r697",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average crediting rate for liability for policyholder account balance, calculated at a point in time.",
        "label": "Policyholder Account Balance, Weighted Average Crediting Rate",
        "terseLabel": "Weighted average crediting rate"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceWeightedAverageCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PolicyholderAccountsPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.",
        "label": "Policyholder Accounts, Policy [Policy Text Block]",
        "terseLabel": "Separate Accounts"
       }
      }
     },
     "localname": "PolicyholderAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "verboseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderFunds": {
     "auth_ref": [
      "r696",
      "r700",
      "r701",
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholder. Includes, but is not limited to, unpaid policy dividend, retrospective refund, and undistributed earnings on participating business. Excludes future policy benefit and claim expense.",
        "label": "Policyholder Account Balance",
        "periodEndLabel": "Policyholders\u2019 funds, end of the period",
        "periodStartLabel": "Policyholders\u2019 funds, beginning of the period"
       }
      }
     },
     "localname": "PolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r19",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19",
      "r789"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r653",
      "r672",
      "r680",
      "r715"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r271",
      "r275"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r821",
      "r822"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r56",
      "r92",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r60",
      "r138"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesChangesinbalancesoflongdurationinsuranceliabilitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r233",
      "r254",
      "r257",
      "r273",
      "r281",
      "r290",
      "r302",
      "r303",
      "r335",
      "r346",
      "r352",
      "r355",
      "r384",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r440",
      "r442",
      "r444",
      "r445",
      "r531",
      "r534",
      "r535",
      "r551",
      "r565",
      "r658",
      "r765",
      "r787",
      "r788",
      "r818",
      "r872"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r117",
      "r208",
      "r664",
      "r789"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "negatedTerseLabel": "Net realized capital losses",
        "terseLabel": "Net realized capital losses"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofConsolidatedOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r848",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r44",
      "r260",
      "r574",
      "r578",
      "r580",
      "r816"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r44",
      "r46",
      "r260",
      "r574",
      "r578",
      "r580",
      "r816"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r84",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Consolidated Operating Income to Adjusted Operating Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r85",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of a significant segment item of information disclosed (for example, liabilities) other than profit (loss), revenues, or assets, between reportable segments in total and the entity's consolidated total for that significant segment item disclosed.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r15",
      "r126",
      "r281",
      "r384",
      "r433",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r218",
      "r221",
      "r894",
      "r897"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r511",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r511",
      "r600",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r852",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r813",
      "r827"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash (included in other current assets)"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r742",
      "r814",
      "r827"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r132",
      "r205",
      "r708",
      "r713",
      "r789"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r228",
      "r286",
      "r287",
      "r288",
      "r291",
      "r300",
      "r303",
      "r388",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r549",
      "r704",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r326",
      "r327",
      "r345",
      "r350",
      "r351",
      "r357",
      "r358",
      "r360",
      "r501",
      "r502",
      "r633"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Intersegment revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r504",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Contract Balances"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r263",
      "r281",
      "r326",
      "r327",
      "r345",
      "r350",
      "r351",
      "r357",
      "r358",
      "r360",
      "r384",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r440",
      "r442",
      "r444",
      "r445",
      "r565",
      "r658",
      "r872"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail &amp; specialty"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r44",
      "r886",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r140",
      "r141",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofEstimatedFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleScheduleofFairValueofConsiderationTransferredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Consideration Transferred"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r32",
      "r128",
      "r129",
      "r130",
      "r131",
      "r179",
      "r180",
      "r182",
      "r199",
      "r770",
      "r772",
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r790",
      "r804",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r200",
      "r804",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Separate Accounts by Major Category of Investment",
        "verboseLabel": "Summary of Separate Account Assets"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Summary of Preliminary Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r52",
      "r53",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Components of Change in Health Care Costs Payable"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r77",
      "r78",
      "r80",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of adjustments resulting from applying new accounting standard"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Summary of Estimated Fair Values of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r82",
      "r83",
      "r86",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized Financial Information Of Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Share repurchase programs"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r355",
      "r360",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r426",
      "r427",
      "r768",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r335",
      "r338",
      "r349",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Other Significant Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Other Significant Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingOtherSignificantReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryAxis": {
     "auth_ref": [
      "r717",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by separate account asset investment.",
        "label": "Separate Account Asset Category [Axis]",
        "terseLabel": "Separate Account Asset Category [Axis]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryDomain": {
     "auth_ref": [
      "r717",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate account asset investment.",
        "label": "Separate Account Asset Category [Domain]",
        "terseLabel": "Separate Account Asset Category [Domain]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r668",
      "r716",
      "r717",
      "r804"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r804",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which separate account asset is invested.",
        "label": "Separate Account, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "SeparateAccountCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountDebtSecurityMember": {
     "auth_ref": [
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporation, government, or governmental agency, municipality, and other institution; in which separate account asset is invested.",
        "label": "Separate Account, Debt Security [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "SeparateAccountDebtSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountLiabilityBenefitPayment": {
     "auth_ref": [
      "r805",
      "r905"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to separate account policyholder from benefit payment.",
        "label": "Separate Account, Liability, Benefit Payment",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "SeparateAccountLiabilityBenefitPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount": {
     "auth_ref": [
      "r719",
      "r805"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of separate account liability payable to policyholder upon surrender of contract before maturity.",
        "label": "Separate Account, Liability, Cash Surrender Value, Amount",
        "terseLabel": "Cash surrender value, end of the period"
       }
      }
     },
     "localname": "SeparateAccountLiabilityCashSurrenderValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance": {
     "auth_ref": [
      "r805",
      "r905"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in separate account liability from performance of investment.",
        "label": "Separate Account, Liability, Increase (Decrease) from Invested Performance",
        "terseLabel": "Investment earnings"
       }
      }
     },
     "localname": "SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange": {
     "auth_ref": [
      "r805",
      "r905"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount increase (decrease) in separate account liability from change, classified as other.",
        "label": "Separate Account, Liability, Increase (Decrease) from Other Change",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SeparateAccountLiabilityIncreaseDecreaseFromOtherChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityPremiumAndDeposit": {
     "auth_ref": [
      "r805",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow to separate account liability from premium and deposit from cash received.",
        "label": "Separate Account, Liability, Premium and Deposit",
        "terseLabel": "Premiums and deposits"
       }
      }
     },
     "localname": "SeparateAccountLiabilityPremiumAndDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Separate Account, Liability [Roll Forward]",
        "terseLabel": "Separate Account, Liability [Roll Forward]"
       }
      }
     },
     "localname": "SeparateAccountLiabilityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal": {
     "auth_ref": [
      "r805",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in separate account liability from contract redemption and withdrawal of funds.",
        "label": "Separate Account, Liability, Surrender and Withdrawal",
        "negatedTerseLabel": "Surrenders and withdrawals"
       }
      }
     },
     "localname": "SeparateAccountLiabilitySurrenderAndWithdrawal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityTableTextBlock": {
     "auth_ref": [
      "r721",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about separate account liability, including, but not limited to change in liability and related cash surrender value.",
        "label": "Separate Account, Liability [Table Text Block]",
        "terseLabel": "Roll Forward of Separate Accounts"
       }
      }
     },
     "localname": "SeparateAccountLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeparateAccountMortgageBackedSecurityMember": {
     "auth_ref": [
      "r904",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security collateralized by real estate mortgage loan, in which separate account asset is invested.",
        "label": "Separate Account, Mortgage-Backed Security [Member]",
        "terseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "SeparateAccountMortgageBackedSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r669",
      "r716",
      "r718",
      "r720",
      "r805"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "periodEndLabel": "Separate Accounts liability, end of the period",
        "periodStartLabel": "Separate Accounts liability, beginning of the period",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares outstanding, balance at end of period (in shares)",
        "periodStartLabel": "Shares outstanding, balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-Term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r192",
      "r193",
      "r203",
      "r815"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r223",
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "terseLabel": "Incurred but not reported (IBNR) claims liability, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r231",
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r355",
      "r360",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r768",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofthePreliminaryValuationofGoodwillAllocatedtoBusinessSegmentsDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r35",
      "r127",
      "r228",
      "r259",
      "r260",
      "r261",
      "r286",
      "r287",
      "r288",
      "r291",
      "r300",
      "r303",
      "r322",
      "r388",
      "r489",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r549",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r580",
      "r599",
      "r704",
      "r705",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r322",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r127",
      "r132",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r35",
      "r127",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r19",
      "r20",
      "r127",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r127",
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased during period, value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r23",
      "r24",
      "r91",
      "r789",
      "r829",
      "r859",
      "r885"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Total CVS Health shareholders\u2019 equity",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r155",
      "r156",
      "r163",
      "r228",
      "r229",
      "r260",
      "r286",
      "r287",
      "r288",
      "r291",
      "r300",
      "r388",
      "r489",
      "r514",
      "r515",
      "r516",
      "r522",
      "r523",
      "r549",
      "r574",
      "r575",
      "r580",
      "r599",
      "r705",
      "r706",
      "r829",
      "r859",
      "r885"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Total shareholders\u2019 equity",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r137",
      "r280",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r488",
      "r489",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r581",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r581",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r581",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalIncomeStatementElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Income Statement Elements [Abstract]",
        "terseLabel": "Condensed Consolidated Statement of Operations:"
       }
      }
     },
     "localname": "SupplementalIncomeStatementElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "negatedLabel": "Decrease in prior years' healthcare costs payable",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionandAssetsHeldforSaleSummaryofPreliminaryFairValuesandWeightedAverageUsefulLivesforIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount": {
     "auth_ref": [
      "r800",
      "r803",
      "r805",
      "r900",
      "r905"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer to (from) liability for policyholder account balance (to) from liability for separate account.",
        "label": "Transfer to (from) Policyholder Account Balance (to) from Separate Account",
        "terseLabel": "Net transfers from general account"
       }
      }
     },
     "localname": "TransferToFromPolicyholderAccountBalanceToFromSeparateAccount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r375",
      "r376",
      "r471",
      "r487",
      "r539",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r856",
      "r857",
      "r858",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Treasury shares outstanding, balance at end of period (in shares)",
        "negatedPeriodStartLabel": "Treasury shares outstanding, balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r34",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r34",
      "r133",
      "r136"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 480 shares at March\u00a031, 2023 and 458 shares at December\u00a031, 2022"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r290",
      "r291",
      "r292",
      "r293",
      "r304",
      "r365",
      "r366",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r514",
      "r515",
      "r516",
      "r520",
      "r521",
      "r522",
      "r523",
      "r527",
      "r528",
      "r529",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r582",
      "r583",
      "r586",
      "r587",
      "r588",
      "r589",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r635",
      "r636",
      "r637",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNewAccountingPronouncementsRecentlyAdoptedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r762",
      "r782",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r782",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "verboseLabel": "Schedule of Debt Securities In An Unrealized Capital Loss Position"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r307",
      "r316"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average diluted shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r305",
      "r316"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(m)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(7))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(7)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/subtopic&trid=4737841",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(6)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14937-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/subtopic&trid=2560295",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506110&loc=d3e32546-158582",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504731&loc=d3e11522-158419",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(g)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(h)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783734-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(g)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783734-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819541-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r806": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r807": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r808": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r809": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r811": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(6))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>109
<FILENAME>0000064803-23-000016-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-23-000016-xbrl.zip
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MMSNWOF-33)-P]M:DU-TPR:+;=W<Z+TT4)O+,L"ID?^P?]W8'@U83WMK9[QW
M?"W>(W-#Z^Q^$G[=X?Y@+1X<_/4=[E?^8, ?S ^P:YL_XMGVY-D>>(+ER^F@
MW^LOFX6.^WC!'=#6H]5FTAA>Z=N]P^GWEQ[[G8OM/%!*V8$__P!X&F(=97F(
M)]/;"F8DQZM>_*B6_UR;)+Q5G\(T#F/3?<GZGNO%CX$B&:),6F:J')M"=>YK
M_G&[6[W\S[\<#P:[[]PG]'?_W2MU;\JQFI=]@<I29<I"9?>I&NIQF(P4S E^
M*G]E(_J^J(:%B4V8&WA(_,&KPM'() :.\,+U#%W8/@-U/S;16,'@]6BD>>AA
M@2V68ZUBN$^=JP)V&/T]_Q1G[JX/<*UM=K&\]H0,G&9+A<RB;0G":4[$'_MM
M/;<X[_>>9QEV]=X\X =[O0'-PVD&BB#L,]IR:I3E\\?+.K9,#Q:TBK(TQ34#
M Z,5/YFIN"IQS>)ZS74QQ<$/8=7RAR7MB9]UF.#VR/*I2!(%3Y6ENG/UPU?U
MP@]@BT9)A=.D3G29AK2MU$MXZH07;P);#=>WW2!U)_5&472%W_^]21(US;,[
MF&DUT;)_LW1D4.:;,(%^8.HG?#4\W'_^9?_H'0XMBG11*!(;C2:QM_[1.]B]
M4564V43G/"E18J!%_AUOR:9P1UFEIIQA*[&&1\BF]/4D!'D$_\%$)M1F,393
MOO,FRV(:,PT4VIGT4$KP*_&6BVQ^&+J^R7#2;+>3JJQ">N2)*6"63<IRKQ8+
M))?@TIPZHS_OPJ0*AXEN=@*B3<%E>CA3(=Y="S]XGBB;3).9&Z8"*3L1F>3W
MMJ*4V7^4E.G4)-_T]M8G9@:;(V;ZO6.<AHLLW3F%=Z5+,CK7*UD^5#FN59 F
M&E9/-J/U",NKO6MQ3<9\+7[5>@;U!?J'E3L"V9#=VXMP 9K4[8YF'RA=PW0&
M&RXL>&'3)DNS4L4F!P$#2SE#-<']!3\ZO0EO-.X@OW.XS,H3E.!54N((4'J#
M]"K5E<[O#(@.VAF&CV2K<X")?@(CF-\33[/R^P>]@\W1:</-V0J#WOZ 3]P-
MV0=GN+)PV< "<>>9&YN<9W!<02?JY?U8D[0.\8201:UU@+*ZS,.HS'+Z'5<B
MZ+(!K$XX2LTT3 (0VYH^"?,RU7!9!N=M1+_DLNZS_)5Z:4"O1;<0KF/8'')4
MP9_86!97$?VJX-S*;W5)?Q0Z2>077._T*S0*<\,/]A(W7%&8HI3'7-#HZDV^
MH@W,MY;X!5\&&W\,Z@><.9&=P3LYJ?!Z_56&@-LV"4&KB6T;J'_7S3A]VI=#
MU/0Y#T''-!QJF15R$"(A'K!W67*'WX8E=5G"6O&E5Q(6I2KOX4W,=D99E:N7
M@_U7:@)O;US,2RIWH#94CH,W[[#SEP9>%6HFTY+/?)B0K'!R27O+"K\+47$B
M_0.?@R1>8FY!DT(-#I:+$OD$QGN49$65DZ*V4#N"4S]THA 5NYSNKHKEMS5L
M(+^!I]8-&G?M'K0]:X=S O/0<SFM7V .-T=@]GM'![[ S/+URLN3MI3,<BLD
M\62?5K!5"MVA?JH"%EY"DI1W"VCK*.*BEHE" A;7KMTL+$SD&&<3!D11QCL$
M5_T0G>UH(8!,U;C7.P4(^Q7<5TU+/%AH6G0TSN816.\'Q^](8D_% 0&;*]4C
MM*Y83#5,_R_O/]76D;.PI)'P%0T@C$%O BE96Q;S3>,LVT&AL7:3W>D\97,"
MSIC(>C-(<QNS&8CBMF#1]7+X"HV>!"81C O7OGP9O5+%5$<@-V#VF]]A<R]C
M'B>([0A$%'4*@\2?*<BQ*#=3&GB<5S=DBH8J!:.H-!03R=$],J+S#CI)"WY\
M[!9E::[!#DN<AX7GN*#NBC"AESW?!YP#\/0[<-%.E%7D7YKHV$1LR@4P:V%5
MSNICAJS#K)C PHW@Z]C<F!)D)%EL>1A+, B>/ ,)2S\C?"%CE.3V=&K>QNLU
M(U]KO4;PY$3UMG$1O!TPYW +Y-$8/@:C$%X?; \Z0<"(#?.X( 7B3J=@P48X
M6UE<>$W8,Q=[X\_=F<GS%L*V*+(D[E#EW9+FF8:GN#,%SJ1=H9?TN5VD[M6X
M=V-7$YC7*4R?N^^32:M2G]*G[;OOW(*1SNHUK2OR2,OJ\5Y0"(LX2<)\YDUY
M[9*86Y^VG48;144V?ST]UBAOC(2,?E1#["Z+G!D1H#<O]#=RHRE>90GUD^"6
M@_629""UT?91_#+A]861^&4">8$\A?2E59K$A,FM0P<41G9?P !=GZ,\FT!G
M\(;K-MT+^(@=JVOL^11:;KV#SE?@[R23CJK"V[8T"IX8U[_MZERN;?=A.CJY
M-7&J9\I_V,:;'%8EF7V)F1CL#%T9(>EJ=)+ HJ5I(+&O\9V6: /F&G<5;IX0
MM!T[KG]P7UV/CPO8/0>[>5 =S$CCY&6"'_"JAJ;!/@P3S_UK/[^FS^=;[WIT
M \LH#W$'UQ,GGSC_=<<9(!NLOKNYIN4A?$%.VK#;F#C3RVX!\8ZJ%=HC/-:
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M!9%!7S@_X10Q#13GB'4KH/R(]P=;L= 4?";[NO4F[:M\?HC$1FV:<^<E:R
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MU19M3@BXQLPLQCBM-RCLSMW% [0'<2L*[' 1O/D0/L(@#BM+"5Q!+8$J8F#
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M,<P/YUZA-35$WX^]%?$IH S%2P*BXIJH@_)3L!)S"ZC_9I,.$R7GM%T';G'
M=57/YI.^R<:+7/E%T6SA.QE523)C.Q>>&G^/,-LF%CW=Q]MW&[1HUTTU&7?D
MP$IKOV33 $'/$*C:$S(64*@0 *^+)X63GV!@BOQO]E6X<>"XAQBO@S?)Y$QL
M5I<JT0BWZ--[5?5[G6"L<!I:$QSQ30^^U(NL'(LSBH9H00=[F+W#KH0I0:9*
MA<]$C=I\?EKK11F.7 :<*4JFNH '9'>O)-JY3'+RC,'WY^+B&VHO+&H-'\G6
M;R1U%;4+V2%5'*$&.VF+"@ESOA<#QL$;SOO>$#/_N3*Z5S#SQ6%&GD[T)K7
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M%3&9S$_U-)RUK[=*"R8FX=7RL?XZQ1H+L-7L8K,W@*F?*$WHKKGOZF72_J8
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M9P^?U$\?QDF]STHA4_%V-D^R!1'ZYCPU#V(#'P&IGSV,D_JD*-$#+5+@[&_
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MQK+KD&#NU\IN],:]#B1K([ $F9-AFWNY<@$6:WDKU'[+U(X.<C\\;2=Z/V+
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M95"?Y^$R[G=1_PT_XK_-C^#_Q-IL88=7=V!7AS\]85=YCUV[KA7:#R=2NG7
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M6I;FI?D1%))I0E[-UU@XT6)G;P:+KD_PK4O6WBK'!2L5LQSL)_;$QEB)-],
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MX?#NASS;;2CI!X$_RO$&P]K4+VP*LZNB,*L-F)"3@K""BYMKCY?,R)G0!-A
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MQQ(G!^WUUL6/5+RVD7&Q9'FVRT]%:><?64DF/5]_7VHF:S)EJ19U:9.K1,V
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M* 8U0T\W9@W067= NPF^FM\MT,L=<(LF#AMQ@]6L@'*;HBPO'*Q"3T #[^W
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M.V*J9$PG'HHX&J-=E)<<RL"CM1T'J8.0:0C,-5O8Z;NE,LEY'"H_Z[G<K'_
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MVGQK9A=7U/^RT%%NQL_']LD6CP1;!I"),YNG5P9/E@P\C $TC'H3^C9)CB[
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M=^) N$9M<^W/R6.Q+>_/O0S^>)(0>\N3$)^/TG !_TR+6?S+_P%02P,$%
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M:=Q288:/-&.F"ZU.T&PZLADY>&>!!@-A+ ZI/-E;CX;%E(NXI:3/BT5:94+
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MAKY+_YZ-?2^KX^K2UN]3VLM2VM^=M*=#N+FAZ5ES;""_)*Z!3:QC*=_2FA^
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M8*BY_\"5-.*!)I^G'7VX($2P3;=1A$ N>*M,2@!SH("_A%JC$1,=<)E0DS4
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MO5#0FW$63<X6ZT(^WTT]OEO.90 ^6. *]#T%W?$:7:N]7$J6BM)E@2DJP\F
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M2IAO>:*K ,,D05AD,@C(I1G(,8'!F$Q#0..@*Z #ITEEP$1/J+^G+$FNXK/
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MV-\&QS-.> +J;[4A!?ZMB:^5T+UE"?7UB(T%'ALD^D#!%#;1"&4&E#U !Z;
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MQBGOS[&E+^&OJ3LS/OT_4$L#!!0    ( -0THU;X7J3N6P,  #X*   2
M83 S,S$R,#(S97@Q-3$N:'1MU599;QLW$'[/KYA(J-,"6BVYMXX(B"4'":"X
MKJ7$R%-!+2DMFUU2(;E6U%]?[A6CMA*C2) B^T#,<@Y^<W XTZ>+W^?K]U<7
MD)DBAZNWY\O7<^@YKGOCSUUWL5[ J_6;)01#A&&MB-#<<"E([KH7ESWH9<;L
MQZY[.!R&!W\HU<Y=7[N5J<#-I=1L2 WMS:;5CET9H;,GTZ>. PN9E@43!E+%
MB&$42LW%#FXHTQ_ <5JIN=P?%=]E!CSD^7 CU0=^2QJ^X29GL\[.U&W^IVY]
MR'0CZ7$VI?P6.'W>XQBQ8$/C($W3,!@%R2;R4A0%*$0C@E*2_(DM2->*-SK:
M''/VO%=PX62L.G\<>,,XW)O)@5.3C3%"O_1JT=ET*X6QYRFKWY"-F0?&#/MD
M')+SG1C7+O4:U8Z=RERJ<1_5WZ3B.%M2\/PX?K;F!=-PR0YP+0LBG@VT38.C
MF>+;1E#SOYG%9.'5OX<&<FSMY%RPS@7L5: O/F5\PPW@<(C_C?AQK"?</*V4
MVHPP]3]YN&3&'@Z*G?7#9 )O!2DIKTKL=06*%_"2"R)23G*[LY6J(%5%/W#K
M:RY_&^_[!03?"TAP,B!OR/&LCR,T\0?-/?H),*\EF(S!*B.*93*G3&D@@M:;
MYY(H"G(+"ZY8:J1EV9_YNQ6\8B0WF6T;:B_5Z;2>J-:_2FWX]OC5(O_A4<"A
MC<(- ^L_D$.U6A\K[[E([]R#S=$6^I8I)M**54M<LQW7IA58&=M>JPZIX=>7
MMMAAY?@O5M=P*8?@^[[C^4F(HCJV+3NQ/-TR8QPFWJ"ET<B/!G=*<4<CY(<M
M[261U\KC*(Z#3A['2>BW-$H2U,KC  <);FE_%,2HH2,_BH*&'&&OT[2-NSO4
M#T:>)2O4M<T$!?YO7ZZ"BB/+JB?8'0.T?G'N7XN!9>=6W#Y#IJF^\G/K2*6@
M3.B&TC+GC0G>=I3MYXZB[\+]930F(P:XKE*9E[2V ]QJU G R/D#;%NJ$7PL
MB:J:&1.T1JS2K,6,&]##G^ NG_6#>*+K%2Z4T ;.^K[MS.]E:6.]7%Y]KTOZ
MJ-J/]OQ<:B/%P"9.:Y)FI;9/D_Y/&>L0WQM#]K*9P\9-R=ZR!X-)I[B1QLAB
MC.Y4R,86<&D>JCPRR[1K,UG5,][L'U!+ P04    " #4-*-6X:7I-@X(  "C
M)0  $@   &$P,S,Q,C R,V5X,S$Q+FAT;>5:;7/;-A+^WE^!RM/$F=$;)=FR
M9,<SJ>V;9)JFN<1WF7[J0"0H8DP2+ !*UOWZ>Q:@+,F24BGGG!/7'VB1 !:+
MW6>?71 \^_'RMXOKW]]?L<1F*7O_KY_?OKE@M4:K]:E[T6I=7E^RU]>_OF6]
M9CM@UYKG1EJI<IZV6E?O:JR66%L,6ZWI=-J<=IM*CUO7'UHDJM=*E3*B&=FH
M=GY&3W 5/#K_X>S'1H-=JK#,1&Y9J 6W(F*ED?F8?8J$N6&-1M7K0A4S+<>)
M99UVI\L^*7TC)]RW6VE3<3Z7<];R]V<M-\G92$6S\[-(3IB,7M:D..9A*/KM
M7C 8]7KQ\6#0YYQW!G'_I!-U3D[^"*!D"]W]&&-GJ7A9RV3>2 3-/^QUFOVC
MPIY.96238=!N_U1S7<_/8I5;S*<QWO_T8M:%<3V&O)&R5F5#DF7%K6WP5([S
MH5MDS0N;#PA5JO3PH.W^3JFE$?-,IK/A\VN9"</>B2G[H#*>/Z\;.*9AA):Q
M[VCD?P2TQ"3N=NH7T8><5.9BOJB@0\NXNDWD2%K6#9K!? U?5X_>1CW8J@&7
M3+=DJ!"^%OJ1+'4AM)6Q##F%P-[:;@#)9^%1/;&JH-NOON3-3GE39[]P+7+V
ML<G>SO(PJ;/W6A@94>SR/&(7B10QN[H586GE1+#?8AA(:*9B=O'OC^RUX*E-
M$,BZ4-K9K<Y"9\89LPFWSPZ.3D[7/?]E%BMX%(%%&JF([;#3GX>8S$G;82,X
M>30S!LUG!\%Q^W3]^H8E'&;38B+%%#QH$VG8GR77 $XZPW/8S3*5LW\HG;&@
MW?CG=M/"F(/3+T;8-VR^SE;S_<P-C ;S9#-VDZMI*J*QJ'LK5K:+%!3)%5(-
MYN$R!VQGK,RM+@76@>3C\A",REF&.RUYRF(>XA%0G($8K?+]UCKD(A3&<#VC
M+AF_$9AW2:;!LPC*8,K4)3',01U"J9&TT"W'<&@2(5RFB0P39DJZ+,9/A1:5
M$%I )DV*[$:)<BKA>@1B(4*G(,DMH)J*L,P)AD5L-%LVPY/%1G=_; @6RQS6
M)T<NK%UW?*;0K)?:91XC\%QXX7>8EA%DPJ-+IJT##9*"M8!#"$N$L31=@*7R
MD[DW-? 824^)Z%&FZ "$*+C136></B$W"8M3-35S^&@QEL:B% ,!TT.O-[2L
M+Z' S)59T_;) J'79-N0<+UBMF<')YV@?VHJ7U?IB*)*^>1U:%XXF[YA2'W.
M>_"&'*6"K,P$(#-*I4EH!'7+0"I$+'0?21.FRI081W2C5>K=6&@5B@B/#3N$
MUR(!&'C77-V&"<_'@KU")'\H4_0(NKP1'!T*KT5P%/D[?RNII,@]?$@^HW!?
M0I7W,NFR\T3QRD0Q)J)UWL<:>E"J<AG[@?#3._J&\'/(7VS#SR4JGC&9T1'T
M7_NX3KDCY*79?0B1^$C 7]5,/BVH4D, 0GHBC2,*]!*YDT/5TX)BEFE*BY0[
M %1Y8>'$>D5AU"A!-]#%J%1&;@=FRA'J.LFUI 5(G[T<<>8DJ32445S(&)=^
M'*U@BP>%L/=R@PJ4+3(L4TYLB&4Y)1:9"2-\GEM.S_@U$M01A(7Q(GI(@OJV
M #;:$6 [A_@:SG8GAYWA!HA.4.YC*#?8^!,+<@,$4O5"T.(ZFKL9P)-\)%-I
M9Y2L-DU+H'>(<,[V>%WINE3].+*]K194E"AS#9Q!R34,E8Z< JX.&HL<.3,%
MYFB77Q"8J0MJ/(\K@%X6X+NGBZQP*[*N)CPM77R3V44<HQ#!/BU'X;I>4-QE
MQAWXRM]NKC$<D# 07&-\)3-2I=VNP2Z,RN]Z"RK3XK\N>=EH7@"ZV!#>$O-]
M$DWP)+$0;6<9;^9U=]&.J"H.7,M&3.S!+92:5!B6FIRRE <V2,V4L7A.;TH@
MRX005.U^V>'JD.?$"*5&O-_K5ZF,2EFX;1SM\/+R3J,77I^$F[MT24SA<"@B
M1Z'.$A6]S;!9NQ%IM:>[U[_^/QMG7^P=?T\E^-'6O=@75^#N[4@T!VY]$=-$
M,<O@680W@6"/%+I6)=UIQU$I6:7-7=9R#R RRZ2U0GR&0$<*>9':(PG]G)!#
M  U\98@/\9_JM7E<B#]+"?5=#)1YZ'9_+_Z.A?8K;)NI(G%O6:$9;5]"*>"S
M*N/<%;Q3P6\HA?B*P"415\NXMS;S+?1>2*AJ4[_EVT &/,) (^ZX8"MJJ@H(
M0^!Z%"IUG\<,DI@I,[@)MG*+J=AWX\N&IYVCME?"KY"*8HU J\,?PM$#/.K>
M?E6NKWL^E_E$I1-!I)[S<?423U>,(K(B53.!UFFB/(?P%6 !" ^2ZYH[NL<9
M9LD_)WOY9Z<7X8N# NNJ]*IU! 0*W8!K4UX8,9S_. 6I%BF?#67N'.0&G:Z#
M:D+DC'1;'6DX%7US=1@V&#1/CKIT'F:AI(WF$U='94UW5-:RT7I;K]D-^EM;
MV\U@:]OGI'8'S>"X^^!B.\W!8/#@4GM0MK-]Z++8EC.O-S&<: J>OZQU:_,!
M%9J&G>*6!:NGBP2P^W[T+OS_Q[\[.;U$**^FMVKQW_FZ?N4SUJV[P^H]5M:F
M==6^BA$>]1!U,_<_.^CU3[_*.7-_I_D_/N89MUO\MM3GK[^\^G#USAVW_O[N
MXO6]CPKVX($]4/6P7:N$0^D(?9E[P<CFIOT,D#TJ'RF>UP[\73RO'GVOA/2W
M[H7OR] [?5.P;O^6*UKV_&[@WA<]A?*?- W]:_.)6/O&9P%L5Q2U%T/X".@N
M[?8A>WP+LG+UGR^Y#ZG._PM02P,$%     @ U#2C5KO2@AT6"   P24  !(
M  !A,#,S,3(P,C-E>#,Q,BYH=&WE6FMSV[82_=Y?@<K3Q)G1^Q%%LN.9U'9O
M/-.D:>(VTT]W(!(4,28)%@ EZ_[ZG@6HER4E4NHTKJ\_T"(!+!:[9\\N")Y^
M?_'+^?4?[RY9;-.$O?OMQY^OSEFEUFA\[)PW&A?7%^SU]9N?6;?>;+%KS3,C
MK5093QJ-R[<55HFMS8>-QG0ZK4\[=:7'C>OW#1+5;21*&5$/;5@Y.Z4GN H>
MGGUW^GVMQBY44*0BLRS0@EL1LL+(;,P^AL+<L%JM['6N\IF6X]BR=K/=81^5
MOI$3[MNMM(DXF\LY;?C[TX:;Y'2DPMG9:2@G3(8O*Y+WH^!%N]4/^FW1'70&
M?-04G=[SGN #T>SUPO^VH&0#W?T88V>)>%E)95:+!<T_[+;K_5YN3Z8RM/&P
MU6S^4'%=STXCE5G,IS'>__1B-H5Q/8:\D;)6I4.29<6MK?%$CK.A6V3%"YL/
M"%2B]/"HZ?Y.J*46\50FL^'3:YD*P]Z**7NO4IX]K1HXIF:$EI'O:.3_!+3$
M).YVZA?1AYQ$9F*^J%:;EG%Y&\N1M*S3JK?9^B)6U%]1-H"]A?Y&VIX+;64D
M TXP?/#:;MKS:^O1W:K'595]B/DT8V_J[#\%F3"KLLM;$1163@3[70:"O=/"
MR)!BDF<A.X^EB-A/,N-9('G"?HE@=*&9BMCY[Q_8:\$3&R- =:ZT\T65!<XU
M,V9C;I\<]5Z<[%K]EG#9&2C/L;Z<AR'8H9:(R [;_7GHR(RT'=9:+_*O'SO;
M[=JJ/SEJ/6^>;%ZO6,QA62TF4DS!;S:6AOU9< TP)C,\A]TL4QG[2>F4M9JU
M7W>;%L8<G!Q@K_*)5;GCF8=KOG:=[;+?C]S :K!/.F,WF9HF(AR+JC=C:;Q0
M09-,(8=@(BXSX';&BLSJ0F AR"HNP<"JG*6XTP3CB =X!!BG8#RK?+^-#ID(
MA#%<SZA+RF\$YEV1:? LA#*8,G'9"7-0AT!J9"-TRS <FH2(EVDL@YB9@B[+
M\5.A12F$%I!*DR!M40:<2O@>D9B+P"E(<G.HID(L<X)A(1O-5LWP:,'1^0)P
M"!8M&&MI[JIC-(5FO=(NLPBAYP(,OX.D""$3+EVQ;15PD!2N.3Q"8"*0)<D2
M+:6CS)VI <A0>E)$CR)!!T!$P8]N.N/T";B)692HJ9GC1XNQ-!9%%BB8'GJ]
MH65U!09FKLR&MH\6"=W=2+A>,]N3(RKR3DSIZS(A45@IG[Z.S3-GTRO&M7#>
M@S?D*!%D928 F5$B34PCJ%L*5B%FH?M0FB!1IL XXANM$N_&7*M A'ALV#&\
M%@K P+OF\C:(>386[!5"^7V1H$>KPVNMWK'P6K1ZH;_SMY(*E<S#A^0SBO<5
M5'DODRY[3Q2M311A(EKG7:RA!R4KE[/O"3_=W@/"SS%_M@L_%ZAYQF1&Q]"?
M]W&5DD? "[/_$&+QD8"_RIE\7E"%A@"$]$0:1Q3H)3(GA^JG)<6LTI06"7<
M*!/#THG5DL*H48)NH(M1B0S=WLH4(U1VDFM)"Y ^?3GBS$A282BEN) Q+O\X
M6L'F#0IA5^4&Y2A<9% DG-@0RW)*+%,31OA$MYJ?\6LDJ",("^-%>)\$];
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MPD<(F\+N'G* ]FM7_W&3^\SJ["]02P,$%     @ U#2C5ALKX3S8!   \1(
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M[$36S9D@)O&USS(/56+C]1^VD!&6RE2_O&6#")]<RR].]MO7X=]02P,$%
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M4R_(PBK>^[K:J#^DQM9;2_J",8W!!.QK*/@7R?O=4G&^UY?)[#%]S6;M8Y-
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M<+QK=^-?UG^.H?+ U^SI]8T6OQE'$XG8WI6#,S^!Y1@-$<I$;:D#1X-E#'\
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MB-$GJ@+,OC8T/<:JU >0,@%37$;N 9*VPCGED/@'+X.?!W1H"CI7J Y&>B[
MLB $ ,W;'U4,(ID\402B:#W4H>ZAX KA@1@?!?"@A *5I-42_T7NRQDABL&4
M]:(^%(^E&+] NKX?C!M(U_>GWH=T!9Z "($<*\<#I54A&!<L"8FA WNZI$*I
MFE4[VMJSP[@9#X^&?L^.XMOA8'=H#\[M:3F_P*7C#QW^H@555; @'I72-E(@
M%!A5SMC@/(N" .2=_K,?_II!\519G,5)*0CQSG,PX)U#&5&M11+11#M)AJ>4
M$3//XJ&/*QZ:@\?$5" >JQGB6F[P$#5.#<ZX:!F)T>E,(N,<['&<0?%4N'O
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M_/'[<Y(1+WV,G!"#M 4Y;/*:AX".C(\,$@N6GJXY-3)^;!G3RF1,F2,N<9:
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MU"CQ:2PI">HA**6# @I2<VFY]LPDF80F<@Z4>-9<F%]1V+G4G:@-&.^2UPK
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M=NF#I^XY<BJT6R]D7:%]7]"^J4.H,]J5%$K&B ?A+<E&AE>0.=Q2FR>;2=E
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M!C5A@3!0A@L0-&JP1C"PS')'$R>1JJT=E75&=6P\8!RWVINFXGCU.+XI,;Q
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M# =)@X,\I]E("-E2"(88K3-Q)Q,:4)/9"D5=C"![ ,<\Z^U7N6JU6-O.W9-
M.DQ7<U#Y<2%^]+.B1R85(F<(JK31%CP(,,@2!)\49JM,R")ZM.Y(_^SJ1%D;
MR5-AN@1,;\H82Z1"8AE0D@P(FK^8P#)6O5..H+;<^0Q3UA%?YX8Y4+X._8@?
MX\CWI\Z4QHO2&YXUA0DVS)O2E<B/QLPZG$[!LXNYJ6G)BU'2G/PZ8KT@T25
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MZWR6(8HP,)BG,1(E$^/6:NL;&3(G</I>+*3JTNAZS'2%]-U"^J8Z49980W@
M1Q4#05& S1,,@;/DLC1Q:9KK9K7HD*MRHSP?%X5J/8YB?MCQ#;4R#?_M#\;G
M(QSX>#U09\/<)-WRDNQ=SLB_OTQ(Y;+VN,S/RA/A!"J=LJ7EN0>!018O203C
M?$Q1VD""W=H1V]P\P))7%=QW>NI2P;UB<-\4*F@C4RP2H#'*<B*CP'BGP(6
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MRRJ^NH3=C22L1<2798Y%KD-F)8'(,&:ZLDE%#,(IHJOX6E\.FXFR0VE#25X
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MT$U31<@DC(P<K!,J*RC#P 0>P08B3=Z'G#6XM</,-M6S$83W):(J!:T/!2W
M0,F@YC*K]H16$*ULH$Q818A)1%I#J@!:8^*Y:;H9:E5B*@*5*$J5YRR E%?
M$U+G*(O&E=!EL6U;RRNK[%/9Y]OLHTN@7EF'/@DA:+#.!,5I9J&LTY6]<_.K
M$LQB!//I!L'PJ)1Q/ "S*8!P)7'5$0K:&A,92YBTV]JQ:C;$N+)+99?6M0V-
M42I-0I1$^,@QY.^I+:7$2$J!56VSOM1S>-.Y0[S,UK,K\2F<@2#&9.J)!(3
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M?%EL_/RM\/?W),)-E?VJ^3-$;@'XRC7U^15<EVOCG_+C-W^RHX\G6A+BL8G
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MT8G.#W].!?\:0+L&[6ZZ^M7>U\@S5<OD.7]RYR)_]2"2@SM1AS=Z^R*I(^9
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M( Q5?[2XWUL0"E;UJ(I1'4X]$0UEJX;:_V?2K4PT-"T8FA]6*]S*NU5%OI:
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M]_+H\RMR_,*?<!(C)]*C:&U"W >+7((?+!+K# W<<="/A._+*TY07]KCWK3
MY&_7%)POZ*BOHO:RGFN!KP6^)>"S6$6>HHR)"QZ5T]K1((QE7F'A&"G 1V]P
MPGL+?-\9^#XO Q_#V)-D(E*!.,2UP4@K(A$V'OM( >Y$/N*([ALN'@KPK<U;
M4_G/@^*MR[[G'[ZV,?"/:TT=NM[(7 GC#QK.-L7C%O<:GU?#WR+4.@C57:5F
MGIADC"(H"<P0ISHA*Q1'A%D5F5$BR8Q0>/5<FS7AZ6H4N%/JM?3*:UT,CUY$
M-\4X6A'=@(BND(A L Q61^2,$(B;2) 1@2"L6 1;2BG.BO7$MTA$'X-SZP8D
MX3;DX(H1V3WDN1MR<#SH^Q9\U@>?RU5^$)W'AOF$7#GVCN<RRAYC)!SFR1/*
M/0=^ %.T(?-EBUPSK93>+3]HI?1;I72%(G"-E:'"(<N5 RDU!.D0.,)$2AML
MQ%8XD%(BMTA*-^1'*.]6!TIL.5MXLV[H19V/?EUDQ;JLKO8+U0$1# 8N#"8Y
MO*+I^J/U-&]^@'8&^#>Y!_>UT/'%#^:N;%W4FU(=Q\]7"5[R0@DI&9(Q!L23
MQLA$X9$TW.-$?/3:E+TY,#XW9&!N3M+NV8/48FZ+N5M+MEO,W1;,7:'K+CJ*
M.6,H!F#J7 F"K ?,9<$)23TE@+6 N6R?X=W!W,+W?RS1N5N7MK!FIM,=A_[_
M'GT$082!&K7588[>_7F"\Y'FAA%$G*.(6\*0 8L76948=<Q(Z>1*)IVSDJ2
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M9*C!"!LAL%<A\!CV#@EK!7N'!1OHFW .;'68;FI!J+/K"7-&"1.,MA5/'K#
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M &P7-.%>^IQ?TMMI?\UJ^UV[#R.R-VSS#<F'<?=9^D'E!5@$5X*/7YG@@V*
M=N\>*9^, GV A"; 8*F@R#K,$0[8P*P89CQ;VTR=07=:XHN)[8TODS,+]M!X
MV8J7R"CVH('=43G?2FT\</6PW<MW1Q9F1Q)E8/5P6#U8@;80H#>L2UQ;QWG0
M!K3%=#+5%T\KJD6RH$5R? 1\PAN;-,+>)\09I4A''!&F@#&@:KA-8!;3Z;.U
M5XLD*_"ALHF#PG]2J+EVO].]J)T-@%44*8["(](WW60?6U=UG9H7-^OP@$[)
M<PWF6.R"W963!36;PV1!:= NUT?1X&M4S/_",]I7=:.R2=CI7=?]J7G;.QE[
M4F'S77W_\63HNBD/HT(OR L%-&JKS.0.G?N[VVG#KSZ.>:*J(G)UD+E@4A2>
M,,1UBHASJY"+7(+,42^"!>ZEQ639'TV,B<$0# N,<\PTDYRDZ*@/CCEJ7K(C
M*S_X>EW4;BZ,VJ>8<ZPT+T"N.V>PV%\(T;^UC[=0?]L]CEE4=UK92S3LV["$
MV%CGLXS_U6D?H^W!L&[93KL'OQ;E*X>[%B^E*-].N[8U. 88!!@FNH3:]U=%
M,<<Z!?R^'8K#L']T1F=?82BV/G\IOHD(8/B2Z\H]V71-3=)SS$SMM_W.&0"X
MX?Q?M=]RFX=V8C.W-8S:VKA:6KWA#%V;C_O9O3CZ&#1L$4+6NZ%.^YVBR"DT
MN5"!*:>_LS"UK;-K19J=G[>]]+KPD^W7FM'"0K+M]B#K[:%S=)CHL-2)1078
M(@=@F4TO*\LTZ _ *)[]_D;AG,TI&T%/3_9HF&9P=K<&9P&4:2TT>L5,U[(I
M>N/1_S< I1R[]V\H7.C%R=9U,D^%88 U%H%B%'60KUL;R]<.AD5DKQHS*Z/A
M=0'#/.C#43DKM&G-Q79,C:*\%I '%Z^+#&;_0Z_?R,1A%/ATT8C-(=, *G\&
M5 .U8F@,6K7CHD1+&2!8-C)/)6B3@L84N19M[6J606I2HPDLSO;]24GL[%5&
MRMM:7Q2&GZBB.#YGH_$LDD*V.MU^X[)\V]!]DIL=(G"T')<^GN31=WK]D<-]
M..-CU3_SR#8[L"J+Y)K'\*81$\TKM_:3E7LC"^60NTUSO4S+6K623.;E/58Y
MN+#""W"9+*3^\CU8MM3'Y1S9:TR\FBX8LJEBS3D M1S;5B<T4J.HQ]GO=D8$
MOJ39C?%9M;W1N@$FW(21GJR=',/ZQ(O@YRB-:+D8<CG7<MT,@7#L-5G4A[BW
M7BRAJV56[MW<*%AWJW2MW[7ROMOFH! S-PS"'4];"D-VW,B;U3;75MBH?3G+
MXID'>&8QT6ZVB6QMHA,%VMEP.AB:%@4^AT%1\=H/6H-RN_!VT*G]!E+0^U<N
MSCV/59\"DXIB, ("F &<:(R99]%;+3A.R91)9;)A,&G,]QK';?AM_)C5UG5+
M"RO^[7@[=XIF_@6-_"/"3,1]^Z.RWF^Q)/#>_@ZM7WX4>]L'K'Y\Q),+WAN%
MM)=@6?!@D /S'6$PY+PAGBKNYXK%>?BTWS0*K^)NWG>Z[PO1*JW /TK!VLK%
M6#_%*^RM)OR>$VZBR2F>)$HJ3[BA!%EA*?)$:*:%\%3SM4VCIP,6;PG(&3ET
M?GL6<!@MEWL"1#WV]U*%#_=;+F)WZXA$$:A,!&'+ ^(JQ[=J*7,->R%TE%I[
M^Z3XD+7!G-A03?J<DVZ-5"E&C1A5@!$Q"60D4\@X;AQQ5'C,UC:5G!LCBA+:
MJ&]__&MD&0!IR6[:3KL@UZ,T^I,<ZV?V2TF#6O:TT\TW I,JPWP:O=I5P9W\
MLBO#ZIJOWT@6WQYQH,(NA7:V;ESOE#1^T+8#L!#* ZZA#,/)!>5SU&#!HT;Y
MZGLG,?:'@3N3A*PJTSY'F7;^<LJTSZS$?F=E]0F7K))"&..#P%QR#]S+$VLX
MU<HRD+D<^_I\=MSL'M[I1-Z<L##.)\I-%'Z3D8%WN_=B7-SZ5\4>'N5_R/:,
M'5IZLZSP'$KGBZV2ZZV7\EU%PO7B.V#']@%;\@[5\0"D'*3[9CQ>[FZ[TQ\Y
M$4+9^&R.Y=9.6EYYARD7_KK:RQG&UMS$B(W:WV#+=D<F[;5K8#S&, >+N!C;
MM<+AUAN]^7K81J;BR%*^R\^W,0-\[N]^6.XNT6=_ E9K,^ZEG^P7;;7#V]),
MWVF/WP,KHW'6C+U7NX=T^DY NR]V+W<O]K:_T/K6D0K!B)R0BW ;$:<P](X0
MAIA,3 4I#07+;P*[J/&"*)*2U#!I3&M-'-@16"0:<J*O)]U.NM,CE3K-9N>\
M\#T5A5>*P-V;SM>1NBY\2;=)QPV:,%U(9UXA&WJ"LX-EPCUUWT(PJU3V1=(-
MI>]7\F2N2BIX@W.SE+(O?!F-%4:L3F,EOOWR VK4_'+U5T9!+/<IO;)214+^
MRON;M;=@@17J_>_L/IFOF_>HJ;):(Y+!?!^,P6) W@*7?,6#47C6GJ.(3*L1
M0C,^TT'4/T85Z/JU[>B+4SJU8;097B\V5T#Q=Z_=30O+L/XKG&6>)^_@_09"
MS7\2\X4?7^:1*0__: &L.A&B+8\>"V:Y$]RY,G >WUU^H=HRF3KF_.U'_?+@
M$MX#EM+AR>'II^;N_N')[N7QQ<'IEW/XN[&;79_;AU/'G/?VW['ZZ2[T"?K7
M>M^J?_CRH]YZ=[FW_6>COO\'_+WS8_?T -=;]5R@_3K5U_X!V=U^=Q1@'BF/
M%J4H+>)&&:2E3LCEPQ$V>9><7-MDZY3R&5[4NPN<W9UR(0O*PHJ_5%CT.K H
M<(*=CI%8FKB(P08=8K(4<_C;$5=AT<O'HLM)+))>$IIB0-$:C;@U#,&\)A1Q
MR'XY'@3/!P#7"9\NL%!A485%SX5%3J@DE'7<6JZ$U(S[1 3GQ"3+N5P:%E5P
M,P_<D#&XP7O;'X\L=M;EC.K1!* ^SC.DJ>7(PK0%YB./V*UM\ADI7AYG6_XL
M<_(+QX>M$-[4QM9@L7^43^6ZYGT<#O<:BQ% _$K)5)_(=!J;F4_7$U, QU;>
M8YBF,+]<QM0G@I/&#4N*[F[O''ELI0DI H@0AS@%XF)9D(@(^% [@UD.0;HM
M8^HBI&<V?ZGD\,G-ADH.GTX.+R?E,#H5I @$>4<"XB$JI)-)2"2%K8M6Q< J
M.7P5E/E^<EC)VSSR1B;E+0!3-BEBQ&*FT3(ZY)+&R H9);&*<D77-JFZPW_X
M&A)W_VR+YC$.C/DL[U\)2!Y+K.\1IOUN&'LWXU)YCF<,9<H/MH?1@I]L/Y9A
M7I7?<&$(=#'-O*FCFJ9H$$W8(VX91EI;@R0WG%A,#,X9YIYZ#Z,2X*=@Y)4
MKYX 3U%VJK%-/ 44@\BG=[Q#-C .9$)ACR4C5+*G=_Q7 OP45/[)!+B2T7ED
M=(KF<ZV=4H3D<W4,<<8#,LHQY",V@D0G#15KFTHLFN:OL+>\7'DYA/O65!R5
MT_PGR*)"KEK"I"6)1PRFI!!8XF2D\UPFLB GP4_0Y6UY5K<\FGNS/EFWTWIK
M>R?OFYWS"F >R>(_BMWM@R-L&*-<4H2% Q*@G0<6'P(2(5<\=DFE9-8V)5X0
MAZ]\=O-6+]&:)Q:T(1@,*\PU!>,*-#PW-@G'526.JRR.EY/B2 (UWE&"L+.R
M#,9Q)"D4:93"4\&DX&N;0K!*')]%'#&/0EIG(^6>$ZTML\H;HX(!Y0@35(GC
M*HLCF13'Q"W/1[91T-SEDKP*61D%(I@YPYV4R@']YD_C9%\)]OTIMCK?;3.?
M>NB=V)"SZUT=<2[.5=XOK=0B_ LKA4&_S0%"Q J>0HR.1<PY!;XF/;=$DYR!
M&SZ_'81NR8]3H=&+0Z-Z8YJK.^^UP1HH@<O. $HQ,CC[WJ.,/!FO",OE)/5T
M8NU_O0Q_W4I*YCS[8C0Z[2-U%CON$W:YU((62@%S"S:*E\8.JEB81<CI%(GW
M,C*01X%4R$7B;&3()!>1=<+#FC))2+_@6)A*5.>MHPR6EF V!6H-5R(X+*0!
MZPI4J_9 YBM1_15%=8K@&TDLT'B&B X89;:/M(L)><&93TQ@H^XKJ@ORL;]H
M=K]5</FQ1&:V/YFFY#%^B->[GV<9 2CRPFF3N%?*D>")\HE2PJQ73P!'4WMZ
M1<!>M2>_1#R:X8[GG(,"5@$Q*K+#@2>DF51("9:(CCP$X7)0C>33E1M?A@?P
M]<JPY,:9E!.6XL0)HTX(@D6@.!GM PF5#/^2,CSMP[<*6V(C2E@GQ#U.R 1'
MD>(*>XZE=J0X4"O-=%'-2H:?>;M-*6-8T)IKQ4F4EF*?+ [4<17QSUQK3R_#
ME9C.(Z93U)\X)K4*$3%N<O@;#TCGWZ+$R3%CO'6@:I71E7/_*M]5[/46>Q+U
ME7@;GHC>5R?@G@A/]MZ.4_<OYWO[.T=!R&BP2TA8Z1'G!JA[\ (1HTS@(K#(
M<.7U>Q44O9+#IY/#:?I-(C=18Y2\D8@[L)XUY@)%[IE+'@/DFDH.7P7-KDZB
M+E[>IGBTP 1(C,)(,Q9SZ1>/G L422>PS@<3-(EKFPPOFD<_S'U^,UEH,>&&
M*,F$D5[:Q".1EFE0##@?A**22W^D$48$_D>%%$RN7;7[A7K@9Z4=K=T[[^A-
M%\ P#S@## J=0<XJ7K@!JNQ;"QRF7R\WUQ.9.U6>P*7A_.?IK0F&0W QF%P,
M,"&>L$6:)PWCZR('[%=4A:??FJAPK,*Q53<7*QQ;(HY-VX<&)BQ1D #L%.+:
M>&2X("A:355B.)>N>OKMF0K'*AQ;=7.[RI7Z.*B:,JT#SS1:$V2LQH@'+% &
M*<1@^G)I-(]5SI5J[I,K]=]%?:=[E6I;9EVN6POMS*[4M=,Z@QYE8[:HM;(]
M*IRU<V78?AX5SMJZJK35KKV_JH@'E_M%];?:7_#PV@[\T7NZWOZT;ULWJX79
ML[/FQ:@.XIUEPG(]^&/X?JL3&JD10ZX=V.WTSH:UPUJQ?]()9?73ZTIGXT=Q
MSF,W%T8-13E5V\J;RSUXR%FG6U8\O%]!T][5\$(/.F>Q;'!9\[XH7'C2C? :
M&(N37BVV<[G57=OU)V7EUV$6+OHKEC83>,-PN?@"7&)#$;HJU<+8!E-L51K+
M-SB^7X/N6=KLUAT (AY>XFDYU8[N5^+I&HVODVQ<%]*LE61@'J_NBXA]?NXB
M</=CI?,,SU-6:K[?R@%=]VFH6V[%^A?2U!GZ::+<\V.F\CZ[@@]9#R^O'MS6
M-=E8B! L:^1639)&&T"_AAR]AAJ!;Z^X\]MQ[OQYG#OO77'G-X\)05B,&-T=
MX+#,G'V+"Y]X\G:^ICQKPQ4+O,]W>OT'+MNE):!Y=4]:9!PR82]\[0T=CN7*
MF[>DZFMQB?\DENS7<6U;IP3+1^0<#QQ3:P/EW$N?B\)H2MW1=B8>F&""BE_8
M73[NTH@]Z30!_8?+K+?5#F^;MM'J[;3]H-N-X3_1-OLGN>#S:]BK^]0\^'KP
M(_^[]^'C#WC'Q<'^2>/@]."\_K5^6J=??L";SP^W/[))!WC]PS\GAZ?OX=]W
M_'#[/?3GSY.]#W\VZJ=;Y(#NLL/]=Y?UTS^^U;?#Q''(+;Y[N7N$F<$J$(HL
MQSQ7]^'(V8214-XXGP0CF*YM$K5NQ'32D^<K3E@AS$M'F'G2+7'FJ0S6^N08
MC]88'J3.65%3T))I?0^(N27OTMQ84\')/'!R.0DG,J3 M7?(.6\1CSH?^0HJ
M!ZU:+K5.,2=FH=.1JDO,GU1AR:ICR3P!19(%3%GBWC.N-'>"!4,Y-80E&YVJ
MV,H*P0N98BN$FN $1H1%C#AG!!EA+)(6\"4JE6,O2K9"[\C?ND@_PHLWYJX=
M"?''6?:35?G9G\+@R24@KH;^W7#DW_WPS4$>OP^=3CAO-)MYRZ_1+;SX?W5Z
MO;WV5J\7^[W_Q&9XW^E^!KP N"FO_-7H-XX+'^;GV.\W"]=F!3@+ YP;(=G0
MQDM_! ACF ; $40"GS%@([GD\F_,:(M3C)BO;9IUMBCKJ,H7_?S&PQ/);26:
M\XCFY:1H*LH%QTHA+21P 2P2<@9^P]YXQ107VL1<GW%!ID8EF,_%Q"LUNFJR
M2B9EU3+B")B?,*"TR*;,D+-2(NUR12UF C:F4*-W53)\3;E@]CO]G.;]YB9@
ME0/F"7<JWN81!]@8@4X%$HL"B9OI74KCWE(B,3,*":\9&/>.(AND0 %S*P)V
M'(CXVJ9BZXS)*JO$KT*V;Y>U2ISF$:<I5SQU6#LA--+)@,YU%-0MQAHYKY2,
M10E2GPL=5:4,5IP?5]KJ"<1KRA5M2?"":HPB!2++.57(T(@1L2E*D>"BI86V
MHC.JA3QGZ=!G#=2\]D0_H@K1*S&@%TYGKP9_IQC[; Q7&+$PC/@\S6BCB5AH
MYI %70MF;[+($*M1XBX297"TE.6$'G>>+ZV<5,NJ)_1X/GL/&:O$Z(%!)4/O
M$=>8$X:1"S0A3H-$AN5 M9!XTLJ[D/,-SF"RE0RM))&M]-23A564 F8"PRPQ
MA1QQ6<"B0"8$ LHJ$<8%A4DM])3@=\C8:W+/EHNSYHIL\D,Z6^O;'[6S;N=[
MHP=C4_EJGY#<7F-%4=RKDP],#V $KX]]E7G_R_OV[8^\A]3OVDX7QMEV+XJ\
M%?5..[>RVVDV"_CIQV[L57M#"P.?W?VM##PE43[]<KX'_3DB7(<8G$-2 T'F
M'$MDF8THEP^PQ)/D"%G;I.N&5V[?7X0E+U58*WF<3QXO)N11)0T0K#3"'C@W
MUU$A&SU!VC@:<RED;>3BZ'8EC,]-MRO-N2*26I_4G"P(IPF5B!%&<J+%!)1=
M"I289=J&I+"FF;=C_+)<T"^!MS^>J;\2\WY)3!UP9+A1-3Q54<'!7'#P;II(
MYV31E-"$/', !R#^R$J+$0V<"P-@X$5<VY3LCJ,1E:-LM6AT)4F/EJ1)"BQ]
M($DDCA3+P?XV1C!)-?#@1'E4-!++\SFC2I!^*0I<"=)C!6F*H7(J>211(Z"E
MH)("C<A([) FF4LDJ6BNMBSO\NR\)K]R/?8?$QSQ2JS@Q6<EZ79 XJN]IL5"
MPNXT2TT2X)L)!D @#>+,P&]86D1IC$P3+6W(YW;6V:+4:^5A>FZ>.BY;E?C,
M)SZ3U#28I*T@PY!#;IE$.EB%,%A_QIO@M#!KFYQ6LO-K4--*+RU'L*:HJK4X
M +AYI"P5H)<X 0WE)(I2@+PEHZ@-A5ZZ:^?C-3E3K\EJS?;[W88;E.4#^IW:
MVW\^U\J\*)5W]0EY+,Q(%3:U#,CX.$UE0V(L$%"^UEN.N-0".1D$B@(;QXC'
MR9>001:DCBM/T7-3V0GQJB1H/@F:9+/1:(]!NR(-NA;Q%# R44?DA8Q<&YQ8
MCCQ<%)NMQ.>YV6REG98F6U.$-D@3098"T-B8S<5<VXR$!'\R[YT3V"59$MHJ
MZ<(L0GL6N[7>B>W^C-H^JI3 2RD8\**?\:H2]?UA>PT_;R'Y7R!_Z5Q=7%WM
M^G?L?CXIDH0NT@:DDTKVG>VV8;1ZH]<5J^I*G^)*G\ZY<>$Y///'47"818H#
MBBX!5_4&(RNL1LXR:>$BIMZM;9(--;V961;I><RJ'T'8'*O_<=1XON+)%0:]
MI+X] (,>:2A7&+3DW9^,05_$4<+26!PQ8MP$P"#+D).,(1RCBV R1VK 7L8;
M>'KOM,*@"H->-@8]TMM08="2-\KR..R<'VG'J,F^;II41!Q+BK2Q'I918E;I
M%+T7!0\R+PB#7E7QKNU&<S!>!_;U%,*8JXN_'( NVY <KJL*0A^\<3@T)8TG
M*0JK$' V@[BF$AEO% J8"8^-9\J$ D*G/;-S0NA/8&Q9-.X.CV"%0K\X"BW;
ME*Q0Z+&;KT-CDB?FDK0<F60PX@$F1(L %B4!A4$M%0!#BS$F*Q2J4.@7,R8K
M%'KL-O70G"24,N]Y0(1',"<3M\A@9A%6G 4IG=/%6;L--5W)X_E0J# G_UUL
M",-_0^/[YJAQ]4$+UK@O__9E,@5;[JD7MY5M==U_7^^Q%Y_?=7'4K:%<< &"
M<];I-?*CWW1C$][Q/?Y^W@C]DY'0C'VK;/T;?/T5ZWJ=O()O_<K8@/B8\SD\
MO>S3W"8B;H[%^,^3[J@U9_8X(M>-]ANR"1K[QC;/[45O[=\W^M1JM-'X $[V
M_?89*'].3&DI\4H*88P/ G,):..!W%O#J5:6I1@57[OE>]1X011)2>K(%1 C
M35Q2$HM$ Z46CS?IJ0=]JU>SM6[L#9K]6B?5[-E9\R)G[>V?Q%JSTSY&8= =
M=J7=@U_;/D(3;3O8;J@->OE66VMU0B,U8H '];N=WEGT>8W66K%_T@GKQ;-2
MI]GLG!>WA]-!KU_4;ZF=QR[<9D,1;&%;(,/P83>>=;J N/#&XJN#MAV$1OX
MAC;D4YO%;["J&\'FCYUMENTZB;%?L[W<D>WH8\O%;HD<C*S7,OB_N57:6K9[
M#&NFWSE[(PK^4,: 7$E5-\1NAI>F/>O%-Z-??@^-WEG37KQIM(NA+;[T^_!9
M0U',RV\"8@J)*R]?K\P-7*[.H>]J^.;AY8WBT@3PE=<$WA!8WWH9;Y!;K_WL
ML41L*$(?]-B?7V.:+[ZQ=(,;N2J-S2-[O\;>X<R\,Q:'B*E[9S#<$O6?)GVX
MF4 E-3MU2^L,-'^6X[<GMGV<LR[6MKS/^) AI"S5.D_HVD]Z_W3\_JKOQ0/?
M-/KP,G_G:)1M!<+:*8'X#1"=V,UWY10W-6A ,Z=NND]\6HEB&>,R'2H M);[
M,\F4[CT\3\DB[K=R0)]]&NJ/6['^A31UMHJ:8"./F<W[A.@]9$G,QHLER\S/
M9_V:4RQ$#I8U<JLF3,6P L/Z941I0;N#+]H_]/:*);\=9\E_#%GRY\R2'Q7.
M?!_Y6=3QX<<_Z16T]E6%3N^!3=BM^4&W"X #UEXN_OD*(ZFOYID^[/32"CN"
M)QW PCF:M$^>&4XHMR::$+%A+JDH#3O:R<J T#NK$>2%51:3?5NNKE=P;JGU
MY[?#KW^>UN'=><,:WHMW]^LG]7UH\^7.Q>'IN^P0I@>7_YQ,.H0/6I^:!ZU=
M=MC*CM_WT,>//W;I.P)M8+NG?[9V"X<P/.?K^W2U)34L1K"WOWODB211T7QB
M*1<C8,0CBR5'5G++)2&)<YV/+4G]E 4_*NA8=>B8I\RE,$R3"'B1HN6"4>@M
MB=PYPP-51(C;L>.6ZI:S0*3"B7EPXG(2)[#%\'\KD?,F ECD,$3%(F*"8<Y4
M"-:KM4T^'82XQ/KO%4JL.DK,D[H#J\A3E#%QP:-R6CL:A+',*RP<(Q7!>!'
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MV.:YO>BM_?MF5NQ&&XV/^N2 W3YM4Y,WQ$*4+9@W].J<>2-G+.R_051M4%H
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MXRBJLR0OQO<_?J"W8EBK!&+7SO_*<GP4D.U, YG#SB09 G*6Y+U+J9&V*J"
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M%K6AL%S'TP.A_1Y*\O$=6@G$F&FQ^Q2"TSI'VGM.%=><)^LUD=83[!D=6NP
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M?^S1HWT-&N0K:&^HO@FJ>Y*DK%3NG45 5EM$23+@@BJ2!%$K&T/F9#>V!>*
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MHLX$4:M87 DMP?KB2I (DJ)%BMHWD]TP?8?!^V;#5P/U>1LNF96L5M6SV25
M7COH4E:@L[/&D9,83;/A]Q7O-XGMKQOP+;:_#+!?]&RX)\Q.$A2$%DEN&8.@
MN02R660O&05BBPIQM9S^P:)Y &!N57M6Y4S/]N(*9LM[WKUDNQ_?A)BC(>\
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M^W9";[M*YN%3-X0#.GI[LE^K Y^4:>C^-/ZR7D?[_D\J-T)'78'V^GGG+/<
M"^D*L67D]U6\_=IE]99&>RMU=/%1C]5L"2GOR5COT[S>I[&V-=#&6M8 7N^J
MURS]?>6>'5?WLQCTEYJR7(P.RS_?OTD1\ <W'9?.Y+896;@#].BKY&^.Z*](
M[T]&1Q^J]JX2^1H)/1=BOM]9DOLN%\=\W]XKZNMW$]!Y[L>Y^_;[RB?B.L7/
M'\R$?J4V?YO"ZTWAET!+-Y'_[)IZK;;=P\.9K ;@!N"A36$#< -P _ ]GL)O
M _AAI<XMGH4N9#\ZB]:W/D-MD&V0;9 />9##8N5K=Q%KTSG$IFR#ONUGE[?L
MOZ^+X'6/ [5KM&NT:PSV&O>!KY:P>FW&5NRTWI?RQ"^W?M\:O3TN0SJJ&5^M
MWDXOC_ZLE_Q<,CT&3D)J9I(+Z#5S7#$>0B3%)$^<+TZF?[[[\\V.,OTXRX,\
M_C#]$F^IH9;_.4W#JSO[>_O^B(N=;A-[%BE\D<]>GY[GV;/[F6YZFF?_"E^]
M>SU^??B*[SY[KE[L_2IW/O^D=FJZZ>=?Y>ZSW?TNY70OROD\^]UW^^-RO7)W
M+]G.NS_4[K/X>6?OCX^OG]7W1;8C?JZIJWSW<UK86T%&(;)#!<8S 5A_"DQE
M<#8F,LHJE=C&-E</L,[.TC ?'-W=^!S1PSP)]'WD==-CF#?EK@=R).C.J*IW
M),A3#H$'"YF,A_)@-5BR"9"XRL:JK#7?V,:'6!*L456CJCNDJJ<Q?CC\<%!/
M4LP.DC?FN@ES\5XK&R+)7"#0'@.@50R"81P,QVB]]UQBJ(<9'QYQ-;=JB&[5
M&<Y?3/YY?/26)LVM6A+Q<A[Q3/F$3@<(DGC1*K4J,PL1#.4DI4S<U?XO\B&V
MWFU:I6F56]0J\]SU&,HPW!F/J5YX*.481=*06!2%QR0#YRT'Z[1/01M!*7:%
MF+$Q66.RQF3+,%GSNI8+;>^<5>EZM_-IMWS.&YV]\E)Y8*1,<;MD!A^9!1:<
M"NB2,"X7\FI^5_.[5N-W+<9Y\ZZ61O:G>63K$+V7 H*W19;8Y,%BLI #HXPL
M4O)40\'ZX2&[B9(F2I80)8LIJCE1JZ2KW7DA4IY:CL9)H%PWV8.P$*)"D,6%
MXEDXG3-6+TKS1EB-L!IA?9NPFJ^T)$7-*RJNA!*923"8"T7%;"!D0^!B\C[H
M:#,KBHKCD'RE%67IWY=DQM]/RG*?;HX."R;C^'T945=JKY;0>W]<?RGC'$T_
MA#3^<SRM?D;KR_-5IY",C99D,$YHE#Q[](6X<N8!I2]ST'(<[R.Y+2C5SJT2
M)+4!+D,&+#^"$PXAF92=$9)3KIMQK1_/PX%\7ZU\']I;4N"PL-U+"E21J:(H
M$ Q+"5#) "'%HEN<UDE[H2/FC6W%E]Z>:MANV&Y9='<(]5X6G;$9DV()M S5
M19$(GI5?O8DR,QN+.9=U.Z<A_:$@?=C"O671K1CQO2RZH'3B+C$(TD= %CD$
MK@ER\FA<$#KK6(R[;<;]P4!^J,:]GW;6K/E-L-W++-/".\4RAQ3(UISX8LVM
MY)!#R$ZD\M!EL>;6F8;MANV6B'6/H-Y/Q,K)(LLI@N+: Z90L^%Y,>M.ADA&
MA<AP8]LLW2>Q07TH4%^O<F]Y6+<$[/E=P^IU>Q&+(L_2 &H>P(7BG*M8'K&E
MX,CY8L1M0_:#0?:ZC'A+7+I]?/<2EPPJQ0(%T)((RL.5Q69[ FV]T43)"99J
MXA+RI?,"&L(;PENFSRU@NI?IDTRVRCBP-MFZ8\:+S689?-(J2!&,R073=NE,
MQ!4"^C%6+8O'D_>UA0^UHF77]2ZBU)Y'S13/A#H)1U9')C1W3MK(U7 2>JXC
M6II3<@V"&R_(]I&Q]CAV$&*A-A0Q@PV(H%+D/#ICF,@;VV)3&S6@7,9V[FO%
MFN7[R.#V\WV:O[(RZ/>2@8PTFN?(@$=>I TR#\X9 <Q*1.TL2P(WMN6F'E0:
M<X/^HX!^<V26 GLO':B8\Y03BQ!EE,7.JP"6:0U1DR8;32B&?F.;ZZ4W$!O4
MAP+U8>O^:^0#-=V_,C[H)0M)<A%M)#"6UY);G($WW$.,R5NM?7(A5N,O63/^
M#X81AFK\6Y6J6X1^+Y?(H;4LV@)]Z16@) 9.UR*;VD@D$D)DO[&-F_PAGJ]N
MT!\V])ON7RZ^U\LF<DK;&+T'-#(!1I8@""LAHT IF&.>3$&[LPWK#P7KZQ7^
MUTXG:O)^A;"?W[=,*=>(?@(3ZF$ ZR1XS!8424-"2F=3@;W:="VN_W" ORXC
MW[*-;A_AO6PC)JW3&CUDK8MA1VW!"B*P2=D"<1.$TAO;9M.H)N,;PENVT1 Q
M/6^UC>/(,CDHYIL!<JO R2R@/,(DN+,.RV/<UGI(-ON1U14J@"B_'BV;9_0
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M1%6US,EFC!Y3K:8*%$X6CU*YY9&#DNKN8^^["N4:1PXO+JBK$7(5/BCPOGC
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M+1Y?/9KMWD2E*7SDG%M[H)=_%/S7W?7V@])Z6WM;>UMOK*WA:FU=-8Y2W]-
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M5=F(FI04P(LD@@L@",O4H6.G):672P[?L7/^7_=V=FB4K\#8OQ/^29T4II(
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MG!N?NR!>4C3/.0(0JPO>*>'9]!-0@A5!5RU"446S,:@2]NX_=P'2GI5HFW1
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M#?+[\?W/G/?K$>5-G0:_M278.%J!VUL]^GK\!4].B0PT-K2RWD$HI8( [[Q
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M*Z48O\F6Y$H(0>J4L,EDWUULUPC2N<B.4K73S;:M@<4K>(\"3?*BUDRF)7V
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M61/KB,8)+,:'6E3-U$SM>3M[P-MINRWK7AWL3;9H-!A1IN'[QA7C >Z6"VV
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MCW!Z9O=#?:Y.F9#;5P!Q49K>%S/_Q^>)_[ZW>6F2LVXBE7T\1;,CYA=5%8D
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MH)"#J0<3U$ODC/?(<AHTE=YQ0Y?&S>82L$UP5:TC8LRS<U,&0TP XRRDQ"E
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M2EJ#C0W1;MUS'R.%9%%(P[GFP'=T5%Y;(P@0'!.PV7H,]3KC)&7<MMUJ/Q:
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M,^H.79F/-\-OO:$&.C^UYZ&=GP-N%N+I8/A7Y4>J'L\-ES.\;XSY0> QJT&
M<\^.^S$VNO"0QX-&/,W/]+UP7@G?E?#=][TU/S3$S,179XXM/7+OYN_&EO8K
M06D.!>5U%I1*457"T@ YF<>C50O'U:.VK'X!;-I'L*''*0>-<<J![T? J@P_
ML^;]W><=O^L@K_T2FC6>.\L+S^+GV*2!>WYQW:G,N>(%+\"(!/UXFH5HQ%:R
MY=H+,[<%F"OPM,EUNA\4@=N@"MY819ZBC(D+'I73VM$@C&5>8>$8&3H("?U1
ME<R;:[4R[C:RP&5S]\/7JK#E_E_P? >XE>/.]/?/AR<'EZWLVJ,YG['5;5V]
MG\A7;.V_SH4M2>OM.]PZ>0_G?K@ZZ/[5;9V\ TOK@.5\QB8]8*TWM]ON-G<_
M7S7?'^$D))/$(IM[[_+@(C*24H2]U$18(QS).V+Y@XIKSQW<+KA2<.6[N**X
M\,%@B1/EW&-AB+526V,BU8R'6.$**;CRU+CR+8 /[R1R'K1UV@1/D/""(4Z(
M0$[[A"ASU'B"/:%YYU*F7]_#E1_PL9I6T%T\Y: Q$M]:(]ANK)SYV5OE8_O?
M.$$3-SY&^M,<T/4@A_(T#//_#K[C6AY/RE^C.2G ]G!@PU,(DQ-),FPB4IPF
M($PJ]T1R&FDIE$_2A"@ #";KA_RG)"$\LH!)R0((3N+>,ZXT=X(%0SDUA"4;
MW5# Z%C OE.BOPC8$PK8!'.H$K9XMD.458A;0Y&+S"&A#-782::CW]J9Y W_
M>6;$8;KG:2V(P]_5OL3L?JKB/Q?ML^/0MQ<@AL]NN_9*&,2/ ]37,_3J-'R\
MGIX"=0^'.CJ%2TBP8$-D 25J!!A)42'G5$(D26V$))BYL+6CEL0EGOL.[95P
MB2)J*Q&U"5;AI/4PHQA)F45-$8HT%J3:S2,E4 NKV(]I^Z:QBK5[X(WRGUP7
MFAN&KI^A_V25Y&<\^K^-!G^_=RLP>ANDBW]X 3P6T]PH7!B2"*QBF#[$N7;(
M$##Z>/#!I^2$=V1KASU);^DB9H](?(J8/:&83= >G21W$7M$ J,YE=8@BSD#
MV@/6A;**4CG56_D823%KH9-_N\[./8UG("C]" ]UE3L5VW:N9M/I#09QL!0#
M;%,AY(D"'<.9>G?:BF<?KJ?I;9ZE/ZHY*E#R<"CYVOP-CRLA7.9WW-M]=R2P
ME3%BAJ(3"G$1);*:$B29X59;R64$$XI.EJ(LWHKZ>RORAC3XJXA>'43OZJ;H
MP7L=\:0!4KU"3'B+N'08:<\I2I10*JQ@"M.M';5@4&2CC.N]O+WEV1G43QQ.
MN(,:/W9VOCOU@!>#N!N'O]_T>]UJIH:04H!C:3K[E6A>O3YR"3/%0T).Q@#&
M-8_(.9]CJX&Y(%,PWF_MF)*ML $ZNTA?;=3V[H'8VW]W%"DSPDJ,A/,"U+8Q
M('V$(*P4YE&#^&&[<-!AX_>DQ+Q9M>Q&*5GC#_9(:!RY<S&:1!/7*6DA>, ,
M.YMAE?/I5>Y+UO@C(^;?DWQ%)0E\E"?$A?#P@V)D33#(6ZV]59*[JD$;GV0L
M93M* 98G!Q:C7+36$$&BX891!_:3UD(')I02&$\OXU^ Y=&!98**>6R)CRPB
MRB080CXHI%F@B#K'#;'$)">!BO'90B%W:B$1L:J^CS<$CX%TA=YYKHUQ2_)6
MW1)RWD=\#G1W7.9N@>(%&^7LGJ]YRL/HW$3SE/OMY#M5"'\;3\X&=TQY*FAN
M3W(^PO*^&1Z0,X[EU+R(K%<.6<U-)%Y@S7.,>EO\J&5*"2T]AK0]C.,4::N'
MM$WZI)+GGAF#+',8 >%)2$OBX8?B"FN=8N!9VN1,#8IJ1(5J?8WG0&I:\:QA
MNU7G17O6Z+<'G^=UU&V U3S7*ZZIFG@:!]MM)0&+ZU6UMEZ=_04KZU9!Z)>I
M_34&=!7[O6(W+Z N6E,"B,($HJS'R%C)$<>*(0/3BUSTPDJ)-:-@-U<>>_K+
MA,88%GM<1$;(_#ZCI_0 %L2JT[NMV'-7$&L%B#5!<*6DPD=,$4LY5\H%CQRG
M$86@73(J!$)Y'1&K\.G"IV^GHMO!<6,PWAW:^-=VSB<\@T4_;:A^6A:CSHOH
M>H?Q/WD)[9['VSMP*B55U- B:FB*5]-+R3TW/)=3%(@+[I$.PB-OE%3)*QPX
MV]IA;#)GMY#F DKU!*5ED>8"2D\#2A/<F HGI>$*#'E#$5=4(4>]0-9(AHF*
M7&3G+^-U J5-*V%0'OB9/O!D9[2;C=16UA>MNN+L?9?^CE]LSE%HC+P=<[9;
MFM*]*DB2!*%"!L-=4MI$%;RQ&!B2H%QOU;:W3[+MD5F6\Y/M8%#UP'&Y8=Q)
MK]]HG_X;!V?=>'K6\#!@GWK]RQ=@SWWYTNM7F1X3(PF7R!>ZKTW.;O0QQV=O
M'2J-<V:_[#-OG+.Y36%FR )9J[8DWWK_9 R=L;O+'+ZVM1J,,>S='(^YFK;4
ME X\!^]E5EL^_Q'_>]X&31EO\H5%D^PW),]^>>^_,7X&X'T^LI"B"XP3 UQ0
M1,GA(\.<YU[/ZOP<,ZP1P7I5,;3-="KL?Z:')[\?-W>/.X?[KZY:;U_C)H7G
M._ETU7S[[FOSZA,\^R?1O/IPUZGP=6__L-OLOK[8>_M/!YX7[O/^ZN#C^\N]
MW>;%P<GKJ[W=5_#_SU>M?VYUD&&MW0]T[]61SWR=1($\201QFRBRT4JD!#'4
M:XHM45L[0%F7Y%.8I_M8G;V@!=>>':XEZX/DT5LO+;?6&\$"$8!Q02@=M)ZU
M*U;!M>7C6O,NKA%/<& I(<]D+IV6JR9089 1#I10XC1*#[@FY+K@VI*JO]0:
MA7:C@Z&+_KQ?-3)^69<R%G5-@%B+4CX?MO_>;GSJP2.=5MZT;_.[R)[5'ZK8
MM58U6GH1J#$&$PQTFAFKC2/<>"V3E]05"KTB57.SIQ!NG7S"N4JG4=Q[HA"S
M"B@TEB+OSDB(L\BYHLE;9K9V%)[<DK'VN0)%8J_)H68VLXQHDN"4)".,Y3@F
M;PB'/TPAAZN3V.9=B8V J8(YA;S3 B16<^0LIL@):8#.$^-MEE@RV;NCMH'T
MC:K^]_<92,#@1:,+ N?;7^"),EVH_)%?>OD?\)R-P;D+[7_;@^^&$+Z'2U,&
M:/-P*>=38QJH,YKRP*5V(EH5N13")!QP81(KPB4RC4E@!X@D,0I&Y?HY2B$7
M#$9:&&RD,M8$LK5#)\OGS E+WX&&QR(2LUI4SUY@$Z4L)IZ(=Y@G;:R- 4BD
ME(Y$"U);B,3J!':"2#"#J4J:(!(#$ E/ W)8<I0P 9RERGB70& 7YA%+%-AG
MYWKPO?Z77I6I4SP//X8?*S$7/CKOL>")@143@Y7:N*A,QJ %^<+-772GYUT4
M>E6"2+Y,P::'8]/-]H0L'V]>'"5#/)' 'H0B0"8X%<C*:!%/0FB,HQ$4R 1Y
M(6N5+UP<$TL6:!><Y<J#'6 I)P&D./E$&%'*@$"K1:-61: ?2Z";-P3Z'6^^
M/S(B.AF3180KBO(.#F0QU0BL.!)=$IAI5@FT7"._Q=JE=ZW= V^49^A-KP__
M/%V4RCT+2Y);$PEAP6'A.6?*:@F0SX--.:[$:'']K C<Q137C_$"I@IK1(26
MB!.GD8Y$(8R#XS(ECVT 2Q)/5C@MOI^-D5@5$E?*"44#YMH0;60PAD2N&<':
MQ.+[69W$3OA^/%52 ;XB'@W85XEAI*G7B/D40H[2$\*SQ$YV5"O.GZ>0N[_B
MH!WBZ5G;=AK=7O_LD_T447[#&(HG:);($2$R8A6<%$ :N'/)<LRC=,PYC&VA
M#ZL"H]NMHJ[>D[W=UT=6:)><XBA@ZW+!BIAK@F)DO'11^LB=R:T7%@X=%5=/
M?24V1H.%,E%;XK@CP5(*_^ &LYRES$*A#RN4V*N[$ANHUA)+BR@V G'K.0(1
MQH@2)I507.G@MG;XPO2AY* \; =<K]N-??\([.%9F#+>, H$V=)$* _.&DJI
MT-1PQ;S05A;V4 OVL/]*P.='Q/(D))@QD5N.>/ 6:6L($B)'":((U@-[6'BO
M1(U]#XOMI%AO4<5.:NDXIMYS \)I%' &1RD7)%I/"FVH!6W8/>"MDX,CHJP,
MDDMDB-*(&Z. -EB-6.+1!<N4$7*:J#Y&4\JU4.15B]1A?9=B_L^1"((-M]8X
MCR/ER@:7#,?$4I88 XQ8-!&DH,+#4:$]J< K,X\PCJC,A=Z3T\BJ*)'5FCJN
MDV!89F=DC8R)8OXO66*98Y)P)PPH <ZY-Q[[*(7'2GJOI"MZ?(42.Z''A2:"
M,9\0)L:!Q/* ++$>44&X5X33Y.+6#M$UDMCGL 5YOW<&%G^XO1%Y$3-_@2ZS
M:XU&0J1D@B;,Q<@YL DIK!5!*ZUYA&,ED;2>4'5Y)[:P?W#D@[2"6(,(]1AQ
M&0S2R5@458(#VKH8-)"+%Y(OO,5U+J&IB^^@H,"]*$!TT)(8%HD3W KO5  4
M<"1X9I3$JF2?UA4%;L8K:'/7'WD.TI^H09&3F"M%>>08%DA%;Q,C7@E"*Q10
MR]KN\K@HL/EYGNM8=[#7[?9.?X;;=2(LG7]CXZQ_/I@L.UBLONNJ_I@%;HS#
MP3AN(OS/6FJ-<YB'A(DJ?II5@6CK[UM4BL(S'%DG=.1>(PIK$W',$@+V9)'2
MPO'L>7=$YS2-.F7P%T?-LJO[4,(X9UX;$%T-#"E8+Z3CEG)FK<'%4;-"D;W%
M>UI7KXX,,33Y)! UGB.N10"1U1X1'C16SCLNU=8.UW7RK6X^MUG0M;2*G@0W
M_$OC-;'4)Y#;8H9'^.5+;]"NJK'W8\=FBO5+)MB(;4_I"^#L( [KM?]$_G.[
M5<&<)'[4>X#!@@Z]\]S)H"+R"]C%M>.NL]=07>;0;(Q6%%YJ0KP#U4AY--1Y
MDG ":]*0Z,W"&4/%5? $T<@<V]A]=Z2=C53JB+0@),<V(G),&61PHDYY9XF7
MP')?P(0NUU6PD"BMV)U8@+0 Z7)\KHSF?6-$>REX"L9HH93V+$3AB(V+QH$+
MD#Y1D!B -.;VL=%%9'U@B <;D,E &F0DF@9N10X2LQ>,L T TBE]UI;/T\4V
MG:%YV'TLF6[K[['DHWG^N[?UUV@L40;FET2/T;I]FK>SO43YDV6CD)ZIH=H-
M(^#)[_[+K5'1V[(:A==??><\P"W^WSS^%X-9PB$QI@6WA#I!)4Z)4>\,6. E
M-#TK0/[#P__]WCFDG7_=R9>3O?WPN?GQ]_;A23@^^/@!'WY\C_?V_SIN[;]B
MA]TW<.;A2?/D VF2F_?_3)H JD=YY$UT#BE O%Q)#2BC9!+9P)1.@20?T]32
MA^,V8KGW7J]*]>Q'']O_9A09E@R=9VF$9(B*3 I@L)Q:[)3Q$91G3"X:'OD#
M=>?@C[9U[4[[[+(LC_F7Q^O+(ZZQ3R00)(DQB#/ID;4.H^1QXH9[Y:W?VM&3
M^0>3R^.+O1RMC;,YFS6^@*4U^#*,2W4NM^_X0^ZTQYSVR8^ZA(X!=01[/'MD
M)A71=8/&_]FZ==9(9^-OIU@'&OK\[/Y3)EK'/3V[K10+HW<&\\;/X_XWO9CW
M8/6C_8QL@H=]:3L7]G*P]?/MQIGM4W1S .^^^_TS\)TVI\"S'*&6:ZX=-TX8
M[9T@RC"C3:"6#F$$SHGA599M8GEDG%&N*.-"4H>#P$#DP"Y.1L/WQX1^U$'V
MSD;.G!HA84T'BCE@D(TZ:$9,Q#S1R-71;J6@"";HFZ;Z+@!=X\]^7OO[<*=?
M.SW_^7G#S"50>]'<?0?/<7#5@GL>&4<\L3@A$6WNAA4U<D9%)+4*6EF8#2^V
M&A%0^DN6GOYY7)$O>8;^MK[7_=([S3W[,O95GQS;TT^QT3Z=TKRV,UH@N<YV
M..]7%X13SH[[,3:Z\"C'@T9N^![NQ<S2SK:TLYV]G>V]T6&SGGU.]RM!:0X%
MY746E$K!?.L%.\?VJUHD[*RZY>\\#;7JO31F[  \TPO/LG]UDP:NM JNO;?^
M?BYQ^:+A(FCJT\PF1ASD"]RD%TH7X<=Z_XV)8EBL(D]1QI2+&2FGM:,A[VWS
M"@O''KHK_7EZ8D:1C*O?/S?W6\<'^YTV_&ZWWKYF!]W77P]/7HG6_E\GK6Z3
M-:_>\U;WW=U(QE6S^_YKD[XYWOOX#GZ_@_N$]L'^FVYS]S-IO6U2>/^KUNXG
M>M#15S?*6Q(X+EH71TQ8X*5>(.VI1AQ[C(Q@#EF3C'#*)REL%1&FR]KP5AH-
M%^BKTXO/4P:4"Q\,ECA1SCT6AE@KM34F4LUX&)8!)07Z:@E]-^N$?KYH?3HR
M3%#C=4#6<XRX]PI912+RCGFJJ#3* E\4+[!>5M+WNO0B7HOR(7_V8[=]WAV&
MDD*L?.NE[M?]-0@?XKJ> \2N,6PT+Z].P^YP4@IN/1RW\!3*YCG309J$DDL,
M*%MPR"7,470Q48QELC&7%.&;7!7LV8NSE"R F"906XPKS9U@P5!.#6$P_VXH
MSG0LSK2(<UW$>8*&B!1DU"#..E"..*$".8TI"L%A+*3',GH09U(G<7ZN_KZU
M($9_G_?[.2+8'U*CB_;9<>C;"Y#[LEEWY>SH>G( 4#]>S\QMNR^UO\: KF*_
M5[#VX5A+IU$G:7(1+@LF7RZG2D)$SF.,(L7*>&R4)FX+<%530G^IT;;!LM-W
M%GG_J8[\Z3Z!+X*]@&!/D"@;G$U"$Z0L]8A'3Y #-$?.$*H#MH(&NK4SV:/I
M/S7<!+Q17II?XVE,[;.<W-G-*4_/S$$S#R0]&0<9S<F?PRDI4/1P*&)3. 9U
M21I%,=)<2,2EE< Q"$.4!J\8TU)C O:<G"Q+,#L8%<],C>7XR:A%D>,ERO$4
MOPP)07""F,J-'[W.'AJM45#6:\ND=3$75V23?IF5R/%S\G"\._TW#L[RHF]$
MV\]93,6UL7I:\>[4]Z,=Q-TX_/VFW^L.9RJ&/V._\G"<^EAPZN$XQ:?P#9(
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M#D\ZJ;G_FN;=^I8GD81&TCDY[.9A:(I(@!E'N!2!67:W<8OV/$G&@XC2<&Q
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M(#>"$'@TEI?QU514=KMT0)Z:<1LH*MV ?BGWHB19T$U%"T8$E>""$IR*M'Q
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M?60(GR0IC25N"V;YQ@+5^.R<^]TA'>(E1&!R*/U!\%YCY($*'?"S9*CT=NF
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M*I5C/25PYF4())OH,^HV(Z@N_JJBMTR?NW?FX!U;K92(N(490A"@#7@IHN7
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MT[X_-)53E>ECE&EOFC@E6>I4DR<B14] )D$<Y9H$RYC2U/-<QNV!?G*ATZP
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MW-/!:V^4RB[%0"%&XT3"9R$'"Q TYS/W=*B"^',(XK"]NINE13& 0'A6"1E
M<L3Y"$1IFQUJ,4@RE_-!TZ<M?^D6B"_6(M2#=8_%X:1[S#4J3Z7+IB5/P-!$
M?':2T.!9\LPC=) 0ZJ?48M;,^_)&P9;!JE8P/Q;,DXZPBXX;&2VQS'$"U$3B
M-&B2P2>79.(VPJLW0BU_,<U/X TO=<GLCVPZ<%\M_DM4L<O/G*I6?916?3]-
MD9P/1BJ!Q(@J1<!*?.0XZE>/WH7PR0IJGDB19H+("\HH_%287U9:59'^6*1/
M\B?CI W"*J)3:0T?G",^149 Y:"SD3D;,1?^M$"\_P3,Z@6>]9A?*X&?M)O+
M+#,KO18I2R8S.C<^.JNXC&"D<#P@K\IW=Q*HZ=N%:]VM:7Y%J?6Q#*X)5F<"
MQ@1B+*# BRB175$P0KUZP^#)K?)J<Z<7HPYF\:]B ).82<IX#@:DTY[I[%.2
MED8J4^T3\$(4PR0=LX9S([(B.0$Z7H9%8JF()&OF8F"."Z5?O>&F]G5:LD8!
M<SS%?#]%7O0YZ[E<X=(*PD_"RF]O$?#V^ 2?'C7"J -RN&B<G>"G#<9M 5SL
M?SX].TQ'9X_L!S#'3A0_^#-^ FE\@='W>?<#>+E5O;,TB>)"A!B-U,% J>27
M5"B7K5)1V<!2+>-_@5QP]9J3V+IH=]Z+79\U<L'$"/.,$Q#<$<^M)S0GEI5E
MACI7R_A_ < KFX+0UD29 #Q$FU*@Z I$R)917GL%O%# 7TP WB3/),\E#%1*
M^B)GQ*M,\4>R(;L BLN7 _B?@%%]I^9#CRKTEYI</;Z._Q?KQ31+Y"UXEP)H
M:T%S9%[@$U<!(!OCF4_ :DWH\JO>M6FN%;5-1H(F@)2+0&*H>CGNH;5<,6%4
M-% "\K4D].6@>I8.:P(L52PDH1TH(3W3@5D:*.6.:<-J2>@R8WF21DDEDP.+
M(NQB&3FG%4%MC3^L$3GQ1"F@WR1J0>B\"=3R7?!+>>6O$.M;3*7M+Y ,7@PE
MK?;JR>>1+NT5,\XZJ0,QP:&]8E80;Q*0Q%R.T0AIA7T:]ZS3(EX,\)>5M5:X
M/_G$TB7<.:/!9YF(X%P2\)")==:0P)6)RFL7<YX#/:WC('[FY'XMN7UV6B4"
M<]$Y*43BX(3QJ$E=8%F5AKZ.B85-[ZH*^)&'FRX5L/+1A2!&:19;>C,BWU*:
M$@;!LZ"55)#G$NM;&KY5JV[G<L))"0@Y::"20IGIAKZ6<@(96)8H0.'NHMNJ
M!Y9!#TP2,>8T*Y.PB<J >B F17P*F2 %,V5$@_<JS"].6(G82RNW?1$5M[7H
M=JEX^>U%M^@\-X([W6_DP?%Y8S_%O<<.W*H%MC7H7@MLGYGH10.:E=,V27L(
M(CG!E,]2X.\IC5;5@5M+3/3"+86TS$N02/28C4CT,D..9Y@BW+ H;2BC=M6K
M-US,ZXS["PVE_]R@%MK9),+_9^]-FZ+(MH;1OY)A//>]W1&5= X[AZWO-8(6
M[6-' W:+IT._&'M*2*VJY*FL O'7W[7VD$,-"(I00)Z.@U"5P]YKKWG,\S1E
MA,F<JSQ)LT@E:2**/"6WG40[$/7UB'K9>N,I)PDM$A\+('Q"!/59(0M?%7FA
MA.!29 $0=;1:*;EM1/T -*/'T@8;\Q0V=[_>KN;7OURK^[6(@SPI2)"H-"0\
M990*1HI Y'$81Z#^#-VO[P&;/.XT'39L<J7I\-'+K_M[(GG_[_O@ SYK[T/Y
M'O8+L$L^[+TCAT?'L!:$Y>_%P9'X*%-:4.S\%7/,BQ4\]1DP7)\SE0:93&+!
MXR?/5]M4?$>S:R:+F*5<I;$D*0FXH*'(6<!Y4"A"@J'9]:/!NT\O/X9$Y8 %
MU%<BDR#=,^'3*$[\F(81B;(\EF&Z=J3;T-OZ'O+[(;GD>\ENV=0MDH3*5 I?
MTISY1-+ 9X2&/J,LSQ-*J<K#)\^'UM;WB*KOF0QM:7DH$[T9&E^V? O -Z5B
M(.J0ICZP\-CG64+\F&2!#/,D2M7-U84/50X_/2ZPE=;O[@0G2-<=*U=)KYA5
M$QPNO9@LQFP.'U2;<_H'8WB=<K3,+E\!1'=;@&[BMR]TMY[Y&QW &:R4[V.E
MG[]II1P>O8?W_8[C>#[O3PX 9A\^O3\Z_GIP]&'\X0A@--E/#J+7\?LC61Q\
MW?U("I9$*J<^E0'%22+<IQF/_2@MDB#)P'ZAX;H,DE^O/WGZ!D3[@)(/'B7_
M_AB#%D!B5H"Y3(0/OX.:P!+J!YRD4JFPR(A8:P ,8Z>_;^QT_#C'3M^R.+UY
MEC7X'+Z78RW['&)*DTQPX<=AGODD+@J?!XSY(I-A&+(8Q)1\\OQ'.I8.<?4M
MINX;=SH,U'V7U+WL;8AI6*A"4C]448XZ;NKG:<C\A!#.4@;J1AJOU7&WA[H?
M@(MAJY->KQ<_'^K1[E/$9F"DW\-(/ZUIYQDQ*0@E@1\("989%9'/913[,4MR
M2E(X1 Z663J4G0V$?UNNGX'P?P;A+VM0*0^5H%GNYY)2(/PP]3F81'Y2T"@K
M6!!F-/TQ#6HH,7M\E1TW5^L_=%()5*8D(5$"*P*5BG%)8U'(/(NSE!":#>.U
MMICCKNGF*0(N92B9G\)I^008K9_'*O%CH8(T4DF>Q.B1BN]YDY6AL=+/80=Y
MH&21L(2RF!-.!)>@>@62!"H514S)4.B_W>Q@60%3@N62<(EMU4*?D)SX+%21
M'] DH"+GL2+(#L*?/N/TD>IA/U;J?X/ERC^OU'\+%[FUZ/! U/+UI?YOT([&
M45I3EQUU6M7SF9J7,X6#M3RNIJHHOW? U@VVE+CE9SP =+R'3OB;KO^_OVG4
MU_&XA2P22H8T#8N$B"1G29[24/$@8W%&XWQS X"A]=OV:()K6K_Q, 6E7F5^
MGN74)RF5/C9W\*ED@<B"A 0Y 4TPN %GW#UUM#]PRHZ(3"/%$Q*3B&14@OI?
MI&G&>$0IB3*YN0O 0-E;1=G+-IZ(XYBFBOA)%N<^"3GS:<&57U 1!"ICA4@Q
M%7=-I>KV$/:]4Y&V;\'WY<H!L-NBU&^UC7G=21I#3Z^-0709I91PQM,H)%G
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M[@S=+)V5)S6;TT_T*@Z2V@PB;4:1E* IEFQLKYBKV42OVHPGG>,LU6IJ)O+
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M\GJ-!:QENETLY9O>!$-3KL%*+VFE:7_ 6A]!FQX+" 4DA<-U^Z.#VLFXMD]
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MRNQX;1\@M\;.RD:V-6_??#>H-*TP8Q<SZ^'YIS9=T%&(TH#6$Z<ZXL;US]4
MJ-D$.S<R3&]O'6=6(VDRB9O(PU)7$/V")J#4NML:ZH%%-29$H90/-_E6?5MU
M CH:??7JK3UN-6M=&*^6P8A.F[+2W8\0H 8B;73=P4.Y/;;0:)@APF2FFL?B
MF..9?H16#H!K5<8-B/# KL>X,LOF9CO>[Q?F"\<ZNNL>K<.':G8,O.&K57_/
MVX1?;<':]LJ%-H0;CEM-QQ?-<K_,C4[$G&+4V:9LU%I[*CAW5TF;.=!%A:EW
M."N/-4FZ1?:GO>HUF>;Z[O;N>SJKPT9)^L9O[A:_LSX/V\W>8?HZ<NL19JN@
MK6/0P%HK/>/4).5J>>7($S["DVS:3\"3T#8!,EY1CC;(6:M]*,,95M=F;0MI
MM&/$0Q]^Q 89:]<F0Q\B^N3/-ZD-:^#7FD6($DY%62*!+G.Q &Q76B]-S<.A
M,+@N2Z\6P?4\X$[[5/?I/_!I*RL;3L.\*6QC+>-TG!*KU.9=7<DJA!WU%[E?
MHRXCV]$E$%;5G)OZU>;:ECGUV9R+H70I>TFO1A>O+;1@/0+=\?X]*<<VZQ_W
MCRW030:$@0M.&3/ ,FZ2%43M;MFMQ!P*SM'1.\2NF(ZKHO\:Q2W>U86>6R6S
M3=MP,<M9^4/ M!<PC;8J8'K-N.@WXYQ+<=$BBUD1)WD<*D5$D+""RB"B49"1
M)*8JNLNXZ&%;EQ$'NJ[0<CZ<-M)P[!:O>W:8T=!Z;&;D^(S)-=$6"E+O*MD[
M6=<07.Z4J9'^'M#[I$>A2(ZH<9L_C9=6C?7@;2?D5K2>+K] IFE5U$OX0-=C
MLT$2]B5*"P/';70?3%='[;HV(A FIA,D5O5-U1I1U.]4Z&)?YF'X:-/V3-_6
MBI9N?14NVH973N"0L56-MGYT%*>;U=7*4_@#K?RR-@VP)Y548^W)%L:B8CI<
M[OW1K1C;-0JDZ[5NK3TSC,L9^B"F[:!5(T/MD5P">1?V!N-9NZ':+8[+S\KH
M4%JOP:U968&Q/QO&=@@UZFW?6NZ85S6M<;$U* NNUFW);:F?J]>E'[R8ML:N
M%6NJ=CZTLB\Q=[S[T?%G*1PK%K.F2-45UMEB5:L5VN#JI<I-4P;JE"4]-]<4
MHFKPV/+5MA&]R;F8SRKF>O\;;0]O7#4,<L^$)+47 2]OC?F-CKYEMX>>(]QW
M2YE5N?*\HFV ZE:C@QKMFVP%'P[A9+JRK\:9*EB\=PV5D)?H_-3%D<9[AV_M
M:*9%J=/TZJ;1_5KG#CJ]CY4-5R/_P!78,DC-0@SP6V7Z3*%_ D>\F&]@&<L.
M7&0PE7%_ (ICQ-;=CC7 $YLFK>%8;JAE+.T1FL/KZ[EV;(Q!N"5KND67_CT[
MWBZ&K^TR=(A/;3J=UHNF*;0;[;+RHH%XOZ$$ G_DO5EPD!S>RR\6M,Y)U%3F
M6B;%M<$P:MP_W1!WU\?82I-UD,)(&?:?,OTP4*JXB:&CGD!HHJIZS.&H;971
M5)<:-H:?,@D<ND8^R0Q*KWOQ2CWIJ%-)V@125RM1[X43ZVA5)+>9%\8!X#@
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M=%(=>1TWT[&;PM:F>7T3B+:]T'^Z#WS^@+IXFX8A>MZ6!L,_;?[9_>[88Z9
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MZ&_5GZC8F) C,]6UG=JIMR_9!"Y ..D*% 313-<PC['NRBP+K#7 .[W69F.
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MAN@K2-! PLHRM$D $)[VPWFXJ6?W"CNZT1TMPUV(YT9 L)F8'B8<-01=3&R
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MTBPA/&<I#K:B3WZ&;G+%0ST"FBZ %U?GFB:!BVG.!+0V+LV6@4^VU#=1K%X
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M U+RA;(+I20[44D&(HP2#+8$AF6;81"ZGF]9H6.%H9^0)):2[.@EV?URB['
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M[,"/M<#S?2T*;-_S'=,F%M:IZ]GLDZ=S!LNS+Y'S+YNE'X:#5V+ZOA&"N'5
MY;J&AQP,+K)AZ]AG.;)]'QQC+Y%Y_V? RGNM@2V-Z4.YQCT' [S0 _<XUGS/
MI!CJ"K00J$,++<<D9NP&OA]BOW2W9Y-NL$<#XK2:9N0>)TL?%@'RSN.\4Q+
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M?V;<RC088UD%N'5M@9L# [X'FH<K%M3"D@UXF=;PLNA1Z/*Y@M]9E$S"7LX
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M#AF]XU0D5<*N>[/OK^^OOU__'OBF0TPKTF+;<4 1T$@CU'0U/0Q\T/^FX;E
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M_2&"C2I@O!*>8>5_V6/=5TQH/2YB?)I$$7 ^\^7NQFDT9M78TZI6IB6([1(
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M?HJ2&%:=9##B#!9>*2B08SS4R.8!!,RH$_?!UX.@1VK<PY2 I4L4.SBCSF-
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M; .<=4/GTGY3J+TPO_6I+76%"Q'>:WIO5\?(FNZQLZ:P@XIUIT@Z-A"LC]S
MD(PZX#O0=I'= K'/0J :,$99W!W^-*-%&4DG0)C,^:T7_68>8?U2"ZOP;P P
MH$!!\>LFL["7L[6L?[W0>ONJORM[@\+%'L368AH/YFF ZKR07=I[N[1[Z[NT
MXW1YI_3(MOS(<P*?1+9N6:$=N(&NAR2VC#!*R.^>=7'UK*W=>\"2),\&EH>:
MQ_Z5#&8N"LB,Y#\O_L_C^#$L['H;TS]1%+QKE4FWG[SRMS8,]:6-I?[U-;GJ
MHX]->>] I+W2L)61]F_,8T.!A4N?4J: E-_H35K!I&#%GV=AED8L7BC<\[^E
MY62M;-A5IJQ][M"\_I6;-5] /M-QD<4896V,L)\*4K)$B/<L_%N4S.UX][]?
M6EM!B&T@P5. T#J2P;@^6_IO]#:%01GUH$\]6<,@>P+%RU#$/VB36H.+I6+O
M((JXXD>.6&-YAB1CD>5JC/[G6DI17G7LB!\Q%M>$W/I<CL81V':+1T0>IT#5
M\!@HZF:+I]ED8,:5QHPKL1?Z@/O#AIL;6UM-JNJP5K,5@!X+."\'GTM$JC&X
M*\5=]>1W+WMJ>8%6YBN@4C3O .#,^TMH68K(+]\I00B8^ILULTT%6_7M][,G
MC3<_CI2?FG208E8*,L70'64>%-L$O\-/8L^["7^!(1VG"68J,0+A>Y7C8I;%
MF)@T(7'KX^TPN0:<$QPCI,(1Q<T6Q#-S1/]G]&4D4A28F1U%=(K#=B+!X#?#
MP-.,]KA2 Y844\1!,:MP5=PYQ6P?MK RGF]<L< D^!DQ:)4VBB[T;>-6=/3N
MIUM@&'R;T$.O_B=G?B\3M-6/RJO/[]Y^^NE'M4'9 X*HZ[AP>?.>1G02TK+/
ME>IPU.."1NV5,NI#7,]$TRHCWE/"/N2<_=9R&!*XR*F!'\%;HFG^XQL1PQ,L
MP8P<8<+1L)R1\E[Q&[$*C +^/XR %$XP/?[?,]!*28I?$7_HO^4L2H+>65$M
M@;>/_GOV$(>JY?MI^6VEQ+2*RC3DL9>/ &S%6!?UV4%"J C-_R8YP\6"BFLI
M,RZ80'C[Y7_@JN%K!A#DLT0GYC!A(U[B#G<:;6(MHA>/<_PPP115P1 "2!W>
M19K&RM/:^YE0^N^:A-AG7M"#TV<X($(1L'A@71;5E.LKS#)D\0DT]_CYS2:[
MC*5P-(*D$1W-!J'Y@/ 9*8V,9&I)1.Z053F/SK,:19+49K:5B*&T28I(.&*&
M'>)9'XX[>IO\)X8JI#)AD@LC_<A-;YYIU&M?=+*,,!Z=BER2-4DP+$]+A*#_
MP>TBHDRYJNW8&PFXMC!BZ_RV:IJIUC8%O$V8;VR;N>?,GL Y 3DN"<MU)@"S
M@Q(:HQV$NYNSDN?S9^1N[GJ2Z13FBFGB2CG+1#HZS'26S1,:F=_Z\[OV&39I
MMEYDHAF+,<XMQ,TM$C[,V^8YGO6[WO(3AP*JQGICUAW:GK"$>[Z_3[)[=KX$
MMRTB&L]*L: )^<8%#<(WY;EX8%E4N, 6T1GW6>;O9FB9(Q'L6Y@=9N^R;,O%
M8"[;:8>55Q&8+&CSYBP*S+3\'$I;@4;$F\,_A-B$:WS7/!4IOMRV$/*(Y*TU
M >@C93Q/<^B!94V^T9RE9\"8!<O(Z"9NW=$F(4V\!%8;C3OO. F1UR\;7E>O
ME9]+#,/S?)Y_ OYOE%]__7RZ2_ZIJ&I,>[XF546B\:RB=8^(?YFY79-[X3MP
M4T[N'K2[!_Y>=@]<N7LPY-T#[^+J;P58#X:N_5WYRA0U1OSP;/7#>P0O8S!^
M  VCF"/.LMV_UZVEU!I/[],JFG$%AJKV+:IO-#=QE[-56N^:-&YV3R=&_&D>
M@WPE@EW7[YG(?MM$L+9TE3=DF.#BQ:&,(9O&9FJ2Y 8>R#),F'=_H!H,G0*\
M7=R/;A.OT;I*XY0P:VTAV*DVH<WY8*I >#?P*8SC]I+X^8XN_P*6:_,+6'_B
MQUD;!64'?@BFT#"+"D"'T3+FU8[Y2IBZ8'0H0O=H4H[)%&\7MT3,JR@P:W**
MQB@5%U)8,MP)1CXS/2<%W/:6;;H#D/'8$S_J$X$DKIAIUF3=".<V3F]8TOQ=
M46:QVMT'2"N6'<N"G;288LX,1K#$:=1[[JE@?&R,QXA69]JDUJ9X-)9B[GKG
M1 P[TL4FRPS=0 6J01^?I-C'.FH"=O,[#!6T@G)'LF]:B@=_8V:D1T @:52I
M'?!.FUSJL,GGY!Z6H QVFM8P= 5H,T.9P)*<)RQ,P'-LT&"%=>%8Z"N!! 'G
MK1UUCBIFVRLQY2=J8_"/P*PMYW<R.+29HNQ\ [H [8J*G,XG 0MF5C5()!9=
M7 06R:J"C<"<D4ZBKN7-A^ XJL<E.PB+1YW%B4Y5N85)YS5&L_A>"T\OU_A1
MD3D9KI[_$+Y<)A;(DXA4D7 KLI,$K*X9()#ZXEOP:0#BF$U%,4.F@56#(NZL
M9 B ]JG/I*R5]RQ:&I4ICY'$Y>R&XZ<1SY_??Y[O+70AU'(8P _HXQO09Y/J
MA!)N@30%A%*V%0 *E7 PM;@2'A\,B5Q3\W,F=X#Y61EQQX^G1H?WG>6#WPGN
M#FCKSC%B_KZ8XBEM ?N&X5M0,HHCRDT!$T#WE07K&)!@B"H169\9GC7B410P
M-\?MH?-J :%++-:>ETG9R6^>,SK'-IO<I(#I-?(!%QY%(L&<!9IK3L9JLPC,
M,4<7MAFCF-7\X"$_;7/'#O[<LFV3A=>P+-6A;Y08#EH?JVF)_)#"72<GCT.M
M"0*+X..:PP#=, L[JG23BXU:E/7"96"HGZ>>5SSEBT4.E7%QQZZ] UG?VBPP
MB??BO!KX7-_@A:^ZFNO3^^N&3YI=-Y@FKVO3&$)<+/) 0$/Z[%@%Z9R/ P53
M-=/&F2VN1QP&(PP\:U(-FT1]#%R(0^:X.D[!_'QB,@-R89F8+*JR), [$;*Y
M'/AIOKY6(JM<3K:DVB7 ]@C;FES-%85RFY;UC)^&%]LU^-B8;1@1/*D"4R;5
MO/H#S=&P9I-L)\35KUCT(N289&E!M^GYGSDLV8$'SME":W(.S&\T/ ?$%]U"
M<FFSO1'H<Z76BJ/.TCIC)V6!ZZI1=\W'0FF3MG,#7L'G$ ,"*//Q <$)7.70
M:3"!QTDZYT_7D$^+H;DNYL0+TV*5>SJK;-3-2/E<,E7,STTW$YR'L;JL@(8(
M.U<.NA"/\[$C?^SZ/+K6.<.' XHM/?;\40BUOX'Q6]PUX;P&'AVV[FRHD1 $
MN-K+),E\QY)YD:VT8J8@7L?75)=K\I.7,*P^3O:(Z:5\TX8%N&9M)@VJKK@;
M&"H>][O6GD#ZP@$[K/6LW0=Y\!25D!>4E?-!BT^LFW=!:TGK >>(V]'-L*WE
MPVV=!U\]%HDLRYH/DZFY+=<Z5-S^5T4R"&H_LG N(2T7I@.S2'C@' 2>ROTQ
M9MGS5\'DV]/DR%"S>G6,#>;/!!KJX[ L2#S7D >R[85.5%L)BV9@7HMMC9".
MR2U(6=):>FBI(S"$*NVH[8A,VSH":I^G@ .V/W\!K2!4J1@2S/ZJ<T^Z9,/.
M7S0_1?X8<'M.K NMJM#)-"ON00YA-;DI PF091K/&*Y9(.$&=UQF,4\6P$H=
M&CL1RRQ\("WPLO%\":.H1> L$9$PXANSIOUE'CJX07.:R6@ *1Y=K+J_:6SC
MJ< -/_&"#,BMF3D_<0,N2EUB994E]X!E?#$6Z*&-5\S7!QL 3_+,F(6/9PWP
MX/"$_%&4G0W-,JV^\=B#0#P+*_ )SXU_ECTHEOD!WT?C)F;"G,-X H87.Y.,
M&U6MD= 4YUJ967-62!$0>(YYOOWR;M1,<L&2HZQR"TZTR1)9/9#-XOK"TI\3
M4+.SN\*5]$\61Z%S8A#I5C\W%UJ#%ZM>L&0KMAM7M0ZML UK=DJW4@24.6',
MRT(P?+?36>,Z-I-?G@.^FUD!I*T7U<RB%R;6MLE&!U?*S#Y:HY1;6_0X]?&R
M*=T(G&K%Y0)WJNM&/>I!L:C:5AX3ED_AVNP1CVEA*JU(9IP.,P=S=3FJU!$<
MR)JH?K%HTGU'+:B-'].Z"J)67Y_JX)-]W-N8JYJU3EX+;PXCED/1O"1.*XRX
M],^@@6V%N1O=6]AYRF8&\.4UB#->EF:= $6!MQ@M:O(Y+%O_2838RC3B.:W%
M34DFK/ A<C]6 &/Y'J_:B#B_\+.XT!^+FUM\7 ^!S"M!?E2L\DQY0_+F-"7+
MZ\WI35$S]=3.HTFS%,]UHP)TQK(S&N,E9,\Q(VWQ!@3:#*-G( )+=M8>[94L
M:0(MO+I6.F7E'<4I58ZKIN+2(D#592S,ZPET'=J')K%@DZQU<X%46I=J?C:W
M,4F8,=*H#+Y7P$RJ6<XY=VX9-(_0UHI9-$30I%+G]A1?72P,$WX+5QR,W7CR
MVXHVX(!+;_%@X7J-I@H2%9JZ&Y!M0CS\54*1"7-964@B%K[@(OWMFLIZ?AO]
MP?J-_N?9L^_#P,!<[T?##T>F]C>-(J+N$6?*N]LMK69?5)8I;5+]YMLFX.7.
M>-98)[E^;EWD49HQ%;RB+#O>97M-['VU/A&J(*8@R4T.%CD('*QKVU3?N251
M)%JHK^A^IKB9[4M )\2\J&19-R?LQ_/B&W<-2!:<87'B0\'B,6/<UZF$E]X
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M/!M%^4++VS2B+;U+$^I(3:B25K.L/M6(S=IV+I)*GTBERY %0IH0>#)6&B4
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MVD>1+Q"FC$%<<[D_1W>#,;7QS=ZA*_L3S6F2=GYM/3;$RV-AC$4?%ZZ7 'R
MVFO>7:5Q^I2O#[@,"MJ#3%54%%08:ILY#CK6E,IFU$>6[SZ]OU;H+<EF\'#5
MI9RJP7Z/(P-T"U]N9AGXM'PO K45C5(6C!D7=T@RX$T7$4ZI;&Q!W+^"Z]V7
M")>816JJJ@-KW))@\P?J%T!8G6KGGL>\JSEWDOB/657W^-\CY>VZ2\AE,2 ;
MC6]2K5Y^]<O;MY^5">A_8+0?P6!O E.+BOWQ_3L$1\';ZZ"^!YL=GLKO51B(
MU$I.4W:-AT$:O@0! D@OT1>8E=5:2+21E[S $9(,[*C>&V? W&5VC]-OGUG
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M1\X&TUN7,VB->C9AYSF#G:0ZD86TLCESDK7?S&#'-JFR/-^A4&1O6[A(8NC
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MTU!MW7\.?UN2Q@F0QGF'8LZ A+=:XK#)]943R+(_P\6.O<VVE PH#=R6/96
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M:!;L[M0^WU$Q)4TR(%;0,PU%@+T,A#*#QP#=-R42$1!67=R1$L@V1U++8(7
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MW178@B^)*0'[$<!U?MWX,KVD6!1.ZB&.ICP9^"V^90N%M/!<<3G:'VZZ8%!
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M!* CD+P?ONOZ#T26<_2M<5(,4Q\9G_@Q>4;8) :.(\+P[7;2L#MH /RHY5O
MXL44#C\B)]>%\UH*-7+LHF+M2 XJN3#(F0M'O^)/Z!4/%JL!12P9WM"OT,T1
MO@0<4[%N FP@)CS":[2ID'=C;^ %VPDM]&GEKD[Q_E8 TU3B"\XD1N]9'(@@
M1$^M[XJ0NWAGA5.OW[MI@8*;FW&8'L  *T$'G+]!"AOLHR<%E!6[/&B1%!"1
M0Y8)>M'P\C8Q=[Z\^P1_M6&H8"EGL7A,WMW,1G!]/I5>@M=#Y7%,UA;"DH5R
M <NC!F4;9KZ#]Y%(U-WU(P>G#LN6AZ6.0<1TIY _.]H@(H@4XZ!M?!?1PH6W
MF;WT..H4ZD3OX  B'S:&K33N8%;:H.O,G2B_PP2?^,1Q\88.M@62'3> =XOA
M IB 'Y!R8\F+4YY8A,F5J?:JJPM_V\$!X#A 4="7_;!C]30$2'"[E40!>/D3
M1\M%N5Q!^XA@&#MW[E(KVV$F_3NR. \;C<A/X,PFL&QTZ^/T=A#?*74%C@P@
M2*I#[@RRZMHGTC< ^%\ W239O%]]&S0C3EBFMRB'7W#'3FY1:5I]DP*O*G4E
M$_B/].?0O6H]C:72J@Z-L;0O\5!>.&,ELL6+,5) 7C^D=PKKG^D(@<)H&#W9
M1'ABBD$)L"=^I^X+%>+*ZT'A$.=THC5&D>'UBA!6IYFO!W1DHS ^T9SDGHI#
MNEP!\IZ+"+-F@(9BP)4@C/#[>S#)4,\)$W)';LK=]5WCVY+["%O=U(39JU'%
MB_ ZD?P=ER 8@TMUYP?G&;N1OD-2*U&TJX^(EBMM+Y"-$;)5DAU9/0IV,XWQ
M^C&S!QVPHD7@=,5D4Q8;RD;MLUOQ\9 82Z2E7FM#@8=4T%;-ZA314(?1-Y"9
MR\D)F.K9:XVN,?SYL%<60(XY3;"5F1WT#U=[:K4 2Q$0CEVXXIYBERSD%:AL
MN9*&IBZ8$# (<I;-SI7MW L\\1?@:20>@WMN@4;"Y=5M@\K[0N4//[(Q<BG$
M"\^]M0'+4U3J&:.?-R.]5H>>[[.KIY)4DO#98/6^L+HLHQ9P#ZPL-!<CJ;/
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M@3S@D)T$\7>6M'E/41%5(%<@-31:$X?RC4?E;"ZQ1NCT)%J.L@<3VY%'0$3
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MZ5LM(4_J9@\-R/1$D5BP.;>[9,2;!9)?DL:,A"U)+D-GS/.!&KT[)&@?X.?
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MRMH]Z0EU6L.G=NBMJ<U20R!==%J#_@[5GAL '1E _59WV%!1Q8'4:7>,\4F
M5$-AOT'+&1K#?@WD?I*3<*'S*U[O%@+XQ IE*N"N"Z=E^S&&[^G]OE@G\/X/
MJ-JT9Z*X?E:9NSV<T8FMQH9:&FK9VH75'NW>RZ2AE(927ABE@+&^<Q&T<Z.6
M7;R1!Z:<"B)(O[/S_645$*0B!E))@;2J9X*F):">EDN=SQ3J8D;U"T_M+X7
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M[4?9 SB<.8L6^T2_P4R4O?4^]TR_/Y&+H%X^?C*5GV2!)4M..EWMM-JB ;_
M4<RYM62RL]8-_!C/X8C^(5P7!WS^#  @V:"8>BXE6!=B_VZ 2(N2O["''N7;
M>R'",BF'&O$?U(NKE93]N-1E/R2,*=DZ@Z4R*S,[/_:YU%5:: 9 64 TC=J9
MILA$GQ.JB2I++*WCJLP%7/C -> 3K)CJ+Z@F 69N"M7>..U !9/\X</^&#(
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M ,F, 8%=FGTTSN0_^S;^DU#2M\CMD=2S76_[)ZFMJ/<?#8#;SS@>I3<$.T?
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MT+<<PB=R7-GPQ(J(\7L1R@O,C,[LI6'VAU $5.ZYC"WP*!AA!=U*#+@&'(<
M![=F&/JOJ(7H6F:LV3DA2UG@(;]'8[L!Q%X9;3:E&8"0J!PJVV.%:2UXH)K*
MJ=ZLVG*\PV !CQ2D%>WH+N#SE?1ED6;MWTI@WTK8XBTHOI\X(DJTL1L>\'O4
MOF53<')66;(TP1W72<N-3-XCJFBN*',4P8J)'-62EG(ZTV BPBD,-E,H@1#?
M 3GDIYG<=AP/T_ HOU.*YC(.C4MI(+XOB*M#5^XE']1C%OIQ8 GM5 K]:?1
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MU>Y"JX=111I*KS>ECQI*KQJE/RNAJ&^:;\(0B7K<&_T3>86^$?PF@CG[S0>
MK!$UD7-A\M"NU!Q8+E^&DJR__'8C%8P\+7.DY2VC1_#"^9GA([BW3A,X<C@.
M,FXXR%EQD-64Q/&XO9*Q\7<_PLRG5+-X--_0 OAR!P'I6]]5$A6.M"'A,/EF
M3OUP0QV35O;)1#?9M9,FN\B@'.H3+%G4=CQG/&[R#RO#=4K"U0[F*SW%;GX3
M420"0,:W+-;]E9F#E2^<.>"4[L/L%)2T:M#H6<*K?XA4PZ2N8R._]F'K]I7P
M450R#?PY^Q!X8/?^B<\75^S__!B$SF^_?6'<^N[Y#\""[U Z\0<.?%J$B>#
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M[X?GJDA0**^4B:J+JY9O;$Z3E$6/@(4(-H=5S$(F,RKR#>"9O+11?7$^DM;
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M"'1TCES 9,CFA.<!.+A=@_^#AY8/ VR,OZL^KW.?CT-_&9_[D>$[RDTE'1@
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MS.>';0Q_.81VQ^,9;-!__>G_ 5!+ P04    " #4-*-6>!1+U+<V  !#5 (
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M%EIZ1XV.A6 A421;2_<&8FV2S!:U4?27TZTW_X?I'4^)LF_YUQWTT[92>X]
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MC:R/&@*S%H(668ED4C ]5*:WIF](V49CO/2FIF9 >M]AF"^[+S< 7:Q-R;@
MQ2:S/G;A+1*@;>"*LU"R;MV%=)>*0?6A-T;%@3)OV)NYH,@(<VT1)5S.GZ>T
MO%BNSE[^C!0?C1<C9H0)E+="B!KK^5P'$7D H;%0-!^\P]8EC<>I&E*4VQ@:
MC572#"HWZ-@JKL^"H68UG,Z:TL$4"YDQ:\"7G%41MDC?VN7L2.*0SL(V!E&?
MRFJ'J-7IW)%!"I)4;5-.PA*:BP//=09>K(PVNX+-6S/63SZ4_GK,^#UV%]>'
M*N8CREJY\J0JER(QPY*%*)(#+J1P* 7GJ75B<0\90XJ_]]#R;30?*NB&!U?J
MT<'%ES>4N];MB[I2/VY*8R-5>)2!(13F/#GP'.KQ00N>,H"ZC^%$Z:%U^T%Z
MAA13-\! ,]&WGVSXBF(Y?%O%^+K\-L<5LZ.0E-2>["B/.I)%)6JBIQ31LJ05
M1U>2;KZI^2V"AE3E;@"'=L)O-U-F,W%KA%[8ZIPA>U-;7IP [XP";B,GIRZB
M$JTKR)?/'E)<W$#+>XFTY='L,/TPCI,UJFJT=&>\VDCPC%;8#$G7)D0C%<00
M/;BB;91>(V_>.+0-74.*;1L H;DJFH'D'7X,9(F0(N[9DCS3FE=G0C"JU XH
MKLD .<K0N%9$5!VR*X7(I?5(EGL)V08&YNG X'!AM]USW(!QMIYJ5K<_?;#,
M1,JC.&5/2AG*T3F%IMYJ%UB=OMS\'/.]A&RC=_MT]'ZXL!LGK6<;$HRK 874
MP'DMV!I.[,5<($E-(8;,6&(_N>O9]GIV3T?/^PNWF7XO6]O&.!]Q>J0J64$A
M+(&J\8>C1 -T9B$D:Z1GK4N?-Q[?D)-+B496][*M!+/J2/)<0;">UXFN B6B
MM:%U3>XN%4,J3NRK[3L5BL-DW0Z]FTK)SQAKDKS95UKE2*_C9#-)<3XB/DW4
M2E)\5"??.*'J7B7Q:V(QPF6=F@>MVU$VI*)%,VRTUTDSO/R\V<R^&I]T@^E:
M6,F.,JQ QMPI2\;<JPA>20M))*68MU[:UC/N'R%I2'6,5@AIJ86>REM7'=\W
MXB_.4B@&.4A6-PTX4JJ5A02,7BB6A BBMZF*#Q$UI )(*WBTU<3! %G-G:\!
M^<OI?-G5)JZ;<+TFJC 9G6<.-,-(!JUFXEH:R,+Y*"M-ZE8N=/_% (\_:DC%
MCD.5WH=TVR:]]].#R6:C9"("Q,9&A4)AN[8)Z^:B=KF7@9A[ ^)898]F5J"-
M[/LJ?,VO[-(HQ))]406X<(*@J1S$0H&-$#Q'%"E9UAH*#Q(SI$)(*R2TD7Q/
M%9' O$\I9)!6\GKHQ5! ZP*PH(HT5BI66F]^?*,BLD=;99B?KZ+T^7G=8OP4
M)G6[^?GB+'3=%_+!ZV:MS!-*E3@PI3)Q62SXY#V@3QA5YK3ZFM]"L@UA0\JM
M]\?%G1[*YCII9P7/9]WB=F]"41$MTQJ\7<7K61.O=20>RFB9U9RYUE7!^^@8
M4C+=#@P'2[QE1]S*_K[%A 3*.*DGX"]9K,>=E"=WS*-FH+)*X!F1A2Q)RM>R
ME+YY9?@;] PI;6Z'A68::+AG_(F>/>N^U+R=6TK+6!' I-/DY!D!4J$%&8C5
MD)V*KOE%(#>>/Z1<N)W.]Y9P'UM_EPRQI%32S@.%=)O1\0%S!!Y0,F:E=:GU
MO-J[5 PI#6ZG[P.EW3C,?5W6-\F$R5^[V?+CU8D.>C6MA]-COII-?TFO,S(F
MR1&$R::&Y0QB-AF"5C$Z9*'PU@G1_M0.*7=NZ"F.H[T^MB'K!7QWN\-1B^2-
M8,!,O6(U4)875O-OBB^._!LJT[S1^!&:#HZE[WSC7A.GHD@Y1\\A)UM Q: H
M*O1D'2S:DE2==]^Z+-V&\B$E;TWQ=R>$/[ZB^^D/4-Q*%C5HGNI8#R(E2N'
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MH8B$XEDN&1KK4VB]9@^DN<6]I2^G\T6WK.<&?YN&BUFWJ-.:-T'22#LL*?H
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M6T>2)GS?3Z%?<_M'*_:EK*O'*(JJHAE+I)&LKIDK6"P>)$9(@(V%$N?IQ^,
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M(I1I'29+DZEUJOJ%[$. 3B2#>"M%W\>9O07>HOSZ)J9UMFL/4-ND$V_!AHV
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MQDDC'1R*']+H+*P,Q"2.V$)4). _)2)SKVF0@>;:]=^'X\4C]Y-'IL4VHF]
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M?5C.EPI5I'^7%:XV*W[VLV$<V""<X]*0& VN%'0@-GE)I&<L,N&$X;7M@(U
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M-33(WMP :_4>] '6R""\%]1Q#,$JJGN<#GO(_3#;QCI:YVE2( VQ1M)2,($
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M]/YJ>4HBQN*P>.!UE*22.8%'RT$$3_P[%#%TT8UMSQG/ AF>H>E XFULA&S
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M1%N>K#)>@TD^UG(4!,R! V.NCHB)R&2GW;S;I.PGSSX+3Z&)X(=1A#63A;N
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M]ZO_Z?NC>,*OL_S/FWP5[WKE)V1):%F+NNM0<D<N#4L)LA!2"TG+%JTS+SK
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M W&;9S.">#V-_W.'SM,QG(TE=(57%X(7"(8\BIQSXBDK\E];AQA>1G2&:C0
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MXAH:HC5][<,L?YG<?/F9"(F3V@+K8Y[GV;?\T(_6>Z^-RZ3TM@ZVR<C!,6Y
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M@9K//]T:%_/%:V!8T#Q*!J)H3N#(B$+!,QG8Y$5S:X-MWEOG14"G;2:TYV2
MV[P[+'>O1A<P S71>0+D,'US&A+U;+KBOE(>(H'W"2A7/,N9"6 YT,;%/2,-
MCP9T4-'9PHQRK6O$1Z!\2U><L1CO(]S&89>'"-!=H':YQF77/V/THK8W<TN.
M=;WU#3$34LL5-\4;5-@AZ++E,0<8J[H[ =-AI->X-\Z[Z>SKM':$6W1\N</C
M0V+*TSIC4O6JQ=2!!,'3WA<-RJ2#TUV:XZS[[-=*X=YR&J1'<IQ^R0^[SZ,V
M0&2)_)C20K)X6:?=7TYK=_KY3]^?W*[.Z2,N;]+DZG/]G>G5]>3J)J?W9 0M
M4NEO-S"A"Y=UF)=@M7<D6;?@M0V@4-#R8[3TW\9[^C@K.P_#\0BU9("T\UZ
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M!^.,PJB $?OT#J@ * O)0KDL.;T9++6>;[8)R_E&=INP,\ QN [7W4O3!=E
M@=K-J X3=FW#7@>5V$/T SAW+R#,B%A*21!*39^I$8[ C /DR>;"N4^NM5$T
MME)LB7".K1-])-ZXSG=Q@?TQQSSY5C?"^Z$ZNMB$7D#)GI-=90,$<@I!22Z-
M= J9[-(_<?VGCV]QM)+]M*G@&E?Z+A!]P.^/X8CH4%G!0#)K:OD"JPV2%#&%
M*7MC1#&E*X]//_IT2-Q#9 -LS/=6#-DL&><WLT5EQJ^S_,^;?!5OLW"3UF2/
M9 XB,P\JY0C!H(40-).!!9V:=_7I .M\+<#6G V1&K*$N [@W5O4!>) 5F$'
M> >ZE6]-[2;5:<S+D#O3"U!E0D?O"X."R.M;%,!G5T"7*(.WR0?9>B;RP51G
MVS7Y$6A.'SI&TICYQQI<F4VN/B\;AP>64R1S.ILZ4E[1 >Y1<D@%BU6**P(\
M@LJLXAK?OFE.: >%V8N-C?9KVWXG/TUGL^F_".)\>=)/R\/W=F]FTNUS6W0J
MV6$%JV,*R3Q)J#D+0BC.G!-:V9BU0_(SHBH7W1ZQYX5P#M</ =C?[VND(^KB
M2E&@4==V.UP#AL3 <1]B848SW;ICR 8H>U]Y/_G8QSW(%Q?VZ0-9I?0#_)PO
MF#+"1R; 25$=/9W!Z>S)5] V":%]CJUS:KNC&W_S:J$;S^ZQAV%C@%R<ITC?
MX6SVG5Z['[]4U^,B9^5B] Y8T76\EN+@@F? E4'IA?!"MQX1^1*>4]2-/20^
MA-FSN*W*O],QFQ\:CS@7:QX/X5&6;#U/?[@D#$B7O"S:V11:W]6L!7(:_.\O
MX\:U6,O><76QBT&+/UZE!;KWX7+R^;9SM&?2<:D#H.($3PE)>FDY&&L8P0Q!
MZ#[#P5]XU.LF>0AY#G#!]G3)_[C"+]/9]>1_Z6"ZG;%YX8L-(M1@L*KCLLA4
M V^X 1ZL<>3G,9M;3U'=ANEU*\8@DF\8;:N*NQ';<G)!G693?V<^OZE;V+OI
M_'K^1[Z^P"R"5AB 85F,X>1UN!HM(:IZ:AD=M.^P.^SZ_->M&:-)?H#TCL=;
MW:*IP=?)-5ZN;';SWZ[BY4TB(^=N+L;?\?HN2>6"\1S0J@S&1Q(8&K)W8BI@
M4=#3HC0\-I_6O"?FUZUM!V'NN>:9<33O#O9%*I('AK5+@C=TW/H$SA0&9%$+
M@=RHJ)J/T.D#\)QT:A=.GBN0;67Q/C?.[I7^44O<_\B7Z=?I[!->Y@NA<O#.
M)9!*T@G-G2(1A53OS3.3PF:VV@%NJRW<&\3K5IAQ.7BN/&X0/WD1VJG">93U
M^6$Z7_#R2PV*SB?ADGY]?GT1@@I!TCFMM:X5#&CK(!X%/"M=.#=<JN;7X/M!
M?MT*=PC>GJN=;^NVW=[^$]&!W@4#S-8I/TES\%@R9%>GB#G+F&Q=![P&QECM
M48=WR?I+]5A:E]8=]?IN1ZW9Y[>C/9!C'6._:"Y-9AI9:*$(#3DF+V50W-KF
M$]O6X#A4ALW>W*XQ<?:2\1"S_%8P+>?N=$ U4$[,>D2'28/9G[$M*K"'N$=4
M!NG0EB@AU.$^BC,-GD4#Q=6;6:N5E*TO.L=4@BT)+:/I0 \I#]*6[VHRG?TQ
MO;[/"/4\.$X'()A;,UD&\(4 D>$B@I9)F0&:5:^ ., HS@;L/&NKMX]H![BW
M7>3_KBUA]2+5<9Z.;%0FR4:5"D*P!:+%J$+RW+/6MW4;P9P$]VU$/42;@R?&
MS6V9!W<V2_)(3*FEI;PF\2N#(,AOB:B893AL;L<I&7M[RG> U@-/$?V!7Y;Z
MW0770,;>)DR',??VY>Q%%=A3X(-O 8_P95:"-5)#JNVD54(/R&G_2S*&J)QV
M9.6\:D788O*-I0=]Y-RX .Z132)^<#_?Y/]S<Y5KF/G>0N'">Q_ .DD&KBT"
M2  <<M)1&>7I[Y4@XX:>N2\^YM"!P5VYF XCR,:5<8^@*0+V<XX+2(_ 22L3
M63<<I-1U0*=#"#DJ<$9$I;7C)<5^+*]_T&GQW$"8P[W-\@=I-0'\\>;SS?R:
MX*EE,X><K3:B ":K@&Q6#B'JQ>TK"N>S(/^U']>;'G5:;#<1:/,.Z(\V'2/6
MPF/&9)<P@BY(ZFA" 5=[A3@R:9-.0A;19=QMAT>=%M]-!-JXI_D3=:S@_IA^
M6VX_2WB^EF G[\%P3Q:**;1T9Q*@*%HFEY61/??R38\Z+;Z;"+1Q,MTC>/KI
M8;,$9WR.247:<E1@H+RJ;>P"G3V<T+K <\X]W^[U#SHMKAL(LV$BW*I9\0,G
M>'^GC_Z+L.D[;,AK(^&H2?<RG3*NUDIZEJKCP1U9%61B]#RVUS[GM'C>7Y0-
ML\Z>[3=N84_\GYO+[X_ Q92U]*R.]*TVA#2B#FA%L,H*:R,OP8F^V_>Z!YT6
MT0V$V3@][/%NPPC9KSG,;G!6T9DE.H':E)3 RMJ"-$4+WC(#A64?DPB,>=-S
M[U[_I-/BNH4X&Z9S/7?^[S1QX?XOP7$3+69).TVH=P>"3A5?9!VY(F.=TX:Y
M4R>:K0\Z+:H;"+-A!M7JGO/8.5A"T\Q@'6T$PM:!1SS2HIE,$&S)3D1.2^]2
MX[3E,:?%\MZ"7!-%:14PDTLO\.ML<DGP[+)]-+.H!:LWM\*1JQ\"!(X% N-.
M)LFXC#W?YPU/.C&J&XAS#=NM@F;F!_%HNUF"$T5RELEL(".1U;%6#D)-$R1,
MQ3F6BNB4J[WM.:?%]/ZB7,-SJV 9?[+E+,$%PN2Y\^!XM1:CS;4=#?WA CKG
M@\^^YSN]]CFGQ?/^HES#<ZL@F?I!/O+_W#* )WW4WB($,A9 %:4A),L(G(M*
M2F94ZOD^KWW.:?&\ORC7\-PJ."9_>!JJ]4LCPGM,Q2O(6-OYH"C@#-8Y(BIH
M45#9HOJ>TFN?=%I<MQ#G&K9;!<@T7\![< $E6U[%Q)!8Y@A"6G(!T2$X2SII
MK'59Y(@I]^1[X[-.B_$V(EW#>;MHF7UD-]ZC$TG3D6(<6"82*%G($\P\ '/1
M&U>L][9G^'O]@TZ+[0;"7$-UJW 9?W+->H\N6&UT"@PDUXH449/I*#(#3PXA
M=RYE(WJ^V^L?=%I4-Q#F&JI;!<OX;7CGT;;#'Y(H&#/>U'IPK)?J!3!B;4S@
ME'7&JRB[3&?N\JP3([R)2-=PWBIL)NBHN6M=1C@_Y:_7=]=P]T"%3T4;MVAB
M76>:Y "^)EN3X\BTSSKSTC?G;-LS3TL'VHIX3<Y*J^B:7K4ZECE42CD6/%D=
M7GG2U9IH$4ID(*S6N<8%16(]#;D-CSHMYIL(= WAK0)LZLD]G5S>TQDGDHF.
MW G+:P-[9(#6UQH(7G2]L7-]<U;6/^BTR&X@S#54MXJQF;M0[VT$4"[C^@:Y
ME<X+LBK1@-*"_ D5/21'*XY<,&52/ZK7/^BTJ&X@S#54MPJSF5M_XB&C1B[C
M@-X'9W(RP#RC;8>,#O"!2["VR"23*09[9C-L?-:I$=Y"I&LX;Q5R4S]8]Q 0
ME,N H'>8O:15%PRU0[?/@"E&0*V%*";RX'K>?ZY_T&FQW4"8:ZAN%6\S/]Q&
MAQX;DLN0H'#1*"3/$4.LBR>(OA@/WBF>0C3$:T]#[86GG1;IK<2ZAOE643=U
M!_$N4J26X0,O8@J<-%'1]^@/),4TM<FDXH+.G6@9ZY^,N.Y)I\5X"W&N8;M5
MX$W81Z&B>W")6^M=2H2+U19K-:V*[$O(WF9MLBRY]'S#US[GM)C>7Y1K>&X5
M==.WML7?D;P&M8P(%"Y=<3I"S'4H>O!D5BB6(),7H4DBVOJ>K_2ZQYP6RWL+
M<@W)K<)LZH<':.(.FM.(3"H!Y DJ4-D)<(Y'D")Y(;A,*O4,JJYYRFE1O*\8
MUQ0 -:OEO#M-'DI6[A&2<>ATMHZ\099!25)$<ALBI$SR\"B$QRZ]E#L][-3X
M;B+4-;2W"J'I12+&@V.HEB&^Y.C\$+*6(-8Z1!8\A.(,T+$B+'J/+/9\NS<]
MZK0H;R+0-82W"J2IY2FS< [5LEA),"V"LPL7 4'I)*I?*,$4G6F#4M')WEE,
MZQYT6F0W$.8:JEL%TO3=[G,;T57+B&ZV5KK($4H1]< 1&GPD;>3*1S(=75:K
M_1>WO]GK'G1:5#<0YAJJVZ6LN2=7\VH9WS,8929/ ;AQY"D43WZ@)6-#N^ 4
MDH4A0\]M?-.C3HON)@)=0WBSK+4?V..=9QGCXU'$4H(#J6L%2Y8<O/ .HG.T
M>%[;@O0MX%W[H-,BNX$PUU#=+FSV.,RCE^Z_<I&EX@O(6/.KK#7@R.VOO>N9
M]708/6NJM_W$7O>@TZ*Z@3#74-VLMM.LW+CKI?48A(K(R#] SP/06EEM"^+K
M4+9<#)8D7<\LEHW/.BW"VXAT#>=[=^S_>3+_.IWCY=]FTYNO[RYQ/I^425S,
M&E@T!S,<#4]*0Q:*\.E,2(LFQ?3:8\[9*]%\X-7+D$ZFBV)#R0\Q"FTSO+OW
MH@O H7HK;@-WH":++2GMKBY[\#%$Z\6M0&TJA0?&P6&M@S7H -%R8%D(B\[G
MR%I/'3J0PFQKQGA0?>E#P]!Z4F?8E.F,OLQT8"ZFNUU=3ZYN<GI/6_3M@*1E
M"*N@LU9Q,*8FB\A,SBY7%D02WJ#2FA<]I/9TAWH &Z8MZ2^IU$",;>P3.=0$
M^C]P5M%^RRW&SC_[L+:SYE_&NCI@/M:^Z]9*4;RR/OA"XF;<&A/0*Z8N7OC<
M8:;*)QDXYNK:""5H.R-;USFE2"T<^J0,>4*A]9L[QE3Y7S'FNSG50EN1)3(H
MT5DRYTL 1\X\>719)N^35C$.NL0'+(?VH';C_>4&PSM*>H Y Q]FTYASFO]*
M4J@8_\C7[\N3,:07GC'O2V$@:^(+'=4(/H@,)B7CG.&9OM]8%[:C.@VM:"S]
MP1N0_W9UG6=Y?OT1K_-BK%JZJV7!S_DB&5E8<I&6+VP]'NOA3.YD(J@^.12H
MAITI_1*ZT]"7@=@8?)+!;90AJV!BTA)<XH6V.NYJ,P(.&9G@3J1$@AE408YB
ME%T[_OM+]5A&V7WZ:SJ[_G-U8I,LEEE5)"1M#:BH,C@;)&3EK$^2"^9;^]-K
M@1Q39*X7NZM#C?:6\A!#K%9!W3ET76 -%(7; .DPL;<&I&U3@STD/J)"H!0F
M)RN J6H85^?>2UNGD$>,2:+&U:ZZKTL1ML34QM.#/H(>@/]Z,KXO[V8Y3:Z7
MK8MH8>3P%\#@<[VIJE/#&8/$0C3H<E:K"<_[3S-\AF)\B[$)0:N3#/>3[@ >
MY_IAC9QC"@XA8B&C*%9,K.9HTS]-X$E9WWJHW;&/L=WGY-];Q@-X!)LF]W5
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MH,,3A[\9D%F$0K8L</'_V[NRYC9R)/V^_P6QN(^7C9#5]HXG/);#=N\\*A)
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M^%KW24C\ML8^N(@,U7/I1@44@3Z[R+6AQFS>D7ZYG$_BQ;(Z39]G[V?3FKA
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MNGKP2S^N_)<]A-Z&@$EH8( DZCIQSH)#Q<!:PQ47VOO6]O:P.WK. OH$>3Y
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M5UN'"J UHIEYVR"R!,_3GY@:VE10'+ZH''MES$QVK(0ZD(@=0?7QZ&X%F3^
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M%+^/JV\Q4/3._[/4G>O+9RX.$]5/$&0S1Z%:'O&]#5;VY+FG_)*>$!2.T=K
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M\_%5$N^)/[PC]6-M'I'>KA8DCSL7_$AQI.X.KKZ8>8P=QY'CEZZ@K?>QENU
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M?E@65?7'"Z"7V*!08$V_NY&7U^? CO$F-^LT-/E<K<:,'<5 K1EXHAIH=+L
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MO5[6!:,^E-J\OQ?E;]J-J9>E5P]YD8LOLBX2US@V;94)%& :XE# ,$44XC!
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MSE_I@!CLYT#81UR? <A$\=4_%^7ZEMY*L"SH"O!2BGP-_KZA]2YROA)YS<4
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M#">9<NJ9:#OPW#AG*_<%J"77;XH1O#X1^I"OJ%Y;ZY=HK\<96V?6IK'CHC$
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M^X9O[&TR(R]H!;X K<B@*[/'#9U!*/G:G;<:<]K->1<87NS-.UT\C((Z9+?
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M0B91'&4PPMPD-R4IS)(LABG!L4PHB@/L=/Y[>JJYO>-5+EDCZ3__$PE1^N]
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MM[,H.G1Q\XGF5/W;?*#JUK7-%J6^?FUGQYBN4YNM.B]ZM%D_-+ [V[;<Z#U
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M[2^ <"8ICY:U([6WL=?8]STV??1^.S#?\>J(^T(Y_LC3/^J>R-:C8).2LW]
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MM+-@>.*3T_-,RAUGU7W-$^<?N"A_)/J%I/'[K;S>WF_+31C@M/DJLQ"3P%Q
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MS#3#AP0RBC#D$4.1TINF-)(N7K;MQ'-SI;O5Q*O:"!T]RG_1CETN',OS6)O
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M<=DH.(]^\=&"VPJM?;.]V%6"*/C#2 XJT3T2FC-<GNC,?MY)R<P9CM=4YC[
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M+-3%<F@N.B46<KE9*ZF4Y)O22%]5TBF7=:@4*ZOVL8LH#DB6!0BRU$3$9I3
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M'[!G\)/1 "SSG\%.";#7PNMEX.4@>G*A!@@PJ9LT'*#7KM %(UV8OO-YUQ6
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M58=/IO4@CA-D2O=K9RU3&:1*$,A1PF6,4A*$5MMH]ZGGQM6M]* 2']SFP"@
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M\+LV3?MZ1)B$E(0)9%SIK0T5#&8BU625)#)5(9,.\2GGIYL;0^EO&[*_4+.
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M]?_O\J,0)Q&C7$&61!KB'&60TIA AH3*,Z2R&'GEH_D*,#5'P\@/=@J EQJ
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M1,$\B5*;;B<@K_Z9QBQ%.-&(>:W5+UJ?VL1KA/,,E+P$S&WV]89AX"G8R#6
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M!1Q8SJE9Q9HN>A=<OAY;5W<PW:SC!(9HZ,/^87BY/LZ7\[5J*%@[FD^3E^O
MT$R0C*LKY;\L ]<!J(>DW3K4G7_,V;+XK)9K@]FBJCMAS*8JUY7?_445\Y5\
MO:[-,$EBFB$,19);A]A6OL=)!K59.K(DX3)E3ED)O7J?V@IPUWB^M70E>",;
M0<O*=5N^T,_\IE;0X_Z5__B<#U0/BOK 1OVE[* 5_J8)(=3R@P.>])"0N\>N
M!X5^I!!V^"'P"FGWAO!$9-N_S=$"W+W5[<:Y^S?2E_?I1:&,5V4TWAE1YLO-
M:M,IF6%+!GQI2I):(I'O#VP9Q;^8)Q_*SQN;77>GV[^7,Y:G4M&40Z&0@CAC
M9JL2)Y8:(*$,$9'GR(\58%AYI[9JU0+6)<AVQ7&L&F!M] !1#!XK37R9IX8=
M=;>-S83&<N"UT*F\T4[A;EVCJD)'J].KH:\5OP&[KV2K?$CFK%%&*1CIUK#2
MCLS7-0KT^U1?XW3;MV*&/5DHGE9%Y3U9VGU5)8<6S^]64LTRH@G62L-,\-3L
M>AB"5 H!4Y0+$B>2L]AIQ7'L;VHK1E,0XH7,-U4U" 7L/=I:<F!%]ZVE<1KW
MTS9_ #2'SK<) &2/*AM.\%Q0;.-T^R/7W'!2=K_TAMMKO3FNGE8E6_RU6&V>
M3$>+C32.>'6_K;)[2MX]J;KG#L6R\7,Y5A@3F.0\@3A/).0HE3".,J)0C!.2
M^[)?]1!C:L:H$LV;^ZH/_HX>Y^"H#NU(-@J 2H,;L-4!=)4 6RW:K?[M:4[Z
M/F1:%P 9CF:KCQ!C$W!= -0!:JY+6AN$%\&R,(BUDI_5^DNA'N>;Q]U/[U:+
M1?7'693'.$<"PXQ& F+&F.6:89"+)-<LEPAA.EM:SC$EOP=C2'"2S6EZTWIZ
M[TDXX-9?K<%3+6H)WC"QWK"%8VPTZ,BY6=;1!F)"C FM4L .5:/,3?<?8*O:
M:+0)7D"/PYS@)M*4R!.\0/3D3_!KNV?R"2OG996>9]UBLT+4$M3_O[NW)I(L
MPS)/(*4,0ZRQ@$0E F98Y8KI..+*BZ[&K=NI^:B5U%7LS+3:GLEXYH>XX>V8
M[A$<Q:&S-UH =R+?M+;RM^:_@]SH\T,J5#*%6Z?CYD9X ;&7ZN#W]F5.I TH
MMA>)B(@$S36&)*,<XD@*R#,4PUA%B-D+$Y'RRF4[T,?4C$U'1,?+;Z< ]'/-
M>L(RDJ=5$8X.R&M_0/O [D^WAZMX,P=4/.:<''JTW\3^4JS,EG/]_,6,ZOIV
M*3_\<S-_LKD-QJV9I7'*LX@**+".(<Y(!&F>1E!F1"1::(F(5Q7 4YU-;:JW
MLE;YB:H5] 8LU?'*=_X(NYF 4+@-; M:,8W[8 6MD/NP0^[S">2\[8(+)($,
MQ,FN1K44+DJ_-AE.[_BG,]I#QJ:U]?/QT\:&NXOB/%8I)S#G>62V*L:0,!)C
M6W)09Y0BY%%CT*OGJ5F5*I.@W H-6"MU%:@HC=SNZ7-^0W#:T@P*[-!!=8OI
M;6-KC,'>B;[+TP!&>&"E[\%%YX>S>XKB8'B/E)[8K0HY7P)IAZ%=+,TP=+[R
MWQ_FX@%45]K86MVOBBHU9JGF3<%=8#R9ZA2D\\[2#-B#6DBX7L%'MK:_[K;Y
M$_BV,6UVIY)IOE!/J\*&]-@::'M;Y(>]+?(7L-DEY-RS^;(FHEZL2IM)7*CZ
M:NQZ]2JMQ\[&UQVH/VS0WCQMC3-0+<> ;6[;M\&"F?>>F&7'!6+U^+1:6F96
ML\6N:#,>5@MC8\O_U0+UIK[5)UY<RJUKTP?*Y.SUI9W(XO1K;[0,SEYJ=K,W
M^S70S_'^Q7PL]^Q>_;QBR_)N^=5\GQ]*>Q9N.E'"?)L;,U=G0D<1(XA"D68I
MQ DWNVU),VBVWII'F*8Z\R(D<.IU:HMF*[29L49JNU)6HOKRAKDA[N:1!\=Q
MX#7RVX=WH.5?N@%1;#PO>T.++4 M=D4)P)95<N/.KEM3M@6_4A6LEMW7;D!'
MWW#.O1>Z@;Q\MSY'=?>]8'CM]_N]/-+1\M?58F&>_9T5<H8Y87D<,9@H6W!.
MQSGD7$B81#&F(D,DEE[W_2\19FH6KSG+J-T7ZSBH]JQRV3E6'O@TN3M8 YTB
M]QR"J9X>@]^L0J#1:* :)GV!O=9I<5>4:9\2'P#MXM/A0VWV9;9Z8L_5;NM.
M_[Q:WG]7Q:-U6&<YR;1*=00)XL+XB)1!SE@$(TZC+$XCC4PK_KDYQ_J;:+[-
M3EQK+Q=&8&@L]6.U+?7EG#H"M)L1O BWL9BBNEA9(:&5$KP_A54/_J?30 2C
M=CK2S<BL3:>5W2=D.O/\I9S8-7M"19ZPN\#^ZK9[^845ZSM]X++\+NLAY1%*
M)=>01+: !\$"<IE$$&=Y%JM81YCT9,4.).'4?+<.+[99 Q;S1R.P^6>7&=N&
MB]H*+*"MT_-KJ?1F 2P>U1ZW0WGQFC.C+U]VJ&_"S1!>=:2'WD]W.+./\)3L
M$YW8\N]%%0<\Q)@R$GMVX+$(SI\=2KXK,6@'AO<XAW;HCOJM-]_M)?9-\?QM
M;=JJK-N,&*]32J&AS+%9)DA&;"%H B.6Y#A7@@J9]G!']WN:J"/:"@I**^F-
M/8JP1'[_"3!!]0% :7_WB\'ZX4__%F7H+TET VR,O5H7<$HZ3[U7H@HVOW@P
M]K/_!\;(S8#WA'P<"[R%^5L-\VE>,&^#>5SW0!;O0 >CFJSC"KZV.2>>'(*T
MXO9Q5:SM4=T[,VMNM7'9;A>+U>^6W\]6$S5V;;ZV%Y9GJ<QEQ#&"/),)Q!BE
MD&(4PSPAB9;2^*T\GZU7:[9PLS!AQ/)R1[?"#3=/;'AJ*SNPPH?DFG >+#>+
M,_X0C)&;<(XYXN7PF!7#J@:VNM4%E"OM*CJ)L;@A?.$>A0+"6:@),3WX NE'
MZ.#=NG^RUS>UG*^*SZNU*N,H3K\H,SN6Z_<;]<U@4_DG,4JB)@%&:\7B)&4P
M%YF$6#/C_V520!H1*K04% NGM'#?CJ<6!XA_,A+_.R@K%<#2Z@#D1H&MZ,#*
M[IZ&Y#4(I\WMD- .O?&NX:SD-LZPQ1@TLM^ ]WOP]DCW\L+9/=MK*+Q'2O;R
MQ#U,WE(?S$ZD+7DU-UK64A\ENTE+O=Z_: U(D6G]H^+%AA7/!N6LF0Q<ZI1G
M*H.Y0KEUR!ED3$<0I2JA*1))HI(>EO](=U.S]X=L?2NUW;5GO4S0,:R]#'P
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M01*BPWQ"00Z(KO9A3.&P:9NYW/Q]^X<6 - B +Y6Z\/^Z=0-8!:'ZW.<!AW
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M\X%>W\LEUZ*^%+RV[O-<9E&N*$2VQ@&F"F*6,!CQ(LWRU)1XQ#YQ?ZX#3\T
M^?LOWW\!]SO16[:(G]O2&7@W#^00< Z\N/_].]C+#!JAP0&/#Y 1Y(M5(+^>
M\["CNNA\P3CTMGG?WS.#2-Z;$;[)I]7:Y-3O3XSVB0898H0HD<*8($U122(@
M2W .62107E 6T=BW#,OY4:=WR%(+#792>R9^."#MQDF!T1O<=78 6^MD&?P^
M3&Z&.T"ALBX<1APWG\(=@E>9$AZW7N2M1[_$[[?:!EOS!PUH5J_+G%"9D"S5
M(*<,(A*G$/,<05Z()(M5GHG(.:#IW&!3,X*TD$?\]%9HXP7->CF6C\/LY:&_
M&+Q1W?,&Q<J%O$?N,M_\<0A[.>8OAO)-O/+](.WKDN_$R,T??_P1;^&,[U3F
MA">^^Q[_3)/O7"[I>K[ZNI8_YGIKO'BNV%V*IH5XD<8L2S'D4:Q)ER$*28H3
M2!G)&<^Y2BARS3$Y-]C42/>Z!(V [CDD9Q'MYM?0. W,KWL1=U %_/I]P+@@
MR^/L$*/E=[@JV\[L<+[G+0+\FJ".V_7GU?)>K@_=[$6L)(ECKNE%"(ARF4&6
MT106I*!%EO*D$$YEJD>1=FK\="2X[U?]&SWT&\;WG9MQMYWL9.;Q[<[;/./[
M=E%]^NL&E=K3C>]SG*!)Q/>=D_4O%-_G"'O8^#[70?LM3Q_*S?Q1/ZM5O>%(
MD'NS+XLIC@I!8!R+&"*ST-"8<LC2G$6ID!)+KU(*/H-/;?%H9!>MU Z_=<(+
M>C?:'PK0@5F\$?N@]--OMO:?K(HR!#]4Z8-5($+U&GI4?NP#RB'=]7J&O[_3
M%GO[M-3/HEJUS_LLQ+K(^XPF!64)RV%,C;\SP1@2D4?&\TD21FC$L-,!L,M@
M4V.GJC;AO!&XG:3I[J<[B_!Y5V=(W 8FH0JRG:R@):PV(7T:!SAAY^[C#(GA
M2#[.B[#T<FZZ@M/AW#S[B-&<FZ[*M)V;SO?TLP]WS%V5Y+M>BM80]0(M3#T,
M;=ZNY\M[?<&7E;9CZW^^H^6\K*OMT#AFN<RA9#F!*#+5=EB1PBPN>(QI@9/(
MJVM+,,FFQMWM(GP[Z6WAB[;\_6IXAYM.-X/T329IX(4BT/QX&ZS!L0QDS8:3
M:U13-SB<AW9P^ 'Z4?BAP^' '?%H@A'^6PK3C<&..<-8(4QI#+G*$XB*B$$<
M"0GSF*DL%SPF;H9S7P&F1LB_KHVK<"<G,(+ZT:[W%+BQZY# 3L%QZPBY-Y/V
MQ2T087H//RHO]@7GD/YZ/Z<?RWW6C[VWVYKO<K-96*^1'F2K__</JI\C[E;6
M5/Y*UYOGF2"FJ9,DD"C3%B;&*21%%,,DCQ*"HKR(I%>#)Z_1I\9OG^4]78!R
M)SB@E<Q@LP(KNY-[,F+[49[??+CQW6 H#TQV>[G!7G!+;[;8^1[M:M_\M1-M
M;[;KA5H@JO,;>U2>ZP7+(<GU>TC/B/+MTU,U EU\6NI5\M$.K.GUZ]JT;ML\
MWVB;DBXVSSMWP-^7^O%_:,;5+%+[ _Z/I.L;TZS5&*3U#^*_ME7EH[H3URS/
M$AR3E$.*#3W*C$ :JUS38QY+@1&6V*MAUGBB3XU;:]'!LY;=,ZQ]O.EV8]]I
M3N+ U-W,GQ$;5.+:K7[]XU[TIDE@P&#[T?$.%;,_GN#CAOZ//B&O,@C&EZ#?
M6O6?<G[_L)'B^H=<TWOY96L.^V[5]P>J/\[;[:;<Z(_(^#R:6L:4L#0N3/4@
MJ:URA+,$8BX2J&*:QU@R'G.O-DF^ DQMW6CD![12 )16<K#:B_XWO_7$>TK<
M5H4A@1Z8VW<8U[*#2GC;D:A"NR7_%7@_7VQM?.X Q:;[HAB(L;V''Y5W^X)S
MR)Z]G],S\G=>/JU*NOAUO=H^?5KRQ5;425]5Q)<4MU7#Y=72U!Y=ZC?D.9[A
M)!6I-K(A5[2 *!8,$A8SF,:$\RP2<:*<$@8NDF)J;-A(YIVTWF\.W)AO<&2'
M=L'6\@.K@.E+4:L VCJ G1)5YPJK1L XV$M #!7?VDN&<>-6+X'I53SJ10_K
M1X:[!WV1FQF.DX1EF74O9!!E)A\J3W)(4\83Q%2,$Z\#IO;#_V6HZP5B;HS4
M%X>!B68GUA70@H7CCF/J!J*$%X\>]4L_IM3A!WSTFI[]L%>+.7]^6"V$C2PW
MGLMW=&$VCM]6BX7>6!HWYBPKN$P45Y!GF.D/-E>0QB2"$G&9%IE**7&J\NHU
MZM2^Y+;0NZ:8M=C@=R,XJ"7W#,IQFP,W"@B.[,#<$ )4_P[;/B"%:K7M-.:X
M/;=]8'C5?-OK9O_P[J]K^3C?/KZ7:L[G<LF?O\E2KG_L(AR?9T5<9%A;#!#Q
MPM2SD!QB9>*[<Q:QJ,B3C#'7^.ZSHTV-C*Z%^!NHI09B)S985W*[!RJ?QUE&
M+*8YIC!+$88HR7+(\HA"C!*$\BR6/(W<JA0%1WJ<^D3CP-S-[\&A&YK7:\SV
MPH):VETPN$=CJ//HN8?3!T5QI'CZNP<):!4ML%+-RU?J'ZK4U,T*R#^?)#<_
MJ^W&U'_BUJU_!>:[3?TCG2\W<FD75KXJ-R7X2:W6^D;Z^&2"K<1\K9]0_ZG<
M\@= R^HQX&F]XK(T98JK/_]LGJOO-+\T LD_YZ4M0+63[&FQ->=D&PWQ$VV)
M]52!7YVAK>4^046/;:JRZ5U2H*9(SM/<D1EP_AFCI08XJ]/.#7"_J>^FGJ\E
M+>5[6?WWT](&.]3>@^5]%?@ZT[L#1#$G>L50.41,+R6$(KWGQUS%19I1D1:S
MI;PW+\J=SZ[?972GKYE47_,K&8;[HJM('VI%]/4+.('NZC$(AN%8OH1*4/!3
M(_+/AHLJ.'=B5RU" Z;K^^$4S GA-.C([@D?(%X[+KSN[N]JK,ZRRYN%_L+F
M:B[%N^>FJ]N6+MK5B6V$_;Y0I.),Q#EF>BN1(H@DRR"+"(4L%3FC/-<;C,2O
M).<EXDS/%MXUI-;+_A?3A?=%B+9=UEL9W/JBP^JX[!FT5-_5*O?WC?:>8G=?
MZAC3-H+OM58#[/4X-0NV8GR=N00&J2 : M: /M[>HHSN$[X4M&,^Y(N?Z4?0
M0LYG'_2>8//\<;Z0ZQO]W/O5^GF6I80C&3&8(,FU?:@TYR9Y"J7(<J$XR6+J
MY%T^\?RIN6XJ$8&5$31"NO'?*02[*2T +@.SE!\DSJ1S1O$C/%)*_LO]ZL?_
MU'=6%*)_V#/'J>>-0@9GE&F^[W.7#1O/9S)Y^"S/E>0%U?83,I4WLBB%3,8I
MC HL4BRY2- @P7QV]*E][E8H\)/>I%0A?#\/$[97(9\2A(HXEC!2RC2MEQAB
M3:^049)%L8QRB86?^3H8]N/8JR?B**\ &W-:W$S.P: >F+T]XRBM^..'3KY
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M%SVQLX3(A.:(0RI1!I%4"A)>%% 1P6A2"$Z$4[S8J0&F1H.-C* 1$A@IW4-
MCX+8S84AH!G<>>:%BE<4:)?JO<) CSYPM#C0+G7:@:"=U_6MLU[G#FI3ZZ--
MZJPJ ;R32ZGFUFPR>:A'_G2[GM_/Z[-9D\KZ3>]&WTEMNDEMJCU\7*S^T&;8
MMWU.Z(S'":%1QF%<9!(BQBFD.4X@R_.(9"J.\SR;:5MOOA+?-W2]<=N:CZ>
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M"LQ4E'LUO3\ZRM28;R\DX":?XZ>J'Z6T!3]7=NWGE>1U+SS/$+;C4+M1WL4
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M6K_P'KY@D =V#%XNUYOX$X/!><H-&6Z R[G^[\LG.J]+8N]J8U?=/VPQV6K
M+W(SPYRAG(D(BBCA$#&60TH2!7E.,\1C3'B>S)[L2?/W#5UO_-G=618?BCB4
M:#BVJ"J) TXU"=CZ_.")/E?F-)/W\Z7M3:?-OLV#!)54/>SLGG.7"LE9FD,N
M2 X1P3DD F>0*2JHX$HDJ)F[#TO'2KTCS5PCSYO,F]2F^-O,F/^B.\@<C+K
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MWI5%-$DS@KUC*GL*,S4&O+WY!)@5SAS<OQ3Z"F@-X8;^V2,<L^]<N=EH8\W
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M&J<014D,<<$S;93A+,J%BGCNM:WV'']J+-W=[R@(XF[[X %Q')BM&\F!^5K
M3XWP)L#WYZJ?5"NY<:]!N%UL3^@"[5-]1Q]U)]H3FL.]9M_'7$YI-]MRLWK4
M1#!32(@(IQ&,:1QI8Q(S2$V"@U1Q(7&J[\BSOL2U&V5J]'1CNO-9G][3IO[
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M6DCP<-C-9>AN+8<3YD97HT[#P)QV01>71JGZFK?LZ'("WS?K[G(HS\0[O9R
M[_*N+Z<>W+>IPT&WRHCQ3&A2C03*(6+:DL.1H)#$!8E,"GR4>K5]^:OTG)1G
M6@PX@>=&==/M[SA<:\9A&RR^:9M$QV:'85H6#KUW_,_YYF&^O%U*LWF<%86,
ML*("LD0(B%!.(<U)9OY)$%5)$D?1%)SC+Z2>&L5\-D>$UA6^6DKK"I^&R_+E
M5+^MZ[OW!/Y+^;HK%$QQ-^N%G.)K,@U7=N_7Y5_2=^WZVDS&4WUT^M[(-?U2
MEG\)7_11>,=R/A\?_)("_K_)S<-*[#M-E57.X"Q+"8\)PI 3TW\YDQAB;)(
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M-!#];QAQS&E&,B;]NLH>'V9J+/6YR8\ 1LZKNF9B+]?Y"5P==Q,7HS7TUL(
M=><+E/]NHQ.'4%N/XX.,NP_I5/35IJ3[ZGY$8$O?FB?NS_<:.X6EU"819RJ*
MM)V2QY#(HH"(J)0H5? T]\HP.3G2U.B@J@QM3^IOV6)>=?KV="2<AM6-"H*
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M2"1?II*!-4<=-_471\5.HB_R](]T:WMM+^6KDT_=$?E'->\Z^?0'4$L#!!0
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M6X=*#=DV 9*KE% %B\T?;\938".+SI WG!$3,;*6"J7BDA"$@W0N4IJXCA4
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MM")>2 RJ:*",AVRR/L^5N+/<80AH.(-YNO"J:?W??KXGO#?XC3/>9J,G-%U
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M8B@/-$HS7C_YRWRV^G*38,/OQG7W)$@WS9.VT+=9(U,I$\-UF7#'&0E@(V%
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M_+<%=.(:Y1A3J>= []]$9 ;_@UM!$:%X5$Q9*47M;/*3! W<J*RFVU)-[@V
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ME$5>0!['<3<B(:12&0&FBPU4\09*.^-H?18I"'"UFT[]F*JAVYKW@JK*RFC
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M#$0%AFCG-JT8O3;=*W0F?$1VJ[>8/I76)A,J?5O"7A7:T/F[LR%WG(PNM?F
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M3*5;H-_BW+J";>5)SMD2#'XIL: PE/%*@O;*.EZ[AVM?O S]G/ \[-U_D=J
MQINU;*_\>+Y.-AQOUV[_;1VK]@@ME6S:S:?O'%.W7<TY+3,P$DDB:W34%>J2
MYD2"32ZRG"/JK/+N?8J><ZW<0Y]]"]Q C0T:^72JC,.F,2&S3!*&'U0NS*C?
MKT?LA=E&[$TU7.P;GGI*:-9Z_+7[^CG*N=19WDS!.]Z4//)!=>S*(52>:61*
M5OQV&;\9"/[0K+%;7YQ*2SVD,D@!SS3'$5I<2<1#MEQ:J?E^R>:#5Q''K7JN
M8=E^Y/=7L_FKU1(AW24]OC^#*>3QLAR??YM^\>/T?.+'UP\>FQJL0=QGHBF4
M%]5:$%=ZMR6MM0B> K6U':7SJ1YN$'./J-HW6!=6;K-6[5$IHP8^ *K,+V$[
MU_($6W?4Q]>Q@*=S5"V@W*Q] U23-3K*5! N0^D(*22Q9:)]#,5WUA2/U]IE
M>O>(.#^8W'S@\U(*A!^XDQPI1\WMOHC>!25P'^+V2&5&N<$=Z1*)1NA N0/A
MZT]A/)"XH<.]<Y!Q/]CK0R/-6JIGL_E\]EMIWGR"'=KYQW6LS&/45+(A)7:_
M/7-NX"*I=-J+1(32GDAE*7&EQ9T-F0LA>$HV5=Y:#U-R]L.>.Y^Z&RE(YB6#
MTCO7E?V D8).D0!/')!GP7._##9B*2KH_]XCG@HB;]8XW*]3/*7ZX/Z'5"HY
M^ %UE8S&7KE*=-(('R*Q,>K2VBZ6ZF!.J'%H_0WC:?_QTME[J?;(POU2G%]G
M2W@(PR)%G@171)O2>D!Z3:SCG"AMO&,IR21Z>9E_"'$MS(\Z"1,_+ANOH8YF
M3<I3?5E.C80>^[B*D<]!%%<R.(>TKGGX(=]M39WER>"91HST938"5<1190DB
MP96X.OKJXU;/I[I" >;^XF4K[5RWV)BS5H88$W$#!91*L!)(X%0$:J/(J79%
MP(]H&M:,71AI#U1OUE-8LQ9O.QP'!=EY+"=8N7L?4<>R/4U9+?=I;Y$;Y"BF
M#,^.$^%!8?C</0EPE 3 'P@+)N>#YE0<XT@]0LO9,UGW/G>W=D5Y+[DAMFN.
M@TP1IZ%T&,L ,I7A?[4ORAXE9F"7J08.[HUEK2+XANLF2X'[>%UZX*?E/5FI
M$H7IB87@3WU:K:=O!]);R;KLK'>UM]X#@;[% X5+=)FUX0@*2RT)D3EB<A+2
M)"V ULZA'D5@C2<H/UQL)T?AO!3>!Q*D !1',"3DR(@"&D$C;ESUK@G'43BL
MQ>H/6P\]8^E);PW;M@_PJ;#\'KZ4Y]'33Z?DEO8_HE)FZ4G*:CW(W5OD!DF:
M>\%2>?>=O2H-]1RQ003B1.EIYH %6OOURF.TG)UKVOO<A] <N8DF6$JL*F/9
M9>:E=2 E6?(80/($^P\JJ[/;G.FI@HU[F:;*RFC9M#SUN*:OEW27?%$WU,LZ
MJ7/J*E:-MASQ$0UQ+GGB5>;<29L4K7WGWM_+NOT-L:Y56?]W)Y)04BAD"UEF
MB4@C)?'92F*]\49X#3E6;XEP"&'-OI4[!B,_LE'GJZ2!E^&;!X![(KO'E>+!
M6J\SR=:B;=<!,'B%2%":#B(/7E>_ACZ,LF$;$?2$M!Z4T@#4;CO.H';V>:$R
M*8&"(50"+6\@3!E3J0C%T"1KGJ*K#K"GZ!FV.4%/L*JF@ ; ]&X^GFU:1KZ'
M./&+1>>/W!T3^0(6<3[NFH*/A$L*A$F$*:4Q,-6>V Q P'D JU)4IO8DLV-I
M'';&2D^@ZU51#0#QN5]\+HD1_*-<D7_UDY(J>0\HNG%<0GKXY^O=-S(Q66=Y
M(CH*Y-6!)5:4GFXV:A>-BDY6MWIGT#OLB):^K.*E%-@ 6'$' G(0)ILH;<?^
M<V]R9,Z3&'/I3N. ! SD2?3. !X"&&+7SNP\3LVP4U=Z EHEX;<%H_*.%*XV
M;S>V1?:W/[^:3&:_E8KE5[/YB]DJ+/-JLOVMS18JKSBHD&7&44:1YI31BZ66
M))8#-PE=6UT[AJU)_[#C5_J'ZF45W "XG_LOXZ6?C/_9*?%M?K$A8\W-7L7]
MED>1;#:>=R,62A\(Y#&4-T(8[5L3P.687?6#_'@ZAQW8TML!WK/"&@#E7V:S
M]-MX,L&-^!HU-OTT+GNO>[R__=&&,6O JY "\8F5NSY5>O1&30!"--32P&WM
MB].#B1MV7$M/\.M'-6UC;O_KFTV5E/4F$LTDPTT5D4%PC# F(R@&6J?:726/
M)G+@(2Z7!V$%734 QC75ZUKT/?^BM-]/$ *AN+^(I$H0AY$84<9YITQ0.=0^
M>Q^G9N Y+GTE<>I(OP$</?3R^^9E^(8EEJT7$EFRL3QFX$:2X# :"YX'PY22
MR%=E0!U UL S7'I"5FU]- "Q]_ 5IBMXA2+<OM/]^WCY^?EJL9Q=P_S>+8Z7
MAHI<GN5P1203$;T"@]:8*:ZDTM[SVCG XR@<>,Q+;R%N;UIJ (/KUUKKT8 [
M+<*V&ZKTM"Z)]60I!C_:)N(9LN6%HUP$GB*K?6(^2=# DUAZ0E@]'30 J%_A
MMQTQS6=3_&N$'8;NW2=RG61RG&29$Y%!!?0OI2="6PU9,VY\[3CT6!H/@]WO
M[3ZC5TTU^Y+IZ9;572:S=DW=YE,O4%'W$/W]U]-EB6A+V1#E7,0C+^!IYR4G
M.KA0!CX%5[U)<8_U=/$SI-4$WN9RD?=J,OOMP^H+ J#L"S_9[6'73<"ZV1Q.
M:2VL5R0R'H@4I>A4:B ,(V9!=12\>KO^$TEMMN;N&!S=J[F[@-H:.%UOV=Q&
MU^6QZ>+-S'=MJ%^-IWX:4;:W]RZWK/J((1 SC&@7- ;@.9!204&2#")9 R'I
M_A!Z-+G-UNO506F_ZFL J4]?KNSMP@ Z>"4TL5I;(CV4?E0)?0S%*;, F<;Z
MO7T.IZ_9(K]SL-B;@EH WWCA/WV:EV&HW4W?)H;?8PJC*.H8;B$E+-I^'BRQ
MBB:2@[$I9M"&U>YV?!!AS9;WG06WZBII &</)8364R>FZ28YN<<BE5R;)"AA
MJ70\5C$2-.V,F*0PRK?:W6MX6Z. ^5@RFZW@.P>#?:NK 43>>AA/A/>E2O&S
MGWZ"Q>OI[N^,T?GX,MEMS\U\E! 3)\(@SU+X6"YM+(DFH='WGG-=.P%8EX-F
M"P3KN)$75W*S>9T?#+DZ.;-SV.=>9%!7C]F=(P<HN<1Y*(_5HBK'=.1H%%7"
M6 3C$)NX0SC7[D%QV7%=MSMLN^[NP*=GN^[RSI@[ZST-2A+&91ES%P)*Q0F2
M8H@Q>6T9[R_ /IS.W]6HKF.0]KB9[$F)39WW[R'./DW'_X3T.J$>QGD,&Q/2
M\8FD[7@YY21:+%;7D/;<'<FXY: L2<D8=,"[?)A@)*; 1( $N7Z[S+HL#)LX
M&@3>EU=] \A_0-*;A]>EU'S]<&R/PVPH2R 2D5IX='2D(8$;3R );[F-R;C:
M3_N.IW+89-,%\=NS AN Z.T.?36>CI?P9OP5[I5=WFS1Q3L_7]Z>53MBN15
MXI9FI2.AV6 TZE'R ;)">0OA5(2@0NW"V>I,#)O>&L1 #Z'^!O!_>^WV-K^9
M33]U K@-:UYMPIK;YM R.Z=M)BGCSI92"&*YB40H"KBY0V)0NXO2D20.FQ:[
M(';[5%VS.82=XJN3\P7W/Z/ZK-L>\P /31TUX*6+E!'%DD35EMHS Y'PZ!-U
M#,!6GY-8<>)M&1[V<;;TDWT![EQN*:-M5)E 9N7=(0-BHV-$6\V- XF;AOY
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MWNQ1V,=.7"3EI)(D3E?O$E' !_)FL";[F7+<A]9!Z CRSC-<.! XJ]-HL0.
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M0_^^6E]]#!]Q6U6W)S]:[FLRKOAM1T,0$&P)8#!F&XQA)9H!2'GBH^=)+$V
MAV/%UD&PO WV[TEDOR*&BV2TC:"E\J#(:X)0D RK<S%[+;1*K<NSGJ9DGI1-
M8ZPT%'8'D'FM&S!S@CXO DKVQ$32&9S)"-$QSY3"%)MOL6W1Y'L2@W.XGSJ%
M]/L&TWZ;*Q,^)8>@O*]#V)*KZXDD( ;TQIEH_:0IYO-KQQT%@='MN&/TT1O
M1C1T!DY<&A2@ R.CC'100Q0!HJ\C(XN-GN.4L/MQVG%' :91.^X8[746O/]Y
M6V?BF-*2.PNEL$PQ;>040"@ZS%HD+V2(^6$V<E#\_N>\0Q.G3]\<)L$.;-7[
M3Q10?,#UYWO,7 BE,65R!P.OW2%.^OI6@F"X#113*EEDZS[/I^CH)X@_4+T/
M-Q<=*^N#\?(5UW'5P'#\N5I^?,# [0O8W;RQFYS$A56<&Q$M6**D!AFNCD<P
M=>ZQ#%QSQL*0Q,^H+^W'[SX.,]-*NP/#<_\,&$%HMTR!R76$)F9&U[75=)-*
M*XLE,#0O/1UK9DYR)[4Q,X=*]AP>H&LZ]"X+VN3=^>F/;/[</(#R"5^9G4T,
MO48(DN&-GX.&0V 9F4O:H6X]2+'A*_.M:_Z=#!_FP'<>'4M,(3,:>+;$:6!D
M!J6(D&6A0T.^N>;-8_?7R>KOQ7H,(AZ%2(WUT,%U]/MB&99I4<TQ">BZRFJW
MK$%QBB4EJY-RZ^:@ZIYEBBEMEBFA+5*[UN49SY R<\S=6N6/M]4=+?\.8/1A
M'98;^N8Z+^(]KK\N$OEJ;\H3W&T^T$=NGO[1319#^(3*9@TIU+P_5P(\R0*"
MR#):GFPVK:NW6](_^]Z[XP'U>#/4/-KM -G?&X";G!>ZR(EZW/76JV0"..$8
M!,L8R5@+XYK/P'F"CGF1-A\J7KR6#U!1!S#[C_=_6WW%]7)[7C\B20DW3_+%
M;7;,"@DQV0!*Q "AMO4P'5T..1B36O>)#Z6MIYOZ$!2L3J"2+J"V[=VLQ_;M
MJE9WIW#Y_CKFQ=?%YEY>OW@6<V8<B(L(JI!KXV+F0(+4(FL9;/.>P&&4S=LL
M-0',FJNC Y"16:?0:Y%^6:V_K-;$WY-R\X$KC3E#9HE.3N:\SKK,8&(VBA?D
MMKDQ&T38O-U+S2'67AD=((Q",%Q\7+[,DRQ6!X\.F+=UF$%,$'0=AY12,(5S
MIDWKXJHA=,W;4]0<7\U5T0&\WN%FL5V.%2[WM8<_A_1WS(\8R[R6D*D ,0=/
MX15FB%BKRV2=H"&(6]?ZHAQ,W+S#>IH#;1JE=("V7U:?/^,ZO<Z7<J:@8M6Y
M9!J4"B2]6#3XF'TJP0ON6S]1#Z5MWA$[S;$VB4IF+H"Y&TWU#"^,0AET6=;I
M0C64$9$.4-W1ZWAF,CKKXI =M*]]SR"HV.ZATERD'5BB=Y@1/]>\]ML]!>^O
M5NGO>[!K7TP)%FR49$VYT.!D)EF1^EFRCJ?4.O/U,D6#H.2ZA]($XI\13)OU
MU<7;]2I?IZLWZUUN$+=9Z(@^:2<99!<**&MJOVA1$#@W+EO+BQJTCXV^X!YT
MZ$]WL'GNNWM*&[1[1VHBZ3Z0<I='QGU6..824IU]IQFKK8;*@!=TG%C./'JC
MC!>#7H*&P>4Q ?-D--OH]#% CA3PS+[+^^LO%%U>+98??_OG%UPO<)GP'06;
M><_=OBO,(?>()*106?(Z032Z0+9<<AT=>CZDF6[@U\V.D&.5NII6PAUX-'<K
MXQ^:W3N#_.=M!5K1@N[03"SQRIQ)GBYO)L!$9IQ4W*74NJ5J%($]I2;;ET-,
MIZL.@/B0I0?"_%S/WO]@_F6UH5AB0_:^\.2ST P8%XSB!U:S9=9 2-$GX0H/
MJO4&BK$TSOOF-R%<'D[2G5)W'6#SY8/]T^7EZA]URBO]^1<B;G'UYVJSN1!!
M2A>LAN2*H(M&)!(H<OICE-)X)T)H75UY")WS>OZGP^CD.AR/4[_#Z1(_5C_B
MPZG@>O\X_E3HE#S#?+(I*EYW1\I$D;HFOJ,, 3R3/ ;G U/-WQ^;4#ZO%] -
MI*?0<P<SS5^Y;%*Z_GQ]60_4W];$W7\LUQ@NJQC^1M[_SUA6:_+$_GF!-<'H
M71V+ZN@&"LJ"5]D"-\8Y%S7CNG5%>!/"YWT<[<:EF$#+'?@9AS)=C_$=TX47
MQ;CQ@*4^N82$%.$&#1D9Q:1:6%M:V^TFA,_['-L_M _7<C^NR?.R_5X*%S+[
MQ'T=&Y%%?9AV="EYFZ"@+2&7@!1(3PSBYVB;]REW/IPVT54S*WOJ?L*+!Q=%
MDX[""WZBGL*'U-]V%?Y_[046O_U[N*J__S9!*^;C#Y]8@*]P,V%[9G'<&U8R
M!(9U7HET$'B4(+EB$;4Q/G8\!'A,4C01JU)[!TRH3'>9(0-B> 'O+ ]!%:E4
M\S6%Y]B>.081A[1GCM%#!^[R<]U<QLB$QDH2DR0QL60AH,S@;+!>II**;YT9
M/MOVS%$J']B>.4;^'<"H::N6,LQX:SDXR<W-<']6)"3OHLQHG9"ML[X_?GOF
M*$!-V9XY1KL=('MX1;#EB;%D(GCE+/GQ=9JH#6;[1U>R-MA\P6K;,NWS:.0<
MA9^#R[O'*+,#E ZN)4[DY0A5ZE3:*$ E<G\\&@^)62/)!$2O6K>^-RWOGNP5
MK1N,3J+*WLO"D^76:B)>9UE Q4(N5!()8E3>^Y DW5JG*@N?[%5K=H@U5T4'
MEF]D+B_99+1/@*(6S-?R-2^2 2E92LDX9G7KZO+VQ5>SUA ?$^Q,IZL.@/AR
MJO<F 49_>D^'_A)O$V+A"A\7]]QF*T0P6@2GP7"50*%+X$KQ('RRS@B;(A]4
MSMXLA7\8'V=5Q#4&=J/2_2? P!F=@_]:7'U:+-\L\?]B6'_'_D4*(=KLMXL8
M%'&,I *9?>UM8B:BDMA\/M/Q5,^+\?F1=^!1: 2#,P+^MHZ(&/[P:;VZ_OCI
M]\77+>_?UWA>9.\XW:L!@N:QODVG7>:F!)E52CZ1LS?3&1C$P+R>S-D>A_;@
M.+>345F^X?X#+I]@WI:LA:N3O$2H3:^V@$M<@+7.9L>5P!.7-8QD8-X@]+Q/
M1E-PG-O)>)KCD+A-PM454X8",FX,1.LM(%/6V((ZBM8#&XZG>MX2S/,^ \?#
MX(R 7]W#U?75*YJX"$%AYBA!6.]K,XP )S0=>Q_IKWU0?K8X>1@'\Q9NGNV!
MF  >'1R.1DT)BJ>0=0B0E..@M&!0UQ] 2(:EF"P7)RX):MI\,EEU:'>'808X
M=-BC,D(->Z%S&U5&'8C9S.ABM!0PA1P@"J-"-"D6;'T CJ?ZK)H)Y\F5'J+?
M#LSZ02FQW\-B_9_A\AHO,O?$4W%0Z.X"E5.$(")"\@9SEG2@FR_S.8[BL\V(
M'H2O%OG/PY1]1M!^+KUUQS@ST49?$N1<-ZUK18R[VM8>19029<S-%^HT(_YL
M<YZG!'Q;")P;]I](8-TQKAU#G[<%%YF<1"4$Q!@4N"A-QF)0B%FQ_Q+Q9YO5
M/#GVFT'@W+#_F%NG2UUC39(VEKBUI8 /P4,NQ;F8T# Q]?R9<12?;=[RY"@_
M3MEG!.UG4U#W. _:*H<1DC!N%R:%$B+X'+6PZ&Q)<]8SO$S]V68F3^W%-P1!
M]_"_U[GLA2FUMX3<LSHS,FBZL63)8"0W+(<DE3QMZKV7+O.NH7N@ L]AE>WW
MTQ[>KC:+^NE-^JA?_NCF7=0C.)ERQ2TK&+AS0(8J@TJ10< L@ ?K&$<>4;<>
M6#E7#S6BM$:J.E+/UAZY1+X*\8S91!84ELA;W]-GV4,]!A$']5"/T$,'5^5S
M+9>:EV2$EF2X!9*8R-<-Q!KPG$E\*K(T;!;YOT0/]1B5#^RA'B/_#F#4M#TH
MN,Q"80DP6E^WN15P%'X!*E<RTB5O0NO(^L?OH1X%J"E[J,=HMP-D#UYT&8@K
M+E(A*V!)RC7]&[D/4*3@(N0Z=MPW1NUY[!Z=#SV'[BP=H\HN(#IH2:9.(F@F
M,I0<-%F 0E&3]A%<5-;60,KS]LMQ^]]9VA$\FZNQ W .6Z\9@_%1,P6"YSIH
M607P23&*XXOSQEMO2NM"X#/8==H---LKL0-D#EK,J8MPWG,%W').OCTQ%K7F
MH'-.609CLFX-S/YWI':#R^8J[ "6(]9X"J\Q2@2A<XT[@X,HB46O#3=2,DER
M;(S-,]FMV@U IU%F!R@=/.E%D"<=C4Q@L8[@CM("Q9H1>$ ZA<H*S*T32>>Q
MD[4;C$ZBRMZ']F2>C69TOK"^ZBN&&4*Q#)SP 9.).>D'Z?(SW.4Z.\2:JZ(#
MR_?:$E+G)6;C*3PSMB[X\D!_P<#Z')/422?7^AVFYQVPLT-P K5U ,)QK0X^
MV^*$*1!]+J P1S+<VH&@@R>T0LYTZ]3DCS8YZH@GGNETU0$0[[.T^8ZE/Y9/
MEP!L_L\U_655[U?\=;%)EZO-]1K_NJ['\$VY_5>W#[:AMI@IRX%+K4D@,=+U
M4 N02")U&+9"BXW!.SE3YS13:A0@7ZCCF1\='1R7EVW-+RN*%)?7J^MGJF?^
MQ,WFPZ>PY.+?Z5]^VCP2RX4/S+% *JK;9NF&K-O5;1!@5.!:8BE)MGXZG9BE
M?AJQ.@#PJ'J4TZ+I[ _77@QOUG^NEA]Q_5@<TJ8DL+;>Z[KL!J.KXJ!(F%3%
M9 Z.'-*N#M>K+/73]/6C':ZV:.K^<#TMA,=,"T11A$,H(0E0,FKPG#O@1=3.
M(<SMH^,FA/?3(79N!V4*9,PXX:%FM YA^+:7XE;D2?#LLQ<04RTR*=*3AVTR
M%,YB4@%5?KBEYLD,9!-BSFENPR'QR#Q:Z]YJC_40+T*R0EFD4\E# D6J@%BK
MHS@+R>6<23&M7QS;<C!/-#$3_":-%D9AX>"3\!77<=7%67CHT%V@MTH@14.>
M(X+*7$*PP4*]K#P70OC25ZC]D(-YC/Z/<!:.PD+WM\+3/%_HX!SYA B!U>FD
MY(. \UZ#]DQ:7V0Q_+31[]-TSN.IGP.J&^BUZ]%JKYW:>YNUZU_?2IS9$NHR
M;6"A;HH7+$/(*"!X%I@43F9QNB;@ YF8-SZ=YT'A]-KOWG2/=>(>".4BZFB-
MT'5_=W1D"VHIAD<.1>G@(UD$QOOR:5YAJ)_'@QG .JG[?PQR?L!HX*$X0DQH
M,3E@KI:3&+K '=<6"BN:6RD*LZU[;29EJ)^'@G,_2"V1T_U]-$@I%])XS"8I
M8+((4*0;B,49<*B8SQAU>KA <9;(XI C,</0N/Z.1'L4G.\HE[O1.1,.=7G\
M)2<:[_(*=Q,.>O$^&&YY+4LGX"H9&*$G!;"$*!]284GRQC9DID$OWB+&C 52
M+O6<:@DN%@_&BR)*(:"$T^;@.QWT,@81APQZ&:.'&2_JS?KJXNUZE:_3U9OU
MK@(;MP,AI!9DU,ECYR75#741P:N4 87@GKP,KMB@=;+T!?<P1'^ZP\]SW]W_
M2)=1RETUE'0?2+FKUL=][;U!1<ZGRN#1E[J<RH$+ 2%*C")8SGD9-$EK&%P>
M$S /9MKH]#% CA3PS-U5[Z^_?*F+.Y8??_OG%UPO<)GP777D]MSMFRH*!2PI
M*@B<)W+I)()CJ,&S(H65+DC]FJ\SXNMF1\BQ2EU-*^%N0/,.JVSH-P^8\4QE
MGTP [AV%OHY9$ANG@V7J/@$>;'PX0><5N#SS1?,D,Z8&2@NI=I!0>&Y^E3)!
M*F\S%"L"**\4.(=V6YK,D+G$S2!W9<P@AB,&TLW:K72(]])2_AW J&G?H;6&
M"8X<2+"U0-<G<)[554&6HPS<F=!ZM\&//Y!N%*"F'$@W1KL=('OX2 EM'<DQ
M&D N(JB2#$21'-A4$A..J>A;5VRTG0]R'B/I1N'GX/D@8Y39 4H'#Y4@1S6B
M4@FRE>3X\#K.S)9('FQ=$^Z%,\/2$'/-!SF/N73'8'025?8^'T1RZYQUM3[%
MTB\Y,W!*1> F21\9\T:D ;%(D_D@YS%?[A"(-5=%!Y9O7#$4)Y/.-1?5 >+T
M2TS@=1TQ0-SIY#P7JO6 ^O:C&28#Z-3!SG2ZZ@"(0W=X/*Y!9:@\6B:!;5=W
M\$B&7)%)-^BBCSE9Q^9:;758ZU(GHQ1& >C ;3[':7/F:_FXTIJZ.SK5)&F]
MSAXMIOEN6>E%"9(NK!3 L$RJ,'1E>2$,\)1X9%I:%]6 ^_UD!/=:R=@4?(.[
M]>9"P@]\/)Y;;7K!@\TL*P667"]0I#V(12%DCXD''X5P<Y^4YVCOM6KQ' ]-
M$WS\Z.?GB?6H%U)9K4/D(!PG_Y3<4O"9PA<6-9KD@RYAR*3).6COM<3Q;,_/
ML?CXT<_/G5",\DGF!$S8FV)07Y?)%\^-#(DI54P/AV;429E]M^X9G92#D-#G
M\2B[H2VO">4?KZ]AU<H7R8EYGF.LV@H0G680I8R695:"X(>?BF9TGL?6W<D/
MPSQZ[R#Q=%@;<DDFU[&^]/\=**<L!!,=8(Y&Z209$ZW'?$[67C[[6MXVV#Z9
M/G_(MO*@'"H,$4P4"52.&1R6 $*FG)1F<6#!;/=MY9W,A9HFN7H*[??IMK1/
MM3WJ&8XFJ/I>'$1=Q5NT!I?H6BL^>*MD#CX?/P%M.OI[3<F>!+)SI&J/P<\/
M?,:>R\P]%%?A&B4S"F2-GY3R D)Q$1A+QBAGM!6EAYCZ=59ZS>O^2"=O"E3]
MZ(?PB?3>0W$9HYEQ=9Z3JML[F:U^>(H@=#&<FVRD9ST<PM=9Z34Y_,,=PL:H
M^M$/X7,RLBE;P>J42J>PMDHQ<)J<!YF"TC%*ZU07)^^8XS9#AOF'.VXM\'/6
M9^R_GDM(/IK884N)+$E 1$\J)"?<%R= 1[(Y!9T2/$]^HH92VVM2^KS.SR38
M.-.4]:-+N"CEF.&DAT27,-_N,=3$O"E1A^!B$*T3?J<:8S1#0ON4YV(N%)S#
M&*-]S\>?J[!L,[/HR4]L/J#H=;HGG$8D@B@\Q@0I,EX'T'#P7A5PTB3)9=&Y
MM%ZXV' :4>U4_TY\;Y;O2-"_;4@GN$_*[XKOK<K&LOHRZ0LQ*@P#3_$&_3&Y
M%(PT/ QB])6I(,.HZ6\&T1@<W)\2,H'T9QXL\RQ'O^(FK1=?JI9JC]&;\G:]
M^H+KJV_;)N$DBB.)(3 7R8:&(.I0.@?>$=_6HA123(FO%ZF;;^#(%/@8 K]V
MRNH5CG^%S[AGJK)XT]R6E4Q,25Z?STF2-M#]'I0"HX30*CNG4Y@2AT^3U2$
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M5K'@.5A>^_(*\V3Q=0!'=M@[E229_?_-S#;!Q_&9V3'*ZA6.SV1Z9.&%N8#
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M2NB@Y.=9CHB1)'(B%\J@CW4"E(7(;0"K670^%H<F#4%3B\Z #@M^#M3XT&Z
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M/7<W=I-+A\K+ JQ4!TR[1,&!0V"A9.Z4MHA#NBD&?MWL"#E6J:MI)=R!<W.
M/;[+YA>F;-&E9L5P6S 9(6I%4LV<ZQ T9]AZ!.4Q],[K*,V2%SJ9>CN \D,.
M_UC29]/?D WX=?%UD7&9+X*Q(M:J)TQ8:XA1092Y/D>%4IQW0I7IAOP\2];9
M)2P/Q,BSV:8V"NL2@_L_UUMCN<$+XUBTGALZPS+>;#]F 4&8.GY69+2A3([
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MK:#P'-0:Z:53J&UN3^Q^=DB6RK'B@.M8M^0F"P%3!%%T%9F/@;6>CS"$KD[
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M#<U=H/U(ZR20<W[P/%77T%"3'0#T-2X^D=#J'[_^]\WD*]U(]QW.>XQ9G;A
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MD\^XS&_*'G+T(EA3M(18IQ"I@&3 VN! ,VVXKGPW?^<ZA+YQ'=AS 7(PC76
MQI<*M%U0R)!$)KE&DEMTX$4V4"*+P7*?,3:?;GP1G16&<CE:*J1O?&VG8)G
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M^1'[@>=[ L9!4!N=?@^0$P7<@1NP/JEO3^<-7]5PW;ZLJT";2)!1Z6T!):0
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M\B4=:M(= D:?0)K(E%)%&]4Z1V>X!DY=Q"F.OP//I\D.X'JV&ADE4&JE:U?
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M4);G\66^4G ^>;H/<K'$E\Z*I(>T!75)T0OIZ/];)[KN2=NXU4K=8'00578
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MPJ&WSNZEQDV:&_;F:2#<?K B?ZK,_#G[NCTFM^SXV@DH>0^&>[+@3"%1.9,
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MSYRN91;X,5\Q982/3("3@H,BVY*\DNPA6&V3$)IVX; C)9ZCKJ?^\$>"X5F
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M2/IB\OG+]4M)J,]\V/^YH_ Q[9O/_ XO)U";JZ82N96G!QBJSW$]6]S,\ZM
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M)=TA6K8YC"RBCU&"937\E<FI<X9Y GYTR+V5[6^DW92,>\*<KN$7('.$N#L
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M5 >'XW_FZE3F].HK[>N/^>'PQS<WRT5]$R:>UULL&"--R &8+IXL#R\!2U#
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MTJ2@K5-,MWYAWTG(>";D4#I_/.WE9/%W<)]^EQ^YEM$5JBQ=3 J$JM.DK1&
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M7=GW*TJ40&)]",[M?9LD6E%*!3*&K'60IH0QF!CWM7DY<FW@,8%>9W^DMHW
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M!I$<[?]4',?6(Q:VW^ZBP#BQI7]B"QV@]IGK3?<W?I@?XLIO8SPOC# V:F1
MT2,E-]YYB)68SK PSQ2F),8,^-WQB2X*CZ\#DI;*/B%"[O?.?RC_IF"!_@Z7
MOV*H;=]70]GZ^J\_^OHZ-.N(\1T3"3(5;;>]EJ9F\BKI$W+C(/!8&]\F<G'<
M$GJ]0)U02^-.Y77"Q_09\\TEOB_GM67,W1^+C!M7_N;NU_"_87E&NY;VZ7+U
MYN[AZP\QRCHJL<Z;%.NP@H"T>[5.$&JGAMK]ES&,*<;6<Z@;B-W7&7T0MGX*
M\5[9F-T5:C<,0Z=M21JRKQ?KSE3:3I#@#(\\1RMR&A7W37<),!VJ7AL +Q?^
M][%&=WC:5 P4BRD9%L&YQ.K%&.U)IADD)I/WFL(A-8K&\G<I_.]ETS&%_WT4
MW$&*^5P=6MDLO2H>*':M#4=J$RYN(J H3DGD(:;6Q;?3*?SO9>.1A?]]%-X!
M;IZO00>72F+.0:%S'E0B]^L4_68C9<PE..M4ZZX'IU3X/P8[;93> 7IVUYY9
M3DQ9;Z"P*&DK)/+)Y(W!&)>1HT?6?!#WJ17^CT%1.^5W@*3=Q-3H<JZ]KL&&
MH.Y91CXE!SQSEUG60:E1-(>_!U-\KI"ZO:UZ -X/=#:?K5;!<E"\Z-I2*T.T
MA0/S@MLH%!-NH@?1_;/#]S+L3G;X/EKN@@C\/*=94:P7O1+UP*[\1R\A&LR0
MHDTB!H8!Q_0C.R%V^%[&VX,=OH\FNP#%T]QFE"H*3R%;K'/@5? ,@J%=$C*=
MN-F(%.7XYP+=L\./ \/Q&CP-=GCA6@EK F0E**KW%FEM,8%U-C%38D"K1V#B
M]-CAA\)C KWV$VH\1&1OK\M R]S<6&WO,EET6H<$L1A9,X)(*B,W&(M#BN@I
M4-.M^79CY)H957-'O*TM-[??6N+5XN9J=1Z6UYA_PZ^TT3;ZK'R?VA:OWOS\
ML: #>Z/8\S_3Y4WMD/?+:D618:7__$DZ%2Y*4RBK3 648XD2664A,F0A)I9<
M=&,<6QMQNHB2&F)DF-=@!V/T%I=Q:$N=VFN1VA4=N3& V3FH;\W <RD@.336
MQZPXMJX63(765^/:-$/K:QFN"W321GQ[?8OW+1KNR4,7WD9.>TE#3'Y]$V7
M*3IVHM4L&F=+$JTY?D^(T444.!VZCE5\!]'@ SN111MCLB1H2HDB9>DA.!>
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M_O,?_P=02P$"% ,4    " #4-*-6Z!G9RO$W  !8:0$ $@
M@ $     83 S,S$R,#(S97@Q,#$N:'1M4$L! A0#%     @ U#2C5KS+TH_T
M.0  HZ ! !(              ( !(3@  &$P,S,Q,C R,V5X,3 R+FAT;5!+
M 0(4 Q0    ( -0THU;,-:&W^C\  )'< 0 2              "  45R  !A
M,#,S,3(P,C-E>#$P,RYH=&U02P$"% ,4    " #4-*-6K1M-34XZ  #.I $
M$@              @ %OL@  83 S,S$R,#(S97@Q,#0N:'1M4$L! A0#%
M  @ U#2C5FD2ZS*V'0  Q*P! !(              ( ![>P  &$P,S,Q,C R
M,V5X,3 U+FAT;5!+ 0(4 Q0    ( -0THU;->\M5*!X  $#< 0 2
M      "  =,* 0!A,#,S,3(P,C-E>#$P-BYH=&U02P$"% ,4    " #4-*-6
M8.<!]7L=  "QF $ $@              @ $K*0$ 83 S,S$R,#(S97@Q,#<N
M:'1M4$L! A0#%     @ U#2C5OA>I.Y; P  /@H  !(              ( !
MUD8! &$P,S,Q,C R,V5X,34Q+FAT;5!+ 0(4 Q0    ( -0THU;AI>DV#@@
M *,E   2              "  6%* 0!A,#,S,3(P,C-E>#,Q,2YH=&U02P$"
M% ,4    " #4-*-6N]*"'18(  #!)0  $@              @ &?4@$ 83 S
M,S$R,#(S97@S,3(N:'1M4$L! A0#%     @ U#2C5ALKX3S8!   \1(  !(
M             ( !Y5H! &$P,S,Q,C R,V5X,S(Q+FAT;5!+ 0(4 Q0    (
M -0THU9$@H YWP0  %83   2              "  >U? 0!A,#,S,3(P,C-E
M>#,R,BYH=&U02P$"% ,4    " #4-*-6+*9EF?H*! "?#38 $
M    @ '\9 $ 8W9S+3(P,C,P,S,Q+FAT;5!+ 0(4 Q0    ( -0THU;&],2D
M>1T  #)8 0 0              "  21P!0!C=G,M,C R,S S,S$N>'-D4$L!
M A0#%     @ U#2C5G@42]2W-@  0U0" !0              ( !RXT% &-V
M<RTR,#(S,#,S,5]C86PN>&UL4$L! A0#%     @ U#2C5E]186< N   -TT(
M !0              ( !M,0% &-V<RTR,#(S,#,S,5]D968N>&UL4$L! A0#
M%     @ U#2C5D?_\BG$#@  ?@\  !,              ( !YGP& &-V<RTR
M,#(S,#,S,5]G,2YJ<&=02P$"% ,4    " #4-*-6J6BKXMU[ 0"SJ \ %
M            @ ';BP8 8W9S+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4
M" #4-*-6FR0SVK/W  #H7PL %               @ 'J!P@ 8W9S+3(P,C,P
A,S,Q7W!R92YX;6Q02P4&     !, $P#%!   S_\(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
